<?xml version="1.0" encoding="UTF-8"?><!-- generator="podbean/5.5" -->
<rss version="2.0"
     xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:wfw="http://wellformedweb.org/CommentAPI/"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:atom="http://www.w3.org/2005/Atom"
     xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
     xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0"
     xmlns:spotify="http://www.spotify.com/ns/rss"
     xmlns:podcast="https://podcastindex.org/namespace/1.0"
    xmlns:media="http://search.yahoo.com/mrss/">

<channel>
    <title>Mayo Clinic Talks</title>
    <atom:link href="https://feed.podbean.com/mayoclinictalks/feed.xml" rel="self" type="application/rss+xml"/>
    <link>https://mayoclinictalks.podbean.com</link>
    <description>Timely consultations relevant for family medicine, primary care, and general internal medicine topics for physicians, nurse practitioners, physician assistants, and residents. Offering CME credit for most episodes at https://ce.mayo.edu/podcast. Produced by @MayoMedEd.</description>
    <pubDate>Tue, 12 May 2026 05:00:00 -0500</pubDate>
    <generator>https://podbean.com/?v=5.5</generator>
    <language>en</language>
        <copyright>© 2021 Mayo Foundation for Medical Education and Research</copyright>
    <category>Education</category>
    <ttl>1440</ttl>
    <itunes:type>episodic</itunes:type>
          <itunes:summary>Timely consultations relevant for family medicine, primary care, and general internal medicine topics for physicians, nurse practitioners, physician assistants, and residents. Offering CME credit for most episodes at https://ce.mayo.edu/podcast. Produced by @MayoMedEd.</itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
<itunes:category text="Education" />
	<itunes:category text="Health &amp; Fitness">
		<itunes:category text="Medicine" />
	</itunes:category>
<itunes:category text="Science" />
    <itunes:owner>
        <itunes:name>Mayo Clinic</itunes:name>
            </itunes:owner>
    	<itunes:block>No</itunes:block>
	<itunes:explicit>false</itunes:explicit>
	<itunes:new-feed-url>https://feed.podbean.com/mayoclinictalks/feed.xml</itunes:new-feed-url>
    <itunes:image href="https://pbcdn1.podbean.com/imglogo/image-logo/5789954/Screenshot_2024-09-19_at_22039_PM_6rkirz.png" />
    <image>
        <url>https://pbcdn1.podbean.com/imglogo/image-logo/5789954/Screenshot_2024-09-19_at_22039_PM_6rkirz.png</url>
        <title>Mayo Clinic Talks</title>
        <link>https://mayoclinictalks.podbean.com</link>
        <width>144</width>
        <height>144</height>
    </image>
    <item>
        <title>Update on Celiac Disease</title>
        <itunes:title>Update on Celiac Disease</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/update-on-celiac-disease/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/update-on-celiac-disease/#comments</comments>        <pubDate>Tue, 12 May 2026 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/e2e8f32f-54c0-3b26-b26b-86863ec37c6a</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.  </p>
<p>Guest: Joseph Murray, M.D. </p>
<p>Celiac Disease affects approximately 1% of the population worldwide and can present at any age, frequently with very subtle, atypical or at times entirely non-GI symptoms. The presentation can be extremely diverse and may involve a variety of organ systems. If not recognized and effectively treated, multiple potentially serious complications can develop. Primary care clinicians are often the initial point of contact, and we need to know the common presenting symptoms, which tests should be ordered when we suspect the disease and when a referral is necessary. We also play a role in long-term management by monitoring for nutritional deficiencies, bone integrity, and the patient’s adherence to a gluten-free diet. In this podcast, we’ll explore Celiac Disease with my guest, Dr. Joseph Murray, a gastroenterologist from the Mayo Clinic, and a nationally recognized specialist in Celiac Disease. We’ll focus on practical information you can apply to your practice. </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.  </p>
<p>Guest: Joseph Murray, M.D. </p>
<p>Celiac Disease affects approximately 1% of the population worldwide and can present at any age, frequently with very subtle, atypical or at times entirely non-GI symptoms. The presentation can be extremely diverse and may involve a variety of organ systems. If not recognized and effectively treated, multiple potentially serious complications can develop. Primary care clinicians are often the initial point of contact, and we need to know the common presenting symptoms, which tests should be ordered when we suspect the disease and when a referral is necessary. We also play a role in long-term management by monitoring for nutritional deficiencies, bone integrity, and the patient’s adherence to a gluten-free diet. In this podcast, we’ll explore Celiac Disease with my guest, Dr. Joseph Murray, a gastroenterologist from the Mayo Clinic, and a nationally recognized specialist in Celiac Disease. We’ll focus on practical information you can apply to your practice. </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7xc2nr6kbghcq4rp/WF9118850_Celiac_Disease_Updates9kbj3.mp3" length="43856997" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.  
Guest: Joseph Murray, M.D. 
Celiac Disease affects approximately 1% of the population worldwide and can present at any age, frequently with very subtle, atypical or at times entirely non-GI symptoms. The presentation can be extremely diverse and may involve a variety of organ systems. If not recognized and effectively treated, multiple potentially serious complications can develop. Primary care clinicians are often the initial point of contact, and we need to know the common presenting symptoms, which tests should be ordered when we suspect the disease and when a referral is necessary. We also play a role in long-term management by monitoring for nutritional deficiencies, bone integrity, and the patient’s adherence to a gluten-free diet. In this podcast, we’ll explore Celiac Disease with my guest, Dr. Joseph Murray, a gastroenterologist from the Mayo Clinic, and a nationally recognized specialist in Celiac Disease. We’ll focus on practical information you can apply to your practice. 
Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1824</itunes:duration>
                <itunes:episode>664</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Lupus Today: Advances in Diagnosis and Treatment</title>
        <itunes:title>Lupus Today: Advances in Diagnosis and Treatment</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/lupus-today-advances-in-diagnosis-and-treatment/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/lupus-today-advances-in-diagnosis-and-treatment/#comments</comments>        <pubDate>Tue, 05 May 2026 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/273cc66b-f7f1-39dc-9402-672d009731c7</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Uma Thanarajasingham, M.D., Ph.D. </p>
<p>Systemic lupus is a chronic autoimmune disease with a variety of immunologic and laboratory abnormalities. It has numerous clinical manifestations potentially involving multiple organs. It’s known as the great imitator because it can mimic a variety of other diseases, and it’s not uncommon for patients to have symptoms for a number of years prior to a diagnosis being established. What symptoms should alert us to the possibility of lupus? What do we do with a low titer, positive ANA? How is a firm diagnosis established and what role does the primary care clinician play in the management of those with lupus? I’ll be asking these questions and more of my guest, Dr. Uma Thanarajasingam from the Division of Rheumatology at the Mayo Clinic as we discuss “Lupus Today: Advances in Diagnosis and Treatment”. </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Uma Thanarajasingham, M.D., Ph.D. </p>
<p>Systemic lupus is a chronic autoimmune disease with a variety of immunologic and laboratory abnormalities. It has numerous clinical manifestations potentially involving multiple organs. It’s known as the great imitator because it can mimic a variety of other diseases, and it’s not uncommon for patients to have symptoms for a number of years prior to a diagnosis being established. What symptoms should alert us to the possibility of lupus? What do we do with a low titer, positive ANA? How is a firm diagnosis established and what role does the primary care clinician play in the management of those with lupus? I’ll be asking these questions and more of my guest, Dr. Uma Thanarajasingam from the Division of Rheumatology at the Mayo Clinic as we discuss “Lupus Today: Advances in Diagnosis and Treatment”. </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rt4gubmqqnkwkz4d/WF9233625_Lupus.mp3" length="44027461" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. 
Guest: Uma Thanarajasingham, M.D., Ph.D. 
Systemic lupus is a chronic autoimmune disease with a variety of immunologic and laboratory abnormalities. It has numerous clinical manifestations potentially involving multiple organs. It’s known as the great imitator because it can mimic a variety of other diseases, and it’s not uncommon for patients to have symptoms for a number of years prior to a diagnosis being established. What symptoms should alert us to the possibility of lupus? What do we do with a low titer, positive ANA? How is a firm diagnosis established and what role does the primary care clinician play in the management of those with lupus? I’ll be asking these questions and more of my guest, Dr. Uma Thanarajasingam from the Division of Rheumatology at the Mayo Clinic as we discuss “Lupus Today: Advances in Diagnosis and Treatment”. 
Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1830</itunes:duration>
                <itunes:episode>663</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pediatric Transplant: Kidney</title>
        <itunes:title>Pediatric Transplant: Kidney</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/pediatric-transplant-kidney/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/pediatric-transplant-kidney/#comments</comments>        <pubDate>Tue, 28 Apr 2026 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/b0cf0dfb-e8af-376e-bf90-0c121caf7fb9</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Carl H. Cramer, III, M.D. </p>
<p>Kidney transplantation has significantly improved the outlook for children with end-stage renal failure. The journey these children follow to transplantation starts in primary care with the recognition of chronic kidney disease, timely referral to nephrology, and long-term coordination of care with the transplant team. What are the most common health conditions which result in chronic kidney disease in children? What are some of the challenges faced in pediatric kidney transplantation and what do primary care clinicians need to know in caring for these children following kidney transplant? These are some of the questions I’ll be asking my guest Dr. Carl Cramer, a pediatric nephrologist and specialist in pediatric renal transplantation at the Mayo Clinic as we discuss “Pediatric Kidney Transplant”. </p>
<p><a href='https://ce.mayo.edu/node/172536'>Mayo Clinic Talks:</a><a href='https://ce.mayo.edu/node/172536'> </a><a href='https://ce.mayo.edu/node/172536'>Transplantation Series</a> </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Carl H. Cramer, III, M.D. </p>
<p>Kidney transplantation has significantly improved the outlook for children with end-stage renal failure. The journey these children follow to transplantation starts in primary care with the recognition of chronic kidney disease, timely referral to nephrology, and long-term coordination of care with the transplant team. What are the most common health conditions which result in chronic kidney disease in children? What are some of the challenges faced in pediatric kidney transplantation and what do primary care clinicians need to know in caring for these children following kidney transplant? These are some of the questions I’ll be asking my guest Dr. Carl Cramer, a pediatric nephrologist and specialist in pediatric renal transplantation at the Mayo Clinic as we discuss “Pediatric Kidney Transplant”. </p>
<p><a href='https://ce.mayo.edu/node/172536'>Mayo Clinic Talks:</a><a href='https://ce.mayo.edu/node/172536'> </a><a href='https://ce.mayo.edu/node/172536'>Transplantation Series</a> </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bwuzirq4bj4vmfh4/WF9257965_Pediatric_Kidney_Transplantalwpz.mp3" length="42828011" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. 
Guest: Carl H. Cramer, III, M.D. 
Kidney transplantation has significantly improved the outlook for children with end-stage renal failure. The journey these children follow to transplantation starts in primary care with the recognition of chronic kidney disease, timely referral to nephrology, and long-term coordination of care with the transplant team. What are the most common health conditions which result in chronic kidney disease in children? What are some of the challenges faced in pediatric kidney transplantation and what do primary care clinicians need to know in caring for these children following kidney transplant? These are some of the questions I’ll be asking my guest Dr. Carl Cramer, a pediatric nephrologist and specialist in pediatric renal transplantation at the Mayo Clinic as we discuss “Pediatric Kidney Transplant”. 
Mayo Clinic Talks: Transplantation Series 
Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1779</itunes:duration>
                <itunes:episode>662</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pediatric Transplant: Heart</title>
        <itunes:title>Pediatric Transplant: Heart</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/pediatric-transplant-heart/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/pediatric-transplant-heart/#comments</comments>        <pubDate>Thu, 23 Apr 2026 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/d86fd8ef-98e7-3a01-baf4-64c98f7e06ba</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Rebecca Ameduri, M.D. </p>
<p>Most primary care clinicians see very few children with advanced heart failure or complicated congenital heart disease. However, when they are a part of our practice, they require timely referral and coordination with other medical specialties, as well as ongoing longitudinal and supportive care not only for the patient but also for their family. A heart transplant is a lifesaving and life-changing procedure for these patients. As the survival of these children improves, more transplant recipients are living into adulthood. For primary care clinicians, what are some early “red flag” symptoms that should raise our suspicion for cardiac failure? What tests should we order and when is the best time for a child to be referred for consideration for a heart transplant? The topic for this podcast is “Pediatric Heart Transplant” and we’ll tackle these issues and more. My guest is Dr. Rebecca Ameduri, a pediatric cardiologist with special expertise in pediatric heart transplantation. </p>
<ul>
<li><a href='https://ce.mayo.edu/content/mayo-clinic-talks-transplantation-series'>Mayo Clinic Talks: Transplantation Series </a></li>
</ul>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Rebecca Ameduri, M.D. </p>
<p>Most primary care clinicians see very few children with advanced heart failure or complicated congenital heart disease. However, when they are a part of our practice, they require timely referral and coordination with other medical specialties, as well as ongoing longitudinal and supportive care not only for the patient but also for their family. A heart transplant is a lifesaving and life-changing procedure for these patients. As the survival of these children improves, more transplant recipients are living into adulthood. For primary care clinicians, what are some early “red flag” symptoms that should raise our suspicion for cardiac failure? What tests should we order and when is the best time for a child to be referred for consideration for a heart transplant? The topic for this podcast is “Pediatric Heart Transplant” and we’ll tackle these issues and more. My guest is Dr. Rebecca Ameduri, a pediatric cardiologist with special expertise in pediatric heart transplantation. </p>
<ul>
<li><a href='https://ce.mayo.edu/content/mayo-clinic-talks-transplantation-series'>Mayo Clinic Talks: Transplantation Series </a></li>
</ul>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kwkqbn8e865pth2e/WF8764488_Pediatric_Heart_Transplant97k0y.mp3" length="38162787" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. 
Guest: Rebecca Ameduri, M.D. 
Most primary care clinicians see very few children with advanced heart failure or complicated congenital heart disease. However, when they are a part of our practice, they require timely referral and coordination with other medical specialties, as well as ongoing longitudinal and supportive care not only for the patient but also for their family. A heart transplant is a lifesaving and life-changing procedure for these patients. As the survival of these children improves, more transplant recipients are living into adulthood. For primary care clinicians, what are some early “red flag” symptoms that should raise our suspicion for cardiac failure? What tests should we order and when is the best time for a child to be referred for consideration for a heart transplant? The topic for this podcast is “Pediatric Heart Transplant” and we’ll tackle these issues and more. My guest is Dr. Rebecca Ameduri, a pediatric cardiologist with special expertise in pediatric heart transplantation. 

Mayo Clinic Talks: Transplantation Series 

Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1585</itunes:duration>
                <itunes:episode>661</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Deep Brain Stimulation for Parkinson’s Disease</title>
        <itunes:title>Deep Brain Stimulation for Parkinson’s Disease</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/deep-brain-stimulation-for-parkinson-s-disease/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/deep-brain-stimulation-for-parkinson-s-disease/#comments</comments>        <pubDate>Tue, 21 Apr 2026 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/6ace5731-b835-3156-bf95-8ddf96f071ce</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Lauren Jackson, M.D. </p>
<p>Deep brain stimulation is an established management option for Parkinson’s Disease. It’s a neurosurgical procedure in which thin electrodes are implanted into various areas of the brain and then connected to a pulse generator that produces electrical stimulation which modulates abnormal brain activity. The procedure has the potential to improve the quality of life in those with Parkinson’s by reducing motor symptoms including tremor, rigidity and bradykinesia. It also enables a reduction in doses of dopaminergic medications. Who’s a candidate for this procedure? Is there an optimal time in the course of the disease to perform it? What can patients expect in terms of symptom improvement? How long do patients see benefits? These are some of the questions I’ll be asking my guest, Dr. Lauren Jackson, a neurologist from the Department of Neurology at the Mayo Clinic. The topic for this podcast is “Deep Brain Stimulation for Parkinson’s Disease”. </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Lauren Jackson, M.D. </p>
<p>Deep brain stimulation is an established management option for Parkinson’s Disease. It’s a neurosurgical procedure in which thin electrodes are implanted into various areas of the brain and then connected to a pulse generator that produces electrical stimulation which modulates abnormal brain activity. The procedure has the potential to improve the quality of life in those with Parkinson’s by reducing motor symptoms including tremor, rigidity and bradykinesia. It also enables a reduction in doses of dopaminergic medications. Who’s a candidate for this procedure? Is there an optimal time in the course of the disease to perform it? What can patients expect in terms of symptom improvement? How long do patients see benefits? These are some of the questions I’ll be asking my guest, Dr. Lauren Jackson, a neurologist from the Department of Neurology at the Mayo Clinic. The topic for this podcast is “Deep Brain Stimulation for Parkinson’s Disease”. </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/v2nym8wh7h39fjua/WF8488357_Parkinson_Disease_and_Brain_Stimulation9wgzo.mp3" length="41533194" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. 
Guest: Lauren Jackson, M.D. 
Deep brain stimulation is an established management option for Parkinson’s Disease. It’s a neurosurgical procedure in which thin electrodes are implanted into various areas of the brain and then connected to a pulse generator that produces electrical stimulation which modulates abnormal brain activity. The procedure has the potential to improve the quality of life in those with Parkinson’s by reducing motor symptoms including tremor, rigidity and bradykinesia. It also enables a reduction in doses of dopaminergic medications. Who’s a candidate for this procedure? Is there an optimal time in the course of the disease to perform it? What can patients expect in terms of symptom improvement? How long do patients see benefits? These are some of the questions I’ll be asking my guest, Dr. Lauren Jackson, a neurologist from the Department of Neurology at the Mayo Clinic. The topic for this podcast is “Deep Brain Stimulation for Parkinson’s Disease”. 
Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1723</itunes:duration>
                <itunes:episode>660</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Advancements in the Diagnosis and Treatment of Parkinson’s Disease</title>
        <itunes:title>Advancements in the Diagnosis and Treatment of Parkinson’s Disease</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/advancements-in-the-diagnosis-and-treatment-of-parkinson-s-disease/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/advancements-in-the-diagnosis-and-treatment-of-parkinson-s-disease/#comments</comments>        <pubDate>Thu, 16 Apr 2026 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/f4beb9a6-bde3-3980-a96e-610483e71b3b</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Forrest Sturgill, M.D. </p>
<p>Parkinson’s Disease is a relatively common neurodegenerative disorder characterized by motor symptoms such as bradykinesia, rigidity and resting tremor, as well as non-motor symptoms such as autonomic dysfunction, mood disorders and cognitive changes. The diagnosis is established with a medical history and physical exam. Parkinson’s is truly a disorder where the neurologist needs to work with the primary care clinician to provide optimal care of the patient. What are the typical presenting symptoms of Parkinson’s? Is an urgent referral to a neurologist necessary? When should pharmacologic treatment be started? The topic for this podcast is “Advancements in the Diagnosis and Treatment of Parkinson’s Disease” and these are some of the questions I’ll be asking my guest, Dr. Forrest Sturgill, a neurologist in the Department of Neurology at the Mayo Clinic.   </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Forrest Sturgill, M.D. </p>
<p>Parkinson’s Disease is a relatively common neurodegenerative disorder characterized by motor symptoms such as bradykinesia, rigidity and resting tremor, as well as non-motor symptoms such as autonomic dysfunction, mood disorders and cognitive changes. The diagnosis is established with a medical history and physical exam. Parkinson’s is truly a disorder where the neurologist needs to work with the primary care clinician to provide optimal care of the patient. What are the typical presenting symptoms of Parkinson’s? Is an urgent referral to a neurologist necessary? When should pharmacologic treatment be started? The topic for this podcast is “Advancements in the Diagnosis and Treatment of Parkinson’s Disease” and these are some of the questions I’ll be asking my guest, Dr. Forrest Sturgill, a neurologist in the Department of Neurology at the Mayo Clinic.   </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ettuihd2gc54fsiw/WF8798104_Diagnostics_and_Treatment_of_Parkinson_Diseaseb48eq.mp3" length="39725400" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. 
Guest: Forrest Sturgill, M.D. 
Parkinson’s Disease is a relatively common neurodegenerative disorder characterized by motor symptoms such as bradykinesia, rigidity and resting tremor, as well as non-motor symptoms such as autonomic dysfunction, mood disorders and cognitive changes. The diagnosis is established with a medical history and physical exam. Parkinson’s is truly a disorder where the neurologist needs to work with the primary care clinician to provide optimal care of the patient. What are the typical presenting symptoms of Parkinson’s? Is an urgent referral to a neurologist necessary? When should pharmacologic treatment be started? The topic for this podcast is “Advancements in the Diagnosis and Treatment of Parkinson’s Disease” and these are some of the questions I’ll be asking my guest, Dr. Forrest Sturgill, a neurologist in the Department of Neurology at the Mayo Clinic.   
Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1651</itunes:duration>
                <itunes:episode>659</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Parkinson’s Disease in Children and Young Adults</title>
        <itunes:title>Parkinson’s Disease in Children and Young Adults</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/parkinson-s-disease-in-children-and-young-adults/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/parkinson-s-disease-in-children-and-young-adults/#comments</comments>        <pubDate>Tue, 14 Apr 2026 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/603f0ed9-ba80-3c72-904e-c538f339ad4b</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Rodolfo Savica, M.D., Ph.D. </p>
<p>We commonly see Parkinson’s Disease in our older patients, but have you ever seen it present in a child or young adult? It can happen. Whereas Parkinson’s Disease in an older patient is likely to be idiopathic, we need to consider genetic conditions as well as secondary causes when it occurs in younger individuals. It’s important for primary care clinicians to recognize young patients with symptoms of Parkinson’s in order to rule out other potentially treatable conditions. Does Parkinson’s present any differently in children or young adults? How fast does it typically progress? Is the management of a child or young adult different? These are some of the questions I’ll be asking my guest, Dr. Rodolfo Savica a neurologist from the Department of Neurology at the Mayo Clinic as we discuss “Parkinson’s Disease in Children and Young Adults”. </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Rodolfo Savica, M.D., Ph.D. </p>
<p>We commonly see Parkinson’s Disease in our older patients, but have you ever seen it present in a child or young adult? It can happen. Whereas Parkinson’s Disease in an older patient is likely to be idiopathic, we need to consider genetic conditions as well as secondary causes when it occurs in younger individuals. It’s important for primary care clinicians to recognize young patients with symptoms of Parkinson’s in order to rule out other potentially treatable conditions. Does Parkinson’s present any differently in children or young adults? How fast does it typically progress? Is the management of a child or young adult different? These are some of the questions I’ll be asking my guest, Dr. Rodolfo Savica a neurologist from the Department of Neurology at the Mayo Clinic as we discuss “Parkinson’s Disease in Children and Young Adults”. </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/t8mc4w77gg4fw5um/WF8442001_Parkinson-Is_it_a_disease_only_of_the_elderly6phc2.mp3" length="44243993" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. 
Guest: Rodolfo Savica, M.D., Ph.D. 
We commonly see Parkinson’s Disease in our older patients, but have you ever seen it present in a child or young adult? It can happen. Whereas Parkinson’s Disease in an older patient is likely to be idiopathic, we need to consider genetic conditions as well as secondary causes when it occurs in younger individuals. It’s important for primary care clinicians to recognize young patients with symptoms of Parkinson’s in order to rule out other potentially treatable conditions. Does Parkinson’s present any differently in children or young adults? How fast does it typically progress? Is the management of a child or young adult different? These are some of the questions I’ll be asking my guest, Dr. Rodolfo Savica a neurologist from the Department of Neurology at the Mayo Clinic as we discuss “Parkinson’s Disease in Children and Young Adults”. 
Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1841</itunes:duration>
                <itunes:episode>658</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Proceedings: Diabetes and Novel Therapies for Diabetes</title>
        <itunes:title>Mayo Clinic Proceedings: Diabetes and Novel Therapies for Diabetes</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-proceedings-diabetes-and-novel-therapies-for-diabetes/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-proceedings-diabetes-and-novel-therapies-for-diabetes/#comments</comments>        <pubDate>Thu, 09 Apr 2026 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/cfb05ace-582f-3982-b909-e533b6a65b4e</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: <a href='https://www.mayo.edu/research/faculty/simha-vinaya-m-b-b-s-m-d/bio-20446134'>Vinaya Simha, M.B.B.S., M.D. </a></p>
<p>For years, we saw very little change in the management of type 2 diabetes. However, over the past decade, numerous new pharmacologic treatment options, innovations in glucose monitoring, and new insulin delivery systems have become available. We’ve also seen a new philosophy regarding the goals of diabetes management. What are the latest medications for diabetes and is there still a role for the older, traditional options? How have the improvements in technology affected the management of diabetes and what are the newly established goals for managing patients with the disease? These are some of the questions I’ll be asking my guest, Dr. Vinaya Simhah from the Division of Endocrinology, Diabetes and Metabolism at the Mayo Clinic as we discuss “Diabetes and Novel Therapies for Diabetes”. </p>
<p>This episode of Mayo Clinic Talks is the third of three podcasts celebrating a remarkable milestone in Mayo Clinic’s history – the 100th anniversary in April this year of our renowned journal, Mayo Clinic Proceedings. Proceedings first appeared in April 1926 and has been in continuous publication ever since. Many significant clinical breakthroughs, pioneered at Mayo Clinic, were first published in the journal, and today the journal brings primary care providers relevant, timely, and important papers on conditions and disorders that are frequently seen in the practice. A great deal of content in Mayo Clinic Proceedings is freely available for you to browse—just go to <a href='https://www.mayoclinicproceedings.org'>https://www.mayoclinicproceedings.org</a> to incorporate this terrific resource in your library.</p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: <a href='https://www.mayo.edu/research/faculty/simha-vinaya-m-b-b-s-m-d/bio-20446134'>Vinaya Simha, M.B.B.S., M.D. </a></p>
<p>For years, we saw very little change in the management of type 2 diabetes. However, over the past decade, numerous new pharmacologic treatment options, innovations in glucose monitoring, and new insulin delivery systems have become available. We’ve also seen a new philosophy regarding the goals of diabetes management. What are the latest medications for diabetes and is there still a role for the older, traditional options? How have the improvements in technology affected the management of diabetes and what are the newly established goals for managing patients with the disease? These are some of the questions I’ll be asking my guest, Dr. Vinaya Simhah from the Division of Endocrinology, Diabetes and Metabolism at the Mayo Clinic as we discuss “Diabetes and Novel Therapies for Diabetes”. </p>
<p>This episode of <em>Mayo Clinic Talks</em> is the third of three podcasts celebrating a remarkable milestone in Mayo Clinic’s history – the 100th anniversary in April this year of our renowned journal, <em>Mayo Clinic Proceedings</em>. <em>Proceedings</em> first appeared in April 1926 and has been in continuous publication ever since. Many significant clinical breakthroughs, pioneered at Mayo Clinic, were first published in the journal, and today the journal brings primary care providers relevant, timely, and important papers on conditions and disorders that are frequently seen in the practice. A great deal of content in <em>Mayo Clinic Proceedings </em>is freely available for you to browse—just go to <a href='https://www.mayoclinicproceedings.org'>https://www.mayoclinicproceedings.org</a> to incorporate this terrific resource in your library.</p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/a4i3ycb9wntypdhi/WF8471653_Diabetes_and_Recent_Novel_Therapies_for_Diabetes_ad8iwtq.mp3" length="48371659" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. 
Guest: Vinaya Simha, M.B.B.S., M.D. 
For years, we saw very little change in the management of type 2 diabetes. However, over the past decade, numerous new pharmacologic treatment options, innovations in glucose monitoring, and new insulin delivery systems have become available. We’ve also seen a new philosophy regarding the goals of diabetes management. What are the latest medications for diabetes and is there still a role for the older, traditional options? How have the improvements in technology affected the management of diabetes and what are the newly established goals for managing patients with the disease? These are some of the questions I’ll be asking my guest, Dr. Vinaya Simhah from the Division of Endocrinology, Diabetes and Metabolism at the Mayo Clinic as we discuss “Diabetes and Novel Therapies for Diabetes”. 
This episode of Mayo Clinic Talks is the third of three podcasts celebrating a remarkable milestone in Mayo Clinic’s history – the 100th anniversary in April this year of our renowned journal, Mayo Clinic Proceedings. Proceedings first appeared in April 1926 and has been in continuous publication ever since. Many significant clinical breakthroughs, pioneered at Mayo Clinic, were first published in the journal, and today the journal brings primary care providers relevant, timely, and important papers on conditions and disorders that are frequently seen in the practice. A great deal of content in Mayo Clinic Proceedings is freely available for you to browse—just go to https://www.mayoclinicproceedings.org to incorporate this terrific resource in your library.
Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2014</itunes:duration>
                <itunes:episode>657</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Proceedings: Healthy Aging</title>
        <itunes:title>Mayo Clinic Proceedings: Healthy Aging</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-proceedings-healthy-aging/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-proceedings-healthy-aging/#comments</comments>        <pubDate>Tue, 07 Apr 2026 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/a167018d-9194-3d35-aec5-3df14178d10b</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: <a href='https://www.mayo.edu/research/faculty/pignolo-robert-j-m-d-ph-d/bio-20246127'>Robert Pignolo, M.D., Ph.D. </a></p>
<p>Our population is aging as our life expectancy increases with time. In general, we’re living longer than those before us. Aging is an interesting concept; we all want to achieve old age, but it’s not something we look forward to. What we really want is to maintain our physical, mental and social well-being in order to achieve a high quality of life as we age. I’m talking about healthy aging and that’s the topic of this podcast. What degree of healthy aging is due to genetic factors vs. intentional choices we make during our life? Which lifestyle behaviors are most important in achieving healthy aging, and what can we learn from those who have lived exceptionally long lives? These are some of the questions I’ll be asking my guest, Dr. Robert Pignolo, an internist and named professor of geriatric medicine in the <a href='https://www.mayo.edu/research/centers-programs/robert-arlene-kogod-center-aging'>Center of Aging</a> at the Mayo Clinic. </p>
<p>This episode of Mayo Clinic Talks is the second of three podcasts celebrating a remarkable milestone in Mayo Clinic’s history – the 100th anniversary in April this year of our renowned journal, Mayo Clinic Proceedings. Proceedings first appeared in April 1926 and has been in continuous publication ever since. Many significant clinical breakthroughs, pioneered at Mayo Clinic, were first published in the journal, and today the journal brings primary care providers relevant, timely, and important papers on conditions and disorders that are frequently seen in the practice. A great deal of content in Mayo Clinic Proceedings is freely available for you to browse—just go to <a href='https://www.mayoclinicproceedings.org'>https://www.mayoclinicproceedings.org</a> to incorporate this terrific resource in your library.</p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: <a href='https://www.mayo.edu/research/faculty/pignolo-robert-j-m-d-ph-d/bio-20246127'>Robert Pignolo, M.D., Ph.D. </a></p>
<p>Our population is aging as our life expectancy increases with time. In general, we’re living longer than those before us. Aging is an interesting concept; we all want to achieve old age, but it’s not something we look forward to. What we really want is to maintain our physical, mental and social well-being in order to achieve a high quality of life as we age. I’m talking about healthy aging and that’s the topic of this podcast. What degree of healthy aging is due to genetic factors vs. intentional choices we make during our life? Which lifestyle behaviors are most important in achieving healthy aging, and what can we learn from those who have lived exceptionally long lives? These are some of the questions I’ll be asking my guest, Dr. Robert Pignolo, an internist and named professor of geriatric medicine in the <a href='https://www.mayo.edu/research/centers-programs/robert-arlene-kogod-center-aging'>Center of Aging</a> at the Mayo Clinic. </p>
<p>This episode of <em>Mayo Clinic Talks</em> is the second of three podcasts celebrating a remarkable milestone in Mayo Clinic’s history – the 100th anniversary in April this year of our renowned journal, <em>Mayo Clinic Proceedings</em>. <em>Proceedings</em> first appeared in April 1926 and has been in continuous publication ever since. Many significant clinical breakthroughs, pioneered at Mayo Clinic, were first published in the journal, and today the journal brings primary care providers relevant, timely, and important papers on conditions and disorders that are frequently seen in the practice. A great deal of content in <em>Mayo Clinic Proceedings </em>is freely available for you to browse—just go to <a href='https://www.mayoclinicproceedings.org'>https://www.mayoclinicproceedings.org</a> to incorporate this terrific resource in your library.</p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/uusiztnwzpykvyd5/WF7722905_Healthy_and_Unhealthy_Aging_adadti9.mp3" length="41206632" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. 
Guest: Robert Pignolo, M.D., Ph.D. 
Our population is aging as our life expectancy increases with time. In general, we’re living longer than those before us. Aging is an interesting concept; we all want to achieve old age, but it’s not something we look forward to. What we really want is to maintain our physical, mental and social well-being in order to achieve a high quality of life as we age. I’m talking about healthy aging and that’s the topic of this podcast. What degree of healthy aging is due to genetic factors vs. intentional choices we make during our life? Which lifestyle behaviors are most important in achieving healthy aging, and what can we learn from those who have lived exceptionally long lives? These are some of the questions I’ll be asking my guest, Dr. Robert Pignolo, an internist and named professor of geriatric medicine in the Center of Aging at the Mayo Clinic. 
This episode of Mayo Clinic Talks is the second of three podcasts celebrating a remarkable milestone in Mayo Clinic’s history – the 100th anniversary in April this year of our renowned journal, Mayo Clinic Proceedings. Proceedings first appeared in April 1926 and has been in continuous publication ever since. Many significant clinical breakthroughs, pioneered at Mayo Clinic, were first published in the journal, and today the journal brings primary care providers relevant, timely, and important papers on conditions and disorders that are frequently seen in the practice. A great deal of content in Mayo Clinic Proceedings is freely available for you to browse—just go to https://www.mayoclinicproceedings.org to incorporate this terrific resource in your library.
Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1710</itunes:duration>
                <itunes:episode>656</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Proceedings: Sleep Disorders and How They Adversely Affect Health</title>
        <itunes:title>Mayo Clinic Proceedings: Sleep Disorders and How They Adversely Affect Health</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-proceedings-sleep-disorders-and-how-they-adversely-affect-health/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-proceedings-sleep-disorders-and-how-they-adversely-affect-health/#comments</comments>        <pubDate>Thu, 02 Apr 2026 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/f1769005-103a-32b2-a6be-16133ffcc024</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: <a href='https://www.mayo.edu/research/faculty/kolla-bhanu-m-d/bio-20470051'>Bhanu Kolla, M.D. </a></p>
<p>We commonly take sleep for granted. That is, until our sleep quantity or quality is compromised. This can result in both mental and physical health problems, including daytime fatigue and sleepiness. Sleep disorders are quite common and often undiagnosed, yet they can contribute to diabetes, cognitive impairment, and cardiovascular disease, potentially leading to premature mortality. Primary care clinicians play a major role in the identification and management of sleep disorders. What are the most common disorders we see in the outpatient setting? What are the presenting symptoms we should watch for? What tests should we do to establish a diagnosis and when should we refer patients we feel may have a sleep disorder? The topic for today’s podcast is sleep disorders, and these are questions I’ll be asking my guest, <a href='https://www.mayo.edu/research/faculty/kolla-bhanu-m-d/bio-20470051'>Dr. Bhanu Kolla</a>, a psychiatrist and sleep medicine specialist from the <a href='https://www.mayoclinic.org/departments-centers/sleep-medicine/sections/overview/ovc-20407454'>Center for Sleep Medicine</a> at the Mayo Clinic.  </p>
<p>This episode of Mayo Clinic Talks is the first of three podcasts celebrating a remarkable milestone in Mayo Clinic’s history – the 100th anniversary in April this year of our renowned journal, Mayo Clinic Proceedings. Proceedings first appeared in April 1926 and has been in continuous publication ever since. Many significant clinical breakthroughs, pioneered at Mayo Clinic, were first published in the journal, and today the journal brings primary care providers relevant, timely, and important papers on conditions and disorders that are frequently seen in the practice. A great deal of content in Mayo Clinic Proceedings is freely available for you to browse—just go to <a href='https://www.mayoclinicproceedings.org'>mayoclinicproceedings.org</a> to incorporate this terrific resource in your library.</p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: <a href='https://www.mayo.edu/research/faculty/kolla-bhanu-m-d/bio-20470051'>Bhanu Kolla, M.D. </a></p>
<p>We commonly take sleep for granted. That is, until our sleep quantity or quality is compromised. This can result in both mental and physical health problems, including daytime fatigue and sleepiness. Sleep disorders are quite common and often undiagnosed, yet they can contribute to diabetes, cognitive impairment, and cardiovascular disease, potentially leading to premature mortality. Primary care clinicians play a major role in the identification and management of sleep disorders. What are the most common disorders we see in the outpatient setting? What are the presenting symptoms we should watch for? What tests should we do to establish a diagnosis and when should we refer patients we feel may have a sleep disorder? The topic for today’s podcast is sleep disorders, and these are questions I’ll be asking my guest, <a href='https://www.mayo.edu/research/faculty/kolla-bhanu-m-d/bio-20470051'>Dr. Bhanu Kolla</a>, a psychiatrist and sleep medicine specialist from the <a href='https://www.mayoclinic.org/departments-centers/sleep-medicine/sections/overview/ovc-20407454'>Center for Sleep Medicine</a> at the Mayo Clinic.  </p>
<p>This episode of Mayo Clinic Talks is the first of three podcasts celebrating a remarkable milestone in Mayo Clinic’s history – the 100th anniversary in April this year of our renowned journal, Mayo Clinic Proceedings. Proceedings first appeared in April 1926 and has been in continuous publication ever since. Many significant clinical breakthroughs, pioneered at Mayo Clinic, were first published in the journal, and today the journal brings primary care providers relevant, timely, and important papers on conditions and disorders that are frequently seen in the practice. A great deal of content in Mayo Clinic Proceedings is freely available for you to browse—just go to <a href='https://www.mayoclinicproceedings.org'>mayoclinicproceedings.org</a> to incorporate this terrific resource in your library.</p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/b2gqfgdwa5taggei/WF8075892_Sleep_Disturbances_ad88e50.mp3" length="45606726" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. 
Guest: Bhanu Kolla, M.D. 
We commonly take sleep for granted. That is, until our sleep quantity or quality is compromised. This can result in both mental and physical health problems, including daytime fatigue and sleepiness. Sleep disorders are quite common and often undiagnosed, yet they can contribute to diabetes, cognitive impairment, and cardiovascular disease, potentially leading to premature mortality. Primary care clinicians play a major role in the identification and management of sleep disorders. What are the most common disorders we see in the outpatient setting? What are the presenting symptoms we should watch for? What tests should we do to establish a diagnosis and when should we refer patients we feel may have a sleep disorder? The topic for today’s podcast is sleep disorders, and these are questions I’ll be asking my guest, Dr. Bhanu Kolla, a psychiatrist and sleep medicine specialist from the Center for Sleep Medicine at the Mayo Clinic.  
This episode of Mayo Clinic Talks is the first of three podcasts celebrating a remarkable milestone in Mayo Clinic’s history – the 100th anniversary in April this year of our renowned journal, Mayo Clinic Proceedings. Proceedings first appeared in April 1926 and has been in continuous publication ever since. Many significant clinical breakthroughs, pioneered at Mayo Clinic, were first published in the journal, and today the journal brings primary care providers relevant, timely, and important papers on conditions and disorders that are frequently seen in the practice. A great deal of content in Mayo Clinic Proceedings is freely available for you to browse—just go to mayoclinicproceedings.org to incorporate this terrific resource in your library.
Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1898</itunes:duration>
                <itunes:episode>655</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Retinal Disorders</title>
        <itunes:title>Retinal Disorders</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/retinal-disorders/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/retinal-disorders/#comments</comments>        <pubDate>Tue, 31 Mar 2026 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/0da707ca-92af-36e2-a9e9-c1c345a57a58</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Brittni A. Scruggs, M.D., Ph.D. </p>
<p>There are a variety of eye disorders which involve the retina, and they all have the potential to cause significant vision loss or blindness if not detected early. Two of the most common retinal disorders we see in primary care include diabetic retinopathy and macular degeneration. Since most health conditions affecting the retina are asymptomatic early in their course making patient screening and risk factor management an important task for primary care clinicians. Appropriate referrals to an ophthalmologist can result in effective treatment and improved outcomes. Which patients are at risk of retinal disorders? What are some “red flag” symptoms which should give us concern? Which medications we prescribe can affect the retina? This podcast is about retinal disorders, and I’ll be asking these questions and more of my guest, Dr. Brittni Scruggs, an ophthalmologist and retinal surgeon at the Mayo Clinic. </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Brittni A. Scruggs, M.D., Ph.D. </p>
<p>There are a variety of eye disorders which involve the retina, and they all have the potential to cause significant vision loss or blindness if not detected early. Two of the most common retinal disorders we see in primary care include diabetic retinopathy and macular degeneration. Since most health conditions affecting the retina are asymptomatic early in their course making patient screening and risk factor management an important task for primary care clinicians. Appropriate referrals to an ophthalmologist can result in effective treatment and improved outcomes. Which patients are at risk of retinal disorders? What are some “red flag” symptoms which should give us concern? Which medications we prescribe can affect the retina? This podcast is about retinal disorders, and I’ll be asking these questions and more of my guest, Dr. Brittni Scruggs, an ophthalmologist and retinal surgeon at the Mayo Clinic. </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/92hjqazyc8t8zsa9/WF8474600_Retinal_Disorders9abbj.mp3" length="47034498" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. 
Guest: Brittni A. Scruggs, M.D., Ph.D. 
There are a variety of eye disorders which involve the retina, and they all have the potential to cause significant vision loss or blindness if not detected early. Two of the most common retinal disorders we see in primary care include diabetic retinopathy and macular degeneration. Since most health conditions affecting the retina are asymptomatic early in their course making patient screening and risk factor management an important task for primary care clinicians. Appropriate referrals to an ophthalmologist can result in effective treatment and improved outcomes. Which patients are at risk of retinal disorders? What are some “red flag” symptoms which should give us concern? Which medications we prescribe can affect the retina? This podcast is about retinal disorders, and I’ll be asking these questions and more of my guest, Dr. Brittni Scruggs, an ophthalmologist and retinal surgeon at the Mayo Clinic. 
Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1955</itunes:duration>
                <itunes:episode>654</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Update in the Management of Hyperlipidemia</title>
        <itunes:title>Update in the Management of Hyperlipidemia</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/update-in-the-management-of-hyperlipidemia/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/update-in-the-management-of-hyperlipidemia/#comments</comments>        <pubDate>Tue, 24 Mar 2026 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/da7c6565-0a1c-3391-a9bd-aec75e5ba06f</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Stephen Kopecky, M.D. </p>
<p>Cardiovascular disease is highly prevalent in our society. Fortunately, we have a variety of treatment options to lower the risk of developing its complications. Over the past decade, there’ve been many changes in managing hyperlipidemia, one of the most important risk factors for cardiovascular disease. This includes a change in assessing our patients’ risk, identification of new risk factors, new testing options, and new pharmacologic options for treating hyperlipidemia. We’ll cover all of these topics in this podcast. My guest is Dr. Stephen Kopecky, a preventive cardiologist at the Mayo Clinic, and we’ll be discussing “Update in the Management of Hyperlipidemia”. </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Stephen Kopecky, M.D. </p>
<p>Cardiovascular disease is highly prevalent in our society. Fortunately, we have a variety of treatment options to lower the risk of developing its complications. Over the past decade, there’ve been many changes in managing hyperlipidemia, one of the most important risk factors for cardiovascular disease. This includes a change in assessing our patients’ risk, identification of new risk factors, new testing options, and new pharmacologic options for treating hyperlipidemia. We’ll cover all of these topics in this podcast. My guest is Dr. Stephen Kopecky, a preventive cardiologist at the Mayo Clinic, and we’ll be discussing “Update in the Management of Hyperlipidemia”. </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3e8ktv8nxu6gunaf/WF7901150_Updates_in_the_Management_of_Hyperlipidemia_ad_1_b6yus.mp3" length="41715908" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. 
Guest: Stephen Kopecky, M.D. 
Cardiovascular disease is highly prevalent in our society. Fortunately, we have a variety of treatment options to lower the risk of developing its complications. Over the past decade, there’ve been many changes in managing hyperlipidemia, one of the most important risk factors for cardiovascular disease. This includes a change in assessing our patients’ risk, identification of new risk factors, new testing options, and new pharmacologic options for treating hyperlipidemia. We’ll cover all of these topics in this podcast. My guest is Dr. Stephen Kopecky, a preventive cardiologist at the Mayo Clinic, and we’ll be discussing “Update in the Management of Hyperlipidemia”. 
Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1730</itunes:duration>
                <itunes:episode>653</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pulmonary Vascular Complications of Liver Disease</title>
        <itunes:title>Pulmonary Vascular Complications of Liver Disease</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/pulmonary-vascular-complications-of-liver-disease/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/pulmonary-vascular-complications-of-liver-disease/#comments</comments>        <pubDate>Tue, 17 Mar 2026 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/9a01696a-8d5b-31ed-ad6b-26c921e00255</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Kathryn del Valle, M.D. </p>
<p>Chronic liver disease can result in a variety of complications which can involve multiple organs. One of these complications can occur in the pulmonary vascular system. Two of the most clinically significant include hepatopulmonary syndrome and Portopulmonary hypertension. Patients with these syndromes may present to their primary care provider and if the medical condition is unrecognized, it can affect morbidity and ultimately the prognosis of the patient. What are the early symptoms and physical findings of hepatopulmonary syndrome and Portopulmonary hypertension? How are they diagnosed, and should we be screening patients with chronic liver disease for these pulmonary vascular disorders? My guest for this podcast is Dr. Kathryn del Valle, from the Division of Pulmonary and Critical Care at the Mayo Clinic and we’ll be discussing “Pulmonary Vascular Complications of Liver Disease”. </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Kathryn del Valle, M.D. </p>
<p>Chronic liver disease can result in a variety of complications which can involve multiple organs. One of these complications can occur in the pulmonary vascular system. Two of the most clinically significant include hepatopulmonary syndrome and Portopulmonary hypertension. Patients with these syndromes may present to their primary care provider and if the medical condition is unrecognized, it can affect morbidity and ultimately the prognosis of the patient. What are the early symptoms and physical findings of hepatopulmonary syndrome and Portopulmonary hypertension? How are they diagnosed, and should we be screening patients with chronic liver disease for these pulmonary vascular disorders? My guest for this podcast is Dr. Kathryn del Valle, from the Division of Pulmonary and Critical Care at the Mayo Clinic and we’ll be discussing “Pulmonary Vascular Complications of Liver Disease”. </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vy9jfyzn46nx45g7/WF8055840_Pulmonary_Vascular_Complications_of_Liver_Diseaseba9jn.mp3" length="35210269" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. 
Guest: Kathryn del Valle, M.D. 
Chronic liver disease can result in a variety of complications which can involve multiple organs. One of these complications can occur in the pulmonary vascular system. Two of the most clinically significant include hepatopulmonary syndrome and Portopulmonary hypertension. Patients with these syndromes may present to their primary care provider and if the medical condition is unrecognized, it can affect morbidity and ultimately the prognosis of the patient. What are the early symptoms and physical findings of hepatopulmonary syndrome and Portopulmonary hypertension? How are they diagnosed, and should we be screening patients with chronic liver disease for these pulmonary vascular disorders? My guest for this podcast is Dr. Kathryn del Valle, from the Division of Pulmonary and Critical Care at the Mayo Clinic and we’ll be discussing “Pulmonary Vascular Complications of Liver Disease”. 
Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1465</itunes:duration>
                <itunes:episode>652</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Non-Hodgkin's Lymphoma</title>
        <itunes:title>Non-Hodgkin's Lymphoma</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/non-hodgkins-lymphoma/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/non-hodgkins-lymphoma/#comments</comments>        <pubDate>Thu, 12 Mar 2026 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/c01d4645-7b75-3f42-92f5-535d41314d76</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Stephen Ansell, M.D., Ph.D. </p>
<p>Non-Hodgkin’s Lymphoma is a group of hematologic malignancies originating in the lymphatic system. There are over 60 subtypes of lymphoma with varying degrees of aggressiveness. It can present with a variety of rather subtle symptoms, often making the diagnosis challenging. Although Non-Hodgkin’s Lymphoma is typically managed by a hematologist or oncologist, the primary care provider plays a role in its recognition, preliminary diagnostic tests and supporting patients through their treatment. What are some of the more common symptoms and signs of Non-Hodgkin’s Lymphoma? Which ones should prompt an urgent referral, and what preliminary tests should we do prior to referring the patient? These are some of the questions I’ll be asking my guest, Dr. Stephen Ansell, Chair of the Division of Hematology at the Mayo Clinic. The topic for this podcast is Non-Hodgkin’s Lymphoma. </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Stephen Ansell, M.D., Ph.D. </p>
<p>Non-Hodgkin’s Lymphoma is a group of hematologic malignancies originating in the lymphatic system. There are over 60 subtypes of lymphoma with varying degrees of aggressiveness. It can present with a variety of rather subtle symptoms, often making the diagnosis challenging. Although Non-Hodgkin’s Lymphoma is typically managed by a hematologist or oncologist, the primary care provider plays a role in its recognition, preliminary diagnostic tests and supporting patients through their treatment. What are some of the more common symptoms and signs of Non-Hodgkin’s Lymphoma? Which ones should prompt an urgent referral, and what preliminary tests should we do prior to referring the patient? These are some of the questions I’ll be asking my guest, Dr. Stephen Ansell, Chair of the Division of Hematology at the Mayo Clinic. The topic for this podcast is Non-Hodgkin’s Lymphoma. </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/uqnptawiya3ufhtw/WF7816303_NON_Hodgkin_s_Lymphoma_mp3_ad_AFar0eh.mp3" length="35721219" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. 
Guest: Stephen Ansell, M.D., Ph.D. 
Non-Hodgkin’s Lymphoma is a group of hematologic malignancies originating in the lymphatic system. There are over 60 subtypes of lymphoma with varying degrees of aggressiveness. It can present with a variety of rather subtle symptoms, often making the diagnosis challenging. Although Non-Hodgkin’s Lymphoma is typically managed by a hematologist or oncologist, the primary care provider plays a role in its recognition, preliminary diagnostic tests and supporting patients through their treatment. What are some of the more common symptoms and signs of Non-Hodgkin’s Lymphoma? Which ones should prompt an urgent referral, and what preliminary tests should we do prior to referring the patient? These are some of the questions I’ll be asking my guest, Dr. Stephen Ansell, Chair of the Division of Hematology at the Mayo Clinic. The topic for this podcast is Non-Hodgkin’s Lymphoma. 
Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1220</itunes:duration>
                <itunes:episode>651</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hodgkin's Lymphoma</title>
        <itunes:title>Hodgkin's Lymphoma</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/hodgkins-lymphoma/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/hodgkins-lymphoma/#comments</comments>        <pubDate>Tue, 10 Mar 2026 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/a2f2c0e4-6ed2-3f09-914a-276850a4a408</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Stephen Ansell, M.D., Ph.D. </p>
<p>Hodgkin’s Lymphoma is an uncommon but very curable malignancy involving the lymphatic system. It most commonly presents in young adults as well as middle-aged and older individuals. Although Hodgkin’s is generally managed by hematologists or oncologists, the primary care provider plays a major role in its recognition, hopefully leading to a timely diagnosis and eventual staging. What are some early signs of Hodgkin’s and what preliminary work-up should we do prior to referring the patient for definitive care? How do we monitor those who have had successful treatment of Hodgkin’s? These are some of the questions I’ll be asking my guest, Dr. Stephen Ansell, Chair of the Division of Hematology at the Mayo Clinic as we discuss Hodgkin’s Lymphoma. </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Stephen Ansell, M.D., Ph.D. </p>
<p>Hodgkin’s Lymphoma is an uncommon but very curable malignancy involving the lymphatic system. It most commonly presents in young adults as well as middle-aged and older individuals. Although Hodgkin’s is generally managed by hematologists or oncologists, the primary care provider plays a major role in its recognition, hopefully leading to a timely diagnosis and eventual staging. What are some early signs of Hodgkin’s and what preliminary work-up should we do prior to referring the patient for definitive care? How do we monitor those who have had successful treatment of Hodgkin’s? These are some of the questions I’ll be asking my guest, Dr. Stephen Ansell, Chair of the Division of Hematology at the Mayo Clinic as we discuss Hodgkin’s Lymphoma. </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9qwrztz9kxnakj9z/WF7816303_Hodgkin_s_Lymphoma_AF9wmte.mp3" length="29459987" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. 
Guest: Stephen Ansell, M.D., Ph.D. 
Hodgkin’s Lymphoma is an uncommon but very curable malignancy involving the lymphatic system. It most commonly presents in young adults as well as middle-aged and older individuals. Although Hodgkin’s is generally managed by hematologists or oncologists, the primary care provider plays a major role in its recognition, hopefully leading to a timely diagnosis and eventual staging. What are some early signs of Hodgkin’s and what preliminary work-up should we do prior to referring the patient for definitive care? How do we monitor those who have had successful treatment of Hodgkin’s? These are some of the questions I’ll be asking my guest, Dr. Stephen Ansell, Chair of the Division of Hematology at the Mayo Clinic as we discuss Hodgkin’s Lymphoma. 
Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1479</itunes:duration>
                <itunes:episode>650</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Heart Health Series | Diastolic Heart Failure</title>
        <itunes:title>Heart Health Series | Diastolic Heart Failure</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/heart-health-series-diastolic-heart-failure/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/heart-health-series-diastolic-heart-failure/#comments</comments>        <pubDate>Tue, 03 Mar 2026 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/75c3ed80-2be5-3042-be79-b1f94cde58cc</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guests: Jae K. Oh, M.D., Tahir S. Kafil, M.D. </p>
<p>Diastolic heart failure is also known as heart failure with preserved ejection fraction. Although we don’t hear the term all that often, it actually represents a fairly large percentage of all cases of heart failure. Some studies suggest it represents the majority of heart failure cases. Older adults are most commonly affected with symptoms similar to those of systolic heart failure. So how do we suspect diastolic heart failure? How should the diagnosis be established, and how does the treatment differ from systolic heart failure? Finally, what role do primary care providers play in the management of the condition? These are some of the questions I’ll be asking my guests, Dr. Jae Oh and Dr. Tahir Kafil, both cardiologists in the Department of Cardiovascular Disease at the Mayo Clinic as we discuss “Diastolic Heart Failure”.  </p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-heart-health'>Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development</a> </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guests: Jae K. Oh, M.D., Tahir S. Kafil, M.D. </p>
<p>Diastolic heart failure is also known as heart failure with preserved ejection fraction. Although we don’t hear the term all that often, it actually represents a fairly large percentage of all cases of heart failure. Some studies suggest it represents the majority of heart failure cases. Older adults are most commonly affected with symptoms similar to those of systolic heart failure. So how do we suspect diastolic heart failure? How should the diagnosis be established, and how does the treatment differ from systolic heart failure? Finally, what role do primary care providers play in the management of the condition? These are some of the questions I’ll be asking my guests, Dr. Jae Oh and Dr. Tahir Kafil, both cardiologists in the Department of Cardiovascular Disease at the Mayo Clinic as we discuss “Diastolic Heart Failure”.  </p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-heart-health'>Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development</a> </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mbzqz4qcne4jt9rw/WF8804232_Diastolic_Heart_Failure9wip0.mp3" length="43257581" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. 
Guests: Jae K. Oh, M.D., Tahir S. Kafil, M.D. 
Diastolic heart failure is also known as heart failure with preserved ejection fraction. Although we don’t hear the term all that often, it actually represents a fairly large percentage of all cases of heart failure. Some studies suggest it represents the majority of heart failure cases. Older adults are most commonly affected with symptoms similar to those of systolic heart failure. So how do we suspect diastolic heart failure? How should the diagnosis be established, and how does the treatment differ from systolic heart failure? Finally, what role do primary care providers play in the management of the condition? These are some of the questions I’ll be asking my guests, Dr. Jae Oh and Dr. Tahir Kafil, both cardiologists in the Department of Cardiovascular Disease at the Mayo Clinic as we discuss “Diastolic Heart Failure”.  
Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development 
Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1797</itunes:duration>
                <itunes:episode>649</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Heart Health Series | Cardiotoxicity of Cancer Therapies</title>
        <itunes:title>Heart Health Series | Cardiotoxicity of Cancer Therapies</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/heart-health-series-cardiotoxicity-of-cancer-therapies/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/heart-health-series-cardiotoxicity-of-cancer-therapies/#comments</comments>        <pubDate>Tue, 24 Feb 2026 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/f4e8b61e-a812-3efe-8918-0819c21fc915</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Balaji Tamarappoo, M.D., Ph.D. </p>
<p>With advances in oncology, patients are living longer than ever following a diagnosis of cancer. Newer treatments have dramatically improved survival. However, we’re also seeing an increasing number of cancer survivors who are at risk for cardiovascular complications; at times during treatment, and sometimes years later. Complications such as heart failure, cardiac arrhythmias, hypertension, and accelerated coronary disease are not uncommonly seen in our primary care practice.  As primary care clinicians, what do we need to know? I’m joined today by Dr. Balaji Tamarappoo, M.D., Ph.D., a cardiologist with expertise in cardio-oncology. We’ll discuss which cancer therapies pose the highest cardiac risks, what baseline and surveillance testing is recommended, if the risk of cardiotoxicity be decreased, and how primary care can partner effectively with oncology and cardiology to protect our patients’ hearts while they battle their malignancy. The topic for today’s podcast is “Cardiotoxicity of Cancer Therapies.” </p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-heart-health'>Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development</a> </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Balaji Tamarappoo, M.D., Ph.D. </p>
<p>With advances in oncology, patients are living longer than ever following a diagnosis of cancer. Newer treatments have dramatically improved survival. However, we’re also seeing an increasing number of cancer survivors who are at risk for cardiovascular complications; at times during treatment, and sometimes years later. Complications such as heart failure, cardiac arrhythmias, hypertension, and accelerated coronary disease are not uncommonly seen in our primary care practice.  As primary care clinicians, what do we need to know? I’m joined today by Dr. Balaji Tamarappoo, M.D., Ph.D., a cardiologist with expertise in cardio-oncology. We’ll discuss which cancer therapies pose the highest cardiac risks, what baseline and surveillance testing is recommended, if the risk of cardiotoxicity be decreased, and how primary care can partner effectively with oncology and cardiology to protect our patients’ hearts while they battle their malignancy. The topic for today’s podcast is “Cardiotoxicity of Cancer Therapies.” </p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-heart-health'>Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development</a> </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/a6aj43c29h255t4y/WF8752106_Cardiotoxicity_of_Cancer_Therapies_and_Their_Diagnosisb20u0.mp3" length="37835499" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. 
Guest: Balaji Tamarappoo, M.D., Ph.D. 
With advances in oncology, patients are living longer than ever following a diagnosis of cancer. Newer treatments have dramatically improved survival. However, we’re also seeing an increasing number of cancer survivors who are at risk for cardiovascular complications; at times during treatment, and sometimes years later. Complications such as heart failure, cardiac arrhythmias, hypertension, and accelerated coronary disease are not uncommonly seen in our primary care practice.  As primary care clinicians, what do we need to know? I’m joined today by Dr. Balaji Tamarappoo, M.D., Ph.D., a cardiologist with expertise in cardio-oncology. We’ll discuss which cancer therapies pose the highest cardiac risks, what baseline and surveillance testing is recommended, if the risk of cardiotoxicity be decreased, and how primary care can partner effectively with oncology and cardiology to protect our patients’ hearts while they battle their malignancy. The topic for today’s podcast is “Cardiotoxicity of Cancer Therapies.” 
Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development 
Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1571</itunes:duration>
                <itunes:episode>648</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Heart Health Series | Pericardial Disease</title>
        <itunes:title>Heart Health Series | Pericardial Disease</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/heart-health-series-pericardial-disease/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/heart-health-series-pericardial-disease/#comments</comments>        <pubDate>Tue, 17 Feb 2026 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/ae39ed74-be63-3313-9de7-7a32d8cec177</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Hema Narayanasamy, M.B.B.S. </p>
<p>Pericardial disease represents a spectrum of both inflammatory and non-inflammatory disorders which involve the pericardium, with acute pericarditis being the most common disorder. Although not often seen in a primary care practice, we still need to consider pericarditis as it can masquerade several other more commonly seen conditions. It’s important to recognize pericardial disease early and decide who needs an urgent referral or hospitalization for appropriate treatment. What are some of the more common causes of pericardial disease? What are the most commonly encountered symptoms, physical exam findings, imaging results, and lab abnormalities? What are the potential complications? The topic for today’s podcast is pericardial disease, and my guest is Dr. Hema Narayanasamy, from the Department of Cardiovascular Disease from the Arizona campus of the Mayo Clinic. </p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-heart-health'>Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development</a> </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Hema Narayanasamy, M.B.B.S. </p>
<p>Pericardial disease represents a spectrum of both inflammatory and non-inflammatory disorders which involve the pericardium, with acute pericarditis being the most common disorder. Although not often seen in a primary care practice, we still need to consider pericarditis as it can masquerade several other more commonly seen conditions. It’s important to recognize pericardial disease early and decide who needs an urgent referral or hospitalization for appropriate treatment. What are some of the more common causes of pericardial disease? What are the most commonly encountered symptoms, physical exam findings, imaging results, and lab abnormalities? What are the potential complications? The topic for today’s podcast is pericardial disease, and my guest is Dr. Hema Narayanasamy, from the Department of Cardiovascular Disease from the Arizona campus of the Mayo Clinic. </p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-heart-health'>Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development</a> </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9zgnhpbtdsziug4b/WF8752176_Pericardial_Disease_V29882o.mp3" length="40408925" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. 
Guest: Hema Narayanasamy, M.B.B.S. 
Pericardial disease represents a spectrum of both inflammatory and non-inflammatory disorders which involve the pericardium, with acute pericarditis being the most common disorder. Although not often seen in a primary care practice, we still need to consider pericarditis as it can masquerade several other more commonly seen conditions. It’s important to recognize pericardial disease early and decide who needs an urgent referral or hospitalization for appropriate treatment. What are some of the more common causes of pericardial disease? What are the most commonly encountered symptoms, physical exam findings, imaging results, and lab abnormalities? What are the potential complications? The topic for today’s podcast is pericardial disease, and my guest is Dr. Hema Narayanasamy, from the Department of Cardiovascular Disease from the Arizona campus of the Mayo Clinic. 
Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development 
Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1681</itunes:duration>
                <itunes:episode>647</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Power of Intervals: High Intensity Interval Training and Reducing Cardiovascular Risk</title>
        <itunes:title>The Power of Intervals: High Intensity Interval Training and Reducing Cardiovascular Risk</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/the-power-of-intervals-high-intensity-interval-training-and-reducing-cardiovascular-risk/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/the-power-of-intervals-high-intensity-interval-training-and-reducing-cardiovascular-risk/#comments</comments>        <pubDate>Tue, 10 Feb 2026 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/a049fbf4-4943-3f0a-90b1-cb7c4fad2853</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Stephen Kopecky, M.D. </p>
<p>We have a variety of pharmacologic options and lifestyle changes we recommend to our patients to reduce their cardiovascular risks. One frequent recommendation is participation in a regular exercise program. One specific type of exercise is high intensity interval training. It’s been shown to improve a variety of metabolic parameters. What does high intensity interval training consist of? What are the specific metabolic benefits? Can all patients participate in this type of exercise? What’s the recommended duration and frequency of training and how good is patient adherence to interval training? The topic for this podcast is “High Intensity Interval Training and Reducing Cardiovascular Risk” and my guest is Dr. Stephen Kopecky, a preventive cardiologist in the Department of Cardiovascular Disease at the Mayo Clinic. </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Stephen Kopecky, M.D. </p>
<p>We have a variety of pharmacologic options and lifestyle changes we recommend to our patients to reduce their cardiovascular risks. One frequent recommendation is participation in a regular exercise program. One specific type of exercise is high intensity interval training. It’s been shown to improve a variety of metabolic parameters. What does high intensity interval training consist of? What are the specific metabolic benefits? Can all patients participate in this type of exercise? What’s the recommended duration and frequency of training and how good is patient adherence to interval training? The topic for this podcast is “High Intensity Interval Training and Reducing Cardiovascular Risk” and my guest is Dr. Stephen Kopecky, a preventive cardiologist in the Department of Cardiovascular Disease at the Mayo Clinic. </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/g3h3mc5x4yuecw4x/WF7901152_The_Power_of_Interval_Training_ad_1_8jykn.mp3" length="29017657" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. 
Guest: Stephen Kopecky, M.D. 
We have a variety of pharmacologic options and lifestyle changes we recommend to our patients to reduce their cardiovascular risks. One frequent recommendation is participation in a regular exercise program. One specific type of exercise is high intensity interval training. It’s been shown to improve a variety of metabolic parameters. What does high intensity interval training consist of? What are the specific metabolic benefits? Can all patients participate in this type of exercise? What’s the recommended duration and frequency of training and how good is patient adherence to interval training? The topic for this podcast is “High Intensity Interval Training and Reducing Cardiovascular Risk” and my guest is Dr. Stephen Kopecky, a preventive cardiologist in the Department of Cardiovascular Disease at the Mayo Clinic. 
Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1203</itunes:duration>
                <itunes:episode>646</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Heart Health Series | Bicuspid Aortic Valve Disease</title>
        <itunes:title>Heart Health Series | Bicuspid Aortic Valve Disease</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/heart-health-series-bicuspid-aortic-valve-disease/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/heart-health-series-bicuspid-aortic-valve-disease/#comments</comments>        <pubDate>Thu, 05 Feb 2026 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/931c01b9-b5e0-3562-ae09-4285af203918</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: George Wang, M.D. </p>
<p>Bicuspid aortic valve is a relatively common congenital heart disease. It can be associated with other genetic disorders such as Turner’s Syndrome or exist as an isolated entity. In most cases, patients with a bicuspid aortic valve are initially asymptomatic; however later in the course, they may develop symptoms related to a subsequent aortic stenosis or regurgitation. It’s also associated with a dilated ascending aorta with potential rupture if unrecognized. Therefore, it’s in the patient’s best interest to diagnose the condition as early as possible. What are the early symptoms and when should we suspect the patient may have a bicuspid aortic valve? What type of surveillance should be performed and when is surgery indicated? These are some of the questions I’ll be asking my guest, Dr. George Wang, a cardiologist in the Department of Cardiovascular Medicine at the Arizona Campus of the Mayo Clinic as we discuss “Bicuspid Aortic Valve Disease”. </p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-heart-health'>Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development</a> </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: George Wang, M.D. </p>
<p>Bicuspid aortic valve is a relatively common congenital heart disease. It can be associated with other genetic disorders such as Turner’s Syndrome or exist as an isolated entity. In most cases, patients with a bicuspid aortic valve are initially asymptomatic; however later in the course, they may develop symptoms related to a subsequent aortic stenosis or regurgitation. It’s also associated with a dilated ascending aorta with potential rupture if unrecognized. Therefore, it’s in the patient’s best interest to diagnose the condition as early as possible. What are the early symptoms and when should we suspect the patient may have a bicuspid aortic valve? What type of surveillance should be performed and when is surgery indicated? These are some of the questions I’ll be asking my guest, Dr. George Wang, a cardiologist in the Department of Cardiovascular Medicine at the Arizona Campus of the Mayo Clinic as we discuss “Bicuspid Aortic Valve Disease”. </p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-heart-health'>Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development</a> </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8vigfm6mqdma3jc9/WF8489220_Bicuspid_Aortic_Valve_Disease_adab0ku.mp3" length="42485228" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. 
Guest: George Wang, M.D. 
Bicuspid aortic valve is a relatively common congenital heart disease. It can be associated with other genetic disorders such as Turner’s Syndrome or exist as an isolated entity. In most cases, patients with a bicuspid aortic valve are initially asymptomatic; however later in the course, they may develop symptoms related to a subsequent aortic stenosis or regurgitation. It’s also associated with a dilated ascending aorta with potential rupture if unrecognized. Therefore, it’s in the patient’s best interest to diagnose the condition as early as possible. What are the early symptoms and when should we suspect the patient may have a bicuspid aortic valve? What type of surveillance should be performed and when is surgery indicated? These are some of the questions I’ll be asking my guest, Dr. George Wang, a cardiologist in the Department of Cardiovascular Medicine at the Arizona Campus of the Mayo Clinic as we discuss “Bicuspid Aortic Valve Disease”. 
Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development 
Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1763</itunes:duration>
                <itunes:episode>645</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Heart Health Series | Cardiac Amyloidosis</title>
        <itunes:title>Heart Health Series | Cardiac Amyloidosis</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/heart-health-series-cardiac-amyloidosis/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/heart-health-series-cardiac-amyloidosis/#comments</comments>        <pubDate>Tue, 03 Feb 2026 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/07fa1201-a0cf-3c77-9510-5a28139c4173</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Julie Rosenthal, M.D. </p>
<p>Cardiac amyloidosis is not a common condition, but it is important for primary care clinicians to recognize it in our patients. It’s commonly underdiagnosed as the symptoms are often assumed to be due to other, more common cardiac problems. Early recognition is important since this can result in improved treatment options and better patient outcomes. So how do we recognize cardiac amyloidosis? What are the presenting symptoms and what’s the best way to establish an accurate diagnosis? I’ll be asking my guest these questions as we discuss cardiac amyloidosis. My guest for tis podcast is Dr. Julie Rosenthal, a cardiologist in the Department of Cardiovascular Medicine at the Arizona campus of the Mayo Clinic.  </p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-heart-health'>Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development</a> </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Julie Rosenthal, M.D. </p>
<p>Cardiac amyloidosis is not a common condition, but it is important for primary care clinicians to recognize it in our patients. It’s commonly underdiagnosed as the symptoms are often assumed to be due to other, more common cardiac problems. Early recognition is important since this can result in improved treatment options and better patient outcomes. So how do we recognize cardiac amyloidosis? What are the presenting symptoms and what’s the best way to establish an accurate diagnosis? I’ll be asking my guest these questions as we discuss cardiac amyloidosis. My guest for tis podcast is Dr. Julie Rosenthal, a cardiologist in the Department of Cardiovascular Medicine at the Arizona campus of the Mayo Clinic.  </p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-heart-health'>Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development</a> </p>
<p>Connect with us! <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-6'>Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6g3u4dntxmevitcb/WF8550550_Updates_in_Amyloid_Treatment9zk00.mp3" length="42659791" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. 
Guest: Julie Rosenthal, M.D. 
Cardiac amyloidosis is not a common condition, but it is important for primary care clinicians to recognize it in our patients. It’s commonly underdiagnosed as the symptoms are often assumed to be due to other, more common cardiac problems. Early recognition is important since this can result in improved treatment options and better patient outcomes. So how do we recognize cardiac amyloidosis? What are the presenting symptoms and what’s the best way to establish an accurate diagnosis? I’ll be asking my guest these questions as we discuss cardiac amyloidosis. My guest for tis podcast is Dr. Julie Rosenthal, a cardiologist in the Department of Cardiovascular Medicine at the Arizona campus of the Mayo Clinic.  
Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development 
Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1775</itunes:duration>
                <itunes:episode>644</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Concussions: What Every Primary Care Provider Should Know</title>
        <itunes:title>Concussions: What Every Primary Care Provider Should Know</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/concussions-what-every-primary-care-provider-should-know/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/concussions-what-every-primary-care-provider-should-know/#comments</comments>        <pubDate>Tue, 27 Jan 2026 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/3cd46882-9791-3246-9c1c-af252e6ee9b6</guid>
                                    <description><![CDATA[<p> Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Matthew B. Anastasi, M.D.</p>
<p>Patients with concussions are commonly seen in primary care practices and concussions don’t spare any particular age group. Children, young adult athletes and older individuals are all at increased risk. They’re a form of traumatic brain injury and while most are self-limiting, they require an accurate assessment, proper management and appropriate follow-up to make sure the patient is recovering and not experiencing complications. When should we suspect a concussion? What questions should we be asking in order to make an accurate diagnosis? What’s the best management of a patient who has had a concussion and finally, when can that patient return to their normal activities? The topic for this podcast is “Concussions: What Every Primary Care Provider Should Know” and my guest is Dr. Matthew Anastasi, a family medicine and sports medicine physician at the Arizona campus of the Mayo Clinic.</p>
<p>Learn more at <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p> Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Matthew B. Anastasi, M.D.</p>
<p>Patients with concussions are commonly seen in primary care practices and concussions don’t spare any particular age group. Children, young adult athletes and older individuals are all at increased risk. They’re a form of traumatic brain injury and while most are self-limiting, they require an accurate assessment, proper management and appropriate follow-up to make sure the patient is recovering and not experiencing complications. When should we suspect a concussion? What questions should we be asking in order to make an accurate diagnosis? What’s the best management of a patient who has had a concussion and finally, when can that patient return to their normal activities? The topic for this podcast is “Concussions: What Every Primary Care Provider Should Know” and my guest is Dr. Matthew Anastasi, a family medicine and sports medicine physician at the Arizona campus of the Mayo Clinic.</p>
<p>Learn more at <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wbdyrs4zim2qkc42/WF7667903_Concussion_Assessment_and_Management_adasiyq.mp3" length="39848096" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ Host: Darryl S. Chutka, M.D.
Guest: Matthew B. Anastasi, M.D.
Patients with concussions are commonly seen in primary care practices and concussions don’t spare any particular age group. Children, young adult athletes and older individuals are all at increased risk. They’re a form of traumatic brain injury and while most are self-limiting, they require an accurate assessment, proper management and appropriate follow-up to make sure the patient is recovering and not experiencing complications. When should we suspect a concussion? What questions should we be asking in order to make an accurate diagnosis? What’s the best management of a patient who has had a concussion and finally, when can that patient return to their normal activities? The topic for this podcast is “Concussions: What Every Primary Care Provider Should Know” and my guest is Dr. Matthew Anastasi, a family medicine and sports medicine physician at the Arizona campus of the Mayo Clinic.
Learn more at https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1656</itunes:duration>
                <itunes:episode>643</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Rx for Weight Loss: A Closer Look Series "The Wins of Losing: GLP-1 Agonists and Reducing Heart Disease Risk"</title>
        <itunes:title>Rx for Weight Loss: A Closer Look Series "The Wins of Losing: GLP-1 Agonists and Reducing Heart Disease Risk"</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/rx-for-weight-loss-a-closer-look-series-the-wins-of-losing-glp-1-agonists-and-reducing-heart-disease-risk/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/rx-for-weight-loss-a-closer-look-series-the-wins-of-losing-glp-1-agonists-and-reducing-heart-disease-risk/#comments</comments>        <pubDate>Tue, 20 Jan 2026 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/fdf86502-73fc-3cc6-8d57-33b84174f91d</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Stephen Kopecky, M.D. </p>
<p>One of the biggest surprises we’ve seen in medicine in the past several years has been the numerous health benefits realized from the GLP-1 agonists. Originally developed for the management of diabetes, they’ve shown significant potential to improve cardiovascular risks, beyond controlling blood glucose and lowering hemoglobin A1c. Several studies have shown reductions in cardiovascular events including MI, stroke as well as reducing overall cardiovascular death. What is the mechanism of action for these cardiovascular benefits? Are there any differences in the various GLP-1 medications available and who’s a candidate for a GLP-1 medication? I’ll get answers to all of these questions and more in this podcast as I speak with Dr. Stephen Kopecky, a preventive cardiologist at the Mayo Clinic. We’ll be discussing “GLP-1 Agonists and Reducing Cardiovascular Risk”. </p>
<p><a href='https://ce.mayo.edu/content/rx-weight-loss-closer-look-series'>Rx for Weight Loss: A Closer Look Series | Mayo Clinic School of Continuous Professional Development</a> </p>
<p>Learn more at <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Stephen Kopecky, M.D. </p>
<p>One of the biggest surprises we’ve seen in medicine in the past several years has been the numerous health benefits realized from the GLP-1 agonists. Originally developed for the management of diabetes, they’ve shown significant potential to improve cardiovascular risks, beyond controlling blood glucose and lowering hemoglobin A1c. Several studies have shown reductions in cardiovascular events including MI, stroke as well as reducing overall cardiovascular death. What is the mechanism of action for these cardiovascular benefits? Are there any differences in the various GLP-1 medications available and who’s a candidate for a GLP-1 medication? I’ll get answers to all of these questions and more in this podcast as I speak with Dr. Stephen Kopecky, a preventive cardiologist at the Mayo Clinic. We’ll be discussing “GLP-1 Agonists and Reducing Cardiovascular Risk”. </p>
<p><a href='https://ce.mayo.edu/content/rx-weight-loss-closer-look-series'>Rx for Weight Loss: A Closer Look Series | Mayo Clinic School of Continuous Professional Development</a> </p>
<p>Learn more at <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6kjjr8pbw523dkhb/WF7901151_GLP-1_Agonists_and_Reducing_Heart_Disease_Riskb6v5t.mp3" length="29359206" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. 
Guest: Stephen Kopecky, M.D. 
One of the biggest surprises we’ve seen in medicine in the past several years has been the numerous health benefits realized from the GLP-1 agonists. Originally developed for the management of diabetes, they’ve shown significant potential to improve cardiovascular risks, beyond controlling blood glucose and lowering hemoglobin A1c. Several studies have shown reductions in cardiovascular events including MI, stroke as well as reducing overall cardiovascular death. What is the mechanism of action for these cardiovascular benefits? Are there any differences in the various GLP-1 medications available and who’s a candidate for a GLP-1 medication? I’ll get answers to all of these questions and more in this podcast as I speak with Dr. Stephen Kopecky, a preventive cardiologist at the Mayo Clinic. We’ll be discussing “GLP-1 Agonists and Reducing Cardiovascular Risk”. 
Rx for Weight Loss: A Closer Look Series | Mayo Clinic School of Continuous Professional Development 
Learn more at https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1217</itunes:duration>
                <itunes:episode>642</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Rx for Weight Loss: A Closer Look Series "Controversies &amp; Future of GLP-1 Medications"</title>
        <itunes:title>Rx for Weight Loss: A Closer Look Series "Controversies &amp; Future of GLP-1 Medications"</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/rx-for-weight-loss-a-closer-look-series-controversies-future-of-glp-1-medications/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/rx-for-weight-loss-a-closer-look-series-controversies-future-of-glp-1-medications/#comments</comments>        <pubDate>Thu, 15 Jan 2026 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/88a942a8-b7e2-3a69-93e8-e3225f843726</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guests: Tamim I. Rajjo, M.D., M.P.H.; Meera Shah, M.B., Ch.B. </p>
<p>The class of medications known as the GLP-1 agonists is very popular with our patients. Although initially indicated for management of diabetes, they’re frequently taken for the weight loss they commonly produce. How long should these medications be taken? Is there anything we can do to help maintain the weight loss achieved with these medications? How significant is the loss of muscle mass which can occur as part of the weight lost with these medications and can this be minimized. Finally, how safe are the compounded and unapproved versions of these medications patients often find more affordable? These are a few of the questions we’ll address in podcast on the GLP-1 medications used for weight loss and we’ll tackle the “Controversies and Future of the GLP-1 Medications”. My guests include Dr. Meera Shah and Dr. Tamim Rajjo, both from the Division of Endocrinology at the Mayo Clinic. </p>
<p><a href='https://ce.mayo.edu/content/rx-weight-loss-closer-look-series'>Rx for Weight Loss: A Closer Look Series | Mayo Clinic School of Continuous Professional Development</a> </p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guests: Tamim I. Rajjo, M.D., M.P.H.; Meera Shah, M.B., Ch.B. </p>
<p>The class of medications known as the GLP-1 agonists is very popular with our patients. Although initially indicated for management of diabetes, they’re frequently taken for the weight loss they commonly produce. How long should these medications be taken? Is there anything we can do to help maintain the weight loss achieved with these medications? How significant is the loss of muscle mass which can occur as part of the weight lost with these medications and can this be minimized. Finally, how safe are the compounded and unapproved versions of these medications patients often find more affordable? These are a few of the questions we’ll address in podcast on the GLP-1 medications used for weight loss and we’ll tackle the “Controversies and Future of the GLP-1 Medications”. My guests include Dr. Meera Shah and Dr. Tamim Rajjo, both from the Division of Endocrinology at the Mayo Clinic. </p>
<p><a href='https://ce.mayo.edu/content/rx-weight-loss-closer-look-series'>Rx for Weight Loss: A Closer Look Series | Mayo Clinic School of Continuous Professional Development</a> </p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tnk45q8fmc4afzu2/WF8101701_More_Than_a_Prescription7h3ml.mp3" length="35248062" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. 
Guests: Tamim I. Rajjo, M.D., M.P.H.; Meera Shah, M.B., Ch.B. 
The class of medications known as the GLP-1 agonists is very popular with our patients. Although initially indicated for management of diabetes, they’re frequently taken for the weight loss they commonly produce. How long should these medications be taken? Is there anything we can do to help maintain the weight loss achieved with these medications? How significant is the loss of muscle mass which can occur as part of the weight lost with these medications and can this be minimized. Finally, how safe are the compounded and unapproved versions of these medications patients often find more affordable? These are a few of the questions we’ll address in podcast on the GLP-1 medications used for weight loss and we’ll tackle the “Controversies and Future of the GLP-1 Medications”. My guests include Dr. Meera Shah and Dr. Tamim Rajjo, both from the Division of Endocrinology at the Mayo Clinic. 
Rx for Weight Loss: A Closer Look Series | Mayo Clinic School of Continuous Professional Development 
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1462</itunes:duration>
                <itunes:episode>641</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Rx for Weight Loss: A Closer Look Series "Importance of Lifestyle Changes with Use of GLP-1 Medications"</title>
        <itunes:title>Rx for Weight Loss: A Closer Look Series "Importance of Lifestyle Changes with Use of GLP-1 Medications"</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/rx-for-weight-loss-a-closer-look-series-importance-of-lifestyle-changes-with-use-of-glp-1-medications/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/rx-for-weight-loss-a-closer-look-series-importance-of-lifestyle-changes-with-use-of-glp-1-medications/#comments</comments>        <pubDate>Tue, 13 Jan 2026 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/c4c708c9-e849-3582-b115-1dc5e247b739</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Tamim Rajjo, M.D., M.P.H. </p>
<p>Using GLP-1 medication for weight loss has become very popular with our patients. In the recent past, this has produced a shortage of these medications available, and those taking them for management of diabetes have found them difficult to obtain. Although in most cases, they are quite successful in producing substantial weight loss, many have regained weight after the medication was discontinued. How much weight can patients expect to lose with these medications? When should these medications be stopped, or should they? Are there strategies that have shown benefit to help patients maintain the weight they lose once the medication is discontinued? This podcast is the second of three on using the GLP-1 medications for weight loss and we’ll discuss “The Importance of Lifestyle Changes with the Use of GLP-1 Medications for Weight Loss”. My guest is Dr. Tamim Rajjo, a physician trained in Preventive Medicine and Obesity Medicine from the Mayo Clinic. </p>
<p><a href='https://ce.mayo.edu/content/rx-weight-loss-closer-look-series'>Rx for Weight Loss: A Closer Look Series | Mayo Clinic School of Continuous Professional Development</a> </p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. </p>
<p>Guest: Tamim Rajjo, M.D., M.P.H. </p>
<p>Using GLP-1 medication for weight loss has become very popular with our patients. In the recent past, this has produced a shortage of these medications available, and those taking them for management of diabetes have found them difficult to obtain. Although in most cases, they are quite successful in producing substantial weight loss, many have regained weight after the medication was discontinued. How much weight can patients expect to lose with these medications? When should these medications be stopped, or should they? Are there strategies that have shown benefit to help patients maintain the weight they lose once the medication is discontinued? This podcast is the second of three on using the GLP-1 medications for weight loss and we’ll discuss “The Importance of Lifestyle Changes with the Use of GLP-1 Medications for Weight Loss”. My guest is Dr. Tamim Rajjo, a physician trained in Preventive Medicine and Obesity Medicine from the Mayo Clinic. </p>
<p><a href='https://ce.mayo.edu/content/rx-weight-loss-closer-look-series'>Rx for Weight Loss: A Closer Look Series | Mayo Clinic School of Continuous Professional Development</a> </p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zqcwm9d4psbdsatt/WF8076150_Long-Term_Strategies_for_Maintenance_with_Weight_Loss_Medicationsbj9lx.mp3" length="37643672" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. 
Guest: Tamim Rajjo, M.D., M.P.H. 
Using GLP-1 medication for weight loss has become very popular with our patients. In the recent past, this has produced a shortage of these medications available, and those taking them for management of diabetes have found them difficult to obtain. Although in most cases, they are quite successful in producing substantial weight loss, many have regained weight after the medication was discontinued. How much weight can patients expect to lose with these medications? When should these medications be stopped, or should they? Are there strategies that have shown benefit to help patients maintain the weight they lose once the medication is discontinued? This podcast is the second of three on using the GLP-1 medications for weight loss and we’ll discuss “The Importance of Lifestyle Changes with the Use of GLP-1 Medications for Weight Loss”. My guest is Dr. Tamim Rajjo, a physician trained in Preventive Medicine and Obesity Medicine from the Mayo Clinic. 
Rx for Weight Loss: A Closer Look Series | Mayo Clinic School of Continuous Professional Development 
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1562</itunes:duration>
                <itunes:episode>640</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Rx for Weight Loss: A Closer Look Series “Who is a Candidate for a GLP-1 Medication?”</title>
        <itunes:title>Rx for Weight Loss: A Closer Look Series “Who is a Candidate for a GLP-1 Medication?”</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/rx-for-weight-loss-a-closer-look-series-who-is-a-candidate-for-a-glp-1-medication/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/rx-for-weight-loss-a-closer-look-series-who-is-a-candidate-for-a-glp-1-medication/#comments</comments>        <pubDate>Thu, 08 Jan 2026 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/f0509791-475a-3e19-be84-9d5509319671</guid>
                                    <description><![CDATA[<p class="p1">Host: Darryl S. Chutka, M.D.</p>
<p class="p1">Guests: Tamim I. Rajjo, M.D., M.P.H.; Meera Shah, M.B., Ch.B.</p>
<p class="p1">Using GLP-1 medications for weight loss has become extremely popular. Is this the latest fad in losing weight, or will these medications completely change our approach to managing obesity? They do appear to be very effective in promoting substantial weight loss. What is the history of these medications? Are there differences in the various GLP-1 medications available? What are the potential adverse effects of this drug class? This podcast is the first in a series of three on the GLP-1 medications prescribed for weight loss. The topic for this podcast is “Who Is a candidate for a GLP-1 Medication?” and my guests include Dr. Meera Shah and Dr. Tamim Rajjo, both from the Division of Endocrinology and Metabolism at the Mayo Clinic.</p>
<p class="p1">Check out the series!</p>
<p class="p1"><a href='https://ce.mayo.edu/content/rx-weight-loss-closer-look-series'>Rx for Weight Loss: A Closer Look Series | Mayo Clinic School of Continuous Professional Development</a></p>
<p class="p1">Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="p1">Host: Darryl S. Chutka, M.D.</p>
<p class="p1">Guests: Tamim I. Rajjo, M.D., M.P.H.; Meera Shah, M.B., Ch.B.</p>
<p class="p1">Using GLP-1 medications for weight loss has become extremely popular. Is this the latest fad in losing weight, or will these medications completely change our approach to managing obesity? They do appear to be very effective in promoting substantial weight loss. What is the history of these medications? Are there differences in the various GLP-1 medications available? What are the potential adverse effects of this drug class? This podcast is the first in a series of three on the GLP-1 medications prescribed for weight loss. The topic for this podcast is “Who Is a candidate for a GLP-1 Medication?” and my guests include Dr. Meera Shah and Dr. Tamim Rajjo, both from the Division of Endocrinology and Metabolism at the Mayo Clinic.</p>
<p class="p1"><em>Check out the series!</em></p>
<p class="p1"><a href='https://ce.mayo.edu/content/rx-weight-loss-closer-look-series'>Rx for Weight Loss: A Closer Look Series | Mayo Clinic School of Continuous Professional Development</a></p>
<p class="p1">Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/y56xa23n8tqdaq3i/WF8102150_Who_Should_Be_Prescribed_Weight_Loss_Medications_AF7rm7w.mp3" length="37976966" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guests: Tamim I. Rajjo, M.D., M.P.H.; Meera Shah, M.B., Ch.B.
Using GLP-1 medications for weight loss has become extremely popular. Is this the latest fad in losing weight, or will these medications completely change our approach to managing obesity? They do appear to be very effective in promoting substantial weight loss. What is the history of these medications? Are there differences in the various GLP-1 medications available? What are the potential adverse effects of this drug class? This podcast is the first in a series of three on the GLP-1 medications prescribed for weight loss. The topic for this podcast is “Who Is a candidate for a GLP-1 Medication?” and my guests include Dr. Meera Shah and Dr. Tamim Rajjo, both from the Division of Endocrinology and Metabolism at the Mayo Clinic.
Check out the series!
Rx for Weight Loss: A Closer Look Series | Mayo Clinic School of Continuous Professional Development
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1577</itunes:duration>
                <itunes:episode>639</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Risks and Benefits of Alcohol</title>
        <itunes:title>The Risks and Benefits of Alcohol</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/the-risks-and-benefits-of-alcohol/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/the-risks-and-benefits-of-alcohol/#comments</comments>        <pubDate>Tue, 06 Jan 2026 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/6e611a8d-db04-387e-ac5e-205f9d042ed7</guid>
                                    <description><![CDATA[<p>WELCOME TO SEASON 6 OF THE MAYO CLINIC TALKS PODCAST!</p>
<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Warren G. Thompson, M.D.</p>
<p>Alcohol can offer a variety of social and potential health benefits when consumed in moderation. However, alcohol is also associated with a variety of health risks, including addiction, increased likelihood of accidents, impaired judgment, cardiovascular problems, hepatic disease and even malignancy. Other than the social benefits, are there true health benefits of alcohol? Is there an amount of alcohol that’s considered safe? How can we as primary care clinicians convey the health risks of alcohol to our patients? The topic for this podcast is the “Risks and Benefits of Alcohol” and these are some of the questions I’ll be asking my guest, Warren G. Thompson, M.D., an internist and preventive medicine specialist at the Mayo Clinic.</p>
<p class="p1">Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>WELCOME TO SEASON 6 OF THE MAYO CLINIC TALKS PODCAST!</p>
<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Warren G. Thompson, M.D.</p>
<p>Alcohol can offer a variety of social and potential health benefits when consumed in moderation. However, alcohol is also associated with a variety of health risks, including addiction, increased likelihood of accidents, impaired judgment, cardiovascular problems, hepatic disease and even malignancy. Other than the social benefits, are there true health benefits of alcohol? Is there an amount of alcohol that’s considered safe? How can we as primary care clinicians convey the health risks of alcohol to our patients? The topic for this podcast is the “Risks and Benefits of Alcohol” and these are some of the questions I’ll be asking my guest, Warren G. Thompson, M.D., an internist and preventive medicine specialist at the Mayo Clinic.</p>
<p class="p1">Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ebynb7tfquv6qqfk/WF6358111_Risks_and_Benefits_of_Alcohol_Promo_AFa3ads.mp3" length="34030975" type="audio/mpeg"/>
        <itunes:summary><![CDATA[WELCOME TO SEASON 6 OF THE MAYO CLINIC TALKS PODCAST!
Host: Darryl S. Chutka, M.D.
Guest: Warren G. Thompson, M.D.
Alcohol can offer a variety of social and potential health benefits when consumed in moderation. However, alcohol is also associated with a variety of health risks, including addiction, increased likelihood of accidents, impaired judgment, cardiovascular problems, hepatic disease and even malignancy. Other than the social benefits, are there true health benefits of alcohol? Is there an amount of alcohol that’s considered safe? How can we as primary care clinicians convey the health risks of alcohol to our patients? The topic for this podcast is the “Risks and Benefits of Alcohol” and these are some of the questions I’ll be asking my guest, Warren G. Thompson, M.D., an internist and preventive medicine specialist at the Mayo Clinic.
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 
 ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1414</itunes:duration>
                <itunes:episode>638</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Re-Release!! "No Loafing Matter" Celiac Disease &amp; Gluten Sensitivity</title>
        <itunes:title>Re-Release!! "No Loafing Matter" Celiac Disease &amp; Gluten Sensitivity</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/re-release-no-loafing-matter-celiac-disease-gluten-sensitivity/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/re-release-no-loafing-matter-celiac-disease-gluten-sensitivity/#comments</comments>        <pubDate>Tue, 30 Dec 2025 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/70ee109a-2c98-38b9-99bf-54d0f53c65be</guid>
                                    <description><![CDATA[<p class="p1">HAPPY HOLIDAYS! Enjoy this re-release from Season 3 of Mayo Clinic Talks:</p>
Host: Darryl S. Chutka, M.D. 
Guest: Amy S. Oxentenko, M.D.
 
It’s estimated that less than 1/3 of individuals with celiac disease have been properly diagnosed. When those with celiac disease ingest gluten, an immune response develops which attacks the small intestine leading to inadequate absorption of nutrients. If left untreated, celiac disease can lead to a variety of nutritional deficiencies as well as other serious consequences. Those with celiac disease are also at increased risk for coronary disease and small bowel cancers. In this podcast we’ll review celiac disease and gluten sensitivity with our guest, Amy S. Oxentenko, M.D., a gastroenterologist at the Mayo Clinic. We’ll discuss the symptoms of celiac disease, how to diagnose the condition and how patients with celiac disease should be managed.
 

<p class="p1">Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="p1"><em>HAPPY HOLIDAYS! Enjoy this re-release from Season 3 of Mayo Clinic Talks:</em></p>
Host: Darryl S. Chutka, M.D. 
Guest: Amy S. Oxentenko, M.D.
 
It’s estimated that less than 1/3 of individuals with celiac disease have been properly diagnosed. When those with celiac disease ingest gluten, an immune response develops which attacks the small intestine leading to inadequate absorption of nutrients. If left untreated, celiac disease can lead to a variety of nutritional deficiencies as well as other serious consequences. Those with celiac disease are also at increased risk for coronary disease and small bowel cancers. In this podcast we’ll review celiac disease and gluten sensitivity with our guest, Amy S. Oxentenko, M.D., a gastroenterologist at the Mayo Clinic. We’ll discuss the symptoms of celiac disease, how to diagnose the condition and how patients with celiac disease should be managed.
 

<p class="p1">Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/q87ypig85jwdtppu/23R01789_409_AF.mp3" length="42581347" type="audio/mpeg"/>
        <itunes:summary><![CDATA[HAPPY HOLIDAYS! Enjoy this re-release from Season 3 of Mayo Clinic Talks:
Host: Darryl S. Chutka, M.D. 
Guest: Amy S. Oxentenko, M.D.
 
It’s estimated that less than 1/3 of individuals with celiac disease have been properly diagnosed. When those with celiac disease ingest gluten, an immune response develops which attacks the small intestine leading to inadequate absorption of nutrients. If left untreated, celiac disease can lead to a variety of nutritional deficiencies as well as other serious consequences. Those with celiac disease are also at increased risk for coronary disease and small bowel cancers. In this podcast we’ll review celiac disease and gluten sensitivity with our guest, Amy S. Oxentenko, M.D., a gastroenterologist at the Mayo Clinic. We’ll discuss the symptoms of celiac disease, how to diagnose the condition and how patients with celiac disease should be managed.
 

Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 
]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1772</itunes:duration>
                <itunes:episode>637</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Re-Release!! "Lettuce Eat" Plant-Based Diets: Healthy and NonHealthy</title>
        <itunes:title>Re-Release!! "Lettuce Eat" Plant-Based Diets: Healthy and NonHealthy</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/re-release-lettuce-eat-plant-based-diets-healthy-and-nonhealthy/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/re-release-lettuce-eat-plant-based-diets-healthy-and-nonhealthy/#comments</comments>        <pubDate>Tue, 23 Dec 2025 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/da6ecd56-c03c-36ea-a720-71c493e11127</guid>
                                    <description><![CDATA[HAPPY HOLIDAYS! Enjoy this re-release from Season 3 of Mayo Clinic Talks:
 
Host: Darryl S. Chutka M.D.
Guest: Lisa Lammert, R.D.N., L.D.
 
Cardiovascular disease is the leading cause of death to individuals in the U.S. Many feel that our typical American diet with its high saturated fat content is a major contributor to this. There’s good evidence that shows plant-based diets are cost-effective in lowering the risk factors for cardiovascular disease including obesity, hyperlipidemia, hypertension, and diabetes. They may also lower the number of medications an individual needs to take to manage their chronic diseases. So, are there any disadvantages to a plant-based diet? Are all plant-based diets healthy and what are the nutritional challenges for a patient on a plant-based diet? We’ll discuss these questions in this podcast on “Plant-Based Diets”. Our guest is Lisa Lammert, a registered dietician and nutritionist at the Mayo Clinic.

<p class="p1"> </p>
<p class="p1">Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<em>HAPPY HOLIDAYS! Enjoy this re-release from Season 3 of Mayo Clinic Talks:</em>
 
Host: Darryl S. Chutka M.D.
Guest: Lisa Lammert, R.D.N., L.D.
 
Cardiovascular disease is the leading cause of death to individuals in the U.S. Many feel that our typical American diet with its high saturated fat content is a major contributor to this. There’s good evidence that shows plant-based diets are cost-effective in lowering the risk factors for cardiovascular disease including obesity, hyperlipidemia, hypertension, and diabetes. They may also lower the number of medications an individual needs to take to manage their chronic diseases. So, are there any disadvantages to a plant-based diet? Are all plant-based diets healthy and what are the nutritional challenges for a patient on a plant-based diet? We’ll discuss these questions in this podcast on “Plant-Based Diets”. Our guest is Lisa Lammert, a registered dietician and nutritionist at the Mayo Clinic.

<p class="p1"> </p>
<p class="p1">Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/e7qvsnpk26njh442/23R01789_428_AF.mp3" length="36970665" type="audio/mpeg"/>
        <itunes:summary><![CDATA[HAPPY HOLIDAYS! Enjoy this re-release from Season 3 of Mayo Clinic Talks:
 
Host: Darryl S. Chutka M.D.
Guest: Lisa Lammert, R.D.N., L.D.
 
Cardiovascular disease is the leading cause of death to individuals in the U.S. Many feel that our typical American diet with its high saturated fat content is a major contributor to this. There’s good evidence that shows plant-based diets are cost-effective in lowering the risk factors for cardiovascular disease including obesity, hyperlipidemia, hypertension, and diabetes. They may also lower the number of medications an individual needs to take to manage their chronic diseases. So, are there any disadvantages to a plant-based diet? Are all plant-based diets healthy and what are the nutritional challenges for a patient on a plant-based diet? We’ll discuss these questions in this podcast on “Plant-Based Diets”. Our guest is Lisa Lammert, a registered dietician and nutritionist at the Mayo Clinic.

 
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 
]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1537</itunes:duration>
                <itunes:episode>636</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Communication and Hospice</title>
        <itunes:title>Communication and Hospice</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/communication-and-hospice/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/communication-and-hospice/#comments</comments>        <pubDate>Tue, 16 Dec 2025 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/28c55147-6dc4-39b7-b35a-bcb63f0b6beb</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Cory Ingram, M.D.</p>
<p>As primary care providers, we have the privilege of guiding our patients through their healthcare journey, healing their medical conditions, managing them through chronic illness and at times, assisting them through the final chapters of their life. The topic for today’s podcast is “Hospice”, an important though often underutilized part of that journey. Hospice is not about giving up, it’s about changing the direction and goal of our care from cure to comfort. It prioritizes quality of life and maintaining dignity for patients going through a very challenging period of their life. My guest is Cory Ingram, M.D., a family medicine and palliative care physician from the Mayo Clinic who has extensive experience and insight into this topic. He’ll guide us through when we should consider hospice, who qualifies for hospice and the importance of good communication skills in helping patients and their families during this last period of their life.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Cory Ingram, M.D.</p>
<p>As primary care providers, we have the privilege of guiding our patients through their healthcare journey, healing their medical conditions, managing them through chronic illness and at times, assisting them through the final chapters of their life. The topic for today’s podcast is “Hospice”, an important though often underutilized part of that journey. Hospice is not about giving up, it’s about changing the direction and goal of our care from cure to comfort. It prioritizes quality of life and maintaining dignity for patients going through a very challenging period of their life. My guest is Cory Ingram, M.D., a family medicine and palliative care physician from the Mayo Clinic who has extensive experience and insight into this topic. He’ll guide us through when we should consider hospice, who qualifies for hospice and the importance of good communication skills in helping patients and their families during this last period of their life.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/npnrmw74k8wfcvpx/WF6665400_Communication_and_Hospice_1_AF80pqn.mp3" length="37869552" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Cory Ingram, M.D.
As primary care providers, we have the privilege of guiding our patients through their healthcare journey, healing their medical conditions, managing them through chronic illness and at times, assisting them through the final chapters of their life. The topic for today’s podcast is “Hospice”, an important though often underutilized part of that journey. Hospice is not about giving up, it’s about changing the direction and goal of our care from cure to comfort. It prioritizes quality of life and maintaining dignity for patients going through a very challenging period of their life. My guest is Cory Ingram, M.D., a family medicine and palliative care physician from the Mayo Clinic who has extensive experience and insight into this topic. He’ll guide us through when we should consider hospice, who qualifies for hospice and the importance of good communication skills in helping patients and their families during this last period of their life.
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1569</itunes:duration>
                <itunes:episode>635</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Nutritional Supplements</title>
        <itunes:title>Nutritional Supplements</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/nutritional-supplements/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/nutritional-supplements/#comments</comments>        <pubDate>Tue, 09 Dec 2025 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/250c01d3-6775-3782-b87d-5c85216086a4</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Andrew R. Jagim, Ph.D.</p>
<p>Nutritional supplements are very popular with our patients. They are supposed to provide benefits that may not be present in our typical diet. Vitamins and minerals are the most common supplements taken, followed closely by sports nutrition products such as protein powders and energy drinks. Consumers buy supplements because they’re readily available, relatively low cost and they believe that supplements will help them achieve health benefits. Patients often assume that supplements are safe, yet some can cause significant health problems, especially when taken in higher doses. Some have the potential to interact with various prescription medications. Are there nutritional supplements our patients should be taking? Which ones are potentially harmful? How safe are these products and do supplements have any regulatory oversight? These are questions I’ll be asking my guest, Andrew R. Jagim, Ph.D., Director of Sports Medicine Research at the Mayo Clinic as we discuss “Nutritional Supplements”.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Andrew R. Jagim, Ph.D.</p>
<p>Nutritional supplements are very popular with our patients. They are supposed to provide benefits that may not be present in our typical diet. Vitamins and minerals are the most common supplements taken, followed closely by sports nutrition products such as protein powders and energy drinks. Consumers buy supplements because they’re readily available, relatively low cost and they believe that supplements will help them achieve health benefits. Patients often assume that supplements are safe, yet some can cause significant health problems, especially when taken in higher doses. Some have the potential to interact with various prescription medications. Are there nutritional supplements our patients should be taking? Which ones are potentially harmful? How safe are these products and do supplements have any regulatory oversight? These are questions I’ll be asking my guest, Andrew R. Jagim, Ph.D., Director of Sports Medicine Research at the Mayo Clinic as we discuss “Nutritional Supplements”.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8krcbyq8gzk8dkch/WF7500552_Supplements_-_Do_They_Work8thd9.mp3" length="36470752" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Andrew R. Jagim, Ph.D.
Nutritional supplements are very popular with our patients. They are supposed to provide benefits that may not be present in our typical diet. Vitamins and minerals are the most common supplements taken, followed closely by sports nutrition products such as protein powders and energy drinks. Consumers buy supplements because they’re readily available, relatively low cost and they believe that supplements will help them achieve health benefits. Patients often assume that supplements are safe, yet some can cause significant health problems, especially when taken in higher doses. Some have the potential to interact with various prescription medications. Are there nutritional supplements our patients should be taking? Which ones are potentially harmful? How safe are these products and do supplements have any regulatory oversight? These are questions I’ll be asking my guest, Andrew R. Jagim, Ph.D., Director of Sports Medicine Research at the Mayo Clinic as we discuss “Nutritional Supplements”.
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1515</itunes:duration>
                <itunes:episode>634</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Provider-Patient Relationship Skills</title>
        <itunes:title>Provider-Patient Relationship Skills</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/provider-patient-relationship-skills/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/provider-patient-relationship-skills/#comments</comments>        <pubDate>Tue, 02 Dec 2025 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/900bb7ae-c064-3d04-a3f5-232c425c4505</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Cory Ingram, M.D.</p>
<p>There are a couple outcomes in taking a medical history. Obviously, one is information gathering. You need to hear the patient’s symptoms to help form your differential diagnosis. The second, and equally important, is to help establish a relationship with that patient. There are several reasons a good provider-patient relationship is important. The patient is more likely to feel positive about their medical encounter, they’re more likely to be adherent to your recommendations regarding their health conditions, and they tend to be more forgiving if they experience an adverse event. What makes up a good provider-patient relationship? What can we do as clinicians to help establish a good relationship with our patients? Can we still establish a good relationship when we practice telemedicine? These are questions I’ll be asking my guest, Cory Ingram, M.D., a palliative care physician at the Mayo Clinic as we discuss “Provider-Patient Relationship Skills”.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Cory Ingram, M.D.</p>
<p>There are a couple outcomes in taking a medical history. Obviously, one is information gathering. You need to hear the patient’s symptoms to help form your differential diagnosis. The second, and equally important, is to help establish a relationship with that patient. There are several reasons a good provider-patient relationship is important. The patient is more likely to feel positive about their medical encounter, they’re more likely to be adherent to your recommendations regarding their health conditions, and they tend to be more forgiving if they experience an adverse event. What makes up a good provider-patient relationship? What can we do as clinicians to help establish a good relationship with our patients? Can we still establish a good relationship when we practice telemedicine? These are questions I’ll be asking my guest, Cory Ingram, M.D., a palliative care physician at the Mayo Clinic as we discuss “Provider-Patient Relationship Skills”.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5bdgb67y264j3arh/WF7608453_Provider-Patient_Relationship_Skills_AF6m25g.mp3" length="43020969" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Cory Ingram, M.D.
There are a couple outcomes in taking a medical history. Obviously, one is information gathering. You need to hear the patient’s symptoms to help form your differential diagnosis. The second, and equally important, is to help establish a relationship with that patient. There are several reasons a good provider-patient relationship is important. The patient is more likely to feel positive about their medical encounter, they’re more likely to be adherent to your recommendations regarding their health conditions, and they tend to be more forgiving if they experience an adverse event. What makes up a good provider-patient relationship? What can we do as clinicians to help establish a good relationship with our patients? Can we still establish a good relationship when we practice telemedicine? These are questions I’ll be asking my guest, Cory Ingram, M.D., a palliative care physician at the Mayo Clinic as we discuss “Provider-Patient Relationship Skills”.
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1788</itunes:duration>
                <itunes:episode>633</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Vascular Medicine Series: Lymphedema Challenges and Successes</title>
        <itunes:title>Vascular Medicine Series: Lymphedema Challenges and Successes</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/vascular-medicine-series-lymphedema-challenges-and-successes/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/vascular-medicine-series-lymphedema-challenges-and-successes/#comments</comments>        <pubDate>Tue, 25 Nov 2025 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/3f8633d5-f3ea-3ba1-b527-31ac3d183680</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guests: William J. Casey III, M.D. and Andrea L. Cheville, M.D.</p>
<p>There are numerous reasons a patient may develop swelling of an extremity. One of the less common reasons, but often misdiagnosed or undiagnosed is lymphedema. What is lymphedema, why does it occur and who’s at risk for it? Early recognition is important to prevent complications and primary care providers play a crucial role in identifying patients with lymphedema, coordinating their care and providing follow-up. How can we differentiate lymphedema from other causes of swelling? What are the potential complications if lymphedema is not correctly diagnosed and finally, what are some of the latest treatments available for the management of lymphedema? The topic for this podcast is “Lymphedema: Challenges and Success” and my guests include Andrea L. Cheville, M.D., a physician in the Department of Physical Medicine and Rehabilitation and William J. Casey, III, M.D., a physician in the Department of Plastic Surgery, both at the Mayo Clinic.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
<p>To hear more about this series: https://ce.mayo.edu/content/mayo-clinic-talks-vascular-medicine-series</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guests: William J. Casey III, M.D. and Andrea L. Cheville, M.D.</p>
<p>There are numerous reasons a patient may develop swelling of an extremity. One of the less common reasons, but often misdiagnosed or undiagnosed is lymphedema. What is lymphedema, why does it occur and who’s at risk for it? Early recognition is important to prevent complications and primary care providers play a crucial role in identifying patients with lymphedema, coordinating their care and providing follow-up. How can we differentiate lymphedema from other causes of swelling? What are the potential complications if lymphedema is not correctly diagnosed and finally, what are some of the latest treatments available for the management of lymphedema? The topic for this podcast is “Lymphedema: Challenges and Success” and my guests include Andrea L. Cheville, M.D., a physician in the Department of Physical Medicine and Rehabilitation and William J. Casey, III, M.D., a physician in the Department of Plastic Surgery, both at the Mayo Clinic.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
<p>To hear more about this series: https://ce.mayo.edu/content/mayo-clinic-talks-vascular-medicine-series</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/frs6gfg5rtc7vydw/WF7637165_Lymphedema_Challenges_and_Successavs4f.mp3" length="45701144" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guests: William J. Casey III, M.D. and Andrea L. Cheville, M.D.
There are numerous reasons a patient may develop swelling of an extremity. One of the less common reasons, but often misdiagnosed or undiagnosed is lymphedema. What is lymphedema, why does it occur and who’s at risk for it? Early recognition is important to prevent complications and primary care providers play a crucial role in identifying patients with lymphedema, coordinating their care and providing follow-up. How can we differentiate lymphedema from other causes of swelling? What are the potential complications if lymphedema is not correctly diagnosed and finally, what are some of the latest treatments available for the management of lymphedema? The topic for this podcast is “Lymphedema: Challenges and Success” and my guests include Andrea L. Cheville, M.D., a physician in the Department of Physical Medicine and Rehabilitation and William J. Casey, III, M.D., a physician in the Department of Plastic Surgery, both at the Mayo Clinic.
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 
To hear more about this series: https://ce.mayo.edu/content/mayo-clinic-talks-vascular-medicine-series]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1900</itunes:duration>
                <itunes:episode>632</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Common Foot Disorders "Agony of De-Feet"</title>
        <itunes:title>Common Foot Disorders "Agony of De-Feet"</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/common-foot-disorders-agony-of-de-feet/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/common-foot-disorders-agony-of-de-feet/#comments</comments>        <pubDate>Tue, 18 Nov 2025 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/1c1a8272-be7a-3c21-a951-47f3c6f1fde3</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Martin G. Ellman, D.P.M.</p>
<p>We don’t really appreciate our feet until they hurt and then we become extremely aware of every step we take. Plantar fasciitis, bunions, metatarsalgia; all foot disorders which can result in foot pain and represent common reasons for an outpatient visit. What’s the role of the primary care clinician in the evaluation of foot pain? How should these conditions be managed? I’ll be reviewing common causes of foot problems as well as the management of foot pain with Martin G. Ellman, D.P.M., a podiatrist at the Mayo Clinic as we discuss “The Agony of De-Feet”.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Martin G. Ellman, D.P.M.</p>
<p>We don’t really appreciate our feet until they hurt and then we become extremely aware of every step we take. Plantar fasciitis, bunions, metatarsalgia; all foot disorders which can result in foot pain and represent common reasons for an outpatient visit. What’s the role of the primary care clinician in the evaluation of foot pain? How should these conditions be managed? I’ll be reviewing common causes of foot problems as well as the management of foot pain with Martin G. Ellman, D.P.M., a podiatrist at the Mayo Clinic as we discuss “The Agony of De-Feet”.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bdmme9rq589aiid7/WF6738270_Common_Foot_Disorders_AFbqggr.mp3" length="32496517" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Martin G. Ellman, D.P.M.
We don’t really appreciate our feet until they hurt and then we become extremely aware of every step we take. Plantar fasciitis, bunions, metatarsalgia; all foot disorders which can result in foot pain and represent common reasons for an outpatient visit. What’s the role of the primary care clinician in the evaluation of foot pain? How should these conditions be managed? I’ll be reviewing common causes of foot problems as well as the management of foot pain with Martin G. Ellman, D.P.M., a podiatrist at the Mayo Clinic as we discuss “The Agony of De-Feet”.
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1335</itunes:duration>
                <itunes:episode>631</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Alzheimer’s Disease and Family Dynamics</title>
        <itunes:title>Alzheimer’s Disease and Family Dynamics</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/alzheimer-s-disease-and-family-dynamics/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/alzheimer-s-disease-and-family-dynamics/#comments</comments>        <pubDate>Tue, 11 Nov 2025 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/2c7a77ca-1dcf-3477-95e4-5b7f3b731d8a</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Christina Chen, M.D.</p>
<p>Alzheimer’s Disease affects not only the patient but also has a significant impact on that patient’s family. The family becomes stressed as emotional and physical burdens develop. The role of the primary care clinician in managing a patient with Alzheimer’s is not only to care for the patient but also help and support families as they go through a very complex, emotional journey. Today’s podcast will cover the changes in family dynamics which commonly occur in Alzheimer’s Disease including caregiver burden, legal decisions which need to be made, and difficult ethical choices which will be made as the disease progresses. What are some common sources of conflict within families as they care for their loved one with Alzheimer’s? What can we do as a clinician to help families through this difficult journey? How do we approach a situation where there’s disagreement in the family regarding management? These are some of the questions I’ll be asking my guest, Christina Chen, M.D., an internist and geriatrician in the Division of Community Internal Medicine at the Mayo Clinic as we discuss “Alzheimer’s Disease and Family Dynamics”.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Christina Chen, M.D.</p>
<p>Alzheimer’s Disease affects not only the patient but also has a significant impact on that patient’s family. The family becomes stressed as emotional and physical burdens develop. The role of the primary care clinician in managing a patient with Alzheimer’s is not only to care for the patient but also help and support families as they go through a very complex, emotional journey. Today’s podcast will cover the changes in family dynamics which commonly occur in Alzheimer’s Disease including caregiver burden, legal decisions which need to be made, and difficult ethical choices which will be made as the disease progresses. What are some common sources of conflict within families as they care for their loved one with Alzheimer’s? What can we do as a clinician to help families through this difficult journey? How do we approach a situation where there’s disagreement in the family regarding management? These are some of the questions I’ll be asking my guest, Christina Chen, M.D., an internist and geriatrician in the Division of Community Internal Medicine at the Mayo Clinic as we discuss “Alzheimer’s Disease and Family Dynamics”.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/j8c4hrmixmsukp2k/WF6748450_Alzheimers_and_Family_Dynamicsa67j9.mp3" length="42835926" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Christina Chen, M.D.
Alzheimer’s Disease affects not only the patient but also has a significant impact on that patient’s family. The family becomes stressed as emotional and physical burdens develop. The role of the primary care clinician in managing a patient with Alzheimer’s is not only to care for the patient but also help and support families as they go through a very complex, emotional journey. Today’s podcast will cover the changes in family dynamics which commonly occur in Alzheimer’s Disease including caregiver burden, legal decisions which need to be made, and difficult ethical choices which will be made as the disease progresses. What are some common sources of conflict within families as they care for their loved one with Alzheimer’s? What can we do as a clinician to help families through this difficult journey? How do we approach a situation where there’s disagreement in the family regarding management? These are some of the questions I’ll be asking my guest, Christina Chen, M.D., an internist and geriatrician in the Division of Community Internal Medicine at the Mayo Clinic as we discuss “Alzheimer’s Disease and Family Dynamics”.
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1780</itunes:duration>
                <itunes:episode>630</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mild Cognitive Impairment</title>
        <itunes:title>Mild Cognitive Impairment</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mild-cognitive-impairment/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mild-cognitive-impairment/#comments</comments>        <pubDate>Tue, 04 Nov 2025 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/66ac3c5e-f862-3409-965b-cfe2648cbd0e</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Ronald C. Petersen, M.D., Ph.D.</p>
<p>We all experience cognitive changes as we age. If you doubt this, try learning to play the piano with a group of 7-and 8-year-olds and see who sounds best at the recital. We tend to have difficulty with new learning and can struggle with short term memory. When do these cognitive changes become pathologic? Dementia results in a gradual decline in cognitive abilities, memory and behavior, severe enough to interfere with daily life. Between the cognitive changes that occur with aging and those with dementia, there is another medical entity, mild cognitive impairment. How does it differ from the normal cognitive changes of aging? How does it differ from dementia? And is it important for us to recognize it? These are some of the questions I’ll be asking my guest for today’s podcast, Ronald C. Petersen, M.D., Ph.D., a neurologist and internationally recognized expert in the field of dementia as we discuss “Mild Cognitive Impairment”. </p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Ronald C. Petersen, M.D., Ph.D.</p>
<p>We all experience cognitive changes as we age. If you doubt this, try learning to play the piano with a group of 7-and 8-year-olds and see who sounds best at the recital. We tend to have difficulty with new learning and can struggle with short term memory. When do these cognitive changes become pathologic? Dementia results in a gradual decline in cognitive abilities, memory and behavior, severe enough to interfere with daily life. Between the cognitive changes that occur with aging and those with dementia, there is another medical entity, mild cognitive impairment. How does it differ from the normal cognitive changes of aging? How does it differ from dementia? And is it important for us to recognize it? These are some of the questions I’ll be asking my guest for today’s podcast, Ronald C. Petersen, M.D., Ph.D., a neurologist and internationally recognized expert in the field of dementia as we discuss “Mild Cognitive Impairment”. </p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/k5k23kmmq59a2wu4/WF7484103_Mild_Cognitive_Impairment_AFajvbo.mp3" length="47606340" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Ronald C. Petersen, M.D., Ph.D.
We all experience cognitive changes as we age. If you doubt this, try learning to play the piano with a group of 7-and 8-year-olds and see who sounds best at the recital. We tend to have difficulty with new learning and can struggle with short term memory. When do these cognitive changes become pathologic? Dementia results in a gradual decline in cognitive abilities, memory and behavior, severe enough to interfere with daily life. Between the cognitive changes that occur with aging and those with dementia, there is another medical entity, mild cognitive impairment. How does it differ from the normal cognitive changes of aging? How does it differ from dementia? And is it important for us to recognize it? These are some of the questions I’ll be asking my guest for today’s podcast, Ronald C. Petersen, M.D., Ph.D., a neurologist and internationally recognized expert in the field of dementia as we discuss “Mild Cognitive Impairment”. 
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1982</itunes:duration>
                <itunes:episode>629</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Prostate Cancer</title>
        <itunes:title>Prostate Cancer</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/prostate-cancer/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/prostate-cancer/#comments</comments>        <pubDate>Thu, 30 Oct 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/a879d09f-6553-37ce-9d41-d2ffe41834b4</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Daniel M. Frendl, M.D., Ph.D.</p>
<p>Prostate cancer is quite common in middle age and older men and represents the second most common malignancy diagnosed in this population. Only skin cancer is more common. Early diagnosis is important and carries an excellent prognosis. There are several management options available for localized disease and some new treatments which can be used for both aggressive and more advanced disease. When should active surveillance be used when prostate cancer has been diagnosed? How does radiation therapy compare to surgical prostatectomy regarding long-term outcomes and what are some of the newer treatment options available for advanced disease? These are some of the questions I’ll be asking my guest, Daniel M. Frendl, M.D., Ph.D., a urologist from the Department of Urology at the Arizona campus of the Mayo Clinic as we discuss “Prostate Cancer”.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Daniel M. Frendl, M.D., Ph.D.</p>
<p>Prostate cancer is quite common in middle age and older men and represents the second most common malignancy diagnosed in this population. Only skin cancer is more common. Early diagnosis is important and carries an excellent prognosis. There are several management options available for localized disease and some new treatments which can be used for both aggressive and more advanced disease. When should active surveillance be used when prostate cancer has been diagnosed? How does radiation therapy compare to surgical prostatectomy regarding long-term outcomes and what are some of the newer treatment options available for advanced disease? These are some of the questions I’ll be asking my guest, Daniel M. Frendl, M.D., Ph.D., a urologist from the Department of Urology at the Arizona campus of the Mayo Clinic as we discuss “Prostate Cancer”.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qbpjyuyha46qi2ft/WF6826452_Prostate_Cancer8069a.mp3" length="37568669" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Daniel M. Frendl, M.D., Ph.D.
Prostate cancer is quite common in middle age and older men and represents the second most common malignancy diagnosed in this population. Only skin cancer is more common. Early diagnosis is important and carries an excellent prognosis. There are several management options available for localized disease and some new treatments which can be used for both aggressive and more advanced disease. When should active surveillance be used when prostate cancer has been diagnosed? How does radiation therapy compare to surgical prostatectomy regarding long-term outcomes and what are some of the newer treatment options available for advanced disease? These are some of the questions I’ll be asking my guest, Daniel M. Frendl, M.D., Ph.D., a urologist from the Department of Urology at the Arizona campus of the Mayo Clinic as we discuss “Prostate Cancer”.
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1563</itunes:duration>
                <itunes:episode>628</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Prostate Cancer Screening</title>
        <itunes:title>Prostate Cancer Screening</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/prostate-cancer-screening/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/prostate-cancer-screening/#comments</comments>        <pubDate>Tue, 28 Oct 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/1830cda9-03b5-3ce4-8912-a4c2710f269d</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Daniel M. Frendl, M.D., Ph.D.</p>
<p>If your practice includes middle age and older men, you’ve very likely diagnosed prostate cancer. It’s the most diagnosed non-skin cancer in men in the U.S. Its incidence rises with age, with a median age of around 66 years. When found early, prostate cancer is very treatable, and in most cases, curable. Prostate specific antigen, or PSA is very effective in detecting early prostate cancer, but its use has been controversial due to the risk of overdiagnosis and overtreatment. What are the current recommendations for prostate cancer screening with PSA? What’s the role of the digital rectal exam? How should we be using the PSA and what other tests are available for prostate cancer screening? The topic for this podcast is “Prostate Cancer Screening” and I’ll be asking these questions to my guest, Daniel M. Frendl, M.D., Ph.D., a urologist at the Arizona campus of the Mayo Clinic.</p>
<p>Tune in this Thursday for our next episode on "Prostate Cancer" releasing October 30, 2025.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Daniel M. Frendl, M.D., Ph.D.</p>
<p>If your practice includes middle age and older men, you’ve very likely diagnosed prostate cancer. It’s the most diagnosed non-skin cancer in men in the U.S. Its incidence rises with age, with a median age of around 66 years. When found early, prostate cancer is very treatable, and in most cases, curable. Prostate specific antigen, or PSA is very effective in detecting early prostate cancer, but its use has been controversial due to the risk of overdiagnosis and overtreatment. What are the current recommendations for prostate cancer screening with PSA? What’s the role of the digital rectal exam? How should we be using the PSA and what other tests are available for prostate cancer screening? The topic for this podcast is “Prostate Cancer Screening” and I’ll be asking these questions to my guest, Daniel M. Frendl, M.D., Ph.D., a urologist at the Arizona campus of the Mayo Clinic.</p>
<p><em>Tune in this Thursday for our next episode on "Prostate Cancer" releasing October 30, 2025.</em></p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9rh9pnk53whie3sd/WF6826452_Prostate_Cancer_Screening69zz9.mp3" length="40902901" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Daniel M. Frendl, M.D., Ph.D.
If your practice includes middle age and older men, you’ve very likely diagnosed prostate cancer. It’s the most diagnosed non-skin cancer in men in the U.S. Its incidence rises with age, with a median age of around 66 years. When found early, prostate cancer is very treatable, and in most cases, curable. Prostate specific antigen, or PSA is very effective in detecting early prostate cancer, but its use has been controversial due to the risk of overdiagnosis and overtreatment. What are the current recommendations for prostate cancer screening with PSA? What’s the role of the digital rectal exam? How should we be using the PSA and what other tests are available for prostate cancer screening? The topic for this podcast is “Prostate Cancer Screening” and I’ll be asking these questions to my guest, Daniel M. Frendl, M.D., Ph.D., a urologist at the Arizona campus of the Mayo Clinic.
Tune in this Thursday for our next episode on "Prostate Cancer" releasing October 30, 2025.
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1700</itunes:duration>
                <itunes:episode>627</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Obstetric and Gynecologic Health Series: Labor and Delivery</title>
        <itunes:title>Obstetric and Gynecologic Health Series: Labor and Delivery</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/obstetric-and-gynecologic-health-series-labor-and-delivery/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/obstetric-and-gynecologic-health-series-labor-and-delivery/#comments</comments>        <pubDate>Thu, 23 Oct 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/e68c67b2-27b0-30b8-9663-dbb088c45b9f</guid>
                                    <description><![CDATA[<p>Guest: Rebecca Smith, Ph. D, APRN, CNM
Hosts: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP</p>
<p>Rebecca Smith provides a comprehensive overview of labor and delivery, including the stages of labor, assessment techniques, and monitoring practices. The episode also addresses potential complications and their management.</p>
<p>Learning Objectives:</p>
<ul>
<li>Describe the stages, duration, and monitoring of labor and delivery.</li>
<li>Compare and contrast complications that may arise during pregnancy and delivery.</li>
</ul>
<p>Learn more about this series: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-obstetric-and-gynecologic-health'>Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Rebecca Smith, Ph. D, APRN, CNM<br>
Hosts: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP</p>
<p>Rebecca Smith provides a comprehensive overview of labor and delivery, including the stages of labor, assessment techniques, and monitoring practices. The episode also addresses potential complications and their management.</p>
<p>Learning Objectives:</p>
<ul>
<li>Describe the stages, duration, and monitoring of labor and delivery.</li>
<li>Compare and contrast complications that may arise during pregnancy and delivery.</li>
</ul>
<p>Learn more about this series: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-obstetric-and-gynecologic-health'>Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8uveeygtj78kceiw/WF6509150_Labor_and_Delivery7suz3.mp3" length="30938328" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Rebecca Smith, Ph. D, APRN, CNMHosts: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP
Rebecca Smith provides a comprehensive overview of labor and delivery, including the stages of labor, assessment techniques, and monitoring practices. The episode also addresses potential complications and their management.
Learning Objectives:

Describe the stages, duration, and monitoring of labor and delivery.
Compare and contrast complications that may arise during pregnancy and delivery.

Learn more about this series: Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development
Connect and listen with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1288</itunes:duration>
                <itunes:episode>626</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Obstetric and Gynecologic Health Series: Complicated Pregnancy</title>
        <itunes:title>Obstetric and Gynecologic Health Series: Complicated Pregnancy</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/obstetric-and-gynecologic-health-series-complicated-pregnancy/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/obstetric-and-gynecologic-health-series-complicated-pregnancy/#comments</comments>        <pubDate>Tue, 21 Oct 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/ae200350-2eff-3f80-b898-6ce56e8c3076</guid>
                                    <description><![CDATA[<p>Guest: Julie Lamppa, APRN, CNM
Hosts: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP</p>
<p>Julie Lamppa discusses complications that can arise during pregnancy, including gestational diabetes, preeclampsia, and other abnormalities. This episode emphasizes early recognition and multidisciplinary management.</p>
<p>Learning Objectives:</p>
<ul>
<li>Differentiate various pregnancy complications and their clinical implications.</li>
</ul>
<p>Learn more about this series: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-obstetric-and-gynecologic-health'>Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Julie Lamppa, APRN, CNM<br>
Hosts: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP</p>
<p>Julie Lamppa discusses complications that can arise during pregnancy, including gestational diabetes, preeclampsia, and other abnormalities. This episode emphasizes early recognition and multidisciplinary management.</p>
<p>Learning Objectives:</p>
<ul>
<li>Differentiate various pregnancy complications and their clinical implications.</li>
</ul>
<p>Learn more about this series: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-obstetric-and-gynecologic-health'>Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6jd4frehzjjtjwse/WF6255251_Complicated_Pregnancy96gl1.mp3" length="64227658" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Julie Lamppa, APRN, CNMHosts: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP
Julie Lamppa discusses complications that can arise during pregnancy, including gestational diabetes, preeclampsia, and other abnormalities. This episode emphasizes early recognition and multidisciplinary management.
Learning Objectives:

Differentiate various pregnancy complications and their clinical implications.

Learn more about this series: Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development
Connect and listen with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2669</itunes:duration>
                <itunes:episode>625</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Obstetric and Gynecologic Health Series: Gynecologic Pain Disorders</title>
        <itunes:title>Obstetric and Gynecologic Health Series: Gynecologic Pain Disorders</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/obstetric-and-gynecologic-health-series-gynecologic-pain-disorders/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/obstetric-and-gynecologic-health-series-gynecologic-pain-disorders/#comments</comments>        <pubDate>Thu, 16 Oct 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/2de716fe-b07d-30fa-925f-52d1399eafc2</guid>
                                    <description><![CDATA[<p>Guest: Jenna Wygant, APRN, CNP, DNP
Hosts: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP</p>
<p>Jenna Wygant discusses common gynecologic pain disorders such as endometriosis and pelvic inflammatory disease. The episode highlights diagnostic challenges and treatment strategies to improve patient outcomes.</p>
<p>Learning Objectives:</p>
<ul>
<li>Identify conditions contributing to gynecologic pain.</li>
<li>Review signs/symptoms, risk factors, diagnostic approaches, and treatment options.</li>
</ul>
<p>Learn more about this series: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-obstetric-and-gynecologic-health'>Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Jenna Wygant, APRN, CNP, DNP<br>
Hosts: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP</p>
<p>Jenna Wygant discusses common gynecologic pain disorders such as endometriosis and pelvic inflammatory disease. The episode highlights diagnostic challenges and treatment strategies to improve patient outcomes.</p>
<p>Learning Objectives:</p>
<ul>
<li>Identify conditions contributing to gynecologic pain.</li>
<li>Review signs/symptoms, risk factors, diagnostic approaches, and treatment options.</li>
</ul>
<p>Learn more about this series: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-obstetric-and-gynecologic-health'>Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kwu2cwhhwvqgd254/WF6011350_Gyn_Pain_Disordersatv6i.mp3" length="26361387" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Jenna Wygant, APRN, CNP, DNPHosts: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP
Jenna Wygant discusses common gynecologic pain disorders such as endometriosis and pelvic inflammatory disease. The episode highlights diagnostic challenges and treatment strategies to improve patient outcomes.
Learning Objectives:

Identify conditions contributing to gynecologic pain.
Review signs/symptoms, risk factors, diagnostic approaches, and treatment options.

Learn more about this series: Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development
Connect and listen with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1097</itunes:duration>
                <itunes:episode>624</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Obstetric and Gynecologic Health Series: Gynecologic Cancer</title>
        <itunes:title>Obstetric and Gynecologic Health Series: Gynecologic Cancer</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/obstetric-and-gynecologic-health-series-gynecologic-cancer/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/obstetric-and-gynecologic-health-series-gynecologic-cancer/#comments</comments>        <pubDate>Tue, 14 Oct 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/0cf392d3-3abc-3e44-940e-a47f00ecde77</guid>
                                    <description><![CDATA[<p>Guest: Casey Lawler, P.A.-C
Hosts: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP</p>
<p>This episode provides an overview of gynecologic cancers, including cervical, ovarian, uterine, and vulvar cancers. Casey Lawler shares insights into the causes, risk factors, and clinical management of these conditions.</p>
<p>Learning Objectives:</p>
<ul>
<li>Describe the major types of gynecologic cancers.</li>
<li>Compare and contrast causes, risk factors, signs/symptoms, diagnostic methods, and treatment options.
<p> </p>
</li>
</ul>
<p>Learn more about this series: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-obstetric-and-gynecologic-health'>Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Casey Lawler, P.A.-C<br>
Hosts: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP</p>
<p>This episode provides an overview of gynecologic cancers, including cervical, ovarian, uterine, and vulvar cancers. Casey Lawler shares insights into the causes, risk factors, and clinical management of these conditions.</p>
<p>Learning Objectives:</p>
<ul>
<li>Describe the major types of gynecologic cancers.</li>
<li>Compare and contrast causes, risk factors, signs/symptoms, diagnostic methods, and treatment options.
<p> </p>
</li>
</ul>
<p>Learn more about this series: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-obstetric-and-gynecologic-health'>Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/n2nkin67y36arkat/WF6456355_Gyn_Cancerb64t6.mp3" length="24585072" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Casey Lawler, P.A.-CHosts: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP
This episode provides an overview of gynecologic cancers, including cervical, ovarian, uterine, and vulvar cancers. Casey Lawler shares insights into the causes, risk factors, and clinical management of these conditions.
Learning Objectives:

Describe the major types of gynecologic cancers.
Compare and contrast causes, risk factors, signs/symptoms, diagnostic methods, and treatment options.
 


Learn more about this series: Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development
Connect and listen with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1014</itunes:duration>
                <itunes:episode>623</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Obstetric and Gynecologic Health Series: Breast Cancer</title>
        <itunes:title>Obstetric and Gynecologic Health Series: Breast Cancer</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/obstetric-and-gynecologic-health-series-breast-cancer/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/obstetric-and-gynecologic-health-series-breast-cancer/#comments</comments>        <pubDate>Tue, 07 Oct 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/c821d420-212b-3a00-8969-6e6098722fe3</guid>
                                    <description><![CDATA[<p>Guest: Susan Kok, M.D.
Hosts: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP</p>
<p>Dr. Susan Kok joins the podcast to explore both non-invasive and invasive breast cancers. This episode covers risk factors, symptom recognition, diagnostic tools, and treatment modalities, with a focus on individualized care and shared decision-making.</p>
<p>Learning Objectives:</p>
<ul>
<li>Understand the spectrum of non-invasive breast cancers.</li>
<li>Identify risk factors, symptoms, and diagnostic tools for invasive breast cancers.</li>
<li>Discuss treatment options tailored to diagnosis and patient preferences.</li>
</ul>
<p>Learn more about this series: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-obstetric-and-gynecologic-health'>Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Susan Kok, M.D.<br>
Hosts: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP</p>
<p>Dr. Susan Kok joins the podcast to explore both non-invasive and invasive breast cancers. This episode covers risk factors, symptom recognition, diagnostic tools, and treatment modalities, with a focus on individualized care and shared decision-making.</p>
<p>Learning Objectives:</p>
<ul>
<li>Understand the spectrum of non-invasive breast cancers.</li>
<li>Identify risk factors, symptoms, and diagnostic tools for invasive breast cancers.</li>
<li>Discuss treatment options tailored to diagnosis and patient preferences.</li>
</ul>
<p>Learn more about this series: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-obstetric-and-gynecologic-health'>Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/77z78wzw2syj9rkk/WF5963650_Breast_Cancerapuqc.mp3" length="55169647" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Susan Kok, M.D.Hosts: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP
Dr. Susan Kok joins the podcast to explore both non-invasive and invasive breast cancers. This episode covers risk factors, symptom recognition, diagnostic tools, and treatment modalities, with a focus on individualized care and shared decision-making.
Learning Objectives:

Understand the spectrum of non-invasive breast cancers.
Identify risk factors, symptoms, and diagnostic tools for invasive breast cancers.
Discuss treatment options tailored to diagnosis and patient preferences.

Learn more about this series: Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development
Connect and listen with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2290</itunes:duration>
                <itunes:episode>622</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Obstetric and Gynecologic Health Series: Benign Breast Tumor Conditions</title>
        <itunes:title>Obstetric and Gynecologic Health Series: Benign Breast Tumor Conditions</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/obstetric-and-gynecologic-health-series-benign-breast-tumor-conditions/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/obstetric-and-gynecologic-health-series-benign-breast-tumor-conditions/#comments</comments>        <pubDate>Tue, 30 Sep 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/ca71226a-5200-3036-adea-d8c7466a2ebd</guid>
                                    <description><![CDATA[<p>Guest: Danielle O’Laughlin, PA-C, MS
Hosts: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP</p>
<p>In this episode, Danielle O’Laughlin discusses benign breast tumor conditions and other non-cancerous growths. Listeners will gain insight into the clinical presentation, diagnostic evaluation, and management strategies for these common breast findings.</p>
<p>Learning Objectives:</p>
<ul>
<li>Review the types of benign breast tumors and their clinical features.</li>
<li>Differentiate between symptoms, diagnostic approaches, and treatment options for various benign breast conditions.</li>
</ul>
<p>Learn more about this series: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-obstetric-and-gynecologic-health'>Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Danielle O’Laughlin, PA-C, MS<br>
Hosts: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP</p>
<p>In this episode, Danielle O’Laughlin discusses benign breast tumor conditions and other non-cancerous growths. Listeners will gain insight into the clinical presentation, diagnostic evaluation, and management strategies for these common breast findings.</p>
<p>Learning Objectives:</p>
<ul>
<li>Review the types of benign breast tumors and their clinical features.</li>
<li>Differentiate between symptoms, diagnostic approaches, and treatment options for various benign breast conditions.</li>
</ul>
<p>Learn more about this series: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-obstetric-and-gynecologic-health'>Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/757zrbfcdsskinqq/WF5998855_Benign_Breast_Tumor_Conditions98zq9.mp3" length="15787976" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Danielle O’Laughlin, PA-C, MSHosts: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP
In this episode, Danielle O’Laughlin discusses benign breast tumor conditions and other non-cancerous growths. Listeners will gain insight into the clinical presentation, diagnostic evaluation, and management strategies for these common breast findings.
Learning Objectives:

Review the types of benign breast tumors and their clinical features.
Differentiate between symptoms, diagnostic approaches, and treatment options for various benign breast conditions.

Learn more about this series: Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development
Connect and listen with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>656</itunes:duration>
                <itunes:episode>621</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Vascular Medicine Series: Vascular Wound Treatments</title>
        <itunes:title>Vascular Medicine Series: Vascular Wound Treatments</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/vascular-medicine-series-vascular-wound-treatments/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/vascular-medicine-series-vascular-wound-treatments/#comments</comments>        <pubDate>Tue, 23 Sep 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/890519f1-3f06-331e-b884-e2550c464775</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Matthew (Mark) Melin, M.D.</p>
<p>Vascular wounds can be quite challenging. If untreated, they can lead to infection, even sepsis, hospitalization and occasionally, amputation. Effective treatment requires an accurate diagnosis and recognition of the specific type of vascular wound you’re dealing with. Even when the type of wound is correctly identified and is being treated appropriately, healing can be slow. What diagnostic tools are available to help us? How does a venous insufficiency ulcer differ from an arterial ulcer? What’s the best treatment for these wounds and when should we refer our patient to a vascular specialist? The topic for this podcast is “Vascular Wound Treatments” and these are some of the questions I’ll be asking my guest, Matthew (Mark) Melin, M.D., a vascular specialist from the Department of Cardiovascular Medicine at the Mayo Clinic.</p>
<p class="p1"><a href='https://ce.mayo.edu/content/mayo-clinic-talks-vascular-whats-circulating'>Mayo Clinic Talks: Vascular "What's Circulating" | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Matthew (Mark) Melin, M.D.</p>
<p>Vascular wounds can be quite challenging. If untreated, they can lead to infection, even sepsis, hospitalization and occasionally, amputation. Effective treatment requires an accurate diagnosis and recognition of the specific type of vascular wound you’re dealing with. Even when the type of wound is correctly identified and is being treated appropriately, healing can be slow. What diagnostic tools are available to help us? How does a venous insufficiency ulcer differ from an arterial ulcer? What’s the best treatment for these wounds and when should we refer our patient to a vascular specialist? The topic for this podcast is “Vascular Wound Treatments” and these are some of the questions I’ll be asking my guest, Matthew (Mark) Melin, M.D., a vascular specialist from the Department of Cardiovascular Medicine at the Mayo Clinic.</p>
<p class="p1"><a href='https://ce.mayo.edu/content/mayo-clinic-talks-vascular-whats-circulating'>Mayo Clinic Talks: Vascular "What's Circulating" | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gffmn4nzh4fsg78z/WF7416550_Vascular_Wound_Treatments6g0bm.mp3" length="42445128" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Matthew (Mark) Melin, M.D.
Vascular wounds can be quite challenging. If untreated, they can lead to infection, even sepsis, hospitalization and occasionally, amputation. Effective treatment requires an accurate diagnosis and recognition of the specific type of vascular wound you’re dealing with. Even when the type of wound is correctly identified and is being treated appropriately, healing can be slow. What diagnostic tools are available to help us? How does a venous insufficiency ulcer differ from an arterial ulcer? What’s the best treatment for these wounds and when should we refer our patient to a vascular specialist? The topic for this podcast is “Vascular Wound Treatments” and these are some of the questions I’ll be asking my guest, Matthew (Mark) Melin, M.D., a vascular specialist from the Department of Cardiovascular Medicine at the Mayo Clinic.
Mayo Clinic Talks: Vascular "What's Circulating" | Mayo Clinic School of Continuous Professional Development
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1765</itunes:duration>
                <itunes:episode>620</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Claiming Your Voice and Why Women in Medicine Need a Clear Professional Narrative</title>
        <itunes:title>Claiming Your Voice and Why Women in Medicine Need a Clear Professional Narrative</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/claiming-your-voice-and-why-women-in-medicine-need-a-clear-professional-narrative/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/claiming-your-voice-and-why-women-in-medicine-need-a-clear-professional-narrative/#comments</comments>        <pubDate>Fri, 19 Sep 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/bed1d465-ffb5-37fe-ad3e-fe4c21ed27a4</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Neha P. Raukar, M.D., M.S.</p>
<p>Women in medicine have made significant strides over the past few decades, yet some still face a variety of challenges and barriers. They commonly encounter inequalities that can affect their professional growth and overall well-being. Common issues include pay disparity, underrepresentation in leadership positions and gender discrimination, just to name a few. Some medical specialties tend to be male-dominated and can be less welcoming to women. As a result, women physicians have higher rates of professional burnout and often experience a less satisfying career. My guest for this podcast is Neha P. Raukar, M.D., M.S., an emergency medicine physician at the Mayo Clinic. The topic we’ll be discussing is “Claiming Your Voice and Why Women in Medicine Need a Clear Professional Narrative”.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Neha P. Raukar, M.D., M.S.</p>
<p>Women in medicine have made significant strides over the past few decades, yet some still face a variety of challenges and barriers. They commonly encounter inequalities that can affect their professional growth and overall well-being. Common issues include pay disparity, underrepresentation in leadership positions and gender discrimination, just to name a few. Some medical specialties tend to be male-dominated and can be less welcoming to women. As a result, women physicians have higher rates of professional burnout and often experience a less satisfying career. My guest for this podcast is Neha P. Raukar, M.D., M.S., an emergency medicine physician at the Mayo Clinic. The topic we’ll be discussing is “Claiming Your Voice and Why Women in Medicine Need a Clear Professional Narrative”.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/993wi62ngruffns2/WF7374621_Why_Women_in_Medicine_Need_a_Clear_Professional_Narrative_AFbbjsy.mp3" length="23342968" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Neha P. Raukar, M.D., M.S.
Women in medicine have made significant strides over the past few decades, yet some still face a variety of challenges and barriers. They commonly encounter inequalities that can affect their professional growth and overall well-being. Common issues include pay disparity, underrepresentation in leadership positions and gender discrimination, just to name a few. Some medical specialties tend to be male-dominated and can be less welcoming to women. As a result, women physicians have higher rates of professional burnout and often experience a less satisfying career. My guest for this podcast is Neha P. Raukar, M.D., M.S., an emergency medicine physician at the Mayo Clinic. The topic we’ll be discussing is “Claiming Your Voice and Why Women in Medicine Need a Clear Professional Narrative”.
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>971</itunes:duration>
                <itunes:episode>619</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Vascular Medicine Series: Vascular Malformations</title>
        <itunes:title>Vascular Medicine Series: Vascular Malformations</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/vascular-medicine-series-vascular-malformations/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/vascular-medicine-series-vascular-malformations/#comments</comments>        <pubDate>Thu, 18 Sep 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/dddd8a9f-0db6-3ec4-89c8-3cd9ee854504</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guests: Haraldur Bjarnason, M.D.; and Megha M. Tollefson, M.D.</p>
<p>Vascular malformations are anomalies of vessels that can cause a variety of potentially serious health problems depending on their type, location, and size. They may involve arterial, venous or lymphatic vessels. They’re often progressive and may enlarge over time. They’re best diagnosed with one or more imaging studies and the treatment depends on the type of vascular malformation. Management usually requires a multi-disciplinary approach in order to be most effective. What are the most common types of vascular malformations? What organs are typically involved? What are some of the more serious medical complications they may cause and how should we manage them? The topic for this podcast is “Vascular Malformations” and these are questions I’ll be asking my guests, Haraldur Bjarnason, M.D., an interventional and vascular radiologist and Megha M. Tollefson, M.D., a dermatologist, both from the Mayo Clinic.</p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-vascular-whats-circulating'>Mayo Clinic Talks: Vascular Medicine Series | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guests: Haraldur Bjarnason, M.D.; and Megha M. Tollefson, M.D.</p>
<p>Vascular malformations are anomalies of vessels that can cause a variety of potentially serious health problems depending on their type, location, and size. They may involve arterial, venous or lymphatic vessels. They’re often progressive and may enlarge over time. They’re best diagnosed with one or more imaging studies and the treatment depends on the type of vascular malformation. Management usually requires a multi-disciplinary approach in order to be most effective. What are the most common types of vascular malformations? What organs are typically involved? What are some of the more serious medical complications they may cause and how should we manage them? The topic for this podcast is “Vascular Malformations” and these are questions I’ll be asking my guests, Haraldur Bjarnason, M.D., an interventional and vascular radiologist and Megha M. Tollefson, M.D., a dermatologist, both from the Mayo Clinic.</p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-vascular-whats-circulating'>Mayo Clinic Talks: Vascular Medicine Series | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/keiesz7sn42p56mt/WF7044241_Vascular_Malformation70hrz.mp3" length="32667264" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guests: Haraldur Bjarnason, M.D.; and Megha M. Tollefson, M.D.
Vascular malformations are anomalies of vessels that can cause a variety of potentially serious health problems depending on their type, location, and size. They may involve arterial, venous or lymphatic vessels. They’re often progressive and may enlarge over time. They’re best diagnosed with one or more imaging studies and the treatment depends on the type of vascular malformation. Management usually requires a multi-disciplinary approach in order to be most effective. What are the most common types of vascular malformations? What organs are typically involved? What are some of the more serious medical complications they may cause and how should we manage them? The topic for this podcast is “Vascular Malformations” and these are questions I’ll be asking my guests, Haraldur Bjarnason, M.D., an interventional and vascular radiologist and Megha M. Tollefson, M.D., a dermatologist, both from the Mayo Clinic.
Mayo Clinic Talks: Vascular Medicine Series | Mayo Clinic School of Continuous Professional Development
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1353</itunes:duration>
                <itunes:episode>618</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Vascular Medicine Series: Thoracic Outlet Syndrome</title>
        <itunes:title>Vascular Medicine Series: Thoracic Outlet Syndrome</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/vascular-medicine-series-thoracic-outlet-syndrome/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/vascular-medicine-series-thoracic-outlet-syndrome/#comments</comments>        <pubDate>Tue, 16 Sep 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/31cfe09c-ad81-3175-87b0-bf25af585b1a</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guests: Sam Farres, M.D.; and Ryan A. Meverden, PA-C</p>
<p>Thoracic outlet syndromes is a great masquerader and often mistaken for a variety of other health conditions including cervical radiculopathy, carpal tunnel syndrome, rotator cuff injury or even multiple sclerosis. It has several causes which account for the variety of its clinical presentations. Because of this, the diagnosis is commonly delayed or diagnosed incorrectly.  Yet, it’s crucial to establish an early and accurate diagnosis as this can prevent potential progression of neurologic damage or in some cases life-threatening vascular complications. It also prevents unnecessary treatments and inappropriate interventions. The topic for this podcast is “Thoracic Outlet Syndrome” and my guests include Ryan Meverden, PA-C, a physician assistant in the Vascular Center at the Rochester campus of the Mayo Clinic and Sam Farres, M.D., Division Chair of Vascular Surgery at the Florida campus of the Mayo Clinic. As we discuss thoracic outlet syndrome, we’ll review the variety of presenting symptoms, potential complications, appropriate tests to evaluate patients and effective management strategies.</p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-vascular-whats-circulating'>Mayo Clinic Talks: Vascular Medicine Series | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guests: Sam Farres, M.D.; and Ryan A. Meverden, PA-C</p>
<p>Thoracic outlet syndromes is a great masquerader and often mistaken for a variety of other health conditions including cervical radiculopathy, carpal tunnel syndrome, rotator cuff injury or even multiple sclerosis. It has several causes which account for the variety of its clinical presentations. Because of this, the diagnosis is commonly delayed or diagnosed incorrectly.  Yet, it’s crucial to establish an early and accurate diagnosis as this can prevent potential progression of neurologic damage or in some cases life-threatening vascular complications. It also prevents unnecessary treatments and inappropriate interventions. The topic for this podcast is “Thoracic Outlet Syndrome” and my guests include Ryan Meverden, PA-C, a physician assistant in the Vascular Center at the Rochester campus of the Mayo Clinic and Sam Farres, M.D., Division Chair of Vascular Surgery at the Florida campus of the Mayo Clinic. As we discuss thoracic outlet syndrome, we’ll review the variety of presenting symptoms, potential complications, appropriate tests to evaluate patients and effective management strategies.</p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-vascular-whats-circulating'>Mayo Clinic Talks: Vascular Medicine Series | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6ws3us94y7tmp4du/WF6653001_Thoracic_Outlet_Syndromeaupdu.mp3" length="26207238" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guests: Sam Farres, M.D.; and Ryan A. Meverden, PA-C
Thoracic outlet syndromes is a great masquerader and often mistaken for a variety of other health conditions including cervical radiculopathy, carpal tunnel syndrome, rotator cuff injury or even multiple sclerosis. It has several causes which account for the variety of its clinical presentations. Because of this, the diagnosis is commonly delayed or diagnosed incorrectly.  Yet, it’s crucial to establish an early and accurate diagnosis as this can prevent potential progression of neurologic damage or in some cases life-threatening vascular complications. It also prevents unnecessary treatments and inappropriate interventions. The topic for this podcast is “Thoracic Outlet Syndrome” and my guests include Ryan Meverden, PA-C, a physician assistant in the Vascular Center at the Rochester campus of the Mayo Clinic and Sam Farres, M.D., Division Chair of Vascular Surgery at the Florida campus of the Mayo Clinic. As we discuss thoracic outlet syndrome, we’ll review the variety of presenting symptoms, potential complications, appropriate tests to evaluate patients and effective management strategies.
Mayo Clinic Talks: Vascular Medicine Series | Mayo Clinic School of Continuous Professional Development
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1080</itunes:duration>
                <itunes:episode>617</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Vascular Medicine Series: Peripheral Arterial Disease</title>
        <itunes:title>Vascular Medicine Series: Peripheral Arterial Disease</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/vascular-medicine-series-peripheral-arterial-disease/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/vascular-medicine-series-peripheral-arterial-disease/#comments</comments>        <pubDate>Thu, 11 Sep 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/1fc89d27-56c9-3945-a89d-55a90b8f751b</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Stan Henkin, M.D.</p>
<p>Peripheral arterial disease is a manifestation of atherosclerosis and becomes more common with advancing age.  In its early stages, it can be quite difficult to diagnose. Although claudication is the most classic symptom, many remain asymptomatic, especially if they have limited ability to ambulate. Although risk factor modification is important in disease management, overall treatment options have been somewhat disappointing. How can we diagnose PAD early and are there advantages in recognizing the disease in an early stage? What are the best ways to establish a diagnosis and what treatment options do we have available?  Our topic for this podcast is “Peripheral Arterial Disease” and these are questions I’ll asking my guest, Stan Henkin, M.D., a vascular medicine specialist from the Department of Cardiovascular Medicine at the Mayo Clinic.</p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-vascular-whats-circulating'>Mayo Clinic Talks: Vascular Medicine Series | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Stan Henkin, M.D.</p>
<p>Peripheral arterial disease is a manifestation of atherosclerosis and becomes more common with advancing age.  In its early stages, it can be quite difficult to diagnose. Although claudication is the most classic symptom, many remain asymptomatic, especially if they have limited ability to ambulate. Although risk factor modification is important in disease management, overall treatment options have been somewhat disappointing. How can we diagnose PAD early and are there advantages in recognizing the disease in an early stage? What are the best ways to establish a diagnosis and what treatment options do we have available?  Our topic for this podcast is “Peripheral Arterial Disease” and these are questions I’ll asking my guest, Stan Henkin, M.D., a vascular medicine specialist from the Department of Cardiovascular Medicine at the Mayo Clinic.</p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-vascular-whats-circulating'>Mayo Clinic Talks: Vascular Medicine Series | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6c5f3hgd3sdejzva/WF6548763_Peripheral_Arterial_Disease7drmw.mp3" length="49491062" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Stan Henkin, M.D.
Peripheral arterial disease is a manifestation of atherosclerosis and becomes more common with advancing age.  In its early stages, it can be quite difficult to diagnose. Although claudication is the most classic symptom, many remain asymptomatic, especially if they have limited ability to ambulate. Although risk factor modification is important in disease management, overall treatment options have been somewhat disappointing. How can we diagnose PAD early and are there advantages in recognizing the disease in an early stage? What are the best ways to establish a diagnosis and what treatment options do we have available?  Our topic for this podcast is “Peripheral Arterial Disease” and these are questions I’ll asking my guest, Stan Henkin, M.D., a vascular medicine specialist from the Department of Cardiovascular Medicine at the Mayo Clinic.
Mayo Clinic Talks: Vascular Medicine Series | Mayo Clinic School of Continuous Professional Development
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2060</itunes:duration>
                <itunes:episode>616</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Vascular Medicine Series: How to Choose Your Anticoagulant</title>
        <itunes:title>Vascular Medicine Series: How to Choose Your Anticoagulant</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/vascular-medicine-series-how-to-choose-your-anticoagulant/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/vascular-medicine-series-how-to-choose-your-anticoagulant/#comments</comments>        <pubDate>Tue, 09 Sep 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/dd840deb-2f17-30ec-9c47-f603193eb3e2</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Ana I. Casanegra, M.D., M.S.</p>
<p>For many decades, we really only had one option for providing chronic anticoagulation, warfarin. We learned how to manage the many drug and food interactions, frequently changing the warfarin dose as we tried to keep our patients in therapeutic range. Now we have a variety of choices with the direct-acting oral anticoagulants, or DOAC’s. How do the newer agents compare to warfarin in effectiveness? Are they really safer than warfarin? Do they ever require any monitoring? What’s the latest on reversing the anticoagulant effect? I’ll be discussing these topics and more with my guest, Ana I. Casanegra, M.D., M.S., a vascular medicine specialist at the Mayo Clinic. The topic for this podcast is “How to Choose Your Anticoagulant”.</p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-vascular-whats-circulating'>Mayo Clinic Talks: Vascular Medicine Series | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Ana I. Casanegra, M.D., M.S.</p>
<p>For many decades, we really only had one option for providing chronic anticoagulation, warfarin. We learned how to manage the many drug and food interactions, frequently changing the warfarin dose as we tried to keep our patients in therapeutic range. Now we have a variety of choices with the direct-acting oral anticoagulants, or DOAC’s. How do the newer agents compare to warfarin in effectiveness? Are they really safer than warfarin? Do they ever require any monitoring? What’s the latest on reversing the anticoagulant effect? I’ll be discussing these topics and more with my guest, Ana I. Casanegra, M.D., M.S., a vascular medicine specialist at the Mayo Clinic. The topic for this podcast is “How to Choose Your Anticoagulant”.</p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-vascular-whats-circulating'>Mayo Clinic Talks: Vascular Medicine Series | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2ay9t9anmggkanqf/WF6738593_Venous_Thrombosis71re3.mp3" length="44009163" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Ana I. Casanegra, M.D., M.S.
For many decades, we really only had one option for providing chronic anticoagulation, warfarin. We learned how to manage the many drug and food interactions, frequently changing the warfarin dose as we tried to keep our patients in therapeutic range. Now we have a variety of choices with the direct-acting oral anticoagulants, or DOAC’s. How do the newer agents compare to warfarin in effectiveness? Are they really safer than warfarin? Do they ever require any monitoring? What’s the latest on reversing the anticoagulant effect? I’ll be discussing these topics and more with my guest, Ana I. Casanegra, M.D., M.S., a vascular medicine specialist at the Mayo Clinic. The topic for this podcast is “How to Choose Your Anticoagulant”.
Mayo Clinic Talks: Vascular Medicine Series | Mayo Clinic School of Continuous Professional Development
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1831</itunes:duration>
                <itunes:episode>615</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Vascular Medicine Series: The New Era in Aortic Imaging</title>
        <itunes:title>Vascular Medicine Series: The New Era in Aortic Imaging</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/vascular-whats-circulating-the-new-era-in-aortic-imaging/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/vascular-whats-circulating-the-new-era-in-aortic-imaging/#comments</comments>        <pubDate>Thu, 04 Sep 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/58eaa30a-3e80-349a-916f-ce938d303c89</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guests: Christopher Francois, M.D.</p>
<p>The risk of thoracic aortic dissection increases as the diameter of the aorta widens. A diameter greater than 5 cm is associated with an increased risk of dissection in the general population. Patients with Marfan Syndrome have defective connective tissue and dissection commonly occurs with diameters less than 5 cm. Other health conditions associated with aortic dilation and potential dissection include Ehlers Danlos and those with bicuspid aortic valves.  It therefore becomes extremely important to accurately assess the aorta. Fortunately, we now have a variety of imaging tools available and several of these tools are relatively new. My guest for today’s podcast is Dr. Christopher Francois, from the Department of Diagnostic Radiology at the Mayo Clinic and he’ll bring us up to date regarding the most recent imaging techniques as we continue our series on vascular medicine. We’ll discuss who’s at risk for an aortic aneurysm, when some of the more traditional imaging is indicated and when we should consider some of the newer imaging tools.</p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-vascular-whats-circulating'>Mayo Clinic Talks: Vascular Medicine Series | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guests: Christopher Francois, M.D.</p>
<p>The risk of thoracic aortic dissection increases as the diameter of the aorta widens. A diameter greater than 5 cm is associated with an increased risk of dissection in the general population. Patients with Marfan Syndrome have defective connective tissue and dissection commonly occurs with diameters less than 5 cm. Other health conditions associated with aortic dilation and potential dissection include Ehlers Danlos and those with bicuspid aortic valves.  It therefore becomes extremely important to accurately assess the aorta. Fortunately, we now have a variety of imaging tools available and several of these tools are relatively new. My guest for today’s podcast is Dr. Christopher Francois, from the Department of Diagnostic Radiology at the Mayo Clinic and he’ll bring us up to date regarding the most recent imaging techniques as we continue our series on vascular medicine. We’ll discuss who’s at risk for an aortic aneurysm, when some of the more traditional imaging is indicated and when we should consider some of the newer imaging tools.</p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-vascular-whats-circulating'>Mayo Clinic Talks: Vascular Medicine Series | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tua8jpmhgeu38dmu/WF6794950_New_Era_of_Aortic_Imaging8fgbe.mp3" length="35454497" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guests: Christopher Francois, M.D.
The risk of thoracic aortic dissection increases as the diameter of the aorta widens. A diameter greater than 5 cm is associated with an increased risk of dissection in the general population. Patients with Marfan Syndrome have defective connective tissue and dissection commonly occurs with diameters less than 5 cm. Other health conditions associated with aortic dilation and potential dissection include Ehlers Danlos and those with bicuspid aortic valves.  It therefore becomes extremely important to accurately assess the aorta. Fortunately, we now have a variety of imaging tools available and several of these tools are relatively new. My guest for today’s podcast is Dr. Christopher Francois, from the Department of Diagnostic Radiology at the Mayo Clinic and he’ll bring us up to date regarding the most recent imaging techniques as we continue our series on vascular medicine. We’ll discuss who’s at risk for an aortic aneurysm, when some of the more traditional imaging is indicated and when we should consider some of the newer imaging tools.
Mayo Clinic Talks: Vascular Medicine Series | Mayo Clinic School of Continuous Professional Development
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1472</itunes:duration>
                <itunes:episode>614</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Vascular Medicine Series: Hereditary Aortic Aneurysms and Dissection</title>
        <itunes:title>Vascular Medicine Series: Hereditary Aortic Aneurysms and Dissection</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/vascular-whats-circulating-hereditary-aortic-aneurysms-and-dissection/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/vascular-whats-circulating-hereditary-aortic-aneurysms-and-dissection/#comments</comments>        <pubDate>Tue, 02 Sep 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/84320de2-ad6a-377e-8cb0-f94e4d9c0e19</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guests: Thais D. Coutinho, M.D., and Kristen A. Sell-Dottin, M.D.</p>
<p>Genetic factors predispose selected individuals to hereditary aortic aneurysms leading to aortic dilation and potential dissection.  They can be seen in a variety of known genetic syndromes, and they differ from aortic aneurysms associated with aging and chronic, uncontrolled hypertension. Early recognition is critical in the management of these patients in preventing serious, often life-threatening aortic dissection. How common are hereditary aortic aneurysms? When and how should we screen patients for this condition? Is a genetic consultation recommended? When should we involve a vascular surgeon when at risk patients are identified? These are some of the questions I’ll be asking my guests, Thais D. Coutinho, M.D., a cardiologist and cardiac surgeon, Kristen A. Sell-Dottin, M.D., both from the Mayo Clinic. We’ll be discussing “Hereditary Aortic Aneurysms and Dissection” as part of our podcast series on “Peripheral Vascular Disease”.</p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-vascular-whats-circulating'>Mayo Clinic Talks: Vascular Medicine Series | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guests: Thais D. Coutinho, M.D., and Kristen A. Sell-Dottin, M.D.</p>
<p>Genetic factors predispose selected individuals to hereditary aortic aneurysms leading to aortic dilation and potential dissection.  They can be seen in a variety of known genetic syndromes, and they differ from aortic aneurysms associated with aging and chronic, uncontrolled hypertension. Early recognition is critical in the management of these patients in preventing serious, often life-threatening aortic dissection. How common are hereditary aortic aneurysms? When and how should we screen patients for this condition? Is a genetic consultation recommended? When should we involve a vascular surgeon when at risk patients are identified? These are some of the questions I’ll be asking my guests, Thais D. Coutinho, M.D., a cardiologist and cardiac surgeon, Kristen A. Sell-Dottin, M.D., both from the Mayo Clinic. We’ll be discussing “Hereditary Aortic Aneurysms and Dissection” as part of our podcast series on “Peripheral Vascular Disease”.</p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-vascular-whats-circulating'>Mayo Clinic Talks: Vascular Medicine Series | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dxs9szxrvbj3ttfz/WF6463517_Hereditary_Aortic_Aneurysms_and_Dissection_promo_AF7seov.mp3" length="46737017" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guests: Thais D. Coutinho, M.D., and Kristen A. Sell-Dottin, M.D.
Genetic factors predispose selected individuals to hereditary aortic aneurysms leading to aortic dilation and potential dissection.  They can be seen in a variety of known genetic syndromes, and they differ from aortic aneurysms associated with aging and chronic, uncontrolled hypertension. Early recognition is critical in the management of these patients in preventing serious, often life-threatening aortic dissection. How common are hereditary aortic aneurysms? When and how should we screen patients for this condition? Is a genetic consultation recommended? When should we involve a vascular surgeon when at risk patients are identified? These are some of the questions I’ll be asking my guests, Thais D. Coutinho, M.D., a cardiologist and cardiac surgeon, Kristen A. Sell-Dottin, M.D., both from the Mayo Clinic. We’ll be discussing “Hereditary Aortic Aneurysms and Dissection” as part of our podcast series on “Peripheral Vascular Disease”.
Mayo Clinic Talks: Vascular Medicine Series | Mayo Clinic School of Continuous Professional Development
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1934</itunes:duration>
                <itunes:episode>613</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Correcting Facial Paralysis Associated with Bell’s Palsy</title>
        <itunes:title>Correcting Facial Paralysis Associated with Bell’s Palsy</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/correcting-facial-paralysis-associated-with-bell-s-palsy/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/correcting-facial-paralysis-associated-with-bell-s-palsy/#comments</comments>        <pubDate>Tue, 26 Aug 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/3db83f1e-c164-3254-ba94-0bd279a8ee62</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Jacob K. Dey, M.D.</p>
<p>Bell’s Palsy is the most common cause of 7th cranial nerve dysfunction and clinically, it has a relatively abrupt onset resulting in unilateral facial paralysis. Fortunately, the majority of patients recover completely without treatment. Unfortunately, in some cases, the facial paralysis is persistent, and surgical intervention may be indicated to help restore facial symmetry. When do patients reach maximum improvement in their facial asymmetry? What is facial synkinesis? What are the various surgical options and how is it determined which one is best for the patient? The topic for this podcast is “Correcting Facial Paralysis Associated with Bell’s Palsy” and these are some of the questions I’ll be asking my guest, facial plastic surgeon, Jacob K. Dey, M.D., from the Division of Facial Plastic &amp; Reconstructive Surgery at the Mayo Clinic.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Jacob K. Dey, M.D.</p>
<p>Bell’s Palsy is the most common cause of 7th cranial nerve dysfunction and clinically, it has a relatively abrupt onset resulting in unilateral facial paralysis. Fortunately, the majority of patients recover completely without treatment. Unfortunately, in some cases, the facial paralysis is persistent, and surgical intervention may be indicated to help restore facial symmetry. When do patients reach maximum improvement in their facial asymmetry? What is facial synkinesis? What are the various surgical options and how is it determined which one is best for the patient? The topic for this podcast is “Correcting Facial Paralysis Associated with Bell’s Palsy” and these are some of the questions I’ll be asking my guest, facial plastic surgeon, Jacob K. Dey, M.D., from the Division of Facial Plastic &amp; Reconstructive Surgery at the Mayo Clinic.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/e5rvsy2i35rh9mtg/WF6277150_Correcting_Facial_Paralysis_Associated_with_Bell_s_Palsy9ii0k.mp3" length="47277911" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Jacob K. Dey, M.D.
Bell’s Palsy is the most common cause of 7th cranial nerve dysfunction and clinically, it has a relatively abrupt onset resulting in unilateral facial paralysis. Fortunately, the majority of patients recover completely without treatment. Unfortunately, in some cases, the facial paralysis is persistent, and surgical intervention may be indicated to help restore facial symmetry. When do patients reach maximum improvement in their facial asymmetry? What is facial synkinesis? What are the various surgical options and how is it determined which one is best for the patient? The topic for this podcast is “Correcting Facial Paralysis Associated with Bell’s Palsy” and these are some of the questions I’ll be asking my guest, facial plastic surgeon, Jacob K. Dey, M.D., from the Division of Facial Plastic &amp; Reconstructive Surgery at the Mayo Clinic.
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1966</itunes:duration>
                <itunes:episode>612</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Measles and Vaccine Hesitancy</title>
        <itunes:title>Measles and Vaccine Hesitancy</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/measles-and-vaccine-hesitancy/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/measles-and-vaccine-hesitancy/#comments</comments>        <pubDate>Tue, 19 Aug 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/e801ce10-a333-359b-abed-4f12fb44157e</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Gregory A. Poland, M.D.</p>
<p>Measles is a viral illness that very recently was considered rare in this country but unfortunately has seen a resurgence in recent times. It’s highly contagious and can lead to severe complications including encephalitis and potentially death. There is an effective vaccine and it’s typically administered along with mumps and rubella as the MMR. The vaccine was introduced in the 1960’s and resulted in a dramatic reduction in the incidence of measles. Despite overwhelming evidence of the vaccine’s safety and efficacy, vaccine hesitancy has resulted in measles outbreaks in communities with lower immunization rates. The topic for today’s podcast is measles and my guest is Greg A. Poland, M.D., a general internist and vaccine research specialist at the Mayo Clinic. We’ll discuss the clinical manifestations of measles, the measles vaccine, vaccine hesitancy and how we as clinicians can most effectively educate our patients about measles.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a></p>
<p>Are you a medical professional, ready to ignite your passion and fuel your success? Join us October 23rd-25th in beautiful Pasadena, California or via livestream for GRIT, where innovation meets inspiration. GRIT in Medicine: Growth, Resilience, Inspiration &amp; Tenacity 2025 will empower healthcare professionals with skills and resources to excel through productivity, personal development, and professional community. Leaders in business and healthcare will present evidence-based strategies and practical tips and tools to promote professional and personal well-being, and you’ll leave encouraged and energized for excellence. Visit ce.mayo.edu/GRIT2025 by September 1st with the discount code GRIT2025 to save $100 on registration. See you soon for GRIT!</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Gregory A. Poland, M.D.</p>
<p>Measles is a viral illness that very recently was considered rare in this country but unfortunately has seen a resurgence in recent times. It’s highly contagious and can lead to severe complications including encephalitis and potentially death. There is an effective vaccine and it’s typically administered along with mumps and rubella as the MMR. The vaccine was introduced in the 1960’s and resulted in a dramatic reduction in the incidence of measles. Despite overwhelming evidence of the vaccine’s safety and efficacy, vaccine hesitancy has resulted in measles outbreaks in communities with lower immunization rates. The topic for today’s podcast is measles and my guest is Greg A. Poland, M.D., a general internist and vaccine research specialist at the Mayo Clinic. We’ll discuss the clinical manifestations of measles, the measles vaccine, vaccine hesitancy and how we as clinicians can most effectively educate our patients about measles.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a></p>
<p><em>Are you a medical professional, ready to ignite your passion and fuel your success? Join us October 23rd-25th in beautiful Pasadena, California or via livestream for GRIT, where innovation meets inspiration. GRIT in Medicine: Growth, Resilience, Inspiration &amp; Tenacity 2025 will empower healthcare professionals with skills and resources to excel through productivity, personal development, and professional community. Leaders in business and healthcare will present evidence-based strategies and practical tips and tools to promote professional and personal well-being, and you’ll leave encouraged and energized for excellence. Visit ce.mayo.edu/GRIT2025 by September 1st with the discount code GRIT2025 to save $100 on registration. See you soon for GRIT!</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/43zkkr5pfnczb7nm/WF6611819_Update_on_Measles_midroll7dz22.mp3" length="40113698" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Gregory A. Poland, M.D.
Measles is a viral illness that very recently was considered rare in this country but unfortunately has seen a resurgence in recent times. It’s highly contagious and can lead to severe complications including encephalitis and potentially death. There is an effective vaccine and it’s typically administered along with mumps and rubella as the MMR. The vaccine was introduced in the 1960’s and resulted in a dramatic reduction in the incidence of measles. Despite overwhelming evidence of the vaccine’s safety and efficacy, vaccine hesitancy has resulted in measles outbreaks in communities with lower immunization rates. The topic for today’s podcast is measles and my guest is Greg A. Poland, M.D., a general internist and vaccine research specialist at the Mayo Clinic. We’ll discuss the clinical manifestations of measles, the measles vaccine, vaccine hesitancy and how we as clinicians can most effectively educate our patients about measles.
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts
Are you a medical professional, ready to ignite your passion and fuel your success? Join us October 23rd-25th in beautiful Pasadena, California or via livestream for GRIT, where innovation meets inspiration. GRIT in Medicine: Growth, Resilience, Inspiration &amp; Tenacity 2025 will empower healthcare professionals with skills and resources to excel through productivity, personal development, and professional community. Leaders in business and healthcare will present evidence-based strategies and practical tips and tools to promote professional and personal well-being, and you’ll leave encouraged and energized for excellence. Visit ce.mayo.edu/GRIT2025 by September 1st with the discount code GRIT2025 to save $100 on registration. See you soon for GRIT!]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1669</itunes:duration>
                <itunes:episode>611</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Integrative Oncology</title>
        <itunes:title>Integrative Oncology</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/integrative-oncology/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/integrative-oncology/#comments</comments>        <pubDate>Tue, 12 Aug 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/9c82f1f9-5ca8-36bf-8b8a-15dbdea065a4</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Stacy D. D’Andre, M.D.</p>
<p>When we diagnose a patient with cancer, we typically focus on finding the most effective treatment for that malignancy: surgery, radiotherapy, chemotherapy, or immunotherapy. However, to a patient, the diagnosis of cancer means much more. Patients commonly experience fear and anxiety just from receiving the diagnosis. Other symptoms may include insomnia, depression, pain, and symptomatic effects from the treatment including nausea, loss of appetite and fatigue to name just a few. The Mayo Clinic Comprehensive Cancer Center has developed an integrative approach to help patients manage the variety of symptoms associated with malignancy. It centers around a multi-disciplinary team which assesses each patient individually and incorporates a variety of complementary treatments as well as physical and emotional support. It also includes nutrition and dietary supplement counseling and recommendations regarding exercise and movement. In this podcast, we’ll learn more about this fascinating approach to treating patients with cancer as we discuss “Integrative Oncology” with my guest, Stacy D. D’Andre, M.D., from the Department of Oncology at the Mayo Clinic.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a></p>
<p>Are you a medical professional, ready to ignite your passion and fuel your success? Join us October 23rd-25th in beautiful Pasadena, California or via livestream for GRIT, where innovation meets inspiration. GRIT in Medicine: Growth, Resilience, Inspiration &amp; Tenacity 2025 will empower healthcare professionals with skills and resources to excel through productivity, personal development, and professional community. Leaders in business and healthcare will present evidence-based strategies and practical tips and tools to promote professional and personal well-being, and you’ll leave encouraged and energized for excellence. Visit ce.mayo.edu/GRIT2025 by September 1st with the discount code GRIT2025 to save $100 on registration. See you soon for GRIT!</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Stacy D. D’Andre, M.D.</p>
<p>When we diagnose a patient with cancer, we typically focus on finding the most effective treatment for that malignancy: surgery, radiotherapy, chemotherapy, or immunotherapy. However, to a patient, the diagnosis of cancer means much more. Patients commonly experience fear and anxiety just from receiving the diagnosis. Other symptoms may include insomnia, depression, pain, and symptomatic effects from the treatment including nausea, loss of appetite and fatigue to name just a few. The Mayo Clinic Comprehensive Cancer Center has developed an integrative approach to help patients manage the variety of symptoms associated with malignancy. It centers around a multi-disciplinary team which assesses each patient individually and incorporates a variety of complementary treatments as well as physical and emotional support. It also includes nutrition and dietary supplement counseling and recommendations regarding exercise and movement. In this podcast, we’ll learn more about this fascinating approach to treating patients with cancer as we discuss “Integrative Oncology” with my guest, Stacy D. D’Andre, M.D., from the Department of Oncology at the Mayo Clinic.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a></p>
<p><em>Are you a medical professional, ready to ignite your passion and fuel your success? Join us October 23rd-25th in beautiful Pasadena, California or via livestream for GRIT, where innovation meets inspiration. GRIT in Medicine: Growth, Resilience, Inspiration &amp; Tenacity 2025 will empower healthcare professionals with skills and resources to excel through productivity, personal development, and professional community. Leaders in business and healthcare will present evidence-based strategies and practical tips and tools to promote professional and personal well-being, and you’ll leave encouraged and energized for excellence. Visit ce.mayo.edu/GRIT2025 by September 1st with the discount code GRIT2025 to save $100 on registration. See you soon for GRIT!</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9bgc67k3ep5587cy/WF6167590_Integrative_Oncology_Insights_midroll7hn81.mp3" length="35998648" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Stacy D. D’Andre, M.D.
When we diagnose a patient with cancer, we typically focus on finding the most effective treatment for that malignancy: surgery, radiotherapy, chemotherapy, or immunotherapy. However, to a patient, the diagnosis of cancer means much more. Patients commonly experience fear and anxiety just from receiving the diagnosis. Other symptoms may include insomnia, depression, pain, and symptomatic effects from the treatment including nausea, loss of appetite and fatigue to name just a few. The Mayo Clinic Comprehensive Cancer Center has developed an integrative approach to help patients manage the variety of symptoms associated with malignancy. It centers around a multi-disciplinary team which assesses each patient individually and incorporates a variety of complementary treatments as well as physical and emotional support. It also includes nutrition and dietary supplement counseling and recommendations regarding exercise and movement. In this podcast, we’ll learn more about this fascinating approach to treating patients with cancer as we discuss “Integrative Oncology” with my guest, Stacy D. D’Andre, M.D., from the Department of Oncology at the Mayo Clinic.
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts
Are you a medical professional, ready to ignite your passion and fuel your success? Join us October 23rd-25th in beautiful Pasadena, California or via livestream for GRIT, where innovation meets inspiration. GRIT in Medicine: Growth, Resilience, Inspiration &amp; Tenacity 2025 will empower healthcare professionals with skills and resources to excel through productivity, personal development, and professional community. Leaders in business and healthcare will present evidence-based strategies and practical tips and tools to promote professional and personal well-being, and you’ll leave encouraged and energized for excellence. Visit ce.mayo.edu/GRIT2025 by September 1st with the discount code GRIT2025 to save $100 on registration. See you soon for GRIT!]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1489</itunes:duration>
                <itunes:episode>610</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Exercise and Bariatric Surgery</title>
        <itunes:title>Exercise and Bariatric Surgery</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/exercise-and-bariatric-surgery/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/exercise-and-bariatric-surgery/#comments</comments>        <pubDate>Tue, 05 Aug 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/cd93e15f-1610-3939-b227-355b5c3d6cc7</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Melinda J. Hahm</p>
<p>Bariatric surgery is very likely the most effective method for long-term weight loss. It’s not unusual for patients to lose well over 50% of their excess body weight. As a result, a variety of chronic health risks are reduced including diabetes, cardiovascular disease, sleep apnea, hypertension to name just a few. Exercise, associated with bariatric surgery is important to help achieve and maintain long-term weight loss and help prevent regaining the weight lost. The topic for this podcast is “Exercise and Bariatric Surgery” and my guest is Melinda J. Hahm, an exercise physiologist from the Mayo Clinic. Some of the topics we’ll discuss include the benefits of exercise associated with bariatric surgery, when patients should start an exercise program in relation to their surgery and what type of exercise is best to help maintain weight loss.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Melinda J. Hahm</p>
<p>Bariatric surgery is very likely the most effective method for long-term weight loss. It’s not unusual for patients to lose well over 50% of their excess body weight. As a result, a variety of chronic health risks are reduced including diabetes, cardiovascular disease, sleep apnea, hypertension to name just a few. Exercise, associated with bariatric surgery is important to help achieve and maintain long-term weight loss and help prevent regaining the weight lost. The topic for this podcast is “Exercise and Bariatric Surgery” and my guest is Melinda J. Hahm, an exercise physiologist from the Mayo Clinic. Some of the topics we’ll discuss include the benefits of exercise associated with bariatric surgery, when patients should start an exercise program in relation to their surgery and what type of exercise is best to help maintain weight loss.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/79ij5tzvgd958m3u/WF5978504_Exercise_and_Bariatric_Surgery_promo_AF6a1iw.mp3" length="35218843" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Melinda J. Hahm
Bariatric surgery is very likely the most effective method for long-term weight loss. It’s not unusual for patients to lose well over 50% of their excess body weight. As a result, a variety of chronic health risks are reduced including diabetes, cardiovascular disease, sleep apnea, hypertension to name just a few. Exercise, associated with bariatric surgery is important to help achieve and maintain long-term weight loss and help prevent regaining the weight lost. The topic for this podcast is “Exercise and Bariatric Surgery” and my guest is Melinda J. Hahm, an exercise physiologist from the Mayo Clinic. Some of the topics we’ll discuss include the benefits of exercise associated with bariatric surgery, when patients should start an exercise program in relation to their surgery and what type of exercise is best to help maintain weight loss.
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1463</itunes:duration>
                <itunes:episode>609</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Parotid Gland Tumors</title>
        <itunes:title>Parotid Gland Tumors</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/parotid-gland-tumors/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/parotid-gland-tumors/#comments</comments>        <pubDate>Tue, 29 Jul 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/d7d426ef-196e-3d5d-a023-e3eb3a1b876d</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Eric J. Moore, M.D.</p>
<p>Salivary gland tumors can be benign or malignant, as well as primary or metastatic. Malignant salivary gland tumors usually present after the 6th decade, whereas benign lesions tend to occur a bit earlier, usually in the 4th to 5th decades. An interesting statistic is that the vast majority of salivary gland tumors occur in the parotid, only about 10% occur in the submandibular salivary gland and less than 4% in the minor salivary glands. Fortunately, most parotid tumors are benign. Previous radiation as well as occupational exposure to silica and nitrosamines have been linked to malignant parotid tumors. What should a primary care clinician do when we discover a mass in the parotid gland? What imaging studies are helpful? What treatment is available and what happens if the tumor recurs? These are all questions I’ll be asking my guest, Eric J. Moore, M.D., Chair of Otolaryngology and Head and Neck Surgery at the Mayo Clinic as we discuss “Parotid Gland Tumors”.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Eric J. Moore, M.D.</p>
<p>Salivary gland tumors can be benign or malignant, as well as primary or metastatic. Malignant salivary gland tumors usually present after the 6th decade, whereas benign lesions tend to occur a bit earlier, usually in the 4th to 5th decades. An interesting statistic is that the vast majority of salivary gland tumors occur in the parotid, only about 10% occur in the submandibular salivary gland and less than 4% in the minor salivary glands. Fortunately, most parotid tumors are benign. Previous radiation as well as occupational exposure to silica and nitrosamines have been linked to malignant parotid tumors. What should a primary care clinician do when we discover a mass in the parotid gland? What imaging studies are helpful? What treatment is available and what happens if the tumor recurs? These are all questions I’ll be asking my guest, Eric J. Moore, M.D., Chair of Otolaryngology and Head and Neck Surgery at the Mayo Clinic as we discuss “Parotid Gland Tumors”.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8z2we8ktzftp99na/WF5996210_Parotid_Gland_Tumors_AF5yzbj.mp3" length="34065945" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Eric J. Moore, M.D.
Salivary gland tumors can be benign or malignant, as well as primary or metastatic. Malignant salivary gland tumors usually present after the 6th decade, whereas benign lesions tend to occur a bit earlier, usually in the 4th to 5th decades. An interesting statistic is that the vast majority of salivary gland tumors occur in the parotid, only about 10% occur in the submandibular salivary gland and less than 4% in the minor salivary glands. Fortunately, most parotid tumors are benign. Previous radiation as well as occupational exposure to silica and nitrosamines have been linked to malignant parotid tumors. What should a primary care clinician do when we discover a mass in the parotid gland? What imaging studies are helpful? What treatment is available and what happens if the tumor recurs? These are all questions I’ll be asking my guest, Eric J. Moore, M.D., Chair of Otolaryngology and Head and Neck Surgery at the Mayo Clinic as we discuss “Parotid Gland Tumors”.
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1417</itunes:duration>
                <itunes:episode>608</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Inflammatory Bowel Disease Series: Inflammatory Bowel Disease (IBD) and Pregnancy</title>
        <itunes:title>Inflammatory Bowel Disease Series: Inflammatory Bowel Disease (IBD) and Pregnancy</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/inflammatory-bowel-disease-series-inflammatory-bowel-disease-ibd-and-pregnancy/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/inflammatory-bowel-disease-series-inflammatory-bowel-disease-ibd-and-pregnancy/#comments</comments>        <pubDate>Tue, 22 Jul 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/c8a28a62-00d5-3fea-809f-481b399a6c1b</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Sunanda V. Kane, M.D.</p>
<p>Most people who develop inflammatory bowel disease are diagnosed before the age of 30. In women, this often occurs during the middle of their reproductive years. Some with inflammatory bowel disease choose to avoid pregnancy, usually due to misconceptions about pregnancy risks. Yet if properly managed, women can experience a normal, uneventful pregnancy and deliver a healthy child.  What effect does inflammatory bowel disease have on fertility? Do patients have a greater chance of a normal pregnancy if the bowel disease is in remission? How can patients minimize the risk of inflammatory bowel disease flares during pregnancy and are the pharmacologic therapies commonly used to treat inflammatory bowel disease safe to use during pregnancy? These are some of the questions I’ll ask my guest, Sunanda V. Kane, M.D., from the Division of Gastroenterology and Hepatology at the Mayo Clinic as we discuss “Inflammatory Bowel Disease and Pregnancy”.</p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease'>https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease</a></p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Sunanda V. Kane, M.D.</p>
<p>Most people who develop inflammatory bowel disease are diagnosed before the age of 30. In women, this often occurs during the middle of their reproductive years. Some with inflammatory bowel disease choose to avoid pregnancy, usually due to misconceptions about pregnancy risks. Yet if properly managed, women can experience a normal, uneventful pregnancy and deliver a healthy child.  What effect does inflammatory bowel disease have on fertility? Do patients have a greater chance of a normal pregnancy if the bowel disease is in remission? How can patients minimize the risk of inflammatory bowel disease flares during pregnancy and are the pharmacologic therapies commonly used to treat inflammatory bowel disease safe to use during pregnancy? These are some of the questions I’ll ask my guest, Sunanda V. Kane, M.D., from the Division of Gastroenterology and Hepatology at the Mayo Clinic as we discuss “Inflammatory Bowel Disease and Pregnancy”.</p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease'>https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease</a></p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wazn9e68bpqx2ihx/WF6443700_IBD_and_Pregnancybtnak.mp3" length="38490459" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Sunanda V. Kane, M.D.
Most people who develop inflammatory bowel disease are diagnosed before the age of 30. In women, this often occurs during the middle of their reproductive years. Some with inflammatory bowel disease choose to avoid pregnancy, usually due to misconceptions about pregnancy risks. Yet if properly managed, women can experience a normal, uneventful pregnancy and deliver a healthy child.  What effect does inflammatory bowel disease have on fertility? Do patients have a greater chance of a normal pregnancy if the bowel disease is in remission? How can patients minimize the risk of inflammatory bowel disease flares during pregnancy and are the pharmacologic therapies commonly used to treat inflammatory bowel disease safe to use during pregnancy? These are some of the questions I’ll ask my guest, Sunanda V. Kane, M.D., from the Division of Gastroenterology and Hepatology at the Mayo Clinic as we discuss “Inflammatory Bowel Disease and Pregnancy”.
https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1592</itunes:duration>
                <itunes:episode>607</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Inflammatory Bowel Disease Series: Inflammatory Bowel Disease in Special Populations: The Elderly, Obese and LGBTQ Patient</title>
        <itunes:title>Inflammatory Bowel Disease Series: Inflammatory Bowel Disease in Special Populations: The Elderly, Obese and LGBTQ Patient</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/inflammatory-bowel-disease-series-inflammatory-bowel-disease-in-special-populations-the-elderly-obese-and-lgbtq-patient/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/inflammatory-bowel-disease-series-inflammatory-bowel-disease-in-special-populations-the-elderly-obese-and-lgbtq-patient/#comments</comments>        <pubDate>Thu, 17 Jul 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/f6fcbcb0-0d4e-3e15-bc20-a5375954d8be</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guests: Amanda M. Johnson, M.D., and Victor G. Chedid, M.D., M.S.</p>
<p>This podcast continues our series on inflammatory bowel disease. The topic is important and timely: “Inflammatory Bowel Disease in Special Populations: The Elderly, the Obese and the LGBTQ Patient.” It’s critical that we broaden our perspective in addressing the unique challenges faced by these often-unrecognized population groups. How common is the presentation of inflammatory bowel disease in those over 65? How does age affect the treatments commonly used? Does obesity alter the disease presentation or activity and what are some of the unique challenges our LGBTQ patients face with inflammatory bowel disease? These are just some of the questions I’ll be asking my guests, Amanda M. Johnson, M.D., and Victor G. Chedid, M.D., M.S., both gastroenterologists at the Mayo Clinic.</p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease'>https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease</a></p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guests: Amanda M. Johnson, M.D., and Victor G. Chedid, M.D., M.S.</p>
<p>This podcast continues our series on inflammatory bowel disease. The topic is important and timely: “Inflammatory Bowel Disease in Special Populations: The Elderly, the Obese and the LGBTQ Patient.” It’s critical that we broaden our perspective in addressing the unique challenges faced by these often-unrecognized population groups. How common is the presentation of inflammatory bowel disease in those over 65? How does age affect the treatments commonly used? Does obesity alter the disease presentation or activity and what are some of the unique challenges our LGBTQ patients face with inflammatory bowel disease? These are just some of the questions I’ll be asking my guests, Amanda M. Johnson, M.D., and Victor G. Chedid, M.D., M.S., both gastroenterologists at the Mayo Clinic.</p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease'>https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease</a></p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6782gayvu2htsfta/WF6563200_IBD_in_Special_Populations68t0q.mp3" length="42142409" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guests: Amanda M. Johnson, M.D., and Victor G. Chedid, M.D., M.S.
This podcast continues our series on inflammatory bowel disease. The topic is important and timely: “Inflammatory Bowel Disease in Special Populations: The Elderly, the Obese and the LGBTQ Patient.” It’s critical that we broaden our perspective in addressing the unique challenges faced by these often-unrecognized population groups. How common is the presentation of inflammatory bowel disease in those over 65? How does age affect the treatments commonly used? Does obesity alter the disease presentation or activity and what are some of the unique challenges our LGBTQ patients face with inflammatory bowel disease? These are just some of the questions I’ll be asking my guests, Amanda M. Johnson, M.D., and Victor G. Chedid, M.D., M.S., both gastroenterologists at the Mayo Clinic.
https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1751</itunes:duration>
                <itunes:episode>606</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Inflammatory Bowel Disease Series: Health Maintenance in Inflammatory Bowel Disease (IBD)</title>
        <itunes:title>Inflammatory Bowel Disease Series: Health Maintenance in Inflammatory Bowel Disease (IBD)</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/inflammatory-bowel-disease-series-health-maintenance-in-inflammatory-bowel-disease-ibd/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/inflammatory-bowel-disease-series-health-maintenance-in-inflammatory-bowel-disease-ibd/#comments</comments>        <pubDate>Tue, 15 Jul 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/d817533f-820a-3657-a615-4e27e5f37513</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Konstantinos A. Papadakis, M.D.</p>
<p>Due to the complexity and new pharmacologic options for the management of inflammatory bowel disease, patients often have their care provided by a gastroenterologist. They may not see their primary care provider as often as in the past and some of their preventive health maintenance may not get performed. Are patients receiving primarily specialty care still receiving good health maintenance?  Are we aware that patients with inflammatory bowel disease have some unique needs regarding their preventive health maintenance and some of the recommendations are different than the general population? These are questions I’ll be asking my guest, gastroenterologist Konstantinos A. Papadakis, M.D., from the Mayo Clinic as we discuss “Health Maintenance in Inflammatory Bowel Disease” as part of our ongoing series on Inflammatory Bowel Disease.</p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease'>https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease</a></p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Konstantinos A. Papadakis, M.D.</p>
<p>Due to the complexity and new pharmacologic options for the management of inflammatory bowel disease, patients often have their care provided by a gastroenterologist. They may not see their primary care provider as often as in the past and some of their preventive health maintenance may not get performed. Are patients receiving primarily specialty care still receiving good health maintenance?  Are we aware that patients with inflammatory bowel disease have some unique needs regarding their preventive health maintenance and some of the recommendations are different than the general population? These are questions I’ll be asking my guest, gastroenterologist Konstantinos A. Papadakis, M.D., from the Mayo Clinic as we discuss “Health Maintenance in Inflammatory Bowel Disease” as part of our ongoing series on Inflammatory Bowel Disease.</p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease'>https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease</a></p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hv8hdxvzg7kiijka/WF6795202_Health_Maintenance_in_IBD7gv2r.mp3" length="29842950" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Konstantinos A. Papadakis, M.D.
Due to the complexity and new pharmacologic options for the management of inflammatory bowel disease, patients often have their care provided by a gastroenterologist. They may not see their primary care provider as often as in the past and some of their preventive health maintenance may not get performed. Are patients receiving primarily specialty care still receiving good health maintenance?  Are we aware that patients with inflammatory bowel disease have some unique needs regarding their preventive health maintenance and some of the recommendations are different than the general population? These are questions I’ll be asking my guest, gastroenterologist Konstantinos A. Papadakis, M.D., from the Mayo Clinic as we discuss “Health Maintenance in Inflammatory Bowel Disease” as part of our ongoing series on Inflammatory Bowel Disease.
https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1241</itunes:duration>
                <itunes:episode>605</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Inflammatory Bowel Disease Series: Pouchitis</title>
        <itunes:title>Inflammatory Bowel Disease Series: Pouchitis</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/inflammatory-bowel-disease-series-pouchitis/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/inflammatory-bowel-disease-series-pouchitis/#comments</comments>        <pubDate>Thu, 10 Jul 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/cc89e782-bed1-3ff6-b33c-916051896e60</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guests: Darrell S. Pardi, M.D., and Laura E. Raffals, M.D.</p>
<p>Pouchitis is a relatively common complication in patients who have ulcerative colitis and have had a proctocolectomy with an ileal pouch-anal anastomosis. It represents inflammation of the ileal pouch and symptoms may include increased stool frequency, cramps, fecal urgency and occasionally bloody stools. The diagnosis is usually suspected from clinical symptoms and confirmed with endoscopy. Are there risk factors for the development of pouchitis? Is an endoscopy necessary for a diagnosis? How should patients be treated and how effective is treatment? These are some of the questions I’ll be asking my guests, Darrell S. Pardi, M.D., and Laura E. Raffals, M.D., both gastroenterologists at the Mayo Clinic. We’ll be discussing “Pouchitis” as part of our podcast series on “Inflammatory Bowel Disease”.</p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease'>https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease</a></p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guests: Darrell S. Pardi, M.D., and Laura E. Raffals, M.D.</p>
<p>Pouchitis is a relatively common complication in patients who have ulcerative colitis and have had a proctocolectomy with an ileal pouch-anal anastomosis. It represents inflammation of the ileal pouch and symptoms may include increased stool frequency, cramps, fecal urgency and occasionally bloody stools. The diagnosis is usually suspected from clinical symptoms and confirmed with endoscopy. Are there risk factors for the development of pouchitis? Is an endoscopy necessary for a diagnosis? How should patients be treated and how effective is treatment? These are some of the questions I’ll be asking my guests, Darrell S. Pardi, M.D., and Laura E. Raffals, M.D., both gastroenterologists at the Mayo Clinic. We’ll be discussing “Pouchitis” as part of our podcast series on “Inflammatory Bowel Disease”.</p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease'>https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease</a></p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nqhv7cpqrn2z5xvr/WF6430509_Pouchitis.mp3" length="38468370" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guests: Darrell S. Pardi, M.D., and Laura E. Raffals, M.D.
Pouchitis is a relatively common complication in patients who have ulcerative colitis and have had a proctocolectomy with an ileal pouch-anal anastomosis. It represents inflammation of the ileal pouch and symptoms may include increased stool frequency, cramps, fecal urgency and occasionally bloody stools. The diagnosis is usually suspected from clinical symptoms and confirmed with endoscopy. Are there risk factors for the development of pouchitis? Is an endoscopy necessary for a diagnosis? How should patients be treated and how effective is treatment? These are some of the questions I’ll be asking my guests, Darrell S. Pardi, M.D., and Laura E. Raffals, M.D., both gastroenterologists at the Mayo Clinic. We’ll be discussing “Pouchitis” as part of our podcast series on “Inflammatory Bowel Disease”.
https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1599</itunes:duration>
                <itunes:episode>604</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Inflammatory Bowel Disease Series: Microscopic Colitis</title>
        <itunes:title>Inflammatory Bowel Disease Series: Microscopic Colitis</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/inflammatory-bowel-disease-series-microscopic-colitis/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/inflammatory-bowel-disease-series-microscopic-colitis/#comments</comments>        <pubDate>Tue, 08 Jul 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/3f4a57ef-5af2-36ad-b252-988fcd7a925e</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guests: Darrell S. Pardi, M.D., and Laura E. Raffals, M.D.</p>
<p>Microscopic colitis is one of the lesser-known members of the inflammatory bowel disease family. Symptoms include chronic, frequent diarrhea and fecal urgency. It’s usually suspected from the patient’s clinical symptoms and diagnosis is established by colonoscopy with biopsy. Biopsy is necessary as the colonic mucosa appears normal at endoscopy. A specific cause isn’t known but it can be associated with several medications. Although it’s not typically a life-threatening condition, it can lead to weight loss and potentially dehydration. How does microscopic colitis differ from ulcerative colitis or Crohn’s Disease? Who’s at risk of developing it? Since these patients usually present to primary care providers, when should we suspect it? How is it managed, and can it be cured?  These are some of the questions I’ll be asking my guests, Darrell S. Pardi, M.D., and Laura E. Raffals, M.D., both gastroenterologists at the Mayo Clinic. We’ll be discussing “Microscopic Colitis” as part of our ongoing series of podcasts on “Inflammatory Bowel Disease”.</p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease'>https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease</a></p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guests: Darrell S. Pardi, M.D., and Laura E. Raffals, M.D.</p>
<p>Microscopic colitis is one of the lesser-known members of the inflammatory bowel disease family. Symptoms include chronic, frequent diarrhea and fecal urgency. It’s usually suspected from the patient’s clinical symptoms and diagnosis is established by colonoscopy with biopsy. Biopsy is necessary as the colonic mucosa appears normal at endoscopy. A specific cause isn’t known but it can be associated with several medications. Although it’s not typically a life-threatening condition, it can lead to weight loss and potentially dehydration. How does microscopic colitis differ from ulcerative colitis or Crohn’s Disease? Who’s at risk of developing it? Since these patients usually present to primary care providers, when should we suspect it? How is it managed, and can it be cured?  These are some of the questions I’ll be asking my guests, Darrell S. Pardi, M.D., and Laura E. Raffals, M.D., both gastroenterologists at the Mayo Clinic. We’ll be discussing “Microscopic Colitis” as part of our ongoing series of podcasts on “Inflammatory Bowel Disease”.</p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease'>https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease</a></p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pa5rrgsr3e73k65c/WF6661669_Microscopic_Colitis_AFalto8.mp3" length="24694240" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guests: Darrell S. Pardi, M.D., and Laura E. Raffals, M.D.
Microscopic colitis is one of the lesser-known members of the inflammatory bowel disease family. Symptoms include chronic, frequent diarrhea and fecal urgency. It’s usually suspected from the patient’s clinical symptoms and diagnosis is established by colonoscopy with biopsy. Biopsy is necessary as the colonic mucosa appears normal at endoscopy. A specific cause isn’t known but it can be associated with several medications. Although it’s not typically a life-threatening condition, it can lead to weight loss and potentially dehydration. How does microscopic colitis differ from ulcerative colitis or Crohn’s Disease? Who’s at risk of developing it? Since these patients usually present to primary care providers, when should we suspect it? How is it managed, and can it be cured?  These are some of the questions I’ll be asking my guests, Darrell S. Pardi, M.D., and Laura E. Raffals, M.D., both gastroenterologists at the Mayo Clinic. We’ll be discussing “Microscopic Colitis” as part of our ongoing series of podcasts on “Inflammatory Bowel Disease”.
https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1024</itunes:duration>
                <itunes:episode>603</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Inflammatory Bowel Disease Series: Inflammatory Bowel Disease (IBD) and its Treatment</title>
        <itunes:title>Inflammatory Bowel Disease Series: Inflammatory Bowel Disease (IBD) and its Treatment</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/inflammatory-bowel-disease-series-inflammatory-bowel-disease-ibd-and-its-treatment/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/inflammatory-bowel-disease-series-inflammatory-bowel-disease-ibd-and-its-treatment/#comments</comments>        <pubDate>Thu, 03 Jul 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/52179142-1e8e-3911-921b-5f5fb3a73bed</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Edward V. Loftus JR, M.D.</p>
<p>Inflammatory Bowel Disease is somewhat of an umbrella term for a group of chronic inflammatory conditions of the GI tract. The most common types include ulcerative colitis and Crohn’s Disease. While there are similarities between the two, there are also differences. For many individuals with inflammatory bowel disease, it’s only a mild illness. Unfortunately for some, it can lead to severe disability and potentially life-threatening complications. What are the similarities and differences between ulcerative colitis and Crohn’s? When should we suspect a patient has an inflammatory bowel disease? What’s the best way to establish a diagnosis and finally, what treatment options do we have? These are just some of the questions I’ll be asking my guest, Edward V. Loftus JR, M.D., from the Division of Gastroenterology and Hepatology at the Mayo Clinic as we discuss “Inflammatory Bowel Disease and Its Treatment”.</p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease'>https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease</a></p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Edward V. Loftus JR, M.D.</p>
<p>Inflammatory Bowel Disease is somewhat of an umbrella term for a group of chronic inflammatory conditions of the GI tract. The most common types include ulcerative colitis and Crohn’s Disease. While there are similarities between the two, there are also differences. For many individuals with inflammatory bowel disease, it’s only a mild illness. Unfortunately for some, it can lead to severe disability and potentially life-threatening complications. What are the similarities and differences between ulcerative colitis and Crohn’s? When should we suspect a patient has an inflammatory bowel disease? What’s the best way to establish a diagnosis and finally, what treatment options do we have? These are just some of the questions I’ll be asking my guest, Edward V. Loftus JR, M.D., from the Division of Gastroenterology and Hepatology at the Mayo Clinic as we discuss “Inflammatory Bowel Disease and Its Treatment”.</p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease'>https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease</a></p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ftxrryip7m5ug8tp/WF6419771_IBD_and_Treatment_AF8wddy.mp3" length="41279900" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Edward V. Loftus JR, M.D.
Inflammatory Bowel Disease is somewhat of an umbrella term for a group of chronic inflammatory conditions of the GI tract. The most common types include ulcerative colitis and Crohn’s Disease. While there are similarities between the two, there are also differences. For many individuals with inflammatory bowel disease, it’s only a mild illness. Unfortunately for some, it can lead to severe disability and potentially life-threatening complications. What are the similarities and differences between ulcerative colitis and Crohn’s? When should we suspect a patient has an inflammatory bowel disease? What’s the best way to establish a diagnosis and finally, what treatment options do we have? These are just some of the questions I’ll be asking my guest, Edward V. Loftus JR, M.D., from the Division of Gastroenterology and Hepatology at the Mayo Clinic as we discuss “Inflammatory Bowel Disease and Its Treatment”.
https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1716</itunes:duration>
                <itunes:episode>602</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Inflammatory Bowel Disease Series: Diagnosing Inflammatory Bowel Disease (IBD) and Monitoring Modalities</title>
        <itunes:title>Inflammatory Bowel Disease Series: Diagnosing Inflammatory Bowel Disease (IBD) and Monitoring Modalities</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/inflammatory-bowel-disease-series-diagnosing-inflammatory-bowel-disease-ibd-and-monitoring-modalities/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/inflammatory-bowel-disease-series-diagnosing-inflammatory-bowel-disease-ibd-and-monitoring-modalities/#comments</comments>        <pubDate>Tue, 01 Jul 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/ee458c09-6e1e-370a-a92b-8773a075d116</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guests: David H. Bruining, M.D., and Nayantara Coelho-Prabhu, M.B.B.S.</p>
<p>An early diagnosis of inflammatory bowel disease is important in preventing long-term complications. Prompt treatment can improve quality of life, reduce the likelihood of hospitalizations, and help maintain remissions. However, establishing a diagnosis is often challenging due to the nonspecific and fluctuating nature of symptoms. Inflammatory bowel disease can also mimic other GI conditions. In addition, diagnostic confirmation usually requires a combination of blood tests, imaging, endoscopy, and histological analysis, making the process both time consuming and complex.  The topic for today's podcast is “Diagnosing Inflammatory Bowel Disease and Monitoring Modalities” and my guests are David H. Bruining, M.D., and Nayantara Coelho-Prabhu, M.B.B.S., from the Division of Gastroenterology and Hepatology at the Rochester campus of the Mayo Clinic.</p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease'>https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease</a>  </p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guests: David H. Bruining, M.D., and Nayantara Coelho-Prabhu, M.B.B.S.</p>
<p>An early diagnosis of inflammatory bowel disease is important in preventing long-term complications. Prompt treatment can improve quality of life, reduce the likelihood of hospitalizations, and help maintain remissions. However, establishing a diagnosis is often challenging due to the nonspecific and fluctuating nature of symptoms. Inflammatory bowel disease can also mimic other GI conditions. In addition, diagnostic confirmation usually requires a combination of blood tests, imaging, endoscopy, and histological analysis, making the process both time consuming and complex.  The topic for today's podcast is “Diagnosing Inflammatory Bowel Disease and Monitoring Modalities” and my guests are David H. Bruining, M.D., and Nayantara Coelho-Prabhu, M.B.B.S., from the Division of Gastroenterology and Hepatology at the Rochester campus of the Mayo Clinic.</p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease'>https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease</a>  </p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/u9jj3sjtvy3n2y2y/WF6637805_IBD_Diagnosis_and_Monitoring_Modalities_AF9t2fd.mp3" length="44520430" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guests: David H. Bruining, M.D., and Nayantara Coelho-Prabhu, M.B.B.S.
An early diagnosis of inflammatory bowel disease is important in preventing long-term complications. Prompt treatment can improve quality of life, reduce the likelihood of hospitalizations, and help maintain remissions. However, establishing a diagnosis is often challenging due to the nonspecific and fluctuating nature of symptoms. Inflammatory bowel disease can also mimic other GI conditions. In addition, diagnostic confirmation usually requires a combination of blood tests, imaging, endoscopy, and histological analysis, making the process both time consuming and complex.  The topic for today's podcast is “Diagnosing Inflammatory Bowel Disease and Monitoring Modalities” and my guests are David H. Bruining, M.D., and Nayantara Coelho-Prabhu, M.B.B.S., from the Division of Gastroenterology and Hepatology at the Rochester campus of the Mayo Clinic.
https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease  
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 
 ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1851</itunes:duration>
                <itunes:episode>601</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes and Your Health Series: The Impact of Ancestry on Genes and Health Disparities</title>
        <itunes:title>Genes and Your Health Series: The Impact of Ancestry on Genes and Health Disparities</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-and-your-health-series-the-impact-of-ancestry-on-genes-and-health-disparities/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-and-your-health-series-the-impact-of-ancestry-on-genes-and-health-disparities/#comments</comments>        <pubDate>Thu, 26 Jun 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/22e47af1-e2b3-3b47-a800-60aec478f085</guid>
                                    <description><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Melissa Davis, Ph.D., Director of the Institute of Translational Genomic Medicine at Morehouse School of Medicine</p>
<p>In this insightful episode, Dr. Melissa Davis delves into the profound influence of genetic ancestry on health outcomes and disparities. Her pioneering work in disparities genomics sheds light on how biological determinants intersect with systemic marginalization to exacerbate cancer health disparities. Dr. Davis discusses groundbreaking research linking ancestry to tumor biology, particularly in breast, prostate, and gynecologic cancers. This episode offers a compelling narrative on the evolving immune system's role in tumor aggressiveness and resistance to standard care, offering a new lens for addressing health inequities.</p>
<p class="p1">Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Melissa Davis, Ph.D., Director of the Institute of Translational Genomic Medicine at Morehouse School of Medicine</p>
<p>In this insightful episode, Dr. Melissa Davis delves into the profound influence of genetic ancestry on health outcomes and disparities. Her pioneering work in disparities genomics sheds light on how biological determinants intersect with systemic marginalization to exacerbate cancer health disparities. Dr. Davis discusses groundbreaking research linking ancestry to tumor biology, particularly in breast, prostate, and gynecologic cancers. This episode offers a compelling narrative on the evolving immune system's role in tumor aggressiveness and resistance to standard care, offering a new lens for addressing health inequities.</p>
<p class="p1">Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cq8ujvbkusvjii4j/WF6087402_EP6_Racial_Disparities_in_Cancer_Outcomes_AF63j1t.mp3" length="60462701" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Denise M. Dupras, M.D., Ph.D.
Guest: Melissa Davis, Ph.D., Director of the Institute of Translational Genomic Medicine at Morehouse School of Medicine
In this insightful episode, Dr. Melissa Davis delves into the profound influence of genetic ancestry on health outcomes and disparities. Her pioneering work in disparities genomics sheds light on how biological determinants intersect with systemic marginalization to exacerbate cancer health disparities. Dr. Davis discusses groundbreaking research linking ancestry to tumor biology, particularly in breast, prostate, and gynecologic cancers. This episode offers a compelling narrative on the evolving immune system's role in tumor aggressiveness and resistance to standard care, offering a new lens for addressing health inequities.
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2514</itunes:duration>
                <itunes:episode>600</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Navigating the Match: What Every Medical Student Needs to Know</title>
        <itunes:title>Navigating the Match: What Every Medical Student Needs to Know</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/navigating-the-match-what-every-medical-student-needs-to-know/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/navigating-the-match-what-every-medical-student-needs-to-know/#comments</comments>        <pubDate>Tue, 24 Jun 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/abeba769-e30c-336e-ba36-cc90d509718f</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guests: Jesse D. Bracamonte, D.O., Casey Martinez, Kiyan Heybati</p>
<p>If you’re a physician, there are several events during your medical journey that you’ll always remember, receiving your letter of acceptance for medical school, medical school graduation and Match Day. For those of you who aren’t physicians, Match Day is a very exciting day for medical students. It represents the day students learn where they’ll be doing their residency training. It’s a complicated process that uses an algorithm to match students and residency positions. But what happens if a student doesn’t match with a residency program, what are their options? What do residency programs consider when ranking the numerous student candidates?  What are some common mistakes students make during the match process and how can students maximize their chances of matching with one of their top residency choices? These are questions I’ll be asking my guests, Jesse D. Bracamonte, D.O., a family physician and Associate Dean of Student Affairs at the Arizona campus of the Mayo Clinic, as well as Casey Martinez and Kiyan Heybati, both senior medical students from the Mayo Clinic Alix School of Medicine. Our topic of discussion for this podcast will be “Navigating the Match: What Every Medical Student Should Know”.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guests: Jesse D. Bracamonte, D.O., Casey Martinez, Kiyan Heybati</p>
<p>If you’re a physician, there are several events during your medical journey that you’ll always remember, receiving your letter of acceptance for medical school, medical school graduation and Match Day. For those of you who aren’t physicians, Match Day is a very exciting day for medical students. It represents the day students learn where they’ll be doing their residency training. It’s a complicated process that uses an algorithm to match students and residency positions. But what happens if a student doesn’t match with a residency program, what are their options? What do residency programs consider when ranking the numerous student candidates?  What are some common mistakes students make during the match process and how can students maximize their chances of matching with one of their top residency choices? These are questions I’ll be asking my guests, Jesse D. Bracamonte, D.O., a family physician and Associate Dean of Student Affairs at the Arizona campus of the Mayo Clinic, as well as Casey Martinez and Kiyan Heybati, both senior medical students from the Mayo Clinic Alix School of Medicine. Our topic of discussion for this podcast will be “Navigating the Match: What Every Medical Student Should Know”.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ww2nmvnkwk2gj7y4/WF6254335_Match_Daybdb8m.mp3" length="42158246" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guests: Jesse D. Bracamonte, D.O., Casey Martinez, Kiyan Heybati
If you’re a physician, there are several events during your medical journey that you’ll always remember, receiving your letter of acceptance for medical school, medical school graduation and Match Day. For those of you who aren’t physicians, Match Day is a very exciting day for medical students. It represents the day students learn where they’ll be doing their residency training. It’s a complicated process that uses an algorithm to match students and residency positions. But what happens if a student doesn’t match with a residency program, what are their options? What do residency programs consider when ranking the numerous student candidates?  What are some common mistakes students make during the match process and how can students maximize their chances of matching with one of their top residency choices? These are questions I’ll be asking my guests, Jesse D. Bracamonte, D.O., a family physician and Associate Dean of Student Affairs at the Arizona campus of the Mayo Clinic, as well as Casey Martinez and Kiyan Heybati, both senior medical students from the Mayo Clinic Alix School of Medicine. Our topic of discussion for this podcast will be “Navigating the Match: What Every Medical Student Should Know”.
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1745</itunes:duration>
                <itunes:episode>598</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes and Your Health Series: Cardiology and Genetics</title>
        <itunes:title>Genes and Your Health Series: Cardiology and Genetics</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-and-your-health-series-cardiology-and-genetics/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-and-your-health-series-cardiology-and-genetics/#comments</comments>        <pubDate>Thu, 19 Jun 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/d6780ea5-13cf-3032-8adc-12b27fc31626</guid>
                                    <description><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: John R. Giudicessi, M.D., Ph.D.</p>
<p>Dr. Giudicessi, a leader in cardiovascular genetics and gene therapy research, discusses the latest advancements in understanding and treating genetic arrhythmias and cardiomyopathies. This episode provides a comprehensive look at how genetics is revolutionizing cardiovascular care, empowering physicians to offer more precise, patient-centered treatments. Dr. Giudicessi’s insights underscore the transformative potential of genetic research in improving outcomes for patients with inheritable cardiovascular diseases.</p>
<p class="p1">Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: John R. Giudicessi, M.D., Ph.D.</p>
<p>Dr. Giudicessi, a leader in cardiovascular genetics and gene therapy research, discusses the latest advancements in understanding and treating genetic arrhythmias and cardiomyopathies. This episode provides a comprehensive look at how genetics is revolutionizing cardiovascular care, empowering physicians to offer more precise, patient-centered treatments. Dr. Giudicessi’s insights underscore the transformative potential of genetic research in improving outcomes for patients with inheritable cardiovascular diseases.</p>
<p class="p1">Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6rm7wsgx53mbfdef/WF5380975_Cardiology_and_Genetics6lqo7.mp3" length="58683993" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Denise M. Dupras, M.D., Ph.D.
Guest: John R. Giudicessi, M.D., Ph.D.
Dr. Giudicessi, a leader in cardiovascular genetics and gene therapy research, discusses the latest advancements in understanding and treating genetic arrhythmias and cardiomyopathies. This episode provides a comprehensive look at how genetics is revolutionizing cardiovascular care, empowering physicians to offer more precise, patient-centered treatments. Dr. Giudicessi’s insights underscore the transformative potential of genetic research in improving outcomes for patients with inheritable cardiovascular diseases.
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2432</itunes:duration>
                <itunes:episode>599</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Class 5 Tuberculosis Cases</title>
        <itunes:title>Class 5 Tuberculosis Cases</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/class-5-tuberculosis-cases/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/class-5-tuberculosis-cases/#comments</comments>        <pubDate>Tue, 17 Jun 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/c8373511-12db-328f-b318-34eefe700326</guid>
                                    <description><![CDATA[<p class="p1">Host: Darryl S. Chutka, M.D.</p>
<p>Guest: John W. Wilson, M.D.</p>
<p>Tuberculosis remains a significant health concern. Globally, in 2023, an estimated 10 million individuals developed active tuberculosis and over one million died of the disease. In the U.S., just under 10, 000 individuals in the U.S. were diagnosed with TB, representing an increase over 2022. While tuberculosis remains a treatable disease, it’s important to suspect and recognize those who may have it. A class 5 tuberculosis case is part of a TB classification system and refers to a suspected tuberculosis infection that requires further investigation. Symptoms may or may not be present and these patients may have an active TB case that could be contagious. This podcast is about class 5 tuberculosis cases, and my guest is infectious disease specialist, John W. Wilson, M.D., from the Mayo Clinic.</p>
<p class="p1">Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="p1">Host: Darryl S. Chutka, M.D.</p>
<p>Guest: John W. Wilson, M.D.</p>
<p>Tuberculosis remains a significant health concern. Globally, in 2023, an estimated 10 million individuals developed active tuberculosis and over one million died of the disease. In the U.S., just under 10, 000 individuals in the U.S. were diagnosed with TB, representing an increase over 2022. While tuberculosis remains a treatable disease, it’s important to suspect and recognize those who may have it. A class 5 tuberculosis case is part of a TB classification system and refers to a suspected tuberculosis infection that requires further investigation. Symptoms may or may not be present and these patients may have an active TB case that could be contagious. This podcast is about class 5 tuberculosis cases, and my guest is infectious disease specialist, John W. Wilson, M.D., from the Mayo Clinic.</p>
<p class="p1">Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ybp3i79sa3chy5ua/WF5843464_Tuberculosis-Class_5_TB_Cases_promo_AFa2kgp.mp3" length="46122196" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: John W. Wilson, M.D.
Tuberculosis remains a significant health concern. Globally, in 2023, an estimated 10 million individuals developed active tuberculosis and over one million died of the disease. In the U.S., just under 10, 000 individuals in the U.S. were diagnosed with TB, representing an increase over 2022. While tuberculosis remains a treatable disease, it’s important to suspect and recognize those who may have it. A class 5 tuberculosis case is part of a TB classification system and refers to a suspected tuberculosis infection that requires further investigation. Symptoms may or may not be present and these patients may have an active TB case that could be contagious. This podcast is about class 5 tuberculosis cases, and my guest is infectious disease specialist, John W. Wilson, M.D., from the Mayo Clinic.
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1919</itunes:duration>
                <itunes:episode>597</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Life as a Student</title>
        <itunes:title>Life as a Student</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/life-as-a-student/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/life-as-a-student/#comments</comments>        <pubDate>Tue, 10 Jun 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/430ce69b-226e-3d44-a00b-f186fd42aafe</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guests: Mary Lang; Caroline M. Gearin; Nick R. Winder, SPT</p>
<p>Students in the various fields of medicine deal with a variety of stresses. Perhaps one of the biggest stresses is getting accepted into their respective school to begin their training. Once enrolled, they’re then provided a large amount of information to be memorized and essentially need to learn a new language. They have pressure to do well on exams and spend countless hours in study or on the wards. Many students deal with financial stresses, often graduating with a tremendous student loan debt. So, what’s life like as a student? How do students deal with these stresses?  What’s the application procedure like and are there ways to increase the chances of getting accepted? Do our schools devote enough time to our students’ wellness and burn-out prevention? These are some of the questions we’ll cover in this podcast as we discuss “Life as a Student”. My three guests are all students in a variety of medical training programs. Mary Lang is a 2nd year medical student at the Mayo Alix School of Medicine after obtaining a degree in biomedical engineering. Caroline Gearin is a 2nd year physician assistant student at the Mayo Clinic School of Health Sciences and also has a bachelor’s degree in health science. Nick Winder is a 2nd year physical therapy student at the Mayo Clinic physical therapy doctoral program.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guests: Mary Lang; Caroline M. Gearin; Nick R. Winder, SPT</p>
<p>Students in the various fields of medicine deal with a variety of stresses. Perhaps one of the biggest stresses is getting accepted into their respective school to begin their training. Once enrolled, they’re then provided a large amount of information to be memorized and essentially need to learn a new language. They have pressure to do well on exams and spend countless hours in study or on the wards. Many students deal with financial stresses, often graduating with a tremendous student loan debt. So, what’s life like as a student? How do students deal with these stresses?  What’s the application procedure like and are there ways to increase the chances of getting accepted? Do our schools devote enough time to our students’ wellness and burn-out prevention? These are some of the questions we’ll cover in this podcast as we discuss “Life as a Student”. My three guests are all students in a variety of medical training programs. Mary Lang is a 2nd year medical student at the Mayo Alix School of Medicine after obtaining a degree in biomedical engineering. Caroline Gearin is a 2nd year physician assistant student at the Mayo Clinic School of Health Sciences and also has a bachelor’s degree in health science. Nick Winder is a 2nd year physical therapy student at the Mayo Clinic physical therapy doctoral program.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rc4kjtnjyk6t5man/WF5955009_Life_as_a_Student_promo6f4o9.mp3" length="48171646" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guests: Mary Lang; Caroline M. Gearin; Nick R. Winder, SPT
Students in the various fields of medicine deal with a variety of stresses. Perhaps one of the biggest stresses is getting accepted into their respective school to begin their training. Once enrolled, they’re then provided a large amount of information to be memorized and essentially need to learn a new language. They have pressure to do well on exams and spend countless hours in study or on the wards. Many students deal with financial stresses, often graduating with a tremendous student loan debt. So, what’s life like as a student? How do students deal with these stresses?  What’s the application procedure like and are there ways to increase the chances of getting accepted? Do our schools devote enough time to our students’ wellness and burn-out prevention? These are some of the questions we’ll cover in this podcast as we discuss “Life as a Student”. My three guests are all students in a variety of medical training programs. Mary Lang is a 2nd year medical student at the Mayo Alix School of Medicine after obtaining a degree in biomedical engineering. Caroline Gearin is a 2nd year physician assistant student at the Mayo Clinic School of Health Sciences and also has a bachelor’s degree in health science. Nick Winder is a 2nd year physical therapy student at the Mayo Clinic physical therapy doctoral program.
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1999</itunes:duration>
                <itunes:episode>596</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pulmonary Hypertension</title>
        <itunes:title>Pulmonary Hypertension</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/pulmonary-hypertension/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/pulmonary-hypertension/#comments</comments>        <pubDate>Tue, 03 Jun 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/32f7d694-ae7b-3c57-8891-1cd0443cd564</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Robert L. Scott, M.D., Ph.D.</p>
<p>Pulmonary hypertension is an important medical condition and often underrecognized in primary care. It has a variety of causes, and its most common presenting symptom is dyspnea. As primary care clinicians, we often see patients with symptoms of dyspnea and pulmonary hypertension is not a health problem we commonly encounter. Yet, early recognition and diagnosis is important and has major implications for patient outcomes. What are some clues that a patient might have pulmonary hypertension? What are its most common causes and what are the potential complications if it goes unrecognized? These are some of the questions I’ll be asking my guest, Robert L. Scott, M.D., Ph.D., from the Department of Cardiovascular Medicine at the Arizona campus of the Mayo Clinic as we discuss “Pulmonary Hypertension”.</p>
<p>** Course link-- <a href='https://ce.mayo.edu/pulmonary-medicine/content/mayo-clinic-pulmonary-hypertension-symposium-2025'>https://ce.mayo.edu/pulmonary-medicine/content/mayo-clinic-pulmonary-hypertension-symposium-2025</a></p>
<p>**Seats are limited, so visit our website to register now! </p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Robert L. Scott, M.D., Ph.D.</p>
<p>Pulmonary hypertension is an important medical condition and often underrecognized in primary care. It has a variety of causes, and its most common presenting symptom is dyspnea. As primary care clinicians, we often see patients with symptoms of dyspnea and pulmonary hypertension is not a health problem we commonly encounter. Yet, early recognition and diagnosis is important and has major implications for patient outcomes. What are some clues that a patient might have pulmonary hypertension? What are its most common causes and what are the potential complications if it goes unrecognized? These are some of the questions I’ll be asking my guest, Robert L. Scott, M.D., Ph.D., from the Department of Cardiovascular Medicine at the Arizona campus of the Mayo Clinic as we discuss “Pulmonary Hypertension”.</p>
<p>** Course link-- <a href='https://ce.mayo.edu/pulmonary-medicine/content/mayo-clinic-pulmonary-hypertension-symposium-2025'>https://ce.mayo.edu/pulmonary-medicine/content/mayo-clinic-pulmonary-hypertension-symposium-2025</a></p>
<p>**Seats are limited, so visit our website to register now! </p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gmpvw4wyzcg48cnt/WF5801905_Pulmonary_AF9t37u.mp3" length="46361814" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Robert L. Scott, M.D., Ph.D.
Pulmonary hypertension is an important medical condition and often underrecognized in primary care. It has a variety of causes, and its most common presenting symptom is dyspnea. As primary care clinicians, we often see patients with symptoms of dyspnea and pulmonary hypertension is not a health problem we commonly encounter. Yet, early recognition and diagnosis is important and has major implications for patient outcomes. What are some clues that a patient might have pulmonary hypertension? What are its most common causes and what are the potential complications if it goes unrecognized? These are some of the questions I’ll be asking my guest, Robert L. Scott, M.D., Ph.D., from the Department of Cardiovascular Medicine at the Arizona campus of the Mayo Clinic as we discuss “Pulmonary Hypertension”.
** Course link-- https://ce.mayo.edu/pulmonary-medicine/content/mayo-clinic-pulmonary-hypertension-symposium-2025
**Seats are limited, so visit our website to register now! 
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1929</itunes:duration>
                <itunes:episode>595</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes and Your Health Series: Colon Cancer</title>
        <itunes:title>Genes and Your Health Series: Colon Cancer</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-and-your-health-series-colon-cancer/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-and-your-health-series-colon-cancer/#comments</comments>        <pubDate>Thu, 29 May 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/07f2d3e4-0abf-39cc-8c91-bb56c13509fa</guid>
                                    <description><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Jewel J. Samadder, M.D., Gastroenterologist and Professor, Mayo Clinic</p>
<p>In this episode of Mayo Clinic Talks, Dr. Denise Dupras interviews Dr. Jewel Samadder about colon cancer, with a focus on how genetics and family history influence cancer risk and screening strategies. Dr. Samadder emphasizes empowering primary care providers to identify patients who may benefit from genetic evaluation and early colonoscopy. He encourages clinicians to take thorough family histories and use them to guide screening strategies, helping catch cancer early — or prevent it entirely.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Jewel J. Samadder, M.D., Gastroenterologist and Professor, Mayo Clinic</p>
<p>In this episode of Mayo Clinic Talks, Dr. Denise Dupras interviews Dr. Jewel Samadder about colon cancer, with a focus on how genetics and family history influence cancer risk and screening strategies. Dr. Samadder emphasizes empowering primary care providers to identify patients who may benefit from genetic evaluation and early colonoscopy. He encourages clinicians to take thorough family histories and use them to guide screening strategies, helping catch cancer early — or prevent it entirely.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mgw8hxan2mx5i2uu/WF5380975_Ep4_Colon_Cancers7nlty.mp3" length="47061466" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Denise M. Dupras, M.D., Ph.D.
Guest: Jewel J. Samadder, M.D., Gastroenterologist and Professor, Mayo Clinic
In this episode of Mayo Clinic Talks, Dr. Denise Dupras interviews Dr. Jewel Samadder about colon cancer, with a focus on how genetics and family history influence cancer risk and screening strategies. Dr. Samadder emphasizes empowering primary care providers to identify patients who may benefit from genetic evaluation and early colonoscopy. He encourages clinicians to take thorough family histories and use them to guide screening strategies, helping catch cancer early — or prevent it entirely.
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1959</itunes:duration>
                <itunes:episode>594</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Obstetric and Gynecologic Health Series: Infertility and Miscarriage</title>
        <itunes:title>Obstetric and Gynecologic Health Series: Infertility and Miscarriage</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/obstetric-and-gynecologic-health-series-infertility-and-miscarriage/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/obstetric-and-gynecologic-health-series-infertility-and-miscarriage/#comments</comments>        <pubDate>Tue, 27 May 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/b421705d-359c-39c7-8550-19916d7d22a5</guid>
                                    <description><![CDATA[<p>Host: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP</p>
<p>Guest: Nicole Callahan, APRN, CNP, MS</p>
<p>In this episode, along with guest Nicole Callahan, APRN, CNP, MS, we explore reproductive health challenges. Starting with the different types of miscarriage—identifying their unique anatomic changes, symptoms, and outcomes. We will cover the basics of both female and male infertility, including when it’s the ideal time to refer patients for specialized care. Finally, we explore ectopic pregnancy, discussing common locations, risk factors, clinical presentation, diagnostic approach, and treatment options.</p>
<p>By the end of this podcasts, listeners will be able to: </p>
<ol>
<li>Identify the differences in anatomic changes, symptoms, and outcomes in the types of miscarriage.</li>
<li>Understand the basics in female and male infertility and when to refer for more advanced care.</li>
<li>Describe an ectopic pregnancy in regard to most common location, risk factors, signs and symptoms, diagnosis, and treatment options.</li>
</ol>
<p>Learn more about this series: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-obstetric-and-gynecologic-health'>Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP</p>
<p>Guest: Nicole Callahan, APRN, CNP, MS</p>
<p>In this episode, along with guest Nicole Callahan, APRN, CNP, MS, we explore reproductive health challenges. Starting with the different types of miscarriage—identifying their unique anatomic changes, symptoms, and outcomes. We will cover the basics of both female and male infertility, including when it’s the ideal time to refer patients for specialized care. Finally, we explore ectopic pregnancy, discussing common locations, risk factors, clinical presentation, diagnostic approach, and treatment options.</p>
<p>By the end of this podcasts, listeners will be able to: </p>
<ol>
<li>Identify the differences in anatomic changes, symptoms, and outcomes in the types of miscarriage.</li>
<li>Understand the basics in female and male infertility and when to refer for more advanced care.</li>
<li>Describe an ectopic pregnancy in regard to most common location, risk factors, signs and symptoms, diagnosis, and treatment options.</li>
</ol>
<p>Learn more about this series: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-obstetric-and-gynecologic-health'>Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hh7mzryc8fckkncf/WF5370465_Infertility_and_Miscarriage_AF60gdd.mp3" length="45790393" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP
Guest: Nicole Callahan, APRN, CNP, MS
In this episode, along with guest Nicole Callahan, APRN, CNP, MS, we explore reproductive health challenges. Starting with the different types of miscarriage—identifying their unique anatomic changes, symptoms, and outcomes. We will cover the basics of both female and male infertility, including when it’s the ideal time to refer patients for specialized care. Finally, we explore ectopic pregnancy, discussing common locations, risk factors, clinical presentation, diagnostic approach, and treatment options.
By the end of this podcasts, listeners will be able to: 

Identify the differences in anatomic changes, symptoms, and outcomes in the types of miscarriage.
Understand the basics in female and male infertility and when to refer for more advanced care.
Describe an ectopic pregnancy in regard to most common location, risk factors, signs and symptoms, diagnosis, and treatment options.

Learn more about this series: Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development
Connect and listen with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development
 ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1904</itunes:duration>
                <itunes:episode>593</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes and Your Health Series: Harnessing the Power of T-Cells for the Treatment of Cancer and Immune Related Diseases</title>
        <itunes:title>Genes and Your Health Series: Harnessing the Power of T-Cells for the Treatment of Cancer and Immune Related Diseases</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-and-your-health-series-harnessing-the-power-of-t-cells-for-the-treatment-of-cancer-and-immune-related-diseases/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-and-your-health-series-harnessing-the-power-of-t-cells-for-the-treatment-of-cancer-and-immune-related-diseases/#comments</comments>        <pubDate>Thu, 22 May 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/84b12388-4dbf-3cfe-a5f8-8ce523d43a56</guid>
                                    <description><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Saad J. Kenderian, M.B., Ch.B.</p>
<p>Dr. Saad Kenderian discusses the use of CAR-T cell therapy, a groundbreaking treatment that genetically modifies a patient's T-cells to target and destroy cancer cells, particularly in blood cancers like leukemia and lymphoma. He highlights the importance of identifying eligible patients, monitoring treatment response, and applying genomics to guide the future of personalized cancer immunotherapy.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Saad J. Kenderian, M.B., Ch.B.</p>
<p>Dr. Saad Kenderian discusses the use of CAR-T cell therapy, a groundbreaking treatment that genetically modifies a patient's T-cells to target and destroy cancer cells, particularly in blood cancers like leukemia and lymphoma. He highlights the importance of identifying eligible patients, monitoring treatment response, and applying genomics to guide the future of personalized cancer immunotherapy.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fdvt75bzny2srqjr/WF5310014_Ep3_CAR-T_AF74crg.mp3" length="57550113" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Denise M. Dupras, M.D., Ph.D.
Guest: Saad J. Kenderian, M.B., Ch.B.
Dr. Saad Kenderian discusses the use of CAR-T cell therapy, a groundbreaking treatment that genetically modifies a patient's T-cells to target and destroy cancer cells, particularly in blood cancers like leukemia and lymphoma. He highlights the importance of identifying eligible patients, monitoring treatment response, and applying genomics to guide the future of personalized cancer immunotherapy.
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2394</itunes:duration>
                <itunes:episode>592</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Obstetric and Gynecologic Health Series: Vaginal Conditions</title>
        <itunes:title>Obstetric and Gynecologic Health Series: Vaginal Conditions</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/obstetric-and-gynecologic-health-series-vaginal-conditions/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/obstetric-and-gynecologic-health-series-vaginal-conditions/#comments</comments>        <pubDate>Tue, 20 May 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/661e65d4-710a-3d06-864b-92010af99611</guid>
                                    <description><![CDATA[<p>Host: Danielle O’Laughlin, PA-C, MS</p>
<p>Guest: Jenna Wygant, APRN, CNP, DNP</p>
<p>In this episode, Jenna Wygant, APRN, CNP, DNP, walks listeners through the most common types of vaginitis, helping providers to confidently differentiate between them.</p>
<p>We’ll explore the definitions, causes, risk factors, signs and symptoms, as well as diagnostic methods and treatment options for each condition. Comparing the features of these common vaginitis conditions will be emphasized throughout the episode.</p>
<p>By the end of this podcasts, listeners will be able to:</p>
<ol>
<li>Differentiate common vaginitis conditions.</li>
<li>Understand the definition, causes/risk factors, signs and symptoms, diagnosis, and treatment for common vaginitis conditions.</li>
<li>Identify features that help compare common vaginitis conditions.</li>
</ol>
<p>Learn more about this series: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-obstetric-and-gynecologic-health'>Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Danielle O’Laughlin, PA-C, MS</p>
<p>Guest: Jenna Wygant, APRN, CNP, DNP</p>
<p>In this episode, Jenna Wygant, APRN, CNP, DNP, walks listeners through the most common types of vaginitis, helping providers to confidently differentiate between them.</p>
<p>We’ll explore the definitions, causes, risk factors, signs and symptoms, as well as diagnostic methods and treatment options for each condition. Comparing the features of these common vaginitis conditions will be emphasized throughout the episode.</p>
<p>By the end of this podcasts, listeners will be able to:</p>
<ol>
<li>Differentiate common vaginitis conditions.</li>
<li>Understand the definition, causes/risk factors, signs and symptoms, diagnosis, and treatment for common vaginitis conditions.</li>
<li>Identify features that help compare common vaginitis conditions.</li>
</ol>
<p>Learn more about this series: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-obstetric-and-gynecologic-health'>Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/iyu4aierguhizfei/WF5370481_Vaginitis_Conditions_AFautnu.mp3" length="30804638" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Danielle O’Laughlin, PA-C, MS
Guest: Jenna Wygant, APRN, CNP, DNP
In this episode, Jenna Wygant, APRN, CNP, DNP, walks listeners through the most common types of vaginitis, helping providers to confidently differentiate between them.
We’ll explore the definitions, causes, risk factors, signs and symptoms, as well as diagnostic methods and treatment options for each condition. Comparing the features of these common vaginitis conditions will be emphasized throughout the episode.
By the end of this podcasts, listeners will be able to:

Differentiate common vaginitis conditions.
Understand the definition, causes/risk factors, signs and symptoms, diagnosis, and treatment for common vaginitis conditions.
Identify features that help compare common vaginitis conditions.

Learn more about this series: Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development
Connect and listen with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1281</itunes:duration>
                <itunes:episode>591</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Obstetric and Gynecologic Health Series: Vulvar Conditions</title>
        <itunes:title>Obstetric and Gynecologic Health Series: Vulvar Conditions</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/obstetric-and-gynecologic-health-series-vulvar-conditions/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/obstetric-and-gynecologic-health-series-vulvar-conditions/#comments</comments>        <pubDate>Thu, 15 May 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/66392b75-194a-32fc-b918-ed7cfd6e31e4</guid>
                                    <description><![CDATA[<p>Host: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP</p>
<p>Guest: Jenna Johnson, APRN, CNP, DNP</p>
<p>In this episode, we focus on understanding and differentiating common vulvar conditions with guest Jenna Johnson, APRN, CNP, DNP. We will cover how to recognize conditions such as risk factors, signs and symptoms, and gain insight into how these conditions are diagnosed and treated. We’ll also highlight helpful ways to compare these common vulvar health conditions.</p>
<p>By the end of this podcast, listeners will be able to:</p>
<ol>
<li>Differentiate common vulvar conditions.</li>
<li>Understand the definition, causes/risk factors, signs and symptoms, diagnosis, and treatment for common vulvar conditions.</li>
<li>Identify features that help compare common vulvar conditions.</li>
</ol>
<p>Learn more about this series: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-obstetric-and-gynecologic-health'>Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP</p>
<p>Guest: Jenna Johnson, APRN, CNP, DNP</p>
<p>In this episode, we focus on understanding and differentiating common vulvar conditions with guest Jenna Johnson, APRN, CNP, DNP. We will cover how to recognize conditions such as risk factors, signs and symptoms, and gain insight into how these conditions are diagnosed and treated. We’ll also highlight helpful ways to compare these common vulvar health conditions.</p>
<p>By the end of this podcast, listeners will be able to:</p>
<ol>
<li>Differentiate common vulvar conditions.</li>
<li>Understand the definition, causes/risk factors, signs and symptoms, diagnosis, and treatment for common vulvar conditions.</li>
<li>Identify features that help compare common vulvar conditions.</li>
</ol>
<p>Learn more about this series: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-obstetric-and-gynecologic-health'>Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xe93yav49p487m3w/WF5349412_Vulvar_Conditionsa6ohj.mp3" length="35041277" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP
Guest: Jenna Johnson, APRN, CNP, DNP
In this episode, we focus on understanding and differentiating common vulvar conditions with guest Jenna Johnson, APRN, CNP, DNP. We will cover how to recognize conditions such as risk factors, signs and symptoms, and gain insight into how these conditions are diagnosed and treated. We’ll also highlight helpful ways to compare these common vulvar health conditions.
By the end of this podcast, listeners will be able to:

Differentiate common vulvar conditions.
Understand the definition, causes/risk factors, signs and symptoms, diagnosis, and treatment for common vulvar conditions.
Identify features that help compare common vulvar conditions.

Learn more about this series: Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development
Connect and listen with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1456</itunes:duration>
                <itunes:episode>590</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Obstetric and Gynecologic Health Series: Contraception</title>
        <itunes:title>Obstetric and Gynecologic Health Series: Contraception</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/obstetric-and-gynecologic-health-series-contraception/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/obstetric-and-gynecologic-health-series-contraception/#comments</comments>        <pubDate>Tue, 13 May 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/01352ef5-c3c8-379f-aef9-79ff392098fa</guid>
                                    <description><![CDATA[<p>Host: Danielle O’Laughlin, PA-C, MS</p>
<p>Guest: Jenna Wygant, APRN, CNP, DNP</p>
<p>Guest, Jenna Wygant, APRN, CNP, DNP, joins us to explore the full spectrum of contraception options - from natural family planning to non-hormonal and hormonal methods. For each type of contraception, an understanding of how each type works, their efficacy, and the potential risks and benefits will be covered. We also break down the different types of emergency contraception and considerations to review when consulting with patients.</p>
<p>By the end of this podcast, listeners will be able to: </p>
<ol>
<li>Define natural family planning, non-hormonal, and hormonal contraceptives.</li>
<li>Understand the use, efficacy, mechanism of action, and risks and benefits for the different types of contraception.</li>
<li>Explain the types and uses of emergency contraception.</li>
</ol>
<p>Learn more about this series: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-obstetric-and-gynecologic-health'>Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Danielle O’Laughlin, PA-C, MS</p>
<p>Guest: Jenna Wygant, APRN, CNP, DNP</p>
<p>Guest, Jenna Wygant, APRN, CNP, DNP, joins us to explore the full spectrum of contraception options - from natural family planning to non-hormonal and hormonal methods. For each type of contraception, an understanding of how each type works, their efficacy, and the potential risks and benefits will be covered. We also break down the different types of emergency contraception and considerations to review when consulting with patients.</p>
<p>By the end of this podcast, listeners will be able to: </p>
<ol>
<li>Define natural family planning, non-hormonal, and hormonal contraceptives.</li>
<li>Understand the use, efficacy, mechanism of action, and risks and benefits for the different types of contraception.</li>
<li>Explain the types and uses of emergency contraception.</li>
</ol>
<p>Learn more about this series: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-obstetric-and-gynecologic-health'>Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/a3hpujf5wdnpztkq/WF5370478_ContraceptionAF.mp3" length="43116231" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Danielle O’Laughlin, PA-C, MS
Guest: Jenna Wygant, APRN, CNP, DNP
Guest, Jenna Wygant, APRN, CNP, DNP, joins us to explore the full spectrum of contraception options - from natural family planning to non-hormonal and hormonal methods. For each type of contraception, an understanding of how each type works, their efficacy, and the potential risks and benefits will be covered. We also break down the different types of emergency contraception and considerations to review when consulting with patients.
By the end of this podcast, listeners will be able to: 

Define natural family planning, non-hormonal, and hormonal contraceptives.
Understand the use, efficacy, mechanism of action, and risks and benefits for the different types of contraception.
Explain the types and uses of emergency contraception.

Learn more about this series: Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development
Connect and listen with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1794</itunes:duration>
                <itunes:episode>589</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Obstetric and Gynecologic Health Series: Menstrual Cycle and Menopause</title>
        <itunes:title>Obstetric and Gynecologic Health Series: Menstrual Cycle and Menopause</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/obstetric-and-gynecologic-health-series-menstrual-cycle-and-menopause/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/obstetric-and-gynecologic-health-series-menstrual-cycle-and-menopause/#comments</comments>        <pubDate>Thu, 08 May 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/29627054-bb9c-3840-af35-6d219661c249</guid>
                                    <description><![CDATA[<p>Host: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP</p>
<p>Guest: Jissy Cyriac, M.D.</p>
<p>In this episode, guest Jissy Cyriac, M.D., will walk us through the complexities of menstrual health by comparing a normal menstrual cycle with the key causes of abnormal uterine bleeding and menopause. Recognizing the signs, symptoms, and treatment options for conditions like endometriosis, adenomyosis, and endometrial hyperplasia. Plus, we’ll highlight essential buzzwords, the gold-standards and helpful ways to help solidify understanding of key aspects of gynecologic health for menstrual cycles, abnormal uterine bleeding causes, and menopause.</p>
<p>By the end of this podcasts, listeners will be able to:</p>
<ol>
<li>Differentiate the normal menstrual cycle versus causes of abnormal uterine bleeding and menopause.</li>
<li>Recognize the signs and symptoms, diagnosis, and treatment options for a few of the abnormal uterine bleeding causes including endometriosis, adenomyosis, and endometrial hyperplasia.</li>
<li>Identify BUZZ words, gold standards, and helpful ways to remember components of the normal menstrual cycle, abnormal uterine bleeding causes, and menopause.</li>
</ol>
<p>Learn more about this series: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-obstetric-and-gynecologic-health'>Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP</p>
<p>Guest: Jissy Cyriac, M.D.</p>
<p>In this episode, guest Jissy Cyriac, M.D., will walk us through the complexities of menstrual health by comparing a normal menstrual cycle with the key causes of abnormal uterine bleeding and menopause. Recognizing the signs, symptoms, and treatment options for conditions like endometriosis, adenomyosis, and endometrial hyperplasia. Plus, we’ll highlight essential buzzwords, the gold-standards and helpful ways to help solidify understanding of key aspects of gynecologic health for menstrual cycles, abnormal uterine bleeding causes, and menopause.</p>
<p>By the end of this podcasts, listeners will be able to:</p>
<ol>
<li>Differentiate the normal menstrual cycle versus causes of abnormal uterine bleeding and menopause.</li>
<li>Recognize the signs and symptoms, diagnosis, and treatment options for a few of the abnormal uterine bleeding causes including endometriosis, adenomyosis, and endometrial hyperplasia.</li>
<li>Identify BUZZ words, gold standards, and helpful ways to remember components of the normal menstrual cycle, abnormal uterine bleeding causes, and menopause.</li>
</ol>
<p>Learn more about this series: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-obstetric-and-gynecologic-health'>Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xaku94rggvniiaic/WF5349442_Menstrual_Cycle-Menopause9cgl1.mp3" length="49290840" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP
Guest: Jissy Cyriac, M.D.
In this episode, guest Jissy Cyriac, M.D., will walk us through the complexities of menstrual health by comparing a normal menstrual cycle with the key causes of abnormal uterine bleeding and menopause. Recognizing the signs, symptoms, and treatment options for conditions like endometriosis, adenomyosis, and endometrial hyperplasia. Plus, we’ll highlight essential buzzwords, the gold-standards and helpful ways to help solidify understanding of key aspects of gynecologic health for menstrual cycles, abnormal uterine bleeding causes, and menopause.
By the end of this podcasts, listeners will be able to:

Differentiate the normal menstrual cycle versus causes of abnormal uterine bleeding and menopause.
Recognize the signs and symptoms, diagnosis, and treatment options for a few of the abnormal uterine bleeding causes including endometriosis, adenomyosis, and endometrial hyperplasia.
Identify BUZZ words, gold standards, and helpful ways to remember components of the normal menstrual cycle, abnormal uterine bleeding causes, and menopause.

Learn more about this series: Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development
Connect and listen with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2050</itunes:duration>
                <itunes:episode>588</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Obstetric and Gynecologic Health Series: Benign Inflammatory Breast Conditions</title>
        <itunes:title>Obstetric and Gynecologic Health Series: Benign Inflammatory Breast Conditions</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/obstetric-and-gynecological-health-series-benign-inflammatory-breast-conditions/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/obstetric-and-gynecological-health-series-benign-inflammatory-breast-conditions/#comments</comments>        <pubDate>Tue, 06 May 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/211d69b7-2d03-370a-a274-dcca69bff894</guid>
                                    <description><![CDATA[<p>Host: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP</p>
<p>Guest: Danielle O’Laughlin, PA-C, MS</p>
<p>In this episode, along with host/guest Danielle O’Laughlin, PA-C, MS, we will discuss benign, inflammatory breast conditions. We will cover how to differentiate between common issues such as mastitis, breast abscess, fat necrosis, galactorrhea, and gynecomastia. We’ll walk through the key signs and symptoms to watch for and explore how each condition is diagnosed and treated. This episode offers valuable insights into these non-cancerous yet very important conditions.</p>
<p>By the end of this podcasts, listeners will be able to:</p>
<ol>
<li>Differentiate the benign, inflammatory breast conditions including mastitis, breast abscess, fat necrosis, galactorrhea, and gynecomastia.</li>
<li>Recognize the signs and symptoms for benign, inflammatory breast conditions.</li>
<li>Summarize the diagnosis and treatment options for benign, inflammatory breast conditions.</li>
</ol>
<p>Learn more about this series: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-obstetric-and-gynecologic-health'>Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP</p>
<p>Guest: Danielle O’Laughlin, PA-C, MS</p>
<p>In this episode, along with host/guest Danielle O’Laughlin, PA-C, MS, we will discuss benign, inflammatory breast conditions. We will cover how to differentiate between common issues such as mastitis, breast abscess, fat necrosis, galactorrhea, and gynecomastia. We’ll walk through the key signs and symptoms to watch for and explore how each condition is diagnosed and treated. This episode offers valuable insights into these non-cancerous yet very important conditions.</p>
<p>By the end of this podcasts, listeners will be able to:</p>
<ol>
<li>Differentiate the benign, inflammatory breast conditions including mastitis, breast abscess, fat necrosis, galactorrhea, and gynecomastia.</li>
<li>Recognize the signs and symptoms for benign, inflammatory breast conditions.</li>
<li>Summarize the diagnosis and treatment options for benign, inflammatory breast conditions.</li>
</ol>
<p>Learn more about this series: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-obstetric-and-gynecologic-health'>Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/97fgg7rhx77tgmkk/WF5370477_Benign_Inflammatory_Conditionsacq4l.mp3" length="21347951" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP
Guest: Danielle O’Laughlin, PA-C, MS
In this episode, along with host/guest Danielle O’Laughlin, PA-C, MS, we will discuss benign, inflammatory breast conditions. We will cover how to differentiate between common issues such as mastitis, breast abscess, fat necrosis, galactorrhea, and gynecomastia. We’ll walk through the key signs and symptoms to watch for and explore how each condition is diagnosed and treated. This episode offers valuable insights into these non-cancerous yet very important conditions.
By the end of this podcasts, listeners will be able to:

Differentiate the benign, inflammatory breast conditions including mastitis, breast abscess, fat necrosis, galactorrhea, and gynecomastia.
Recognize the signs and symptoms for benign, inflammatory breast conditions.
Summarize the diagnosis and treatment options for benign, inflammatory breast conditions.

Learn more about this series: Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development
Connect and listen with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>888</itunes:duration>
                <itunes:episode>587</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Barrett’s Esophagus</title>
        <itunes:title>Barrett’s Esophagus</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/barrett-s-esophagus/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/barrett-s-esophagus/#comments</comments>        <pubDate>Tue, 29 Apr 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/7611ad20-36fa-37e1-b16f-739f17891c48</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guests: Cadman L. Leggett, M.D., and Chamil C. Codipilly, M.D.</p>
<p>Occasional heartburn from gastroesophageal reflux is usually nothing more than an occasional nuisance for most patients.  However, when the reflux becomes chronic, it can become more serious.  One complication is Barrett’s esophagus. On occasion, Barrett’s can develop into esophageal adenocarcinoma, an aggressive malignancy with a survival rate of only around 20% at 5 years.  Although usually seen in those with chronic acid reflux, Barrett’s can occasionally occur in those without any clinical evidence of acid reflux.  When should a patient with acid reflux receive an upper endoscopy?  What’s the significance of finding Barrett’s esophagus on an endoscopy?  How often does Barrett’s develop into esophageal cancer and does treatment prevent this from happening?  In this podcast, these are just some of the questions I’ll be asking our guests, Cadman L. Leggett, M.D., and Chamil C. Codipilly, M.D., both from the Division of Gastroenterology and Hepatology at the Mayo Clinic as we discuss Barrett’s Esophagus.</p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guests: Cadman L. Leggett, M.D., and Chamil C. Codipilly, M.D.</p>
<p>Occasional heartburn from gastroesophageal reflux is usually nothing more than an occasional nuisance for most patients.  However, when the reflux becomes chronic, it can become more serious.  One complication is Barrett’s esophagus. On occasion, Barrett’s can develop into esophageal adenocarcinoma, an aggressive malignancy with a survival rate of only around 20% at 5 years.  Although usually seen in those with chronic acid reflux, Barrett’s can occasionally occur in those without any clinical evidence of acid reflux.  When should a patient with acid reflux receive an upper endoscopy?  What’s the significance of finding Barrett’s esophagus on an endoscopy?  How often does Barrett’s develop into esophageal cancer and does treatment prevent this from happening?  In this podcast, these are just some of the questions I’ll be asking our guests, Cadman L. Leggett, M.D., and Chamil C. Codipilly, M.D., both from the Division of Gastroenterology and Hepatology at the Mayo Clinic as we discuss Barrett’s Esophagus.</p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ekrmet7c5k7srnez/WF4527304_Barretts_Esophagus_midroll_AF9mmv2.mp3" length="36266514" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guests: Cadman L. Leggett, M.D., and Chamil C. Codipilly, M.D.
Occasional heartburn from gastroesophageal reflux is usually nothing more than an occasional nuisance for most patients.  However, when the reflux becomes chronic, it can become more serious.  One complication is Barrett’s esophagus. On occasion, Barrett’s can develop into esophageal adenocarcinoma, an aggressive malignancy with a survival rate of only around 20% at 5 years.  Although usually seen in those with chronic acid reflux, Barrett’s can occasionally occur in those without any clinical evidence of acid reflux.  When should a patient with acid reflux receive an upper endoscopy?  What’s the significance of finding Barrett’s esophagus on an endoscopy?  How often does Barrett’s develop into esophageal cancer and does treatment prevent this from happening?  In this podcast, these are just some of the questions I’ll be asking our guests, Cadman L. Leggett, M.D., and Chamil C. Codipilly, M.D., both from the Division of Gastroenterology and Hepatology at the Mayo Clinic as we discuss Barrett’s Esophagus.
Connect and listen with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1504</itunes:duration>
                <itunes:episode>586</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes and Your Health Series: mRNA: What it is, What it Does, and Hope in Rare Diseases</title>
        <itunes:title>Genes and Your Health Series: mRNA: What it is, What it Does, and Hope in Rare Diseases</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-and-your-health-series-mrna-what-it-is-what-it-does-and-hope-in-rare-diseases/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-and-your-health-series-mrna-what-it-is-what-it-does-and-hope-in-rare-diseases/#comments</comments>        <pubDate>Thu, 24 Apr 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/e6066377-8292-385e-a1df-25c65e14a8dc</guid>
                                    <description><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Michael Zimmer, Ph.D., Director of Rare Diseases at Moderna Therapeutics</p>
<p>This episode of Genes &amp; Your Health welcomes Dr. Michael Zimmer from Moderna Therapeutics, who discusses how mRNA technology is being applied to treat rare genetic diseases, especially liver-based metabolic disorders. Dr. Zimmer explains how mRNA can help the body produce missing proteins, the challenges of delivering these therapies, and the promise they hold for previously untreatable conditions.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Michael Zimmer, Ph.D., Director of Rare Diseases at Moderna Therapeutics</p>
<p>This episode of Genes &amp; Your Health welcomes Dr. Michael Zimmer from Moderna Therapeutics, who discusses how mRNA technology is being applied to treat rare genetic diseases, especially liver-based metabolic disorders. Dr. Zimmer explains how mRNA can help the body produce missing proteins, the challenges of delivering these therapies, and the promise they hold for previously untreatable conditions.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4bttepn87vef5c9u/WF5327303_mRNA.mp3" length="55623169" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Denise M. Dupras, M.D., Ph.D.
Guest: Michael Zimmer, Ph.D., Director of Rare Diseases at Moderna Therapeutics
This episode of Genes &amp; Your Health welcomes Dr. Michael Zimmer from Moderna Therapeutics, who discusses how mRNA technology is being applied to treat rare genetic diseases, especially liver-based metabolic disorders. Dr. Zimmer explains how mRNA can help the body produce missing proteins, the challenges of delivering these therapies, and the promise they hold for previously untreatable conditions.
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2315</itunes:duration>
                <itunes:episode>585</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Transplantation Series: Lung Transplantation</title>
        <itunes:title>Transplantation Series: Lung Transplantation</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/transplantation-series-lung-transplantation/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/transplantation-series-lung-transplantation/#comments</comments>        <pubDate>Tue, 22 Apr 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/84dca6b9-103c-3922-a7f1-3d56bbc3410b</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: John Haney, M.D., M.P.H.</p>
<p>Lung transplantation remains a very viable option for patients with end-stage pulmonary disease who no longer respond to medical management. Over 5,000 lung transplants are performed annually around the world. However, its estimated that over 10 times this number are candidates and awaiting a transplant. A shortage of organs remains the major limiting factor. What are the common indications and who’s a candidate for a lung transplant? How are patients prioritized and chosen? What advances have been made in the field and what challenges remain? Finally, what role does the primary care clinician play in lung transplantation? I’ll be discussing these questions and more with my guest, Jack Haney, M.D., M.P.H., chair of cardiothoracic surgery at the Jacksonville campus of the Mayo Clinic. The topic for this podcast is “Lung Transplantation”.</p>
<p>Learn more about this Transplant Series:  <a href='https://ce.mayo.edu/content/mayo-clinic-talks-donate-life-transplantation-series'>Mayo Clinic Talks: Donate Life: Transplantation Series | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with Mayo Clinic’s Transplant Center online at <a href='https://mayoclinic.org/transplant'>https://mayoclinic.org/transplant</a> or on X @MayoTransplant.</p>
<p>To learn more and register to be an organ donor please visit <a href='https://careinfo.mayoclinic.org/organ-donation'>https://careinfo.mayoclinic.org/organ-donation</a>.</p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: John Haney, M.D., M.P.H.</p>
<p>Lung transplantation remains a very viable option for patients with end-stage pulmonary disease who no longer respond to medical management. Over 5,000 lung transplants are performed annually around the world. However, its estimated that over 10 times this number are candidates and awaiting a transplant. A shortage of organs remains the major limiting factor. What are the common indications and who’s a candidate for a lung transplant? How are patients prioritized and chosen? What advances have been made in the field and what challenges remain? Finally, what role does the primary care clinician play in lung transplantation? I’ll be discussing these questions and more with my guest, Jack Haney, M.D., M.P.H., chair of cardiothoracic surgery at the Jacksonville campus of the Mayo Clinic. The topic for this podcast is “Lung Transplantation”.</p>
<p>Learn more about this Transplant Series:  <a href='https://ce.mayo.edu/content/mayo-clinic-talks-donate-life-transplantation-series'>Mayo Clinic Talks: Donate Life: Transplantation Series | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with Mayo Clinic’s Transplant Center online at <a href='https://mayoclinic.org/transplant'>https://mayoclinic.org/transplant</a> or on X @MayoTransplant.</p>
<p>To learn more and register to be an organ donor please visit <a href='https://careinfo.mayoclinic.org/organ-donation'>https://careinfo.mayoclinic.org/organ-donation</a>.</p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/24ryvzxjragundsy/WF5597641_Lung_Transplant_AF7tn84.mp3" length="41924771" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: John Haney, M.D., M.P.H.
Lung transplantation remains a very viable option for patients with end-stage pulmonary disease who no longer respond to medical management. Over 5,000 lung transplants are performed annually around the world. However, its estimated that over 10 times this number are candidates and awaiting a transplant. A shortage of organs remains the major limiting factor. What are the common indications and who’s a candidate for a lung transplant? How are patients prioritized and chosen? What advances have been made in the field and what challenges remain? Finally, what role does the primary care clinician play in lung transplantation? I’ll be discussing these questions and more with my guest, Jack Haney, M.D., M.P.H., chair of cardiothoracic surgery at the Jacksonville campus of the Mayo Clinic. The topic for this podcast is “Lung Transplantation”.
Learn more about this Transplant Series:  Mayo Clinic Talks: Donate Life: Transplantation Series | Mayo Clinic School of Continuous Professional Development
Connect with Mayo Clinic’s Transplant Center online at https://mayoclinic.org/transplant or on X @MayoTransplant.
To learn more and register to be an organ donor please visit https://careinfo.mayoclinic.org/organ-donation.
Connect and listen with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1741</itunes:duration>
                <itunes:episode>584</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes and Your Health Series: Microbiome Wellness Index 2</title>
        <itunes:title>Genes and Your Health Series: Microbiome Wellness Index 2</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-and-your-health-series-microbiome-wellness-index-2/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-and-your-health-series-microbiome-wellness-index-2/#comments</comments>        <pubDate>Thu, 17 Apr 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/c116730a-f37c-3a94-95f3-3ccd2cc4ba38</guid>
                                    <description><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Heidi Nelson, M.D., Emeritus Chair of the Department of Surgery and past Chair of the Division of Colon &amp; Rectal Surgery at Mayo Clinic in Rochester</p>
<p>Guest: Jaeyun Sung, Ph.D., Associate Professor of Biomedical Informatics and Senior Associate Consultant II in the Department of Quantitative Health Sciences, Mayo Clinic Rochester</p>
<p>This episode of Genes &amp; Your Health presents the results of the Gut Microbiome Wellness Index 2 study, which examines the differences between the gut microbiomes of healthy and disease-affected populations. Drs. Nelson and Sung discussed a potential future where a stool gut microbiome profile could be used as a barometer of general gut health and outlined how the microbiome can be altered and used to predict overall health.  They also covered factors that can contribute to returning the gut microbiome to healthy status after a disruption.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Heidi Nelson, M.D., Emeritus Chair of the Department of Surgery and past Chair of the Division of Colon &amp; Rectal Surgery at Mayo Clinic in Rochester</p>
<p>Guest: Jaeyun Sung, Ph.D., Associate Professor of Biomedical Informatics and Senior Associate Consultant II in the Department of Quantitative Health Sciences, Mayo Clinic Rochester</p>
<p>This episode of Genes &amp; Your Health presents the results of the Gut Microbiome Wellness Index 2 study, which examines the differences between the gut microbiomes of healthy and disease-affected populations. Drs. Nelson and Sung discussed a potential future where a stool gut microbiome profile could be used as a barometer of general gut health and outlined how the microbiome can be altered and used to predict overall health.  They also covered factors that can contribute to returning the gut microbiome to healthy status after a disruption.</p>
<p>Connect with us and learn more here: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3q78bzv2fbxb928m/WF5377554_Genes-Microbiome_Wellness_Index_2_AF67zab.mp3" length="66428509" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Denise M. Dupras, M.D., Ph.D.
Guest: Heidi Nelson, M.D., Emeritus Chair of the Department of Surgery and past Chair of the Division of Colon &amp; Rectal Surgery at Mayo Clinic in Rochester
Guest: Jaeyun Sung, Ph.D., Associate Professor of Biomedical Informatics and Senior Associate Consultant II in the Department of Quantitative Health Sciences, Mayo Clinic Rochester
This episode of Genes &amp; Your Health presents the results of the Gut Microbiome Wellness Index 2 study, which examines the differences between the gut microbiomes of healthy and disease-affected populations. Drs. Nelson and Sung discussed a potential future where a stool gut microbiome profile could be used as a barometer of general gut health and outlined how the microbiome can be altered and used to predict overall health.  They also covered factors that can contribute to returning the gut microbiome to healthy status after a disruption.
Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2760</itunes:duration>
                <itunes:episode>583</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Transplantation Series: What's New in Organ Transplantation Surgery</title>
        <itunes:title>Transplantation Series: What's New in Organ Transplantation Surgery</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/transplantation-series-whats-new-in-organ-transplantation-surgery/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/transplantation-series-whats-new-in-organ-transplantation-surgery/#comments</comments>        <pubDate>Tue, 15 Apr 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/0e4d9c18-9df8-393f-84bd-560e2c18cc2f</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Julie K. Heimbach, M.D.</p>
<p>In 2024, over 48,000 organ transplants were performed in the U.S., representing an increase over the number performed the year before. There was also an increase in the number of transplants performed internationally, offering hope to patients worldwide with organ failure. Significant advancements have been made in the field of organ transplantation, and this is responsible for the success of the organ transplantation program. What are some of the major milestones that have taken place since the initial organ transplant? How has technology improved the success of an organ transplanted? What role will xenotransplantation, or transplantation of animal organs play in the future? These are some of the questions I’ll be asking my guest, Julie K. Heimbach, M.D., transplant surgeon and director of the Transplant Center at the Mayo Clinic. The topic for this podcast is “What’s New in Transplant Surgery?”</p>
<p>Learn more about this Transplant Series:  <a href='https://ce.mayo.edu/content/mayo-clinic-talks-donate-life-transplantation-series'>Mayo Clinic Talks: Donate Life: Transplantation Series | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with Mayo Clinic’s Transplant Center online at <a href='https://mayoclinic.org/transplant'>https://mayoclinic.org/transplant</a> or on X @MayoTransplant.</p>
<p>To learn more and register to be an organ donor please visit <a href='https://careinfo.mayoclinic.org/organ-donation'>https://careinfo.mayoclinic.org/organ-donation</a>.</p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Julie K. Heimbach, M.D.</p>
<p>In 2024, over 48,000 organ transplants were performed in the U.S., representing an increase over the number performed the year before. There was also an increase in the number of transplants performed internationally, offering hope to patients worldwide with organ failure. Significant advancements have been made in the field of organ transplantation, and this is responsible for the success of the organ transplantation program. What are some of the major milestones that have taken place since the initial organ transplant? How has technology improved the success of an organ transplanted? What role will xenotransplantation, or transplantation of animal organs play in the future? These are some of the questions I’ll be asking my guest, Julie K. Heimbach, M.D., transplant surgeon and director of the Transplant Center at the Mayo Clinic. The topic for this podcast is “What’s New in Transplant Surgery?”</p>
<p>Learn more about this Transplant Series:  <a href='https://ce.mayo.edu/content/mayo-clinic-talks-donate-life-transplantation-series'>Mayo Clinic Talks: Donate Life: Transplantation Series | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with Mayo Clinic’s Transplant Center online at <a href='https://mayoclinic.org/transplant'>https://mayoclinic.org/transplant</a> or on X @MayoTransplant.</p>
<p>To learn more and register to be an organ donor please visit <a href='https://careinfo.mayoclinic.org/organ-donation'>https://careinfo.mayoclinic.org/organ-donation</a>.</p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/g6jwsstuiad6hu9k/WF5744700_What_s_New_in_Transplant_Surgeryalr8y.mp3" length="36062149" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Julie K. Heimbach, M.D.
In 2024, over 48,000 organ transplants were performed in the U.S., representing an increase over the number performed the year before. There was also an increase in the number of transplants performed internationally, offering hope to patients worldwide with organ failure. Significant advancements have been made in the field of organ transplantation, and this is responsible for the success of the organ transplantation program. What are some of the major milestones that have taken place since the initial organ transplant? How has technology improved the success of an organ transplanted? What role will xenotransplantation, or transplantation of animal organs play in the future? These are some of the questions I’ll be asking my guest, Julie K. Heimbach, M.D., transplant surgeon and director of the Transplant Center at the Mayo Clinic. The topic for this podcast is “What’s New in Transplant Surgery?”
Learn more about this Transplant Series:  Mayo Clinic Talks: Donate Life: Transplantation Series | Mayo Clinic School of Continuous Professional Development
Connect with Mayo Clinic’s Transplant Center online at https://mayoclinic.org/transplant or on X @MayoTransplant.
To learn more and register to be an organ donor please visit https://careinfo.mayoclinic.org/organ-donation.
Connect and listen with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1499</itunes:duration>
                <itunes:episode>582</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Transplantation Series: AI in Transplantation Medicine</title>
        <itunes:title>Transplantation Series: AI in Transplantation Medicine</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/transplantation-series-ai-in-transplantation-medicine/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/transplantation-series-ai-in-transplantation-medicine/#comments</comments>        <pubDate>Thu, 10 Apr 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/fa3738e1-2e2d-34bc-9aed-5e4edaa24a9c</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Rohan M. Goswami, M.D.</p>
<p>The benefits of artificial intelligence or AI are just beginning to be recognized. AI has the potential to improve productivity and efficiency in the workplace, reduce errors and help sort out complex issues. The field of healthcare is finding roles for AI by improving the management of patient data, enhancing clinical decision making and assisting in medical imaging analysis. The integration of AI in transplantation medicine is evolving and has the potential to revolutionize the field. Can AI assist in organ matching and allocation? Can it predict graft survival and organ rejection?  What ethical concerns does AI bring to the specialty?  I’ll be discussing these issues in this podcast as we tackle the topic of “AI in Transplantation Medicine”. My guest for this podcast is Rohan M. Goswami, M.D., a cardiologist and specialist in Transplant Medicine from the Mayo Clinic.</p>
<p>Learn more about this Transplant Series:  <a href='https://ce.mayo.edu/content/mayo-clinic-talks-donate-life-transplantation-series'>Mayo Clinic Talks: Donate Life: Transplantation Series | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with Mayo Clinic’s Transplant Center online at <a href='https://mayoclinic.org/transplant'>https://mayoclinic.org/transplant</a> or on X @MayoTransplant.</p>
<p>To learn more and register to be an organ donor please visit <a href='https://careinfo.mayoclinic.org/organ-donation'>https://careinfo.mayoclinic.org/organ-donation</a>.</p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Rohan M. Goswami, M.D.</p>
<p>The benefits of artificial intelligence or AI are just beginning to be recognized. AI has the potential to improve productivity and efficiency in the workplace, reduce errors and help sort out complex issues. The field of healthcare is finding roles for AI by improving the management of patient data, enhancing clinical decision making and assisting in medical imaging analysis. The integration of AI in transplantation medicine is evolving and has the potential to revolutionize the field. Can AI assist in organ matching and allocation? Can it predict graft survival and organ rejection?  What ethical concerns does AI bring to the specialty?  I’ll be discussing these issues in this podcast as we tackle the topic of “AI in Transplantation Medicine”. My guest for this podcast is Rohan M. Goswami, M.D., a cardiologist and specialist in Transplant Medicine from the Mayo Clinic.</p>
<p>Learn more about this Transplant Series:  <a href='https://ce.mayo.edu/content/mayo-clinic-talks-donate-life-transplantation-series'>Mayo Clinic Talks: Donate Life: Transplantation Series | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with Mayo Clinic’s Transplant Center online at <a href='https://mayoclinic.org/transplant'>https://mayoclinic.org/transplant</a> or on X @MayoTransplant.</p>
<p>To learn more and register to be an organ donor please visit <a href='https://careinfo.mayoclinic.org/organ-donation'>https://careinfo.mayoclinic.org/organ-donation</a>.</p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9w7buecu6pss7khk/WF5510197_AI_in_Transplantation6ksyr.mp3" length="32245377" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Rohan M. Goswami, M.D.
The benefits of artificial intelligence or AI are just beginning to be recognized. AI has the potential to improve productivity and efficiency in the workplace, reduce errors and help sort out complex issues. The field of healthcare is finding roles for AI by improving the management of patient data, enhancing clinical decision making and assisting in medical imaging analysis. The integration of AI in transplantation medicine is evolving and has the potential to revolutionize the field. Can AI assist in organ matching and allocation? Can it predict graft survival and organ rejection?  What ethical concerns does AI bring to the specialty?  I’ll be discussing these issues in this podcast as we tackle the topic of “AI in Transplantation Medicine”. My guest for this podcast is Rohan M. Goswami, M.D., a cardiologist and specialist in Transplant Medicine from the Mayo Clinic.
Learn more about this Transplant Series:  Mayo Clinic Talks: Donate Life: Transplantation Series | Mayo Clinic School of Continuous Professional Development
Connect with Mayo Clinic’s Transplant Center online at https://mayoclinic.org/transplant or on X @MayoTransplant.
To learn more and register to be an organ donor please visit https://careinfo.mayoclinic.org/organ-donation.
Connect and listen with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1339</itunes:duration>
                <itunes:episode>581</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Transplantation Series: Cardiac Transplantation</title>
        <itunes:title>Transplantation Series: Cardiac Transplantation</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/transplantation-series-cardiac-transplantation/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/transplantation-series-cardiac-transplantation/#comments</comments>        <pubDate>Tue, 08 Apr 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/0793fa1a-a7f2-3aeb-a316-844cfefa1228</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Ruben J. Crespo-Diaz, M.D., Ph.D.</p>
<p>The world’s first human-to-human heart transplant was performed in 1967 and represented a significant breakthrough for medical science. Although the transplant patient only survived 18 days, it was still a historic event. Since this initial heart transplant, significant improvements have been made in the field of organ transplantation and currently, approximately 5000 heart transplants are performed annually. Unfortunately, over ten times this number could benefit from the procedure. What’s the limiting factor in the number of heart transplants performed? What are the current criteria of eligibility for a heart transplant? What are some of the improvements in the field of cardiac transplant surgery? I’ll get answers to these questions and more from my guest, Ruben J. Crespo-Diaz, M.D., Ph.D., from the Department of Cardiovascular Medicine at the Mayo Clinic. The topic for this podcast is “Cardiac Transplant”.</p>
<p>Learn more about this Transplant Series:  <a href='https://ce.mayo.edu/content/mayo-clinic-talks-donate-life-transplantation-series'>Mayo Clinic Talks: Donate Life: Transplantation Series | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with Mayo Clinic’s Transplant Center online at <a href='https://mayoclinic.org/transplant'>https://mayoclinic.org/transplant</a> or on X @MayoTransplant.</p>
<p>To learn more and register to be an organ donor please visit <a href='https://careinfo.mayoclinic.org/organ-donation'>https://careinfo.mayoclinic.org/organ-donation</a>.</p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Ruben J. Crespo-Diaz, M.D., Ph.D.</p>
<p>The world’s first human-to-human heart transplant was performed in 1967 and represented a significant breakthrough for medical science. Although the transplant patient only survived 18 days, it was still a historic event. Since this initial heart transplant, significant improvements have been made in the field of organ transplantation and currently, approximately 5000 heart transplants are performed annually. Unfortunately, over ten times this number could benefit from the procedure. What’s the limiting factor in the number of heart transplants performed? What are the current criteria of eligibility for a heart transplant? What are some of the improvements in the field of cardiac transplant surgery? I’ll get answers to these questions and more from my guest, Ruben J. Crespo-Diaz, M.D., Ph.D., from the Department of Cardiovascular Medicine at the Mayo Clinic. The topic for this podcast is “Cardiac Transplant”.</p>
<p>Learn more about this Transplant Series:  <a href='https://ce.mayo.edu/content/mayo-clinic-talks-donate-life-transplantation-series'>Mayo Clinic Talks: Donate Life: Transplantation Series | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with Mayo Clinic’s Transplant Center online at <a href='https://mayoclinic.org/transplant'>https://mayoclinic.org/transplant</a> or on X @MayoTransplant.</p>
<p>To learn more and register to be an organ donor please visit <a href='https://careinfo.mayoclinic.org/organ-donation'>https://careinfo.mayoclinic.org/organ-donation</a>.</p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dkwygign66jh6nv5/WF6033405_Cardiac_Transplant9h4ki.mp3" length="42837465" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Ruben J. Crespo-Diaz, M.D., Ph.D.
The world’s first human-to-human heart transplant was performed in 1967 and represented a significant breakthrough for medical science. Although the transplant patient only survived 18 days, it was still a historic event. Since this initial heart transplant, significant improvements have been made in the field of organ transplantation and currently, approximately 5000 heart transplants are performed annually. Unfortunately, over ten times this number could benefit from the procedure. What’s the limiting factor in the number of heart transplants performed? What are the current criteria of eligibility for a heart transplant? What are some of the improvements in the field of cardiac transplant surgery? I’ll get answers to these questions and more from my guest, Ruben J. Crespo-Diaz, M.D., Ph.D., from the Department of Cardiovascular Medicine at the Mayo Clinic. The topic for this podcast is “Cardiac Transplant”.
Learn more about this Transplant Series:  Mayo Clinic Talks: Donate Life: Transplantation Series | Mayo Clinic School of Continuous Professional Development
Connect with Mayo Clinic’s Transplant Center online at https://mayoclinic.org/transplant or on X @MayoTransplant.
To learn more and register to be an organ donor please visit https://careinfo.mayoclinic.org/organ-donation.
Connect and listen with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1778</itunes:duration>
                <itunes:episode>580</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Transplantation Series: Pancreas Transplantation</title>
        <itunes:title>Transplantation Series: Pancreas Transplantation</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/transplantation-series-pancreas-transplantation/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/transplantation-series-pancreas-transplantation/#comments</comments>        <pubDate>Thu, 03 Apr 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/93b3f54c-8d73-3f40-9efa-f364f70309f5</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guests: Nitin N. Katariya, M.D., and Lavanya Kodali, M.B.B.S., M.D.</p>
<p>At this time, about 11% of the population in the U.S. has diabetes.  This represents nearly 40 million people. And this number is increasing, not only in the U.S. but around the world. Although we have more medical options now than ever before for managing diabetes, the treatment is less than optimal. Another option is a pancreas transplant. What’s the status of pancreatic transplantation? Who’s a candidate for the procedure? How effective is it and what does the future hold for the procedure?  The topic for this podcast is “Pancreas Transplantation” and I’ll be discussing these questions with Nitin N. Katariya, M.D., a transplant surgeon and Lavanya Kodali, M.B.B.S., M.D., a nephrologist and specialist in renal transplant, both from the Arizona campus of the Mayo Clinic.</p>
<p>Learn more about this Transplant Series:  <a href='https://ce.mayo.edu/content/mayo-clinic-talks-donate-life-transplantation-series'>Mayo Clinic Talks: Donate Life: Transplantation Series | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with Mayo Clinic’s Transplant Center online at <a href='https://mayoclinic.org/transplant'>https://mayoclinic.org/transplant</a> or on X @MayoTransplant</p>
<p>To learn more and register to be an organ donor please visit <a href='https://careinfo.mayoclinic.org/organ-donation'>https://careinfo.mayoclinic.org/organ-donation</a>.</p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guests: Nitin N. Katariya, M.D., and Lavanya Kodali, M.B.B.S., M.D.</p>
<p>At this time, about 11% of the population in the U.S. has diabetes.  This represents nearly 40 million people. And this number is increasing, not only in the U.S. but around the world. Although we have more medical options now than ever before for managing diabetes, the treatment is less than optimal. Another option is a pancreas transplant. What’s the status of pancreatic transplantation? Who’s a candidate for the procedure? How effective is it and what does the future hold for the procedure?  The topic for this podcast is “Pancreas Transplantation” and I’ll be discussing these questions with Nitin N. Katariya, M.D., a transplant surgeon and Lavanya Kodali, M.B.B.S., M.D., a nephrologist and specialist in renal transplant, both from the Arizona campus of the Mayo Clinic.</p>
<p>Learn more about this Transplant Series:  <a href='https://ce.mayo.edu/content/mayo-clinic-talks-donate-life-transplantation-series'>Mayo Clinic Talks: Donate Life: Transplantation Series | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with Mayo Clinic’s Transplant Center online at <a href='https://mayoclinic.org/transplant'>https://mayoclinic.org/transplant</a> or on X @MayoTransplant</p>
<p>To learn more and register to be an organ donor please visit <a href='https://careinfo.mayoclinic.org/organ-donation'>https://careinfo.mayoclinic.org/organ-donation</a>.</p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/v5un6izd7xr5p8jv/WF5694043_Pancreas_Transplant_AF67mgf.mp3" length="42766459" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guests: Nitin N. Katariya, M.D., and Lavanya Kodali, M.B.B.S., M.D.
At this time, about 11% of the population in the U.S. has diabetes.  This represents nearly 40 million people. And this number is increasing, not only in the U.S. but around the world. Although we have more medical options now than ever before for managing diabetes, the treatment is less than optimal. Another option is a pancreas transplant. What’s the status of pancreatic transplantation? Who’s a candidate for the procedure? How effective is it and what does the future hold for the procedure?  The topic for this podcast is “Pancreas Transplantation” and I’ll be discussing these questions with Nitin N. Katariya, M.D., a transplant surgeon and Lavanya Kodali, M.B.B.S., M.D., a nephrologist and specialist in renal transplant, both from the Arizona campus of the Mayo Clinic.
Learn more about this Transplant Series:  Mayo Clinic Talks: Donate Life: Transplantation Series | Mayo Clinic School of Continuous Professional Development
Connect with Mayo Clinic’s Transplant Center online at https://mayoclinic.org/transplant or on X @MayoTransplant
To learn more and register to be an organ donor please visit https://careinfo.mayoclinic.org/organ-donation.
Connect and listen with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1777</itunes:duration>
                <itunes:episode>579</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Transplantation Series: Expanded Donor Criteria for Organ Transplantation</title>
        <itunes:title>Transplantation Series: Expanded Donor Criteria for Organ Transplantation</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/transplantation-series-expanded-donor-criteria-for-organ-transplantation/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/transplantation-series-expanded-donor-criteria-for-organ-transplantation/#comments</comments>        <pubDate>Tue, 01 Apr 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/7ea7f036-ed35-3951-8ffe-9349fb3194fa</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: C. Burcin Taner, M.D.</p>
<p>Recently, the criteria for organ donors have expanded in order to address the increasing difference between the number of available organs and the demand for transplants. Advancements in medical technology, a better understanding of transplant immunology, and the improvement of transplant surgery techniques have allowed for the inclusion of a greater pool of donors with various health conditions, which excluded them as donors in the past. Understanding the delicate balance between expanding the criteria for transplantation and maintaining a high quality of life for the recipients has been important in advancing the field of organ transplantation. The topic for this podcast is “Expanded Donor Criteria for Organ Transplantation” and my guest is C. Burcin Taner, M.D., Professor of Surgery and Chair of the Department of Transplantation at the Florida campus of the Mayo Clinic.</p>
<p>Learn more about our Transplant Series:  <a href='https://ce.mayo.edu/content/mayo-clinic-talks-donate-life-transplantation-series'>Mayo Clinic Talks: Donate Life: Transplantation Series | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with Mayo Clinic’s Transplant Center online at <a href='https://mayoclinic.org/transplant'>https://mayoclinic.org/transplant</a> or on X @MayoTransplant</p>
<p>To learn more and register to be an organ donor please visit <a href='https://careinfo.mayoclinic.org/organ-donation'>https://careinfo.mayoclinic.org/organ-donation</a>.</p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: C. Burcin Taner, M.D.</p>
<p>Recently, the criteria for organ donors have expanded in order to address the increasing difference between the number of available organs and the demand for transplants. Advancements in medical technology, a better understanding of transplant immunology, and the improvement of transplant surgery techniques have allowed for the inclusion of a greater pool of donors with various health conditions, which excluded them as donors in the past. Understanding the delicate balance between expanding the criteria for transplantation and maintaining a high quality of life for the recipients has been important in advancing the field of organ transplantation. The topic for this podcast is “Expanded Donor Criteria for Organ Transplantation” and my guest is C. Burcin Taner, M.D., Professor of Surgery and Chair of the Department of Transplantation at the Florida campus of the Mayo Clinic.</p>
<p>Learn more about our Transplant Series:  <a href='https://ce.mayo.edu/content/mayo-clinic-talks-donate-life-transplantation-series'>Mayo Clinic Talks: Donate Life: Transplantation Series | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with Mayo Clinic’s Transplant Center online at <a href='https://mayoclinic.org/transplant'>https://mayoclinic.org/transplant</a> or on X @MayoTransplant</p>
<p>To learn more and register to be an organ donor please visit <a href='https://careinfo.mayoclinic.org/organ-donation'>https://careinfo.mayoclinic.org/organ-donation</a>.</p>
<p>Connect and listen with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mabx8nidmtbnzkdu/WF5438730_Expanding_Donor_Criteria_AF69zo9.mp3" length="34337343" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: C. Burcin Taner, M.D.
Recently, the criteria for organ donors have expanded in order to address the increasing difference between the number of available organs and the demand for transplants. Advancements in medical technology, a better understanding of transplant immunology, and the improvement of transplant surgery techniques have allowed for the inclusion of a greater pool of donors with various health conditions, which excluded them as donors in the past. Understanding the delicate balance between expanding the criteria for transplantation and maintaining a high quality of life for the recipients has been important in advancing the field of organ transplantation. The topic for this podcast is “Expanded Donor Criteria for Organ Transplantation” and my guest is C. Burcin Taner, M.D., Professor of Surgery and Chair of the Department of Transplantation at the Florida campus of the Mayo Clinic.
Learn more about our Transplant Series:  Mayo Clinic Talks: Donate Life: Transplantation Series | Mayo Clinic School of Continuous Professional Development
Connect with Mayo Clinic’s Transplant Center online at https://mayoclinic.org/transplant or on X @MayoTransplant
To learn more and register to be an organ donor please visit https://careinfo.mayoclinic.org/organ-donation.
Connect and listen with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1426</itunes:duration>
                <itunes:episode>578</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clearing the Fog on Cataracts</title>
        <itunes:title>Clearing the Fog on Cataracts</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/clearing-the-fog-on-cataracts/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/clearing-the-fog-on-cataracts/#comments</comments>        <pubDate>Tue, 25 Mar 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/32bf886f-d239-3aa8-926d-5f63999c7936</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Amir R. Khan, M.D.</p>
<p>Although cataracts are typically seen in middle age and older individuals, they can occur at any age. They represent one of the leading causes of impaired vision and blindness worldwide. They typically develop slowly, and most patients aren’t often aware of symptoms until they’ve have progressed significantly. Fortunately, there’s very effective treatment available which can restore a patient’s vision. In today’s podcast, we’ll discuss cataracts, their symptoms and management with Amir R. Khan, M.D., an ophthalmologist at the Mayo Clinic.</p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Amir R. Khan, M.D.</p>
<p>Although cataracts are typically seen in middle age and older individuals, they can occur at any age. They represent one of the leading causes of impaired vision and blindness worldwide. They typically develop slowly, and most patients aren’t often aware of symptoms until they’ve have progressed significantly. Fortunately, there’s very effective treatment available which can restore a patient’s vision. In today’s podcast, we’ll discuss cataracts, their symptoms and management with Amir R. Khan, M.D., an ophthalmologist at the Mayo Clinic.</p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/iqui5dvhdv4j4qtv/25R02302_Khan_Cataracts.mp3" length="30119964" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Amir R. Khan, M.D.
Although cataracts are typically seen in middle age and older individuals, they can occur at any age. They represent one of the leading causes of impaired vision and blindness worldwide. They typically develop slowly, and most patients aren’t often aware of symptoms until they’ve have progressed significantly. Fortunately, there’s very effective treatment available which can restore a patient’s vision. In today’s podcast, we’ll discuss cataracts, their symptoms and management with Amir R. Khan, M.D., an ophthalmologist at the Mayo Clinic.
Connect with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1250</itunes:duration>
                <itunes:episode>576</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Tuberculosis (TB) in Children</title>
        <itunes:title>Tuberculosis (TB) in Children</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/tuberculosis-tb-in-children/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/tuberculosis-tb-in-children/#comments</comments>        <pubDate>Mon, 24 Mar 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/5932782d-845a-3c30-a0c2-505bfd610c18</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: James T. Gaensbauer, M.D., M.S.</p>
<p>Each year, we recognize World TB Day on March 24. This annual event commemorates the date in 1882 when Dr. Robert Koch announced his discovery of Mycobacterium tuberculosis, the bacillus that causes tuberculosis (TB). World TB Day is a day to educate the public about the impact of TB around the world.  </p>
<p>The CDC, along with our partners and colleagues around the world, share successes in TB prevention and control and raise awareness of the challenges that hinder our progress toward the elimination of this devastating disease.</p>
<p>Tuberculosis continues to be a global health concern.  Despite being preventable and very treatable, this disease continues to cause suffering and death.  It accounted for an estimated one and a quarter million deaths worldwide in 2023. In the United States, cases have been increasing over the past several years, and this is also true in children, especially in those under the age of 5 years. What are the common risk factors for tuberculosis in children? Is the disease different in children compared to adults? What should we, as a primary care provider do when we suspect tuberculosis in a young patient? These are some of the questions I’ll be asking my guest for this podcast, James T. Gaensbauer, M.D., M.S., a pediatric infectious disease specialist at the Mayo Clinic as we discuss “Tuberculosis in Children”.</p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: James T. Gaensbauer, M.D., M.S.</p>
<p><em>Each year, we recognize World TB Day on March 24. This annual event commemorates the date in 1882 when Dr. Robert Koch announced his discovery of Mycobacterium tuberculosis, the bacillus that causes tuberculosis (TB).</em><em> </em><em>World TB Day is a day to educate the public about the impact of TB around the world.  </em></p>
<p><em>The CDC, along with our partners and colleagues around the world, share successes in TB prevention and control and raise awareness of the challenges that hinder our progress toward the elimination of this devastating disease.</em></p>
<p>Tuberculosis continues to be a global health concern.  Despite being preventable and very treatable, this disease continues to cause suffering and death.  It accounted for an estimated one and a quarter million deaths worldwide in 2023. In the United States, cases have been increasing over the past several years, and this is also true in children, especially in those under the age of 5 years. What are the common risk factors for tuberculosis in children? Is the disease different in children compared to adults? What should we, as a primary care provider do when we suspect tuberculosis in a young patient? These are some of the questions I’ll be asking my guest for this podcast, James T. Gaensbauer, M.D., M.S., a pediatric infectious disease specialist at the Mayo Clinic as we discuss “Tuberculosis in Children”.</p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kemh6kerk3h3xaqp/WF5824153_Pediatric_Tuberculosisboyqj.mp3" length="39692120" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: James T. Gaensbauer, M.D., M.S.
Each year, we recognize World TB Day on March 24. This annual event commemorates the date in 1882 when Dr. Robert Koch announced his discovery of Mycobacterium tuberculosis, the bacillus that causes tuberculosis (TB). World TB Day is a day to educate the public about the impact of TB around the world.  
The CDC, along with our partners and colleagues around the world, share successes in TB prevention and control and raise awareness of the challenges that hinder our progress toward the elimination of this devastating disease.
Tuberculosis continues to be a global health concern.  Despite being preventable and very treatable, this disease continues to cause suffering and death.  It accounted for an estimated one and a quarter million deaths worldwide in 2023. In the United States, cases have been increasing over the past several years, and this is also true in children, especially in those under the age of 5 years. What are the common risk factors for tuberculosis in children? Is the disease different in children compared to adults? What should we, as a primary care provider do when we suspect tuberculosis in a young patient? These are some of the questions I’ll be asking my guest for this podcast, James T. Gaensbauer, M.D., M.S., a pediatric infectious disease specialist at the Mayo Clinic as we discuss “Tuberculosis in Children”.
Connect with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1649</itunes:duration>
                <itunes:episode>577</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Human Optimization Project: Understanding Calories | What They Are, What They Do, and How to Get Them Right</title>
        <itunes:title>The Human Optimization Project: Understanding Calories | What They Are, What They Do, and How to Get Them Right</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/the-human-optimization-project-understanding-calories-what-they-are-what-they-do-and-how-to-get-them-right/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/the-human-optimization-project-understanding-calories-what-they-are-what-they-do-and-how-to-get-them-right/#comments</comments>        <pubDate>Thu, 20 Mar 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/a826eaf0-17fd-3454-b6e5-dfa3013a3bd1</guid>
                                    <description><![CDATA[<p>Host: Christopher L. Camp, M.D.</p>
<p>Guest: Jason Ewoldt, M.S., RDN</p>
<p>There aren’t many words out there than can conjure up emotions, confusion, and frustration quite like the word we are discussing today, and that word is “calories.” However, a discussion on calories doesn’t have to be so complex and loaded with this unnecessary baggage. Today, we are going to bring clarity to the topic by focusing on what you really need to know from both a scientific and practical perspective. In addition to better understanding what they are, we will discuss ways to help you know what your body’s caloric needs are for losing weight or maintaining a healthy weight. Finally, we will discuss practical strategies that help you achieve your fitness and health goals.</p>
<p>The three big questions we will tackle in this episode are:
1) What are calories, and why do they matter?</p>
<p>2) Why do people often misunderstand calories, and why is it so hard to get it right?</p>
<p>3) What can I do to figure out my caloric needs and actually stick to them?</p>
<p>To help us answer these questions, my guest today is Jason Ewoldt M.S., RDN, who is a registered and licensed dietician and certified sports specialist dietician at Mayo Clinic.</p>
<p>Learn more about The Human Optimization Project: <a href='https://ce.mayo.edu/node/171044'>Mayo Clinic Talks: Human Optimization | Mayo Clinic School of Continuous Professional Development</a></p>
<p>X: <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2F32290571.isolation.zscaler.com%2Fprofile%2F0cb16706-78ca-4463-bfa9-40812abb1ea5%2Fzia-session%2F%3Fcontrols_id%3D8e02ebc6-54ff-4413-b28f-c208349004f8%26region%3Dcle%26tenant%3D9bdf164cfefd%26user%3D44b53b87503195d67154b5641037ffa0e8bb994b364004b6bbad60a161c976bf%26original_url%3Dhttps%253A%252F%252Fx.com%252FMayoHumanOpProj%26key%3Dsh-1%26hmac%3D705a2b4026965a3d7eb520e97569be763ebb33198ce750849fea0679522fd45d&amp;data=05%7C02%7CFricker.Mandy%40mayo.edu%7C93db53b0737446ad026f08dd56b7192f%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638762066575598991%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=rU32ZKE2mnXcf%2FnnCmoRo%2BxYGNCziZ2X%2FlTHjLSa3HE%3D&amp;reserved=0'>@MayoHumanOpProj</a></p>
<p>Instagram: <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2F32290571.isolation.zscaler.com%2Fprofile%2F0cb16706-78ca-4463-bfa9-40812abb1ea5%2Fzia-session%2F%3Fcontrols_id%3Dcf37b518-1cca-49bd-9762-046c47ef0232%26region%3Dcle%26tenant%3D9bdf164cfefd%26user%3D44b53b87503195d67154b5641037ffa0e8bb994b364004b6bbad60a161c976bf%26original_url%3Dhttps%253A%252F%252Fwww.instagram.com%252Fmayo_human_op_proj%252F%26key%3Dsh-1%26hmac%3Dd66ae0593635689ca2be04a63da0226771d130c4e579e190168a5ab2ffa63283&amp;data=05%7C02%7CFricker.Mandy%40mayo.edu%7C93db53b0737446ad026f08dd56b7192f%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638762066575628116%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=p7WSqE2zoqLilsbrXk7IbkGXoI7yj8r6sBPiE58tCWk%3D&amp;reserved=0'>@Mayo_Human_Op_Prog</a></p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Christopher L. Camp, M.D.</p>
<p>Guest: Jason Ewoldt, M.S., RDN</p>
<p>There aren’t many words out there than can conjure up emotions, confusion, and frustration quite like the word we are discussing today, and that word is “calories.” However, a discussion on calories doesn’t have to be so complex and loaded with this unnecessary baggage. Today, we are going to bring clarity to the topic by focusing on what you really need to know from both a scientific and practical perspective. In addition to better understanding what they are, we will discuss ways to help you know what your body’s caloric needs are for losing weight or maintaining a healthy weight. Finally, we will discuss practical strategies that help you achieve your fitness and health goals.</p>
<p>The three big questions we will tackle in this episode are:<br>
<em>1) What are calories, and why do they matter?</em></p>
<p><em>2) Why do people often misunderstand calories, and why is it so hard to get it right?</em></p>
<p><em>3) What can I do to figure out my caloric needs and actually stick to them?</em></p>
<p>To help us answer these questions, my guest today is Jason Ewoldt M.S., RDN, who is a registered and licensed dietician and certified sports specialist dietician at Mayo Clinic.</p>
<p>Learn more about The Human Optimization Project: <a href='https://ce.mayo.edu/node/171044'>Mayo Clinic Talks: Human Optimization | Mayo Clinic School of Continuous Professional Development</a></p>
<p>X: <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2F32290571.isolation.zscaler.com%2Fprofile%2F0cb16706-78ca-4463-bfa9-40812abb1ea5%2Fzia-session%2F%3Fcontrols_id%3D8e02ebc6-54ff-4413-b28f-c208349004f8%26region%3Dcle%26tenant%3D9bdf164cfefd%26user%3D44b53b87503195d67154b5641037ffa0e8bb994b364004b6bbad60a161c976bf%26original_url%3Dhttps%253A%252F%252Fx.com%252FMayoHumanOpProj%26key%3Dsh-1%26hmac%3D705a2b4026965a3d7eb520e97569be763ebb33198ce750849fea0679522fd45d&amp;data=05%7C02%7CFricker.Mandy%40mayo.edu%7C93db53b0737446ad026f08dd56b7192f%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638762066575598991%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=rU32ZKE2mnXcf%2FnnCmoRo%2BxYGNCziZ2X%2FlTHjLSa3HE%3D&amp;reserved=0'>@MayoHumanOpProj</a></p>
<p>Instagram: <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2F32290571.isolation.zscaler.com%2Fprofile%2F0cb16706-78ca-4463-bfa9-40812abb1ea5%2Fzia-session%2F%3Fcontrols_id%3Dcf37b518-1cca-49bd-9762-046c47ef0232%26region%3Dcle%26tenant%3D9bdf164cfefd%26user%3D44b53b87503195d67154b5641037ffa0e8bb994b364004b6bbad60a161c976bf%26original_url%3Dhttps%253A%252F%252Fwww.instagram.com%252Fmayo_human_op_proj%252F%26key%3Dsh-1%26hmac%3Dd66ae0593635689ca2be04a63da0226771d130c4e579e190168a5ab2ffa63283&amp;data=05%7C02%7CFricker.Mandy%40mayo.edu%7C93db53b0737446ad026f08dd56b7192f%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638762066575628116%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=p7WSqE2zoqLilsbrXk7IbkGXoI7yj8r6sBPiE58tCWk%3D&amp;reserved=0'>@Mayo_Human_Op_Prog</a></p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wcv3h32b3729yrbi/25R02302_575_Ewoldt_Understanding_Calories_AFaa1q7.mp3" length="77042547" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Christopher L. Camp, M.D.
Guest: Jason Ewoldt, M.S., RDN
There aren’t many words out there than can conjure up emotions, confusion, and frustration quite like the word we are discussing today, and that word is “calories.” However, a discussion on calories doesn’t have to be so complex and loaded with this unnecessary baggage. Today, we are going to bring clarity to the topic by focusing on what you really need to know from both a scientific and practical perspective. In addition to better understanding what they are, we will discuss ways to help you know what your body’s caloric needs are for losing weight or maintaining a healthy weight. Finally, we will discuss practical strategies that help you achieve your fitness and health goals.
The three big questions we will tackle in this episode are:1) What are calories, and why do they matter?
2) Why do people often misunderstand calories, and why is it so hard to get it right?
3) What can I do to figure out my caloric needs and actually stick to them?
To help us answer these questions, my guest today is Jason Ewoldt M.S., RDN, who is a registered and licensed dietician and certified sports specialist dietician at Mayo Clinic.
Learn more about The Human Optimization Project: Mayo Clinic Talks: Human Optimization | Mayo Clinic School of Continuous Professional Development
X: @MayoHumanOpProj
Instagram: @Mayo_Human_Op_Prog
Connect with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3203</itunes:duration>
                <itunes:episode>575</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Human Optimization Project: Moving From Stress to Joy | How to Cultivate Happiness and Joy at Home and Work</title>
        <itunes:title>The Human Optimization Project: Moving From Stress to Joy | How to Cultivate Happiness and Joy at Home and Work</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/the-human-optimization-project-moving-from-stress-to-joy-how-to-cultivate-happiness-and-joy-at-home-and-work/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/the-human-optimization-project-moving-from-stress-to-joy-how-to-cultivate-happiness-and-joy-at-home-and-work/#comments</comments>        <pubDate>Tue, 18 Mar 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/37c436fe-006e-30c6-8367-81047257f869</guid>
                                    <description><![CDATA[<p>Host: Christopher L. Camp, M.D.</p>
<p>Guest: Darryl S. Chutka, M.D.</p>
<p>We would all be open to the idea of a little less stress in our lives, especially if we can fill that with joy and happiness. For most of us, this holds true for both our personal and professional lives. But in this age of increasing pressure, demands, expectations, and deadlines, is that even a realistic expectation? Today we are going to dive deep into the meaning of joy, why so many of us don’t get enough, and how that is impacting our overall lives. In addition to that, we will discuss some intentional strategies for replacing stress with joy to help us become our best selves.</p>
<p>The three big questions we will tackle in this episode are:
1) How do you define joy and happiness, and how do they play a role in our everyday lives?</p>
<p>2) Why do so many of us struggle with finding joy in our lives, and how is that impacting us?</p>
<p>3) How can we intentionally design our lives and work to experience more joy, and make joy our default?</p>
<p>To help us answer these questions, my guest today is Darryl S. Chutka, M.D., General Internal Medicine Physician at Mayo Clinic and the host of the Mayo Clinic Talks Podcast.</p>
<p>Learn more about The Human Optimization Project: <a href='https://ce.mayo.edu/node/171044'>Mayo Clinic Talks: Human Optimization | Mayo Clinic School of Continuous Professional Development</a></p>
<p>X: <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2F32290571.isolation.zscaler.com%2Fprofile%2F0cb16706-78ca-4463-bfa9-40812abb1ea5%2Fzia-session%2F%3Fcontrols_id%3D8e02ebc6-54ff-4413-b28f-c208349004f8%26region%3Dcle%26tenant%3D9bdf164cfefd%26user%3D44b53b87503195d67154b5641037ffa0e8bb994b364004b6bbad60a161c976bf%26original_url%3Dhttps%253A%252F%252Fx.com%252FMayoHumanOpProj%26key%3Dsh-1%26hmac%3D705a2b4026965a3d7eb520e97569be763ebb33198ce750849fea0679522fd45d&amp;data=05%7C02%7CFricker.Mandy%40mayo.edu%7C93db53b0737446ad026f08dd56b7192f%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638762066575598991%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=rU32ZKE2mnXcf%2FnnCmoRo%2BxYGNCziZ2X%2FlTHjLSa3HE%3D&amp;reserved=0'>@MayoHumanOpProj</a></p>
<p>Instagram: <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2F32290571.isolation.zscaler.com%2Fprofile%2F0cb16706-78ca-4463-bfa9-40812abb1ea5%2Fzia-session%2F%3Fcontrols_id%3Dcf37b518-1cca-49bd-9762-046c47ef0232%26region%3Dcle%26tenant%3D9bdf164cfefd%26user%3D44b53b87503195d67154b5641037ffa0e8bb994b364004b6bbad60a161c976bf%26original_url%3Dhttps%253A%252F%252Fwww.instagram.com%252Fmayo_human_op_proj%252F%26key%3Dsh-1%26hmac%3Dd66ae0593635689ca2be04a63da0226771d130c4e579e190168a5ab2ffa63283&amp;data=05%7C02%7CFricker.Mandy%40mayo.edu%7C93db53b0737446ad026f08dd56b7192f%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638762066575628116%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=p7WSqE2zoqLilsbrXk7IbkGXoI7yj8r6sBPiE58tCWk%3D&amp;reserved=0'>@Mayo_Human_Op_Prog</a></p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Christopher L. Camp, M.D.</p>
<p>Guest: Darryl S. Chutka, M.D.</p>
<p>We would all be open to the idea of a little less stress in our lives, especially if we can fill that with joy and happiness. For most of us, this holds true for both our personal and professional lives. But in this age of increasing pressure, demands, expectations, and deadlines, is that even a realistic expectation? Today we are going to dive deep into the meaning of joy, why so many of us don’t get enough, and how that is impacting our overall lives. In addition to that, we will discuss some intentional strategies for replacing stress with joy to help us become our best selves.</p>
<p>The three big questions we will tackle in this episode are:<br>
<em>1) How do you define joy and happiness, and how do they play a role in our everyday lives?</em></p>
<p><em>2) Why do so many of us struggle with finding joy in our lives, and how is that impacting us?</em></p>
<p><em>3) How can we intentionally design our lives and work to experience more joy, and make joy our default?</em></p>
<p>To help us answer these questions, my guest today is Darryl S. Chutka, M.D., General Internal Medicine Physician at Mayo Clinic and the host of the Mayo Clinic Talks Podcast.</p>
<p>Learn more about The Human Optimization Project: <a href='https://ce.mayo.edu/node/171044'>Mayo Clinic Talks: Human Optimization | Mayo Clinic School of Continuous Professional Development</a></p>
<p>X: <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2F32290571.isolation.zscaler.com%2Fprofile%2F0cb16706-78ca-4463-bfa9-40812abb1ea5%2Fzia-session%2F%3Fcontrols_id%3D8e02ebc6-54ff-4413-b28f-c208349004f8%26region%3Dcle%26tenant%3D9bdf164cfefd%26user%3D44b53b87503195d67154b5641037ffa0e8bb994b364004b6bbad60a161c976bf%26original_url%3Dhttps%253A%252F%252Fx.com%252FMayoHumanOpProj%26key%3Dsh-1%26hmac%3D705a2b4026965a3d7eb520e97569be763ebb33198ce750849fea0679522fd45d&amp;data=05%7C02%7CFricker.Mandy%40mayo.edu%7C93db53b0737446ad026f08dd56b7192f%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638762066575598991%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=rU32ZKE2mnXcf%2FnnCmoRo%2BxYGNCziZ2X%2FlTHjLSa3HE%3D&amp;reserved=0'>@MayoHumanOpProj</a></p>
<p>Instagram: <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2F32290571.isolation.zscaler.com%2Fprofile%2F0cb16706-78ca-4463-bfa9-40812abb1ea5%2Fzia-session%2F%3Fcontrols_id%3Dcf37b518-1cca-49bd-9762-046c47ef0232%26region%3Dcle%26tenant%3D9bdf164cfefd%26user%3D44b53b87503195d67154b5641037ffa0e8bb994b364004b6bbad60a161c976bf%26original_url%3Dhttps%253A%252F%252Fwww.instagram.com%252Fmayo_human_op_proj%252F%26key%3Dsh-1%26hmac%3Dd66ae0593635689ca2be04a63da0226771d130c4e579e190168a5ab2ffa63283&amp;data=05%7C02%7CFricker.Mandy%40mayo.edu%7C93db53b0737446ad026f08dd56b7192f%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638762066575628116%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=p7WSqE2zoqLilsbrXk7IbkGXoI7yj8r6sBPiE58tCWk%3D&amp;reserved=0'>@Mayo_Human_Op_Prog</a></p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bizn4uhx3bj4v7im/25R02302_574_Chutka_Finding_Joy_in_Life_and_Work_AFa2in1.mp3" length="66695000" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Christopher L. Camp, M.D.
Guest: Darryl S. Chutka, M.D.
We would all be open to the idea of a little less stress in our lives, especially if we can fill that with joy and happiness. For most of us, this holds true for both our personal and professional lives. But in this age of increasing pressure, demands, expectations, and deadlines, is that even a realistic expectation? Today we are going to dive deep into the meaning of joy, why so many of us don’t get enough, and how that is impacting our overall lives. In addition to that, we will discuss some intentional strategies for replacing stress with joy to help us become our best selves.
The three big questions we will tackle in this episode are:1) How do you define joy and happiness, and how do they play a role in our everyday lives?
2) Why do so many of us struggle with finding joy in our lives, and how is that impacting us?
3) How can we intentionally design our lives and work to experience more joy, and make joy our default?
To help us answer these questions, my guest today is Darryl S. Chutka, M.D., General Internal Medicine Physician at Mayo Clinic and the host of the Mayo Clinic Talks Podcast.
Learn more about The Human Optimization Project: Mayo Clinic Talks: Human Optimization | Mayo Clinic School of Continuous Professional Development
X: @MayoHumanOpProj
Instagram: @Mayo_Human_Op_Prog
Connect with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2773</itunes:duration>
                <itunes:episode>574</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Human Optimization Project: Creating Winning Cultures | Building and Maintaining an Optimal Culture for Teams and Individuals</title>
        <itunes:title>The Human Optimization Project: Creating Winning Cultures | Building and Maintaining an Optimal Culture for Teams and Individuals</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/the-human-optimization-project-creating-winning-cultures-building-and-maintaining-an-optimal-culture-for-teams-and-individuals/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/the-human-optimization-project-creating-winning-cultures-building-and-maintaining-an-optimal-culture-for-teams-and-individuals/#comments</comments>        <pubDate>Thu, 13 Mar 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/1506a0dc-e18e-38f5-96e7-68f36d03201d</guid>
                                    <description><![CDATA[<p>Host: Christopher L. Camp, M.D.</p>
<p>Guest: Christina K. Zorn</p>
<p>“Culture” is a word that gets a lot of attention, and deservedly so! It is often thought of as the lifeblood of an organization. However, many of us don’t think about the fact that “culture” doesn’t just exist at the level of large organizations. Culture exists for smaller groups, teams, families, and even individuals. In today’s episode, we will work to define “culture”, discuss its impact on groups (large and small) and individuals, provide real world examples of the impact of culture, and discuss ways of optimizing culture in both the workplace and at home.</p>
<p>The three big questions we will tackle in this episode are:
1) What exactly is “culture” and why is it so critical to success?</p>
<p>2) How does “culture” impact behavior and outcomes at work and at home?</p>
<p>3) What steps can I take to contribute to a positive culture in the workplace and for my own personal development?</p>
<p>To help us answer these questions, my guest today is Christina K. Zorn, who is the Chief Administrative Officer of Mayo Clinic.</p>
<p>Learn more about The Human Optimization Project: <a href='https://ce.mayo.edu/node/171044'>Mayo Clinic Talks: Human Optimization | Mayo Clinic School of Continuous Professional Development</a></p>
<p>X: <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2F32290571.isolation.zscaler.com%2Fprofile%2F0cb16706-78ca-4463-bfa9-40812abb1ea5%2Fzia-session%2F%3Fcontrols_id%3D8e02ebc6-54ff-4413-b28f-c208349004f8%26region%3Dcle%26tenant%3D9bdf164cfefd%26user%3D44b53b87503195d67154b5641037ffa0e8bb994b364004b6bbad60a161c976bf%26original_url%3Dhttps%253A%252F%252Fx.com%252FMayoHumanOpProj%26key%3Dsh-1%26hmac%3D705a2b4026965a3d7eb520e97569be763ebb33198ce750849fea0679522fd45d&amp;data=05%7C02%7CFricker.Mandy%40mayo.edu%7C93db53b0737446ad026f08dd56b7192f%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638762066575598991%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=rU32ZKE2mnXcf%2FnnCmoRo%2BxYGNCziZ2X%2FlTHjLSa3HE%3D&amp;reserved=0'>@MayoHumanOpProj</a></p>
<p>Instagram: <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2F32290571.isolation.zscaler.com%2Fprofile%2F0cb16706-78ca-4463-bfa9-40812abb1ea5%2Fzia-session%2F%3Fcontrols_id%3Dcf37b518-1cca-49bd-9762-046c47ef0232%26region%3Dcle%26tenant%3D9bdf164cfefd%26user%3D44b53b87503195d67154b5641037ffa0e8bb994b364004b6bbad60a161c976bf%26original_url%3Dhttps%253A%252F%252Fwww.instagram.com%252Fmayo_human_op_proj%252F%26key%3Dsh-1%26hmac%3Dd66ae0593635689ca2be04a63da0226771d130c4e579e190168a5ab2ffa63283&amp;data=05%7C02%7CFricker.Mandy%40mayo.edu%7C93db53b0737446ad026f08dd56b7192f%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638762066575628116%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=p7WSqE2zoqLilsbrXk7IbkGXoI7yj8r6sBPiE58tCWk%3D&amp;reserved=0'>@Mayo_Human_Op_Prog</a></p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Christopher L. Camp, M.D.</p>
<p>Guest: Christina K. Zorn</p>
<p>“Culture” is a word that gets a lot of attention, and deservedly so! It is often thought of as the lifeblood of an organization. However, many of us don’t think about the fact that “culture” doesn’t just exist at the level of large organizations. Culture exists for smaller groups, teams, families, and even individuals. In today’s episode, we will work to define “culture”, discuss its impact on groups (large and small) and individuals, provide real world examples of the impact of culture, and discuss ways of optimizing culture in both the workplace and at home.</p>
<p>The three big questions we will tackle in this episode are:<br>
<em>1) What exactly is “culture” and why is it so critical to success?</em></p>
<p><em>2) How does “culture” impact behavior and outcomes at work and at home?</em></p>
<p><em>3) What steps can I take to contribute to a positive culture in the workplace and for my own personal development?</em></p>
<p>To help us answer these questions, my guest today is Christina K. Zorn, who is the Chief Administrative Officer of Mayo Clinic.</p>
<p>Learn more about The Human Optimization Project: <a href='https://ce.mayo.edu/node/171044'>Mayo Clinic Talks: Human Optimization | Mayo Clinic School of Continuous Professional Development</a></p>
<p>X: <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2F32290571.isolation.zscaler.com%2Fprofile%2F0cb16706-78ca-4463-bfa9-40812abb1ea5%2Fzia-session%2F%3Fcontrols_id%3D8e02ebc6-54ff-4413-b28f-c208349004f8%26region%3Dcle%26tenant%3D9bdf164cfefd%26user%3D44b53b87503195d67154b5641037ffa0e8bb994b364004b6bbad60a161c976bf%26original_url%3Dhttps%253A%252F%252Fx.com%252FMayoHumanOpProj%26key%3Dsh-1%26hmac%3D705a2b4026965a3d7eb520e97569be763ebb33198ce750849fea0679522fd45d&amp;data=05%7C02%7CFricker.Mandy%40mayo.edu%7C93db53b0737446ad026f08dd56b7192f%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638762066575598991%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=rU32ZKE2mnXcf%2FnnCmoRo%2BxYGNCziZ2X%2FlTHjLSa3HE%3D&amp;reserved=0'>@MayoHumanOpProj</a></p>
<p>Instagram: <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2F32290571.isolation.zscaler.com%2Fprofile%2F0cb16706-78ca-4463-bfa9-40812abb1ea5%2Fzia-session%2F%3Fcontrols_id%3Dcf37b518-1cca-49bd-9762-046c47ef0232%26region%3Dcle%26tenant%3D9bdf164cfefd%26user%3D44b53b87503195d67154b5641037ffa0e8bb994b364004b6bbad60a161c976bf%26original_url%3Dhttps%253A%252F%252Fwww.instagram.com%252Fmayo_human_op_proj%252F%26key%3Dsh-1%26hmac%3Dd66ae0593635689ca2be04a63da0226771d130c4e579e190168a5ab2ffa63283&amp;data=05%7C02%7CFricker.Mandy%40mayo.edu%7C93db53b0737446ad026f08dd56b7192f%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638762066575628116%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=p7WSqE2zoqLilsbrXk7IbkGXoI7yj8r6sBPiE58tCWk%3D&amp;reserved=0'>@Mayo_Human_Op_Prog</a></p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/s33mxv733wskbdu6/25R02302_HumanOptimization_Camp_Zorn_v1_AF7fjsa.mp3" length="118448640" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Christopher L. Camp, M.D.
Guest: Christina K. Zorn
“Culture” is a word that gets a lot of attention, and deservedly so! It is often thought of as the lifeblood of an organization. However, many of us don’t think about the fact that “culture” doesn’t just exist at the level of large organizations. Culture exists for smaller groups, teams, families, and even individuals. In today’s episode, we will work to define “culture”, discuss its impact on groups (large and small) and individuals, provide real world examples of the impact of culture, and discuss ways of optimizing culture in both the workplace and at home.
The three big questions we will tackle in this episode are:1) What exactly is “culture” and why is it so critical to success?
2) How does “culture” impact behavior and outcomes at work and at home?
3) What steps can I take to contribute to a positive culture in the workplace and for my own personal development?
To help us answer these questions, my guest today is Christina K. Zorn, who is the Chief Administrative Officer of Mayo Clinic.
Learn more about The Human Optimization Project: Mayo Clinic Talks: Human Optimization | Mayo Clinic School of Continuous Professional Development
X: @MayoHumanOpProj
Instagram: @Mayo_Human_Op_Prog
Connect with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2961</itunes:duration>
                <itunes:episode>573</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Human Optimization Project: Emotional Intelligence Explained | How to Recognize, Understand, and Use Your Emotions to Be a More Effective Human</title>
        <itunes:title>The Human Optimization Project: Emotional Intelligence Explained | How to Recognize, Understand, and Use Your Emotions to Be a More Effective Human</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/the-human-optimization-project-emotional-intelligence-explained-how-to-recognize-understand-and-use-your-emotions-to-be-a-more-effective-human/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/the-human-optimization-project-emotional-intelligence-explained-how-to-recognize-understand-and-use-your-emotions-to-be-a-more-effective-human/#comments</comments>        <pubDate>Tue, 11 Mar 2025 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/28c3575e-95db-304f-b213-1aec213b6b6a</guid>
                                    <description><![CDATA[<p>Host: Christopher L. Camp, M.D.</p>
<p>Guest: Mary Ann Djonne, M.Ed.</p>
<p>Most of us have heard the term “Emotional Intelligence,” and we understand that it’s generally important to our happiness and interpersonal relationships. However, most of us aren’t able to define it precisely or understand the key components that make it up. While many may think they do a good job of evaluating the emotional intelligence of others, it can be quite difficult to objectively evaluate our own levels of emotional intelligence. Once we better understand our own emotional intelligence, then comes the very challenging task of trying to improve it in a meaningful way. All of this can seem quite daunting, so we are going to help with that.</p>
<p>The three big questions we will tackle in this episode are:
1) What exactly is “Emotional Intelligence”?</p>
<p>2) What are the benefits and why should I make it a priority to improve my Emotional Intelligence?</p>
<p>3) What are the actual steps I can take to maximize my own Emotional Intelligence?</p>
<p>To help us answer these questions, my guest today is Mary Ann Djonne, Professional Certified Executive Coach and Senior Advisor in Work Force Learning at Mayo Clinic.</p>
<p>Learn more about The Human Optimization Project: <a href='https://ce.mayo.edu/node/171044'>Mayo Clinic Talks: Human Optimization | Mayo Clinic School of Continuous Professional Development</a></p>
<p>X: <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2F32290571.isolation.zscaler.com%2Fprofile%2F0cb16706-78ca-4463-bfa9-40812abb1ea5%2Fzia-session%2F%3Fcontrols_id%3D8e02ebc6-54ff-4413-b28f-c208349004f8%26region%3Dcle%26tenant%3D9bdf164cfefd%26user%3D44b53b87503195d67154b5641037ffa0e8bb994b364004b6bbad60a161c976bf%26original_url%3Dhttps%253A%252F%252Fx.com%252FMayoHumanOpProj%26key%3Dsh-1%26hmac%3D705a2b4026965a3d7eb520e97569be763ebb33198ce750849fea0679522fd45d&amp;data=05%7C02%7CFricker.Mandy%40mayo.edu%7C93db53b0737446ad026f08dd56b7192f%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638762066575598991%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=rU32ZKE2mnXcf%2FnnCmoRo%2BxYGNCziZ2X%2FlTHjLSa3HE%3D&amp;reserved=0'>@MayoHumanOpProj</a></p>
<p>Instagram: <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2F32290571.isolation.zscaler.com%2Fprofile%2F0cb16706-78ca-4463-bfa9-40812abb1ea5%2Fzia-session%2F%3Fcontrols_id%3Dcf37b518-1cca-49bd-9762-046c47ef0232%26region%3Dcle%26tenant%3D9bdf164cfefd%26user%3D44b53b87503195d67154b5641037ffa0e8bb994b364004b6bbad60a161c976bf%26original_url%3Dhttps%253A%252F%252Fwww.instagram.com%252Fmayo_human_op_proj%252F%26key%3Dsh-1%26hmac%3Dd66ae0593635689ca2be04a63da0226771d130c4e579e190168a5ab2ffa63283&amp;data=05%7C02%7CFricker.Mandy%40mayo.edu%7C93db53b0737446ad026f08dd56b7192f%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638762066575628116%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=p7WSqE2zoqLilsbrXk7IbkGXoI7yj8r6sBPiE58tCWk%3D&amp;reserved=0'>@Mayo_Human_Op_Prog</a></p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Christopher L. Camp, M.D.</p>
<p>Guest: Mary Ann Djonne, M.Ed.</p>
<p>Most of us have heard the term “Emotional Intelligence,” and we understand that it’s generally important to our happiness and interpersonal relationships. However, most of us aren’t able to define it precisely or understand the key components that make it up. While many may think they do a good job of evaluating the emotional intelligence of others, it can be quite difficult to objectively evaluate our own levels of emotional intelligence. Once we better understand our own emotional intelligence, then comes the very challenging task of trying to improve it in a meaningful way. All of this can seem quite daunting, so we are going to help with that.</p>
<p>The three big questions we will tackle in this episode are:<br>
<em>1) What exactly is “Emotional Intelligence”?</em></p>
<p><em>2) What are the benefits and why should I make it a priority to improve my Emotional Intelligence?</em></p>
<p><em>3) What are the actual steps I can take to maximize my own Emotional Intelligence?</em></p>
<p>To help us answer these questions, my guest today is Mary Ann Djonne, Professional Certified Executive Coach and Senior Advisor in Work Force Learning at Mayo Clinic.</p>
<p>Learn more about The Human Optimization Project: <a href='https://ce.mayo.edu/node/171044'>Mayo Clinic Talks: Human Optimization | Mayo Clinic School of Continuous Professional Development</a></p>
<p>X: <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2F32290571.isolation.zscaler.com%2Fprofile%2F0cb16706-78ca-4463-bfa9-40812abb1ea5%2Fzia-session%2F%3Fcontrols_id%3D8e02ebc6-54ff-4413-b28f-c208349004f8%26region%3Dcle%26tenant%3D9bdf164cfefd%26user%3D44b53b87503195d67154b5641037ffa0e8bb994b364004b6bbad60a161c976bf%26original_url%3Dhttps%253A%252F%252Fx.com%252FMayoHumanOpProj%26key%3Dsh-1%26hmac%3D705a2b4026965a3d7eb520e97569be763ebb33198ce750849fea0679522fd45d&amp;data=05%7C02%7CFricker.Mandy%40mayo.edu%7C93db53b0737446ad026f08dd56b7192f%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638762066575598991%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=rU32ZKE2mnXcf%2FnnCmoRo%2BxYGNCziZ2X%2FlTHjLSa3HE%3D&amp;reserved=0'>@MayoHumanOpProj</a></p>
<p>Instagram: <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2F32290571.isolation.zscaler.com%2Fprofile%2F0cb16706-78ca-4463-bfa9-40812abb1ea5%2Fzia-session%2F%3Fcontrols_id%3Dcf37b518-1cca-49bd-9762-046c47ef0232%26region%3Dcle%26tenant%3D9bdf164cfefd%26user%3D44b53b87503195d67154b5641037ffa0e8bb994b364004b6bbad60a161c976bf%26original_url%3Dhttps%253A%252F%252Fwww.instagram.com%252Fmayo_human_op_proj%252F%26key%3Dsh-1%26hmac%3Dd66ae0593635689ca2be04a63da0226771d130c4e579e190168a5ab2ffa63283&amp;data=05%7C02%7CFricker.Mandy%40mayo.edu%7C93db53b0737446ad026f08dd56b7192f%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638762066575628116%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=p7WSqE2zoqLilsbrXk7IbkGXoI7yj8r6sBPiE58tCWk%3D&amp;reserved=0'>@Mayo_Human_Op_Prog</a></p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/c3mvvbpjuv6k42f7/WF5260254_Emotional_Intelligence80mln.mp3" length="78386292" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Christopher L. Camp, M.D.
Guest: Mary Ann Djonne, M.Ed.
Most of us have heard the term “Emotional Intelligence,” and we understand that it’s generally important to our happiness and interpersonal relationships. However, most of us aren’t able to define it precisely or understand the key components that make it up. While many may think they do a good job of evaluating the emotional intelligence of others, it can be quite difficult to objectively evaluate our own levels of emotional intelligence. Once we better understand our own emotional intelligence, then comes the very challenging task of trying to improve it in a meaningful way. All of this can seem quite daunting, so we are going to help with that.
The three big questions we will tackle in this episode are:1) What exactly is “Emotional Intelligence”?
2) What are the benefits and why should I make it a priority to improve my Emotional Intelligence?
3) What are the actual steps I can take to maximize my own Emotional Intelligence?
To help us answer these questions, my guest today is Mary Ann Djonne, Professional Certified Executive Coach and Senior Advisor in Work Force Learning at Mayo Clinic.
Learn more about The Human Optimization Project: Mayo Clinic Talks: Human Optimization | Mayo Clinic School of Continuous Professional Development
X: @MayoHumanOpProj
Instagram: @Mayo_Human_Op_Prog
Connect with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3259</itunes:duration>
                <itunes:episode>572</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Human Optimization Project: Exercise Simplified | Essential Components of the Ideal Workout Plan</title>
        <itunes:title>The Human Optimization Project: Exercise Simplified | Essential Components of the Ideal Workout Plan</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/human-optimization-exercise-simplified-essential-components-of-the-ideal-workout-plan/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/human-optimization-exercise-simplified-essential-components-of-the-ideal-workout-plan/#comments</comments>        <pubDate>Thu, 06 Mar 2025 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/a7de6db2-6e44-33eb-9b08-30e3498572ce</guid>
                                    <description><![CDATA[<p>Host: Christopher L. Camp, M.D.</p>
<p>Guest:  Andrea Hayden MS, RSCC - Sports Performance Coach</p>
<p>Description:  The amount of “exercise” information, recommendations, plans, and opinions out there is greater than it’s ever been. Although our increasing knowledge is generally helpful, it’s easy to get lost in the rapidly evolving sea of information. This is particularly true because much of the information we hear is contradictory, and many people claim to have the perfect (and only) answer for us. Our goal for today is to help you cut through all of this noise and focus on what you really need to know to establish a successful workout routine for yourself.</p>
<p>The three big questions we will tackle in this episode are:
1) What is meant by an “ideal” or “optimal” workout plan?</p>
<p>2) How do I make sense of all the exercise recommendations out there?</p>
<p>3) What do I need to do to create an ideal exercise routine for my needs?</p>
<p>To help us answer these questions, my guest today is the Head Sports Performance Coach for the Minnesota Lynx WNBA Basketball Team, Andrea Hayden MS, RSCC.</p>
<p>Learn more about The Human Optimization Project: <a href='https://ce.mayo.edu/node/171044'>Mayo Clinic Talks: Human Optimization | Mayo Clinic School of Continuous Professional Development</a></p>
<p>X: <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2F32290571.isolation.zscaler.com%2Fprofile%2F0cb16706-78ca-4463-bfa9-40812abb1ea5%2Fzia-session%2F%3Fcontrols_id%3D8e02ebc6-54ff-4413-b28f-c208349004f8%26region%3Dcle%26tenant%3D9bdf164cfefd%26user%3D44b53b87503195d67154b5641037ffa0e8bb994b364004b6bbad60a161c976bf%26original_url%3Dhttps%253A%252F%252Fx.com%252FMayoHumanOpProj%26key%3Dsh-1%26hmac%3D705a2b4026965a3d7eb520e97569be763ebb33198ce750849fea0679522fd45d&amp;data=05%7C02%7CFricker.Mandy%40mayo.edu%7C93db53b0737446ad026f08dd56b7192f%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638762066575598991%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=rU32ZKE2mnXcf%2FnnCmoRo%2BxYGNCziZ2X%2FlTHjLSa3HE%3D&amp;reserved=0'>@MayoHumanOpProj</a></p>
<p>Instagram: <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2F32290571.isolation.zscaler.com%2Fprofile%2F0cb16706-78ca-4463-bfa9-40812abb1ea5%2Fzia-session%2F%3Fcontrols_id%3Dcf37b518-1cca-49bd-9762-046c47ef0232%26region%3Dcle%26tenant%3D9bdf164cfefd%26user%3D44b53b87503195d67154b5641037ffa0e8bb994b364004b6bbad60a161c976bf%26original_url%3Dhttps%253A%252F%252Fwww.instagram.com%252Fmayo_human_op_proj%252F%26key%3Dsh-1%26hmac%3Dd66ae0593635689ca2be04a63da0226771d130c4e579e190168a5ab2ffa63283&amp;data=05%7C02%7CFricker.Mandy%40mayo.edu%7C93db53b0737446ad026f08dd56b7192f%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638762066575628116%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=p7WSqE2zoqLilsbrXk7IbkGXoI7yj8r6sBPiE58tCWk%3D&amp;reserved=0'>@Mayo_Human_Op_Prog</a></p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Christopher L. Camp, M.D.</p>
<p>Guest:  Andrea Hayden MS, RSCC - Sports Performance Coach</p>
<p>Description:  The amount of “exercise” information, recommendations, plans, and opinions out there is greater than it’s ever been. Although our increasing knowledge is generally helpful, it’s easy to get lost in the rapidly evolving sea of information. This is particularly true because much of the information we hear is contradictory, and many people claim to have the perfect (and only) answer for us. Our goal for today is to help you cut through all of this noise and focus on what you really need to know to establish a successful workout routine for yourself.</p>
<p>The three big questions we will tackle in this episode are:<br>
<em>1) What is meant by an “ideal” or “optimal” workout plan?</em></p>
<p><em>2) How do I make sense of all the exercise recommendations out there?</em></p>
<p><em>3) What do I need to do to create an ideal exercise routine for my needs?</em></p>
<p>To help us answer these questions, my guest today is the Head Sports Performance Coach for the Minnesota Lynx WNBA Basketball Team, Andrea Hayden MS, RSCC.</p>
<p>Learn more about The Human Optimization Project: <a href='https://ce.mayo.edu/node/171044'>Mayo Clinic Talks: Human Optimization | Mayo Clinic School of Continuous Professional Development</a></p>
<p>X: <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2F32290571.isolation.zscaler.com%2Fprofile%2F0cb16706-78ca-4463-bfa9-40812abb1ea5%2Fzia-session%2F%3Fcontrols_id%3D8e02ebc6-54ff-4413-b28f-c208349004f8%26region%3Dcle%26tenant%3D9bdf164cfefd%26user%3D44b53b87503195d67154b5641037ffa0e8bb994b364004b6bbad60a161c976bf%26original_url%3Dhttps%253A%252F%252Fx.com%252FMayoHumanOpProj%26key%3Dsh-1%26hmac%3D705a2b4026965a3d7eb520e97569be763ebb33198ce750849fea0679522fd45d&amp;data=05%7C02%7CFricker.Mandy%40mayo.edu%7C93db53b0737446ad026f08dd56b7192f%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638762066575598991%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=rU32ZKE2mnXcf%2FnnCmoRo%2BxYGNCziZ2X%2FlTHjLSa3HE%3D&amp;reserved=0'>@MayoHumanOpProj</a></p>
<p>Instagram: <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2F32290571.isolation.zscaler.com%2Fprofile%2F0cb16706-78ca-4463-bfa9-40812abb1ea5%2Fzia-session%2F%3Fcontrols_id%3Dcf37b518-1cca-49bd-9762-046c47ef0232%26region%3Dcle%26tenant%3D9bdf164cfefd%26user%3D44b53b87503195d67154b5641037ffa0e8bb994b364004b6bbad60a161c976bf%26original_url%3Dhttps%253A%252F%252Fwww.instagram.com%252Fmayo_human_op_proj%252F%26key%3Dsh-1%26hmac%3Dd66ae0593635689ca2be04a63da0226771d130c4e579e190168a5ab2ffa63283&amp;data=05%7C02%7CFricker.Mandy%40mayo.edu%7C93db53b0737446ad026f08dd56b7192f%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638762066575628116%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=p7WSqE2zoqLilsbrXk7IbkGXoI7yj8r6sBPiE58tCWk%3D&amp;reserved=0'>@Mayo_Human_Op_Prog</a></p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cmujk5gpdzd53pnx/WF5722600_Exercise_Simplified97fpx.mp3" length="67967417" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Christopher L. Camp, M.D.
Guest:  Andrea Hayden MS, RSCC - Sports Performance Coach
Description:  The amount of “exercise” information, recommendations, plans, and opinions out there is greater than it’s ever been. Although our increasing knowledge is generally helpful, it’s easy to get lost in the rapidly evolving sea of information. This is particularly true because much of the information we hear is contradictory, and many people claim to have the perfect (and only) answer for us. Our goal for today is to help you cut through all of this noise and focus on what you really need to know to establish a successful workout routine for yourself.
The three big questions we will tackle in this episode are:1) What is meant by an “ideal” or “optimal” workout plan?
2) How do I make sense of all the exercise recommendations out there?
3) What do I need to do to create an ideal exercise routine for my needs?
To help us answer these questions, my guest today is the Head Sports Performance Coach for the Minnesota Lynx WNBA Basketball Team, Andrea Hayden MS, RSCC.
Learn more about The Human Optimization Project: Mayo Clinic Talks: Human Optimization | Mayo Clinic School of Continuous Professional Development
X: @MayoHumanOpProj
Instagram: @Mayo_Human_Op_Prog
Connect with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2824</itunes:duration>
                <itunes:episode>571</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Human Optimization Project: The Challenging but Achievable Quest for Accomplishing More While Also Improving Wellness</title>
        <itunes:title>The Human Optimization Project: The Challenging but Achievable Quest for Accomplishing More While Also Improving Wellness</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/human-optimization-the-challenging-but-achievable-quest-for-accomplishing-more-while-also-improving-wellness/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/human-optimization-the-challenging-but-achievable-quest-for-accomplishing-more-while-also-improving-wellness/#comments</comments>        <pubDate>Tue, 04 Mar 2025 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/27588e84-c27b-38f5-9bb6-f035646cca4d</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Christopher L. Camp, M.D.</p>
<p>Being a healthcare clinician is an extremely rewarding occupation, but it can be stressful. Every year, we’re asked to do more and more, the patients seem to get more challenging, and we get less time to spend with each one. A significant number of clinicians report emotional and psychological distress, and burnout remains a major problem in healthcare providers. This increased stress and pressure is not just unique to physicians, and these struggles are common for all of us, regardless of career or position. How do we remain in an optimally functioning state? Does our physical health affect our cognitive function? Given the obstacles we face, how do we continue to achieve joy and happiness in our work and our life while continue to meet the ever-growing demands of the world? These are questions my guest is hoping to answer in a project he’s about to undertake on “Human Optimization”. My guest for this podcast is Christopher L. Camp, M.D., an orthopedic surgeon and sports medicine specialist at the Mayo Clinic. We’re going to discuss his project and why he decided to tackle this important topic. </p>
<p>Learn more about The Human Optimization Project: <a href='https://ce.mayo.edu/node/171044'>Mayo Clinic Talks: Human Optimization | Mayo Clinic School of Continuous Professional Development</a></p>
<p>X: <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2F32290571.isolation.zscaler.com%2Fprofile%2F0cb16706-78ca-4463-bfa9-40812abb1ea5%2Fzia-session%2F%3Fcontrols_id%3D8e02ebc6-54ff-4413-b28f-c208349004f8%26region%3Dcle%26tenant%3D9bdf164cfefd%26user%3D44b53b87503195d67154b5641037ffa0e8bb994b364004b6bbad60a161c976bf%26original_url%3Dhttps%253A%252F%252Fx.com%252FMayoHumanOpProj%26key%3Dsh-1%26hmac%3D705a2b4026965a3d7eb520e97569be763ebb33198ce750849fea0679522fd45d&amp;data=05%7C02%7CFricker.Mandy%40mayo.edu%7C93db53b0737446ad026f08dd56b7192f%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638762066575598991%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=rU32ZKE2mnXcf%2FnnCmoRo%2BxYGNCziZ2X%2FlTHjLSa3HE%3D&amp;reserved=0'>@MayoHumanOpProj</a></p>
<p>Instagram: <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2F32290571.isolation.zscaler.com%2Fprofile%2F0cb16706-78ca-4463-bfa9-40812abb1ea5%2Fzia-session%2F%3Fcontrols_id%3Dcf37b518-1cca-49bd-9762-046c47ef0232%26region%3Dcle%26tenant%3D9bdf164cfefd%26user%3D44b53b87503195d67154b5641037ffa0e8bb994b364004b6bbad60a161c976bf%26original_url%3Dhttps%253A%252F%252Fwww.instagram.com%252Fmayo_human_op_proj%252F%26key%3Dsh-1%26hmac%3Dd66ae0593635689ca2be04a63da0226771d130c4e579e190168a5ab2ffa63283&amp;data=05%7C02%7CFricker.Mandy%40mayo.edu%7C93db53b0737446ad026f08dd56b7192f%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638762066575628116%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=p7WSqE2zoqLilsbrXk7IbkGXoI7yj8r6sBPiE58tCWk%3D&amp;reserved=0'>@Mayo_Human_Op_Prog</a></p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Christopher L. Camp, M.D.</p>
<p>Being a healthcare clinician is an extremely rewarding occupation, but it can be stressful. Every year, we’re asked to do more and more, the patients seem to get more challenging, and we get less time to spend with each one. A significant number of clinicians report emotional and psychological distress, and burnout remains a major problem in healthcare providers. This increased stress and pressure is not just unique to physicians, and these struggles are common for all of us, regardless of career or position. How do we remain in an optimally functioning state? Does our physical health affect our cognitive function? Given the obstacles we face, how do we continue to achieve joy and happiness in our work and our life while continue to meet the ever-growing demands of the world? These are questions my guest is hoping to answer in a project he’s about to undertake on “Human Optimization”. My guest for this podcast is Christopher L. Camp, M.D., an orthopedic surgeon and sports medicine specialist at the Mayo Clinic. We’re going to discuss his project and why he decided to tackle this important topic. </p>
<p>Learn more about The Human Optimization Project: <a href='https://ce.mayo.edu/node/171044'>Mayo Clinic Talks: Human Optimization | Mayo Clinic School of Continuous Professional Development</a></p>
<p>X: <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2F32290571.isolation.zscaler.com%2Fprofile%2F0cb16706-78ca-4463-bfa9-40812abb1ea5%2Fzia-session%2F%3Fcontrols_id%3D8e02ebc6-54ff-4413-b28f-c208349004f8%26region%3Dcle%26tenant%3D9bdf164cfefd%26user%3D44b53b87503195d67154b5641037ffa0e8bb994b364004b6bbad60a161c976bf%26original_url%3Dhttps%253A%252F%252Fx.com%252FMayoHumanOpProj%26key%3Dsh-1%26hmac%3D705a2b4026965a3d7eb520e97569be763ebb33198ce750849fea0679522fd45d&amp;data=05%7C02%7CFricker.Mandy%40mayo.edu%7C93db53b0737446ad026f08dd56b7192f%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638762066575598991%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=rU32ZKE2mnXcf%2FnnCmoRo%2BxYGNCziZ2X%2FlTHjLSa3HE%3D&amp;reserved=0'>@MayoHumanOpProj</a></p>
<p>Instagram: <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2F32290571.isolation.zscaler.com%2Fprofile%2F0cb16706-78ca-4463-bfa9-40812abb1ea5%2Fzia-session%2F%3Fcontrols_id%3Dcf37b518-1cca-49bd-9762-046c47ef0232%26region%3Dcle%26tenant%3D9bdf164cfefd%26user%3D44b53b87503195d67154b5641037ffa0e8bb994b364004b6bbad60a161c976bf%26original_url%3Dhttps%253A%252F%252Fwww.instagram.com%252Fmayo_human_op_proj%252F%26key%3Dsh-1%26hmac%3Dd66ae0593635689ca2be04a63da0226771d130c4e579e190168a5ab2ffa63283&amp;data=05%7C02%7CFricker.Mandy%40mayo.edu%7C93db53b0737446ad026f08dd56b7192f%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638762066575628116%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=p7WSqE2zoqLilsbrXk7IbkGXoI7yj8r6sBPiE58tCWk%3D&amp;reserved=0'>@Mayo_Human_Op_Prog</a></p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/e3riy4qyvvwj95gt/WF5363860_Intro_to_Human_Optimization_Project6doec.mp3" length="39649090" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Christopher L. Camp, M.D.
Being a healthcare clinician is an extremely rewarding occupation, but it can be stressful. Every year, we’re asked to do more and more, the patients seem to get more challenging, and we get less time to spend with each one. A significant number of clinicians report emotional and psychological distress, and burnout remains a major problem in healthcare providers. This increased stress and pressure is not just unique to physicians, and these struggles are common for all of us, regardless of career or position. How do we remain in an optimally functioning state? Does our physical health affect our cognitive function? Given the obstacles we face, how do we continue to achieve joy and happiness in our work and our life while continue to meet the ever-growing demands of the world? These are questions my guest is hoping to answer in a project he’s about to undertake on “Human Optimization”. My guest for this podcast is Christopher L. Camp, M.D., an orthopedic surgeon and sports medicine specialist at the Mayo Clinic. We’re going to discuss his project and why he decided to tackle this important topic. 
Learn more about The Human Optimization Project: Mayo Clinic Talks: Human Optimization | Mayo Clinic School of Continuous Professional Development
X: @MayoHumanOpProj
Instagram: @Mayo_Human_Op_Prog
Connect with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1649</itunes:duration>
                <itunes:episode>570</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Evaluation and Management of Adnexal Masses</title>
        <itunes:title>The Evaluation and Management of Adnexal Masses</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/the-evaluation-and-management-of-adnexal-masses/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/the-evaluation-and-management-of-adnexal-masses/#comments</comments>        <pubDate>Tue, 25 Feb 2025 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/ff5e7853-238f-3156-baa8-a13a681cda12</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Carrie L. Langstraat, M.D.</p>
<p>It’s estimated that up to 10% of women in the U.S. will develop an adnexal mass at some point in their life. Whereas most adnexal masses are gynecologic in origin, they may also represent disease of the urinary or GI system. Although adnexal masses may produce symptoms, when present, they tend to be subtle and non-specific. What questions should we be asking our patients with an adnexal mass to help determine its cause? What components of the physical exam may be useful in the evaluation and what tests should we order to further characterize adnexal masses? These are questions I’ll be asking our guest for this podcast as we discuss “The Evaluation and Management of Adnexal Masses”. My guest is Carrie L. Langstraat, M.D., from the Department of Obstetrics and Gynecology at the Mayo Clinic.</p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Carrie L. Langstraat, M.D.</p>
<p>It’s estimated that up to 10% of women in the U.S. will develop an adnexal mass at some point in their life. Whereas most adnexal masses are gynecologic in origin, they may also represent disease of the urinary or GI system. Although adnexal masses may produce symptoms, when present, they tend to be subtle and non-specific. What questions should we be asking our patients with an adnexal mass to help determine its cause? What components of the physical exam may be useful in the evaluation and what tests should we order to further characterize adnexal masses? These are questions I’ll be asking our guest for this podcast as we discuss “The Evaluation and Management of Adnexal Masses”. My guest is Carrie L. Langstraat, M.D., from the Department of Obstetrics and Gynecology at the Mayo Clinic.</p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/22rx7e8b69mr698b/WF4527304_Adnexal_Masses_AFb0thj.mp3" length="30048115" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Carrie L. Langstraat, M.D.
It’s estimated that up to 10% of women in the U.S. will develop an adnexal mass at some point in their life. Whereas most adnexal masses are gynecologic in origin, they may also represent disease of the urinary or GI system. Although adnexal masses may produce symptoms, when present, they tend to be subtle and non-specific. What questions should we be asking our patients with an adnexal mass to help determine its cause? What components of the physical exam may be useful in the evaluation and what tests should we order to further characterize adnexal masses? These are questions I’ll be asking our guest for this podcast as we discuss “The Evaluation and Management of Adnexal Masses”. My guest is Carrie L. Langstraat, M.D., from the Department of Obstetrics and Gynecology at the Mayo Clinic.
Connect with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1248</itunes:duration>
                <itunes:episode>569</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Heart Health Edition: Pharmacologic Options to Maintain a Healthy Heart</title>
        <itunes:title>Heart Health Edition: Pharmacologic Options to Maintain a Healthy Heart</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/heart-health-edition-pharmacologic-options-to-maintain-a-healthy-heart/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/heart-health-edition-pharmacologic-options-to-maintain-a-healthy-heart/#comments</comments>        <pubDate>Thu, 20 Feb 2025 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/cc1534e8-c3e4-34b6-abd3-50ffc9ecef19</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Thomas C. Gerber, M.D., Ph.D.</p>
<p>Like an automobile engine, our heart runs longer and better when it’s well cared for. In our last podcast, we reviewed the various lifestyle changes our patients can make which benefit the heart and keep it healthy. We’re going to continue that discussion in this podcast and concentrate on the pharmacologic options we have available. Which statin should we use? How do we manage the statin intolerant patient? Does Co-Q10 give benefit? These are questions I’ll be asking my guest, Thomas C. Gerber, M.D., Ph.D., a preventive cardiologist from the Department of Cardiovascular Diseases at the Mayo Clinic as discuss “Pharmacologic Options to Maintain a Healthy Heart.”</p>
<p>For more information on heart health, check out <a href='https://ce.mayo.edu/node/169834'>Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Thomas C. Gerber, M.D., Ph.D.</p>
<p>Like an automobile engine, our heart runs longer and better when it’s well cared for. In our last podcast, we reviewed the various lifestyle changes our patients can make which benefit the heart and keep it healthy. We’re going to continue that discussion in this podcast and concentrate on the pharmacologic options we have available. Which statin should we use? How do we manage the statin intolerant patient? Does Co-Q10 give benefit? These are questions I’ll be asking my guest, Thomas C. Gerber, M.D., Ph.D., a preventive cardiologist from the Department of Cardiovascular Diseases at the Mayo Clinic as discuss “Pharmacologic Options to Maintain a Healthy Heart.”</p>
<p>For more information on heart health, check out <a href='https://ce.mayo.edu/node/169834'>Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/e784xtxu8xh6fd9t/WF5564757_Pharmacologic_Options_for_Healthy_Heartbjdks.mp3" length="35902166" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Thomas C. Gerber, M.D., Ph.D.
Like an automobile engine, our heart runs longer and better when it’s well cared for. In our last podcast, we reviewed the various lifestyle changes our patients can make which benefit the heart and keep it healthy. We’re going to continue that discussion in this podcast and concentrate on the pharmacologic options we have available. Which statin should we use? How do we manage the statin intolerant patient? Does Co-Q10 give benefit? These are questions I’ll be asking my guest, Thomas C. Gerber, M.D., Ph.D., a preventive cardiologist from the Department of Cardiovascular Diseases at the Mayo Clinic as discuss “Pharmacologic Options to Maintain a Healthy Heart.”
For more information on heart health, check out Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development
Connect with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1493</itunes:duration>
                <itunes:episode>568</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Heart Health Edition: Primary Prevention - How to Keep Your Heart Healthy</title>
        <itunes:title>Heart Health Edition: Primary Prevention - How to Keep Your Heart Healthy</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/heart-health-edition-primary-prevention-how-to-keep-your-heart-healthy/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/heart-health-edition-primary-prevention-how-to-keep-your-heart-healthy/#comments</comments>        <pubDate>Tue, 18 Feb 2025 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/d6e87160-7e11-34e4-9ca4-1ca14b3d613b</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Thomas C. Gerber, M.D., Ph.D.</p>
<p>The heart is an amazing organ. At rest, the average heart beats approximately 4500 times per hour, slightly over 100,000 times per day. It’s quite a reliable organ and unlike our kidneys, lungs and eyes, we only have one heart. We expect a lot from it, if it stops working for even a minute, everything else in our body shuts down. Like an automobile engine, it runs longer and better if it’s well cared for. What can we recommend to our patients and what can we do for ourselves to keep the heart healthy? My guest for today’s podcast is Thomas C. Gerber, M.D., Ph.D., a preventive cardiologist from the Department of Cardiovascular Diseases at the Mayo Clinic and we’re going to discuss preventive strategies to maintain a healthy heart.</p>
<p>For more information on heart health, check out <a href='https://ce.mayo.edu/node/169834'>Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Thomas C. Gerber, M.D., Ph.D.</p>
<p>The heart is an amazing organ. At rest, the average heart beats approximately 4500 times per hour, slightly over 100,000 times per day. It’s quite a reliable organ and unlike our kidneys, lungs and eyes, we only have one heart. We expect a lot from it, if it stops working for even a minute, everything else in our body shuts down. Like an automobile engine, it runs longer and better if it’s well cared for. What can we recommend to our patients and what can we do for ourselves to keep the heart healthy? My guest for today’s podcast is Thomas C. Gerber, M.D., Ph.D., a preventive cardiologist from the Department of Cardiovascular Diseases at the Mayo Clinic and we’re going to discuss preventive strategies to maintain a healthy heart.</p>
<p>For more information on heart health, check out <a href='https://ce.mayo.edu/node/169834'>Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/yptcb4gu7rnjtisz/WF5370461_How_to_Keep_your_Heart_Healthy7vqq7.mp3" length="33166693" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Thomas C. Gerber, M.D., Ph.D.
The heart is an amazing organ. At rest, the average heart beats approximately 4500 times per hour, slightly over 100,000 times per day. It’s quite a reliable organ and unlike our kidneys, lungs and eyes, we only have one heart. We expect a lot from it, if it stops working for even a minute, everything else in our body shuts down. Like an automobile engine, it runs longer and better if it’s well cared for. What can we recommend to our patients and what can we do for ourselves to keep the heart healthy? My guest for today’s podcast is Thomas C. Gerber, M.D., Ph.D., a preventive cardiologist from the Department of Cardiovascular Diseases at the Mayo Clinic and we’re going to discuss preventive strategies to maintain a healthy heart.
For more information on heart health, check out Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development
Connect with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1378</itunes:duration>
                <itunes:episode>567</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Heart Health Edition: Hypertrophic Cardiomyopathy (HCM)</title>
        <itunes:title>Heart Health Edition: Hypertrophic Cardiomyopathy (HCM)</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/heart-health-edition-hypertrophic-cardiomyopathy-hcm/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/heart-health-edition-hypertrophic-cardiomyopathy-hcm/#comments</comments>        <pubDate>Thu, 13 Feb 2025 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/8984dccd-563c-3018-bbed-58591ba0717f</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Jeffrey B. Geske, M.D.</p>
<p>Hypertrophic cardiomyopathy affects 1 in 500 adults or about 600,000 individuals in the U.S. and represents the most common inherited cardiomyopathy.  It often goes undetected, and it’s estimated that about 85% of those with the condition remain undiagnosed. HCM can produce a variety of symptoms, the most serious being sudden death. The topic for this podcast is Hypertrophic Cardiomyopathy.  What are the clues that might make us suspect a patient has HCM and how should we confirm the diagnosis? Are we able to prevent sudden death in patients with the condition and finally, what is the most effective treatment? I’ll asking these questions of my guest, Jeffrey B. Geske, M.D., from the Department of Cardiovascular Diseases at Mayo Clinic.</p>
<p>For more information on heart health, check out <a href='https://ce.mayo.edu/node/169834'>Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Jeffrey B. Geske, M.D.</p>
<p>Hypertrophic cardiomyopathy affects 1 in 500 adults or about 600,000 individuals in the U.S. and represents the most common inherited cardiomyopathy.  It often goes undetected, and it’s estimated that about 85% of those with the condition remain undiagnosed. HCM can produce a variety of symptoms, the most serious being sudden death. The topic for this podcast is Hypertrophic Cardiomyopathy.  What are the clues that might make us suspect a patient has HCM and how should we confirm the diagnosis? Are we able to prevent sudden death in patients with the condition and finally, what is the most effective treatment? I’ll asking these questions of my guest, Jeffrey B. Geske, M.D., from the Department of Cardiovascular Diseases at Mayo Clinic.</p>
<p>For more information on heart health, check out <a href='https://ce.mayo.edu/node/169834'>Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nq3z9cqujbcwkmvh/WF5173999_Hypertrophic_Cardiomyopathy9wno6.mp3" length="47819298" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Jeffrey B. Geske, M.D.
Hypertrophic cardiomyopathy affects 1 in 500 adults or about 600,000 individuals in the U.S. and represents the most common inherited cardiomyopathy.  It often goes undetected, and it’s estimated that about 85% of those with the condition remain undiagnosed. HCM can produce a variety of symptoms, the most serious being sudden death. The topic for this podcast is Hypertrophic Cardiomyopathy.  What are the clues that might make us suspect a patient has HCM and how should we confirm the diagnosis? Are we able to prevent sudden death in patients with the condition and finally, what is the most effective treatment? I’ll asking these questions of my guest, Jeffrey B. Geske, M.D., from the Department of Cardiovascular Diseases at Mayo Clinic.
For more information on heart health, check out Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development
Connect with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1989</itunes:duration>
                <itunes:episode>566</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Heart Health Edition: Cardiac Rehabilitation</title>
        <itunes:title>Heart Health Edition: Cardiac Rehabilitation</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/heart-health-edition-cardiac-rehabilitation/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/heart-health-edition-cardiac-rehabilitation/#comments</comments>        <pubDate>Tue, 11 Feb 2025 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/8f7a888b-a225-339a-bd12-f2039bfc2674</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Francisco Lopez-Jimenez, M.D., M.S.</p>
<p>Heart disease is the leading cause of death in the United States as well as globally. It’s estimated that over 700,000 individuals in the U.S. die annually from some form of cardiac conditions, most often coronary heart disease.  Cardiac rehabilitation is often recommended to our patients who have a variety of cardiac health problems, and it’s intended to improve this mortality rate. But what exactly is cardiac rehabilitation? Who’s a candidate for it? Who’s qualified to supervise a cardiac rehab program and has it been proven to reduce mortality? I’ll be getting answers to these questions as we discuss “Cardiac Rehabilitation”. My guest for this podcast is Francisco Lopez-Jimenez, M.D., M.S., a preventive cardiologist from the Department of Cardiovascular Diseases at the Mayo Clinic.</p>
<p>For more information on heart health, check out <a href='https://ce.mayo.edu/node/169834'>Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Francisco Lopez-Jimenez, M.D., M.S.</p>
<p>Heart disease is the leading cause of death in the United States as well as globally. It’s estimated that over 700,000 individuals in the U.S. die annually from some form of cardiac conditions, most often coronary heart disease.  Cardiac rehabilitation is often recommended to our patients who have a variety of cardiac health problems, and it’s intended to improve this mortality rate. But what exactly is cardiac rehabilitation? Who’s a candidate for it? Who’s qualified to supervise a cardiac rehab program and has it been proven to reduce mortality? I’ll be getting answers to these questions as we discuss “Cardiac Rehabilitation”. My guest for this podcast is Francisco Lopez-Jimenez, M.D., M.S., a preventive cardiologist from the Department of Cardiovascular Diseases at the Mayo Clinic.</p>
<p>For more information on heart health, check out <a href='https://ce.mayo.edu/node/169834'>Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3ivfmebsemgce6ab/WF5173998_Cardiac_Rehabilitation6bk9m.mp3" length="32456424" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Francisco Lopez-Jimenez, M.D., M.S.
Heart disease is the leading cause of death in the United States as well as globally. It’s estimated that over 700,000 individuals in the U.S. die annually from some form of cardiac conditions, most often coronary heart disease.  Cardiac rehabilitation is often recommended to our patients who have a variety of cardiac health problems, and it’s intended to improve this mortality rate. But what exactly is cardiac rehabilitation? Who’s a candidate for it? Who’s qualified to supervise a cardiac rehab program and has it been proven to reduce mortality? I’ll be getting answers to these questions as we discuss “Cardiac Rehabilitation”. My guest for this podcast is Francisco Lopez-Jimenez, M.D., M.S., a preventive cardiologist from the Department of Cardiovascular Diseases at the Mayo Clinic.
For more information on heart health, check out Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development
Connect with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1348</itunes:duration>
                <itunes:episode>565</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Heart Health Edition: Lowering Blood Pressure</title>
        <itunes:title>Heart Health Edition: Lowering Blood Pressure</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/heart-health-edition-lowering-blood-pressure/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/heart-health-edition-lowering-blood-pressure/#comments</comments>        <pubDate>Thu, 06 Feb 2025 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/ffa18293-6c43-3c7d-8852-4075854855da</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Sandra J. Taler, M.D.</p>
<p>Hypertension is an extremely common health problem, affecting at least half of all adults in the United States. Since it’s typically asymptomatic, a significant number of individuals are unaware that they have the condition. In those who are aware of the diagnosis, the majority have blood pressures that are not adequately controlled. Once we’ve established that a patient has hypertension and needs treatment, how should we start? What are effective lifestyle changes? When is pharmacologic therapy indicated and what are the recommended medications for the initial management of hypertension? We’ll be discussing these topics and more as we review the topic “Lowering Blood Pressure”. My guest for this podcast is nephrologist and hypertension specialist Sandra J. Taler, M.D., from the Mayo Clinic.</p>
<p>For more information on heart health, check out <a href='https://ce.mayo.edu/node/169834'>Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Sandra J. Taler, M.D.</p>
<p>Hypertension is an extremely common health problem, affecting at least half of all adults in the United States. Since it’s typically asymptomatic, a significant number of individuals are unaware that they have the condition. In those who are aware of the diagnosis, the majority have blood pressures that are not adequately controlled. Once we’ve established that a patient has hypertension and needs treatment, how should we start? What are effective lifestyle changes? When is pharmacologic therapy indicated and what are the recommended medications for the initial management of hypertension? We’ll be discussing these topics and more as we review the topic “Lowering Blood Pressure”. My guest for this podcast is nephrologist and hypertension specialist Sandra J. Taler, M.D., from the Mayo Clinic.</p>
<p>For more information on heart health, check out <a href='https://ce.mayo.edu/node/169834'>Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wq2xzt83mq8yuy27/WF5283000_Lowering_Blood_Pressurebbqru.mp3" length="44716542" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Sandra J. Taler, M.D.
Hypertension is an extremely common health problem, affecting at least half of all adults in the United States. Since it’s typically asymptomatic, a significant number of individuals are unaware that they have the condition. In those who are aware of the diagnosis, the majority have blood pressures that are not adequately controlled. Once we’ve established that a patient has hypertension and needs treatment, how should we start? What are effective lifestyle changes? When is pharmacologic therapy indicated and what are the recommended medications for the initial management of hypertension? We’ll be discussing these topics and more as we review the topic “Lowering Blood Pressure”. My guest for this podcast is nephrologist and hypertension specialist Sandra J. Taler, M.D., from the Mayo Clinic.
For more information on heart health, check out Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development
Connect with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1860</itunes:duration>
                <itunes:episode>564</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Heart Health Edition: Heart Disease in Women</title>
        <itunes:title>Heart Health Edition: Heart Disease in Women</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/heart-health-edition-heart-disease-in-women/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/heart-health-edition-heart-disease-in-women/#comments</comments>        <pubDate>Tue, 04 Feb 2025 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/fc6389aa-e803-3f15-ba2f-6e1a65cd6af7</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Sharonne N. Hayes, M.D.</p>
<p>We tend to think of heart disease as a health problem for men, yet it’s the leading cause of death for women in the United States and is responsible for over 1/3 of all deaths in women each year, more than all malignancies combined. Women tend to have more atypical symptoms and often delay seeking help when they have symptoms. As clinicians, we need to realize that we commonly underdiagnose heart disease in women. How do the symptoms of heart disease differ in women compared to men? Do women have different cardiovascular disease risk factors than men? And as health care clinicians, what do we need to do to be more aware of heart disease in our female patients? I’ll be asking these questions of my guest for this podcast as we discuss “Heart Disease in Women”. My guest is Sharonne N. Hayes, M.D., a cardiologist at the Mayo Clinic.</p>
<p>For more information on heart health, check out <a href='https://ce.mayo.edu/node/169834'>Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Sharonne N. Hayes, M.D.</p>
<p>We tend to think of heart disease as a health problem for men, yet it’s the leading cause of death for women in the United States and is responsible for over 1/3 of all deaths in women each year, more than all malignancies combined. Women tend to have more atypical symptoms and often delay seeking help when they have symptoms. As clinicians, we need to realize that we commonly underdiagnose heart disease in women. How do the symptoms of heart disease differ in women compared to men? Do women have different cardiovascular disease risk factors than men? And as health care clinicians, what do we need to do to be more aware of heart disease in our female patients? I’ll be asking these questions of my guest for this podcast as we discuss “Heart Disease in Women”. My guest is Sharonne N. Hayes, M.D., a cardiologist at the Mayo Clinic.</p>
<p>For more information on heart health, check out <a href='https://ce.mayo.edu/node/169834'>Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/sx9kd72hynrp3ybv/WF5281150_Heart_Disease_In_Women_And_National_Wear_Red_Day741zc.mp3" length="42030824" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Sharonne N. Hayes, M.D.
We tend to think of heart disease as a health problem for men, yet it’s the leading cause of death for women in the United States and is responsible for over 1/3 of all deaths in women each year, more than all malignancies combined. Women tend to have more atypical symptoms and often delay seeking help when they have symptoms. As clinicians, we need to realize that we commonly underdiagnose heart disease in women. How do the symptoms of heart disease differ in women compared to men? Do women have different cardiovascular disease risk factors than men? And as health care clinicians, what do we need to do to be more aware of heart disease in our female patients? I’ll be asking these questions of my guest for this podcast as we discuss “Heart Disease in Women”. My guest is Sharonne N. Hayes, M.D., a cardiologist at the Mayo Clinic.
For more information on heart health, check out Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development
Connect with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1747</itunes:duration>
                <itunes:episode>563</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Perioperative Medical Assessment</title>
        <itunes:title>Perioperative Medical Assessment</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/perioperative-medical-assessment/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/perioperative-medical-assessment/#comments</comments>        <pubDate>Tue, 28 Jan 2025 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/f10263fe-7316-389b-8edf-a173e4a1dca8</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Chris R. Stephenson, M.D., M.H.P.E.</p>
<p>Some patients about to have a surgical procedure will have a preoperative assessment completed by the anesthesiologist on the day of the surgery. However, in many cases, patients are having an evaluation at a perioperative clinic, well prior to their procedure. Although this results in an additional visit for the patient, there are advantages to this approach. Benefits include improvements in hospital efficiency, cost savings from shorter hospital stays and more appropriate use of laboratory tests. So, what does a perioperative assessment consist of? Do they assist the surgeon in their postoperative management of the patient, and does it result in better clinical outcomes? This podcast will address the perioperative medical assessment, and these are some of the questions I’ll be asking my guest, Chris R. Stephenson, M.D., M.H.P.E., from the Division of General Internal Medicine at the Mayo Clinic.</p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Chris R. Stephenson, M.D., M.H.P.E.</p>
<p>Some patients about to have a surgical procedure will have a preoperative assessment completed by the anesthesiologist on the day of the surgery. However, in many cases, patients are having an evaluation at a perioperative clinic, well prior to their procedure. Although this results in an additional visit for the patient, there are advantages to this approach. Benefits include improvements in hospital efficiency, cost savings from shorter hospital stays and more appropriate use of laboratory tests. So, what does a perioperative assessment consist of? Do they assist the surgeon in their postoperative management of the patient, and does it result in better clinical outcomes? This podcast will address the perioperative medical assessment, and these are some of the questions I’ll be asking my guest, Chris R. Stephenson, M.D., M.H.P.E., from the Division of General Internal Medicine at the Mayo Clinic.</p>
<p>Connect with <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6tcpv5ks3yfz7b2v/WF4160798_Perioperative_Medical_Assessmentbeety.mp3" length="36196882" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Chris R. Stephenson, M.D., M.H.P.E.
Some patients about to have a surgical procedure will have a preoperative assessment completed by the anesthesiologist on the day of the surgery. However, in many cases, patients are having an evaluation at a perioperative clinic, well prior to their procedure. Although this results in an additional visit for the patient, there are advantages to this approach. Benefits include improvements in hospital efficiency, cost savings from shorter hospital stays and more appropriate use of laboratory tests. So, what does a perioperative assessment consist of? Do they assist the surgeon in their postoperative management of the patient, and does it result in better clinical outcomes? This podcast will address the perioperative medical assessment, and these are some of the questions I’ll be asking my guest, Chris R. Stephenson, M.D., M.H.P.E., from the Division of General Internal Medicine at the Mayo Clinic.
Connect with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1506</itunes:duration>
                <itunes:episode>562</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Life as a Physician Edition: Part 2 "Financial Well-Being"</title>
        <itunes:title>Life as a Physician Edition: Part 2 "Financial Well-Being"</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/life-as-a-physician-edition-part-2-financial-well-being/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/life-as-a-physician-edition-part-2-financial-well-being/#comments</comments>        <pubDate>Thu, 23 Jan 2025 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/6acf004d-4b62-3bfb-9281-91d582e80618</guid>
                                    <description><![CDATA[<p>Hosts: Sanj Kakar, M.D. and Dawn Marie R. Davis, M.D.</p>
<p>Guests: Rosanne M. Boser and Jonathan L. Verhelst, CFP(R)</p>
<p>Financial solvency and independence are relevant for all individuals, though physicians have unique aspects to financial health due to a long training period, education expenses, and lack of formal financial instruction. On today’s podcast, we discuss the most common conundrums physicians face regarding financial literacy and financial well-being.</p>
<p>Learn more at <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Hosts: Sanj Kakar, M.D. and Dawn Marie R. Davis, M.D.</p>
<p>Guests: Rosanne M. Boser and Jonathan L. Verhelst, CFP(R)</p>
<p>Financial solvency and independence are relevant for all individuals, though physicians have unique aspects to financial health due to a long training period, education expenses, and lack of formal financial instruction. On today’s podcast, we discuss the most common conundrums physicians face regarding financial literacy and financial well-being.</p>
<p>Learn more at <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dm4n9dp36escujg6/241203_Kakar_Davis_Boser_Verhelst_v1_part2.mp3" length="60062400" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Hosts: Sanj Kakar, M.D. and Dawn Marie R. Davis, M.D.
Guests: Rosanne M. Boser and Jonathan L. Verhelst, CFP(R)
Financial solvency and independence are relevant for all individuals, though physicians have unique aspects to financial health due to a long training period, education expenses, and lack of formal financial instruction. On today’s podcast, we discuss the most common conundrums physicians face regarding financial literacy and financial well-being.
Learn more at https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1502</itunes:duration>
                <itunes:episode>561</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Life as a Physician Edition: Part 1 "Financial Well-Being"</title>
        <itunes:title>Life as a Physician Edition: Part 1 "Financial Well-Being"</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/life-as-a-physician-edition-part-1-financial-well-being/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/life-as-a-physician-edition-part-1-financial-well-being/#comments</comments>        <pubDate>Tue, 21 Jan 2025 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/5c05bca5-d013-39e3-8431-9bb61aa671c3</guid>
                                    <description><![CDATA[<p>Hosts: Sanj Kakar, M.D. and Dawn Marie R. Davis, M.D.</p>
<p>Guests: Rosanne M. Boser and Jonathan L. Verhelst, CFP(R)</p>
<p>Financial solvency and independence are relevant for all individuals, though physicians have unique aspects to financial health due to a long training period, education expenses, and lack of formal financial instruction. On today’s podcast, we discuss the most common conundrums physicians face regarding financial literacy and financial well-being.</p>
<p>Be sure to listen to Part 2 of this topic airing this Thursday, January 23, 2025!</p>
<p>Learn more at <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Hosts: Sanj Kakar, M.D. and Dawn Marie R. Davis, M.D.</p>
<p>Guests: Rosanne M. Boser and Jonathan L. Verhelst, CFP(R)</p>
<p>Financial solvency and independence are relevant for all individuals, though physicians have unique aspects to financial health due to a long training period, education expenses, and lack of formal financial instruction. On today’s podcast, we discuss the most common conundrums physicians face regarding financial literacy and financial well-being.</p>
<p>Be sure to listen to Part 2 of this topic airing this Thursday, January 23, 2025!</p>
<p>Learn more at <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dfyyymb8kpwvg745/241203_Kakar_Davis_Boser_Verhelst_v1_part1.mp3" length="57751680" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Hosts: Sanj Kakar, M.D. and Dawn Marie R. Davis, M.D.
Guests: Rosanne M. Boser and Jonathan L. Verhelst, CFP(R)
Financial solvency and independence are relevant for all individuals, though physicians have unique aspects to financial health due to a long training period, education expenses, and lack of formal financial instruction. On today’s podcast, we discuss the most common conundrums physicians face regarding financial literacy and financial well-being.
Be sure to listen to Part 2 of this topic airing this Thursday, January 23, 2025!
Learn more at https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1444</itunes:duration>
                <itunes:episode>560</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Life as a Physician Series: Part 2 "Mentorship and Sponsorship"</title>
        <itunes:title>Life as a Physician Series: Part 2 "Mentorship and Sponsorship"</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/life-as-a-physician-series-part-2-mentorship-and-sponsorship/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/life-as-a-physician-series-part-2-mentorship-and-sponsorship/#comments</comments>        <pubDate>Thu, 16 Jan 2025 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/d9f3e59b-9e09-3cbf-9111-1e1a197a2173</guid>
                                    <description><![CDATA[<p>Hosts: Sanj Kakar, M.D. and Dawn Marie R. Davis, M.D.</p>
<p>Guests: Sophie J. Bakri, M.D., Amy S. Oxentenko, M.D. and Charanjit S. Rihal, M.D.</p>
<p>Healthcare takes a village, not only to care for patients, but also to maximize one’s potential as a physician. On today’s podcast, we will discuss the importance of mentorship and sponsorship for professional and personal growth and success.</p>
<p>Learn more at <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Hosts: Sanj Kakar, M.D. and Dawn Marie R. Davis, M.D.</p>
<p>Guests: Sophie J. Bakri, M.D., Amy S. Oxentenko, M.D. and Charanjit S. Rihal, M.D.</p>
<p>Healthcare takes a village, not only to care for patients, but also to maximize one’s potential as a physician. On today’s podcast, we will discuss the importance of mentorship and sponsorship for professional and personal growth and success.</p>
<p>Learn more at <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/a9dhtyv9c27b8a7n/241126_Kakar_Davis_Rihal_Bakri_Oxentenko_part2_HumanOptimizationPromo_AF9v8ci.mp3" length="53223360" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Hosts: Sanj Kakar, M.D. and Dawn Marie R. Davis, M.D.
Guests: Sophie J. Bakri, M.D., Amy S. Oxentenko, M.D. and Charanjit S. Rihal, M.D.
Healthcare takes a village, not only to care for patients, but also to maximize one’s potential as a physician. On today’s podcast, we will discuss the importance of mentorship and sponsorship for professional and personal growth and success.
Learn more at https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1331</itunes:duration>
                <itunes:episode>559</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Life as a Physician Series: Part 1 "Mentorship and Sponsorship"</title>
        <itunes:title>Life as a Physician Series: Part 1 "Mentorship and Sponsorship"</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/life-as-a-physician-series-part-1-mentorship-and-sponsorship/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/life-as-a-physician-series-part-1-mentorship-and-sponsorship/#comments</comments>        <pubDate>Tue, 14 Jan 2025 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/4e71b533-881a-3503-aa88-685df8384d97</guid>
                                    <description><![CDATA[<p>Hosts: Sanj Kakar, M.D. and Dawn Marie R. Davis, M.D.</p>
<p>Guests: Sophie J. Bakri, M.D., Amy S. Oxentenko, M.D. and Charanjit S. Rihal, M.D.</p>
<p>Healthcare takes a village, not only to care for patients, but also to maximize one’s potential as a physician. On today’s podcast, we will discuss the importance of mentorship and sponsorship for professional and personal growth and success.</p>
<p>Stay tuned as Part 2 of "Mentorship and Sponsorship" releases this Thursday, January 16, 2025!</p>
<p>Learn more at <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
<p> </p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Hosts: Sanj Kakar, M.D. and Dawn Marie R. Davis, M.D.</p>
<p>Guests: Sophie J. Bakri, M.D., Amy S. Oxentenko, M.D. and Charanjit S. Rihal, M.D.</p>
<p>Healthcare takes a village, not only to care for patients, but also to maximize one’s potential as a physician. On today’s podcast, we will discuss the importance of mentorship and sponsorship for professional and personal growth and success.</p>
<p>Stay tuned as Part 2 of "Mentorship and Sponsorship" releases this Thursday, January 16, 2025!</p>
<p>Learn more at <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
<p> </p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/h7pnacbw3enjhpgh/241126_Kakar_Davis_Rihal_Bakri_Oxentenko_part1_HumanOptimizationPromo.mp3" length="70317120" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Hosts: Sanj Kakar, M.D. and Dawn Marie R. Davis, M.D.
Guests: Sophie J. Bakri, M.D., Amy S. Oxentenko, M.D. and Charanjit S. Rihal, M.D.
Healthcare takes a village, not only to care for patients, but also to maximize one’s potential as a physician. On today’s podcast, we will discuss the importance of mentorship and sponsorship for professional and personal growth and success.
Stay tuned as Part 2 of "Mentorship and Sponsorship" releases this Thursday, January 16, 2025!
Learn more at https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 
 
 ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1758</itunes:duration>
                <itunes:episode>558</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Life as a Physician Series: Part 2 "Retiring Gracefully: Life After Medicine"</title>
        <itunes:title>Life as a Physician Series: Part 2 "Retiring Gracefully: Life After Medicine"</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/life-as-a-physician-series-part-2-retiring-gracefully-life-after-medicine/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/life-as-a-physician-series-part-2-retiring-gracefully-life-after-medicine/#comments</comments>        <pubDate>Thu, 09 Jan 2025 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/b7abcc84-d1cb-3459-b802-e08e0b4812bb</guid>
                                    <description><![CDATA[<p>Hosts: Sanj Kakar, M.D. and Dawn Marie R. Davis, M.D.</p>
<p>Guests: Deborah J. Lightner, M.D. and Edward T. Creagan, M.D.</p>
<p>A career in medicine is rewarding and challenging. It is imperative physicians are prepared to transition to life beyond medicine as they consider retirement.  In this episode of our series, "Life as a Physician", we will discuss the transition to retirement, life after retirement, and how it impacts one’s personal and professional life.</p>
<p>Learn more at <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Hosts: Sanj Kakar, M.D. and Dawn Marie R. Davis, M.D.</p>
<p>Guests: Deborah J. Lightner, M.D. and Edward T. Creagan, M.D.</p>
<p>A career in medicine is rewarding and challenging. It is imperative physicians are prepared to transition to life beyond medicine as they consider retirement.  In this episode of our series, "Life as a Physician", we will discuss the transition to retirement, life after retirement, and how it impacts one’s personal and professional life.</p>
<p>Learn more at <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/y5xjy3p8wrpfm5ur/241029_Kakar_Davis_Creagan_Lightner_AUDIOedit_part2_v1.mp3" length="33724800" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Hosts: Sanj Kakar, M.D. and Dawn Marie R. Davis, M.D.
Guests: Deborah J. Lightner, M.D. and Edward T. Creagan, M.D.
A career in medicine is rewarding and challenging. It is imperative physicians are prepared to transition to life beyond medicine as they consider retirement.  In this episode of our series, "Life as a Physician", we will discuss the transition to retirement, life after retirement, and how it impacts one’s personal and professional life.
Learn more at https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1405</itunes:duration>
                <itunes:episode>557</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Life as a Physician Series: Part 1 "Retiring Gracefully: Life After Medicine"</title>
        <itunes:title>Life as a Physician Series: Part 1 "Retiring Gracefully: Life After Medicine"</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/life-as-a-physician-series-part-1-retiring-gracefully/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/life-as-a-physician-series-part-1-retiring-gracefully/#comments</comments>        <pubDate>Tue, 07 Jan 2025 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/d6982d52-9436-3a3b-9077-04cddd59dbc4</guid>
                                    <description><![CDATA[<p>Hosts: Sanj Kakar, M.D. and Dawn Marie R. Davis, M.D.</p>
<p>Guests: Deborah J. Lightner, M.D. and Edward T. Creagan, M.D.</p>
<p>A career in medicine is rewarding and challenging. It is imperative physicians are prepared to transition to life beyond medicine as they consider retirement.  In this episode of our series, "Life as a Physician", we will discuss the transition to retirement, life after retirement, and how it impacts one’s personal and professional life.</p>
<p>Stay tuned as Part 2 of "Retiring Gracefully: Life After Medicine" releases on Thursday, January 9, 2025!</p>
<p>Learn more at <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Hosts: Sanj Kakar, M.D. and Dawn Marie R. Davis, M.D.</p>
<p>Guests: Deborah J. Lightner, M.D. and Edward T. Creagan, M.D.</p>
<p>A career in medicine is rewarding and challenging. It is imperative physicians are prepared to transition to life beyond medicine as they consider retirement.  In this episode of our series, "Life as a Physician", we will discuss the transition to retirement, life after retirement, and how it impacts one’s personal and professional life.</p>
<p>Stay tuned as Part 2 of "Retiring Gracefully: Life After Medicine" releases on Thursday, January 9, 2025!</p>
<p>Learn more at <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jvhrdfwk57pakmnz/241029_Kakar_Davis_Creagan_Lightner_AUDIOedit_part1_v1.mp3" length="33726528" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Hosts: Sanj Kakar, M.D. and Dawn Marie R. Davis, M.D.
Guests: Deborah J. Lightner, M.D. and Edward T. Creagan, M.D.
A career in medicine is rewarding and challenging. It is imperative physicians are prepared to transition to life beyond medicine as they consider retirement.  In this episode of our series, "Life as a Physician", we will discuss the transition to retirement, life after retirement, and how it impacts one’s personal and professional life.
Stay tuned as Part 2 of "Retiring Gracefully: Life After Medicine" releases on Thursday, January 9, 2025!
Learn more at https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1405</itunes:duration>
                <itunes:episode>556</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Bell's Palsy</title>
        <itunes:title>Bell's Palsy</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/bells-palsy/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/bells-palsy/#comments</comments>        <pubDate>Thu, 02 Jan 2025 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/912a4ed9-542e-33ea-bc78-80dc6888b042</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Guest: Jacob K. Dey, M.D.</p>
<p>Bell’s Palsy typically causes acute unilateral weakness of the facial muscles. Although it can occur at any age, Its most common in middle age and older adults. It tends to occur more often in females, especially during pregnancy. Although most cases resolve with time, treatment is available and recommended. The topic of this podcast is Bell’s Palsy, and my guest is Jacob Dey, M.D., a facial plastic surgeon in the Division of Facial Plastic &amp; Reconstructive Surgery in the Department of Otolaryngology/Head &amp; Neck Surgery at the Mayo Clinic. We’ll discuss the pathophysiology of Bell’s Palsy, the typical course of the illness, it’s potential complications and the various treatment options.</p>
<p>Connect with the Mayo Clinic Talks Podcast <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>HERE</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Guest: Jacob K. Dey, M.D.</p>
<p>Bell’s Palsy typically causes acute unilateral weakness of the facial muscles. Although it can occur at any age, Its most common in middle age and older adults. It tends to occur more often in females, especially during pregnancy. Although most cases resolve with time, treatment is available and recommended. The topic of this podcast is Bell’s Palsy, and my guest is Jacob Dey, M.D., a facial plastic surgeon in the Division of Facial Plastic &amp; Reconstructive Surgery in the Department of Otolaryngology/Head &amp; Neck Surgery at the Mayo Clinic. We’ll discuss the pathophysiology of Bell’s Palsy, the typical course of the illness, it’s potential complications and the various treatment options.</p>
<p>Connect with the Mayo Clinic Talks Podcast <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts'>HERE</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pz6arvxvwsxac6hu/WF4180050_Bell_s_Palsy_and_Facial_Paralysis7zmrs.mp3" length="42906959" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Guest: Jacob K. Dey, M.D.
Bell’s Palsy typically causes acute unilateral weakness of the facial muscles. Although it can occur at any age, Its most common in middle age and older adults. It tends to occur more often in females, especially during pregnancy. Although most cases resolve with time, treatment is available and recommended. The topic of this podcast is Bell’s Palsy, and my guest is Jacob Dey, M.D., a facial plastic surgeon in the Division of Facial Plastic &amp; Reconstructive Surgery in the Department of Otolaryngology/Head &amp; Neck Surgery at the Mayo Clinic. We’ll discuss the pathophysiology of Bell’s Palsy, the typical course of the illness, it’s potential complications and the various treatment options.
Connect with the Mayo Clinic Talks Podcast HERE]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1782</itunes:duration>
                <itunes:episode>555</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>RE-RELEASE from Season 2: Mayo Clinic Talks "This Podcast Will Make Your Head Spin"</title>
        <itunes:title>RE-RELEASE from Season 2: Mayo Clinic Talks "This Podcast Will Make Your Head Spin"</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/re-release-from-season-2-mayo-clinic-talks-this-podcast-will-make-your-head-spin/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/re-release-from-season-2-mayo-clinic-talks-this-podcast-will-make-your-head-spin/#comments</comments>        <pubDate>Tue, 31 Dec 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/1d6b6268-0f51-33c4-a71f-bf8c47c9fd05</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Scott D. Eggers, M.D. </p>
<p>Today, we're airing a popular episode from Season 2 of Mayo Clinic Talks!  Happy Holidays!</p>
<p>The complaint of dizziness is a common symptom our patients experience. It has a variety of causes; fortunately, most of them are benign. Despite the fact we frequently see patients with this medical concern, we still struggle evaluating them. Part of the difficulty is that dizziness means different things to different people and the cause of dizziness can be caused by disorders in one of several organ systems. To help us evaluate dizziness, Dr. Scott Eggers, a neurologist at the Mayo Clinic, reviews why dizziness is so difficult to evaluate and how we should evaluate a patient who complains of dizziness. We also explore the most common causes of dizziness including benign positional vertigo and vestibular neuritis. Finally, Dr. Eggers reviews symptoms that are suspicious for an ominous cause of dizziness.</p>
<p>To listen to Part 2: <a href='https://www.podbean.com/pu/pbblog-5t26h-585902'>https://www.podbean.com/pu/pbblog-5t26h-585902</a>  </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Scott D. Eggers, M.D. </p>
<p>Today, we're airing a popular episode from Season 2 of Mayo Clinic Talks!  Happy Holidays!</p>
<p>The complaint of dizziness is a common symptom our patients experience. It has a variety of causes; fortunately, most of them are benign. Despite the fact we frequently see patients with this medical concern, we still struggle evaluating them. Part of the difficulty is that dizziness means different things to different people and the cause of dizziness can be caused by disorders in one of several organ systems. To help us evaluate dizziness, Dr. Scott Eggers, a neurologist at the Mayo Clinic, reviews why dizziness is so difficult to evaluate and how we should evaluate a patient who complains of dizziness. We also explore the most common causes of dizziness including benign positional vertigo and vestibular neuritis. Finally, Dr. Eggers reviews symptoms that are suspicious for an ominous cause of dizziness.</p>
<p><em>To listen to Part 2</em>: <a href='https://www.podbean.com/pu/pbblog-5t26h-585902'>https://www.podbean.com/pu/pbblog-5t26h-585902</a>  </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/i56i3debzvtyskki/Dizziness_Re-release_AF7al2t.mp3" length="39118698" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Scott D. Eggers, M.D. 
Today, we're airing a popular episode from Season 2 of Mayo Clinic Talks!  Happy Holidays!
The complaint of dizziness is a common symptom our patients experience. It has a variety of causes; fortunately, most of them are benign. Despite the fact we frequently see patients with this medical concern, we still struggle evaluating them. Part of the difficulty is that dizziness means different things to different people and the cause of dizziness can be caused by disorders in one of several organ systems. To help us evaluate dizziness, Dr. Scott Eggers, a neurologist at the Mayo Clinic, reviews why dizziness is so difficult to evaluate and how we should evaluate a patient who complains of dizziness. We also explore the most common causes of dizziness including benign positional vertigo and vestibular neuritis. Finally, Dr. Eggers reviews symptoms that are suspicious for an ominous cause of dizziness.
To listen to Part 2: https://www.podbean.com/pu/pbblog-5t26h-585902  
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1629</itunes:duration>
                <itunes:episode>554</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Crohn's Disease</title>
        <itunes:title>Crohn's Disease</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/crohns-disease/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/crohns-disease/#comments</comments>        <pubDate>Thu, 26 Dec 2024 11:41:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/ca4652f0-9076-3266-9aa9-9c556e021d6e</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Guest: Jana Al Hashash, M.D., M.S.</p>




<p>Crohn’s Disease is an inflammatory bowel disease, but on occasion, it can involve much more than the bowel. The disease can affect any part of the digestive tract, from the mouth to the anus. It’s estimated that more than half a million people in the U.S. have Crohn’s disease and over time, it’s become more common, not only in the U.S., but in other parts of the world as well. It can result in a variety of complications and also results in an increased risk of colon cancer. The topic for this podcast is Crohn’s Disease and my guest is Jana Al Hashash, M.D., M.S., from the Division of Gastroenterology and Hepatology from the Mayo Clinic in Jacksonville, Florida. We’ll be discussing the typical presenting symptoms of Crohn’s, the recommended evaluation of a patient with suspected Crohn’s and the current treatment options.</p>




<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Guest: Jana Al Hashash, M.D., M.S.</p>




<p>Crohn’s Disease is an inflammatory bowel disease, but on occasion, it can involve much more than the bowel. The disease can affect any part of the digestive tract, from the mouth to the anus. It’s estimated that more than half a million people in the U.S. have Crohn’s disease and over time, it’s become more common, not only in the U.S., but in other parts of the world as well. It can result in a variety of complications and also results in an increased risk of colon cancer. The topic for this podcast is Crohn’s Disease and my guest is Jana Al Hashash, M.D., M.S., from the Division of Gastroenterology and Hepatology from the Mayo Clinic in Jacksonville, Florida. We’ll be discussing the typical presenting symptoms of Crohn’s, the recommended evaluation of a patient with suspected Crohn’s and the current treatment options.</p>




<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xi324447fkeqhjnw/WF4247329_Crohn_s_Disease_AFae4gs.mp3" length="36491283" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Guest: Jana Al Hashash, M.D., M.S.




Crohn’s Disease is an inflammatory bowel disease, but on occasion, it can involve much more than the bowel. The disease can affect any part of the digestive tract, from the mouth to the anus. It’s estimated that more than half a million people in the U.S. have Crohn’s disease and over time, it’s become more common, not only in the U.S., but in other parts of the world as well. It can result in a variety of complications and also results in an increased risk of colon cancer. The topic for this podcast is Crohn’s Disease and my guest is Jana Al Hashash, M.D., M.S., from the Division of Gastroenterology and Hepatology from the Mayo Clinic in Jacksonville, Florida. We’ll be discussing the typical presenting symptoms of Crohn’s, the recommended evaluation of a patient with suspected Crohn’s and the current treatment options.




Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1516</itunes:duration>
                <itunes:episode>553</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>RE-RELEASE from Season 2: Mayo Clinic Talks "Evaluating Hematuria"</title>
        <itunes:title>RE-RELEASE from Season 2: Mayo Clinic Talks "Evaluating Hematuria"</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/re-release-from-season-2-mayo-clinic-talks-evaluating-hematuria/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/re-release-from-season-2-mayo-clinic-talks-evaluating-hematuria/#comments</comments>        <pubDate>Tue, 24 Dec 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/751fa07a-4bd2-3e02-81e7-69876fa1cbcc</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Aaron M. Potretzke, M.D.</p>
<p>Today, we're airing a popular episode from Season 2 of Mayo Clinic Talks!  Happy Holidays!</p>
<p>Microscopic hematuria, and less commonly gross hematuria, are conditions commonly seen by the primary care provider. Malignancy is the most ominous cause of hematuria. Fortunately, other causes are much more likely. Since this is a relatively common health condition, when should we investigate hematuria and what should the evaluation consist of? How do we evaluate a patient’s risk for urinary tract malignancy? Dr. Aaron Potretzke, a urologist at Mayo Clinic, joins us to discuss these questions.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Aaron M. Potretzke, M.D.</p>
<p>Today, we're airing a popular episode from Season 2 of Mayo Clinic Talks!  Happy Holidays!</p>
<p>Microscopic hematuria, and less commonly gross hematuria, are conditions commonly seen by the primary care provider. Malignancy is the most ominous cause of hematuria. Fortunately, other causes are much more likely. Since this is a relatively common health condition, when should we investigate hematuria and what should the evaluation consist of? How do we evaluate a patient’s risk for urinary tract malignancy? Dr. Aaron Potretzke, a urologist at Mayo Clinic, joins us to discuss these questions.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vzhr7gzpchq983ei/Evaluating_Hematuria_Re-release_AF79si7.mp3" length="28042580" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Aaron M. Potretzke, M.D.
Today, we're airing a popular episode from Season 2 of Mayo Clinic Talks!  Happy Holidays!
Microscopic hematuria, and less commonly gross hematuria, are conditions commonly seen by the primary care provider. Malignancy is the most ominous cause of hematuria. Fortunately, other causes are much more likely. Since this is a relatively common health condition, when should we investigate hematuria and what should the evaluation consist of? How do we evaluate a patient’s risk for urinary tract malignancy? Dr. Aaron Potretzke, a urologist at Mayo Clinic, joins us to discuss these questions.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1168</itunes:duration>
                <itunes:episode>552</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Holiday Stress and Wellness Edition: Alcohol Use and the Holidays</title>
        <itunes:title>Holiday Stress and Wellness Edition: Alcohol Use and the Holidays</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/holiday-stress-and-wellness-edition-alcohol-use-and-the-holidays/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/holiday-stress-and-wellness-edition-alcohol-use-and-the-holidays/#comments</comments>        <pubDate>Thu, 19 Dec 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/de1d4732-ec46-3258-ab39-6167d58c3500</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Terry D. Schneekloth, M.D.</p>
<p>According to the National Institute on Alcohol Abuse and Alcoholism, there’s a significant increase in alcohol consumption during holidays. Christmas and New Years are times of celebration and alcohol use is often part of that celebration. Binge drinking is common, and this can result in impaired judgment, motor vehicle accidents, and risky behaviors. Who’s at greatest risk for alcohol-related behaviors? How can we as health care clinicians detect those at risk for a problem with alcohol during the holidays and what advice can we give our patients recovering from an alcohol addiction to get through the holidays and maintain their sobriety? The topic for this podcast is “Alcohol Use and the Holidays” and these are some of the questions I’ll be asking my guest, Terry Schneekloth, M.D., from the Department of Psychiatry and Psychology at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Terry D. Schneekloth, M.D.</p>
<p>According to the National Institute on Alcohol Abuse and Alcoholism, there’s a significant increase in alcohol consumption during holidays. Christmas and New Years are times of celebration and alcohol use is often part of that celebration. Binge drinking is common, and this can result in impaired judgment, motor vehicle accidents, and risky behaviors. Who’s at greatest risk for alcohol-related behaviors? How can we as health care clinicians detect those at risk for a problem with alcohol during the holidays and what advice can we give our patients recovering from an alcohol addiction to get through the holidays and maintain their sobriety? The topic for this podcast is “Alcohol Use and the Holidays” and these are some of the questions I’ll be asking my guest, Terry Schneekloth, M.D., from the Department of Psychiatry and Psychology at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3u2ubrb9f2ms8r83/WF5134871_Alcoholism_and_the_Holidaysapjno.mp3" length="34131221" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Terry D. Schneekloth, M.D.
According to the National Institute on Alcohol Abuse and Alcoholism, there’s a significant increase in alcohol consumption during holidays. Christmas and New Years are times of celebration and alcohol use is often part of that celebration. Binge drinking is common, and this can result in impaired judgment, motor vehicle accidents, and risky behaviors. Who’s at greatest risk for alcohol-related behaviors? How can we as health care clinicians detect those at risk for a problem with alcohol during the holidays and what advice can we give our patients recovering from an alcohol addiction to get through the holidays and maintain their sobriety? The topic for this podcast is “Alcohol Use and the Holidays” and these are some of the questions I’ll be asking my guest, Terry Schneekloth, M.D., from the Department of Psychiatry and Psychology at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1420</itunes:duration>
                <itunes:episode>551</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Holiday Stress and Wellness Edition: Holiday Stress and Mental Health</title>
        <itunes:title>Holiday Stress and Wellness Edition: Holiday Stress and Mental Health</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/holiday-stress-and-wellness-edition-holiday-stress-and-mental-health/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/holiday-stress-and-wellness-edition-holiday-stress-and-mental-health/#comments</comments>        <pubDate>Tue, 17 Dec 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/3f5870c1-f417-3f86-a909-7a14089c7449</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Mark A. Frye, M.D.</p>
<p>For many, the holidays are a time for happiness and connecting with family and friends. It’s often a time of celebration. But for some, it can be a time of increased stress, anxiety and sadness. In some cases, our good health habits such as eating healthy, regular exercise and getting adequate sleep are replaced by overeating, consuming excess alcohol and taking on too many responsibilities. A recent study by the American Psychological Society found that 89% of those surveyed felt stressed during the holiday season. What are the most common reasons for this stress? Can we avoid it? If not, what are the best ways to manage it? I’ll be discussing these topics with my guest, Mark Frye, M.D., a psychiatrist from the Mayo Clinic. The topic for this podcast is “Holiday Stress and Mental Health”.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Mark A. Frye, M.D.</p>
<p>For many, the holidays are a time for happiness and connecting with family and friends. It’s often a time of celebration. But for some, it can be a time of increased stress, anxiety and sadness. In some cases, our good health habits such as eating healthy, regular exercise and getting adequate sleep are replaced by overeating, consuming excess alcohol and taking on too many responsibilities. A recent study by the American Psychological Society found that 89% of those surveyed felt stressed during the holiday season. What are the most common reasons for this stress? Can we avoid it? If not, what are the best ways to manage it? I’ll be discussing these topics with my guest, Mark Frye, M.D., a psychiatrist from the Mayo Clinic. The topic for this podcast is “Holiday Stress and Mental Health”.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vjjn49auvbktuw65/WF5106752_Holiday_Stress_and_Mental_Health7hv6p.mp3" length="43582114" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Mark A. Frye, M.D.
For many, the holidays are a time for happiness and connecting with family and friends. It’s often a time of celebration. But for some, it can be a time of increased stress, anxiety and sadness. In some cases, our good health habits such as eating healthy, regular exercise and getting adequate sleep are replaced by overeating, consuming excess alcohol and taking on too many responsibilities. A recent study by the American Psychological Society found that 89% of those surveyed felt stressed during the holiday season. What are the most common reasons for this stress? Can we avoid it? If not, what are the best ways to manage it? I’ll be discussing these topics with my guest, Mark Frye, M.D., a psychiatrist from the Mayo Clinic. The topic for this podcast is “Holiday Stress and Mental Health”.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1812</itunes:duration>
                <itunes:episode>550</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Holiday Stress and Wellness Edition: Exercise and the Holidays</title>
        <itunes:title>Holiday Stress and Wellness Edition: Exercise and the Holidays</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/holiday-stress-and-wellness-edition-exercise-and-the-holidays/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/holiday-stress-and-wellness-edition-exercise-and-the-holidays/#comments</comments>        <pubDate>Thu, 12 Dec 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/307f9c94-c8ae-3e4b-b61c-d22c70b410ef</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Amanda R. Bonikowske, Ph.D.</p>
<p>There are many benefits of exercise, from improving our mental health to reducing the risk of chronic disease. It can improve our sleep, increase our energy and can help establish relationships with others. It’s an activity that almost anyone can do, and it doesn’t have to cost a thing, other than an individual’s time. The holiday season will soon be upon us as well as its associated stress and in many cases, weight gain. Can exercise help with some of these problems associated with the holidays? How much exercise is optimal? What kind of exercise should we recommend for those who are unable to participate in vigorous exercise? Does it matter if we do one type of exercise or is a variety of exercise better? These are questions I’ll be asking my guest, Amanda Bonikowske, Ph.D., an exercise physiologist from the Department of Cardiovascular Diseases at the Mayo Clinic as we discuss “Exercise and the Holidays”.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Amanda R. Bonikowske, Ph.D.</p>
<p>There are many benefits of exercise, from improving our mental health to reducing the risk of chronic disease. It can improve our sleep, increase our energy and can help establish relationships with others. It’s an activity that almost anyone can do, and it doesn’t have to cost a thing, other than an individual’s time. The holiday season will soon be upon us as well as its associated stress and in many cases, weight gain. Can exercise help with some of these problems associated with the holidays? How much exercise is optimal? What kind of exercise should we recommend for those who are unable to participate in vigorous exercise? Does it matter if we do one type of exercise or is a variety of exercise better? These are questions I’ll be asking my guest, Amanda Bonikowske, Ph.D., an exercise physiologist from the Department of Cardiovascular Diseases at the Mayo Clinic as we discuss “Exercise and the Holidays”.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4xa9t9gzsdaaqj43/WF5115808_Exercise_and_the_Holidays_with_midrolla78eg.mp3" length="36181949" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Amanda R. Bonikowske, Ph.D.
There are many benefits of exercise, from improving our mental health to reducing the risk of chronic disease. It can improve our sleep, increase our energy and can help establish relationships with others. It’s an activity that almost anyone can do, and it doesn’t have to cost a thing, other than an individual’s time. The holiday season will soon be upon us as well as its associated stress and in many cases, weight gain. Can exercise help with some of these problems associated with the holidays? How much exercise is optimal? What kind of exercise should we recommend for those who are unable to participate in vigorous exercise? Does it matter if we do one type of exercise or is a variety of exercise better? These are questions I’ll be asking my guest, Amanda Bonikowske, Ph.D., an exercise physiologist from the Department of Cardiovascular Diseases at the Mayo Clinic as we discuss “Exercise and the Holidays”.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1504</itunes:duration>
                <itunes:episode>549</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Holiday Stress and Wellness Edition: Pharmacologic Management of Depression</title>
        <itunes:title>Holiday Stress and Wellness Edition: Pharmacologic Management of Depression</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/holiday-stress-and-wellness-edition-pharmacologic-management-of-depression/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/holiday-stress-and-wellness-edition-pharmacologic-management-of-depression/#comments</comments>        <pubDate>Tue, 10 Dec 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/2651237d-385c-31b0-97f0-7a884dd83418</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guests: Bruce Sutor, M.D. &amp; Megan R. Leloux, Pharm.D., R.Ph., BCPP</p>
<p>Depression is very common both in the U.S. and worldwide. It’s estimated that major depression affects over 8% of American adults, representing over 20 million individuals. Fortunately, we now have a variety of pharmacologic options for the management of depression and they’re much safer than what we had available in the past. However, we now have so many choices, how do we know which medication is best for our patient? What’s the difference between an SSRI and an SNRI? Is there an anti-depressant that’s also effective in treating anxiety? Are some medications better for our elderly patients? I’ll be asking these questions and more to my guests, psychiatrist Bruce Sutor, M.D., and pharmacist Megan R. Leloux, Pharm.D., R.Ph., BCPP, from the Mayo Clinic as we discuss “Pharmacologic Management of Depression” as part of our “Holiday Stress and Wellness” podcast series.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guests: Bruce Sutor, M.D. &amp; Megan R. Leloux, Pharm.D., R.Ph., BCPP</p>
<p>Depression is very common both in the U.S. and worldwide. It’s estimated that major depression affects over 8% of American adults, representing over 20 million individuals. Fortunately, we now have a variety of pharmacologic options for the management of depression and they’re much safer than what we had available in the past. However, we now have so many choices, how do we know which medication is best for our patient? What’s the difference between an SSRI and an SNRI? Is there an anti-depressant that’s also effective in treating anxiety? Are some medications better for our elderly patients? I’ll be asking these questions and more to my guests, psychiatrist Bruce Sutor, M.D., and pharmacist Megan R. Leloux, Pharm.D., R.Ph., BCPP, from the Mayo Clinic as we discuss “Pharmacologic Management of Depression” as part of our “Holiday Stress and Wellness” podcast series.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/w29imu7byi55g7fi/WF5088815_Pharmacologic_Management_of_Depression_midroll_AF6pfmg.mp3" length="40632009" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guests: Bruce Sutor, M.D. &amp; Megan R. Leloux, Pharm.D., R.Ph., BCPP
Depression is very common both in the U.S. and worldwide. It’s estimated that major depression affects over 8% of American adults, representing over 20 million individuals. Fortunately, we now have a variety of pharmacologic options for the management of depression and they’re much safer than what we had available in the past. However, we now have so many choices, how do we know which medication is best for our patient? What’s the difference between an SSRI and an SNRI? Is there an anti-depressant that’s also effective in treating anxiety? Are some medications better for our elderly patients? I’ll be asking these questions and more to my guests, psychiatrist Bruce Sutor, M.D., and pharmacist Megan R. Leloux, Pharm.D., R.Ph., BCPP, from the Mayo Clinic as we discuss “Pharmacologic Management of Depression” as part of our “Holiday Stress and Wellness” podcast series.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1687</itunes:duration>
                <itunes:episode>548</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Holiday Stress and Wellness Edition: Seasonal Depression</title>
        <itunes:title>Holiday Stress and Wellness Edition: Seasonal Depression</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/holiday-stress-and-wellness-edition-seasonal-depression/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/holiday-stress-and-wellness-edition-seasonal-depression/#comments</comments>        <pubDate>Thu, 05 Dec 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/c554cf9a-5e9a-3f77-992b-347d324bdaf9</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Craig N. Sawchuk, Ph.D., L.P.</p>
<p>It’s relatively common for individuals to feel somewhat sad or have the “winter blues” when the days get shorter and then feel better when we get our daylight back in the spring. However, for some, mood changes can be more serious, and they may be experiencing seasonal affective disorder, a type of depression characterized by recurrent mood changes related to a change in the season. It’s estimated that up to 10 million Americans are affected by this disorder. What’s the natural history of seasonal affective disorder? Is it the same as depression which tends to occur around the holidays? Is seasonal affective disorder related to the time of year or the amount of sunlight and does it ever occur during the summer months? I’ll be asking these questions and more of my guest as we discuss “Seasonal Depression” as part of our “Holiday Stress and Wellness” podcast series. My guest for today’s podcast is psychologist Craig N. Sawchuk, Ph.D., L.P., from the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Craig N. Sawchuk, Ph.D., L.P.</p>
<p>It’s relatively common for individuals to feel somewhat sad or have the “winter blues” when the days get shorter and then feel better when we get our daylight back in the spring. However, for some, mood changes can be more serious, and they may be experiencing seasonal affective disorder, a type of depression characterized by recurrent mood changes related to a change in the season. It’s estimated that up to 10 million Americans are affected by this disorder. What’s the natural history of seasonal affective disorder? Is it the same as depression which tends to occur around the holidays? Is seasonal affective disorder related to the time of year or the amount of sunlight and does it ever occur during the summer months? I’ll be asking these questions and more of my guest as we discuss “Seasonal Depression” as part of our “Holiday Stress and Wellness” podcast series. My guest for today’s podcast is psychologist Craig N. Sawchuk, Ph.D., L.P., from the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4ihfag75tzizgigf/WF5039182_Seasonal_Depression7d8rv.mp3" length="36067091" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Craig N. Sawchuk, Ph.D., L.P.
It’s relatively common for individuals to feel somewhat sad or have the “winter blues” when the days get shorter and then feel better when we get our daylight back in the spring. However, for some, mood changes can be more serious, and they may be experiencing seasonal affective disorder, a type of depression characterized by recurrent mood changes related to a change in the season. It’s estimated that up to 10 million Americans are affected by this disorder. What’s the natural history of seasonal affective disorder? Is it the same as depression which tends to occur around the holidays? Is seasonal affective disorder related to the time of year or the amount of sunlight and does it ever occur during the summer months? I’ll be asking these questions and more of my guest as we discuss “Seasonal Depression” as part of our “Holiday Stress and Wellness” podcast series. My guest for today’s podcast is psychologist Craig N. Sawchuk, Ph.D., L.P., from the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1500</itunes:duration>
                <itunes:episode>547</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Holiday Stress and Wellness Edition: How to Avoid Gaining Weight During the Holidays</title>
        <itunes:title>Holiday Stress and Wellness Edition: How to Avoid Gaining Weight During the Holidays</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/holiday-stress-and-wellness-edition-how-to-avoid-gaining-weight-during-the-holidays/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/holiday-stress-and-wellness-edition-how-to-avoid-gaining-weight-during-the-holidays/#comments</comments>        <pubDate>Tue, 03 Dec 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/b62a4069-9c60-34e4-8a75-6cf94b8bd430</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Tara Schmidt, RDN, LD</p>
<p>It’s not uncommon to gain a pound or two each year as we get older. For many, most of our annual weight gain occurs during the holidays.  It’s a time of celebration and is filled with parties and events, often with high calorie foods and drinks. Holidays can also be stressful, and many find some relief of stress by eating. Weight gain during the holidays occurs so easily and quickly, yet losing this weight can be quite challenging and can take months. In fact, some studies have shown that weight put on during the holidays never comes off. How do we deal with the abundance of food we’re exposed to over the holidays? How should we approach holiday parties? How can we avoid contributing to the problem when we bring food to holiday events? With the holidays approaching, today’s podcast is directed at our own personal health in our “Holiday Stress and Wellness Series” as we discuss “How to Avoid Gaining Weight During the Holidays.” My guest for this podcast is registered dietician and nutritionist Tara Schmidt, RDN, LD, from the Mayo Clinic.</p>
<p>Check out our guest’s podcast, “Mayo Clinic on Nutrition” <a href='https://mcpress.mayoclinic.org/podcasts/on-nutrition/'>Here</a> <a href='https://mcpress.mayoclinic.org/podcasts/on-nutrition/'>https://mcpress.mayoclinic.org/podcasts/on-nutrition/</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Tara Schmidt, RDN, LD</p>
<p>It’s not uncommon to gain a pound or two each year as we get older. For many, most of our annual weight gain occurs during the holidays.  It’s a time of celebration and is filled with parties and events, often with high calorie foods and drinks. Holidays can also be stressful, and many find some relief of stress by eating. Weight gain during the holidays occurs so easily and quickly, yet losing this weight can be quite challenging and can take months. In fact, some studies have shown that weight put on during the holidays never comes off. How do we deal with the abundance of food we’re exposed to over the holidays? How should we approach holiday parties? How can we avoid contributing to the problem when we bring food to holiday events? With the holidays approaching, today’s podcast is directed at our own personal health in our “Holiday Stress and Wellness Series” as we discuss “How to Avoid Gaining Weight During the Holidays.” My guest for this podcast is registered dietician and nutritionist Tara Schmidt, RDN, LD, from the Mayo Clinic.</p>
<p>Check out our guest’s podcast, “Mayo Clinic on Nutrition” <a href='https://mcpress.mayoclinic.org/podcasts/on-nutrition/'>Here</a> <a href='https://mcpress.mayoclinic.org/podcasts/on-nutrition/'>https://mcpress.mayoclinic.org/podcasts/on-nutrition/</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3csx8hpfrtupz6n6/WF5028954_Gaining_Weight_during_the_Holidays868n8.mp3" length="43838138" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Tara Schmidt, RDN, LD
It’s not uncommon to gain a pound or two each year as we get older. For many, most of our annual weight gain occurs during the holidays.  It’s a time of celebration and is filled with parties and events, often with high calorie foods and drinks. Holidays can also be stressful, and many find some relief of stress by eating. Weight gain during the holidays occurs so easily and quickly, yet losing this weight can be quite challenging and can take months. In fact, some studies have shown that weight put on during the holidays never comes off. How do we deal with the abundance of food we’re exposed to over the holidays? How should we approach holiday parties? How can we avoid contributing to the problem when we bring food to holiday events? With the holidays approaching, today’s podcast is directed at our own personal health in our “Holiday Stress and Wellness Series” as we discuss “How to Avoid Gaining Weight During the Holidays.” My guest for this podcast is registered dietician and nutritionist Tara Schmidt, RDN, LD, from the Mayo Clinic.
Check out our guest’s podcast, “Mayo Clinic on Nutrition” Here https://mcpress.mayoclinic.org/podcasts/on-nutrition/
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1826</itunes:duration>
                <itunes:episode>546</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Nicotine Dependence: Update on Vaping</title>
        <itunes:title>Nicotine Dependence: Update on Vaping</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/nicotine-dependence-update-on-vaping/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/nicotine-dependence-update-on-vaping/#comments</comments>        <pubDate>Tue, 26 Nov 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/9a609b1f-c996-3efe-bd03-0235175e4b83</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.  </p>
<p>Guest: Jon O. Ebbert, M.D.</p>
<p>According to the CDC, in 2020 nearly 20% of high school students reported using a vaping product, and nearly a quarter of them indicated they used the product daily. It’s now known that vaping has potential health risks and is just as addictive as combustible tobacco products with some vaping cartridges having a higher concentration of nicotine than cigarettes. In this podcast, we’ll discuss nicotine dependence with an update on vaping. My guest is Jon O. Ebbert, M.D., an internist and nicotine dependence specialist at the Mayo Clinic. I’ll be asking Dr. Ebbert about the health risks of vaping, including second-hand exposure, the likelihood of “vapers” to switch to traditional tobacco products and whether vaping has any potential to help individuals discontinue use of tobacco products.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.  </p>
<p>Guest: Jon O. Ebbert, M.D.</p>
<p>According to the CDC, in 2020 nearly 20% of high school students reported using a vaping product, and nearly a quarter of them indicated they used the product daily. It’s now known that vaping has potential health risks and is just as addictive as combustible tobacco products with some vaping cartridges having a higher concentration of nicotine than cigarettes. In this podcast, we’ll discuss nicotine dependence with an update on vaping. My guest is Jon O. Ebbert, M.D., an internist and nicotine dependence specialist at the Mayo Clinic. I’ll be asking Dr. Ebbert about the health risks of vaping, including second-hand exposure, the likelihood of “vapers” to switch to traditional tobacco products and whether vaping has any potential to help individuals discontinue use of tobacco products.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/k73k4vegqge8pc35/24R02130_545_Ebbert_Vaping_Updates_AF8dvv1.mp3" length="32279411" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.  
Guest: Jon O. Ebbert, M.D.
According to the CDC, in 2020 nearly 20% of high school students reported using a vaping product, and nearly a quarter of them indicated they used the product daily. It’s now known that vaping has potential health risks and is just as addictive as combustible tobacco products with some vaping cartridges having a higher concentration of nicotine than cigarettes. In this podcast, we’ll discuss nicotine dependence with an update on vaping. My guest is Jon O. Ebbert, M.D., an internist and nicotine dependence specialist at the Mayo Clinic. I’ll be asking Dr. Ebbert about the health risks of vaping, including second-hand exposure, the likelihood of “vapers” to switch to traditional tobacco products and whether vaping has any potential to help individuals discontinue use of tobacco products.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1342</itunes:duration>
                <itunes:episode>545</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Inflammation and Cardiometabolic Disease: Chronic Kidney Disease as a Systemic Inflammatory Syndrome</title>
        <itunes:title>Inflammation and Cardiometabolic Disease: Chronic Kidney Disease as a Systemic Inflammatory Syndrome</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/inflammation-and-cardiometabolic-disease-chronic-kidney-disease-as-a-systemic-inflammatory-syndrome/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/inflammation-and-cardiometabolic-disease-chronic-kidney-disease-as-a-systemic-inflammatory-syndrome/#comments</comments>        <pubDate>Thu, 21 Nov 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/e2346118-1d84-38cf-8f9d-6cfedc478cb5</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.  </p>
<p>Guest: Aleksandra Kukla, M.D.</p>
<p>In 2023, an estimated 14% of all adults in the U.S. or just over 35 million individuals had chronic kidney disease and it’s even more common in the elderly population affecting over 1/3 of those over the age of 65. It represents the 8th leading cause of death in the U.S. It’s now known that chronic kidney disease is associated with systemic inflammation, which is responsible for a variety of complications including atherosclerosis and subsequent cardiovascular disease. Does kidney disease result in inflammation or does inflammation produce renal dysfunction? Are there inflammatory markers we could measure to assess this inflammation? Can we do anything to reduce the inflammation and if so, does it improve patient outcome? These are just some of the questions I’ll be asking my guest, Aleksandra Kukla, M.D., from the Division of Nephrology at the Mayo Clinic as we discuss “Chronic Kidney Disease as a Systemic Inflammatory Syndrome”.</p>
<p>These talks on Inflammation and Cardiometabolic Disease are sponsored by <a href='https://www.novonordisk.com/'>Novo Nordisk</a></p>
<p>Learn more about this series <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-inflammation-and-cardiometabolic-disease'>HERE</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.  </p>
<p>Guest: Aleksandra Kukla, M.D.</p>
<p>In 2023, an estimated 14% of all adults in the U.S. or just over 35 million individuals had chronic kidney disease and it’s even more common in the elderly population affecting over 1/3 of those over the age of 65. It represents the 8th leading cause of death in the U.S. It’s now known that chronic kidney disease is associated with systemic inflammation, which is responsible for a variety of complications including atherosclerosis and subsequent cardiovascular disease. Does kidney disease result in inflammation or does inflammation produce renal dysfunction? Are there inflammatory markers we could measure to assess this inflammation? Can we do anything to reduce the inflammation and if so, does it improve patient outcome? These are just some of the questions I’ll be asking my guest, Aleksandra Kukla, M.D., from the Division of Nephrology at the Mayo Clinic as we discuss “Chronic Kidney Disease as a Systemic Inflammatory Syndrome”.</p>
<p>These talks on Inflammation and Cardiometabolic Disease are sponsored by <a href='https://www.novonordisk.com/'>Novo Nordisk</a></p>
<p>Learn more about this series <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-inflammation-and-cardiometabolic-disease'>HERE</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/usfzus68zeqwhxas/24R02286_544_Kukla_Renal_Awareness-Inflammation_AFbkbsg.mp3" length="26713148" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.  
Guest: Aleksandra Kukla, M.D.
In 2023, an estimated 14% of all adults in the U.S. or just over 35 million individuals had chronic kidney disease and it’s even more common in the elderly population affecting over 1/3 of those over the age of 65. It represents the 8th leading cause of death in the U.S. It’s now known that chronic kidney disease is associated with systemic inflammation, which is responsible for a variety of complications including atherosclerosis and subsequent cardiovascular disease. Does kidney disease result in inflammation or does inflammation produce renal dysfunction? Are there inflammatory markers we could measure to assess this inflammation? Can we do anything to reduce the inflammation and if so, does it improve patient outcome? These are just some of the questions I’ll be asking my guest, Aleksandra Kukla, M.D., from the Division of Nephrology at the Mayo Clinic as we discuss “Chronic Kidney Disease as a Systemic Inflammatory Syndrome”.
These talks on Inflammation and Cardiometabolic Disease are sponsored by Novo Nordisk
Learn more about this series HERE
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1109</itunes:duration>
                <itunes:episode>544</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Inflammation and Cardiometabolic Disease Edition: Obesity - The Linking Pathology</title>
        <itunes:title>Inflammation and Cardiometabolic Disease Edition: Obesity - The Linking Pathology</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/inflammation-and-cardiometabolic-disease-edition-obesity-the-linking-pathology/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/inflammation-and-cardiometabolic-disease-edition-obesity-the-linking-pathology/#comments</comments>        <pubDate>Tue, 19 Nov 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/20eee3ef-8bd8-329f-b53b-f154caadc1b4</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Maria L. Collazo-Clavell, M.D.</p>
<p>Its common knowledge that those who are obese are at greater risk for developing metabolic syndrome, diabetes and cardiovascular disease. However, the reason for this association has not always been clear. It does appear that systemic inflammation plays a major role and obesity triggers this inflammation. But what specifically initiates the inflammation? How can we measure it? Most importantly, can we reduce or eliminate this inflammation and prevent the progression to these cardiometabolic states? My guest for this podcast is Maria L. Collazo-Clavell, M.D., from the Division of Endocrinology and Metabolism at the Mayo Clinic and we’ll discuss “Inflammation and Cardiometabolic Disease: Obesity- The Linking Pathology”.</p>
<p>These talks on Inflammation and Cardiometabolic Disease are sponsored by <a href='https://www.novonordisk.com/'>Novo Nordisk</a></p>
<p>Learn more about this series <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-inflammation-and-cardiometabolic-disease'>HERE</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.</p>
<p>Guest: Maria L. Collazo-Clavell, M.D.</p>
<p>Its common knowledge that those who are obese are at greater risk for developing metabolic syndrome, diabetes and cardiovascular disease. However, the reason for this association has not always been clear. It does appear that systemic inflammation plays a major role and obesity triggers this inflammation. But what specifically initiates the inflammation? How can we measure it? Most importantly, can we reduce or eliminate this inflammation and prevent the progression to these cardiometabolic states? My guest for this podcast is Maria L. Collazo-Clavell, M.D., from the Division of Endocrinology and Metabolism at the Mayo Clinic and we’ll discuss “Inflammation and Cardiometabolic Disease: Obesity- The Linking Pathology”.</p>
<p>These talks on Inflammation and Cardiometabolic Disease are sponsored by <a href='https://www.novonordisk.com/'>Novo Nordisk</a></p>
<p>Learn more about this series <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-inflammation-and-cardiometabolic-disease'>HERE</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qncmhhfnyuxs9xr9/24R02286_Collazo_Obesity_The_Linking_Pathology_AF_mp385kh3.mp3" length="39570803" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.
Guest: Maria L. Collazo-Clavell, M.D.
Its common knowledge that those who are obese are at greater risk for developing metabolic syndrome, diabetes and cardiovascular disease. However, the reason for this association has not always been clear. It does appear that systemic inflammation plays a major role and obesity triggers this inflammation. But what specifically initiates the inflammation? How can we measure it? Most importantly, can we reduce or eliminate this inflammation and prevent the progression to these cardiometabolic states? My guest for this podcast is Maria L. Collazo-Clavell, M.D., from the Division of Endocrinology and Metabolism at the Mayo Clinic and we’ll discuss “Inflammation and Cardiometabolic Disease: Obesity- The Linking Pathology”.
These talks on Inflammation and Cardiometabolic Disease are sponsored by Novo Nordisk
Learn more about this series HERE
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1645</itunes:duration>
                <itunes:episode>543</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Inflammation and Cardiometabolic Disease Edition: Hepatic Inflammation and Metabolic Dysfunction-Associated Steatohepatitis (MASH)</title>
        <itunes:title>Inflammation and Cardiometabolic Disease Edition: Hepatic Inflammation and Metabolic Dysfunction-Associated Steatohepatitis (MASH)</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/inflammation-and-cardiometabolic-disease-edition-hepatic-inflammation-and-metabolic-dysfunction-associated-steatohepatitis-mash/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/inflammation-and-cardiometabolic-disease-edition-hepatic-inflammation-and-metabolic-dysfunction-associated-steatohepatitis-mash/#comments</comments>        <pubDate>Thu, 14 Nov 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/5cef153c-af3d-35d2-98c6-a536e580b691</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Alina M. Allen, M.D., M.S.</p>
<p>Fat deposits in the liver are quite common and many individuals have no idea they have the condition. A minority of those individuals will develop an associated hepatic inflammation. It’s not entirely clear why some progress to this state, although there are some known risk factors. Steatohepatitis is a potentially serious health problem and can lead to end-stage liver disease. It’s also associated with cardiovascular disease and all of its complications. The topic for today’s podcast is Hepatic Inflammation and Metabolic Dysfunction-Associated Steatohepatitis. My guest is Alina M. Allen, M.D., M.S., from the Division of Gastroenterology and Hepatology at the Mayo Clinic. What are the risk factors for this health problem? Should we be screening patients for its presence and how should it be managed. These are just some of the topics we’ll discuss in this podcast.</p>
<p>These talks on Inflammation and Cardiometabolic Disease are sponsored by <a href='https://www.novonordisk.com/'>Novo Nordisk</a></p>
<p>Learn more about this series <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-inflammation-and-cardiometabolic-disease'>HERE</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Alina M. Allen, M.D., M.S.</p>
<p>Fat deposits in the liver are quite common and many individuals have no idea they have the condition. A minority of those individuals will develop an associated hepatic inflammation. It’s not entirely clear why some progress to this state, although there are some known risk factors. Steatohepatitis is a potentially serious health problem and can lead to end-stage liver disease. It’s also associated with cardiovascular disease and all of its complications. The topic for today’s podcast is Hepatic Inflammation and Metabolic Dysfunction-Associated Steatohepatitis. My guest is Alina M. Allen, M.D., M.S., from the Division of Gastroenterology and Hepatology at the Mayo Clinic. What are the risk factors for this health problem? Should we be screening patients for its presence and how should it be managed. These are just some of the topics we’ll discuss in this podcast.</p>
<p>These talks on Inflammation and Cardiometabolic Disease are sponsored by <a href='https://www.novonordisk.com/'>Novo Nordisk</a></p>
<p>Learn more about this series <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-inflammation-and-cardiometabolic-disease'>HERE</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dttrdwb3ka2jfkcj/WF5122458_MASH.mp3" length="43445850" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Alina M. Allen, M.D., M.S.
Fat deposits in the liver are quite common and many individuals have no idea they have the condition. A minority of those individuals will develop an associated hepatic inflammation. It’s not entirely clear why some progress to this state, although there are some known risk factors. Steatohepatitis is a potentially serious health problem and can lead to end-stage liver disease. It’s also associated with cardiovascular disease and all of its complications. The topic for today’s podcast is Hepatic Inflammation and Metabolic Dysfunction-Associated Steatohepatitis. My guest is Alina M. Allen, M.D., M.S., from the Division of Gastroenterology and Hepatology at the Mayo Clinic. What are the risk factors for this health problem? Should we be screening patients for its presence and how should it be managed. These are just some of the topics we’ll discuss in this podcast.
These talks on Inflammation and Cardiometabolic Disease are sponsored by Novo Nordisk
Learn more about this series HERE
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1806</itunes:duration>
                <itunes:episode>542</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Inflammation and Cardiometabolic Disease Edition: hs-CRP and Cardiovascular Disease</title>
        <itunes:title>Inflammation and Cardiometabolic Disease Edition: hs-CRP and Cardiovascular Disease</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/inflammation-and-cardiometabolic-disease-edition-hs-crp-and-cardiovascular-disease/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/inflammation-and-cardiometabolic-disease-edition-hs-crp-and-cardiovascular-disease/#comments</comments>        <pubDate>Tue, 12 Nov 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/248c23c0-33f4-3855-b3d4-a9bd04e8c44f</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Regis I. Fernandes, M.D.</p>
<p>Inflammation commonly occurs as a response to injury or infection but can lead to damage when it develops in healthy tissue. It’s now known that inflammation plays a key role in the development of cardiovascular disease. It produces damage to the endovascular arterial cells allowing plaque to form within the artery leading to stenosis, thereby reducing coronary blood flow. What initiates the inflammatory response as it develops in otherwise healthy arteries? How should we use the hs-CRP in measuring inflammation in cardiovascular disease? Does our management of cardiovascular disease result in a decrease in hs-CRP? These are some of the questions I’ll be asking my guest, Regis I. Fernandes, M.D., a preventive cardiologist from the Mayo Clinic as we discuss “hs-CRP and Cardiovascular Disease”.</p>
<p>These talks on Inflammation and Cardiometabolic Disease are sponsored by <a href='https://www.novonordisk.com/'>Novo Nordisk</a></p>
<p>Learn more about this series <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-inflammation-and-cardiometabolic-disease'>HERE</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Regis I. Fernandes, M.D.</p>
<p>Inflammation commonly occurs as a response to injury or infection but can lead to damage when it develops in healthy tissue. It’s now known that inflammation plays a key role in the development of cardiovascular disease. It produces damage to the endovascular arterial cells allowing plaque to form within the artery leading to stenosis, thereby reducing coronary blood flow. What initiates the inflammatory response as it develops in otherwise healthy arteries? How should we use the hs-CRP in measuring inflammation in cardiovascular disease? Does our management of cardiovascular disease result in a decrease in hs-CRP? These are some of the questions I’ll be asking my guest, Regis I. Fernandes, M.D., a preventive cardiologist from the Mayo Clinic as we discuss “hs-CRP and Cardiovascular Disease”.</p>
<p>These talks on Inflammation and Cardiometabolic Disease are sponsored by <a href='https://www.novonordisk.com/'>Novo Nordisk</a></p>
<p>Learn more about this series <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-inflammation-and-cardiometabolic-disease'>HERE</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/i62jz42cc2ibguse/WF5116017_CRP_and_CV_Disease9olgs.mp3" length="33856334" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Regis I. Fernandes, M.D.
Inflammation commonly occurs as a response to injury or infection but can lead to damage when it develops in healthy tissue. It’s now known that inflammation plays a key role in the development of cardiovascular disease. It produces damage to the endovascular arterial cells allowing plaque to form within the artery leading to stenosis, thereby reducing coronary blood flow. What initiates the inflammatory response as it develops in otherwise healthy arteries? How should we use the hs-CRP in measuring inflammation in cardiovascular disease? Does our management of cardiovascular disease result in a decrease in hs-CRP? These are some of the questions I’ll be asking my guest, Regis I. Fernandes, M.D., a preventive cardiologist from the Mayo Clinic as we discuss “hs-CRP and Cardiovascular Disease”.
These talks on Inflammation and Cardiometabolic Disease are sponsored by Novo Nordisk
Learn more about this series HERE
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1406</itunes:duration>
                <itunes:episode>541</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Inflammation and Cardiometabolic Disease Edition: Type 2 Diabetes as an Inflammatory Disease</title>
        <itunes:title>Inflammation and Cardiometabolic Disease Edition: Type 2 Diabetes as an Inflammatory Disease</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/inflammation-and-cardiometabolic-disease-edition-type-2-diabetes-as-an-inflammatory-disease/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/inflammation-and-cardiometabolic-disease-edition-type-2-diabetes-as-an-inflammatory-disease/#comments</comments>        <pubDate>Thu, 07 Nov 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/9321598e-1087-3c72-98fe-b06ca48b6721</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Vinaya Simha, M.B.B.S., M.D.</p>
<p>Type 2 Diabetes is a commonly seen condition in a general medical practice. It’s estimated that over 38 million adults have the disease. When we think of diabetes, we think of a metabolic condition with patients who have hyperglycemia, often overweight, and occasionally have renal, eye and/or neurologic complications. But, do we ever think of diabetes as an inflammatory disease? How is inflammation associated with diabetes? What are the mediators of inflammation in diabetics and when we treat diabetes, are we reducing the associated inflammation in addition to lowering blood glucose? These are questions I’ll be asking our guest, Vinaya Simha, M.B.B.S., M.D., from the Division of Endocrinology and Metabolic Disease at the Mayo Clinic as we discuss “Type 2 Diabetes as an Inflammatory Disease”.</p>
<p>These talks on Inflammation and Cardiometabolic Disease are sponsored by <a href='https://www.novonordisk.com/'>Novo Nordisk</a></p>
<p>Learn more about this series <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-inflammation-and-cardiometabolic-disease'>HERE</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Vinaya Simha, M.B.B.S., M.D.</p>
<p>Type 2 Diabetes is a commonly seen condition in a general medical practice. It’s estimated that over 38 million adults have the disease. When we think of diabetes, we think of a metabolic condition with patients who have hyperglycemia, often overweight, and occasionally have renal, eye and/or neurologic complications. But, do we ever think of diabetes as an inflammatory disease? How is inflammation associated with diabetes? What are the mediators of inflammation in diabetics and when we treat diabetes, are we reducing the associated inflammation in addition to lowering blood glucose? These are questions I’ll be asking our guest, Vinaya Simha, M.B.B.S., M.D., from the Division of Endocrinology and Metabolic Disease at the Mayo Clinic as we discuss “Type 2 Diabetes as an Inflammatory Disease”.</p>
<p>These talks on Inflammation and Cardiometabolic Disease are sponsored by <a href='https://www.novonordisk.com/'>Novo Nordisk</a></p>
<p>Learn more about this series <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-inflammation-and-cardiometabolic-disease'>HERE</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fqsvjtnj46gymedj/WF5000557_Diabetes_and_Inflammation_adbpgxt.mp3" length="46077369" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Vinaya Simha, M.B.B.S., M.D.
Type 2 Diabetes is a commonly seen condition in a general medical practice. It’s estimated that over 38 million adults have the disease. When we think of diabetes, we think of a metabolic condition with patients who have hyperglycemia, often overweight, and occasionally have renal, eye and/or neurologic complications. But, do we ever think of diabetes as an inflammatory disease? How is inflammation associated with diabetes? What are the mediators of inflammation in diabetics and when we treat diabetes, are we reducing the associated inflammation in addition to lowering blood glucose? These are questions I’ll be asking our guest, Vinaya Simha, M.B.B.S., M.D., from the Division of Endocrinology and Metabolic Disease at the Mayo Clinic as we discuss “Type 2 Diabetes as an Inflammatory Disease”.
These talks on Inflammation and Cardiometabolic Disease are sponsored by Novo Nordisk
Learn more about this series HERE
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1917</itunes:duration>
                <itunes:episode>540</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Inflammation and Cardiometabolic Disease Edition: Interplay Between Cholesterol, Inflammation and Thrombosis</title>
        <itunes:title>Inflammation and Cardiometabolic Disease Edition: Interplay Between Cholesterol, Inflammation and Thrombosis</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/inflammation-and-cardiometabolic-disease-edition-interplay-between-cholesterol-inflammation-and-thrombosis/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/inflammation-and-cardiometabolic-disease-edition-interplay-between-cholesterol-inflammation-and-thrombosis/#comments</comments>        <pubDate>Tue, 05 Nov 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/a8c997d8-df03-326b-acfb-1c9e4ab9b6d4</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Atul Jain, M.D., M.S.</p>
<p>Cardiovascular disease is the leading cause of death for both men and women and it’s responsible for 1 in every 5 deaths. It’s estimated to cost over $250 billion a year, which includes the cost of medical services, medications and lost productivity. Patients with cardiovascular disease are commonly seen in a general medical practice and since it’s such a common health problem, we’re all pretty comfortable managing these patients. But do we know what’s happening pathologically? What’s the role of cholesterol and inflammation in cardiovascular disease?  What causes the inflammation? How do we measure it and most importantly, can we do anything about it? I’ll be asking these questions of our guest, internist Atul Jain, M.D., M.S., from the Division of General Internal Medicine at the Mayo Clinic as we discuss the interplay between cholesterol, inflammation and thrombosis in cardiovascular disease.</p>
<p>These talks on Inflammation and Cardiometabolic Disease are sponsored by <a href='https://www.novonordisk.com/'>Novo Nordisk</a></p>
<p>Learn more about this series <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-inflammation-and-cardiometabolic-disease'>HERE</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Atul Jain, M.D., M.S.</p>
<p>Cardiovascular disease is the leading cause of death for both men and women and it’s responsible for 1 in every 5 deaths. It’s estimated to cost over $250 billion a year, which includes the cost of medical services, medications and lost productivity. Patients with cardiovascular disease are commonly seen in a general medical practice and since it’s such a common health problem, we’re all pretty comfortable managing these patients. But do we know what’s happening pathologically? What’s the role of cholesterol and inflammation in cardiovascular disease?  What causes the inflammation? How do we measure it and most importantly, can we do anything about it? I’ll be asking these questions of our guest, internist Atul Jain, M.D., M.S., from the Division of General Internal Medicine at the Mayo Clinic as we discuss the interplay between cholesterol, inflammation and thrombosis in cardiovascular disease.</p>
<p>These talks on Inflammation and Cardiometabolic Disease are sponsored by <a href='https://www.novonordisk.com/'>Novo Nordisk</a></p>
<p>Learn more about this series <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-inflammation-and-cardiometabolic-disease'>HERE</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mzkfd79xgdky2c53/WF5023910_Cholesterol_Inflammation_and_Thrombosis_ad_AF7eqyw.mp3" length="33438157" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Atul Jain, M.D., M.S.
Cardiovascular disease is the leading cause of death for both men and women and it’s responsible for 1 in every 5 deaths. It’s estimated to cost over $250 billion a year, which includes the cost of medical services, medications and lost productivity. Patients with cardiovascular disease are commonly seen in a general medical practice and since it’s such a common health problem, we’re all pretty comfortable managing these patients. But do we know what’s happening pathologically? What’s the role of cholesterol and inflammation in cardiovascular disease?  What causes the inflammation? How do we measure it and most importantly, can we do anything about it? I’ll be asking these questions of our guest, internist Atul Jain, M.D., M.S., from the Division of General Internal Medicine at the Mayo Clinic as we discuss the interplay between cholesterol, inflammation and thrombosis in cardiovascular disease.
These talks on Inflammation and Cardiometabolic Disease are sponsored by Novo Nordisk
Learn more about this series HERE
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1392</itunes:duration>
                <itunes:episode>539</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Back to School Edition | Pediatric Mental Health Disorders</title>
        <itunes:title>Back to School Edition | Pediatric Mental Health Disorders</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/back-to-school-edition-pediatric-mental-health-disorders/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/back-to-school-edition-pediatric-mental-health-disorders/#comments</comments>        <pubDate>Thu, 31 Oct 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/c6e47b2e-99fb-38bd-a94a-a1099cdc6be6</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Joselyn R. Lebow, Ph.D., L.P.</p>
<p>Unfortunately, mental health problems are common in our youth. A recent study by the CDC found that among adolescents aged 12 to 17, just under 21% had experienced a major depressive episode within the past year. Among high school students, more than 35% reported feeling sad or hopeless, with nearly 20% seriously contemplating suicide and mental health disorders are not limited to our teens. Over 17% of children aged 2 through 8 have had a diagnosis of a mental, behavioral or developmental disorder. Are mental health disorders in our youth increasing? How might depression present in a child or adolescent? How common is suicide in our youth and how often are suicide attempts successful? I’ll be asking these questions and more to my guest in today’s podcast on “Pediatric Mental Health Disorders” as part of our “Back to School” podcast series. My guest is child psychologist Joselyn R. Lebow, Ph.D., L.P., from the Mayo Clinic.</p>
<p>To learn more about this series, check it out <a href='https://ce.mayo.edu/content/mayo-clinic-talks-back-school-series'>HERE</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Joselyn R. Lebow, Ph.D., L.P.</p>
<p>Unfortunately, mental health problems are common in our youth. A recent study by the CDC found that among adolescents aged 12 to 17, just under 21% had experienced a major depressive episode within the past year. Among high school students, more than 35% reported feeling sad or hopeless, with nearly 20% seriously contemplating suicide and mental health disorders are not limited to our teens. Over 17% of children aged 2 through 8 have had a diagnosis of a mental, behavioral or developmental disorder. Are mental health disorders in our youth increasing? How might depression present in a child or adolescent? How common is suicide in our youth and how often are suicide attempts successful? I’ll be asking these questions and more to my guest in today’s podcast on “Pediatric Mental Health Disorders” as part of our “Back to School” podcast series. My guest is child psychologist Joselyn R. Lebow, Ph.D., L.P., from the Mayo Clinic.</p>
<p>To learn more about this series, check it out <a href='https://ce.mayo.edu/content/mayo-clinic-talks-back-school-series'>HERE</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/93pubnm8nk385is5/WF5034142_Pediatric_Mental_Health_AFbvoj7.mp3" length="28708518" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Joselyn R. Lebow, Ph.D., L.P.
Unfortunately, mental health problems are common in our youth. A recent study by the CDC found that among adolescents aged 12 to 17, just under 21% had experienced a major depressive episode within the past year. Among high school students, more than 35% reported feeling sad or hopeless, with nearly 20% seriously contemplating suicide and mental health disorders are not limited to our teens. Over 17% of children aged 2 through 8 have had a diagnosis of a mental, behavioral or developmental disorder. Are mental health disorders in our youth increasing? How might depression present in a child or adolescent? How common is suicide in our youth and how often are suicide attempts successful? I’ll be asking these questions and more to my guest in today’s podcast on “Pediatric Mental Health Disorders” as part of our “Back to School” podcast series. My guest is child psychologist Joselyn R. Lebow, Ph.D., L.P., from the Mayo Clinic.
To learn more about this series, check it out HERE
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1193</itunes:duration>
                <itunes:episode>538</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Back to School Edition | Pediatric and Adolescent Ophthalmologic Concerns</title>
        <itunes:title>Back to School Edition | Pediatric and Adolescent Ophthalmologic Concerns</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/back-to-school-edition-pediatric-and-adolescent-ophthalmologic-concerns/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/back-to-school-edition-pediatric-and-adolescent-ophthalmologic-concerns/#comments</comments>        <pubDate>Tue, 29 Oct 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/e4ffc46a-2654-36b8-98ed-98b72082394a</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Erick D. Bothun, M.D.</p>
<p>It’s estimated that more than 1 in 20 preschool-age children and 1 in 4 school-age children have a vision disorder. Since the eyes are the source of sensory input for much of the learning that takes place in our children, these statistics take on real importance. Vision problems in childhood can result in developmental delays and are often misdiagnosed as learning disabilities. As adults, we’re aware of changes and problems with our vision. Children who have never known clear vision may not realize their vision is impaired. What are the most common eye disorders in children? How many of our pre-school children are receiving vision screening? What are common signs a child may have a vision impairment? These are just some of the questions I’ll asking my guest, Erick D. Bothun, M.D., from the Department of Ophthalmology at the Mayo Clinic. As part of our “Back to School” Series, we’ll be discussing “Pediatric and Adolescent Ophthalmologic Concerns”.</p>
<p>To learn more about this series, check it out <a href='https://ce.mayo.edu/content/mayo-clinic-talks-back-school-series'>HERE</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Erick D. Bothun, M.D.</p>
<p>It’s estimated that more than 1 in 20 preschool-age children and 1 in 4 school-age children have a vision disorder. Since the eyes are the source of sensory input for much of the learning that takes place in our children, these statistics take on real importance. Vision problems in childhood can result in developmental delays and are often misdiagnosed as learning disabilities. As adults, we’re aware of changes and problems with our vision. Children who have never known clear vision may not realize their vision is impaired. What are the most common eye disorders in children? How many of our pre-school children are receiving vision screening? What are common signs a child may have a vision impairment? These are just some of the questions I’ll asking my guest, Erick D. Bothun, M.D., from the Department of Ophthalmology at the Mayo Clinic. As part of our “Back to School” Series, we’ll be discussing “Pediatric and Adolescent Ophthalmologic Concerns”.</p>
<p>To learn more about this series, check it out <a href='https://ce.mayo.edu/content/mayo-clinic-talks-back-school-series'>HERE</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hh3h2hatusge4wti/WF5077108_Pediatric_and_Adolescent_Ophthalmology_Concerns_AF6g7fi.mp3" length="42988835" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Erick D. Bothun, M.D.
It’s estimated that more than 1 in 20 preschool-age children and 1 in 4 school-age children have a vision disorder. Since the eyes are the source of sensory input for much of the learning that takes place in our children, these statistics take on real importance. Vision problems in childhood can result in developmental delays and are often misdiagnosed as learning disabilities. As adults, we’re aware of changes and problems with our vision. Children who have never known clear vision may not realize their vision is impaired. What are the most common eye disorders in children? How many of our pre-school children are receiving vision screening? What are common signs a child may have a vision impairment? These are just some of the questions I’ll asking my guest, Erick D. Bothun, M.D., from the Department of Ophthalmology at the Mayo Clinic. As part of our “Back to School” Series, we’ll be discussing “Pediatric and Adolescent Ophthalmologic Concerns”.
To learn more about this series, check it out HERE
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1789</itunes:duration>
                <itunes:episode>537</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Back to School Edition | Pediatric and Adolescent Sleep Medicine</title>
        <itunes:title>Back to School Edition | Pediatric and Adolescent Sleep Medicine</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/back-to-school-edition-pediatric-and-adolescent-sleep-medicine/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/back-to-school-edition-pediatric-and-adolescent-sleep-medicine/#comments</comments>        <pubDate>Thu, 24 Oct 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/bc947a07-2604-3199-b6b5-12a493a88607</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Julie M. Baughn, M.D.</p>
<p>Sleep is very important for a child’s physical and mental health and plays a vital role in the development of cognitive and motor skills.  The American Academy of Pediatrics estimates that up to 50% of children and 40% of adolescents have problems with their sleep, which may manifest as issues in school, mood disorders as well as relationship problems with others. What kind of sleep problems do children and adolescents commonly experience? When should we suspect impaired sleep is causing problems and do children and adolescents have some of the same sleep disorders as adults? I’ll be asking these questions and more as we explore “Pediatric and Adolescent Sleep Medicine” as part of our “Back to School” series of podcasts. My guest is Julie M. Baughn, M.D., a pulmonologist and sleep specialist at the Mayo Clinic.</p>
<p>To learn more about this series, check it out <a href='https://ce.mayo.edu/content/mayo-clinic-talks-back-school-series'>HERE</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Julie M. Baughn, M.D.</p>
<p>Sleep is very important for a child’s physical and mental health and plays a vital role in the development of cognitive and motor skills.  The American Academy of Pediatrics estimates that up to 50% of children and 40% of adolescents have problems with their sleep, which may manifest as issues in school, mood disorders as well as relationship problems with others. What kind of sleep problems do children and adolescents commonly experience? When should we suspect impaired sleep is causing problems and do children and adolescents have some of the same sleep disorders as adults? I’ll be asking these questions and more as we explore “Pediatric and Adolescent Sleep Medicine” as part of our “Back to School” series of podcasts. My guest is Julie M. Baughn, M.D., a pulmonologist and sleep specialist at the Mayo Clinic.</p>
<p>To learn more about this series, check it out <a href='https://ce.mayo.edu/content/mayo-clinic-talks-back-school-series'>HERE</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qdb7css6cfqe3sci/WF4841200_Pediatric_and_Adolescent_Sleep_Medicine_AF9usx2.mp3" length="26520155" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Julie M. Baughn, M.D.
Sleep is very important for a child’s physical and mental health and plays a vital role in the development of cognitive and motor skills.  The American Academy of Pediatrics estimates that up to 50% of children and 40% of adolescents have problems with their sleep, which may manifest as issues in school, mood disorders as well as relationship problems with others. What kind of sleep problems do children and adolescents commonly experience? When should we suspect impaired sleep is causing problems and do children and adolescents have some of the same sleep disorders as adults? I’ll be asking these questions and more as we explore “Pediatric and Adolescent Sleep Medicine” as part of our “Back to School” series of podcasts. My guest is Julie M. Baughn, M.D., a pulmonologist and sleep specialist at the Mayo Clinic.
To learn more about this series, check it out HERE
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1101</itunes:duration>
                <itunes:episode>536</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Diverticular Disease</title>
        <itunes:title>Diverticular Disease</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/diverticular-disease/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/diverticular-disease/#comments</comments>        <pubDate>Tue, 22 Oct 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/c4cd22fe-c34b-3742-b18c-a625ea1490d8</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>[@chutkaMD]</a></p>
<p>Guests: Sahil Khanna, M.B.B.S., M.S., and Sherief Shawki, M.B., B.Ch., M.D.</p>
<p>Diverticulosis is quite common. Its prevalence varies with age from fewer than 20% at age 40 to 60% by age 60. It's far more common in the left colon and tends to be progressive with both the number and size of the diverticula, both increasing with age. There are potential complications of diverticulosis, with diverticulitis being most common. This also tends to increase in prevalence with age and appears to be increasing with time. Can diverticulitis be prevented? What’s the best way to manage a patient with acute diverticulitis and when is surgery indicated? I’ll be asking these questions and more to my guests, Sahil Khanna, M.B.B.S., M.S., from the Division of Gastroenterology and Hepatology and Sherief Shawki, M.B., B.Ch., M.D., from the Division of Colorectal Surgery at the Mayo Clinic. The topic for this podcast is diverticular disease.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>[@chutkaMD]</a></p>
<p>Guests: Sahil Khanna, M.B.B.S., M.S., and Sherief Shawki, M.B., B.Ch., M.D.</p>
<p>Diverticulosis is quite common. Its prevalence varies with age from fewer than 20% at age 40 to 60% by age 60. It's far more common in the left colon and tends to be progressive with both the number and size of the diverticula, both increasing with age. There are potential complications of diverticulosis, with diverticulitis being most common. This also tends to increase in prevalence with age and appears to be increasing with time. Can diverticulitis be prevented? What’s the best way to manage a patient with acute diverticulitis and when is surgery indicated? I’ll be asking these questions and more to my guests, Sahil Khanna, M.B.B.S., M.S., from the Division of Gastroenterology and Hepatology and Sherief Shawki, M.B., B.Ch., M.D., from the Division of Colorectal Surgery at the Mayo Clinic. The topic for this podcast is diverticular disease.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/k9x95nwu8pmnhfmw/WF3736252_Diverticular_Disease_Course_Ad_V3_AF89ayh.mp3" length="46360656" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guests: Sahil Khanna, M.B.B.S., M.S., and Sherief Shawki, M.B., B.Ch., M.D.
Diverticulosis is quite common. Its prevalence varies with age from fewer than 20% at age 40 to 60% by age 60. It's far more common in the left colon and tends to be progressive with both the number and size of the diverticula, both increasing with age. There are potential complications of diverticulosis, with diverticulitis being most common. This also tends to increase in prevalence with age and appears to be increasing with time. Can diverticulitis be prevented? What’s the best way to manage a patient with acute diverticulitis and when is surgery indicated? I’ll be asking these questions and more to my guests, Sahil Khanna, M.B.B.S., M.S., from the Division of Gastroenterology and Hepatology and Sherief Shawki, M.B., B.Ch., M.D., from the Division of Colorectal Surgery at the Mayo Clinic. The topic for this podcast is diverticular disease.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1929</itunes:duration>
                <itunes:episode>535</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Back to School Edition | Pediatric and Adolescent Sports Injuries</title>
        <itunes:title>Back to School Edition | Pediatric and Adolescent Sports Injuries</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/back-to-school-edition-pediatric-and-adolescent-sports-injuries/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/back-to-school-edition-pediatric-and-adolescent-sports-injuries/#comments</comments>        <pubDate>Thu, 17 Oct 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/b50f9d6e-5e36-32e4-a7f7-b1626fb49aee</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: David B. Soma, M.D.</p>
<p>Participation in sports in children and adolescents is extremely common and its popularity is increasing. Although sports play an important role in promoting health and developing interpersonal relationships, its estimated that injuries related to playing sports is quite common, especially musculoskeletal injuries. The literature describes prevalence rates ranging from 34 to 65%. This leads to lost school days and significant health care costs. Which sports carry the greatest risk of injury? Are there any differences in injuries in girls vs. boys? Can sports injuries be prevented and are the benefits of participation in sports worth the risk of serious injury? We’ll discuss these issues and more as part of our “Back to School” podcast series. The topic for this podcast is “Pediatric and Adolescent Sports Injuries” and my guest is David B. Soma, M.D., from the Department of Pediatric and Adolescent Medicine at the Mayo Clinic.</p>
<p>To learn more about this series, check it out <a href='https://ce.mayo.edu/content/mayo-clinic-talks-back-school-series'>HERE</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: David B. Soma, M.D.</p>
<p>Participation in sports in children and adolescents is extremely common and its popularity is increasing. Although sports play an important role in promoting health and developing interpersonal relationships, its estimated that injuries related to playing sports is quite common, especially musculoskeletal injuries. The literature describes prevalence rates ranging from 34 to 65%. This leads to lost school days and significant health care costs. Which sports carry the greatest risk of injury? Are there any differences in injuries in girls vs. boys? Can sports injuries be prevented and are the benefits of participation in sports worth the risk of serious injury? We’ll discuss these issues and more as part of our “Back to School” podcast series. The topic for this podcast is “Pediatric and Adolescent Sports Injuries” and my guest is David B. Soma, M.D., from the Department of Pediatric and Adolescent Medicine at the Mayo Clinic.</p>
<p>To learn more about this series, check it out <a href='https://ce.mayo.edu/content/mayo-clinic-talks-back-school-series'>HERE</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ecar65mvggyurnem/24R02279_534_Soma_Sports_Injuries_and_Concussions_AF6i8w2.mp3" length="32756006" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: David B. Soma, M.D.
Participation in sports in children and adolescents is extremely common and its popularity is increasing. Although sports play an important role in promoting health and developing interpersonal relationships, its estimated that injuries related to playing sports is quite common, especially musculoskeletal injuries. The literature describes prevalence rates ranging from 34 to 65%. This leads to lost school days and significant health care costs. Which sports carry the greatest risk of injury? Are there any differences in injuries in girls vs. boys? Can sports injuries be prevented and are the benefits of participation in sports worth the risk of serious injury? We’ll discuss these issues and more as part of our “Back to School” podcast series. The topic for this podcast is “Pediatric and Adolescent Sports Injuries” and my guest is David B. Soma, M.D., from the Department of Pediatric and Adolescent Medicine at the Mayo Clinic.
To learn more about this series, check it out HERE
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1361</itunes:duration>
                <itunes:episode>534</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Back to School Edition | Pediatric and Adolescent Diet &amp; Nutrition</title>
        <itunes:title>Back to School Edition | Pediatric and Adolescent Diet &amp; Nutrition</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/back-to-school-edition-pediatric-and-adolescent-diet-nutrition/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/back-to-school-edition-pediatric-and-adolescent-diet-nutrition/#comments</comments>        <pubDate>Thu, 10 Oct 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/3808dcfa-d4da-31fb-a300-c16abe40f975</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Angela C. Mattke, M.D.</p>
<p>Providing good nutrition and developing healthy eating habits is extremely important for our children. It sets a pattern and can impact their health throughout their adult life. However, this goal has many challenges. Parents must battle effective media marketing for unhealthy foods, deal with ever available and convenient fast-food options and struggle with time constraints in their busy families. How healthy are the diets of our children? How can parents manage their own busy schedules and still prepare healthy meals and what’s our role as health care clinicians in promoting healthy nutrition in our children. This podcast in our “Back to School” series will focus on these questions as we discuss “Pediatric and Adolescent Diet and Nutrition”. My guest is Angela C. Mattke, M.D., a pediatrician from the Division of Community Pediatrics and Adolescent Medicine at the Mayo Clinic.</p>
<p>To learn more about this series, check it out <a href='https://ce.mayo.edu/content/mayo-clinic-talks-back-school-series'>HERE</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Angela C. Mattke, M.D.</p>
<p>Providing good nutrition and developing healthy eating habits is extremely important for our children. It sets a pattern and can impact their health throughout their adult life. However, this goal has many challenges. Parents must battle effective media marketing for unhealthy foods, deal with ever available and convenient fast-food options and struggle with time constraints in their busy families. How healthy are the diets of our children? How can parents manage their own busy schedules and still prepare healthy meals and what’s our role as health care clinicians in promoting healthy nutrition in our children. This podcast in our “Back to School” series will focus on these questions as we discuss “Pediatric and Adolescent Diet and Nutrition”. My guest is Angela C. Mattke, M.D., a pediatrician from the Division of Community Pediatrics and Adolescent Medicine at the Mayo Clinic.</p>
<p>To learn more about this series, check it out <a href='https://ce.mayo.edu/content/mayo-clinic-talks-back-school-series'>HERE</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7zxiwxxmnjwivdcs/WF4909936_Pediatric_and_Adolescent_Diet_Nutrition801ii.mp3" length="38602032" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Angela C. Mattke, M.D.
Providing good nutrition and developing healthy eating habits is extremely important for our children. It sets a pattern and can impact their health throughout their adult life. However, this goal has many challenges. Parents must battle effective media marketing for unhealthy foods, deal with ever available and convenient fast-food options and struggle with time constraints in their busy families. How healthy are the diets of our children? How can parents manage their own busy schedules and still prepare healthy meals and what’s our role as health care clinicians in promoting healthy nutrition in our children. This podcast in our “Back to School” series will focus on these questions as we discuss “Pediatric and Adolescent Diet and Nutrition”. My guest is Angela C. Mattke, M.D., a pediatrician from the Division of Community Pediatrics and Adolescent Medicine at the Mayo Clinic.
To learn more about this series, check it out HERE
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1604</itunes:duration>
                <itunes:episode>532</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Back to School Edition | Immunization Update</title>
        <itunes:title>Back to School Edition | Immunization Update</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/back-to-school-edition-immunization-update/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/back-to-school-edition-immunization-update/#comments</comments>        <pubDate>Tue, 08 Oct 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/64880e38-73c6-3885-befa-0c61466bece9</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Robert M. Jacobson, M.D.</p>
<p>Pencils, books and lots of dreams is what many children will experience as they head back to school. It’s a time filled with a variety of emotions: excitement and anticipation over what the next 9 months will bring. For some, it’s a time of sadness as summer comes to an end. It’s also a time to review and update immunizations. What’s recommended for school and what’s required? What are the common reasons parents refuse immunizations for their children and how do we address the many myths people have about immunizations? I’ll be getting the answers to these questions in today’s podcast from our guest, Bob M. Jacobson, M.D., from the Division of Community Pediatrics and Adolescents at Mayo Clinic.</p>
<p>To learn more about this series, check it out <a href='https://ce.mayo.edu/content/mayo-clinic-talks-back-school-series'>HERE</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Robert M. Jacobson, M.D.</p>
<p>Pencils, books and lots of dreams is what many children will experience as they head back to school. It’s a time filled with a variety of emotions: excitement and anticipation over what the next 9 months will bring. For some, it’s a time of sadness as summer comes to an end. It’s also a time to review and update immunizations. What’s recommended for school and what’s required? What are the common reasons parents refuse immunizations for their children and how do we address the many myths people have about immunizations? I’ll be getting the answers to these questions in today’s podcast from our guest, Bob M. Jacobson, M.D., from the Division of Community Pediatrics and Adolescents at Mayo Clinic.</p>
<p>To learn more about this series, check it out <a href='https://ce.mayo.edu/content/mayo-clinic-talks-back-school-series'>HERE</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jfiqyxcjzyrwmjjn/WF4852105_Pediatric_and_Adolescent_Immunizations_AF9bwkq.mp3" length="43100883" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Robert M. Jacobson, M.D.
Pencils, books and lots of dreams is what many children will experience as they head back to school. It’s a time filled with a variety of emotions: excitement and anticipation over what the next 9 months will bring. For some, it’s a time of sadness as summer comes to an end. It’s also a time to review and update immunizations. What’s recommended for school and what’s required? What are the common reasons parents refuse immunizations for their children and how do we address the many myths people have about immunizations? I’ll be getting the answers to these questions in today’s podcast from our guest, Bob M. Jacobson, M.D., from the Division of Community Pediatrics and Adolescents at Mayo Clinic.
To learn more about this series, check it out HERE
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1792</itunes:duration>
                <itunes:episode>531</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Conversations in OB/GYN: Infectious Diseases in Pregnancy: Part Two</title>
        <itunes:title>Conversations in OB/GYN: Infectious Diseases in Pregnancy: Part Two</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/conversations-in-obgyn-infectious-diseases-in-pregnancy-part-two/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/conversations-in-obgyn-infectious-diseases-in-pregnancy-part-two/#comments</comments>        <pubDate>Thu, 03 Oct 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/688e99d6-ab82-3bbe-a510-3d4cddc2416b</guid>
                                    <description><![CDATA[<p>Hosts: <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fwww.mayoclinichealthsystem.org.mcas.ms%2Fproviders%2Fchatura-alur-md-mph%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Chatura Alur, M.D., M.P.H.</a> | <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fcommunityhealth.mayoclinic.org.mcas.ms%2Fproviders%2Fmeghan-theofiles-md%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Meghan G. Theofiles, M.D.</a> </p>
<p>Guest: <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fquarterly.mayo.edu.mcas.ms%2Fdirectory%2Fperson%2Fperson.htm%3Fper_id%3D20764154%26displaymode%3D%26McasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Regan N. Theiler, M.D., Ph.D.</a> </p>
<p>Welcome to our OB/GYN mini-series! “Help me OB/GYN! You’re my only hope”.  </p>
<p>Today, we are going to be discussing inpatient management of infections in pregnant patients. Specifically, infections that might show up on a general medicine service or in the emergency department. To help us understand how to better assess and manage these patients, we are joined by Regan N. Theiler, M.D., Ph.D., obstetrical hospitalist and immediate past-chair of the Division of Obstetrics and Gynecology at Mayo Clinic in Rochester.  </p>
<p>To learn more about this series, click <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2Fcontent%2Fmayo-clinic-talks-conversations-obgyn%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>here</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Hosts: <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fwww.mayoclinichealthsystem.org.mcas.ms%2Fproviders%2Fchatura-alur-md-mph%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Chatura Alur, M.D., M.P.H.</a> | <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fcommunityhealth.mayoclinic.org.mcas.ms%2Fproviders%2Fmeghan-theofiles-md%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Meghan G. Theofiles, M.D.</a> </p>
<p>Guest: <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fquarterly.mayo.edu.mcas.ms%2Fdirectory%2Fperson%2Fperson.htm%3Fper_id%3D20764154%26displaymode%3D%26McasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Regan N. Theiler, M.D., Ph.D.</a> </p>
<p>Welcome to our OB/GYN mini-series! “Help me OB/GYN! You’re my only hope”.  </p>
<p>Today, we are going to be discussing inpatient management of infections in pregnant patients. Specifically, infections that might show up on a general medicine service or in the emergency department. To help us understand how to better assess and manage these patients, we are joined by Regan N. Theiler, M.D., Ph.D., obstetrical hospitalist and immediate past-chair of the Division of Obstetrics and Gynecology at Mayo Clinic in Rochester.  </p>
<p>To learn more about this series, click <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2Fcontent%2Fmayo-clinic-talks-conversations-obgyn%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>here</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/j35c3pzw64duc5gv/WF4561051_Infectious_Disease_Part_2_V2_AF6rl1b.mp3" length="46297001" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Hosts: Chatura Alur, M.D., M.P.H. | Meghan G. Theofiles, M.D. 
Guest: Regan N. Theiler, M.D., Ph.D. 
Welcome to our OB/GYN mini-series! “Help me OB/GYN! You’re my only hope”.  
Today, we are going to be discussing inpatient management of infections in pregnant patients. Specifically, infections that might show up on a general medicine service or in the emergency department. To help us understand how to better assess and manage these patients, we are joined by Regan N. Theiler, M.D., Ph.D., obstetrical hospitalist and immediate past-chair of the Division of Obstetrics and Gynecology at Mayo Clinic in Rochester.  
To learn more about this series, click here 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1925</itunes:duration>
                <itunes:episode>528</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Lifting the Veil on Female Sexual Dysfunction</title>
        <itunes:title>Lifting the Veil on Female Sexual Dysfunction</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/lifting-the-veil-on-female-sexual-dysfunction/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/lifting-the-veil-on-female-sexual-dysfunction/#comments</comments>        <pubDate>Tue, 01 Oct 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/07c8c3a7-c687-30bc-ba6f-071fa2d1c697</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Richa Sood, M.D., M.S.</p>
<p>Concerns and problems related to sexual health in women are common and can be very distressing. They can occur at any stage of life and can lead to issues with self-image and potential problems in establishing and maintaining relationships with a partner. To complicate things, this problem is often not mentioned by the patient when they are seen by their health care provider. The issues are often complex and can involve physiology, emotions, lifestyle as well as several other factors. In this podcast, we’ll discuss female sexual concerns and dysfunction. What are common sexual problems patients experience? How do we evaluate the patient’s concerns? How are the problems managed and most importantly, how do we encourage our patients to let us know when they are having problems related to their sexual health. My guest is Richa Sood, M.D., M.S., an internist and specialist in women’s health at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Richa Sood, M.D., M.S.</p>
<p>Concerns and problems related to sexual health in women are common and can be very distressing. They can occur at any stage of life and can lead to issues with self-image and potential problems in establishing and maintaining relationships with a partner. To complicate things, this problem is often not mentioned by the patient when they are seen by their health care provider. The issues are often complex and can involve physiology, emotions, lifestyle as well as several other factors. In this podcast, we’ll discuss female sexual concerns and dysfunction. What are common sexual problems patients experience? How do we evaluate the patient’s concerns? How are the problems managed and most importantly, how do we encourage our patients to let us know when they are having problems related to their sexual health. My guest is Richa Sood, M.D., M.S., an internist and specialist in women’s health at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cvrcu2ninjhq5g6f/WF3682152_Female_Sexual_Dysfunction9ub0n.mp3" length="39188414" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Richa Sood, M.D., M.S.
Concerns and problems related to sexual health in women are common and can be very distressing. They can occur at any stage of life and can lead to issues with self-image and potential problems in establishing and maintaining relationships with a partner. To complicate things, this problem is often not mentioned by the patient when they are seen by their health care provider. The issues are often complex and can involve physiology, emotions, lifestyle as well as several other factors. In this podcast, we’ll discuss female sexual concerns and dysfunction. What are common sexual problems patients experience? How do we evaluate the patient’s concerns? How are the problems managed and most importantly, how do we encourage our patients to let us know when they are having problems related to their sexual health. My guest is Richa Sood, M.D., M.S., an internist and specialist in women’s health at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1621</itunes:duration>
                <itunes:episode>529</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Conversations in OB/GYN Edition | Infectious Diseases in Pregnancy: Part One</title>
        <itunes:title>Conversations in OB/GYN Edition | Infectious Diseases in Pregnancy: Part One</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/conversations-in-obgyn-edition-infectious-diseases-in-pregnancy-part-one/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/conversations-in-obgyn-edition-infectious-diseases-in-pregnancy-part-one/#comments</comments>        <pubDate>Thu, 26 Sep 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/fc7362af-1a8e-353c-897d-6ff2d8c0750a</guid>
                                    <description><![CDATA[<p>Hosts: <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fwww.mayoclinichealthsystem.org.mcas.ms%2Fproviders%2Fchatura-alur-md-mph%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Chatura Alur, M.D., M.P.H.</a> | <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fcommunityhealth.mayoclinic.org.mcas.ms%2Fproviders%2Fmeghan-theofiles-md%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Meghan G. Theofiles, M.D.</a> </p>
<p>Guest: <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fquarterly.mayo.edu.mcas.ms%2Fdirectory%2Fperson%2Fperson.htm%3Fper_id%3D20764154%26displaymode%3D%26McasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Regan N. Theiler, M.D., Ph.D.</a> </p>
<p>Welcome to our OB/GYN mini-series! “Help me OB/GYN! You’re my only hope”. </p>
<p>Today, we’ll be discussing common infections during pregnancy. We are joined by Regan N. Theiler, M.D., Ph.D., obstetrical hospitalist and immediate past-chair of the Division of Obstetrics and Gynecology at Mayo Clinic in Rochester. Not only does she serve on the National Clinical Committee for the American College of Obstetrics and Gynecology, but she has also earned a Ph.D. in microbiology and immunology. </p>
<p>To learn more about this series, click <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2Fcontent%2Fmayo-clinic-talks-conversations-obgyn%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>here</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Hosts: <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fwww.mayoclinichealthsystem.org.mcas.ms%2Fproviders%2Fchatura-alur-md-mph%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Chatura Alur, M.D., M.P.H.</a> | <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fcommunityhealth.mayoclinic.org.mcas.ms%2Fproviders%2Fmeghan-theofiles-md%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Meghan G. Theofiles, M.D.</a> </p>
<p>Guest: <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fquarterly.mayo.edu.mcas.ms%2Fdirectory%2Fperson%2Fperson.htm%3Fper_id%3D20764154%26displaymode%3D%26McasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Regan N. Theiler, M.D., Ph.D.</a> </p>
<p>Welcome to our OB/GYN mini-series! “Help me OB/GYN! You’re my only hope”. </p>
<p>Today, we’ll be discussing common infections during pregnancy. We are joined by Regan N. Theiler, M.D., Ph.D., obstetrical hospitalist and immediate past-chair of the Division of Obstetrics and Gynecology at Mayo Clinic in Rochester. Not only does she serve on the National Clinical Committee for the American College of Obstetrics and Gynecology, but she has also earned a Ph.D. in microbiology and immunology. </p>
<p>To learn more about this series, click <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2Fcontent%2Fmayo-clinic-talks-conversations-obgyn%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>here</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ep8n3i373yidjxfw/WF4561050_Infectious_Disease_Part_1_AF8xer0.mp3" length="52743004" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Hosts: Chatura Alur, M.D., M.P.H. | Meghan G. Theofiles, M.D. 
Guest: Regan N. Theiler, M.D., Ph.D. 
Welcome to our OB/GYN mini-series! “Help me OB/GYN! You’re my only hope”. 
Today, we’ll be discussing common infections during pregnancy. We are joined by Regan N. Theiler, M.D., Ph.D., obstetrical hospitalist and immediate past-chair of the Division of Obstetrics and Gynecology at Mayo Clinic in Rochester. Not only does she serve on the National Clinical Committee for the American College of Obstetrics and Gynecology, but she has also earned a Ph.D. in microbiology and immunology. 
To learn more about this series, click here 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2193</itunes:duration>
                <itunes:episode>526</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Testicular Tissue Cryopreservation</title>
        <itunes:title>Testicular Tissue Cryopreservation</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/testicular-tissue-cryopreservation/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/testicular-tissue-cryopreservation/#comments</comments>        <pubDate>Tue, 24 Sep 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/8424e5d3-349e-3916-9486-cfdc2527b188</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>[@chutkaMD]</a></p>
<p>Guest: Candace F. Granberg, M.D.</p>
<p>Developments in cancer treatment have resulted in significant improvements in the survival of malignancy in young children. Unfortunately, these treatments often result in infertility. If these children are pre-pubertal, preservation of mature sperm is not possible. But there is now a procedure which may result in the preservation of fertility by removing testicular tissue, subjecting it to cryopreservation to preserve stem cells capable of producing viable sperm in the future. This procedure is known as testicular tissue cryopreservation and I’ll be discussing it with our guest, Candace F. Granberg, M.D., a urologist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>[@chutkaMD]</a></p>
<p>Guest: Candace F. Granberg, M.D.</p>
<p>Developments in cancer treatment have resulted in significant improvements in the survival of malignancy in young children. Unfortunately, these treatments often result in infertility. If these children are pre-pubertal, preservation of mature sperm is not possible. But there is now a procedure which may result in the preservation of fertility by removing testicular tissue, subjecting it to cryopreservation to preserve stem cells capable of producing viable sperm in the future. This procedure is known as testicular tissue cryopreservation and I’ll be discussing it with our guest, Candace F. Granberg, M.D., a urologist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3qb36fsfgfk8q7cd/WF3703673_Testicular_Tissue_Cryopreservation_V2ammi7.mp3" length="33612175" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Candace F. Granberg, M.D.
Developments in cancer treatment have resulted in significant improvements in the survival of malignancy in young children. Unfortunately, these treatments often result in infertility. If these children are pre-pubertal, preservation of mature sperm is not possible. But there is now a procedure which may result in the preservation of fertility by removing testicular tissue, subjecting it to cryopreservation to preserve stem cells capable of producing viable sperm in the future. This procedure is known as testicular tissue cryopreservation and I’ll be discussing it with our guest, Candace F. Granberg, M.D., a urologist at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1396</itunes:duration>
                <itunes:episode>530</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Conversations in OB/GYN Edition | Unexpected Pregnancy</title>
        <itunes:title>Conversations in OB/GYN Edition | Unexpected Pregnancy</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/conversations-in-obgyn-edition-unexpected-pregnancy/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/conversations-in-obgyn-edition-unexpected-pregnancy/#comments</comments>        <pubDate>Thu, 19 Sep 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/53ff60c0-0961-362f-9536-b00eecdae7a1</guid>
                                    <description><![CDATA[<p>Hosts: <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fwww.mayoclinichealthsystem.org.mcas.ms%2Fproviders%2Fchatura-alur-md-mph%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Chatura Alur, M.D., M.P.H.</a> | <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fcommunityhealth.mayoclinic.org.mcas.ms%2Fproviders%2Fmeghan-theofiles-md%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Meghan G. Theofiles, M.D.</a> </p>
<p>Guest: <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fquarterly.mayo.edu.mcas.ms%2Fdirectory%2Fperson%2Fperson.htm%3Fper_id%3D15104109%26search_criteria_display%3D%2527wygant%2527%2B%26McasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Jenna N. Wygant, APRN, C.N.P., D.N.P.</a> </p>
<p>Welcome to our OB/GYN mini-series! “Help me OB/GYN! You’re my only hope”. </p>
<p>Sometimes we encounter unexpected pregnancies as healthcare professionals and clinicians. To help us “skill-up” for those conversations, we have Jenna N. Wygant, APRN, C.N.P., D.N.P. She is an advanced practitioner and assistant professor of Obstetrics and Gynecology at Mayo Clinic in Rochester.  </p>
<p>To learn more about this series, click <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2Fcontent%2Fmayo-clinic-talks-conversations-obgyn%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>here</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Hosts: <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fwww.mayoclinichealthsystem.org.mcas.ms%2Fproviders%2Fchatura-alur-md-mph%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Chatura Alur, M.D., M.P.H.</a> | <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fcommunityhealth.mayoclinic.org.mcas.ms%2Fproviders%2Fmeghan-theofiles-md%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Meghan G. Theofiles, M.D.</a> </p>
<p>Guest: <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fquarterly.mayo.edu.mcas.ms%2Fdirectory%2Fperson%2Fperson.htm%3Fper_id%3D15104109%26search_criteria_display%3D%2527wygant%2527%2B%26McasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Jenna N. Wygant, APRN, C.N.P., D.N.P.</a> </p>
<p>Welcome to our OB/GYN mini-series! “Help me OB/GYN! You’re my only hope”. </p>
<p>Sometimes we encounter unexpected pregnancies as healthcare professionals and clinicians. To help us “skill-up” for those conversations, we have Jenna N. Wygant, APRN, C.N.P., D.N.P. She is an advanced practitioner and assistant professor of Obstetrics and Gynecology at Mayo Clinic in Rochester.  </p>
<p>To learn more about this series, click <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2Fcontent%2Fmayo-clinic-talks-conversations-obgyn%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>here</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wpbnmwus3y8djhra/WF4232631_Unexpected_Pregnancy_AFb0868.mp3" length="42569445" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Hosts: Chatura Alur, M.D., M.P.H. | Meghan G. Theofiles, M.D. 
Guest: Jenna N. Wygant, APRN, C.N.P., D.N.P. 
Welcome to our OB/GYN mini-series! “Help me OB/GYN! You’re my only hope”. 
Sometimes we encounter unexpected pregnancies as healthcare professionals and clinicians. To help us “skill-up” for those conversations, we have Jenna N. Wygant, APRN, C.N.P., D.N.P. She is an advanced practitioner and assistant professor of Obstetrics and Gynecology at Mayo Clinic in Rochester.  
To learn more about this series, click here 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1759</itunes:duration>
                <itunes:episode>525</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Conversations in OB/GYN Edition | Hyperemesis</title>
        <itunes:title>Conversations in OB/GYN Edition | Hyperemesis</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/conversations-in-obgyn-edition-hyperemesis/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/conversations-in-obgyn-edition-hyperemesis/#comments</comments>        <pubDate>Thu, 12 Sep 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/1702709f-9b6e-32ba-afc4-f38e21453c9b</guid>
                                    <description><![CDATA[<p>Hosts: <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fwww.mayoclinichealthsystem.org.mcas.ms%2Fproviders%2Fchatura-alur-md-mph%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Chatura Alur, M.D., M.P.H.</a> | <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fcommunityhealth.mayoclinic.org.mcas.ms%2Fproviders%2Fmeghan-theofiles-md%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Meghan G. Theofiles, M.D.</a> </p>
<p>Guest: <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fquarterly.mayo.edu.mcas.ms%2Fdirectory%2Fperson%2Fperson.htm%3Fper_id%3D12594628%26displaymode%3D%26McasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Margaret E. Long, M.D.</a> </p>
<p>Welcome to our OB/GYN mini-series! “Help me OB/GYN! You’re my only hope”. </p>
<p>Today, we’re going to be talking about nausea and vomiting in pregnancy. We definitely see this in the healthcare setting, outside of the specialty office; and sometimes I wonder, do I know the latest and greatest information about this and how do we best manage these patients. To help us with this, we have Margaret E. Long, M.D. She’s an obstetrician and gynecologist researcher and award-winning educator and one of our faculty members here at the Mayo Clinic. </p>
<p>To learn more about this series, click <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2Fcontent%2Fmayo-clinic-talks-conversations-obgyn%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>here</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Hosts: <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fwww.mayoclinichealthsystem.org.mcas.ms%2Fproviders%2Fchatura-alur-md-mph%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Chatura Alur, M.D., M.P.H.</a> | <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fcommunityhealth.mayoclinic.org.mcas.ms%2Fproviders%2Fmeghan-theofiles-md%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Meghan G. Theofiles, M.D.</a> </p>
<p>Guest: <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fquarterly.mayo.edu.mcas.ms%2Fdirectory%2Fperson%2Fperson.htm%3Fper_id%3D12594628%26displaymode%3D%26McasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Margaret E. Long, M.D.</a> </p>
<p>Welcome to our OB/GYN mini-series! “Help me OB/GYN! You’re my only hope”. </p>
<p>Today, we’re going to be talking about nausea and vomiting in pregnancy. We definitely see this in the healthcare setting, outside of the specialty office; and sometimes I wonder, do I know the latest and greatest information about this and how do we best manage these patients. To help us with this, we have Margaret E. Long, M.D. She’s an obstetrician and gynecologist researcher and award-winning educator and one of our faculty members here at the Mayo Clinic. </p>
<p>To learn more about this series, click <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2Fcontent%2Fmayo-clinic-talks-conversations-obgyn%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>here</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/92xky5hrfpufc2fv/WF4251902_Hyperemesis_AF7r69y.mp3" length="31388314" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Hosts: Chatura Alur, M.D., M.P.H. | Meghan G. Theofiles, M.D. 
Guest: Margaret E. Long, M.D. 
Welcome to our OB/GYN mini-series! “Help me OB/GYN! You’re my only hope”. 
Today, we’re going to be talking about nausea and vomiting in pregnancy. We definitely see this in the healthcare setting, outside of the specialty office; and sometimes I wonder, do I know the latest and greatest information about this and how do we best manage these patients. To help us with this, we have Margaret E. Long, M.D. She’s an obstetrician and gynecologist researcher and award-winning educator and one of our faculty members here at the Mayo Clinic. 
To learn more about this series, click here 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1302</itunes:duration>
                <itunes:episode>524</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Venous Thrombosis (DVT)</title>
        <itunes:title>Venous Thrombosis (DVT)</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/venous-thrombosis-dvt/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/venous-thrombosis-dvt/#comments</comments>        <pubDate>Tue, 10 Sep 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/bc381871-8f5f-30f0-8282-9b331087b45b</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Ana I. Casanegra, M.D., M.S.</p>
<p>Venous thrombosis is an under diagnosed and potentially serious health condition, yet in many cases its preventable and certainly treatable when found.  Its most serious potential complication is embolization, most commonly to the lung. As a medical condition, venous thrombosis has been known for many years. In fact, the triad of contributing factors to venous thrombosis including venous stasis, vascular injury and hypercoagulability were discovered in the mid-1800’s. Despite the long duration we’ve been diagnosing and treating the health problem, there’s still much we need to learn about it. The topic for today’s podcast is venous thrombosis and we’ll discuss its risk factors, how to diagnose a DVT and the best management recommendations. My guest will be Ana I. Casanegra, M.D., M.S., a vascular medicine specialist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Ana I. Casanegra, M.D., M.S.</p>
<p>Venous thrombosis is an under diagnosed and potentially serious health condition, yet in many cases its preventable and certainly treatable when found.  Its most serious potential complication is embolization, most commonly to the lung. As a medical condition, venous thrombosis has been known for many years. In fact, the triad of contributing factors to venous thrombosis including venous stasis, vascular injury and hypercoagulability were discovered in the mid-1800’s. Despite the long duration we’ve been diagnosing and treating the health problem, there’s still much we need to learn about it. The topic for today’s podcast is venous thrombosis and we’ll discuss its risk factors, how to diagnose a DVT and the best management recommendations. My guest will be Ana I. Casanegra, M.D., M.S., a vascular medicine specialist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/i6yhcd9rzty9qf8z/WF3683767_Venous_Thrombosis_AF6m45f.mp3" length="39696618" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Ana I. Casanegra, M.D., M.S.
Venous thrombosis is an under diagnosed and potentially serious health condition, yet in many cases its preventable and certainly treatable when found.  Its most serious potential complication is embolization, most commonly to the lung. As a medical condition, venous thrombosis has been known for many years. In fact, the triad of contributing factors to venous thrombosis including venous stasis, vascular injury and hypercoagulability were discovered in the mid-1800’s. Despite the long duration we’ve been diagnosing and treating the health problem, there’s still much we need to learn about it. The topic for today’s podcast is venous thrombosis and we’ll discuss its risk factors, how to diagnose a DVT and the best management recommendations. My guest will be Ana I. Casanegra, M.D., M.S., a vascular medicine specialist at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1650</itunes:duration>
                <itunes:episode>523</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Conversations in OB/GYN Edition | Loss Management</title>
        <itunes:title>Conversations in OB/GYN Edition | Loss Management</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/conversations-in-obgyn-edition-loss-management/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/conversations-in-obgyn-edition-loss-management/#comments</comments>        <pubDate>Thu, 05 Sep 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/6a198c87-ae0e-378a-b187-478d46bc5c97</guid>
                                    <description><![CDATA[<p>Hosts: <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fwww.mayoclinichealthsystem.org.mcas.ms%2Fproviders%2Fchatura-alur-md-mph%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Chatura Alur, M.D., M.P.H.</a> | <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fcommunityhealth.mayoclinic.org.mcas.ms%2Fproviders%2Fmeghan-theofiles-md%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Meghan G. Theofiles, M.D.</a> </p>
<p>Guest: J<a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fmcpress.mayoclinic.org.mcas.ms%2Fauthors%2Fjulie-lamppa%2F%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>ulie A. Lamppa, APRN, CNM</a> </p>
<p>Welcome to our OB/GYN mini-series! “Help me OB/GYN! You’re my only hope”. </p>
<p>Today, we’re back with Julie A. Lamppa, APRN, CNM, director of our midwifery services at Mayo Clinic Rochester and director of the Early Pregnancy Care Clinic at Mayo Clinic in Rochester. For this episode, we will be continuing our conversation about first trimester bleeding but going more towards how it relates to pregnancy loss. </p>
<p>To learn more about this series, click <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2Fcontent%2Fmayo-clinic-talks-conversations-obgyn%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>here</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Hosts: <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fwww.mayoclinichealthsystem.org.mcas.ms%2Fproviders%2Fchatura-alur-md-mph%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Chatura Alur, M.D., M.P.H.</a> | <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fcommunityhealth.mayoclinic.org.mcas.ms%2Fproviders%2Fmeghan-theofiles-md%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Meghan G. Theofiles, M.D.</a> </p>
<p>Guest: J<a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fmcpress.mayoclinic.org.mcas.ms%2Fauthors%2Fjulie-lamppa%2F%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>ulie A. Lamppa, APRN, CNM</a> </p>
<p>Welcome to our OB/GYN mini-series! “Help me OB/GYN! You’re my only hope”. </p>
<p>Today, we’re back with Julie A. Lamppa, APRN, CNM, director of our midwifery services at Mayo Clinic Rochester and director of the Early Pregnancy Care Clinic at Mayo Clinic in Rochester. For this episode, we will be continuing our conversation about first trimester bleeding but going more towards how it relates to pregnancy loss. </p>
<p>To learn more about this series, click <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2Fcontent%2Fmayo-clinic-talks-conversations-obgyn%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>here</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zjbv6a6kus5w2x3n/WF4228314_Loss_Management_AF806yo.mp3" length="56446439" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Hosts: Chatura Alur, M.D., M.P.H. | Meghan G. Theofiles, M.D. 
Guest: Julie A. Lamppa, APRN, CNM 
Welcome to our OB/GYN mini-series! “Help me OB/GYN! You’re my only hope”. 
Today, we’re back with Julie A. Lamppa, APRN, CNM, director of our midwifery services at Mayo Clinic Rochester and director of the Early Pregnancy Care Clinic at Mayo Clinic in Rochester. For this episode, we will be continuing our conversation about first trimester bleeding but going more towards how it relates to pregnancy loss. 
To learn more about this series, click here 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2339</itunes:duration>
                <itunes:episode>522</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Conversations in OB/GYN Edition | First Trimester Bleeding</title>
        <itunes:title>Conversations in OB/GYN Edition | First Trimester Bleeding</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/conversations-in-obgyn-edition-first-trimester-bleeding/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/conversations-in-obgyn-edition-first-trimester-bleeding/#comments</comments>        <pubDate>Tue, 03 Sep 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/b6174714-4139-3953-955f-0549dbfa75a0</guid>
                                    <description><![CDATA[<p>Hosts: <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fwww.mayoclinichealthsystem.org.mcas.ms%2Fproviders%2Fchatura-alur-md-mph%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Chatura Alur, M.D., M.P.H.</a> | <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fcommunityhealth.mayoclinic.org.mcas.ms%2Fproviders%2Fmeghan-theofiles-md%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Meghan G. Theofiles, M.D.</a> </p>
<p>Guest: <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fmcpress.mayoclinic.org.mcas.ms%2Fauthors%2Fjulie-lamppa%2F%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Julie A. Lamppa, APRN, CNM</a> </p>
<p>Welcome to our OB/GYN mini-series! “Help me OB/GYN! You’re my only hope”. </p>
<p>This podcast edition is specifically designed for the non-OB/GYN frontline provider.  </p>
<p>Today, we’re going to be addressing first trimester bleeding and we are joined by our content expert, Julie A. Lamppa, APRN, CNM. She is the director of our midwifery services at Mayo Clinic Rochester and the director of the Early Pregnancy Care Clinic at Mayo Clinic in Rochester. </p>
<p>To learn more about this series, click <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2Fcontent%2Fmayo-clinic-talks-conversations-obgyn%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>here</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Hosts: <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fwww.mayoclinichealthsystem.org.mcas.ms%2Fproviders%2Fchatura-alur-md-mph%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Chatura Alur, M.D., M.P.H.</a> | <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fcommunityhealth.mayoclinic.org.mcas.ms%2Fproviders%2Fmeghan-theofiles-md%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Meghan G. Theofiles, M.D.</a> </p>
<p>Guest: <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fmcpress.mayoclinic.org.mcas.ms%2Fauthors%2Fjulie-lamppa%2F%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>Julie A. Lamppa, APRN, CNM</a> </p>
<p>Welcome to our OB/GYN mini-series! “Help me OB/GYN! You’re my only hope”. </p>
<p>This podcast edition is specifically designed for the non-OB/GYN frontline provider.  </p>
<p>Today, we’re going to be addressing first trimester bleeding and we are joined by our content expert, Julie A. Lamppa, APRN, CNM. She is the director of our midwifery services at Mayo Clinic Rochester and the director of the Early Pregnancy Care Clinic at Mayo Clinic in Rochester. </p>
<p>To learn more about this series, click <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2Fcontent%2Fmayo-clinic-talks-conversations-obgyn%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>here</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D15600&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/atvaihqhs4enj68p/WF4228312_First_Trimester_Bleeding_AF_mp362o2x.mp3" length="58802314" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Hosts: Chatura Alur, M.D., M.P.H. | Meghan G. Theofiles, M.D. 
Guest: Julie A. Lamppa, APRN, CNM 
Welcome to our OB/GYN mini-series! “Help me OB/GYN! You’re my only hope”. 
This podcast edition is specifically designed for the non-OB/GYN frontline provider.  
Today, we’re going to be addressing first trimester bleeding and we are joined by our content expert, Julie A. Lamppa, APRN, CNM. She is the director of our midwifery services at Mayo Clinic Rochester and the director of the Early Pregnancy Care Clinic at Mayo Clinic in Rochester. 
To learn more about this series, click here 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2437</itunes:duration>
                <itunes:episode>521</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Working Effectively with Patients with Obsessive Compulsive Disorder (OCD)</title>
        <itunes:title>Working Effectively with Patients with Obsessive Compulsive Disorder (OCD)</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/working-effectively-with-patients-with-obsessive-compulsive-disorder-ocd/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/working-effectively-with-patients-with-obsessive-compulsive-disorder-ocd/#comments</comments>        <pubDate>Tue, 27 Aug 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/d6278398-ce86-33a1-b150-9a5c9fc67f12</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Craig N. Sawchuk, Ph.D., L.P.</p>
<p>It’s estimated that 1 in 40 adults have obsessive compulsive disorder. Obsessions are repetitive, unwanted thoughts that are very difficult to control. They commonly cause distress and anxiety and are often focused on a specific theme such as germs and contamination. Compulsions are repetitive behaviors or thoughts that help make the obsessive thoughts go away. They can be very time consuming and prevent the individual from participating in activities the person values. Treatment is available for patients with OCD, and most can be helped. We’ll discuss OCD with our guest, Craig N. Sawchuk, Ph.D., L.P., a psychologist at the Mayo Clinic and find out how patients with OCD present, common obsessions they experience and how OCD can be managed.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Craig N. Sawchuk, Ph.D., L.P.</p>
<p>It’s estimated that 1 in 40 adults have obsessive compulsive disorder. Obsessions are repetitive, unwanted thoughts that are very difficult to control. They commonly cause distress and anxiety and are often focused on a specific theme such as germs and contamination. Compulsions are repetitive behaviors or thoughts that help make the obsessive thoughts go away. They can be very time consuming and prevent the individual from participating in activities the person values. Treatment is available for patients with OCD, and most can be helped. We’ll discuss OCD with our guest, Craig N. Sawchuk, Ph.D., L.P., a psychologist at the Mayo Clinic and find out how patients with OCD present, common obsessions they experience and how OCD can be managed.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8isas393vv77jath/WF3272572_Patients_with_OCD_AFaww5u.mp3" length="42418429" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Craig N. Sawchuk, Ph.D., L.P.
It’s estimated that 1 in 40 adults have obsessive compulsive disorder. Obsessions are repetitive, unwanted thoughts that are very difficult to control. They commonly cause distress and anxiety and are often focused on a specific theme such as germs and contamination. Compulsions are repetitive behaviors or thoughts that help make the obsessive thoughts go away. They can be very time consuming and prevent the individual from participating in activities the person values. Treatment is available for patients with OCD, and most can be helped. We’ll discuss OCD with our guest, Craig N. Sawchuk, Ph.D., L.P., a psychologist at the Mayo Clinic and find out how patients with OCD present, common obsessions they experience and how OCD can be managed.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1764</itunes:duration>
                <itunes:episode>519</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes and Your Health Edition | GeneRx: Revolutionizing Primary Care with Pharmacogenomics</title>
        <itunes:title>Genes and Your Health Edition | GeneRx: Revolutionizing Primary Care with Pharmacogenomics</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-and-your-health-edition-generx-revolutionizing-primary-care-with-pharmacogenomics/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-and-your-health-edition-generx-revolutionizing-primary-care-with-pharmacogenomics/#comments</comments>        <pubDate>Thu, 22 Aug 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/8daeeda4-44c0-3eef-a60a-74418b97d737</guid>
                                    <description><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Isa J. Houwink, M.D., Ph.D.</p>
<p>Pharmacogenomics (PGx) is transforming everyday primary care practice. By using patients’ genetic profiles, providers are guiding more precise, personalized treatments. In this episode of Genes &amp; Your Health podcast, primary care physicians Dr. Denise Dupra and Dr. Isa J. Houwink discuss their practical applications and integration of PGx. The tips, tools and case studies shared, including how to optimize medication outcomes, reduce adverse drug reactions and deliver better patient care, is beneficial for all primary care providers.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Isa J. Houwink, M.D., Ph.D.</p>
<p>Pharmacogenomics (PGx) is transforming everyday primary care practice. By using patients’ genetic profiles, providers are guiding more precise, personalized treatments. In this episode of Genes &amp; Your Health podcast, primary care physicians Dr. Denise Dupra and Dr. Isa J. Houwink discuss their practical applications and integration of PGx. The tips, tools and case studies shared, including how to optimize medication outcomes, reduce adverse drug reactions and deliver better patient care, is beneficial for all primary care providers.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zm9usa2it7jk7g5v/WF4558552_Revolutionizing_Primary_Care_with_Pharmacogenomicsamb09.mp3" length="45044701" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Denise M. Dupras, M.D., Ph.D.
Guest: Isa J. Houwink, M.D., Ph.D.
Pharmacogenomics (PGx) is transforming everyday primary care practice. By using patients’ genetic profiles, providers are guiding more precise, personalized treatments. In this episode of Genes &amp; Your Health podcast, primary care physicians Dr. Denise Dupra and Dr. Isa J. Houwink discuss their practical applications and integration of PGx. The tips, tools and case studies shared, including how to optimize medication outcomes, reduce adverse drug reactions and deliver better patient care, is beneficial for all primary care providers.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1872</itunes:duration>
                <itunes:episode>520</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes and Your Health Edition | Antisense Oligonucleotide (ASO) Therapeutics for Rare Genetic Disease</title>
        <itunes:title>Genes and Your Health Edition | Antisense Oligonucleotide (ASO) Therapeutics for Rare Genetic Disease</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-and-your-health-edition-antisense-oligonucleotide-aso-therapeutics-for-rare-genetic-disease/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-and-your-health-edition-antisense-oligonucleotide-aso-therapeutics-for-rare-genetic-disease/#comments</comments>        <pubDate>Thu, 15 Aug 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/402c73b6-ef21-3d0e-8746-343500c95ca5</guid>
                                    <description><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Margot A. Cousin, Ph.D.</p>
<p>This episode of Genes &amp; Your Health provides a comprehensive look at how ASO (Antisense Oligonucleotide) therapy is paving the way for personalized medicine and offering new hope for patients with previously untreatable conditions. Margot A. Cousin, Ph.D., an Assistant Professor of Medical Genetics in the Department of Molecular Medicine and Director of the N-or-1 Therapeutics Program in the Center for Individualized Medicine, walks us through an overview of what antisense oligonucleotides are and how they work.  We then discuss clinical applications, success stories, and potential new applications to transform treatment approaches. </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Margot A. Cousin, Ph.D.</p>
<p>This episode of Genes &amp; Your Health provides a comprehensive look at how ASO (Antisense Oligonucleotide) therapy is paving the way for personalized medicine and offering new hope for patients with previously untreatable conditions. Margot A. Cousin, Ph.D., an Assistant Professor of Medical Genetics in the Department of Molecular Medicine and Director of the N-or-1 Therapeutics Program in the Center for Individualized Medicine, walks us through an overview of what antisense oligonucleotides are and how they work.  We then discuss clinical applications, success stories, and potential new applications to transform treatment approaches. </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/yntirt9dxekivzvz/24R02130_516_Ep5_Genes_ASO_Therapy_AF6yhxx.mp3" length="44035691" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Denise M. Dupras, M.D., Ph.D.
Guest: Margot A. Cousin, Ph.D.
This episode of Genes &amp; Your Health provides a comprehensive look at how ASO (Antisense Oligonucleotide) therapy is paving the way for personalized medicine and offering new hope for patients with previously untreatable conditions. Margot A. Cousin, Ph.D., an Assistant Professor of Medical Genetics in the Department of Molecular Medicine and Director of the N-or-1 Therapeutics Program in the Center for Individualized Medicine, walks us through an overview of what antisense oligonucleotides are and how they work.  We then discuss clinical applications, success stories, and potential new applications to transform treatment approaches. 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1831</itunes:duration>
                <itunes:episode>516</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Weight Changes Associated with Antidepressants</title>
        <itunes:title>Weight Changes Associated with Antidepressants</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/weight-changes-associated-with-antidepressants/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/weight-changes-associated-with-antidepressants/#comments</comments>        <pubDate>Tue, 13 Aug 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/fa908be1-c5e9-3c82-8c22-c21140b1e402</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: <a href='https://www.mayoclinic.org/biographies/frye-mark-a-m-d/bio-20054920'>Mark A. Frye, M.D.</a></p>
<p>We have a variety of antidepressant medications available to us including SSRI’s, SNRI’s and others, and for the most part they’re very well tolerated by our patients. They are much better tolerated compared to some of our older options such as the tricyclic antidepressants and MAO inhibitors. These older products often produced cardiovascular and anticholinergic adverse effects, not commonly seen with our newer medications.  However, our newer antidepressants do have a relatively common adverse effect. They tend to produce weight changes, usually a weight increase. Which antidepressants tend to produce the most weight gain? How much weight does the typical patient gain from these medications? Is the weight gained typically maintained or lost when the medication is stopped? In this podcast, I’ll be discussing these questions and more with Mark A. Frye, M.D., a psychiatrist at the Mayo Clinic.</p>
<p>To learn more about this topic: <a href='https://pubmed.ncbi.nlm.nih.gov/38950403/'>https://pubmed.ncbi.nlm.nih.gov/38950403/</a></p>
<p>Join us at the Swissotel in Chicago for two days of learning, networking, and advancing patient care. Seats are limited, so visit our website to register now!</p>
<p><a href='https://ce.mayo.edu/psychiatry-and-psychology/content/national-network-depression-centers-best-practices-mood-disorders-collaboration-mayo-clinic#group-tabs-node-course-default1'>National Network of Depression Centers Best Practices for Mood Disorders in Collaboration with Mayo Clinic 2024 | Mayo Clinic School of Continuous Professional Development | CME Course Conference</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: <a href='https://www.mayoclinic.org/biographies/frye-mark-a-m-d/bio-20054920'>Mark A. Frye, M.D.</a></p>
<p>We have a variety of antidepressant medications available to us including SSRI’s, SNRI’s and others, and for the most part they’re very well tolerated by our patients. They are much better tolerated compared to some of our older options such as the tricyclic antidepressants and MAO inhibitors. These older products often produced cardiovascular and anticholinergic adverse effects, not commonly seen with our newer medications.  However, our newer antidepressants do have a relatively common adverse effect. They tend to produce weight changes, usually a weight increase. Which antidepressants tend to produce the most weight gain? How much weight does the typical patient gain from these medications? Is the weight gained typically maintained or lost when the medication is stopped? In this podcast, I’ll be discussing these questions and more with Mark A. Frye, M.D., a psychiatrist at the Mayo Clinic.</p>
<p>To learn more about this topic: <a href='https://pubmed.ncbi.nlm.nih.gov/38950403/'>https://pubmed.ncbi.nlm.nih.gov/38950403/</a></p>
<p>Join us at the Swissotel in Chicago for two days of learning, networking, and advancing patient care. Seats are limited, so visit our website to register now!</p>
<p><a href='https://ce.mayo.edu/psychiatry-and-psychology/content/national-network-depression-centers-best-practices-mood-disorders-collaboration-mayo-clinic#group-tabs-node-course-default1'>National Network of Depression Centers Best Practices for Mood Disorders in Collaboration with Mayo Clinic 2024 | Mayo Clinic School of Continuous Professional Development | CME Course Conference</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/whwudx3fqa26q3si/WF4772600_Weight_Change_Across_Antidepressant_Treatments93rp5.mp3" length="41644791" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Mark A. Frye, M.D.
We have a variety of antidepressant medications available to us including SSRI’s, SNRI’s and others, and for the most part they’re very well tolerated by our patients. They are much better tolerated compared to some of our older options such as the tricyclic antidepressants and MAO inhibitors. These older products often produced cardiovascular and anticholinergic adverse effects, not commonly seen with our newer medications.  However, our newer antidepressants do have a relatively common adverse effect. They tend to produce weight changes, usually a weight increase. Which antidepressants tend to produce the most weight gain? How much weight does the typical patient gain from these medications? Is the weight gained typically maintained or lost when the medication is stopped? In this podcast, I’ll be discussing these questions and more with Mark A. Frye, M.D., a psychiatrist at the Mayo Clinic.
To learn more about this topic: https://pubmed.ncbi.nlm.nih.gov/38950403/
Join us at the Swissotel in Chicago for two days of learning, networking, and advancing patient care. Seats are limited, so visit our website to register now!
National Network of Depression Centers Best Practices for Mood Disorders in Collaboration with Mayo Clinic 2024 | Mayo Clinic School of Continuous Professional Development | CME Course Conference
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1732</itunes:duration>
                <itunes:episode>517</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes &amp; Your Health Edition | Microbiome and Ovarian Cancer</title>
        <itunes:title>Genes &amp; Your Health Edition | Microbiome and Ovarian Cancer</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-microbiome-and-ovarian-cancer/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-microbiome-and-ovarian-cancer/#comments</comments>        <pubDate>Thu, 08 Aug 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/2db2e8e3-b968-3d67-9542-cbdd1e18d753</guid>
                                    <description><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D. </p>
<p>Guest: Marina Walther-Antonio, Ph.D.</p>
<p>Can microbe populations affect women’s health in areas like ovarian cancer or predicting pre-term delivery? Tune into this episode of Genes &amp; Your Health with Marina Walther-Antonio, Ph.D., a microbiome researcher within Mayo Clinic's Center for Individualized Medicine, to learn what recent research studies suggest about the interaction of the microbiome, the environment, and the genome. </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D. </p>
<p>Guest: Marina Walther-Antonio, Ph.D.</p>
<p>Can microbe populations affect women’s health in areas like ovarian cancer or predicting pre-term delivery? Tune into this episode of Genes &amp; Your Health with Marina Walther-Antonio, Ph.D., a microbiome researcher within Mayo Clinic's Center for Individualized Medicine, to learn what recent research studies suggest about the interaction of the microbiome, the environment, and the genome. </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/sz82fun45i3aet2h/Ep4_Microbiome_and_Ovarian_Cancer6j41g.mp3" length="51043963" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Denise M. Dupras, M.D., Ph.D. 
Guest: Marina Walther-Antonio, Ph.D.
Can microbe populations affect women’s health in areas like ovarian cancer or predicting pre-term delivery? Tune into this episode of Genes &amp; Your Health with Marina Walther-Antonio, Ph.D., a microbiome researcher within Mayo Clinic's Center for Individualized Medicine, to learn what recent research studies suggest about the interaction of the microbiome, the environment, and the genome. 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2111</itunes:duration>
                <itunes:episode>515</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Obesity Pharmacotherapy Management</title>
        <itunes:title>Obesity Pharmacotherapy Management</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/obesity-pharmacotherapy-management/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/obesity-pharmacotherapy-management/#comments</comments>        <pubDate>Tue, 06 Aug 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/1044a9bc-dde2-3c19-8fea-a56d60b0ea32</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Kristina M. Thurber, Pharm D., R.PH.</p>
<p>Obesity in the U.S. is reaching epidemic proportions. Managing our overweight patients has been challenging, with few being able to adopt and adhere to a healthy diet and exercise program. There is a class of medications that improves blood glucose in type 2 diabetics and in most cases also results in significant weight loss. These medications are known as glucagon-like peptide 1 or GLP-1 agonists. A substantial number of patients are taking these medications, some for management of diabetes but for many others, the weight loss they produce. How do these medications work to produce weight loss? How much weight loss can patients expect? How much do they cost and most importantly, are these medications the solution to obesity as a health problem? In this podcast, I’ll be discussing these questions with my guest, Kristina M. Thurber, Pharm D., R.P.H., a pharmacist at the Mayo Clinic as we review “Obesity Pharmacotherapy Management”.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Kristina M. Thurber, Pharm D., R.PH.</p>
<p>Obesity in the U.S. is reaching epidemic proportions. Managing our overweight patients has been challenging, with few being able to adopt and adhere to a healthy diet and exercise program. There is a class of medications that improves blood glucose in type 2 diabetics and in most cases also results in significant weight loss. These medications are known as glucagon-like peptide 1 or GLP-1 agonists. A substantial number of patients are taking these medications, some for management of diabetes but for many others, the weight loss they produce. How do these medications work to produce weight loss? How much weight loss can patients expect? How much do they cost and most importantly, are these medications the solution to obesity as a health problem? In this podcast, I’ll be discussing these questions with my guest, Kristina M. Thurber, Pharm D., R.P.H., a pharmacist at the Mayo Clinic as we review “Obesity Pharmacotherapy Management”.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9mbds3buj9quh97g/WF3736251_Obesity_Pharmacotherapy_Management7tm2d.mp3" length="30860408" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Kristina M. Thurber, Pharm D., R.PH.
Obesity in the U.S. is reaching epidemic proportions. Managing our overweight patients has been challenging, with few being able to adopt and adhere to a healthy diet and exercise program. There is a class of medications that improves blood glucose in type 2 diabetics and in most cases also results in significant weight loss. These medications are known as glucagon-like peptide 1 or GLP-1 agonists. A substantial number of patients are taking these medications, some for management of diabetes but for many others, the weight loss they produce. How do these medications work to produce weight loss? How much weight loss can patients expect? How much do they cost and most importantly, are these medications the solution to obesity as a health problem? In this podcast, I’ll be discussing these questions with my guest, Kristina M. Thurber, Pharm D., R.P.H., a pharmacist at the Mayo Clinic as we review “Obesity Pharmacotherapy Management”.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1278</itunes:duration>
                <itunes:episode>514</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes and Your Health Edition | Legal Aspects of Genetic Testing</title>
        <itunes:title>Genes and Your Health Edition | Legal Aspects of Genetic Testing</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-and-your-health-edition-legal-aspects-of-genetic-testing/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-and-your-health-edition-legal-aspects-of-genetic-testing/#comments</comments>        <pubDate>Thu, 01 Aug 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/69deea82-5074-3499-8b48-383560230eaf</guid>
                                    <description><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D. </p>
<p>Guest:  Jessica Kelly, JD</p>
<p>Join our expert hosts as they delve into the intersection of genetic science and the legal landscape in this episode of Genes &amp; Your Health. </p>
<p>Jessica Kelly, J.D., and Denise M. Dupras, M.D., Ph.D., discuss the latest advancements in genetic research, personalized medicine, and how these innovations are shaping the future of healthcare. They also explore the legal implications, from privacy concerns and ethical considerations to the policies governing genetic data usage and patient rights. </p>
<p>Whether you're a healthcare professional, a legal expert, or simply curious about the future of genetics, this episode offers valuable insights and thought-provoking discussions. Tune in to stay informed about the cutting-edge developments at the nexus of genetics and the law. </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter @MayoMedEd. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D. </p>
<p>Guest:  Jessica Kelly, JD</p>
<p>Join our expert hosts as they delve into the intersection of genetic science and the legal landscape in this episode of Genes &amp; Your Health. </p>
<p>Jessica Kelly, J.D., and Denise M. Dupras, M.D., Ph.D., discuss the latest advancements in genetic research, personalized medicine, and how these innovations are shaping the future of healthcare. They also explore the legal implications, from privacy concerns and ethical considerations to the policies governing genetic data usage and patient rights. </p>
<p>Whether you're a healthcare professional, a legal expert, or simply curious about the future of genetics, this episode offers valuable insights and thought-provoking discussions. Tune in to stay informed about the cutting-edge developments at the nexus of genetics and the law. </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter @MayoMedEd. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zn2aume39pbm2nim/Ep3_Legal_and_Genetics7jq4w.mp3" length="50691240" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Denise M. Dupras, M.D., Ph.D. 
Guest:  Jessica Kelly, JD
Join our expert hosts as they delve into the intersection of genetic science and the legal landscape in this episode of Genes &amp; Your Health. 
Jessica Kelly, J.D., and Denise M. Dupras, M.D., Ph.D., discuss the latest advancements in genetic research, personalized medicine, and how these innovations are shaping the future of healthcare. They also explore the legal implications, from privacy concerns and ethical considerations to the policies governing genetic data usage and patient rights. 
Whether you're a healthcare professional, a legal expert, or simply curious about the future of genetics, this episode offers valuable insights and thought-provoking discussions. Tune in to stay informed about the cutting-edge developments at the nexus of genetics and the law. 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2110</itunes:duration>
                <itunes:episode>513</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Sarcomas</title>
        <itunes:title>Sarcomas</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/sarcomas/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/sarcomas/#comments</comments>        <pubDate>Tue, 30 Jul 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/37e37eb4-e090-3491-8d0a-e8b4da796828</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D., <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guests: Steven I. Robinson, M.B.B.S., and Brittany L. Siontis, M.D.</p>
<p>When you think of malignancies, sarcomas don’t usually come to mind. They are very uncommon and can occur in numerous locations. In addition, they can be very difficult to diagnose as the symptoms they produce are often very subtle. Approximately 15,000 cases of sarcoma are diagnosed each year in the U.S. and because July is Sarcoma Awareness Month, we’re going to do our part to raise awareness of sarcomas. My guests for this podcast include Steven I. Robinson, M.B.B.S. and Brittany L. Siontis, M.D., both from the Department of Oncology at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D., <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guests: Steven I. Robinson, M.B.B.S., and Brittany L. Siontis, M.D.</p>
<p>When you think of malignancies, sarcomas don’t usually come to mind. They are very uncommon and can occur in numerous locations. In addition, they can be very difficult to diagnose as the symptoms they produce are often very subtle. Approximately 15,000 cases of sarcoma are diagnosed each year in the U.S. and because July is Sarcoma Awareness Month, we’re going to do our part to raise awareness of sarcomas. My guests for this podcast include Steven I. Robinson, M.B.B.S. and Brittany L. Siontis, M.D., both from the Department of Oncology at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/q62urajf4gyizi37/WF4189608_Sarcomas_Intro.mp3" length="26270479" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D., [@chutkaMD]
Guests: Steven I. Robinson, M.B.B.S., and Brittany L. Siontis, M.D.
When you think of malignancies, sarcomas don’t usually come to mind. They are very uncommon and can occur in numerous locations. In addition, they can be very difficult to diagnose as the symptoms they produce are often very subtle. Approximately 15,000 cases of sarcoma are diagnosed each year in the U.S. and because July is Sarcoma Awareness Month, we’re going to do our part to raise awareness of sarcomas. My guests for this podcast include Steven I. Robinson, M.B.B.S. and Brittany L. Siontis, M.D., both from the Department of Oncology at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1091</itunes:duration>
                <itunes:episode>512</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes and Your Health Edition | AI in Cardiology and Primary Care</title>
        <itunes:title>Genes and Your Health Edition | AI in Cardiology and Primary Care</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-and-your-health-edition-ai-in-cardiology-and-primary-care/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-and-your-health-edition-ai-in-cardiology-and-primary-care/#comments</comments>        <pubDate>Thu, 25 Jul 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/ccbf2e65-483a-388b-9e7b-c2fb022788eb</guid>
                                    <description><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D. </p>
<p>Guest:  Peter A. Noseworthy, M.D., M.B.A.</p>
<p>Rapid advances in artificial intelligence, or AI, are changing everyday medical practice. In this episode of Genes &amp; Your Health, explore the transformative role of AI in cardiology and primary care practices.  Don’t miss this fascinating episode of Genes &amp; Your Health with Peter A. Noseworthy, M.D., M.B.A., Professor of Medicine and Chair of the Division of Heart Rhythm Services at the Mayo Clinic.  We’ll discuss the power of AI in early detection of heart disease, streamlined workflows for better patient outcomes, and ethical considerations of using AI in healthcare. </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter @MayoMedEd. </p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D. </p>
<p>Guest:  Peter A. Noseworthy, M.D., M.B.A.</p>
<p>Rapid advances in artificial intelligence, or AI, are changing everyday medical practice. In this episode of Genes &amp; Your Health, explore the transformative role of AI in cardiology and primary care practices.  Don’t miss this fascinating episode of Genes &amp; Your Health with Peter A. Noseworthy, M.D., M.B.A., Professor of Medicine and Chair of the Division of Heart Rhythm Services at the Mayo Clinic.  We’ll discuss the power of AI in early detection of heart disease, streamlined workflows for better patient outcomes, and ethical considerations of using AI in healthcare. </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter @MayoMedEd. </p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/sh5ji4srtbh9sy3h/Ep2_AI_in_Cardiology_and_Primary_Care_Video_V371lvn.mp3" length="27901416" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Denise M. Dupras, M.D., Ph.D. 
Guest:  Peter A. Noseworthy, M.D., M.B.A.
Rapid advances in artificial intelligence, or AI, are changing everyday medical practice. In this episode of Genes &amp; Your Health, explore the transformative role of AI in cardiology and primary care practices.  Don’t miss this fascinating episode of Genes &amp; Your Health with Peter A. Noseworthy, M.D., M.B.A., Professor of Medicine and Chair of the Division of Heart Rhythm Services at the Mayo Clinic.  We’ll discuss the power of AI in early detection of heart disease, streamlined workflows for better patient outcomes, and ethical considerations of using AI in healthcare. 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 
 ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2030</itunes:duration>
                <itunes:episode>511</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>From Head to Toe: How to Perform a Skin Exam</title>
        <itunes:title>From Head to Toe: How to Perform a Skin Exam</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/from-head-to-toe-how-to-perform-a-skin-exam/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/from-head-to-toe-how-to-perform-a-skin-exam/#comments</comments>        <pubDate>Tue, 23 Jul 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/465347a9-72f6-35b3-8a99-72ea3b600e15</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D., <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Emma F. Johnson, M.D.</p>
<p>For both men and women, skin cancer is the most common malignancy and unlike colon, breast and lung cancer, skin cancers should be visible as they exist on the exterior of our bodies. Primary care providers need to be proficient in examining the skin of our patients and recognizing suspicious skin lesions. It’s just not possible to send all patients to a dermatologist for a skin exam. In this podcast, we’ll explore what questions we should ask our patients before we perform an exam of their skin, how we fit a skin exam into our busy schedules, and when a photograph of a skin lesion might be of benefit. Our guest for this podcast is Emma F. Johnson, M.D., a dermatologist from the Mayo Clinic. </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D., <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Emma F. Johnson, M.D.</p>
<p>For both men and women, skin cancer is the most common malignancy and unlike colon, breast and lung cancer, skin cancers should be visible as they exist on the exterior of our bodies. Primary care providers need to be proficient in examining the skin of our patients and recognizing suspicious skin lesions. It’s just not possible to send all patients to a dermatologist for a skin exam. In this podcast, we’ll explore what questions we should ask our patients before we perform an exam of their skin, how we fit a skin exam into our busy schedules, and when a photograph of a skin lesion might be of benefit. Our guest for this podcast is Emma F. Johnson, M.D., a dermatologist from the Mayo Clinic. </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vcupx7e5qp7uviug/WF2244059_Skin_Exam_Intro8ig6k.mp3" length="35726626" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D., [@chutkaMD]
Guest: Emma F. Johnson, M.D.
For both men and women, skin cancer is the most common malignancy and unlike colon, breast and lung cancer, skin cancers should be visible as they exist on the exterior of our bodies. Primary care providers need to be proficient in examining the skin of our patients and recognizing suspicious skin lesions. It’s just not possible to send all patients to a dermatologist for a skin exam. In this podcast, we’ll explore what questions we should ask our patients before we perform an exam of their skin, how we fit a skin exam into our busy schedules, and when a photograph of a skin lesion might be of benefit. Our guest for this podcast is Emma F. Johnson, M.D., a dermatologist from the Mayo Clinic. 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1485</itunes:duration>
                <itunes:episode>510</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes and your Health Edition | Answers from the Lab: Cell Free DNA and Testing for Cancer</title>
        <itunes:title>Genes and your Health Edition | Answers from the Lab: Cell Free DNA and Testing for Cancer</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-and-your-health-edition-answers-from-the-lab-cell-free-dna-and-testing-for-cancer/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-and-your-health-edition-answers-from-the-lab-cell-free-dna-and-testing-for-cancer/#comments</comments>        <pubDate>Thu, 18 Jul 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/d1ab6681-8a9c-3688-9e07-981997d4f12f</guid>
                                    <description><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Aaron S. Mansfield, M.D.</p>
<p>Can a simple blood draw diagnose cancer?  Join this episode of Genes &amp; Your Health with Aaron Mansfield, M.D., a Mayo Clinic medical oncologist whose focus is on thoracic malignancies and early therapeutics, as we discuss the science behind non-invasive cancer screening, how cell-free DNA tests can help diagnose some cancers earlier than ever before, what limitations exist, and what promise the future holds. </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Aaron S. Mansfield, M.D.</p>
<p>Can a simple blood draw diagnose cancer?  Join this episode of Genes &amp; Your Health with Aaron Mansfield, M.D., a Mayo Clinic medical oncologist whose focus is on thoracic malignancies and early therapeutics, as we discuss the science behind non-invasive cancer screening, how cell-free DNA tests can help diagnose some cancers earlier than ever before, what limitations exist, and what promise the future holds. </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bjxfeyeuat4ubycf/Ep1_Cell_Free_DNA_and_Testing_for_Cancer6dkka.mp3" length="42366607" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Denise M. Dupras, M.D., Ph.D.
Guest: Aaron S. Mansfield, M.D.
Can a simple blood draw diagnose cancer?  Join this episode of Genes &amp; Your Health with Aaron Mansfield, M.D., a Mayo Clinic medical oncologist whose focus is on thoracic malignancies and early therapeutics, as we discuss the science behind non-invasive cancer screening, how cell-free DNA tests can help diagnose some cancers earlier than ever before, what limitations exist, and what promise the future holds. 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1756</itunes:duration>
                <itunes:episode>509</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Artificial Intelligence (AI) in Medicine: Part 2</title>
        <itunes:title>Artificial Intelligence (AI) in Medicine: Part 2</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/artificial-intelligence-ai-in-medicine-part-2/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/artificial-intelligence-ai-in-medicine-part-2/#comments</comments>        <pubDate>Thu, 11 Jul 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/50f1586c-456e-3759-a76a-619661a27a44</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Jason D. Greenwood, M.D., M.S.</p>
<p>Artificial intelligence is currently one of the most commonly discussed topics, but how does it relate to the practice of medicine? According to a recent publication in the Journal of the American Board of Family Medicine, “AI has the potential to fundamentally change the way society thinks about medicine, the way medicine is practiced, and the way medicine is taught.” That’s a pretty all-encompassing statement regarding the effect AI will have on what we do. Is AI beneficial to us as clinicians? Are there challenges associated with it? What are its shortcomings? In this podcast, I’ll be asking my guest, Jason D. Greenwood, M.D., M.S., a family physician at the Mayo Clinic these questions and as we discuss Artificial Intelligence in Medicine in this two-part release on July 9 and July 11!</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Jason D. Greenwood, M.D., M.S.</p>
<p>Artificial intelligence is currently one of the most commonly discussed topics, but how does it relate to the practice of medicine? According to a recent publication in the Journal of the American Board of Family Medicine, “AI has the potential to fundamentally change the way society thinks about medicine, the way medicine is practiced, and the way medicine is taught.” That’s a pretty all-encompassing statement regarding the effect AI will have on what we do. Is AI beneficial to us as clinicians? Are there challenges associated with it? What are its shortcomings? In this podcast, I’ll be asking my guest, Jason D. Greenwood, M.D., M.S., a family physician at the Mayo Clinic these questions and as we discuss Artificial Intelligence in Medicine in this two-part release on July 9 and July 11!</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/x9hj447nth5ntsiy/WF3644215_AI_in_Primary_Care_Part_Twob0m86.mp3" length="31536817" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Jason D. Greenwood, M.D., M.S.
Artificial intelligence is currently one of the most commonly discussed topics, but how does it relate to the practice of medicine? According to a recent publication in the Journal of the American Board of Family Medicine, “AI has the potential to fundamentally change the way society thinks about medicine, the way medicine is practiced, and the way medicine is taught.” That’s a pretty all-encompassing statement regarding the effect AI will have on what we do. Is AI beneficial to us as clinicians? Are there challenges associated with it? What are its shortcomings? In this podcast, I’ll be asking my guest, Jason D. Greenwood, M.D., M.S., a family physician at the Mayo Clinic these questions and as we discuss Artificial Intelligence in Medicine in this two-part release on July 9 and July 11!
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1308</itunes:duration>
                <itunes:episode>507</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Artificial Intelligence (AI) in Medicine: Part 1</title>
        <itunes:title>Artificial Intelligence (AI) in Medicine: Part 1</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/artificial-intelligence-and-medicine-part-1/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/artificial-intelligence-and-medicine-part-1/#comments</comments>        <pubDate>Tue, 09 Jul 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/a8a6047b-44c0-3332-98ba-a4c6f805fb54</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Jason D. Greenwood, M.D., M.S.</p>
<p>Artificial intelligence is currently one of the most commonly discussed topics, but how does it relate to the practice of medicine? According to a recent publication in the Journal of the American Board of Family Medicine, “AI has the potential to fundamentally change the way society thinks about medicine, the way medicine is practiced, and the way medicine is taught.” That’s a pretty all-encompassing statement regarding the effect AI will have on what we do. Is AI beneficial to us as clinicians? Are there challenges associated with it? What are its shortcomings? In this podcast, I’ll be asking my guest, Jason D. Greenwood, M.D., M.S., a family physician at the Mayo Clinic these questions and as we discuss Artificial Intelligence in Medicine in this two-part release on July 9 and July 11 this week!</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Jason D. Greenwood, M.D., M.S.</p>
<p>Artificial intelligence is currently one of the most commonly discussed topics, but how does it relate to the practice of medicine? According to a recent publication in the Journal of the American Board of Family Medicine, “AI has the potential to fundamentally change the way society thinks about medicine, the way medicine is practiced, and the way medicine is taught.” That’s a pretty all-encompassing statement regarding the effect AI will have on what we do. Is AI beneficial to us as clinicians? Are there challenges associated with it? What are its shortcomings? In this podcast, I’ll be asking my guest, Jason D. Greenwood, M.D., M.S., a family physician at the Mayo Clinic these questions and as we discuss Artificial Intelligence in Medicine in this two-part release on July 9 and July 11 this week!</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/i27snb9fricqv6up/WF3644215_AI_in_Primary_Care_Part_One8mrrr.mp3" length="27139470" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Jason D. Greenwood, M.D., M.S.
Artificial intelligence is currently one of the most commonly discussed topics, but how does it relate to the practice of medicine? According to a recent publication in the Journal of the American Board of Family Medicine, “AI has the potential to fundamentally change the way society thinks about medicine, the way medicine is practiced, and the way medicine is taught.” That’s a pretty all-encompassing statement regarding the effect AI will have on what we do. Is AI beneficial to us as clinicians? Are there challenges associated with it? What are its shortcomings? In this podcast, I’ll be asking my guest, Jason D. Greenwood, M.D., M.S., a family physician at the Mayo Clinic these questions and as we discuss Artificial Intelligence in Medicine in this two-part release on July 9 and July 11 this week!
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1126</itunes:duration>
                <itunes:episode>506</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Management of Varicose Veins</title>
        <itunes:title>Management of Varicose Veins</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/management-of-varicose-veins/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/management-of-varicose-veins/#comments</comments>        <pubDate>Tue, 02 Jul 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/b60021c3-dc7c-392a-be06-748a7fe5d9e9</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Newton B. Neidert, M.D.</p>
<p>Varicose veins are quite common and for most, they’re a minor nuisance. However, for some individuals, they have the potential to be much more than a cosmetic health problem. They can lead to a variety of symptoms including skin discoloration, discomfort, extremity swelling and occasionally skin ulceration. Fortunately, there have been numerous advances in the management of varicose veins and in this podcast, I’ll discuss these advances with interventional radiologist, Newton B. Neidert, M.D., from the Mayo Clinic. We’ll discuss who’s at risk for varicose veins, typical symptoms patients experience and the conservative as well as more invasive treatment options.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>[@chutkaMD]</a></p>
<p>Guest: Newton B. Neidert, M.D.</p>
<p>Varicose veins are quite common and for most, they’re a minor nuisance. However, for some individuals, they have the potential to be much more than a cosmetic health problem. They can lead to a variety of symptoms including skin discoloration, discomfort, extremity swelling and occasionally skin ulceration. Fortunately, there have been numerous advances in the management of varicose veins and in this podcast, I’ll discuss these advances with interventional radiologist, Newton B. Neidert, M.D., from the Mayo Clinic. We’ll discuss who’s at risk for varicose veins, typical symptoms patients experience and the conservative as well as more invasive treatment options.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=2a4ea4e5363e3fbb0851d4f63b7a950be780727e9f9f5a5427421003c25e0d19'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/uizpqgv8yiuumtjc/WF3668500_Management_of_Varicose_Veins_AFb9m06.mp3" length="39612641" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Newton B. Neidert, M.D.
Varicose veins are quite common and for most, they’re a minor nuisance. However, for some individuals, they have the potential to be much more than a cosmetic health problem. They can lead to a variety of symptoms including skin discoloration, discomfort, extremity swelling and occasionally skin ulceration. Fortunately, there have been numerous advances in the management of varicose veins and in this podcast, I’ll discuss these advances with interventional radiologist, Newton B. Neidert, M.D., from the Mayo Clinic. We’ll discuss who’s at risk for varicose veins, typical symptoms patients experience and the conservative as well as more invasive treatment options.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1640</itunes:duration>
                <itunes:episode>505</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Healthcare of the Transgender Patient</title>
        <itunes:title>Healthcare of the Transgender Patient</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/healthcare-of-the-transgender-patient/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/healthcare-of-the-transgender-patient/#comments</comments>        <pubDate>Tue, 25 Jun 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/741270d7-f301-3a27-a4fc-2e92f2707b7a</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>[@chutkaMD]</a></p>
<p>Guest: Natalie C. Erbs, M.D.</p>
<p>There is abundant research that indicates there are healthcare inequities experienced by transgender individuals. Transgender patients have the same basic health care needs as any patient. However, in addition, they might also have gender-related healthcare needs and concerns. It’s important for us to meet these healthcare needs, and this requires some special knowledge. The special needs of the transgender patient may be related to gender-affirming hormonal therapy or surgery, or it may relate to gender-specific preventive healthcare. This podcast will explore transgender health care. We’ll discuss the difficulties experienced by transgender patients, the specific healthcare needs they have and how we can become more educated in providing healthcare to transgender patients. My guest is Natalie C. Erbs, M.D., from the Department of Family Medicine at the Mayo Clinic.</p>
<p><a href='https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-minute-coming-out-as-lgbtq-to-your-health-care-provider/'>Mayo Clinic Minute: Coming out as LGBTQ to your health care provider - Mayo Clinic News Network</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>[@chutkaMD]</a></p>
<p>Guest: Natalie C. Erbs, M.D.</p>
<p>There is abundant research that indicates there are healthcare inequities experienced by transgender individuals. Transgender patients have the same basic health care needs as any patient. However, in addition, they might also have gender-related healthcare needs and concerns. It’s important for us to meet these healthcare needs, and this requires some special knowledge. The special needs of the transgender patient may be related to gender-affirming hormonal therapy or surgery, or it may relate to gender-specific preventive healthcare. This podcast will explore transgender health care. We’ll discuss the difficulties experienced by transgender patients, the specific healthcare needs they have and how we can become more educated in providing healthcare to transgender patients. My guest is Natalie C. Erbs, M.D., from the Department of Family Medicine at the Mayo Clinic.</p>
<p><a href='https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-minute-coming-out-as-lgbtq-to-your-health-care-provider/'>Mayo Clinic Minute: Coming out as LGBTQ to your health care provider - Mayo Clinic News Network</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/z2xvy7u8hhzjqjtj/WF3656085_Care_for_Transgender_Gender_Diverse_and_Intersex6kr4p.mp3" length="35998398" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Natalie C. Erbs, M.D.
There is abundant research that indicates there are healthcare inequities experienced by transgender individuals. Transgender patients have the same basic health care needs as any patient. However, in addition, they might also have gender-related healthcare needs and concerns. It’s important for us to meet these healthcare needs, and this requires some special knowledge. The special needs of the transgender patient may be related to gender-affirming hormonal therapy or surgery, or it may relate to gender-specific preventive healthcare. This podcast will explore transgender health care. We’ll discuss the difficulties experienced by transgender patients, the specific healthcare needs they have and how we can become more educated in providing healthcare to transgender patients. My guest is Natalie C. Erbs, M.D., from the Department of Family Medicine at the Mayo Clinic.
Mayo Clinic Minute: Coming out as LGBTQ to your health care provider - Mayo Clinic News Network
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1496</itunes:duration>
                <itunes:episode>503</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Handle with Care to Giving Bad News</title>
        <itunes:title>Handle with Care to Giving Bad News</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/handle-with-care-to-giving-bad-news/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/handle-with-care-to-giving-bad-news/#comments</comments>        <pubDate>Tue, 11 Jun 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/0c774dd5-4ffa-3255-af48-382ef1c018c2</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>[@chutkaMD]</a></p>
<p>Guest: Amanda K. Lorenz, M.D.</p>
<p>Giving our patients bad or unexpected news is one of the most difficult, but also one of the most important responsibilities we have as health care clinicians. This is when our patients need us the most and we need to do this with compassion and empathy. This is best done face to face and ideally once we have established a good relationship with our patient. Unfortunately, this isn’t always possible. A clinician in the emergency department telling a patient they’ve suffered an MI or a radiologist explaining a worrisome finding on mammogram may have just recently met the patient. What’s the best way to give our patients bad news? Can we become better at this? What can we expect from our patients after they hear the news? And how much information should we share with them? These are all topics we’ll discuss with our guest, Amanda K. Lorenz, M.D., a palliative medicine physician. Our topic for this podcast is “Giving Bad News”.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>[@chutkaMD]</a></p>
<p>Guest: Amanda K. Lorenz, M.D.</p>
<p>Giving our patients bad or unexpected news is one of the most difficult, but also one of the most important responsibilities we have as health care clinicians. This is when our patients need us the most and we need to do this with compassion and empathy. This is best done face to face and ideally once we have established a good relationship with our patient. Unfortunately, this isn’t always possible. A clinician in the emergency department telling a patient they’ve suffered an MI or a radiologist explaining a worrisome finding on mammogram may have just recently met the patient. What’s the best way to give our patients bad news? Can we become better at this? What can we expect from our patients after they hear the news? And how much information should we share with them? These are all topics we’ll discuss with our guest, Amanda K. Lorenz, M.D., a palliative medicine physician. Our topic for this podcast is “Giving Bad News”.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cszde6x8287b79ma/WF3371951_Breaking_Bad_News_new_musicadvww.mp3" length="38059576" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Amanda K. Lorenz, M.D.
Giving our patients bad or unexpected news is one of the most difficult, but also one of the most important responsibilities we have as health care clinicians. This is when our patients need us the most and we need to do this with compassion and empathy. This is best done face to face and ideally once we have established a good relationship with our patient. Unfortunately, this isn’t always possible. A clinician in the emergency department telling a patient they’ve suffered an MI or a radiologist explaining a worrisome finding on mammogram may have just recently met the patient. What’s the best way to give our patients bad news? Can we become better at this? What can we expect from our patients after they hear the news? And how much information should we share with them? These are all topics we’ll discuss with our guest, Amanda K. Lorenz, M.D., a palliative medicine physician. Our topic for this podcast is “Giving Bad News”.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1579</itunes:duration>
                <itunes:episode>502</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Infertility</title>
        <itunes:title>Infertility</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/infertility/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/infertility/#comments</comments>        <pubDate>Tue, 04 Jun 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/ed64c036-8c91-31d2-b6c8-7bbfdaf38674</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>[@chutkaMD]</a></p>
<p>Guest: Ali J. Ainsworth, M.D.</p>
<p>A successful pregnancy is a complicated process. It involves a combination of precise timing as well as anatomic and physiologic conditions which need to be intact and functioning normally. When pregnancy is unable to be achieved, it can be due to a problem in the female, the male, or both. It’s relatively common and can result in significant frustration. Psychological problems also commonly result. The topic for today’s podcast is infertility; it’s causes, evaluation and management. My guest is Ali J. Ainsworth, M.D., a specialist in reproductive endocrinology and infertility from the Department of Obstetrics and Gynecology at the Mayo Clinic.</p>
<p>June is Infertility Awareness Month</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at</p>
<p><a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>[@chutkaMD]</a></p>
<p>Guest: Ali J. Ainsworth, M.D.</p>
<p>A successful pregnancy is a complicated process. It involves a combination of precise timing as well as anatomic and physiologic conditions which need to be intact and functioning normally. When pregnancy is unable to be achieved, it can be due to a problem in the female, the male, or both. It’s relatively common and can result in significant frustration. Psychological problems also commonly result. The topic for today’s podcast is infertility; it’s causes, evaluation and management. My guest is Ali J. Ainsworth, M.D., a specialist in reproductive endocrinology and infertility from the Department of Obstetrics and Gynecology at the Mayo Clinic.</p>
<p>June is Infertility Awareness Month</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at</p>
<p><a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wcexi64gyzvxsi68/WF3943537_Infertility.mp3" length="29125783" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Ali J. Ainsworth, M.D.
A successful pregnancy is a complicated process. It involves a combination of precise timing as well as anatomic and physiologic conditions which need to be intact and functioning normally. When pregnancy is unable to be achieved, it can be due to a problem in the female, the male, or both. It’s relatively common and can result in significant frustration. Psychological problems also commonly result. The topic for today’s podcast is infertility; it’s causes, evaluation and management. My guest is Ali J. Ainsworth, M.D., a specialist in reproductive endocrinology and infertility from the Department of Obstetrics and Gynecology at the Mayo Clinic.
June is Infertility Awareness Month
Connect with the Mayo Clinic’s School of Continuous Professional Development online at
https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1211</itunes:duration>
                <itunes:episode>501</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Update in Immunizations 2024</title>
        <itunes:title>Update in Immunizations 2024</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/update-in-immunizations-2024/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/update-in-immunizations-2024/#comments</comments>        <pubDate>Tue, 28 May 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/7c0f9534-471b-31c6-87b6-23dd6099bf78</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>[@chutkaMD]</a></p>
<p>Guest: Robert M. Jacobson, M.D.</p>
<p>Immunizations are one of the greatest success stories in modern medicine and it’s estimated that they’ve saved more lives and prevented more disabilities than any other medical intervention. They’re probably responsible, more than any other medical advance in contributing to our increased longevity as a population. They’re also extremely cost-effective and their benefits far outweigh the very small risks they carry. This podcast will review new information regarding immunizations and how we as clinicians can increase our patients’ immunization rates. Our guest is Robert M. Jacobson, M.D., a pediatrician, and expert in immunizations from the Department of Pediatrics at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>[@chutkaMD]</a></p>
<p>Guest: Robert M. Jacobson, M.D.</p>
<p>Immunizations are one of the greatest success stories in modern medicine and it’s estimated that they’ve saved more lives and prevented more disabilities than any other medical intervention. They’re probably responsible, more than any other medical advance in contributing to our increased longevity as a population. They’re also extremely cost-effective and their benefits far outweigh the very small risks they carry. This podcast will review new information regarding immunizations and how we as clinicians can increase our patients’ immunization rates. Our guest is Robert M. Jacobson, M.D., a pediatrician, and expert in immunizations from the Department of Pediatrics at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nxw33mw5296kcwnt/WF3648807_Vaccine_Updates_for_20248oq2s.mp3" length="41649200" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Robert M. Jacobson, M.D.
Immunizations are one of the greatest success stories in modern medicine and it’s estimated that they’ve saved more lives and prevented more disabilities than any other medical intervention. They’re probably responsible, more than any other medical advance in contributing to our increased longevity as a population. They’re also extremely cost-effective and their benefits far outweigh the very small risks they carry. This podcast will review new information regarding immunizations and how we as clinicians can increase our patients’ immunization rates. Our guest is Robert M. Jacobson, M.D., a pediatrician, and expert in immunizations from the Department of Pediatrics at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1731</itunes:duration>
                <itunes:episode>500</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Inhalation Injuries in First Responders</title>
        <itunes:title>Inhalation Injuries in First Responders</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/inhalation-injuries-in-first-responders/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/inhalation-injuries-in-first-responders/#comments</comments>        <pubDate>Tue, 14 May 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/953d433a-d4a4-3925-9971-a0e31f4fd73d</guid>
                                    <description><![CDATA[<p>Host: Joshua D. Luciew, MPAS, P.A.-C.</p>
<p>Guest: Brittany A. Strelow, DMSc, P.A.-C., M.S.</p>
<p>Air pollution is a pervasive issue that surrounds us every day, with varying degrees of severity depending on our environment. As we go about our daily lives, we unknowingly inhale harmful substances that are present in the air. But what happens when this exposure is magnified, and individuals such as first responders are continuously exposed to severe air pollutants, like fire smoke?</p>
<p>In the United States alone, fire departments respond to a fire every 21 seconds, exposing numerous individuals to the dangers of smoke inhalation. </p>
<p>Tune in as we delve into smoke inhalation injury, exploring who is most at risk, and how this silent killer can have long-term effects on our health.</p>
<p>National EMS Week is May 19 – May 25</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Joshua D. Luciew, MPAS, P.A.-C.</p>
<p>Guest: Brittany A. Strelow, DMSc, P.A.-C., M.S.</p>
<p>Air pollution is a pervasive issue that surrounds us every day, with varying degrees of severity depending on our environment. As we go about our daily lives, we unknowingly inhale harmful substances that are present in the air. But what happens when this exposure is magnified, and individuals such as first responders are continuously exposed to severe air pollutants, like fire smoke?</p>
<p>In the United States alone, fire departments respond to a fire every 21 seconds, exposing numerous individuals to the dangers of smoke inhalation. </p>
<p>Tune in as we delve into smoke inhalation injury, exploring who is most at risk, and how this silent killer can have long-term effects on our health.</p>
<p>National EMS Week is May 19 – May 25</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ujt8u4bqpr5hmx8h/WF3941067_Inhalation_Injuries_in_First_Responders_AF8jcpe.mp3" length="37184744" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Joshua D. Luciew, MPAS, P.A.-C.
Guest: Brittany A. Strelow, DMSc, P.A.-C., M.S.
Air pollution is a pervasive issue that surrounds us every day, with varying degrees of severity depending on our environment. As we go about our daily lives, we unknowingly inhale harmful substances that are present in the air. But what happens when this exposure is magnified, and individuals such as first responders are continuously exposed to severe air pollutants, like fire smoke?
In the United States alone, fire departments respond to a fire every 21 seconds, exposing numerous individuals to the dangers of smoke inhalation. 
Tune in as we delve into smoke inhalation injury, exploring who is most at risk, and how this silent killer can have long-term effects on our health.
National EMS Week is May 19 – May 25
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1529</itunes:duration>
                <itunes:episode>498</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Lab Medicine Edition | CBC: Platelets (Thrombocytosis, Thrombocytopenia)</title>
        <itunes:title>Lab Medicine Edition | CBC: Platelets (Thrombocytosis, Thrombocytopenia)</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/lab-medicine-edition-cbc-platelets-thrombocytosis-thrombocytopenia/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/lab-medicine-edition-cbc-platelets-thrombocytosis-thrombocytopenia/#comments</comments>        <pubDate>Thu, 09 May 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/80001933-c983-3a6a-83f7-ef8904a0d2e1</guid>
                                    <description><![CDATA[<p>HOST: Andy Herber, P.A.-C.</p>
<p>GUEST: Ronald S. Go, M.D.</p>
<p>Join our host, Andy J. Herber, P.A.-C., as he discusses the complete blood count (CBC), which is one of the most ordered laboratory tests in the primary care setting. Providers are frequently tasked with evaluating all aspects of the CBC. A keen understanding of this laboratory test is essential to providing quality care for patients. <a href='https://www.mayoclinic.org/biographies/go-ronald-s-m-d/bio-20055650'>Ronald S. Go, M.D</a>. returns as a guest to discuss abnormal platelet test results and its implication on patient management.</p>
<p>Learn more about our Lab Medicine Edition <a href='https://ce.mayo.edu/content/mayo-clinic-talks-lab-medicine-edition'>here</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>HOST: Andy Herber, P.A.-C.</p>
<p>GUEST: Ronald S. Go, M.D.</p>
<p>Join our host, Andy J. Herber, P.A.-C., as he discusses the complete blood count (CBC), which is one of the most ordered laboratory tests in the primary care setting. Providers are frequently tasked with evaluating all aspects of the CBC. A keen understanding of this laboratory test is essential to providing quality care for patients. <a href='https://www.mayoclinic.org/biographies/go-ronald-s-m-d/bio-20055650'>Ronald S. Go, M.D</a>. returns as a guest to discuss abnormal platelet test results and its implication on patient management.</p>
<p>Learn more about our Lab Medicine Edition <a href='https://ce.mayo.edu/content/mayo-clinic-talks-lab-medicine-edition'>here</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/a2x68gxagjv66uvd/WF2985070_Platelets_V2_AF9zcdf.mp3" length="43898931" type="audio/mpeg"/>
        <itunes:summary><![CDATA[HOST: Andy Herber, P.A.-C.
GUEST: Ronald S. Go, M.D.
Join our host, Andy J. Herber, P.A.-C., as he discusses the complete blood count (CBC), which is one of the most ordered laboratory tests in the primary care setting. Providers are frequently tasked with evaluating all aspects of the CBC. A keen understanding of this laboratory test is essential to providing quality care for patients. Ronald S. Go, M.D. returns as a guest to discuss abnormal platelet test results and its implication on patient management.
Learn more about our Lab Medicine Edition here
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1822</itunes:duration>
                <itunes:episode>497</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Prenatal Care</title>
        <itunes:title>Prenatal Care</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/prenatal-care/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/prenatal-care/#comments</comments>        <pubDate>Tue, 07 May 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/d44bb64c-4bf2-3404-a35b-5e2f07f4b01c</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D., <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>[@chutkaMD]</a></p>
<p>Guest: Michele A. Hanson, M.D.</p>
<p>There are a variety of things a woman can do to increase the odds of successful pregnancy. One of the most important is receiving regular prenatal care. It provides major benefits to both the mother and the unborn child. It’s been shown to reduce the risk of pregnancy complications as well as the risk of complications to the fetus. It’s one of the best ways to increase the likelihood of a healthy pregnancy. When should prenatal care begin? What does good prenatal care consist of? How often should a woman be seen for prenatal care?  In this podcast, we’ll be covering these topics and more as we discuss “Prenatal Care” with my guest, Michele A. Hanson, M.D., a family medicine physician at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D., <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FChutkaMD%255d%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>[@chutkaMD]</a></p>
<p>Guest: Michele A. Hanson, M.D.</p>
<p>There are a variety of things a woman can do to increase the odds of successful pregnancy. One of the most important is receiving regular prenatal care. It provides major benefits to both the mother and the unborn child. It’s been shown to reduce the risk of pregnancy complications as well as the risk of complications to the fetus. It’s one of the best ways to increase the likelihood of a healthy pregnancy. When should prenatal care begin? What does good prenatal care consist of? How often should a woman be seen for prenatal care?  In this podcast, we’ll be covering these topics and more as we discuss “Prenatal Care” with my guest, Michele A. Hanson, M.D., a family medicine physician at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Fce.mayo.edu.mcas.ms%2F%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>https://ce.mayo.edu/</a> or on Twitter <a href='https://mcas-proxyweb.mcas.ms/certificate-checker?login=false&amp;originalUrl=https%3A%2F%2Ftwitter.com.mcas.ms%2FMayoMedEd%3FMcasTsid%3D20892&amp;McasCSRF=e15e9c5488181e80284073023d097117f3ddadec1b000da309d682358df55787'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tqeakpzhi36fnsuy/WF3910670_Prenatal_Evaluations_and_Care_AF72ov9.mp3" length="33683017" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D., [@chutkaMD]
Guest: Michele A. Hanson, M.D.
There are a variety of things a woman can do to increase the odds of successful pregnancy. One of the most important is receiving regular prenatal care. It provides major benefits to both the mother and the unborn child. It’s been shown to reduce the risk of pregnancy complications as well as the risk of complications to the fetus. It’s one of the best ways to increase the likelihood of a healthy pregnancy. When should prenatal care begin? What does good prenatal care consist of? How often should a woman be seen for prenatal care?  In this podcast, we’ll be covering these topics and more as we discuss “Prenatal Care” with my guest, Michele A. Hanson, M.D., a family medicine physician at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1394</itunes:duration>
                <itunes:episode>496</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Lab Medicine Edition | CBC: White Blood Cell Count (WBC) (Leukocytosis, Leukopenia)</title>
        <itunes:title>Lab Medicine Edition | CBC: White Blood Cell Count (WBC) (Leukocytosis, Leukopenia)</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/lab-medicine-edition-cbc-white-blood-cell-count-wbc-leukocytosis-leukopenia/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/lab-medicine-edition-cbc-white-blood-cell-count-wbc-leukocytosis-leukopenia/#comments</comments>        <pubDate>Thu, 02 May 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/7e0b0c86-259a-30a8-bbd1-4402d6417362</guid>
                                    <description><![CDATA[<p>HOST: Andy Herber, P.A.-C.</p>
<p>GUEST: Ronald S. Go, M.D.</p>
<p>Join our host, Andy J. Herber, P.A.-C. as he discusses the complete blood count (CBC), which is one of the most ordered laboratory tests in the primary care setting. Providers are frequently tasked with evaluating all aspects of the CBC.  A keen understanding of this laboratory test is essential to providing quality care for patients.  Joining us again to discuss white blood cell count abnormalities is renown Mayo Clinic Hematologist, <a href='https://www.mayoclinic.org/biographies/go-ronald-s-m-d/bio-20055650'>Ronald S. Go, M.D.</a></p>
<p>Learn more about our Lab Medicine Edition <a href='https://ce.mayo.edu/content/mayo-clinic-talks-lab-medicine-edition'>here</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>HOST: Andy Herber, P.A.-C.</p>
<p>GUEST: Ronald S. Go, M.D.</p>
<p>Join our host, Andy J. Herber, P.A.-C. as he discusses the complete blood count (CBC), which is one of the most ordered laboratory tests in the primary care setting. Providers are frequently tasked with evaluating all aspects of the CBC.  A keen understanding of this laboratory test is essential to providing quality care for patients.  Joining us again to discuss white blood cell count abnormalities is renown Mayo Clinic Hematologist, <a href='https://www.mayoclinic.org/biographies/go-ronald-s-m-d/bio-20055650'>Ronald S. Go, M.D.</a></p>
<p>Learn more about our Lab Medicine Edition <a href='https://ce.mayo.edu/content/mayo-clinic-talks-lab-medicine-edition'>here</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ygbjs49ea2jghs36/WF2985069_White_Blood_Cells_V26ndp6.mp3" length="41840379" type="audio/mpeg"/>
        <itunes:summary><![CDATA[HOST: Andy Herber, P.A.-C.
GUEST: Ronald S. Go, M.D.
Join our host, Andy J. Herber, P.A.-C. as he discusses the complete blood count (CBC), which is one of the most ordered laboratory tests in the primary care setting. Providers are frequently tasked with evaluating all aspects of the CBC.  A keen understanding of this laboratory test is essential to providing quality care for patients.  Joining us again to discuss white blood cell count abnormalities is renown Mayo Clinic Hematologist, Ronald S. Go, M.D.
Learn more about our Lab Medicine Edition here
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1733</itunes:duration>
                <itunes:episode>495</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Esophageal Cancer Diagnosis and Care for the Primary Care Provider</title>
        <itunes:title>Esophageal Cancer Diagnosis and Care for the Primary Care Provider</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/esophageal-cancer-diagnosis-and-care-for-the-primary-care-provider/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/esophageal-cancer-diagnosis-and-care-for-the-primary-care-provider/#comments</comments>        <pubDate>Tue, 30 Apr 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/d9771866-8811-36c4-a161-6850c955e4fb</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D., <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Tanios S. Bekaii-Saab, M.D.</p>
<p>Although esophageal cancer is not a common malignancy, when found it often has a poor prognosis. It’s about four times more likely to occur in a male than a female. Although a variety of malignancies can develop in the esophagus, most tend to be either squamous cell or adenocarcinoma. Fortunately, the rates of esophageal cancer have been decreasing slightly over the past decade. Despite the fact that esophageal cancer often produces symptoms, the survival rate has not been very good, although due to new and improved treatments it has been improving. The topic for today’s podcast is esophageal cancer and my guest is Tanios S. Bekaii-Saab, M.D., the division chair for Hematology/Oncology at the Mayo Clinic in Phoenix, Arizona. We’ll discuss the risk factors for esophageal cancer, its common presenting symptoms, how to establish a diagnosis and the various treatment options available.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D., <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Tanios S. Bekaii-Saab, M.D.</p>
<p>Although esophageal cancer is not a common malignancy, when found it often has a poor prognosis. It’s about four times more likely to occur in a male than a female. Although a variety of malignancies can develop in the esophagus, most tend to be either squamous cell or adenocarcinoma. Fortunately, the rates of esophageal cancer have been decreasing slightly over the past decade. Despite the fact that esophageal cancer often produces symptoms, the survival rate has not been very good, although due to new and improved treatments it has been improving. The topic for today’s podcast is esophageal cancer and my guest is Tanios S. Bekaii-Saab, M.D., the division chair for Hematology/Oncology at the Mayo Clinic in Phoenix, Arizona. We’ll discuss the risk factors for esophageal cancer, its common presenting symptoms, how to establish a diagnosis and the various treatment options available.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/te55qcwx5y3f3p35/WF3678333_Esophageal_Cancer_and_Primary_Care8brvy.mp3" length="39241487" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D., [@chutkaMD]
Guest: Tanios S. Bekaii-Saab, M.D.
Although esophageal cancer is not a common malignancy, when found it often has a poor prognosis. It’s about four times more likely to occur in a male than a female. Although a variety of malignancies can develop in the esophagus, most tend to be either squamous cell or adenocarcinoma. Fortunately, the rates of esophageal cancer have been decreasing slightly over the past decade. Despite the fact that esophageal cancer often produces symptoms, the survival rate has not been very good, although due to new and improved treatments it has been improving. The topic for today’s podcast is esophageal cancer and my guest is Tanios S. Bekaii-Saab, M.D., the division chair for Hematology/Oncology at the Mayo Clinic in Phoenix, Arizona. We’ll discuss the risk factors for esophageal cancer, its common presenting symptoms, how to establish a diagnosis and the various treatment options available.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1624</itunes:duration>
                <itunes:episode>494</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Lab Medicine Edition | CBC: Hemoglobin/Anemia (Micro, Macro, Hemolytic)</title>
        <itunes:title>Lab Medicine Edition | CBC: Hemoglobin/Anemia (Micro, Macro, Hemolytic)</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/lab-medicine-edition-cbc-hemoglobinanemia-micro-macro-hemolytic/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/lab-medicine-edition-cbc-hemoglobinanemia-micro-macro-hemolytic/#comments</comments>        <pubDate>Thu, 25 Apr 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/178cb131-5268-3034-9070-6eee1ae3334a</guid>
                                    <description><![CDATA[<p>HOST: Andy Herber, P.A.-C.</p>
<p>GUEST: Ronald S. Go, M.D.</p>
<p>Join our host, Andy J. Herber, P.A.-C., as he discusses the complete blood count (CBC), which is one of the most ordered laboratory tests in the primary care setting.  Providers are frequently tasked with evaluating all aspects of the CBC. A keen understanding of this laboratory test is essential to providing quality care for patients. Joining the first episode of this series is renown Mayo Clinic Hematologist, <a href='https://www.mayoclinic.org/biographies/go-ronald-s-m-d/bio-20055650'>Ronald S. Go, M.D</a>., who will be discussing evaluating abnormalities, hemoglobin and differing types of anemia.</p>
<p>Learn more about our Lab Medicine Edition <a href='https://ce.mayo.edu/content/mayo-clinic-talks-lab-medicine-edition'>here</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>HOST: Andy Herber, P.A.-C.</p>
<p>GUEST: Ronald S. Go, M.D.</p>
<p>Join our host, Andy J. Herber, P.A.-C., as he discusses the complete blood count (CBC), which is one of the most ordered laboratory tests in the primary care setting.  Providers are frequently tasked with evaluating all aspects of the CBC. A keen understanding of this laboratory test is essential to providing quality care for patients. Joining the first episode of this series is renown Mayo Clinic Hematologist, <a href='https://www.mayoclinic.org/biographies/go-ronald-s-m-d/bio-20055650'>Ronald S. Go, M.D</a>., who will be discussing evaluating abnormalities, hemoglobin and differing types of anemia.</p>
<p>Learn more about our Lab Medicine Edition <a href='https://ce.mayo.edu/content/mayo-clinic-talks-lab-medicine-edition'>here</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qmkarcqcaqj39bp7/WF2985068_Hemoglobin_V2.mp3" length="51485012" type="audio/mpeg"/>
        <itunes:summary><![CDATA[HOST: Andy Herber, P.A.-C.
GUEST: Ronald S. Go, M.D.
Join our host, Andy J. Herber, P.A.-C., as he discusses the complete blood count (CBC), which is one of the most ordered laboratory tests in the primary care setting.  Providers are frequently tasked with evaluating all aspects of the CBC. A keen understanding of this laboratory test is essential to providing quality care for patients. Joining the first episode of this series is renown Mayo Clinic Hematologist, Ronald S. Go, M.D., who will be discussing evaluating abnormalities, hemoglobin and differing types of anemia.
Learn more about our Lab Medicine Edition here
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2134</itunes:duration>
                <itunes:episode>493</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Lab Medicine Edition | Electrolytes: Calcium (Hypercalcemia, Hypocalcemia)</title>
        <itunes:title>Lab Medicine Edition | Electrolytes: Calcium (Hypercalcemia, Hypocalcemia)</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/lab-medicine-edition-electrolytes-calcium-hypercalcemia-hypocalcemia/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/lab-medicine-edition-electrolytes-calcium-hypercalcemia-hypocalcemia/#comments</comments>        <pubDate>Thu, 18 Apr 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/8185aff4-9154-3990-b541-88a34bcade16</guid>
                                    <description><![CDATA[<p>HOST: Andy Herber, P.A.-C.</p>
<p>GUEST: Mira T. Keddis, M.D.</p>
<p>Join our host, Andy J. Herber, P.A.-C. to take a deeper look at hypercalcemia and hypocalcemia. This podcast will do a review of the management of calcium disorders with guest,  <a href='https://www.mayoclinic.org/biographies/keddis-mira-t-m-d/bio-20055681'>Mira T. Keddis, M.D.</a></p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-lab-medicine-edition'>Mayo Clinic Talks: Lab Medicine Edition | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>HOST: Andy Herber, P.A.-C.</p>
<p>GUEST: Mira T. Keddis, M.D.</p>
<p>Join our host, Andy J. Herber, P.A.-C. to take a deeper look at hypercalcemia and hypocalcemia. This podcast will do a review of the management of calcium disorders with guest,  <a href='https://www.mayoclinic.org/biographies/keddis-mira-t-m-d/bio-20055681'>Mira T. Keddis, M.D.</a></p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-lab-medicine-edition'>Mayo Clinic Talks: Lab Medicine Edition | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5ik7tzztdr6zvtez/WF2823601_Calcium_V2_AF8hz0m.mp3" length="45251456" type="audio/mpeg"/>
        <itunes:summary><![CDATA[HOST: Andy Herber, P.A.-C.
GUEST: Mira T. Keddis, M.D.
Join our host, Andy J. Herber, P.A.-C. to take a deeper look at hypercalcemia and hypocalcemia. This podcast will do a review of the management of calcium disorders with guest,  Mira T. Keddis, M.D.
Mayo Clinic Talks: Lab Medicine Edition | Mayo Clinic School of Continuous Professional Development
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1882</itunes:duration>
                <itunes:episode>492</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Lab Medicine Edition | Electrolytes: Potassium (Hyperkalemia, Hypokalemia)</title>
        <itunes:title>Lab Medicine Edition | Electrolytes: Potassium (Hyperkalemia, Hypokalemia)</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/lab-medicine-edition-electrolytes-potassium-hyperkalemia-hypokalemia/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/lab-medicine-edition-electrolytes-potassium-hyperkalemia-hypokalemia/#comments</comments>        <pubDate>Thu, 11 Apr 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/317d0b2f-2a09-3ab8-b7ec-400f4a1de397</guid>
                                    <description><![CDATA[<p>HOST: Andy Herber, P.A.-C.</p>
<p>GUEST: Mira T. Keddis, M.D.</p>
<p>Join our host, Andy J. Herber, P.A.-C., as he explores potassium disorders that are commonly encountered by Primary Care Providers. High and Low potassium if not appropriately managed can lead to lethal complications. This episode provides a discussion about the workup and management of Hyperkalemia and Hypokalemia with <a href='https://www.mayoclinic.org/biographies/keddis-mira-t-m-d/bio-20055681'>Mira T. Keddis, M.D.</a></p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-lab-medicine-edition'>Mayo Clinic Talks: Lab Medicine Edition | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>HOST: Andy Herber, P.A.-C.</p>
<p>GUEST: Mira T. Keddis, M.D.</p>
<p>Join our host, Andy J. Herber, P.A.-C., as he explores potassium disorders that are commonly encountered by Primary Care Providers. High and Low potassium if not appropriately managed can lead to lethal complications. This episode provides a discussion about the workup and management of Hyperkalemia and Hypokalemia with <a href='https://www.mayoclinic.org/biographies/keddis-mira-t-m-d/bio-20055681'>Mira T. Keddis, M.D.</a></p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-lab-medicine-edition'>Mayo Clinic Talks: Lab Medicine Edition | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6ekfvd/WF2823600_Potassium_V2.mp3" length="46741335" type="audio/mpeg"/>
        <itunes:summary><![CDATA[HOST: Andy Herber, P.A.-C.
GUEST: Mira T. Keddis, M.D.
Join our host, Andy J. Herber, P.A.-C., as he explores potassium disorders that are commonly encountered by Primary Care Providers. High and Low potassium if not appropriately managed can lead to lethal complications. This episode provides a discussion about the workup and management of Hyperkalemia and Hypokalemia with Mira T. Keddis, M.D.
Mayo Clinic Talks: Lab Medicine Edition | Mayo Clinic School of Continuous Professional Development
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1942</itunes:duration>
                <itunes:episode>489</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>When to Refer a Patient for a Lung Transplant</title>
        <itunes:title>When to Refer a Patient for a Lung Transplant</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/when-to-refer-a-patient-for-a-lung-transplant/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/when-to-refer-a-patient-for-a-lung-transplant/#comments</comments>        <pubDate>Tue, 09 Apr 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/cf973d1d-d112-3cb9-870a-bf1b1bd657be</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Kelly Pennington, M.D.</p>
<p>Guest: Sahar Saddoughi, M.D., Ph.D.</p>
<p>The lung is one of the most common organs transplanted, trailing transplants of kidney, liver, and heart, with over 2600 performed in 2022. Lung transplantation may involve transplanting either one or both lungs, and occasionally performed together with a heart transplant. Although some patients with a lung transplant have lived more than 10 years, only about half are alive after 5 years. In this podcast, we’ll discuss “When to Refer a Patient for a Lung Transplant”. Who’s a candidate for a lung transplant and when should we think about this for our patients? How successful is a lung transplant and what are conditions that would exclude a patient from the procedure? These are all questions I’ll be asking my guests, thoracic surgeon, Sahar Saddoughi, M.D., Ph.D., and pulmonologist, Kelly Pennington, M.D., both from the Mayo Clinic in honor of ‘National Donate Life Month’.                 </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
<p><a href='https://www.mayoclinic.org/departments-centers/lung-transplant/home/orc-20211835'>https://www.mayoclinic.org/departments-centers/lung-transplant/home/orc-20211835</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Kelly Pennington, M.D.</p>
<p>Guest: Sahar Saddoughi, M.D., Ph.D.</p>
<p>The lung is one of the most common organs transplanted, trailing transplants of kidney, liver, and heart, with over 2600 performed in 2022. Lung transplantation may involve transplanting either one or both lungs, and occasionally performed together with a heart transplant. Although some patients with a lung transplant have lived more than 10 years, only about half are alive after 5 years. In this podcast, we’ll discuss “When to Refer a Patient for a Lung Transplant”. Who’s a candidate for a lung transplant and when should we think about this for our patients? How successful is a lung transplant and what are conditions that would exclude a patient from the procedure? These are all questions I’ll be asking my guests, thoracic surgeon, Sahar Saddoughi, M.D., Ph.D., and pulmonologist, Kelly Pennington, M.D., both from the Mayo Clinic in honor of ‘National Donate Life Month’.                 </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
<p><a href='https://www.mayoclinic.org/departments-centers/lung-transplant/home/orc-20211835'>https://www.mayoclinic.org/departments-centers/lung-transplant/home/orc-20211835</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/c6wjpv/WF3560827_When_to_Refer_for_Lung_Transplant_new_music_AFbklp3.mp3" length="33538708" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Kelly Pennington, M.D.
Guest: Sahar Saddoughi, M.D., Ph.D.
The lung is one of the most common organs transplanted, trailing transplants of kidney, liver, and heart, with over 2600 performed in 2022. Lung transplantation may involve transplanting either one or both lungs, and occasionally performed together with a heart transplant. Although some patients with a lung transplant have lived more than 10 years, only about half are alive after 5 years. In this podcast, we’ll discuss “When to Refer a Patient for a Lung Transplant”. Who’s a candidate for a lung transplant and when should we think about this for our patients? How successful is a lung transplant and what are conditions that would exclude a patient from the procedure? These are all questions I’ll be asking my guests, thoracic surgeon, Sahar Saddoughi, M.D., Ph.D., and pulmonologist, Kelly Pennington, M.D., both from the Mayo Clinic in honor of ‘National Donate Life Month’.                 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 
https://www.mayoclinic.org/departments-centers/lung-transplant/home/orc-20211835]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1388</itunes:duration>
                <itunes:episode>488</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Lab Medicine Edition | Electrolytes: Sodium (Hypernatremia, Hyponatremia)</title>
        <itunes:title>Lab Medicine Edition | Electrolytes: Sodium (Hypernatremia, Hyponatremia)</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/lab-medicine-edition-electrolytes-sodium-hypernatremia-hyponatremia/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/lab-medicine-edition-electrolytes-sodium-hypernatremia-hyponatremia/#comments</comments>        <pubDate>Thu, 04 Apr 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/275df96d-7315-3793-8138-dadf9578b8cf</guid>
                                    <description><![CDATA[<p>HOST: Andy Herber, P.A.-C.</p>
<p>GUEST: Mira T. Keddis, M.D.</p>
<p>Join our host, Andy J. Herber, P.A.-C., as he explores Hyponatremia and Hypernatremia; common findings in both the inpatient and outpatient settings. Sodium disorders are associated with an increased morbidity and mortality for patients. Guest, <a href='https://www.mayoclinic.org/biographies/keddis-mira-t-m-d/bio-20055681'>Mira T. Keddis, M.D.</a> , renown Mayo Clinic Nephrologist, joins the podcast to provide guidance on understanding evaluations and management of sodium abnormalities.</p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-lab-medicine-edition'>Mayo Clinic Talks: Lab Medicine Edition | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>HOST: Andy Herber, P.A.-C.</p>
<p>GUEST: Mira T. Keddis, M.D.</p>
<p>Join our host, Andy J. Herber, P.A.-C., as he explores Hyponatremia and Hypernatremia; common findings in both the inpatient and outpatient settings. Sodium disorders are associated with an increased morbidity and mortality for patients. Guest, <a href='https://www.mayoclinic.org/biographies/keddis-mira-t-m-d/bio-20055681'>Mira T. Keddis, M.D.</a> , renown Mayo Clinic Nephrologist, joins the podcast to provide guidance on understanding evaluations and management of sodium abnormalities.</p>
<p><a href='https://ce.mayo.edu/content/mayo-clinic-talks-lab-medicine-edition'>Mayo Clinic Talks: Lab Medicine Edition | Mayo Clinic School of Continuous Professional Development</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/sn8549/WF2792334_Sodium_V2_AF7913v.mp3" length="49709720" type="audio/mpeg"/>
        <itunes:summary><![CDATA[HOST: Andy Herber, P.A.-C.
GUEST: Mira T. Keddis, M.D.
Join our host, Andy J. Herber, P.A.-C., as he explores Hyponatremia and Hypernatremia; common findings in both the inpatient and outpatient settings. Sodium disorders are associated with an increased morbidity and mortality for patients. Guest, Mira T. Keddis, M.D. , renown Mayo Clinic Nephrologist, joins the podcast to provide guidance on understanding evaluations and management of sodium abnormalities.
Mayo Clinic Talks: Lab Medicine Edition | Mayo Clinic School of Continuous Professional Development
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2065</itunes:duration>
                <itunes:episode>487</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>When to Refer a Patient for a Heart Transplant</title>
        <itunes:title>When to Refer a Patient for a Heart Transplant</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/when-to-refer-a-patient-for-heart-a-transplant/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/when-to-refer-a-patient-for-heart-a-transplant/#comments</comments>        <pubDate>Tue, 02 Apr 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/e8941354-e473-3343-8c50-3a5f70bc6f17</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Drew N. Rosenbaum, M.D.</p>
<p>The first heart transplant patient survived only 18 days as the early attempts of heart transplantation were plagued by immune rejection of the transplanted organ. Today, thanks to the many advances in organ transplantation, heart transplant patients typically lead productive lives for years. 75% of heart transplant patients live at least 5 years and nearly 85% return to work. Who’s a candidate for a heart transplant? How long do patients typically wait for a heart transplant and when should we think about a heart transplant for our patients? These are questions I’ll be asking my guest, Drew N. Rosenbaum, M.D., a cardiologist from the <a href='https://www.mayoclinic.org/departments-centers/heart-transplant/home/orc-20211823'>Mayo Clinic</a>. The topic for this podcast is “When to Refer a Patient for a Heart Transplant” in honor of 'National Donate Life Month'.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Drew N. Rosenbaum, M.D.</p>
<p>The first heart transplant patient survived only 18 days as the early attempts of heart transplantation were plagued by immune rejection of the transplanted organ. Today, thanks to the many advances in organ transplantation, heart transplant patients typically lead productive lives for years. 75% of heart transplant patients live at least 5 years and nearly 85% return to work. Who’s a candidate for a heart transplant? How long do patients typically wait for a heart transplant and when should we think about a heart transplant for our patients? These are questions I’ll be asking my guest, Drew N. Rosenbaum, M.D., a cardiologist from the <a href='https://www.mayoclinic.org/departments-centers/heart-transplant/home/orc-20211823'>Mayo Clinic</a>. The topic for this podcast is “When to Refer a Patient for a Heart Transplant” in honor of '<em>National Donate Life Month</em>'.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rt8a6e/WF3440753_When_to_Refer_a_Patient_for_Heart_Transplant_New_music_AFah2j2.mp3" length="32086082" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Drew N. Rosenbaum, M.D.
The first heart transplant patient survived only 18 days as the early attempts of heart transplantation were plagued by immune rejection of the transplanted organ. Today, thanks to the many advances in organ transplantation, heart transplant patients typically lead productive lives for years. 75% of heart transplant patients live at least 5 years and nearly 85% return to work. Who’s a candidate for a heart transplant? How long do patients typically wait for a heart transplant and when should we think about a heart transplant for our patients? These are questions I’ll be asking my guest, Drew N. Rosenbaum, M.D., a cardiologist from the Mayo Clinic. The topic for this podcast is “When to Refer a Patient for a Heart Transplant” in honor of 'National Donate Life Month'.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1328</itunes:duration>
                <itunes:episode>486</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Menopause and Women's Health Edition | Menopause and Sexual Health</title>
        <itunes:title>Menopause and Women's Health Edition | Menopause and Sexual Health</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/menopause-and-womens-health-edition-menopause-and-sexual-health/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/menopause-and-womens-health-edition-menopause-and-sexual-health/#comments</comments>        <pubDate>Thu, 28 Mar 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/a8d92408-bd63-3e70-9349-97a5c34521c3</guid>
                                    <description><![CDATA[<p>HOST - Dawn Marie R. Davis, M.D.</p>
<p>GUEST - Jennifer Vencill, PhD, LP</p>
<p>Sexual health during menopause is often a forgotten topic for female patients. Dr. Jennifer Vencill joins the podcast to discuss common sexual health concerns normal, what to expect, and how to seek assistance for patients in terms of sexual health during menopause and later life.</p>
<p></p>
<p>This episode is brought to you by: <a href='https://www.astellas.com/us/'>https://www.astellas.com/us/ </a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>ce.mayo.edu</a>  or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.  To learn more about this episode:</p>
<p><a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition'>https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>HOST - Dawn Marie R. Davis, M.D.</p>
<p>GUEST - Jennifer Vencill, PhD, LP</p>
<p>Sexual health during menopause is often a forgotten topic for female patients. Dr. Jennifer Vencill joins the podcast to discuss common sexual health concerns normal, what to expect, and how to seek assistance for patients in terms of sexual health during menopause and later life.</p>
<p></p>
<p>This episode is brought to you by: <a href='https://www.astellas.com/us/'>https://www.astellas.com/us/ </a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>ce.mayo.edu</a>  or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.  To learn more about this episode:</p>
<p><a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition'>https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/u4cqns/Ep6_WF3643800_Menopause_and_Female_Sexual_Health_intro_AF91xv6.mp3" length="45258399" type="audio/mpeg"/>
        <itunes:summary><![CDATA[HOST - Dawn Marie R. Davis, M.D.
GUEST - Jennifer Vencill, PhD, LP
Sexual health during menopause is often a forgotten topic for female patients. Dr. Jennifer Vencill joins the podcast to discuss common sexual health concerns normal, what to expect, and how to seek assistance for patients in terms of sexual health during menopause and later life.

This episode is brought to you by: https://www.astellas.com/us/ 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at ce.mayo.edu  or on Twitter @MayoMedEd.  To learn more about this episode:
https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1871</itunes:duration>
                <itunes:episode>483</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Menopause and Women's Health Edition | Hormones and Sexual Health After Cancer</title>
        <itunes:title>Menopause and Women's Health Edition | Hormones and Sexual Health After Cancer</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/menopause-and-womens-health-edition-hormones-and-sexual-health-after-cancer/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/menopause-and-womens-health-edition-hormones-and-sexual-health-after-cancer/#comments</comments>        <pubDate>Thu, 21 Mar 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/539a07a0-43c8-38fe-ae0d-453c808b2708</guid>
                                    <description><![CDATA[<p>HOST - Dawn Marie R. Davis, M.D.</p>
<p>GUEST - Carol Kuhle, DO, MPH </p>
<p>Guest, Dr. Carol Kuhle, joins the podcast to discuss the importance of hormones, hormone regulation, sexual health and hormone driven cancers. The needs of women with cancer and cancer survivors are often overlooked when it comes to the effect of hormones and the outcomes for sexual health and relationships for these patients.</p>
<p></p>
<p>This episode is brought to you by: <a href='https://www.astellas.com/us/'>https://www.astellas.com/us/ </a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>ce.mayo.edu</a>  or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.  To learn more about this episode:</p>
<p><a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition'>https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>HOST - Dawn Marie R. Davis, M.D.</p>
<p>GUEST - Carol Kuhle, DO, MPH </p>
<p>Guest, Dr. Carol Kuhle, joins the podcast to discuss the importance of hormones, hormone regulation, sexual health and hormone driven cancers. The needs of women with cancer and cancer survivors are often overlooked when it comes to the effect of hormones and the outcomes for sexual health and relationships for these patients.</p>
<p></p>
<p>This episode is brought to you by: <a href='https://www.astellas.com/us/'>https://www.astellas.com/us/ </a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>ce.mayo.edu</a>  or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.  To learn more about this episode:</p>
<p><a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition'>https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gbqgzt/Ep5_WF3702154_Hormones_Sexual_Health_after_Cancer_AFaj0ss.mp3" length="48285403" type="audio/mpeg"/>
        <itunes:summary><![CDATA[HOST - Dawn Marie R. Davis, M.D.
GUEST - Carol Kuhle, DO, MPH 
Guest, Dr. Carol Kuhle, joins the podcast to discuss the importance of hormones, hormone regulation, sexual health and hormone driven cancers. The needs of women with cancer and cancer survivors are often overlooked when it comes to the effect of hormones and the outcomes for sexual health and relationships for these patients.

This episode is brought to you by: https://www.astellas.com/us/ 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at ce.mayo.edu  or on Twitter @MayoMedEd.  To learn more about this episode:
https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2007</itunes:duration>
                <itunes:episode>482</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Tuberculosis</title>
        <itunes:title>Tuberculosis</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/tuberculosis/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/tuberculosis/#comments</comments>        <pubDate>Tue, 19 Mar 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/9a8dbdf5-42a6-379c-a65d-b0f6e7149edc</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Zelalem Temesgen, M.D.</p>
<p>It’s thought that a variant of tuberculosis originated in East Africa around 3 million years ago with the current strain of Mycobacterium tuberculosis dating back at least 20,000 years. Although easily spread from one person to another, not everyone infected develops active disease. The management of tuberculosis varies, and although there is a vaccine, it’s not commonly used in the U.S.  Effective pharmacologic treatment is available, however drug-resistant strains have presented challenges in some cases. This podcast is in recognition of World Tuberculosis Day, March 24, the day that Dr. Robert Koch reported Mycobacterium Tuberculosis. We’ll discuss the disease, it’s diagnosis and management with infectious disease specialist and Professor of Medicine, Zelalem Temesgen, M.D., from the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Zelalem Temesgen, M.D.</p>
<p>It’s thought that a variant of tuberculosis originated in East Africa around 3 million years ago with the current strain of Mycobacterium tuberculosis dating back at least 20,000 years. Although easily spread from one person to another, not everyone infected develops active disease. The management of tuberculosis varies, and although there is a vaccine, it’s not commonly used in the U.S.  Effective pharmacologic treatment is available, however drug-resistant strains have presented challenges in some cases. This podcast is in recognition of World Tuberculosis Day, March 24, the day that Dr. Robert Koch reported Mycobacterium Tuberculosis. We’ll discuss the disease, it’s diagnosis and management with infectious disease specialist and Professor of Medicine, Zelalem Temesgen, M.D., from the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hjs6vq/WF4004807_Tuberculosis_AF7gk60.mp3" length="40126327" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Zelalem Temesgen, M.D.
It’s thought that a variant of tuberculosis originated in East Africa around 3 million years ago with the current strain of Mycobacterium tuberculosis dating back at least 20,000 years. Although easily spread from one person to another, not everyone infected develops active disease. The management of tuberculosis varies, and although there is a vaccine, it’s not commonly used in the U.S.  Effective pharmacologic treatment is available, however drug-resistant strains have presented challenges in some cases. This podcast is in recognition of World Tuberculosis Day, March 24, the day that Dr. Robert Koch reported Mycobacterium Tuberculosis. We’ll discuss the disease, it’s diagnosis and management with infectious disease specialist and Professor of Medicine, Zelalem Temesgen, M.D., from the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1664</itunes:duration>
                <itunes:episode>484</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Menopause and Women's Health Edition | Topical and Non-Hormonal Therapies</title>
        <itunes:title>Menopause and Women's Health Edition | Topical and Non-Hormonal Therapies</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/menopause-and-womens-health-edition-topical-and-non-hormonal-therapies/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/menopause-and-womens-health-edition-topical-and-non-hormonal-therapies/#comments</comments>        <pubDate>Thu, 14 Mar 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/a155b8fc-c79e-35ca-9a58-605a250fe0be</guid>
                                    <description><![CDATA[<p>HOST - Dawn Marie R. Davis, M.D.</p>
<p>GUEST - Hannah C. Nordhues, M.D.</p>
<p>GUEST - Amber Klindworth, P.A.-C.</p>
<p>Menopause symptoms for women not only have a personal impact on the individual, but also a public health impact. Studies have shown an annual economic impact of 1.8 billion dollars in lost workdays and 25 billion dollars in medical costs for women coping with the symptoms of menopause. Hannah C. Nordhues, M.D., and Amber Klindworth, P.A.-C., serve as guests to discuss the impact of menopause on everyday life for women and discuss non-hormonal treatment options for these patients.</p>
<p></p>
<p>This episode is brought to you by: <a href='https://www.astellas.com/us/'>https://www.astellas.com/us/ </a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>ce.mayo.edu</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.  To learn more about this episode:</p>
<p><a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition'>https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition</a> </p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>HOST - Dawn Marie R. Davis, M.D.</p>
<p>GUEST - Hannah C. Nordhues, M.D.</p>
<p>GUEST - Amber Klindworth, P.A.-C.</p>
<p>Menopause symptoms for women not only have a personal impact on the individual, but also a public health impact. Studies have shown an annual economic impact of 1.8 billion dollars in lost workdays and 25 billion dollars in medical costs for women coping with the symptoms of menopause. Hannah C. Nordhues, M.D., and Amber Klindworth, P.A.-C., serve as guests to discuss the impact of menopause on everyday life for women and discuss non-hormonal treatment options for these patients.</p>
<p></p>
<p>This episode is brought to you by: <a href='https://www.astellas.com/us/'>https://www.astellas.com/us/ </a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>ce.mayo.edu</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.  To learn more about this episode:</p>
<p><a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition'>https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition</a> </p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dn5zz6/Ep4_WF3736250_Topical_and_NonHormonal_Therapy_intro_AF9o1j2.mp3" length="40875026" type="audio/mpeg"/>
        <itunes:summary><![CDATA[HOST - Dawn Marie R. Davis, M.D.
GUEST - Hannah C. Nordhues, M.D.
GUEST - Amber Klindworth, P.A.-C.
Menopause symptoms for women not only have a personal impact on the individual, but also a public health impact. Studies have shown an annual economic impact of 1.8 billion dollars in lost workdays and 25 billion dollars in medical costs for women coping with the symptoms of menopause. Hannah C. Nordhues, M.D., and Amber Klindworth, P.A.-C., serve as guests to discuss the impact of menopause on everyday life for women and discuss non-hormonal treatment options for these patients.

This episode is brought to you by: https://www.astellas.com/us/ 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at ce.mayo.edu or on Twitter @MayoMedEd.  To learn more about this episode:
https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition 
 ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1699</itunes:duration>
                <itunes:episode>481</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Update in Asthma</title>
        <itunes:title>Update in Asthma</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/update-in-asthma/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/update-in-asthma/#comments</comments>        <pubDate>Tue, 12 Mar 2024 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/af587fb9-1c1b-34af-832e-28b2fc106812</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: John C. Lewis, M.D.</p>
<p>It’s estimated that 25 million people in the U.S. have asthma; this represents about 1 in every 13 individuals. It’s more common in females and is a leading cause of chronic disease in children. Asthma represents a common reason for an outpatient visit and is unfortunately, also a relatively common reason for hospitalization. Although it’s felt that almost all deaths from asthma are preventable with appropriate management, over 3,000 people per year die from asthma. How do we properly evaluate patients we suspect have asthma? What are the goals for their management and what are the current recommendations for treatment? For this podcast we’ll discuss an update in asthma with my guest, John C. Lewis, M.D., from the Division of Allergic Disease at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>ce.mayo.edu</a> access this podcast and more <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-4-online-course'>here</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: John C. Lewis, M.D.</p>
<p>It’s estimated that 25 million people in the U.S. have asthma; this represents about 1 in every 13 individuals. It’s more common in females and is a leading cause of chronic disease in children. Asthma represents a common reason for an outpatient visit and is unfortunately, also a relatively common reason for hospitalization. Although it’s felt that almost all deaths from asthma are preventable with appropriate management, over 3,000 people per year die from asthma. How do we properly evaluate patients we suspect have asthma? What are the goals for their management and what are the current recommendations for treatment? For this podcast we’ll discuss an update in asthma with my guest, John C. Lewis, M.D., from the Division of Allergic Disease at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>ce.mayo.edu</a> access this podcast and more <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-4-online-course'>here</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/s8vmpp/WF2090016_Asthma_Guidelines_new_music_AF9ho33.mp3" length="43773871" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: John C. Lewis, M.D.
It’s estimated that 25 million people in the U.S. have asthma; this represents about 1 in every 13 individuals. It’s more common in females and is a leading cause of chronic disease in children. Asthma represents a common reason for an outpatient visit and is unfortunately, also a relatively common reason for hospitalization. Although it’s felt that almost all deaths from asthma are preventable with appropriate management, over 3,000 people per year die from asthma. How do we properly evaluate patients we suspect have asthma? What are the goals for their management and what are the current recommendations for treatment? For this podcast we’ll discuss an update in asthma with my guest, John C. Lewis, M.D., from the Division of Allergic Disease at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at ce.mayo.edu access this podcast and more here or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1816</itunes:duration>
                <itunes:episode>480</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Menopause &amp; Women's Health Edition | Menopause and Hormonal Therapy</title>
        <itunes:title>Menopause &amp; Women's Health Edition | Menopause and Hormonal Therapy</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/womens-health-menopause-edition-menopause-and-hormonal-therapy/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/womens-health-menopause-edition-menopause-and-hormonal-therapy/#comments</comments>        <pubDate>Thu, 07 Mar 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/5072eed6-9d78-3658-9e93-1fe00585d8d6</guid>
                                    <description><![CDATA[<p>HOST - Dawn Marie R. Davis, M.D. </p>
<p>GUEST - Jewel M. Kling, M.D., M.P.H. </p>
<p>The number of midlife women transitioning into menopause is substantial with more than one million women in the U.S. entering menopause each year. Symptoms such as vasomotor symptoms (VMS), mood and sleep disturbances, and sexual problems are common during the menopause transition, yet often go untreated. Menopausal hormone therapy (HT) is often the preferred and most effective treatment option for menopausal symptoms. Dr. Juliana (Jewel) Kling joins the podcast to discuss this important topic.</p>
<p></p>
<p>This episode is brought to you by: <a href='https://www.astellas.com/us/'>https://www.astellas.com/us/ </a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.  Learn more about this episode at:</p>
<p><a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition'>https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition</a></p>
<p>*Episode Addendum: terminology “micronized progesterone acetate”; said in error: “medroxyprogesterone acetate” </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>HOST - Dawn Marie R. Davis, M.D. </p>
<p>GUEST - Jewel M. Kling, M.D., M.P.H. </p>
<p>The number of midlife women transitioning into menopause is substantial with more than one million women in the U.S. entering menopause each year. Symptoms such as vasomotor symptoms (VMS), mood and sleep disturbances, and sexual problems are common during the menopause transition, yet often go untreated. Menopausal hormone therapy (HT) is often the preferred and most effective treatment option for menopausal symptoms. Dr. Juliana (Jewel) Kling joins the podcast to discuss this important topic.</p>
<p></p>
<p><em>This episode is brought to you by: </em><a href='https://www.astellas.com/us/'><em>https://www.astellas.com/us/ </em></a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.  Learn more about this episode at:</p>
<p><a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition'>https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition</a></p>
<p>*Episode Addendum: terminology “micronized progesterone acetate”; said in error: “medroxyprogesterone acetate” </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rf25ge/Ep3_WF3683933_Menopause_Hormonal_Therapy_intro8jdcx.mp3" length="45387916" type="audio/mpeg"/>
        <itunes:summary><![CDATA[HOST - Dawn Marie R. Davis, M.D. 
GUEST - Jewel M. Kling, M.D., M.P.H. 
The number of midlife women transitioning into menopause is substantial with more than one million women in the U.S. entering menopause each year. Symptoms such as vasomotor symptoms (VMS), mood and sleep disturbances, and sexual problems are common during the menopause transition, yet often go untreated. Menopausal hormone therapy (HT) is often the preferred and most effective treatment option for menopausal symptoms. Dr. Juliana (Jewel) Kling joins the podcast to discuss this important topic.

This episode is brought to you by: https://www.astellas.com/us/ 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.  Learn more about this episode at:
https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition
*Episode Addendum: terminology “micronized progesterone acetate”; said in error: “medroxyprogesterone acetate” ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1888</itunes:duration>
                <itunes:episode>479</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>A Career in Academic Medicine</title>
        <itunes:title>A Career in Academic Medicine</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/a-career-in-academic-medicine/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/a-career-in-academic-medicine/#comments</comments>        <pubDate>Tue, 05 Mar 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/d09777cc-e963-378d-bda6-67769dc78896</guid>
                                    <description><![CDATA[<p>Hosts: Sanj Kakar, M.D., <a href='https://twitter.com/i/flow/login?redirect_after_login=%2Fsanjkakar'>@sanjkakar</a> | Dawn R. Davis, M.D.</p>
<p>Guests: Rondell P. Graham, M.B.B.S. | Laura E. Raffals, M.D. | Sophie J. Bakri, M.D.</p>
<p>A career in academic medicine can be rewarding, but also requires careful consideration to determine the best pathway to pursue. Join hosts Sanj Kakar, M.D. and Dawn Davis, M.D. as they discuss with our guests their personal journeys and lessons learned. Guests for this episode are Sophie J. Bakri, M.D, a Professor and Chair of Ophthalmology in Rochester, MN, Rondell P. Graham, M.B.B.S. a Professor of Laboratory Medicine and Pathology, along with a Consultant Pathologist in Rochester, MN and Laura Raffals, M.D., a Professor of Medicine and Chair of the Operations Coordinating Group for Mayo Clinic.</p>
<p>This episode is a special video offering of Mayo Clinic Talks podcast - To watch the full video please visit: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-4-online-course'>ce.mayo.edu </a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Hosts: Sanj Kakar, M.D., <a href='https://twitter.com/i/flow/login?redirect_after_login=%2Fsanjkakar'>@sanjkakar</a> | Dawn R. Davis, M.D.</p>
<p>Guests: Rondell P. Graham, M.B.B.S. | Laura E. Raffals, M.D. | Sophie J. Bakri, M.D.</p>
<p>A career in academic medicine can be rewarding, but also requires careful consideration to determine the best pathway to pursue. Join hosts Sanj Kakar, M.D. and Dawn Davis, M.D. as they discuss with our guests their personal journeys and lessons learned. Guests for this episode are Sophie J. Bakri, M.D, a Professor and Chair of Ophthalmology in Rochester, MN, Rondell P. Graham, M.B.B.S. a Professor of Laboratory Medicine and Pathology, along with a Consultant Pathologist in Rochester, MN and Laura Raffals, M.D., a Professor of Medicine and Chair of the Operations Coordinating Group for Mayo Clinic.</p>
<p><em>This episode is a special video offering of Mayo Clinic Talks podcast - To watch the full video please visit: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcast-season-4-online-course'>ce.mayo.edu </a></em></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/p7iibd/2023-08-29-MCTalks-CareerinAcademicMed-NL-VF-MP3_AF9rr5e.mp3" length="132422400" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Hosts: Sanj Kakar, M.D., @sanjkakar | Dawn R. Davis, M.D.
Guests: Rondell P. Graham, M.B.B.S. | Laura E. Raffals, M.D. | Sophie J. Bakri, M.D.
A career in academic medicine can be rewarding, but also requires careful consideration to determine the best pathway to pursue. Join hosts Sanj Kakar, M.D. and Dawn Davis, M.D. as they discuss with our guests their personal journeys and lessons learned. Guests for this episode are Sophie J. Bakri, M.D, a Professor and Chair of Ophthalmology in Rochester, MN, Rondell P. Graham, M.B.B.S. a Professor of Laboratory Medicine and Pathology, along with a Consultant Pathologist in Rochester, MN and Laura Raffals, M.D., a Professor of Medicine and Chair of the Operations Coordinating Group for Mayo Clinic.
This episode is a special video offering of Mayo Clinic Talks podcast - To watch the full video please visit: ce.mayo.edu 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3311</itunes:duration>
                <itunes:episode>478</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Menopause and Women's Health Edition | Menopause and Bone Health</title>
        <itunes:title>Menopause and Women's Health Edition | Menopause and Bone Health</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/menopause-and-womens-health-edition-menopause-and-bone-health/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/menopause-and-womens-health-edition-menopause-and-bone-health/#comments</comments>        <pubDate>Thu, 29 Feb 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/7da518e6-e588-3bd2-a5d2-79028815469b</guid>
                                    <description><![CDATA[<p>HOST - Dawn Marie R. Davis, M.D. </p>
<p>GUEST - Suneela Vegunta, M.D. </p>
<p>Dr. Suneela Vegunta joins the podcast to discuss the importance of the protecting the musculoskeletal system in patients during the menopause stage of life. Hormonal decline can have a significant impact on bone density, mobility and independence, causing osteopenia and osteoporosis. Topics covered in this episode include the impact of hormones on bone density, risk factors for osteoporosis and strategies to maintain and protect bone health. </p>
<p>This episode is brought to you by: <a href='https://www.astellas.com/us/'>https://www.astellas.com</a></p>
<p></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.  To learn more about this episode at:</p>
<p><a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition'>https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>HOST - Dawn Marie R. Davis, M.D. </p>
<p>GUEST - Suneela Vegunta, M.D. </p>
<p>Dr. Suneela Vegunta joins the podcast to discuss the importance of the protecting the musculoskeletal system in patients during the menopause stage of life. Hormonal decline can have a significant impact on bone density, mobility and independence, causing osteopenia and osteoporosis. Topics covered in this episode include the impact of hormones on bone density, risk factors for osteoporosis and strategies to maintain and protect bone health. </p>
<p><em>This episode is brought to you by: <a href='https://www.astellas.com/us/'>https://www.astellas.com</a></em></p>
<p></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.  To learn more about this episode at:</p>
<p><a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition'>https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/94ymhf/Ep2_WF3675968_Menopause_and_Bone_Health_intro90t9f.mp3" length="44847857" type="audio/mpeg"/>
        <itunes:summary><![CDATA[HOST - Dawn Marie R. Davis, M.D. 
GUEST - Suneela Vegunta, M.D. 
Dr. Suneela Vegunta joins the podcast to discuss the importance of the protecting the musculoskeletal system in patients during the menopause stage of life. Hormonal decline can have a significant impact on bone density, mobility and independence, causing osteopenia and osteoporosis. Topics covered in this episode include the impact of hormones on bone density, risk factors for osteoporosis and strategies to maintain and protect bone health. 
This episode is brought to you by: https://www.astellas.com

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.  To learn more about this episode at:
https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1865</itunes:duration>
                <itunes:episode>477</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Menopause and Women's Health Edition | Introduction to Menopause</title>
        <itunes:title>Menopause and Women's Health Edition | Introduction to Menopause</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/menopause-and-womens-health-edition-introduction-to-menopause/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/menopause-and-womens-health-edition-introduction-to-menopause/#comments</comments>        <pubDate>Tue, 27 Feb 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/c4ff0cfc-4015-3133-bdda-4150c66872d2</guid>
                                    <description><![CDATA[<p class="Default">HOST - Dawn Marie R. Davis, M.D. </p>
<p class="Default">GUEST - Jackie M. Thielen, M.D.</p>
<p>Menopausal concerns in women have been often neglected due to uncertainty and misunderstanding. The goal of this podcast is to offer clarity regarding the basics of menopause. Guest Dr. Jackie Thielen, who is the founding medical director for the Women's Health Specialty Clinic on the Mayo Clinic Florida campus, is the guest speaker kicking off this women’s health mini-series focusing on Menopause.  </p>
<p>This episode is brought to you by: <a href='https://www.astellas.com/us/'>https://www.astellas.com</a></p>
<p></p>
<p class="Default">Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.  To learn more about this episode at:</p>
<p class="Default"><a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition'>https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition</a>  </p>
]]></description>
                                                            <content:encoded><![CDATA[<p class="Default">HOST - Dawn Marie R. Davis, M.D. </p>
<p class="Default">GUEST - Jackie M. Thielen, M.D.</p>
<p>Menopausal concerns in women have been often neglected due to uncertainty and misunderstanding. The goal of this podcast is to offer clarity regarding the basics of menopause. Guest Dr. Jackie Thielen, who is the founding medical director for the Women's Health Specialty Clinic on the Mayo Clinic Florida campus, is the guest speaker kicking off this women’s health mini-series focusing on Menopause.  </p>
<p><em>This episode is brought to you by: <a href='https://www.astellas.com/us/'>https://www.astellas.com</a></em></p>
<p></p>
<p class="Default">Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.  To learn more about this episode at:</p>
<p class="Default"><a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition'>https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition</a>  </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bev5z6/Ep1_WF3925979_Intro_to_Menopause_Intro63k94.mp3" length="47440786" type="audio/mpeg"/>
        <itunes:summary><![CDATA[HOST - Dawn Marie R. Davis, M.D. 
GUEST - Jackie M. Thielen, M.D.
Menopausal concerns in women have been often neglected due to uncertainty and misunderstanding. The goal of this podcast is to offer clarity regarding the basics of menopause. Guest Dr. Jackie Thielen, who is the founding medical director for the Women's Health Specialty Clinic on the Mayo Clinic Florida campus, is the guest speaker kicking off this women’s health mini-series focusing on Menopause.  
This episode is brought to you by: https://www.astellas.com

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.  To learn more about this episode at:
https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition  ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1972</itunes:duration>
                <itunes:episode>476</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Identifying and Treating Thyroid Disorders</title>
        <itunes:title>Identifying and Treating Thyroid Disorders</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/identifying-and-treating-thyroid-disorders/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/identifying-and-treating-thyroid-disorders/#comments</comments>        <pubDate>Tue, 20 Feb 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/29de7ce9-566c-3526-af84-4b50ffa04c14</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: M. Regina Castro, M.D.</p>
<p>It’s estimated that at least 12% of the U.S. population have some form of thyroid disorder. It’s more common in women and well over half of all patients with a thyroid dysfunction don’t know they have a problem. We encounter patients with hypothyroidism often; especially sub-clinical hypothyroidism and thyroid nodules are also found frequently. What do we need to consider when contemplating thyroid replacement therapy in a patient? How long do we need to re-image thyroid nodules? And when should we refer a patient with a thyroid nodule for a fine needle aspirate? In this podcast, I’ll discuss these questions and more with M. Regina Castro, M.D., from the Division of Endocrinology and Metabolism at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: M. Regina Castro, M.D.</p>
<p>It’s estimated that at least 12% of the U.S. population have some form of thyroid disorder. It’s more common in women and well over half of all patients with a thyroid dysfunction don’t know they have a problem. We encounter patients with hypothyroidism often; especially sub-clinical hypothyroidism and thyroid nodules are also found frequently. What do we need to consider when contemplating thyroid replacement therapy in a patient? How long do we need to re-image thyroid nodules? And when should we refer a patient with a thyroid nodule for a fine needle aspirate? In this podcast, I’ll discuss these questions and more with M. Regina Castro, M.D., from the Division of Endocrinology and Metabolism at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vuqukn/WF2189578_Thyroid_Problems_V2_AF8u45q.mp3" length="38539490" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: M. Regina Castro, M.D.
It’s estimated that at least 12% of the U.S. population have some form of thyroid disorder. It’s more common in women and well over half of all patients with a thyroid dysfunction don’t know they have a problem. We encounter patients with hypothyroidism often; especially sub-clinical hypothyroidism and thyroid nodules are also found frequently. What do we need to consider when contemplating thyroid replacement therapy in a patient? How long do we need to re-image thyroid nodules? And when should we refer a patient with a thyroid nodule for a fine needle aspirate? In this podcast, I’ll discuss these questions and more with M. Regina Castro, M.D., from the Division of Endocrinology and Metabolism at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1602</itunes:duration>
                <itunes:episode>475</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/WF3911563-MCTalks-1080x1080_d8fbx5.jpg" />    </item>
    <item>
        <title>Rheumatology Edition | Temporal Arteritis</title>
        <itunes:title>Rheumatology Edition | Temporal Arteritis</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/rheumatology-edition-temporal-arteritis/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/rheumatology-edition-temporal-arteritis/#comments</comments>        <pubDate>Thu, 15 Feb 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/02c64130-b439-3539-bc04-da0b02b8a176</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka. M.D.; <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Cornelia M. Weyand, M.D., Ph.D.</p>
<p>Guest: Kenneth J. Warrington, M.D.</p>
<p>Rheumatologic problems are some of the most common health conditions we see as primary care professionals. In many cases, taking months and sometimes years to properly diagnose, rheumatologic conditions can become frustrating for both the provider and the patient. There are a variety of new tests available to help us establish a diagnosis, as well as multiple new and effective treatment options. This episode is part of a seven-episode mini-series on Mayo Clinic Talks dedicated to rheumatologic health problems to aid in the recognition, diagnosis, and treatment for your patients. Please find these episodes where you listen to podcasts or on ce.mayo.edu.</p>
<p>Temporal arteritis is an inflammatory rheumatologic disorder that typically occurs in those over the age of 50. It can have devastating complications including loss of vision and stroke. It can have various presentations and at times can be challenging to diagnose. It also has an interesting relationship with polymyalgia rheumatica. Although there are abnormal lab tests associated with temporal arteritis, there is no one diagnostic test. A temporal artery biopsy is performed to establish a definitive diagnosis. Our topic for today’s podcast is temporal arteritis and my guests include Cornelia M. Weyand, M.D., Ph.D. and Kenneth J. Warrington, M.D., both from the Division of Rheumatology at the Mayo Clinic. We’ll discuss the typical symptoms of temporal arteritis, its potential complications, how to make a diagnosis and its treatment.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. Learn more about our Rheumatology Edition here: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-rheumatology-edition'>https://ce.mayo.edu/content/mayo-clinic-talks-rheumatology-edition</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka. M.D.; <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Cornelia M. Weyand, M.D., Ph.D.</p>
<p>Guest: Kenneth J. Warrington, M.D.</p>
<p>Rheumatologic problems are some of the most common health conditions we see as primary care professionals. In many cases, taking months and sometimes years to properly diagnose, rheumatologic conditions can become frustrating for both the provider and the patient. There are a variety of new tests available to help us establish a diagnosis, as well as multiple new and effective treatment options. This episode is part of a seven-episode mini-series on Mayo Clinic Talks dedicated to rheumatologic health problems to aid in the recognition, diagnosis, and treatment for your patients. Please find these episodes where you listen to podcasts or on ce.mayo.edu.</p>
<p>Temporal arteritis is an inflammatory rheumatologic disorder that typically occurs in those over the age of 50. It can have devastating complications including loss of vision and stroke. It can have various presentations and at times can be challenging to diagnose. It also has an interesting relationship with polymyalgia rheumatica. Although there are abnormal lab tests associated with temporal arteritis, there is no one diagnostic test. A temporal artery biopsy is performed to establish a definitive diagnosis. Our topic for today’s podcast is temporal arteritis and my guests include Cornelia M. Weyand, M.D., Ph.D. and Kenneth J. Warrington, M.D., both from the Division of Rheumatology at the Mayo Clinic. We’ll discuss the typical symptoms of temporal arteritis, its potential complications, how to make a diagnosis and its treatment.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. Learn more about our Rheumatology Edition here: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-rheumatology-edition'>https://ce.mayo.edu/content/mayo-clinic-talks-rheumatology-edition</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qqbh7b/WF2663823_Temporal_Arteritis_music_and_intro_AFbl5xl.mp3" length="45237264" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka. M.D.; [@chutkaMD]
Guest: Cornelia M. Weyand, M.D., Ph.D.
Guest: Kenneth J. Warrington, M.D.
Rheumatologic problems are some of the most common health conditions we see as primary care professionals. In many cases, taking months and sometimes years to properly diagnose, rheumatologic conditions can become frustrating for both the provider and the patient. There are a variety of new tests available to help us establish a diagnosis, as well as multiple new and effective treatment options. This episode is part of a seven-episode mini-series on Mayo Clinic Talks dedicated to rheumatologic health problems to aid in the recognition, diagnosis, and treatment for your patients. Please find these episodes where you listen to podcasts or on ce.mayo.edu.
Temporal arteritis is an inflammatory rheumatologic disorder that typically occurs in those over the age of 50. It can have devastating complications including loss of vision and stroke. It can have various presentations and at times can be challenging to diagnose. It also has an interesting relationship with polymyalgia rheumatica. Although there are abnormal lab tests associated with temporal arteritis, there is no one diagnostic test. A temporal artery biopsy is performed to establish a definitive diagnosis. Our topic for today’s podcast is temporal arteritis and my guests include Cornelia M. Weyand, M.D., Ph.D. and Kenneth J. Warrington, M.D., both from the Division of Rheumatology at the Mayo Clinic. We’ll discuss the typical symptoms of temporal arteritis, its potential complications, how to make a diagnosis and its treatment.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. Learn more about our Rheumatology Edition here: https://ce.mayo.edu/content/mayo-clinic-talks-rheumatology-edition ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1864</itunes:duration>
                <itunes:episode>474</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Outpatient Antibiotic Stewardship</title>
        <itunes:title>Outpatient Antibiotic Stewardship</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/outpatient-antibiotic-stewardship/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/outpatient-antibiotic-stewardship/#comments</comments>        <pubDate>Tue, 13 Feb 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/2d68b529-ef87-3c4e-8628-eddeccbfcf9d</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Kelsey L. Jensen, Pharm.D., R.Ph.</p>
<p>Guest: Daniel Ilges, Pharm.D., R.Ph., BCIPD</p>
<p>The appropriate use of antibiotics is important for a variety of reasons. It helps keep our patients safe, helps maintain antibiotic effectiveness in treating bacterial infections, and helps control the cost of patient care. Very few new antibiotics have been introduced in the past few decades. Because of this, as well as the accelerated emergence of antibiotic resistance, it’s more important than ever that we practice careful and responsible use of antibiotics. Antibiotic stewardship is the effort to measure and improve how antibiotics are prescribed by clinicians and used by patients. This podcast will focus on out-patient antibiotic stewardship and my guests include Kelsey L. Jensen, Pharm.D., R.Ph., and Daniel Ilges, Pharm.D., R.Ph., BCIPD, both pharmacists at the Mayo Clinic. We’ll discuss how antibiotics are often prescribed incorrectly, the barriers we face as clinicians in prescribing antibiotics and how we can all improve our antibiotic stewardship.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Kelsey L. Jensen, Pharm.D., R.Ph.</p>
<p>Guest: Daniel Ilges, Pharm.D., R.Ph., BCIPD</p>
<p>The appropriate use of antibiotics is important for a variety of reasons. It helps keep our patients safe, helps maintain antibiotic effectiveness in treating bacterial infections, and helps control the cost of patient care. Very few new antibiotics have been introduced in the past few decades. Because of this, as well as the accelerated emergence of antibiotic resistance, it’s more important than ever that we practice careful and responsible use of antibiotics. Antibiotic stewardship is the effort to measure and improve how antibiotics are prescribed by clinicians and used by patients. This podcast will focus on out-patient antibiotic stewardship and my guests include Kelsey L. Jensen, Pharm.D., R.Ph., and Daniel Ilges, Pharm.D., R.Ph., BCIPD, both pharmacists at the Mayo Clinic. We’ll discuss how antibiotics are often prescribed incorrectly, the barriers we face as clinicians in prescribing antibiotics and how we can all improve our antibiotic stewardship.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zgk6ut/WF2766259_Outpatient_Antibiotic_Stewardship_V2_AF9iqzk.mp3" length="33236155" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Kelsey L. Jensen, Pharm.D., R.Ph.
Guest: Daniel Ilges, Pharm.D., R.Ph., BCIPD
The appropriate use of antibiotics is important for a variety of reasons. It helps keep our patients safe, helps maintain antibiotic effectiveness in treating bacterial infections, and helps control the cost of patient care. Very few new antibiotics have been introduced in the past few decades. Because of this, as well as the accelerated emergence of antibiotic resistance, it’s more important than ever that we practice careful and responsible use of antibiotics. Antibiotic stewardship is the effort to measure and improve how antibiotics are prescribed by clinicians and used by patients. This podcast will focus on out-patient antibiotic stewardship and my guests include Kelsey L. Jensen, Pharm.D., R.Ph., and Daniel Ilges, Pharm.D., R.Ph., BCIPD, both pharmacists at the Mayo Clinic. We’ll discuss how antibiotics are often prescribed incorrectly, the barriers we face as clinicians in prescribing antibiotics and how we can all improve our antibiotic stewardship.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1382</itunes:duration>
                <itunes:episode>473</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Rheumatology Edition | What Primary Care Providers Need to Know About Polymyalgia Rheumatica</title>
        <itunes:title>Rheumatology Edition | What Primary Care Providers Need to Know About Polymyalgia Rheumatica</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/rheumatology-edition-what-primary-care-providers-need-to-know-about-polymyalgia-rheumatica/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/rheumatology-edition-what-primary-care-providers-need-to-know-about-polymyalgia-rheumatica/#comments</comments>        <pubDate>Thu, 08 Feb 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/28d51edc-2cbd-3fb8-b9d1-c20936ff3db6</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka. M.D.; <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Cornelia M. Weyand, M.D., Ph.D.</p>
<p>Guest: Kenneth J. Warrington, M.D.</p>
<p>Rheumatologic problems are some of the most common health conditions we see as primary care professionals. In many cases, taking months and sometimes years to properly diagnose, rheumatologic conditions can become frustrating for both the provider and the patient. There are a variety of new tests available to help us establish a diagnosis, as well as multiple new and effective treatment options. This episode is part of a seven-episode mini-series on Mayo Clinic Talks dedicated to rheumatologic health problems to aid in the recognition, diagnosis, and treatment for your patients. Please find these episodes where you listen to podcasts or on ce.mayo.edu.</p>
<p>Polymyalgia rheumatica was first described in 1966 as a case report. It can have a wide range of symptoms and at times, can be challenging to diagnose. As with most rheumatologic disorders, the exact cause isn’t known. While there are no specific laboratory tests which establish a diagnosis, there are some that are very useful. One of the most important features of polymyalgia is its relationship with vasculitis and temporal arteritis. In this podcast, we’ll discuss polymyalgia rheumatica with rheumatologists Cornelia M. Weyand, M.D., Ph.D., and Kenneth J. Warrington, M.D., from the Mayo Clinic. We’ll review the typical presenting symptoms, how to establish a diagnosis, helpful laboratory tests and its management.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. Learn more about our Rheumatology Edition here: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-rheumatology-edition'>https://ce.mayo.edu/content/mayo-clinic-talks-rheumatology-edition</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka. M.D.; <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Cornelia M. Weyand, M.D., Ph.D.</p>
<p>Guest: Kenneth J. Warrington, M.D.</p>
<p>Rheumatologic problems are some of the most common health conditions we see as primary care professionals. In many cases, taking months and sometimes years to properly diagnose, rheumatologic conditions can become frustrating for both the provider and the patient. There are a variety of new tests available to help us establish a diagnosis, as well as multiple new and effective treatment options. This episode is part of a seven-episode mini-series on Mayo Clinic Talks dedicated to rheumatologic health problems to aid in the recognition, diagnosis, and treatment for your patients. Please find these episodes where you listen to podcasts or on ce.mayo.edu.</p>
<p>Polymyalgia rheumatica was first described in 1966 as a case report. It can have a wide range of symptoms and at times, can be challenging to diagnose. As with most rheumatologic disorders, the exact cause isn’t known. While there are no specific laboratory tests which establish a diagnosis, there are some that are very useful. One of the most important features of polymyalgia is its relationship with vasculitis and temporal arteritis. In this podcast, we’ll discuss polymyalgia rheumatica with rheumatologists Cornelia M. Weyand, M.D., Ph.D., and Kenneth J. Warrington, M.D., from the Mayo Clinic. We’ll review the typical presenting symptoms, how to establish a diagnosis, helpful laboratory tests and its management.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. Learn more about our Rheumatology Edition here: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-rheumatology-edition'>https://ce.mayo.edu/content/mayo-clinic-talks-rheumatology-edition</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ca8ukf/WF2535123_GCA_PMR_music_and_intro920dk.mp3" length="44970599" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka. M.D.; [@chutkaMD]
Guest: Cornelia M. Weyand, M.D., Ph.D.
Guest: Kenneth J. Warrington, M.D.
Rheumatologic problems are some of the most common health conditions we see as primary care professionals. In many cases, taking months and sometimes years to properly diagnose, rheumatologic conditions can become frustrating for both the provider and the patient. There are a variety of new tests available to help us establish a diagnosis, as well as multiple new and effective treatment options. This episode is part of a seven-episode mini-series on Mayo Clinic Talks dedicated to rheumatologic health problems to aid in the recognition, diagnosis, and treatment for your patients. Please find these episodes where you listen to podcasts or on ce.mayo.edu.
Polymyalgia rheumatica was first described in 1966 as a case report. It can have a wide range of symptoms and at times, can be challenging to diagnose. As with most rheumatologic disorders, the exact cause isn’t known. While there are no specific laboratory tests which establish a diagnosis, there are some that are very useful. One of the most important features of polymyalgia is its relationship with vasculitis and temporal arteritis. In this podcast, we’ll discuss polymyalgia rheumatica with rheumatologists Cornelia M. Weyand, M.D., Ph.D., and Kenneth J. Warrington, M.D., from the Mayo Clinic. We’ll review the typical presenting symptoms, how to establish a diagnosis, helpful laboratory tests and its management.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. Learn more about our Rheumatology Edition here: https://ce.mayo.edu/content/mayo-clinic-talks-rheumatology-edition ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1871</itunes:duration>
                <itunes:episode>472</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Chest Pain: What’s the Best Test?</title>
        <itunes:title>Chest Pain: What’s the Best Test?</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/chest-pain-what-s-the-best-test/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/chest-pain-what-s-the-best-test/#comments</comments>        <pubDate>Tue, 06 Feb 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/0ae0e826-dce7-3f77-9e6c-3666b5ea0e7a</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Katie A. Young, MD</p>
<p>We now have a variety of tests to assess patients who present with chest pain. These tests include such basic assessment tools such as a resting ECG to the most invasive of cardiac tests, a coronary angiogram. But there are multiple tests in between these two extremes. Each have their specific benefits and limitations. Which test or tests should we order for patients with chest pain? What are the potential risks of these tests to the patient? In this podcast, we’ll discuss these questions and more with cardiologist Katie A. Young, M.D., from the Department of Cardiovascular Disease from the Mayo Clinic. The topic for today’s podcast is “Chest Pain: What’s the Best Test?”</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Katie A. Young, MD</p>
<p>We now have a variety of tests to assess patients who present with chest pain. These tests include such basic assessment tools such as a resting ECG to the most invasive of cardiac tests, a coronary angiogram. But there are multiple tests in between these two extremes. Each have their specific benefits and limitations. Which test or tests should we order for patients with chest pain? What are the potential risks of these tests to the patient? In this podcast, we’ll discuss these questions and more with cardiologist Katie A. Young, M.D., from the Department of Cardiovascular Disease from the Mayo Clinic. The topic for today’s podcast is “Chest Pain: What’s the Best Test?”</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cddbae/WF3334387_Chest_Pain-What_s_the_Best_Test_V2_AF7ewe3.mp3" length="34064747" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Katie A. Young, MD
We now have a variety of tests to assess patients who present with chest pain. These tests include such basic assessment tools such as a resting ECG to the most invasive of cardiac tests, a coronary angiogram. But there are multiple tests in between these two extremes. Each have their specific benefits and limitations. Which test or tests should we order for patients with chest pain? What are the potential risks of these tests to the patient? In this podcast, we’ll discuss these questions and more with cardiologist Katie A. Young, M.D., from the Department of Cardiovascular Disease from the Mayo Clinic. The topic for today’s podcast is “Chest Pain: What’s the Best Test?”
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1416</itunes:duration>
                <itunes:episode>471</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Rheumatology Edition | Sjogren’s Syndrome “The Basics”</title>
        <itunes:title>Rheumatology Edition | Sjogren’s Syndrome “The Basics”</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/rheumatology-edition-sjogren-s-syndrome-the-basics/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/rheumatology-edition-sjogren-s-syndrome-the-basics/#comments</comments>        <pubDate>Thu, 01 Feb 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/40be50b0-2136-3167-9ee7-b37f93eac176</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka. M.D.; <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Alicia M. Hinze, M.D., M.H.S.</p>
<p>Rheumatologic problems are some of the most common health conditions we see as primary care professionals. In many cases, taking months and sometimes years to properly diagnose, rheumatologic conditions can become frustrating for both the provider and the patient. There are a variety of new tests available to help us establish a diagnosis, as well as multiple new and effective treatment options. This episode is part of a seven-episode mini-series on Mayo Clinic Talks dedicated to rheumatologic health problems to aid in the recognition, diagnosis, and treatment for your patients. Please find these episodes where you listen to podcasts or on ce.mayo.edu.</p>
<p>Sjogren’s is an autoimmune disorder that has a somewhat unusual presentation. In addition to arthralgias, patients often develop a dry mouth and dry eyes and symptoms can vary from person to person. It also commonly mimics other medical conditions, and this may account for its typically delayed diagnosis. Like most other autoimmune diseases, the exact cause isn’t known, but Sjogren’s is treatable. In this podcast, we’ll review the presentation of Sjogren’s, how to establish a diagnosis and how patients with the condition should be managed. Our guest is Alicia M. Hinze, M.D., M.H.S., from the Division of Rheumatology at the Mayo Clinic.  </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. Learn more about our Rheumatology Edition here: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-rheumatology-edition'>https://ce.mayo.edu/content/mayo-clinic-talks-rheumatology-edition</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka. M.D.; <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Alicia M. Hinze, M.D., M.H.S.</p>
<p>Rheumatologic problems are some of the most common health conditions we see as primary care professionals. In many cases, taking months and sometimes years to properly diagnose, rheumatologic conditions can become frustrating for both the provider and the patient. There are a variety of new tests available to help us establish a diagnosis, as well as multiple new and effective treatment options. This episode is part of a seven-episode mini-series on Mayo Clinic Talks dedicated to rheumatologic health problems to aid in the recognition, diagnosis, and treatment for your patients. Please find these episodes where you listen to podcasts or on ce.mayo.edu.</p>
<p>Sjogren’s is an autoimmune disorder that has a somewhat unusual presentation. In addition to arthralgias, patients often develop a dry mouth and dry eyes and symptoms can vary from person to person. It also commonly mimics other medical conditions, and this may account for its typically delayed diagnosis. Like most other autoimmune diseases, the exact cause isn’t known, but Sjogren’s is treatable. In this podcast, we’ll review the presentation of Sjogren’s, how to establish a diagnosis and how patients with the condition should be managed. Our guest is Alicia M. Hinze, M.D., M.H.S., from the Division of Rheumatology at the Mayo Clinic.  </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. Learn more about our Rheumatology Edition here: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-rheumatology-edition'>https://ce.mayo.edu/content/mayo-clinic-talks-rheumatology-edition</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nt3p22/WF2529859_Sjogren_s_Syndrome_music_and_introadpe4.mp3" length="37360339" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka. M.D.; [@chutkaMD]
Guest: Alicia M. Hinze, M.D., M.H.S.
Rheumatologic problems are some of the most common health conditions we see as primary care professionals. In many cases, taking months and sometimes years to properly diagnose, rheumatologic conditions can become frustrating for both the provider and the patient. There are a variety of new tests available to help us establish a diagnosis, as well as multiple new and effective treatment options. This episode is part of a seven-episode mini-series on Mayo Clinic Talks dedicated to rheumatologic health problems to aid in the recognition, diagnosis, and treatment for your patients. Please find these episodes where you listen to podcasts or on ce.mayo.edu.
Sjogren’s is an autoimmune disorder that has a somewhat unusual presentation. In addition to arthralgias, patients often develop a dry mouth and dry eyes and symptoms can vary from person to person. It also commonly mimics other medical conditions, and this may account for its typically delayed diagnosis. Like most other autoimmune diseases, the exact cause isn’t known, but Sjogren’s is treatable. In this podcast, we’ll review the presentation of Sjogren’s, how to establish a diagnosis and how patients with the condition should be managed. Our guest is Alicia M. Hinze, M.D., M.H.S., from the Division of Rheumatology at the Mayo Clinic.  
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. Learn more about our Rheumatology Edition here: https://ce.mayo.edu/content/mayo-clinic-talks-rheumatology-edition ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1538</itunes:duration>
                <itunes:episode>470</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Blood Donation and How it Relates to Primary Care</title>
        <itunes:title>Blood Donation and How it Relates to Primary Care</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/blood-donation-and-how-it-relates-to-primary-care/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/blood-donation-and-how-it-relates-to-primary-care/#comments</comments>        <pubDate>Tue, 30 Jan 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/a45b9adc-0dd4-345e-9b25-3d6c4ffdf136</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka. M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Justin E. Juskewitch, M.D., Ph.D.</p>
<p>January is National Blood Donor Month | Here are a few interesting facts regarding blood donations:</p>
<p>Over 4.5 million American lives are saved each year by blood transfusion and approximately 40,000 units of donated blood are used each day in the U.S.  A single individual involved in a motor vehicle accident can easily require over 100 units of blood.  We each have about 10 units of blood in our body and each donation represents about one unit. Surprisingly, only 38% of the population is eligible to donate blood and of these eligible individuals, only 5%, actually donate. The topic for this podcast is “Blood Donation and How it Relates to Primary Care” and my guest is Justin E. Juskewitch, M.D., Ph.D., from Transfusion Medicine at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka. M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Justin E. Juskewitch, M.D., Ph.D.</p>
<p>January is National Blood Donor Month | Here are a few interesting facts regarding blood donations:</p>
<p>Over 4.5 million American lives are saved each year by blood transfusion and approximately 40,000 units of donated blood are used each day in the U.S.  A single individual involved in a motor vehicle accident can easily require over 100 units of blood.  We each have about 10 units of blood in our body and each donation represents about one unit. Surprisingly, only 38% of the population is eligible to donate blood and of these eligible individuals, only 5%, actually donate. The topic for this podcast is “Blood Donation and How it Relates to Primary Care” and my guest is Justin E. Juskewitch, M.D., Ph.D., from Transfusion Medicine at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/45hsjh/WF3605334_Blood_Donation_V2b5kyh.mp3" length="40403774" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka. M.D. [@chutkaMD]
Guest: Justin E. Juskewitch, M.D., Ph.D.
January is National Blood Donor Month | Here are a few interesting facts regarding blood donations:
Over 4.5 million American lives are saved each year by blood transfusion and approximately 40,000 units of donated blood are used each day in the U.S.  A single individual involved in a motor vehicle accident can easily require over 100 units of blood.  We each have about 10 units of blood in our body and each donation represents about one unit. Surprisingly, only 38% of the population is eligible to donate blood and of these eligible individuals, only 5%, actually donate. The topic for this podcast is “Blood Donation and How it Relates to Primary Care” and my guest is Justin E. Juskewitch, M.D., Ph.D., from Transfusion Medicine at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1677</itunes:duration>
                <itunes:episode>469</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Rheumatology Edition | When to Suspect (RA) Rheumatoid Arthritis</title>
        <itunes:title>Rheumatology Edition | When to Suspect (RA) Rheumatoid Arthritis</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/rheumatology-edition-when-to-suspect-ra-rheumatoid-arthritis/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/rheumatology-edition-when-to-suspect-ra-rheumatoid-arthritis/#comments</comments>        <pubDate>Thu, 25 Jan 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/f2aad581-b2b0-374e-9c76-df28783eedc6</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka. M.D.; <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Vanessa L. Kronzer, M.D.</p>
<p>Rheumatologic problems are some of the most common health conditions we see as primary care professionals. In many cases, taking months and sometimes years to properly diagnose, rheumatologic conditions can become frustrating for both the provider and the patient. There are a variety of new tests available to help us establish a diagnosis, as well as multiple new and effective treatment options. This episode is part of a seven-episode mini-series on Mayo Clinic Talks dedicated to rheumatologic health problems to aid in the recognition, diagnosis, and treatment for your patients. Please find these episodes where you listen to podcasts or on ce.mayo.edu.</p>
<p>Rheumatoid arthritis is a chronic inflammatory, autoimmune disorder. While it typically results in a symmetric and erosive arthritis, many patients have an atypical presentation and up to 40% of those with rheumatoid arthritis have extra-articular manifestations. It tends to be progressive over years and can be quite debilitating. Fortunately, there are some new treatments available which have given our patients hope of a remission from this disease. This podcast will explore rheumatoid arthritis and we’ll discuss its clinical manifestations, how to establish a diagnosis and its management. Our guest is Vanessa L. Kronzer, M.D., from the Division of Rheumatology at the Mayo Clinic. </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. Learn more about our Rheumatology Edition here: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-rheumatology-edition'>https://ce.mayo.edu/content/mayo-clinic-talks-rheumatology-edition</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka. M.D.; <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Vanessa L. Kronzer, M.D.</p>
<p>Rheumatologic problems are some of the most common health conditions we see as primary care professionals. In many cases, taking months and sometimes years to properly diagnose, rheumatologic conditions can become frustrating for both the provider and the patient. There are a variety of new tests available to help us establish a diagnosis, as well as multiple new and effective treatment options. This episode is part of a seven-episode mini-series on Mayo Clinic Talks dedicated to rheumatologic health problems to aid in the recognition, diagnosis, and treatment for your patients. Please find these episodes where you listen to podcasts or on ce.mayo.edu.</p>
<p>Rheumatoid arthritis is a chronic inflammatory, autoimmune disorder. While it typically results in a symmetric and erosive arthritis, many patients have an atypical presentation and up to 40% of those with rheumatoid arthritis have extra-articular manifestations. It tends to be progressive over years and can be quite debilitating. Fortunately, there are some new treatments available which have given our patients hope of a remission from this disease. This podcast will explore rheumatoid arthritis and we’ll discuss its clinical manifestations, how to establish a diagnosis and its management. Our guest is Vanessa L. Kronzer, M.D., from the Division of Rheumatology at the Mayo Clinic. </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. Learn more about our Rheumatology Edition here: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-rheumatology-edition'>https://ce.mayo.edu/content/mayo-clinic-talks-rheumatology-edition</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9dqp8d/WF2535050_When_to_Supspect_RA_music_and_intro_AFbdxkh.mp3" length="33536600" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka. M.D.; [@chutkaMD]
Guest: Vanessa L. Kronzer, M.D.
Rheumatologic problems are some of the most common health conditions we see as primary care professionals. In many cases, taking months and sometimes years to properly diagnose, rheumatologic conditions can become frustrating for both the provider and the patient. There are a variety of new tests available to help us establish a diagnosis, as well as multiple new and effective treatment options. This episode is part of a seven-episode mini-series on Mayo Clinic Talks dedicated to rheumatologic health problems to aid in the recognition, diagnosis, and treatment for your patients. Please find these episodes where you listen to podcasts or on ce.mayo.edu.
Rheumatoid arthritis is a chronic inflammatory, autoimmune disorder. While it typically results in a symmetric and erosive arthritis, many patients have an atypical presentation and up to 40% of those with rheumatoid arthritis have extra-articular manifestations. It tends to be progressive over years and can be quite debilitating. Fortunately, there are some new treatments available which have given our patients hope of a remission from this disease. This podcast will explore rheumatoid arthritis and we’ll discuss its clinical manifestations, how to establish a diagnosis and its management. Our guest is Vanessa L. Kronzer, M.D., from the Division of Rheumatology at the Mayo Clinic. 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. Learn more about our Rheumatology Edition here: https://ce.mayo.edu/content/mayo-clinic-talks-rheumatology-edition ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1387</itunes:duration>
                <itunes:episode>468</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Update in Cervical Cancer Screening</title>
        <itunes:title>Update in Cervical Cancer Screening</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/update-in-cervical-cancer-screening/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/update-in-cervical-cancer-screening/#comments</comments>        <pubDate>Tue, 23 Jan 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/f513df22-9498-3900-8cff-dbd813bbd40b</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D., <a href='https://twitter.com/chutkamd'>@ChutkaMD</a></p>
<p>Guest: Evelyn A. Reynolds, M.D.</p>
<p>January is Cervical Cancer Awareness Month | Cervical cancer is the fourth most common malignancy in women worldwide, although the number of new cases in the U.S. has been declining. The vast majority of cervical cancers are caused by infection with the Human Papilloma Virus. Due to a combination of HPV immunization and early detection with cervical cancer screening, advanced cases are becoming much less common and when detected early, cervical cancer is one of the more treatable malignancies. Although cervical cancer screening is relatively easy to perform, the guidelines for performing the test have become more complicated. In this podcast, we’ll discuss cervical cancer screening with my guest Evelyn A. Reynolds, M.D., from the Department of Obstetrics and Gynecology at the Mayo Clinic. I’ll be asking her when to start screening, how often patients should be screened, when we can stop screening and more.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D., <a href='https://twitter.com/chutkamd'>@ChutkaMD</a></p>
<p>Guest: Evelyn A. Reynolds, M.D.</p>
<p>January is Cervical Cancer Awareness Month | Cervical cancer is the fourth most common malignancy in women worldwide, although the number of new cases in the U.S. has been declining. The vast majority of cervical cancers are caused by infection with the Human Papilloma Virus. Due to a combination of HPV immunization and early detection with cervical cancer screening, advanced cases are becoming much less common and when detected early, cervical cancer is one of the more treatable malignancies. Although cervical cancer screening is relatively easy to perform, the guidelines for performing the test have become more complicated. In this podcast, we’ll discuss cervical cancer screening with my guest Evelyn A. Reynolds, M.D., from the Department of Obstetrics and Gynecology at the Mayo Clinic. I’ll be asking her when to start screening, how often patients should be screened, when we can stop screening and more.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7zgku8/WF3706169_Update_on_Cervical_Cancer_Screening_Recommendations_AF68sph.mp3" length="28809040" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D., @ChutkaMD
Guest: Evelyn A. Reynolds, M.D.
January is Cervical Cancer Awareness Month | Cervical cancer is the fourth most common malignancy in women worldwide, although the number of new cases in the U.S. has been declining. The vast majority of cervical cancers are caused by infection with the Human Papilloma Virus. Due to a combination of HPV immunization and early detection with cervical cancer screening, advanced cases are becoming much less common and when detected early, cervical cancer is one of the more treatable malignancies. Although cervical cancer screening is relatively easy to perform, the guidelines for performing the test have become more complicated. In this podcast, we’ll discuss cervical cancer screening with my guest Evelyn A. Reynolds, M.D., from the Department of Obstetrics and Gynecology at the Mayo Clinic. I’ll be asking her when to start screening, how often patients should be screened, when we can stop screening and more.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1197</itunes:duration>
                <itunes:episode>467</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Rheumatology Edition | Is It Always Lupus?</title>
        <itunes:title>Rheumatology Edition | Is It Always Lupus?</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/rheumatology-edition-is-it-always-lupus/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/rheumatology-edition-is-it-always-lupus/#comments</comments>        <pubDate>Thu, 18 Jan 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/42a66312-adc3-31a6-b6a8-a0f1ac428d8f</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka. M.D.; <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Ali A. Duarte Garcia, M.D.</p>
<p>Rheumatologic problems are some of the most common health conditions we see as primary care professionals. In many cases, taking months and sometimes years to properly diagnose, rheumatologic conditions can become frustrating for both the provider and the patient. There are a variety of new tests available to help us establish a diagnosis, as well as multiple new and effective treatment options. This episode is part of a seven-episode mini-series on Mayo Clinic Talks dedicated to rheumatologic health problems to aid in the recognition, diagnosis, and treatment for your patients. Please find these episodes where you listen to podcasts or on ce.mayo.edu.</p>
<p>Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease with a variety of immunological and laboratory abnormalities, as well as numerous clinical manifestations. It can affect almost every organ and has the potential to cause severe organ damage. Most patients experience flares of the disease alternating with periods of remission. Lupus is much more common in women than men and there are significant geographical and ethnic differences in the incidence and eventual outcome of the disease. It’s known as the great imitator because it can mimic a variety of other diseases and it’s not uncommon for patients to have symptoms for over 5 years, before a diagnosis of lupus is established. The topic for this podcast is systemic lupus and our guest is Ali A. Duarte Garcia, M.D., a rheumatologist from the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. Learn more about our Rheumatology Edition here: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-rheumatology-edition'>https://ce.mayo.edu/content/mayo-clinic-talks-rheumatology-edition</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka. M.D.; <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Ali A. Duarte Garcia, M.D.</p>
<p>Rheumatologic problems are some of the most common health conditions we see as primary care professionals. In many cases, taking months and sometimes years to properly diagnose, rheumatologic conditions can become frustrating for both the provider and the patient. There are a variety of new tests available to help us establish a diagnosis, as well as multiple new and effective treatment options. This episode is part of a seven-episode mini-series on Mayo Clinic Talks dedicated to rheumatologic health problems to aid in the recognition, diagnosis, and treatment for your patients. Please find these episodes where you listen to podcasts or on ce.mayo.edu.</p>
<p>Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease with a variety of immunological and laboratory abnormalities, as well as numerous clinical manifestations. It can affect almost every organ and has the potential to cause severe organ damage. Most patients experience flares of the disease alternating with periods of remission. Lupus is much more common in women than men and there are significant geographical and ethnic differences in the incidence and eventual outcome of the disease. It’s known as the great imitator because it can mimic a variety of other diseases and it’s not uncommon for patients to have symptoms for over 5 years, before a diagnosis of lupus is established. The topic for this podcast is systemic lupus and our guest is Ali A. Duarte Garcia, M.D., a rheumatologist from the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. Learn more about our Rheumatology Edition here: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-rheumatology-edition'>https://ce.mayo.edu/content/mayo-clinic-talks-rheumatology-edition</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qb7vp9/WF2535891_Is_It_Always_Lupus_music_and_intro_AFa9scx.mp3" length="33636910" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka. M.D.; [@chutkaMD]
Guest: Ali A. Duarte Garcia, M.D.
Rheumatologic problems are some of the most common health conditions we see as primary care professionals. In many cases, taking months and sometimes years to properly diagnose, rheumatologic conditions can become frustrating for both the provider and the patient. There are a variety of new tests available to help us establish a diagnosis, as well as multiple new and effective treatment options. This episode is part of a seven-episode mini-series on Mayo Clinic Talks dedicated to rheumatologic health problems to aid in the recognition, diagnosis, and treatment for your patients. Please find these episodes where you listen to podcasts or on ce.mayo.edu.
Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease with a variety of immunological and laboratory abnormalities, as well as numerous clinical manifestations. It can affect almost every organ and has the potential to cause severe organ damage. Most patients experience flares of the disease alternating with periods of remission. Lupus is much more common in women than men and there are significant geographical and ethnic differences in the incidence and eventual outcome of the disease. It’s known as the great imitator because it can mimic a variety of other diseases and it’s not uncommon for patients to have symptoms for over 5 years, before a diagnosis of lupus is established. The topic for this podcast is systemic lupus and our guest is Ali A. Duarte Garcia, M.D., a rheumatologist from the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. Learn more about our Rheumatology Edition here: https://ce.mayo.edu/content/mayo-clinic-talks-rheumatology-edition ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1397</itunes:duration>
                <itunes:episode>466</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Rheumatology Edition | When Are Rheumatology Lab Tests Indicated?</title>
        <itunes:title>Rheumatology Edition | When Are Rheumatology Lab Tests Indicated?</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/rheumatology-edition-when-are-rheumatology-lab-tests-indicated/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/rheumatology-edition-when-are-rheumatology-lab-tests-indicated/#comments</comments>        <pubDate>Thu, 11 Jan 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/f6848478-a972-3f98-ab3d-b51f473929dd</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka. M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Ashima Makol, M.B.B.S.</p>
<p>Guest: Matthew J. Koster, M.D.</p>
<p>Rheumatologic problems are some of the most common health conditions we see as primary care professionals. In many cases, taking months and sometimes years to properly diagnose, rheumatologic conditions can become frustrating for both the provider and the patient. There are a variety of new tests available to help us establish a diagnosis, as well as multiple new and effective treatment options. This episode is part of a seven-episode mini-series on Mayo Clinic Talks dedicated to rheumatologic health problems to aid in the recognition, diagnosis, and treatment for your patients. Please find these episodes where you listen to podcasts or on ce.mayo.edu.</p>
<p>We have multiple laboratory tests available to help us diagnose rheumatologic conditions; rheumatoid factor, ANA, ESR, CRP and more. It’s gotten quite confusing trying to decide which tests to order when we suspect a specific rheumatologic problem. When are these tests helpful? How specific are these tests for the condition we’re trying to diagnose and what does it mean when we have a positive but low titer test in an asymptomatic patient? In today’s podcast, we’ll answer these questions and more with our guests, Ashima Makol, M.B.B.S., and Matthew J. Koster, M.D., both from the Division of Rheumatology at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka. M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Ashima Makol, M.B.B.S.</p>
<p>Guest: Matthew J. Koster, M.D.</p>
<p>Rheumatologic problems are some of the most common health conditions we see as primary care professionals. In many cases, taking months and sometimes years to properly diagnose, rheumatologic conditions can become frustrating for both the provider and the patient. There are a variety of new tests available to help us establish a diagnosis, as well as multiple new and effective treatment options. This episode is part of a seven-episode mini-series on Mayo Clinic Talks dedicated to rheumatologic health problems to aid in the recognition, diagnosis, and treatment for your patients. Please find these episodes where you listen to podcasts or on ce.mayo.edu.</p>
<p>We have multiple laboratory tests available to help us diagnose rheumatologic conditions; rheumatoid factor, ANA, ESR, CRP and more. It’s gotten quite confusing trying to decide which tests to order when we suspect a specific rheumatologic problem. When are these tests helpful? How specific are these tests for the condition we’re trying to diagnose and what does it mean when we have a positive but low titer test in an asymptomatic patient? In today’s podcast, we’ll answer these questions and more with our guests, Ashima Makol, M.B.B.S., and Matthew J. Koster, M.D., both from the Division of Rheumatology at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xzubif/WF2537588_When_Are_Rheumatology_Labs_Indicated_music_and_intro72l9v.mp3" length="45372504" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka. M.D. [@chutkaMD]
Guest: Ashima Makol, M.B.B.S.
Guest: Matthew J. Koster, M.D.
Rheumatologic problems are some of the most common health conditions we see as primary care professionals. In many cases, taking months and sometimes years to properly diagnose, rheumatologic conditions can become frustrating for both the provider and the patient. There are a variety of new tests available to help us establish a diagnosis, as well as multiple new and effective treatment options. This episode is part of a seven-episode mini-series on Mayo Clinic Talks dedicated to rheumatologic health problems to aid in the recognition, diagnosis, and treatment for your patients. Please find these episodes where you listen to podcasts or on ce.mayo.edu.
We have multiple laboratory tests available to help us diagnose rheumatologic conditions; rheumatoid factor, ANA, ESR, CRP and more. It’s gotten quite confusing trying to decide which tests to order when we suspect a specific rheumatologic problem. When are these tests helpful? How specific are these tests for the condition we’re trying to diagnose and what does it mean when we have a positive but low titer test in an asymptomatic patient? In today’s podcast, we’ll answer these questions and more with our guests, Ashima Makol, M.B.B.S., and Matthew J. Koster, M.D., both from the Division of Rheumatology at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1888</itunes:duration>
                <itunes:episode>464</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Rheumatology Edition | What Everyone Should Know About Gout</title>
        <itunes:title>Rheumatology Edition | What Everyone Should Know About Gout</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/rheumatology-edition-what-everyone-should-know-about-gout/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/rheumatology-edition-what-everyone-should-know-about-gout/#comments</comments>        <pubDate>Tue, 09 Jan 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/e78360e5-d15a-38f8-abf4-c38cf68ec54d</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka. M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Lynne S. Peterson, M.D.</p>
<p>Guest: Clement J. Michet JR, M.D.</p>
<p>Rheumatologic problems are some of the most common health conditions we see as primary care professionals. In many cases, taking months and sometimes years to properly diagnose, rheumatologic conditions can become frustrating for both the provider and the patient. There are a variety of new tests available to help us establish a diagnosis, as well as multiple new and effective treatment options. This episode is the first of a seven-episode mini-series on Mayo Clinic Talks dedicated to rheumatologic health problems to aid in the recognition, diagnosis, and treatment for your patients. Please stayed tuned in future weeks for the next six episodes!</p>
<p>Gout is the most common inflammatory arthritis and is a result of the deposition of monosodium urate crystals in and around the joints. It’s typically a mono-articular arthritis and is more common in men. Many patients who have had an acute attack of gout say it’s the worst pain they have ever experienced. Management consists of both treating acute episodes as well as preventing future attacks. The topic of this podcast is “What Everyone Should Know About Gout” and our guests include Lynne S. Peterson, M.D., and Clement J. Michet JR, M.D., both rheumatologists from the Mayo Clinic. We’ll discuss the pathophysiology of gout, its typical presentation, how to establish a diagnosis and management tips.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka. M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Lynne S. Peterson, M.D.</p>
<p>Guest: Clement J. Michet JR, M.D.</p>
<p>Rheumatologic problems are some of the most common health conditions we see as primary care professionals. In many cases, taking months and sometimes years to properly diagnose, rheumatologic conditions can become frustrating for both the provider and the patient. There are a variety of new tests available to help us establish a diagnosis, as well as multiple new and effective treatment options. This episode is the first of a seven-episode mini-series on Mayo Clinic Talks dedicated to rheumatologic health problems to aid in the recognition, diagnosis, and treatment for your patients. Please stayed tuned in future weeks for the next six episodes!</p>
<p>Gout is the most common inflammatory arthritis and is a result of the deposition of monosodium urate crystals in and around the joints. It’s typically a mono-articular arthritis and is more common in men. Many patients who have had an acute attack of gout say it’s the worst pain they have ever experienced. Management consists of both treating acute episodes as well as preventing future attacks. The topic of this podcast is “What Everyone Should Know About Gout” and our guests include Lynne S. Peterson, M.D., and Clement J. Michet JR, M.D., both rheumatologists from the Mayo Clinic. We’ll discuss the pathophysiology of gout, its typical presentation, how to establish a diagnosis and management tips.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/idrtkn/WF2529451_What_Everyone_Should_Know_About_Gout_music_and_introbocqp.mp3" length="41385880" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka. M.D. [@chutkaMD]
Guest: Lynne S. Peterson, M.D.
Guest: Clement J. Michet JR, M.D.
Rheumatologic problems are some of the most common health conditions we see as primary care professionals. In many cases, taking months and sometimes years to properly diagnose, rheumatologic conditions can become frustrating for both the provider and the patient. There are a variety of new tests available to help us establish a diagnosis, as well as multiple new and effective treatment options. This episode is the first of a seven-episode mini-series on Mayo Clinic Talks dedicated to rheumatologic health problems to aid in the recognition, diagnosis, and treatment for your patients. Please stayed tuned in future weeks for the next six episodes!
Gout is the most common inflammatory arthritis and is a result of the deposition of monosodium urate crystals in and around the joints. It’s typically a mono-articular arthritis and is more common in men. Many patients who have had an acute attack of gout say it’s the worst pain they have ever experienced. Management consists of both treating acute episodes as well as preventing future attacks. The topic of this podcast is “What Everyone Should Know About Gout” and our guests include Lynne S. Peterson, M.D., and Clement J. Michet JR, M.D., both rheumatologists from the Mayo Clinic. We’ll discuss the pathophysiology of gout, its typical presentation, how to establish a diagnosis and management tips.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1722</itunes:duration>
                <itunes:episode>463</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>THE BEST OF SEASON 1: Exercise is Medicine ”Adding Years to Life and Life to Years”</title>
        <itunes:title>THE BEST OF SEASON 1: Exercise is Medicine ”Adding Years to Life and Life to Years”</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/the-best-of-season-1-exercise-is-medicine-adding-years-to-life-and-life-to-years/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/the-best-of-season-1-exercise-is-medicine-adding-years-to-life-and-life-to-years/#comments</comments>        <pubDate>Tue, 02 Jan 2024 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/2bd8e0ef-9196-3746-9c12-9d87763fc2a5</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a> </p>
<p>Guest: Robert Scales, Ph.D., M.S.</p>
<p>As we bid farewell to the year 2023 and embrace the possibilities for 2024, what better time to refocus on both us and our patient’s well-being? In today's episode, we’re going to revisit an episode from Season One, “Exercise is Medicine: Adding Years to Life and Life to Years”. During the annual intersection of the new year and new exercise routines, this is a very fitting topic!</p>
<p>Let’s take a listen to how exercise can truly play a role in our overall health and well-being from our featured guest speaker, Robert Scales, Ph.D., M.S.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a> </p>
<p>Guest: Robert Scales, Ph.D., M.S.</p>
<p>As we bid farewell to the year 2023 and embrace the possibilities for 2024, what better time to refocus on both us and our patient’s well-being? In today's episode, we’re going to revisit an episode from Season One, “Exercise is Medicine: Adding Years to Life and Life to Years”. During the annual intersection of the new year and new exercise routines, this is a very fitting topic!</p>
<p>Let’s take a listen to how exercise can truly play a role in our overall health and well-being from our featured guest speaker, Robert Scales, Ph.D., M.S.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/y5n2ez/WF3668615_Season_4_re-release_AFb1cun.mp3" length="36201601" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD] 
Guest: Robert Scales, Ph.D., M.S.
As we bid farewell to the year 2023 and embrace the possibilities for 2024, what better time to refocus on both us and our patient’s well-being? In today's episode, we’re going to revisit an episode from Season One, “Exercise is Medicine: Adding Years to Life and Life to Years”. During the annual intersection of the new year and new exercise routines, this is a very fitting topic!
Let’s take a listen to how exercise can truly play a role in our overall health and well-being from our featured guest speaker, Robert Scales, Ph.D., M.S.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1507</itunes:duration>
                <itunes:episode>462</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>THE BEST OF SEASON 1: Microaggressions in Medicine</title>
        <itunes:title>THE BEST OF SEASON 1: Microaggressions in Medicine</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/the-best-of-season-1-microaggressions-in-medicine/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/the-best-of-season-1-microaggressions-in-medicine/#comments</comments>        <pubDate>Tue, 26 Dec 2023 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/11baa03e-65e4-3f34-9aa6-dab36edd1fd9</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D%5B@'>[@chutkaMD]</a></p>
<p>Guests: Catherine Njathi-Ori, M.D. | Erin O'Brien, M.D. | Nafisseh Warner, M.D.</p>
<p>Today we’re excited to bring back a special lecture by popular demand from Season 1 of Mayo Clinic Talks Podcast.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D%5B@'>[@chutkaMD]</a></p>
<p>Guests: Catherine Njathi-Ori, M.D. | Erin O'Brien, M.D. | Nafisseh Warner, M.D.</p>
<p>Today we’re excited to bring back a special lecture by popular demand from Season 1 of Mayo Clinic Talks Podcast.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9ndepi/VT3795198_2022_Anesthesia66yfy.mp3" length="34875967" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guests: Catherine Njathi-Ori, M.D. | Erin O'Brien, M.D. | Nafisseh Warner, M.D.
Today we’re excited to bring back a special lecture by popular demand from Season 1 of Mayo Clinic Talks Podcast.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1452</itunes:duration>
                <itunes:episode>460</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Assessing the Older Patient with New Cognitive Symptoms</title>
        <itunes:title>Assessing the Older Patient with New Cognitive Symptoms</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/assessing-the-older-patient-with-new-cognitive-symptoms/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/assessing-the-older-patient-with-new-cognitive-symptoms/#comments</comments>        <pubDate>Tue, 19 Dec 2023 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/b30c8b7c-81a6-369a-abf8-5a0a12fbc5f5</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D., <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Ericka E. Tung, M.D., M.P.H.</p>
<p>If we see older patients, we commonly see Alzheimer’s Disease and other dementias in our practice. At times, the presenting symptoms can be quite subtle and it’s not uncommon for the diagnosis to take several years to establish. Very often, any early symptoms which are noticed are attributed to the aging process. Although we don’t have very effective options for treating dementia, it’s still important to diagnose the condition as early as possible. In this podcast, we’ll be discussing “Assessing the Older Patient with New Cognitive Symptoms.” We’ll review the usefulness of a mental status exam, recommended lab tests, whether a brain imaging study is indicated and more with our guest, Ericka E. Tung, M.D., M.P.H., an internist, and geriatrician from the Division of Community Internal Medicine at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D., <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Ericka E. Tung, M.D., M.P.H.</p>
<p>If we see older patients, we commonly see Alzheimer’s Disease and other dementias in our practice. At times, the presenting symptoms can be quite subtle and it’s not uncommon for the diagnosis to take several years to establish. Very often, any early symptoms which are noticed are attributed to the aging process. Although we don’t have very effective options for treating dementia, it’s still important to diagnose the condition as early as possible. In this podcast, we’ll be discussing “Assessing the Older Patient with New Cognitive Symptoms.” We’ll review the usefulness of a mental status exam, recommended lab tests, whether a brain imaging study is indicated and more with our guest, Ericka E. Tung, M.D., M.P.H., an internist, and geriatrician from the Division of Community Internal Medicine at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6ae4aq/WF2489552_Older_Adult_With_New_Cognitive_Symptoms_AFbg5gw.mp3" length="34750301" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D., [@chutkaMD]
Guest: Ericka E. Tung, M.D., M.P.H.
If we see older patients, we commonly see Alzheimer’s Disease and other dementias in our practice. At times, the presenting symptoms can be quite subtle and it’s not uncommon for the diagnosis to take several years to establish. Very often, any early symptoms which are noticed are attributed to the aging process. Although we don’t have very effective options for treating dementia, it’s still important to diagnose the condition as early as possible. In this podcast, we’ll be discussing “Assessing the Older Patient with New Cognitive Symptoms.” We’ll review the usefulness of a mental status exam, recommended lab tests, whether a brain imaging study is indicated and more with our guest, Ericka E. Tung, M.D., M.P.H., an internist, and geriatrician from the Division of Community Internal Medicine at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1446</itunes:duration>
                <itunes:episode>459</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Functional Bowel Disorders: Identification &amp; Treatment Updates</title>
        <itunes:title>Functional Bowel Disorders: Identification &amp; Treatment Updates</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/dissecting-the-funk-of-functional-bowel-disorders/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/dissecting-the-funk-of-functional-bowel-disorders/#comments</comments>        <pubDate>Tue, 12 Dec 2023 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/62477aff-8b52-3431-8474-fbff84260439</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D., <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Tisha N. Lunsford, M.D.</p>
<p>Functional bowel disorders are very common, most often tend to affect those under the age of 50 and can cause symptoms ranging from a mild inconvenience to severe debilitation. Symptoms can vary significantly from patient to patient and the treatment varies with the predominant symptoms. While the exact cause isn’t known, there are a few interesting associations with other health conditions. In this podcast, we’ll discuss functional bowel disorders with gastroenterologist, Tisha N. Lunsford, M.D., from the Mayo Clinic. We’ll review common symptoms, the recommended evaluation, and the available management options for functional bowel disorders. </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D., <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Tisha N. Lunsford, M.D.</p>
<p>Functional bowel disorders are very common, most often tend to affect those under the age of 50 and can cause symptoms ranging from a mild inconvenience to severe debilitation. Symptoms can vary significantly from patient to patient and the treatment varies with the predominant symptoms. While the exact cause isn’t known, there are a few interesting associations with other health conditions. In this podcast, we’ll discuss functional bowel disorders with gastroenterologist, Tisha N. Lunsford, M.D., from the Mayo Clinic. We’ll review common symptoms, the recommended evaluation, and the available management options for functional bowel disorders. </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cvd292/WF2236900_Functional_Bowel_Disorder_AF87kky.mp3" length="37962586" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D., [@chutkaMD]
Guest: Tisha N. Lunsford, M.D.
Functional bowel disorders are very common, most often tend to affect those under the age of 50 and can cause symptoms ranging from a mild inconvenience to severe debilitation. Symptoms can vary significantly from patient to patient and the treatment varies with the predominant symptoms. While the exact cause isn’t known, there are a few interesting associations with other health conditions. In this podcast, we’ll discuss functional bowel disorders with gastroenterologist, Tisha N. Lunsford, M.D., from the Mayo Clinic. We’ll review common symptoms, the recommended evaluation, and the available management options for functional bowel disorders. 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1567</itunes:duration>
                <itunes:episode>458</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Taking Care of Your Personal Well-Being “In Their Own Words”</title>
        <itunes:title>Taking Care of Your Personal Well-Being “In Their Own Words”</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/taking-care-of-your-personal-well-being-in-their-own-words/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/taking-care-of-your-personal-well-being-in-their-own-words/#comments</comments>        <pubDate>Tue, 05 Dec 2023 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/3d58587d-70d7-3e38-a5f1-11d2f52548c4</guid>
                                    <description><![CDATA[<p>Hosts: Sanj Kakar, M.D., <a href='https://twitter.com/i/flow/login?redirect_after_login=%2Fsanjkakar'>@sanjkakar</a> | Dawn R. Davis, M.D.</p>
<p>Guests: Brian T. Carlsen, M.D.| Sharonne N. Hayes, M.D.</p>
<p>Health care professionals often struggle with personal well-being due to career demands. There are simple and straightforward ways to improve well-being despite a demanding profession. We welcome you to learn from two Mayo Clinic physicians who share their personal journeys and suggestions for well-being.</p>
<p>Watch the full episode here: <a href='https://ce.mayo.edu/internal-medicine/content/taking-care-your-personal-well-being-their-own-words'>https://ce.mayo.edu/internal-medicine/content/taking-care-your-personal-well-being-their-own-words</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Hosts: Sanj Kakar, M.D., <a href='https://twitter.com/i/flow/login?redirect_after_login=%2Fsanjkakar'>@sanjkakar</a> | Dawn R. Davis, M.D.</p>
<p>Guests: Brian T. Carlsen, M.D.| Sharonne N. Hayes, M.D.</p>
<p>Health care professionals often struggle with personal well-being due to career demands. There are simple and straightforward ways to improve well-being despite a demanding profession. We welcome you to learn from two Mayo Clinic physicians who share their personal journeys and suggestions for well-being.</p>
<p>Watch the full episode here: <a href='https://ce.mayo.edu/internal-medicine/content/taking-care-your-personal-well-being-their-own-words'>https://ce.mayo.edu/internal-medicine/content/taking-care-your-personal-well-being-their-own-words</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qits6c/2023-08-01-MCTalks-PersonalWellBeing-InTheirOwnWords-VF-A.mp3" length="61646400" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Hosts: Sanj Kakar, M.D., @sanjkakar | Dawn R. Davis, M.D.
Guests: Brian T. Carlsen, M.D.| Sharonne N. Hayes, M.D.
Health care professionals often struggle with personal well-being due to career demands. There are simple and straightforward ways to improve well-being despite a demanding profession. We welcome you to learn from two Mayo Clinic physicians who share their personal journeys and suggestions for well-being.
Watch the full episode here: https://ce.mayo.edu/internal-medicine/content/taking-care-your-personal-well-being-their-own-words 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2568</itunes:duration>
                <itunes:episode>457</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Taking Care of Your Personal Well-Being “From the Experts”</title>
        <itunes:title>Taking Care of Your Personal Well-Being “From the Experts”</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/taking-care-of-your-personal-well-being-from-the-experts/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/taking-care-of-your-personal-well-being-from-the-experts/#comments</comments>        <pubDate>Tue, 28 Nov 2023 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/ac87d590-5f57-3a7c-890e-a0e28d98c635</guid>
                                    <description><![CDATA[<p>Hosts: Sanj Kakar, M.D., <a href='https://twitter.com/i/flow/login?redirect_after_login=%2Fsanjkakar'>@sanjkakar</a> | Dawn R. Davis, M.D.</p>
<p>Guests: Donald D. Hensrud, M.D., M.S.| Shanda Blackmon, M.D., M.P.H. | Colin P. West, M.D., Ph.D.</p>
<p>Well-being is a timely and important topic for patients and health care professionals alike. Physicians and allied health staff must take care of themselves to optimally serve others. We welcome you to learn about health care professional well-being from three Mayo Clinic physicians who are nationally recognized experts in the field.</p>
<p>Watch the full-length video <a href='https://ce.mayo.edu/internal-medicine/content/taking-care-your-personal-well-being-experts'>here</a></p>
<p>Learn more and connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Hosts: Sanj Kakar, M.D., <a href='https://twitter.com/i/flow/login?redirect_after_login=%2Fsanjkakar'>@sanjkakar</a> | Dawn R. Davis, M.D.</p>
<p>Guests: Donald D. Hensrud, M.D., M.S.| Shanda Blackmon, M.D., M.P.H. | Colin P. West, M.D., Ph.D.</p>
<p>Well-being is a timely and important topic for patients and health care professionals alike. Physicians and allied health staff must take care of themselves to optimally serve others. We welcome you to learn about health care professional well-being from three Mayo Clinic physicians who are nationally recognized experts in the field.</p>
<p>Watch the full-length video <a href='https://ce.mayo.edu/internal-medicine/content/taking-care-your-personal-well-being-experts'>here</a></p>
<p>Learn more and connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mwzt3c/2023-07-25-MCTalks-PersonalWellBeing-FromtheExperts-AF.mp3" length="94205952" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Hosts: Sanj Kakar, M.D., @sanjkakar | Dawn R. Davis, M.D.
Guests: Donald D. Hensrud, M.D., M.S.| Shanda Blackmon, M.D., M.P.H. | Colin P. West, M.D., Ph.D.
Well-being is a timely and important topic for patients and health care professionals alike. Physicians and allied health staff must take care of themselves to optimally serve others. We welcome you to learn about health care professional well-being from three Mayo Clinic physicians who are nationally recognized experts in the field.
Watch the full-length video here
Learn more and connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>3925</itunes:duration>
                <itunes:episode>454</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes &amp; Your Health | Respiratory Disease and Health Disparities</title>
        <itunes:title>Genes &amp; Your Health | Respiratory Disease and Health Disparities</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-your-health-respiratory-disease-and-health-disparities/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-your-health-respiratory-disease-and-health-disparities/#comments</comments>        <pubDate>Wed, 15 Nov 2023 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/dec840fa-aa8e-34a5-bd47-b6527d5ef951</guid>
                                    <description><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Victor E. Ortega, M.D., Ph.D.</p>
<p>Common respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) often present differently in individuals.  What is the genetic basis for this difference and how can we use knowledge of genetic factors to support patient care? Additionally, the implications of applying genetics across diverse populations are explored. Listen in to hear about this and more in Mayo Clinic Center for Individualized Medicine’s Genes &amp; Your Health podcast miniseries featuring Victor E. Ortega, M.D., Ph.D.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Victor E. Ortega, M.D., Ph.D.</p>
<p>Common respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) often present differently in individuals.  What is the genetic basis for this difference and how can we use knowledge of genetic factors to support patient care? Additionally, the implications of applying genetics across diverse populations are explored. Listen in to hear about this and more in Mayo Clinic Center for Individualized Medicine’s Genes &amp; Your Health podcast miniseries featuring Victor E. Ortega, M.D., Ph.D.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/sffimv/Ep_6_WF3087507_Respiratory_Disease_and_Health_Disparities9z634.mp3" length="40043032" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Denise M. Dupras, M.D., Ph.D.
Guest: Victor E. Ortega, M.D., Ph.D.
Common respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) often present differently in individuals.  What is the genetic basis for this difference and how can we use knowledge of genetic factors to support patient care? Additionally, the implications of applying genetics across diverse populations are explored. Listen in to hear about this and more in Mayo Clinic Center for Individualized Medicine’s Genes &amp; Your Health podcast miniseries featuring Victor E. Ortega, M.D., Ph.D.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1664</itunes:duration>
                <itunes:episode>455</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pain Management Beyond Opioids</title>
        <itunes:title>Pain Management Beyond Opioids</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/pain-management-beyond-opioids/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/pain-management-beyond-opioids/#comments</comments>        <pubDate>Tue, 14 Nov 2023 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/697581d9-0f05-3802-81da-93643ce7cb70</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D., <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Christy L. Hunt, D.O.</p>
<p>Pain management is a combination of science and art. We have a variety of treatment options to choose from however some have significant potential for harm and some the potential to be abused and carry the risk of dependence. We need to choose our treatments carefully, based on the type of pain we are treating as well as other health conditions found in our patient. In addition to the various analgesic products, other options include injections, nerve blocks and several integrative medicine alternatives. In this podcast, we’ll discuss the various pain management options we have available and hopefully give you some new ideas to help manage pain in your patients. Our guest for this podcast is Christy L. Hunt, D.O., a Pain Medicine specialist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at</p>
<p><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D., <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Christy L. Hunt, D.O.</p>
<p>Pain management is a combination of science and art. We have a variety of treatment options to choose from however some have significant potential for harm and some the potential to be abused and carry the risk of dependence. We need to choose our treatments carefully, based on the type of pain we are treating as well as other health conditions found in our patient. In addition to the various analgesic products, other options include injections, nerve blocks and several integrative medicine alternatives. In this podcast, we’ll discuss the various pain management options we have available and hopefully give you some new ideas to help manage pain in your patients. Our guest for this podcast is Christy L. Hunt, D.O., a Pain Medicine specialist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at</p>
<p><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vpgsah/WF2201250_Pain_Mangement_Beyond_Opioids_AF8y6mz.mp3" length="41058884" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D., [@chutkaMD]
Guest: Christy L. Hunt, D.O.
Pain management is a combination of science and art. We have a variety of treatment options to choose from however some have significant potential for harm and some the potential to be abused and carry the risk of dependence. We need to choose our treatments carefully, based on the type of pain we are treating as well as other health conditions found in our patient. In addition to the various analgesic products, other options include injections, nerve blocks and several integrative medicine alternatives. In this podcast, we’ll discuss the various pain management options we have available and hopefully give you some new ideas to help manage pain in your patients. Our guest for this podcast is Christy L. Hunt, D.O., a Pain Medicine specialist at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at
https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1707</itunes:duration>
                <itunes:episode>448</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Osteoporosis, Fragility &amp; Bone Health Edition | “Hip Hip Hooray” The Surgical Management of Hip &amp; Knee Arthritis</title>
        <itunes:title>Osteoporosis, Fragility &amp; Bone Health Edition | “Hip Hip Hooray” The Surgical Management of Hip &amp; Knee Arthritis</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/osteoporosis-fragility-bone-health-edition-hip-hip-hooray-the-surgical-management-of-hip-knee-arthritis/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/osteoporosis-fragility-bone-health-edition-hip-hip-hooray-the-surgical-management-of-hip-knee-arthritis/#comments</comments>        <pubDate>Thu, 09 Nov 2023 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/7ce9c031-7ab6-334b-b20f-7913759148c9</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Matthew P. Abdel, M.D.</p>
<p>Arthritis of the hip or knee is a common cause of pain and disability. It can cause significant limitations in mobility and a reduced quality of life. Hip and knee replacements have the potential to change all that. They’re safe, have a high success rate and can allow the patient to get back to a healthy, active lifestyle. Who’s a candidate for a hip or knee replacement? What’s the optimal timing of the procedure? What’s important in obtaining an optimal outcome from surgery and what are the complications of a hip or knee replacement? Our guest for today’s podcast is Matthew P. Abdel, M.D., an orthopedic surgeon at the Mayo Clinic. He’ll be answering these questions and more as we discuss the surgical management of hip and knee arthritis. </p>
<p><a href='https://www.usdairy.com/about-us/national-dairy-council'>https://www.usdairy.com/about-us/national-dairy-council</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Matthew P. Abdel, M.D.</p>
<p>Arthritis of the hip or knee is a common cause of pain and disability. It can cause significant limitations in mobility and a reduced quality of life. Hip and knee replacements have the potential to change all that. They’re safe, have a high success rate and can allow the patient to get back to a healthy, active lifestyle. Who’s a candidate for a hip or knee replacement? What’s the optimal timing of the procedure? What’s important in obtaining an optimal outcome from surgery and what are the complications of a hip or knee replacement? Our guest for today’s podcast is Matthew P. Abdel, M.D., an orthopedic surgeon at the Mayo Clinic. He’ll be answering these questions and more as we discuss the surgical management of hip and knee arthritis. </p>
<p><a href='https://www.usdairy.com/about-us/national-dairy-council'>https://www.usdairy.com/about-us/national-dairy-council</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6fst74/WF2790766_Surgical_Management_of_Hip_and_Knee_Arthritis_V296n1f.mp3" length="32080835" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Matthew P. Abdel, M.D.
Arthritis of the hip or knee is a common cause of pain and disability. It can cause significant limitations in mobility and a reduced quality of life. Hip and knee replacements have the potential to change all that. They’re safe, have a high success rate and can allow the patient to get back to a healthy, active lifestyle. Who’s a candidate for a hip or knee replacement? What’s the optimal timing of the procedure? What’s important in obtaining an optimal outcome from surgery and what are the complications of a hip or knee replacement? Our guest for today’s podcast is Matthew P. Abdel, M.D., an orthopedic surgeon at the Mayo Clinic. He’ll be answering these questions and more as we discuss the surgical management of hip and knee arthritis. 
https://www.usdairy.com/about-us/national-dairy-council
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 
 ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1335</itunes:duration>
                <itunes:episode>451</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes &amp; Your Health Edition | Genetic Informed Risk Assessments</title>
        <itunes:title>Genes &amp; Your Health Edition | Genetic Informed Risk Assessments</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-genetic-informed-risk-assessments/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-genetic-informed-risk-assessments/#comments</comments>        <pubDate>Wed, 08 Nov 2023 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/1e9f8dbe-e690-3749-8a57-215ca35e2c7e</guid>
                                    <description><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Kullo, Iftikhar J., M.D.</p>
<p>While genetic conditions and risk for disease have traditionally been focused on monogenetic causes, it is now recognized that multiple genetic changes are often involved in risk for disease. What conditions are polygenetic and what should we be looking for to help identify these risks for our patients? Find out more in the latest episode of Mayo Clinic Center for Individualized Medicine’s Genes &amp; Your Health podcast miniseries featuring Iftikhar J. Kullo.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Kullo, Iftikhar J., M.D.</p>
<p>While genetic conditions and risk for disease have traditionally been focused on monogenetic causes, it is now recognized that multiple genetic changes are often involved in risk for disease. What conditions are polygenetic and what should we be looking for to help identify these risks for our patients? Find out more in the latest episode of Mayo Clinic Center for Individualized Medicine’s Genes &amp; Your Health podcast miniseries featuring Iftikhar J. Kullo.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/y7cddm/WF3087507_Genetic_Informed_Risk_Assessmentsa4b6y.mp3" length="46608221" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Denise M. Dupras, M.D., Ph.D.
Guest: Kullo, Iftikhar J., M.D.
While genetic conditions and risk for disease have traditionally been focused on monogenetic causes, it is now recognized that multiple genetic changes are often involved in risk for disease. What conditions are polygenetic and what should we be looking for to help identify these risks for our patients? Find out more in the latest episode of Mayo Clinic Center for Individualized Medicine’s Genes &amp; Your Health podcast miniseries featuring Iftikhar J. Kullo.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1938</itunes:duration>
                <itunes:episode>453</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Attention-Deficit / Hyperactivity Disorder (ADHD) in Adults</title>
        <itunes:title>Attention-Deficit / Hyperactivity Disorder (ADHD) in Adults</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/attention-deficit-hyperactivity-disorder-adhd-in-adults/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/attention-deficit-hyperactivity-disorder-adhd-in-adults/#comments</comments>        <pubDate>Tue, 07 Nov 2023 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/fd4ff6c8-8c44-3f64-a969-980e0404f57a</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D., <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Mohit Chauhan, M.B.B.S.</p>
<p>Attention-deficit / hyperactivity disorder (ADHD) has the potential to impact and impair multiple aspects of life, including underachievement in education, difficulty with employment and challenging social relationships. ADHD has long been felt to be a disorder of childhood that gradually diminishes as one approaches adulthood, however it’s now being questioned whether ADHD can develop in adulthood. It’s thought that around 4% of adults have ADHD and that the majority are undiagnosed and untreated. In this podcast, we’ll discuss ADHD in adults, its effects on those who have it, and how it can be managed. Our guest is Mohit Chauhan, M.B.B.S., a psychiatrist from the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at</p>
<p><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D., <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Mohit Chauhan, M.B.B.S.</p>
<p>Attention-deficit / hyperactivity disorder (ADHD) has the potential to impact and impair multiple aspects of life, including underachievement in education, difficulty with employment and challenging social relationships. ADHD has long been felt to be a disorder of childhood that gradually diminishes as one approaches adulthood, however it’s now being questioned whether ADHD can develop in adulthood. It’s thought that around 4% of adults have ADHD and that the majority are undiagnosed and untreated. In this podcast, we’ll discuss ADHD in adults, its effects on those who have it, and how it can be managed. Our guest is Mohit Chauhan, M.B.B.S., a psychiatrist from the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at</p>
<p><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8jwgme/WF1981505_ADHD_in_Adults_AF9alc9.mp3" length="31822684" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D., [@chutkaMD]
Guest: Mohit Chauhan, M.B.B.S.
Attention-deficit / hyperactivity disorder (ADHD) has the potential to impact and impair multiple aspects of life, including underachievement in education, difficulty with employment and challenging social relationships. ADHD has long been felt to be a disorder of childhood that gradually diminishes as one approaches adulthood, however it’s now being questioned whether ADHD can develop in adulthood. It’s thought that around 4% of adults have ADHD and that the majority are undiagnosed and untreated. In this podcast, we’ll discuss ADHD in adults, its effects on those who have it, and how it can be managed. Our guest is Mohit Chauhan, M.B.B.S., a psychiatrist from the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at
https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1323</itunes:duration>
                <itunes:episode>447</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Osteoporosis, Fragility &amp; Bone Health Edition | “Sticks &amp; Stones May Break My Bones” Common Fractures Associated with Osteoporosis</title>
        <itunes:title>Osteoporosis, Fragility &amp; Bone Health Edition | “Sticks &amp; Stones May Break My Bones” Common Fractures Associated with Osteoporosis</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/osteoporosis-fragility-bone-health-edition-sticks-stones-may-break-my-bones-common-fractures-associated-with-osteoporosis/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/osteoporosis-fragility-bone-health-edition-sticks-stones-may-break-my-bones-common-fractures-associated-with-osteoporosis/#comments</comments>        <pubDate>Thu, 02 Nov 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/008ba3a7-d24d-35b5-84b2-cef79fd0c68c</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Krystin A. Hidden, M.D.</p>
<p>Guest: Jad Sfeir, M.D., M.S.</p>
<p>Osteoporosis is responsible for approximately two million fractures per year. It’s estimated that 50% of all women and 25% of all men over age 50 will suffer an osteoporosis-related fracture.  Bone fractures, especially of the spine and hip are the most serious complications of osteoporosis. While vertebral compression fractures can cause chronic back pain, hip fractures can result in chronic disability and even death. Yet nearly 80% of older Americans who suffer fractures have not been tested or treated for osteoporosis and it is a very treatable condition. Today’s podcast is about common fractures associated with osteoporosis and my guests include Krystin A. Hidden, M.D., from the Department of Orthopedic Surgery and Jad Sfeir, M.D., M.S., from the Division of Endocrinology and Metabolism.</p>
<p></p>
<p><a href='https://www.usdairy.com/about-us/national-dairy-council'>https://www.usdairy.com/about-us/national-dairy-council</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Krystin A. Hidden, M.D.</p>
<p>Guest: Jad Sfeir, M.D., M.S.</p>
<p>Osteoporosis is responsible for approximately two million fractures per year. It’s estimated that 50% of all women and 25% of all men over age 50 will suffer an osteoporosis-related fracture.  Bone fractures, especially of the spine and hip are the most serious complications of osteoporosis. While vertebral compression fractures can cause chronic back pain, hip fractures can result in chronic disability and even death. Yet nearly 80% of older Americans who suffer fractures have not been tested or treated for osteoporosis and it is a very treatable condition. Today’s podcast is about common fractures associated with osteoporosis and my guests include Krystin A. Hidden, M.D., from the Department of Orthopedic Surgery and Jad Sfeir, M.D., M.S., from the Division of Endocrinology and Metabolism.</p>
<p></p>
<p><a href='https://www.usdairy.com/about-us/national-dairy-council'>https://www.usdairy.com/about-us/national-dairy-council</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mnqmef/WF2615064_Common_Fractures_Associated_with_Osteoporosis_AF8lhes.mp3" length="30531512" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Krystin A. Hidden, M.D.
Guest: Jad Sfeir, M.D., M.S.
Osteoporosis is responsible for approximately two million fractures per year. It’s estimated that 50% of all women and 25% of all men over age 50 will suffer an osteoporosis-related fracture.  Bone fractures, especially of the spine and hip are the most serious complications of osteoporosis. While vertebral compression fractures can cause chronic back pain, hip fractures can result in chronic disability and even death. Yet nearly 80% of older Americans who suffer fractures have not been tested or treated for osteoporosis and it is a very treatable condition. Today’s podcast is about common fractures associated with osteoporosis and my guests include Krystin A. Hidden, M.D., from the Department of Orthopedic Surgery and Jad Sfeir, M.D., M.S., from the Division of Endocrinology and Metabolism.

https://www.usdairy.com/about-us/national-dairy-council
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1270</itunes:duration>
                <itunes:episode>449</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes &amp; Your Health Edition | Spotlight on PGx: Pain</title>
        <itunes:title>Genes &amp; Your Health Edition | Spotlight on PGx: Pain</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-spotlight-on-pgx-pain/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-spotlight-on-pgx-pain/#comments</comments>        <pubDate>Wed, 01 Nov 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/4d5bc532-2ba1-3555-af0c-597e7808c427</guid>
                                    <description><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Wayne Nicholson, M.D., Pharm.D.</p>
<p>Guest: Eric T. T. Matey, Pharm.D., R.Ph.</p>
<p>Do you know the correlation between pharmacogenomics (PGx), or the interaction between a patient’s genes and their response to medications, and pain management? How could you incorporate PGx into your pain management toolbox? And how can you use PGx to help inform appropriate medication and dosage? Tune into this episode of Mayo Clinic Center for Individualized Medicine’s Genes &amp; Your Health miniseries, “Spotlight on PGx: Pain,” featuring Nick T. Nicholson, M.D., Pharm.D. and Eric T. Matey, Pharm.D., R.Ph. to find out!</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Wayne Nicholson, M.D., Pharm.D.</p>
<p>Guest: Eric T. T. Matey, Pharm.D., R.Ph.</p>
<p>Do you know the correlation between pharmacogenomics (PGx), or the interaction between a patient’s genes and their response to medications, and pain management? How could you incorporate PGx into your pain management toolbox? And how can you use PGx to help inform appropriate medication and dosage? Tune into this episode of Mayo Clinic Center for Individualized Medicine’s Genes &amp; Your Health miniseries, “Spotlight on PGx: Pain,” featuring Nick T. Nicholson, M.D., Pharm.D. and Eric T. Matey, Pharm.D., R.Ph. to find out!</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/877f4g/Ep_4_WF2691453_Spotlight_on_PGx-Pain8ojxt.mp3" length="45029821" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Denise M. Dupras, M.D., Ph.D.
Guest: Wayne Nicholson, M.D., Pharm.D.
Guest: Eric T. T. Matey, Pharm.D., R.Ph.
Do you know the correlation between pharmacogenomics (PGx), or the interaction between a patient’s genes and their response to medications, and pain management? How could you incorporate PGx into your pain management toolbox? And how can you use PGx to help inform appropriate medication and dosage? Tune into this episode of Mayo Clinic Center for Individualized Medicine’s Genes &amp; Your Health miniseries, “Spotlight on PGx: Pain,” featuring Nick T. Nicholson, M.D., Pharm.D. and Eric T. Matey, Pharm.D., R.Ph. to find out!
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1852</itunes:duration>
                <itunes:episode>452</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Intimate Partner Violence</title>
        <itunes:title>Intimate Partner Violence</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/intimate-partner-violence/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/intimate-partner-violence/#comments</comments>        <pubDate>Tue, 31 Oct 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/43378f68-fb06-3d40-bdbd-5688e13585ef</guid>
                                    <description><![CDATA[<p>Host: Joshua D. Luciew, MPAS, PA-C</p>
<p>Guest: Cesar A. Gonzalez, Ph.D., L.P.</p>
<p>Guest: Maryam Mahmood, M.B., Ch.B.</p>
<p>As primary care providers, we are charged with ensuring our patients are healthy.  According to the World Health Organization, “health is a state of complete physical, mental, and social well-being and not merely the absence of disease or infirmity.”  However, sometimes our patients will not inform us of what problems or difficulties that they may be facing in their lives, which makes it difficult to help in these situations.</p>
<p>As result, we must screen or ask patients specific questions in attempts to make sure they are okay. One such example that we may screen for in these instances is intimate partner violence.</p>
<p>This condition has many presentations and can affect anyone. Intimate partner violence or domestic violence is reported to be a serious, preventable, public health concern as it affects more than 32 million Americans.</p>
<p>Tune in to this episode to learn more about what intimate partner violence looks like, the psychology behind intimate partner violence perpetrators, how we should be screening for this, and what we can do to help our patients in these situations.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Joshua D. Luciew, MPAS, PA-C</p>
<p>Guest: Cesar A. Gonzalez, Ph.D., L.P.</p>
<p>Guest: Maryam Mahmood, M.B., Ch.B.</p>
<p>As primary care providers, we are charged with ensuring our patients are healthy.  According to the World Health Organization, <em>“health is a state of complete physical, mental, and social well-being and not merely the absence of disease or infirmity.”</em>  However, sometimes our patients will not inform us of what problems or difficulties that they may be facing in their lives, which makes it difficult to help in these situations.</p>
<p>As result, we must screen or ask patients specific questions in attempts to make sure they are okay. One such example that we may screen for in these instances is intimate partner violence.</p>
<p>This condition has many presentations and can affect anyone. Intimate partner violence or domestic violence is reported to be a serious, preventable, public health concern as it affects more than 32 million Americans.</p>
<p>Tune in to this episode to learn more about what intimate partner violence looks like, the psychology behind intimate partner violence perpetrators, how we should be screening for this, and what we can do to help our patients in these situations.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/f2s7bp/WF2248536_Intimate_Partner_Violence9nuff.mp3" length="49604607" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Joshua D. Luciew, MPAS, PA-C
Guest: Cesar A. Gonzalez, Ph.D., L.P.
Guest: Maryam Mahmood, M.B., Ch.B.
As primary care providers, we are charged with ensuring our patients are healthy.  According to the World Health Organization, “health is a state of complete physical, mental, and social well-being and not merely the absence of disease or infirmity.”  However, sometimes our patients will not inform us of what problems or difficulties that they may be facing in their lives, which makes it difficult to help in these situations.
As result, we must screen or ask patients specific questions in attempts to make sure they are okay. One such example that we may screen for in these instances is intimate partner violence.
This condition has many presentations and can affect anyone. Intimate partner violence or domestic violence is reported to be a serious, preventable, public health concern as it affects more than 32 million Americans.
Tune in to this episode to learn more about what intimate partner violence looks like, the psychology behind intimate partner violence perpetrators, how we should be screening for this, and what we can do to help our patients in these situations.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2046</itunes:duration>
                <itunes:episode>442</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Osteoporosis, Fragility &amp; Bone Health Edition | “Stiffen Up” Management of Osteoporosis</title>
        <itunes:title>Osteoporosis, Fragility &amp; Bone Health Edition | “Stiffen Up” Management of Osteoporosis</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/osteoporosis-fragility-bone-health-edition-stiffen-up-management-of-osteoporosis/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/osteoporosis-fragility-bone-health-edition-stiffen-up-management-of-osteoporosis/#comments</comments>        <pubDate>Thu, 26 Oct 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/a2071341-96e4-3dcd-9d81-f13b035f0dbc</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Kurt A. Kennel, M.D.</p>
<p>According to the Bone Health and Osteoporosis Foundation, over 50 million Americans have osteoporosis. Up to one in two women and one in four men will experience a bone fracture due to the disease. Osteoporosis is a common cause of hip, wrist and vertebral fractures and can result in significant complications including chronic pain, disability and even death. When detected early, these complications need not occur and we now have a variety of very effective treatments for osteoporosis, some relatively new. In this podcast, we’ll discuss the treatment options for osteoporosis with Kurt A. Kennel, M.D., an endocrinologist at the Mayo Clinic. </p>
<p><a href='https://www.usdairy.com/about-us/national-dairy-council'>https://www.usdairy.com/about-us/national-dairy-council</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Kurt A. Kennel, M.D.</p>
<p>According to the Bone Health and Osteoporosis Foundation, over 50 million Americans have osteoporosis. Up to one in two women and one in four men will experience a bone fracture due to the disease. Osteoporosis is a common cause of hip, wrist and vertebral fractures and can result in significant complications including chronic pain, disability and even death. When detected early, these complications need not occur and we now have a variety of very effective treatments for osteoporosis, some relatively new. In this podcast, we’ll discuss the treatment options for osteoporosis with Kurt A. Kennel, M.D., an endocrinologist at the Mayo Clinic. </p>
<p><a href='https://www.usdairy.com/about-us/national-dairy-council'>https://www.usdairy.com/about-us/national-dairy-council</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/b2jzb8/WF2782415_Stiffen_Up_-_Management_of_Osteoporosis_AF7gi9k.mp3" length="31094896" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Kurt A. Kennel, M.D.
According to the Bone Health and Osteoporosis Foundation, over 50 million Americans have osteoporosis. Up to one in two women and one in four men will experience a bone fracture due to the disease. Osteoporosis is a common cause of hip, wrist and vertebral fractures and can result in significant complications including chronic pain, disability and even death. When detected early, these complications need not occur and we now have a variety of very effective treatments for osteoporosis, some relatively new. In this podcast, we’ll discuss the treatment options for osteoporosis with Kurt A. Kennel, M.D., an endocrinologist at the Mayo Clinic. 
https://www.usdairy.com/about-us/national-dairy-council
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1293</itunes:duration>
                <itunes:episode>443</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes &amp; Your Health Edition | Navigating the Genetic Testing World - The Role of a Genetic Counselor</title>
        <itunes:title>Genes &amp; Your Health Edition | Navigating the Genetic Testing World - The Role of a Genetic Counselor</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-navigating-the-genetic-testing-world-the-role-of-a-genetic-counselor/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-navigating-the-genetic-testing-world-the-role-of-a-genetic-counselor/#comments</comments>        <pubDate>Wed, 25 Oct 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/65bcbf44-333a-3860-b8ac-cc91c24d58eb</guid>
                                    <description><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Jennifer L. Kemppainen, M.S., CGC</p>
<p>With increased availability and accessibility of genetic testing, genetic counselors are playing a critical role in helping patients understand family and medical histories and genetic indications and conditions that may impact them or their loved ones. How do genetic counselors help patients to feel comfortable and understand the often-confusing world of genetic testing? Learn more in this episode of Mayo Clinic's Center for Individualized Medicine Genes &amp; Your Health podcast miniseries featuring Jennifer L. Kemppainen, M.S., CGC, Supervisor of Genetic Counselors and Assistant Professor in Medical Genetics at Mayo Clinic in Minnesota.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Jennifer L. Kemppainen, M.S., CGC</p>
<p>With increased availability and accessibility of genetic testing, genetic counselors are playing a critical role in helping patients understand family and medical histories and genetic indications and conditions that may impact them or their loved ones. How do genetic counselors help patients to feel comfortable and understand the often-confusing world of genetic testing? Learn more in this episode of Mayo Clinic's Center for Individualized Medicine Genes &amp; Your Health podcast miniseries featuring Jennifer L. Kemppainen, M.S., CGC, Supervisor of Genetic Counselors and Assistant Professor in Medical Genetics at Mayo Clinic in Minnesota.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ynnbfd/Ep_3_WF3087509_Navigating_the_Genetic_Testing_World-_The_Role_of_a_Genetic_Counselor8b537.mp3" length="47487875" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Denise M. Dupras, M.D., Ph.D.
Guest: Jennifer L. Kemppainen, M.S., CGC
With increased availability and accessibility of genetic testing, genetic counselors are playing a critical role in helping patients understand family and medical histories and genetic indications and conditions that may impact them or their loved ones. How do genetic counselors help patients to feel comfortable and understand the often-confusing world of genetic testing? Learn more in this episode of Mayo Clinic's Center for Individualized Medicine Genes &amp; Your Health podcast miniseries featuring Jennifer L. Kemppainen, M.S., CGC, Supervisor of Genetic Counselors and Assistant Professor in Medical Genetics at Mayo Clinic in Minnesota.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1970</itunes:duration>
                <itunes:episode>450</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Nutrition &amp; Cardiovascular Health</title>
        <itunes:title>Nutrition &amp; Cardiovascular Health</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/nutrition-cardiovascular-health/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/nutrition-cardiovascular-health/#comments</comments>        <pubDate>Tue, 24 Oct 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/c9d02068-dee1-3f18-81e6-55139eff4e6f</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guests: Stephen Kopecky, M.D.</p>
<p>Guest: Tara Schmidt, M. ED, RDN, LD</p>
<p>It’s a well-accepted fact that diet plays a significant role in the development as well as prevention of cardiovascular disease, a major cause of morbidity and mortality in the U.S. The typical U.S. diet results in a predisposition to obesity, hypertension, and hyperlipidemia; all risk factors for cardiovascular disease.  Fortunately, diet is a potentially reversible risk factor. As health care clinicians, its our responsibility to assess our patients’ diet and make recommendations for a healthy food intake to reduce their risk of cardiovascular disease. The topic for this podcast is nutrition and cardiovascular health and my guests include preventive cardiologist Stephen Kopecky, M.D., and registered dietician and nutritionist Tara Schmidt, both from the Mayo Clinic.</p>
<p style="text-align: center;"> </p>
<p><a href='https://www.usdairy.com/about-us/national-dairy-council'>https://www.usdairy.com/about-us/national-dairy-council</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guests: Stephen Kopecky, M.D.</p>
<p>Guest: Tara Schmidt, M. ED, RDN, LD</p>
<p>It’s a well-accepted fact that diet plays a significant role in the development as well as prevention of cardiovascular disease, a major cause of morbidity and mortality in the U.S. The typical U.S. diet results in a predisposition to obesity, hypertension, and hyperlipidemia; all risk factors for cardiovascular disease.  Fortunately, diet is a potentially reversible risk factor. As health care clinicians, its our responsibility to assess our patients’ diet and make recommendations for a healthy food intake to reduce their risk of cardiovascular disease. The topic for this podcast is nutrition and cardiovascular health and my guests include preventive cardiologist Stephen Kopecky, M.D., and registered dietician and nutritionist Tara Schmidt, both from the Mayo Clinic.</p>
<p style="text-align: center;"> </p>
<p><a href='https://www.usdairy.com/about-us/national-dairy-council'>https://www.usdairy.com/about-us/national-dairy-council</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jmc89m/WF2491650_Nutrition_and_Cardiovascular_Health_ad_AF60c63.mp3" length="29446085" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guests: Stephen Kopecky, M.D.
Guest: Tara Schmidt, M. ED, RDN, LD
It’s a well-accepted fact that diet plays a significant role in the development as well as prevention of cardiovascular disease, a major cause of morbidity and mortality in the U.S. The typical U.S. diet results in a predisposition to obesity, hypertension, and hyperlipidemia; all risk factors for cardiovascular disease.  Fortunately, diet is a potentially reversible risk factor. As health care clinicians, its our responsibility to assess our patients’ diet and make recommendations for a healthy food intake to reduce their risk of cardiovascular disease. The topic for this podcast is nutrition and cardiovascular health and my guests include preventive cardiologist Stephen Kopecky, M.D., and registered dietician and nutritionist Tara Schmidt, both from the Mayo Clinic.
 
https://www.usdairy.com/about-us/national-dairy-council
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1225</itunes:duration>
                <itunes:episode>446</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Osteoporosis, Fragility &amp; Bone Health Edition | Osteoporosis “Getting to the Core”</title>
        <itunes:title>Osteoporosis, Fragility &amp; Bone Health Edition | Osteoporosis “Getting to the Core”</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/osteoporosis-fragility-bone-health-edition-osteoporosis-getting-to-the-core/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/osteoporosis-fragility-bone-health-edition-osteoporosis-getting-to-the-core/#comments</comments>        <pubDate>Thu, 19 Oct 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/dd5aa52b-b16b-3447-b12a-2647a083d916</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Jad Sfeir, M.D., M.S.</p>
<p>80% of those with osteoporosis are women and many have no idea they have it. While a variety of bone fractures can result from osteoporosis, hip fractures are the most serious complication. They represent a significant economic burden and often result in major changes to an individual’s lifestyle. The good news is osteoporosis can be detected with relatively simple screening tests and we now have a variety of treatment options available to manage the condition and reduce the risk of fracture. The topic for this podcast is osteoporosis, and our guest is Jad Sfeir, M.D., M.S., an endocrinologist at the Mayo Clinic. We’ll discuss the pathophysiology of osteoporosis, who and when to screen and the latest management options. </p>
<p><a href='https://www.usdairy.com/about-us/national-dairy-council'>https://www.usdairy.com/about-us/national-dairy-council</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Jad Sfeir, M.D., M.S.</p>
<p>80% of those with osteoporosis are women and many have no idea they have it. While a variety of bone fractures can result from osteoporosis, hip fractures are the most serious complication. They represent a significant economic burden and often result in major changes to an individual’s lifestyle. The good news is osteoporosis can be detected with relatively simple screening tests and we now have a variety of treatment options available to manage the condition and reduce the risk of fracture. The topic for this podcast is osteoporosis, and our guest is Jad Sfeir, M.D., M.S., an endocrinologist at the Mayo Clinic. We’ll discuss the pathophysiology of osteoporosis, who and when to screen and the latest management options. </p>
<p><a href='https://www.usdairy.com/about-us/national-dairy-council'>https://www.usdairy.com/about-us/national-dairy-council</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/s47tgk/WF2701842_Osteroperosis_and_Bone_Health_Intro80jok.mp3" length="48298344" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Jad Sfeir, M.D., M.S.
80% of those with osteoporosis are women and many have no idea they have it. While a variety of bone fractures can result from osteoporosis, hip fractures are the most serious complication. They represent a significant economic burden and often result in major changes to an individual’s lifestyle. The good news is osteoporosis can be detected with relatively simple screening tests and we now have a variety of treatment options available to manage the condition and reduce the risk of fracture. The topic for this podcast is osteoporosis, and our guest is Jad Sfeir, M.D., M.S., an endocrinologist at the Mayo Clinic. We’ll discuss the pathophysiology of osteoporosis, who and when to screen and the latest management options. 
https://www.usdairy.com/about-us/national-dairy-council
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2008</itunes:duration>
                <itunes:episode>441</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes &amp; Your Health Edition | Ethical Considerations</title>
        <itunes:title>Genes &amp; Your Health Edition | Ethical Considerations</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-ethical-considerations/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-ethical-considerations/#comments</comments>        <pubDate>Wed, 18 Oct 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/431e22d1-63bb-321e-8907-b6a10c206197</guid>
                                    <description><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Karen Meagher, Ph.D.</p>
<p>In today’s world, primary care physicians have a variety of genetic and genomic testing available for patients. But what ethical considerations should be kept in mind during patient visits to ensure the needs of the patient always come first? Find out in this episode of Mayo Clinic Center for Individualized Medicine’s Genes &amp; Your Health podcast miniseries featuring Karen Meagher, Ph.D, assistant professor in the Biomedical Ethics Research Program at Mayo Clinic in Minnesota.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Karen Meagher, Ph.D.</p>
<p>In today’s world, primary care physicians have a variety of genetic and genomic testing available for patients. But what ethical considerations should be kept in mind during patient visits to ensure the needs of the patient always come first? Find out in this episode of Mayo Clinic Center for Individualized Medicine’s Genes &amp; Your Health podcast miniseries featuring Karen Meagher, Ph.D, assistant professor in the Biomedical Ethics Research Program at Mayo Clinic in Minnesota.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ywgwdy/Ep_2_WF2713539_Ethical_Considerations7bvf7.mp3" length="39667152" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Denise M. Dupras, M.D., Ph.D.
Guest: Karen Meagher, Ph.D.
In today’s world, primary care physicians have a variety of genetic and genomic testing available for patients. But what ethical considerations should be kept in mind during patient visits to ensure the needs of the patient always come first? Find out in this episode of Mayo Clinic Center for Individualized Medicine’s Genes &amp; Your Health podcast miniseries featuring Karen Meagher, Ph.D, assistant professor in the Biomedical Ethics Research Program at Mayo Clinic in Minnesota.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1649</itunes:duration>
                <itunes:episode>445</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>“Hacking” The Unexplained Chronic Cough</title>
        <itunes:title>“Hacking” The Unexplained Chronic Cough</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/hacking-the-unexplained-chronic-cough/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/hacking-the-unexplained-chronic-cough/#comments</comments>        <pubDate>Tue, 17 Oct 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/756805df-edc6-3fd7-8629-5ab64a0eefd7</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D., <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Sumedh S. Hoskote, M.B.B.S.</p>
<p>A patient with an unexplained cough is commonly seen in an outpatient primary care practice. While there are several potential causes, fortunately, most are relatively benign. However, determining the cause can be challenging and its best to use an organized approach in the evaluation. Using the patient’s history, chest imaging studies, pulmonary function and occasionally laboratory tests, we’re usually able to determine the cause. What are the most common causes of a persistent cough? What approach is recommended in the evaluation? And what should we do when no cause is apparent? We’ll discuss “The Unexplained Chronic Cough” in this podcast with our guest, Sumedh S. Hoskote, M.B.B.S., a pulmonologist in the Division of Pulmonary and Critical Care at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D., <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Sumedh S. Hoskote, M.B.B.S.</p>
<p>A patient with an unexplained cough is commonly seen in an outpatient primary care practice. While there are several potential causes, fortunately, most are relatively benign. However, determining the cause can be challenging and its best to use an organized approach in the evaluation. Using the patient’s history, chest imaging studies, pulmonary function and occasionally laboratory tests, we’re usually able to determine the cause. What are the most common causes of a persistent cough? What approach is recommended in the evaluation? And what should we do when no cause is apparent? We’ll discuss “The Unexplained Chronic Cough” in this podcast with our guest, Sumedh S. Hoskote, M.B.B.S., a pulmonologist in the Division of Pulmonary and Critical Care at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fuaw64/WF2032280_Chronic_Cough_AFb078s.mp3" length="37684222" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D., [@chutkaMD]
Guest: Sumedh S. Hoskote, M.B.B.S.
A patient with an unexplained cough is commonly seen in an outpatient primary care practice. While there are several potential causes, fortunately, most are relatively benign. However, determining the cause can be challenging and its best to use an organized approach in the evaluation. Using the patient’s history, chest imaging studies, pulmonary function and occasionally laboratory tests, we’re usually able to determine the cause. What are the most common causes of a persistent cough? What approach is recommended in the evaluation? And what should we do when no cause is apparent? We’ll discuss “The Unexplained Chronic Cough” in this podcast with our guest, Sumedh S. Hoskote, M.B.B.S., a pulmonologist in the Division of Pulmonary and Critical Care at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1565</itunes:duration>
                <itunes:episode>439</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Osteoporosis, Fragility &amp; Bone Health Edition | Calcium &amp; Vitamin D “When Enough is Enough”</title>
        <itunes:title>Osteoporosis, Fragility &amp; Bone Health Edition | Calcium &amp; Vitamin D “When Enough is Enough”</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/osteoporosis-fragility-bone-health-edition-calcium-vitamin-d-when-enough-is-enough/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/osteoporosis-fragility-bone-health-edition-calcium-vitamin-d-when-enough-is-enough/#comments</comments>        <pubDate>Thu, 12 Oct 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/f4ba6cbe-769c-3b11-9108-0d926bc9fba4</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Daniel L. Hurley, M.D.</p>
<p>Calcium and vitamin D are essential in building healthy bone; they’re especially important early in life as our bone mineral density increases. Yet many individuals are not receiving adequate amounts of calcium or vitamin D. What are the most common dietary sources of calcium? Is dietary calcium superior to calcium supplements? Should our patients be taking supplemental calcium and/or vitamin D? In this podcast, we’ll review the importance of calcium and vitamin D and I’ll be discussing these questions with our guest, endocrinologist and bone specialist, Daniel L. Hurley, M.D., from the Division of Endocrinology and Metabolism at the Mayo Clinic.</p>
<p><a href='https://www.usdairy.com/about-us/national-dairy-council'>https://www.usdairy.com/about-us/national-dairy-council</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Daniel L. Hurley, M.D.</p>
<p>Calcium and vitamin D are essential in building healthy bone; they’re especially important early in life as our bone mineral density increases. Yet many individuals are not receiving adequate amounts of calcium or vitamin D. What are the most common dietary sources of calcium? Is dietary calcium superior to calcium supplements? Should our patients be taking supplemental calcium and/or vitamin D? In this podcast, we’ll review the importance of calcium and vitamin D and I’ll be discussing these questions with our guest, endocrinologist and bone specialist, Daniel L. Hurley, M.D., from the Division of Endocrinology and Metabolism at the Mayo Clinic.</p>
<p><a href='https://www.usdairy.com/about-us/national-dairy-council'>https://www.usdairy.com/about-us/national-dairy-council</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2dibxc/WF2633400_Calcium_Vitamin_D_Intro_AF5zy7u.mp3" length="34447846" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Daniel L. Hurley, M.D.
Calcium and vitamin D are essential in building healthy bone; they’re especially important early in life as our bone mineral density increases. Yet many individuals are not receiving adequate amounts of calcium or vitamin D. What are the most common dietary sources of calcium? Is dietary calcium superior to calcium supplements? Should our patients be taking supplemental calcium and/or vitamin D? In this podcast, we’ll review the importance of calcium and vitamin D and I’ll be discussing these questions with our guest, endocrinologist and bone specialist, Daniel L. Hurley, M.D., from the Division of Endocrinology and Metabolism at the Mayo Clinic.
https://www.usdairy.com/about-us/national-dairy-council
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1422</itunes:duration>
                <itunes:episode>440</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes &amp; Your Health Edition | All in the Family</title>
        <itunes:title>Genes &amp; Your Health Edition | All in the Family</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-all-in-the-family/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-all-in-the-family/#comments</comments>        <pubDate>Wed, 11 Oct 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/7ff97c9e-6a11-326b-8cfc-b3d4016b0967</guid>
                                    <description><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Richard Presutti, D.O.</p>
<p>With the rapid changing field of genetic testing, a common question we receive from primary care providers is, “where do I start”? Well, it’s all in the family… history, that is. During this episode of Genes &amp; Your Health, learn more about the importance of family history, what it can tell us, and different criteria to look for. This episode features Richard Presutti, D.O., an assistant professor and chair of the Department of Family Medicine for Mayo Clinic in Florida, and a co-director of Genomics in Action for Mayo Clinic’s Center for Individualized Medicine.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Richard Presutti, D.O.</p>
<p>With the rapid changing field of genetic testing, a common question we receive from primary care providers is, “where do I start”? Well, it’s all in the family… history, that is. During this episode of Genes &amp; Your Health, learn more about the importance of family history, what it can tell us, and different criteria to look for. This episode features Richard Presutti, D.O., an assistant professor and chair of the Department of Family Medicine for Mayo Clinic in Florida, and a co-director of Genomics in Action for Mayo Clinic’s Center for Individualized Medicine.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ridp6n/Ep_1_WF2716045_Its_all_in_the_Family8hw1o.mp3" length="42343971" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Denise M. Dupras, M.D., Ph.D.
Guest: Richard Presutti, D.O.
With the rapid changing field of genetic testing, a common question we receive from primary care providers is, “where do I start”? Well, it’s all in the family… history, that is. During this episode of Genes &amp; Your Health, learn more about the importance of family history, what it can tell us, and different criteria to look for. This episode features Richard Presutti, D.O., an assistant professor and chair of the Department of Family Medicine for Mayo Clinic in Florida, and a co-director of Genomics in Action for Mayo Clinic’s Center for Individualized Medicine.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1761</itunes:duration>
                <itunes:episode>444</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Osteoporosis, Fragility &amp; Bone Health Edition | Bone Basics &amp; Tips for Good Bone Health</title>
        <itunes:title>Osteoporosis, Fragility &amp; Bone Health Edition | Bone Basics &amp; Tips for Good Bone Health</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/osteoporosis-fragility-bone-health-edition-bone-basics-tips-for-good-bone-health/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/osteoporosis-fragility-bone-health-edition-bone-basics-tips-for-good-bone-health/#comments</comments>        <pubDate>Tue, 10 Oct 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/ad0a6ccd-e0f6-338c-8a70-069ec33ab5ae</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Daniel L. Hurley, M.D.</p>
<p>We now have a variety of pharmacologic options for treating osteoporosis which are effective in increasing bone density, but more importantly decreasing the risk of fractures. However, rather than treating osteoporosis, what advice can we give our patients that will help prevent loss of bone mass and hopefully prevent osteoporosis. Do we know what it takes to build strong, healthy bones? Which nutrients are important for bone development? What role does exercise play and what type of exercise should we be recommending? I’ll be asking these questions and more to our guest, Daniel L. Hurley, M.D., an endocrinologist at the Mayo Clinic as we discuss “Bone Basics and Tips for Good Bone Health”.</p>
<p></p>
<p><a href='https://www.usdairy.com/about-us/national-dairy-council'>https://www.usdairy.com/about-us/national-dairy-council</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Daniel L. Hurley, M.D.</p>
<p>We now have a variety of pharmacologic options for treating osteoporosis which are effective in increasing bone density, but more importantly decreasing the risk of fractures. However, rather than treating osteoporosis, what advice can we give our patients that will help prevent loss of bone mass and hopefully prevent osteoporosis. Do we know what it takes to build strong, healthy bones? Which nutrients are important for bone development? What role does exercise play and what type of exercise should we be recommending? I’ll be asking these questions and more to our guest, Daniel L. Hurley, M.D., an endocrinologist at the Mayo Clinic as we discuss “Bone Basics and Tips for Good Bone Health”.</p>
<p></p>
<p><a href='https://www.usdairy.com/about-us/national-dairy-council'>https://www.usdairy.com/about-us/national-dairy-council</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3mieuf/WF2809356_Fragility_and_Bone_Health7e7it.mp3" length="36403288" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Daniel L. Hurley, M.D.
We now have a variety of pharmacologic options for treating osteoporosis which are effective in increasing bone density, but more importantly decreasing the risk of fractures. However, rather than treating osteoporosis, what advice can we give our patients that will help prevent loss of bone mass and hopefully prevent osteoporosis. Do we know what it takes to build strong, healthy bones? Which nutrients are important for bone development? What role does exercise play and what type of exercise should we be recommending? I’ll be asking these questions and more to our guest, Daniel L. Hurley, M.D., an endocrinologist at the Mayo Clinic as we discuss “Bone Basics and Tips for Good Bone Health”.

https://www.usdairy.com/about-us/national-dairy-council
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1514</itunes:duration>
                <itunes:episode>438</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Valvular Heart Disease: The Mitral Valve</title>
        <itunes:title>Valvular Heart Disease: The Mitral Valve</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/valvular-heart-disease-the-mitral-valve/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/valvular-heart-disease-the-mitral-valve/#comments</comments>        <pubDate>Tue, 03 Oct 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/8499f430-7884-3176-85c0-7aa8d52dcacd</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Rekha Mankad, M.D.</p>
<p>Mitral valve disorders are extremely common, one of the most common is mitral valve prolapse. The majority of these patients live their life without symptoms, but some go on to develop significant mitral regurgitation or less likely, mitral stenosis. How can we recognize mitral valve disease and what’s recommended to confirm a diagnosis? How should these patients be followed? Do they need a lifetime of cardiac imaging? When is a cardiologist needed to help manage these patients? In this podcast, we’ll discuss these questions and more with cardiologist Rekha Mankad, M.D., a cardiologist from the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Rekha Mankad, M.D.</p>
<p>Mitral valve disorders are extremely common, one of the most common is mitral valve prolapse. The majority of these patients live their life without symptoms, but some go on to develop significant mitral regurgitation or less likely, mitral stenosis. How can we recognize mitral valve disease and what’s recommended to confirm a diagnosis? How should these patients be followed? Do they need a lifetime of cardiac imaging? When is a cardiologist needed to help manage these patients? In this podcast, we’ll discuss these questions and more with cardiologist Rekha Mankad, M.D., a cardiologist from the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/k269q4/WF1999751_Mitral_Valve_Disease8qxm8.mp3" length="29087137" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Rekha Mankad, M.D.
Mitral valve disorders are extremely common, one of the most common is mitral valve prolapse. The majority of these patients live their life without symptoms, but some go on to develop significant mitral regurgitation or less likely, mitral stenosis. How can we recognize mitral valve disease and what’s recommended to confirm a diagnosis? How should these patients be followed? Do they need a lifetime of cardiac imaging? When is a cardiologist needed to help manage these patients? In this podcast, we’ll discuss these questions and more with cardiologist Rekha Mankad, M.D., a cardiologist from the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1201</itunes:duration>
                <itunes:episode>437</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Valvular Heart Disease: The Aortic Valve</title>
        <itunes:title>Valvular Heart Disease: The Aortic Valve</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/valvular-heart-disease-the-aortic-valve/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/valvular-heart-disease-the-aortic-valve/#comments</comments>        <pubDate>Tue, 26 Sep 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/d0426a58-37e5-329c-97c4-66b33972120c</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Rekha Mankad, M.D.</p>
<p>It’s estimated that between 2% and 3% of the population has some form of valvular heart disease and this increases with age. Most of these patients are initially cared for by primary care providers. Most valvular disease deaths are due to disease of the aortic valve and it’s important to recognize these patients early in order to assess for progression and the need for surgical intervention. What are the presenting symptoms of aortic valve disease? What’s the best way to manage and follow these patients and when should a cardiologist and cardiac surgeon become involved in the care of the patient? In this podcast, we’ll discuss these questions and more with cardiologist Rekha Mankad, M.D., from the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at</p>
<p><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Rekha Mankad, M.D.</p>
<p>It’s estimated that between 2% and 3% of the population has some form of valvular heart disease and this increases with age. Most of these patients are initially cared for by primary care providers. Most valvular disease deaths are due to disease of the aortic valve and it’s important to recognize these patients early in order to assess for progression and the need for surgical intervention. What are the presenting symptoms of aortic valve disease? What’s the best way to manage and follow these patients and when should a cardiologist and cardiac surgeon become involved in the care of the patient? In this podcast, we’ll discuss these questions and more with cardiologist Rekha Mankad, M.D., from the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at</p>
<p><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zhuswm/WF2345313_Aortic_Valve_Disease_AF8knpm.mp3" length="36817417" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Rekha Mankad, M.D.
It’s estimated that between 2% and 3% of the population has some form of valvular heart disease and this increases with age. Most of these patients are initially cared for by primary care providers. Most valvular disease deaths are due to disease of the aortic valve and it’s important to recognize these patients early in order to assess for progression and the need for surgical intervention. What are the presenting symptoms of aortic valve disease? What’s the best way to manage and follow these patients and when should a cardiologist and cardiac surgeon become involved in the care of the patient? In this podcast, we’ll discuss these questions and more with cardiologist Rekha Mankad, M.D., from the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at
https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1532</itunes:duration>
                <itunes:episode>435</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Thyroid Hormone &amp; Brain Development in Children</title>
        <itunes:title>Thyroid Hormone &amp; Brain Development in Children</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/thyroid-hormone-brain-development-in-children/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/thyroid-hormone-brain-development-in-children/#comments</comments>        <pubDate>Tue, 19 Sep 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/832fbbd1-7ae2-3e32-93ca-546c3f7149ff</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Siobhan Pittock, M.B., B. Ch</p>
<p>Thyroid hormone plays an important role in metabolism of adults. It plays an even more important role in children. Undiagnosed hypothyroidism in children not only impairs metabolism but can result in stunted physical growth and impaired cognitive development. Congenital hypothyroidism is one of the most common causes of intellectual disability. This may present as poor performance or behavior problems in school. It can also be associated with hearing and language development. The topic for this podcast is “Thyroid Hormone and Brain Development in Children” and my guest is Siobhan Pittock, M.B., B. Ch, a pediatric endocrinologist from the Mayo Clinic. We’ll discuss how thyroid hormone affects brain development, the causes of hypothyroidism in a fetus or newborn and whether brain damage from hypothyroidism in childhood is reversible.</p>
<p></p>
<p><a href='https://www.usdairy.com/about-us/national-dairy-council'>https://www.usdairy.com/about-us/national-dairy-council</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Siobhan Pittock, M.B., B. Ch</p>
<p>Thyroid hormone plays an important role in metabolism of adults. It plays an even more important role in children. Undiagnosed hypothyroidism in children not only impairs metabolism but can result in stunted physical growth and impaired cognitive development. Congenital hypothyroidism is one of the most common causes of intellectual disability. This may present as poor performance or behavior problems in school. It can also be associated with hearing and language development. The topic for this podcast is “Thyroid Hormone and Brain Development in Children” and my guest is Siobhan Pittock, M.B., B. Ch, a pediatric endocrinologist from the Mayo Clinic. We’ll discuss how thyroid hormone affects brain development, the causes of hypothyroidism in a fetus or newborn and whether brain damage from hypothyroidism in childhood is reversible.</p>
<p></p>
<p><a href='https://www.usdairy.com/about-us/national-dairy-council'>https://www.usdairy.com/about-us/national-dairy-council</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qfwbzn/WF2756103_Thyroid_and_Child_Brain_Development_AF6jg74.mp3" length="43337042" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Siobhan Pittock, M.B., B. Ch
Thyroid hormone plays an important role in metabolism of adults. It plays an even more important role in children. Undiagnosed hypothyroidism in children not only impairs metabolism but can result in stunted physical growth and impaired cognitive development. Congenital hypothyroidism is one of the most common causes of intellectual disability. This may present as poor performance or behavior problems in school. It can also be associated with hearing and language development. The topic for this podcast is “Thyroid Hormone and Brain Development in Children” and my guest is Siobhan Pittock, M.B., B. Ch, a pediatric endocrinologist from the Mayo Clinic. We’ll discuss how thyroid hormone affects brain development, the causes of hypothyroidism in a fetus or newborn and whether brain damage from hypothyroidism in childhood is reversible.

https://www.usdairy.com/about-us/national-dairy-council
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1802</itunes:duration>
                <itunes:episode>436</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Tired Teens: Chronic Fatigue in Adolescents</title>
        <itunes:title>Tired Teens: Chronic Fatigue in Adolescents</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/tired-teens-chronic-fatigue-in-adolescents/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/tired-teens-chronic-fatigue-in-adolescents/#comments</comments>        <pubDate>Tue, 12 Sep 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/1d17342a-044d-3aa1-a024-253cff80ff9f</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Philip R. Fischer, M.D.</p>
<p>Among adolescents, complaints regarding fatigue are relatively common and it’s been assumed to be associated with the hormonal changes of puberty, the various social conflicts common in adolescence and a variety of educational expectations. At times, fatigue becomes chronic and may be accompanied by other physical symptoms including mood disorders, headaches, musculoskeletal pains, and various GI symptoms. When chronic fatigue in adolescence has been investigated, no single causal factor has been found and its likely to be multi-factorial. The topic for this podcast is “Chronic Fatigue in Adolescents” and we’ll discuss this with our guest Philip R. Fischer, M.D., a pediatrician from the Department of Pediatrics at the Mayo Clinic.</p>
<p><a href='https://mcpress.mayoclinic.org/product/tired-teens/'>https://mcpress.mayoclinic.org/product/tired-teens/</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Philip R. Fischer, M.D.</p>
<p>Among adolescents, complaints regarding fatigue are relatively common and it’s been assumed to be associated with the hormonal changes of puberty, the various social conflicts common in adolescence and a variety of educational expectations. At times, fatigue becomes chronic and may be accompanied by other physical symptoms including mood disorders, headaches, musculoskeletal pains, and various GI symptoms. When chronic fatigue in adolescence has been investigated, no single causal factor has been found and its likely to be multi-factorial. The topic for this podcast is “Chronic Fatigue in Adolescents” and we’ll discuss this with our guest Philip R. Fischer, M.D., a pediatrician from the Department of Pediatrics at the Mayo Clinic.</p>
<p><a href='https://mcpress.mayoclinic.org/product/tired-teens/'>https://mcpress.mayoclinic.org/product/tired-teens/</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wc84p3/WF2211103_Chronic_Fatigue_in_Teens_AF70zwj.mp3" length="35475336" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Philip R. Fischer, M.D.
Among adolescents, complaints regarding fatigue are relatively common and it’s been assumed to be associated with the hormonal changes of puberty, the various social conflicts common in adolescence and a variety of educational expectations. At times, fatigue becomes chronic and may be accompanied by other physical symptoms including mood disorders, headaches, musculoskeletal pains, and various GI symptoms. When chronic fatigue in adolescence has been investigated, no single causal factor has been found and its likely to be multi-factorial. The topic for this podcast is “Chronic Fatigue in Adolescents” and we’ll discuss this with our guest Philip R. Fischer, M.D., a pediatrician from the Department of Pediatrics at the Mayo Clinic.
https://mcpress.mayoclinic.org/product/tired-teens/
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1474</itunes:duration>
                <itunes:episode>434</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>”The Heat is On” Heat-Related Conditions</title>
        <itunes:title>”The Heat is On” Heat-Related Conditions</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/the-heat-is-on-heat-related-conditions/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/the-heat-is-on-heat-related-conditions/#comments</comments>        <pubDate>Tue, 05 Sep 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/5a3025f4-1f48-3068-85d5-bb073b9541d7</guid>
                                    <description><![CDATA[<p>Host: Sanj Kakar, M.D. <a href='https://twitter.com/i/flow/login?redirect_after_login=%2Fsanjkakar'>@sanjkakar</a> </p>
<p>Guest: Neha P. Raukar, M.D., M.S</p>
<p>We’ve all been experiencing the intense heat and humidity, and did you know that this past July was one of the hottest months on record. Exposure to heat poses a major threat to high-risk populations by substantially contributing to increased morbidity and mortality. Our podcast today is tackling the most common heat-related conditions with Neha P. Raukar, M.D., M.S., Associate Professor of Emergency Medicine.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Sanj Kakar, M.D. <a href='https://twitter.com/i/flow/login?redirect_after_login=%2Fsanjkakar'>@sanjkakar</a> </p>
<p>Guest: Neha P. Raukar, M.D., M.S</p>
<p>We’ve all been experiencing the intense heat and humidity, and did you know that this past July was one of the hottest months on record. Exposure to heat poses a major threat to high-risk populations by substantially contributing to increased morbidity and mortality. Our podcast today is tackling the most common heat-related conditions with Neha P. Raukar, M.D., M.S., Associate Professor of Emergency Medicine.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/itce7e/WF3057105_Heat-Related_Stress_Illness_AFa5885.mp3" length="19260221" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Sanj Kakar, M.D. @sanjkakar 
Guest: Neha P. Raukar, M.D., M.S
We’ve all been experiencing the intense heat and humidity, and did you know that this past July was one of the hottest months on record. Exposure to heat poses a major threat to high-risk populations by substantially contributing to increased morbidity and mortality. Our podcast today is tackling the most common heat-related conditions with Neha P. Raukar, M.D., M.S., Associate Professor of Emergency Medicine.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>801</itunes:duration>
                <itunes:episode>433</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>What’s New with C. Difficile?</title>
        <itunes:title>What’s New with C. Difficile?</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/what-s-new-with-c-difficile/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/what-s-new-with-c-difficile/#comments</comments>        <pubDate>Tue, 29 Aug 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/221af2f7-8955-346f-a08e-dc9c81f6a476</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Sahil Khanna, M.B.B.S., M.S.</p>
<p>It’s estimated that C. difficile causes about a half million infections each year in the U.S. and 1 in 6 of those will have a recurrence within a couple months. Although C. difficile typically occurs following the use of antibiotics, it can also be spread from one individual to another, especially in hospitals and skilled nursing facilities. What are the common symptoms of an infection with C. difficile? How do we test for it? How should an infection be treated and what do we do with patients who have one or more recurrences. In this podcast, we’ll be discussing “What’s New with C. Difficile?” and these are some of the questions I’ll be asking our guest, Sahil Khanna, M.B.B.S., M.S., a gastroenterologist from the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Sahil Khanna, M.B.B.S., M.S.</p>
<p>It’s estimated that C. difficile causes about a half million infections each year in the U.S. and 1 in 6 of those will have a recurrence within a couple months. Although C. difficile typically occurs following the use of antibiotics, it can also be spread from one individual to another, especially in hospitals and skilled nursing facilities. What are the common symptoms of an infection with C. difficile? How do we test for it? How should an infection be treated and what do we do with patients who have one or more recurrences. In this podcast, we’ll be discussing “What’s New with C. Difficile?” and these are some of the questions I’ll be asking our guest, Sahil Khanna, M.B.B.S., M.S., a gastroenterologist from the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5w35ik/WF2017013_C_Difficile_AFba696.mp3" length="37838248" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Sahil Khanna, M.B.B.S., M.S.
It’s estimated that C. difficile causes about a half million infections each year in the U.S. and 1 in 6 of those will have a recurrence within a couple months. Although C. difficile typically occurs following the use of antibiotics, it can also be spread from one individual to another, especially in hospitals and skilled nursing facilities. What are the common symptoms of an infection with C. difficile? How do we test for it? How should an infection be treated and what do we do with patients who have one or more recurrences. In this podcast, we’ll be discussing “What’s New with C. Difficile?” and these are some of the questions I’ll be asking our guest, Sahil Khanna, M.B.B.S., M.S., a gastroenterologist from the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1576</itunes:duration>
                <itunes:episode>432</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Role of Nutrition in Lowering the Risk of Chronic Disease</title>
        <itunes:title>The Role of Nutrition in Lowering the Risk of Chronic Disease</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/the-role-of-nutrition-in-lowering-the-risk-of-chronic-disease/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/the-role-of-nutrition-in-lowering-the-risk-of-chronic-disease/#comments</comments>        <pubDate>Tue, 22 Aug 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/32df13c7-3fd7-3adb-8d7b-098724d75c22</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Katherine A. Zeratsky, R.D.N., L.D.</p>
<p>Chronic disease is creating a tremendous financial impact on our healthcare system. Cardiovascular disease alone accounts for approximately 18 million deaths globally, annually. Most often, we think of pharmacologic therapy in managing chronic disease, yet there’s good evidence that shows adults who eat a healthy diet have a lower risk of suffering from a variety of chronic diseases. Diet can play an extremely important role in preventing and managing such conditions as hypertension, hyperlipidemia, osteoporosis, and malignancy. Today’s podcast will review the role of nutrition in lowering the risk of chronic disease and our guest is registered dietician and nutritionist, Katherine A. Zeratsky, R.D.N., L.D., from the Division of Endocrinology at the Mayo Clinic.</p>
<p></p>
<p><a href='https://www.usdairy.com/about-us/national-dairy-council'>https://www.usdairy.com/about-us/national-dairy-council</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Katherine A. Zeratsky, R.D.N., L.D.</p>
<p>Chronic disease is creating a tremendous financial impact on our healthcare system. Cardiovascular disease alone accounts for approximately 18 million deaths globally, annually. Most often, we think of pharmacologic therapy in managing chronic disease, yet there’s good evidence that shows adults who eat a healthy diet have a lower risk of suffering from a variety of chronic diseases. Diet can play an extremely important role in preventing and managing such conditions as hypertension, hyperlipidemia, osteoporosis, and malignancy. Today’s podcast will review the role of nutrition in lowering the risk of chronic disease and our guest is registered dietician and nutritionist, Katherine A. Zeratsky, R.D.N., L.D., from the Division of Endocrinology at the Mayo Clinic.</p>
<p></p>
<p><a href='https://www.usdairy.com/about-us/national-dairy-council'>https://www.usdairy.com/about-us/national-dairy-council</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/brichv/WF2565907_Role_of_Nutrition_in_Lowering_Chronic_Disease_adaka09.mp3" length="44621318" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Katherine A. Zeratsky, R.D.N., L.D.
Chronic disease is creating a tremendous financial impact on our healthcare system. Cardiovascular disease alone accounts for approximately 18 million deaths globally, annually. Most often, we think of pharmacologic therapy in managing chronic disease, yet there’s good evidence that shows adults who eat a healthy diet have a lower risk of suffering from a variety of chronic diseases. Diet can play an extremely important role in preventing and managing such conditions as hypertension, hyperlipidemia, osteoporosis, and malignancy. Today’s podcast will review the role of nutrition in lowering the risk of chronic disease and our guest is registered dietician and nutritionist, Katherine A. Zeratsky, R.D.N., L.D., from the Division of Endocrinology at the Mayo Clinic.

https://www.usdairy.com/about-us/national-dairy-council
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1831</itunes:duration>
                <itunes:episode>431</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Diagnostic Uncertainty &amp; Undiagnosed Illness</title>
        <itunes:title>Diagnostic Uncertainty &amp; Undiagnosed Illness</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/diagnostic-uncertainty-undiagnosed-illness/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/diagnostic-uncertainty-undiagnosed-illness/#comments</comments>        <pubDate>Tue, 15 Aug 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/05ce1bb2-78fe-38b5-ad1d-087852f78627</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Liz A. Gilman, M.D.</p>
<p>Guest: Chris R. Stephenson, M.D., M.H.P.E.</p>
<p>As clinicians, we’re used to obtaining health information from our patients through a medical history, performing a physical exam and ordering a variety of lab tests or imaging studies. We then formulate a differential diagnosis and eventually a diagnosis to explain the patient’s health problem. But what happens when a diagnosis isn’t obvious or we’re uncertain what may be causing the patient’s problems. What if a patient asks us a question and we don’t know the answer? How do we express our uncertainty to our patients and how do our patients react to our uncertainty? In this podcast, we’ll discuss diagnostic uncertainty and how to approach our patients when we can’t find a specific diagnosis to explain their symptoms. Our guests include Liz A. Gilman, M.D., and Chris R. Stephenson, M.D., M.H.P.E., both from the Division of General Internal Medicine at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Liz A. Gilman, M.D.</p>
<p>Guest: Chris R. Stephenson, M.D., M.H.P.E.</p>
<p>As clinicians, we’re used to obtaining health information from our patients through a medical history, performing a physical exam and ordering a variety of lab tests or imaging studies. We then formulate a differential diagnosis and eventually a diagnosis to explain the patient’s health problem. But what happens when a diagnosis isn’t obvious or we’re uncertain what may be causing the patient’s problems. What if a patient asks us a question and we don’t know the answer? How do we express our uncertainty to our patients and how do our patients react to our uncertainty? In this podcast, we’ll discuss diagnostic uncertainty and how to approach our patients when we can’t find a specific diagnosis to explain their symptoms. Our guests include Liz A. Gilman, M.D., and Chris R. Stephenson, M.D., M.H.P.E., both from the Division of General Internal Medicine at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qcjihb/WF2038900_Complex_Coordination_of_Care_Diagnosis_of_Unresolved_Illness_AF64sfa.mp3" length="29906773" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka M.D. [@chutkaMD]
Guest: Liz A. Gilman, M.D.
Guest: Chris R. Stephenson, M.D., M.H.P.E.
As clinicians, we’re used to obtaining health information from our patients through a medical history, performing a physical exam and ordering a variety of lab tests or imaging studies. We then formulate a differential diagnosis and eventually a diagnosis to explain the patient’s health problem. But what happens when a diagnosis isn’t obvious or we’re uncertain what may be causing the patient’s problems. What if a patient asks us a question and we don’t know the answer? How do we express our uncertainty to our patients and how do our patients react to our uncertainty? In this podcast, we’ll discuss diagnostic uncertainty and how to approach our patients when we can’t find a specific diagnosis to explain their symptoms. Our guests include Liz A. Gilman, M.D., and Chris R. Stephenson, M.D., M.H.P.E., both from the Division of General Internal Medicine at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1244</itunes:duration>
                <itunes:episode>430</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Psychiatric Issues Stemming From COVID-19</title>
        <itunes:title>Psychiatric Issues Stemming From COVID-19</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/psychiatric-issues-stemming-from-covid-19/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/psychiatric-issues-stemming-from-covid-19/#comments</comments>        <pubDate>Tue, 08 Aug 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/cc918c39-fd36-3ad3-ac67-e6a80025d3ab</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Teresa A. Rummans, M.D.</p>
<p>The COVID-19 pandemic has caused innumerable health complications. One complication which hasn’t received a lot of attention has been the effect seen on mental health. Since the pandemic, the incidence of mental illness has increased dramatically, both in patients who have been infected as well as those suffering the social consequences of the pandemic. This has led to mental health disorders representing a major cause of disability. What can we learn from a historical perspective as a result of previous pandemics? How does the COVID-19 virus produce the variety of neuropsychiatric disorders commonly seen? And most importantly, how can we help our patients with their mental health disorders associated with the pandemic? This podcast will review “Psychiatric Issues Stemming From COVID-19” with our guest, Teresa A. Rummans, M.D., a psychiatrist from the Department of Psychiatry and Psychology at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Teresa A. Rummans, M.D.</p>
<p>The COVID-19 pandemic has caused innumerable health complications. One complication which hasn’t received a lot of attention has been the effect seen on mental health. Since the pandemic, the incidence of mental illness has increased dramatically, both in patients who have been infected as well as those suffering the social consequences of the pandemic. This has led to mental health disorders representing a major cause of disability. What can we learn from a historical perspective as a result of previous pandemics? How does the COVID-19 virus produce the variety of neuropsychiatric disorders commonly seen? And most importantly, how can we help our patients with their mental health disorders associated with the pandemic? This podcast will review “Psychiatric Issues Stemming From COVID-19” with our guest, Teresa A. Rummans, M.D., a psychiatrist from the Department of Psychiatry and Psychology at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/etust4/WF1981506_Mental_Issues_from_COVID_AF6afpx.mp3" length="30722885" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka M.D. [@chutkaMD]
Guest: Teresa A. Rummans, M.D.
The COVID-19 pandemic has caused innumerable health complications. One complication which hasn’t received a lot of attention has been the effect seen on mental health. Since the pandemic, the incidence of mental illness has increased dramatically, both in patients who have been infected as well as those suffering the social consequences of the pandemic. This has led to mental health disorders representing a major cause of disability. What can we learn from a historical perspective as a result of previous pandemics? How does the COVID-19 virus produce the variety of neuropsychiatric disorders commonly seen? And most importantly, how can we help our patients with their mental health disorders associated with the pandemic? This podcast will review “Psychiatric Issues Stemming From COVID-19” with our guest, Teresa A. Rummans, M.D., a psychiatrist from the Department of Psychiatry and Psychology at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1637</itunes:duration>
                <itunes:episode>429</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>“Lettuce Eat” Plant-Based Diets: Healthy &amp; Non-Healthy</title>
        <itunes:title>“Lettuce Eat” Plant-Based Diets: Healthy &amp; Non-Healthy</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/lettuce-eat-plant-based-diets-healthy-non-healthy/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/lettuce-eat-plant-based-diets-healthy-non-healthy/#comments</comments>        <pubDate>Tue, 01 Aug 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/627a902d-62bf-3511-a811-6d17dcc6fbdb</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Lisa Lammert, R.D.N., L.D.</p>
<p>Cardiovascular disease is the leading cause of death to individuals in the U.S. Many feel that our typical American diet with its high saturated fat content is a major contributor to this. There’s good evidence that shows plant-based diets are cost-effective in lowering the risk factors for cardiovascular disease including obesity, hyperlipidemia, hypertension, and diabetes. They may also lower the number of medications an individual needs to take to manage their chronic diseases. So, are there any disadvantages to a plant-based diet? Are all plant-based diets healthy and what are the nutritional challenges for a patient on a plant-based diet? We’ll discuss these questions in this podcast on “Plant-Based Diets”. Our guest is Lisa Lammert, a registered dietician and nutritionist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Lisa Lammert, R.D.N., L.D.</p>
<p>Cardiovascular disease is the leading cause of death to individuals in the U.S. Many feel that our typical American diet with its high saturated fat content is a major contributor to this. There’s good evidence that shows plant-based diets are cost-effective in lowering the risk factors for cardiovascular disease including obesity, hyperlipidemia, hypertension, and diabetes. They may also lower the number of medications an individual needs to take to manage their chronic diseases. So, are there any disadvantages to a plant-based diet? Are all plant-based diets healthy and what are the nutritional challenges for a patient on a plant-based diet? We’ll discuss these questions in this podcast on “Plant-Based Diets”. Our guest is Lisa Lammert, a registered dietician and nutritionist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rjys5k/WF2184400_Plant_Based_Diet_V2_AF8abj6.mp3" length="36970665" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka M.D. [@chutkaMD]
Guest: Lisa Lammert, R.D.N., L.D.
Cardiovascular disease is the leading cause of death to individuals in the U.S. Many feel that our typical American diet with its high saturated fat content is a major contributor to this. There’s good evidence that shows plant-based diets are cost-effective in lowering the risk factors for cardiovascular disease including obesity, hyperlipidemia, hypertension, and diabetes. They may also lower the number of medications an individual needs to take to manage their chronic diseases. So, are there any disadvantages to a plant-based diet? Are all plant-based diets healthy and what are the nutritional challenges for a patient on a plant-based diet? We’ll discuss these questions in this podcast on “Plant-Based Diets”. Our guest is Lisa Lammert, a registered dietician and nutritionist at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1537</itunes:duration>
                <itunes:episode>428</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Obesity Edition | Post Bariatric Patient: Common Issues &amp; Weight Regain</title>
        <itunes:title>Obesity Edition | Post Bariatric Patient: Common Issues &amp; Weight Regain</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/obesity-edition-post-bariatric-patient-common-issues-weight-regain/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/obesity-edition-post-bariatric-patient-common-issues-weight-regain/#comments</comments>        <pubDate>Thu, 27 Jul 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/5f476199-1e4e-3e19-b60f-dca858821329</guid>
                                    <description><![CDATA[<p>Host: Ishna A. Sharma, M.D. (<a href='https://twitter.com/IshnaSharmaMD'>@IshnaSharmaMD</a>)</p>
<p>Guest: Julia A. Jurgensen, APRN, C.N.P., D.N.P.</p>
<p>The issue of obesity has become a significant public health concern not only in the United States but across the globe. Bariatric surgery was performed on almost 200,000 patients in the U.S. alone in 2020. Despite the recommendation for regular follow-up visits with bariatric providers, studies indicate a high rate of loss to follow-up among these patients. Consequently, they may seek assistance from a primary care physician years later, presenting concerns such as malnutrition or weight gain. Today, we are fortunate to have Julia A. Jurgensen, APRN, C.N.P., D.N.P. , a Mayo Clinic nurse practitioner who specializes in obesity and has vast experience managing patients who have undergone bariatric surgery.</p>
<p>Link to weight loss blog referenced in the episode:</p>
<p><a href='https://connect.mayoclinic.org/blog/weight-management-1/tab/newsfeed/#ch-tab-navigation'>https://connect.mayoclinic.org/blog/weight-management-1/tab/newsfeed/#ch-tab-navigation</a></p>
<p><a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-obesity-edition-online-cme-course#group-tabs-node-course-default2'>Mayo Clinic Talks Obesity Edition Online CME Course</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Ishna A. Sharma, M.D. (<a href='https://twitter.com/IshnaSharmaMD'>@IshnaSharmaMD</a>)</p>
<p>Guest: Julia A. Jurgensen, APRN, C.N.P., D.N.P.</p>
<p>The issue of obesity has become a significant public health concern not only in the United States but across the globe. Bariatric surgery was performed on almost 200,000 patients in the U.S. alone in 2020. Despite the recommendation for regular follow-up visits with bariatric providers, studies indicate a high rate of loss to follow-up among these patients. Consequently, they may seek assistance from a primary care physician years later, presenting concerns such as malnutrition or weight gain. Today, we are fortunate to have Julia A. Jurgensen, APRN, C.N.P., D.N.P. , a Mayo Clinic nurse practitioner who specializes in obesity and has vast experience managing patients who have undergone bariatric surgery.</p>
<p>Link to weight loss blog referenced in the episode:</p>
<p><a href='https://connect.mayoclinic.org/blog/weight-management-1/tab/newsfeed/#ch-tab-navigation'>https://connect.mayoclinic.org/blog/weight-management-1/tab/newsfeed/#ch-tab-navigation</a></p>
<p><a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-obesity-edition-online-cme-course#group-tabs-node-course-default2'>Mayo Clinic Talks Obesity Edition Online CME Course</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6sh6av/WF2152700_Post_Bariatric_Patient_new_outro_AFb11q5.mp3" length="27667486" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Ishna A. Sharma, M.D. (@IshnaSharmaMD)
Guest: Julia A. Jurgensen, APRN, C.N.P., D.N.P.
The issue of obesity has become a significant public health concern not only in the United States but across the globe. Bariatric surgery was performed on almost 200,000 patients in the U.S. alone in 2020. Despite the recommendation for regular follow-up visits with bariatric providers, studies indicate a high rate of loss to follow-up among these patients. Consequently, they may seek assistance from a primary care physician years later, presenting concerns such as malnutrition or weight gain. Today, we are fortunate to have Julia A. Jurgensen, APRN, C.N.P., D.N.P. , a Mayo Clinic nurse practitioner who specializes in obesity and has vast experience managing patients who have undergone bariatric surgery.
Link to weight loss blog referenced in the episode:
https://connect.mayoclinic.org/blog/weight-management-1/tab/newsfeed/#ch-tab-navigation
Mayo Clinic Talks Obesity Edition Online CME Course
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1130</itunes:duration>
                <itunes:episode>427</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Alopecia: Handling Our Patients with Hair Loss</title>
        <itunes:title>Alopecia: Handling Our Patients with Hair Loss</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/alopecia-handling-our-patients-with-hair-loss/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/alopecia-handling-our-patients-with-hair-loss/#comments</comments>        <pubDate>Tue, 25 Jul 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/70dc6a58-687d-3389-97b1-382f20966198</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Jason C. Sluzevich, M.D.</p>
<p>Hair loss is quite common and although it occurs more commonly in men, it can also occur in women. It’s estimated that up to 80% of men and nearly 50% of women experience hair loss. While it’s not a life-or-death health issue, it can have a negative effect on confidence and self-esteem and a significant amount of money is spent on hair regrowth products and restoration procedures. Did you know that about 95% of our total skin area is covered in hair and you can lose up to 50% of your hair before it’s noticeable to others? How does hair loss differ in males and females? Why do some men go bald? And how effective is the pharmacologic treatment that’s available in producing hair regrowth? We’ll discuss these questions and more with our guest, Jason C. Sluzevich, M.D., a dermatologist at the Mayo Clinic. The topic for this podcast is “Handling Our Patients with Hair Loss”.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Jason C. Sluzevich, M.D.</p>
<p>Hair loss is quite common and although it occurs more commonly in men, it can also occur in women. It’s estimated that up to 80% of men and nearly 50% of women experience hair loss. While it’s not a life-or-death health issue, it can have a negative effect on confidence and self-esteem and a significant amount of money is spent on hair regrowth products and restoration procedures. Did you know that about 95% of our total skin area is covered in hair and you can lose up to 50% of your hair before it’s noticeable to others? How does hair loss differ in males and females? Why do some men go bald? And how effective is the pharmacologic treatment that’s available in producing hair regrowth? We’ll discuss these questions and more with our guest, Jason C. Sluzevich, M.D., a dermatologist at the Mayo Clinic. The topic for this podcast is “Handling Our Patients with Hair Loss”.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5y56s7/WF2094358_Alopecia_AFarw27.mp3" length="36150430" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Jason C. Sluzevich, M.D.
Hair loss is quite common and although it occurs more commonly in men, it can also occur in women. It’s estimated that up to 80% of men and nearly 50% of women experience hair loss. While it’s not a life-or-death health issue, it can have a negative effect on confidence and self-esteem and a significant amount of money is spent on hair regrowth products and restoration procedures. Did you know that about 95% of our total skin area is covered in hair and you can lose up to 50% of your hair before it’s noticeable to others? How does hair loss differ in males and females? Why do some men go bald? And how effective is the pharmacologic treatment that’s available in producing hair regrowth? We’ll discuss these questions and more with our guest, Jason C. Sluzevich, M.D., a dermatologist at the Mayo Clinic. The topic for this podcast is “Handling Our Patients with Hair Loss”.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1504</itunes:duration>
                <itunes:episode>426</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Obesity Edition | Pediatric Obesity</title>
        <itunes:title>Obesity Edition | Pediatric Obesity</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/obesity-edition-pediatric-obesity/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/obesity-edition-pediatric-obesity/#comments</comments>        <pubDate>Thu, 20 Jul 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/83b3456e-bbc0-321c-b581-ecbcce9afcab</guid>
                                    <description><![CDATA[<p>Host: Ishna A. Sharma, M.D. (<a href='https://twitter.com/IshnaSharmaMD'>@IshnaSharmaMD</a>)</p>
<p>Guest: Seema Kumar, M.D.</p>
<p>Guest: Todd A. Kellogg M.D.</p>
<p>The topic of concern that is currently growing in both the United States and around the world is the issue of childhood obesity. According to the CDC growth charts, the number of children and adolescents affected in the US is about 15 million, with the prevalence reaching nearly 20% between the years 2017 and 2020. This is characterized by having a BMI that is at or above the 95th percentile. In order to delve deeper into this issue, we are pleased to have Seema Kumar, M.D., a pediatric endocrinologist at Mayo Clinic, and Todd A. Kellogg, M.D., a metabolic and bariatric surgeon, joining us today.</p>
<p>Resources mentioned in the episode: <a href='https://www.aap.org/en/patient-care/institute-for-healthy-childhood-weight/clinical-supports-for-obesity-prevention/'>American Academy of Pediatrics community resources</a></p>
<p><a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-obesity-edition-online-cme-course#group-tabs-node-course-default2'>Mayo Clinic Talks Obesity Edition Online CME Course</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Ishna A. Sharma, M.D. (<a href='https://twitter.com/IshnaSharmaMD'>@IshnaSharmaMD</a>)</p>
<p>Guest: Seema Kumar, M.D.</p>
<p>Guest: Todd A. Kellogg M.D.</p>
<p>The topic of concern that is currently growing in both the United States and around the world is the issue of childhood obesity. According to the CDC growth charts, the number of children and adolescents affected in the US is about 15 million, with the prevalence reaching nearly 20% between the years 2017 and 2020. This is characterized by having a BMI that is at or above the 95th percentile. In order to delve deeper into this issue, we are pleased to have Seema Kumar, M.D., a pediatric endocrinologist at Mayo Clinic, and Todd A. Kellogg, M.D., a metabolic and bariatric surgeon, joining us today.</p>
<p>Resources mentioned in the episode: <a href='https://www.aap.org/en/patient-care/institute-for-healthy-childhood-weight/clinical-supports-for-obesity-prevention/'>American Academy of Pediatrics community resources</a></p>
<p><a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-obesity-edition-online-cme-course#group-tabs-node-course-default2'>Mayo Clinic Talks Obesity Edition Online CME Course</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wu6c3g/WF2088301_Pediatric_Obesity_new_intro_AF93rh3.mp3" length="23142365" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Ishna A. Sharma, M.D. (@IshnaSharmaMD)
Guest: Seema Kumar, M.D.
Guest: Todd A. Kellogg M.D.
The topic of concern that is currently growing in both the United States and around the world is the issue of childhood obesity. According to the CDC growth charts, the number of children and adolescents affected in the US is about 15 million, with the prevalence reaching nearly 20% between the years 2017 and 2020. This is characterized by having a BMI that is at or above the 95th percentile. In order to delve deeper into this issue, we are pleased to have Seema Kumar, M.D., a pediatric endocrinologist at Mayo Clinic, and Todd A. Kellogg, M.D., a metabolic and bariatric surgeon, joining us today.
Resources mentioned in the episode: American Academy of Pediatrics community resources
Mayo Clinic Talks Obesity Edition Online CME Course
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>969</itunes:duration>
                <itunes:episode>425</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Vestibular Schwannomas (aka Acoustic Neuromas)</title>
        <itunes:title>Vestibular Schwannomas (aka Acoustic Neuromas)</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/vestibular-schwannomas-aka-acoustic-neuromas/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/vestibular-schwannomas-aka-acoustic-neuromas/#comments</comments>        <pubDate>Tue, 18 Jul 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/337b9dcb-2abf-30a1-a763-8bb6b0a04f59</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Michael J. Link, M.D.</p>
<p>Guest: Matthew L. Carlson, M.D.</p>
<p>Hearing loss is a commonly seen symptom in a primary care office practice, as is tinnitus and vertigo. Fortunately, they’re almost always due to a benign cause. However, these symptoms may represent something more ominous, an acoustic neuroma, also known as a vestibular schwannoma. It’s important to consider this diagnosis when we see them in our patients, as there is the potential for serious consequences to develop if this remains untreated. What type of hearing loss is associated with a vestibular schwannoma? What are the other associated symptoms? How do we go about evaluating these patients and how are they best treated? I’ll be asking these questions of our guests Michael J. Link, M.D., a neurosurgeon from the Department of Neurologic Surgery and Mathew L. Carlson, M.D., a head and neck surgeon from the Department of Otolaryngology, both at the Mayo Clinic in Rochester, Minnesota. Our topic for this podcast is vestibular schwannomas.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Michael J. Link, M.D.</p>
<p>Guest: Matthew L. Carlson, M.D.</p>
<p>Hearing loss is a commonly seen symptom in a primary care office practice, as is tinnitus and vertigo. Fortunately, they’re almost always due to a benign cause. However, these symptoms may represent something more ominous, an acoustic neuroma, also known as a vestibular schwannoma. It’s important to consider this diagnosis when we see them in our patients, as there is the potential for serious consequences to develop if this remains untreated. What type of hearing loss is associated with a vestibular schwannoma? What are the other associated symptoms? How do we go about evaluating these patients and how are they best treated? I’ll be asking these questions of our guests Michael J. Link, M.D., a neurosurgeon from the Department of Neurologic Surgery and Mathew L. Carlson, M.D., a head and neck surgeon from the Department of Otolaryngology, both at the Mayo Clinic in Rochester, Minnesota. Our topic for this podcast is vestibular schwannomas.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cpxjiu/WF2053954_Vestibula_Schwannomas_AF7uzo9.mp3" length="38985940" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Michael J. Link, M.D.
Guest: Matthew L. Carlson, M.D.
Hearing loss is a commonly seen symptom in a primary care office practice, as is tinnitus and vertigo. Fortunately, they’re almost always due to a benign cause. However, these symptoms may represent something more ominous, an acoustic neuroma, also known as a vestibular schwannoma. It’s important to consider this diagnosis when we see them in our patients, as there is the potential for serious consequences to develop if this remains untreated. What type of hearing loss is associated with a vestibular schwannoma? What are the other associated symptoms? How do we go about evaluating these patients and how are they best treated? I’ll be asking these questions of our guests Michael J. Link, M.D., a neurosurgeon from the Department of Neurologic Surgery and Mathew L. Carlson, M.D., a head and neck surgeon from the Department of Otolaryngology, both at the Mayo Clinic in Rochester, Minnesota. Our topic for this podcast is vestibular schwannomas.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1620</itunes:duration>
                <itunes:episode>424</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Obesity Edition | Surgical Weight Loss</title>
        <itunes:title>Obesity Edition | Surgical Weight Loss</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/obesity-edition-surgical-weight-loss/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/obesity-edition-surgical-weight-loss/#comments</comments>        <pubDate>Thu, 13 Jul 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/ea002b7f-df8f-33f0-a6f0-b7209271169d</guid>
                                    <description><![CDATA[<p>Host: Ishna Sharma, MD (<a href='https://twitter.com/IshnaSharmaMD'>@IshnaSharmaMD</a>)</p>
<p>Guest: Omar M. Ghanem, M.D.</p>
<p>Obesity has become a significant public health crisis worldwide, with the United States being no exception. A range of treatments is available, but metabolic and bariatric surgery is widely regarded as the most effective and sustainable option for managing obesity. In fact, this type of surgery can reduce the risk of premature death by 30% to 50%. Today's guest is Omar M. Ghanem, M.D., a prominent metabolic bariatric and foregut surgeon at Mayo Clinic. Dr. Ghanem is renowned for his extensive research work, which has resulted in over 75 peer-reviewed publications.</p>
<p><a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-obesity-edition-online-cme-course#group-tabs-node-course-default2'>Mayo Clinic Talks Obesity Edition Online CME Course</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Ishna Sharma, MD (<a href='https://twitter.com/IshnaSharmaMD'>@IshnaSharmaMD</a>)</p>
<p>Guest: Omar M. Ghanem, M.D.</p>
<p>Obesity has become a significant public health crisis worldwide, with the United States being no exception. A range of treatments is available, but metabolic and bariatric surgery is widely regarded as the most effective and sustainable option for managing obesity. In fact, this type of surgery can reduce the risk of premature death by 30% to 50%. Today's guest is Omar M. Ghanem, M.D., a prominent metabolic bariatric and foregut surgeon at Mayo Clinic. Dr. Ghanem is renowned for his extensive research work, which has resulted in over 75 peer-reviewed publications.</p>
<p><a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-obesity-edition-online-cme-course#group-tabs-node-course-default2'>Mayo Clinic Talks Obesity Edition Online CME Course</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ap54d9/WF2218253_Surgical_Weight_Loss_AF8dc06.mp3" length="27783151" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Ishna Sharma, MD (@IshnaSharmaMD)
Guest: Omar M. Ghanem, M.D.
Obesity has become a significant public health crisis worldwide, with the United States being no exception. A range of treatments is available, but metabolic and bariatric surgery is widely regarded as the most effective and sustainable option for managing obesity. In fact, this type of surgery can reduce the risk of premature death by 30% to 50%. Today's guest is Omar M. Ghanem, M.D., a prominent metabolic bariatric and foregut surgeon at Mayo Clinic. Dr. Ghanem is renowned for his extensive research work, which has resulted in over 75 peer-reviewed publications.
Mayo Clinic Talks Obesity Edition Online CME Course
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1147</itunes:duration>
                <itunes:episode>423</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Food Intolerance: When “Food Allergies” Aren’t Allergies</title>
        <itunes:title>Food Intolerance: When “Food Allergies” Aren’t Allergies</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/food-intolerance-when-food-allergies-aren-t-allergies/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/food-intolerance-when-food-allergies-aren-t-allergies/#comments</comments>        <pubDate>Tue, 11 Jul 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/5e4c7f44-ddf2-3c9f-8d45-523198facc9e</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Imad Absah, M.D.</p>
<p>Food intolerance is relatively common. It represents a gut sensitivity to one or more foods, usually resulting in various GI symptoms. A food intolerance is not the same as a food allergy, although our patients often consider their symptoms an allergy to a specific food. Food intolerance doesn’t result in any significant health disorder or serious complications and is usually more of a nuisance to the patient. The treatment varies depending on the food involved. The topic for this podcast is food intolerance and our guest is Imad Absah, M.D., a pediatric gastroenterologist from the Mayo Clinic. We’ll discuss how we determine if a patient is experiencing a food intolerance or a food allergy, the most common offending foods, the mechanisms for food intolerance and how we manage the condition.</p>
<p></p>
<p><a href='https://www.usdairy.com/about-us/national-dairy-council'>https://www.usdairy.com/about-us/national-dairy-council</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Imad Absah, M.D.</p>
<p>Food intolerance is relatively common. It represents a gut sensitivity to one or more foods, usually resulting in various GI symptoms. A food intolerance is not the same as a food allergy, although our patients often consider their symptoms an allergy to a specific food. Food intolerance doesn’t result in any significant health disorder or serious complications and is usually more of a nuisance to the patient. The treatment varies depending on the food involved. The topic for this podcast is food intolerance and our guest is Imad Absah, M.D., a pediatric gastroenterologist from the Mayo Clinic. We’ll discuss how we determine if a patient is experiencing a food intolerance or a food allergy, the most common offending foods, the mechanisms for food intolerance and how we manage the condition.</p>
<p></p>
<p><a href='https://www.usdairy.com/about-us/national-dairy-council'>https://www.usdairy.com/about-us/national-dairy-council</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/k9q9ym/WF1244500_Food_Intolerance_or_Food_Allergy_ad9rtlw.mp3" length="28975421" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Imad Absah, M.D.
Food intolerance is relatively common. It represents a gut sensitivity to one or more foods, usually resulting in various GI symptoms. A food intolerance is not the same as a food allergy, although our patients often consider their symptoms an allergy to a specific food. Food intolerance doesn’t result in any significant health disorder or serious complications and is usually more of a nuisance to the patient. The treatment varies depending on the food involved. The topic for this podcast is food intolerance and our guest is Imad Absah, M.D., a pediatric gastroenterologist from the Mayo Clinic. We’ll discuss how we determine if a patient is experiencing a food intolerance or a food allergy, the most common offending foods, the mechanisms for food intolerance and how we manage the condition.

https://www.usdairy.com/about-us/national-dairy-council
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1180</itunes:duration>
                <itunes:episode>422</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Obesity Edition | Endoscopic Weight Loss</title>
        <itunes:title>Obesity Edition | Endoscopic Weight Loss</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/obesity-edition-endoscopic-weight-loss/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/obesity-edition-endoscopic-weight-loss/#comments</comments>        <pubDate>Thu, 06 Jul 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/48cccb42-5c73-31c3-a2b5-c5696af3a70b</guid>
                                    <description><![CDATA[<p>Host: Dr. Ishna Sharma, MD (<a href='https://twitter.com/IshnaSharmaMD'>@IshnaSharmaMD</a>)</p>
<p>Guest: Barham K. Abu Dayyeh, M.D., M.P.H.</p>
<p>The problem of obesity is a major public health concern both in the U.S. and globally. Despite the roughly 250,000 bariatric procedures performed in the U.S. annually, only 4% of them are endoscopic procedures. It's noteworthy that the use of endoscopy for managing obesity is still in its developmental stage. Today, we are privileged to have Barham K. Abu Dayyeh, M.D., M.P.H., a bariatric endoscopy specialist and gastroenterologist at Mayo Clinic, to share his valuable insights.</p>
<p><a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-obesity-edition-online-cme-course#group-tabs-node-course-default2'>Mayo Clinic Talks Obesity Edition Online CME Course</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Dr. Ishna Sharma, MD (<a href='https://twitter.com/IshnaSharmaMD'>@IshnaSharmaMD</a>)</p>
<p>Guest: Barham K. Abu Dayyeh, M.D., M.P.H.</p>
<p>The problem of obesity is a major public health concern both in the U.S. and globally. Despite the roughly 250,000 bariatric procedures performed in the U.S. annually, only 4% of them are endoscopic procedures. It's noteworthy that the use of endoscopy for managing obesity is still in its developmental stage. Today, we are privileged to have Barham K. Abu Dayyeh, M.D., M.P.H., a bariatric endoscopy specialist and gastroenterologist at Mayo Clinic, to share his valuable insights.</p>
<p><a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-obesity-edition-online-cme-course#group-tabs-node-course-default2'>Mayo Clinic Talks Obesity Edition Online CME Course</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9buvra/WF2152704_Endoscopic_Treatment_new_intro_AF9e1om.mp3" length="35882108" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Dr. Ishna Sharma, MD (@IshnaSharmaMD)
Guest: Barham K. Abu Dayyeh, M.D., M.P.H.
The problem of obesity is a major public health concern both in the U.S. and globally. Despite the roughly 250,000 bariatric procedures performed in the U.S. annually, only 4% of them are endoscopic procedures. It's noteworthy that the use of endoscopy for managing obesity is still in its developmental stage. Today, we are privileged to have Barham K. Abu Dayyeh, M.D., M.P.H., a bariatric endoscopy specialist and gastroenterologist at Mayo Clinic, to share his valuable insights.
Mayo Clinic Talks Obesity Edition Online CME Course
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1499</itunes:duration>
                <itunes:episode>421</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Functional Dyspepsia: BOOM! BANG! Burning &amp; Pain!</title>
        <itunes:title>Functional Dyspepsia: BOOM! BANG! Burning &amp; Pain!</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/functional-dyspepsia-boom-bang-burning-pain/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/functional-dyspepsia-boom-bang-burning-pain/#comments</comments>        <pubDate>Tue, 04 Jul 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/cada1ada-5039-390b-b613-0a3d09ad1068</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: David J. Cangemi, M.D.</p>
<p>Functional dyspepsia, also known as non-ulcer dyspepsia, represents chronic upper GI symptoms of indigestion and not infrequently abdominal discomfort. Diagnosing functional dyspepsia can be challenging since there are no definitive diagnostic tests. This often results in patients seeking multiple medical opinions searching for a specific cause and treatment for their symptoms. What are the common presenting symptoms of functional dyspepsia? What’s an appropriate evaluation and how do we treat our patients who have it? In this podcast, we’ll discuss these questions and more with David J. Cangemi, M.D., a gastroenterologist from the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: David J. Cangemi, M.D.</p>
<p>Functional dyspepsia, also known as non-ulcer dyspepsia, represents chronic upper GI symptoms of indigestion and not infrequently abdominal discomfort. Diagnosing functional dyspepsia can be challenging since there are no definitive diagnostic tests. This often results in patients seeking multiple medical opinions searching for a specific cause and treatment for their symptoms. What are the common presenting symptoms of functional dyspepsia? What’s an appropriate evaluation and how do we treat our patients who have it? In this podcast, we’ll discuss these questions and more with David J. Cangemi, M.D., a gastroenterologist from the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jw5ukc/WF2065662_Functional_Dyspepsia_AF6a8lw.mp3" length="36133650" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: David J. Cangemi, M.D.
Functional dyspepsia, also known as non-ulcer dyspepsia, represents chronic upper GI symptoms of indigestion and not infrequently abdominal discomfort. Diagnosing functional dyspepsia can be challenging since there are no definitive diagnostic tests. This often results in patients seeking multiple medical opinions searching for a specific cause and treatment for their symptoms. What are the common presenting symptoms of functional dyspepsia? What’s an appropriate evaluation and how do we treat our patients who have it? In this podcast, we’ll discuss these questions and more with David J. Cangemi, M.D., a gastroenterologist from the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1488</itunes:duration>
                <itunes:episode>420</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Obesity Edition | Medical Weight Loss</title>
        <itunes:title>Obesity Edition | Medical Weight Loss</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/obesity-edition-medical-weight-loss/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/obesity-edition-medical-weight-loss/#comments</comments>        <pubDate>Thu, 29 Jun 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/aaf0a01a-07e9-3793-a388-d438b9c4c52f</guid>
                                    <description><![CDATA[<p>Host: Ishna Sharma, M.D. <a href='https://twitter.com/IshnaSharmaMD'>https://twitter.com/IshnaSharmaMD</a></p>
<p>Guest: Maria Collazo-Clavell, M.D.</p>
<p>An escalating public health concern on a global scale is the growing prevalence of obesity, which is also a cause for concern within the United States. Statistical data reveals that approximately 15% of American adults make an attempt to shed off excess weight at some stage in their lives using supplements. Currently, there are a range of supplements and pharmaceuticals that have received approval from the FDA for weight loss purposes. Our esteemed guest today is Maria L. Collazo-Clavell, M.D., an authority in the fields of obesity and endocrinology, who is affiliated with the Mayo Clinic.</p>
<p><a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-obesity-edition-online-cme-course#group-tabs-node-course-default2'>Mayo Clinic Talks Obesity Edition Online CME Course</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Ishna Sharma, M.D. <a href='https://twitter.com/IshnaSharmaMD'>https://twitter.com/IshnaSharmaMD</a></p>
<p>Guest: Maria Collazo-Clavell, M.D.</p>
<p>An escalating public health concern on a global scale is the growing prevalence of obesity, which is also a cause for concern within the United States. Statistical data reveals that approximately 15% of American adults make an attempt to shed off excess weight at some stage in their lives using supplements. Currently, there are a range of supplements and pharmaceuticals that have received approval from the FDA for weight loss purposes. Our esteemed guest today is Maria L. Collazo-Clavell, M.D., an authority in the fields of obesity and endocrinology, who is affiliated with the Mayo Clinic.</p>
<p><a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-obesity-edition-online-cme-course#group-tabs-node-course-default2'>Mayo Clinic Talks Obesity Edition Online CME Course</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3cbe5w/WF2390634_Medical_Weight_Loss_AFb3akt.mp3" length="24187462" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Ishna Sharma, M.D. https://twitter.com/IshnaSharmaMD
Guest: Maria Collazo-Clavell, M.D.
An escalating public health concern on a global scale is the growing prevalence of obesity, which is also a cause for concern within the United States. Statistical data reveals that approximately 15% of American adults make an attempt to shed off excess weight at some stage in their lives using supplements. Currently, there are a range of supplements and pharmaceuticals that have received approval from the FDA for weight loss purposes. Our esteemed guest today is Maria L. Collazo-Clavell, M.D., an authority in the fields of obesity and endocrinology, who is affiliated with the Mayo Clinic.
Mayo Clinic Talks Obesity Edition Online CME Course
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1005</itunes:duration>
                <itunes:episode>419</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>HIV &amp; Attitudes Towards PrEP</title>
        <itunes:title>HIV &amp; Attitudes Towards PrEP</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/hiv-attitudes-towards-prep/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/hiv-attitudes-towards-prep/#comments</comments>        <pubDate>Tue, 27 Jun 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/58b660b7-3371-3a32-86cc-3f4948eb6d6a</guid>
                                    <description><![CDATA[<p>Host: Joshua D. Luciew, MPAS, PA-C</p>
<p>Guest: Maryam Mahmood, M.B., Ch.B.</p>
<p>Guest: Cesar A. Gonzalez, Ph.D., L.P.</p>
<p>As primary care providers, evaluating patients with a virus is a common part of our practice. This ranges from colds, a painful shingles outbreak, COVID-19, RSV bronchiolitis, influenza, and many more.</p>
<p>Oftentimes, after a detailed physical exam, we tell our patients the cause of their symptoms are due to a virus and that their symptoms should improve in a couple days to weeks. However, we know that sometimes the symptoms of a viral infection can be a harbinger of more severe disease.</p>
<p>In today’s talk, we will be discussing a virus. Acute infection with this virus can present with fever, fatigue, myalgias, arthralgias, lymphadenopathy, sore throat, headache, diarrhea, weight loss, and rash.</p>
<p>This constellation of symptoms, especially when they persist for a prolonged duration of time can be representative of an acute HIV infection.</p>
<p>Tune in to this episode to learn more about the pathophysiology of HIV, how a patient can contract HIV, the tests to perform when an acute HIV infection is suspected, how to prevent an HIV infection, and to learn a bit more about anal Pap smears.</p>
<p> Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Joshua D. Luciew, MPAS, PA-C</p>
<p>Guest: Maryam Mahmood, M.B., Ch.B.</p>
<p>Guest: Cesar A. Gonzalez, Ph.D., L.P.</p>
<p>As primary care providers, evaluating patients with a virus is a common part of our practice. This ranges from colds, a painful shingles outbreak, COVID-19, RSV bronchiolitis, influenza, and many more.</p>
<p>Oftentimes, after a detailed physical exam, we tell our patients the cause of their symptoms are due to a virus and that their symptoms should improve in a couple days to weeks. However, we know that sometimes the symptoms of a viral infection can be a harbinger of more severe disease.</p>
<p>In today’s talk, we will be discussing a virus. Acute infection with this virus can present with fever, fatigue, myalgias, arthralgias, lymphadenopathy, sore throat, headache, diarrhea, weight loss, and rash.</p>
<p>This constellation of symptoms, especially when they persist for a prolonged duration of time can be representative of an acute HIV infection.</p>
<p>Tune in to this episode to learn more about the pathophysiology of HIV, how a patient can contract HIV, the tests to perform when an acute HIV infection is suspected, how to prevent an HIV infection, and to learn a bit more about anal Pap smears.</p>
<p> Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ckjpje/WF2248535_HIV_AF6zalh.mp3" length="49726121" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Joshua D. Luciew, MPAS, PA-C
Guest: Maryam Mahmood, M.B., Ch.B.
Guest: Cesar A. Gonzalez, Ph.D., L.P.
As primary care providers, evaluating patients with a virus is a common part of our practice. This ranges from colds, a painful shingles outbreak, COVID-19, RSV bronchiolitis, influenza, and many more.
Oftentimes, after a detailed physical exam, we tell our patients the cause of their symptoms are due to a virus and that their symptoms should improve in a couple days to weeks. However, we know that sometimes the symptoms of a viral infection can be a harbinger of more severe disease.
In today’s talk, we will be discussing a virus. Acute infection with this virus can present with fever, fatigue, myalgias, arthralgias, lymphadenopathy, sore throat, headache, diarrhea, weight loss, and rash.
This constellation of symptoms, especially when they persist for a prolonged duration of time can be representative of an acute HIV infection.
Tune in to this episode to learn more about the pathophysiology of HIV, how a patient can contract HIV, the tests to perform when an acute HIV infection is suspected, how to prevent an HIV infection, and to learn a bit more about anal Pap smears.
 Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2054</itunes:duration>
                <itunes:episode>418</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Obesity Edition | Obese Adult Patient Presents to Primary Care Provider</title>
        <itunes:title>Obesity Edition | Obese Adult Patient Presents to Primary Care Provider</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/obesity-edition-obese-adult-patient-presents-to-primary-care-provider/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/obesity-edition-obese-adult-patient-presents-to-primary-care-provider/#comments</comments>        <pubDate>Thu, 22 Jun 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/ae5866e8-2f71-3906-9530-4e048d97226b</guid>
                                    <description><![CDATA[<p>Host: Ishna A. Sharma, M.D. <a href='https://twitter.com/IshnaSharmaMD'>https://twitter.com/IshnaSharmaMD</a></p>
<p>Guest: Meera Shah, M.B., Ch.B.</p>
<p>Obesity has become a significant public health crisis in both the U.S. and around the world. Globally, over 1.9 million people are overweight, and 650 million people are obese. In the U.S., 39.8% of the adult population is obese. Obesity leads to hypertension, hyperlipidemia, coronary artery disease, diabetes, sleep apnea and even certain cancers. Outside of the morbidity and mortality associated with this, obesity also leads to almost $200 billion annually in healthcare costs. Obesity is a complex medical issue, and one of the first settings a patient may receive care for this is at the PCP office.</p>
<p>This episode is the first episode in our Obesity Edition focused on how a primary care physician can help an obese adult patient who visits them in clinic. This episode will concentrate on the basics: How to approach the conversation with a patient; How to guide their next steps; How to continue caring for an obese patient once they are underway in their management. Today, we’re joined by Meera Shah, M.B., Ch.B., a Mayo Clinic endocrinologist specializing in obesity, who will help guide us in answering these questions and more. </p>
<p><a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-obesity-edition-online-cme-course#group-tabs-node-course-default2'>Mayo Clinic Talks Obesity Edition Online CME Course</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Ishna A. Sharma, M.D. <a href='https://twitter.com/IshnaSharmaMD'>https://twitter.com/IshnaSharmaMD</a></p>
<p>Guest: Meera Shah, M.B., Ch.B.</p>
<p>Obesity has become a significant public health crisis in both the U.S. and around the world. Globally, over 1.9 million people are overweight, and 650 million people are obese. In the U.S., 39.8% of the adult population is obese. Obesity leads to hypertension, hyperlipidemia, coronary artery disease, diabetes, sleep apnea and even certain cancers. Outside of the morbidity and mortality associated with this, obesity also leads to almost $200 billion annually in healthcare costs. Obesity is a complex medical issue, and one of the first settings a patient may receive care for this is at the PCP office.</p>
<p>This episode is the first episode in our Obesity Edition focused on how a primary care physician can help an obese adult patient who visits them in clinic. This episode will concentrate on the basics: How to approach the conversation with a patient; How to guide their next steps; How to continue caring for an obese patient once they are underway in their management. Today, we’re joined by Meera Shah, M.B., Ch.B., a Mayo Clinic endocrinologist specializing in obesity, who will help guide us in answering these questions and more. </p>
<p><a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-obesity-edition-online-cme-course#group-tabs-node-course-default2'>Mayo Clinic Talks Obesity Edition Online CME Course</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/e5ui3v/WF2084900_Present_to_PCP_Office_AF8kvf2.mp3" length="26206661" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Ishna A. Sharma, M.D. https://twitter.com/IshnaSharmaMD
Guest: Meera Shah, M.B., Ch.B.
Obesity has become a significant public health crisis in both the U.S. and around the world. Globally, over 1.9 million people are overweight, and 650 million people are obese. In the U.S., 39.8% of the adult population is obese. Obesity leads to hypertension, hyperlipidemia, coronary artery disease, diabetes, sleep apnea and even certain cancers. Outside of the morbidity and mortality associated with this, obesity also leads to almost $200 billion annually in healthcare costs. Obesity is a complex medical issue, and one of the first settings a patient may receive care for this is at the PCP office.
This episode is the first episode in our Obesity Edition focused on how a primary care physician can help an obese adult patient who visits them in clinic. This episode will concentrate on the basics: How to approach the conversation with a patient; How to guide their next steps; How to continue caring for an obese patient once they are underway in their management. Today, we’re joined by Meera Shah, M.B., Ch.B., a Mayo Clinic endocrinologist specializing in obesity, who will help guide us in answering these questions and more. 
Mayo Clinic Talks Obesity Edition Online CME Course
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1082</itunes:duration>
                <itunes:episode>415</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Healthy Start: Nutrition in Early Childhood</title>
        <itunes:title>Healthy Start: Nutrition in Early Childhood</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/healthy-start-nutrition-in-early-childhood/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/healthy-start-nutrition-in-early-childhood/#comments</comments>        <pubDate>Tue, 20 Jun 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/aff8734c-d9ba-3ac1-974c-4a81edc8a487</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Angela C. Mattke, M.D.</p>
<p>The early years of a child are extremely important for establishing growth, maturation, and development. Good nutrition is felt to be an important component for these benefits to take place.  Yet, there’s evidence that a substantial proportion of our children are not receiving the nutrition they should. Inadequate nutrition can lead to issues not only in later childhood but chronic health problems in adulthood as well. The topic for this podcast is “Nutrition in Early Childhood”. We’ll be discussing such issues as: What are the most common nutritional deficiencies our young children face? What are the potential long-term complications of inadequate nutrition in early childhood and what’s the solution to improving nutrition? My guest is Angela C. Mattke, M.D., a pediatrician from the Division of Community Pediatrics and Adolescent Medicine at the Mayo Clinic. </p>
<p></p>
<p><a href='https://www.usdairy.com/about-us/national-dairy-council'>https://www.usdairy.com/about-us/national-dairy-council</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Angela C. Mattke, M.D.</p>
<p>The early years of a child are extremely important for establishing growth, maturation, and development. Good nutrition is felt to be an important component for these benefits to take place.  Yet, there’s evidence that a substantial proportion of our children are not receiving the nutrition they should. Inadequate nutrition can lead to issues not only in later childhood but chronic health problems in adulthood as well. The topic for this podcast is “Nutrition in Early Childhood”. We’ll be discussing such issues as: What are the most common nutritional deficiencies our young children face? What are the potential long-term complications of inadequate nutrition in early childhood and what’s the solution to improving nutrition? My guest is Angela C. Mattke, M.D., a pediatrician from the Division of Community Pediatrics and Adolescent Medicine at the Mayo Clinic. </p>
<p></p>
<p><a href='https://www.usdairy.com/about-us/national-dairy-council'>https://www.usdairy.com/about-us/national-dairy-council</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4a4h6h/WF2458100_Nutrition_for_Early_Childhood_AF9fefv.mp3" length="30356579" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Angela C. Mattke, M.D.
The early years of a child are extremely important for establishing growth, maturation, and development. Good nutrition is felt to be an important component for these benefits to take place.  Yet, there’s evidence that a substantial proportion of our children are not receiving the nutrition they should. Inadequate nutrition can lead to issues not only in later childhood but chronic health problems in adulthood as well. The topic for this podcast is “Nutrition in Early Childhood”. We’ll be discussing such issues as: What are the most common nutritional deficiencies our young children face? What are the potential long-term complications of inadequate nutrition in early childhood and what’s the solution to improving nutrition? My guest is Angela C. Mattke, M.D., a pediatrician from the Division of Community Pediatrics and Adolescent Medicine at the Mayo Clinic. 

https://www.usdairy.com/about-us/national-dairy-council
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1260</itunes:duration>
                <itunes:episode>417</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>LGBTQIA+ Health for Primary Care</title>
        <itunes:title>LGBTQIA+ Health for Primary Care</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/lgbtqia-health-for-primary-care/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/lgbtqia-health-for-primary-care/#comments</comments>        <pubDate>Tue, 13 Jun 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/dc1d935c-a4f5-34fd-9fdf-05a6c7f0084e</guid>
                                    <description><![CDATA[
Host: Joshua D. Luciew, MPAS, P.A.-C.


 
Guest: Juliana (Jewel) M. Kling, M.D., M.P.H.
 

<p>Individuals who belong to the LGBTQIA+ population are a part of the communities we provide care. Every member of this group is unique, and recognizing how sexual orientation and gender identity influences each person, including how these concepts may evolve and change over a life span, can help us provide more inclusive and whole person care. Many members of the LGBTQIA+ population either do not have access to, or do not seek quality medical care due to stigma and discrimination, which then leads to many disparities. By learning how to provide culturally sensitive care, we can help reduce healthcare disparities for LGBTQIA+ folks. Tune in to this episode to learn more about the LGBTQIA+ community, some of the disparities the community faces, and learn about some special considerations that may arise in your care of the LGBTQIA+ patient.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[
Host: Joshua D. Luciew, MPAS, P.A.-C.


 
Guest: Juliana (Jewel) M. Kling, M.D., M.P.H.
 

<p>Individuals who belong to the LGBTQIA+ population are a part of the communities we provide care. Every member of this group is unique, and recognizing how sexual orientation and gender identity influences each person, including how these concepts may evolve and change over a life span, can help us provide more inclusive and whole person care. Many members of the LGBTQIA+ population either do not have access to, or do not seek quality medical care due to stigma and discrimination, which then leads to many disparities. By learning how to provide culturally sensitive care, we can help reduce healthcare disparities for LGBTQIA+ folks. Tune in to this episode to learn more about the LGBTQIA+ community, some of the disparities the community faces, and learn about some special considerations that may arise in your care of the LGBTQIA+ patient.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/x3mrgg/WF2125954_LGBTQIA_Healthcare_AF6z6po.mp3" length="55133074" type="audio/mpeg"/>
        <itunes:summary><![CDATA[
Host: Joshua D. Luciew, MPAS, P.A.-C.


 
Guest: Juliana (Jewel) M. Kling, M.D., M.P.H.
 

Individuals who belong to the LGBTQIA+ population are a part of the communities we provide care. Every member of this group is unique, and recognizing how sexual orientation and gender identity influences each person, including how these concepts may evolve and change over a life span, can help us provide more inclusive and whole person care. Many members of the LGBTQIA+ population either do not have access to, or do not seek quality medical care due to stigma and discrimination, which then leads to many disparities. By learning how to provide culturally sensitive care, we can help reduce healthcare disparities for LGBTQIA+ folks. Tune in to this episode to learn more about the LGBTQIA+ community, some of the disparities the community faces, and learn about some special considerations that may arise in your care of the LGBTQIA+ patient.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2286</itunes:duration>
                <itunes:episode>412</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Testosterone Supplementation in Men: Risks, Benefits &amp; Best Practices</title>
        <itunes:title>Testosterone Supplementation in Men: Risks, Benefits &amp; Best Practices</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/testosterone-supplementation-in-men-risks-benefits-best-practices/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/testosterone-supplementation-in-men-risks-benefits-best-practices/#comments</comments>        <pubDate>Tue, 06 Jun 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/9217af8c-387c-3807-b5d0-fceceec681f3</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Nahid Punjani, M.D., M.P.H</p>
<p>Testosterone has a variety of health benefits. It helps maintain bone density, muscle mass, red blood cell production and sexual function. Testosterone levels in men tend to peak between age 30 to 40 then gradually decline and it’s not unusual to find low testosterone levels in men over the age of 50. It’s also known that in men with hypogonadism, testosterone supplementation can improve libido, bone density and muscle mass. Should we be checking testosterone levels in our middle-age male patients? How do we determine who should receive testosterone supplementation and finally what are the risks of supplementation? In this podcast, these are all questions I’ll be asking our guest, Nahid Punjani, M.D., M.P.H, a urologist at the Mayo Clinic as we discuss “Testosterone Supplementation in Men”.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Nahid Punjani, M.D., M.P.H</p>
<p>Testosterone has a variety of health benefits. It helps maintain bone density, muscle mass, red blood cell production and sexual function. Testosterone levels in men tend to peak between age 30 to 40 then gradually decline and it’s not unusual to find low testosterone levels in men over the age of 50. It’s also known that in men with hypogonadism, testosterone supplementation can improve libido, bone density and muscle mass. Should we be checking testosterone levels in our middle-age male patients? How do we determine who should receive testosterone supplementation and finally what are the risks of supplementation? In this podcast, these are all questions I’ll be asking our guest, Nahid Punjani, M.D., M.P.H, a urologist at the Mayo Clinic as we discuss “Testosterone Supplementation in Men”.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/sqspf9/WF1985531_Testosterone_AFbpxnv.mp3" length="28907764" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Nahid Punjani, M.D., M.P.H
Testosterone has a variety of health benefits. It helps maintain bone density, muscle mass, red blood cell production and sexual function. Testosterone levels in men tend to peak between age 30 to 40 then gradually decline and it’s not unusual to find low testosterone levels in men over the age of 50. It’s also known that in men with hypogonadism, testosterone supplementation can improve libido, bone density and muscle mass. Should we be checking testosterone levels in our middle-age male patients? How do we determine who should receive testosterone supplementation and finally what are the risks of supplementation? In this podcast, these are all questions I’ll be asking our guest, Nahid Punjani, M.D., M.P.H, a urologist at the Mayo Clinic as we discuss “Testosterone Supplementation in Men”.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1201</itunes:duration>
                <itunes:episode>416</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Celiac Disease &amp; Gluten Sensitivity: “No Loafing Matter”</title>
        <itunes:title>Celiac Disease &amp; Gluten Sensitivity: “No Loafing Matter”</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/celiac-disease-gluten-sensitivity-no-loafing-matter/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/celiac-disease-gluten-sensitivity-no-loafing-matter/#comments</comments>        <pubDate>Tue, 30 May 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/8cf8ee90-fc8d-3c12-b4f1-3ced96abb854</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Amy S. Oxentenko, M.D.</p>
<p>It’s estimated that less than 1/3 of individuals with celiac disease have been properly diagnosed. When those with celiac disease ingest gluten, an immune response develops which attacks the small intestine leading to inadequate absorption of nutrients. If left untreated, celiac disease can lead to a variety of nutritional deficiencies as well as other serious consequences. Those with celiac disease are also at increased risk for coronary disease and small bowel cancers. In this podcast we’ll review celiac disease and gluten sensitivity with our guest, Amy S. Oxentenko, M.D., a gastroenterologist at the Mayo Clinic. We’ll discuss the symptoms of celiac disease, how to diagnose the condition and how patients with celiac disease should be managed.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Amy S. Oxentenko, M.D.</p>
<p>It’s estimated that less than 1/3 of individuals with celiac disease have been properly diagnosed. When those with celiac disease ingest gluten, an immune response develops which attacks the small intestine leading to inadequate absorption of nutrients. If left untreated, celiac disease can lead to a variety of nutritional deficiencies as well as other serious consequences. Those with celiac disease are also at increased risk for coronary disease and small bowel cancers. In this podcast we’ll review celiac disease and gluten sensitivity with our guest, Amy S. Oxentenko, M.D., a gastroenterologist at the Mayo Clinic. We’ll discuss the symptoms of celiac disease, how to diagnose the condition and how patients with celiac disease should be managed.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/yd6wu5/WF2201563_Celiac_Disease_Gluten_Intolerance_AF7hoas.mp3" length="42581347" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Amy S. Oxentenko, M.D.
It’s estimated that less than 1/3 of individuals with celiac disease have been properly diagnosed. When those with celiac disease ingest gluten, an immune response develops which attacks the small intestine leading to inadequate absorption of nutrients. If left untreated, celiac disease can lead to a variety of nutritional deficiencies as well as other serious consequences. Those with celiac disease are also at increased risk for coronary disease and small bowel cancers. In this podcast we’ll review celiac disease and gluten sensitivity with our guest, Amy S. Oxentenko, M.D., a gastroenterologist at the Mayo Clinic. We’ll discuss the symptoms of celiac disease, how to diagnose the condition and how patients with celiac disease should be managed.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1772</itunes:duration>
                <itunes:episode>409</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Sleep Medicine Edition | Violent Dreams, Sleepwalking &amp; Other Strange Nighttime Events</title>
        <itunes:title>Sleep Medicine Edition | Violent Dreams, Sleepwalking &amp; Other Strange Nighttime Events</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/sleep-medicine-edition-violent-dreams-sleepwalking-other-strange-nighttime-events/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/sleep-medicine-edition-violent-dreams-sleepwalking-other-strange-nighttime-events/#comments</comments>        <pubDate>Thu, 25 May 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/56db017a-9c47-3b56-8cee-829543e95d3e</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guests: Robin M. Lloyd, M.D., & Michael Silber, M.B. Ch.B.</p>
<p>In most people, sleep is a peaceful activity. Dreaming is a normal component of our sleep and represents activity of the brain at a time the rest of our body is inactive. However, for some individuals sleep is not a peaceful activity. Some can experience very violent dreams, often associated with physical movements. Sleepwalking is another nighttime activity which some experience.  Violent dreams and sleepwalking can place the patient as well as others at risk for injury. How common are these behaviors? What causes them and how can these patients be treated. In this podcast, we’ll discuss violent dreams, sleep walking and other strange nighttime events with Mayo Clinic sleep specialists, Robin M. Lloyd, M.D., from the Department of Pediatrics and Adolescent Medicine and Michael Silber, M.B. Ch.B., from the Department of Neurology.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guests: Robin M. Lloyd, M.D., & Michael Silber, M.B. Ch.B.</p>
<p>In most people, sleep is a peaceful activity. Dreaming is a normal component of our sleep and represents activity of the brain at a time the rest of our body is inactive. However, for some individuals sleep is not a peaceful activity. Some can experience very violent dreams, often associated with physical movements. Sleepwalking is another nighttime activity which some experience.  Violent dreams and sleepwalking can place the patient as well as others at risk for injury. How common are these behaviors? What causes them and how can these patients be treated. In this podcast, we’ll discuss violent dreams, sleep walking and other strange nighttime events with Mayo Clinic sleep specialists, Robin M. Lloyd, M.D., from the Department of Pediatrics and Adolescent Medicine and Michael Silber, M.B. Ch.B., from the Department of Neurology.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vuqprc/WF2169301_Violent_Dreams_and_Sleepwalking_AFah8qq.mp3" length="49142294" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guests: Robin M. Lloyd, M.D., & Michael Silber, M.B. Ch.B.
In most people, sleep is a peaceful activity. Dreaming is a normal component of our sleep and represents activity of the brain at a time the rest of our body is inactive. However, for some individuals sleep is not a peaceful activity. Some can experience very violent dreams, often associated with physical movements. Sleepwalking is another nighttime activity which some experience.  Violent dreams and sleepwalking can place the patient as well as others at risk for injury. How common are these behaviors? What causes them and how can these patients be treated. In this podcast, we’ll discuss violent dreams, sleep walking and other strange nighttime events with Mayo Clinic sleep specialists, Robin M. Lloyd, M.D., from the Department of Pediatrics and Adolescent Medicine and Michael Silber, M.B. Ch.B., from the Department of Neurology.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2044</itunes:duration>
                <itunes:episode>414</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Food Allergy: Common Causes, Diagnosis &amp; Treatment</title>
        <itunes:title>Food Allergy: Common Causes, Diagnosis &amp; Treatment</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/food-allergy-common-causes-diagnosis-treatment/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/food-allergy-common-causes-diagnosis-treatment/#comments</comments>        <pubDate>Tue, 23 May 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/49bbb06f-d631-33a5-8e7a-83a97dceee0b</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/chutkamd'>@ChutkaMD</a></p>
<p>Guest: Gerald W. Volcheck, M.D.</p>
<p>Food allergy is an immune reaction that develops following ingestion of sometimes even a very small amount of the offending food product. It’s thought to occur in up to 4% of adults and is not to be confused with a food intolerance, which is much more common. It’s important to recognize patients who develop a food allergy as they can develop not only relatively benign problems such as GI symptoms or hives, but also more severe and potentially life-threatening conditions such as bronchospasm or even anaphylaxis. What are the most common foods that produce allergies? How should these patients be evaluated and how do we manage them? Our topic for this podcast is “Food Allergy” and these are some of the questions I’ll be asking our guest, Gerald W. Volcheck, M.D., from the Division of Allergic Diseases at the Mayo Clinic.</p>
<p></p>
<p><a href='https://www.usdairy.com/about-us/national-dairy-council'> </a></p>
<p><a href='https://www.usdairy.com/about-us/national-dairy-council'>https://www.usdairy.com/about-us/national-dairy-council</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/chutkamd'>@ChutkaMD</a></p>
<p>Guest: Gerald W. Volcheck, M.D.</p>
<p>Food allergy is an immune reaction that develops following ingestion of sometimes even a very small amount of the offending food product. It’s thought to occur in up to 4% of adults and is not to be confused with a food intolerance, which is much more common. It’s important to recognize patients who develop a food allergy as they can develop not only relatively benign problems such as GI symptoms or hives, but also more severe and potentially life-threatening conditions such as bronchospasm or even anaphylaxis. What are the most common foods that produce allergies? How should these patients be evaluated and how do we manage them? Our topic for this podcast is “Food Allergy” and these are some of the questions I’ll be asking our guest, Gerald W. Volcheck, M.D., from the Division of Allergic Diseases at the Mayo Clinic.</p>
<p></p>
<p><a href='https://www.usdairy.com/about-us/national-dairy-council'> </a></p>
<p><a href='https://www.usdairy.com/about-us/national-dairy-council'>https://www.usdairy.com/about-us/national-dairy-council</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/r4h9en/WF2186365_Food_Allergy_With_Ad6elks.mp3" length="37398993" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. @ChutkaMD
Guest: Gerald W. Volcheck, M.D.
Food allergy is an immune reaction that develops following ingestion of sometimes even a very small amount of the offending food product. It’s thought to occur in up to 4% of adults and is not to be confused with a food intolerance, which is much more common. It’s important to recognize patients who develop a food allergy as they can develop not only relatively benign problems such as GI symptoms or hives, but also more severe and potentially life-threatening conditions such as bronchospasm or even anaphylaxis. What are the most common foods that produce allergies? How should these patients be evaluated and how do we manage them? Our topic for this podcast is “Food Allergy” and these are some of the questions I’ll be asking our guest, Gerald W. Volcheck, M.D., from the Division of Allergic Diseases at the Mayo Clinic.

 
https://www.usdairy.com/about-us/national-dairy-council
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1531</itunes:duration>
                <itunes:episode>413</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Sleep Medicine Edition | Restless Leg Syndrome (RLS)</title>
        <itunes:title>Sleep Medicine Edition | Restless Leg Syndrome (RLS)</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/sleep-medicine-edition-restless-leg-syndrome-rls/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/sleep-medicine-edition-restless-leg-syndrome-rls/#comments</comments>        <pubDate>Thu, 18 May 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/7093db5e-f632-3c47-a5cb-176fbbd09924</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Michael Silber, M.B. Ch.B.</p>
<p>It’s estimated that up to 10% of the U.S. population has restless leg syndrome, with most patients middle aged or older. Since it tends to occur in the latter part of the day, it commonly interferes with an individual’s ability to sleep and is one of several known sleep disorders. Unfortunately, there is no cure, however there are a variety of treatment options available. The topic for this podcast is restless leg syndrome and my guest is sleep specialist and neurologist, Michael Silber, M.B. Ch.B., from the Mayo Clinic. We’ll discuss the symptoms and pathophysiology of restless leg syndrome, other medical conditions often confused with it as well as the various treatment options.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Michael Silber, M.B. Ch.B.</p>
<p>It’s estimated that up to 10% of the U.S. population has restless leg syndrome, with most patients middle aged or older. Since it tends to occur in the latter part of the day, it commonly interferes with an individual’s ability to sleep and is one of several known sleep disorders. Unfortunately, there is no cure, however there are a variety of treatment options available. The topic for this podcast is restless leg syndrome and my guest is sleep specialist and neurologist, Michael Silber, M.B. Ch.B., from the Mayo Clinic. We’ll discuss the symptoms and pathophysiology of restless leg syndrome, other medical conditions often confused with it as well as the various treatment options.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/aj8u4z/WF2181109_Restless_Legs_AFa5h10.mp3" length="41374286" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Michael Silber, M.B. Ch.B.
It’s estimated that up to 10% of the U.S. population has restless leg syndrome, with most patients middle aged or older. Since it tends to occur in the latter part of the day, it commonly interferes with an individual’s ability to sleep and is one of several known sleep disorders. Unfortunately, there is no cure, however there are a variety of treatment options available. The topic for this podcast is restless leg syndrome and my guest is sleep specialist and neurologist, Michael Silber, M.B. Ch.B., from the Mayo Clinic. We’ll discuss the symptoms and pathophysiology of restless leg syndrome, other medical conditions often confused with it as well as the various treatment options.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1722</itunes:duration>
                <itunes:episode>411</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Women in Medicine</title>
        <itunes:title>Women in Medicine</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/women-in-medicine/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/women-in-medicine/#comments</comments>        <pubDate>Tue, 16 May 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/30a9ca70-f839-3bf9-b9ba-c0dcfaa95b0c</guid>
                                    <description><![CDATA[<p>Hosts: <a href='https://www.mayoclinic.org/biographies/davis-dawn-marie-r-m-d/bio-20054974'>Dawn Marie R. Davis, M.D</a>. and <a href='https://www.mayoclinic.org/biographies/kakar-sanjeev-sanj-m-d/bio-20055340'>Sanjeev (Sanj) Kakar, M.D</a>.</p>
<p>Guest: <a href='https://www.mayoclinic.org/biographies/o-brien-erin-k-m-d/bio-20055535'>Erin K. O'Brien, M.D</a>.</p>
<p>Guest: <a href='https://www.mayoclinic.org/biographies/pritt-bobbi-s-m-d/bio-20514068'>Bobbi S. Pritt, M.D</a>.</p>
<p>Guest: <a href='https://www.mayoclinic.org/biographies/pruthi-sandhya-m-d/bio-20053925'>Sandhya Pruthi, M.D</a>.</p>
<p>Our society is changing with women assuming more prominent roles. We have a female Vice President and recent books by Sheryl Sandberg (Lean In) and Michelle Obama (The Light We Carry), have highlighted the importance in inequities women have, and continue to have, on a daily basis. Mayo Clinic continues to evolve and lead this change in healthcare with female leaders incorporated throughout the practice. To celebrate this, we invited three dynamic physicians at Mayo Clinic’s Rochester campus, Erin K. O’Brien, M.D., Bobbi S. Pritt, M.D., and Sandhya Pruthi, M.D., to share their stories and perspectives in this week’s podcast.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Hosts: <a href='https://www.mayoclinic.org/biographies/davis-dawn-marie-r-m-d/bio-20054974'>Dawn Marie R. Davis, M.D</a>. and <a href='https://www.mayoclinic.org/biographies/kakar-sanjeev-sanj-m-d/bio-20055340'>Sanjeev (Sanj) Kakar, M.D</a>.</p>
<p>Guest: <a href='https://www.mayoclinic.org/biographies/o-brien-erin-k-m-d/bio-20055535'>Erin K. O'Brien, M.D</a>.</p>
<p>Guest: <a href='https://www.mayoclinic.org/biographies/pritt-bobbi-s-m-d/bio-20514068'>Bobbi S. Pritt, M.D</a>.</p>
<p>Guest: <a href='https://www.mayoclinic.org/biographies/pruthi-sandhya-m-d/bio-20053925'>Sandhya Pruthi, M.D</a>.</p>
<p>Our society is changing with women assuming more prominent roles. We have a female Vice President and recent books by Sheryl Sandberg (Lean In) and Michelle Obama (The Light We Carry), have highlighted the importance in inequities women have, and continue to have, on a daily basis. Mayo Clinic continues to evolve and lead this change in healthcare with female leaders incorporated throughout the practice. To celebrate this, we invited three dynamic physicians at Mayo Clinic’s Rochester campus, Erin K. O’Brien, M.D., Bobbi S. Pritt, M.D., and Sandhya Pruthi, M.D., to share their stories and perspectives in this week’s podcast.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6xeeaa/WF2222800_Women_in_Medicine_V2_FINAL8cqpl.mp3" length="57438993" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Hosts: Dawn Marie R. Davis, M.D. and Sanjeev (Sanj) Kakar, M.D.
Guest: Erin K. O'Brien, M.D.
Guest: Bobbi S. Pritt, M.D.
Guest: Sandhya Pruthi, M.D.
Our society is changing with women assuming more prominent roles. We have a female Vice President and recent books by Sheryl Sandberg (Lean In) and Michelle Obama (The Light We Carry), have highlighted the importance in inequities women have, and continue to have, on a daily basis. Mayo Clinic continues to evolve and lead this change in healthcare with female leaders incorporated throughout the practice. To celebrate this, we invited three dynamic physicians at Mayo Clinic’s Rochester campus, Erin K. O’Brien, M.D., Bobbi S. Pritt, M.D., and Sandhya Pruthi, M.D., to share their stories and perspectives in this week’s podcast.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2519</itunes:duration>
                <itunes:episode>410</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Sleep Medicine Edition | Medications for Insomnia: What Works?</title>
        <itunes:title>Sleep Medicine Edition | Medications for Insomnia: What Works?</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/sleep-medicine-edition-medications-for-insomnia-what-works/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/sleep-medicine-edition-medications-for-insomnia-what-works/#comments</comments>        <pubDate>Thu, 11 May 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/57ef01df-0d28-3388-80ba-73e2c1bc2053</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Bhanuprakash (Bhanu) Kolla, M.D.</p>
<p>A common question we get from patients is “What can you give me to help me sleep?”. Explaining how our sleep changes with age; becoming less efficient, more fragmented with multiple reasons for nighttime awakenings is met with understanding from the patient but is always followed by the question “So, what are you going to give me to help me sleep?”.  How does sleep change with aging? Why do we often have difficulty falling and staying asleep, and does the ideal pharmacologic agent exist that can be taken nightly, helps us fall asleep, remain asleep throughout the night and allow us to wake up feeling refreshed in the morning? In this podcast, we’ll discuss these questions with our guest, Bhanuprakash (Bhanu) Kolla, M.D., a psychiatrist from the Department of Psychiatry and Psychology at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Bhanuprakash (Bhanu) Kolla, M.D.</p>
<p>A common question we get from patients is “What can you give me to help me sleep?”. Explaining how our sleep changes with age; becoming less efficient, more fragmented with multiple reasons for nighttime awakenings is met with understanding from the patient but is always followed by the question “So, what are you going to give me to help me sleep?”.  How does sleep change with aging? Why do we often have difficulty falling and staying asleep, and does the ideal pharmacologic agent exist that can be taken nightly, helps us fall asleep, remain asleep throughout the night and allow us to wake up feeling refreshed in the morning? In this podcast, we’ll discuss these questions with our guest, Bhanuprakash (Bhanu) Kolla, M.D., a psychiatrist from the Department of Psychiatry and Psychology at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wuhjmy/WF2152706_Medications_for_Insomnia_AFbqts5.mp3" length="35003338" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Bhanuprakash (Bhanu) Kolla, M.D.
A common question we get from patients is “What can you give me to help me sleep?”. Explaining how our sleep changes with age; becoming less efficient, more fragmented with multiple reasons for nighttime awakenings is met with understanding from the patient but is always followed by the question “So, what are you going to give me to help me sleep?”.  How does sleep change with aging? Why do we often have difficulty falling and staying asleep, and does the ideal pharmacologic agent exist that can be taken nightly, helps us fall asleep, remain asleep throughout the night and allow us to wake up feeling refreshed in the morning? In this podcast, we’ll discuss these questions with our guest, Bhanuprakash (Bhanu) Kolla, M.D., a psychiatrist from the Department of Psychiatry and Psychology at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1457</itunes:duration>
                <itunes:episode>407</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Tick Talk of Lyme Disease: How to Diagnose &amp; When to Treat</title>
        <itunes:title>The Tick Talk of Lyme Disease: How to Diagnose &amp; When to Treat</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/the-ticktalk-of-lyme-disease-how-to-diagnose-when-to-treat/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/the-ticktalk-of-lyme-disease-how-to-diagnose-when-to-treat/#comments</comments>        <pubDate>Tue, 09 May 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/0d726bb6-c3ed-3601-aa16-24454cf1dcb2</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Elitza S. Theel, Ph.D.</p>
<p>Lyme disease is quite common with more than 400,000 new cases per year in the United States alone. It’s associated with a constellation of typical symptoms, but it can also produce symptoms which are very unusual and vague. As a result, it can mimic a variety of other diseases. An accurate diagnosis of Lyme disease can be challenging, often resulting in a delay or even lack of treatment. In this podcast, we’ll discuss the typical presentation of Lyme disease as well as some of its more unusual presenting symptoms. We’ll also cover how to establish a diagnosis and its current treatment recommendations. Our guest is Elitza S. Theel, Ph.D., a clinical microbiologist from the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Elitza S. Theel, Ph.D.</p>
<p>Lyme disease is quite common with more than 400,000 new cases per year in the United States alone. It’s associated with a constellation of typical symptoms, but it can also produce symptoms which are very unusual and vague. As a result, it can mimic a variety of other diseases. An accurate diagnosis of Lyme disease can be challenging, often resulting in a delay or even lack of treatment. In this podcast, we’ll discuss the typical presentation of Lyme disease as well as some of its more unusual presenting symptoms. We’ll also cover how to establish a diagnosis and its current treatment recommendations. Our guest is Elitza S. Theel, Ph.D., a clinical microbiologist from the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bbvdpv/WF1257501_Lyme_Disease_AF8ykxn.mp3" length="35588328" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Elitza S. Theel, Ph.D.
Lyme disease is quite common with more than 400,000 new cases per year in the United States alone. It’s associated with a constellation of typical symptoms, but it can also produce symptoms which are very unusual and vague. As a result, it can mimic a variety of other diseases. An accurate diagnosis of Lyme disease can be challenging, often resulting in a delay or even lack of treatment. In this podcast, we’ll discuss the typical presentation of Lyme disease as well as some of its more unusual presenting symptoms. We’ll also cover how to establish a diagnosis and its current treatment recommendations. Our guest is Elitza S. Theel, Ph.D., a clinical microbiologist from the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1478</itunes:duration>
                <itunes:episode>408</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Sleep Medicine Edition | Cognitive Behavioral Therapy for Treatment of Insomnia</title>
        <itunes:title>Sleep Medicine Edition | Cognitive Behavioral Therapy for Treatment of Insomnia</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/sleep-medicine-edition-cognitive-behavioral-therapy-for-treatment-of-insomnia/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/sleep-medicine-edition-cognitive-behavioral-therapy-for-treatment-of-insomnia/#comments</comments>        <pubDate>Thu, 04 May 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/c7bdfe2c-3267-3bda-892d-4eec7d44d346</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Michael H. Silber, M.B.Ch.B.</p>
<p>Difficulty initiating and maintaining sleep is a common problem for many patients. Over-the-counter sleeping aids are used by many and we commonly get asked for prescription medications to help with their sleep. Unfortunately, the ideal sleeping medication doesn’t exist and many have potentially worrisome adverse effects, some produce daytime somnolence and others may have the potential to produce dependence. Cognitive behavioral therapy is an alternative treatment option to pharmacologic therapy and is safe, can be easily taught, and offers an alternative to the many with chronic insomnia. In this podcast, we’ll discuss this innovative treatment option with sleep expert, Michael H. Silber, M.B.Ch.B., a neurologist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Michael H. Silber, M.B.Ch.B.</p>
<p>Difficulty initiating and maintaining sleep is a common problem for many patients. Over-the-counter sleeping aids are used by many and we commonly get asked for prescription medications to help with their sleep. Unfortunately, the ideal sleeping medication doesn’t exist and many have potentially worrisome adverse effects, some produce daytime somnolence and others may have the potential to produce dependence. Cognitive behavioral therapy is an alternative treatment option to pharmacologic therapy and is safe, can be easily taught, and offers an alternative to the many with chronic insomnia. In this podcast, we’ll discuss this innovative treatment option with sleep expert, Michael H. Silber, M.B.Ch.B., a neurologist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/p6ytdz/WF2181108_Behavioral_Techniques_for_Insomnia_AF97y1b.mp3" length="31929734" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Michael H. Silber, M.B.Ch.B.
Difficulty initiating and maintaining sleep is a common problem for many patients. Over-the-counter sleeping aids are used by many and we commonly get asked for prescription medications to help with their sleep. Unfortunately, the ideal sleeping medication doesn’t exist and many have potentially worrisome adverse effects, some produce daytime somnolence and others may have the potential to produce dependence. Cognitive behavioral therapy is an alternative treatment option to pharmacologic therapy and is safe, can be easily taught, and offers an alternative to the many with chronic insomnia. In this podcast, we’ll discuss this innovative treatment option with sleep expert, Michael H. Silber, M.B.Ch.B., a neurologist at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1329</itunes:duration>
                <itunes:episode>406</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Seasonal Allergies: It’s Not Easy To Be Sneezy</title>
        <itunes:title>Seasonal Allergies: It’s Not Easy To Be Sneezy</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/seasonal-allergies-it-s-not-easy-to-be-sneezy/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/seasonal-allergies-it-s-not-easy-to-be-sneezy/#comments</comments>        <pubDate>Tue, 02 May 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/36fd82f7-c7ad-3980-92fd-4114e244c9ec</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Mansi J. Kanuga, M.D.</p>
<p>Millions of Americans suffer from seasonal allergies causing a variety of symptoms which often force them to stay indoors and limit their activities. Allergic rhinitis carries a significant economic burden accounting for an estimated 2 million lost school days, and 6 million lost workdays per year. Fortunately, there are numerous treatment options available. The topic for today’s podcast is seasonal allergies and our guest is Mansi J. Kanuga, M.D., an allergist at the Mayo Clinic. We’ll discuss how to use the patient’s history to determine the patient’s allergies, when allergy tests are indicated and management of seasonal allergies.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Mansi J. Kanuga, M.D.</p>
<p>Millions of Americans suffer from seasonal allergies causing a variety of symptoms which often force them to stay indoors and limit their activities. Allergic rhinitis carries a significant economic burden accounting for an estimated 2 million lost school days, and 6 million lost workdays per year. Fortunately, there are numerous treatment options available. The topic for today’s podcast is seasonal allergies and our guest is Mansi J. Kanuga, M.D., an allergist at the Mayo Clinic. We’ll discuss how to use the patient’s history to determine the patient’s allergies, when allergy tests are indicated and management of seasonal allergies.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kdhdyf/WF1267250_Seasonal_Allergies_AF9renl.mp3" length="30403030" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Mansi J. Kanuga, M.D.
Millions of Americans suffer from seasonal allergies causing a variety of symptoms which often force them to stay indoors and limit their activities. Allergic rhinitis carries a significant economic burden accounting for an estimated 2 million lost school days, and 6 million lost workdays per year. Fortunately, there are numerous treatment options available. The topic for today’s podcast is seasonal allergies and our guest is Mansi J. Kanuga, M.D., an allergist at the Mayo Clinic. We’ll discuss how to use the patient’s history to determine the patient’s allergies, when allergy tests are indicated and management of seasonal allergies.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1265</itunes:duration>
                <itunes:episode>405</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Sleep Medicine Edition | Sleep Apnea &amp; its Complications</title>
        <itunes:title>Sleep Medicine Edition | Sleep Apnea &amp; its Complications</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/sleep-medicine-edition-sleep-apnea-its-complications/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/sleep-medicine-edition-sleep-apnea-its-complications/#comments</comments>        <pubDate>Thu, 27 Apr 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/0e115aba-328b-36bb-b714-43e8bb2a4fb0</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D., <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Timothy I. Morgenthaler, M.D.</p>
<p>It’s estimated that about 30 million people in the U.S. have sleep apnea and most don’t even know they have it. Only 20% of those with sleep apnea have been diagnosed with the condition. Sleep apnea becomes more common with advancing age and is thought to be present in up to 80% of men over the age of 80. With an increased prevalence of obesity in our population, the numbers of those with sleep apnea has increased dramatically. We’re all aware of the daytime drowsiness that is so common in patients who are untreated, but there are other numerous and potentially serious complications that can also occur. In today’s podcast, we’ll discuss the common presenting symptoms of sleep apnea, how to diagnose the condition, and the potential consequences in those who remain untreated. Our guest is Timothy I. Morgenthaler, M.D., a sleep specialist from the Division of Pulmonary and Critical Care Medicine at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D., <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Timothy I. Morgenthaler, M.D.</p>
<p>It’s estimated that about 30 million people in the U.S. have sleep apnea and most don’t even know they have it. Only 20% of those with sleep apnea have been diagnosed with the condition. Sleep apnea becomes more common with advancing age and is thought to be present in up to 80% of men over the age of 80. With an increased prevalence of obesity in our population, the numbers of those with sleep apnea has increased dramatically. We’re all aware of the daytime drowsiness that is so common in patients who are untreated, but there are other numerous and potentially serious complications that can also occur. In today’s podcast, we’ll discuss the common presenting symptoms of sleep apnea, how to diagnose the condition, and the potential consequences in those who remain untreated. Our guest is Timothy I. Morgenthaler, M.D., a sleep specialist from the Division of Pulmonary and Critical Care Medicine at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/y35vqm/WF2169614_Is_Sleep_Apnea_Harmful8be8g.mp3" length="34044045" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D., [@chutkaMD]
Guest: Timothy I. Morgenthaler, M.D.
It’s estimated that about 30 million people in the U.S. have sleep apnea and most don’t even know they have it. Only 20% of those with sleep apnea have been diagnosed with the condition. Sleep apnea becomes more common with advancing age and is thought to be present in up to 80% of men over the age of 80. With an increased prevalence of obesity in our population, the numbers of those with sleep apnea has increased dramatically. We’re all aware of the daytime drowsiness that is so common in patients who are untreated, but there are other numerous and potentially serious complications that can also occur. In today’s podcast, we’ll discuss the common presenting symptoms of sleep apnea, how to diagnose the condition, and the potential consequences in those who remain untreated. Our guest is Timothy I. Morgenthaler, M.D., a sleep specialist from the Division of Pulmonary and Critical Care Medicine at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1415</itunes:duration>
                <itunes:episode>404</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Benign Scrotal Masses &amp; Testicular Cancer Screening</title>
        <itunes:title>Benign Scrotal Masses &amp; Testicular Cancer Screening</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/benign-scrotal-masses-testicular-cancer-screening/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/benign-scrotal-masses-testicular-cancer-screening/#comments</comments>        <pubDate>Tue, 25 Apr 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/3423d795-d8b3-3590-8b1b-a7f8a60d12c2</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D., <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Bradley C. Liebovich, M.D.</p>
<p>Testicular cancer accounts for only around 1% of all cancers in men and is most common in males from age 15 to 35. Around 10,000 new cases are diagnosed per year resulting in about 400 deaths. While testicular cancer is relatively uncommon, other abnormalities occur in the scrotum which are quite common and fortunately, relatively benign. Most of these conditions present as a scrotal mass and can be quite frightening to the patient if they discover them.  In today’s podcast, we’ll discuss scrotal masses including testicular cancer with our guest, Bradley C. Liebovich, M.D., from the Department of Urology at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D., <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Bradley C. Liebovich, M.D.</p>
<p>Testicular cancer accounts for only around 1% of all cancers in men and is most common in males from age 15 to 35. Around 10,000 new cases are diagnosed per year resulting in about 400 deaths. While testicular cancer is relatively uncommon, other abnormalities occur in the scrotum which are quite common and fortunately, relatively benign. Most of these conditions present as a scrotal mass and can be quite frightening to the patient if they discover them.  In today’s podcast, we’ll discuss scrotal masses including testicular cancer with our guest, Bradley C. Liebovich, M.D., from the Department of Urology at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3uncig/WF2082654_Scrotum_and_Testicular_Cancer_AF7m67h.mp3" length="50186856" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D., [@chutkaMD]
Guest: Bradley C. Liebovich, M.D.
Testicular cancer accounts for only around 1% of all cancers in men and is most common in males from age 15 to 35. Around 10,000 new cases are diagnosed per year resulting in about 400 deaths. While testicular cancer is relatively uncommon, other abnormalities occur in the scrotum which are quite common and fortunately, relatively benign. Most of these conditions present as a scrotal mass and can be quite frightening to the patient if they discover them.  In today’s podcast, we’ll discuss scrotal masses including testicular cancer with our guest, Bradley C. Liebovich, M.D., from the Department of Urology at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2085</itunes:duration>
                <itunes:episode>403</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Sleep Medicine Edition | The Patient Who Cannot Tolerate CPAP: Alternative Approaches to Obstructive Sleep Apnea</title>
        <itunes:title>Sleep Medicine Edition | The Patient Who Cannot Tolerate CPAP: Alternative Approaches to Obstructive Sleep Apnea</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/sleep-medicine-edition-the-patient-who-cannot-tolerate-cpap-alternative-approaches-to-obstructive-sleep-apnea/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/sleep-medicine-edition-the-patient-who-cannot-tolerate-cpap-alternative-approaches-to-obstructive-sleep-apnea/#comments</comments>        <pubDate>Thu, 20 Apr 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/306df639-e573-3f43-a60d-c885739228dc</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Eric J. Olson, M.D.</p>
<p>It’s estimated that about 30 million people in the U.S. have sleep apnea and the worldwide prevalence is approaching 1 billion. The traditional treatment is continuous positive airway pressure or CPAP which is quite effective and used to enhance ventilation. Unfortunately, there are a significant number of patients with sleep apnea who can’t tolerate CPAP. This may result in an untreated patient, increasing their risks to a variety of potentially serious complications. How do we manage the CPAP-intolerant patient? What else is available for the patient with sleep apnea? Which patients are candidates for these alternative treatments and how effective are they? In this podcast, we’ll discuss these questions and more with our guest, sleep expert Eric J. Olson, M.D., from the Division of Pulmonary and Critical Care at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Eric J. Olson, M.D.</p>
<p>It’s estimated that about 30 million people in the U.S. have sleep apnea and the worldwide prevalence is approaching 1 billion. The traditional treatment is continuous positive airway pressure or CPAP which is quite effective and used to enhance ventilation. Unfortunately, there are a significant number of patients with sleep apnea who can’t tolerate CPAP. This may result in an untreated patient, increasing their risks to a variety of potentially serious complications. How do we manage the CPAP-intolerant patient? What else is available for the patient with sleep apnea? Which patients are candidates for these alternative treatments and how effective are they? In this podcast, we’ll discuss these questions and more with our guest, sleep expert Eric J. Olson, M.D., from the Division of Pulmonary and Critical Care at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cn82wi/WF2152705_Alternate_Approaches_to_Obstructive_Sleep_Apnea_AF8sj87.mp3" length="43824491" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Eric J. Olson, M.D.
It’s estimated that about 30 million people in the U.S. have sleep apnea and the worldwide prevalence is approaching 1 billion. The traditional treatment is continuous positive airway pressure or CPAP which is quite effective and used to enhance ventilation. Unfortunately, there are a significant number of patients with sleep apnea who can’t tolerate CPAP. This may result in an untreated patient, increasing their risks to a variety of potentially serious complications. How do we manage the CPAP-intolerant patient? What else is available for the patient with sleep apnea? Which patients are candidates for these alternative treatments and how effective are they? In this podcast, we’ll discuss these questions and more with our guest, sleep expert Eric J. Olson, M.D., from the Division of Pulmonary and Critical Care at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1822</itunes:duration>
                <itunes:episode>402</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Sleep Medicine Edition | The Sleepy or Fatigued Patient: Yawning for Relief</title>
        <itunes:title>Sleep Medicine Edition | The Sleepy or Fatigued Patient: Yawning for Relief</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/sleep-medicine-edition-the-sleepy-or-fatigued-patient-yawning-for-relief/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/sleep-medicine-edition-the-sleepy-or-fatigued-patient-yawning-for-relief/#comments</comments>        <pubDate>Tue, 18 Apr 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/c7db638b-e6ab-37e8-8387-5e169de1cec3</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Michael H. Silber, M.B., Ch.B.</p>
<p>Depending on the patient, a complaint of feeling tired, fatigued or sleepy may all mean the same thing. In others they may not feel that sleepiness is the same as fatigue or tiredness. Once we sort out what the patient is actually describing, how do we evaluate the sleepy patient? How much sleep do we need per night and what’s an inadequate amount of sleep? How do we evaluate the quality of a patient’s sleep and what role does age play in the evaluation of a patient’s sleep? These are questions we’ll discuss with our guest for this podcast, Michael H. Silber, M.B., Ch.B., a neurologist and sleep expert at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Michael H. Silber, M.B., Ch.B.</p>
<p>Depending on the patient, a complaint of feeling tired, fatigued or sleepy may all mean the same thing. In others they may not feel that sleepiness is the same as fatigue or tiredness. Once we sort out what the patient is actually describing, how do we evaluate the sleepy patient? How much sleep do we need per night and what’s an inadequate amount of sleep? How do we evaluate the quality of a patient’s sleep and what role does age play in the evaluation of a patient’s sleep? These are questions we’ll discuss with our guest for this podcast, Michael H. Silber, M.B., Ch.B., a neurologist and sleep expert at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hwvq63/WF2181107_Sleepy_Patient_AF661aw.mp3" length="33486546" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Michael H. Silber, M.B., Ch.B.
Depending on the patient, a complaint of feeling tired, fatigued or sleepy may all mean the same thing. In others they may not feel that sleepiness is the same as fatigue or tiredness. Once we sort out what the patient is actually describing, how do we evaluate the sleepy patient? How much sleep do we need per night and what’s an inadequate amount of sleep? How do we evaluate the quality of a patient’s sleep and what role does age play in the evaluation of a patient’s sleep? These are questions we’ll discuss with our guest for this podcast, Michael H. Silber, M.B., Ch.B., a neurologist and sleep expert at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1394</itunes:duration>
                <itunes:episode>401</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Liver Transplant Selection Criteria</title>
        <itunes:title>Liver Transplant Selection Criteria</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/liver-transplant-selection-criteria/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/liver-transplant-selection-criteria/#comments</comments>        <pubDate>Tue, 11 Apr 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/1fd57bde-dece-300d-9f5e-b0b878cceaf4</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: <a href='https://www.mayoclinic.org/biographies/leise-michael-d-m-d/bio-20055037'>Michael D. Leise, M.D.</a></p>
<p>The liver is the second-most transplanted organ; nearly 10,000 patients received a liver transplant in 2021. The major factor, which has limited the transplants performed, has been the availability of the donated organs and some patients have waited several years before an acceptable organ becomes available. Transplants can be performed for a variety of end-stage liver diseases, usually giving patients years of additional life. Who’s a candidate for a liver transplant and what criteria for selection are required? Our topic for this podcast is “Liver Transplant Selection Criteria” and we’ll discuss this topic with our guest, Michael D. Leise, M.D., from the Division of Gastroenterology and Hepatology at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: <a href='https://www.mayoclinic.org/biographies/leise-michael-d-m-d/bio-20055037'>Michael D. Leise, M.D.</a></p>
<p>The liver is the second-most transplanted organ; nearly 10,000 patients received a liver transplant in 2021. The major factor, which has limited the transplants performed, has been the availability of the donated organs and some patients have waited several years before an acceptable organ becomes available. Transplants can be performed for a variety of end-stage liver diseases, usually giving patients years of additional life. Who’s a candidate for a liver transplant and what criteria for selection are required? Our topic for this podcast is “Liver Transplant Selection Criteria” and we’ll discuss this topic with our guest, Michael D. Leise, M.D., from the Division of Gastroenterology and Hepatology at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rvt9ie/WF2057658_Liver_Transplant_Selection_FINALb60u4.mp3" length="33109112" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Michael D. Leise, M.D.
The liver is the second-most transplanted organ; nearly 10,000 patients received a liver transplant in 2021. The major factor, which has limited the transplants performed, has been the availability of the donated organs and some patients have waited several years before an acceptable organ becomes available. Transplants can be performed for a variety of end-stage liver diseases, usually giving patients years of additional life. Who’s a candidate for a liver transplant and what criteria for selection are required? Our topic for this podcast is “Liver Transplant Selection Criteria” and we’ll discuss this topic with our guest, Michael D. Leise, M.D., from the Division of Gastroenterology and Hepatology at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1374</itunes:duration>
                <itunes:episode>400</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Post-Kidney Transplant Care for Primary Care Providers</title>
        <itunes:title>Post-Kidney Transplant Care for Primary Care Providers</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/post-kidney-transplant-care-for-primary-care-providers/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/post-kidney-transplant-care-for-primary-care-providers/#comments</comments>        <pubDate>Tue, 04 Apr 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/ce6fbc47-c528-3e65-949a-d9bab1971561</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: <a href='https://www.mayoclinic.org/biographies/riad-samy-m-m-d/bio-20540731'>Samy M. Riad, M.D.</a></p>
<p>Kidney transplants are quite common; over 20,000 transplants will have been performed by the end of 2022 and there are currently just under 90,000 individuals on the national transplant waiting list. They’ve been remarkably successful in giving patients with renal failure an improved quality of life. However, patients who have had kidney transplants have unique medical needs. Since most transplant patients will return to their primary care providers for the majority of their ongoing care, what important information do we need to successfully care for these patients? What unique medical needs do they have? And what potential health problems are more commonly seen in transplant patients? In this podcast, our guest, Samy M. Riad, M.D., a nephrologist at the Mayo Clinic will answer these questions and more as we discuss the management of the post-renal transplant patient.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: <a href='https://www.mayoclinic.org/biographies/riad-samy-m-m-d/bio-20540731'>Samy M. Riad, M.D.</a></p>
<p>Kidney transplants are quite common; over 20,000 transplants will have been performed by the end of 2022 and there are currently just under 90,000 individuals on the national transplant waiting list. They’ve been remarkably successful in giving patients with renal failure an improved quality of life. However, patients who have had kidney transplants have unique medical needs. Since most transplant patients will return to their primary care providers for the majority of their ongoing care, what important information do we need to successfully care for these patients? What unique medical needs do they have? And what potential health problems are more commonly seen in transplant patients? In this podcast, our guest, Samy M. Riad, M.D., a nephrologist at the Mayo Clinic will answer these questions and more as we discuss the management of the post-renal transplant patient.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wabdyp/WF1519632_Post_Kidney_Transplant_AFa2ldi.mp3" length="36592839" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Samy M. Riad, M.D.
Kidney transplants are quite common; over 20,000 transplants will have been performed by the end of 2022 and there are currently just under 90,000 individuals on the national transplant waiting list. They’ve been remarkably successful in giving patients with renal failure an improved quality of life. However, patients who have had kidney transplants have unique medical needs. Since most transplant patients will return to their primary care providers for the majority of their ongoing care, what important information do we need to successfully care for these patients? What unique medical needs do they have? And what potential health problems are more commonly seen in transplant patients? In this podcast, our guest, Samy M. Riad, M.D., a nephrologist at the Mayo Clinic will answer these questions and more as we discuss the management of the post-renal transplant patient.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1519</itunes:duration>
                <itunes:episode>399</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Prostate Cancer &amp; Men’s Health Edition | Primary Care Management of the Post-Prostate Cancer Patient</title>
        <itunes:title>Prostate Cancer &amp; Men’s Health Edition | Primary Care Management of the Post-Prostate Cancer Patient</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/prostate-cancer-men-s-health-edition-primary-care-management-of-the-post-prostate-cancer-patient/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/prostate-cancer-men-s-health-edition-primary-care-management-of-the-post-prostate-cancer-patient/#comments</comments>        <pubDate>Fri, 31 Mar 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/78c84c83-82e4-3b96-8dd7-2a96cd2b72cc</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: <a href='https://www.mayoclinic.org/biographies/cheney-scott-m-m-d/bio-20428818'>Scott M. Cheney, M.D.</a></p>
<p>Except for skin cancer, prostate cancer is the most common malignancy in males. 1 in 8 men will be diagnosed with prostate cancer during his lifetime, most over the age of 65. If diagnosed early, treatment is quite effective and results in a very favorable survival rate. Several very effective treatment options are now available for patients. In this podcast, we’ll discuss the various treatments and what patients can expect following each option. We’ll review how a post-prostate cancer patient should be followed by their primary care provider and when there might be reason for concern of a recurrence. The guest for this podcast is Scott M. Cheney, M.D., a urologist from the Mayo Clinic in Phoenix, Arizona.</p>
<p>This episode is brought to you by: Astellas Oncology | <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fastellasoncology.com%2F&data=05%7C01%7CMCTPODCAST%40mayo.edu%7C661ae4ee179c4214054808db21a49102%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638140762916955660%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=LbBQxtOdtK%2BPvWoBIqvbZTuSFjhB%2FICAAIDyIFuQ8Qg%3D&reserved=0'>https://astellasoncology.com/</a></p>
<p></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: <a href='https://www.mayoclinic.org/biographies/cheney-scott-m-m-d/bio-20428818'>Scott M. Cheney, M.D.</a></p>
<p>Except for skin cancer, prostate cancer is the most common malignancy in males. 1 in 8 men will be diagnosed with prostate cancer during his lifetime, most over the age of 65. If diagnosed early, treatment is quite effective and results in a very favorable survival rate. Several very effective treatment options are now available for patients. In this podcast, we’ll discuss the various treatments and what patients can expect following each option. We’ll review how a post-prostate cancer patient should be followed by their primary care provider and when there might be reason for concern of a recurrence. The guest for this podcast is Scott M. Cheney, M.D., a urologist from the Mayo Clinic in Phoenix, Arizona.</p>
<p>This episode is brought to you by: <em>Astellas Oncology</em> | <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fastellasoncology.com%2F&data=05%7C01%7CMCTPODCAST%40mayo.edu%7C661ae4ee179c4214054808db21a49102%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638140762916955660%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=LbBQxtOdtK%2BPvWoBIqvbZTuSFjhB%2FICAAIDyIFuQ8Qg%3D&reserved=0'>https://astellasoncology.com/</a></p>
<p></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5ssz6m/WF2315809_Management_of_the_Post-Prostate_Cancer_Patient_adb532p.mp3" length="35389180" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Scott M. Cheney, M.D.
Except for skin cancer, prostate cancer is the most common malignancy in males. 1 in 8 men will be diagnosed with prostate cancer during his lifetime, most over the age of 65. If diagnosed early, treatment is quite effective and results in a very favorable survival rate. Several very effective treatment options are now available for patients. In this podcast, we’ll discuss the various treatments and what patients can expect following each option. We’ll review how a post-prostate cancer patient should be followed by their primary care provider and when there might be reason for concern of a recurrence. The guest for this podcast is Scott M. Cheney, M.D., a urologist from the Mayo Clinic in Phoenix, Arizona.
This episode is brought to you by: Astellas Oncology | https://astellasoncology.com/

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1472</itunes:duration>
                <itunes:episode>398</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Prostate Cancer &amp; Men’s Health Edition | Updates in Advanced Prostate Cancer</title>
        <itunes:title>Prostate Cancer &amp; Men’s Health Edition | Updates in Advanced Prostate Cancer</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/prostate-cancer-men-s-health-edition-updates-in-advanced-prostate-cancer/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/prostate-cancer-men-s-health-edition-updates-in-advanced-prostate-cancer/#comments</comments>        <pubDate>Wed, 29 Mar 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/7d099410-ba2d-3854-a016-e69ec3f5bc78</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Alan H. Bryce, M.D.</p>
<p>Prostate cancer is the second most common malignancy in men, second only to skin cancer and due to increased efforts in screening, most prostate cancers are found very early, and these men have an excellent survival rate. Unfortunately, a percentage of men develop an advanced prostate cancer and the disease becomes much more aggressive with significantly lower survival rates. Who’s at risk for advanced prostate cancer? How does the survival rate change with metastatic disease? Finally, what are the various treatment options and how effective are they? In this podcast, we’ll discuss these questions with our guest, Alan H. Bryce, M.D., from the Division of Hematology and Oncology at the Mayo Clinic.</p>
<p>This episode is brought to you by: Astellas Oncology | <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fastellasoncology.com%2F&data=05%7C01%7CMCTPODCAST%40mayo.edu%7C661ae4ee179c4214054808db21a49102%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638140762916955660%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=LbBQxtOdtK%2BPvWoBIqvbZTuSFjhB%2FICAAIDyIFuQ8Qg%3D&reserved=0'>https://astellasoncology.com/</a></p>
<p></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Alan H. Bryce, M.D.</p>
<p>Prostate cancer is the second most common malignancy in men, second only to skin cancer and due to increased efforts in screening, most prostate cancers are found very early, and these men have an excellent survival rate. Unfortunately, a percentage of men develop an advanced prostate cancer and the disease becomes much more aggressive with significantly lower survival rates. Who’s at risk for advanced prostate cancer? How does the survival rate change with metastatic disease? Finally, what are the various treatment options and how effective are they? In this podcast, we’ll discuss these questions with our guest, Alan H. Bryce, M.D., from the Division of Hematology and Oncology at the Mayo Clinic.</p>
<p>This episode is brought to you by: <em>Astellas Oncology</em> | <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fastellasoncology.com%2F&data=05%7C01%7CMCTPODCAST%40mayo.edu%7C661ae4ee179c4214054808db21a49102%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638140762916955660%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=LbBQxtOdtK%2BPvWoBIqvbZTuSFjhB%2FICAAIDyIFuQ8Qg%3D&reserved=0'>https://astellasoncology.com/</a></p>
<p></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4d8b9y/WF2321567_Updates_in_Advanced_Prostate_Cancer_ad_AF8habn.mp3" length="38371868" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Alan H. Bryce, M.D.
Prostate cancer is the second most common malignancy in men, second only to skin cancer and due to increased efforts in screening, most prostate cancers are found very early, and these men have an excellent survival rate. Unfortunately, a percentage of men develop an advanced prostate cancer and the disease becomes much more aggressive with significantly lower survival rates. Who’s at risk for advanced prostate cancer? How does the survival rate change with metastatic disease? Finally, what are the various treatment options and how effective are they? In this podcast, we’ll discuss these questions with our guest, Alan H. Bryce, M.D., from the Division of Hematology and Oncology at the Mayo Clinic.
This episode is brought to you by: Astellas Oncology | https://astellasoncology.com/

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1595</itunes:duration>
                <itunes:episode>397</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Prostate Cancer &amp; Men’s Health Edition | Prostate Cancer &amp; Sexual Health</title>
        <itunes:title>Prostate Cancer &amp; Men’s Health Edition | Prostate Cancer &amp; Sexual Health</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/prostate-cancer-men-s-health-edition-prostate-cancer-sexual-health/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/prostate-cancer-men-s-health-edition-prostate-cancer-sexual-health/#comments</comments>        <pubDate>Mon, 27 Mar 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/b2f2b5bc-b19c-3a4b-9c12-c4624b30f08f</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Nahid Punjani, M.D., M.P.H.</p>
<p>Issues related to the prostate can play a significant role in a man’s sexual function. We commonly use medications for benign prostate problems such as BPH which can produce adverse effects. It’s also very common for the treatment of prostate cancer, whether we use radiation therapy, surgical prostatectomy, or hormonal therapy to cause sexual dysfunction. In this podcast, we’ll review the important role the prostate plays in sexual function as we discuss the “Prostate and Sexual Health” with our guest, Nahid Punjani, M.D., M.P.H., a urologist at the Mayo Clinic.</p>
<p>This episode is brought to you by: Astellas Oncology | <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fastellasoncology.com%2F&data=05%7C01%7CMCTPODCAST%40mayo.edu%7C661ae4ee179c4214054808db21a49102%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638140762916955660%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=LbBQxtOdtK%2BPvWoBIqvbZTuSFjhB%2FICAAIDyIFuQ8Qg%3D&reserved=0'>https://astellasoncology.com/</a></p>
<p></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Nahid Punjani, M.D., M.P.H.</p>
<p>Issues related to the prostate can play a significant role in a man’s sexual function. We commonly use medications for benign prostate problems such as BPH which can produce adverse effects. It’s also very common for the treatment of prostate cancer, whether we use radiation therapy, surgical prostatectomy, or hormonal therapy to cause sexual dysfunction. In this podcast, we’ll review the important role the prostate plays in sexual function as we discuss the “Prostate and Sexual Health” with our guest, Nahid Punjani, M.D., M.P.H., a urologist at the Mayo Clinic.</p>
<p>This episode is brought to you by: <em>Astellas Oncology</em> | <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fastellasoncology.com%2F&data=05%7C01%7CMCTPODCAST%40mayo.edu%7C661ae4ee179c4214054808db21a49102%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638140762916955660%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=LbBQxtOdtK%2BPvWoBIqvbZTuSFjhB%2FICAAIDyIFuQ8Qg%3D&reserved=0'>https://astellasoncology.com/</a></p>
<p></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/f4mfps/WF2339754_Prostate_Cancer_and_Sexual_Health_ad_VFbavxd.mp3" length="27114964" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Nahid Punjani, M.D., M.P.H.
Issues related to the prostate can play a significant role in a man’s sexual function. We commonly use medications for benign prostate problems such as BPH which can produce adverse effects. It’s also very common for the treatment of prostate cancer, whether we use radiation therapy, surgical prostatectomy, or hormonal therapy to cause sexual dysfunction. In this podcast, we’ll review the important role the prostate plays in sexual function as we discuss the “Prostate and Sexual Health” with our guest, Nahid Punjani, M.D., M.P.H., a urologist at the Mayo Clinic.
This episode is brought to you by: Astellas Oncology | https://astellasoncology.com/

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1127</itunes:duration>
                <itunes:episode>396</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Prostate Cancer &amp; Men’s Health Edition | Treatment of Prostate Cancer</title>
        <itunes:title>Prostate Cancer &amp; Men’s Health Edition | Treatment of Prostate Cancer</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/prostate-cancer-men-s-health-edition-treatment-of-prostate-cancer/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/prostate-cancer-men-s-health-edition-treatment-of-prostate-cancer/#comments</comments>        <pubDate>Fri, 24 Mar 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/f5d6ec5f-4e99-321f-9c10-af41229d1553</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: R. Jeffrey Karnes, M.D.</p>
<p>Prostate cancer is the most common solid organ malignancy in males, and it’s estimated that 1 in 8 men will develop prostate cancer during their lifetime.  When diagnosed early, it has an excellent survival rate with a variety of very effective treatment options. What are the advantages and disadvantages of each?  Why would one option be chosen over another and how do the adverse effects of the various treatments differ? In this podcast, I’ll be discussing these questions with our guest, R. Jeffrey Karnes, M.D., a urologist at the Mayo Clinic.</p>
<p>This episode is brought to you by: Astellas Oncology | <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fastellasoncology.com%2F&data=05%7C01%7CMCTPODCAST%40mayo.edu%7C661ae4ee179c4214054808db21a49102%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638140762916955660%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=LbBQxtOdtK%2BPvWoBIqvbZTuSFjhB%2FICAAIDyIFuQ8Qg%3D&reserved=0'>https://astellasoncology.com/</a></p>
<p></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: R. Jeffrey Karnes, M.D.</p>
<p>Prostate cancer is the most common solid organ malignancy in males, and it’s estimated that 1 in 8 men will develop prostate cancer during their lifetime.  When diagnosed early, it has an excellent survival rate with a variety of very effective treatment options. What are the advantages and disadvantages of each?  Why would one option be chosen over another and how do the adverse effects of the various treatments differ? In this podcast, I’ll be discussing these questions with our guest, R. Jeffrey Karnes, M.D., a urologist at the Mayo Clinic.</p>
<p>This episode is brought to you by: <em>Astellas Oncology</em> | <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fastellasoncology.com%2F&data=05%7C01%7CMCTPODCAST%40mayo.edu%7C661ae4ee179c4214054808db21a49102%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638140762916955660%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=LbBQxtOdtK%2BPvWoBIqvbZTuSFjhB%2FICAAIDyIFuQ8Qg%3D&reserved=0'>https://astellasoncology.com/</a></p>
<p></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/q6fgmv/WF2321500_Prostate_Cancer_Treatment_ad6ysv5.mp3" length="33160566" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: R. Jeffrey Karnes, M.D.
Prostate cancer is the most common solid organ malignancy in males, and it’s estimated that 1 in 8 men will develop prostate cancer during their lifetime.  When diagnosed early, it has an excellent survival rate with a variety of very effective treatment options. What are the advantages and disadvantages of each?  Why would one option be chosen over another and how do the adverse effects of the various treatments differ? In this podcast, I’ll be discussing these questions with our guest, R. Jeffrey Karnes, M.D., a urologist at the Mayo Clinic.
This episode is brought to you by: Astellas Oncology | https://astellasoncology.com/

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1376</itunes:duration>
                <itunes:episode>395</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Prostate Cancer &amp; Men’s Health Edition | Screening for Prostate Cancer</title>
        <itunes:title>Prostate Cancer &amp; Men’s Health Edition | Screening for Prostate Cancer</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/prostate-cancer-men-s-health-edition-screening-for-prostate-cancer/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/prostate-cancer-men-s-health-edition-screening-for-prostate-cancer/#comments</comments>        <pubDate>Wed, 22 Mar 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/f9a17671-547e-346d-ad1b-ef6f859d861d</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Daniel M. Frendl, M.D., Ph.D.</p>
<p>Prostate cancer is one of the most common malignancies in men, second only to skin cancer. It’s estimated that 1 in 8 men will develop prostate cancer during their lifetime. The predominant screening test for prostate cancer has been the prostate specific antigen or PSA.  However, there has been some controversy surrounding the use of PSA. It’s an easily administered test, it’s relatively inexpensive and it’s capable of identifying men with possible prostate cancer. So, what’s the controversy? Is the PSA an effective screening test? Who should be tested and how have urologists modified their practice to manage patients with an elevated PSA? We’ll discuss these questions in today’s podcast on “Screening for Prostate Cancer” with our guest, Daniel M. Frendl, M.D., Ph.D., a urologist at the Mayo Clinic.</p>
<p>This episode is brought to you by: Astellas Oncology | <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fastellasoncology.com%2F&data=05%7C01%7CMCTPODCAST%40mayo.edu%7C661ae4ee179c4214054808db21a49102%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638140762916955660%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=LbBQxtOdtK%2BPvWoBIqvbZTuSFjhB%2FICAAIDyIFuQ8Qg%3D&reserved=0'>https://astellasoncology.com/</a></p>
<p></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Daniel M. Frendl, M.D., Ph.D.</p>
<p>Prostate cancer is one of the most common malignancies in men, second only to skin cancer. It’s estimated that 1 in 8 men will develop prostate cancer during their lifetime. The predominant screening test for prostate cancer has been the prostate specific antigen or PSA.  However, there has been some controversy surrounding the use of PSA. It’s an easily administered test, it’s relatively inexpensive and it’s capable of identifying men with possible prostate cancer. So, what’s the controversy? Is the PSA an effective screening test? Who should be tested and how have urologists modified their practice to manage patients with an elevated PSA? We’ll discuss these questions in today’s podcast on “Screening for Prostate Cancer” with our guest, Daniel M. Frendl, M.D., Ph.D., a urologist at the Mayo Clinic.</p>
<p>This episode is brought to you by: <em>Astellas Oncology</em> | <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fastellasoncology.com%2F&data=05%7C01%7CMCTPODCAST%40mayo.edu%7C661ae4ee179c4214054808db21a49102%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638140762916955660%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=LbBQxtOdtK%2BPvWoBIqvbZTuSFjhB%2FICAAIDyIFuQ8Qg%3D&reserved=0'>https://astellasoncology.com/</a></p>
<p></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6pcq9a/WF2331950_Prostate_Cancer_Screening_ad_VF7zeij.mp3" length="48291903" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Daniel M. Frendl, M.D., Ph.D.
Prostate cancer is one of the most common malignancies in men, second only to skin cancer. It’s estimated that 1 in 8 men will develop prostate cancer during their lifetime. The predominant screening test for prostate cancer has been the prostate specific antigen or PSA.  However, there has been some controversy surrounding the use of PSA. It’s an easily administered test, it’s relatively inexpensive and it’s capable of identifying men with possible prostate cancer. So, what’s the controversy? Is the PSA an effective screening test? Who should be tested and how have urologists modified their practice to manage patients with an elevated PSA? We’ll discuss these questions in today’s podcast on “Screening for Prostate Cancer” with our guest, Daniel M. Frendl, M.D., Ph.D., a urologist at the Mayo Clinic.
This episode is brought to you by: Astellas Oncology | https://astellasoncology.com/

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 
 ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2007</itunes:duration>
                <itunes:episode>394</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Prostate Cancer &amp; Men’s Health Edition | Benign Prostatic Hyperplasia (BPH)</title>
        <itunes:title>Prostate Cancer &amp; Men’s Health Edition | Benign Prostatic Hyperplasia (BPH)</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/prostate-cancer-men-s-health-edition-benign-prostatic-hyperplasia-bph/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/prostate-cancer-men-s-health-edition-benign-prostatic-hyperplasia-bph/#comments</comments>        <pubDate>Mon, 20 Mar 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/db84680c-b6f8-37eb-ad1e-e7efbed6944c</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Mitchell R. Humphreys, M.D.</p>
<p>Benign prostatic hyperplasia or BPH is quite common in middle-age and older men. It’s estimated that up to 70% of men over age 60 have symptoms from BPH. While BPH is not a life-threatening condition, it does produce symptoms which can negatively affect the lifestyle of our patients. Since most of the patients with BPH are managed by primary care providers, we should be comfortable with the variety of treatment options available. When should treatment be initiated? What’s available pharmacologically? And when should a urologist be consulted to consider a surgical option? In this podcast, we’ll discuss these questions and more with Mitchell R. Humphreys, M.D., from the Department of Urology at the Mayo Clinic. </p>
<p>This episode is brought to you by: Astellas Oncology | <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fastellasoncology.com%2F&data=05%7C01%7CMCTPODCAST%40mayo.edu%7C661ae4ee179c4214054808db21a49102%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638140762916955660%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=LbBQxtOdtK%2BPvWoBIqvbZTuSFjhB%2FICAAIDyIFuQ8Qg%3D&reserved=0'>https://astellasoncology.com/</a></p>
<p></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Mitchell R. Humphreys, M.D.</p>
<p>Benign prostatic hyperplasia or BPH is quite common in middle-age and older men. It’s estimated that up to 70% of men over age 60 have symptoms from BPH. While BPH is not a life-threatening condition, it does produce symptoms which can negatively affect the lifestyle of our patients. Since most of the patients with BPH are managed by primary care providers, we should be comfortable with the variety of treatment options available. When should treatment be initiated? What’s available pharmacologically? And when should a urologist be consulted to consider a surgical option? In this podcast, we’ll discuss these questions and more with Mitchell R. Humphreys, M.D., from the Department of Urology at the Mayo Clinic. </p>
<p>This episode is brought to you by: <em>Astellas Oncology</em> | <a href='https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fastellasoncology.com%2F&data=05%7C01%7CMCTPODCAST%40mayo.edu%7C661ae4ee179c4214054808db21a49102%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638140762916955660%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=LbBQxtOdtK%2BPvWoBIqvbZTuSFjhB%2FICAAIDyIFuQ8Qg%3D&reserved=0'>https://astellasoncology.com/</a></p>
<p></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cftxma/WF2332015_Begnign_Prostatic_Hyperplasia_ad_AFbmbk1.mp3" length="38891468" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Mitchell R. Humphreys, M.D.
Benign prostatic hyperplasia or BPH is quite common in middle-age and older men. It’s estimated that up to 70% of men over age 60 have symptoms from BPH. While BPH is not a life-threatening condition, it does produce symptoms which can negatively affect the lifestyle of our patients. Since most of the patients with BPH are managed by primary care providers, we should be comfortable with the variety of treatment options available. When should treatment be initiated? What’s available pharmacologically? And when should a urologist be consulted to consider a surgical option? In this podcast, we’ll discuss these questions and more with Mitchell R. Humphreys, M.D., from the Department of Urology at the Mayo Clinic. 
This episode is brought to you by: Astellas Oncology | https://astellasoncology.com/

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 
 ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1619</itunes:duration>
                <itunes:episode>393</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Healthcare Professional Burnout: Contributors, Consequences &amp; Solutions</title>
        <itunes:title>Healthcare Professional Burnout: Contributors, Consequences &amp; Solutions</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/healthcare-professional-burnout-contributors-consequences-solutions/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/healthcare-professional-burnout-contributors-consequences-solutions/#comments</comments>        <pubDate>Tue, 14 Mar 2023 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/783f9462-0577-315e-8240-94ae2747fa09</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Colin P. West, M.D., Ph.D.</p>
<p>The practice of medicine is often stressful and at times, even frustrating. Sometimes the stress and frustration can get out of hand and lead us to feeling overwhelmed and hopeless. This has been described as burnout. There’s good evidence to suggest that well over half of all physicians practicing in the U.S. have exhibited some symptoms of burnout at some time during their career. Healthcare professional burnout not only has negative consequences for the clinician, but also for patients, as patient care can often suffer. What are the symptoms of burnout, can we prevent them and how can we manage those who are experiencing professional burnout? We’ll discuss these questions and more with Colin P. West, M.D., Ph.D., an internist in the Division of General Internal Medicine at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Colin P. West, M.D., Ph.D.</p>
<p>The practice of medicine is often stressful and at times, even frustrating. Sometimes the stress and frustration can get out of hand and lead us to feeling overwhelmed and hopeless. This has been described as burnout. There’s good evidence to suggest that well over half of all physicians practicing in the U.S. have exhibited some symptoms of burnout at some time during their career. Healthcare professional burnout not only has negative consequences for the clinician, but also for patients, as patient care can often suffer. What are the symptoms of burnout, can we prevent them and how can we manage those who are experiencing professional burnout? We’ll discuss these questions and more with Colin P. West, M.D., Ph.D., an internist in the Division of General Internal Medicine at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xfjb43/WF2074054_Burnout_FINAL8u7me.mp3" length="59762880" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Colin P. West, M.D., Ph.D.
The practice of medicine is often stressful and at times, even frustrating. Sometimes the stress and frustration can get out of hand and lead us to feeling overwhelmed and hopeless. This has been described as burnout. There’s good evidence to suggest that well over half of all physicians practicing in the U.S. have exhibited some symptoms of burnout at some time during their career. Healthcare professional burnout not only has negative consequences for the clinician, but also for patients, as patient care can often suffer. What are the symptoms of burnout, can we prevent them and how can we manage those who are experiencing professional burnout? We’ll discuss these questions and more with Colin P. West, M.D., Ph.D., an internist in the Division of General Internal Medicine at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2490</itunes:duration>
                <itunes:episode>392</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Nutrition History Taking: A Practical Approach</title>
        <itunes:title>Nutrition History Taking: A Practical Approach</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/taking-a-nutritional-history-just-for-the-health-of-it/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/taking-a-nutritional-history-just-for-the-health-of-it/#comments</comments>        <pubDate>Tue, 07 Mar 2023 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/f1f2f474-5b8c-3915-86ad-27937b128a38</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Tara Schmidt, MEd, RDN, LD</p>
<p>Nutrition is so important to our health. What and how much we eat can help keep us healthy or increase our risk of developing a number of health problems including cardiovascular disease, diabetes, malignancy or a variety of degenerative health conditions. Unfortunately, many of our patients obtain their information regarding nutrition from the media which is often very inaccurate. It’s our responsibility as primary care providers to assess our patients’ nutritional status and give them accurate recommendations regarding dietary changes they should make in order to remain healthy. This starts with a nutritional history. Yet very few of us have had any formal education in nutrition. How do we take a nutritional history? What are the important questions to ask? We’ll discuss this and other nutritional issues with our guest for this podcast, Tara Schmidt, MEd, RDN, LD, a registered dietician at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Tara Schmidt, MEd, RDN, LD</p>
<p>Nutrition is so important to our health. What and how much we eat can help keep us healthy or increase our risk of developing a number of health problems including cardiovascular disease, diabetes, malignancy or a variety of degenerative health conditions. Unfortunately, many of our patients obtain their information regarding nutrition from the media which is often very inaccurate. It’s our responsibility as primary care providers to assess our patients’ nutritional status and give them accurate recommendations regarding dietary changes they should make in order to remain healthy. This starts with a nutritional history. Yet very few of us have had any formal education in nutrition. How do we take a nutritional history? What are the important questions to ask? We’ll discuss this and other nutritional issues with our guest for this podcast, Tara Schmidt, MEd, RDN, LD, a registered dietician at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dqn7t4/WF2006200_Nutrition_History_Taking_FINAL81sxq.mp3" length="35432215" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Tara Schmidt, MEd, RDN, LD
Nutrition is so important to our health. What and how much we eat can help keep us healthy or increase our risk of developing a number of health problems including cardiovascular disease, diabetes, malignancy or a variety of degenerative health conditions. Unfortunately, many of our patients obtain their information regarding nutrition from the media which is often very inaccurate. It’s our responsibility as primary care providers to assess our patients’ nutritional status and give them accurate recommendations regarding dietary changes they should make in order to remain healthy. This starts with a nutritional history. Yet very few of us have had any formal education in nutrition. How do we take a nutritional history? What are the important questions to ask? We’ll discuss this and other nutritional issues with our guest for this podcast, Tara Schmidt, MEd, RDN, LD, a registered dietician at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1474</itunes:duration>
                <itunes:episode>391</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>THE BEST OF SEASON 1: Varicose Veins &amp; Venous Insufficiency</title>
        <itunes:title>THE BEST OF SEASON 1: Varicose Veins &amp; Venous Insufficiency</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/the-best-of-season-1-varicose-veins-venous-insufficiency/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/the-best-of-season-1-varicose-veins-venous-insufficiency/#comments</comments>        <pubDate>Tue, 28 Feb 2023 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/19f5f7b7-b31b-3e27-a1d2-8ccce70f818f</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D%5B@'>[@chutkaMD]</a></p>
<p>Guest: Thom W. Rooke, M.D.</p>
<p>Today, we’re excited to bring back a special lecture by popular demand from Season 1 of Mayo Clinic Talks Podcast. </p>
<p>We’ll be discussing varicose veins and venous insufficiency with Thom W. Rooke, M.D., from Cardiovascular Medicine at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D%5B@'>[@chutkaMD]</a></p>
<p>Guest: Thom W. Rooke, M.D.</p>
<p>Today, we’re excited to bring back a special lecture by popular demand from Season 1 of Mayo Clinic Talks Podcast. </p>
<p>We’ll be discussing varicose veins and venous insufficiency with Thom W. Rooke, M.D., from Cardiovascular Medicine at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/z3uf4x/VT3779801_2022_Vericose_Veins_FINAL6oow5.mp3" length="31805001" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Thom W. Rooke, M.D.
Today, we’re excited to bring back a special lecture by popular demand from Season 1 of Mayo Clinic Talks Podcast. 
We’ll be discussing varicose veins and venous insufficiency with Thom W. Rooke, M.D., from Cardiovascular Medicine at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1324</itunes:duration>
                <itunes:episode>390</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Multiple Sclerosis: A Primary Care Perspective</title>
        <itunes:title>Multiple Sclerosis: A Primary Care Perspective</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/multiple-sclerosis-a-primary-care-perspective/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/multiple-sclerosis-a-primary-care-perspective/#comments</comments>        <pubDate>Tue, 21 Feb 2023 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/75e13d7d-c2e6-37a0-aa7a-86d0d37a6060</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Eoin Flanagan, M.B., B.Ch.</p>
<p>Nearly 1 million individuals in the U.S. have multiple sclerosis. Most acquire the disease between the ages of 20 and 50. It’s often difficult to establish a diagnosis as the symptoms can be vague and often vary significantly from one individual to another.  The disease can be very frightening, often debilitating, and progressive; up until recently, we’ve had very little to offer patients in the way of treatment.  However, in the past few years there have been numerous advances in treatment options which have given hope to the many patients with MS. We’ll be discussing multiple sclerosis in this podcast. Our guest is Eoin Flanagan, M.B., B.Ch., a neurologist from the Department of Neurology at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Eoin Flanagan, M.B., B.Ch.</p>
<p>Nearly 1 million individuals in the U.S. have multiple sclerosis. Most acquire the disease between the ages of 20 and 50. It’s often difficult to establish a diagnosis as the symptoms can be vague and often vary significantly from one individual to another.  The disease can be very frightening, often debilitating, and progressive; up until recently, we’ve had very little to offer patients in the way of treatment.  However, in the past few years there have been numerous advances in treatment options which have given hope to the many patients with MS. We’ll be discussing multiple sclerosis in this podcast. Our guest is Eoin Flanagan, M.B., B.Ch., a neurologist from the Department of Neurology at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/e2aatg/WF2017380_Multiple_Sclerosis_FINAL7vor7.mp3" length="34993857" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Eoin Flanagan, M.B., B.Ch.
Nearly 1 million individuals in the U.S. have multiple sclerosis. Most acquire the disease between the ages of 20 and 50. It’s often difficult to establish a diagnosis as the symptoms can be vague and often vary significantly from one individual to another.  The disease can be very frightening, often debilitating, and progressive; up until recently, we’ve had very little to offer patients in the way of treatment.  However, in the past few years there have been numerous advances in treatment options which have given hope to the many patients with MS. We’ll be discussing multiple sclerosis in this podcast. Our guest is Eoin Flanagan, M.B., B.Ch., a neurologist from the Department of Neurology at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1456</itunes:duration>
                <itunes:episode>389</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Determining the Source of GI Blood Loss</title>
        <itunes:title>Determining the Source of GI Blood Loss</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/determining-the-source-of-gi-blood-loss/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/determining-the-source-of-gi-blood-loss/#comments</comments>        <pubDate>Tue, 14 Feb 2023 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/01f2f437-50fa-3090-b966-9b7e5246639b</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Andrew C. Storm, M.D.</p>
<p>Determining the source of GI blood loss can be a challenging dilemma. On occasion, we have clues regarding where we should start looking, but in some cases, no such clues exist. It’s best to use a stepwise approach to determining the source and in most cases, this will give us the answer we need. When a cause is found, most tend to be from an upper GI source rather than the colon. Whereas an upper endoscopy and colonoscopy will determine the source in the majority, in some cases, more aggressive techniques are required. In this podcast, we’ll be discussing GI blood loss, and which approach we should use to determine the source. Our guest is Andrew C. Storm, M.D., a gastroenterologist from the Division of Gastroenterology and Hepatology at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD]</a></p>
<p>Guest: Andrew C. Storm, M.D.</p>
<p>Determining the source of GI blood loss can be a challenging dilemma. On occasion, we have clues regarding where we should start looking, but in some cases, no such clues exist. It’s best to use a stepwise approach to determining the source and in most cases, this will give us the answer we need. When a cause is found, most tend to be from an upper GI source rather than the colon. Whereas an upper endoscopy and colonoscopy will determine the source in the majority, in some cases, more aggressive techniques are required. In this podcast, we’ll be discussing GI blood loss, and which approach we should use to determine the source. Our guest is Andrew C. Storm, M.D., a gastroenterologist from the Division of Gastroenterology and Hepatology at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/g8mpmk/WF1992489_GI_Blood_Loss_FINALbce6t.mp3" length="39280234" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Andrew C. Storm, M.D.
Determining the source of GI blood loss can be a challenging dilemma. On occasion, we have clues regarding where we should start looking, but in some cases, no such clues exist. It’s best to use a stepwise approach to determining the source and in most cases, this will give us the answer we need. When a cause is found, most tend to be from an upper GI source rather than the colon. Whereas an upper endoscopy and colonoscopy will determine the source in the majority, in some cases, more aggressive techniques are required. In this podcast, we’ll be discussing GI blood loss, and which approach we should use to determine the source. Our guest is Andrew C. Storm, M.D., a gastroenterologist from the Division of Gastroenterology and Hepatology at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1633</itunes:duration>
                <itunes:episode>388</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Year 3 of COVID-19: Harsh Truths, Brutal Realities &amp; Glimmers of Hope</title>
        <itunes:title>Year 3 of COVID-19: Harsh Truths, Brutal Realities &amp; Glimmers of Hope</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/year-3-of-covid-19-harsh-truths-brutal-realities-glimmers-of-hope/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/year-3-of-covid-19-harsh-truths-brutal-realities-glimmers-of-hope/#comments</comments>        <pubDate>Tue, 07 Feb 2023 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/0ac3a1e4-12c5-31c3-9ab0-dfe832719974</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD</a>]</p>
<p>Guest: Greg A. Poland, M.D. <a href='https://twitter.com/drgregpoland'>[@drgregpoland]</a></p>
<p>Severe acute respiratory syndrome coronavirus 2, also known as COVID-19, is a novel virus with a rapidly changing genotype. It’s responsible for over a million deaths so far. One of every 300 Americans have died as a result of the virus and infection with COVID-19, and it has been responsible for a reduction in life expectancy in the U.S. for both 2021 and 2022. There are 4 widely available, approved vaccines in the United States, yet an inadequate number of individuals have been immunized and very few are still wearing protective masks. The consequences of this include continued excess morbidity and mortality as well as the development of a variety of new variants of the virus. Our guest for this podcast is Greg A. Poland, M.D., an internist, and the director of vaccine research at the Mayo Clinic. He’s also the lead author of an article published in Mayo Clinic Proceedings in December 2022. The article is entitled “Year 3 of COVID-19: Harsh Truths, Brutal Realities and Glimmers of Hope”. We’ll be discussing some of the key points from this article.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD</a>]</p>
<p>Guest: Greg A. Poland, M.D. <a href='https://twitter.com/drgregpoland'>[@drgregpoland]</a></p>
<p>Severe acute respiratory syndrome coronavirus 2, also known as COVID-19, is a novel virus with a rapidly changing genotype. It’s responsible for over a million deaths so far. One of every 300 Americans have died as a result of the virus and infection with COVID-19, and it has been responsible for a reduction in life expectancy in the U.S. for both 2021 and 2022. There are 4 widely available, approved vaccines in the United States, yet an inadequate number of individuals have been immunized and very few are still wearing protective masks. The consequences of this include continued excess morbidity and mortality as well as the development of a variety of new variants of the virus. Our guest for this podcast is Greg A. Poland, M.D., an internist, and the director of vaccine research at the Mayo Clinic. He’s also the lead author of an article published in Mayo Clinic Proceedings in December 2022. The article is entitled “Year 3 of COVID-19: Harsh Truths, Brutal Realities and Glimmers of Hope”. We’ll be discussing some of the key points from this article.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9kraug/WF1833601_Covid_Year_3_V3b40gj.mp3" length="45515148" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Greg A. Poland, M.D. [@drgregpoland]
Severe acute respiratory syndrome coronavirus 2, also known as COVID-19, is a novel virus with a rapidly changing genotype. It’s responsible for over a million deaths so far. One of every 300 Americans have died as a result of the virus and infection with COVID-19, and it has been responsible for a reduction in life expectancy in the U.S. for both 2021 and 2022. There are 4 widely available, approved vaccines in the United States, yet an inadequate number of individuals have been immunized and very few are still wearing protective masks. The consequences of this include continued excess morbidity and mortality as well as the development of a variety of new variants of the virus. Our guest for this podcast is Greg A. Poland, M.D., an internist, and the director of vaccine research at the Mayo Clinic. He’s also the lead author of an article published in Mayo Clinic Proceedings in December 2022. The article is entitled “Year 3 of COVID-19: Harsh Truths, Brutal Realities and Glimmers of Hope”. We’ll be discussing some of the key points from this article.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1893</itunes:duration>
                <itunes:episode>387</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>THE BEST OF SEASON 1: Effective Communication Skills for a Time Strapped Practice</title>
        <itunes:title>THE BEST OF SEASON 1: Effective Communication Skills for a Time Strapped Practice</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/the-best-of-season-1-effective-communication-skills-for-a-time-strapped-practice/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/the-best-of-season-1-effective-communication-skills-for-a-time-strapped-practice/#comments</comments>        <pubDate>Tue, 31 Jan 2023 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/faf747f1-ccc5-3171-a224-f40121a33e6e</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D%5B@'>[@chutkaMD]</a></p>
<p>Guest: Daniel L. Hurley, M.D.</p>
<p>Today we’re excited to bring back a special lecture by popular demand from Season 1 of Mayo Clinic Talks Podcast.</p>
<p>Today we’re joined by Daniel L. Hurley, M.D., a Mayo Clinic Endocrinologist and heavily awarded educator and practitioner.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D%5B@'>[@chutkaMD]</a></p>
<p>Guest: Daniel L. Hurley, M.D.</p>
<p>Today we’re excited to bring back a special lecture by popular demand from Season 1 of Mayo Clinic Talks Podcast.</p>
<p>Today we’re joined by Daniel L. Hurley, M.D., a Mayo Clinic Endocrinologist and heavily awarded educator and practitioner.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rkaj73/VT3826409_2022_Provider_Communication_FINAL9bkdb.mp3" length="31741649" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Daniel L. Hurley, M.D.
Today we’re excited to bring back a special lecture by popular demand from Season 1 of Mayo Clinic Talks Podcast.
Today we’re joined by Daniel L. Hurley, M.D., a Mayo Clinic Endocrinologist and heavily awarded educator and practitioner.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1322</itunes:duration>
                <itunes:episode>386</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>How to Use Pulmonary Function Tests Effectively</title>
        <itunes:title>How to Use Pulmonary Function Tests Effectively</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/how-to-use-pulmonary-function-tests-effectively/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/how-to-use-pulmonary-function-tests-effectively/#comments</comments>        <pubDate>Tue, 24 Jan 2023 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/1ba5ec7d-af2f-3d90-8240-b7d211d4dc02</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.  <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD</a>;]</p>
<p>Guest: Alexander S. Niven, M.D.</p>
<p>Pulmonary function tests are extremely useful in both diagnosing and managing patients with respiratory disease. In addition to a medical history, physical exam and imaging studies, they give us a great deal of information of the pulmonary physiology and help us understand why patients have various respiratory symptoms. However, there are quite a number of pulmonary function tests available to us and which tests we should order can be confusing. Do we know when spirometry, lung volumes or diffusion capacity will be useful for evaluating the various pulmonary conditions? Our guest for this podcast is Alexander S. Niven, M.D., from the Division of Pulmonary and Critical Care Medicine at the Mayo Clinic and he’ll provide answers to these questions and more as we discuss “How to Use Pulmonary Function Tests Effectively”.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.  <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD</a>;]</p>
<p>Guest: Alexander S. Niven, M.D.</p>
<p>Pulmonary function tests are extremely useful in both diagnosing and managing patients with respiratory disease. In addition to a medical history, physical exam and imaging studies, they give us a great deal of information of the pulmonary physiology and help us understand why patients have various respiratory symptoms. However, there are quite a number of pulmonary function tests available to us and which tests we should order can be confusing. Do we know when spirometry, lung volumes or diffusion capacity will be useful for evaluating the various pulmonary conditions? Our guest for this podcast is Alexander S. Niven, M.D., from the Division of Pulmonary and Critical Care Medicine at the Mayo Clinic and he’ll provide answers to these questions and more as we discuss “How to Use Pulmonary Function Tests Effectively”.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qtbhcy/WF2016005_Pulmonary_Function_Tests_FINALa2ka3.mp3" length="43265717" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.  [@chutkaMD;]
Guest: Alexander S. Niven, M.D.
Pulmonary function tests are extremely useful in both diagnosing and managing patients with respiratory disease. In addition to a medical history, physical exam and imaging studies, they give us a great deal of information of the pulmonary physiology and help us understand why patients have various respiratory symptoms. However, there are quite a number of pulmonary function tests available to us and which tests we should order can be confusing. Do we know when spirometry, lung volumes or diffusion capacity will be useful for evaluating the various pulmonary conditions? Our guest for this podcast is Alexander S. Niven, M.D., from the Division of Pulmonary and Critical Care Medicine at the Mayo Clinic and he’ll provide answers to these questions and more as we discuss “How to Use Pulmonary Function Tests Effectively”.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1800</itunes:duration>
                <itunes:episode>386</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Obesity Update in Women</title>
        <itunes:title>Obesity Update in Women</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/obesity-update-in-women/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/obesity-update-in-women/#comments</comments>        <pubDate>Tue, 17 Jan 2023 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/c9ccc4b9-2ca2-3ebc-b064-4116c076e9e3</guid>
                                    <description><![CDATA[<p>Guest: Ekta Kapoor, M.B.B.S.</p>
<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD'>[@chutkaMD]</a></p>
<p>Obesity is becoming a serious epidemic in the United States, and it’s estimated that if current trends continue, by 2030 nearly half of all adults in the U.S. will be obese. Prevalence rates of obesity are steadily increasing in both men and women and some of the highest rates are seen in post-menopausal women. Obesity carries an increased risk for a variety of medical conditions and death rates of several types of cancer increase in obese women. The topic for this podcast is obesity in women and our guest is women’s health expert, Ekta Kapoor, M.B.B.S., from the Mayo Clinic. We’ll discuss reasons women tend to develop obesity in middle age, the risks associated with the type of obesity that occurs following menopause and effective strategies to manage weight gain with aging in women.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Ekta Kapoor, M.B.B.S.</p>
<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD'>[@chutkaMD]</a></p>
<p>Obesity is becoming a serious epidemic in the United States, and it’s estimated that if current trends continue, by 2030 nearly half of all adults in the U.S. will be obese. Prevalence rates of obesity are steadily increasing in both men and women and some of the highest rates are seen in post-menopausal women. Obesity carries an increased risk for a variety of medical conditions and death rates of several types of cancer increase in obese women. The topic for this podcast is obesity in women and our guest is women’s health expert, Ekta Kapoor, M.B.B.S., from the Mayo Clinic. We’ll discuss reasons women tend to develop obesity in middle age, the risks associated with the type of obesity that occurs following menopause and effective strategies to manage weight gain with aging in women.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/sns3s7/WF1163418_Obesity_in_Women_FINALaweap.mp3" length="38872549" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Ekta Kapoor, M.B.B.S.
Host: Darryl S. Chutka, M.D. [@chutkaMD]
Obesity is becoming a serious epidemic in the United States, and it’s estimated that if current trends continue, by 2030 nearly half of all adults in the U.S. will be obese. Prevalence rates of obesity are steadily increasing in both men and women and some of the highest rates are seen in post-menopausal women. Obesity carries an increased risk for a variety of medical conditions and death rates of several types of cancer increase in obese women. The topic for this podcast is obesity in women and our guest is women’s health expert, Ekta Kapoor, M.B.B.S., from the Mayo Clinic. We’ll discuss reasons women tend to develop obesity in middle age, the risks associated with the type of obesity that occurs following menopause and effective strategies to manage weight gain with aging in women.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1617</itunes:duration>
                <itunes:episode>385</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>THE BEST OF SEASON 1: The Risks &amp; Benefits of Coffee</title>
        <itunes:title>THE BEST OF SEASON 1: The Risks &amp; Benefits of Coffee</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/the-best-of-season-1-the-risks-benefits-of-coffee/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/the-best-of-season-1-the-risks-benefits-of-coffee/#comments</comments>        <pubDate>Tue, 10 Jan 2023 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/a6c0fe2f-ac16-304a-a692-5b76d1092844</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D%5B@'>[@chutkaMD]</a></p>
<p>Guest: Donald D. Hensrud, M.D., M.S.</p>
<p>Today we’re excited to bring back a special lecture by popular demand from Season 1 of the Mayo Clinic Talks Podcast.</p>
<p>Darryl S. Chutka, M.D., a general internist at Mayo Clinic in Rochester, Minnesota, and Donald D. Hensrud, M.D., M.S., a physician in Preventative Medicine & the Medical Director for the Mayo Clinic Healthy Living Program discusses the risks and benefits of drinking coffee.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D%5B@'>[@chutkaMD]</a></p>
<p>Guest: Donald D. Hensrud, M.D., M.S.</p>
<p>Today we’re excited to bring back a special lecture by popular demand from Season 1 of the Mayo Clinic Talks Podcast.</p>
<p>Darryl S. Chutka, M.D., a general internist at Mayo Clinic in Rochester, Minnesota, and Donald D. Hensrud, M.D., M.S., a physician in Preventative Medicine & the Medical Director for the Mayo Clinic Healthy Living Program discusses the risks and benefits of drinking coffee.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/i56qbu/VT3742399_2022_Coffee_FINALafw9s.mp3" length="16757719" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Donald D. Hensrud, M.D., M.S.
Today we’re excited to bring back a special lecture by popular demand from Season 1 of the Mayo Clinic Talks Podcast.
Darryl S. Chutka, M.D., a general internist at Mayo Clinic in Rochester, Minnesota, and Donald D. Hensrud, M.D., M.S., a physician in Preventative Medicine & the Medical Director for the Mayo Clinic Healthy Living Program discusses the risks and benefits of drinking coffee.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>697</itunes:duration>
                <itunes:episode>383</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Sudden Cardiac Arrest in Athletes</title>
        <itunes:title>Sudden Cardiac Arrest in Athletes</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/sudden-cardiac-arrest-in-athletes/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/sudden-cardiac-arrest-in-athletes/#comments</comments>        <pubDate>Mon, 09 Jan 2023 11:12:20 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/98392155-fd51-39ad-bf6c-1a194fc55fbb</guid>
                                    <description><![CDATA[<p>Host: <a href='https://www.mayoclinic.org/biographies/kakar-sanjeev-sanj-m-d/bio-20055340'>Sanjeev (Sanj) Kakar, M.D.</a>, [<a href='https://twitter.com/sanjkakar'>@sanjkakar</a>]</p>
<p>Guest: <a href='https://www.mayoclinic.org/biographies/ackerman-michael-j-m-d-ph-d/bio-20053036'>Michael J. Ackerman, M.D., Ph.D.</a></p>
<p>Guest: <a href='https://www.mayoclinic.org/biographies/munger-thomas-m-m-d/bio-20053812'>Thomas M. Munger, M.D.</a></p>
<p>Much attention has been paid to sudden cardiac arrest in athletes. Did you know the likelihood of sudden cardiac arrest in high school athletes is between 1 in 50,000 to 1 in 80,000 and for college-aged players, the risk is estimated at 1 in 13,426. Among National Collegiate Athletic Association (NCAA) athletes, there is an increased risk in those who are male, of black race and play basketball. In this podcast, we discuss what the causes of sudden cardiac arrest are, the role of screening protocols and what can be done in patients who experience this event with cardiology experts Tom M. Munger, M.D., and Michael J. Ackerman, M.D., Ph.D.</p>
<p>SPECIAL EPISODE: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcasts-special-episode-sudden-cardiac-arrest-athletes'>https://ce.mayo.edu/content/mayo-clinic-talks-podcasts-special-episode-sudden-cardiac-arrest-athletes</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: <a href='https://www.mayoclinic.org/biographies/kakar-sanjeev-sanj-m-d/bio-20055340'>Sanjeev (Sanj) Kakar, M.D.</a>, [<a href='https://twitter.com/sanjkakar'>@sanjkakar</a>]</p>
<p>Guest: <a href='https://www.mayoclinic.org/biographies/ackerman-michael-j-m-d-ph-d/bio-20053036'>Michael J. Ackerman, M.D., Ph.D.</a></p>
<p>Guest: <a href='https://www.mayoclinic.org/biographies/munger-thomas-m-m-d/bio-20053812'>Thomas M. Munger, M.D.</a></p>
<p>Much attention has been paid to sudden cardiac arrest in athletes. Did you know the likelihood of sudden cardiac arrest in high school athletes is between 1 in 50,000 to 1 in 80,000 and for college-aged players, the risk is estimated at 1 in 13,426. Among National Collegiate Athletic Association (NCAA) athletes, there is an increased risk in those who are male, of black race and play basketball. In this podcast, we discuss what the causes of sudden cardiac arrest are, the role of screening protocols and what can be done in patients who experience this event with cardiology experts Tom M. Munger, M.D., and Michael J. Ackerman, M.D., Ph.D.</p>
<p>SPECIAL EPISODE: <a href='https://ce.mayo.edu/content/mayo-clinic-talks-podcasts-special-episode-sudden-cardiac-arrest-athletes'>https://ce.mayo.edu/content/mayo-clinic-talks-podcasts-special-episode-sudden-cardiac-arrest-athletes</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/t7na2h/WF2119900_Cardiac_Arrest_in_Athletes_V298na4.mp3" length="45960878" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Sanjeev (Sanj) Kakar, M.D., [@sanjkakar]
Guest: Michael J. Ackerman, M.D., Ph.D.
Guest: Thomas M. Munger, M.D.
Much attention has been paid to sudden cardiac arrest in athletes. Did you know the likelihood of sudden cardiac arrest in high school athletes is between 1 in 50,000 to 1 in 80,000 and for college-aged players, the risk is estimated at 1 in 13,426. Among National Collegiate Athletic Association (NCAA) athletes, there is an increased risk in those who are male, of black race and play basketball. In this podcast, we discuss what the causes of sudden cardiac arrest are, the role of screening protocols and what can be done in patients who experience this event with cardiology experts Tom M. Munger, M.D., and Michael J. Ackerman, M.D., Ph.D.
SPECIAL EPISODE: https://ce.mayo.edu/content/mayo-clinic-talks-podcasts-special-episode-sudden-cardiac-arrest-athletes
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1911</itunes:duration>
                <itunes:episode>384</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Management of Patients with Late-Stage Dementia: A Caring Hand</title>
        <itunes:title>Management of Patients with Late-Stage Dementia: A Caring Hand</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/management-of-patients-with-late-stage-dementia-a-caring-hand/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/management-of-patients-with-late-stage-dementia-a-caring-hand/#comments</comments>        <pubDate>Tue, 03 Jan 2023 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/2721d09f-ea61-3634-a220-bfe2899cda50</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D%5B@'>[@chutkaMD]</a></p>
<p>Guest: Mairead M. Bartley, M.B., B.Ch., B.A.O.</p>
<p>Dementia is a devastating health condition for patients, their families, and a challenging disease for primary care providers. Whereas the diagnosis is usually straightforward to establish, the pharmacologic treatment options have been, at best, disappointing. With little to nothing to offer our patients which would improve their cognitive status; our responsibility for their management doesn’t end there. We still have a responsibility to provide ongoing care to these patients as well as their caregivers as they progress into the later stages of dementia. This brings up numerous management challenges including maintaining our patient’s independence, as well as numerous safety and nutrition issues. This podcast will review the management of the patient with later stage dementia with our guest is Mairead M. Bartley, M.B., B.Ch., B.A.O., a geriatrician and internist in the Division of Community Medicine at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD%5D%5B@'>[@chutkaMD]</a></p>
<p>Guest: Mairead M. Bartley, M.B., B.Ch., B.A.O.</p>
<p>Dementia is a devastating health condition for patients, their families, and a challenging disease for primary care providers. Whereas the diagnosis is usually straightforward to establish, the pharmacologic treatment options have been, at best, disappointing. With little to nothing to offer our patients which would improve their cognitive status; our responsibility for their management doesn’t end there. We still have a responsibility to provide ongoing care to these patients as well as their caregivers as they progress into the later stages of dementia. This brings up numerous management challenges including maintaining our patient’s independence, as well as numerous safety and nutrition issues. This podcast will review the management of the patient with later stage dementia with our guest is Mairead M. Bartley, M.B., B.Ch., B.A.O., a geriatrician and internist in the Division of Community Medicine at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kwmr83/WF1306152_Dementia_FINAL7gqiz.mp3" length="33708239" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Mairead M. Bartley, M.B., B.Ch., B.A.O.
Dementia is a devastating health condition for patients, their families, and a challenging disease for primary care providers. Whereas the diagnosis is usually straightforward to establish, the pharmacologic treatment options have been, at best, disappointing. With little to nothing to offer our patients which would improve their cognitive status; our responsibility for their management doesn’t end there. We still have a responsibility to provide ongoing care to these patients as well as their caregivers as they progress into the later stages of dementia. This brings up numerous management challenges including maintaining our patient’s independence, as well as numerous safety and nutrition issues. This podcast will review the management of the patient with later stage dementia with our guest is Mairead M. Bartley, M.B., B.Ch., B.A.O., a geriatrician and internist in the Division of Community Medicine at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1403</itunes:duration>
                <itunes:episode>382</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Alternative Therapies for Hyperlipidemia: The Lipid-ome of Lowering Cholesterol</title>
        <itunes:title>Alternative Therapies for Hyperlipidemia: The Lipid-ome of Lowering Cholesterol</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/alternative-therapies-for-hyperlipidemia-the-lipid-ome-of-lowering-cholesterol/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/alternative-therapies-for-hyperlipidemia-the-lipid-ome-of-lowering-cholesterol/#comments</comments>        <pubDate>Tue, 27 Dec 2022 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/dc7320ca-f995-33e7-99cb-ff0aa86fcb09</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD'>[@ChutkaMD]</a></p>
<p>Guest: Stephen Kopecky, M.D. <a href='https://twitter.com/drstevekopecky?lang=en'>[@DrSteveKopecky]</a></p>
<p>Hyperlipidemia is extremely common in the U.S., and we have a variety of pharmacologic agents which are very effective in treating this condition and improving our patients’ lipid profile. Yet there are patients who have elevated lipids but may not meet the criteria for pharmacologic therapy and other patients who don’t tolerate the medications we commonly prescribe. What are the alternative treatments available for managing hyperlipidemia and how effective are they?  How do they compare with pharmacologic therapy? We’ll discuss these issues and more in this podcast with our guest, preventive cardiologist Stephen Kopecky, M.D., from the Mayo Clinic. </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD'>[@ChutkaMD]</a></p>
<p>Guest: Stephen Kopecky, M.D. <a href='https://twitter.com/drstevekopecky?lang=en'>[@DrSteveKopecky]</a></p>
<p>Hyperlipidemia is extremely common in the U.S., and we have a variety of pharmacologic agents which are very effective in treating this condition and improving our patients’ lipid profile. Yet there are patients who have elevated lipids but may not meet the criteria for pharmacologic therapy and other patients who don’t tolerate the medications we commonly prescribe. What are the alternative treatments available for managing hyperlipidemia and how effective are they?  How do they compare with pharmacologic therapy? We’ll discuss these issues and more in this podcast with our guest, preventive cardiologist Stephen Kopecky, M.D., from the Mayo Clinic. </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vznx7s/WF1104043_Lower_Cholesterol_FINAL924ji.mp3" length="28504168" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@ChutkaMD]
Guest: Stephen Kopecky, M.D. [@DrSteveKopecky]
Hyperlipidemia is extremely common in the U.S., and we have a variety of pharmacologic agents which are very effective in treating this condition and improving our patients’ lipid profile. Yet there are patients who have elevated lipids but may not meet the criteria for pharmacologic therapy and other patients who don’t tolerate the medications we commonly prescribe. What are the alternative treatments available for managing hyperlipidemia and how effective are they?  How do they compare with pharmacologic therapy? We’ll discuss these issues and more in this podcast with our guest, preventive cardiologist Stephen Kopecky, M.D., from the Mayo Clinic. 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1184</itunes:duration>
                <itunes:episode>381</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hand &amp; Wrist Disorders: Lend Me a Hand (&amp; Wrist)</title>
        <itunes:title>Hand &amp; Wrist Disorders: Lend Me a Hand (&amp; Wrist)</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/hand-wrist-disorders-lend-me-a-hand-wrist/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/hand-wrist-disorders-lend-me-a-hand-wrist/#comments</comments>        <pubDate>Tue, 20 Dec 2022 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/53eeb81a-7f9c-350e-99dd-fb2abe4adfdf</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. [@<a href='https://twitter.com/ChutkaMD'>chutkaMD</a>]</p>
<p>Guest: Sanjeev (Sanj) Kakar, M.D. <a href='https://twitter.com/sanjkakar'>[@sanjkakar]</a></p>
<p>The hand and wrist are very complex parts of our anatomy and composed of multiple tendons, muscles, and nerves. The hand also contains over 30 bones. Hand or wrist complaints are some of the more common reasons patients come to their primary care provider, and at times, the cause can be quite elusive. We need to be able to accurately assess the patient’s symptoms, diagnose the various disorders and determine which ones need to be referred for specialty care and which ones we can manage on our own. In this podcast, we’ll discuss some of the most common hand and wrist disorders with Sanjeev Kakar, M.D., a hand specialist from the Department of Orthopedics at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. [@<a href='https://twitter.com/ChutkaMD'>chutkaMD</a>]</p>
<p>Guest: Sanjeev (Sanj) Kakar, M.D. <a href='https://twitter.com/sanjkakar'>[@sanjkakar]</a></p>
<p>The hand and wrist are very complex parts of our anatomy and composed of multiple tendons, muscles, and nerves. The hand also contains over 30 bones. Hand or wrist complaints are some of the more common reasons patients come to their primary care provider, and at times, the cause can be quite elusive. We need to be able to accurately assess the patient’s symptoms, diagnose the various disorders and determine which ones need to be referred for specialty care and which ones we can manage on our own. In this podcast, we’ll discuss some of the most common hand and wrist disorders with Sanjeev Kakar, M.D., a hand specialist from the Department of Orthopedics at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/eje8jh/WF1159610_Ulnar_Wrist_Pain_FINAL9lulh.mp3" length="30684585" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Sanjeev (Sanj) Kakar, M.D. [@sanjkakar]
The hand and wrist are very complex parts of our anatomy and composed of multiple tendons, muscles, and nerves. The hand also contains over 30 bones. Hand or wrist complaints are some of the more common reasons patients come to their primary care provider, and at times, the cause can be quite elusive. We need to be able to accurately assess the patient’s symptoms, diagnose the various disorders and determine which ones need to be referred for specialty care and which ones we can manage on our own. In this podcast, we’ll discuss some of the most common hand and wrist disorders with Sanjeev Kakar, M.D., a hand specialist from the Department of Orthopedics at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1278</itunes:duration>
                <itunes:episode>380</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Chronic Kidney Disease: What Primary Care Providers Need to Know</title>
        <itunes:title>Chronic Kidney Disease: What Primary Care Providers Need to Know</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/chronic-kidney-disease-what-primary-care-providers-need-to-know/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/chronic-kidney-disease-what-primary-care-providers-need-to-know/#comments</comments>        <pubDate>Tue, 13 Dec 2022 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/aa10c187-0fe4-339f-83e9-7c6247fa83e3</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. [<a href='https://twitter.com/ChutkaMD'>@chutkaMD</a>]</p>
<p>Guest: Mira T. Keddis, M.D. [<a href='https://twitter.com/keddis_mira'>@keddis_mira</a>]</p>
<p>Chronic kidney disease can have a major impact on a patient’s quality of life; reducing their energy level, impacting their diet and may limit medications or alter medication dosages we prescribe. It’s estimated that kidney disease affects nearly 40 million people in the U.S. or 15% of the population, and two out of five adults with severe kidney disease don’t even know they have it. As primary care providers, we need to know how to prevent kidney disease, how we assess renal function and how to manage those with moderate to severe renal impairment. Our guest for today’s podcast is Mira T. Keddis, M.D., a nephrologist at the Mayo Clinic in Scottsdale, Arizona.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. [<a href='https://twitter.com/ChutkaMD'>@chutkaMD</a>]</p>
<p>Guest: Mira T. Keddis, M.D. [<a href='https://twitter.com/keddis_mira'>@keddis_mira</a>]</p>
<p>Chronic kidney disease can have a major impact on a patient’s quality of life; reducing their energy level, impacting their diet and may limit medications or alter medication dosages we prescribe. It’s estimated that kidney disease affects nearly 40 million people in the U.S. or 15% of the population, and two out of five adults with severe kidney disease don’t even know they have it. As primary care providers, we need to know how to prevent kidney disease, how we assess renal function and how to manage those with moderate to severe renal impairment. Our guest for today’s podcast is Mira T. Keddis, M.D., a nephrologist at the Mayo Clinic in Scottsdale, Arizona.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ch6tpp/WF1198564_Chronic_Kidney_Disease_FINAL7q9vd.mp3" length="35429416" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Mira T. Keddis, M.D. [@keddis_mira]
Chronic kidney disease can have a major impact on a patient’s quality of life; reducing their energy level, impacting their diet and may limit medications or alter medication dosages we prescribe. It’s estimated that kidney disease affects nearly 40 million people in the U.S. or 15% of the population, and two out of five adults with severe kidney disease don’t even know they have it. As primary care providers, we need to know how to prevent kidney disease, how we assess renal function and how to manage those with moderate to severe renal impairment. Our guest for today’s podcast is Mira T. Keddis, M.D., a nephrologist at the Mayo Clinic in Scottsdale, Arizona.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1475</itunes:duration>
                <itunes:episode>379</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Glaucoma: Not So Easy on the Eyes</title>
        <itunes:title>Glaucoma: Not So Easy on the Eyes</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/glaucoma-not-so-easy-on-the-eyes/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/glaucoma-not-so-easy-on-the-eyes/#comments</comments>        <pubDate>Tue, 06 Dec 2022 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/3dabfa85-0fc6-3dd1-a6e4-e1dd4e81dc23</guid>
                                    <description><![CDATA[<p>Guest: Cheryl L. Khanna, M.D.</p>
<p>Host: Darryl S. Chutka, M.D.  <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD</a>]</p>
<p>Glaucoma is a very common eye disease affecting more than 70 million people worldwide and it’s a leading cause of blindness, accounting for over 12% of blindness around the world. While it tends to be more common in older individuals, it can occur in younger patients as well. There are a variety of types of glaucoma as well as several new treatment options available. In this podcast, we’ll discuss the various types of glaucoma, its treatment options and what we should do as primary care providers to help patients get a proper diagnosis and prevent the vision loss which can be associated with glaucoma. Our guest is Cheryl L. Khanna, M.D., an ophthalmologic surgeon at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Cheryl L. Khanna, M.D.</p>
<p>Host: Darryl S. Chutka, M.D.  <a href='https://twitter.com/ChutkaMD%5D'>[@chutkaMD</a>]</p>
<p>Glaucoma is a very common eye disease affecting more than 70 million people worldwide and it’s a leading cause of blindness, accounting for over 12% of blindness around the world. While it tends to be more common in older individuals, it can occur in younger patients as well. There are a variety of types of glaucoma as well as several new treatment options available. In this podcast, we’ll discuss the various types of glaucoma, its treatment options and what we should do as primary care providers to help patients get a proper diagnosis and prevent the vision loss which can be associated with glaucoma. Our guest is Cheryl L. Khanna, M.D., an ophthalmologic surgeon at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/uav528/WF1274102_Glaucoma_FINAL9hqg3.mp3" length="30508704" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Cheryl L. Khanna, M.D.
Host: Darryl S. Chutka, M.D.  [@chutkaMD]
Glaucoma is a very common eye disease affecting more than 70 million people worldwide and it’s a leading cause of blindness, accounting for over 12% of blindness around the world. While it tends to be more common in older individuals, it can occur in younger patients as well. There are a variety of types of glaucoma as well as several new treatment options available. In this podcast, we’ll discuss the various types of glaucoma, its treatment options and what we should do as primary care providers to help patients get a proper diagnosis and prevent the vision loss which can be associated with glaucoma. Our guest is Cheryl L. Khanna, M.D., an ophthalmologic surgeon at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1270</itunes:duration>
                <itunes:episode>378</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Abortion: What the Primary Care Provider Should Know</title>
        <itunes:title>Abortion: What the Primary Care Provider Should Know</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/abortion-what-the-primary-care-provider-should-know/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/abortion-what-the-primary-care-provider-should-know/#comments</comments>        <pubDate>Tue, 29 Nov 2022 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/d131c99f-9003-3cf7-9fc8-e0ed7549872b</guid>
                                    <description><![CDATA[<p>Guest: Regan N. Theiler, M.D., Ph.D.</p>
<p>Host: Darryl S. Chutka, M.D. @chutkaMD</p>
<p>Abortion is a common procedure. three out of ten pregnancies and six out of ten unintended pregnancies end with an induced abortion. Overall, about one in four women in the U.S. will have an abortion by the age of 45 years. The U.S. Supreme Court’s June 2022 ruling to overturn Roe vs. Wade has shifted the legal battle over abortion to the states, resulting in some states prohibiting abortion and others moving to safeguard it. The topic for this podcast is abortion and what the primary care provider should know. Our guest is Regan N. Theiler, M.D., Ph.D., from the Department of Obstetrics and Gynecology at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
<p>Faculty Twitter: </p>
<p>[@chutkaMD; <a href='https://twitter.com/ChutkaMD%5D'>https://twitter.com/ChutkaMD]</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Regan N. Theiler, M.D., Ph.D.</p>
<p>Host: Darryl S. Chutka, M.D. @chutkaMD</p>
<p>Abortion is a common procedure. three out of ten pregnancies and six out of ten unintended pregnancies end with an induced abortion. Overall, about one in four women in the U.S. will have an abortion by the age of 45 years. The U.S. Supreme Court’s June 2022 ruling to overturn Roe vs. Wade has shifted the legal battle over abortion to the states, resulting in some states prohibiting abortion and others moving to safeguard it. The topic for this podcast is abortion and what the primary care provider should know. Our guest is Regan N. Theiler, M.D., Ph.D., from the Department of Obstetrics and Gynecology at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
<p>Faculty Twitter: </p>
<p>[@chutkaMD; <a href='https://twitter.com/ChutkaMD%5D'>https://twitter.com/ChutkaMD]</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/e8kumy/WF1217612_Abortion_V3_FINALa5qk8.mp3" length="24741659" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Regan N. Theiler, M.D., Ph.D.
Host: Darryl S. Chutka, M.D. @chutkaMD
Abortion is a common procedure. three out of ten pregnancies and six out of ten unintended pregnancies end with an induced abortion. Overall, about one in four women in the U.S. will have an abortion by the age of 45 years. The U.S. Supreme Court’s June 2022 ruling to overturn Roe vs. Wade has shifted the legal battle over abortion to the states, resulting in some states prohibiting abortion and others moving to safeguard it. The topic for this podcast is abortion and what the primary care provider should know. Our guest is Regan N. Theiler, M.D., Ph.D., from the Department of Obstetrics and Gynecology at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Faculty Twitter: 
[@chutkaMD; https://twitter.com/ChutkaMD] ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1028</itunes:duration>
                <itunes:episode>377</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Vaccine Recommendations: 2022 Important Updates</title>
        <itunes:title>Vaccine Recommendations: 2022 Important Updates</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/vaccine-recommendations-2022-important-updates/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/vaccine-recommendations-2022-important-updates/#comments</comments>        <pubDate>Tue, 22 Nov 2022 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/c40e5b4e-fffd-36a2-9243-d6968785df5d</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. [@chutkaMD]</p>
<p>Guest: Robert M. Jacobson, M.D. [@RobertJMD]</p>
<p>Immunizations are one of the greatest success stories in modern medicine and it’s estimated that they’ve saved more lives and prevented more disabilities than any other medical intervention. They’re probably responsible, more than any other medical advance, in contributing to our increased longevity as a population. They’re also extremely cost-effective and their benefits far outweigh the very small risks they carry. This podcast will review new information regarding immunizations and how we as clinicians can increase our patients’ immunization rates. Our guest is Robert M. Jacobson, M.D., a pediatrician, and expert in immunizations from the Department of Pediatrics at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
<p>Faculty Twitter: </p>
<p>[@chutkaMD; <a href='https://twitter.com/ChutkaMD%5D'>https://twitter.com/ChutkaMD]</a> </p>
<p>[@RobertJMD; https://twitter.com/robertjmd]</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. [@chutkaMD]</p>
<p>Guest: Robert M. Jacobson, M.D. [@RobertJMD]</p>
<p>Immunizations are one of the greatest success stories in modern medicine and it’s estimated that they’ve saved more lives and prevented more disabilities than any other medical intervention. They’re probably responsible, more than any other medical advance, in contributing to our increased longevity as a population. They’re also extremely cost-effective and their benefits far outweigh the very small risks they carry. This podcast will review new information regarding immunizations and how we as clinicians can increase our patients’ immunization rates. Our guest is Robert M. Jacobson, M.D., a pediatrician, and expert in immunizations from the Department of Pediatrics at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
<p>Faculty Twitter: </p>
<p>[@chutkaMD; <a href='https://twitter.com/ChutkaMD%5D'>https://twitter.com/ChutkaMD]</a> </p>
<p>[@RobertJMD; https://twitter.com/robertjmd]</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6qjujf/WF1299102_Vaccine_Recommendations9819p.mp3" length="38367570" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Robert M. Jacobson, M.D. [@RobertJMD]
Immunizations are one of the greatest success stories in modern medicine and it’s estimated that they’ve saved more lives and prevented more disabilities than any other medical intervention. They’re probably responsible, more than any other medical advance, in contributing to our increased longevity as a population. They’re also extremely cost-effective and their benefits far outweigh the very small risks they carry. This podcast will review new information regarding immunizations and how we as clinicians can increase our patients’ immunization rates. Our guest is Robert M. Jacobson, M.D., a pediatrician, and expert in immunizations from the Department of Pediatrics at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 
Faculty Twitter: 
[@chutkaMD; https://twitter.com/ChutkaMD] 
[@RobertJMD; https://twitter.com/robertjmd]]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1598</itunes:duration>
                <itunes:episode>376</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>What To Know About Home Genetic Testing</title>
        <itunes:title>What To Know About Home Genetic Testing</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/what-to-know-about-home-genetic-testing/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/what-to-know-about-home-genetic-testing/#comments</comments>        <pubDate>Tue, 15 Nov 2022 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/578ec3ba-c5b1-3d34-9c96-df7ef20cb827</guid>
                                    <description><![CDATA[<p>Guest: Matthew J. Ferber, Ph.D.</p>
<p>Host: Darryl S. Chutka, M.D. [@chutkaMD]</p>
<p>Over the past decade or so, we’ve learned a great deal about the human genome, and this has allowed us to determine which medical conditions our patients are at an increased risk of developing and which medications may be best suited for their medical problems. In addition to the clinical genetic tests we use in our practice, direct to consumer home genetic testing has become extremely popular. This podcast will review home genetic testing and what information patients can expect with these tests, whether the information they receive is accurate and how home genetic testing differs from the genetic tests we order. Our guest is Matthew J. Ferber, Ph.D., a clinical molecular geneticist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Matthew J. Ferber, Ph.D.</p>
<p>Host: Darryl S. Chutka, M.D. [@chutkaMD]</p>
<p>Over the past decade or so, we’ve learned a great deal about the human genome, and this has allowed us to determine which medical conditions our patients are at an increased risk of developing and which medications may be best suited for their medical problems. In addition to the clinical genetic tests we use in our practice, direct to consumer home genetic testing has become extremely popular. This podcast will review home genetic testing and what information patients can expect with these tests, whether the information they receive is accurate and how home genetic testing differs from the genetic tests we order. Our guest is Matthew J. Ferber, Ph.D., a clinical molecular geneticist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/j3qygk/WF1267251_Home_Genetic_Tests_FINAL8t3et.mp3" length="37440019" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Matthew J. Ferber, Ph.D.
Host: Darryl S. Chutka, M.D. [@chutkaMD]
Over the past decade or so, we’ve learned a great deal about the human genome, and this has allowed us to determine which medical conditions our patients are at an increased risk of developing and which medications may be best suited for their medical problems. In addition to the clinical genetic tests we use in our practice, direct to consumer home genetic testing has become extremely popular. This podcast will review home genetic testing and what information patients can expect with these tests, whether the information they receive is accurate and how home genetic testing differs from the genetic tests we order. Our guest is Matthew J. Ferber, Ph.D., a clinical molecular geneticist at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1558</itunes:duration>
                <itunes:episode>375</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Evaluation &amp; Management of Osteoporosis: Make No Bones About It</title>
        <itunes:title>Evaluation &amp; Management of Osteoporosis: Make No Bones About It</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/evaluation-management-of-osteoporosis-make-no-bones-about-it/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/evaluation-management-of-osteoporosis-make-no-bones-about-it/#comments</comments>        <pubDate>Tue, 08 Nov 2022 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/9d7a81c2-ddbb-3ef4-8a2b-acb033e507d0</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. (@chutkaMD) <a href='https://twitter.com/ChutkaMD%5D'>https://twitter.com/ChutkaMD</a></p>
<p>Guest: Kurt A. Kennel, M.D.</p>
<p>Hip fractures have had a major impact on our healthcare system with an economic burden estimated to be over $20 billion per year. Due to the increasing age of our population, they’ll have an even greater impact in the future. In addition to the economic burden, hip fractures often result in major changes to one’s lifestyle. As a result, the detection, prevention and management of osteoporosis becomes an important health strategy. The topic for this podcast is osteoporosis and our guest is Kurt A. Kennel, MD., a Mayo Clinic Endocrinologist, and specialist in bone metabolism.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. (@chutkaMD) <a href='https://twitter.com/ChutkaMD%5D'>https://twitter.com/ChutkaMD</a></p>
<p>Guest: Kurt A. Kennel, M.D.</p>
<p>Hip fractures have had a major impact on our healthcare system with an economic burden estimated to be over $20 billion per year. Due to the increasing age of our population, they’ll have an even greater impact in the future. In addition to the economic burden, hip fractures often result in major changes to one’s lifestyle. As a result, the detection, prevention and management of osteoporosis becomes an important health strategy. The topic for this podcast is osteoporosis and our guest is Kurt A. Kennel, MD., a Mayo Clinic Endocrinologist, and specialist in bone metabolism.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dj3z3h/WF1275350_Osteoperosis_FINALa7l6v.mp3" length="44252191" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. (@chutkaMD) https://twitter.com/ChutkaMD
Guest: Kurt A. Kennel, M.D.
Hip fractures have had a major impact on our healthcare system with an economic burden estimated to be over $20 billion per year. Due to the increasing age of our population, they’ll have an even greater impact in the future. In addition to the economic burden, hip fractures often result in major changes to one’s lifestyle. As a result, the detection, prevention and management of osteoporosis becomes an important health strategy. The topic for this podcast is osteoporosis and our guest is Kurt A. Kennel, MD., a Mayo Clinic Endocrinologist, and specialist in bone metabolism.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1843</itunes:duration>
                <itunes:episode>374</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Reducing Medical Supply Chain Vulnerability: Now You See It, Now You Don’t</title>
        <itunes:title>Reducing Medical Supply Chain Vulnerability: Now You See It, Now You Don’t</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/reducing-medical-supply-chain-vulnerability-now-you-see-it-now-you-don-t/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/reducing-medical-supply-chain-vulnerability-now-you-see-it-now-you-don-t/#comments</comments>        <pubDate>Tue, 01 Nov 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/efb7d458-7531-3bed-9f65-3d4ffda2729e</guid>
                                    <description><![CDATA[<p>Guest: Pritish K. Tosh, M.D. <a href='https://twitter.com/drpritishtosh'>(@DrPritishTosh</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@chutkaMD</a>)</p>
<p>The COVID-19 pandemic exposed the vulnerability of the medical product supply chain and its impact on providing optimal healthcare. The spread of the disease was accompanied by not only shortages of personal protective equipment but also medications and many other products we depend on every day in our clinical practice. We’ve learned that we cannot provide adequate or timely health care when there are shortages of important products. As a result, the health of our patients and healthcare providers has been endangered. It’s also resulted in a rationing of care and an increased risk of error as we’re forced to use sub-standard or replacement products. It’s caused us to look for new solutions to reduce our medical supply chain vulnerabilities. Our guest for this podcast is Pritish K. Tosh, M.D., an infectious disease specialist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
<p>Twitter Handles:</p>
<p>(<a href='https://twitter.com/ChutkaMD'>@chutkaMD</a>); <a href='https://twitter.com/ChutkaMD'>https://twitter.com/ChutkaMD</a> </p>
<p><a href='https://twitter.com/drpritishtosh'>(@DrPritishTosh</a>); <a href='https://twitter.com/drpritishtosh'>https://twitter.com/drpritishtosh</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Pritish K. Tosh, M.D. <a href='https://twitter.com/drpritishtosh'>(@DrPritishTosh</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@chutkaMD</a>)</p>
<p>The COVID-19 pandemic exposed the vulnerability of the medical product supply chain and its impact on providing optimal healthcare. The spread of the disease was accompanied by not only shortages of personal protective equipment but also medications and many other products we depend on every day in our clinical practice. We’ve learned that we cannot provide adequate or timely health care when there are shortages of important products. As a result, the health of our patients and healthcare providers has been endangered. It’s also resulted in a rationing of care and an increased risk of error as we’re forced to use sub-standard or replacement products. It’s caused us to look for new solutions to reduce our medical supply chain vulnerabilities. Our guest for this podcast is Pritish K. Tosh, M.D., an infectious disease specialist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
<p>Twitter Handles:</p>
<p>(<a href='https://twitter.com/ChutkaMD'>@chutkaMD</a>); <a href='https://twitter.com/ChutkaMD'>https://twitter.com/ChutkaMD</a> </p>
<p><a href='https://twitter.com/drpritishtosh'>(@DrPritishTosh</a>); <a href='https://twitter.com/drpritishtosh'>https://twitter.com/drpritishtosh</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7324u9/WF1255400_Supply_Chain_FINAL88b3b.mp3" length="34379460" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Pritish K. Tosh, M.D. (@DrPritishTosh)
Host: Darryl S. Chutka, M.D. (@chutkaMD)
The COVID-19 pandemic exposed the vulnerability of the medical product supply chain and its impact on providing optimal healthcare. The spread of the disease was accompanied by not only shortages of personal protective equipment but also medications and many other products we depend on every day in our clinical practice. We’ve learned that we cannot provide adequate or timely health care when there are shortages of important products. As a result, the health of our patients and healthcare providers has been endangered. It’s also resulted in a rationing of care and an increased risk of error as we’re forced to use sub-standard or replacement products. It’s caused us to look for new solutions to reduce our medical supply chain vulnerabilities. Our guest for this podcast is Pritish K. Tosh, M.D., an infectious disease specialist at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 
Twitter Handles:
(@chutkaMD); https://twitter.com/ChutkaMD 
(@DrPritishTosh); https://twitter.com/drpritishtosh]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1432</itunes:duration>
                <itunes:episode>373</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Colon Polyps: A Real Bum-mer</title>
        <itunes:title>Colon Polyps: A Real Bum-mer</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/colon-polyps-a-real-bum-mer/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/colon-polyps-a-real-bum-mer/#comments</comments>        <pubDate>Tue, 25 Oct 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/7e69ece2-ae1f-3349-bdf5-821dde10246f</guid>
                                    <description><![CDATA[<p>Guest: John B. Kisiel, M.D. (<a href='https://twitter.com/DrJohnKisiel'>@DrJohnKisiel</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@chutkaMD</a>)</p>
<p>Colon polyps are relatively common in our population and, in most cases, are relatively easily found and removed, thereby reducing one's risk of developing colorectal cancer. What are the various types of colon polyps and which polyps have a greater tendency to become malignant? How long does it take a polyp to develop into colon cancer and how often does colonoscopy miss polyps?  These are just some of the topics we’ll discuss in today’s podcast. Our guest is John B. Kisiel, M.D., a gastroenterologist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: John B. Kisiel, M.D. (<a href='https://twitter.com/DrJohnKisiel'>@DrJohnKisiel</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@chutkaMD</a>)</p>
<p>Colon polyps are relatively common in our population and, in most cases, are relatively easily found and removed, thereby reducing one's risk of developing colorectal cancer. What are the various types of colon polyps and which polyps have a greater tendency to become malignant? How long does it take a polyp to develop into colon cancer and how often does colonoscopy miss polyps?  These are just some of the topics we’ll discuss in today’s podcast. Our guest is John B. Kisiel, M.D., a gastroenterologist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/q5ktqw/WF1260660_Colon_Polyps_FINAL7wd90.mp3" length="35149906" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: John B. Kisiel, M.D. (@DrJohnKisiel)
Host: Darryl S. Chutka, M.D. (@chutkaMD)
Colon polyps are relatively common in our population and, in most cases, are relatively easily found and removed, thereby reducing one's risk of developing colorectal cancer. What are the various types of colon polyps and which polyps have a greater tendency to become malignant? How long does it take a polyp to develop into colon cancer and how often does colonoscopy miss polyps?  These are just some of the topics we’ll discuss in today’s podcast. Our guest is John B. Kisiel, M.D., a gastroenterologist at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1462</itunes:duration>
                <itunes:episode>372</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes &amp; Your Health Edition: Precision Medicine for Obesity: From Phenotypes to Multi Omics</title>
        <itunes:title>Genes &amp; Your Health Edition: Precision Medicine for Obesity: From Phenotypes to Multi Omics</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-precision-medicine-for-obesity-from-phenotypes-to-multi-omics/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-precision-medicine-for-obesity-from-phenotypes-to-multi-omics/#comments</comments>        <pubDate>Thu, 20 Oct 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/58ba8c1f-485f-3924-af2e-e5c0affb4c50</guid>
                                    <description><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Andres J. Acosta, M.D., Ph.D. (<a href='https://twitter.com/dr_aac'>@dr_aac</a>)</p>
<p>The obesity epidemic continues to escalate in the United States and obesity rates are increasing around the world. It is estimated that by 2030, 50% of adults and 25% of children worldwide will be obese. Patients are the interaction of their genetics and environment; this episode explores the importance of understanding the mechanisms behind food intake regulation and weight to develop individualized therapies to treat obesity. Our guest for this episode is Andres J. Acosta, M.D., Ph.D., a physician-scientist at Mayo Clinic in Rochester, Minnesota. He is also an assistant professor of medicine at Mayo Clinic College of Medicine and Science, and principal investigator of the Precision Medicine for Obesity Laboratory.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Guest: Andres J. Acosta, M.D., Ph.D. (<a href='https://twitter.com/dr_aac'>@dr_aac</a>)</p>
<p>The obesity epidemic continues to escalate in the United States and obesity rates are increasing around the world. It is estimated that by 2030, 50% of adults and 25% of children worldwide will be obese. Patients are the interaction of their genetics and environment; this episode explores the importance of understanding the mechanisms behind food intake regulation and weight to develop individualized therapies to treat obesity. Our guest for this episode is Andres J. Acosta, M.D., Ph.D., a physician-scientist at Mayo Clinic in Rochester, Minnesota. He is also an assistant professor of medicine at Mayo Clinic College of Medicine and Science, and principal investigator of the Precision Medicine for Obesity Laboratory.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/a3ahe5/WF1254753_Genes_and_Obesity_FINAL7zrsq.mp3" length="39872155" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Denise M. Dupras, M.D., Ph.D.
Guest: Andres J. Acosta, M.D., Ph.D. (@dr_aac)
The obesity epidemic continues to escalate in the United States and obesity rates are increasing around the world. It is estimated that by 2030, 50% of adults and 25% of children worldwide will be obese. Patients are the interaction of their genetics and environment; this episode explores the importance of understanding the mechanisms behind food intake regulation and weight to develop individualized therapies to treat obesity. Our guest for this episode is Andres J. Acosta, M.D., Ph.D., a physician-scientist at Mayo Clinic in Rochester, Minnesota. He is also an assistant professor of medicine at Mayo Clinic College of Medicine and Science, and principal investigator of the Precision Medicine for Obesity Laboratory.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1661</itunes:duration>
                <itunes:episode>371</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Uterine Fibroids: Under Pressure</title>
        <itunes:title>Uterine Fibroids: Under Pressure</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/uterine-fibroids-under-pressure/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/uterine-fibroids-under-pressure/#comments</comments>        <pubDate>Tue, 18 Oct 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/19eafb75-7038-3b0b-b6f3-8cbe0067432e</guid>
                                    <description><![CDATA[<p>Guest: Elizabeth (Ebbie) A. Stewart, M.D.</p>
<p>Host: Darryl S. Chutka, M.D.</p>
<p>Uterine fibroids are the most common tumor of the female reproductive tract and women who are approaching menopause are at greatest risk for having them. In most cases, they don’t produce symptoms and only a minority of women require treatment. The topic for this podcast is uterine fibroids and we’ll discuss how fibroids can be diagnosed, their most common symptoms, who requires treatment and some of the latest treatment options with our guest, Elizabeth A. Stewart, M.D., from the Department of Obstetrics and Gynecology at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Elizabeth (Ebbie) A. Stewart, M.D.</p>
<p>Host: Darryl S. Chutka, M.D.</p>
<p>Uterine fibroids are the most common tumor of the female reproductive tract and women who are approaching menopause are at greatest risk for having them. In most cases, they don’t produce symptoms and only a minority of women require treatment. The topic for this podcast is uterine fibroids and we’ll discuss how fibroids can be diagnosed, their most common symptoms, who requires treatment and some of the latest treatment options with our guest, Elizabeth A. Stewart, M.D., from the Department of Obstetrics and Gynecology at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gnyi8y/WF1196764_Uterine_Fibroids_FINAL732j9.mp3" length="34318282" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Elizabeth (Ebbie) A. Stewart, M.D.
Host: Darryl S. Chutka, M.D.
Uterine fibroids are the most common tumor of the female reproductive tract and women who are approaching menopause are at greatest risk for having them. In most cases, they don’t produce symptoms and only a minority of women require treatment. The topic for this podcast is uterine fibroids and we’ll discuss how fibroids can be diagnosed, their most common symptoms, who requires treatment and some of the latest treatment options with our guest, Elizabeth A. Stewart, M.D., from the Department of Obstetrics and Gynecology at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1428</itunes:duration>
                <itunes:episode>370</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes &amp; Your Health Edition: Epigenomics Research – Understanding Genetics of Treatment Resistance</title>
        <itunes:title>Genes &amp; Your Health Edition: Epigenomics Research – Understanding Genetics of Treatment Resistance</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-epigenomics-research-%e2%80%93-understanding-genetics-of-treatment-resistance/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-epigenomics-research-%e2%80%93-understanding-genetics-of-treatment-resistance/#comments</comments>        <pubDate>Thu, 13 Oct 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/f33773e5-807b-3129-9eea-6ee75e9c0fc5</guid>
                                    <description><![CDATA[<p>Guest:   Alexandre Gaspar Maia, Ph.D. <a href='https://twitter.com/gasparma1a'>(@gasparma1a</a>)</p>
<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Epigenomics is a fascinating field in which researchers chart the locations and understand the functions of all chemical tags that mark the genome. The epigenome is the first boundary from the exterior world to our DNA sequence, and it can change dramatically. This episode discusses the state of the art of epigenomics analysis and the epigenome in the context of specific cells. Additionally, it explores the future of epigenomics for individualized medicine and in better understanding genetics of treatment resistance. The guest for this episode is Alexandre Gaspar Maia, Ph.D., an assistant professor in the Functional Genomics Laboratory at Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest:   Alexandre Gaspar Maia, Ph.D. <a href='https://twitter.com/gasparma1a'>(@gasparma1a</a>)</p>
<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Epigenomics is a fascinating field in which researchers chart the locations and understand the functions of all chemical tags that mark the genome. The epigenome is the first boundary from the exterior world to our DNA sequence, and it can change dramatically. This episode discusses the state of the art of epigenomics analysis and the epigenome in the context of specific cells. Additionally, it explores the future of epigenomics for individualized medicine and in better understanding genetics of treatment resistance. The guest for this episode is Alexandre Gaspar Maia, Ph.D., an assistant professor in the Functional Genomics Laboratory at Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zfj9sn/WF1309500_Epigenomics_FINAL81t3d.mp3" length="30800261" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest:   Alexandre Gaspar Maia, Ph.D. (@gasparma1a)
Host: Denise M. Dupras, M.D., Ph.D.
Epigenomics is a fascinating field in which researchers chart the locations and understand the functions of all chemical tags that mark the genome. The epigenome is the first boundary from the exterior world to our DNA sequence, and it can change dramatically. This episode discusses the state of the art of epigenomics analysis and the epigenome in the context of specific cells. Additionally, it explores the future of epigenomics for individualized medicine and in better understanding genetics of treatment resistance. The guest for this episode is Alexandre Gaspar Maia, Ph.D., an assistant professor in the Functional Genomics Laboratory at Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1281</itunes:duration>
                <itunes:episode>369</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Scoliosis: Around The Bend</title>
        <itunes:title>Scoliosis: Around The Bend</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/scoliosis-around-the-bend/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/scoliosis-around-the-bend/#comments</comments>        <pubDate>Tue, 11 Oct 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/e5de8191-f1ad-30c9-a1e3-b1effd869e71</guid>
                                    <description><![CDATA[<p>Host: Edward R. Laskowski, M.D</p>
<p>Guest: Anthony A. Stans, M.D.</p>
<p>The evaluation and treatment of scoliosis is an area that has created some controversy over the years.  Should we be screening kids in school?  When do we brace kids with scoliosis?  And what are the indications for surgery? To help us answer these questions and more, I am delighted to welcome Anthony A. Stans, M.D., a consultant in the Division of Pediatric Orthopedic Surgery with special interest in the treatment of spinal deformity.  He is past Chair of the Mayo Clinic Division of Pediatric Orthopedic Surgery and past Surgeon in Chief for the Mayo Clinic Children’s Center.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Edward R. Laskowski, M.D</p>
<p>Guest: Anthony A. Stans, M.D.</p>
<p>The evaluation and treatment of scoliosis is an area that has created some controversy over the years.  Should we be screening kids in school?  When do we brace kids with scoliosis?  And what are the indications for surgery? To help us answer these questions and more, I am delighted to welcome Anthony A. Stans, M.D., a consultant in the Division of Pediatric Orthopedic Surgery with special interest in the treatment of spinal deformity.  He is past Chair of the Mayo Clinic Division of Pediatric Orthopedic Surgery and past Surgeon in Chief for the Mayo Clinic Children’s Center.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3dwffr/WF1183400_Scoliosis_FINAL7d409.mp3" length="39308616" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Edward R. Laskowski, M.D
Guest: Anthony A. Stans, M.D.
The evaluation and treatment of scoliosis is an area that has created some controversy over the years.  Should we be screening kids in school?  When do we brace kids with scoliosis?  And what are the indications for surgery? To help us answer these questions and more, I am delighted to welcome Anthony A. Stans, M.D., a consultant in the Division of Pediatric Orthopedic Surgery with special interest in the treatment of spinal deformity.  He is past Chair of the Mayo Clinic Division of Pediatric Orthopedic Surgery and past Surgeon in Chief for the Mayo Clinic Children’s Center.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1634</itunes:duration>
                <itunes:episode>368</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes &amp; Your Health Edition: Neurodegenerative Brain Disease</title>
        <itunes:title>Genes &amp; Your Health Edition: Neurodegenerative Brain Disease</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-neurodegenerative-brain-disease/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-neurodegenerative-brain-disease/#comments</comments>        <pubDate>Thu, 06 Oct 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/b07bb93d-8f92-3670-ae96-361cb008b306</guid>
                                    <description><![CDATA[<p>Guest: Bradley F. Boeve, M.D.</p>
<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Family history is so important in deciphering genetic causes for neurodegenerative disorders. As we study polygenetic situations, we are learning that often it is not just one gene, but the contribution of multiple genes that lead to the presentation of a patient with cognitive or brain function deterioration that occurs at a variable rate. In this episode, we discuss genes and neurodegenerative brain disease, and our guest is Bradley F. Boeve, M.D., a consultant in the Department of Neurology and the Center for Sleep Medicine, as well as a professor of neurology at the Mayo Clinic in Rochester, Minnesota.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Bradley F. Boeve, M.D.</p>
<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Family history is so important in deciphering genetic causes for neurodegenerative disorders. As we study polygenetic situations, we are learning that often it is not just one gene, but the contribution of multiple genes that lead to the presentation of a patient with cognitive or brain function deterioration that occurs at a variable rate. In this episode, we discuss genes and neurodegenerative brain disease, and our guest is Bradley F. Boeve, M.D., a consultant in the Department of Neurology and the Center for Sleep Medicine, as well as a professor of neurology at the Mayo Clinic in Rochester, Minnesota.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5f33da/WF1053047_Neurodegenerative_Diseases_FINALbhd7m.mp3" length="46136549" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Bradley F. Boeve, M.D.
Host: Denise M. Dupras, M.D., Ph.D.
Family history is so important in deciphering genetic causes for neurodegenerative disorders. As we study polygenetic situations, we are learning that often it is not just one gene, but the contribution of multiple genes that lead to the presentation of a patient with cognitive or brain function deterioration that occurs at a variable rate. In this episode, we discuss genes and neurodegenerative brain disease, and our guest is Bradley F. Boeve, M.D., a consultant in the Department of Neurology and the Center for Sleep Medicine, as well as a professor of neurology at the Mayo Clinic in Rochester, Minnesota.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1921</itunes:duration>
                <itunes:episode>367</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Psoriasis: Let’s Talk Rash-tionally</title>
        <itunes:title>Psoriasis: Let’s Talk Rash-tionally</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/psoriasis-let-s-talk-rash-tionally/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/psoriasis-let-s-talk-rash-tionally/#comments</comments>        <pubDate>Tue, 04 Oct 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/dec62609-20ce-3be3-b8e7-3472e36c1065</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. @chutkaMD</p>
<p>Guest: Jason C. Sluzevich, M.D.</p>
<p>Psoriasis is a somewhat atypical dermatologic condition which can come and go over time. In many, there may be seasonal effects and in some, psoriasis can have an associated arthritis. It has a characteristic distribution and while it has no cure, there are a variety of established and new treatment options. In this podcast, we’ll review how to diagnose psoriasis, its characteristic appearance, its associated arthritis, and management strategies with Jason C. Sluzevich, M.D., a dermatologist from the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. @chutkaMD</p>
<p>Guest: Jason C. Sluzevich, M.D.</p>
<p>Psoriasis is a somewhat atypical dermatologic condition which can come and go over time. In many, there may be seasonal effects and in some, psoriasis can have an associated arthritis. It has a characteristic distribution and while it has no cure, there are a variety of established and new treatment options. In this podcast, we’ll review how to diagnose psoriasis, its characteristic appearance, its associated arthritis, and management strategies with Jason C. Sluzevich, M.D., a dermatologist from the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ixqr92/WF1143902_Psoriasis_FINAL8mqic.mp3" length="28472650" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. @chutkaMD
Guest: Jason C. Sluzevich, M.D.
Psoriasis is a somewhat atypical dermatologic condition which can come and go over time. In many, there may be seasonal effects and in some, psoriasis can have an associated arthritis. It has a characteristic distribution and while it has no cure, there are a variety of established and new treatment options. In this podcast, we’ll review how to diagnose psoriasis, its characteristic appearance, its associated arthritis, and management strategies with Jason C. Sluzevich, M.D., a dermatologist from the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1184</itunes:duration>
                <itunes:episode>366</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes &amp; Your Health Edition: Breast Cancer &amp; SNPs- What Are They &amp; What Do We Know?</title>
        <itunes:title>Genes &amp; Your Health Edition: Breast Cancer &amp; SNPs- What Are They &amp; What Do We Know?</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-breast-cancer-snps-what-are-they-what-do-we-know/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-breast-cancer-snps-what-are-they-what-do-we-know/#comments</comments>        <pubDate>Thu, 29 Sep 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/cbe70c18-1db7-3323-9c68-a7eebb7c7b92</guid>
                                    <description><![CDATA[<p>Guests: Sandhya Pruthi, M.D. (<a href='https://twitter.com/DrSandhyaPruthi'>@DrSandhyaPruthi</a>)</p>
<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>What is precision prevention? As providers, what can we do to best determine who is at high risk for breast cancer, and when to make appropriate decisions about interventions to reduce an individual’s risk for getting breast cancer? In this episode of our Genes & Your Health edition from the Center for Individualized Medicine, we will learn more about breast cancer, breast cancer genes and the role of single nucleotide polymorphisms (SNPs) in breast cancer risk assessment. Our guest is Sandhya Pruthi, M.D., a Mayo Clinic physician in breast disease and a consultant and Professor of Medicine in the Department of General Internal Medicine in Rochester, Minnesota.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guests: Sandhya Pruthi, M.D. (<a href='https://twitter.com/DrSandhyaPruthi'>@DrSandhyaPruthi</a>)</p>
<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>What is precision prevention? As providers, what can we do to best determine who is at high risk for breast cancer, and when to make appropriate decisions about interventions to reduce an individual’s risk for getting breast cancer? In this episode of our Genes & Your Health edition from the Center for Individualized Medicine, we will learn more about breast cancer, breast cancer genes and the role of single nucleotide polymorphisms (SNPs) in breast cancer risk assessment. Our guest is Sandhya Pruthi, M.D., a Mayo Clinic physician in breast disease and a consultant and Professor of Medicine in the Department of General Internal Medicine in Rochester, Minnesota.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bgzb7e/WF1042107_Breast_Cancer_and_SNPs_FINALb6f7l.mp3" length="45685033" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guests: Sandhya Pruthi, M.D. (@DrSandhyaPruthi)
Host: Denise M. Dupras, M.D., Ph.D.
What is precision prevention? As providers, what can we do to best determine who is at high risk for breast cancer, and when to make appropriate decisions about interventions to reduce an individual’s risk for getting breast cancer? In this episode of our Genes & Your Health edition from the Center for Individualized Medicine, we will learn more about breast cancer, breast cancer genes and the role of single nucleotide polymorphisms (SNPs) in breast cancer risk assessment. Our guest is Sandhya Pruthi, M.D., a Mayo Clinic physician in breast disease and a consultant and Professor of Medicine in the Department of General Internal Medicine in Rochester, Minnesota.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1904</itunes:duration>
                <itunes:episode>365</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Helping Your Patients Live Younger Longer</title>
        <itunes:title>Helping Your Patients Live Younger Longer</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/helping-your-patients-live-younger-longer/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/helping-your-patients-live-younger-longer/#comments</comments>        <pubDate>Tue, 27 Sep 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/65a56b34-37a3-3a04-88f1-02145676f39d</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D.  @ChutkaMD</p>
<p>Guest: Stephen Kopecky, M.D.</p>
<p>Most of us want to live longer, but we want to live a healthy life and avoid the many health problems associated with growing older. Many of the health issues associated with aging have significant morbidity and have the potential to significantly affect our quality of life. Do we know how to avoid these health problems and stay healthy into our older ages? What should we be advising our patients to help them live younger longer? We’ll discuss these questions with our guest today, Stephen Kopecky, M.D., a preventive cardiologist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D.  @ChutkaMD</p>
<p>Guest: Stephen Kopecky, M.D.</p>
<p>Most of us want to live longer, but we want to live a healthy life and avoid the many health problems associated with growing older. Many of the health issues associated with aging have significant morbidity and have the potential to significantly affect our quality of life. Do we know how to avoid these health problems and stay healthy into our older ages? What should we be advising our patients to help them live younger longer? We’ll discuss these questions with our guest today, Stephen Kopecky, M.D., a preventive cardiologist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/73yvws/WF1105228_Live_Younger_Longer_FINAL74wnt.mp3" length="29568244" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D.  @ChutkaMD
Guest: Stephen Kopecky, M.D.
Most of us want to live longer, but we want to live a healthy life and avoid the many health problems associated with growing older. Many of the health issues associated with aging have significant morbidity and have the potential to significantly affect our quality of life. Do we know how to avoid these health problems and stay healthy into our older ages? What should we be advising our patients to help them live younger longer? We’ll discuss these questions with our guest today, Stephen Kopecky, M.D., a preventive cardiologist at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1231</itunes:duration>
                <itunes:episode>364</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes &amp; Your Health Edition: Polycystic Kidney Disease &amp; Genetic Testing - Aiming for Accurate Diagnosis</title>
        <itunes:title>Genes &amp; Your Health Edition: Polycystic Kidney Disease &amp; Genetic Testing - Aiming for Accurate Diagnosis</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-and-your-health-edition-polycystic-kidney-disease-and-genetic-testing-aiming-for-accurate-diagnosis/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-and-your-health-edition-polycystic-kidney-disease-and-genetic-testing-aiming-for-accurate-diagnosis/#comments</comments>        <pubDate>Thu, 22 Sep 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/48d2eb86-c789-3749-b74c-4acf233479b0</guid>
                                    <description><![CDATA[<p>Guest: Fouad T. Chebib, M.D.</p>
<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>What is polycystic kidney disease? Is it all genetic? As providers, what should we be considering and what patients should we think about screening with genetic testing? Join this episode of our Genes & Your Health edition from the Center for Individualized Medicine to learn more about the role of genes in polycystic kidney disease. This episode features Fouad T. Chebib, M.D., a Mayo Clinic nephrologist from Jacksonville, Florida, whose specialty is in polycystic kidney disease.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Fouad T. Chebib, M.D.</p>
<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>What is polycystic kidney disease? Is it all genetic? As providers, what should we be considering and what patients should we think about screening with genetic testing? Join this episode of our Genes & Your Health edition from the Center for Individualized Medicine to learn more about the role of genes in polycystic kidney disease. This episode features Fouad T. Chebib, M.D., a Mayo Clinic nephrologist from Jacksonville, Florida, whose specialty is in polycystic kidney disease.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/q9ip5d/WF1090817_Polycystic_Kidney_Disease_FINAL932br.mp3" length="48617653" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Fouad T. Chebib, M.D.
Host: Denise M. Dupras, M.D., Ph.D.
What is polycystic kidney disease? Is it all genetic? As providers, what should we be considering and what patients should we think about screening with genetic testing? Join this episode of our Genes & Your Health edition from the Center for Individualized Medicine to learn more about the role of genes in polycystic kidney disease. This episode features Fouad T. Chebib, M.D., a Mayo Clinic nephrologist from Jacksonville, Florida, whose specialty is in polycystic kidney disease.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2024</itunes:duration>
                <itunes:episode>363</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes &amp; Your Health Edition: Exposomics - The Next Frontier</title>
        <itunes:title>Genes &amp; Your Health Edition: Exposomics - The Next Frontier</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-exposomics-the-next-frontier/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-exposomics-the-next-frontier/#comments</comments>        <pubDate>Tue, 20 Sep 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/9e09913f-1de2-3991-aad2-b00d4b985b20</guid>
                                    <description><![CDATA[<p>Guest: Konstantinos N. Lazaridis, M.D.</p>
<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>What does the exposome mean? In this episode, we will define the exposome and explore how assessing exposures in an organized fashion will help us better understand the gene environment interaction. The guest for this episode of our Genes & Your Health edition from the Center for Individualized Medicine is Konstantinos N. Lazaridis, M.D., a Mayo Clinic physician in the Division of Gastroenterology and Hematology, as well as the Bernard and Edith Waterman Director, Microbiome Program, Center for Individualized Medicine and Carlson and Nelson Endowed Director, Center for Individualized Medicine.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Konstantinos N. Lazaridis, M.D.</p>
<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>What does the exposome mean? In this episode, we will define the exposome and explore how assessing exposures in an organized fashion will help us better understand the gene environment interaction. The guest for this episode of our <em>Genes & Your Health</em> edition from the Center for Individualized Medicine is Konstantinos N. Lazaridis, M.D., a Mayo Clinic physician in the Division of Gastroenterology and Hematology, as well as the Bernard and Edith Waterman Director, Microbiome Program, Center for Individualized Medicine and Carlson and Nelson Endowed Director, Center for Individualized Medicine.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tm4zp7/WF1033251_Exposomics_FINALa1ngh.mp3" length="30847713" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Konstantinos N. Lazaridis, M.D.
Host: Denise M. Dupras, M.D., Ph.D.
What does the exposome mean? In this episode, we will define the exposome and explore how assessing exposures in an organized fashion will help us better understand the gene environment interaction. The guest for this episode of our Genes & Your Health edition from the Center for Individualized Medicine is Konstantinos N. Lazaridis, M.D., a Mayo Clinic physician in the Division of Gastroenterology and Hematology, as well as the Bernard and Edith Waterman Director, Microbiome Program, Center for Individualized Medicine and Carlson and Nelson Endowed Director, Center for Individualized Medicine.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1328</itunes:duration>
                <itunes:episode>362</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Monoclonal Gammopathy of Undetermined Significance (MGUS)</title>
        <itunes:title>Monoclonal Gammopathy of Undetermined Significance (MGUS)</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/monoclonal-gammopathy-of-undetermined-significance-mgus/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/monoclonal-gammopathy-of-undetermined-significance-mgus/#comments</comments>        <pubDate>Tue, 13 Sep 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/1573512c-a10b-37f8-89d8-0ef2fa54649b</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. (@ChutkaMD)</p>
<p>Guest: Wilson I. Gonsalves, M.D.</p>
<p>Monoclonal gammopathies represent abnormal proteins produced by plasma cells. The most common monoclonal gammopathy is monoclonal gammopathy of undetermined significance or MGUS. While MGUS itself is not a malignancy and doesn’t require treatment, patients with MGUS have an increased risk of developing a variety of hematologic malignancies and therefore do require surveillance. The topic for today’s podcast is monoclonal gammopathy of undetermined significance and our guest is Wilson I. Gonsalves, M.D., a hematologist and oncologist from the Division of Hematology at the Mayo Clinic. We’ll discuss how to diagnose MGUS, who is more likely to develop this condition and how patients with it should be followed. </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. (@ChutkaMD)</p>
<p>Guest: Wilson I. Gonsalves, M.D.</p>
<p>Monoclonal gammopathies represent abnormal proteins produced by plasma cells. The most common monoclonal gammopathy is monoclonal gammopathy of undetermined significance or MGUS. While MGUS itself is not a malignancy and doesn’t require treatment, patients with MGUS have an increased risk of developing a variety of hematologic malignancies and therefore do require surveillance. The topic for today’s podcast is monoclonal gammopathy of undetermined significance and our guest is Wilson I. Gonsalves, M.D., a hematologist and oncologist from the Division of Hematology at the Mayo Clinic. We’ll discuss how to diagnose MGUS, who is more likely to develop this condition and how patients with it should be followed. </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/sgnsvw/WF1140788_Monoclonal_Gammopathy_FINAL89sb7.mp3" length="41836781" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Guest: Wilson I. Gonsalves, M.D.
Monoclonal gammopathies represent abnormal proteins produced by plasma cells. The most common monoclonal gammopathy is monoclonal gammopathy of undetermined significance or MGUS. While MGUS itself is not a malignancy and doesn’t require treatment, patients with MGUS have an increased risk of developing a variety of hematologic malignancies and therefore do require surveillance. The topic for today’s podcast is monoclonal gammopathy of undetermined significance and our guest is Wilson I. Gonsalves, M.D., a hematologist and oncologist from the Division of Hematology at the Mayo Clinic. We’ll discuss how to diagnose MGUS, who is more likely to develop this condition and how patients with it should be followed. 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1742</itunes:duration>
                <itunes:episode>361</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: Updated COVID-19 boosters target omicron variants</title>
        <itunes:title>Mayo Clinic Q&amp;A: Updated COVID-19 boosters target omicron variants</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-updated-covid-19-boosters-target-omicron-variants/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-updated-covid-19-boosters-target-omicron-variants/#comments</comments>        <pubDate>Tue, 06 Sep 2022 11:01:50 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/d7d9f85b-7616-3cd3-bf15-a5fc5bc58571</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded on August 31, 2022</p>
<p>Guest: Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>The first significant change to COVID-19 vaccines since their rollout came this week as the Food and Drug Administration <a href='https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-moderna-pfizer-biontech-bivalent-covid-19-vaccines-use?utm_medium=email&utm_source=govdelivery'>granted emergency use authorization</a> for updated Moderna and Pfizer COVID-19 boosters aimed at the omicron variants. The <a href='https://www.cdc.gov/'>Centers for Disease Control and Prevention (CDC)</a> also signed off on the recommendation, clearing the way for the new COVID-19 booster to be administered.</p>
<p>The new boosters are bivalent vaccines, meaning they target more than one strain of the virus. The new formulation targets the BA.4 and BA.5 omicron variants, in addition to the original coronavirus strain. BA.5 is responsible for nearly 90% of all new COVID-19 cases in the U.S., according to the <a href='https://covid.cdc.gov/covid-data-tracker/#variant-proportions'>CDC</a>.</p>
<p>The Pfizer bivalent booster is approved for people 12 and up if they have already received their primary COVID-19 vaccine series and it has been at least two months since their last vaccine dose. The Moderna bivalent booster is available on the same timeline to people 18 and up.</p>
<p>"This booster recommendation is in anticipation that there will be yet another surge as college students, grade school and high school students are gathering back together," explains <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.136537328.1903245515.1583502589-382127956.1576426874'>Dr. Gregory Poland</a>, head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>. "We're also preparing for cooler weather, meaning more indoor activities, family gatherings and the holidays — often without masks, unfortunately. We still need to take COVID seriously."</p>
<p>Another big concern for vaccine experts is the upcoming <a href='https://newsnetwork.mayoclinic.org/discussion/expect-a-different-flu-season-why-youll-want-to-be-vaccinated-for-flu/'>flu season</a>. The Southern Hemisphere is often an indicator of what's to come for the U.S. Australia's flu season exceeded its five-year average, particularly affecting children under age 5, according to a recent <a href='https://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-ozflu-flucurr.htm'>report</a>.</p>
<p>Experts worry that the relaxing of masking and social distancing recommendations that were in place for COVID-19 purposes the past two winters will be a factor. These measures also protected people from the flu.</p>
<p>"When cold weather moves us indoors, a high viral circulation occurs in schools and other indoor settings. I think we are very likely to see a bad flu year," says Dr. Poland. "Now I know we've been predicting that for two years, but for the most part, people wore masks and it didn't happen. I don't think that'll be the case this year. People are not wearing masks, and we are very likely to get hit hard by influenza."</p>
<p>On the Mayo Clinic Q&A podcast, Dr. Poland discusses the latest COVID-19 news and touches on other news, including monkeypox, polio and the upcoming flu season.</p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded on August 31, 2022</p>
<p>Guest: Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>The first significant change to COVID-19 vaccines since their rollout came this week as the Food and Drug Administration <a href='https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-moderna-pfizer-biontech-bivalent-covid-19-vaccines-use?utm_medium=email&utm_source=govdelivery'>granted emergency use authorization</a> for updated Moderna and Pfizer COVID-19 boosters aimed at the omicron variants. The <a href='https://www.cdc.gov/'>Centers for Disease Control and Prevention (CDC)</a> also signed off on the recommendation, clearing the way for the new COVID-19 booster to be administered.</p>
<p>The new boosters are bivalent vaccines, meaning they target more than one strain of the virus. The new formulation targets the BA.4 and BA.5 omicron variants, in addition to the original coronavirus strain. BA.5 is responsible for nearly 90% of all new COVID-19 cases in the U.S., according to the <a href='https://covid.cdc.gov/covid-data-tracker/#variant-proportions'>CDC</a>.</p>
<p>The Pfizer bivalent booster is approved for people 12 and up if they have already received their primary COVID-19 vaccine series and it has been at least two months since their last vaccine dose. The Moderna bivalent booster is available on the same timeline to people 18 and up.</p>
<p>"This booster recommendation is in anticipation that there will be yet another surge as college students, grade school and high school students are gathering back together," explains <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.136537328.1903245515.1583502589-382127956.1576426874'>Dr. Gregory Poland</a>, head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>. "We're also preparing for cooler weather, meaning more indoor activities, family gatherings and the holidays — often without masks, unfortunately. We still need to take COVID seriously."</p>
<p>Another big concern for vaccine experts is the upcoming <a href='https://newsnetwork.mayoclinic.org/discussion/expect-a-different-flu-season-why-youll-want-to-be-vaccinated-for-flu/'>flu season</a>. The Southern Hemisphere is often an indicator of what's to come for the U.S. Australia's flu season exceeded its five-year average, particularly affecting children under age 5, according to a recent <a href='https://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-ozflu-flucurr.htm'>report</a>.</p>
<p>Experts worry that the relaxing of masking and social distancing recommendations that were in place for COVID-19 purposes the past two winters will be a factor. These measures also protected people from the flu.</p>
<p>"When cold weather moves us indoors, a high viral circulation occurs in schools and other indoor settings. I think we are very likely to see a bad flu year," says Dr. Poland. "Now I know we've been predicting that for two years, but for the most part, people wore masks and it didn't happen. I don't think that'll be the case this year. People are not wearing masks, and we are very likely to get hit hard by influenza."</p>
<p>On the Mayo Clinic Q&A podcast, Dr. Poland discusses the latest COVID-19 news and touches on other news, including monkeypox, polio and the upcoming flu season.</p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/954pt2/CPD_20220831.mp3" length="10600969" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded on August 31, 2022
Guest: Gregory A. Poland, M.D. (@drgregpoland)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
The first significant change to COVID-19 vaccines since their rollout came this week as the Food and Drug Administration granted emergency use authorization for updated Moderna and Pfizer COVID-19 boosters aimed at the omicron variants. The Centers for Disease Control and Prevention (CDC) also signed off on the recommendation, clearing the way for the new COVID-19 booster to be administered.
The new boosters are bivalent vaccines, meaning they target more than one strain of the virus. The new formulation targets the BA.4 and BA.5 omicron variants, in addition to the original coronavirus strain. BA.5 is responsible for nearly 90% of all new COVID-19 cases in the U.S., according to the CDC.
The Pfizer bivalent booster is approved for people 12 and up if they have already received their primary COVID-19 vaccine series and it has been at least two months since their last vaccine dose. The Moderna bivalent booster is available on the same timeline to people 18 and up.
"This booster recommendation is in anticipation that there will be yet another surge as college students, grade school and high school students are gathering back together," explains Dr. Gregory Poland, head of Mayo Clinic's Vaccine Research Group. "We're also preparing for cooler weather, meaning more indoor activities, family gatherings and the holidays — often without masks, unfortunately. We still need to take COVID seriously."
Another big concern for vaccine experts is the upcoming flu season. The Southern Hemisphere is often an indicator of what's to come for the U.S. Australia's flu season exceeded its five-year average, particularly affecting children under age 5, according to a recent report.
Experts worry that the relaxing of masking and social distancing recommendations that were in place for COVID-19 purposes the past two winters will be a factor. These measures also protected people from the flu.
"When cold weather moves us indoors, a high viral circulation occurs in schools and other indoor settings. I think we are very likely to see a bad flu year," says Dr. Poland. "Now I know we've been predicting that for two years, but for the most part, people wore masks and it didn't happen. I don't think that'll be the case this year. People are not wearing masks, and we are very likely to get hit hard by influenza."
On the Mayo Clinic Q&A podcast, Dr. Poland discusses the latest COVID-19 news and touches on other news, including monkeypox, polio and the upcoming flu season.
 ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1314</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Plantar Fasciitis: Best Step Forward</title>
        <itunes:title>Plantar Fasciitis: Best Step Forward</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/plantar-fasciitis-best-step-forward/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/plantar-fasciitis-best-step-forward/#comments</comments>        <pubDate>Tue, 06 Sep 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/7e46ada4-6c4c-3fe6-87c7-0e03857bb6af</guid>
                                    <description><![CDATA[<p>Host: Joshua D. Luciew, P.A.-C.</p>
<p>Guest: Arthur J. De Luigi, D.O., M.H.A. (@DrDeLuigi, <a href='https://twitter.com/drdeluigi'>https://twitter.com/drdeluigi</a>)</p>
<p>Heel and foot pain can be a burdensome symptom for our patients, as discomfort can be experienced with each step they take, hindering locomotion.</p>
<p>Many different patient populations are required to be on their feet for their job or for various wellness goals, which can exacerbate their painful heel and foot or deter them from exercise.</p>
<p>In this episode, we will explore the most common cause of heel and foot pain: plantar fasciitis. Listeners will learn from a Mayo Clinic specialist in Physical Medicine and Rehabilitation how plantar fasciitis develops, how it is properly diagnosed, and learn the best approaches for treatments of this condition to help patients resume their previous physical activities, pain-free.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Joshua D. Luciew, P.A.-C.</p>
<p>Guest: Arthur J. De Luigi, D.O., M.H.A. (@DrDeLuigi, <a href='https://twitter.com/drdeluigi'>https://twitter.com/drdeluigi</a>)</p>
<p>Heel and foot pain can be a burdensome symptom for our patients, as discomfort can be experienced with each step they take, hindering locomotion.</p>
<p>Many different patient populations are required to be on their feet for their job or for various wellness goals, which can exacerbate their painful heel and foot or deter them from exercise.</p>
<p>In this episode, we will explore the most common cause of heel and foot pain: plantar fasciitis. Listeners will learn from a Mayo Clinic specialist in Physical Medicine and Rehabilitation how plantar fasciitis develops, how it is properly diagnosed, and learn the best approaches for treatments of this condition to help patients resume their previous physical activities, pain-free.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/m6nngv/WF1165452_Plantar_Fasciitis_FINAL84e4t.mp3" length="31955403" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Joshua D. Luciew, P.A.-C.
Guest: Arthur J. De Luigi, D.O., M.H.A. (@DrDeLuigi, https://twitter.com/drdeluigi)
Heel and foot pain can be a burdensome symptom for our patients, as discomfort can be experienced with each step they take, hindering locomotion.
Many different patient populations are required to be on their feet for their job or for various wellness goals, which can exacerbate their painful heel and foot or deter them from exercise.
In this episode, we will explore the most common cause of heel and foot pain: plantar fasciitis. Listeners will learn from a Mayo Clinic specialist in Physical Medicine and Rehabilitation how plantar fasciitis develops, how it is properly diagnosed, and learn the best approaches for treatments of this condition to help patients resume their previous physical activities, pain-free.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1329</itunes:duration>
                <itunes:episode>360</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Peripheral Neuropathies: On Pins and Needles</title>
        <itunes:title>Peripheral Neuropathies: On Pins and Needles</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/peripheral-neuropathies-on-pins-and-needles/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/peripheral-neuropathies-on-pins-and-needles/#comments</comments>        <pubDate>Tue, 30 Aug 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/6798077b-91d5-36f9-9058-1f6866d103ac</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD'>(@ChutkaMD</a>)</p>
<p>Guest: Julie A. Khoury, M.D.</p>
<p>Peripheral neuropathy is a relatively common neurologic condition we frequently see in primary care. Some patients may describe the symptoms as paresthesias and they represent a minor nuisance, however others may have very painful dysesthesias. Since some peripheral neuropathies are reversible, we need to know when to suspect a peripheral neuropathy, how to evaluate patients who have them and the possible treatment options. We’ll discuss peripheral neuropathies in this podcast with Julie A. Khoury, M.D., a neurologist at the Mayo Clinic in Phoenix, Arizona.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD'>(@ChutkaMD</a>)</p>
<p>Guest: Julie A. Khoury, M.D.</p>
<p>Peripheral neuropathy is a relatively common neurologic condition we frequently see in primary care. Some patients may describe the symptoms as paresthesias and they represent a minor nuisance, however others may have very painful dysesthesias. Since some peripheral neuropathies are reversible, we need to know when to suspect a peripheral neuropathy, how to evaluate patients who have them and the possible treatment options. We’ll discuss peripheral neuropathies in this podcast with Julie A. Khoury, M.D., a neurologist at the Mayo Clinic in Phoenix, Arizona.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8x2ez2/WF1103840_Peripheral_Neuropathy_FINALafvgt.mp3" length="30249742" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Guest: Julie A. Khoury, M.D.
Peripheral neuropathy is a relatively common neurologic condition we frequently see in primary care. Some patients may describe the symptoms as paresthesias and they represent a minor nuisance, however others may have very painful dysesthesias. Since some peripheral neuropathies are reversible, we need to know when to suspect a peripheral neuropathy, how to evaluate patients who have them and the possible treatment options. We’ll discuss peripheral neuropathies in this podcast with Julie A. Khoury, M.D., a neurologist at the Mayo Clinic in Phoenix, Arizona.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1259</itunes:duration>
                <itunes:episode>359</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Kidney Stones: This Too Shall Pass</title>
        <itunes:title>Kidney Stones: This Too Shall Pass</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/kidney-stones-this-too-shall-pass/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/kidney-stones-this-too-shall-pass/#comments</comments>        <pubDate>Tue, 23 Aug 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/6bacbcfd-df1f-3434-b2b3-5ccce20f494a</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD'>(@ChutkaMD</a>)</p>
<p>Guest: Ivan E. Porter, II M.D.</p>
<p>Kidney stones are quite common and represent one of the most common disorders of the urinary system. When symptomatic, stones are relatively easy to diagnose as they tend to cause a very characteristic clinical presentation. While most stones will pass through the urinary system, others will require a variety of treatment options. The topic for today’s podcast is kidney stones and we’ll discuss the diagnosis, management, and prevention of stones with Ivan E. Porter, II M.D., a nephrologist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. <a href='https://twitter.com/ChutkaMD'>(@ChutkaMD</a>)</p>
<p>Guest: Ivan E. Porter, II M.D.</p>
<p>Kidney stones are quite common and represent one of the most common disorders of the urinary system. When symptomatic, stones are relatively easy to diagnose as they tend to cause a very characteristic clinical presentation. While most stones will pass through the urinary system, others will require a variety of treatment options. The topic for today’s podcast is kidney stones and we’ll discuss the diagnosis, management, and prevention of stones with Ivan E. Porter, II M.D., a nephrologist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hgm3wm/WF729251_Kidney_Stones_FINALa7xux.mp3" length="19270259" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Guest: Ivan E. Porter, II M.D.
Kidney stones are quite common and represent one of the most common disorders of the urinary system. When symptomatic, stones are relatively easy to diagnose as they tend to cause a very characteristic clinical presentation. While most stones will pass through the urinary system, others will require a variety of treatment options. The topic for today’s podcast is kidney stones and we’ll discuss the diagnosis, management, and prevention of stones with Ivan E. Porter, II M.D., a nephrologist at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1200</itunes:duration>
                <itunes:episode>358</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Managing Hypertension in the Elderly</title>
        <itunes:title>Managing Hypertension in the Elderly</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/managing-hypertension-in-the-elderly/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/managing-hypertension-in-the-elderly/#comments</comments>        <pubDate>Tue, 16 Aug 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/58175c2c-7c5b-35c1-bf79-d1a5f23a6d2d</guid>
                                    <description><![CDATA[<p>Guest: Sandra J. Taler, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>It’s estimated that over 70% of those 65 and older have hypertension and there’s good evidence to show that less than half of these elderly individuals are adequately controlled. While there are many similarities between hypertension in the elderly and the general population, there are also some important differences. The elderly are more likely to have systolic hypertension, take multiple medications and they’re more likely to experience more frequent and serious adverse drug reactions. In this podcast, we’ll learn more about hypertension in the elderly from Sandra J. Taler, M.D., a nephrologist and hypertension specialist at the Mayo Clinic in Rochester, Minnesota.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Sandra J. Taler, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>It’s estimated that over 70% of those 65 and older have hypertension and there’s good evidence to show that less than half of these elderly individuals are adequately controlled. While there are many similarities between hypertension in the elderly and the general population, there are also some important differences. The elderly are more likely to have systolic hypertension, take multiple medications and they’re more likely to experience more frequent and serious adverse drug reactions. In this podcast, we’ll learn more about hypertension in the elderly from Sandra J. Taler, M.D., a nephrologist and hypertension specialist at the Mayo Clinic in Rochester, Minnesota.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gmdpw7/WF771490_Elderly_Hypertension_FINAL809pl.mp3" length="20949606" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Sandra J. Taler, M.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
It’s estimated that over 70% of those 65 and older have hypertension and there’s good evidence to show that less than half of these elderly individuals are adequately controlled. While there are many similarities between hypertension in the elderly and the general population, there are also some important differences. The elderly are more likely to have systolic hypertension, take multiple medications and they’re more likely to experience more frequent and serious adverse drug reactions. In this podcast, we’ll learn more about hypertension in the elderly from Sandra J. Taler, M.D., a nephrologist and hypertension specialist at the Mayo Clinic in Rochester, Minnesota.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1305</itunes:duration>
                <itunes:episode>357</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Treating Sacroiliac (SI Joint) vs. Chronic Lower Back Pain</title>
        <itunes:title>Treating Sacroiliac (SI Joint) vs. Chronic Lower Back Pain</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/treating-sacroiliac-si-joint-vs-chronic-lower-back-pain/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/treating-sacroiliac-si-joint-vs-chronic-lower-back-pain/#comments</comments>        <pubDate>Tue, 09 Aug 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/06694f61-c893-3651-adb5-6686ff15eff2</guid>
                                    <description><![CDATA[<p>Host: Sanjeev (Sanj) Kakar, M.D. (<a href='https://twitter.com/sanjkakar'>sanjkakar</a>)</p>
<p>Guest: William W. Cross, III, M.D. (<a href='https://twitter.com/williamcross3md'>@WilliamCross3MD</a>)</p>
<p>Did you know the lifetime prevalence of generalized low back pain is estimated at 60% to 70% in industrialized countries? Often overlooked, the sacroiliac or SI joint can cause approximately one third of these cases. How do you determine the difference between the two? In this week’s podcast, we discuss the diagnosis of SI joint dysfunction and the different modalities for treatment, including non-operative and surgical management with William W. Cross, M.D., an Associate Professor in the Department of Orthopedic Surgery at Mayo Clinic in Rochester, Minnesota.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
<p>Resource:  </p>
<ul><li><a href='https://www.mayoclinic.org/departments-centers/sacroiliac-joint-clinic-in-minnesota/overview/ovc-20472398'>Sacroiliac Joint Clinic in Minnesota - Overview - Mayo Clinic</a></li>
</ul>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Sanjeev (Sanj) Kakar, M.D. (<a href='https://twitter.com/sanjkakar'>sanjkakar</a>)</p>
<p>Guest: William W. Cross, III, M.D. (<a href='https://twitter.com/williamcross3md'>@WilliamCross3MD</a>)</p>
<p>Did you know the lifetime prevalence of generalized low back pain is estimated at 60% to 70% in industrialized countries? Often overlooked, the sacroiliac<em> or SI joint</em> can cause approximately one third of these cases. How do you determine the difference between the two? In this week’s podcast, we discuss the diagnosis of SI joint dysfunction and the different modalities for treatment, including non-operative and surgical management with William W. Cross, M.D., an Associate Professor in the Department of Orthopedic Surgery at Mayo Clinic in Rochester, Minnesota.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
<p>Resource:  </p>
<ul><li><a href='https://www.mayoclinic.org/departments-centers/sacroiliac-joint-clinic-in-minnesota/overview/ovc-20472398'>Sacroiliac Joint Clinic in Minnesota - Overview - Mayo Clinic</a></li>
</ul>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/h6qk44/WF728454_Chronic_Lower_Back_and_SI_Joint_Pain_DONE75mn3.mp3" length="30649585" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Sanjeev (Sanj) Kakar, M.D. (sanjkakar)
Guest: William W. Cross, III, M.D. (@WilliamCross3MD)
Did you know the lifetime prevalence of generalized low back pain is estimated at 60% to 70% in industrialized countries? Often overlooked, the sacroiliac or SI joint can cause approximately one third of these cases. How do you determine the difference between the two? In this week’s podcast, we discuss the diagnosis of SI joint dysfunction and the different modalities for treatment, including non-operative and surgical management with William W. Cross, M.D., an Associate Professor in the Department of Orthopedic Surgery at Mayo Clinic in Rochester, Minnesota.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 
Resource:  
Sacroiliac Joint Clinic in Minnesota - Overview - Mayo Clinic
]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1276</itunes:duration>
                <itunes:episode>356</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Headache Edition: Status Migrainosus and Headache in the ER</title>
        <itunes:title>Headache Edition: Status Migrainosus and Headache in the ER</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/headache-edition-status-migrainosus-and-headache-in-the-er/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/headache-edition-status-migrainosus-and-headache-in-the-er/#comments</comments>        <pubDate>Thu, 04 Aug 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/69215b50-4114-3293-a0af-75462a8fe899</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-headache-edition-online-cme-course'>Mayo Clinic Talks Podcast: Headache Edition - Online CME Course</a>.</p>
<p>Guest: Mark A. Whealy, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Headache disorders are extremely common, and patients frequently seek our help in the outpatient setting regarding management of their headaches. On occasion, they may present to the emergency department for more severe or prolonged headaches. With this podcast, we will continue our series on headaches as we discuss intractable migraine, also known as status migrainosus. We’ll also discuss other headaches commonly seen in the emergency department. How serious is status migrainosus? How should patients with these headaches be evaluated and what are the most effective management strategies? We’ll discuss these questions with Mark A. Whealy, M.D., a neurologist and headache specialist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-headache-edition-online-cme-course'>Mayo Clinic Talks Podcast: Headache Edition - Online CME Course</a>.</p>
<p>Guest: Mark A. Whealy, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Headache disorders are extremely common, and patients frequently seek our help in the outpatient setting regarding management of their headaches. On occasion, they may present to the emergency department for more severe or prolonged headaches. With this podcast, we will continue our series on headaches as we discuss intractable migraine, also known as status migrainosus. We’ll also discuss other headaches commonly seen in the emergency department. How serious is status migrainosus? How should patients with these headaches be evaluated and what are the most effective management strategies? We’ll discuss these questions with Mark A. Whealy, M.D., a neurologist and headache specialist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/24sdfz/22R01505_08_A01.mp3" length="17771974" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit Mayo Clinic Talks Podcast: Headache Edition - Online CME Course.
Guest: Mark A. Whealy, M.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Headache disorders are extremely common, and patients frequently seek our help in the outpatient setting regarding management of their headaches. On occasion, they may present to the emergency department for more severe or prolonged headaches. With this podcast, we will continue our series on headaches as we discuss intractable migraine, also known as status migrainosus. We’ll also discuss other headaches commonly seen in the emergency department. How serious is status migrainosus? How should patients with these headaches be evaluated and what are the most effective management strategies? We’ll discuss these questions with Mark A. Whealy, M.D., a neurologist and headache specialist at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1106</itunes:duration>
                <itunes:episode>355</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Endometriosis: An Issue with Tissue</title>
        <itunes:title>Endometriosis: An Issue with Tissue</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/endometriosis-an-issue-with-tissue/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/endometriosis-an-issue-with-tissue/#comments</comments>        <pubDate>Tue, 02 Aug 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/8e5a2fdd-9fed-33e2-853c-4ee81f711fe9</guid>
                                    <description><![CDATA[<p>Guest: Tatnai L. Burnett, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Endometriosis affects approximately one in ten women during their reproductive age and can result in chronic abdominal symptoms, including pelvic pain and at times infertility. It can produce a variety of vague symptoms which commonly causes a delay in establishing a diagnosis. Since women commonly present to their primary care providers, we need to consider endometriosis as a cause of their symptoms. While there is no cure, this chronic condition can be effectively managed. The topic for this podcast is endometriosis and our guest is Tatnai L. Burnett, M.D., from the Department of Obstetrics and Gynecology at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Tatnai L. Burnett, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Endometriosis affects approximately one in ten women during their reproductive age and can result in chronic abdominal symptoms, including pelvic pain and at times infertility. It can produce a variety of vague symptoms which commonly causes a delay in establishing a diagnosis. Since women commonly present to their primary care providers, we need to consider endometriosis as a cause of their symptoms. While there is no cure, this chronic condition can be effectively managed. The topic for this podcast is endometriosis and our guest is Tatnai L. Burnett, M.D., from the Department of Obstetrics and Gynecology at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7nsq2i/WF769852_Endometriosis_FINALaoubt.mp3" length="29639513" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Tatnai L. Burnett, M.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Endometriosis affects approximately one in ten women during their reproductive age and can result in chronic abdominal symptoms, including pelvic pain and at times infertility. It can produce a variety of vague symptoms which commonly causes a delay in establishing a diagnosis. Since women commonly present to their primary care providers, we need to consider endometriosis as a cause of their symptoms. While there is no cure, this chronic condition can be effectively managed. The topic for this podcast is endometriosis and our guest is Tatnai L. Burnett, M.D., from the Department of Obstetrics and Gynecology at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1845</itunes:duration>
                <itunes:episode>354</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Headache Edition: Pediatric Headaches</title>
        <itunes:title>Headache Edition: Pediatric Headaches</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/headache-edition-pediatric-headaches/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/headache-edition-pediatric-headaches/#comments</comments>        <pubDate>Thu, 28 Jul 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/c2e4bb6d-a82c-388c-b259-04ef7ae7bff6</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-headache-edition-online-cme-course'>Mayo Clinic Talks Podcast: Headache Edition - Online CME Course</a>.</p>
<p>Guest: Juliana H. VanderPluym, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Headaches in children are relatively common and although there are many similarities to headaches in adults, there are some differences as well. Symptoms can be slightly different, and these differences can make it more difficult to establish a specific diagnosis in a child. This podcast will continue our series on headaches and the topic will be “Headaches in Children”. We’ll cover such topics as: Do infants get headaches? How often are headaches in children serious? And is the management of headaches in children any different than in adults? Our guest for this topic is Juliana H. VanderPluym, M.D., a neurologist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-headache-edition-online-cme-course'>Mayo Clinic Talks Podcast: Headache Edition - Online CME Course</a>.</p>
<p>Guest: Juliana H. VanderPluym, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Headaches in children are relatively common and although there are many similarities to headaches in adults, there are some differences as well. Symptoms can be slightly different, and these differences can make it more difficult to establish a specific diagnosis in a child. This podcast will continue our series on headaches and the topic will be “Headaches in Children”. We’ll cover such topics as: Do infants get headaches? How often are headaches in children serious? And is the management of headaches in children any different than in adults? Our guest for this topic is Juliana H. VanderPluym, M.D., a neurologist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8wi8kk/22R01505_10_A01.mp3" length="33785543" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit Mayo Clinic Talks Podcast: Headache Edition - Online CME Course.
Guest: Juliana H. VanderPluym, M.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Headaches in children are relatively common and although there are many similarities to headaches in adults, there are some differences as well. Symptoms can be slightly different, and these differences can make it more difficult to establish a specific diagnosis in a child. This podcast will continue our series on headaches and the topic will be “Headaches in Children”. We’ll cover such topics as: Do infants get headaches? How often are headaches in children serious? And is the management of headaches in children any different than in adults? Our guest for this topic is Juliana H. VanderPluym, M.D., a neurologist at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1406</itunes:duration>
                <itunes:episode>353</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Elevated Triglycerides: Implications for Cardiovascular Health</title>
        <itunes:title>Elevated Triglycerides: Implications for Cardiovascular Health</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/elevated-triglycerides-implications-for-cardiovascular-health/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/elevated-triglycerides-implications-for-cardiovascular-health/#comments</comments>        <pubDate>Tue, 26 Jul 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/cfe19aad-8ec4-34ff-9399-32e55f7d0bc7</guid>
                                    <description><![CDATA[<p>Host: Joshua D. Luciew, MPAS, P.A.-C.</p>
<p>Guest: Abigail K. Stockland, APRN, C.N.P., M.S.N.</p>
<p>Guest: Michaeleen M. Burroughs, M.S., RDN, LD</p>
<p>A fasting lipid panel is part of a patient’s routine health maintenance visit. This common laboratory test has many values on it including total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides. This test helps clinicians calculate a patient’s 10-year atherosclerotic cardiovascular disease risk (ASCVD risk) to help guide treatments. If a patient's risk is determined to be high, statin medications can be considered. However, despite using statin therapy and addressing modifiable risk factors, some patients still have elevated triglycerides.  What role do triglycerides play in a patient's health?  Does hypertriglyceridemia contribute to cardiovascular disease? Tune in to this episode to find out more from our panel discussion.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Joshua D. Luciew, MPAS, P.A.-C.</p>
<p>Guest: Abigail K. Stockland, APRN, C.N.P., M.S.N.</p>
<p>Guest: Michaeleen M. Burroughs, M.S., RDN, LD</p>
<p>A fasting lipid panel is part of a patient’s routine health maintenance visit. This common laboratory test has many values on it including total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides. This test helps clinicians calculate a patient’s 10-year atherosclerotic cardiovascular disease risk (ASCVD risk) to help guide treatments. If a patient's risk is determined to be high, statin medications can be considered. However, despite using statin therapy and addressing modifiable risk factors, some patients still have elevated triglycerides.  What role do triglycerides play in a patient's health?  Does hypertriglyceridemia contribute to cardiovascular disease? Tune in to this episode to find out more from our panel discussion.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7ehwfp/WF951850_High_Triglycerides_FINAL8uqo2.mp3" length="42718242" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Joshua D. Luciew, MPAS, P.A.-C.
Guest: Abigail K. Stockland, APRN, C.N.P., M.S.N.
Guest: Michaeleen M. Burroughs, M.S., RDN, LD
A fasting lipid panel is part of a patient’s routine health maintenance visit. This common laboratory test has many values on it including total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides. This test helps clinicians calculate a patient’s 10-year atherosclerotic cardiovascular disease risk (ASCVD risk) to help guide treatments. If a patient's risk is determined to be high, statin medications can be considered. However, despite using statin therapy and addressing modifiable risk factors, some patients still have elevated triglycerides.  What role do triglycerides play in a patient's health?  Does hypertriglyceridemia contribute to cardiovascular disease? Tune in to this episode to find out more from our panel discussion.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1779</itunes:duration>
                <itunes:episode>352</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Headache Edition: Serious Secondary Headaches</title>
        <itunes:title>Headache Edition: Serious Secondary Headaches</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/headache-edition-serious-secondary-headaches/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/headache-edition-serious-secondary-headaches/#comments</comments>        <pubDate>Thu, 21 Jul 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/91e521c5-68cd-3153-bad0-0053d1c54907</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-headache-edition-online-cme-course'>Mayo Clinic Talks Podcast: Headache Edition - Online CME Course</a>.</p>
<p>Guest: Chia-Chun Chiang, M.D. (<a href='https://twitter.com/chiachunchiang?lang=en'>@chiachunchiang</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Headaches have a variety of causes and for most they are a minor nuisance. Fortunately, most have a benign cause. However, there are some headaches which are associated with a serious health problem. Since many of these patients will present to their primary care providers with their headaches, we need to recognize clues they may describe that allow us to suspect their headache may not be benign. In this podcast, we’ll continue our series on headaches and discuss serious, secondary headaches with Chia-Chun Chiang, M.D., a neurologist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-headache-edition-online-cme-course'>Mayo Clinic Talks Podcast: Headache Edition - Online CME Course</a>.</p>
<p>Guest: Chia-Chun Chiang, M.D. (<a href='https://twitter.com/chiachunchiang?lang=en'>@chiachunchiang</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Headaches have a variety of causes and for most they are a minor nuisance. Fortunately, most have a benign cause. However, there are some headaches which are associated with a serious health problem. Since many of these patients will present to their primary care providers with their headaches, we need to recognize clues they may describe that allow us to suspect their headache may not be benign. In this podcast, we’ll continue our series on headaches and discuss serious, secondary headaches with Chia-Chun Chiang, M.D., a neurologist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9vcmmu/22R01505_03_A01.mp3" length="23109856" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit Mayo Clinic Talks Podcast: Headache Edition - Online CME Course.
Guest: Chia-Chun Chiang, M.D. (@chiachunchiang)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Headaches have a variety of causes and for most they are a minor nuisance. Fortunately, most have a benign cause. However, there are some headaches which are associated with a serious health problem. Since many of these patients will present to their primary care providers with their headaches, we need to recognize clues they may describe that allow us to suspect their headache may not be benign. In this podcast, we’ll continue our series on headaches and discuss serious, secondary headaches with Chia-Chun Chiang, M.D., a neurologist at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1439</itunes:duration>
                <itunes:episode>351</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Outs and Ins of Vitamins</title>
        <itunes:title>The Outs and Ins of Vitamins</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/the-outs-and-ins-of-vitamins/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/the-outs-and-ins-of-vitamins/#comments</comments>        <pubDate>Tue, 19 Jul 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/04757b2b-aab3-36ba-9191-2a4ea7328ac1</guid>
                                    <description><![CDATA[<p>Guest: Donald D. Hensrud, M.D., M.S.</p>
<p>Host: Edward (Edward R.) R. Laskowski, M.D. (<a href='https://twitter.com/DrEdSportsMed'>@DrEdSportsMed</a>)</p>
<p>A recent Harris poll found that 86% of people take some sort of vitamin or supplement, and a recent research study found that approximately 60% of people report using dietary supplements in the past 30 days.  Multiple claims are made regarding the benefits of vitamins. How do we know which are true?  How do we sift through all the hype? When should we consider taking vitamins or recommending them for our patients? This episode features Donald D. Hensrud, M.D., M.S., an Associate Professor of Nutrition and Preventive Medicine at Mayo Clinic Rochester, Director of the Mayo Clinic Healthy Living Program, and editor of multiple books on healthy eating and living a healthy lifestyle, including The Mayo Clinic Diet and The New Mayo Clinic cookbook.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Donald D. Hensrud, M.D., M.S.</p>
<p>Host: Edward (Edward R.) R. Laskowski, M.D. (<a href='https://twitter.com/DrEdSportsMed'>@DrEdSportsMed</a>)</p>
<p>A recent Harris poll found that 86% of people take some sort of vitamin or supplement, and a recent research study found that approximately 60% of people report using dietary supplements in the past 30 days.  Multiple claims are made regarding the benefits of vitamins. How do we know which are true?  How do we sift through all the hype? When should we consider taking vitamins or recommending them for our patients? This episode features Donald D. Hensrud, M.D., M.S., an Associate Professor of Nutrition and Preventive Medicine at Mayo Clinic Rochester, Director of the Mayo Clinic Healthy Living Program, and editor of multiple books on healthy eating and living a healthy lifestyle, including The Mayo Clinic Diet and The New Mayo Clinic cookbook.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rk6zm5/WF750402_Vitamins_FINAL7uaj8.mp3" length="19899994" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Donald D. Hensrud, M.D., M.S.
Host: Edward (Edward R.) R. Laskowski, M.D. (@DrEdSportsMed)
A recent Harris poll found that 86% of people take some sort of vitamin or supplement, and a recent research study found that approximately 60% of people report using dietary supplements in the past 30 days.  Multiple claims are made regarding the benefits of vitamins. How do we know which are true?  How do we sift through all the hype? When should we consider taking vitamins or recommending them for our patients? This episode features Donald D. Hensrud, M.D., M.S., an Associate Professor of Nutrition and Preventive Medicine at Mayo Clinic Rochester, Director of the Mayo Clinic Healthy Living Program, and editor of multiple books on healthy eating and living a healthy lifestyle, including The Mayo Clinic Diet and The New Mayo Clinic cookbook.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1240</itunes:duration>
                <itunes:episode>350</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: BA.5 omicron variant fueling latest COVID-19 surge</title>
        <itunes:title>Mayo Clinic Q&amp;A: BA.5 omicron variant fueling latest COVID-19 surge</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-ba5-omicron-variant-fueling-latest-covid-19-surge/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-ba5-omicron-variant-fueling-latest-covid-19-surge/#comments</comments>        <pubDate>Mon, 18 Jul 2022 08:41:04 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/f62fef05-39e7-3447-85cf-d922f649fd2e</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in July 2022</p>
<p>Guest: Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Danielle (DeeDee) J. Stiepan</p>
<p>The BA.5 omicron variant is now the dominant strain in the U.S., and it is leading to a new wave of COVID-19 infections. BA.5 was responsible for nearly 54% of COVID-19 cases in the U.S., and BA.4, a similar variant, accounted for another 17%, according to the latest data from the <a href='https://www.cdc.gov/'>Centers for Disease Control and Prevention</a>. </p>
<p>Experts are concerned because this particular variant appears to be good at evading the immune system. </p>
<p>"This BA.5 variant is hypercontagious, and right behind it, new variants are coming," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.136537328.1903245515.1583502589-382127956.1576426874'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>. "We will continue to generate these variants until people are masked and immunized." </p>
<p>Dr. Poland explains that the transmissibility of BA.5 represents the evolution of the virus to become more contagious and able to evade immune protection from previous infection or vaccination. </p>
<p>"Whether you've been vaccinated, whether you've been previously infected, whether you've been previously infected and vaccinated, you have very little protection against BA.5 in terms of getting infected or having mild to moderate infection," says Dr. Poland. "Thankfully, you still do have good protection against dying, being hospitalized or ending up on a ventilator if you are up to date on your vaccinations." </p>
<p>Due to the consequences of reinfection, including the possibility of long COVID-19, Dr. Poland urges people to continue to take precautions to protect themselves.</p>
<p>"The reality is, it's important to be up to date on the COVID-19 vaccinations that are recommended for your age group, health condition, etc.," says Dr. Poland. "Sometime this fall, we may well have a variant-focused vaccine, so get it when it becomes available. And wear a proper mask properly when you are indoors around people who are not your family or in a crowded outdoor venue."</p>
<p>On the Mayo Clinic Q&A podcast, Dr. Poland shares the latest COVID-19 news and answers listener questions.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in July 2022</p>
<p>Guest: Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Danielle (DeeDee) J. Stiepan</p>
<p>The BA.5 omicron variant is now the dominant strain in the U.S., and it is leading to a new wave of COVID-19 infections. BA.5 was responsible for nearly 54% of COVID-19 cases in the U.S., and BA.4, a similar variant, accounted for another 17%, according to the latest data from the <a href='https://www.cdc.gov/'>Centers for Disease Control and Prevention</a>. </p>
<p>Experts are concerned because this particular variant appears to be good at evading the immune system. </p>
<p>"This BA.5 variant is hypercontagious, and right behind it, new variants are coming," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.136537328.1903245515.1583502589-382127956.1576426874'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>. "We will continue to generate these variants until people are masked and immunized." </p>
<p>Dr. Poland explains that the transmissibility of BA.5 represents the evolution of the virus to become more contagious and able to evade immune protection from previous infection or vaccination. </p>
<p>"Whether you've been vaccinated, whether you've been previously infected, whether you've been previously infected and vaccinated, you have very little protection against BA.5 in terms of getting infected or having mild to moderate infection," says Dr. Poland. "Thankfully, you still do have good protection against dying, being hospitalized or ending up on a ventilator if you are up to date on your vaccinations." </p>
<p>Due to the consequences of reinfection, including the possibility of long COVID-19, Dr. Poland urges people to continue to take precautions to protect themselves.</p>
<p>"The reality is, it's important to be up to date on the COVID-19 vaccinations that are recommended for your age group, health condition, etc.," says Dr. Poland. "Sometime this fall, we may well have a variant-focused vaccine, so get it when it becomes available. And wear a proper mask properly when you are indoors around people who are not your family or in a crowded outdoor venue."</p>
<p>On the Mayo Clinic Q&A podcast, Dr. Poland shares the latest COVID-19 news and answers listener questions.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kub2q5/Mayo_Clinic_Q_A_-_Dr_Gregory_Poland_-_COVID-19_Update_07_15_22bn36i.mp3" length="36546649" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in July 2022
Guest: Gregory A. Poland, M.D. (@drgregpoland)
Host: Danielle (DeeDee) J. Stiepan
The BA.5 omicron variant is now the dominant strain in the U.S., and it is leading to a new wave of COVID-19 infections. BA.5 was responsible for nearly 54% of COVID-19 cases in the U.S., and BA.4, a similar variant, accounted for another 17%, according to the latest data from the Centers for Disease Control and Prevention. 
Experts are concerned because this particular variant appears to be good at evading the immune system. 
"This BA.5 variant is hypercontagious, and right behind it, new variants are coming," says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group. "We will continue to generate these variants until people are masked and immunized." 
Dr. Poland explains that the transmissibility of BA.5 represents the evolution of the virus to become more contagious and able to evade immune protection from previous infection or vaccination. 
"Whether you've been vaccinated, whether you've been previously infected, whether you've been previously infected and vaccinated, you have very little protection against BA.5 in terms of getting infected or having mild to moderate infection," says Dr. Poland. "Thankfully, you still do have good protection against dying, being hospitalized or ending up on a ventilator if you are up to date on your vaccinations." 
Due to the consequences of reinfection, including the possibility of long COVID-19, Dr. Poland urges people to continue to take precautions to protect themselves.
"The reality is, it's important to be up to date on the COVID-19 vaccinations that are recommended for your age group, health condition, etc.," says Dr. Poland. "Sometime this fall, we may well have a variant-focused vaccine, so get it when it becomes available. And wear a proper mask properly when you are indoors around people who are not your family or in a crowded outdoor venue."
On the Mayo Clinic Q&A podcast, Dr. Poland shares the latest COVID-19 news and answers listener questions.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1519</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Headache Edition: Unusual Headaches</title>
        <itunes:title>Headache Edition: Unusual Headaches</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/headache-edition-unusual-headaches/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/headache-edition-unusual-headaches/#comments</comments>        <pubDate>Thu, 14 Jul 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/daf4b77a-a368-3acd-bf50-89a08f66c0a8</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-headache-edition-online-cme-course'>Mayo Clinic Talks Podcast: Headache Edition - Online CME Course</a>.</p>
<p>Guest: Narayan R. Kissoon, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Headaches are quite common and essentially everyone has experienced them; some have more than others. While most headaches are merely an annoyance, others can be quite debilitating and result in missed work and lost productivity. While tension headaches are the most common overall, migraines are the type most often seen by healthcare providers. While tension and migraines represent the majority of headaches, it’s important for healthcare providers to recognize when a headache falls into the unusual category. This podcast will continue our series on headaches with our guest, Narayan R. Kissoon, M.D., a neurologist and headache specialist at the Mayo Clinic as we discuss unusual headaches.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-headache-edition-online-cme-course'>Mayo Clinic Talks Podcast: Headache Edition - Online CME Course</a>.</p>
<p>Guest: Narayan R. Kissoon, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Headaches are quite common and essentially everyone has experienced them; some have more than others. While most headaches are merely an annoyance, others can be quite debilitating and result in missed work and lost productivity. While tension headaches are the most common overall, migraines are the type most often seen by healthcare providers. While tension and migraines represent the majority of headaches, it’s important for healthcare providers to recognize when a headache falls into the unusual category. This podcast will continue our series on headaches with our guest, Narayan R. Kissoon, M.D., a neurologist and headache specialist at the Mayo Clinic as we discuss unusual headaches.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/g5i6rg/22R01505_07_A01.mp3" length="16698536" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit Mayo Clinic Talks Podcast: Headache Edition - Online CME Course.
Guest: Narayan R. Kissoon, M.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Headaches are quite common and essentially everyone has experienced them; some have more than others. While most headaches are merely an annoyance, others can be quite debilitating and result in missed work and lost productivity. While tension headaches are the most common overall, migraines are the type most often seen by healthcare providers. While tension and migraines represent the majority of headaches, it’s important for healthcare providers to recognize when a headache falls into the unusual category. This podcast will continue our series on headaches with our guest, Narayan R. Kissoon, M.D., a neurologist and headache specialist at the Mayo Clinic as we discuss unusual headaches.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1038</itunes:duration>
                <itunes:episode>349</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Selection Criteria for Kidney Transplantation</title>
        <itunes:title>Selection Criteria for Kidney Transplantation</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/selection-criteria-for-kidney-transplantation/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/selection-criteria-for-kidney-transplantation/#comments</comments>        <pubDate>Tue, 12 Jul 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/37e1cf94-147e-3906-9c18-c7e4ca81c78d</guid>
                                    <description><![CDATA[<p>Guest: Carrie A. Schinstock, M.D. (@caschinstock)</p>
<p>Host: Darryl S. Chutka (@ChutkaMD)</p>
<p>Kidney transplants were initially performed in the early 1950’s; however, most of these early transplants failed due to immune system rejection. Successful transplants were generally limited to those performed in identical twins. With the discovery of immunosuppressant therapy, organ rejection became less of an issue and successful kidney transplants have become more common. Currently, in the U.S. over 20,000 kidney transplants are performed annually. Who is a candidate for a kidney transplant? What is the current success rate and what is the optimal timing for a transplant in patients with end stage renal disease? We’ll discuss these questions in this podcast on kidney transplantation with our guest, Carrie A. Schinstock, M.D., a nephrologist from the Division of Nephrology and Hypertension at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Carrie A. Schinstock, M.D. (@caschinstock)</p>
<p>Host: Darryl S. Chutka (@ChutkaMD)</p>
<p>Kidney transplants were initially performed in the early 1950’s; however, most of these early transplants failed due to immune system rejection. Successful transplants were generally limited to those performed in identical twins. With the discovery of immunosuppressant therapy, organ rejection became less of an issue and successful kidney transplants have become more common. Currently, in the U.S. over 20,000 kidney transplants are performed annually. Who is a candidate for a kidney transplant? What is the current success rate and what is the optimal timing for a transplant in patients with end stage renal disease? We’ll discuss these questions in this podcast on kidney transplantation with our guest, Carrie A. Schinstock, M.D., a nephrologist from the Division of Nephrology and Hypertension at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/y68fg2/WF958152_Kidney_Transplant_Program_FINALaaljq.mp3" length="19042998" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Carrie A. Schinstock, M.D. (@caschinstock)
Host: Darryl S. Chutka (@ChutkaMD)
Kidney transplants were initially performed in the early 1950’s; however, most of these early transplants failed due to immune system rejection. Successful transplants were generally limited to those performed in identical twins. With the discovery of immunosuppressant therapy, organ rejection became less of an issue and successful kidney transplants have become more common. Currently, in the U.S. over 20,000 kidney transplants are performed annually. Who is a candidate for a kidney transplant? What is the current success rate and what is the optimal timing for a transplant in patients with end stage renal disease? We’ll discuss these questions in this podcast on kidney transplantation with our guest, Carrie A. Schinstock, M.D., a nephrologist from the Division of Nephrology and Hypertension at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1185</itunes:duration>
                <itunes:episode>348</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Headache Edition: Chronic Daily Headaches</title>
        <itunes:title>Headache Edition: Chronic Daily Headaches</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/headache-edition-chronic-daily-headaches/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/headache-edition-chronic-daily-headaches/#comments</comments>        <pubDate>Thu, 07 Jul 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/2f305d8d-60f1-37b8-b127-51e92d04db09</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-headache-edition-online-cme-course'>Mayo Clinic Talks Podcast: Headache Edition - Online CME Course</a>.</p>
<p>Guest: Rashmi B. Halker Singh, M.D. <a href='https://twitter.com/rashmihalker?s=20&t=Sn7KHYO4d29FNH95pQYv3Q'>(@rashmihalker</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Essentially everyone has an occasional headache and it is usually nothing more than a minor nuisance. However, there are individuals who have very frequent headaches, and they can have a significant influence on that person’s lifestyle and quality of life. The topic for this podcast is chronic daily headache, which represents a description of a variety of both primary and secondary headaches that occur frequently. Our guest is Rashmi Halker Singh, M.D., a neurologist, and specialist in headache medicine at the Mayo Clinic in Scottsdale, Arizona. We’ll discuss what types of headaches patients with chronic daily headache tend to have, how this syndrome develops, and how you should evaluate and manage these patients.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-headache-edition-online-cme-course'>Mayo Clinic Talks Podcast: Headache Edition - Online CME Course</a>.</p>
<p>Guest: Rashmi B. Halker Singh, M.D. <a href='https://twitter.com/rashmihalker?s=20&t=Sn7KHYO4d29FNH95pQYv3Q'>(@rashmihalker</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Essentially everyone has an occasional headache and it is usually nothing more than a minor nuisance. However, there are individuals who have very frequent headaches, and they can have a significant influence on that person’s lifestyle and quality of life. The topic for this podcast is chronic daily headache, which represents a description of a variety of both primary and secondary headaches that occur frequently. Our guest is Rashmi Halker Singh, M.D., a neurologist, and specialist in headache medicine at the Mayo Clinic in Scottsdale, Arizona. We’ll discuss what types of headaches patients with chronic daily headache tend to have, how this syndrome develops, and how you should evaluate and manage these patients.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dm3mg6/22R01505_09_A01.mp3" length="41525812" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit Mayo Clinic Talks Podcast: Headache Edition - Online CME Course.
Guest: Rashmi B. Halker Singh, M.D. (@rashmihalker)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Essentially everyone has an occasional headache and it is usually nothing more than a minor nuisance. However, there are individuals who have very frequent headaches, and they can have a significant influence on that person’s lifestyle and quality of life. The topic for this podcast is chronic daily headache, which represents a description of a variety of both primary and secondary headaches that occur frequently. Our guest is Rashmi Halker Singh, M.D., a neurologist, and specialist in headache medicine at the Mayo Clinic in Scottsdale, Arizona. We’ll discuss what types of headaches patients with chronic daily headache tend to have, how this syndrome develops, and how you should evaluate and manage these patients.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1730</itunes:duration>
                <itunes:episode>347</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Cervical Cancer Screening</title>
        <itunes:title>Cervical Cancer Screening</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/cervical-cancer-screening/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/cervical-cancer-screening/#comments</comments>        <pubDate>Tue, 05 Jul 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/39c6d751-b193-3b1a-9af0-0e24ecd64d29</guid>
                                    <description><![CDATA[<p>Host: Darryl S. Chutka, M.D. (@ChutkaMD)</p>
<p>Guest: Kathy L. MacLaughlin, M.D.</p>
<p>Worldwide, cervical cancer is a very common malignancy for women, although the number of new cases in the U.S. has been declining. The overwhelming majority of cases are caused by infection with the human papilloma virus and due to a combination of HPV immunization and early detection with cervical cancer screening, advanced cervical cancer should be preventable. If it does occur, cervical cancer is one of the more treatable malignancies when detected early. If you perform cervical cancer screening for your patients, you know the guidelines have become a bit more complicated than in the past. To help us sort out who is a candidate for cervical cancer screening, when screening should start, how often it should be performed and when it can stop, we have as our guest for this podcast, Kathy L. MacLaughlin, M.D., a family physician in the Department of Family Medicine at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Darryl S. Chutka, M.D. (@ChutkaMD)</p>
<p>Guest: Kathy L. MacLaughlin, M.D.</p>
<p>Worldwide, cervical cancer is a very common malignancy for women, although the number of new cases in the U.S. has been declining. The overwhelming majority of cases are caused by infection with the human papilloma virus and due to a combination of HPV immunization and early detection with cervical cancer screening, advanced cervical cancer should be preventable. If it does occur, cervical cancer is one of the more treatable malignancies when detected early. If you perform cervical cancer screening for your patients, you know the guidelines have become a bit more complicated than in the past. To help us sort out who is a candidate for cervical cancer screening, when screening should start, how often it should be performed and when it can stop, we have as our guest for this podcast, Kathy L. MacLaughlin, M.D., a family physician in the Department of Family Medicine at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cpkb3x/WF712258_Cervical_Cancer_FINALaxs7g.mp3" length="18335235" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Guest: Kathy L. MacLaughlin, M.D.
Worldwide, cervical cancer is a very common malignancy for women, although the number of new cases in the U.S. has been declining. The overwhelming majority of cases are caused by infection with the human papilloma virus and due to a combination of HPV immunization and early detection with cervical cancer screening, advanced cervical cancer should be preventable. If it does occur, cervical cancer is one of the more treatable malignancies when detected early. If you perform cervical cancer screening for your patients, you know the guidelines have become a bit more complicated than in the past. To help us sort out who is a candidate for cervical cancer screening, when screening should start, how often it should be performed and when it can stop, we have as our guest for this podcast, Kathy L. MacLaughlin, M.D., a family physician in the Department of Family Medicine at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1143</itunes:duration>
                <itunes:episode>346</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Headache Edition: Migraine Advocacy &amp; Special Considerations in Women</title>
        <itunes:title>Headache Edition: Migraine Advocacy &amp; Special Considerations in Women</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/headache-edition-migraine-in-women/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/headache-edition-migraine-in-women/#comments</comments>        <pubDate>Thu, 30 Jun 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/a3eff652-6760-371a-b7ba-ef8c03a816ca</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-headache-edition-online-cme-course'>Mayo Clinic Talks Podcast: Headache Edition - Online CME Course</a>.</p>
<p>Guest: Amaal J. Starling, M.D. (<a href='https://twitter.com/AmaalStarlingMD'>@AmaalStarlingMD</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Migraine is four-times more common in women than men and because of migraine predominance in females, it is a significant women’s health issue. Migraine commonly results in loss of productivity and this has a significant economic burden. According to a recent report from the Society for Women’s Health Research, it’s estimated that migraine costs the United States is an estimated $78 billion per year, with women accounting for approximately 80% of the direct medical and lost labor costs.  This podcast will continue our series on headaches and will concentrate on migraine in women. Our guest for this topic is Amaal J. Starling, M.D., a neurologist at the Mayo Clinic in Scottsdale, Arizona. We’ll discuss why migraine is more common in females, how the prevalence changes throughout a woman’s lifetime and specific treatment recommendations for women with migraine.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-headache-edition-online-cme-course'>Mayo Clinic Talks Podcast: Headache Edition - Online CME Course</a>.</p>
<p>Guest: Amaal J. Starling, M.D. (<a href='https://twitter.com/AmaalStarlingMD'>@AmaalStarlingMD</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Migraine is four-times more common in women than men and because of migraine predominance in females, it is a significant women’s health issue. Migraine commonly results in loss of productivity and this has a significant economic burden. According to a recent report from the Society for Women’s Health Research, it’s estimated that migraine costs the United States is an estimated $78 billion per year, with women accounting for approximately 80% of the direct medical and lost labor costs.  This podcast will continue our series on headaches and will concentrate on migraine in women. Our guest for this topic is Amaal J. Starling, M.D., a neurologist at the Mayo Clinic in Scottsdale, Arizona. We’ll discuss why migraine is more common in females, how the prevalence changes throughout a woman’s lifetime and specific treatment recommendations for women with migraine.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dtjgej/22R01505_02_A01.mp3" length="24710218" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit Mayo Clinic Talks Podcast: Headache Edition - Online CME Course.
Guest: Amaal J. Starling, M.D. (@AmaalStarlingMD)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Migraine is four-times more common in women than men and because of migraine predominance in females, it is a significant women’s health issue. Migraine commonly results in loss of productivity and this has a significant economic burden. According to a recent report from the Society for Women’s Health Research, it’s estimated that migraine costs the United States is an estimated $78 billion per year, with women accounting for approximately 80% of the direct medical and lost labor costs.  This podcast will continue our series on headaches and will concentrate on migraine in women. Our guest for this topic is Amaal J. Starling, M.D., a neurologist at the Mayo Clinic in Scottsdale, Arizona. We’ll discuss why migraine is more common in females, how the prevalence changes throughout a woman’s lifetime and specific treatment recommendations for women with migraine.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1541</itunes:duration>
                <itunes:episode>345</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Cannabidiol (CBD): Discussing Benefits and Risks with Patients</title>
        <itunes:title>Cannabidiol (CBD): Discussing Benefits and Risks with Patients</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/cannabidiol-cbd-discussing-benefits-and-risks-with-patients/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/cannabidiol-cbd-discussing-benefits-and-risks-with-patients/#comments</comments>        <pubDate>Tue, 28 Jun 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/2e9d12bb-9fd7-3c4d-b226-fbaeb21babcf</guid>
                                    <description><![CDATA[<p>Guest: Thomas P. Pittelkow, D.O., M.P.H.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Cannabidiol (CBD) is a popular natural remedy used for a variety of common ailments and is one of more than 100 chemical compounds called cannabinoids derived from the cannabis plant. Tetrahydrocannabinol (THC) is the main psychoactive cannabinoid found in cannabis. However, unlike THC, CBD does not have psychoactive properties. There are claims this compound treats not only pain, but a variety of mental health issues, symptoms of malignancy and may even have some cardiovascular benefits. Are all these claims true? What’s been proven? What do we know about the safety of this product? We’ll get the answers to these questions as we discuss Cannabidiol (CBD) with Thomas P. Pittelkow, D.O., M.P.H., an anesthesiologist and pain medicine specialist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Thomas P. Pittelkow, D.O., M.P.H.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Cannabidiol (CBD) is a popular natural remedy used for a variety of common ailments and is one of more than 100 chemical compounds called cannabinoids derived from the cannabis plant. Tetrahydrocannabinol (THC) is the main psychoactive cannabinoid found in cannabis. However, unlike THC, CBD does not have psychoactive properties. There are claims this compound treats not only pain, but a variety of mental health issues, symptoms of malignancy and may even have some cardiovascular benefits. Are all these claims true? What’s been proven? What do we know about the safety of this product? We’ll get the answers to these questions as we discuss Cannabidiol (CBD) with Thomas P. Pittelkow, D.O., M.P.H., an anesthesiologist and pain medicine specialist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/p2urvh/WF749054_CBD_Oil_FINAL7zhbz.mp3" length="28409624" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Thomas P. Pittelkow, D.O., M.P.H.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Cannabidiol (CBD) is a popular natural remedy used for a variety of common ailments and is one of more than 100 chemical compounds called cannabinoids derived from the cannabis plant. Tetrahydrocannabinol (THC) is the main psychoactive cannabinoid found in cannabis. However, unlike THC, CBD does not have psychoactive properties. There are claims this compound treats not only pain, but a variety of mental health issues, symptoms of malignancy and may even have some cardiovascular benefits. Are all these claims true? What’s been proven? What do we know about the safety of this product? We’ll get the answers to these questions as we discuss Cannabidiol (CBD) with Thomas P. Pittelkow, D.O., M.P.H., an anesthesiologist and pain medicine specialist at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1769</itunes:duration>
                <itunes:episode>344</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Headache Edition: Interdisciplinary Pain Rehabilitation Treatment for Chronic Headache</title>
        <itunes:title>Headache Edition: Interdisciplinary Pain Rehabilitation Treatment for Chronic Headache</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/headache-edition-interdisciplinary-pain-rehabilitation-treatment-for-chronic-headache/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/headache-edition-interdisciplinary-pain-rehabilitation-treatment-for-chronic-headache/#comments</comments>        <pubDate>Thu, 23 Jun 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/90f9aba2-8a7d-3fb0-9b47-196a45e9c591</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-headache-edition-online-cme-course'>Mayo Clinic Talks Podcast: Headache Edition - Online CME Course</a>.</p>
<p>Guest: Christopher D. Sletten, Ph.D., L.P.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Chronic headache is one of the more challenging medical conditions primary care providers commonly face. Whereas the traditional medical model views pain as a problem to be treated and relieved, this model often fails when dealing with patients experiencing chronic headaches. On the other hand, the bio-psychosocial model fits patients with chronic headache much better and when this model is used in the management, patients often have a much better outcome. This podcast is another in our series of headaches and will address the use of a cognitive-behavioral approach with an interdisciplinary team in the evaluation and management of patients with chronic headaches. Our guest Christopher D. Sletten, Ph.D., L.P., a psychologist at the Mayo Clinic in Jacksonville, Florida.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-headache-edition-online-cme-course'>Mayo Clinic Talks Podcast: Headache Edition - Online CME Course</a>.</p>
<p>Guest: Christopher D. Sletten, Ph.D., L.P.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Chronic headache is one of the more challenging medical conditions primary care providers commonly face. Whereas the traditional medical model views pain as a problem to be treated and relieved, this model often fails when dealing with patients experiencing chronic headaches. On the other hand, the bio-psychosocial model fits patients with chronic headache much better and when this model is used in the management, patients often have a much better outcome. This podcast is another in our series of headaches and will address the use of a cognitive-behavioral approach with an interdisciplinary team in the evaluation and management of patients with chronic headaches. Our guest Christopher D. Sletten, Ph.D., L.P., a psychologist at the Mayo Clinic in Jacksonville, Florida.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2c665d/22R01505_04_A01.mp3" length="24912132" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit Mayo Clinic Talks Podcast: Headache Edition - Online CME Course.
Guest: Christopher D. Sletten, Ph.D., L.P.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Chronic headache is one of the more challenging medical conditions primary care providers commonly face. Whereas the traditional medical model views pain as a problem to be treated and relieved, this model often fails when dealing with patients experiencing chronic headaches. On the other hand, the bio-psychosocial model fits patients with chronic headache much better and when this model is used in the management, patients often have a much better outcome. This podcast is another in our series of headaches and will address the use of a cognitive-behavioral approach with an interdisciplinary team in the evaluation and management of patients with chronic headaches. Our guest Christopher D. Sletten, Ph.D., L.P., a psychologist at the Mayo Clinic in Jacksonville, Florida.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1552</itunes:duration>
                <itunes:episode>343</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>COVID-19 Update</title>
        <itunes:title>COVID-19 Update</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/covid-19-update/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/covid-19-update/#comments</comments>        <pubDate>Wed, 22 Jun 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/07a8001a-622d-3e10-9daf-cb7ff6823ad0</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in June 2022</p>
<p>Guest: Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>As immunity wanes for many vaccinated adults and omicron and its subvariants continue to circulate, it seems that just about everyone knows someone with a case of COVID-19.</p>
<p>The steady increase in COVID-19 infections is due to changing, highly contagious variants, <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.136537328.1903245515.1583502589-382127956.1576426874'>explains Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>. Dr. Poland says it’s still important to take the precaution of mask-wearing in public areas, even if you have been vaccinated and have received your boosters.</p>
<p>"I can’t say it enough. This is so hypercontagious that, regardless of having had three or four doses of vaccine or of having previous COVID-19, you still run an appreciable chance of getting COVID," explains Dr. Poland. "The risk in that case is not of death or hospitalization, but of the complications and long-haul symptoms of COVID-19. And that’s what we’re trying to prevent in people." </p>
<p>For parents, there is positive news this week, as the Food and Drug Administration (FDA) advisory panel voted unanimously to authorize emergency use of the Pfizer and Moderna COVID-19 vaccines for children under 5. For this age group, the Pfizer vaccine will be given in three doses while the Moderna vaccine will be given in two doses.</p>
<p>The FDA panel's recommendation now goes to the <a href='https://www.cdc.gov/vaccines/acip/index.html'>Advisory Committee on Immunization Practices (ACIP)</a> at the Centers for Disease Control and Prevention for approval before shots can be administered, possibly beginning as early as next week.</p>
<p>On the Mayo Clinic Q&A podcast, Dr. Poland shares the latest COVID-19 news, answers listener questions, and discusses another infectious disease outbreak: <a href='https://newsnetwork.mayoclinic.org/discussion/questions-and-answers-about-monkeypox/'>monkeypox</a>.</p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in June 2022</p>
<p>Guest: Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>As immunity wanes for many vaccinated adults and omicron and its subvariants continue to circulate, it seems that just about everyone knows someone with a case of COVID-19.</p>
<p>The steady increase in COVID-19 infections is due to changing, highly contagious variants, <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.136537328.1903245515.1583502589-382127956.1576426874'>explains Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>. Dr. Poland says it’s still important to take the precaution of mask-wearing in public areas, even if you have been vaccinated and have received your boosters.</p>
<p>"I can’t say it enough. This is so hypercontagious that, regardless of having had three or four doses of vaccine or of having previous COVID-19, you still run an appreciable chance of getting COVID," explains Dr. Poland. "The risk in that case is not of death or hospitalization, but of the complications and long-haul symptoms of COVID-19. And that’s what we’re trying to prevent in people." </p>
<p>For parents, there is positive news this week, as the Food and Drug Administration (FDA) advisory panel voted unanimously to authorize emergency use of the Pfizer and Moderna COVID-19 vaccines for children under 5. For this age group, the Pfizer vaccine will be given in three doses while the Moderna vaccine will be given in two doses.</p>
<p>The FDA panel's recommendation now goes to the <a href='https://www.cdc.gov/vaccines/acip/index.html'>Advisory Committee on Immunization Practices (ACIP)</a> at the Centers for Disease Control and Prevention for approval before shots can be administered, possibly beginning as early as next week.</p>
<p>On the Mayo Clinic Q&A podcast, Dr. Poland shares the latest COVID-19 news, answers listener questions, and discusses another infectious disease outbreak: <a href='https://newsnetwork.mayoclinic.org/discussion/questions-and-answers-about-monkeypox/'>monkeypox</a>.</p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cj6y8j/Mayo_Clinic_Q_A_-_Dr_Gregory_Poland_06_17_2299fei.mp3" length="32138896" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in June 2022
Guest: Gregory A. Poland, M.D. (@drgregpoland)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
As immunity wanes for many vaccinated adults and omicron and its subvariants continue to circulate, it seems that just about everyone knows someone with a case of COVID-19.
The steady increase in COVID-19 infections is due to changing, highly contagious variants, explains Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group. Dr. Poland says it’s still important to take the precaution of mask-wearing in public areas, even if you have been vaccinated and have received your boosters.
"I can’t say it enough. This is so hypercontagious that, regardless of having had three or four doses of vaccine or of having previous COVID-19, you still run an appreciable chance of getting COVID," explains Dr. Poland. "The risk in that case is not of death or hospitalization, but of the complications and long-haul symptoms of COVID-19. And that’s what we’re trying to prevent in people." 
For parents, there is positive news this week, as the Food and Drug Administration (FDA) advisory panel voted unanimously to authorize emergency use of the Pfizer and Moderna COVID-19 vaccines for children under 5. For this age group, the Pfizer vaccine will be given in three doses while the Moderna vaccine will be given in two doses.
The FDA panel's recommendation now goes to the Advisory Committee on Immunization Practices (ACIP) at the Centers for Disease Control and Prevention for approval before shots can be administered, possibly beginning as early as next week.
On the Mayo Clinic Q&A podcast, Dr. Poland shares the latest COVID-19 news, answers listener questions, and discusses another infectious disease outbreak: monkeypox.
 ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1336</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Assessing and Supporting Patients with Alcohol Use Disorder</title>
        <itunes:title>Assessing and Supporting Patients with Alcohol Use Disorder</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/assessing-and-supporting-patients-with-alcohol-use-disorder/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/assessing-and-supporting-patients-with-alcohol-use-disorder/#comments</comments>        <pubDate>Tue, 21 Jun 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/c59072db-b925-3cf4-906e-4a26567885b6</guid>
                                    <description><![CDATA[<p>Guest: Terry D. Schneekloth, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Unhealthy use of alcohol has the potential to affect not only the individual who consumes the alcohol, but a variety of others as well. Alcohol is the most used addictive substance, with an estimated prevalence of 7% of the United States population. Excessive alcohol use has the potential to cause damage to essentially every organ system and is thought to reduce one’s life expectance by approximately 10 years. Whereas treatment is available and has the potential to be very successful, it often requires an ongoing, lifetime of therapy. Our guest for this podcast is Terry D. Schneekloth, M.D., a psychiatrist and addiction medicine specialist at the Mayo Clinic in Scottsdale, Arizona. This podcast discusses when you should suspect alcoholism in your patients, how to make a diagnosis and which management techniques have been shown to be effective.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Terry D. Schneekloth, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Unhealthy use of alcohol has the potential to affect not only the individual who consumes the alcohol, but a variety of others as well. Alcohol is the most used addictive substance, with an estimated prevalence of 7% of the United States population. Excessive alcohol use has the potential to cause damage to essentially every organ system and is thought to reduce one’s life expectance by approximately 10 years. Whereas treatment is available and has the potential to be very successful, it often requires an ongoing, lifetime of therapy. Our guest for this podcast is Terry D. Schneekloth, M.D., a psychiatrist and addiction medicine specialist at the Mayo Clinic in Scottsdale, Arizona. This podcast discusses when you should suspect alcoholism in your patients, how to make a diagnosis and which management techniques have been shown to be effective.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5gxutz/WF778352_Alcoholism_FINALalexw.mp3" length="42816791" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Terry D. Schneekloth, M.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Unhealthy use of alcohol has the potential to affect not only the individual who consumes the alcohol, but a variety of others as well. Alcohol is the most used addictive substance, with an estimated prevalence of 7% of the United States population. Excessive alcohol use has the potential to cause damage to essentially every organ system and is thought to reduce one’s life expectance by approximately 10 years. Whereas treatment is available and has the potential to be very successful, it often requires an ongoing, lifetime of therapy. Our guest for this podcast is Terry D. Schneekloth, M.D., a psychiatrist and addiction medicine specialist at the Mayo Clinic in Scottsdale, Arizona. This podcast discusses when you should suspect alcoholism in your patients, how to make a diagnosis and which management techniques have been shown to be effective.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1783</itunes:duration>
                <itunes:episode>342</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Headache Edition: Migraine Treatment</title>
        <itunes:title>Headache Edition: Migraine Treatment</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/headache-edition-migraine-treatment/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/headache-edition-migraine-treatment/#comments</comments>        <pubDate>Thu, 16 Jun 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/568caa9c-572c-31a5-abdc-b310852e6f07</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-headache-edition-online-cme-course'>Mayo Clinic Talks Podcast: Headache Edition - Online CME Course</a>.</p>
<p>Guest: Fred (Michael) M. Cutrer, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>It is estimated that nearly 40 million individuals in the United States have migraines and they’re responsible for a significant amount of lost productivity and healthcare costs. The estimates of the economic impact of migraines in the United States alone approaches $36 billion per year. Many of our patients struggle with adequate management of their migraines; healthcare providers are often confused about the many treatment options now available. This podcast will review and clarify the various treatments for migraines, both for abortive therapy as well as prevention. Our guest is Fred (Michael) M. Cutrer, M.D., a neurologist and headache specialist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-headache-edition-online-cme-course'>Mayo Clinic Talks Podcast: Headache Edition - Online CME Course</a>.</p>
<p>Guest: Fred (Michael) M. Cutrer, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>It is estimated that nearly 40 million individuals in the United States have migraines and they’re responsible for a significant amount of lost productivity and healthcare costs. The estimates of the economic impact of migraines in the United States alone approaches $36 billion per year. Many of our patients struggle with adequate management of their migraines; healthcare providers are often confused about the many treatment options now available. This podcast will review and clarify the various treatments for migraines, both for abortive therapy as well as prevention. Our guest is Fred (Michael) M. Cutrer, M.D., a neurologist and headache specialist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tr32uj/22R01505_01_A01.mp3" length="27171277" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit Mayo Clinic Talks Podcast: Headache Edition - Online CME Course.
Guest: Fred (Michael) M. Cutrer, M.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
It is estimated that nearly 40 million individuals in the United States have migraines and they’re responsible for a significant amount of lost productivity and healthcare costs. The estimates of the economic impact of migraines in the United States alone approaches $36 billion per year. Many of our patients struggle with adequate management of their migraines; healthcare providers are often confused about the many treatment options now available. This podcast will review and clarify the various treatments for migraines, both for abortive therapy as well as prevention. Our guest is Fred (Michael) M. Cutrer, M.D., a neurologist and headache specialist at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1689</itunes:duration>
                <itunes:episode>341</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Managing Patients with Lynch Syndrome</title>
        <itunes:title>Managing Patients with Lynch Syndrome</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/managing-patients-with-lynch-syndrome/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/managing-patients-with-lynch-syndrome/#comments</comments>        <pubDate>Tue, 14 Jun 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/1b9063ee-5fde-30d8-8236-709ffed90d99</guid>
                                    <description><![CDATA[<p>Guest: Eric J. Dozois, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>In the mid-1960’s Dr. Henry Lynch first described a condition characterized as the “cancer family syndrome” in which members of families demonstrated an increased risk of a variety of malignancies. This eventually became known as “Lynch Syndrome”. Lynch Syndrome is a genetic disorder and can be the underlying cause of premature colon cancer as well as other malignancies. There are some clues to its presence and specific recommendations for managing patients with the condition. The topic for this podcast is Lynch Syndrome and we’ll learn more about the disorder from our guest, Eric J. Dozois, M.D., a colorectal surgeon at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Eric J. Dozois, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>In the mid-1960’s Dr. Henry Lynch first described a condition characterized as the “cancer family syndrome” in which members of families demonstrated an increased risk of a variety of malignancies. This eventually became known as “Lynch Syndrome”. Lynch Syndrome is a genetic disorder and can be the underlying cause of premature colon cancer as well as other malignancies. There are some clues to its presence and specific recommendations for managing patients with the condition. The topic for this podcast is Lynch Syndrome and we’ll learn more about the disorder from our guest, Eric J. Dozois, M.D., a colorectal surgeon at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fyxmfs/WF752700_Lynch_Syndrome_FINAL8ijim.mp3" length="18823075" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Eric J. Dozois, M.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
In the mid-1960’s Dr. Henry Lynch first described a condition characterized as the “cancer family syndrome” in which members of families demonstrated an increased risk of a variety of malignancies. This eventually became known as “Lynch Syndrome”. Lynch Syndrome is a genetic disorder and can be the underlying cause of premature colon cancer as well as other malignancies. There are some clues to its presence and specific recommendations for managing patients with the condition. The topic for this podcast is Lynch Syndrome and we’ll learn more about the disorder from our guest, Eric J. Dozois, M.D., a colorectal surgeon at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1172</itunes:duration>
                <itunes:episode>340</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Headache Edition: Migraine</title>
        <itunes:title>Headache Edition: Migraine</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/headache-edition-migraine/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/headache-edition-migraine/#comments</comments>        <pubDate>Thu, 09 Jun 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/9d929f09-4b4f-3b97-8577-b260798ff892</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-headache-edition-online-cme-course'>Mayo Clinic Talks Podcast: Headache Edition - Online CME Course</a>.</p>
<p>Guest: Carrie (Beth) E. Robertson, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Migraine represents a major public health problem and is relatively common affecting an estimated 36 million individuals per year. It is much more likely to affect females and typically accounts for up to four million visits to the Emergency Department and over four million outpatient office visits per year. Migraines are most common in women of childbearing age and are associated with a significant loss of productivity, resulting in a major economic impact. In this podcast, we’ll continue our series on headache and will focus on migraine. We’ll review the diagnosis, what’s happening in the brain during a migraine attack and the benefits of lifestyle changes in the management of migraine. Our guest for this episode is Carrie (Beth) E. Robertson, M.D., a neurologist at the Mayo Clinic in Rochester, Minnesota.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-headache-edition-online-cme-course'>Mayo Clinic Talks Podcast: Headache Edition - Online CME Course</a>.</p>
<p>Guest: Carrie (Beth) E. Robertson, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Migraine represents a major public health problem and is relatively common affecting an estimated 36 million individuals per year. It is much more likely to affect females and typically accounts for up to four million visits to the Emergency Department and over four million outpatient office visits per year. Migraines are most common in women of childbearing age and are associated with a significant loss of productivity, resulting in a major economic impact. In this podcast, we’ll continue our series on headache and will focus on migraine. We’ll review the diagnosis, what’s happening in the brain during a migraine attack and the benefits of lifestyle changes in the management of migraine. Our guest for this episode is Carrie (Beth) E. Robertson, M.D., a neurologist at the Mayo Clinic in Rochester, Minnesota.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wxfwff/22R01505_06_A01.mp3" length="20543458" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit Mayo Clinic Talks Podcast: Headache Edition - Online CME Course.
Guest: Carrie (Beth) E. Robertson, M.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Migraine represents a major public health problem and is relatively common affecting an estimated 36 million individuals per year. It is much more likely to affect females and typically accounts for up to four million visits to the Emergency Department and over four million outpatient office visits per year. Migraines are most common in women of childbearing age and are associated with a significant loss of productivity, resulting in a major economic impact. In this podcast, we’ll continue our series on headache and will focus on migraine. We’ll review the diagnosis, what’s happening in the brain during a migraine attack and the benefits of lifestyle changes in the management of migraine. Our guest for this episode is Carrie (Beth) E. Robertson, M.D., a neurologist at the Mayo Clinic in Rochester, Minnesota.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1282</itunes:duration>
                <itunes:episode>339</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Headache Edition: Approach to the Evaluation of Headache</title>
        <itunes:title>Headache Edition: Approach to the Evaluation of Headache</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/headache-edition-approach-to-the-evaluation-of-headache/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/headache-edition-approach-to-the-evaluation-of-headache/#comments</comments>        <pubDate>Tue, 07 Jun 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/2fffe949-68fc-395d-aa4f-469f9b096bb9</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-headache-edition-online-cme-course'>Mayo Clinic Talks Podcast: Headache Edition - Online CME Course</a>.</p>
<p>Guest: Jerry W. Swanson, M.D., M.H.P.E.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Everyone has experienced a headache and for most of us, they are just a minor inconvenience. Unfortunately for some, headaches represent a major health problem. The pain can be intense and may result in major lifestyle changes including sudden change in plans, loss of productivity, and strained relationships. As primary care providers, patients with chronic, recurrent headaches can represent some of the most challenging patients we see. Fortunately, only rarely do headaches represent a serious threat to one’s life, but one still needs to be alert to potential clues indicating the possibility of the headaches representing a serious medical condition. There have also been numerous new treatments available for the management of migraines.</p>
<p>This will be the first in a series of podcasts dedicated to the topic of headache. We’re also going to honor one of the Mayo Clinic’s most prestigious physicians in the field of headache. Jerry W. Swanson, M.D., M.H.P.E. has been a neurologist at Mayo for 39 years and has been a specialist in the evaluation and management of patients with headaches. He brings experience and a wealth of knowledge to this topic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-headache-edition-online-cme-course'>Mayo Clinic Talks Podcast: Headache Edition - Online CME Course</a>.</p>
<p>Guest: Jerry W. Swanson, M.D., M.H.P.E.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Everyone has experienced a headache and for most of us, they are just a minor inconvenience. Unfortunately for some, headaches represent a major health problem. The pain can be intense and may result in major lifestyle changes including sudden change in plans, loss of productivity, and strained relationships. As primary care providers, patients with chronic, recurrent headaches can represent some of the most challenging patients we see. Fortunately, only rarely do headaches represent a serious threat to one’s life, but one still needs to be alert to potential clues indicating the possibility of the headaches representing a serious medical condition. There have also been numerous new treatments available for the management of migraines.</p>
<p>This will be the first in a series of podcasts dedicated to the topic of headache. We’re also going to honor one of the Mayo Clinic’s most prestigious physicians in the field of headache. Jerry W. Swanson, M.D., M.H.P.E. has been a neurologist at Mayo for 39 years and has been a specialist in the evaluation and management of patients with headaches. He brings experience and a wealth of knowledge to this topic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fbqaz2/22R01505_05_A01.mp3" length="27692764" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit Mayo Clinic Talks Podcast: Headache Edition - Online CME Course.
Guest: Jerry W. Swanson, M.D., M.H.P.E.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Everyone has experienced a headache and for most of us, they are just a minor inconvenience. Unfortunately for some, headaches represent a major health problem. The pain can be intense and may result in major lifestyle changes including sudden change in plans, loss of productivity, and strained relationships. As primary care providers, patients with chronic, recurrent headaches can represent some of the most challenging patients we see. Fortunately, only rarely do headaches represent a serious threat to one’s life, but one still needs to be alert to potential clues indicating the possibility of the headaches representing a serious medical condition. There have also been numerous new treatments available for the management of migraines.
This will be the first in a series of podcasts dedicated to the topic of headache. We’re also going to honor one of the Mayo Clinic’s most prestigious physicians in the field of headache. Jerry W. Swanson, M.D., M.H.P.E. has been a neurologist at Mayo for 39 years and has been a specialist in the evaluation and management of patients with headaches. He brings experience and a wealth of knowledge to this topic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1723</itunes:duration>
                <itunes:episode>338</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pediatric Topics: Evaluation of a Suspected Inborn Error of Metabolism</title>
        <itunes:title>Pediatric Topics: Evaluation of a Suspected Inborn Error of Metabolism</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/pediatric-topics-evaluation-of-a-suspected-inborn-error-of-metabolism/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/pediatric-topics-evaluation-of-a-suspected-inborn-error-of-metabolism/#comments</comments>        <pubDate>Thu, 02 Jun 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/d72f76bc-f159-3ceb-83a8-1ef762b15aaf</guid>
                                    <description><![CDATA[<p>Guest: Brendan C. Lanpher, M.D.</p>
<p>Host: David J. Sas, D.O. (<a href='https://twitter.com/davidsas1'>@davidsas1</a>)</p>
<p>Inborn errors of metabolism can present in a variety of ways depending on the specific type of disease.  The most critical presentation to identify occurs in the neonatal period when more severe diseases can cause acute decompensation.  These patients require appropriate evaluation and timely, expert management for good outcomes.  Diagnostic testing, including newborn screening, is advancing rapidly as are innovative treatment methods, making this an exciting field for clinicians. The guest for this episode is Brendan C. Lanpher, M.D., a board-certified geneticist at the Mayo Clinic Children’s Center in Rochester, Minnesota.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Brendan C. Lanpher, M.D.</p>
<p>Host: David J. Sas, D.O. (<a href='https://twitter.com/davidsas1'>@davidsas1</a>)</p>
<p>Inborn errors of metabolism can present in a variety of ways depending on the specific type of disease.  The most critical presentation to identify occurs in the neonatal period when more severe diseases can cause acute decompensation.  These patients require appropriate evaluation and timely, expert management for good outcomes.  Diagnostic testing, including newborn screening, is advancing rapidly as are innovative treatment methods, making this an exciting field for clinicians. The guest for this episode is Brendan C. Lanpher, M.D., a board-certified geneticist at the Mayo Clinic Children’s Center in Rochester, Minnesota.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hyqtb6/WF919496_Inborn_Error_of_Metabolism_FINAL7eqog.mp3" length="23292335" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Brendan C. Lanpher, M.D.
Host: David J. Sas, D.O. (@davidsas1)
Inborn errors of metabolism can present in a variety of ways depending on the specific type of disease.  The most critical presentation to identify occurs in the neonatal period when more severe diseases can cause acute decompensation.  These patients require appropriate evaluation and timely, expert management for good outcomes.  Diagnostic testing, including newborn screening, is advancing rapidly as are innovative treatment methods, making this an exciting field for clinicians. The guest for this episode is Brendan C. Lanpher, M.D., a board-certified geneticist at the Mayo Clinic Children’s Center in Rochester, Minnesota.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1449</itunes:duration>
                <itunes:episode>337</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Women and Depression</title>
        <itunes:title>Women and Depression</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/women-and-depression/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/women-and-depression/#comments</comments>        <pubDate>Tue, 31 May 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/6ff9a1ab-5674-35f9-a537-7f0cf47cec3f</guid>
                                    <description><![CDATA[<p>Host: Joshua D. Luciew, MPAS, P.A.-C.   </p>
<p>Guest: Neeta Jain, M.D.</p>
<p>Depression is a common condition that we see in our practices. It is a multifactorial disease that can affect patients of all ages. In this episode, we discuss women and depression, as women are twice as likely as men to receive this diagnosis. We will explore how this condition is diagnosed, depression subtypes, what effect hormones have on a woman’s mental health, and how we can help treat this condition for our patients through various parts of their life. The guest for today’s episode is Neeta Jain, M.D., Mayo Clinic Board Certified Psychiatrist at Mayo Clinic in Arizona.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Host: Joshua D. Luciew, MPAS, P.A.-C.   </p>
<p>Guest: Neeta Jain, M.D.</p>
<p>Depression is a common condition that we see in our practices. It is a multifactorial disease that can affect patients of all ages. In this episode, we discuss women and depression, as women are twice as likely as men to receive this diagnosis. We will explore how this condition is diagnosed, depression subtypes, what effect hormones have on a woman’s mental health, and how we can help treat this condition for our patients through various parts of their life. The guest for today’s episode is Neeta Jain, M.D., Mayo Clinic Board Certified Psychiatrist at Mayo Clinic in Arizona.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/r538sr/WF702650_Women_in_Depression_V2_FINAL8nc9c.mp3" length="39188203" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Host: Joshua D. Luciew, MPAS, P.A.-C.   
Guest: Neeta Jain, M.D.
Depression is a common condition that we see in our practices. It is a multifactorial disease that can affect patients of all ages. In this episode, we discuss women and depression, as women are twice as likely as men to receive this diagnosis. We will explore how this condition is diagnosed, depression subtypes, what effect hormones have on a woman’s mental health, and how we can help treat this condition for our patients through various parts of their life. The guest for today’s episode is Neeta Jain, M.D., Mayo Clinic Board Certified Psychiatrist at Mayo Clinic in Arizona.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1630</itunes:duration>
                <itunes:episode>336</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Pediatric Topics: Undescended Testicles – Evaluation and Management</title>
        <itunes:title>Pediatric Topics: Undescended Testicles – Evaluation and Management</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/pediatric-topics-undescended-testicles-evaluation-and-management/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/pediatric-topics-undescended-testicles-evaluation-and-management/#comments</comments>        <pubDate>Thu, 26 May 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/40c4f1d2-90e3-354d-8f62-d66ff815c8c9</guid>
                                    <description><![CDATA[<p>Guest: Candace F. Granberg, M.D. (<a href='https://twitter.com/candacegranberg'>@candacegranberg</a>)</p>
<p>Host: David J. Sas, D.O. (<a href='https://twitter.com/davidsas1'>@davidsas1</a>)</p>
<p>Detection and management of undescended testicles (cryptorchidism) is a common issue for newborn and infant boys.  This episode discusses proper diagnostic techniques for cryptorchidism, including how to distinguish between a retractile testicle and a truly undescended testicle, as well as when to refer infants to a pediatric urologist for further evaluation and management.  Further, we identify the indications for surgical correction and what parents and pediatricians should expect from this surgery. The guest for this episode is Candace F. Granberg, M.D., a board-certified pediatric urologist at the Mayo Clinic Children’s Center in Rochester, Minnesota.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Candace F. Granberg, M.D. (<a href='https://twitter.com/candacegranberg'>@candacegranberg</a>)</p>
<p>Host: David J. Sas, D.O. (<a href='https://twitter.com/davidsas1'>@davidsas1</a>)</p>
<p>Detection and management of undescended testicles (cryptorchidism) is a common issue for newborn and infant boys.  This episode discusses proper diagnostic techniques for cryptorchidism, including how to distinguish between a retractile testicle and a truly undescended testicle, as well as when to refer infants to a pediatric urologist for further evaluation and management.  Further, we identify the indications for surgical correction and what parents and pediatricians should expect from this surgery. The guest for this episode is Candace F. Granberg, M.D., a board-certified pediatric urologist at the Mayo Clinic Children’s Center in Rochester, Minnesota.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fnu2uh/WF791750_Undecended_Testicle_FINAL9i4x4.mp3" length="20307915" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Candace F. Granberg, M.D. (@candacegranberg)
Host: David J. Sas, D.O. (@davidsas1)
Detection and management of undescended testicles (cryptorchidism) is a common issue for newborn and infant boys.  This episode discusses proper diagnostic techniques for cryptorchidism, including how to distinguish between a retractile testicle and a truly undescended testicle, as well as when to refer infants to a pediatric urologist for further evaluation and management.  Further, we identify the indications for surgical correction and what parents and pediatricians should expect from this surgery. The guest for this episode is Candace F. Granberg, M.D., a board-certified pediatric urologist at the Mayo Clinic Children’s Center in Rochester, Minnesota.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1267</itunes:duration>
                <itunes:episode>335</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Adrenal Insufficiency: Investigation and Management</title>
        <itunes:title>Adrenal Insufficiency: Investigation and Management</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/adrenal-insufficiency-investigation-and-management/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/adrenal-insufficiency-investigation-and-management/#comments</comments>        <pubDate>Tue, 24 May 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/4dddce8e-1be8-3e77-ba3a-4cc7742d805e</guid>
                                    <description><![CDATA[<p>Guest: Irina Bancos, M.D. (<a href='https://twitter.com/IrinaBancos'>@IrinaBancos</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Fatigue, weakness, and loss of appetite are very vague and non-specific symptoms, and unfortunately relatively common complaints our patients describe to us. However, they may also be the presenting symptoms of adrenal insufficiency. If untreated, serious complications can develop, the most serious being an adrenal crisis. Adrenal insufficiency is relatively uncommon and unless we think about it, we’re likely to either make a delayed diagnosis or possibly miss the disorder altogether. The topic for this podcast is adrenal insufficiency. We’ll review its symptoms, the recommended evaluation and management with Irina Bancos, M.D., an endocrinologist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Irina Bancos, M.D. (<a href='https://twitter.com/IrinaBancos'>@IrinaBancos</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Fatigue, weakness, and loss of appetite are very vague and non-specific symptoms, and unfortunately relatively common complaints our patients describe to us. However, they may also be the presenting symptoms of adrenal insufficiency. If untreated, serious complications can develop, the most serious being an adrenal crisis. Adrenal insufficiency is relatively uncommon and unless we think about it, we’re likely to either make a delayed diagnosis or possibly miss the disorder altogether. The topic for this podcast is adrenal insufficiency. We’ll review its symptoms, the recommended evaluation and management with Irina Bancos, M.D., an endocrinologist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/j3mmqh/WF729255_Adrenal_Insufficiency_FINAL6hmws.mp3" length="25206603" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Irina Bancos, M.D. (@IrinaBancos)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Fatigue, weakness, and loss of appetite are very vague and non-specific symptoms, and unfortunately relatively common complaints our patients describe to us. However, they may also be the presenting symptoms of adrenal insufficiency. If untreated, serious complications can develop, the most serious being an adrenal crisis. Adrenal insufficiency is relatively uncommon and unless we think about it, we’re likely to either make a delayed diagnosis or possibly miss the disorder altogether. The topic for this podcast is adrenal insufficiency. We’ll review its symptoms, the recommended evaluation and management with Irina Bancos, M.D., an endocrinologist at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1571</itunes:duration>
                <itunes:episode>334</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: COVID-19 news update</title>
        <itunes:title>Mayo Clinic Q&amp;A: COVID-19 news update</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-covid-19-news-update-1652978557/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-covid-19-news-update-1652978557/#comments</comments>        <pubDate>Thu, 19 May 2022 11:42:37 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/fa28c7c3-9433-305e-84ae-9a889f59f345</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in May 2022</p>
<p>Guest: Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>The widespread availability of at-home <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> tests have made it easier for people to know if they have the virus, and to take measures to protect themselves and others. But there is a downside. Because the majority of tests are now done at home and often not reported, the official counts on COVID-19 infection rates are not as accurate as they have been in past waves of the virus. </p>
<p>"Because the majority of testing is being done at home, we can no longer tell you accurately about the positivity rate for a given community for a given state like we used to be able to," explains <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview'>Mayo Clinic's Vaccine Research Group</a>. "And this is problematic. It means that we lose our ability to understand what's called genetic epidemiology — the ability to trace how these variants are moving, how fast they're moving, and whether they're changing and evolving into yet different subvariants or new variants. We've lost that ability now."</p>
<p>The most recent omicron subvariant, BA 2.12.1, has cases on the rise again and the U.S. passed a tragic milestone last week, reaching <a href='https://www.whitehouse.gov/briefing-room/presidential-actions/2022/05/12/a-proclamation-on-remembering-the-1000000-americans-lost-to-covid-19/'>1 million COVID-19 deaths</a> in the country.</p>
<p>In an effort to capture a more accurate picture, the latest tool being used by public health officials to track COVID-19 infection rates is <a href='https://newsnetwork.mayoclinic.org/discussion/testing-wastewater-for-covid-19-the-clearest-path-to-understanding-community-infection/'>wastewater surveillance</a>. By looking for the presence of the COVID-19 virus shed by people, wastewater surveillance can give a more accurate picture of how much virus is in the community. This detects virus not only from those who test at home, but also from people who are asymptomatic and, therefore, didn't get tested.</p>
<p>On the Mayo Clinic Q&A podcast, Dr. Poland discusses the current state of COVID-19 in the U.S., including what we know about the latest subvariants.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in May 2022</p>
<p>Guest: Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>The widespread availability of at-home <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> tests have made it easier for people to know if they have the virus, and to take measures to protect themselves and others. But there is a downside. Because the majority of tests are now done at home and often not reported, the official counts on COVID-19 infection rates are not as accurate as they have been in past waves of the virus. </p>
<p>"Because the majority of testing is being done at home, we can no longer tell you accurately about the positivity rate for a given community for a given state like we used to be able to," explains <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview'>Mayo Clinic's Vaccine Research Group</a>. "And this is problematic. It means that we lose our ability to understand what's called genetic epidemiology — the ability to trace how these variants are moving, how fast they're moving, and whether they're changing and evolving into yet different subvariants or new variants. We've lost that ability now."</p>
<p>The most recent omicron subvariant, BA 2.12.1, has cases on the rise again and the U.S. passed a tragic milestone last week, reaching <a href='https://www.whitehouse.gov/briefing-room/presidential-actions/2022/05/12/a-proclamation-on-remembering-the-1000000-americans-lost-to-covid-19/'>1 million COVID-19 deaths</a> in the country.</p>
<p>In an effort to capture a more accurate picture, the latest tool being used by public health officials to track COVID-19 infection rates is <a href='https://newsnetwork.mayoclinic.org/discussion/testing-wastewater-for-covid-19-the-clearest-path-to-understanding-community-infection/'>wastewater surveillance</a>. By looking for the presence of the COVID-19 virus shed by people, wastewater surveillance can give a more accurate picture of how much virus is in the community. This detects virus not only from those who test at home, but also from people who are asymptomatic and, therefore, didn't get tested.</p>
<p>On the Mayo Clinic Q&A podcast, Dr. Poland discusses the current state of COVID-19 in the U.S., including what we know about the latest subvariants.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tfh3qb/Mayo_Clinic_Q_A_-_Dr_Gregory_Poland_-_05_17_226lqft.mp3" length="30627643" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in May 2022
Guest: Gregory A. Poland, M.D. (@drgregpoland)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
The widespread availability of at-home COVID-19 tests have made it easier for people to know if they have the virus, and to take measures to protect themselves and others. But there is a downside. Because the majority of tests are now done at home and often not reported, the official counts on COVID-19 infection rates are not as accurate as they have been in past waves of the virus. 
"Because the majority of testing is being done at home, we can no longer tell you accurately about the positivity rate for a given community for a given state like we used to be able to," explains Dr. Gregory Poland, head of Mayo Clinic's Vaccine Research Group. "And this is problematic. It means that we lose our ability to understand what's called genetic epidemiology — the ability to trace how these variants are moving, how fast they're moving, and whether they're changing and evolving into yet different subvariants or new variants. We've lost that ability now."
The most recent omicron subvariant, BA 2.12.1, has cases on the rise again and the U.S. passed a tragic milestone last week, reaching 1 million COVID-19 deaths in the country.
In an effort to capture a more accurate picture, the latest tool being used by public health officials to track COVID-19 infection rates is wastewater surveillance. By looking for the presence of the COVID-19 virus shed by people, wastewater surveillance can give a more accurate picture of how much virus is in the community. This detects virus not only from those who test at home, but also from people who are asymptomatic and, therefore, didn't get tested.
On the Mayo Clinic Q&A podcast, Dr. Poland discusses the current state of COVID-19 in the U.S., including what we know about the latest subvariants.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1272</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Evaluating Adrenal Incidentalomas</title>
        <itunes:title>Evaluating Adrenal Incidentalomas</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/evaluating-adrenal-incidentalomas/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/evaluating-adrenal-incidentalomas/#comments</comments>        <pubDate>Tue, 17 May 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/e64e25a2-98d1-3969-ab74-59775635790b</guid>
                                    <description><![CDATA[<p>Guest: Irina Bancos, M.D. (<a href='https://twitter.com/IrinaBancos'>@IrinaBancos</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>The widespread use of CT and MRI scans has resulted in frequent serendipitous findings, including adrenal nodules. When these nodules are found, two questions need to be answered. Is the nodule malignant and is this nodule metabolically active? This podcast will address these incidentally found adrenal nodules, also known as adrenal incidentalomas. We’ll review when these nodules should be investigated, the likelihood they represent a malignancy and how to assess if they’re metabolically active. Our guest for this podcast is Irina Bancos, M.D., an endocrinologist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Irina Bancos, M.D. (<a href='https://twitter.com/IrinaBancos'>@IrinaBancos</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>The widespread use of CT and MRI scans has resulted in frequent serendipitous findings, including adrenal nodules. When these nodules are found, two questions need to be answered. Is the nodule malignant and is this nodule metabolically active? This podcast will address these incidentally found adrenal nodules, also known as adrenal incidentalomas. We’ll review when these nodules should be investigated, the likelihood they represent a malignancy and how to assess if they’re metabolically active. Our guest for this podcast is Irina Bancos, M.D., an endocrinologist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/66apdf/WF729254_Adrenal_Incidentalomas_FINALah57v.mp3" length="22829325" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Irina Bancos, M.D. (@IrinaBancos)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
The widespread use of CT and MRI scans has resulted in frequent serendipitous findings, including adrenal nodules. When these nodules are found, two questions need to be answered. Is the nodule malignant and is this nodule metabolically active? This podcast will address these incidentally found adrenal nodules, also known as adrenal incidentalomas. We’ll review when these nodules should be investigated, the likelihood they represent a malignancy and how to assess if they’re metabolically active. Our guest for this podcast is Irina Bancos, M.D., an endocrinologist at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1423</itunes:duration>
                <itunes:episode>333</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Eating Disorders Edition: Adult Eating Disorders</title>
        <itunes:title>Eating Disorders Edition: Adult Eating Disorders</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/eating-disorders-edition-adult-eating-disorders/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/eating-disorders-edition-adult-eating-disorders/#comments</comments>        <pubDate>Thu, 12 May 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/c944c85c-1782-3494-a7a1-667a565d292e</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/node/126199/'>Mayo Clinic Talks Podcast: Eating Disorders Edition</a></p>
<p>Guest(s):   Scott Crow, M.D.; Carol B. Peterson, Ph.D., L.P.</p>
<p>Host:  Jocelyn R. Lebow, Ph.D., L.P.</p>
<p>While eating disorders are often thought of as disorders of adolescence, they impact adult patients across their lifespan. While many of the characteristics of these disorders are similar for pediatric vs. adult patients, there are important differences in how a primary care provider should assess and treat these illnesses in adults. As with younger patients, most adults report presenting initially to their primary care provider with their eating concerns, and many never seek additional care. This episode focuses on best practices for primary care providers in assessing and treating adult patients with eating disorders. Our guests are Scott Crow, M.D., Adjunct Professor of Psychiatry at the University of Minnesota and Vice President of Psychiatry at Accanto Health, and Carol B. Peterson, Ph.D., L.P., Clinical Psychologist and Professor in the Department of Psychiatry and Behavioral Sciences at the University of Minnesota.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/node/126199/'>Mayo Clinic Talks Podcast: Eating Disorders Edition</a></p>
<p>Guest(s):   Scott Crow, M.D.; Carol B. Peterson, Ph.D., L.P.</p>
<p>Host:  Jocelyn R. Lebow, Ph.D., L.P.</p>
<p>While eating disorders are often thought of as disorders of adolescence, they impact adult patients across their lifespan. While many of the characteristics of these disorders are similar for pediatric vs. adult patients, there are important differences in how a primary care provider should assess and treat these illnesses in adults. As with younger patients, most adults report presenting initially to their primary care provider with their eating concerns, and many never seek additional care. This episode focuses on best practices for primary care providers in assessing and treating adult patients with eating disorders. Our guests are Scott Crow, M.D., Adjunct Professor of Psychiatry at the University of Minnesota and Vice President of Psychiatry at Accanto Health, and Carol B. Peterson, Ph.D., L.P., Clinical Psychologist and Professor in the Department of Psychiatry and Behavioral Sciences at the University of Minnesota.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/83wcy5/WF766652_Adult_Eating_Disorders_FINAL7dixk.mp3" length="21897027" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: Mayo Clinic Talks Podcast: Eating Disorders Edition
Guest(s):   Scott Crow, M.D.; Carol B. Peterson, Ph.D., L.P.
Host:  Jocelyn R. Lebow, Ph.D., L.P.
While eating disorders are often thought of as disorders of adolescence, they impact adult patients across their lifespan. While many of the characteristics of these disorders are similar for pediatric vs. adult patients, there are important differences in how a primary care provider should assess and treat these illnesses in adults. As with younger patients, most adults report presenting initially to their primary care provider with their eating concerns, and many never seek additional care. This episode focuses on best practices for primary care providers in assessing and treating adult patients with eating disorders. Our guests are Scott Crow, M.D., Adjunct Professor of Psychiatry at the University of Minnesota and Vice President of Psychiatry at Accanto Health, and Carol B. Peterson, Ph.D., L.P., Clinical Psychologist and Professor in the Department of Psychiatry and Behavioral Sciences at the University of Minnesota.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1362</itunes:duration>
                <itunes:episode>327</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Role of Monoclonal Antibodies in the Treatment of COVID-19</title>
        <itunes:title>The Role of Monoclonal Antibodies in the Treatment of COVID-19</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/the-role-of-monoclonal-antibodies-in-the-treatment-of-covid-19/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/the-role-of-monoclonal-antibodies-in-the-treatment-of-covid-19/#comments</comments>        <pubDate>Tue, 10 May 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/e6aed9fa-e110-3346-8366-751a3a289425</guid>
                                    <description><![CDATA[<p>Guest: Raymund R. Razonable, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Monoclonal antibodies are laboratory-synthesized and mimic our immune system in fighting harmful pathogens. In addition to convalescent plasma and anti-viral medication, monoclonal antibodies have played an important role in the treatment of infections due to COVID-19. The use of monoclonal antibodies has been shown to shorten the duration of symptoms as well as reduce the risk of hospitalization and mortality due to COVID-19. This podcast will focus on monoclonal antibodies and our guest is Raymund R. Razonable, M.D., from the Division of Infectious Disease at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
<p>Resource:</p>
<ul><li>O’Horo J, Challener DW, Anderson RJ, Arndt RF, Ausman SE, Hall ST, Heyliger A, Kennedy BD, Sweeten PW, Ganesh R, Razonable RR, Rates of Severe Outcomes After Bamlanivimab-Etesevimab and Casirivimab-Imdevimab Treatment of High-Risk Patients With Mild to Moderate Coronavirus Disease-2019, Mayo Clinic Proceedings (2022), doi: <a href='https://doi.org/10.1016/j.mayocp.2022.02.009'>https://doi.org/10.1016/j.mayocp.2022.02.009</a>.</li>
</ul>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Raymund R. Razonable, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Monoclonal antibodies are laboratory-synthesized and mimic our immune system in fighting harmful pathogens. In addition to convalescent plasma and anti-viral medication, monoclonal antibodies have played an important role in the treatment of infections due to COVID-19. The use of monoclonal antibodies has been shown to shorten the duration of symptoms as well as reduce the risk of hospitalization and mortality due to COVID-19. This podcast will focus on monoclonal antibodies and our guest is Raymund R. Razonable, M.D., from the Division of Infectious Disease at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
<p>Resource:</p>
<ul><li>O’Horo J, Challener DW, Anderson RJ, Arndt RF, Ausman SE, Hall ST, Heyliger A, Kennedy BD, Sweeten PW, Ganesh R, Razonable RR, Rates of Severe Outcomes After Bamlanivimab-Etesevimab and Casirivimab-Imdevimab Treatment of High-Risk Patients With Mild to Moderate Coronavirus Disease-2019, Mayo Clinic Proceedings (2022), doi: <a href='https://doi.org/10.1016/j.mayocp.2022.02.009'>https://doi.org/10.1016/j.mayocp.2022.02.009</a>.</li>
</ul>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jn4zg5/WF954300_Monoclonial_Antibodies_FINALapao2.mp3" length="30185803" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Raymund R. Razonable, M.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Monoclonal antibodies are laboratory-synthesized and mimic our immune system in fighting harmful pathogens. In addition to convalescent plasma and anti-viral medication, monoclonal antibodies have played an important role in the treatment of infections due to COVID-19. The use of monoclonal antibodies has been shown to shorten the duration of symptoms as well as reduce the risk of hospitalization and mortality due to COVID-19. This podcast will focus on monoclonal antibodies and our guest is Raymund R. Razonable, M.D., from the Division of Infectious Disease at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Resource:
O’Horo J, Challener DW, Anderson RJ, Arndt RF, Ausman SE, Hall ST, Heyliger A, Kennedy BD, Sweeten PW, Ganesh R, Razonable RR, Rates of Severe Outcomes After Bamlanivimab-Etesevimab and Casirivimab-Imdevimab Treatment of High-Risk Patients With Mild to Moderate Coronavirus Disease-2019, Mayo Clinic Proceedings (2022), doi: https://doi.org/10.1016/j.mayocp.2022.02.009.
]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1256</itunes:duration>
                <itunes:episode>332</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: COVID-19 news update</title>
        <itunes:title>Mayo Clinic Q&amp;A: COVID-19 news update</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-covid-19-news-update-1651771318/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-covid-19-news-update-1651771318/#comments</comments>        <pubDate>Fri, 06 May 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/3cd96a0b-0d13-3e87-a6be-bfe2379c8650</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in April 2022</p>
<p>Guest: Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>An estimated 3 out of 4 U.S. children and more than half of all adults have been infected with <a href='https://www.mayoclinic.org/diseases-conditions/coronavirus/symptoms-causes/syc-20479963?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a>, according to a <a href='https://www.cdc.gov/mmwr/volumes/71/wr/mm7117e3.htm?s_cid=mm7117e3_w'>report released on Tuesday, April 26</a> by the Centers for Disease Control and Prevention. But a Mayo Clinic expert says more information is needed to get the complete picture.</p>
<p>"This was a convenient sample. In other words, people who were having blood drawn for other reasons were tested,"explains <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview'>Mayo Clinic's Vaccine Research Group</a>. "That does not reflect the full population or differences by race or geographic location. And the detection of antibodies does not necessarily mean that you are protected from infection. So, there's a lot of nuance around understanding that headline."</p>
<p>The research study looked at more than 200,000 blood samples and found that signs of past infection rose dramatically during the omicron surge between December 2021 and February.</p>
<p>Other COVID-19 news this week includes a push to make treatments more available, the rising incidence of new omicron subvariants, and changes in mask recommendations. Dr. Poland cautions that COVID-19 is still present and encourages wearing a mask in crowded spaces, even when there isn't a requirement to do so.</p>
<p>"If only one of us is wearing a mask and the other one isn't and is infected, you still have pretty high protection — but not the same level of protection as if both of us wearing one," says Dr. Poland. "So, it's it is not futile to be the only one wearing a mask. In fact, I think it sends a message."</p>
<p>On the Mayo Clinic Q&A podcast, Dr. Poland discusses the latest COVID-19 news and answers listener questions.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in April 2022</p>
<p>Guest: Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>An estimated 3 out of 4 U.S. children and more than half of all adults have been infected with <a href='https://www.mayoclinic.org/diseases-conditions/coronavirus/symptoms-causes/syc-20479963?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a>, according to a <a href='https://www.cdc.gov/mmwr/volumes/71/wr/mm7117e3.htm?s_cid=mm7117e3_w'>report released on Tuesday, April 26</a> by the Centers for Disease Control and Prevention. But a Mayo Clinic expert says more information is needed to get the complete picture.</p>
<p>"This was a convenient sample. In other words, people who were having blood drawn for other reasons were tested,"explains <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview'>Mayo Clinic's Vaccine Research Group</a>. "That does not reflect the full population or differences by race or geographic location. And the detection of antibodies does not necessarily mean that you are protected from infection. So, there's a lot of nuance around understanding that headline."</p>
<p>The research study looked at more than 200,000 blood samples and found that signs of past infection rose dramatically during the omicron surge between December 2021 and February.</p>
<p>Other COVID-19 news this week includes a push to make treatments more available, the rising incidence of new omicron subvariants, and changes in mask recommendations. Dr. Poland cautions that COVID-19 is still present and encourages wearing a mask in crowded spaces, even when there isn't a requirement to do so.</p>
<p>"If only one of us is wearing a mask and the other one isn't and is infected, you still have pretty high protection — but not the same level of protection as if both of us wearing one," says Dr. Poland. "So, it's it is not futile to be the only one wearing a mask. In fact, I think it sends a message."</p>
<p>On the Mayo Clinic Q&A podcast, Dr. Poland discusses the latest COVID-19 news and answers listener questions.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/e2n9vr/Mayo_Clinic_Q_A_-_Dr_Gregory_Poland_-_4_29_226gwbh.mp3" length="40862542" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in April 2022
Guest: Gregory A. Poland, M.D. (@drgregpoland)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
An estimated 3 out of 4 U.S. children and more than half of all adults have been infected with COVID-19, according to a report released on Tuesday, April 26 by the Centers for Disease Control and Prevention. But a Mayo Clinic expert says more information is needed to get the complete picture.
"This was a convenient sample. In other words, people who were having blood drawn for other reasons were tested,"explains Dr. Gregory Poland, head of Mayo Clinic's Vaccine Research Group. "That does not reflect the full population or differences by race or geographic location. And the detection of antibodies does not necessarily mean that you are protected from infection. So, there's a lot of nuance around understanding that headline."
The research study looked at more than 200,000 blood samples and found that signs of past infection rose dramatically during the omicron surge between December 2021 and February.
Other COVID-19 news this week includes a push to make treatments more available, the rising incidence of new omicron subvariants, and changes in mask recommendations. Dr. Poland cautions that COVID-19 is still present and encourages wearing a mask in crowded spaces, even when there isn't a requirement to do so.
"If only one of us is wearing a mask and the other one isn't and is infected, you still have pretty high protection — but not the same level of protection as if both of us wearing one," says Dr. Poland. "So, it's it is not futile to be the only one wearing a mask. In fact, I think it sends a message."
On the Mayo Clinic Q&A podcast, Dr. Poland discusses the latest COVID-19 news and answers listener questions.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1700</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Eating Disorders Edition: Case Discussions</title>
        <itunes:title>Eating Disorders Edition: Case Discussions</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/eating-disorders-edition-case-discussions/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/eating-disorders-edition-case-discussions/#comments</comments>        <pubDate>Thu, 05 May 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/71cf4d8f-d587-3610-abd1-afb37c088db3</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/node/126199/'>Mayo Clinic Talks Podcast: Eating Disorders Edition</a></p>
<p>Guests:  Angela C. Mattke, M.D. (<a href='https://twitter.com/DrAngelaMattke'>@DrAngelaMattke</a>); Paige I. Partain, M.D.</p>
<p>Host:  Jocelyn R. Lebow, Ph.D., L.P.</p>
<p>Though the Diagnostic and Statistical Manual of Mental Disorders (DSM–5) is clear in classifying eating disorders, clinicians understand it is rare to be presented with a straightforward case. Patients present with comorbidities and family circumstances that muddy the clinical picture and the treatment plan. This case-based episode focuses on how primary care providers can treat children with eating disorders. This episode will examine complicated eating disorder cases, featuring guests Angela C. Mattke, M.D. and Paige I. Partain, M.D., Mayo Clinic Children’s Center pediatricians, and colleagues and collaborators in the primary care child and adolescent eating disorder clinic at Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/node/126199/'>Mayo Clinic Talks Podcast: Eating Disorders Edition</a></p>
<p>Guests:  Angela C. Mattke, M.D. (<a href='https://twitter.com/DrAngelaMattke'>@DrAngelaMattke</a>); Paige I. Partain, M.D.</p>
<p>Host:  Jocelyn R. Lebow, Ph.D., L.P.</p>
<p>Though the Diagnostic and Statistical Manual of Mental Disorders (DSM–5) is clear in classifying eating disorders, clinicians understand it is rare to be presented with a straightforward case. Patients present with comorbidities and family circumstances that muddy the clinical picture and the treatment plan. This case-based episode focuses on how primary care providers can treat children with eating disorders. This episode will examine complicated eating disorder cases, featuring guests Angela C. Mattke, M.D. and Paige I. Partain, M.D., Mayo Clinic Children’s Center pediatricians, and colleagues and collaborators in the primary care child and adolescent eating disorder clinic at Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4zmd6h/WF769855_Case_Discussions_FINAL6sugp.mp3" length="23808762" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: Mayo Clinic Talks Podcast: Eating Disorders Edition
Guests:  Angela C. Mattke, M.D. (@DrAngelaMattke); Paige I. Partain, M.D.
Host:  Jocelyn R. Lebow, Ph.D., L.P.
Though the Diagnostic and Statistical Manual of Mental Disorders (DSM–5) is clear in classifying eating disorders, clinicians understand it is rare to be presented with a straightforward case. Patients present with comorbidities and family circumstances that muddy the clinical picture and the treatment plan. This case-based episode focuses on how primary care providers can treat children with eating disorders. This episode will examine complicated eating disorder cases, featuring guests Angela C. Mattke, M.D. and Paige I. Partain, M.D., Mayo Clinic Children’s Center pediatricians, and colleagues and collaborators in the primary care child and adolescent eating disorder clinic at Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1481</itunes:duration>
                <itunes:episode>326</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Fragility Fractures</title>
        <itunes:title>Fragility Fractures</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/fragility-fractures/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/fragility-fractures/#comments</comments>        <pubDate>Tue, 03 May 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/cd65d020-76ec-3b9f-9d61-5dd680894a32</guid>
                                    <description><![CDATA[<p>Guest: Ann E. Kearns, M.D., Ph.D.         </p>
<p>Host: Sanjeev (Sanj) Kakar, M.D. (<a href='https://twitter.com/sanjkakar'>@sanjkakar</a>)</p>
<p>It is estimated that worldwide, one in three women, and one in five men over the age of 50 will experience osteoporosis fractures during their lifetimes. In this podcast, we discuss risk factors and management of fragility fractures and bone health with Ann E. Kearns, M.D., Ph.D., a Consultant Endocrinologist and Associate Professor within the Department of Medicine at Mayo Clinic in Rochester, Minnesota.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Ann E. Kearns, M.D., Ph.D.         </p>
<p>Host: Sanjeev (Sanj) Kakar, M.D. (<a href='https://twitter.com/sanjkakar'>@sanjkakar</a>)</p>
<p>It is estimated that worldwide, one in three women, and one in five men over the age of 50 will experience osteoporosis fractures during their lifetimes. In this podcast, we discuss risk factors and management of fragility fractures and bone health with Ann E. Kearns, M.D., Ph.D., a Consultant Endocrinologist and Associate Professor within the Department of Medicine at Mayo Clinic in Rochester, Minnesota.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vvbh7m/WF737663_Fragility_Fractures_V2_FINAL6ef17.mp3" length="26606958" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Ann E. Kearns, M.D., Ph.D.         
Host: Sanjeev (Sanj) Kakar, M.D. (@sanjkakar)
It is estimated that worldwide, one in three women, and one in five men over the age of 50 will experience osteoporosis fractures during their lifetimes. In this podcast, we discuss risk factors and management of fragility fractures and bone health with Ann E. Kearns, M.D., Ph.D., a Consultant Endocrinologist and Associate Professor within the Department of Medicine at Mayo Clinic in Rochester, Minnesota.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1093</itunes:duration>
                <itunes:episode>331</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Eating Disorders Edition: Basic Principles of Treatment for the Primary Care Provider</title>
        <itunes:title>Eating Disorders Edition: Basic Principles of Treatment for the Primary Care Provider</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/eating-disorders-edition-basic-principles-of-treatment-for-the-primary-care-provider/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/eating-disorders-edition-basic-principles-of-treatment-for-the-primary-care-provider/#comments</comments>        <pubDate>Thu, 28 Apr 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/57e20bfb-cb46-3598-9afb-d858203e4a6f</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/node/126199/'>Mayo Clinic Talks Podcast: Eating Disorders Edition</a></p>
<p>Guests:  Angela C. Mattke, M.D. (<a href='https://twitter.com/DrAngelaMattke'>@DrAngelaMattke</a>); Paige I. Partain, M.D.</p>
<p>Host:  Jocelyn R. Lebow, Ph.D., L.P.</p>
<p>We understand eating disorders are serious and evidence-based Family Based Treatment (FBT) is scarce but effective. This episode will discuss strategies informed by evidence based FBT principles that can be used by providers in primary care settings to address eating disorder symptoms. Though typically the responsibilities of primary care providers in eating disorder treatment are limited to case identification, referral, and medical management, these providers have vast experience empowering caregivers to help their children change behavior.  Equipping primary care providers to deliver evidence-based treatment for restrictive eating disorders has the potential to expand access to early intervention and improve outcomes.</p>
<p>Our guests for this episode are Angela C. Mattke, M.D. and Paige I. Partain, M.D., Mayo Clinic Children’s Center pediatricians, and colleagues and collaborators in the primary care child and adolescent eating disorder clinic at Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/node/126199/'>Mayo Clinic Talks Podcast: Eating Disorders Edition</a></p>
<p>Guests:  Angela C. Mattke, M.D. (<a href='https://twitter.com/DrAngelaMattke'>@DrAngelaMattke</a>); Paige I. Partain, M.D.</p>
<p>Host:  Jocelyn R. Lebow, Ph.D., L.P.</p>
<p>We understand eating disorders are serious and evidence-based Family Based Treatment (FBT) is scarce but effective. This episode will discuss strategies informed by evidence based FBT principles that can be used by providers in primary care settings to address eating disorder symptoms. Though typically the responsibilities of primary care providers in eating disorder treatment are limited to case identification, referral, and medical management, these providers have vast experience empowering caregivers to help their children change behavior.  Equipping primary care providers to deliver evidence-based treatment for restrictive eating disorders has the potential to expand access to early intervention and improve outcomes.</p>
<p>Our guests for this episode are Angela C. Mattke, M.D. and Paige I. Partain, M.D., Mayo Clinic Children’s Center pediatricians, and colleagues and collaborators in the primary care child and adolescent eating disorder clinic at Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7fsg7j/WF724634_Basic_Principles_for_the_PCP_FINALa27mw.mp3" length="27221830" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: Mayo Clinic Talks Podcast: Eating Disorders Edition
Guests:  Angela C. Mattke, M.D. (@DrAngelaMattke); Paige I. Partain, M.D.
Host:  Jocelyn R. Lebow, Ph.D., L.P.
We understand eating disorders are serious and evidence-based Family Based Treatment (FBT) is scarce but effective. This episode will discuss strategies informed by evidence based FBT principles that can be used by providers in primary care settings to address eating disorder symptoms. Though typically the responsibilities of primary care providers in eating disorder treatment are limited to case identification, referral, and medical management, these providers have vast experience empowering caregivers to help their children change behavior.  Equipping primary care providers to deliver evidence-based treatment for restrictive eating disorders has the potential to expand access to early intervention and improve outcomes.
Our guests for this episode are Angela C. Mattke, M.D. and Paige I. Partain, M.D., Mayo Clinic Children’s Center pediatricians, and colleagues and collaborators in the primary care child and adolescent eating disorder clinic at Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
 ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1695</itunes:duration>
                <itunes:episode>325</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Use of Race in Clinical Algorithms</title>
        <itunes:title>The Use of Race in Clinical Algorithms</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/the-use-of-race-in-clinical-algorithms/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/the-use-of-race-in-clinical-algorithms/#comments</comments>        <pubDate>Tue, 26 Apr 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/bdabfecc-62fd-3ccc-aac2-a3c90b97233a</guid>
                                    <description><![CDATA[<p>Guest: Ramla N. Kasozi, M.B., Ch.B., M.P.H.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>There is currently a debate regarding the use of race and ethnic categories in clinical decision-making. There are numerous studies which claim data from race is a factor and should be considered when designing practice guidelines and clinical algorithms. Some feel that any benefit is small compared to the potential harm that could occur regarding the past abuse of race used in medicine. Unfortunately, many questions remain unanswered. Is race a reliable proxy for genetic differences? Are there genetic differences which explain the basis behind race-based algorithms? And what are the potential dangers of using race-adjusted algorithms? This podcast reviews these topics with Ramla N. Kasozi, M.B., Ch.B., M.P.H., a family physician at the Mayo Clinic in Jacksonville, Florida.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Ramla N. Kasozi, M.B., Ch.B., M.P.H.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>There is currently a debate regarding the use of race and ethnic categories in clinical decision-making. There are numerous studies which claim data from race is a factor and should be considered when designing practice guidelines and clinical algorithms. Some feel that any benefit is small compared to the potential harm that could occur regarding the past abuse of race used in medicine. Unfortunately, many questions remain unanswered. Is race a reliable proxy for genetic differences? Are there genetic differences which explain the basis behind race-based algorithms? And what are the potential dangers of using race-adjusted algorithms? This podcast reviews these topics with Ramla N. Kasozi, M.B., Ch.B., M.P.H., a family physician at the Mayo Clinic in Jacksonville, Florida.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/s2kdye/WF843852_Race_in_Clinical_Algorithms_FINALak4bq.mp3" length="15808756" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Ramla N. Kasozi, M.B., Ch.B., M.P.H.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
There is currently a debate regarding the use of race and ethnic categories in clinical decision-making. There are numerous studies which claim data from race is a factor and should be considered when designing practice guidelines and clinical algorithms. Some feel that any benefit is small compared to the potential harm that could occur regarding the past abuse of race used in medicine. Unfortunately, many questions remain unanswered. Is race a reliable proxy for genetic differences? Are there genetic differences which explain the basis behind race-based algorithms? And what are the potential dangers of using race-adjusted algorithms? This podcast reviews these topics with Ramla N. Kasozi, M.B., Ch.B., M.P.H., a family physician at the Mayo Clinic in Jacksonville, Florida.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>985</itunes:duration>
                <itunes:episode>329</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Eating Disorders Edition: Treatment for Eating Disorders</title>
        <itunes:title>Eating Disorders Edition: Treatment for Eating Disorders</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/eating-disorders-edition-treatment-for-eating-disorders/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/eating-disorders-edition-treatment-for-eating-disorders/#comments</comments>        <pubDate>Thu, 21 Apr 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/d7e7d0c0-ecb7-321c-a26a-3a62535a9c0b</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/node/126199/'>Mayo Clinic Talks Podcast: Eating Disorders Edition</a></p>
<p>Guest(s):  Jocelyn R. Lebow, Ph.D., L.P.</p>
<p>Host:  Angela C. Mattke, M.D. (<a href='https://twitter.com/DrAngelaMattke'>@DrAngelaMattke</a>)</p>
<p>Eating disorders impact an estimated 3-15% of adolescents and, if left untreated, or only partially treated, can become chronic conditions. Relapse is also common in eating disorders with over 40% of patients reporting at least one relapse in some studies. Despite these sobering statistics, when adolescent patients complete a course of good, evidence-based treatment, they can expect to make and maintain a full recovery from their symptoms. Primary care providers play a critical role in helping patients and their families find care and determine whether the care they’re getting is having the right effect. This episode will concentrate on different types of eating disorder treatment: what’s out there and what the evidence says works best. Our guest is Jocelyn R. Lebow, Ph.D., L.P., a Mayo Clinic child and adolescent psychologist and collaborator in the Mayo Clinic primary care child and adolescent eating disorder clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd.</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/node/126199/'>Mayo Clinic Talks Podcast: Eating Disorders Edition</a></p>
<p>Guest(s):  Jocelyn R. Lebow, Ph.D., L.P.</p>
<p>Host:  Angela C. Mattke, M.D. (<a href='https://twitter.com/DrAngelaMattke'>@DrAngelaMattke</a>)</p>
<p>Eating disorders impact an estimated 3-15% of adolescents and, if left untreated, or only partially treated, can become chronic conditions. Relapse is also common in eating disorders with over 40% of patients reporting at least one relapse in some studies. Despite these sobering statistics, when adolescent patients complete a course of good, evidence-based treatment, they can expect to make and maintain a full recovery from their symptoms. Primary care providers play a critical role in helping patients and their families find care and determine whether the care they’re getting is having the right effect. This episode will concentrate on different types of eating disorder treatment: what’s out there and what the evidence says works best. Our guest is Jocelyn R. Lebow, Ph.D., L.P., a Mayo Clinic child and adolescent psychologist and collaborator in the Mayo Clinic primary care child and adolescent eating disorder clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd.</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zu9nig/WF723766_Treatment_for_Eating_Disorders_FINALb0pks.mp3" length="20219900" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: Mayo Clinic Talks Podcast: Eating Disorders Edition
Guest(s):  Jocelyn R. Lebow, Ph.D., L.P.
Host:  Angela C. Mattke, M.D. (@DrAngelaMattke)
Eating disorders impact an estimated 3-15% of adolescents and, if left untreated, or only partially treated, can become chronic conditions. Relapse is also common in eating disorders with over 40% of patients reporting at least one relapse in some studies. Despite these sobering statistics, when adolescent patients complete a course of good, evidence-based treatment, they can expect to make and maintain a full recovery from their symptoms. Primary care providers play a critical role in helping patients and their families find care and determine whether the care they’re getting is having the right effect. This episode will concentrate on different types of eating disorder treatment: what’s out there and what the evidence says works best. Our guest is Jocelyn R. Lebow, Ph.D., L.P., a Mayo Clinic child and adolescent psychologist and collaborator in the Mayo Clinic primary care child and adolescent eating disorder clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1258</itunes:duration>
                <itunes:episode>324</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Secondary Hypertension: Identifying Clues in Patients</title>
        <itunes:title>Secondary Hypertension: Identifying Clues in Patients</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/secondary-hypertension-identifying-clues-in-patients/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/secondary-hypertension-identifying-clues-in-patients/#comments</comments>        <pubDate>Tue, 19 Apr 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/ce4401b3-dec5-389c-b6c1-e902e7f2063c</guid>
                                    <description><![CDATA[<p>Guest: Sandra J. Taler, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (@ChutkaMD) </p>
<p>Nearly half of all adults in the United States have some degree of hypertension and it’s one of the most common reasons patients are seen in an outpatient practice. The vast majority have essential or primary hypertension and they usually respond to a combination of lifestyle changes and often pharmacologic therapy. A small percentage of these cases have secondary hypertension and often do not respond to treatment unless the underlying cause is found and corrected. At times, it can be difficult to identify the cause of secondary hypertension as the clues may be quite subtle or even non-existent. Our guest for today’s podcast is Sandra J. Taler, M.D. from the Division of Nephrology and a hypertension specialist from the Mayo Clinic. We’ll discuss when you should suspect secondary hypertension, the clues the patient may give us regarding its cause and its management.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Sandra J. Taler, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (@ChutkaMD) </p>
<p>Nearly half of all adults in the United States have some degree of hypertension and it’s one of the most common reasons patients are seen in an outpatient practice. The vast majority have essential or primary hypertension and they usually respond to a combination of lifestyle changes and often pharmacologic therapy. A small percentage of these cases have secondary hypertension and often do not respond to treatment unless the underlying cause is found and corrected. At times, it can be difficult to identify the cause of secondary hypertension as the clues may be quite subtle or even non-existent. Our guest for today’s podcast is Sandra J. Taler, M.D. from the Division of Nephrology and a hypertension specialist from the Mayo Clinic. We’ll discuss when you should suspect secondary hypertension, the clues the patient may give us regarding its cause and its management.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rric9d/WF7149000_Secondary_Hypertension_FINAL61bmq.mp3" length="22278957" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Sandra J. Taler, M.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD) 
Nearly half of all adults in the United States have some degree of hypertension and it’s one of the most common reasons patients are seen in an outpatient practice. The vast majority have essential or primary hypertension and they usually respond to a combination of lifestyle changes and often pharmacologic therapy. A small percentage of these cases have secondary hypertension and often do not respond to treatment unless the underlying cause is found and corrected. At times, it can be difficult to identify the cause of secondary hypertension as the clues may be quite subtle or even non-existent. Our guest for today’s podcast is Sandra J. Taler, M.D. from the Division of Nephrology and a hypertension specialist from the Mayo Clinic. We’ll discuss when you should suspect secondary hypertension, the clues the patient may give us regarding its cause and its management.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1388</itunes:duration>
                <itunes:episode>330</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Eating Disorders Edition: Medical Management of Eating Disorders in Primary Care</title>
        <itunes:title>Eating Disorders Edition: Medical Management of Eating Disorders in Primary Care</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/eating-disorders-edition-medical-management-of-eating-disorders-in-primary-care/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/eating-disorders-edition-medical-management-of-eating-disorders-in-primary-care/#comments</comments>        <pubDate>Thu, 14 Apr 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/bf489e10-06e1-30ac-84e4-e9b6cc770e01</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/node/126199/'>Mayo Clinic Talks Podcast: Eating Disorders Edition</a></p>
<p>Guests:  Marcie L. Billings, M.D.; Paige I. Partain, M.D.</p>
<p>Host:  Angela C. Mattke, M.D. (<a href='https://twitter.com/DrAngelaMattke'>@DrAngelaMattke</a>)</p>
<p>The medical evaluation for eating disorders is very important. It is the primary care provider’s role to rule out other causes of weight loss, especially when eating disorder signs might not be as apparent at the beginning or the patient isn’t entirely forthcoming. Additionally, the patient and their family have an inherent trust in a primary care provider as their long-term medical provider. This episode will focus on the medical evaluation and management of eating disorders – what vital signs are significant, what labs are necessary including how often they should be performed, how frequently patients need to be seen in collaboration with their therapist, and how to determine if a patient is medically unstable and needing immediate admission for monitoring and treatment. The guests for this episode are Marcie L. Billings, M.D. and Paige I. Partain, M.D., Mayo Clinic Children’s Center pediatricians, and colleagues and collaborators in the primary care child and adolescent eating disorder clinic at Mayo Clinic. </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/node/126199/'>Mayo Clinic Talks Podcast: Eating Disorders Edition</a></p>
<p>Guests:  Marcie L. Billings, M.D.; Paige I. Partain, M.D.</p>
<p>Host:  Angela C. Mattke, M.D. (<a href='https://twitter.com/DrAngelaMattke'>@DrAngelaMattke</a>)</p>
<p>The medical evaluation for eating disorders is very important. It is the primary care provider’s role to rule out other causes of weight loss, especially when eating disorder signs might not be as apparent at the beginning or the patient isn’t entirely forthcoming. Additionally, the patient and their family have an inherent trust in a primary care provider as their long-term medical provider. This episode will focus on the medical evaluation and management of eating disorders – what vital signs are significant, what labs are necessary including how often they should be performed, how frequently patients need to be seen in collaboration with their therapist, and how to determine if a patient is medically unstable and needing immediate admission for monitoring and treatment. The guests for this episode are Marcie L. Billings, M.D. and Paige I. Partain, M.D., Mayo Clinic Children’s Center pediatricians, and colleagues and collaborators in the primary care child and adolescent eating disorder clinic at Mayo Clinic. </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/93de96/WF758324_Medical_Management_of_Eating_DisordersFINAL61fzm.mp3" length="24139046" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: Mayo Clinic Talks Podcast: Eating Disorders Edition
Guests:  Marcie L. Billings, M.D.; Paige I. Partain, M.D.
Host:  Angela C. Mattke, M.D. (@DrAngelaMattke)
The medical evaluation for eating disorders is very important. It is the primary care provider’s role to rule out other causes of weight loss, especially when eating disorder signs might not be as apparent at the beginning or the patient isn’t entirely forthcoming. Additionally, the patient and their family have an inherent trust in a primary care provider as their long-term medical provider. This episode will focus on the medical evaluation and management of eating disorders – what vital signs are significant, what labs are necessary including how often they should be performed, how frequently patients need to be seen in collaboration with their therapist, and how to determine if a patient is medically unstable and needing immediate admission for monitoring and treatment. The guests for this episode are Marcie L. Billings, M.D. and Paige I. Partain, M.D., Mayo Clinic Children’s Center pediatricians, and colleagues and collaborators in the primary care child and adolescent eating disorder clinic at Mayo Clinic. 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1502</itunes:duration>
                <itunes:episode>323</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Treating Hypertension: Doing What’s Best for Your Patient</title>
        <itunes:title>Treating Hypertension: Doing What’s Best for Your Patient</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/treating-hypertension-doing-what-s-best-for-your-patient/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/treating-hypertension-doing-what-s-best-for-your-patient/#comments</comments>        <pubDate>Tue, 12 Apr 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/47caa7ec-c39c-3409-85c0-0a3bf65e2f01</guid>
                                    <description><![CDATA[<p>Guest: Ivan E. Porter, II M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Nearly half of all adults in the United States have hypertension and it’s one of the most common reasons for an outpatient visit. Despite this, it’s estimated that only about a fourth of those diagnosed with hypertension are adequately controlled and about 20% of adults with hypertension are unaware that they even have it. Since uncontrolled hypertension can increase the risk of cerebral, cardiac and renal events, it’s important to make an accurate diagnosis and appropriately manage patients with the condition. The topic for this podcast is hypertension and we’ll discuss the changes in blood pressure with aging, the definition of hypertension, the proper technique of checking blood pressure and helpful management techniques with today’s guest, Ivan E. Porter, II M.D., a nephrologist and hypertension specialist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Ivan E. Porter, II M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Nearly half of all adults in the United States have hypertension and it’s one of the most common reasons for an outpatient visit. Despite this, it’s estimated that only about a fourth of those diagnosed with hypertension are adequately controlled and about 20% of adults with hypertension are unaware that they even have it. Since uncontrolled hypertension can increase the risk of cerebral, cardiac and renal events, it’s important to make an accurate diagnosis and appropriately manage patients with the condition. The topic for this podcast is hypertension and we’ll discuss the changes in blood pressure with aging, the definition of hypertension, the proper technique of checking blood pressure and helpful management techniques with today’s guest, Ivan E. Porter, II M.D., a nephrologist and hypertension specialist at the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zwkjnq/WF729250_Hypertension_FINAL6wa7i.mp3" length="26379405" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Ivan E. Porter, II M.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Nearly half of all adults in the United States have hypertension and it’s one of the most common reasons for an outpatient visit. Despite this, it’s estimated that only about a fourth of those diagnosed with hypertension are adequately controlled and about 20% of adults with hypertension are unaware that they even have it. Since uncontrolled hypertension can increase the risk of cerebral, cardiac and renal events, it’s important to make an accurate diagnosis and appropriately manage patients with the condition. The topic for this podcast is hypertension and we’ll discuss the changes in blood pressure with aging, the definition of hypertension, the proper technique of checking blood pressure and helpful management techniques with today’s guest, Ivan E. Porter, II M.D., a nephrologist and hypertension specialist at the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1642</itunes:duration>
                <itunes:episode>328</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Eating Disorders Edition: Identification and Assessment of Eating Disorders for the Primary Care Provider</title>
        <itunes:title>Eating Disorders Edition: Identification and Assessment of Eating Disorders for the Primary Care Provider</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/eating-disorders-edition-identification-and-assessment-of-eating-disorders-for-the-primary-care-provider/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/eating-disorders-edition-identification-and-assessment-of-eating-disorders-for-the-primary-care-provider/#comments</comments>        <pubDate>Thu, 07 Apr 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/06346aff-d4f9-324c-b159-7742b25822ab</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/node/126199/'>Mayo Clinic Talks Podcast: Eating Disorders Edition</a></p>
<p>Guest:  Paige I. Partain, M.D.</p>
<p>Host:  Jocelyn R. Lebow, Ph.D., L.P.</p>
<p>Child and adolescent eating disorders are serious diseases, characterized by a range of physical and psychological consequences. They are often associated with a chronic course and numerous relapses. This episode focuses on how primary care providers can assess for and identify eating disorders in child and adolescent patients. We will discuss high yield assessment questions and tools that you can use in your primary care practice when you suspect a young patient may meet the criteria for an eating disorder. Our guest is Paige I. Partain, M.D., Mayo Clinic Children’s Center pediatrician and collaborator in the primary care child and adolescent eating disorder clinic at Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/node/126199/'>Mayo Clinic Talks Podcast: Eating Disorders Edition</a></p>
<p>Guest:  Paige I. Partain, M.D.</p>
<p>Host:  Jocelyn R. Lebow, Ph.D., L.P.</p>
<p>Child and adolescent eating disorders are serious diseases, characterized by a range of physical and psychological consequences. They are often associated with a chronic course and numerous relapses. This episode focuses on how primary care providers can assess for and identify eating disorders in child and adolescent patients. We will discuss high yield assessment questions and tools that you can use in your primary care practice when you suspect a young patient may meet the criteria for an eating disorder. Our guest is Paige I. Partain, M.D., Mayo Clinic Children’s Center pediatrician and collaborator in the primary care child and adolescent eating disorder clinic at Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7f2zqy/WF724609_Assessment_for_Primary_Providers_FINAL71il9.mp3" length="21164204" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: Mayo Clinic Talks Podcast: Eating Disorders Edition
Guest:  Paige I. Partain, M.D.
Host:  Jocelyn R. Lebow, Ph.D., L.P.
Child and adolescent eating disorders are serious diseases, characterized by a range of physical and psychological consequences. They are often associated with a chronic course and numerous relapses. This episode focuses on how primary care providers can assess for and identify eating disorders in child and adolescent patients. We will discuss high yield assessment questions and tools that you can use in your primary care practice when you suspect a young patient may meet the criteria for an eating disorder. Our guest is Paige I. Partain, M.D., Mayo Clinic Children’s Center pediatrician and collaborator in the primary care child and adolescent eating disorder clinic at Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1318</itunes:duration>
                <itunes:episode>322</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Eating Disorders Edition: Eating Disorders 101: Background and Debunking Myths</title>
        <itunes:title>Eating Disorders Edition: Eating Disorders 101: Background and Debunking Myths</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/eating-disorders-edition-eating-disorders-101-background-and-debunking-myths/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/eating-disorders-edition-eating-disorders-101-background-and-debunking-myths/#comments</comments>        <pubDate>Tue, 05 Apr 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/cc122948-a7c6-3fac-a2c4-6aea095dd76a</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/node/126199/'>Mayo Clinic Talks Podcast: Eating Disorders Edition</a></p>
<p>Guest:  Jocelyn R. Lebow, Ph.D., L.P.</p>
<p>Host:  Angela C. Mattke, M.D. (<a href='https://twitter.com/DrAngelaMattke'>@DrAngelaMattke</a>)</p>
<p>Eating disorders are a huge problem in our country. Whether realizing it or not, primary care providers who treat teenagers are likely caring for patients with eating disorders.  Though estimates vary, approximately 3-15% of adolescents will experience an eating disorder. Along with the numerous physical and psychological consequences of these illnesses, eating disorders also have the second-highest mortality rate of any mental illness: one in five patients will die from complications related to their eating disorder. </p>
<p>This episode is the first episode in our Eating Disorders edition, which focuses on how primary care providers may treat children with eating disorders. This episode will concentrate on the basics: what are eating disorders, what do they do to our patients, and what myths and misunderstandings exist that hinder effective identification and treatment. Our guest is Jocelyn R. Lebow, Ph.D., L.P., a Mayo Clinic child and adolescent psychologist, and collaborator in the Mayo Clinic primary care child and adolescent eating disorder clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/node/126199/'>Mayo Clinic Talks Podcast: Eating Disorders Edition</a></p>
<p>Guest:  Jocelyn R. Lebow, Ph.D., L.P.</p>
<p>Host:  Angela C. Mattke, M.D. (<a href='https://twitter.com/DrAngelaMattke'>@DrAngelaMattke</a>)</p>
<p>Eating disorders are a huge problem in our country. Whether realizing it or not, primary care providers who treat teenagers are likely caring for patients with eating disorders.  Though estimates vary, approximately 3-15% of adolescents will experience an eating disorder. Along with the numerous physical and psychological consequences of these illnesses, eating disorders also have the second-highest mortality rate of any mental illness: one in five patients will die from complications related to their eating disorder. </p>
<p>This episode is the first episode in our Eating Disorders edition, which focuses on how primary care providers may treat children with eating disorders. This episode will concentrate on the basics: what are eating disorders, what do they do to our patients, and what myths and misunderstandings exist that hinder effective identification and treatment. Our guest is Jocelyn R. Lebow, Ph.D., L.P., a Mayo Clinic child and adolescent psychologist, and collaborator in the Mayo Clinic primary care child and adolescent eating disorder clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xvqy2e/WF723765_Eating_Disorders_101_FINAL8em7a.mp3" length="24225816" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: Mayo Clinic Talks Podcast: Eating Disorders Edition
Guest:  Jocelyn R. Lebow, Ph.D., L.P.
Host:  Angela C. Mattke, M.D. (@DrAngelaMattke)
Eating disorders are a huge problem in our country. Whether realizing it or not, primary care providers who treat teenagers are likely caring for patients with eating disorders.  Though estimates vary, approximately 3-15% of adolescents will experience an eating disorder. Along with the numerous physical and psychological consequences of these illnesses, eating disorders also have the second-highest mortality rate of any mental illness: one in five patients will die from complications related to their eating disorder. 
This episode is the first episode in our Eating Disorders edition, which focuses on how primary care providers may treat children with eating disorders. This episode will concentrate on the basics: what are eating disorders, what do they do to our patients, and what myths and misunderstandings exist that hinder effective identification and treatment. Our guest is Jocelyn R. Lebow, Ph.D., L.P., a Mayo Clinic child and adolescent psychologist, and collaborator in the Mayo Clinic primary care child and adolescent eating disorder clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1507</itunes:duration>
                <itunes:episode>321</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: COVID-19 metrics improve, expert still urges caution</title>
        <itunes:title>Mayo Clinic Q&amp;A: COVID-19 metrics improve, expert still urges caution</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-covid-19-metrics-improve-expert-still-urges-caution/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-covid-19-metrics-improve-expert-still-urges-caution/#comments</comments>        <pubDate>Thu, 31 Mar 2022 13:08:35 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/c6bd348c-c7e2-350a-a51d-8197c0e2819d</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in March 2022</p>
<p>Guest: Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>Hospitalizations and deaths due to COVID-19 continue to decline, leading to some optimism about the way forward from pandemic to endemic. But experts still urge caution as the omicron subvariant, named BA.2, has quickly become the dominant strain in the U.S.</p>
<p>"When you look around the nation, all of the metrics, with the exception of BA.2, have fallen precipitously," explains <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview'>Mayo Clinic's Vaccine Research Group</a>. "But we need to be very cautious about pretending that the pandemic is over."</p>
<p>Dr. Poland explains that each time there has been a waning number of COVID-19 infections, people have let down their guard and relaxed precautions, which has led to another surge. Dr. Poland still recommends masking in crowded indoor settings and urges people to be fully vaccinated and boosted against COVID-19 to reduce the chance of infection.</p>
<p>"We're just coming down into a quiet period," says Dr. Poland. "But every time we've seen this set of markers in the past, we've had a new variant that's caused a surge. The question is, will it be BA.2, one of the newer variants that have been identified, or something completely unexpected? We just don't know."</p>
<p>On the Mayo Clinic Q&A podcast, Dr. Poland discusses the latest COVID-19 news including potential changes to booster recommendations, data on vaccine protection for pregnant women, and the latest information on COVID-19 vaccines for children under 5.</p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in March 2022</p>
<p>Guest: Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>Hospitalizations and deaths due to COVID-19 continue to decline, leading to some optimism about the way forward from pandemic to endemic. But experts still urge caution as the omicron subvariant, named BA.2, has quickly become the dominant strain in the U.S.</p>
<p>"When you look around the nation, all of the metrics, with the exception of BA.2, have fallen precipitously," explains <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview'>Mayo Clinic's Vaccine Research Group</a>. "But we need to be very cautious about pretending that the pandemic is over."</p>
<p>Dr. Poland explains that each time there has been a waning number of COVID-19 infections, people have let down their guard and relaxed precautions, which has led to another surge. Dr. Poland still recommends masking in crowded indoor settings and urges people to be fully vaccinated and boosted against COVID-19 to reduce the chance of infection.</p>
<p>"We're just coming down into a quiet period," says Dr. Poland. "But every time we've seen this set of markers in the past, we've had a new variant that's caused a surge. The question is, will it be BA.2, one of the newer variants that have been identified, or something completely unexpected? We just don't know."</p>
<p>On the Mayo Clinic Q&A podcast, Dr. Poland discusses the latest COVID-19 news including potential changes to booster recommendations, data on vaccine protection for pregnant women, and the latest information on COVID-19 vaccines for children under 5.</p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/74v72p/Mayo_Clinic_Q_A_-_Dr_Gregory_Poland_COVID-19_Update_03_30_2294l7s.mp3" length="31618694" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in March 2022
Guest: Gregory A. Poland, M.D. (@drgregpoland)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
Hospitalizations and deaths due to COVID-19 continue to decline, leading to some optimism about the way forward from pandemic to endemic. But experts still urge caution as the omicron subvariant, named BA.2, has quickly become the dominant strain in the U.S.
"When you look around the nation, all of the metrics, with the exception of BA.2, have fallen precipitously," explains Dr. Gregory Poland, head of Mayo Clinic's Vaccine Research Group. "But we need to be very cautious about pretending that the pandemic is over."
Dr. Poland explains that each time there has been a waning number of COVID-19 infections, people have let down their guard and relaxed precautions, which has led to another surge. Dr. Poland still recommends masking in crowded indoor settings and urges people to be fully vaccinated and boosted against COVID-19 to reduce the chance of infection.
"We're just coming down into a quiet period," says Dr. Poland. "But every time we've seen this set of markers in the past, we've had a new variant that's caused a surge. The question is, will it be BA.2, one of the newer variants that have been identified, or something completely unexpected? We just don't know."
On the Mayo Clinic Q&A podcast, Dr. Poland discusses the latest COVID-19 news including potential changes to booster recommendations, data on vaccine protection for pregnant women, and the latest information on COVID-19 vaccines for children under 5.
 ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1970</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Colorectal Cancer – Screening Guidelines Updates</title>
        <itunes:title>Colorectal Cancer – Screening Guidelines Updates</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/colorectal-cancer-%e2%80%93-screening-guidelines-updates/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/colorectal-cancer-%e2%80%93-screening-guidelines-updates/#comments</comments>        <pubDate>Tue, 29 Mar 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/65ce659b-47cc-3094-9b2c-292332e8c7ed</guid>
                                    <description><![CDATA[<p>Guest: John B. Kisiel, M.D. <a href='https://twitter.com/DrJohnKisiel'>(@DrJohnKisiel</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Colorectal cancer is the third most commonly occurring cancer for both men and women and ranks second to lung cancer as a cause of cancer mortality. Yet it’s estimated that up to one quarter of eligible adults in the United States have never been screened for colorectal cancer and nearly one third are not up to date with their screening. We now have a variety of accepted screening tests for colorectal cancer and each carries its own risks and benefits. This podcast will review colorectal cancer screening, including when we should start screening, the various available screening tests, as well as their advantages and limitations. Our guest for this episode is gastroenterologist, Dr. John Kisiel from the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: John B. Kisiel, M.D. <a href='https://twitter.com/DrJohnKisiel'>(@DrJohnKisiel</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Colorectal cancer is the third most commonly occurring cancer for both men and women and ranks second to lung cancer as a cause of cancer mortality. Yet it’s estimated that up to one quarter of eligible adults in the United States have never been screened for colorectal cancer and nearly one third are not up to date with their screening. We now have a variety of accepted screening tests for colorectal cancer and each carries its own risks and benefits. This podcast will review colorectal cancer screening, including when we should start screening, the various available screening tests, as well as their advantages and limitations. Our guest for this episode is gastroenterologist, Dr. John Kisiel from the Mayo Clinic.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8vse3x/WF714901_Colon_Cancer_FINAL8z8ux.mp3" length="28302823" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: John B. Kisiel, M.D. (@DrJohnKisiel)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Colorectal cancer is the third most commonly occurring cancer for both men and women and ranks second to lung cancer as a cause of cancer mortality. Yet it’s estimated that up to one quarter of eligible adults in the United States have never been screened for colorectal cancer and nearly one third are not up to date with their screening. We now have a variety of accepted screening tests for colorectal cancer and each carries its own risks and benefits. This podcast will review colorectal cancer screening, including when we should start screening, the various available screening tests, as well as their advantages and limitations. Our guest for this episode is gastroenterologist, Dr. John Kisiel from the Mayo Clinic.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2000</itunes:duration>
                <itunes:episode>320</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Post COVID Syndrome</title>
        <itunes:title>Post COVID Syndrome</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/post-covid-syndrome/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/post-covid-syndrome/#comments</comments>        <pubDate>Tue, 22 Mar 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/ee92301d-71bb-32c6-b4f6-27ac260bedbc</guid>
                                    <description><![CDATA[<p>Guest: Greg Vanichkachorn, M.D., M.P.H. (<a href='https://twitter.com/DoctorGregVan'>@DoctorGregVan</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>While most patients who have COVID-19 completely recover within a few weeks, there are some patients who continue to experience symptoms that can last for months. These patients may require our care for an extended period of time.  Although much has been learned about COVID-19 over the past couple of years, there is still a great deal that’s not known. The topic for this podcast is post-COVID syndrome and our guest is Greg Vanichkachorn, M.D., M.P.H., a preventive medicine physician and specialist in Public Health. We’ll discuss the typical symptoms, duration of symptoms, and who is most likely to develop post-COVID syndrome.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Greg Vanichkachorn, M.D., M.P.H. (<a href='https://twitter.com/DoctorGregVan'>@DoctorGregVan</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>While most patients who have COVID-19 completely recover within a few weeks, there are some patients who continue to experience symptoms that can last for months. These patients may require our care for an extended period of time.  Although much has been learned about COVID-19 over the past couple of years, there is still a great deal that’s not known. The topic for this podcast is post-COVID syndrome and our guest is Greg Vanichkachorn, M.D., M.P.H., a preventive medicine physician and specialist in Public Health. We’ll discuss the typical symptoms, duration of symptoms, and who is most likely to develop post-COVID syndrome.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3cmmib/WF764146_Post_COVID_Syndrome_FINAL921ti.mp3" length="19914091" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Greg Vanichkachorn, M.D., M.P.H. (@DoctorGregVan)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
While most patients who have COVID-19 completely recover within a few weeks, there are some patients who continue to experience symptoms that can last for months. These patients may require our care for an extended period of time.  Although much has been learned about COVID-19 over the past couple of years, there is still a great deal that’s not known. The topic for this podcast is post-COVID syndrome and our guest is Greg Vanichkachorn, M.D., M.P.H., a preventive medicine physician and specialist in Public Health. We’ll discuss the typical symptoms, duration of symptoms, and who is most likely to develop post-COVID syndrome.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1241</itunes:duration>
                <itunes:episode>319</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: COVID-19 Update</title>
        <itunes:title>Mayo Clinic Q&amp;A: COVID-19 Update</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-covid-19-update/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-covid-19-update/#comments</comments>        <pubDate>Thu, 17 Mar 2022 10:56:33 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/c0d917da-7088-3376-9958-9952447f26e5</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in March 2022</p>
<p>Guest: Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>Last week marked two years since the <a href='https://www.who.int/'>World Health Organization</a> declared COVID-19 to be a pandemic. While infection rates and hospitalizations in the U.S. continue to decline, there are some areas of concern globally.</p>
<p>"China, Hong Kong, Ireland, the U.K. and Denmark are seeing surges back up again," explains <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview'>Mayo Clinic's Vaccine Research Group</a>. "These countries, many of us experts believe, prematurely dropped mask-wearing and nonpharmaceutical interventions, and really have stopped pushing and encouraging people to get vaccinated. I think that's a mistake."</p>
<p>Dr. Poland explains that public health measures — and vaccination and boosters — are still the best way to protect yourself from COVID-19.</p>
<p>"What can I say but what we have said all along," implores Dr. Poland. "Hands, face, space and vaccines. It works."</p>
<p>On the Mayo Clinic Q&A podcast, Dr. Poland discusses the latest COVID-19 news, including a study on the true death toll of COVID-19, an update on the BA.2 variant and the latest on vaccines for children under 5.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in March 2022</p>
<p>Guest: Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>Last week marked two years since the <a href='https://www.who.int/'>World Health Organization</a> declared COVID-19 to be a pandemic. While infection rates and hospitalizations in the U.S. continue to decline, there are some areas of concern globally.</p>
<p>"China, Hong Kong, Ireland, the U.K. and Denmark are seeing surges back up again," explains <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview'>Mayo Clinic's Vaccine Research Group</a>. "These countries, many of us experts believe, prematurely dropped mask-wearing and nonpharmaceutical interventions, and really have stopped pushing and encouraging people to get vaccinated. I think that's a mistake."</p>
<p>Dr. Poland explains that public health measures — and vaccination and boosters — are still the best way to protect yourself from COVID-19.</p>
<p>"What can I say but what we have said all along," implores Dr. Poland. "Hands, face, space and vaccines. It works."</p>
<p>On the Mayo Clinic Q&A podcast, Dr. Poland discusses the latest COVID-19 news, including a study on the true death toll of COVID-19, an update on the BA.2 variant and the latest on vaccines for children under 5.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/435sr8/Mayo_Clinic_Q_A_-_Dr_Gregory_Poland_-_COVID-19_Update_-_03_16_2268qhd.mp3" length="25872675" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in March 2022
Guest: Gregory A. Poland, M.D. (@drgregpoland)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
Last week marked two years since the World Health Organization declared COVID-19 to be a pandemic. While infection rates and hospitalizations in the U.S. continue to decline, there are some areas of concern globally.
"China, Hong Kong, Ireland, the U.K. and Denmark are seeing surges back up again," explains Dr. Gregory Poland, head of Mayo Clinic's Vaccine Research Group. "These countries, many of us experts believe, prematurely dropped mask-wearing and nonpharmaceutical interventions, and really have stopped pushing and encouraging people to get vaccinated. I think that's a mistake."
Dr. Poland explains that public health measures — and vaccination and boosters — are still the best way to protect yourself from COVID-19.
"What can I say but what we have said all along," implores Dr. Poland. "Hands, face, space and vaccines. It works."
On the Mayo Clinic Q&A podcast, Dr. Poland discusses the latest COVID-19 news, including a study on the true death toll of COVID-19, an update on the BA.2 variant and the latest on vaccines for children under 5.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1611</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Skin Cancer and Skin Lesions: What to Look For</title>
        <itunes:title>Skin Cancer and Skin Lesions: What to Look For</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/skin-cancer-and-skin-lesions-what-to-look-for/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/skin-cancer-and-skin-lesions-what-to-look-for/#comments</comments>        <pubDate>Tue, 15 Mar 2022 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/a5a54b6f-3f3d-3ca0-aab2-f35564d3b603</guid>
                                    <description><![CDATA[<p>Guest: Dawn Marie R. Davis, M.D.</p>
<p>Host: Sanjeev (Sanj) Kakar, M.D. (<a href='https://twitter.com/sanjkakar'>@sanjkakar</a>)</p>
<p>Did you know that skin cancer is the number one cancer in the United States, with an estimated 3.5 million cases a year? In fact, your lifetime incidence is 1 in 5, or 20%. In this week’s podcast, Dawn Marie R. Davis, M.D., a Pediatric and Adult Dermatologist at Mayo Clinic in Rochester, Minnesota, discusses all things skin cancer. She provides tips and tricks in the management of common forms of skin cancer that providers need to be aware of when patients present with skin lesions. Dr. Davis also discusses the role of skin-protecting creams and their applicability to persons of all skin colors.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Dawn Marie R. Davis, M.D.</p>
<p>Host: Sanjeev (Sanj) Kakar, M.D. (<a href='https://twitter.com/sanjkakar'>@sanjkakar</a>)</p>
<p>Did you know that skin cancer is the number one cancer in the United States, with an estimated 3.5 million cases a year? In fact, your lifetime incidence is 1 in 5, or 20%. In this week’s podcast, Dawn Marie R. Davis, M.D., a Pediatric and Adult Dermatologist at Mayo Clinic in Rochester, Minnesota, discusses all things skin cancer. She provides tips and tricks in the management of common forms of skin cancer that providers need to be aware of when patients present with skin lesions. Dr. Davis also discusses the role of skin-protecting creams and their applicability to persons of all skin colors.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/agj74p/WF717804_Skin_Care_FINALa86c0.mp3" length="21986636" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Dawn Marie R. Davis, M.D.
Host: Sanjeev (Sanj) Kakar, M.D. (@sanjkakar)
Did you know that skin cancer is the number one cancer in the United States, with an estimated 3.5 million cases a year? In fact, your lifetime incidence is 1 in 5, or 20%. In this week’s podcast, Dawn Marie R. Davis, M.D., a Pediatric and Adult Dermatologist at Mayo Clinic in Rochester, Minnesota, discusses all things skin cancer. She provides tips and tricks in the management of common forms of skin cancer that providers need to be aware of when patients present with skin lesions. Dr. Davis also discusses the role of skin-protecting creams and their applicability to persons of all skin colors.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
 ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1371</itunes:duration>
                <itunes:episode>318</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mild Cognitive Impairment, Dementia, and Alzheimer’s Disease</title>
        <itunes:title>Mild Cognitive Impairment, Dementia, and Alzheimer’s Disease</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/alzheimer-s-disease/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/alzheimer-s-disease/#comments</comments>        <pubDate>Tue, 08 Mar 2022 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/3f8226c5-6246-3fc2-92a2-83207c39b9cf</guid>
                                    <description><![CDATA[<p>Guest: Ronald C. Petersen, M.D., Ph.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Nearly six million people in the United States age 65 and older have Alzheimer’s Disease; of these about 80% are 75 years old and older. It is a devastating disease, not only for the patient, but also for the family of the patient involved. Unfortunately, currently available treatment for Alzheimer’s has been disappointing. Cure or even stability of the cognitive loss is not possible. The topics for today’s podcast include mild cognitive impairment and dementia, focusing on Alzheimer’s Disease, and our guest is Ronald C. Petersen, M.D., a Mayo Clinic neurologist and specialist in Alzheimer’s Disease and other dementias. We’ll discuss the evaluation, the current available treatment as well as what might be on the horizon in the management of this disease.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Ronald C. Petersen, M.D., Ph.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Nearly six million people in the United States age 65 and older have Alzheimer’s Disease; of these about 80% are 75 years old and older. It is a devastating disease, not only for the patient, but also for the family of the patient involved. Unfortunately, currently available treatment for Alzheimer’s has been disappointing. Cure or even stability of the cognitive loss is not possible. The topics for today’s podcast include mild cognitive impairment and dementia, focusing on Alzheimer’s Disease, and our guest is Ronald C. Petersen, M.D., a Mayo Clinic neurologist and specialist in Alzheimer’s Disease and other dementias. We’ll discuss the evaluation, the current available treatment as well as what might be on the horizon in the management of this disease.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xuhtyu/WF712271_Alzheimers_FINALbku0z.mp3" length="28246212" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Ronald C. Petersen, M.D., Ph.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Nearly six million people in the United States age 65 and older have Alzheimer’s Disease; of these about 80% are 75 years old and older. It is a devastating disease, not only for the patient, but also for the family of the patient involved. Unfortunately, currently available treatment for Alzheimer’s has been disappointing. Cure or even stability of the cognitive loss is not possible. The topics for today’s podcast include mild cognitive impairment and dementia, focusing on Alzheimer’s Disease, and our guest is Ronald C. Petersen, M.D., a Mayo Clinic neurologist and specialist in Alzheimer’s Disease and other dementias. We’ll discuss the evaluation, the current available treatment as well as what might be on the horizon in the management of this disease.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1763</itunes:duration>
                <itunes:episode>317</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Heart Disease in Women</title>
        <itunes:title>Heart Disease in Women</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/heart-disease-in-women/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/heart-disease-in-women/#comments</comments>        <pubDate>Tue, 01 Mar 2022 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/bc740830-e88e-39f7-91ac-7f2fd290b985</guid>
                                    <description><![CDATA[<p>Guest: Sharonne N. Hayes, M.D. (<a href='https://twitter.com/SharonneHayes'>@SharonneHayes</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p> </p>
<p>Cardiovascular disease remains the leading cause of death for individuals in the United States. Many assume this is primarily a disease of men, but it also continues to be the leading cause of mortality in women, accounting for one of every three female deaths. There’s also evidence that symptoms of cardiovascular disease may be somewhat different than in males. As a result, women are often given a different evaluation and may receive different treatment than males. To help us sort this out, our guest for this podcast is Sharonne N. Hayes, M.D., a cardiologist and specialist in women’s heart disease from the Mayo Clinic. We’ll discuss the misconceptions of cardiovascular disease in women, the variety of symptoms they may develop and treatment considerations that may be different than men typically receive.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Sharonne N. Hayes, M.D. (<a href='https://twitter.com/SharonneHayes'>@SharonneHayes</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p> </p>
<p>Cardiovascular disease remains the leading cause of death for individuals in the United States. Many assume this is primarily a disease of men, but it also continues to be the leading cause of mortality in women, accounting for one of every three female deaths. There’s also evidence that symptoms of cardiovascular disease may be somewhat different than in males. As a result, women are often given a different evaluation and may receive different treatment than males. To help us sort this out, our guest for this podcast is Sharonne N. Hayes, M.D., a cardiologist and specialist in women’s heart disease from the Mayo Clinic. We’ll discuss the misconceptions of cardiovascular disease in women, the variety of symptoms they may develop and treatment considerations that may be different than men typically receive.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rq3iuh/WF691052_SCAD_FINALbjoiq.mp3" length="22084808" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Sharonne N. Hayes, M.D. (@SharonneHayes)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
 
Cardiovascular disease remains the leading cause of death for individuals in the United States. Many assume this is primarily a disease of men, but it also continues to be the leading cause of mortality in women, accounting for one of every three female deaths. There’s also evidence that symptoms of cardiovascular disease may be somewhat different than in males. As a result, women are often given a different evaluation and may receive different treatment than males. To help us sort this out, our guest for this podcast is Sharonne N. Hayes, M.D., a cardiologist and specialist in women’s heart disease from the Mayo Clinic. We’ll discuss the misconceptions of cardiovascular disease in women, the variety of symptoms they may develop and treatment considerations that may be different than men typically receive.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
 ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1376</itunes:duration>
                <itunes:episode>316</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Amyloidosis: Recognition, Diagnosis and Treatment</title>
        <itunes:title>Amyloidosis: Recognition, Diagnosis and Treatment</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/amyloidosis-recognition-diagnosis-and-treatment/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/amyloidosis-recognition-diagnosis-and-treatment/#comments</comments>        <pubDate>Tue, 22 Feb 2022 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/54636cf8-7633-3c5a-a26e-5fb5841b578e</guid>
                                    <description><![CDATA[<p>Guest: Eli Muchtar, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Amyloidosis is an uncommon disease, possibly even considered rare. It has a variety of presentations and some varieties tend to occur in association with other diseases. The presenting symptoms depend on the organ system involved. Unless we think of the condition, we may miss the opportunity to diagnose it early. As a result, many patients are diagnosed with amyloidosis at a rather advanced stage. The topic for this podcast is amyloidosis and our guest is Eli Muchtar, M.D., from the Division of Hematology at the Mayo Clinic. We’ll discuss the common organ systems affected by amyloidosis, how it’s diagnosed, the available treatment and the research currently taking place in amyloidosis.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Eli Muchtar, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Amyloidosis is an uncommon disease, possibly even considered rare. It has a variety of presentations and some varieties tend to occur in association with other diseases. The presenting symptoms depend on the organ system involved. Unless we think of the condition, we may miss the opportunity to diagnose it early. As a result, many patients are diagnosed with amyloidosis at a rather advanced stage. The topic for this podcast is amyloidosis and our guest is Eli Muchtar, M.D., from the Division of Hematology at the Mayo Clinic. We’ll discuss the common organ systems affected by amyloidosis, how it’s diagnosed, the available treatment and the research currently taking place in amyloidosis.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/yr984p/WF691061_Amyloidosis_FINALbvmgx.mp3" length="25788989" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Eli Muchtar, M.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Amyloidosis is an uncommon disease, possibly even considered rare. It has a variety of presentations and some varieties tend to occur in association with other diseases. The presenting symptoms depend on the organ system involved. Unless we think of the condition, we may miss the opportunity to diagnose it early. As a result, many patients are diagnosed with amyloidosis at a rather advanced stage. The topic for this podcast is amyloidosis and our guest is Eli Muchtar, M.D., from the Division of Hematology at the Mayo Clinic. We’ll discuss the common organ systems affected by amyloidosis, how it’s diagnosed, the available treatment and the research currently taking place in amyloidosis.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1605</itunes:duration>
                <itunes:episode>311</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: COVID-19 News Update</title>
        <itunes:title>Mayo Clinic Q&amp;A: COVID-19 News Update</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-covid-19-news-update/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-covid-19-news-update/#comments</comments>        <pubDate>Thu, 17 Feb 2022 09:32:12 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/c3043ab4-1ec3-3e92-8a72-23c17c5d04e2</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in February 2022</p>
<p>Guest: Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>As the U.S. moves beyond the omicron surge of the <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> pandemic, key indicators are dropping.</p>
<p>"Both the acute indicators — number of cases — and the lagging indicators — hospitalizations and then deaths — are all dropping slowly, but they're surely dropping," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview'>Mayo Clinic's Vaccine Research Group</a>. </p>
<p>Experts warn that <a href='https://newsnetwork.mayoclinic.org/discussion/cases-down-but-mayo-clinic-expert-says-covid-19-pandemic-isnt-over/'>caution is still needed</a> to protect yourself in certain situations, including masking in crowded indoor settings and making sure you are up to date with your COVID-19 vaccinations and boosters.</p>
<p>While the latest surge wanes, COVID-19 research continues. </p>
<p>On the Mayo Clinic Q&A podcast, Dr. Poland discusses the latest COVID-19 news, including a new study on the <a href='https://www.nature.com/articles/s41591-022-01689-3'>long-term effects of COVID-19 on the heart</a> and why Pfizer is delaying the request for emergency use authorization of its COVID-19 vaccine for children under 5.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in February 2022</p>
<p>Guest: Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>As the U.S. moves beyond the omicron surge of the <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> pandemic, key indicators are dropping.</p>
<p>"Both the acute indicators — number of cases — and the lagging indicators — hospitalizations and then deaths — are all dropping slowly, but they're surely dropping," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview'>Mayo Clinic's Vaccine Research Group</a>. </p>
<p>Experts warn that <a href='https://newsnetwork.mayoclinic.org/discussion/cases-down-but-mayo-clinic-expert-says-covid-19-pandemic-isnt-over/'>caution is still needed</a> to protect yourself in certain situations, including masking in crowded indoor settings and making sure you are up to date with your COVID-19 vaccinations and boosters.</p>
<p>While the latest surge wanes, COVID-19 research continues. </p>
<p>On the Mayo Clinic Q&A podcast, Dr. Poland discusses the latest COVID-19 news, including a new study on the <a href='https://www.nature.com/articles/s41591-022-01689-3'>long-term effects of COVID-19 on the heart</a> and why Pfizer is delaying the request for emergency use authorization of its COVID-19 vaccine for children under 5.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xxkkwi/Mayo_Clinic_Q_A_-_Dr_Gregory_Poland_-_COVID-19_Update_-_02_16_22ad0nu.mp3" length="13914068" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in February 2022
Guest: Gregory A. Poland, M.D. (@drgregpoland)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
As the U.S. moves beyond the omicron surge of the COVID-19 pandemic, key indicators are dropping.
"Both the acute indicators — number of cases — and the lagging indicators — hospitalizations and then deaths — are all dropping slowly, but they're surely dropping," says Dr. Gregory Poland, head of Mayo Clinic's Vaccine Research Group. 
Experts warn that caution is still needed to protect yourself in certain situations, including masking in crowded indoor settings and making sure you are up to date with your COVID-19 vaccinations and boosters.
While the latest surge wanes, COVID-19 research continues. 
On the Mayo Clinic Q&A podcast, Dr. Poland discusses the latest COVID-19 news, including a new study on the long-term effects of COVID-19 on the heart and why Pfizer is delaying the request for emergency use authorization of its COVID-19 vaccine for children under 5.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1153</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Infertility in Males</title>
        <itunes:title>Infertility in Males</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/infertility-in-males/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/infertility-in-males/#comments</comments>        <pubDate>Tue, 15 Feb 2022 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/5f3a663a-d379-30f2-b3d1-a4f9a46fce28</guid>
                                    <description><![CDATA[<p>Guest: Sevann Helo, M.D. (<a href='https://twitter.com/Helo_MD'>@Helo_MD</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Approximately one in seven couples is considered infertile. In a significant number of these couples, male infertility plays a role. Many of these couples will initially present to their primary care provider for help. Depending on our practice, we may not see all that many patients with this concern and, as a result, we might not be comfortable with the evaluation of the infertile couple. Today’s podcast will review infertility in males and hopefully give us a better understanding of the causes of infertility and how to evaluate the infertile male. Our guest for today’s podcast is Sevann Helo, M.D., a urologist at the Mayo Clinic. We’ll discuss what it takes for fertilization to take place, risk factors for infertility in males, the evaluation of the male for infertility, potential treatment options and effectiveness of treatment.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Sevann Helo, M.D. (<a href='https://twitter.com/Helo_MD'>@Helo_MD</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Approximately one in seven couples is considered infertile. In a significant number of these couples, male infertility plays a role. Many of these couples will initially present to their primary care provider for help. Depending on our practice, we may not see all that many patients with this concern and, as a result, we might not be comfortable with the evaluation of the infertile couple. Today’s podcast will review infertility in males and hopefully give us a better understanding of the causes of infertility and how to evaluate the infertile male. Our guest for today’s podcast is Sevann Helo, M.D., a urologist at the Mayo Clinic. We’ll discuss what it takes for fertilization to take place, risk factors for infertility in males, the evaluation of the male for infertility, potential treatment options and effectiveness of treatment.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jz6qgs/WF691601_Male_Infertility_FINALbtnyu.mp3" length="16875406" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Sevann Helo, M.D. (@Helo_MD)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Approximately one in seven couples is considered infertile. In a significant number of these couples, male infertility plays a role. Many of these couples will initially present to their primary care provider for help. Depending on our practice, we may not see all that many patients with this concern and, as a result, we might not be comfortable with the evaluation of the infertile couple. Today’s podcast will review infertility in males and hopefully give us a better understanding of the causes of infertility and how to evaluate the infertile male. Our guest for today’s podcast is Sevann Helo, M.D., a urologist at the Mayo Clinic. We’ll discuss what it takes for fertilization to take place, risk factors for infertility in males, the evaluation of the male for infertility, potential treatment options and effectiveness of treatment.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1050</itunes:duration>
                <itunes:episode>315</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Dental Infections in the Primary Care Setting</title>
        <itunes:title>Dental Infections in the Primary Care Setting</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/dental-infections-in-the-primary-care-setting/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/dental-infections-in-the-primary-care-setting/#comments</comments>        <pubDate>Tue, 08 Feb 2022 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/7ee5c6d4-ecf8-3cf0-a6ee-7b6432138a43</guid>
                                    <description><![CDATA[<p>Guest: Olivia (Liv) M. Muller, D.D.S.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Dental caries and periodontal disease are commonly seen by primary care providers in the outpatient setting. In fact, dental caries is the most common disease in the United States, both in children and adults. Up to 50% of children have dental caries, and most adults have at least one tooth with decay or have a filling. Gingivitis is also quite common in adults; it is present in up to half of all individuals between the ages of 35 and 45. Yet, unless we go into dentistry, healthcare providers don’t get much training in the evaluation of dental conditions. The topic of discussion for this podcast is dental care and dental infections. Our guest is Olivia (Liv) M. Muller, D.D.S., an Assistant Professor of Dentistry at the Mayo Clinic. We’ll discuss which dental problems we’re likely to encounter in our patients, recommendations we can give them to prevent dental infections and some of the more common complications of dental infections.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Olivia (Liv) M. Muller, D.D.S.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Dental caries and periodontal disease are commonly seen by primary care providers in the outpatient setting. In fact, dental caries is the most common disease in the United States, both in children and adults. Up to 50% of children have dental caries, and most adults have at least one tooth with decay or have a filling. Gingivitis is also quite common in adults; it is present in up to half of all individuals between the ages of 35 and 45. Yet, unless we go into dentistry, healthcare providers don’t get much training in the evaluation of dental conditions. The topic of discussion for this podcast is dental care and dental infections. Our guest is Olivia (Liv) M. Muller, D.D.S., an Assistant Professor of Dentistry at the Mayo Clinic. We’ll discuss which dental problems we’re likely to encounter in our patients, recommendations we can give them to prevent dental infections and some of the more common complications of dental infections.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/btyidb/WF691602_Dental_Infections_FINAL7iam3.mp3" length="21701477" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Olivia (Liv) M. Muller, D.D.S.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Dental caries and periodontal disease are commonly seen by primary care providers in the outpatient setting. In fact, dental caries is the most common disease in the United States, both in children and adults. Up to 50% of children have dental caries, and most adults have at least one tooth with decay or have a filling. Gingivitis is also quite common in adults; it is present in up to half of all individuals between the ages of 35 and 45. Yet, unless we go into dentistry, healthcare providers don’t get much training in the evaluation of dental conditions. The topic of discussion for this podcast is dental care and dental infections. Our guest is Olivia (Liv) M. Muller, D.D.S., an Assistant Professor of Dentistry at the Mayo Clinic. We’ll discuss which dental problems we’re likely to encounter in our patients, recommendations we can give them to prevent dental infections and some of the more common complications of dental infections.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1352</itunes:duration>
                <itunes:episode>314</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: Omicron wave wanes, new variant arises</title>
        <itunes:title>Mayo Clinic Q&amp;A: Omicron wave wanes, new variant arises</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-covid-19-testing-scenarios-%e2%80%94-what-test-and-when-1643923582/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-covid-19-testing-scenarios-%e2%80%94-what-test-and-when-1643923582/#comments</comments>        <pubDate>Thu, 03 Feb 2022 15:39:29 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/9495cf9a-f82c-32ad-ad65-0885c801c453</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in January 2022</p>
<p>Guest: Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>The number of new <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> cases in the U.S. is dropping as the omicron wave wanes in many places, but some parts of the country lag behind.</p>
<p>"As a nation, it looks like we've kind of gotten to the peak and are now starting on the decline, but it's very uneven," explains <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview'>Mayo Clinic's Vaccine Research Group</a>. "That's what's happening in the big Northeast cities, and maybe in L.A., for example. But if you look at the rest of the nation, it's not clear that they have peaked yet."</p>
<p>And on the heels of the latest surge, a <a href='https://newsnetwork.mayoclinic.org/discussion/what-mayo-clinic-covid-19-experts-know-about-new-omicron-ba-2-subvariant/'>new omicron subvariant</a> — BA.2 — is emerging. Early indications are that the new subvariant may be more transmissible, but it does not appear to cause more severe disease than the original omicron strain.</p>
<p>Mayo experts, including Dr. Poland, continue to urge COVID-19 vaccinations and boosters as the best defense against the latest variants. </p>
<p>"By getting two doses of vaccine and a booster, or a dose of Johnson & Johnson and a booster, you move yourself into a category of maximal protection such that if you have a normal immune system, you are probably going to have trivial or even asymptomatic disease if you get infected with COVID-19," explains Dr. Poland. </p>
<p>On the Mayo Clinic Q&A podcast, Dr. Poland discusses the latest information on COVID-19 and answers listener questions.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in January 2022</p>
<p>Guest: Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>The number of new <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> cases in the U.S. is dropping as the omicron wave wanes in many places, but some parts of the country lag behind.</p>
<p>"As a nation, it looks like we've kind of gotten to the peak and are now starting on the decline, but it's very uneven," explains <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview'>Mayo Clinic's Vaccine Research Group</a>. "That's what's happening in the big Northeast cities, and maybe in L.A., for example. But if you look at the rest of the nation, it's not clear that they have peaked yet."</p>
<p>And on the heels of the latest surge, a <a href='https://newsnetwork.mayoclinic.org/discussion/what-mayo-clinic-covid-19-experts-know-about-new-omicron-ba-2-subvariant/'>new omicron subvariant</a> — BA.2 — is emerging. Early indications are that the new subvariant may be more transmissible, but it does not appear to cause more severe disease than the original omicron strain.</p>
<p>Mayo experts, including Dr. Poland, continue to urge COVID-19 vaccinations and boosters as the best defense against the latest variants. </p>
<p>"By getting two doses of vaccine and a booster, or a dose of Johnson & Johnson and a booster, you move yourself into a category of maximal protection such that if you have a normal immune system, you are probably going to have trivial or even asymptomatic disease if you get infected with COVID-19," explains Dr. Poland. </p>
<p>On the Mayo Clinic Q&A podcast, Dr. Poland discusses the latest information on COVID-19 and answers listener questions.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nz632a/Mayo_Clinic_Q_A_-_Dr_Gregory_Poland_-_COVID-19_Update_-_02_02_22bn6su.mp3" length="17333537" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in January 2022
Guest: Gregory A. Poland, M.D. (@drgregpoland)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
The number of new COVID-19 cases in the U.S. is dropping as the omicron wave wanes in many places, but some parts of the country lag behind.
"As a nation, it looks like we've kind of gotten to the peak and are now starting on the decline, but it's very uneven," explains Dr. Gregory Poland, head of Mayo Clinic's Vaccine Research Group. "That's what's happening in the big Northeast cities, and maybe in L.A., for example. But if you look at the rest of the nation, it's not clear that they have peaked yet."
And on the heels of the latest surge, a new omicron subvariant — BA.2 — is emerging. Early indications are that the new subvariant may be more transmissible, but it does not appear to cause more severe disease than the original omicron strain.
Mayo experts, including Dr. Poland, continue to urge COVID-19 vaccinations and boosters as the best defense against the latest variants. 
"By getting two doses of vaccine and a booster, or a dose of Johnson & Johnson and a booster, you move yourself into a category of maximal protection such that if you have a normal immune system, you are probably going to have trivial or even asymptomatic disease if you get infected with COVID-19," explains Dr. Poland. 
On the Mayo Clinic Q&A podcast, Dr. Poland discusses the latest information on COVID-19 and answers listener questions.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1437</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Shining a Light on Seasonal Affective Disorder</title>
        <itunes:title>Shining a Light on Seasonal Affective Disorder</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/shining-a-light-on-seasonal-affective-disorder/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/shining-a-light-on-seasonal-affective-disorder/#comments</comments>        <pubDate>Tue, 01 Feb 2022 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/140d3196-fa48-3676-9b7b-b5066980ab65</guid>
                                    <description><![CDATA[<p>Guest: Craig N. Sawchuk, Ph.D., L.P.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>It is quite common for individuals to go through periods where they feel somewhat sad and discouraged and often these mood changes tend to occur with the changes in seasons, especially during the winter months. In some cases, these mood changes become more serious and can result in depression. When people experience depressive episodes in the late fall and winter, this may represent Seasonal Affective Disorder. Our guest today is Craig N. Sawchuk, Ph.D., L.P., a psychologist in the Department of Psychiatry & Psychology at the Mayo Clinic. Our topic for this podcast is Seasonal Affective Disorder. We’ll discuss its frequency, how we can recognize it in our patients, and the available treatment options.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Craig N. Sawchuk, Ph.D., L.P.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>It is quite common for individuals to go through periods where they feel somewhat sad and discouraged and often these mood changes tend to occur with the changes in seasons, especially during the winter months. In some cases, these mood changes become more serious and can result in depression. When people experience depressive episodes in the late fall and winter, this may represent Seasonal Affective Disorder. Our guest today is Craig N. Sawchuk, Ph.D., L.P., a psychologist in the Department of Psychiatry & Psychology at the Mayo Clinic. Our topic for this podcast is Seasonal Affective Disorder. We’ll discuss its frequency, how we can recognize it in our patients, and the available treatment options.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rykfg3/WF710661_Seasonal_Affective_Disorder_FINALaaz38.mp3" length="26291602" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Craig N. Sawchuk, Ph.D., L.P.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
It is quite common for individuals to go through periods where they feel somewhat sad and discouraged and often these mood changes tend to occur with the changes in seasons, especially during the winter months. In some cases, these mood changes become more serious and can result in depression. When people experience depressive episodes in the late fall and winter, this may represent Seasonal Affective Disorder. Our guest today is Craig N. Sawchuk, Ph.D., L.P., a psychologist in the Department of Psychiatry & Psychology at the Mayo Clinic. Our topic for this podcast is Seasonal Affective Disorder. We’ll discuss its frequency, how we can recognize it in our patients, and the available treatment options.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1635</itunes:duration>
                <itunes:episode>313</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: COVID-19 testing scenarios — what test and when?</title>
        <itunes:title>Mayo Clinic Q&amp;A: COVID-19 testing scenarios — what test and when?</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-covid-19-testing-scenarios-%e2%80%94-what-test-and-when/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-covid-19-testing-scenarios-%e2%80%94-what-test-and-when/#comments</comments>        <pubDate>Thu, 27 Jan 2022 15:35:54 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/b3092221-3745-3a9c-9619-aa6e9373fd73</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in January 2022</p>
<p>Guest: Matthew J. Binnicker, Ph.D. (<a href='https://mobile.twitter.com/DrMattBinnicker'>@DrMattBinnicker</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>Testing for COVID-19 is a part of the strategy to end the pandemic. But understanding testing — <a href='https://newsnetwork.mayoclinic.org/discussion/covid-19-tests-different-types-and-when-to-use-them/'>different types of tests and how and when to use them</a> — can be confusing. Lab-run polymerase chain reaction, or PCR, tests and at-home antigen tests each have a role.</p>
<p>"PCR tests are really sensitive, meaning we can detect really low levels of the virus in a sample," explains <a href='https://www.mayoclinic.org/biographies/binnicker-matthew-j-ph-d/bio-20513862'>Dr. Matthew Binnicker</a>, director of Clinical Virology at Mayo Clinic. "They're very specific, meaning we shouldn't get many false positive results with PCR tests."</p>
<p>At-home antigen tests use a nasal swab and can produce results in 15 minutes, but they also have an increased chance of false-negative results, depending on when you test. </p>
<p>"At-home rapid antigen tests look for a viral protein in the patient sample," says Dr. Binnicker. "So they're quick and easy, but they also have some important limitations."</p>
<p>So if you're worried you might have COVID-19, what test should you take and when? </p>
<p>On the Q&A podcast, Dr. Binnicker walks through various scenarios and makes testing recommendations for what to do if:</p>
<ul><li>You think you’ve been exposed but I don’t have symptoms.</li>
<li>You have symptoms of COVID-19.</li>
<li>You had COVID-19 and want to know if you're “in the clear” to return to work, school or activities.</li>
</ul>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in January 2022</p>
<p>Guest: Matthew J. Binnicker, Ph.D. (<a href='https://mobile.twitter.com/DrMattBinnicker'>@DrMattBinnicker</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>Testing for COVID-19 is a part of the strategy to end the pandemic. But understanding testing — <a href='https://newsnetwork.mayoclinic.org/discussion/covid-19-tests-different-types-and-when-to-use-them/'>different types of tests and how and when to use them</a> — can be confusing. Lab-run polymerase chain reaction, or PCR, tests and at-home antigen tests each have a role.</p>
<p>"PCR tests are really sensitive, meaning we can detect really low levels of the virus in a sample," explains <a href='https://www.mayoclinic.org/biographies/binnicker-matthew-j-ph-d/bio-20513862'>Dr. Matthew Binnicker</a>, director of Clinical Virology at Mayo Clinic. "They're very specific, meaning we shouldn't get many false positive results with PCR tests."</p>
<p>At-home antigen tests use a nasal swab and can produce results in 15 minutes, but they also have an increased chance of false-negative results, depending on when you test. </p>
<p>"At-home rapid antigen tests look for a viral protein in the patient sample," says Dr. Binnicker. "So they're quick and easy, but they also have some important limitations."</p>
<p>So if you're worried you might have COVID-19, what test should you take and when? </p>
<p>On the Q&A podcast, Dr. Binnicker walks through various scenarios and makes testing recommendations for what to do if:</p>
<ul><li>You think you’ve been exposed but I don’t have symptoms.</li>
<li>You have symptoms of COVID-19.</li>
<li>You had COVID-19 and want to know if you're “in the clear” to return to work, school or activities.</li>
</ul>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/q3wa8d/Mayo_Clinic_Q_A_-_Dr_Matthew_Binnicker_-_COVID-19_testing_01_26_2296llp.mp3" length="16626072" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in January 2022
Guest: Matthew J. Binnicker, Ph.D. (@DrMattBinnicker)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
Testing for COVID-19 is a part of the strategy to end the pandemic. But understanding testing — different types of tests and how and when to use them — can be confusing. Lab-run polymerase chain reaction, or PCR, tests and at-home antigen tests each have a role.
"PCR tests are really sensitive, meaning we can detect really low levels of the virus in a sample," explains Dr. Matthew Binnicker, director of Clinical Virology at Mayo Clinic. "They're very specific, meaning we shouldn't get many false positive results with PCR tests."
At-home antigen tests use a nasal swab and can produce results in 15 minutes, but they also have an increased chance of false-negative results, depending on when you test. 
"At-home rapid antigen tests look for a viral protein in the patient sample," says Dr. Binnicker. "So they're quick and easy, but they also have some important limitations."
So if you're worried you might have COVID-19, what test should you take and when? 
On the Q&A podcast, Dr. Binnicker walks through various scenarios and makes testing recommendations for what to do if:
You think you’ve been exposed but I don’t have symptoms.
You have symptoms of COVID-19.
You had COVID-19 and want to know if you're “in the clear” to return to work, school or activities.
]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1033</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Chiropractic Care for Back Pain</title>
        <itunes:title>Chiropractic Care for Back Pain</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/chiropractic-care-for-back-pain/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/chiropractic-care-for-back-pain/#comments</comments>        <pubDate>Tue, 25 Jan 2022 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/e5b01436-1cfe-3fb9-bc07-02fa61c21ab9</guid>
                                    <description><![CDATA[<p>Guest: Benjamin (Ben) D. Holmes, D.C., Ph.D.</p>
<p>Host: Edward R. Laskowski, M.D. (<a href='https://twitter.com/DrEdSportsMed'>@DrEdSportsMed</a>)</p>
<p>Low back pain is one of the most common conditions that physicians see in their practices. Studies indicate that, by the age of 50 years old, approximately 80% of people will experience low back pain in their lives. Joining us today is Benjamin D. Holmes, D.C., Ph.D. a practicing chiropractor and one of the spine specialists in the Mayo Clinic Spine Center. Dr. Holmes will discuss various treatment interventions for back pain, as well as misconceptions and assumptions regarding chiropractic treatment. </p>
<p>Additional Resources:</p>
<ul><li>Foster, N. E., Anema, J. R., Cherkin, D., Chou, R., Cohen, S. P., Gross, D. P., ... & Woolf, A. (2018). Prevention and treatment of low back pain: evidence, challenges, and promising directions. The Lancet, 391(10137), 2368-2383.</li>
<li>Bialosky, J. E., George, S. Z., Horn, M. E., Price, D. D., Staud, R., & Robinson, M. E. (2014). Spinal manipulative therapy–specific changes in pain sensitivity in individuals with low back pain (NCT01168999). The Journal of Pain, 15(2), 136-148.</li>
<li>Cook, C., Learman, K., Showalter, C., Kabbaz, V., & O'Halloran, B. (2013). Early use of thrust manipulation versus non-thrust manipulation: a randomized clinical trial. Manual Therapy, 18(3), 191-198.</li>
<li>Chou, R., Fu, R., Carrino, J. A., & Deyo, R. A. (2009). Imaging strategies for low-back pain: systematic review and meta-analysis. The Lancet, 373(9662), 463-472.</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Benjamin (Ben) D. Holmes, D.C., Ph.D.</p>
<p>Host: Edward R. Laskowski, M.D. (<a href='https://twitter.com/DrEdSportsMed'>@DrEdSportsMed</a>)</p>
<p>Low back pain is one of the most common conditions that physicians see in their practices. Studies indicate that, by the age of 50 years old, approximately 80% of people will experience low back pain in their lives. Joining us today is Benjamin D. Holmes, D.C., Ph.D. a practicing chiropractor and one of the spine specialists in the Mayo Clinic Spine Center. Dr. Holmes will discuss various treatment interventions for back pain, as well as misconceptions and assumptions regarding chiropractic treatment. </p>
<p>Additional Resources:</p>
<ul><li>Foster, N. E., Anema, J. R., Cherkin, D., Chou, R., Cohen, S. P., Gross, D. P., ... & Woolf, A. (2018). Prevention and treatment of low back pain: evidence, challenges, and promising directions. <em>The Lancet</em>, <em>391</em>(10137), 2368-2383.</li>
<li>Bialosky, J. E., George, S. Z., Horn, M. E., Price, D. D., Staud, R., & Robinson, M. E. (2014). Spinal manipulative therapy–specific changes in pain sensitivity in individuals with low back pain (NCT01168999). <em>The Journal of Pain</em>, <em>15</em>(2), 136-148.</li>
<li>Cook, C., Learman, K., Showalter, C., Kabbaz, V., & O'Halloran, B. (2013). Early use of thrust manipulation versus non-thrust manipulation: a randomized clinical trial. <em>Manual Therapy</em>, <em>18</em>(3), 191-198.</li>
<li>Chou, R., Fu, R., Carrino, J. A., & Deyo, R. A. (2009). Imaging strategies for low-back pain: systematic review and meta-analysis. <em>The Lancet</em>, <em>373</em>(9662), 463-472.</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/w2kchn/21R01084_312_FINAL.mp3" length="25142898" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Benjamin (Ben) D. Holmes, D.C., Ph.D.
Host: Edward R. Laskowski, M.D. (@DrEdSportsMed)
Low back pain is one of the most common conditions that physicians see in their practices. Studies indicate that, by the age of 50 years old, approximately 80% of people will experience low back pain in their lives. Joining us today is Benjamin D. Holmes, D.C., Ph.D. a practicing chiropractor and one of the spine specialists in the Mayo Clinic Spine Center. Dr. Holmes will discuss various treatment interventions for back pain, as well as misconceptions and assumptions regarding chiropractic treatment. 
Additional Resources:
Foster, N. E., Anema, J. R., Cherkin, D., Chou, R., Cohen, S. P., Gross, D. P., ... & Woolf, A. (2018). Prevention and treatment of low back pain: evidence, challenges, and promising directions. The Lancet, 391(10137), 2368-2383.
Bialosky, J. E., George, S. Z., Horn, M. E., Price, D. D., Staud, R., & Robinson, M. E. (2014). Spinal manipulative therapy–specific changes in pain sensitivity in individuals with low back pain (NCT01168999). The Journal of Pain, 15(2), 136-148.
Cook, C., Learman, K., Showalter, C., Kabbaz, V., & O'Halloran, B. (2013). Early use of thrust manipulation versus non-thrust manipulation: a randomized clinical trial. Manual Therapy, 18(3), 191-198.
Chou, R., Fu, R., Carrino, J. A., & Deyo, R. A. (2009). Imaging strategies for low-back pain: systematic review and meta-analysis. The Lancet, 373(9662), 463-472.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1564</itunes:duration>
                <itunes:episode>312</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: Why getting infected with COVID-19 is still a bad idea</title>
        <itunes:title>Mayo Clinic Q&amp;A: Why getting infected with COVID-19 is still a bad idea</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-why-getting-infected-with-covid-19-is-still-a-bad-idea/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-why-getting-infected-with-covid-19-is-still-a-bad-idea/#comments</comments>        <pubDate>Thu, 20 Jan 2022 09:13:21 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/80982056-efdf-3786-ae66-83c0137162c9</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in January 2022</p>
<p>Guest: Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>With the highly transmissible omicron variant spread across the U.S., it may seem inevitable that most people will get infected with <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a>. But Mayo Clinic experts explain why it is important to continue to be vigilant and take measures to avoid COVID-19 infection. </p>
<p>"One of the many negatives about saying, 'Well, I'll just go ahead and get infected and get it over with' is you can spread the virus to highly vulnerable people," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview'>Mayo Clinic's Vaccine Research Group</a>. "Parents, grandparents, people too young to be immunized, and people whose immune systems might not be working well are all at risk of more severe disease. While your case may be mild, theirs may not." </p>
<p>Dr. Poland cautions that the sheer number of infections is stressing the health care system, and <a href='https://newsnetwork.mayoclinic.org/discussion/whats-the-latest-on-monoclonal-antibody-therapies-to-treat-covid-19/'>treatments for omicron</a> are more limited than they were for the delta variant.</p>
<p>"The role of testing and of getting boosted is critical to our response to this, and remember, even though you might have mild disease, every time this virus infects somebody, it is the opportunity for further mutation." says Dr. Poland. </p>
<p>Vaccination, boosting and <a href='https://newsnetwork.mayoclinic.org/discussion/how-to-decide-what-mask-is-best-for-you/'>masking</a> are all necessary to prevent the spread of omicron.</p>
<p>"Your best chance of protecting yourself is to be fully vaccinated, wear a proper mask properly when in public, and to avoid crowded indoor settings," says Dr. Poland.</p>
<p>On the Mayo Clinic Q&A podcast, Dr. Poland discusses the omicron surge and answers listener questions.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> </a><a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> </a><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> </a><a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in January 2022</p>
<p>Guest: Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>With the highly transmissible omicron variant spread across the U.S., it may seem inevitable that most people will get infected with <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a>. But Mayo Clinic experts explain why it is important to continue to be vigilant and take measures to avoid COVID-19 infection. </p>
<p>"One of the many negatives about saying, 'Well, I'll just go ahead and get infected and get it over with' is you can spread the virus to highly vulnerable people," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview'>Mayo Clinic's Vaccine Research Group</a>. "Parents, grandparents, people too young to be immunized, and people whose immune systems might not be working well are all at risk of more severe disease. While your case may be mild, theirs may not." </p>
<p>Dr. Poland cautions that the sheer number of infections is stressing the health care system, and <a href='https://newsnetwork.mayoclinic.org/discussion/whats-the-latest-on-monoclonal-antibody-therapies-to-treat-covid-19/'>treatments for omicron</a> are more limited than they were for the delta variant.</p>
<p>"The role of testing and of getting boosted is critical to our response to this, and remember, even though you might have mild disease, every time this virus infects somebody, it is the opportunity for further mutation." says Dr. Poland. </p>
<p>Vaccination, boosting and <a href='https://newsnetwork.mayoclinic.org/discussion/how-to-decide-what-mask-is-best-for-you/'>masking</a> are all necessary to prevent the spread of omicron.</p>
<p>"Your best chance of protecting yourself is to be fully vaccinated, wear a proper mask properly when in public, and to avoid crowded indoor settings," says Dr. Poland.</p>
<p>On the Mayo Clinic Q&A podcast, Dr. Poland discusses the omicron surge and answers listener questions.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> </a><a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> </a><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> </a><a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rwgdh3/Mayo_Clinic_Q_A_-_Dr_Gregory_Poland_-_01_19_2292bvj.mp3" length="32491634" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in January 2022
Guest: Gregory A. Poland, M.D. (@drgregpoland)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
With the highly transmissible omicron variant spread across the U.S., it may seem inevitable that most people will get infected with COVID-19. But Mayo Clinic experts explain why it is important to continue to be vigilant and take measures to avoid COVID-19 infection. 
"One of the many negatives about saying, 'Well, I'll just go ahead and get infected and get it over with' is you can spread the virus to highly vulnerable people," says Dr. Gregory Poland, head of Mayo Clinic's Vaccine Research Group. "Parents, grandparents, people too young to be immunized, and people whose immune systems might not be working well are all at risk of more severe disease. While your case may be mild, theirs may not." 
Dr. Poland cautions that the sheer number of infections is stressing the health care system, and treatments for omicron are more limited than they were for the delta variant.
"The role of testing and of getting boosted is critical to our response to this, and remember, even though you might have mild disease, every time this virus infects somebody, it is the opportunity for further mutation." says Dr. Poland. 
Vaccination, boosting and masking are all necessary to prevent the spread of omicron.
"Your best chance of protecting yourself is to be fully vaccinated, wear a proper mask properly when in public, and to avoid crowded indoor settings," says Dr. Poland.
On the Mayo Clinic Q&A podcast, Dr. Poland discusses the omicron surge and answers listener questions.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2024</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Improving Medication Adherence</title>
        <itunes:title>Improving Medication Adherence</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/improving-medication-adherence/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/improving-medication-adherence/#comments</comments>        <pubDate>Tue, 18 Jan 2022 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/ab9ac677-b298-35f7-b422-6b06f339d2c6</guid>
                                    <description><![CDATA[<p>Guest: Kristina M. Thurber, Pharm.D., R.Ph.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>There are a variety of outstanding pharmaceutical products we use to treat the multiple health problems our patients develop and every year, clinical research has provided us with new and improved therapeutic options. When we prescribe a medication to a patient, we generally assume they’ll take it exactly as prescribed. Unfortunately, that’s not necessarily true. Non-adherence to chronic medications is surprisingly common and can account for up to half of all treatment failures. Our guest for this podcast is Kristina M. Thurber, Pharm.D., R.Ph., a medication therapy pharmacist at the Mayo Clinic. We’ll discuss the prevalence of medication adherence, its causes, how we can recognize it in our patients and management strategies to improve adherence.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Kristina M. Thurber, Pharm.D., R.Ph.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>There are a variety of outstanding pharmaceutical products we use to treat the multiple health problems our patients develop and every year, clinical research has provided us with new and improved therapeutic options. When we prescribe a medication to a patient, we generally assume they’ll take it exactly as prescribed. Unfortunately, that’s not necessarily true. Non-adherence to chronic medications is surprisingly common and can account for up to half of all treatment failures. Our guest for this podcast is Kristina M. Thurber, Pharm.D., R.Ph., a medication therapy pharmacist at the Mayo Clinic. We’ll discuss the prevalence of medication adherence, its causes, how we can recognize it in our patients and management strategies to improve adherence.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8du5rg/WF710657_Medication_Non-Adherance8ekqc.mp3" length="21563396" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Kristina M. Thurber, Pharm.D., R.Ph.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
There are a variety of outstanding pharmaceutical products we use to treat the multiple health problems our patients develop and every year, clinical research has provided us with new and improved therapeutic options. When we prescribe a medication to a patient, we generally assume they’ll take it exactly as prescribed. Unfortunately, that’s not necessarily true. Non-adherence to chronic medications is surprisingly common and can account for up to half of all treatment failures. Our guest for this podcast is Kristina M. Thurber, Pharm.D., R.Ph., a medication therapy pharmacist at the Mayo Clinic. We’ll discuss the prevalence of medication adherence, its causes, how we can recognize it in our patients and management strategies to improve adherence.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1343</itunes:duration>
                <itunes:episode>310</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>All Age-Related Changes May Not Be Inevitable: Senescent Cells and Anti-Aging</title>
        <itunes:title>All Age-Related Changes May Not Be Inevitable: Senescent Cells and Anti-Aging</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/all-age-related-changes-may-not-be-inevitable-senescent-cells-and-anti-aging/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/all-age-related-changes-may-not-be-inevitable-senescent-cells-and-anti-aging/#comments</comments>        <pubDate>Tue, 11 Jan 2022 07:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/2278cc18-f996-3abf-a877-01f0d2274506</guid>
                                    <description><![CDATA[<p>Guest: Nathan K. LeBrasseur, Ph.D., M.S. (<a href='https://twitter.com/NKLeBRASSEUR'>@NKLeBRASSEUR</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>The effects of aging occur in all our organs. In muscles, there is a reduction in strength and stamina; the brain shows a decrease in cognitive function and the ability to learn new information. Aging causes a reduced ability of the liver to metabolize drugs and the kidney’s ability to eliminate various waste products. Our guest for this podcast is aging researcher Nathan K. LeBrasseur, Ph.D., M.S., the senior author of a study recently published in the journal “Aging Cell.” The authors described significant benefits from exercise on a cellular level which correlated with an improvement in physical changes related to aging. We’ll discuss cellular changes which occur with aging, the significance of senescent cells and how exercise can reduce the impact of aging on both a cellular level as well as clinically.</p>
<p>Specific topics:</p>
<ul><li>The effects of aging on a cellular level</li>
<li>Variability in the rate of aging in individuals</li>
<li>Function of senescent cells</li>
<li>Effects of exercise on senescent cells</li>
<li>Clinical correlations resulting from the elimination of senescent cells</li>
<li>Recommendations clinicians can give their patients to reduce the effects of aging</li>
</ul>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Nathan K. LeBrasseur, Ph.D., M.S. (<a href='https://twitter.com/NKLeBRASSEUR'>@NKLeBRASSEUR</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>The effects of aging occur in all our organs. In muscles, there is a reduction in strength and stamina; the brain shows a decrease in cognitive function and the ability to learn new information. Aging causes a reduced ability of the liver to metabolize drugs and the kidney’s ability to eliminate various waste products. Our guest for this podcast is aging researcher Nathan K. LeBrasseur, Ph.D., M.S., the senior author of a study recently published in the journal “Aging Cell.” The authors described significant benefits from exercise on a cellular level which correlated with an improvement in physical changes related to aging. We’ll discuss cellular changes which occur with aging, the significance of senescent cells and how exercise can reduce the impact of aging on both a cellular level as well as clinically.</p>
<p>Specific topics:</p>
<ul><li>The effects of aging on a cellular level</li>
<li>Variability in the rate of aging in individuals</li>
<li>Function of senescent cells</li>
<li>Effects of exercise on senescent cells</li>
<li>Clinical correlations resulting from the elimination of senescent cells</li>
<li>Recommendations clinicians can give their patients to reduce the effects of aging</li>
</ul>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hx7rcm/WF632810_Senescent_Cells_FINALaj845.mp3" length="19920175" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Nathan K. LeBrasseur, Ph.D., M.S. (@NKLeBRASSEUR)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
The effects of aging occur in all our organs. In muscles, there is a reduction in strength and stamina; the brain shows a decrease in cognitive function and the ability to learn new information. Aging causes a reduced ability of the liver to metabolize drugs and the kidney’s ability to eliminate various waste products. Our guest for this podcast is aging researcher Nathan K. LeBrasseur, Ph.D., M.S., the senior author of a study recently published in the journal “Aging Cell.” The authors described significant benefits from exercise on a cellular level which correlated with an improvement in physical changes related to aging. We’ll discuss cellular changes which occur with aging, the significance of senescent cells and how exercise can reduce the impact of aging on both a cellular level as well as clinically.
Specific topics:
The effects of aging on a cellular level
Variability in the rate of aging in individuals
Function of senescent cells
Effects of exercise on senescent cells
Clinical correlations resulting from the elimination of senescent cells
Recommendations clinicians can give their patients to reduce the effects of aging
]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1480</itunes:duration>
                <itunes:episode>308</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: January Bringing an Omicron Surge</title>
        <itunes:title>Mayo Clinic Q&amp;A: January Bringing an Omicron Surge</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-january-bringing-an-omicron-surge/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-january-bringing-an-omicron-surge/#comments</comments>        <pubDate>Thu, 06 Jan 2022 14:39:38 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/29e6ad3b-0839-38ec-9783-acbac16f8794</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in January 2022</p>
<p>Guest: Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>The rapid spread of <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> due to the omicron variant continues, and experts expect a January surge across the U.S. </p>
<p>"This is spreading unlike anything we've seen in the U.S.," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview'>Mayo Clinic's Vaccine Research Group</a>.  "Over the last seven days, we're now averaging about 400,000 or so new cases a day."</p>
<p>While people who are fully vaccinated can get breakthrough infections and spread the virus to others, COVID-19 vaccines effectively prevent severe illness. Mayo Clinic experts urge people to protect themselves by getting vaccinated and wearing a mask. Being fully vaccinated, including getting a booster when eligible, offers the highest protection possible against COVID-19. </p>
<p>"The good news is, for those who are immunized and boosted, we are winning the battle," says Dr. Poland. "Getting immunized is basically a weapon against this virus."</p>
<p>On the Mayo Clinic Q&A podcast, Dr. Poland discusses the omicron surge and the importance of vaccines and boosters for COVID-19.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> </a><a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> </a><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> </a><a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in January 2022</p>
<p>Guest: Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>The rapid spread of <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> due to the omicron variant continues, and experts expect a January surge across the U.S. </p>
<p>"This is spreading unlike anything we've seen in the U.S.," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview'>Mayo Clinic's Vaccine Research Group</a>.  "Over the last seven days, we're now averaging about 400,000 or so new cases a day."</p>
<p>While people who are fully vaccinated can get breakthrough infections and spread the virus to others, COVID-19 vaccines effectively prevent severe illness. Mayo Clinic experts urge people to protect themselves by getting vaccinated and wearing a mask. Being fully vaccinated, including getting a booster when eligible, offers the highest protection possible against COVID-19. </p>
<p>"The good news is, for those who are immunized and boosted, we are winning the battle," says Dr. Poland. "Getting immunized is basically a weapon against this virus."</p>
<p>On the Mayo Clinic Q&A podcast, Dr. Poland discusses the omicron surge and the importance of vaccines and boosters for COVID-19.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> </a><a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> </a><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> </a><a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5wy4xt/Mayo_Clinic_Q_A_-_Dr_Gregory_Poland_COVID-19_Update_01_05_20229l55f.mp3" length="15762185" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in January 2022
Guest: Gregory A. Poland, M.D. (@drgregpoland)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
The rapid spread of COVID-19 due to the omicron variant continues, and experts expect a January surge across the U.S. 
"This is spreading unlike anything we've seen in the U.S.," says Dr. Gregory Poland, head of Mayo Clinic's Vaccine Research Group.  "Over the last seven days, we're now averaging about 400,000 or so new cases a day."
While people who are fully vaccinated can get breakthrough infections and spread the virus to others, COVID-19 vaccines effectively prevent severe illness. Mayo Clinic experts urge people to protect themselves by getting vaccinated and wearing a mask. Being fully vaccinated, including getting a booster when eligible, offers the highest protection possible against COVID-19. 
"The good news is, for those who are immunized and boosted, we are winning the battle," says Dr. Poland. "Getting immunized is basically a weapon against this virus."
On the Mayo Clinic Q&A podcast, Dr. Poland discusses the omicron surge and the importance of vaccines and boosters for COVID-19.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1306</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Temporal Arteritis</title>
        <itunes:title>Temporal Arteritis</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-temporal-arteritis/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-temporal-arteritis/#comments</comments>        <pubDate>Tue, 04 Jan 2022 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/9eaf2dc5-06ac-3425-b4e7-f76cd7003553</guid>
                                    <description><![CDATA[<p>Guest: Andy Abril, M.D. (<a href='https://twitter.com/andyabrilmd'>@andyabrilMD</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Temporal arteritis is a vasculitis involving medium-sized vessels and typically occurs in those over the age of 50. If diagnosed and treated early, there is an excellent likelihood of recovery. However, temporal arteritis often mimics other health problems and this commonly results in a delay in the diagnosis. If untreated, serious complications can occur, including permanent blindness or stroke. The topic for this podcast is temporal arteritis and our guest is Andy Abril, M.D., Chair of the Division of Rheumatology at the Mayo Clinic in Jacksonville, Florida. We’ll discuss the risk factors, presenting symptoms and complications of temporal arteritis, as well as the recommendations for establishing a diagnosis and initiating appropriate treatment.</p>
<p>Specific topics discussed:</p>
<ul><li>Risk factors for temporal arteritis</li>
<li>Presenting symptoms</li>
<li>Complications of untreated temporal arteritis</li>
<li>Extra-cranial artery involvement of patients with temporal arteritis</li>
<li>Relationship of temporal arteritis and polymyalgia rheumatica</li>
<li>Laboratory abnormalities in temporal arteritis</li>
<li>Importance of an early temporal artery biopsy in establishing a diagnosis</li>
<li>Treatment recommendations</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Andy Abril, M.D. (<a href='https://twitter.com/andyabrilmd'>@andyabrilMD</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Temporal arteritis is a vasculitis involving medium-sized vessels and typically occurs in those over the age of 50. If diagnosed and treated early, there is an excellent likelihood of recovery. However, temporal arteritis often mimics other health problems and this commonly results in a delay in the diagnosis. If untreated, serious complications can occur, including permanent blindness or stroke. The topic for this podcast is temporal arteritis and our guest is Andy Abril, M.D., Chair of the Division of Rheumatology at the Mayo Clinic in Jacksonville, Florida. We’ll discuss the risk factors, presenting symptoms and complications of temporal arteritis, as well as the recommendations for establishing a diagnosis and initiating appropriate treatment.</p>
<p>Specific topics discussed:</p>
<ul><li>Risk factors for temporal arteritis</li>
<li>Presenting symptoms</li>
<li>Complications of untreated temporal arteritis</li>
<li>Extra-cranial artery involvement of patients with temporal arteritis</li>
<li>Relationship of temporal arteritis and polymyalgia rheumatica</li>
<li>Laboratory abnormalities in temporal arteritis</li>
<li>Importance of an early temporal artery biopsy in establishing a diagnosis</li>
<li>Treatment recommendations</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5ncbvb/21R01084_FINAL.mp3" length="19149406" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Andy Abril, M.D. (@andyabrilMD)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Temporal arteritis is a vasculitis involving medium-sized vessels and typically occurs in those over the age of 50. If diagnosed and treated early, there is an excellent likelihood of recovery. However, temporal arteritis often mimics other health problems and this commonly results in a delay in the diagnosis. If untreated, serious complications can occur, including permanent blindness or stroke. The topic for this podcast is temporal arteritis and our guest is Andy Abril, M.D., Chair of the Division of Rheumatology at the Mayo Clinic in Jacksonville, Florida. We’ll discuss the risk factors, presenting symptoms and complications of temporal arteritis, as well as the recommendations for establishing a diagnosis and initiating appropriate treatment.
Specific topics discussed:
Risk factors for temporal arteritis
Presenting symptoms
Complications of untreated temporal arteritis
Extra-cranial artery involvement of patients with temporal arteritis
Relationship of temporal arteritis and polymyalgia rheumatica
Laboratory abnormalities in temporal arteritis
Importance of an early temporal artery biopsy in establishing a diagnosis
Treatment recommendations
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>71460</itunes:duration>
                <itunes:episode>305</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Nutritional Supplement Edition: Research and Regulation</title>
        <itunes:title>Nutritional Supplement Edition: Research and Regulation</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/nutritional-supplement-edition-research-and-regulation/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/nutritional-supplement-edition-research-and-regulation/#comments</comments>        <pubDate>Thu, 30 Dec 2021 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/a5907fb0-f722-369d-a5d6-3a370fd8869d</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='https://mayocl.in/3DxIWJu'>Mayo Clinic Talks Podcast: Nutritional Supplement Edition</a></p>
<p>Guest:  Andrew R. Jagim, PhD</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/chutkaMD'>@ChutkaMD</a>)</p>
<p>How can we tell if the claims made by nutritional supplement companies are factual?  In this episode we'll discuss the research currently being done in this field and whether the research findings are valid.  Finally, we’ll talk about regulation of nutritional supplements. Our guest for this podcast is Andrew R. Jagim, Ph.D., the director of Sports Medicine research at the Mayo Clinic.</p>
<p>Specific topics:</p>
<ul><li>Importance of a foundation of good nutrition and exercise related to the benefits of nutritional supplements</li>
<li>Amount and quality of research being done on nutritional supplements</li>
<li>Regulation of nutritional supplements</li>
<li>How healthcare providers and consumers can judge the many claims made by manufactures of nutritional supplements</li>
</ul>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='https://mayocl.in/3DxIWJu'>Mayo Clinic Talks Podcast: Nutritional Supplement Edition</a></p>
<p>Guest:  Andrew R. Jagim, PhD</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/chutkaMD'>@ChutkaMD</a>)</p>
<p>How can we tell if the claims made by nutritional supplement companies are factual?  In this episode we'll discuss the research currently being done in this field and whether the research findings are valid.  Finally, we’ll talk about regulation of nutritional supplements. Our guest for this podcast is Andrew R. Jagim, Ph.D., the director of Sports Medicine research at the Mayo Clinic.</p>
<p>Specific topics:</p>
<ul><li>Importance of a foundation of good nutrition and exercise related to the benefits of nutritional supplements</li>
<li>Amount and quality of research being done on nutritional supplements</li>
<li>Regulation of nutritional supplements</li>
<li>How healthcare providers and consumers can judge the many claims made by manufactures of nutritional supplements</li>
</ul>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/p43hcn/NUTRITION_EPISODE_FIVE_FINAL_USE_THISbnyme.mp3" length="36603916" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: Mayo Clinic Talks Podcast: Nutritional Supplement Edition
Guest:  Andrew R. Jagim, PhD
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
How can we tell if the claims made by nutritional supplement companies are factual?  In this episode we'll discuss the research currently being done in this field and whether the research findings are valid.  Finally, we’ll talk about regulation of nutritional supplements. Our guest for this podcast is Andrew R. Jagim, Ph.D., the director of Sports Medicine research at the Mayo Clinic.
Specific topics:
Importance of a foundation of good nutrition and exercise related to the benefits of nutritional supplements
Amount and quality of research being done on nutritional supplements
Regulation of nutritional supplements
How healthcare providers and consumers can judge the many claims made by manufactures of nutritional supplements
]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1127</itunes:duration>
                <itunes:episode>303</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Lung Cancer Screening</title>
        <itunes:title>Lung Cancer Screening</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/lung-cancer-screening/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/lung-cancer-screening/#comments</comments>        <pubDate>Tue, 28 Dec 2021 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/f39037d4-a100-38d2-933a-f4d269f88e55</guid>
                                    <description><![CDATA[<p>Guest: Sebastian Fernandez-Bussy, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Lung cancer is the second most common malignancy in both men and women.  Survival rates depend on how early the cancer is discovered, with a survival rate much higher in localized disease than for patients with distant metastases. Therefore, an early diagnosis becomes extremely important. One of the problems with early diagnosis is that until recently, we’ve not had an effective screening test for lung cancer. In this podcast, we’ll be speaking with Sebastian Fernandez-Bussy, M.D., an Interventional Pulmonologist from the Division of Pulmonary and Critical Care at the Mayo Clinic in Jacksonville, Florida, and we’ll discuss proven techniques for lung cancer screening.</p>
<p>Specific topics:</p>
<ul><li>Benefits in survival in finding lung cancer at an early stage</li>
<li>Candidates for screening patients at an increased risk for lung cancer</li>
<li>Evidence showing the benefits of lung cancer screening</li>
<li>Differences in radiation for chest CT scans used for screening vs. a typical diagnostic chest CT scan</li>
<li>Frequency of indeterminate pulmonary nodules found on chest CT</li>
<li>Insurance and Medicare coverage for lung cancer screening</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Sebastian Fernandez-Bussy, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Lung cancer is the second most common malignancy in both men and women.  Survival rates depend on how early the cancer is discovered, with a survival rate much higher in localized disease than for patients with distant metastases. Therefore, an early diagnosis becomes extremely important. One of the problems with early diagnosis is that until recently, we’ve not had an effective screening test for lung cancer. In this podcast, we’ll be speaking with Sebastian Fernandez-Bussy, M.D., an Interventional Pulmonologist from the Division of Pulmonary and Critical Care at the Mayo Clinic in Jacksonville, Florida, and we’ll discuss proven techniques for lung cancer screening.</p>
<p>Specific topics:</p>
<ul><li>Benefits in survival in finding lung cancer at an early stage</li>
<li>Candidates for screening patients at an increased risk for lung cancer</li>
<li>Evidence showing the benefits of lung cancer screening</li>
<li>Differences in radiation for chest CT scans used for screening vs. a typical diagnostic chest CT scan</li>
<li>Frequency of indeterminate pulmonary nodules found on chest CT</li>
<li>Insurance and Medicare coverage for lung cancer screening</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jvch3y/WF527287_Lung_Cancer_Screeningbafmf.mp3" length="15682556" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Sebastian Fernandez-Bussy, M.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Lung cancer is the second most common malignancy in both men and women.  Survival rates depend on how early the cancer is discovered, with a survival rate much higher in localized disease than for patients with distant metastases. Therefore, an early diagnosis becomes extremely important. One of the problems with early diagnosis is that until recently, we’ve not had an effective screening test for lung cancer. In this podcast, we’ll be speaking with Sebastian Fernandez-Bussy, M.D., an Interventional Pulmonologist from the Division of Pulmonary and Critical Care at the Mayo Clinic in Jacksonville, Florida, and we’ll discuss proven techniques for lung cancer screening.
Specific topics:
Benefits in survival in finding lung cancer at an early stage
Candidates for screening patients at an increased risk for lung cancer
Evidence showing the benefits of lung cancer screening
Differences in radiation for chest CT scans used for screening vs. a typical diagnostic chest CT scan
Frequency of indeterminate pulmonary nodules found on chest CT
Insurance and Medicare coverage for lung cancer screening
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>976</itunes:duration>
                <itunes:episode>298</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Nutritional Supplements Edition: Family Medicine Case Studies</title>
        <itunes:title>Nutritional Supplements Edition: Family Medicine Case Studies</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/nutritional-supplements-edition-family-medicine-case-studies/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/nutritional-supplements-edition-family-medicine-case-studies/#comments</comments>        <pubDate>Thu, 23 Dec 2021 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/c4740b30-25f1-3ad9-a1d2-be1f1ce89db5</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='https://mayocl.in/3DxIWJu'>Mayo Clinic Talks Podcast: Nutritional Supplement Edition</a></p>
<p>Guests:</p>
<p>Andrew R. Jagim, Ph.D.</p>
<p>Jakob R. Erickson, D.O.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/chutkaMD'>@ChutkaMD</a>)</p>
<p>The care of athletes often requires special knowledge that many healthcare providers are less familiar with.  Athletes may have somewhat unique health problems related to their endurance or strength training.  They may also be taking a variety of nutritional supplements which could cause health issues.  This case-based podcast covers a couple different examples of health issues experienced by athletes. Featured guests include Andrew R. Jagim, Ph.D. and Jacob R. Erickson, D.O. from Sports Medicine at Mayo Clinic. We’ll discuss some of the medical issues often faced by athletes.</p>
<p>Specific topics:</p>
<ul><li>Iron-deficiency anemia</li>
<li>Relative Energy Deficiency in Sport</li>
<li>Vitamin D deficiency and hypervitaminosis D</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='https://mayocl.in/3DxIWJu'>Mayo Clinic Talks Podcast: Nutritional Supplement Edition</a></p>
<p>Guests:</p>
<p>Andrew R. Jagim, Ph.D.</p>
<p>Jakob R. Erickson, D.O.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/chutkaMD'>@ChutkaMD</a>)</p>
<p>The care of athletes often requires special knowledge that many healthcare providers are less familiar with.  Athletes may have somewhat unique health problems related to their endurance or strength training.  They may also be taking a variety of nutritional supplements which could cause health issues.  This case-based podcast covers a couple different examples of health issues experienced by athletes. Featured guests include Andrew R. Jagim, Ph.D. and Jacob R. Erickson, D.O. from Sports Medicine at Mayo Clinic. We’ll discuss some of the medical issues often faced by athletes.</p>
<p>Specific topics:</p>
<ul><li>Iron-deficiency anemia</li>
<li>Relative Energy Deficiency in Sport</li>
<li>Vitamin D deficiency and hypervitaminosis D</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cf2sdv/WF314801_Lab_Orders_and_Screening_Tools8ox35.mp3" length="24203893" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: Mayo Clinic Talks Podcast: Nutritional Supplement Edition
Guests:
Andrew R. Jagim, Ph.D.
Jakob R. Erickson, D.O.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
The care of athletes often requires special knowledge that many healthcare providers are less familiar with.  Athletes may have somewhat unique health problems related to their endurance or strength training.  They may also be taking a variety of nutritional supplements which could cause health issues.  This case-based podcast covers a couple different examples of health issues experienced by athletes. Featured guests include Andrew R. Jagim, Ph.D. and Jacob R. Erickson, D.O. from Sports Medicine at Mayo Clinic. We’ll discuss some of the medical issues often faced by athletes.
Specific topics:
Iron-deficiency anemia
Relative Energy Deficiency in Sport
Vitamin D deficiency and hypervitaminosis D
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1506</itunes:duration>
                <itunes:episode>302</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Infertility in Females</title>
        <itunes:title>Infertility in Females</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/infertility-in-females/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/infertility-in-females/#comments</comments>        <pubDate>Tue, 21 Dec 2021 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/cc37c246-b55f-3eab-b5b0-ae92bea29f09</guid>
                                    <description><![CDATA[<p>Guest: Elizabeth A. Stewart, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Infertility can be related to health issues in the male, female or both. Whatever the reason, infertility can put a major strain on a couple’s relationship. To add to the stress, infertility often results in multiple exams, tests, injections and procedures for one or both of the couple. Fortunately, the cause of infertility can often be found and in some cases, treatment is effective, resulting in a successful pregnancy and birth. The topic of discussion for this podcast is infertility, specifically infertility in females. Our guest is Dr. Elizabeth (Ebbie) A. Stewart, a physician in the Department of Obstetrics and Gynecology and Division of Endocrinology and Infertility. We’ll review the prevalence of infertility in females, males and both, risk factors for infertility, the most common causes of infertility and the evaluation a primary care provider can perform.</p>
<p>Specific topics discussed:</p>
<ul><li>Definition of infertility</li>
<li>Prevalence of infertility</li>
<li>Risk factors for infertility</li>
<li>Recommended evaluation by primary care providers</li>
<li>Specialized evaluation performed by an infertility expert</li>
<li>Common causes of infertility in females</li>
<li>Success of infertility treatment</li>
<li>Invitro fertilization as a treatment alternative to infertility including cost, success rate and risk of multiple births</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Elizabeth A. Stewart, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Infertility can be related to health issues in the male, female or both. Whatever the reason, infertility can put a major strain on a couple’s relationship. To add to the stress, infertility often results in multiple exams, tests, injections and procedures for one or both of the couple. Fortunately, the cause of infertility can often be found and in some cases, treatment is effective, resulting in a successful pregnancy and birth. The topic of discussion for this podcast is infertility, specifically infertility in females. Our guest is Dr. Elizabeth (Ebbie) A. Stewart, a physician in the Department of Obstetrics and Gynecology and Division of Endocrinology and Infertility. We’ll review the prevalence of infertility in females, males and both, risk factors for infertility, the most common causes of infertility and the evaluation a primary care provider can perform.</p>
<p>Specific topics discussed:</p>
<ul><li>Definition of infertility</li>
<li>Prevalence of infertility</li>
<li>Risk factors for infertility</li>
<li>Recommended evaluation by primary care providers</li>
<li>Specialized evaluation performed by an infertility expert</li>
<li>Common causes of infertility in females</li>
<li>Success of infertility treatment</li>
<li>Invitro fertilization as a treatment alternative to infertility including cost, success rate and risk of multiple births</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mj39up/Infertility.mp3" length="22852061" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Elizabeth A. Stewart, M.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Infertility can be related to health issues in the male, female or both. Whatever the reason, infertility can put a major strain on a couple’s relationship. To add to the stress, infertility often results in multiple exams, tests, injections and procedures for one or both of the couple. Fortunately, the cause of infertility can often be found and in some cases, treatment is effective, resulting in a successful pregnancy and birth. The topic of discussion for this podcast is infertility, specifically infertility in females. Our guest is Dr. Elizabeth (Ebbie) A. Stewart, a physician in the Department of Obstetrics and Gynecology and Division of Endocrinology and Infertility. We’ll review the prevalence of infertility in females, males and both, risk factors for infertility, the most common causes of infertility and the evaluation a primary care provider can perform.
Specific topics discussed:
Definition of infertility
Prevalence of infertility
Risk factors for infertility
Recommended evaluation by primary care providers
Specialized evaluation performed by an infertility expert
Common causes of infertility in females
Success of infertility treatment
Invitro fertilization as a treatment alternative to infertility including cost, success rate and risk of multiple births
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1422</itunes:duration>
                <itunes:episode>297</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: Experts urge COVID-19 boosters to fight omicron surge</title>
        <itunes:title>Mayo Clinic Q&amp;A: Experts urge COVID-19 boosters to fight omicron surge</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-experts-urge-covid-19-boosters-to-fight-omicron-surge/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-experts-urge-covid-19-boosters-to-fight-omicron-surge/#comments</comments>        <pubDate>Fri, 17 Dec 2021 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/ef704bfe-36ed-349b-bf8c-2880784f6acf</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in December 2021</p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>More Americans are now eligible for <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> booster doses as the Centers for Disease Control and Prevention approved the Pfizer vaccine booster for 16- and 17-year-olds late last week. Previously, only those 18 and older were eligible.</p>
<p>Early research suggests that a booster dose of the Pfizer COVID-19 vaccine improves protection against severe disease caused by the omicron variant, according to Pfizer.</p>
<p>Mayo Clinic experts say, regardless of the variant, prevention of infection works. Getting a booster offers the highest protection possible against COVID-19.</p>
<p>"Omicron infection rates are picking up rapidly," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview'>Mayo Clinic's Vaccine Research Group</a>. "If we do not take the proper precaution over the holiday, we are going to see a January omicron surge."</p>
<p>Dr. Poland explains that there are two threats — delta and omicron COVID-19 variants — but there is a solution. "Masking and boosting — those are key to protecting yourself and your family."</p>
<p>On the Mayo Clinic Q&A podcast, Dr. Poland discusses the latest on COVID-19 variants and shares advice on how to stay safe this holiday season.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> </a><a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> </a><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> </a><a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in December 2021</p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>More Americans are now eligible for <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> booster doses as the Centers for Disease Control and Prevention approved the Pfizer vaccine booster for 16- and 17-year-olds late last week. Previously, only those 18 and older were eligible.</p>
<p>Early research suggests that a booster dose of the Pfizer COVID-19 vaccine improves protection against severe disease caused by the omicron variant, according to Pfizer.</p>
<p>Mayo Clinic experts say, regardless of the variant, prevention of infection works. Getting a booster offers the highest protection possible against COVID-19.</p>
<p>"Omicron infection rates are picking up rapidly," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview'>Mayo Clinic's Vaccine Research Group</a>. "If we do not take the proper precaution over the holiday, we are going to see a January omicron surge."</p>
<p>Dr. Poland explains that there are two threats — delta and omicron COVID-19 variants — but there is a solution. "Masking and boosting — those are key to protecting yourself and your family."</p>
<p>On the Mayo Clinic Q&A podcast, Dr. Poland discusses the latest on COVID-19 variants and shares advice on how to stay safe this holiday season.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> </a><a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> </a><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> </a><a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7chbfe/Mayo_Clinic_Q_A_-_Dr_Gregory_Poland_12_15_21_COVID_19_Updatebptp1.mp3" length="24591482" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in December 2021
Guest:  Gregory A. Poland, M.D. (@drgregpoland)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
More Americans are now eligible for COVID-19 booster doses as the Centers for Disease Control and Prevention approved the Pfizer vaccine booster for 16- and 17-year-olds late last week. Previously, only those 18 and older were eligible.
Early research suggests that a booster dose of the Pfizer COVID-19 vaccine improves protection against severe disease caused by the omicron variant, according to Pfizer.
Mayo Clinic experts say, regardless of the variant, prevention of infection works. Getting a booster offers the highest protection possible against COVID-19.
"Omicron infection rates are picking up rapidly," says Dr. Gregory Poland, head of Mayo Clinic's Vaccine Research Group. "If we do not take the proper precaution over the holiday, we are going to see a January omicron surge."
Dr. Poland explains that there are two threats — delta and omicron COVID-19 variants — but there is a solution. "Masking and boosting — those are key to protecting yourself and your family."
On the Mayo Clinic Q&A podcast, Dr. Poland discusses the latest on COVID-19 variants and shares advice on how to stay safe this holiday season.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1531</itunes:duration>
                <itunes:episode>309</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Nutritional Supplement Edition: Weight Loss and Thermogenic Agents</title>
        <itunes:title>Nutritional Supplement Edition: Weight Loss and Thermogenic Agents</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/nutritional-supplement-edition-weight-loss-and-thermogenic-agents/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/nutritional-supplement-edition-weight-loss-and-thermogenic-agents/#comments</comments>        <pubDate>Thu, 16 Dec 2021 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/25d7789d-2170-34ed-b86f-612d157b3f8b</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='https://mayocl.in/3DxIWJu'>Mayo Clinic Talks Podcast: Nutritional Supplement Edition</a></p>
<p>Guest:  Andrew R. Jagim, Ph.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/chutkaMD'>@ChutkaMD</a>)</p>
<p>Are there supplements available that really assist with weight loss? How can you help your patients navigate the market? What is safe and what do they need to look out for? Andrew R. Jagim, Ph.D., the director for Sports Medicine research at the Mayo Clinic, answers these questions in this episode.  We discuss the importance of diet and exercise in weight loss and the benefits nutritional supplements may add.  We also discuss some of the more common supplements promoted to enhance thermogenesis and weight loss as well as their proposed mechanism of action.</p>
<p>Specific topics:</p>
<ul><li>Popular nutritional supplements for enhancing weight loss</li>
<li>Accuracy of claims for nutritional supplements</li>
<li>Importance of diet and exercise in producing significant weight loss</li>
<li>Potential benefits of a nutritional supplement in addition to exercise and diet in producing significant weight loss</li>
<li>Common supplements promoted to enhance weight loss</li>
</ul>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='https://mayocl.in/3DxIWJu'>Mayo Clinic Talks Podcast: Nutritional Supplement Edition</a></p>
<p>Guest:  Andrew R. Jagim, Ph.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/chutkaMD'>@ChutkaMD</a>)</p>
<p>Are there supplements available that really assist with weight loss? How can you help your patients navigate the market? What is safe and what do they need to look out for? Andrew R. Jagim, Ph.D., the director for Sports Medicine research at the Mayo Clinic, answers these questions in this episode.  We discuss the importance of diet and exercise in weight loss and the benefits nutritional supplements may add.  We also discuss some of the more common supplements promoted to enhance thermogenesis and weight loss as well as their proposed mechanism of action.</p>
<p>Specific topics:</p>
<ul><li>Popular nutritional supplements for enhancing weight loss</li>
<li>Accuracy of claims for nutritional supplements</li>
<li>Importance of diet and exercise in producing significant weight loss</li>
<li>Potential benefits of a nutritional supplement in addition to exercise and diet in producing significant weight loss</li>
<li>Common supplements promoted to enhance weight loss</li>
</ul>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/z54xat/WF314802_Weight_Loss_and_Thermogenic6jm1h.mp3" length="19683588" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: Mayo Clinic Talks Podcast: Nutritional Supplement Edition
Guest:  Andrew R. Jagim, Ph.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Are there supplements available that really assist with weight loss? How can you help your patients navigate the market? What is safe and what do they need to look out for? Andrew R. Jagim, Ph.D., the director for Sports Medicine research at the Mayo Clinic, answers these questions in this episode.  We discuss the importance of diet and exercise in weight loss and the benefits nutritional supplements may add.  We also discuss some of the more common supplements promoted to enhance thermogenesis and weight loss as well as their proposed mechanism of action.
Specific topics:
Popular nutritional supplements for enhancing weight loss
Accuracy of claims for nutritional supplements
Importance of diet and exercise in producing significant weight loss
Potential benefits of a nutritional supplement in addition to exercise and diet in producing significant weight loss
Common supplements promoted to enhance weight loss
]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1227</itunes:duration>
                <itunes:episode>301</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Influenza Vaccine 2021</title>
        <itunes:title>Influenza Vaccine 2021</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/influenza-vaccine-2021/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/influenza-vaccine-2021/#comments</comments>        <pubDate>Tue, 14 Dec 2021 07:30:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/05719ebd-5e7f-32b4-911b-493e954ef9f7</guid>
                                    <description><![CDATA[<p>Guest: Robert M. Jacobson, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Preventing influenza is important for a variety of reasons. Influenza is not a benign illness. In recent years, it’s accounted for up to 700,000 hospitalizations and over 50,000 deaths annually. The vaccine not only saves lives but also helps prevent hospitalizations as well as the need for the ICU. The occupancy rates of both have been severely stressed due to COVID. Despite the fact that the vaccine has been shown to be effective in all age groups, a significant percent of the population do not receive it. This podcast will discuss the influenza vaccine, it’s overall effectiveness in preventing the illness, the optimal time of year to receive the vaccine and tips on how to increase the likelihood that our patients will agree to receive it. Our guest is Dr. Robert M. Jacobson, a pediatrician and immunization expert at the Mayo Clinic.</p>
<p>Specific topics:</p>
<ul><li>Possible impact on the susceptibility or severity of influenza for the 2021/2022 season given there was such a reduction in influenza cases last year</li>
<li>The time of year the vaccine for the current influenza season is released</li>
<li>The optimal time of year to receive the influenza vaccine</li>
<li>The effectiveness of the influenza vaccine in preventing the illness</li>
<li>The likelihood we’ll see testing for both COVID and influenza increase this winter</li>
<li>Tips on increasing the number of patients who agree to receive the influenza vaccine</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Robert M. Jacobson, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Preventing influenza is important for a variety of reasons. Influenza is not a benign illness. In recent years, it’s accounted for up to 700,000 hospitalizations and over 50,000 deaths annually. The vaccine not only saves lives but also helps prevent hospitalizations as well as the need for the ICU. The occupancy rates of both have been severely stressed due to COVID. Despite the fact that the vaccine has been shown to be effective in all age groups, a significant percent of the population do not receive it. This podcast will discuss the influenza vaccine, it’s overall effectiveness in preventing the illness, the optimal time of year to receive the vaccine and tips on how to increase the likelihood that our patients will agree to receive it. Our guest is Dr. Robert M. Jacobson, a pediatrician and immunization expert at the Mayo Clinic.</p>
<p>Specific topics:</p>
<ul><li>Possible impact on the susceptibility or severity of influenza for the 2021/2022 season given there was such a reduction in influenza cases last year</li>
<li>The time of year the vaccine for the current influenza season is released</li>
<li>The optimal time of year to receive the influenza vaccine</li>
<li>The effectiveness of the influenza vaccine in preventing the illness</li>
<li>The likelihood we’ll see testing for both COVID and influenza increase this winter</li>
<li>Tips on increasing the number of patients who agree to receive the influenza vaccine</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5ncbvb/21R01084_FINAL.mp3" length="19149406" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Robert M. Jacobson, M.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Preventing influenza is important for a variety of reasons. Influenza is not a benign illness. In recent years, it’s accounted for up to 700,000 hospitalizations and over 50,000 deaths annually. The vaccine not only saves lives but also helps prevent hospitalizations as well as the need for the ICU. The occupancy rates of both have been severely stressed due to COVID. Despite the fact that the vaccine has been shown to be effective in all age groups, a significant percent of the population do not receive it. This podcast will discuss the influenza vaccine, it’s overall effectiveness in preventing the illness, the optimal time of year to receive the vaccine and tips on how to increase the likelihood that our patients will agree to receive it. Our guest is Dr. Robert M. Jacobson, a pediatrician and immunization expert at the Mayo Clinic.
Specific topics:
Possible impact on the susceptibility or severity of influenza for the 2021/2022 season given there was such a reduction in influenza cases last year
The time of year the vaccine for the current influenza season is released
The optimal time of year to receive the influenza vaccine
The effectiveness of the influenza vaccine in preventing the illness
The likelihood we’ll see testing for both COVID and influenza increase this winter
Tips on increasing the number of patients who agree to receive the influenza vaccine
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1285</itunes:duration>
                <itunes:episode>296</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: Post COVID-19 syndrome can be a long haul</title>
        <itunes:title>Mayo Clinic Q&amp;A: Post COVID-19 syndrome can be a long haul</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-post-covid-19-syndrome-can-be-a-long-haul/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-post-covid-19-syndrome-can-be-a-long-haul/#comments</comments>        <pubDate>Fri, 10 Dec 2021 08:01:47 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/e12b08ff-95fe-3bd5-9d0b-7b8335b3ff3f</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in December 2021</p>
<p>Guest:  Greg Vanichkachorn, M.D., M.P.H. (<a href='https://twitter.com/DoctorGregVan'>@DoctorGregVan</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>Most people who have COVID-19 recover completely within a few weeks. But some people — even those who had mild versions of the disease — continue to experience symptoms after their initial recovery. </p>
<p>Sometimes called “long haulers” or “long COVID," these patients can have fatigue, shortness of breath, brain fog and other symptoms long after the time of their infection.</p>
<p><a href='https://www.mayoclinic.org/diseases-conditions/coronavirus/in-depth/coronavirus-long-term-effects/art-20490351%20?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Post-COVID-19 syndrome</a> conditions are generally considered to be effects of COVID-19 that persist for more than four weeks after you've been diagnosed with COVID-19 infection.</p>
<p>A recent <a href='https://newsnetwork.mayoclinic.org/discussion/post-covid-symptoms-women-differ-distinctly-from-men/'>Mayo Clinic study</a> on post-COVID-19 symptoms found that more women than men suffer long-term effects. Women predominantly showed symptoms of fatigue, followed by muscle pain and low blood pressure, while men primarily experienced shortness of breath.</p>
<p>Research is also underway to better understand what may be causing post-COVID-19 syndrome.</p>
<p>"We do have some research now that shows that some of the cells that are used to create immunity after an infection, they may be malfunctioning in this condition in patients with long-haul COVID," says  <a href='https://www.mayoclinic.org/biographies/vanichkachorn-greg-m-d-m-p-h/bio-20470118?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Greg Vanichkachorn</a>, director of Mayo Clinic’s COVID Activity Rehabilitation Program. "We also now have some research that shows that patients with this condition can have antibodies against themselves, otherwise known as an auto-antibody. And this may be associated with the long-haul COVID state, so immune dysfunction and auto immunity, they may be at play here."</p>
<p>The <a href='https://connect.mayoclinic.org/blog/post-covid-recovery/tab/next-steps/'>COVID Activity Rehabilitation Program</a> at Mayo Clinic helps people experiencing post-COVID-19 syndrome by working with patients to decrease symptoms and improve overall functioning and quality of life. </p>
<p>On the Mayo Clinic Q&A podcast, Dr. Vanichkachorn discusses how treatment can help patients who suffer from post-COVID-19 syndrome.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> </a><a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> </a><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> </a><a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in December 2021</p>
<p>Guest:  Greg Vanichkachorn, M.D., M.P.H. (<a href='https://twitter.com/DoctorGregVan'>@DoctorGregVan</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>Most people who have COVID-19 recover completely within a few weeks. But some people — even those who had mild versions of the disease — continue to experience symptoms after their initial recovery. </p>
<p>Sometimes called “long haulers” or “long COVID," these patients can have fatigue, shortness of breath, brain fog and other symptoms long after the time of their infection.</p>
<p><a href='https://www.mayoclinic.org/diseases-conditions/coronavirus/in-depth/coronavirus-long-term-effects/art-20490351%20?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Post-COVID-19 syndrome</a> conditions are generally considered to be effects of COVID-19 that persist for more than four weeks after you've been diagnosed with COVID-19 infection.</p>
<p>A recent <a href='https://newsnetwork.mayoclinic.org/discussion/post-covid-symptoms-women-differ-distinctly-from-men/'>Mayo Clinic study</a> on post-COVID-19 symptoms found that more women than men suffer long-term effects. Women predominantly showed symptoms of fatigue, followed by muscle pain and low blood pressure, while men primarily experienced shortness of breath.</p>
<p>Research is also underway to better understand what may be causing post-COVID-19 syndrome.</p>
<p>"We do have some research now that shows that some of the cells that are used to create immunity after an infection, they may be malfunctioning in this condition in patients with long-haul COVID," says  <a href='https://www.mayoclinic.org/biographies/vanichkachorn-greg-m-d-m-p-h/bio-20470118?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Greg Vanichkachorn</a>, director of Mayo Clinic’s COVID Activity Rehabilitation Program. "We also now have some research that shows that patients with this condition can have antibodies against themselves, otherwise known as an auto-antibody. And this may be associated with the long-haul COVID state, so immune dysfunction and auto immunity, they may be at play here."</p>
<p>The <a href='https://connect.mayoclinic.org/blog/post-covid-recovery/tab/next-steps/'>COVID Activity Rehabilitation Program</a> at Mayo Clinic helps people experiencing post-COVID-19 syndrome by working with patients to decrease symptoms and improve overall functioning and quality of life. </p>
<p>On the Mayo Clinic Q&A podcast, Dr. Vanichkachorn discusses how treatment can help patients who suffer from post-COVID-19 syndrome.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> </a><a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> </a><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> </a><a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/763x5k/Mayo_Clinic_Q_A_-_Dr_Greg_Vanichkachorn_-_COVID_Long_Haulers_12_08_218hsx6.mp3" length="13426515" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in December 2021
Guest:  Greg Vanichkachorn, M.D., M.P.H. (@DoctorGregVan)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
Most people who have COVID-19 recover completely within a few weeks. But some people — even those who had mild versions of the disease — continue to experience symptoms after their initial recovery. 
Sometimes called “long haulers” or “long COVID," these patients can have fatigue, shortness of breath, brain fog and other symptoms long after the time of their infection.
Post-COVID-19 syndrome conditions are generally considered to be effects of COVID-19 that persist for more than four weeks after you've been diagnosed with COVID-19 infection.
A recent Mayo Clinic study on post-COVID-19 symptoms found that more women than men suffer long-term effects. Women predominantly showed symptoms of fatigue, followed by muscle pain and low blood pressure, while men primarily experienced shortness of breath.
Research is also underway to better understand what may be causing post-COVID-19 syndrome.
"We do have some research now that shows that some of the cells that are used to create immunity after an infection, they may be malfunctioning in this condition in patients with long-haul COVID," says  Dr. Greg Vanichkachorn, director of Mayo Clinic’s COVID Activity Rehabilitation Program. "We also now have some research that shows that patients with this condition can have antibodies against themselves, otherwise known as an auto-antibody. And this may be associated with the long-haul COVID state, so immune dysfunction and auto immunity, they may be at play here."
The COVID Activity Rehabilitation Program at Mayo Clinic helps people experiencing post-COVID-19 syndrome by working with patients to decrease symptoms and improve overall functioning and quality of life. 
On the Mayo Clinic Q&A podcast, Dr. Vanichkachorn discusses how treatment can help patients who suffer from post-COVID-19 syndrome.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>835</itunes:duration>
                <itunes:episode>307</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Nutritional Supplements Edition: Strength, Power, and Performance</title>
        <itunes:title>Nutritional Supplements Edition: Strength, Power, and Performance</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/nutritional-supplements-edition-strength-power-and-performance/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/nutritional-supplements-edition-strength-power-and-performance/#comments</comments>        <pubDate>Thu, 09 Dec 2021 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/b0474553-944d-3bac-88cf-e4011f353f21</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='https://mayocl.in/3DxIWJu'>Mayo Clinic Talks Podcast: Nutritional Supplement Edition</a></p>
<p>Guest:  Andrew R. Jagim, Ph.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/chutkaMD'>@ChutkaMD</a>)</p>
<p>Nutritional supplements are being promoted to enhance a variety of areas of physical fitness. This episode focuses on the impact on strength, power and overall performance. Our guest for this podcast is Andrew R. Jagim, Ph.D., the director of Sports Medicine research at Mayo Clinic.</p>
<p>Specific topics:</p>
<ul><li>Activities that benefit from increased strength and performance
<ul><li>Lifestyle strategies used to enhance strength and performance</li>
<li>Common nutritional supplements used to increase strength and performance</li>
<li>Safety concerns regarding the use of nutritional supplements</li>
</ul>
</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='https://mayocl.in/3DxIWJu'>Mayo Clinic Talks Podcast: Nutritional Supplement Edition</a></p>
<p>Guest:  Andrew R. Jagim, Ph.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/chutkaMD'>@ChutkaMD</a>)</p>
<p>Nutritional supplements are being promoted to enhance a variety of areas of physical fitness. This episode focuses on the impact on strength, power and overall performance. Our guest for this podcast is Andrew R. Jagim, Ph.D., the director of Sports Medicine research at Mayo Clinic.</p>
<p>Specific topics:</p>
<ul><li>Activities that benefit from increased strength and performance
<ul><li>Lifestyle strategies used to enhance strength and performance</li>
<li>Common nutritional supplements used to increase strength and performance</li>
<li>Safety concerns regarding the use of nutritional supplements</li>
</ul>
</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/scucdf/WF314800_-_Strength_and_Power8yuhb.mp3" length="22437005" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: Mayo Clinic Talks Podcast: Nutritional Supplement Edition
Guest:  Andrew R. Jagim, Ph.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Nutritional supplements are being promoted to enhance a variety of areas of physical fitness. This episode focuses on the impact on strength, power and overall performance. Our guest for this podcast is Andrew R. Jagim, Ph.D., the director of Sports Medicine research at Mayo Clinic.
Specific topics:
Activities that benefit from increased strength and performance
Lifestyle strategies used to enhance strength and performance
Common nutritional supplements used to increase strength and performance
Safety concerns regarding the use of nutritional supplements

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1399</itunes:duration>
                <itunes:episode>300</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Recommendation for Your Arthritic Patients - Keep Them Moving</title>
        <itunes:title>Recommendation for Your Arthritic Patients - Keep Them Moving</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/recommendation-for-your-arthritic-patients-keep-them-moving/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/recommendation-for-your-arthritic-patients-keep-them-moving/#comments</comments>        <pubDate>Tue, 07 Dec 2021 10:06:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/c03d31fe-9b35-302f-90e7-41840b487014</guid>
                                    <description><![CDATA[<p>Guest: Edward R. Laskowski, M.D. (<a href='https://twitter.com/DrEdSportsMed'>@DrEdSportsMed</a>) </p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Arthritis is one of the most common health conditions our patients have for eliminating exercise from their daily routine, yet the American College of Rheumatology feels that exercise should be one of the mainstays of treatment for those with arthritis. How do we convince our patients of the importance of continued exercise despite their arthritis? Are some types of exercise better than others? Can exercise make their arthritis worse? We’ll discuss these questions with Dr. Edward R. Laskowski, a Sports Medicine physician from the Department of Physical Medicine and Rehabilitation at Mayo Clinic.</p>
<p>Specific topics:</p>
<ul><li>Benefits of exercise in patients who have arthritis</li>
<li>Exercises that patients with arthritis should avoid</li>
<li>What patients should do if they have increased joint pain after exercising</li>
<li>Joint-friendly exercises that can be done by most patients</li>
<li>Importance of performing resistance as well as aerobic exercise</li>
<li>Recommended frequency and duration of exercise</li>
<li>Exercises for the was with inflammatory arthritis</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Edward R. Laskowski, M.D. (<a href='https://twitter.com/DrEdSportsMed'>@DrEdSportsMed</a>) </p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Arthritis is one of the most common health conditions our patients have for eliminating exercise from their daily routine, yet the American College of Rheumatology feels that exercise should be one of the mainstays of treatment for those with arthritis. How do we convince our patients of the importance of continued exercise despite their arthritis? Are some types of exercise better than others? Can exercise make their arthritis worse? We’ll discuss these questions with Dr. Edward R. Laskowski, a Sports Medicine physician from the Department of Physical Medicine and Rehabilitation at Mayo Clinic.</p>
<p>Specific topics:</p>
<ul><li>Benefits of exercise in patients who have arthritis</li>
<li>Exercises that patients with arthritis should avoid</li>
<li>What patients should do if they have increased joint pain after exercising</li>
<li>Joint-friendly exercises that can be done by most patients</li>
<li>Importance of performing resistance as well as aerobic exercise</li>
<li>Recommended frequency and duration of exercise</li>
<li>Exercises for the was with inflammatory arthritis</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4du6hq/WF324953_Arthritis_and_Exercise82a9f.mp3" length="19651240" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Edward R. Laskowski, M.D. (@DrEdSportsMed) 
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Arthritis is one of the most common health conditions our patients have for eliminating exercise from their daily routine, yet the American College of Rheumatology feels that exercise should be one of the mainstays of treatment for those with arthritis. How do we convince our patients of the importance of continued exercise despite their arthritis? Are some types of exercise better than others? Can exercise make their arthritis worse? We’ll discuss these questions with Dr. Edward R. Laskowski, a Sports Medicine physician from the Department of Physical Medicine and Rehabilitation at Mayo Clinic.
Specific topics:
Benefits of exercise in patients who have arthritis
Exercises that patients with arthritis should avoid
What patients should do if they have increased joint pain after exercising
Joint-friendly exercises that can be done by most patients
Importance of performing resistance as well as aerobic exercise
Recommended frequency and duration of exercise
Exercises for the was with inflammatory arthritis
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1225</itunes:duration>
                <itunes:episode>295</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Nutritional Supplement Edition: Exercise Endurance and Recovery</title>
        <itunes:title>Nutritional Supplement Edition: Exercise Endurance and Recovery</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/nutritional-supplement-edition-exercise-endurance-and-recovery/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/nutritional-supplement-edition-exercise-endurance-and-recovery/#comments</comments>        <pubDate>Thu, 02 Dec 2021 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/f753d035-9cc5-3fc3-809b-21b39fe771f1</guid>
                                    <description><![CDATA[<p>Guest: Andrew R. Jagim, Ph.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/chutkaMD'>@ChutkaMD</a>)</p>
<p>Can nutritional supplements help to increase exercise endurance? What types of supplements can help with short term – immediate improvements and which can assist with longer term recovery? Andrew R. Jagim, Ph.D., director of Sports Medicine research at Mayo Clinic joins us to discuss some of the claims that we can hear about nutritional supplements promoted to prove one's endurance, increase exercise economy, and improve tolerance of high-intensity exercise.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Andrew R. Jagim, Ph.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/chutkaMD'>@ChutkaMD</a>)</p>
<p>Can nutritional supplements help to increase exercise endurance? What types of supplements can help with short term – immediate improvements and which can assist with longer term recovery? Andrew R. Jagim, Ph.D., director of Sports Medicine research at Mayo Clinic joins us to discuss some of the claims that we can hear about nutritional supplements promoted to prove one's endurance, increase exercise economy, and improve tolerance of high-intensity exercise.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/c7iktw/WF314420_Endurance_Performanceadad0.mp3" length="16217050" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Andrew R. Jagim, Ph.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Can nutritional supplements help to increase exercise endurance? What types of supplements can help with short term – immediate improvements and which can assist with longer term recovery? Andrew R. Jagim, Ph.D., director of Sports Medicine research at Mayo Clinic joins us to discuss some of the claims that we can hear about nutritional supplements promoted to prove one's endurance, increase exercise economy, and improve tolerance of high-intensity exercise.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1010</itunes:duration>
                <itunes:episode>299</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: Boosters reduce vulnerability to COVID-19 variants</title>
        <itunes:title>Mayo Clinic Q&amp;A: Boosters reduce vulnerability to COVID-19 variants</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-boosters-reduce-vulnerability-to-covid-19-variants/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-boosters-reduce-vulnerability-to-covid-19-variants/#comments</comments>        <pubDate>Wed, 01 Dec 2021 10:17:40 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/b486eb5c-eb77-3cde-9d71-71cc3d81d8ce</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in November, 2021</p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>Omicron, a new <a href='https://www.mayoclinic.org/coronavirus-covid-19%20?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> variant of concern, has been detected in all regions of the world, including North America. While research and clinical observations on the new strain are underway, it is not yet known what impact, if any, omicron will have on the immune response, transmissibility, or specific COVID-19 treatments.</p>
<p>The emergence of omicron is a reminder to take important steps to protect yourself against COVID-19.</p>
<p>"The answer is masking and boosters," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview'>Mayo Clinic's Vaccine Research Group</a>. </p>
<p>Dr. Poland is encouraged by vaccine booster rates in the U.S. "In a relatively short period of time, about 36% of adults who are eligible have indeed gotten a booster," says Dr. Poland. "There's plenty of vaccine available. So in the strongest possible terms, I would recommend getting that booster."</p>
<p>Adults who are six months past completing their initial Moderna or Pfizer COVID-19 vaccination series are eligible to receive a booster dose, as are adults who are two months past completing their initial dose of the Johnson & Johnson vaccine.</p>
<p>On the Mayo Clinic Q&A podcast, Dr. Poland discusses the omicron variant and COVID-19 boosters, and he answers some listener questions.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> </a><a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> </a><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> </a><a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in November, 2021</p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>Omicron, a new <a href='https://www.mayoclinic.org/coronavirus-covid-19%20?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> variant of concern, has been detected in all regions of the world, including North America. While research and clinical observations on the new strain are underway, it is not yet known what impact, if any, omicron will have on the immune response, transmissibility, or specific COVID-19 treatments.</p>
<p>The emergence of omicron is a reminder to take important steps to protect yourself against COVID-19.</p>
<p>"The answer is masking and boosters," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview'>Mayo Clinic's Vaccine Research Group</a>. </p>
<p>Dr. Poland is encouraged by vaccine booster rates in the U.S. "In a relatively short period of time, about 36% of adults who are eligible have indeed gotten a booster," says Dr. Poland. "There's plenty of vaccine available. So in the strongest possible terms, I would recommend getting that booster."</p>
<p>Adults who are six months past completing their initial Moderna or Pfizer COVID-19 vaccination series are eligible to receive a booster dose, as are adults who are two months past completing their initial dose of the Johnson & Johnson vaccine.</p>
<p>On the Mayo Clinic Q&A podcast, Dr. Poland discusses the omicron variant and COVID-19 boosters, and he answers some listener questions.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> </a><a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> </a><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> </a><a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rb43zt/Mayo_Clinic_Q_A_-_Dr_Gregory_Poland_-_12_01_2169t2b.mp3" length="16883150" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in November, 2021
Guest:  Gregory A. Poland, M.D. (@drgregpoland)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
Omicron, a new COVID-19 variant of concern, has been detected in all regions of the world, including North America. While research and clinical observations on the new strain are underway, it is not yet known what impact, if any, omicron will have on the immune response, transmissibility, or specific COVID-19 treatments.
The emergence of omicron is a reminder to take important steps to protect yourself against COVID-19.
"The answer is masking and boosters," says Dr. Gregory Poland, head of Mayo Clinic's Vaccine Research Group. 
Dr. Poland is encouraged by vaccine booster rates in the U.S. "In a relatively short period of time, about 36% of adults who are eligible have indeed gotten a booster," says Dr. Poland. "There's plenty of vaccine available. So in the strongest possible terms, I would recommend getting that booster."
Adults who are six months past completing their initial Moderna or Pfizer COVID-19 vaccination series are eligible to receive a booster dose, as are adults who are two months past completing their initial dose of the Johnson & Johnson vaccine.
On the Mayo Clinic Q&A podcast, Dr. Poland discusses the omicron variant and COVID-19 boosters, and he answers some listener questions.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
 ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>84000</itunes:duration>
                <itunes:episode>306</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Nutritional Supplement Edition: A Critical Overview</title>
        <itunes:title>Nutritional Supplement Edition: A Critical Overview</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/nutritional-supplements-edition-introduction/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/nutritional-supplements-edition-introduction/#comments</comments>        <pubDate>Tue, 30 Nov 2021 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/d809e919-0017-38dd-84aa-da4c499791b9</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='https://mayocl.in/3DxIWJu'>Mayo Clinic Talks Podcast: Nutritional Supplement Edition</a></p>
<p>Guest:  Andrew R. Jagim, PhD</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/chutkaMD'>@ChutkaMD</a>)</p>
<p>Imagine taking a supplement that increases muscle mass, improves strength and endurance, promotes weight loss, helps prevent injury from exercise and promotes healing. Do these supplements exist and are they safe? This episode discusses nutritional supplements. We will discuss proven benefits as well as risks. Our guest for this podcast is Andrew R. Jagim, Ph.D., the director of Sports Medicine research at Mayo Clinic.</p>
<p>Specific topics:</p>
<ul><li>Definition of nutritional supplements</li>
<li>Common reasons to take these products</li>
<li>Accuracy of claims that nutritional supplements improve fitness and enhance performance</li>
<li>Research conducted on nutritional supplements</li>
<li>Regulation of the nutritional supplement industry</li>
<li>Potential safety issues in taking nutritional supplements</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='https://mayocl.in/3DxIWJu'>Mayo Clinic Talks Podcast: Nutritional Supplement Edition</a></p>
<p>Guest:  Andrew R. Jagim, PhD</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/chutkaMD'>@ChutkaMD</a>)</p>
<p>Imagine taking a supplement that increases muscle mass, improves strength and endurance, promotes weight loss, helps prevent injury from exercise and promotes healing. Do these supplements exist and are they safe? This episode discusses nutritional supplements. We will discuss proven benefits as well as risks. Our guest for this podcast is Andrew R. Jagim, Ph.D., the director of Sports Medicine research at Mayo Clinic.</p>
<p>Specific topics:</p>
<ul><li>Definition of nutritional supplements</li>
<li>Common reasons to take these products</li>
<li>Accuracy of claims that nutritional supplements improve fitness and enhance performance</li>
<li>Research conducted on nutritional supplements</li>
<li>Regulation of the nutritional supplement industry</li>
<li>Potential safety issues in taking nutritional supplements</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/mayomeded'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qxtts6/WF312204_Introduction8vdjf.mp3" length="30825441" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: Mayo Clinic Talks Podcast: Nutritional Supplement Edition
Guest:  Andrew R. Jagim, PhD
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Imagine taking a supplement that increases muscle mass, improves strength and endurance, promotes weight loss, helps prevent injury from exercise and promotes healing. Do these supplements exist and are they safe? This episode discusses nutritional supplements. We will discuss proven benefits as well as risks. Our guest for this podcast is Andrew R. Jagim, Ph.D., the director of Sports Medicine research at Mayo Clinic.
Specific topics:
Definition of nutritional supplements
Common reasons to take these products
Accuracy of claims that nutritional supplements improve fitness and enhance performance
Research conducted on nutritional supplements
Regulation of the nutritional supplement industry
Potential safety issues in taking nutritional supplements
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1922</itunes:duration>
                <itunes:episode>291</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Racism in Pain Medicine</title>
        <itunes:title>Racism in Pain Medicine</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/racism-in-pain-medicine/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/racism-in-pain-medicine/#comments</comments>        <pubDate>Tue, 23 Nov 2021 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/b7309687-a785-3f92-aa46-03cb975deb56</guid>
                                    <description><![CDATA[<p>Guest: Natalie H. Strand, M.D. (<a href='https://twitter.com/DrNatStrand'>@DrNatStrand</a>)</p>
<p>Host: Amit K. Ghosh, M.D. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>)</p>
<p>Racial biases can influence diagnosis and treatment decisions. It is important to normalize implicit biases and be aware of our own biases to reduce disparities and improve health care for patients. Joining us today is Natalie Strand, M.D., a consultant in the Department of Anesthesiology and Perioperative Medicine at the Mayo Clinic Hospital in Phoenix, AZ. She will discuss the unique, relevant and timely topic of racism in pain medicine, including the occurrence of racism in medicine at all levels – from patient care, diagnoses and outcomes to professional development of physicians. She describes our responsibility and how, if we want to engage in anti-racism, we must do it at all levels in medicine.</p>
<p>Additional Resources:</p>
<ul><li>Strand, N. H., Mariano, E. R., Goree, J. H., Narouze, S., Doshi, T. L., Freeman, J.A., Pearson, A. C. S. (2021). Racism in Pain Medicine: We Can and Should Do More. Mayo Clinic Proceedings, 96(6), 1394-1400. <a href='https://doi.org/10.1016/j.mayocp.2021.02.030'>https://doi.org/10.1016/j.mayocp.2021.02.030</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Natalie H. Strand, M.D. (<a href='https://twitter.com/DrNatStrand'>@DrNatStrand</a>)</p>
<p>Host: Amit K. Ghosh, M.D. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>)</p>
<p>Racial biases can influence diagnosis and treatment decisions. It is important to normalize implicit biases and be aware of our own biases to reduce disparities and improve health care for patients. Joining us today is Natalie Strand, M.D., a consultant in the Department of Anesthesiology and Perioperative Medicine at the Mayo Clinic Hospital in Phoenix, AZ. She will discuss the unique, relevant and timely topic of racism in pain medicine, including the occurrence of racism in medicine at all levels – from patient care, diagnoses and outcomes to professional development of physicians. She describes our responsibility and how, if we want to engage in anti-racism, we must do it at all levels in medicine.</p>
<p>Additional Resources:</p>
<ul><li>Strand, N. H., Mariano, E. R., Goree, J. H., Narouze, S., Doshi, T. L., Freeman, J.A., Pearson, A. C. S. (2021). Racism in Pain Medicine: We Can and Should Do More. <em>Mayo Clinic Proceedings</em>, 96(6), 1394-1400. <a href='https://doi.org/10.1016/j.mayocp.2021.02.030'>https://doi.org/10.1016/j.mayocp.2021.02.030</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/z65erv/WF392900_Racism_in_Pain_Medicine9g6cr.mp3" length="34785494" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Natalie H. Strand, M.D. (@DrNatStrand)
Host: Amit K. Ghosh, M.D. (@AmitGhosh006)
Racial biases can influence diagnosis and treatment decisions. It is important to normalize implicit biases and be aware of our own biases to reduce disparities and improve health care for patients. Joining us today is Natalie Strand, M.D., a consultant in the Department of Anesthesiology and Perioperative Medicine at the Mayo Clinic Hospital in Phoenix, AZ. She will discuss the unique, relevant and timely topic of racism in pain medicine, including the occurrence of racism in medicine at all levels – from patient care, diagnoses and outcomes to professional development of physicians. She describes our responsibility and how, if we want to engage in anti-racism, we must do it at all levels in medicine.
Additional Resources:
Strand, N. H., Mariano, E. R., Goree, J. H., Narouze, S., Doshi, T. L., Freeman, J.A., Pearson, A. C. S. (2021). Racism in Pain Medicine: We Can and Should Do More. Mayo Clinic Proceedings, 96(6), 1394-1400. https://doi.org/10.1016/j.mayocp.2021.02.030
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2167</itunes:duration>
                <itunes:episode>290</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: Travel trends and colder temperatures could mean a COVID-19 holiday surge</title>
        <itunes:title>Mayo Clinic Q&amp;A: Travel trends and colder temperatures could mean a COVID-19 holiday surge</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-travel-trends-and-colder-temperatures-could-mean-a-covid-19-holiday-surge/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-travel-trends-and-colder-temperatures-could-mean-a-covid-19-holiday-surge/#comments</comments>        <pubDate>Mon, 22 Nov 2021 09:57:37 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/9b6b24ef-e85a-3d32-b5d2-3d5ccca7333e</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in November, 2021</p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>Cold weather, increased travel, waning immunity and the potential for new variants may serve up the perfect recipe for a holiday <a href='https://www.mayoclinic.org/coronavirus-covid-19'>COVID-19</a> surge, according to <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview'>Mayo Clinic's Vaccine Research Group</a>.  </p>
<p>"I have consistently said what's very likely to happen as we get to the cooler weather and see the trends in travel is that we will have another surge," says Dr. Poland. "We're in this unusual situation where the pandemic is actually getting worse because humans don't want to believe that the pandemic is just as important now as it was a year ago."</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland answers several listener questions and talks more about being vigilant against COVID-19 as the U.S. heads into a second winter with this coronavirus. He also addresses the recent news that wild deer have shown evidence of COVID-19 infection and what that might mean in the battle to eliminate the disease. </p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> </a><a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> </a><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> </a><a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in November, 2021</p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>Cold weather, increased travel, waning immunity and the potential for new variants may serve up the perfect recipe for a holiday <a href='https://www.mayoclinic.org/coronavirus-covid-19'>COVID-19</a> surge, according to <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview'>Mayo Clinic's Vaccine Research Group</a>.  </p>
<p>"I have consistently said what's very likely to happen as we get to the cooler weather and see the trends in travel is that we will have another surge," says Dr. Poland. "We're in this unusual situation where the pandemic is actually getting worse because humans don't want to believe that the pandemic is just as important now as it was a year ago."</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland answers several listener questions and talks more about being vigilant against COVID-19 as the U.S. heads into a second winter with this coronavirus. He also addresses the recent news that wild deer have shown evidence of COVID-19 infection and what that might mean in the battle to eliminate the disease. </p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> </a><a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> </a><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> </a><a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dd63gp/Mayo_Clinic_Q_A_-_Dr_Poland_-_11_17_218p5i0.mp3" length="18313394" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in November, 2021
Guest:  Gregory A. Poland, M.D. (@drgregpoland)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
Cold weather, increased travel, waning immunity and the potential for new variants may serve up the perfect recipe for a holiday COVID-19 surge, according to Dr. Gregory Poland, head of Mayo Clinic's Vaccine Research Group.  
"I have consistently said what's very likely to happen as we get to the cooler weather and see the trends in travel is that we will have another surge," says Dr. Poland. "We're in this unusual situation where the pandemic is actually getting worse because humans don't want to believe that the pandemic is just as important now as it was a year ago."
In this Mayo Clinic Q&A podcast, Dr. Poland answers several listener questions and talks more about being vigilant against COVID-19 as the U.S. heads into a second winter with this coronavirus. He also addresses the recent news that wild deer have shown evidence of COVID-19 infection and what that might mean in the battle to eliminate the disease. 
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1139</itunes:duration>
                <itunes:episode>304</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes and Your Health Series: Hot Topics in Phage Therapy</title>
        <itunes:title>Genes and Your Health Series: Hot Topics in Phage Therapy</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-and-your-health-series-hot-topics-in-phage-therapy/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-and-your-health-series-hot-topics-in-phage-therapy/#comments</comments>        <pubDate>Thu, 18 Nov 2021 09:53:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/a19e74eb-ad19-3ea1-9fb6-721ff121f7a6</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health#group-tabs-node-course-default2'>Mayo Clinic Talks Podcast: Genes & Your Health</a></p>
<p>Guests: Gina A. Suh, M.D.</p>
<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>What is Phage Therapy? When was it discovered? Where is it used? We know about antibiotics, antifungals, and antivirals, but this is a whole new world! Have no fear, this episode is here from the Genes & Your Health miniseries to help demystify all there is to know about Phages.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health#group-tabs-node-course-default2'>Mayo Clinic Talks Podcast: Genes & Your Health</a></p>
<p>Guests: Gina A. Suh, M.D.</p>
<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>What is Phage Therapy? When was it discovered? Where is it used? We know about antibiotics, antifungals, and antivirals, but this is a whole new world! Have no fear, this episode is here from the Genes & Your Health miniseries to help demystify all there is to know about Phages.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hntrsu/WF392902_Phage_Therapy7urgs.mp3" length="26397764" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: Mayo Clinic Talks Podcast: Genes & Your Health
Guests: Gina A. Suh, M.D.
Host: Denise M. Dupras, M.D., Ph.D.
What is Phage Therapy? When was it discovered? Where is it used? We know about antibiotics, antifungals, and antivirals, but this is a whole new world! Have no fear, this episode is here from the Genes & Your Health miniseries to help demystify all there is to know about Phages.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
 ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1640</itunes:duration>
                <itunes:episode>294</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hyperlipidemia</title>
        <itunes:title>Hyperlipidemia</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/hyperlipidemia/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/hyperlipidemia/#comments</comments>        <pubDate>Tue, 16 Nov 2021 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/ef86ed68-b36a-3abb-984b-137177b8abac</guid>
                                    <description><![CDATA[<p>Guest: Monique A. Freund, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Hyperlipidemia is one of the major risk factors for cardiovascular disease. It’s known that a combination of lifestyle changes and pharmacologic therapy has proven effective in reducing the complications of cardiovascular disease. Despite this, it’s estimated that less than 35% of those patients with hyperlipidemia are adequately managed. Why aren’t we doing a better job at managing this major public health problem? In this podcast, we’ll be speaking with Monique A. Freund, M.D., a cardiologist at Mayo Clinic. We’ll discuss how to optimize management of hyperlipidemia, which lifestyle changes are beneficial, when to use pharmacologic therapy and how to manage patients with statin intolerance.</p>
<p>Specific topics:</p>
<ul><li>Relative importance of elevated LDLc, low HDLc and elevated triglycerides</li>
<li>Effective non-pharmacologic therapy for treating elevated LDLc, low HDLc and elevated triglycerides</li>
<li>When to consider starting a patient on a statin</li>
<li>Benefits of fish oil</li>
<li>Mechanism of action of statins</li>
<li>Statin intolerance</li>
<li>When to use ezetimibe</li>
<li>When to use one of the PCSK9-inhibitors</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Monique A. Freund, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Hyperlipidemia is one of the major risk factors for cardiovascular disease. It’s known that a combination of lifestyle changes and pharmacologic therapy has proven effective in reducing the complications of cardiovascular disease. Despite this, it’s estimated that less than 35% of those patients with hyperlipidemia are adequately managed. Why aren’t we doing a better job at managing this major public health problem? In this podcast, we’ll be speaking with Monique A. Freund, M.D., a cardiologist at Mayo Clinic. We’ll discuss how to optimize management of hyperlipidemia, which lifestyle changes are beneficial, when to use pharmacologic therapy and how to manage patients with statin intolerance.</p>
<p>Specific topics:</p>
<ul><li>Relative importance of elevated LDLc, low HDLc and elevated triglycerides</li>
<li>Effective non-pharmacologic therapy for treating elevated LDLc, low HDLc and elevated triglycerides</li>
<li>When to consider starting a patient on a statin</li>
<li>Benefits of fish oil</li>
<li>Mechanism of action of statins</li>
<li>Statin intolerance</li>
<li>When to use ezetimibe</li>
<li>When to use one of the PCSK9-inhibitors</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3mu7tp/WF449782_Hyperlipidemia.mp3" length="27924437" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Monique A. Freund, M.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Hyperlipidemia is one of the major risk factors for cardiovascular disease. It’s known that a combination of lifestyle changes and pharmacologic therapy has proven effective in reducing the complications of cardiovascular disease. Despite this, it’s estimated that less than 35% of those patients with hyperlipidemia are adequately managed. Why aren’t we doing a better job at managing this major public health problem? In this podcast, we’ll be speaking with Monique A. Freund, M.D., a cardiologist at Mayo Clinic. We’ll discuss how to optimize management of hyperlipidemia, which lifestyle changes are beneficial, when to use pharmacologic therapy and how to manage patients with statin intolerance.
Specific topics:
Relative importance of elevated LDLc, low HDLc and elevated triglycerides
Effective non-pharmacologic therapy for treating elevated LDLc, low HDLc and elevated triglycerides
When to consider starting a patient on a statin
Benefits of fish oil
Mechanism of action of statins
Statin intolerance
When to use ezetimibe
When to use one of the PCSK9-inhibitors
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1741</itunes:duration>
                <itunes:episode>289</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes and Your Health Series: Predicting the Future: What Role is Artificial Intelligence Playing Today and What Can We Expect in the Future?</title>
        <itunes:title>Genes and Your Health Series: Predicting the Future: What Role is Artificial Intelligence Playing Today and What Can We Expect in the Future?</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-and-your-health-series-predicting-the-future-what-role-is-artificial-intelligence-playing-today-and-what-can-we-expect-in-the-future/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-and-your-health-series-predicting-the-future-what-role-is-artificial-intelligence-playing-today-and-what-can-we-expect-in-the-future/#comments</comments>        <pubDate>Thu, 11 Nov 2021 09:51:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/bc9ac824-4ae9-3d3d-aabe-f43c2933ef32</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health#group-tabs-node-course-default2'>Mayo Clinic Talks Podcast: Genes & Your Health</a></p>
<p>Guests: Christopher (Chris) A. Aakre (<a href='https://twitter.com/ChrisAakreMD'>@ChrisAakreMD</a>), M.D.; Bradley J. Erickson, M.D., Ph.D.</p>
<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Artificial Intelligence has begun being utilized in Radiology. In fact, it was boldly predicted that Radiology would become an obsolete profession as a result! How has it altered this practice? How will it alter our practices moving forward? Join this episode of our Genes & Your Health miniseries from the Center of Individualized Medicine to learn these answers and more!</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health#group-tabs-node-course-default2'>Mayo Clinic Talks Podcast: Genes & Your Health</a></p>
<p>Guests: Christopher (Chris) A. Aakre (<a href='https://twitter.com/ChrisAakreMD'>@ChrisAakreMD</a>), M.D.; Bradley J. Erickson, M.D., Ph.D.</p>
<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Artificial Intelligence has begun being utilized in Radiology. In fact, it was boldly predicted that Radiology would become an obsolete profession as a result! How has it altered this practice? How will it alter our practices moving forward? Join this episode of our Genes & Your Health miniseries from the Center of Individualized Medicine to learn these answers and more!</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/k8m92e/WF527286_What_Role_is_AI_Playingbghl2.mp3" length="31575440" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: Mayo Clinic Talks Podcast: Genes & Your Health
Guests: Christopher (Chris) A. Aakre (@ChrisAakreMD), M.D.; Bradley J. Erickson, M.D., Ph.D.
Host: Denise M. Dupras, M.D., Ph.D.
Artificial Intelligence has begun being utilized in Radiology. In fact, it was boldly predicted that Radiology would become an obsolete profession as a result! How has it altered this practice? How will it alter our practices moving forward? Join this episode of our Genes & Your Health miniseries from the Center of Individualized Medicine to learn these answers and more!
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1966</itunes:duration>
                <itunes:episode>293</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Eyes Have It: Common External Eye Conditions</title>
        <itunes:title>The Eyes Have It: Common External Eye Conditions</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/the-eyes-have-it-common-external-eye-conditions/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/the-eyes-have-it-common-external-eye-conditions/#comments</comments>        <pubDate>Tue, 09 Nov 2021 05:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/92156723-4d82-3e1d-91e2-378f808cbdb8</guid>
                                    <description><![CDATA[<p>Guest: Amir R. Khan, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>External eye disorders are commonly seen in a primary care provider’s office, yet very few of us have ever had any formal training in ophthalmology. Fortunately, most of the external eye problems are relatively benign, though not all. It’s important to be able to recognize these conditions since some may be associated with a variety of systemic diseases. In this podcast, Amir Khan, M.D., an ophthalmologist at Mayo Clinic, joins Dr. Chutka to discuss how to recognize commonly seen external eye conditions. Links to specific topics below include additional information and images for most of the covered conditions.</p>
<p>Specific topics:</p>
<ul><li>Viral versus bacterial conjunctivitis: <a href='https://www.mayoclinic.org/diseases-conditions/pink-eye/symptoms-causes/syc-20376355'>https://www.mayoclinic.org/diseases-conditions/pink-eye/symptoms-causes/syc-20376355</a></li>
<li>Scleritis and episcleritis</li>
<li>Blepharitis: <a href='https://www.mayoclinic.org/diseases-conditions/blepharitis/symptoms-causes/syc-20370141'>https://www.mayoclinic.org/diseases-conditions/blepharitis/symptoms-causes/syc-20370141</a></li>
<li>Sty (Hordeolum): <a href='https://www.mayoclinic.org/diseases-conditions/sty/symptoms-causes/syc-20378017'>https://www.mayoclinic.org/diseases-conditions/sty/symptoms-causes/syc-20378017</a></li>
<li>Ectropion versus entropion: <a href='https://www.mayoclinic.org/diseases-conditions/ectropion/symptoms-causes/syc-20351164'>https://www.mayoclinic.org/diseases-conditions/ectropion/symptoms-causes/syc-20351164</a>; <a href='https://www.mayoclinic.org/diseases-conditions/entropion/symptoms-causes/syc-20351125'>https://www.mayoclinic.org/diseases-conditions/entropion/symptoms-causes/syc-20351125</a></li>
<li>Subconjunctival hemorrhage: <a href='https://www.mayoclinic.org/diseases-conditions/subconjunctival-hemorrhage/symptoms-causes/syc-20353826'>https://www.mayoclinic.org/diseases-conditions/subconjunctival-hemorrhage/symptoms-causes/syc-20353826</a></li>
<li>Herpes zoster ophthalmicus</li>
<li>Corneal abrasions: <a href='https://www.mayoclinic.org/first-aid/first-aid-corneal-abrasion/basics/art-20056659'>https://www.mayoclinic.org/first-aid/first-aid-corneal-abrasion/basics/art-20056659</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Amir R. Khan, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>External eye disorders are commonly seen in a primary care provider’s office, yet very few of us have ever had any formal training in ophthalmology. Fortunately, most of the external eye problems are relatively benign, though not all. It’s important to be able to recognize these conditions since some may be associated with a variety of systemic diseases. In this podcast, Amir Khan, M.D., an ophthalmologist at Mayo Clinic, joins Dr. Chutka to discuss how to recognize commonly seen external eye conditions. Links to specific topics below include additional information and images for most of the covered conditions.</p>
<p>Specific topics:</p>
<ul><li>Viral versus bacterial conjunctivitis: <a href='https://www.mayoclinic.org/diseases-conditions/pink-eye/symptoms-causes/syc-20376355'>https://www.mayoclinic.org/diseases-conditions/pink-eye/symptoms-causes/syc-20376355</a></li>
<li>Scleritis and episcleritis</li>
<li>Blepharitis: <a href='https://www.mayoclinic.org/diseases-conditions/blepharitis/symptoms-causes/syc-20370141'>https://www.mayoclinic.org/diseases-conditions/blepharitis/symptoms-causes/syc-20370141</a></li>
<li>Sty (Hordeolum): <a href='https://www.mayoclinic.org/diseases-conditions/sty/symptoms-causes/syc-20378017'>https://www.mayoclinic.org/diseases-conditions/sty/symptoms-causes/syc-20378017</a></li>
<li>Ectropion versus entropion: <a href='https://www.mayoclinic.org/diseases-conditions/ectropion/symptoms-causes/syc-20351164'>https://www.mayoclinic.org/diseases-conditions/ectropion/symptoms-causes/syc-20351164</a>; <a href='https://www.mayoclinic.org/diseases-conditions/entropion/symptoms-causes/syc-20351125'>https://www.mayoclinic.org/diseases-conditions/entropion/symptoms-causes/syc-20351125</a></li>
<li>Subconjunctival hemorrhage: <a href='https://www.mayoclinic.org/diseases-conditions/subconjunctival-hemorrhage/symptoms-causes/syc-20353826'>https://www.mayoclinic.org/diseases-conditions/subconjunctival-hemorrhage/symptoms-causes/syc-20353826</a></li>
<li>Herpes zoster ophthalmicus</li>
<li>Corneal abrasions: <a href='https://www.mayoclinic.org/first-aid/first-aid-corneal-abrasion/basics/art-20056659'>https://www.mayoclinic.org/first-aid/first-aid-corneal-abrasion/basics/art-20056659</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jukhu6/WF436858_Common_Eye_Conditions7c46m.mp3" length="19427097" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Amir R. Khan, M.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
External eye disorders are commonly seen in a primary care provider’s office, yet very few of us have ever had any formal training in ophthalmology. Fortunately, most of the external eye problems are relatively benign, though not all. It’s important to be able to recognize these conditions since some may be associated with a variety of systemic diseases. In this podcast, Amir Khan, M.D., an ophthalmologist at Mayo Clinic, joins Dr. Chutka to discuss how to recognize commonly seen external eye conditions. Links to specific topics below include additional information and images for most of the covered conditions.
Specific topics:
Viral versus bacterial conjunctivitis: https://www.mayoclinic.org/diseases-conditions/pink-eye/symptoms-causes/syc-20376355
Scleritis and episcleritis
Blepharitis: https://www.mayoclinic.org/diseases-conditions/blepharitis/symptoms-causes/syc-20370141
Sty (Hordeolum): https://www.mayoclinic.org/diseases-conditions/sty/symptoms-causes/syc-20378017
Ectropion versus entropion: https://www.mayoclinic.org/diseases-conditions/ectropion/symptoms-causes/syc-20351164; https://www.mayoclinic.org/diseases-conditions/entropion/symptoms-causes/syc-20351125
Subconjunctival hemorrhage: https://www.mayoclinic.org/diseases-conditions/subconjunctival-hemorrhage/symptoms-causes/syc-20353826
Herpes zoster ophthalmicus
Corneal abrasions: https://www.mayoclinic.org/first-aid/first-aid-corneal-abrasion/basics/art-20056659
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1209</itunes:duration>
                <itunes:episode>288</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: Building a wall of immunity against COVID-19</title>
        <itunes:title>Mayo Clinic Q&amp;A: Building a wall of immunity against COVID-19</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-building-a-wall-of-immunity-against-covid-19/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-building-a-wall-of-immunity-against-covid-19/#comments</comments>        <pubDate>Fri, 05 Nov 2021 08:14:01 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/0112afef-a0ff-3986-be6b-d56a2479e790</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in November  3, 2021</p>
<p>Guest:  Elie F. Berbari, M.D.</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>In anticipation of more <a href='https://www.mayoclinic.org/coronavirus-covid-19'>COVID-19</a> vaccine approvals this week, <a href='https://www.mayoclinic.org/biographies/berbari-elie-f-m-d/bio-20053110?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Dr. Elie Berbari</a>, chair of the Division of Infectious Diseases at Mayo Clinic, says it's good news that younger children will now have more protection against COVID-19.</p>
<p>"It's important that we reach a very high level of vaccination rates to achieve kind of a wall of immunity that could prevent transmission and prevent us from these repeated peaks that we've been dealing with over the last year and a half during this pandemic," says Dr. Berbari. </p>
<p>In this Mayo Clinic Q&A podcast, Dr. Berbari also talks about the rare cases of myocarditis and how the Food and Drug Administration is monitoring those cases. Dr. Berbari also addresses additional COVID-19 vaccine doses for immunocompromised people, the importance of masking, even if vaccinated, and he answers a number of listener questions.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> </a><a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> </a><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> </a><a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in November  3, 2021</p>
<p>Guest:  Elie F. Berbari, M.D.</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>In anticipation of more <a href='https://www.mayoclinic.org/coronavirus-covid-19'>COVID-19</a> vaccine approvals this week, <a href='https://www.mayoclinic.org/biographies/berbari-elie-f-m-d/bio-20053110?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Dr. Elie Berbari</a>, chair of the Division of Infectious Diseases at Mayo Clinic, says it's good news that younger children will now have more protection against COVID-19.</p>
<p>"It's important that we reach a very high level of vaccination rates to achieve kind of a wall of immunity that could prevent transmission and prevent us from these repeated peaks that we've been dealing with over the last year and a half during this pandemic," says Dr. Berbari. </p>
<p>In this Mayo Clinic Q&A podcast, Dr. Berbari also talks about the rare cases of myocarditis and how the Food and Drug Administration is monitoring those cases. Dr. Berbari also addresses additional COVID-19 vaccine doses for immunocompromised people, the importance of masking, even if vaccinated, and he answers a number of listener questions.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> </a><a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> </a><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> </a><a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wszhbk/Mayo_Clinic_Q_A_-_Dr_Elie_Berbari_-_Covid_Update_11_03_219ffnd.mp3" length="23144516" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in November  3, 2021
Guest:  Elie F. Berbari, M.D.
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
In anticipation of more COVID-19 vaccine approvals this week, Dr. Elie Berbari, chair of the Division of Infectious Diseases at Mayo Clinic, says it's good news that younger children will now have more protection against COVID-19.
"It's important that we reach a very high level of vaccination rates to achieve kind of a wall of immunity that could prevent transmission and prevent us from these repeated peaks that we've been dealing with over the last year and a half during this pandemic," says Dr. Berbari. 
In this Mayo Clinic Q&A podcast, Dr. Berbari also talks about the rare cases of myocarditis and how the Food and Drug Administration is monitoring those cases. Dr. Berbari also addresses additional COVID-19 vaccine doses for immunocompromised people, the importance of masking, even if vaccinated, and he answers a number of listener questions.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1441</itunes:duration>
                <itunes:episode>292</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes &amp; Your Health Edition - Preparing Your Practice for the Increased Use of Genomics</title>
        <itunes:title>Genes &amp; Your Health Edition - Preparing Your Practice for the Increased Use of Genomics</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-preparing-your-practice-for-the-increased-use-of-genomics/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-preparing-your-practice-for-the-increased-use-of-genomics/#comments</comments>        <pubDate>Thu, 04 Nov 2021 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/16e910e7-d075-321e-8eb4-d619ca8e396f</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health#group-tabs-node-course-default2'>Mayo Clinic Talks Podcast: Genes & Your Health</a></p>
<p>Guests: Megan A. Allyse, Ph.D. (<a href='https://twitter.com/MAllyse'>@MAllyse</a>); Jennifer (Jenny) L. Anderson, M.S., CGC; Radhika Dhamija, M.B.B.S. (<a href='https://twitter.com/NeurogenesDr'>@NeurogenesDr</a>)</p>
<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Genetic testing is increasingly becoming mainstream. Not only is it first-line testing for many different indications, but we have begun seeing an increase in predictive genomics for healthy patients as well. How can your practice prepare for what is here and what is to come? Tune in to this episode of the Genes & Your Health miniseries from the Center for Individualized Medicine to find out.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health#group-tabs-node-course-default2'>Mayo Clinic Talks Podcast: Genes & Your Health</a></p>
<p>Guests: Megan A. Allyse, Ph.D. (<a href='https://twitter.com/MAllyse'>@MAllyse</a>); Jennifer (Jenny) L. Anderson, M.S., CGC; Radhika Dhamija, M.B.B.S. (<a href='https://twitter.com/NeurogenesDr'>@NeurogenesDr</a>)</p>
<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Genetic testing is increasingly becoming mainstream. Not only is it first-line testing for many different indications, but we have begun seeing an increase in predictive genomics for healthy patients as well. How can your practice prepare for what is here and what is to come? Tune in to this episode of the Genes & Your Health miniseries from the Center for Individualized Medicine to find out.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/65xv8u/WF392901_Preparing_Your_Practice_V2ackho.mp3" length="39084251" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: Mayo Clinic Talks Podcast: Genes & Your Health
Guests: Megan A. Allyse, Ph.D. (@MAllyse); Jennifer (Jenny) L. Anderson, M.S., CGC; Radhika Dhamija, M.B.B.S. (@NeurogenesDr)
Host: Denise M. Dupras, M.D., Ph.D.
Genetic testing is increasingly becoming mainstream. Not only is it first-line testing for many different indications, but we have begun seeing an increase in predictive genomics for healthy patients as well. How can your practice prepare for what is here and what is to come? Tune in to this episode of the Genes & Your Health miniseries from the Center for Individualized Medicine to find out.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2436</itunes:duration>
                <itunes:episode>287</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Developing Equitable Care Models for Diabetic Patients</title>
        <itunes:title>Developing Equitable Care Models for Diabetic Patients</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/developing-equitable-care-models-for-diabetic-patients/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/developing-equitable-care-models-for-diabetic-patients/#comments</comments>        <pubDate>Tue, 02 Nov 2021 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/ec87173f-59b8-39aa-bc20-7cd4e557aae9</guid>
                                    <description><![CDATA[<p>Guest: Rozalina G. McCoy, M.D., M.S. (<a href='https://twitter.com/RozalinaMD'>@RozalinaMD</a>)</p>
<p>Host: Amit K. Ghosh, M.D. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>)</p>
<p>Diabetic research starts with understanding contemporary treatment practices (overtreatment and undertreatment, misuse or underuse of glucose-lowering medications, comparative effectiveness of different diabetes medications), the resulting impact on patient health and the disparities in both treatment practices and outcomes. In this episode Rozalina McCoy, M.D., M.S., associate professor of medicine and consultant in the Division of Community Internal Medicine at Mayo Clinic’s Rochester campus, joins us to discuss developing care delivery models that support high-quality, evidence-based, patient-centered, and equitable diabetes care.</p>
<p>Additional resources:</p>
<ul><li>McCoy RG, Galindo RJ, Swarna KS, et al. Sociodemographic, clinical, and treatment-related factors associated with hyperglycemic crises among adults with type 1 or type 2 diabetes in the US from 2014 to 2020. JAMA Netw Open. 2021;4(9):e2123471. doi:<a href='https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2783670'>1001/jamanetworkopen.2021.23471</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Rozalina G. McCoy, M.D., M.S. (<a href='https://twitter.com/RozalinaMD'>@RozalinaMD</a>)</p>
<p>Host: Amit K. Ghosh, M.D. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>)</p>
<p>Diabetic research starts with understanding contemporary treatment practices (overtreatment and undertreatment, misuse or underuse of glucose-lowering medications, comparative effectiveness of different diabetes medications), the resulting impact on patient health and the disparities in both treatment practices and outcomes. In this episode Rozalina McCoy, M.D., M.S., associate professor of medicine and consultant in the Division of Community Internal Medicine at Mayo Clinic’s Rochester campus, joins us to discuss developing care delivery models that support high-quality, evidence-based, patient-centered, and equitable diabetes care.</p>
<p>Additional resources:</p>
<ul><li>McCoy RG, Galindo RJ, Swarna KS, et al. Sociodemographic, clinical, and treatment-related factors associated with hyperglycemic crises among adults with type 1 or type 2 diabetes in the US from 2014 to 2020. JAMA Netw Open. 2021;4(9):e2123471. doi:<a href='https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2783670'>1001/jamanetworkopen.2021.23471</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kqh9f7/WF420950_Diabetes_V2.mp3" length="39268555" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Rozalina G. McCoy, M.D., M.S. (@RozalinaMD)
Host: Amit K. Ghosh, M.D. (@AmitGhosh006)
Diabetic research starts with understanding contemporary treatment practices (overtreatment and undertreatment, misuse or underuse of glucose-lowering medications, comparative effectiveness of different diabetes medications), the resulting impact on patient health and the disparities in both treatment practices and outcomes. In this episode Rozalina McCoy, M.D., M.S., associate professor of medicine and consultant in the Division of Community Internal Medicine at Mayo Clinic’s Rochester campus, joins us to discuss developing care delivery models that support high-quality, evidence-based, patient-centered, and equitable diabetes care.
Additional resources:
McCoy RG, Galindo RJ, Swarna KS, et al. Sociodemographic, clinical, and treatment-related factors associated with hyperglycemic crises among adults with type 1 or type 2 diabetes in the US from 2014 to 2020. JAMA Netw Open. 2021;4(9):e2123471. doi:1001/jamanetworkopen.2021.23471
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2444</itunes:duration>
                <itunes:episode>285</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes &amp; Your Health Edition - Genomics for Cardiovascular Health in Primary Care</title>
        <itunes:title>Genes &amp; Your Health Edition - Genomics for Cardiovascular Health in Primary Care</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-genomics-for-cardiovascular-health-in-primary-care/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-genomics-for-cardiovascular-health-in-primary-care/#comments</comments>        <pubDate>Thu, 28 Oct 2021 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/494117fd-a544-378f-a27f-a3df1b4ab749</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health#group-tabs-node-course-default2'>Mayo Clinic Talks Podcast: Genes & Your Health</a></p>
<p>Guest: Iftikhar J. Kullo, M.D. (<a href='https://twitter.com/iftikhar_kullo'>@iftikhar_kullo</a>)</p>
<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>What is familial hypercholesterolemia? Who should be tested for it? Are there genetic variants that are associated with cardiovascular diseases? How young do we start screening? This installment of the Genes & Your Health miniseries from the Center for Individualized Medicine is here to help answer these questions and more!</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health#group-tabs-node-course-default2'>Mayo Clinic Talks Podcast: Genes & Your Health</a></p>
<p>Guest: Iftikhar J. Kullo, M.D. (<a href='https://twitter.com/iftikhar_kullo'>@iftikhar_kullo</a>)</p>
<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>What is familial hypercholesterolemia? Who should be tested for it? Are there genetic variants that are associated with cardiovascular diseases? How young do we start screening? This installment of the Genes & Your Health miniseries from the Center for Individualized Medicine is here to help answer these questions and more!</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2e64g9/WF273756_Genomics_for_CV_Healtha35sv.mp3" length="28046880" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: Mayo Clinic Talks Podcast: Genes & Your Health
Guest: Iftikhar J. Kullo, M.D. (@iftikhar_kullo)
Host: Denise M. Dupras, M.D., Ph.D.
What is familial hypercholesterolemia? Who should be tested for it? Are there genetic variants that are associated with cardiovascular diseases? How young do we start screening? This installment of the Genes & Your Health miniseries from the Center for Individualized Medicine is here to help answer these questions and more!
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1747</itunes:duration>
                <itunes:episode>286</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Preserving Sight with Macular Degeneration</title>
        <itunes:title>Preserving Sight with Macular Degeneration</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/preserving-sight-with-macular-degeneration/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/preserving-sight-with-macular-degeneration/#comments</comments>        <pubDate>Tue, 26 Oct 2021 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/6faddac5-9489-348a-9cea-c68d37e2fc2d</guid>
                                    <description><![CDATA[<p>Guest: Sophie J. Bakri, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Macular degeneration is the most common cause of vision loss in individuals over the age of 50. The loss of central vision from macular degeneration can result in significant lifestyle changes in patients. They may no longer be able to read, write or drive. In this podcast, we’ll discuss macular degeneration with Sophie Bakri, M.D., an ophthalmologist at Mayo Clinic. She’ll review the two types and pathology of macular degeneration, its presentation, risk factors and preventive strategies, and new treatments on the horizon.</p>
<p>Specific topics:</p>
<ul><li>Pathologic changes in macular degeneration</li>
<li>Vision loss associated with macular degeneration</li>
<li>Possible causes of macular degeneration</li>
<li>Risk factors</li>
<li>Typical course of macular degeneration</li>
<li>The difference between wet and dry macular degeneration</li>
<li>Treatment strategies</li>
<li>Preventive strategies</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Sophie J. Bakri, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Macular degeneration is the most common cause of vision loss in individuals over the age of 50. The loss of central vision from macular degeneration can result in significant lifestyle changes in patients. They may no longer be able to read, write or drive. In this podcast, we’ll discuss macular degeneration with Sophie Bakri, M.D., an ophthalmologist at Mayo Clinic. She’ll review the two types and pathology of macular degeneration, its presentation, risk factors and preventive strategies, and new treatments on the horizon.</p>
<p>Specific topics:</p>
<ul><li>Pathologic changes in macular degeneration</li>
<li>Vision loss associated with macular degeneration</li>
<li>Possible causes of macular degeneration</li>
<li>Risk factors</li>
<li>Typical course of macular degeneration</li>
<li>The difference between wet and dry macular degeneration</li>
<li>Treatment strategies</li>
<li>Preventive strategies</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6eb62y/WF449783_Macular_Degeneration96teg.mp3" length="18947531" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Sophie J. Bakri, M.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Macular degeneration is the most common cause of vision loss in individuals over the age of 50. The loss of central vision from macular degeneration can result in significant lifestyle changes in patients. They may no longer be able to read, write or drive. In this podcast, we’ll discuss macular degeneration with Sophie Bakri, M.D., an ophthalmologist at Mayo Clinic. She’ll review the two types and pathology of macular degeneration, its presentation, risk factors and preventive strategies, and new treatments on the horizon.
Specific topics:
Pathologic changes in macular degeneration
Vision loss associated with macular degeneration
Possible causes of macular degeneration
Risk factors
Typical course of macular degeneration
The difference between wet and dry macular degeneration
Treatment strategies
Preventive strategies
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1180</itunes:duration>
                <itunes:episode>284</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: Changing COVID-19 recommendations means the science is working</title>
        <itunes:title>Mayo Clinic Q&amp;A: Changing COVID-19 recommendations means the science is working</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-changing-covid-19-recommendations-means-the-science-is-working/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-changing-covid-19-recommendations-means-the-science-is-working/#comments</comments>        <pubDate>Fri, 22 Oct 2021 13:49:18 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/6012ae2e-ad42-3431-a38d-148d02c23007</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in October, 2021</p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>As continuing research guides medical recommendations, it seems that there are COVID-19 updates released daily. These recommendations cover a range of topics, including whether COVID-19 booster vaccinations are necessary to whether COVID-19 vaccines can be mixed and matched.</p>
<p>"The fact that recommendations are changing is not evidence people don't know what they're doing," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview'>Mayo Clinic's Vaccine Research Group</a>. "It's evidence that they do know what they're doing and are paying close attention to new data that's coming along. Then they're adjusting recommendations based on the latest data."</p>
<p>Dr. Poland continues to urge people to get the latest COVID-19 news from credible sources. </p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland walks through the recent recommendations, corrects misperceptions and answers a number of listener questions.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> </a><a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> </a><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> </a><a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in October, 2021</p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>As continuing research guides medical recommendations, it seems that there are COVID-19 updates released daily. These recommendations cover a range of topics, including whether COVID-19 booster vaccinations are necessary to whether COVID-19 vaccines can be mixed and matched.</p>
<p>"The fact that recommendations are changing is not evidence people don't know what they're doing," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview'>Mayo Clinic's Vaccine Research Group</a>. "It's evidence that they do know what they're doing and are paying close attention to new data that's coming along. Then they're adjusting recommendations based on the latest data."</p>
<p>Dr. Poland continues to urge people to get the latest COVID-19 news from credible sources. </p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland walks through the recent recommendations, corrects misperceptions and answers a number of listener questions.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> </a><a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> </a><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> </a><a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dqwk2b/Mayo_Clinic_Q_A_-_Dr_Gregory_Poland_-_COVID_19_Update_-_10_20_217frpk.mp3" length="19518416" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in October, 2021
Guest:  Gregory A. Poland, M.D. (@drgregpoland)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
As continuing research guides medical recommendations, it seems that there are COVID-19 updates released daily. These recommendations cover a range of topics, including whether COVID-19 booster vaccinations are necessary to whether COVID-19 vaccines can be mixed and matched.
"The fact that recommendations are changing is not evidence people don't know what they're doing," says Dr. Gregory Poland, head of Mayo Clinic's Vaccine Research Group. "It's evidence that they do know what they're doing and are paying close attention to new data that's coming along. Then they're adjusting recommendations based on the latest data."
Dr. Poland continues to urge people to get the latest COVID-19 news from credible sources. 
In this Mayo Clinic Q&A podcast, Dr. Poland walks through the recent recommendations, corrects misperceptions and answers a number of listener questions.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1216</itunes:duration>
                <itunes:episode>283</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes &amp; Your Health Edition - Cell-Free DNA: Implications in Practice</title>
        <itunes:title>Genes &amp; Your Health Edition - Cell-Free DNA: Implications in Practice</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-cell-free-dna-implications-in-practice/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-cell-free-dna-implications-in-practice/#comments</comments>        <pubDate>Thu, 21 Oct 2021 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/f7ec6ef2-ebb3-3bc5-a5d8-798a80521e65</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health'>Mayo Clinic Talks Podcast: Genes & Your Health</a></p>
<p>Guests: Minetta C. Liu, M.D.; Myra J. Wick, M.D., Ph.D. (<a href='https://twitter.com/MyraWickMD'>@MyraWickMD</a>)</p>
<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>What is cell-free DNA? How does this type of DNA interact with our body? How is it useful in the clinical setting? Advances in technologies has expanded our understanding of cell-free DNA and its implications. Where are we now and what can we look for in the future? Find out these answers and more in the seventh episode of the Genes & Your Health miniseries from the Center for Individualized Medicine.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health'>Mayo Clinic Talks Podcast: Genes & Your Health</a></p>
<p>Guests: Minetta C. Liu, M.D.; Myra J. Wick, M.D., Ph.D. (<a href='https://twitter.com/MyraWickMD'>@MyraWickMD</a>)</p>
<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>What is cell-free DNA? How does this type of DNA interact with our body? How is it useful in the clinical setting? Advances in technologies has expanded our understanding of cell-free DNA and its implications. Where are we now and what can we look for in the future? Find out these answers and more in the seventh episode of the Genes & Your Health miniseries from the Center for Individualized Medicine.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/h8eta5/WF324952_Cell_free_DNAafom1.mp3" length="31609576" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: Mayo Clinic Talks Podcast: Genes & Your Health
Guests: Minetta C. Liu, M.D.; Myra J. Wick, M.D., Ph.D. (@MyraWickMD)
Host: Denise M. Dupras, M.D., Ph.D.
What is cell-free DNA? How does this type of DNA interact with our body? How is it useful in the clinical setting? Advances in technologies has expanded our understanding of cell-free DNA and its implications. Where are we now and what can we look for in the future? Find out these answers and more in the seventh episode of the Genes & Your Health miniseries from the Center for Individualized Medicine.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1969</itunes:duration>
                <itunes:episode>282</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>A Neurologist’s Take on Syncope</title>
        <itunes:title>A Neurologist’s Take on Syncope</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/a-neurologist-s-take-on-syncope/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/a-neurologist-s-take-on-syncope/#comments</comments>        <pubDate>Tue, 19 Oct 2021 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/9bef9be4-9a43-3022-ac2e-4f26f7865f4b</guid>
                                    <description><![CDATA[<p>Guest: Paola Sandroni, M.D., Ph.D.</p>
<p>Host: Amit K. Ghosh, M.D. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>)</p>
<p>Syncope is defined as the sudden and transient loss of consciousness and postural tone due to global reduction of blood flow to the reticular activating system. Syncopal episodes are followed by a rapid and spontaneous recovery.  Joining us today is Paola Sandroni, M.D., Ph.D., a neurologist at Mayo Clinic’s Rochester Campus. She will help us sort through the complicated subject of syncope, including its main etiologies and how to distinguish which is affecting your patient. She also outlines the nuances of evidence-based evaluation of syncope, which is largely guided by the patient’s presentation.</p>
<p>Additional resources:</p>
<ul><li>Thiruganasambandamoorthy V, Kwong K, Wells GA, Sivilotti MLA, Mukarram M, Rowe BH, Lang E, Perry JJ, Sheldon R, Stiell IG, Taljaard M. Development of the Canadian Syncope Risk Score to predict serious adverse events after emergency department assessment of syncope. CMAJ. 2016 Sep 6;188(12):E289-E298. doi: <a href='https://doi.org/10.1503/cmaj.151469'>1503/cmaj.151469</a>. Epub 2016 Jul 4. PMID: 27378464; PMCID: PMC5008955</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Paola Sandroni, M.D., Ph.D.</p>
<p>Host: Amit K. Ghosh, M.D. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>)</p>
<p>Syncope is defined as the sudden and transient loss of consciousness and postural tone due to global reduction of blood flow to the reticular activating system. Syncopal episodes are followed by a rapid and spontaneous recovery.  Joining us today is Paola Sandroni, M.D., Ph.D., a neurologist at Mayo Clinic’s Rochester Campus. She will help us sort through the complicated subject of syncope, including its main etiologies and how to distinguish which is affecting your patient. She also outlines the nuances of evidence-based evaluation of syncope, which is largely guided by the patient’s presentation.</p>
<p>Additional resources:</p>
<ul><li>Thiruganasambandamoorthy V, Kwong K, Wells GA, Sivilotti MLA, Mukarram M, Rowe BH, Lang E, Perry JJ, Sheldon R, Stiell IG, Taljaard M. Development of the Canadian Syncope Risk Score to predict serious adverse events after emergency department assessment of syncope. CMAJ. 2016 Sep 6;188(12):E289-E298. doi: <a href='https://doi.org/10.1503/cmaj.151469'>1503/cmaj.151469</a>. Epub 2016 Jul 4. PMID: 27378464; PMCID: PMC5008955</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fk8y3k/WF273755_Syncope.mp3" length="28109400" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Paola Sandroni, M.D., Ph.D.
Host: Amit K. Ghosh, M.D. (@AmitGhosh006)
Syncope is defined as the sudden and transient loss of consciousness and postural tone due to global reduction of blood flow to the reticular activating system. Syncopal episodes are followed by a rapid and spontaneous recovery.  Joining us today is Paola Sandroni, M.D., Ph.D., a neurologist at Mayo Clinic’s Rochester Campus. She will help us sort through the complicated subject of syncope, including its main etiologies and how to distinguish which is affecting your patient. She also outlines the nuances of evidence-based evaluation of syncope, which is largely guided by the patient’s presentation.
Additional resources:
Thiruganasambandamoorthy V, Kwong K, Wells GA, Sivilotti MLA, Mukarram M, Rowe BH, Lang E, Perry JJ, Sheldon R, Stiell IG, Taljaard M. Development of the Canadian Syncope Risk Score to predict serious adverse events after emergency department assessment of syncope. CMAJ. 2016 Sep 6;188(12):E289-E298. doi: 1503/cmaj.151469. Epub 2016 Jul 4. PMID: 27378464; PMCID: PMC5008955
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1749</itunes:duration>
                <itunes:episode>281</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes &amp; Your Health Edition - Why Does It Matter? Genes, Hormones, and Women’s Health</title>
        <itunes:title>Genes &amp; Your Health Edition - Why Does It Matter? Genes, Hormones, and Women’s Health</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-why-does-it-matter-genes-hormones-and-women-s-health/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-why-does-it-matter-genes-hormones-and-women-s-health/#comments</comments>        <pubDate>Thu, 14 Oct 2021 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/600736c7-b35d-3cb5-9c3f-d47fadd765e1</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health#group-tabs-node-course-default1'>Mayo Clinic Talks Podcast: Genes & Your Health</a></p>
<p>
Guests: Stephanie S. Faubion, M.D., M.B.A. (@StephFaubionMD); Kejal Kantarci, M.D. (@KejalKantarciMD); Juliana (Jewel) M. Kling, M.D., M.P.H. (@DrJewelKling)

Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>
Is hormone therapy good or bad for women? What are the myths surrounding it? Is the varying experience of menopause genetic? Join the sixth episode of Mayo Clinic Center for Individualized Medicine’s Genes & Your Health Edition to dive into women’s health and hormones and what you need to know for your practice.  </p>
<p>Additional resources:
• USPSTF Recommendations Statement for Breast Cancer: Medication Use to Reduce Risk https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction 
• Mayo Clinic Center for Individualized Medicine: https://www.mayo.edu/research/centers-programs/center-individualized-medicine </p>
<p>Connect with the Mayo Clinic School of Continuous Professional Development online at <a href='%20https%3A/ce.mayo.edu/'>https://ce.mayo.edu/ </a>or on Twitter @MayoMedEd. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health#group-tabs-node-course-default1'>Mayo Clinic Talks Podcast: Genes & Your Health</a></p>
<p><br>
Guests: Stephanie S. Faubion, M.D., M.B.A. (@StephFaubionMD); Kejal Kantarci, M.D. (@KejalKantarciMD); Juliana (Jewel) M. Kling, M.D., M.P.H. (@DrJewelKling)<br>
<br>
Host: Denise M. Dupras, M.D., Ph.D.</p>
<p><br>
Is hormone therapy good or bad for women? What are the myths surrounding it? Is the varying experience of menopause genetic? Join the sixth episode of Mayo Clinic Center for Individualized Medicine’s Genes & Your Health Edition to dive into women’s health and hormones and what you need to know for your practice.  </p>
<p>Additional resources:<br>
• USPSTF Recommendations Statement for Breast Cancer: Medication Use to Reduce Risk https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction <br>
• Mayo Clinic Center for Individualized Medicine: https://www.mayo.edu/research/centers-programs/center-individualized-medicine </p>
<p>Connect with the Mayo Clinic School of Continuous Professional Development online at <a href='%20https%3A/ce.mayo.edu/'>https://ce.mayo.edu/ </a>or on Twitter @MayoMedEd. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ystbau/WF160954_Women_Menopause_and_Genomics_V2a2r51.mp3" length="39424612" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: Mayo Clinic Talks Podcast: Genes & Your Health
Guests: Stephanie S. Faubion, M.D., M.B.A. (@StephFaubionMD); Kejal Kantarci, M.D. (@KejalKantarciMD); Juliana (Jewel) M. Kling, M.D., M.P.H. (@DrJewelKling)Host: Denise M. Dupras, M.D., Ph.D.
Is hormone therapy good or bad for women? What are the myths surrounding it? Is the varying experience of menopause genetic? Join the sixth episode of Mayo Clinic Center for Individualized Medicine’s Genes & Your Health Edition to dive into women’s health and hormones and what you need to know for your practice.  
Additional resources:• USPSTF Recommendations Statement for Breast Cancer: Medication Use to Reduce Risk https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction • Mayo Clinic Center for Individualized Medicine: https://www.mayo.edu/research/centers-programs/center-individualized-medicine 
Connect with the Mayo Clinic School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2455</itunes:duration>
                <itunes:episode>274</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Using Artificial Intelligence to Combat COVID-19</title>
        <itunes:title>Using Artificial Intelligence to Combat COVID-19</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/using-artificial-intelligence-to-combat-covid-19/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/using-artificial-intelligence-to-combat-covid-19/#comments</comments>        <pubDate>Tue, 12 Oct 2021 11:42:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/9466f44c-d70c-3037-9582-a2375e43eb39</guid>
                                    <description><![CDATA[<p>Guest: Thomas Caulfield, Ph.D.</p>
<p>Host: Amit K Ghosh, M.D., MBA (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>)</p>
<p>In this podcast, Dr. Thomas Caulfield from Mayo Clinic Florida describes a novel approach for SARS-CoV2 multi-drug targeting using artificial intelligence. Dr. Caulfield is leading a national team of investigators from Harvard, University of California, In Vivo Biosystems and Mayo Clinic to perform large-scale in silico and in vivo experiments on de novo drugs to better understand COVID-19 and halt its progression.  University of California hosts a live virus BSL3 facility for rapidly screening novel compounds that Dr. Caulfield's lab designs in silico and refines with feedback using machine learning techniques and data layering.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Thomas Caulfield, Ph.D.</p>
<p>Host: Amit K Ghosh, M.D., MBA (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>)</p>
<p>In this podcast, Dr. Thomas Caulfield from Mayo Clinic Florida describes a novel approach for SARS-CoV2 multi-drug targeting using artificial intelligence. Dr. Caulfield is leading a national team of investigators from Harvard, University of California, In Vivo Biosystems and Mayo Clinic to perform large-scale in silico and in vivo experiments on de novo drugs to better understand COVID-19 and halt its progression.  University of California hosts a live virus BSL3 facility for rapidly screening novel compounds that Dr. Caulfield's lab designs in silico and refines with feedback using machine learning techniques and data layering.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/k6byyz/WF436859_Using_AI_to_Combat_COVID7tvuj.mp3" length="29661817" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Thomas Caulfield, Ph.D.
Host: Amit K Ghosh, M.D., MBA (@AmitGhosh006)
In this podcast, Dr. Thomas Caulfield from Mayo Clinic Florida describes a novel approach for SARS-CoV2 multi-drug targeting using artificial intelligence. Dr. Caulfield is leading a national team of investigators from Harvard, University of California, In Vivo Biosystems and Mayo Clinic to perform large-scale in silico and in vivo experiments on de novo drugs to better understand COVID-19 and halt its progression.  University of California hosts a live virus BSL3 facility for rapidly screening novel compounds that Dr. Caulfield's lab designs in silico and refines with feedback using machine learning techniques and data layering.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1843</itunes:duration>
                <itunes:episode>280</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes &amp; Your Health Edition - How Does Your Microbiome Impact Your Health?</title>
        <itunes:title>Genes &amp; Your Health Edition - How Does Your Microbiome Impact Your Health?</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-how-does-your-microbiome-impact-your-health/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-how-does-your-microbiome-impact-your-health/#comments</comments>        <pubDate>Thu, 07 Oct 2021 09:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/1e7a4e41-79a8-3aa7-b04c-863b9ac3a4b0</guid>
                                    <description><![CDATA[<p>To claim credit for this series, visit: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health#group-tabs-node-course-default1'>Mayo Clinic Talks Podcast: Genes & Your Health</a>

Guest: Purna C. Kashyap, M.B.B.S. (@KashyapPurna); Marina R. Walther-Antonio, Ph.D.
Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>
What is the microbiome? How does the microbiome interact with our body? How much of us is nurture, how much is nature? The whole concept of microbiome may be a new idea but have no fear this fifth episode of the Genes & Your Health Edition from the Mayo Clinic Center for Individualized Medicine is here to help answer those questions and more!</p>
<p>Additional resources:</p>
<ul><li>Mayo Clinic Center for Individualized Medicine: https://www.mayo.edu/research/centers-programs/center-individualized-medicine </li>
</ul>
<p>Connect with the Mayo Clinic School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter @MayoMedEd. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this series, visit: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health#group-tabs-node-course-default1'>Mayo Clinic Talks Podcast: Genes & Your Health</a><br>
<br>
Guest: Purna C. Kashyap, M.B.B.S. (@KashyapPurna); Marina R. Walther-Antonio, Ph.D.<br>
Host: Denise M. Dupras, M.D., Ph.D.</p>
<p><br>
What is the microbiome? How does the microbiome interact with our body? How much of us is nurture, how much is nature? The whole concept of microbiome may be a new idea but have no fear this fifth episode of the Genes & Your Health Edition from the Mayo Clinic Center for Individualized Medicine is here to help answer those questions and more!</p>
<p>Additional resources:</p>
<ul><li>Mayo Clinic Center for Individualized Medicine: https://www.mayo.edu/research/centers-programs/center-individualized-medicine </li>
</ul>
<p>Connect with the Mayo Clinic School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter @MayoMedEd. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/atmnq8/WF185501_-_Microbiome_V29jwsa.mp3" length="29851192" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this series, visit: Mayo Clinic Talks Podcast: Genes & Your HealthGuest: Purna C. Kashyap, M.B.B.S. (@KashyapPurna); Marina R. Walther-Antonio, Ph.D.Host: Denise M. Dupras, M.D., Ph.D.
What is the microbiome? How does the microbiome interact with our body? How much of us is nurture, how much is nature? The whole concept of microbiome may be a new idea but have no fear this fifth episode of the Genes & Your Health Edition from the Mayo Clinic Center for Individualized Medicine is here to help answer those questions and more!
Additional resources:
Mayo Clinic Center for Individualized Medicine: https://www.mayo.edu/research/centers-programs/center-individualized-medicine 
Connect with the Mayo Clinic School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1858</itunes:duration>
                <itunes:episode>273</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: Breaking Down COVID-19 Vaccine Booster Approvals</title>
        <itunes:title>Mayo Clinic Q&amp;A: Breaking Down COVID-19 Vaccine Booster Approvals</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-breaking-down-covid-19-vaccine-booster-approvals/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-breaking-down-covid-19-vaccine-booster-approvals/#comments</comments>        <pubDate>Wed, 06 Oct 2021 10:47:11 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/cb07021a-80ce-30ed-a901-9967ce541434</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in September 29, 2021</p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>The path to approvals for a booster dose of the Pfizer <a href='https://newsnetwork.mayoclinic.org/podcast/q-a/?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19 vaccine</a> has seemed complicated. </p>
<p>"This is a confusing set of recommendations," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>. "So let's look at the four groups approved for only the Pfizer booster, thus far. If you got a primary series of the Pfizer vaccine, you're 65 and older, and it's been six months or more, you are eligible for a booster. If you're 50–64 and you have medical conditions that place you at high risk, you are eligible for the booster. If you're 18–49, you may be able to get a booster based on a medical condition and if you talk with your health care provider to weigh risks and benefits. And, finally, for people 18–64 years old, who are health care providers in congregate living situations or who have occupations that place them at high risk for transmission, such as school teachers, they also may be eligible. That should happen very soon."</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland talks more about the approval process for COVID-19 vaccine boosters, including for the Moderna and Johnson & Johnson COVID-19 vaccines. He also discusses the possibility that emergency use approval for children, down to age 5, could come before the end of October.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> </a><a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> </a><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> </a><a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in September 29, 2021</p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)</p>
<p>The path to approvals for a booster dose of the Pfizer <a href='https://newsnetwork.mayoclinic.org/podcast/q-a/?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19 vaccine</a> has seemed complicated. </p>
<p>"This is a confusing set of recommendations," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>. "So let's look at the four groups approved for only the Pfizer booster, thus far. If you got a primary series of the Pfizer vaccine, you're 65 and older, and it's been six months or more, you are eligible for a booster. If you're 50–64 and you have medical conditions that place you at high risk, you are eligible for the booster. If you're 18–49, you may be able to get a booster based on a medical condition and if you talk with your health care provider to weigh risks and benefits. And, finally, for people 18–64 years old, who are health care providers in congregate living situations or who have occupations that place them at high risk for transmission, such as school teachers, they also may be eligible. That should happen very soon."</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland talks more about the approval process for COVID-19 vaccine boosters, including for the Moderna and Johnson & Johnson COVID-19 vaccines. He also discusses the possibility that emergency use approval for children, down to age 5, could come before the end of October.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> </a><a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> </a><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> </a><a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/yej52n/Mayo_Clinic_Q_A_-_Dr_Gregory_Poland_09_29_216o9ac.mp3" length="24579909" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in September 29, 2021
Guest:  Gregory A. Poland, M.D. (@drgregpoland)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
The path to approvals for a booster dose of the Pfizer COVID-19 vaccine has seemed complicated. 
"This is a confusing set of recommendations," says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group. "So let's look at the four groups approved for only the Pfizer booster, thus far. If you got a primary series of the Pfizer vaccine, you're 65 and older, and it's been six months or more, you are eligible for a booster. If you're 50–64 and you have medical conditions that place you at high risk, you are eligible for the booster. If you're 18–49, you may be able to get a booster based on a medical condition and if you talk with your health care provider to weigh risks and benefits. And, finally, for people 18–64 years old, who are health care providers in congregate living situations or who have occupations that place them at high risk for transmission, such as school teachers, they also may be eligible. That should happen very soon."
In this Mayo Clinic Q&A podcast, Dr. Poland talks more about the approval process for COVID-19 vaccine boosters, including for the Moderna and Johnson & Johnson COVID-19 vaccines. He also discusses the possibility that emergency use approval for children, down to age 5, could come before the end of October.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1530</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Breast Imaging for Patients with Dense Breast Tissue</title>
        <itunes:title>Breast Imaging for Patients with Dense Breast Tissue</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/breast-imaging-for-patients-with-dense-breast-tissue/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/breast-imaging-for-patients-with-dense-breast-tissue/#comments</comments>        <pubDate>Tue, 05 Oct 2021 09:09:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/5bf70c3a-03e8-313d-9137-3b5735bbcb0a</guid>
                                    <description><![CDATA[<p>Guest: Christina A. Dilaveri, M.D. (<a href='https://twitter.com/CDilaveri'>@CDilaveri</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p> </p>
<p>Breast cancer is very treatable when detected early. Therefore, early detection becomes very important as it significantly reduces a patient’s risk of developing metastases and death. Breast imaging plays an extremely important role in the detection of early breast cancer, and we now have several modalities of breast imaging available, each with its advantages and disadvantages. Our guest for this podcast is Christina Dilaveri, M.D. a breast disease specialist, from Mayo Clinic’s Rochester Campus. We’ll discuss mammography, ultrasound, MRI, and molecular breast imaging, when they’re indicated, and the advantages of each. You’ll hear which patients should have more than a mammogram and how often it should be performed.</p>
<p>Specific topics discussed:</p>
<ul><li>The various types of mammography available</li>
<li>Indications for breast ultrasound</li>
<li>Benefits of breast MRI</li>
<li>When breast MRI should be performed</li>
<li>Benefits of molecular breast imaging</li>
<li>When molecular breast imaging should be performed</li>
</ul>
<p>Connect with the Mayo Clinic School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Christina A. Dilaveri, M.D. (<a href='https://twitter.com/CDilaveri'>@CDilaveri</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p> </p>
<p>Breast cancer is very treatable when detected early. Therefore, early detection becomes very important as it significantly reduces a patient’s risk of developing metastases and death. Breast imaging plays an extremely important role in the detection of early breast cancer, and we now have several modalities of breast imaging available, each with its advantages and disadvantages. Our guest for this podcast is Christina Dilaveri, M.D. a breast disease specialist, from Mayo Clinic’s Rochester Campus. We’ll discuss mammography, ultrasound, MRI, and molecular breast imaging, when they’re indicated, and the advantages of each. You’ll hear which patients should have more than a mammogram and how often it should be performed.</p>
<p>Specific topics discussed:</p>
<ul><li>The various types of mammography available</li>
<li>Indications for breast ultrasound</li>
<li>Benefits of breast MRI</li>
<li>When breast MRI should be performed</li>
<li>Benefits of molecular breast imaging</li>
<li>When molecular breast imaging should be performed</li>
</ul>
<p>Connect with the Mayo Clinic School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2uu642/WF491509_Dense_Breasts7jyad.mp3" length="18379820" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Christina A. Dilaveri, M.D. (@CDilaveri)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
 
Breast cancer is very treatable when detected early. Therefore, early detection becomes very important as it significantly reduces a patient’s risk of developing metastases and death. Breast imaging plays an extremely important role in the detection of early breast cancer, and we now have several modalities of breast imaging available, each with its advantages and disadvantages. Our guest for this podcast is Christina Dilaveri, M.D. a breast disease specialist, from Mayo Clinic’s Rochester Campus. We’ll discuss mammography, ultrasound, MRI, and molecular breast imaging, when they’re indicated, and the advantages of each. You’ll hear which patients should have more than a mammogram and how often it should be performed.
Specific topics discussed:
The various types of mammography available
Indications for breast ultrasound
Benefits of breast MRI
When breast MRI should be performed
Benefits of molecular breast imaging
When molecular breast imaging should be performed
Connect with the Mayo Clinic School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1144</itunes:duration>
                <itunes:episode>275</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes &amp; Your Health Edition - Genomics and Cancer: Primary Care Impact and Research Advances</title>
        <itunes:title>Genes &amp; Your Health Edition - Genomics and Cancer: Primary Care Impact and Research Advances</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-genomics-and-cancer-primary-care-impact-and-research-advances/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-genomics-and-cancer-primary-care-impact-and-research-advances/#comments</comments>        <pubDate>Thu, 30 Sep 2021 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/fdf91da7-e58b-3fe2-a79e-277fc4a38845</guid>
                                    <description><![CDATA[<p>To claim credit for this series, visit: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health#group-tabs-node-course-default1'>Mayo Clinic Talks Podcast: Genes & Your Health</a>  </p>
<p>
Guest: Niloy Jewel J. Samadder, M.D. (@J_Samadder)  
Host: Denise M. Dupras, M.D., Ph.D.  </p>
<p>
Can we find the cause of a patient’s cancer? Is it possible to provide targeted treatment to prevent future cancers by understanding what genetic predispositions a patient or their family members have? In a recently published study, nearly one in six to one in eight cancer patients, depending on which type of cancer they had, carried a genetic predisposition to the development of their cancer. How can we translate these findings into our practice for the benefit of our patients and their families? Tune in to episode four of our Genes & Your Health Edition from the Mayo Clinic Center for Individualized Medicine.</p>
<p>Additional resources:</p>
<ul><li>Samadder NJ, Riegert-Johnson D, Boardman L, et al. Comparison of universal genetic testing vs guideline-directed targeted testing for patients with hereditary cancer syndrome. JAMA Oncol. 2021;7(2):230–237. doi: 10.1001/jamaoncol.2020.6252</li>
<li>Uson, PLS. Riegert-Johnson, D. Boardman, L. Kisiel, J. et al. Germline cancer susceptibility gene testing in unselected patients with colorectal adenocarcinoma: a multicenter prospective study. Clin Gastroenterol Hepatol. 2021 April 20; doi: 10.1016/j.cgh.2021.04.013</li>
<li>Mayo Clinic’s Center for Individualized Medicine: https://www.mayo.edu/research/centers-programs/center-individualized-medicine </li>
</ul>
<p>Connect with the Mayo Clinic School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter @MayoMedEd.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this series, visit: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health#group-tabs-node-course-default1'>Mayo Clinic Talks Podcast: Genes & Your Health</a>  </p>
<p><br>
Guest: Niloy Jewel J. Samadder, M.D. (@J_Samadder)  <br>
Host: Denise M. Dupras, M.D., Ph.D.  </p>
<p><br>
Can we find the cause of a patient’s cancer? Is it possible to provide targeted treatment to prevent future cancers by understanding what genetic predispositions a patient or their family members have? In a recently published study, nearly one in six to one in eight cancer patients, depending on which type of cancer they had, carried a genetic predisposition to the development of their cancer. How can we translate these findings into our practice for the benefit of our patients and their families? Tune in to episode four of our Genes & Your Health Edition from the Mayo Clinic Center for Individualized Medicine.</p>
<p>Additional resources:</p>
<ul><li>Samadder NJ, Riegert-Johnson D, Boardman L, et al. Comparison of universal genetic testing vs guideline-directed targeted testing for patients with hereditary cancer syndrome. JAMA Oncol. 2021;7(2):230–237. doi: 10.1001/jamaoncol.2020.6252</li>
<li>Uson, PLS. Riegert-Johnson, D. Boardman, L. Kisiel, J. et al. Germline cancer susceptibility gene testing in unselected patients with colorectal adenocarcinoma: a multicenter prospective study. Clin Gastroenterol Hepatol. 2021 April 20; doi: 10.1016/j.cgh.2021.04.013</li>
<li>Mayo Clinic’s Center for Individualized Medicine: https://www.mayo.edu/research/centers-programs/center-individualized-medicine </li>
</ul>
<p>Connect with the Mayo Clinic School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter @MayoMedEd.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/4tgw2c/WF251630_-_Genomics_and_Cancer_for_Primary_Care7lcxo.mp3" length="26475167" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this series, visit: Mayo Clinic Talks Podcast: Genes & Your Health  
Guest: Niloy Jewel J. Samadder, M.D. (@J_Samadder)  Host: Denise M. Dupras, M.D., Ph.D.  
Can we find the cause of a patient’s cancer? Is it possible to provide targeted treatment to prevent future cancers by understanding what genetic predispositions a patient or their family members have? In a recently published study, nearly one in six to one in eight cancer patients, depending on which type of cancer they had, carried a genetic predisposition to the development of their cancer. How can we translate these findings into our practice for the benefit of our patients and their families? Tune in to episode four of our Genes & Your Health Edition from the Mayo Clinic Center for Individualized Medicine.
Additional resources:
Samadder NJ, Riegert-Johnson D, Boardman L, et al. Comparison of universal genetic testing vs guideline-directed targeted testing for patients with hereditary cancer syndrome. JAMA Oncol. 2021;7(2):230–237. doi: 10.1001/jamaoncol.2020.6252
Uson, PLS. Riegert-Johnson, D. Boardman, L. Kisiel, J. et al. Germline cancer susceptibility gene testing in unselected patients with colorectal adenocarcinoma: a multicenter prospective study. Clin Gastroenterol Hepatol. 2021 April 20; doi: 10.1016/j.cgh.2021.04.013
Mayo Clinic’s Center for Individualized Medicine: https://www.mayo.edu/research/centers-programs/center-individualized-medicine 
Connect with the Mayo Clinic School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1650</itunes:duration>
                <itunes:episode>272</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Evolution of COVID-19 Testing</title>
        <itunes:title>The Evolution of COVID-19 Testing</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/what-you-need-to-know-about-covid-19-testing/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/what-you-need-to-know-about-covid-19-testing/#comments</comments>        <pubDate>Tue, 28 Sep 2021 05:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/cbdbed18-1a56-3c54-ae1b-07c04bb0052a</guid>
                                    <description><![CDATA[<p>Guest: Matthew J. Binnicker, Ph.D. (<a href='https://twitter.com/DrMattBinnicker'>@DrMattBinnicker</a>)</p>
<p>Host: Amit K. Ghosh, M.D. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>)</p>
<p> </p>
<p>In this podcast Matthew J. Binnicker, Ph.D. discusses the development of different types of testing available to diagnose SARS-CoV2 infection. Binnicker discusses the test characteristics of the rapid antigen tests and RT-PCR test and its variability based on the time when the test was performed. He also discusses the optimal timing of diagnostic testing (rapid testing, RT-PCR) and the role and limitations of antibody testing in COVID-19.</p>
<p> </p>
<p>Additional resources:</p>
<p>Shah AS, Tande AJ, Challener DW, O’Horo JC, Binnicker MJ, Berbari EF. Diagnostic stewardship: An essential element in a rapidly evolving COVID-19 pandemic. Mayo Clin Proc. 2020;95(9):S17-S19. DOI: <a href='https://doi.org/10.1016/j.mayocp.2020.05.039'>https://doi.org/10.1016/j.mayocp.2020.05.039</a></p>
<p> </p>
<p>Connect with the Mayo Clinic School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Matthew J. Binnicker, Ph.D. (<a href='https://twitter.com/DrMattBinnicker'>@DrMattBinnicker</a>)</p>
<p>Host: Amit K. Ghosh, M.D. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>)</p>
<p> </p>
<p>In this podcast Matthew J. Binnicker, Ph.D. discusses the development of different types of testing available to diagnose SARS-CoV2 infection. Binnicker discusses the test characteristics of the rapid antigen tests and RT-PCR test and its variability based on the time when the test was performed. He also discusses the optimal timing of diagnostic testing (rapid testing, RT-PCR) and the role and limitations of antibody testing in COVID-19.</p>
<p> </p>
<p>Additional resources:</p>
<p>Shah AS, Tande AJ, Challener DW, O’Horo JC, Binnicker MJ, Berbari EF. Diagnostic stewardship: An essential element in a rapidly evolving COVID-19 pandemic. Mayo Clin Proc. 2020;95(9):S17-S19. DOI: <a href='https://doi.org/10.1016/j.mayocp.2020.05.039'>https://doi.org/10.1016/j.mayocp.2020.05.039</a></p>
<p> </p>
<p>Connect with the Mayo Clinic School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/899vau/WF488567_COVID_Testing_History_Binniker72uq4.mp3" length="34642857" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Matthew J. Binnicker, Ph.D. (@DrMattBinnicker)
Host: Amit K. Ghosh, M.D. (@AmitGhosh006)
 
In this podcast Matthew J. Binnicker, Ph.D. discusses the development of different types of testing available to diagnose SARS-CoV2 infection. Binnicker discusses the test characteristics of the rapid antigen tests and RT-PCR test and its variability based on the time when the test was performed. He also discusses the optimal timing of diagnostic testing (rapid testing, RT-PCR) and the role and limitations of antibody testing in COVID-19.
 
Additional resources:
Shah AS, Tande AJ, Challener DW, O’Horo JC, Binnicker MJ, Berbari EF. Diagnostic stewardship: An essential element in a rapidly evolving COVID-19 pandemic. Mayo Clin Proc. 2020;95(9):S17-S19. DOI: https://doi.org/10.1016/j.mayocp.2020.05.039
 
Connect with the Mayo Clinic School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2157</itunes:duration>
                <itunes:episode>276</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes &amp; Your Health Edition - Pharmacogenomics and its Value for Primary Care</title>
        <itunes:title>Genes &amp; Your Health Edition - Pharmacogenomics and its Value for Primary Care</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-pharmacogenomics-and-its-value-for-primary-care/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-pharmacogenomics-and-its-value-for-primary-care/#comments</comments>        <pubDate>Thu, 23 Sep 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/351b9e05-aef8-3ee7-b2bb-bd0bef62b41e</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health#group-tabs-node-course-default1'>https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health#group-tabs-node-course-default1</a></p>
<p>Guest: Jessica A. Wright, Pharm.D., R.Ph.</p>
<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Pharmacogenomics helps to identify how your patients’ DNA may affect their response to medications. But there's a lot of different genes! How do we get started? What resources are out there? Do we have to worry about every drug a patient is on? Find out these answers and more in episode three of the Genes & Your Health Edition from the Mayo Clinic Center for Individualized Medicine.</p>
<p>Additional resources:</p>
<ul><li>PharmGKB: <a href='http://www.pharmgkb.org'>pharmgkb.org</a></li>
<li>Clinical Pharmacogenetics Implementation Consortium (CPIC®): <a href='http://www.cpicpgx.org'>cpicpgx.org</a></li>
<li>Basic Pharmacogenomics Nomenclature: <a href='https://www.pharmgkb.org/page/glossary'>https://www.pharmgkb.org/page/glossary</a></li>
<li>NIH’s National Human Genome Research Institute: Healthcare Provider Resources: <a href='https://www.genome.gov/For-Health-Professionals/Provider-Genomics-Education-Resources'>https://www.genome.gov/For-Health-Professionals/Provider-Genomics-Education-Resources</a></li>
<li>Mayo Clinic Center for Individualized Medicine: <a href='https://www.mayo.edu/research/centers-programs/center-individualized-medicine'>https://www.mayo.edu/research/centers-programs/center-individualized-medicine</a></li>
</ul>
<p>Connect with the Mayo Clinic School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health#group-tabs-node-course-default1'>https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health#group-tabs-node-course-default1</a></p>
<p>Guest: Jessica A. Wright, Pharm.D., R.Ph.</p>
<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>Pharmacogenomics helps to identify how your patients’ DNA may affect their response to medications. But there's a lot of different genes! How do we get started? What resources are out there? Do we have to worry about every drug a patient is on? Find out these answers and more in episode three of the Genes & Your Health Edition from the Mayo Clinic Center for Individualized Medicine.</p>
<p>Additional resources:</p>
<ul><li>PharmGKB: <a href='http://www.pharmgkb.org'>pharmgkb.org</a></li>
<li>Clinical Pharmacogenetics Implementation Consortium (CPIC®): <a href='http://www.cpicpgx.org'>cpicpgx.org</a></li>
<li>Basic Pharmacogenomics Nomenclature: <a href='https://www.pharmgkb.org/page/glossary'>https://www.pharmgkb.org/page/glossary</a></li>
<li>NIH’s National Human Genome Research Institute: Healthcare Provider Resources: <a href='https://www.genome.gov/For-Health-Professionals/Provider-Genomics-Education-Resources'>https://www.genome.gov/For-Health-Professionals/Provider-Genomics-Education-Resources</a></li>
<li>Mayo Clinic Center for Individualized Medicine: <a href='https://www.mayo.edu/research/centers-programs/center-individualized-medicine'>https://www.mayo.edu/research/centers-programs/center-individualized-medicine</a></li>
</ul>
<p>Connect with the Mayo Clinic School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/z79kh6/WF130429_-_Pharmocogenomics_Dupras_V39uqfw.mp3" length="28590701" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health#group-tabs-node-course-default1
Guest: Jessica A. Wright, Pharm.D., R.Ph.
Host: Denise M. Dupras, M.D., Ph.D.
Pharmacogenomics helps to identify how your patients’ DNA may affect their response to medications. But there's a lot of different genes! How do we get started? What resources are out there? Do we have to worry about every drug a patient is on? Find out these answers and more in episode three of the Genes & Your Health Edition from the Mayo Clinic Center for Individualized Medicine.
Additional resources:
PharmGKB: pharmgkb.org
Clinical Pharmacogenetics Implementation Consortium (CPIC®): cpicpgx.org
Basic Pharmacogenomics Nomenclature: https://www.pharmgkb.org/page/glossary
NIH’s National Human Genome Research Institute: Healthcare Provider Resources: https://www.genome.gov/For-Health-Professionals/Provider-Genomics-Education-Resources
Mayo Clinic Center for Individualized Medicine: https://www.mayo.edu/research/centers-programs/center-individualized-medicine
Connect with the Mayo Clinic School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1783</itunes:duration>
                <itunes:episode>270</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Regenerative Techniques for the Larynx</title>
        <itunes:title>Regenerative Techniques for the Larynx</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/regenerative-techniques-for-the-larynx/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/regenerative-techniques-for-the-larynx/#comments</comments>        <pubDate>Tue, 21 Sep 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/b06aaa80-6a87-3c23-95d4-f0e91be81672</guid>
                                    <description><![CDATA[<p>Guest: David G. Lott, M.D.</p>
<p>Host: Amit K. Ghosh, M.D. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>)</p>
<p>About 60,000 Americans have had their vocal cords removed due to disease or trauma necessitating a laryngectomy. Post-laryngectomy, patients are unable to speak, are at risk for aspiration, and many suffer from significant anguish resulting in depression. Fortunately, there are several treatment options available, the first being laryngeal transplant. While laryngeal transplantation allows patients to smell, taste, swallow, and communicate, it has drawbacks. Currently only a small number of larynx transplants are done in the U.S., and only a select few patients with laryngectomy qualify for larynx transplant. In this episode, Dr. David Lott, division chair of laryngology at Mayo Clinic’s Arizona campus, discusses the role of regenerative medicine, which has shown promise in using 3D printing and a patient’s stem cells in creating a larynx.</p>
<p>Connect with the Mayo Clinic School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: David G. Lott, M.D.</p>
<p>Host: Amit K. Ghosh, M.D. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>)</p>
<p>About 60,000 Americans have had their vocal cords removed due to disease or trauma necessitating a laryngectomy. Post-laryngectomy, patients are unable to speak, are at risk for aspiration, and many suffer from significant anguish resulting in depression. Fortunately, there are several treatment options available, the first being laryngeal transplant. While laryngeal transplantation allows patients to smell, taste, swallow, and communicate, it has drawbacks. Currently only a small number of larynx transplants are done in the U.S., and only a select few patients with laryngectomy qualify for larynx transplant. In this episode, Dr. David Lott, division chair of laryngology at Mayo Clinic’s Arizona campus, discusses the role of regenerative medicine, which has shown promise in using 3D printing and a patient’s stem cells in creating a larynx.</p>
<p>Connect with the Mayo Clinic School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/h758br/WF184605_Regenerative_Techniques_for_the_Larynx9oh8r.mp3" length="21336217" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: David G. Lott, M.D.
Host: Amit K. Ghosh, M.D. (@AmitGhosh006)
About 60,000 Americans have had their vocal cords removed due to disease or trauma necessitating a laryngectomy. Post-laryngectomy, patients are unable to speak, are at risk for aspiration, and many suffer from significant anguish resulting in depression. Fortunately, there are several treatment options available, the first being laryngeal transplant. While laryngeal transplantation allows patients to smell, taste, swallow, and communicate, it has drawbacks. Currently only a small number of larynx transplants are done in the U.S., and only a select few patients with laryngectomy qualify for larynx transplant. In this episode, Dr. David Lott, division chair of laryngology at Mayo Clinic’s Arizona campus, discusses the role of regenerative medicine, which has shown promise in using 3D printing and a patient’s stem cells in creating a larynx.
Connect with the Mayo Clinic School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1328</itunes:duration>
                <itunes:episode>269</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes &amp; Your Health Edition - How Does Viral Genetics Influence Transmission, Diagnosis, and Severity of COVID-19?</title>
        <itunes:title>Genes &amp; Your Health Edition - How Does Viral Genetics Influence Transmission, Diagnosis, and Severity of COVID-19?</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-how-does-viral-genetics-influence-transmission-diagnosis-and-severity-of-covid-19/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-how-does-viral-genetics-influence-transmission-diagnosis-and-severity-of-covid-19/#comments</comments>        <pubDate>Thu, 16 Sep 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/2d2c8057-4112-37be-b762-eb36fd4f4c82</guid>
                                    <description><![CDATA[<p>To claim credit for this series, visit: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health#group-tabs-node-course-default1'>https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health#group-tabs-node-course-default1</a></p>
<p>Guests: Andrew D. Badley, M.D. (<a href='https://twitter.com/BadleyAndrew'>@BadleyAndrew</a>); Matthew J. Binnicker, Ph.D. (<a href='https://twitter.com/DrMattBinnicker'>@DrMattBinnicker</a>)</p>
<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>COVID-19. Variants. The future. Does one test fit all?  Will the vaccine continue to provide protection against future variants? What makes the Delta variant more transmissible? Join the second episode of our Genes & Your Health Edition from the Mayo Clinic Center for Individualized Medicine to learn how viral genetics influence transmission, diagnosis, and severity of COVID-19.</p>
<p>Additional resources:</p>
<ul><li>Mayo Clinic Center for Individualized Medicine: <a href='https://www.mayo.edu/research/centers-programs/center-individualized-medicine'>https://www.mayo.edu/research/centers-programs/center-individualized-medicine</a></li>
</ul>
<p>Connect with the Mayo Clinic School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this series, visit: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health#group-tabs-node-course-default1'>https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health#group-tabs-node-course-default1</a></p>
<p>Guests: Andrew D. Badley, M.D. (<a href='https://twitter.com/BadleyAndrew'>@BadleyAndrew</a>); Matthew J. Binnicker, Ph.D. (<a href='https://twitter.com/DrMattBinnicker'>@DrMattBinnicker</a>)</p>
<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>COVID-19. Variants. The future. Does one test fit all?  Will the vaccine continue to provide protection against future variants? What makes the Delta variant more transmissible? Join the second episode of our Genes & Your Health Edition from the Mayo Clinic Center for Individualized Medicine to learn how viral genetics influence transmission, diagnosis, and severity of COVID-19.</p>
<p>Additional resources:</p>
<ul><li>Mayo Clinic Center for Individualized Medicine: <a href='https://www.mayo.edu/research/centers-programs/center-individualized-medicine'>https://www.mayo.edu/research/centers-programs/center-individualized-medicine</a></li>
</ul>
<p>Connect with the Mayo Clinic School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/huss9d/WF351254_Viral_Genetics_V2b0fnz.mp3" length="33195051" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this series, visit: https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health#group-tabs-node-course-default1
Guests: Andrew D. Badley, M.D. (@BadleyAndrew); Matthew J. Binnicker, Ph.D. (@DrMattBinnicker)
Host: Denise M. Dupras, M.D., Ph.D.
COVID-19. Variants. The future. Does one test fit all?  Will the vaccine continue to provide protection against future variants? What makes the Delta variant more transmissible? Join the second episode of our Genes & Your Health Edition from the Mayo Clinic Center for Individualized Medicine to learn how viral genetics influence transmission, diagnosis, and severity of COVID-19.
Additional resources:
Mayo Clinic Center for Individualized Medicine: https://www.mayo.edu/research/centers-programs/center-individualized-medicine
Connect with the Mayo Clinic School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2069</itunes:duration>
                <itunes:episode>268</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Genes &amp; Your Health Edition - Genomics and Healthcare, Why Does it Matter?</title>
        <itunes:title>Genes &amp; Your Health Edition - Genomics and Healthcare, Why Does it Matter?</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-genomics-and-healthcare-why-does-it-matter/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/genes-your-health-edition-genomics-and-healthcare-why-does-it-matter/#comments</comments>        <pubDate>Tue, 14 Sep 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/06334c0e-f689-3b8a-b0de-0f7e97aa6adb</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health#group-tabs-node-course-default1'>https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health#group-tabs-node-course-default1</a></p>
<p>Guests: Matthew J. Ferber, Ph.D. (<a href='https://twitter.com/Matt_Ferber'>@Matt_Ferber</a>); Teresa M. Kruisselbrink, M.S., CGC (<a href='https://twitter.com/T_Kruisselbrink'>@T_Kruisselbrink</a>); William C. Palmer, M.D. (<a href='https://twitter.com/williampalmermd'>@williampalmermd</a>)</p>
<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>For so long we've heard Genetic Testing is coming. Well guess what, it’s here!  We have over 25 million people who have chosen to participate in direct-to-consumer testing alone. What does this mean for primary care, and does it matter? Find out in the first episode of our Genes & Your Health Edition from the Mayo Clinic Center for Individualized Medicine.</p>
<p>Additional resources:</p>
<ul><li>TAPESTRY Study: <a href='https://www.mayo.edu/research/clinical-trials/cls-20477323?_ga=2.268706548.460922620.1627479724-1519128218.1623079535'>https://www.mayo.edu/research/clinical-trials/cls-20477323?_ga=2.268706548.460922620.1627479724-1519128218.1623079535</a></li>
<li>Mayo Clinic Center for Individualized Medicine: <a href='https://www.mayo.edu/research/centers-programs/center-individualized-medicine'>https://www.mayo.edu/research/centers-programs/center-individualized-medicine</a></li>
</ul>
<p>Connect with the Mayo Clinic School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health#group-tabs-node-course-default1'>https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health#group-tabs-node-course-default1</a></p>
<p>Guests: Matthew J. Ferber, Ph.D. (<a href='https://twitter.com/Matt_Ferber'>@Matt_Ferber</a>); Teresa M. Kruisselbrink, M.S., CGC (<a href='https://twitter.com/T_Kruisselbrink'>@T_Kruisselbrink</a>); William C. Palmer, M.D. (<a href='https://twitter.com/williampalmermd'>@williampalmermd</a>)</p>
<p>Host: Denise M. Dupras, M.D., Ph.D.</p>
<p>For so long we've heard Genetic Testing is coming. Well guess what, it’s here!  We have over 25 million people who have chosen to participate in direct-to-consumer testing alone. What does this mean for primary care, and does it matter? Find out in the first episode of our Genes & Your Health Edition from the Mayo Clinic Center for Individualized Medicine.</p>
<p>Additional resources:</p>
<ul><li>TAPESTRY Study: <a href='https://www.mayo.edu/research/clinical-trials/cls-20477323?_ga=2.268706548.460922620.1627479724-1519128218.1623079535'>https://www.mayo.edu/research/clinical-trials/cls-20477323?_ga=2.268706548.460922620.1627479724-1519128218.1623079535</a></li>
<li>Mayo Clinic Center for Individualized Medicine: <a href='https://www.mayo.edu/research/centers-programs/center-individualized-medicine'>https://www.mayo.edu/research/centers-programs/center-individualized-medicine</a></li>
</ul>
<p>Connect with the Mayo Clinic School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gymx5d/WF197504_-_Introductory_Session_V26o580.mp3" length="33917200" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: https://ce.mayo.edu/online-education/content/mayo-clinic-talks-podcast-genes-your-health#group-tabs-node-course-default1
Guests: Matthew J. Ferber, Ph.D. (@Matt_Ferber); Teresa M. Kruisselbrink, M.S., CGC (@T_Kruisselbrink); William C. Palmer, M.D. (@williampalmermd)
Host: Denise M. Dupras, M.D., Ph.D.
For so long we've heard Genetic Testing is coming. Well guess what, it’s here!  We have over 25 million people who have chosen to participate in direct-to-consumer testing alone. What does this mean for primary care, and does it matter? Find out in the first episode of our Genes & Your Health Edition from the Mayo Clinic Center for Individualized Medicine.
Additional resources:
TAPESTRY Study: https://www.mayo.edu/research/clinical-trials/cls-20477323?_ga=2.268706548.460922620.1627479724-1519128218.1623079535
Mayo Clinic Center for Individualized Medicine: https://www.mayo.edu/research/centers-programs/center-individualized-medicine
Connect with the Mayo Clinic School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2113</itunes:duration>
                <itunes:episode>267</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Variants, Virulence, and Vaccines, Oh My!</title>
        <itunes:title>Variants, Virulence, and Vaccines, Oh My!</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/variants-virulence-and-vaccines-oh-my/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/variants-virulence-and-vaccines-oh-my/#comments</comments>        <pubDate>Tue, 07 Sep 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/7922822c-a54d-3123-8d91-418b3efe6729</guid>
                                    <description><![CDATA[<p>Guest: Elitza S. Theel, Ph.D. (<a href='https://twitter.com/ElliTheelPhD'>@ElliTheelPhD</a>)</p>
<p>Host: Amit K. Ghosh, M.D. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>)</p>
<p>Dr. Elitza Theel, Professor of Laboratory Medicine and Pathology and Director of Infectious Diseases Serology Laboratory at Mayo Clinic’s Rochester Campus, discusses our immune response to vaccination and natural infection and outlines the different types of antibody assays currently available. Dr. Theel also discusses the concept of herd immunity in the context of different circulating SARS-CoV-2 variants and the increased need to get higher rates of vaccination in the community as the infectivity and transmissibility of circulating SARS-CoV-2 variants changes. We also discuss the status of correlates of protective immunity against SARS-CoV-2 and the need for booster vaccine doses for immunocompromised individuals. </p>
<p>Additional resources:</p>
<ul><li>Interim Guidelines for COVID-19 Antibody Testing in Clinical and Public Health Settings <a href='https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antibody-tests-guidelines.html'>https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antibody-tests-guidelines.html</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Elitza S. Theel, Ph.D. (<a href='https://twitter.com/ElliTheelPhD'>@ElliTheelPhD</a>)</p>
<p>Host: Amit K. Ghosh, M.D. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>)</p>
<p>Dr. Elitza Theel, Professor of Laboratory Medicine and Pathology and Director of Infectious Diseases Serology Laboratory at Mayo Clinic’s Rochester Campus, discusses our immune response to vaccination and natural infection and outlines the different types of antibody assays currently available. Dr. Theel also discusses the concept of herd immunity in the context of different circulating SARS-CoV-2 variants and the increased need to get higher rates of vaccination in the community as the infectivity and transmissibility of circulating SARS-CoV-2 variants changes. We also discuss the status of correlates of protective immunity against SARS-CoV-2 and the need for booster vaccine doses for immunocompromised individuals. </p>
<p>Additional resources:</p>
<ul><li>Interim Guidelines for COVID-19 Antibody Testing in Clinical and Public Health Settings <a href='https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antibody-tests-guidelines.html'>https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antibody-tests-guidelines.html</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/j9c5uy/WF488566_Antibody_Responseb8img.mp3" length="26784702" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Elitza S. Theel, Ph.D. (@ElliTheelPhD)
Host: Amit K. Ghosh, M.D. (@AmitGhosh006)
Dr. Elitza Theel, Professor of Laboratory Medicine and Pathology and Director of Infectious Diseases Serology Laboratory at Mayo Clinic’s Rochester Campus, discusses our immune response to vaccination and natural infection and outlines the different types of antibody assays currently available. Dr. Theel also discusses the concept of herd immunity in the context of different circulating SARS-CoV-2 variants and the increased need to get higher rates of vaccination in the community as the infectivity and transmissibility of circulating SARS-CoV-2 variants changes. We also discuss the status of correlates of protective immunity against SARS-CoV-2 and the need for booster vaccine doses for immunocompromised individuals. 
Additional resources:
Interim Guidelines for COVID-19 Antibody Testing in Clinical and Public Health Settings https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antibody-tests-guidelines.html
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1667</itunes:duration>
                <itunes:episode>266</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Evaluating Hematuria</title>
        <itunes:title>Evaluating Hematuria</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/correct-evaluation-of-hematuria/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/correct-evaluation-of-hematuria/#comments</comments>        <pubDate>Tue, 31 Aug 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/0385d040-92b9-362f-ac0c-881bfbc7333a</guid>
                                    <description><![CDATA[<p>Guest: Aaron M. Potretzke, M.D. (<a href='https://twitter.com/potretzke'>@potretzke</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Microscopic hematuria, and less commonly gross hematuria, are conditions commonly seen by the primary care provider. Malignancy is the most ominous cause of hematuria. Fortunately, other causes are much more likely. Since this is a relatively common health condition, when should we investigate hematuria and what should the evaluation consist of? How do we evaluate a patient’s risk for urinary tract malignancy? Dr. Aaron Potretzke, a urologist at Mayo Clinic joins us to discuss these questions.</p>
<p>Specific topics:</p>
<ul><li>Definition of hematuria</li>
<li>Benign causes of hematuria</li>
<li>Risk of malignancy in low, medium, and high-risk patients</li>
<li>Stratifying malignancy risk in patients for genitourinary malignancy</li>
<li>Recommended evaluation for patients with hematuria</li>
<li>How to manage patients with persistent hematuria despite a negative evaluation</li>
<li>Role of urine cytology in the evaluation of hematuria</li>
</ul>
<p>Additional resources:</p>
<ul><li>American Urological Association hematuria guideline and algorithm: <a href='https://www.auanet.org/guidelines/guidelines/microhematuria'>https://www.auanet.org/guidelines/guidelines/microhematuria</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Aaron M. Potretzke, M.D. (<a href='https://twitter.com/potretzke'>@potretzke</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Microscopic hematuria, and less commonly gross hematuria, are conditions commonly seen by the primary care provider. Malignancy is the most ominous cause of hematuria. Fortunately, other causes are much more likely. Since this is a relatively common health condition, when should we investigate hematuria and what should the evaluation consist of? How do we evaluate a patient’s risk for urinary tract malignancy? Dr. Aaron Potretzke, a urologist at Mayo Clinic joins us to discuss these questions.</p>
<p>Specific topics:</p>
<ul><li>Definition of hematuria</li>
<li>Benign causes of hematuria</li>
<li>Risk of malignancy in low, medium, and high-risk patients</li>
<li>Stratifying malignancy risk in patients for genitourinary malignancy</li>
<li>Recommended evaluation for patients with hematuria</li>
<li>How to manage patients with persistent hematuria despite a negative evaluation</li>
<li>Role of urine cytology in the evaluation of hematuria</li>
</ul>
<p>Additional resources:</p>
<ul><li>American Urological Association hematuria guideline and algorithm: <a href='https://www.auanet.org/guidelines/guidelines/microhematuria'>https://www.auanet.org/guidelines/guidelines/microhematuria</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wnmkza/WF314419_Hematuria_Eval_for_the_PCPbvyln.mp3" length="18513420" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Aaron M. Potretzke, M.D. (@potretzke)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Microscopic hematuria, and less commonly gross hematuria, are conditions commonly seen by the primary care provider. Malignancy is the most ominous cause of hematuria. Fortunately, other causes are much more likely. Since this is a relatively common health condition, when should we investigate hematuria and what should the evaluation consist of? How do we evaluate a patient’s risk for urinary tract malignancy? Dr. Aaron Potretzke, a urologist at Mayo Clinic joins us to discuss these questions.
Specific topics:
Definition of hematuria
Benign causes of hematuria
Risk of malignancy in low, medium, and high-risk patients
Stratifying malignancy risk in patients for genitourinary malignancy
Recommended evaluation for patients with hematuria
How to manage patients with persistent hematuria despite a negative evaluation
Role of urine cytology in the evaluation of hematuria
Additional resources:
American Urological Association hematuria guideline and algorithm: https://www.auanet.org/guidelines/guidelines/microhematuria
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1152</itunes:duration>
                <itunes:episode>265</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Exercise is First-Line Treatment for Your Parkinson's Patients</title>
        <itunes:title>Exercise is First-Line Treatment for Your Parkinson's Patients</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/parkinsons-exercise/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/parkinsons-exercise/#comments</comments>        <pubDate>Tue, 24 Aug 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/fed1b8f5-ab89-3400-9dc5-cee617cebe93</guid>
                                    <description><![CDATA[<p>Guest: Edward R. Laskowski, M.D. (<a href='https://twitter.com/DrEdSportsMed'>@DrEdSportsMed</a>)</p>
<p>Host: Sanjeev (Sanj) Kakar, M.D. (<a href='https://twitter.com/sanjkakar'>@sanjkakar</a>)</p>
<p>Daily exercise has so many health and emotional benefits – it can help decrease your blood pressure, promote cardiovascular wellbeing, alleviate stress, and assist with weight loss and blood sugar control. Parkinson’s disease is a condition that affects the central nervous system, and in particular the brain, that can lead to shakiness, poor balance, and frequent falls. Joining us in this episode is Edward Laskowski, M.D., a professor of physical medicine and rehabilitation and sports medicine specialist at Mayo Clinic’s Rochester Campus, to discuss why exercise is first-line treatment for your Parkinson’s patients.</p>
<p>Additional resources:</p>
<ul><li>Mayo Clinic: <a href='https://www.mayoclinic.org/diseases-conditions/parkinsons-disease/symptoms-causes/syc-20376055'>https://www.mayoclinic.org/diseases-conditions/parkinsons-disease/symptoms-causes/syc-20376055</a></li>
<li>The Michael J. Fox Foundation for Parkinson’s Research: <a href='https://www.michaeljfox.org/'>https://www.michaeljfox.org/</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Edward R. Laskowski, M.D. (<a href='https://twitter.com/DrEdSportsMed'>@DrEdSportsMed</a>)</p>
<p>Host: Sanjeev (Sanj) Kakar, M.D. (<a href='https://twitter.com/sanjkakar'>@sanjkakar</a>)</p>
<p>Daily exercise has so many health and emotional benefits – it can help decrease your blood pressure, promote cardiovascular wellbeing, alleviate stress, and assist with weight loss and blood sugar control. Parkinson’s disease is a condition that affects the central nervous system, and in particular the brain, that can lead to shakiness, poor balance, and frequent falls. Joining us in this episode is Edward Laskowski, M.D., a professor of physical medicine and rehabilitation and sports medicine specialist at Mayo Clinic’s Rochester Campus, to discuss why exercise is first-line treatment for your Parkinson’s patients.</p>
<p>Additional resources:</p>
<ul><li>Mayo Clinic: <a href='https://www.mayoclinic.org/diseases-conditions/parkinsons-disease/symptoms-causes/syc-20376055'>https://www.mayoclinic.org/diseases-conditions/parkinsons-disease/symptoms-causes/syc-20376055</a></li>
<li>The Michael J. Fox Foundation for Parkinson’s Research: <a href='https://www.michaeljfox.org/'>https://www.michaeljfox.org/</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8nychs/WF351255_Parkinsons_and_Exerciseaws7q.mp3" length="15537080" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Edward R. Laskowski, M.D. (@DrEdSportsMed)
Host: Sanjeev (Sanj) Kakar, M.D. (@sanjkakar)
Daily exercise has so many health and emotional benefits – it can help decrease your blood pressure, promote cardiovascular wellbeing, alleviate stress, and assist with weight loss and blood sugar control. Parkinson’s disease is a condition that affects the central nervous system, and in particular the brain, that can lead to shakiness, poor balance, and frequent falls. Joining us in this episode is Edward Laskowski, M.D., a professor of physical medicine and rehabilitation and sports medicine specialist at Mayo Clinic’s Rochester Campus, to discuss why exercise is first-line treatment for your Parkinson’s patients.
Additional resources:
Mayo Clinic: https://www.mayoclinic.org/diseases-conditions/parkinsons-disease/symptoms-causes/syc-20376055
The Michael J. Fox Foundation for Parkinson’s Research: https://www.michaeljfox.org/
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>968</itunes:duration>
                <itunes:episode>264</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Parkinson's Disease - It's More Than Just a Tremor</title>
        <itunes:title>Parkinson's Disease - It's More Than Just a Tremor</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/parkinsons-disease-its-more-than-just-a-tremor/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/parkinsons-disease-its-more-than-just-a-tremor/#comments</comments>        <pubDate>Tue, 17 Aug 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/fd0004a7-b6fd-3076-96af-fe3997eb3111</guid>
                                    <description><![CDATA[<p>Guest: Jeremy K. Cutsforth-Gregory, M.D. (<a href='https://twitter.com/JCGneuro'>@JCGneuro</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Parkinson’s Disease is one of the more common neurodegenerative diseases, in fact, patients with Parkinson’s outnumber those with multiple sclerosis, ALS, and muscular dystrophy combined. It tends to affect older patients, although on rare occasions it can be seen in those under the age of 50. It can have a devastating effect on an individual’s lifestyle as the physical symptoms of the disease tend to gradually progress over years. This podcast will feature Dr. Jeremy Cutsforth-Gregory, a neurologist at the Mayo Clinic, as we discuss the evaluation and management of Parkinson’s Disease.</p>
<p>Specific topics:</p>
<ul><li>Pathophysiology of Parkinson’s Disease</li>
<li>Common presenting symptoms of Parkinson’s</li>
<li>Assessing patients with tremor</li>
<li>Complications of advanced Parkinson’s</li>
<li>Pharmacologic management of Parkinson’s</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Jeremy K. Cutsforth-Gregory, M.D. (<a href='https://twitter.com/JCGneuro'>@JCGneuro</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Parkinson’s Disease is one of the more common neurodegenerative diseases, in fact, patients with Parkinson’s outnumber those with multiple sclerosis, ALS, and muscular dystrophy combined. It tends to affect older patients, although on rare occasions it can be seen in those under the age of 50. It can have a devastating effect on an individual’s lifestyle as the physical symptoms of the disease tend to gradually progress over years. This podcast will feature Dr. Jeremy Cutsforth-Gregory, a neurologist at the Mayo Clinic, as we discuss the evaluation and management of Parkinson’s Disease.</p>
<p>Specific topics:</p>
<ul><li>Pathophysiology of Parkinson’s Disease</li>
<li>Common presenting symptoms of Parkinson’s</li>
<li>Assessing patients with tremor</li>
<li>Complications of advanced Parkinson’s</li>
<li>Pharmacologic management of Parkinson’s</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cfimha/WF126675_-_Parkinson_s_Diseaseaegdk.mp3" length="18130144" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Jeremy K. Cutsforth-Gregory, M.D. (@JCGneuro)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Parkinson’s Disease is one of the more common neurodegenerative diseases, in fact, patients with Parkinson’s outnumber those with multiple sclerosis, ALS, and muscular dystrophy combined. It tends to affect older patients, although on rare occasions it can be seen in those under the age of 50. It can have a devastating effect on an individual’s lifestyle as the physical symptoms of the disease tend to gradually progress over years. This podcast will feature Dr. Jeremy Cutsforth-Gregory, a neurologist at the Mayo Clinic, as we discuss the evaluation and management of Parkinson’s Disease.
Specific topics:
Pathophysiology of Parkinson’s Disease
Common presenting symptoms of Parkinson’s
Assessing patients with tremor
Complications of advanced Parkinson’s
Pharmacologic management of Parkinson’s
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1129</itunes:duration>
                <itunes:episode>263</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Working from the Ground Up to Impact Gender Disparities in COVID-19</title>
        <itunes:title>Working from the Ground Up to Impact Gender Disparities in COVID-19</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/working-from-the-ground-up-to-impact-gender-disparities-in-covid-19/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/working-from-the-ground-up-to-impact-gender-disparities-in-covid-19/#comments</comments>        <pubDate>Tue, 10 Aug 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/0072ad82-d4d6-3a03-b12f-d36b52f0cdfc</guid>
                                    <description><![CDATA[<p>Guest: Carol L. Kuhle, D.O., M.P.H. (<a href='https://twitter.com/clkejd'>@clkejd</a>)</p>
<p>Host: Anjali Bhagra, M.D. (<a href='https://twitter.com/anjalibhagramd'>@anjalibhagramd</a>)</p>
<p>Anjali Bhagra, M.D., and Carol L. Kuhle, D.O., M.P.H., discuss the narrative they recently published in Mayo Clinic Proceedings, which outlines and highlights the further widening of preexisting gender disparities in response to the COVID-19 pandemic. What can we do to identify and mitigate these issues?</p>
<p>Additional resources:</p>
<ul><li>Nordhues, HC. Bhagra, A. Stroud, NN. Vencill, JA. Kuhle, CL. COVID-19 gender disparities and mitigation recommendations: a narrative review. Mayo Clin Proc. 2021 April 20; 96(7): 1907-1920. doi: <a href='https://doi.org/10.1016/j.mayocp.2021.04.009'>https://doi.org/10.1016/j.mayocp.2021.04.009</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Carol L. Kuhle, D.O., M.P.H. (<a href='https://twitter.com/clkejd'>@clkejd</a>)</p>
<p>Host: Anjali Bhagra, M.D. (<a href='https://twitter.com/anjalibhagramd'>@anjalibhagramd</a>)</p>
<p>Anjali Bhagra, M.D., and Carol L. Kuhle, D.O., M.P.H., discuss the narrative they recently published in <em>Mayo Clinic Proceedings</em>, which outlines and highlights the further widening of preexisting gender disparities in response to the COVID-19 pandemic. What can we do to identify and mitigate these issues?</p>
<p>Additional resources:</p>
<ul><li>Nordhues, HC. Bhagra, A. Stroud, NN. Vencill, JA. Kuhle, CL. COVID-19 gender disparities and mitigation recommendations: a narrative review. <em>Mayo Clin Proc</em>. 2021 April 20; 96(7): 1907-1920. doi: <a href='https://doi.org/10.1016/j.mayocp.2021.04.009'>https://doi.org/10.1016/j.mayocp.2021.04.009</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/b3izeh/WF351252_-_Gender_Disparities_in_COVID8tlak.mp3" length="17420827" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Carol L. Kuhle, D.O., M.P.H. (@clkejd)
Host: Anjali Bhagra, M.D. (@anjalibhagramd)
Anjali Bhagra, M.D., and Carol L. Kuhle, D.O., M.P.H., discuss the narrative they recently published in Mayo Clinic Proceedings, which outlines and highlights the further widening of preexisting gender disparities in response to the COVID-19 pandemic. What can we do to identify and mitigate these issues?
Additional resources:
Nordhues, HC. Bhagra, A. Stroud, NN. Vencill, JA. Kuhle, CL. COVID-19 gender disparities and mitigation recommendations: a narrative review. Mayo Clin Proc. 2021 April 20; 96(7): 1907-1920. doi: https://doi.org/10.1016/j.mayocp.2021.04.009
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1084</itunes:duration>
                <itunes:episode>262</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: The COVID-19 Delta Variant has Changed Everything</title>
        <itunes:title>Mayo Clinic Q&amp;A: The COVID-19 Delta Variant has Changed Everything</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-the-covid-19-delta-variant-has-changed-everything/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-the-covid-19-delta-variant-has-changed-everything/#comments</comments>        <pubDate>Fri, 06 Aug 2021 09:01:50 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/a2a95e57-9d61-37b3-b91c-146d8818a0df</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded August, 2021</p>
<p>Guest: Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)  </p>
<p>A fourth <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> surge is blanketing the U.S., and the delta variant is the culprit.</p>
<p>"Where did this delta variant come from? It came from unvaccinated people getting infected in large numbers allowing the virus to continue mutating," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>.</p>
<p>In the past, a person with <a href='https://www.mayoclinic.org/diseases-conditions/coronavirus/symptoms-causes/syc-20479963?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> might infect two to four people. But with the delta variant, one person can infect nine people, according to Dr. Poland. He says if you want to protect yourself and your family, wear a mask, especially indoors, and get vaccinated with an appropriate series of one of the COVID-19 vaccines.</p>
<p>"These are the most studied vaccines in the history of the world," Dr. Poland emphasizes. "There have never been this many people who have received this many doses of vaccines during this amount of time with as much scrutiny as these COVID-19 vaccines have had."</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland answers questions about a person's waning immunity and the likelihood of COVID-19 booster shots. He also explains the two phases of immunity and goes into detail about the extensive Federal Drug Administration license approval process for COVID-19 vaccines.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> </a><a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> </a><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> </a><a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded August, 2021</p>
<p>Guest: Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)  </p>
<p>A fourth <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> surge is blanketing the U.S., and the delta variant is the culprit.</p>
<p>"Where did this delta variant come from? It came from unvaccinated people getting infected in large numbers allowing the virus to continue mutating," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>.</p>
<p>In the past, a person with <a href='https://www.mayoclinic.org/diseases-conditions/coronavirus/symptoms-causes/syc-20479963?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> might infect two to four people. But with the delta variant, one person can infect nine people, according to Dr. Poland. He says if you want to protect yourself and your family, wear a mask, especially indoors, and get vaccinated with an appropriate series of one of the COVID-19 vaccines.</p>
<p>"These are the most studied vaccines in the history of the world," Dr. Poland emphasizes. "There have never been this many people who have received this many doses of vaccines during this amount of time with as much scrutiny as these COVID-19 vaccines have had."</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland answers questions about a person's waning immunity and the likelihood of COVID-19 booster shots. He also explains the two phases of immunity and goes into detail about the extensive Federal Drug Administration license approval process for COVID-19 vaccines.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> </a><a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> </a><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> </a><a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rqsmxk/Mayo_Clinic_Q_A_-_Dr_Gregory_Poland_-_COVID-19_Update_-_08_04_219xk30.mp3" length="32055806" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded August, 2021
Guest: Gregory A. Poland, M.D. (@drgregpoland)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)  
A fourth COVID-19 surge is blanketing the U.S., and the delta variant is the culprit.
"Where did this delta variant come from? It came from unvaccinated people getting infected in large numbers allowing the virus to continue mutating," says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group.
In the past, a person with COVID-19 might infect two to four people. But with the delta variant, one person can infect nine people, according to Dr. Poland. He says if you want to protect yourself and your family, wear a mask, especially indoors, and get vaccinated with an appropriate series of one of the COVID-19 vaccines.
"These are the most studied vaccines in the history of the world," Dr. Poland emphasizes. "There have never been this many people who have received this many doses of vaccines during this amount of time with as much scrutiny as these COVID-19 vaccines have had."
In this Mayo Clinic Q&A podcast, Dr. Poland answers questions about a person's waning immunity and the likelihood of COVID-19 booster shots. He also explains the two phases of immunity and goes into detail about the extensive Federal Drug Administration license approval process for COVID-19 vaccines.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1997</itunes:duration>
                <itunes:episode>261</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>Will We Be Replaced by Computers? Artificial Intelligence and Medicine</title>
        <itunes:title>Will We Be Replaced by Computers? Artificial Intelligence and Medicine</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/will-we-be-replaced-by-computers-artificial-intelligence-and-medicine/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/will-we-be-replaced-by-computers-artificial-intelligence-and-medicine/#comments</comments>        <pubDate>Tue, 03 Aug 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/8e77e3e2-7e68-3795-b556-73e0260827ce</guid>
                                    <description><![CDATA[<p>Guest: Steve G. Peters, M.D.</p>
<p>Host: Sanjeev Kakar, M.D. (<a href='https://twitter.com/sanjkakar'>@sanjkakar</a>)</p>
<p>No doubt you’ve heard the term “artificial intelligence,” by now; but what is it exactly? How can medicine use AI to improve patient care and outcomes? Will it one day replace doctors’ years of training? Steve Peters, M.D. a pulmonary and critical care medicine consultant, with a special interest in AI, at Mayo Clinic’s Rochester campus. Dr. Peters will help us take a look into the not-so-distant future as we explore AI and its role in medicine.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Steve G. Peters, M.D.</p>
<p>Host: Sanjeev Kakar, M.D. (<a href='https://twitter.com/sanjkakar'>@sanjkakar</a>)</p>
<p>No doubt you’ve heard the term “artificial intelligence,” by now; but what is it exactly? How can medicine use AI to improve patient care and outcomes? Will it one day replace doctors’ years of training? Steve Peters, M.D. a pulmonary and critical care medicine consultant, with a special interest in AI, at Mayo Clinic’s Rochester campus. Dr. Peters will help us take a look into the not-so-distant future as we explore AI and its role in medicine.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/az6p3h/WF154892_-_AI_and_Quality_Improvement7zw8r.mp3" length="25808725" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Steve G. Peters, M.D.
Host: Sanjeev Kakar, M.D. (@sanjkakar)
No doubt you’ve heard the term “artificial intelligence,” by now; but what is it exactly? How can medicine use AI to improve patient care and outcomes? Will it one day replace doctors’ years of training? Steve Peters, M.D. a pulmonary and critical care medicine consultant, with a special interest in AI, at Mayo Clinic’s Rochester campus. Dr. Peters will help us take a look into the not-so-distant future as we explore AI and its role in medicine.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1607</itunes:duration>
                <itunes:episode>260</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: Stopping the Spiral of the COVID-19 Delta Variant</title>
        <itunes:title>Mayo Clinic Q&amp;A: Stopping the Spiral of the COVID-19 Delta Variant</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-stopping-the-spiral-of-the-covid-19-delta-variant/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-stopping-the-spiral-of-the-covid-19-delta-variant/#comments</comments>        <pubDate>Fri, 30 Jul 2021 10:59:32 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/b81ec44b-06d6-3338-83ac-98877b64756a</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded July, 2021</p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)   </p>
<p>Transmission of the <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> delta variant is increasing.</p>
<p>"We're in this constant spiral, right now,” says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>.</p>
<p>“The delta variant is so highly contagious,” he says. “The number of delta viral particles in the upper respiratory system is reportedly 1,000 times higher than with the original COVID-19 virus. If we can't find ways to get people vaccinated, we are going to be in a world of hurt. And I don't say that to be alarmist. I say it to be a realist, based on what’s happening right in front of us.”</p>
<p>But Dr. Poland says the spiral can be stopped by getting higher rates of immunization. </p>
<p>"Getting a COVID-19 vaccine will prevent the development of worse and worse variants. It will prevent severe cases of hospitalization and death, even in the face of a variant,” he says. "The alternative is to lose another 600,000-plus Americans. Only this time it will, unfortunately, involve younger people."</p>
<p>Dr. Poland explains further, "Every time somebody gets infected with the delta variant, there's the opportunity for that virus to mutate and transmit to other people," says Dr. Poland. "This means that immunization rates to control herd immunity will probably have to be in the 85% to 95% range."</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland continues to talk about the delta variant, breakthrough infections, booster shots and much more.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded July, 2021</p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)   </p>
<p>Transmission of the <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> delta variant is increasing.</p>
<p>"We're in this constant spiral, right now,” says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>.</p>
<p>“The delta variant is so highly contagious,” he says. “The number of delta viral particles in the upper respiratory system is reportedly 1,000 times higher than with the original COVID-19 virus. If we can't find ways to get people vaccinated, we are going to be in a world of hurt. And I don't say that to be alarmist. I say it to be a realist, based on what’s happening right in front of us.”</p>
<p>But Dr. Poland says the spiral can be stopped by getting higher rates of immunization. </p>
<p>"Getting a COVID-19 vaccine will prevent the development of worse and worse variants. It will prevent severe cases of hospitalization and death, even in the face of a variant,” he says. "The alternative is to lose another 600,000-plus Americans. Only this time it will, unfortunately, involve younger people."</p>
<p>Dr. Poland explains further, "Every time somebody gets infected with the delta variant, there's the opportunity for that virus to mutate and transmit to other people," says Dr. Poland. "This means that immunization rates to control herd immunity will probably have to be in the 85% to 95% range."</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland continues to talk about the delta variant, breakthrough infections, booster shots and much more.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/y2afma/Mayo_Clinic_Podcast_-_Dr_Gregory_Poland_-_07_28_21aiv9c.mp3" length="24656229" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded July, 2021
Guest:  Gregory A. Poland, M.D. (@drgregpoland) 
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)   
Transmission of the COVID-19 delta variant is increasing.
"We're in this constant spiral, right now,” says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group.
“The delta variant is so highly contagious,” he says. “The number of delta viral particles in the upper respiratory system is reportedly 1,000 times higher than with the original COVID-19 virus. If we can't find ways to get people vaccinated, we are going to be in a world of hurt. And I don't say that to be alarmist. I say it to be a realist, based on what’s happening right in front of us.”
But Dr. Poland says the spiral can be stopped by getting higher rates of immunization. 
"Getting a COVID-19 vaccine will prevent the development of worse and worse variants. It will prevent severe cases of hospitalization and death, even in the face of a variant,” he says. "The alternative is to lose another 600,000-plus Americans. Only this time it will, unfortunately, involve younger people."
Dr. Poland explains further, "Every time somebody gets infected with the delta variant, there's the opportunity for that virus to mutate and transmit to other people," says Dr. Poland. "This means that immunization rates to control herd immunity will probably have to be in the 85% to 95% range."
In this Mayo Clinic Q&A podcast, Dr. Poland continues to talk about the delta variant, breakthrough infections, booster shots and much more.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1535</itunes:duration>
                        <itunes:episodeType>bonus</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>What’s That Sound? Maybe It’s Stridor</title>
        <itunes:title>What’s That Sound? Maybe It’s Stridor</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/what-s-that-sound-maybe-it-s-stridor/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/what-s-that-sound-maybe-it-s-stridor/#comments</comments>        <pubDate>Tue, 27 Jul 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/7d39e722-e368-3093-b267-e4845c10f624</guid>
                                    <description><![CDATA[<p>Guest: Shelagh A. Cofer, M.D. (<a href='https://twitter.com/ShelaghCoferMD'>@ShelaghCoferMD</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Stridor is a musical sound due to disrupted airflow in an individual’s airway. In many instances it’s due to a benign cause but it can also represent a serious problem, possibly even life-threatening. In today’s podcast, we’ll learn about the various causes of stridor and when we need to be concerned that it represents a serious health issue. Our guest for this podcast is Dr. Shelagh Cofer, a pediatric otolaryngology specialist at the Mayo Clinic. We’ll discuss how stridor differs from wheezing, the most common causes of stridor in both children and adults and what symptoms we should be watching for that might suggest a serious cause for stridor. We’ll also cover the evaluation of patients with stridor, which imaging studies may be helpful and when an ENT consultation is warranted.</p>
<p>Specific topics:</p>
<ul><li>Definition of stridor</li>
<li>Difference between stridor, stertor, and wheezing</li>
<li>Most common causes of stridor in both children and adults</li>
<li>Croup as a form of stridor</li>
<li>Important questions we should be asking our patients about stridor to identify those at risk for airway obstruction – including the SPECS-R mnemonic</li>
<li>Tests and imaging studies which may be helpful in the evaluation of a patient with stridor</li>
<li>Treatments for the more common causes of stridor</li>
</ul>
<p>Additional resources:</p>
<ul><li>Zoumalan, R; Maddalozzo, J; Holinger, LD. Etiology of stridor in infants. Ann Otol Rhinol Laryngol. 2007; 116(5):329-334. doi: 10.1.1896.429 <a href='https://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.896.429&rep=rep1&type=pdf'>https://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.896.429&rep=rep1&type=pdf</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Shelagh A. Cofer, M.D. (<a href='https://twitter.com/ShelaghCoferMD'>@ShelaghCoferMD</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Stridor is a musical sound due to disrupted airflow in an individual’s airway. In many instances it’s due to a benign cause but it can also represent a serious problem, possibly even life-threatening. In today’s podcast, we’ll learn about the various causes of stridor and when we need to be concerned that it represents a serious health issue. Our guest for this podcast is Dr. Shelagh Cofer, a pediatric otolaryngology specialist at the Mayo Clinic. We’ll discuss how stridor differs from wheezing, the most common causes of stridor in both children and adults and what symptoms we should be watching for that might suggest a serious cause for stridor. We’ll also cover the evaluation of patients with stridor, which imaging studies may be helpful and when an ENT consultation is warranted.</p>
<p>Specific topics:</p>
<ul><li>Definition of stridor</li>
<li>Difference between stridor, stertor, and wheezing</li>
<li>Most common causes of stridor in both children and adults</li>
<li>Croup as a form of stridor</li>
<li>Important questions we should be asking our patients about stridor to identify those at risk for airway obstruction – including the SPECS-R mnemonic</li>
<li>Tests and imaging studies which may be helpful in the evaluation of a patient with stridor</li>
<li>Treatments for the more common causes of stridor</li>
</ul>
<p>Additional resources:</p>
<ul><li>Zoumalan, R; Maddalozzo, J; Holinger, LD. Etiology of stridor in infants.<em> Ann Otol Rhinol Laryngol</em>. 2007; 116(5):329-334. doi: 10.1.1896.429 <a href='https://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.896.429&rep=rep1&type=pdf'>https://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.896.429&rep=rep1&type=pdf</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5f6dc7/WF197506_-_Stridor60kp6.mp3" length="19234959" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Shelagh A. Cofer, M.D. (@ShelaghCoferMD)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Stridor is a musical sound due to disrupted airflow in an individual’s airway. In many instances it’s due to a benign cause but it can also represent a serious problem, possibly even life-threatening. In today’s podcast, we’ll learn about the various causes of stridor and when we need to be concerned that it represents a serious health issue. Our guest for this podcast is Dr. Shelagh Cofer, a pediatric otolaryngology specialist at the Mayo Clinic. We’ll discuss how stridor differs from wheezing, the most common causes of stridor in both children and adults and what symptoms we should be watching for that might suggest a serious cause for stridor. We’ll also cover the evaluation of patients with stridor, which imaging studies may be helpful and when an ENT consultation is warranted.
Specific topics:
Definition of stridor
Difference between stridor, stertor, and wheezing
Most common causes of stridor in both children and adults
Croup as a form of stridor
Important questions we should be asking our patients about stridor to identify those at risk for airway obstruction – including the SPECS-R mnemonic
Tests and imaging studies which may be helpful in the evaluation of a patient with stridor
Treatments for the more common causes of stridor
Additional resources:
Zoumalan, R; Maddalozzo, J; Holinger, LD. Etiology of stridor in infants. Ann Otol Rhinol Laryngol. 2007; 116(5):329-334. doi: 10.1.1896.429 https://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.896.429&rep=rep1&type=pdf
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1199</itunes:duration>
                <itunes:episode>259</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: On the Verge of Predicted COVID-19 Surge with Delta Variant</title>
        <itunes:title>Mayo Clinic Q&amp;A: On the Verge of Predicted COVID-19 Surge with Delta Variant</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-on-the-verge-of-predicted-covid-19-surge-with-delta-variant/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-on-the-verge-of-predicted-covid-19-surge-with-delta-variant/#comments</comments>        <pubDate>Thu, 22 Jul 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/af57cb4a-9339-3ec4-a4c9-04507f1fff72</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded July, 2021</p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)   </p>
<p>The delta variant is being blamed for <a href='https://www.mayoclinic.org/coronavirus-covid-19/map'>hot spots</a> in the U.S. where cases of <a href='https://www.mayoclinic.org/coronavirus-covid-19'>COVID-19</a> are on the rise. These hot spots account for most cases in the U.S. They are also the geographical areas that tend to have the lowest vaccination rates. </p>
<p>"It's no surprise that the two go together," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>.</p>
<p>"This (delta variant) is the bad actor that we predicted it would be," adds Dr. Poland. "Our seven-day average is getting up to 19,000 cases a day in the U.S. We were down to 3,000. So we're starting to see, just as we predicted, a surge as people took masks off and as restrictions were lifted before we had achieved high rates of immunization."</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland expands on how the highly transmissible delta variant continues to spread. He also talks about the possibility of COVID-19 vaccine boosters, explains how the Vaccine Adverse Event Reporting System works, and much more as he answers listener questions.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded July, 2021</p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)   </p>
<p>The delta variant is being blamed for <a href='https://www.mayoclinic.org/coronavirus-covid-19/map'>hot spots</a> in the U.S. where cases of <a href='https://www.mayoclinic.org/coronavirus-covid-19'>COVID-19</a> are on the rise. These hot spots account for most cases in the U.S. They are also the geographical areas that tend to have the lowest vaccination rates. </p>
<p>"It's no surprise that the two go together," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>.</p>
<p>"This (delta variant) is the bad actor that we predicted it would be," adds Dr. Poland. "Our seven-day average is getting up to 19,000 cases a day in the U.S. We were down to 3,000. So we're starting to see, just as we predicted, a surge as people took masks off and as restrictions were lifted before we had achieved high rates of immunization."</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland expands on how the highly transmissible delta variant continues to spread. He also talks about the possibility of COVID-19 vaccine boosters, explains how the Vaccine Adverse Event Reporting System works, and much more as he answers listener questions.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hu74rn/Mayo_Clinic_Q_A_-_Dr_Gregory_Poland_-_COVID-19_Update_7_15_219pp2v.mp3" length="29795352" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded July, 2021
Guest:  Gregory A. Poland, M.D. (@drgregpoland) 
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)   
The delta variant is being blamed for hot spots in the U.S. where cases of COVID-19 are on the rise. These hot spots account for most cases in the U.S. They are also the geographical areas that tend to have the lowest vaccination rates. 
"It's no surprise that the two go together," says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group.
"This (delta variant) is the bad actor that we predicted it would be," adds Dr. Poland. "Our seven-day average is getting up to 19,000 cases a day in the U.S. We were down to 3,000. So we're starting to see, just as we predicted, a surge as people took masks off and as restrictions were lifted before we had achieved high rates of immunization."
In this Mayo Clinic Q&A podcast, Dr. Poland expands on how the highly transmissible delta variant continues to spread. He also talks about the possibility of COVID-19 vaccine boosters, explains how the Vaccine Adverse Event Reporting System works, and much more as he answers listener questions.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1859</itunes:duration>
                        <itunes:episodeType>bonus</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>Multidisciplinary Approach to Pelvic Pain</title>
        <itunes:title>Multidisciplinary Approach to Pelvic Pain</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/multidisciplinary-approach-to-pelvic-pain/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/multidisciplinary-approach-to-pelvic-pain/#comments</comments>        <pubDate>Tue, 20 Jul 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/91d887cf-6d19-3254-a296-41dd35079b3e</guid>
                                    <description><![CDATA[<p>Guest: Isabel C. Green, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Pelvic pain can be challenging. It can have a variety of presenting symptoms since it can originate from a variety of organ systems. When pelvic pain becomes chronic, it becomes even more challenging. It’s associated with significant direct medical costs as well as indirect costs as it frequently results in work absenteeism. Patients with chronic pelvic pain are often initially evaluated by primary care providers, but referral to specialists is quite common. Due to the variety of symptoms associated with chronic pelvic pain, multiple specialties often are asked to evaluate these patients. This frequently results in patients being passed back and forth between various medical specialties. It therefore becomes important for primary care providers to become comfortable evaluating and managing patients with pelvic pain. Our guest for this podcast is Dr. Isabel Green, a physician from the Department of Obstetrics and Gynecology at the Mayo Clinic. We’ll discuss how to effectively evaluate patients with pelvic pain, “red flag symptoms” to watch for, useful laboratory tests to order, and common imaging studies which can be helpful in establishing a cause for the pain. We’ll also discuss the benefits of a multi-disciplinary approach to pelvic pain.</p>
<p>Specific topics:</p>
<ul><li>Categorization of pelvic pain</li>
<li>Appropriate evaluation of pelvic pain including the clinical history, physical exam, laboratory tests and imaging studies</li>
<li>Relationship of chronic pelvic pain with other symptoms such as anxiety, depression, insomnia, and work/relationship issues</li>
<li>Chronic pelvic pain representing a form of centralized pain</li>
<li>Advantages of a multi-disciplinary approach to evaluating and managing chronic pelvic pain</li>
</ul>
<p>Additional resources:</p>
<ul><li>Chronic pelvic pain: ACOG practice bulletin, number 218. Obstet Gynecol. 2020 Mar; 135(3):e98-e109. doi: <a href='https://doi.org/10.1097/aog.0000000000003716'>1097/AOG.0000000000003716</a>.</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Isabel C. Green, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Pelvic pain can be challenging. It can have a variety of presenting symptoms since it can originate from a variety of organ systems. When pelvic pain becomes chronic, it becomes even more challenging. It’s associated with significant direct medical costs as well as indirect costs as it frequently results in work absenteeism. Patients with chronic pelvic pain are often initially evaluated by primary care providers, but referral to specialists is quite common. Due to the variety of symptoms associated with chronic pelvic pain, multiple specialties often are asked to evaluate these patients. This frequently results in patients being passed back and forth between various medical specialties. It therefore becomes important for primary care providers to become comfortable evaluating and managing patients with pelvic pain. Our guest for this podcast is Dr. Isabel Green, a physician from the Department of Obstetrics and Gynecology at the Mayo Clinic. We’ll discuss how to effectively evaluate patients with pelvic pain, “red flag symptoms” to watch for, useful laboratory tests to order, and common imaging studies which can be helpful in establishing a cause for the pain. We’ll also discuss the benefits of a multi-disciplinary approach to pelvic pain.</p>
<p>Specific topics:</p>
<ul><li>Categorization of pelvic pain</li>
<li>Appropriate evaluation of pelvic pain including the clinical history, physical exam, laboratory tests and imaging studies</li>
<li>Relationship of chronic pelvic pain with other symptoms such as anxiety, depression, insomnia, and work/relationship issues</li>
<li>Chronic pelvic pain representing a form of centralized pain</li>
<li>Advantages of a multi-disciplinary approach to evaluating and managing chronic pelvic pain</li>
</ul>
<p>Additional resources:</p>
<ul><li>Chronic pelvic pain: ACOG practice bulletin, number 218. <em>Obstet Gynecol</em>. 2020 Mar; 135(3):e98-e109. doi: <a href='https://doi.org/10.1097/aog.0000000000003716'>1097/AOG.0000000000003716</a>.</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/icvh62/WF71878_-_Pelvic_Pain8tl3w.mp3" length="28349183" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Isabel C. Green, M.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Pelvic pain can be challenging. It can have a variety of presenting symptoms since it can originate from a variety of organ systems. When pelvic pain becomes chronic, it becomes even more challenging. It’s associated with significant direct medical costs as well as indirect costs as it frequently results in work absenteeism. Patients with chronic pelvic pain are often initially evaluated by primary care providers, but referral to specialists is quite common. Due to the variety of symptoms associated with chronic pelvic pain, multiple specialties often are asked to evaluate these patients. This frequently results in patients being passed back and forth between various medical specialties. It therefore becomes important for primary care providers to become comfortable evaluating and managing patients with pelvic pain. Our guest for this podcast is Dr. Isabel Green, a physician from the Department of Obstetrics and Gynecology at the Mayo Clinic. We’ll discuss how to effectively evaluate patients with pelvic pain, “red flag symptoms” to watch for, useful laboratory tests to order, and common imaging studies which can be helpful in establishing a cause for the pain. We’ll also discuss the benefits of a multi-disciplinary approach to pelvic pain.
Specific topics:
Categorization of pelvic pain
Appropriate evaluation of pelvic pain including the clinical history, physical exam, laboratory tests and imaging studies
Relationship of chronic pelvic pain with other symptoms such as anxiety, depression, insomnia, and work/relationship issues
Chronic pelvic pain representing a form of centralized pain
Advantages of a multi-disciplinary approach to evaluating and managing chronic pelvic pain
Additional resources:
Chronic pelvic pain: ACOG practice bulletin, number 218. Obstet Gynecol. 2020 Mar; 135(3):e98-e109. doi: 1097/AOG.0000000000003716.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1766</itunes:duration>
                <itunes:episode>258</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Identifying and Treating Urinary Urge Incontinence</title>
        <itunes:title>Identifying and Treating Urinary Urge Incontinence</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/identifying-and-treating-urinary-urge-incontinence/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/identifying-and-treating-urinary-urge-incontinence/#comments</comments>        <pubDate>Tue, 13 Jul 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/9c3ba5ff-973a-32c2-a678-a789ad5e1de9</guid>
                                    <description><![CDATA[<p>Guest: Brian J. Linder, M.D. (<a href='https://twitter.com/brianjlinder'>@brianjlinder</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Patients rarely mention urinary incontinence to us as a problem as many assume it’s a normal change of aging. However, it’s a major quality-of-life issue. Many with incontinence are reluctant to go out in public and those who do, usually know the location of all the nearby restrooms. Yet, with proper evaluation and treatment, essentially all patients can be helped, and in many cases, they can be cured. In this podcast, we’ll discuss urgency urinary incontinence, one of the most common forms of incontinence. We’ll cover the questions you should ask your patients to make a diagnosis, what evaluation you should do, and what treatment options are available. Our guest for this topic is Dr. Brian Linder, a urologist at the Mayo Clinic.</p>
<p>Specific topics:</p>
<ul><li>The various types of urinary incontinence</li>
<li>Important questions to ask patients to make a diagnosis</li>
<li>Effective use of a voiding diary</li>
<li>Physical exam recommendations</li>
<li>Helpful laboratory tests</li>
<li>When urodynamic studies are indicated</li>
<li>Non-pharmacologic treatment options</li>
<li>Medications useful in treating urgency incontinence</li>
<li>Treatment options for the refractory patient</li>
</ul>
<p>Additional resource:</p>
<ul><li><a href='https://www.auanet.org/guidelines/overactive-bladder-(oab)-guideline'>https://www.auanet.org/guidelines/overactive-bladder-(oab)-guideline</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Brian J. Linder, M.D. (<a href='https://twitter.com/brianjlinder'>@brianjlinder</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Patients rarely mention urinary incontinence to us as a problem as many assume it’s a normal change of aging. However, it’s a major quality-of-life issue. Many with incontinence are reluctant to go out in public and those who do, usually know the location of all the nearby restrooms. Yet, with proper evaluation and treatment, essentially all patients can be helped, and in many cases, they can be cured. In this podcast, we’ll discuss urgency urinary incontinence, one of the most common forms of incontinence. We’ll cover the questions you should ask your patients to make a diagnosis, what evaluation you should do, and what treatment options are available. Our guest for this topic is Dr. Brian Linder, a urologist at the Mayo Clinic.</p>
<p>Specific topics:</p>
<ul><li>The various types of urinary incontinence</li>
<li>Important questions to ask patients to make a diagnosis</li>
<li>Effective use of a voiding diary</li>
<li>Physical exam recommendations</li>
<li>Helpful laboratory tests</li>
<li>When urodynamic studies are indicated</li>
<li>Non-pharmacologic treatment options</li>
<li>Medications useful in treating urgency incontinence</li>
<li>Treatment options for the refractory patient</li>
</ul>
<p>Additional resource:</p>
<ul><li><a href='https://www.auanet.org/guidelines/overactive-bladder-(oab)-guideline'>https://www.auanet.org/guidelines/overactive-bladder-(oab)-guideline</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mtypc3/WF126672_-_Urgency_Urinary_Incontinence5ztb3.mp3" length="19813877" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Brian J. Linder, M.D. (@brianjlinder)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Patients rarely mention urinary incontinence to us as a problem as many assume it’s a normal change of aging. However, it’s a major quality-of-life issue. Many with incontinence are reluctant to go out in public and those who do, usually know the location of all the nearby restrooms. Yet, with proper evaluation and treatment, essentially all patients can be helped, and in many cases, they can be cured. In this podcast, we’ll discuss urgency urinary incontinence, one of the most common forms of incontinence. We’ll cover the questions you should ask your patients to make a diagnosis, what evaluation you should do, and what treatment options are available. Our guest for this topic is Dr. Brian Linder, a urologist at the Mayo Clinic.
Specific topics:
The various types of urinary incontinence
Important questions to ask patients to make a diagnosis
Effective use of a voiding diary
Physical exam recommendations
Helpful laboratory tests
When urodynamic studies are indicated
Non-pharmacologic treatment options
Medications useful in treating urgency incontinence
Treatment options for the refractory patient
Additional resource:
https://www.auanet.org/guidelines/overactive-bladder-(oab)-guideline
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1235</itunes:duration>
                <itunes:episode>257</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: Summer Travel and People Not in Your Bubble During COVID-19 Pandemic</title>
        <itunes:title>Mayo Clinic Q&amp;A: Summer Travel and People Not in Your Bubble During COVID-19 Pandemic</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-summer-travel-and-people-not-in-your-bubble-during-covid-19-pandemic/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-summer-travel-and-people-not-in-your-bubble-during-covid-19-pandemic/#comments</comments>        <pubDate>Wed, 07 Jul 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/d84ca03a-2207-36f7-9233-f2522add3d88</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded June, 2021</p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)   </p>
<p>"The reason we have the <a href='https://www.mayoclinic.org/coronavirus-covid-19'>COVID-19</a> delta variant, the reason we have the delta plus variant is because of unimmunized people who get infected," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>. He adds that 99.2% of the recorded COVID-19 deaths in the U.S. are in people not vaccinated against the virus. </p>
<p>This is why he cautions folks who may be traveling this Fourth of July holiday and throughout the summer. </p>
<p>"You don't know what variants people are carrying, how symptomatic they are, the health of their immune system, or if they've been vaccinated," says Dr. Poland. "When you are around groups of people indoors that are not in your bubble, so to speak, I think you should still wear a proper mask." </p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland explains why, even if you are fully vaccinated for COVID-19, you should still consider being masked in some situations. He also discusses breakthrough infections in certain subpopulations, and what that may mean for needing booster shots.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded June, 2021</p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)   </p>
<p>"The reason we have the <a href='https://www.mayoclinic.org/coronavirus-covid-19'>COVID-19</a> delta variant, the reason we have the delta plus variant is because of unimmunized people who get infected," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>. He adds that 99.2% of the recorded COVID-19 deaths in the U.S. are in people not vaccinated against the virus. </p>
<p>This is why he cautions folks who may be traveling this Fourth of July holiday and throughout the summer. </p>
<p>"You don't know what variants people are carrying, how symptomatic they are, the health of their immune system, or if they've been vaccinated," says Dr. Poland. "When you are around groups of people indoors that are not in your bubble, so to speak, I think you should still wear a proper mask." </p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland explains why, even if you are fully vaccinated for COVID-19, you should still consider being masked in some situations. He also discusses breakthrough infections in certain subpopulations, and what that may mean for needing booster shots.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/83erbq/Mayo_Clinic_Q_A_-_Dr_Gregory_Poland_-_06_30_218x25e.mp3" length="25853631" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded June, 2021
Guest:  Gregory A. Poland, M.D. (@drgregpoland) 
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)   
"The reason we have the COVID-19 delta variant, the reason we have the delta plus variant is because of unimmunized people who get infected," says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group. He adds that 99.2% of the recorded COVID-19 deaths in the U.S. are in people not vaccinated against the virus. 
This is why he cautions folks who may be traveling this Fourth of July holiday and throughout the summer. 
"You don't know what variants people are carrying, how symptomatic they are, the health of their immune system, or if they've been vaccinated," says Dr. Poland. "When you are around groups of people indoors that are not in your bubble, so to speak, I think you should still wear a proper mask." 
In this Mayo Clinic Q&A podcast, Dr. Poland explains why, even if you are fully vaccinated for COVID-19, you should still consider being masked in some situations. He also discusses breakthrough infections in certain subpopulations, and what that may mean for needing booster shots.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1611</itunes:duration>
                        <itunes:episodeType>bonus</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>Postural Orthostatic Tachycardia Syndrome (POTS) in Adult Patients</title>
        <itunes:title>Postural Orthostatic Tachycardia Syndrome (POTS) in Adult Patients</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/postural-orthostatic-tachycardia-syndrome-pots-in-adult-patients/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/postural-orthostatic-tachycardia-syndrome-pots-in-adult-patients/#comments</comments>        <pubDate>Tue, 06 Jul 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/5c6407f5-0a7c-3c50-88c9-ae230377dc12</guid>
                                    <description><![CDATA[<p>Guest: Jeremy K. Cutsforth-Gregory, M.D. (<a href='https://twitter.com/JCGneuro'>@JCGneuro</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Postural Orthostatic Tachycardia Syndrome, or POTS, is a medical condition manifested by tachycardia that occurs after standing or prolonged sitting and is often associated with symptoms such as dizziness, fatigue, and occasionally syncope. POTS can be difficult to diagnose as patients often present with a variety of vague, and what seem like unrelated, symptoms. Management of patients with POTS can be equally difficult as there’s no one treatment which is effective in all patients. However, patients with POTS often have typical symptoms and objective findings on physical exam. Once a diagnosis is made, effective treatment is available and many patients with POTS can be helped with non-pharmacologic therapy. To help us understand POTS and its management, we’ll speak with Dr. Jeremy Cutsforth-Gregory, a neurologist at the Mayo Clinic. We’ll discuss the proposed theories regarding the cause of POTS, the different types of POTS, pathologic findings in patients with POTS, and the management of patient with POTS.</p>
<p>Specific Topics:</p>
<ul><li>Typical symptoms of POTS</li>
<li>Risk factors for POTS</li>
<li>Theories regarding the cause of POTS</li>
<li>Description of the varieties of POTS</li>
<li>How to diagnose POTS</li>
<li>Pathologic and pharmacologic abnormalities related to POTS</li>
<li>Management of patients with POTS</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Jeremy K. Cutsforth-Gregory, M.D. (<a href='https://twitter.com/JCGneuro'>@JCGneuro</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Postural Orthostatic Tachycardia Syndrome, or POTS, is a medical condition manifested by tachycardia that occurs after standing or prolonged sitting and is often associated with symptoms such as dizziness, fatigue, and occasionally syncope. POTS can be difficult to diagnose as patients often present with a variety of vague, and what seem like unrelated, symptoms. Management of patients with POTS can be equally difficult as there’s no one treatment which is effective in all patients. However, patients with POTS often have typical symptoms and objective findings on physical exam. Once a diagnosis is made, effective treatment is available and many patients with POTS can be helped with non-pharmacologic therapy. To help us understand POTS and its management, we’ll speak with Dr. Jeremy Cutsforth-Gregory, a neurologist at the Mayo Clinic. We’ll discuss the proposed theories regarding the cause of POTS, the different types of POTS, pathologic findings in patients with POTS, and the management of patient with POTS.</p>
<p>Specific Topics:</p>
<ul><li>Typical symptoms of POTS</li>
<li>Risk factors for POTS</li>
<li>Theories regarding the cause of POTS</li>
<li>Description of the varieties of POTS</li>
<li>How to diagnose POTS</li>
<li>Pathologic and pharmacologic abnormalities related to POTS</li>
<li>Management of patients with POTS</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rp2gbu/WF126673_-_Adult_POTS6dzkn.mp3" length="22706795" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Jeremy K. Cutsforth-Gregory, M.D. (@JCGneuro)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Postural Orthostatic Tachycardia Syndrome, or POTS, is a medical condition manifested by tachycardia that occurs after standing or prolonged sitting and is often associated with symptoms such as dizziness, fatigue, and occasionally syncope. POTS can be difficult to diagnose as patients often present with a variety of vague, and what seem like unrelated, symptoms. Management of patients with POTS can be equally difficult as there’s no one treatment which is effective in all patients. However, patients with POTS often have typical symptoms and objective findings on physical exam. Once a diagnosis is made, effective treatment is available and many patients with POTS can be helped with non-pharmacologic therapy. To help us understand POTS and its management, we’ll speak with Dr. Jeremy Cutsforth-Gregory, a neurologist at the Mayo Clinic. We’ll discuss the proposed theories regarding the cause of POTS, the different types of POTS, pathologic findings in patients with POTS, and the management of patient with POTS.
Specific Topics:
Typical symptoms of POTS
Risk factors for POTS
Theories regarding the cause of POTS
Description of the varieties of POTS
How to diagnose POTS
Pathologic and pharmacologic abnormalities related to POTS
Management of patients with POTS
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1415</itunes:duration>
                <itunes:episode>256</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Regenerative Medicine Edition Ep.10: FDA Regulatory Process and Clinical Trials</title>
        <itunes:title>Regenerative Medicine Edition Ep.10: FDA Regulatory Process and Clinical Trials</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/regenerative-medicine-series-ep10-fda-regulatory-process-and-clinical-trials/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/regenerative-medicine-series-ep10-fda-regulatory-process-and-clinical-trials/#comments</comments>        <pubDate>Thu, 01 Jul 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/5900ecc7-2951-3dd4-b0b0-f33088cf919e</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='http://www.ce.mayo.edu/regmedonline'>www.ce.mayo.edu/regmedonline</a></p>
<p>Guest: Drew M. Witter, CCRP</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>“Stem Cell Clinics” throughout the U.S. promote stem cell therapy for a variety of health conditions including osteoarthritis, autism, macular degeneration, Parkinson’s Disease, Alzheimer’s Disease and most recently COVID-19 infections. How can our patients be assured that the regenerative medicine therapy effectively treats their health condition and the products they receive are safe? In this podcast, we discuss regulations regarding regenerative medicine, the process of obtaining FDA-approval and which regenerative medicine therapies are FDA-approved. Our guest will be Drew Witter, a Program Manager from the Office of Research and Regulatory Support at the Mayo Clinic.</p>
<p>Specific topics discussed:</p>
<ul><li>Process of taking regenerative medicine from the research lab to the clinical practice</li>
<li>How regulators ensure the safety and effectiveness of regenerative therapies</li>
<li>The process of acquiring FDA-approval</li>
<li>Regenerative medicine therapies that are FDA-approved</li>
<li>How patients and clinicians learn of FDA-regulated regenerative medicine clinical trials</li>
</ul>
<p>Additional resources:</p>
<ul><li>Clinical Trials available at Mayo Clinic through the Center for Regenerative Medicine: <a href='https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/patient-care/clinical-trials'>https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/patient-care/clinical-trials</a></li>
<li>U.S. National Library of Medicine: <a href='https://www.clinicaltrials.gov/'>https://www.clinicaltrials.gov/</a></li>
<li>Center Watch: <a href='https://www.centerwatch.com/'>https://www.centerwatch.com/</a></li>
</ul>
<p>Additional educational opportunities from Mayo Clinic: </p>
<ul><li><a href='https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education'>https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education</a></li>
<li><a href='https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/'>https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='http://www.ce.mayo.edu/regmedonline'>www.ce.mayo.edu/regmedonline</a></p>
<p>Guest: Drew M. Witter, CCRP</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>“Stem Cell Clinics” throughout the U.S. promote stem cell therapy for a variety of health conditions including osteoarthritis, autism, macular degeneration, Parkinson’s Disease, Alzheimer’s Disease and most recently COVID-19 infections. How can our patients be assured that the regenerative medicine therapy effectively treats their health condition and the products they receive are safe? In this podcast, we discuss regulations regarding regenerative medicine, the process of obtaining FDA-approval and which regenerative medicine therapies are FDA-approved. Our guest will be Drew Witter, a Program Manager from the Office of Research and Regulatory Support at the Mayo Clinic.</p>
<p>Specific topics discussed:</p>
<ul><li>Process of taking regenerative medicine from the research lab to the clinical practice</li>
<li>How regulators ensure the safety and effectiveness of regenerative therapies</li>
<li>The process of acquiring FDA-approval</li>
<li>Regenerative medicine therapies that are FDA-approved</li>
<li>How patients and clinicians learn of FDA-regulated regenerative medicine clinical trials</li>
</ul>
<p>Additional resources:</p>
<ul><li>Clinical Trials available at Mayo Clinic through the Center for Regenerative Medicine: <a href='https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/patient-care/clinical-trials'>https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/patient-care/clinical-trials</a></li>
<li>U.S. National Library of Medicine: <a href='https://www.clinicaltrials.gov/'>https://www.clinicaltrials.gov/</a></li>
<li>Center Watch: <a href='https://www.centerwatch.com/'>https://www.centerwatch.com/</a></li>
</ul>
<p>Additional educational opportunities from Mayo Clinic: </p>
<ul><li><a href='https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education'>https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education</a></li>
<li><a href='https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/'>https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/i2tf4r/VT3988595_-_Witter7h0d2.mp3" length="18268992" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: www.ce.mayo.edu/regmedonline
Guest: Drew M. Witter, CCRP
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
“Stem Cell Clinics” throughout the U.S. promote stem cell therapy for a variety of health conditions including osteoarthritis, autism, macular degeneration, Parkinson’s Disease, Alzheimer’s Disease and most recently COVID-19 infections. How can our patients be assured that the regenerative medicine therapy effectively treats their health condition and the products they receive are safe? In this podcast, we discuss regulations regarding regenerative medicine, the process of obtaining FDA-approval and which regenerative medicine therapies are FDA-approved. Our guest will be Drew Witter, a Program Manager from the Office of Research and Regulatory Support at the Mayo Clinic.
Specific topics discussed:
Process of taking regenerative medicine from the research lab to the clinical practice
How regulators ensure the safety and effectiveness of regenerative therapies
The process of acquiring FDA-approval
Regenerative medicine therapies that are FDA-approved
How patients and clinicians learn of FDA-regulated regenerative medicine clinical trials
Additional resources:
Clinical Trials available at Mayo Clinic through the Center for Regenerative Medicine: https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/patient-care/clinical-trials
U.S. National Library of Medicine: https://www.clinicaltrials.gov/
Center Watch: https://www.centerwatch.com/
Additional educational opportunities from Mayo Clinic: 
https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education
https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1137</itunes:duration>
                <itunes:episode>255</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Primary Care Management of the Post-Prostate Cancer Patient</title>
        <itunes:title>Primary Care Management of the Post-Prostate Cancer Patient</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/primary-care-management-of-the-post-prostate-cancer-patient/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/primary-care-management-of-the-post-prostate-cancer-patient/#comments</comments>        <pubDate>Tue, 29 Jun 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/5d274b82-9e47-3fe3-8fde-635cc0f5ecb6</guid>
                                    <description><![CDATA[<p>Guest: Matthew K. Tollefson, M.D. (<a href='https://twitter.com/MattTollefsonMD'>@MattTollefsonMD</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Other than skin cancer, prostate cancer is the most common cancer in men in the United States and will affect 1 in every 6 men 65 years and older. Fortunately, when detected early, it is very treatable. Long-term follow-up of patients with treated prostate cancer is usually performed by primary care providers. How often should these patients be seen? How much of an exam is recommended? Which tests should be ordered? When are imaging tests indicated and which studies are the most helpful? This podcast will address these questions and more as we discuss the primary care management of the post-prostate cancer patient with Dr. Matthew Tollefson, a urologist from the Mayo Clinic.</p>
<p>Specific topics discussed:</p>
<ul><li>Current treatment options for prostate cancer</li>
<li>Determinants for choosing one of the treatment options for prostate cancer</li>
<li>When and how often patients should receive follow-up for prostate cancer</li>
<li>Laboratory tests recommended for the follow-up of prostate cancer patients</li>
<li>When a detectable PSA is concerning following prostate cancer treatment</li>
<li>Imaging studies recommended for following prostate cancer patients and when they are indicated</li>
<li>Treatment options for recurrent prostate cancer</li>
<li>Future treatment options for prostate cancer which have potential</li>
</ul>
<p>Additional resources:</p>
<ul><li><a href='https://www.auanet.org/guidelines/advanced-prostate-cancer'>https://www.auanet.org/guidelines/advanced-prostate-cancer</a></li>
<li><a href='https://www.mayoclinic.org/diseases-conditions/prostate-cancer/symptoms-causes/syc-20353087'>https://www.mayoclinic.org/diseases-conditions/prostate-cancer/symptoms-causes/syc-20353087</a></li>
<li><a href='https://www.mayoclinic.org/medical-professionals/urology'>https://www.mayoclinic.org/medical-professionals/urology</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Matthew K. Tollefson, M.D. (<a href='https://twitter.com/MattTollefsonMD'>@MattTollefsonMD</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Other than skin cancer, prostate cancer is the most common cancer in men in the United States and will affect 1 in every 6 men 65 years and older. Fortunately, when detected early, it is very treatable. Long-term follow-up of patients with treated prostate cancer is usually performed by primary care providers. How often should these patients be seen? How much of an exam is recommended? Which tests should be ordered? When are imaging tests indicated and which studies are the most helpful? This podcast will address these questions and more as we discuss the primary care management of the post-prostate cancer patient with Dr. Matthew Tollefson, a urologist from the Mayo Clinic.</p>
<p>Specific topics discussed:</p>
<ul><li>Current treatment options for prostate cancer</li>
<li>Determinants for choosing one of the treatment options for prostate cancer</li>
<li>When and how often patients should receive follow-up for prostate cancer</li>
<li>Laboratory tests recommended for the follow-up of prostate cancer patients</li>
<li>When a detectable PSA is concerning following prostate cancer treatment</li>
<li>Imaging studies recommended for following prostate cancer patients and when they are indicated</li>
<li>Treatment options for recurrent prostate cancer</li>
<li>Future treatment options for prostate cancer which have potential</li>
</ul>
<p>Additional resources:</p>
<ul><li><a href='https://www.auanet.org/guidelines/advanced-prostate-cancer'>https://www.auanet.org/guidelines/advanced-prostate-cancer</a></li>
<li><a href='https://www.mayoclinic.org/diseases-conditions/prostate-cancer/symptoms-causes/syc-20353087'>https://www.mayoclinic.org/diseases-conditions/prostate-cancer/symptoms-causes/syc-20353087</a></li>
<li><a href='https://www.mayoclinic.org/medical-professionals/urology'>https://www.mayoclinic.org/medical-professionals/urology</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/t8cme7/WF64623_-_Prostate_Cancer_Treatment826bf.mp3" length="20027437" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Matthew K. Tollefson, M.D. (@MattTollefsonMD)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Other than skin cancer, prostate cancer is the most common cancer in men in the United States and will affect 1 in every 6 men 65 years and older. Fortunately, when detected early, it is very treatable. Long-term follow-up of patients with treated prostate cancer is usually performed by primary care providers. How often should these patients be seen? How much of an exam is recommended? Which tests should be ordered? When are imaging tests indicated and which studies are the most helpful? This podcast will address these questions and more as we discuss the primary care management of the post-prostate cancer patient with Dr. Matthew Tollefson, a urologist from the Mayo Clinic.
Specific topics discussed:
Current treatment options for prostate cancer
Determinants for choosing one of the treatment options for prostate cancer
When and how often patients should receive follow-up for prostate cancer
Laboratory tests recommended for the follow-up of prostate cancer patients
When a detectable PSA is concerning following prostate cancer treatment
Imaging studies recommended for following prostate cancer patients and when they are indicated
Treatment options for recurrent prostate cancer
Future treatment options for prostate cancer which have potential
Additional resources:
https://www.auanet.org/guidelines/advanced-prostate-cancer
https://www.mayoclinic.org/diseases-conditions/prostate-cancer/symptoms-causes/syc-20353087
https://www.mayoclinic.org/medical-professionals/urology
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1247</itunes:duration>
                <itunes:episode>254</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: COVID-19 Vaccination Rates Stalling, Infections From the Delta Variant Rising</title>
        <itunes:title>Mayo Clinic Q&amp;A: COVID-19 Vaccination Rates Stalling, Infections From the Delta Variant Rising</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-covid-19-vaccination-rates-stalling-infections-from-the-delta-variant-rising/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-covid-19-vaccination-rates-stalling-infections-from-the-delta-variant-rising/#comments</comments>        <pubDate>Fri, 25 Jun 2021 08:37:34 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/679db920-ed83-3fb7-8286-9ed3415eea7c</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded June 21, 2021</p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)   </p>
<p>Summer and fall are going to be a dangerous time for people in the U.S. who have not been vaccinated for <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a>, according to <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>. </p>
<p>"I really think this exponential rise in the number of sequences that are delta must be taken seriously," says Dr. Poland. "We are seeing a surge again, in hospitalizations in the UK, because of the delta variant in people who have not been vaccinated or who only got one dose of vaccine. This is a really critical message for the public to hear because in the U.S. we are stalled in vaccination rates."</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland talks more about a possible COVID-19 surge and being emotionally ready for the pandemic to be over. He also answers listener questions about COVID-19 reinfection, the latest on antiviral development for COVID-19, and the latest news about COVID-19 vaccines affecting menstrual cycles and sperm quality.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded June 21, 2021</p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)   </p>
<p>Summer and fall are going to be a dangerous time for people in the U.S. who have not been vaccinated for <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a>, according to <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>. </p>
<p>"I really think this exponential rise in the number of sequences that are delta must be taken seriously," says Dr. Poland. "We are seeing a surge again, in hospitalizations in the UK, because of the delta variant in people who have not been vaccinated or who only got one dose of vaccine. This is a really critical message for the public to hear because in the U.S. we are stalled in vaccination rates."</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland talks more about a possible COVID-19 surge and being emotionally ready for the pandemic to be over. He also answers listener questions about COVID-19 reinfection, the latest on antiviral development for COVID-19, and the latest news about COVID-19 vaccines affecting menstrual cycles and sperm quality.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/n5pbi8/Mayo_Clinic_Q_A_-_Dr_Gregory_Poland_-_06_23_21bb3vd.mp3" length="25988351" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded June 21, 2021
To claim credit visit: https://ce.mayo.edu/covid19podcast 
Guest:  Gregory A. Poland, M.D. (@drgregpoland) 
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)   
Summer and fall are going to be a dangerous time for people in the U.S. who have not been vaccinated for COVID-19, according to Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group. 
"I really think this exponential rise in the number of sequences that are delta must be taken seriously," says Dr. Poland. "We are seeing a surge again, in hospitalizations in the UK, because of the delta variant in people who have not been vaccinated or who only got one dose of vaccine. This is a really critical message for the public to hear because in the U.S. we are stalled in vaccination rates."
In this Mayo Clinic Q&A podcast, Dr. Poland talks more about a possible COVID-19 surge and being emotionally ready for the pandemic to be over. He also answers listener questions about COVID-19 reinfection, the latest on antiviral development for COVID-19, and the latest news about COVID-19 vaccines affecting menstrual cycles and sperm quality.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1619</itunes:duration>
                        <itunes:episodeType>bonus</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>Regenerative Medicine Edition Ep.9: Cardiac Regenerative Therapies</title>
        <itunes:title>Regenerative Medicine Edition Ep.9: Cardiac Regenerative Therapies</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/regenerative-medicine-series-ep9-cardiac-regenerative-therapies/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/regenerative-medicine-series-ep9-cardiac-regenerative-therapies/#comments</comments>        <pubDate>Thu, 24 Jun 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/e1f49bb1-8086-345d-bb35-488ff132e60f</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='http://www.ce.mayo.edu/regmedonline'>www.ce.mayo.edu/regmedonline</a></p>
<p>Guest: Atta Behfar, M.D., Ph.D. (<a href='https://twitter.com/AttaBehfar'>@AttaBehfar</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Traditional treatment of cardiac disease, especially advanced congestive heart failure has been limited. Transplantation has potential for benefit; however, organ shortage remains a barrier. It’s anticipated that regenerative medicine will help solve this unmet need with new treatment options to repair damaged heart tissue. This podcast will discuss regenerative medicine for cardiovascular disease with Dr. Atta Behfar, a Mayo Clinic cardiologist with expertise in advanced heart failure and transplantation. We’ll review the progress made in regenerative medicine in management of cardiovascular disease, what treatment options are currently available and the potential treatment options which will become available in the future.</p>
<p>Specific topics discussed:</p>
<ul><li>Regenerative potential of the cardiovascular system</li>
<li>Current challenges in management of patients with cardiovascular disease</li>
<li>Progress in regenerative medicine for the cardiovascular system</li>
<li>Limitations in regenerative cardiac therapy using regenerative medicine</li>
<li>Future potential for regenerative medicine treatment of cardiovascular disease</li>
<li>Patients who are candidates for cardiac regenerative therapies</li>
</ul>
<p> Additional resources:</p>
<ul><li>Clinical Trials available at Mayo Clinic through the Center for Regenerative Medicine: <a href='https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/patient-care/clinical-trials'>https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/patient-care/clinical-trials</a></li>
<li>U.S. National Library of Medicine: <a href='https://www.clinicaltrials.gov/'>https://www.clinicaltrials.gov/</a></li>
<li>Center Watch: <a href='https://www.centerwatch.com/'>https://www.centerwatch.com/</a></li>
</ul>
<p> Additional educational opportunities from Mayo Clinic: </p>
<ul><li><a href='https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education'>https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education</a></li>
<li><a href='https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/'>https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='http://www.ce.mayo.edu/regmedonline'>www.ce.mayo.edu/regmedonline</a></p>
<p>Guest: Atta Behfar, M.D., Ph.D. (<a href='https://twitter.com/AttaBehfar'>@AttaBehfar</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Traditional treatment of cardiac disease, especially advanced congestive heart failure has been limited. Transplantation has potential for benefit; however, organ shortage remains a barrier. It’s anticipated that regenerative medicine will help solve this unmet need with new treatment options to repair damaged heart tissue. This podcast will discuss regenerative medicine for cardiovascular disease with Dr. Atta Behfar, a Mayo Clinic cardiologist with expertise in advanced heart failure and transplantation. We’ll review the progress made in regenerative medicine in management of cardiovascular disease, what treatment options are currently available and the potential treatment options which will become available in the future.</p>
<p>Specific topics discussed:</p>
<ul><li>Regenerative potential of the cardiovascular system</li>
<li>Current challenges in management of patients with cardiovascular disease</li>
<li>Progress in regenerative medicine for the cardiovascular system</li>
<li>Limitations in regenerative cardiac therapy using regenerative medicine</li>
<li>Future potential for regenerative medicine treatment of cardiovascular disease</li>
<li>Patients who are candidates for cardiac regenerative therapies</li>
</ul>
<p> Additional resources:</p>
<ul><li>Clinical Trials available at Mayo Clinic through the Center for Regenerative Medicine: <a href='https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/patient-care/clinical-trials'>https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/patient-care/clinical-trials</a></li>
<li>U.S. National Library of Medicine: <a href='https://www.clinicaltrials.gov/'>https://www.clinicaltrials.gov/</a></li>
<li>Center Watch: <a href='https://www.centerwatch.com/'>https://www.centerwatch.com/</a></li>
</ul>
<p> Additional educational opportunities from Mayo Clinic: </p>
<ul><li><a href='https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education'>https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education</a></li>
<li><a href='https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/'>https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nqsk8b/WF64624_-_Behfar6jr8a.mp3" length="20734546" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: www.ce.mayo.edu/regmedonline
Guest: Atta Behfar, M.D., Ph.D. (@AttaBehfar)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Traditional treatment of cardiac disease, especially advanced congestive heart failure has been limited. Transplantation has potential for benefit; however, organ shortage remains a barrier. It’s anticipated that regenerative medicine will help solve this unmet need with new treatment options to repair damaged heart tissue. This podcast will discuss regenerative medicine for cardiovascular disease with Dr. Atta Behfar, a Mayo Clinic cardiologist with expertise in advanced heart failure and transplantation. We’ll review the progress made in regenerative medicine in management of cardiovascular disease, what treatment options are currently available and the potential treatment options which will become available in the future.
Specific topics discussed:
Regenerative potential of the cardiovascular system
Current challenges in management of patients with cardiovascular disease
Progress in regenerative medicine for the cardiovascular system
Limitations in regenerative cardiac therapy using regenerative medicine
Future potential for regenerative medicine treatment of cardiovascular disease
Patients who are candidates for cardiac regenerative therapies
 Additional resources:
Clinical Trials available at Mayo Clinic through the Center for Regenerative Medicine: https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/patient-care/clinical-trials
U.S. National Library of Medicine: https://www.clinicaltrials.gov/
Center Watch: https://www.centerwatch.com/
 Additional educational opportunities from Mayo Clinic: 
https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education
https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1292</itunes:duration>
                <itunes:episode>253</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: Examining Reports of Heart Inflammation in Young People After Second COVID-19 Vaccine</title>
        <itunes:title>Mayo Clinic Q&amp;A: Examining Reports of Heart Inflammation in Young People After Second COVID-19 Vaccine</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-examining-reports-of-heart-inflammation-in-young-people-after-second-covid-19-vaccine/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-examining-reports-of-heart-inflammation-in-young-people-after-second-covid-19-vaccine/#comments</comments>        <pubDate>Wed, 23 Jun 2021 01:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/c015a566-df7e-39f7-a98a-a46c5da9dbf7</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded June 14, 2021</p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)   </p>
<p>The <a href='https://www.cdc.gov/'>Centers for Disease Control and Prevention</a>'s Advisory Committee on Immunization Practices is holding an emergency COVID-19 <a href='https://www.cdc.gov/vaccines/acip/meetings/downloads/agenda-archive/agenda-2021-06-18-508.pdf'>meeting</a> this week to discuss COVID-19 vaccine safety as it relates to news that young people may develop myocarditis after receiving a second dose of a messenger RNA <a href='https://www.mayoclinic.org/coronavirus-covid-19%20?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> vaccine.</p>
<p><a href='https://www.mayoclinic.org/diseases-conditions/myocarditis/symptoms-causes/syc-20352539%20?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Myocarditis</a>, which is an inflammation of the heart muscle, is usually caused by a viral infection. But it can result from a reaction to a drug or be part of a more general inflammatory condition. Signs and symptoms include chest pain, fatigue, shortness of breath and arrhythmias.</p>
<p>"There have been about 789 cases reported," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>. "And that can happen for a whole variety of reasons." </p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland details the concerns about the myocarditis reports. He also discusses the latest news on the COVID-19 delta variant, and he explains what scientists are calling the "two-track pandemic."</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded June 14, 2021</p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)   </p>
<p>The <a href='https://www.cdc.gov/'>Centers for Disease Control and Prevention</a>'s Advisory Committee on Immunization Practices is holding an emergency COVID-19 <a href='https://www.cdc.gov/vaccines/acip/meetings/downloads/agenda-archive/agenda-2021-06-18-508.pdf'>meeting</a> this week to discuss COVID-19 vaccine safety as it relates to news that young people may develop myocarditis after receiving a second dose of a messenger RNA <a href='https://www.mayoclinic.org/coronavirus-covid-19%20?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> vaccine.</p>
<p><a href='https://www.mayoclinic.org/diseases-conditions/myocarditis/symptoms-causes/syc-20352539%20?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Myocarditis</a>, which is an inflammation of the heart muscle, is usually caused by a viral infection. But it can result from a reaction to a drug or be part of a more general inflammatory condition. Signs and symptoms include chest pain, fatigue, shortness of breath and arrhythmias.</p>
<p>"There have been about 789 cases reported," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>. "And that can happen for a whole variety of reasons." </p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland details the concerns about the myocarditis reports. He also discusses the latest news on the COVID-19 delta variant, and he explains what scientists are calling the "two-track pandemic."</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ghujxp/Mayo_Clinic_Q_A_-_Dr_Gregory_Poland_-_06_16_2165gn9.mp3" length="18622372" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded June 14, 2021
Guest:  Gregory A. Poland, M.D. (@drgregpoland) 
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)   
The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices is holding an emergency COVID-19 meeting this week to discuss COVID-19 vaccine safety as it relates to news that young people may develop myocarditis after receiving a second dose of a messenger RNA COVID-19 vaccine.
Myocarditis, which is an inflammation of the heart muscle, is usually caused by a viral infection. But it can result from a reaction to a drug or be part of a more general inflammatory condition. Signs and symptoms include chest pain, fatigue, shortness of breath and arrhythmias.
"There have been about 789 cases reported," says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group. "And that can happen for a whole variety of reasons." 
In this Mayo Clinic Q&A podcast, Dr. Poland details the concerns about the myocarditis reports. He also discusses the latest news on the COVID-19 delta variant, and he explains what scientists are calling the "two-track pandemic."
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1159</itunes:duration>
                        <itunes:episodeType>bonus</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>The Sobering Statistics of Alcohol Use Disorder</title>
        <itunes:title>The Sobering Statistics of Alcohol Use Disorder</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/the-sobering-statistics-of-alcohol-use-disorder/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/the-sobering-statistics-of-alcohol-use-disorder/#comments</comments>        <pubDate>Tue, 22 Jun 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/80de6376-01c1-313a-94b8-bebaa1b8d319</guid>
                                    <description><![CDATA[<p>Guest: Terry D. Schneekloth, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>According to the 2019 National Survey on Drug Use and Health, nearly 26% of individuals 18 and older reported that they engaged in binge drinking and slightly over 6% engaged in heavy alcohol use within the past month. Binge drinkers were 70 to 90 times more likely to have an alcohol-related emergency department visit. Based on their data from this study, they estimated that nearly 15 million people ages 12 and older had alcohol use disorder. It’s also known that those with alcohol use disorder commonly seek care from primary care providers for alcohol-related medical problems. Our guest for this podcast is Terry Schneekloth, M.D., a psychiatrist and addiction specialist at Mayo Clinic.</p>
<p>Specific topics discussed:</p>
<ul><li>Definition of alcohol use disorder</li>
<li>Risk factors for alcohol use disorder</li>
<li>Role of genetics</li>
<li>Questions primary care providers should ask to explore the possibility of an alcohol use disorder in patients</li>
<li>Physical exam or lab findings which could suggest an alcohol use disorder</li>
<li>Available treatment options and their alcohol use disorder effectiveness</li>
</ul>
<p>Additional Resources:</p>
<ul><li>World Health Organization (WHO). Alcohol Use Disorders Identification Test (AUDIT). 2001 November 18; <a href='https://www.who.int/publications/i/item/audit-the-alcohol-use-disorders-identification-test-guidelines-for-use-in-primary-health-care'>https://www.who.int/publications/i/item/audit-the-alcohol-use-disorders-identification-test-guidelines-for-use-in-primary-health-care</a></li>
<li>National Institute on Alcohol Abuse and Alcoholism (NIAAA). National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III) study: <a href='https://www.niaaa.nih.gov/research/nesarc-iii'>https://www.niaaa.nih.gov/research/nesarc-iii</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Terry D. Schneekloth, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>According to the 2019 National Survey on Drug Use and Health, nearly 26% of individuals 18 and older reported that they engaged in binge drinking and slightly over 6% engaged in heavy alcohol use within the past month. Binge drinkers were 70 to 90 times more likely to have an alcohol-related emergency department visit. Based on their data from this study, they estimated that nearly 15 million people ages 12 and older had alcohol use disorder. It’s also known that those with alcohol use disorder commonly seek care from primary care providers for alcohol-related medical problems. Our guest for this podcast is Terry Schneekloth, M.D., a psychiatrist and addiction specialist at Mayo Clinic.</p>
<p>Specific topics discussed:</p>
<ul><li>Definition of alcohol use disorder</li>
<li>Risk factors for alcohol use disorder</li>
<li>Role of genetics</li>
<li>Questions primary care providers should ask to explore the possibility of an alcohol use disorder in patients</li>
<li>Physical exam or lab findings which could suggest an alcohol use disorder</li>
<li>Available treatment options and their alcohol use disorder effectiveness</li>
</ul>
<p>Additional Resources:</p>
<ul><li>World Health Organization (WHO). Alcohol Use Disorders Identification Test (AUDIT). 2001 November 18; <a href='https://www.who.int/publications/i/item/audit-the-alcohol-use-disorders-identification-test-guidelines-for-use-in-primary-health-care'>https://www.who.int/publications/i/item/audit-the-alcohol-use-disorders-identification-test-guidelines-for-use-in-primary-health-care</a></li>
<li>National Institute on Alcohol Abuse and Alcoholism (NIAAA). National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III) study: <a href='https://www.niaaa.nih.gov/research/nesarc-iii'>https://www.niaaa.nih.gov/research/nesarc-iii</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tx9v4g/WF64625_-_Alcohol_Use_Disordersal50s.mp3" length="26076325" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Terry D. Schneekloth, M.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
According to the 2019 National Survey on Drug Use and Health, nearly 26% of individuals 18 and older reported that they engaged in binge drinking and slightly over 6% engaged in heavy alcohol use within the past month. Binge drinkers were 70 to 90 times more likely to have an alcohol-related emergency department visit. Based on their data from this study, they estimated that nearly 15 million people ages 12 and older had alcohol use disorder. It’s also known that those with alcohol use disorder commonly seek care from primary care providers for alcohol-related medical problems. Our guest for this podcast is Terry Schneekloth, M.D., a psychiatrist and addiction specialist at Mayo Clinic.
Specific topics discussed:
Definition of alcohol use disorder
Risk factors for alcohol use disorder
Role of genetics
Questions primary care providers should ask to explore the possibility of an alcohol use disorder in patients
Physical exam or lab findings which could suggest an alcohol use disorder
Available treatment options and their alcohol use disorder effectiveness
Additional Resources:
World Health Organization (WHO). Alcohol Use Disorders Identification Test (AUDIT). 2001 November 18; https://www.who.int/publications/i/item/audit-the-alcohol-use-disorders-identification-test-guidelines-for-use-in-primary-health-care
National Institute on Alcohol Abuse and Alcoholism (NIAAA). National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III) study: https://www.niaaa.nih.gov/research/nesarc-iii
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1625</itunes:duration>
                <itunes:episode>252</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Regenerative Medicine Edition Ep.8: Neuroregenerative Therapies</title>
        <itunes:title>Regenerative Medicine Edition Ep.8: Neuroregenerative Therapies</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/regenerative-medicine-series-ep8-neuroregenerative-therapies/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/regenerative-medicine-series-ep8-neuroregenerative-therapies/#comments</comments>        <pubDate>Thu, 17 Jun 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/113cf43f-fd8e-31a6-97e7-f1b473ffc4bc</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='http://www.ce.mayo.edu/regmedonline'>www.ce.mayo.edu/regmedonline</a></p>
<p>Guest: Nathan Staff, M.D. (<a href='https://twitter.com/NathanStaffMD'>@NathanStaffMD</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>The cells in our nervous system are extremely specialized, especially those in the brain. Unfortunately, nervous tissue does not have a great potential to regain function once it is lost. Exciting research is being done in the field of neuro-regenerative medicine which will give hope for improvement to those with chronic neurodegenerative disease or nerve damage from injury. Dr. Nathan Staff, a Mayo Clinic neurologist, joins us regarding the challenges with the current management of chronic neurodegenerative diseases and the future potential for treating such conditions as Parkinson’s Disease, Alzheimer’s Disease, ALS and other neurodegenerative disease with regenerative medicine therapies.</p>
<p>Specific topics discussed:</p>
<ul><li>Current research in regenerative medicine treatment for chronic neurodegenerative disease</li>
<li>Currently used regenerative medicine in neurologic conditions</li>
<li>New treatment options on the horizon for chronic neurodegenerative disease using regenerative medicine therapy</li>
</ul>
<p> Additional educational opportunities from Mayo Clinic: </p>
<ul><li><a href='https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education'>https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education</a></li>
<li><a href='https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/'>https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='http://www.ce.mayo.edu/regmedonline'>www.ce.mayo.edu/regmedonline</a></p>
<p>Guest: Nathan Staff, M.D. (<a href='https://twitter.com/NathanStaffMD'>@NathanStaffMD</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>The cells in our nervous system are extremely specialized, especially those in the brain. Unfortunately, nervous tissue does not have a great potential to regain function once it is lost. Exciting research is being done in the field of neuro-regenerative medicine which will give hope for improvement to those with chronic neurodegenerative disease or nerve damage from injury. Dr. Nathan Staff, a Mayo Clinic neurologist, joins us regarding the challenges with the current management of chronic neurodegenerative diseases and the future potential for treating such conditions as Parkinson’s Disease, Alzheimer’s Disease, ALS and other neurodegenerative disease with regenerative medicine therapies.</p>
<p>Specific topics discussed:</p>
<ul><li>Current research in regenerative medicine treatment for chronic neurodegenerative disease</li>
<li>Currently used regenerative medicine in neurologic conditions</li>
<li>New treatment options on the horizon for chronic neurodegenerative disease using regenerative medicine therapy</li>
</ul>
<p> Additional educational opportunities from Mayo Clinic: </p>
<ul><li><a href='https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education'>https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education</a></li>
<li><a href='https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/'>https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ipigj4/VT3986824_-_Staffaa6uz.mp3" length="17965904" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: www.ce.mayo.edu/regmedonline
Guest: Nathan Staff, M.D. (@NathanStaffMD)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
The cells in our nervous system are extremely specialized, especially those in the brain. Unfortunately, nervous tissue does not have a great potential to regain function once it is lost. Exciting research is being done in the field of neuro-regenerative medicine which will give hope for improvement to those with chronic neurodegenerative disease or nerve damage from injury. Dr. Nathan Staff, a Mayo Clinic neurologist, joins us regarding the challenges with the current management of chronic neurodegenerative diseases and the future potential for treating such conditions as Parkinson’s Disease, Alzheimer’s Disease, ALS and other neurodegenerative disease with regenerative medicine therapies.
Specific topics discussed:
Current research in regenerative medicine treatment for chronic neurodegenerative disease
Currently used regenerative medicine in neurologic conditions
New treatment options on the horizon for chronic neurodegenerative disease using regenerative medicine therapy
 Additional educational opportunities from Mayo Clinic: 
https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education
https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1118</itunes:duration>
                <itunes:episode>251</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Agony of Da Feet - Assessing Foot and Ankle Pain and Injury</title>
        <itunes:title>The Agony of Da Feet - Assessing Foot and Ankle Pain and Injury</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/the-agony-of-da-feet-assessing-foot-and-ankle-pain-and-injury/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/the-agony-of-da-feet-assessing-foot-and-ankle-pain-and-injury/#comments</comments>        <pubDate>Tue, 15 Jun 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/3d2a97b5-6a4e-3b18-943f-2b483e62d550</guid>
                                    <description><![CDATA[<p>Guest: Daniel B. Ryssman, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Generally, we take our feet for granted. It’s not unusual for a person to take 8- to 10-thousand steps per day. That translates to over 115,000 miles in a lifetime. By the time we reach 70 years old, the average person will have walked the equivalent of 4 times around the globe. Yet, we stop taking our feet for granted when they hurt, and it’s estimated that 75% of Americans will experience foot problems of varying degrees of severity during their lifetime. In this podcast, we’ll discuss foot and ankle pain with Daniel Ryssman, M.D., an orthopedist and sports medicine physician from Mayo Clinic. We’ll review some of the common injuries to the ankle such as sprains and fractures as well as common chronic conditions of the foot such as plantar fasciitis and bunions. Dr. Ryssman delves into the best ways to prevent, diagnose, and treat these conditions as well as what, if any, imaging to order.</p>
<p>Specific topics discussed:</p>
<ul><li>Ankle sprains</li>
<li>Ankle fractures</li>
<li>Achilles’ tendon rupture</li>
<li>Plantar fasciitis</li>
<li>Bunions</li>
<li>Metatarsalgia</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Daniel B. Ryssman, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Generally, we take our feet for granted. It’s not unusual for a person to take 8- to 10-thousand steps per day. That translates to over 115,000 miles in a lifetime. By the time we reach 70 years old, the average person will have walked the equivalent of 4 times around the globe. Yet, we stop taking our feet for granted when they hurt, and it’s estimated that 75% of Americans will experience foot problems of varying degrees of severity during their lifetime. In this podcast, we’ll discuss foot and ankle pain with Daniel Ryssman, M.D., an orthopedist and sports medicine physician from Mayo Clinic. We’ll review some of the common injuries to the ankle such as sprains and fractures as well as common chronic conditions of the foot such as plantar fasciitis and bunions. Dr. Ryssman delves into the best ways to prevent, diagnose, and treat these conditions as well as what, if any, imaging to order.</p>
<p>Specific topics discussed:</p>
<ul><li>Ankle sprains</li>
<li>Ankle fractures</li>
<li>Achilles’ tendon rupture</li>
<li>Plantar fasciitis</li>
<li>Bunions</li>
<li>Metatarsalgia</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hqbr7g/WF74098_Foot_and_Ankle_Injuries6qv89.mp3" length="22054798" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Daniel B. Ryssman, M.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Generally, we take our feet for granted. It’s not unusual for a person to take 8- to 10-thousand steps per day. That translates to over 115,000 miles in a lifetime. By the time we reach 70 years old, the average person will have walked the equivalent of 4 times around the globe. Yet, we stop taking our feet for granted when they hurt, and it’s estimated that 75% of Americans will experience foot problems of varying degrees of severity during their lifetime. In this podcast, we’ll discuss foot and ankle pain with Daniel Ryssman, M.D., an orthopedist and sports medicine physician from Mayo Clinic. We’ll review some of the common injuries to the ankle such as sprains and fractures as well as common chronic conditions of the foot such as plantar fasciitis and bunions. Dr. Ryssman delves into the best ways to prevent, diagnose, and treat these conditions as well as what, if any, imaging to order.
Specific topics discussed:
Ankle sprains
Ankle fractures
Achilles’ tendon rupture
Plantar fasciitis
Bunions
Metatarsalgia
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1374</itunes:duration>
                <itunes:episode>250</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>COVID-19 Miniseries Episode 75: Mayo Clinic Q&amp;A - A Dangerous Phase of the COVID-19 Pandemic for Those who are Unvaccinated</title>
        <itunes:title>COVID-19 Miniseries Episode 75: Mayo Clinic Q&amp;A - A Dangerous Phase of the COVID-19 Pandemic for Those who are Unvaccinated</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-75-mayo-clinic-qa-a-dangerous-phase-of-the-covid-19-pandemic-for-those-who-are-unvaccinated/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-75-mayo-clinic-qa-a-dangerous-phase-of-the-covid-19-pandemic-for-those-who-are-unvaccinated/#comments</comments>        <pubDate>Fri, 11 Jun 2021 09:41:12 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/cc06e3fe-ece6-3264-90b8-f3cd82a3b450</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded June, 2021</p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)   </p>
<p>If you've been vaccinated for <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a>, you're able to go shopping, eat in restaurants and travel on airplanes without the same worry of becoming infected with COVID-19 that existed just months ago. But for those who are unvaccinated, getting infected with COVID-19 — even with just minor symptoms — should be a concern, according to <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>.</p>
<p>"For those who have been vaccinated, life is resuming back to a sense of normalcy," says Dr. Poland. "But for the unvaccinated, they now live in a dangerous phase of the pandemic, where we're seeing circulating variants that are much more transmissible and may cause worse cases of the disease than what happened last year at this time. I think the people who are unvaccinated may not realize that."</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland also offers information on more COVID-19 studies underway and he talks about COVID-19 vaccine research protocols that will be able to help scientists with other vaccine research, such as HIV vaccine research. Also, he answers listener questions, such as, "Does someone who has already been infected with COVID-19, really need to be fully vaccinated for COVID-19 or would just a booster be needed?"</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded June, 2021</p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)   </p>
<p>If you've been vaccinated for <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a>, you're able to go shopping, eat in restaurants and travel on airplanes without the same worry of becoming infected with COVID-19 that existed just months ago. But for those who are unvaccinated, getting infected with COVID-19 — even with just minor symptoms — should be a concern, according to <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>.</p>
<p>"For those who have been vaccinated, life is resuming back to a sense of normalcy," says Dr. Poland. "But for the unvaccinated, they now live in a dangerous phase of the pandemic, where we're seeing circulating variants that are much more transmissible and may cause worse cases of the disease than what happened last year at this time. I think the people who are unvaccinated may not realize that."</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland also offers information on more COVID-19 studies underway and he talks about COVID-19 vaccine research protocols that will be able to help scientists with other vaccine research, such as HIV vaccine research. Also, he answers listener questions, such as, "Does someone who has already been infected with COVID-19, really need to be fully vaccinated for COVID-19 or would just a booster be needed?"</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/emcawm/Mayo_Clinic_Q_A_-_Dr_Gregory_Poland_-_06_09_2189zhp.mp3" length="29701863" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded June, 2021
To claim credit visit: https://ce.mayo.edu/covid19podcast 
Guest:  Gregory A. Poland, M.D. (@drgregpoland) 
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)   
If you've been vaccinated for COVID-19, you're able to go shopping, eat in restaurants and travel on airplanes without the same worry of becoming infected with COVID-19 that existed just months ago. But for those who are unvaccinated, getting infected with COVID-19 — even with just minor symptoms — should be a concern, according to Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group.
"For those who have been vaccinated, life is resuming back to a sense of normalcy," says Dr. Poland. "But for the unvaccinated, they now live in a dangerous phase of the pandemic, where we're seeing circulating variants that are much more transmissible and may cause worse cases of the disease than what happened last year at this time. I think the people who are unvaccinated may not realize that."
In this Mayo Clinic Q&A podcast, Dr. Poland also offers information on more COVID-19 studies underway and he talks about COVID-19 vaccine research protocols that will be able to help scientists with other vaccine research, such as HIV vaccine research. Also, he answers listener questions, such as, "Does someone who has already been infected with COVID-19, really need to be fully vaccinated for COVID-19 or would just a booster be needed?"
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1850</itunes:duration>
                <itunes:episode>249</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Regenerative Medicine Edition Ep.7: Preventing Osteoarthritis of the Knee</title>
        <itunes:title>Regenerative Medicine Edition Ep.7: Preventing Osteoarthritis of the Knee</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/regenerative-medicine-series-ep7-preventing-osteoarthritis-of-the-knee/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/regenerative-medicine-series-ep7-preventing-osteoarthritis-of-the-knee/#comments</comments>        <pubDate>Thu, 10 Jun 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/3494edd0-b206-3df2-ada8-8349d2f5777a</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='http://www.ce.mayo.edu/regmedonline'>www.ce.mayo.edu/regmedonline</a></p>
<p>Guest: Daniel Saris, M.D., Ph.D. (<a href='https://twitter.com/sarisnl'>@sarisnl</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Osteoarthritis of the knee is extremely common, and it’s estimated that 1 in 2 people are likely to develop symptomatic knee osteoarthritis in their lifetime. Its known that damaged cartilage is the precursor to osteoarthritis. Many individuals have had partial or complete meniscectomies for meniscal tears in the past and those individuals were then likely to eventually develop knee osteoarthritis. What if damaged cartilage was repaired instead of surgically removed? Could that be an effective treatment recommendation we could give to our patients to help prevent or treat osteoarthritis? Our podcast guest today is Dr. Daniel Saris and he has some fascinating information related to cartilage damage and repair using regenerative medicine techniques.</p>
<p>Specific topics discussed:</p>
<ul><li>How meniscal damage relates to osteoarthritis</li>
<li>Ability of cartilage to repair itself when damaged</li>
<li>Repairing a damaged meniscus instead of a partial or complete meniscectomy</li>
<li>Specific techniques of repairing cartilage</li>
<li>Success in treating patients with cartilage repair</li>
<li>Future treatment options for osteoarthritis using regenerative medicine</li>
</ul>
<p> Additional educational opportunities from Mayo Clinic: </p>
<ul><li><a href='https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education'>https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education</a></li>
<li><a href='https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/'>https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='http://www.ce.mayo.edu/regmedonline'>www.ce.mayo.edu/regmedonline</a></p>
<p>Guest: Daniel Saris, M.D., Ph.D. (<a href='https://twitter.com/sarisnl'>@sarisnl</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Osteoarthritis of the knee is extremely common, and it’s estimated that 1 in 2 people are likely to develop symptomatic knee osteoarthritis in their lifetime. Its known that damaged cartilage is the precursor to osteoarthritis. Many individuals have had partial or complete meniscectomies for meniscal tears in the past and those individuals were then likely to eventually develop knee osteoarthritis. What if damaged cartilage was repaired instead of surgically removed? Could that be an effective treatment recommendation we could give to our patients to help prevent or treat osteoarthritis? Our podcast guest today is Dr. Daniel Saris and he has some fascinating information related to cartilage damage and repair using regenerative medicine techniques.</p>
<p>Specific topics discussed:</p>
<ul><li>How meniscal damage relates to osteoarthritis</li>
<li>Ability of cartilage to repair itself when damaged</li>
<li>Repairing a damaged meniscus instead of a partial or complete meniscectomy</li>
<li>Specific techniques of repairing cartilage</li>
<li>Success in treating patients with cartilage repair</li>
<li>Future treatment options for osteoarthritis using regenerative medicine</li>
</ul>
<p> Additional educational opportunities from Mayo Clinic: </p>
<ul><li><a href='https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education'>https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education</a></li>
<li><a href='https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/'>https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5vnvsi/VT3988591_-_Saris7o10q.mp3" length="21111063" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: www.ce.mayo.edu/regmedonline
Guest: Daniel Saris, M.D., Ph.D. (@sarisnl)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Osteoarthritis of the knee is extremely common, and it’s estimated that 1 in 2 people are likely to develop symptomatic knee osteoarthritis in their lifetime. Its known that damaged cartilage is the precursor to osteoarthritis. Many individuals have had partial or complete meniscectomies for meniscal tears in the past and those individuals were then likely to eventually develop knee osteoarthritis. What if damaged cartilage was repaired instead of surgically removed? Could that be an effective treatment recommendation we could give to our patients to help prevent or treat osteoarthritis? Our podcast guest today is Dr. Daniel Saris and he has some fascinating information related to cartilage damage and repair using regenerative medicine techniques.
Specific topics discussed:
How meniscal damage relates to osteoarthritis
Ability of cartilage to repair itself when damaged
Repairing a damaged meniscus instead of a partial or complete meniscectomy
Specific techniques of repairing cartilage
Success in treating patients with cartilage repair
Future treatment options for osteoarthritis using regenerative medicine
 Additional educational opportunities from Mayo Clinic: 
https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education
https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1316</itunes:duration>
                <itunes:episode>248</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>COVID-19 Miniseries Episode 74: The World is Flat – Addressing Anosmia in Post-COVID Patients</title>
        <itunes:title>COVID-19 Miniseries Episode 74: The World is Flat – Addressing Anosmia in Post-COVID Patients</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/covid-19_miniseries_episode_74_the_world_is_flat_addressing_anosmia_in_post-covid_patients/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/covid-19_miniseries_episode_74_the_world_is_flat_addressing_anosmia_in_post-covid_patients/#comments</comments>        <pubDate>Tue, 08 Jun 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/ef4bfcb7-b895-3eb5-9eca-fb5df7262a39</guid>
                                    <description><![CDATA[<p>Guest: Erin K. O'Brien, M.D. (<a href='https://twitter.com/ErinOBrienMD'>@ErinOBrienMD</a>) </p>
<p>Host: Amit K. Ghosh, M.D. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>) </p>
<p>Erin O’Brien, M.D., division chair of Rhinology in Rochester, MN, joins us again to provide an evidence-based update on anosmia and its prevalence in post-COVID patients. She reviews the postulated mechanism by which anosmia occurs in this group of patients, and how this effects patients’ safety, mental health, and overall wellbeing. Dr. O’Brien also gives an overview of treatment options, such as various methods of olfactory training, and what physicians need to know when counseling their patients with post-COVID anosmia. </p>
<p>Additional resources: </p>
<ul><li>Video on olfactory training: <a href='https://www.youtube.com/watch?v=Qrr0so6pFOs%5C'>https://www.youtube.com/watch?v=Qrr0so6pFOs</a> </li>
<li>Abscent – resources for patients with anosmia: <a href='https://abscent.org/'>https://abscent.org/</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Erin K. O'Brien, M.D. (<a href='https://twitter.com/ErinOBrienMD'>@ErinOBrienMD</a>) </p>
<p>Host: Amit K. Ghosh, M.D. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>) </p>
<p>Erin O’Brien, M.D., division chair of Rhinology in Rochester, MN, joins us again to provide an evidence-based update on anosmia and its prevalence in post-COVID patients. She reviews the postulated mechanism by which anosmia occurs in this group of patients, and how this effects patients’ safety, mental health, and overall wellbeing. Dr. O’Brien also gives an overview of treatment options, such as various methods of olfactory training, and what physicians need to know when counseling their patients with post-COVID anosmia. </p>
<p>Additional resources: </p>
<ul><li>Video on olfactory training: <a href='https://www.youtube.com/watch?v=Qrr0so6pFOs%5C'>https://www.youtube.com/watch?v=Qrr0so6pFOs</a> </li>
<li>Abscent – resources for patients with anosmia: <a href='https://abscent.org/'>https://abscent.org/</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qfkzjq/WF241440_Anosmia_in_Post-COVID_Patients70dx8.mp3" length="20531804" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Erin K. O'Brien, M.D. (@ErinOBrienMD) 
Host: Amit K. Ghosh, M.D. (@AmitGhosh006) 
Erin O’Brien, M.D., division chair of Rhinology in Rochester, MN, joins us again to provide an evidence-based update on anosmia and its prevalence in post-COVID patients. She reviews the postulated mechanism by which anosmia occurs in this group of patients, and how this effects patients’ safety, mental health, and overall wellbeing. Dr. O’Brien also gives an overview of treatment options, such as various methods of olfactory training, and what physicians need to know when counseling their patients with post-COVID anosmia. 
Additional resources: 
Video on olfactory training: https://www.youtube.com/watch?v=Qrr0so6pFOs 
Abscent – resources for patients with anosmia: https://abscent.org/
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1279</itunes:duration>
                <itunes:episode>247</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Regenerative Medicine Edition Ep.6: New Options for Treating Musculoskeletal Pain</title>
        <itunes:title>Regenerative Medicine Edition Ep.6: New Options for Treating Musculoskeletal Pain</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/regenerative-medicine-series-ep6-new-options-for-treating-musculoskeletal-pain/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/regenerative-medicine-series-ep6-new-options-for-treating-musculoskeletal-pain/#comments</comments>        <pubDate>Thu, 03 Jun 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/df5dcfb1-afc1-3504-9b10-b8340fedc266</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='http://www.ce.mayo.edu/regmedonline'>www.ce.mayo.edu/regmedonline</a></p>
<p>Guest: Shane A. Shapiro, M.D. (<a href='https://twitter.com/ShaneShapiroMD'>@ShaneShapiroMD</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Musculoskeletal pain is extremely common and when severe, patients often gain significant benefit from joint replacements. However, until our patients reach the point where surgery is an option, our efforts to help patients with the chronic joint pain often leave much to be desired. A relatively new treatment approach has appeared in the past decade, musculoskeletal regenerative medicine. But does the research back up the numerous claims of benefit? This podcast will review the current treatment options available and future potential of regenerative medicine for musculoskeletal problems with Dr. Shane Shapiro, a sports medicine physician in the Department of Orthopedics at the Mayo Clinic. We’ll discuss the current regenerative products and therapies available to optimize patient outcomes, potential adverse effects of the therapies and the numerous claims by many clinicians regarding the benefit potential for regenerative medicine in musculoskeletal disease.</p>
<p> Specific topics discussed:</p>
<ul><li>Challenges of currently available traditional treatment for musculoskeletal conditions</li>
<li>Benefits of stem cell injections for osteoarthritis</li>
<li>Potential adverse effects of stem cell injections</li>
<li>Currently available regenerative medicine therapies that have shown benefit to patients</li>
<li>Validity of the many claims made by clinicians regarding the benefits of stem cell injections</li>
</ul>
<p> Additional educational opportunities from Mayo Clinic: </p>
<ul><li><a href='https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education'>https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education</a></li>
<li><a href='https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/'>https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='http://www.ce.mayo.edu/regmedonline'>www.ce.mayo.edu/regmedonline</a></p>
<p>Guest: Shane A. Shapiro, M.D. (<a href='https://twitter.com/ShaneShapiroMD'>@ShaneShapiroMD</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Musculoskeletal pain is extremely common and when severe, patients often gain significant benefit from joint replacements. However, until our patients reach the point where surgery is an option, our efforts to help patients with the chronic joint pain often leave much to be desired. A relatively new treatment approach has appeared in the past decade, musculoskeletal regenerative medicine. But does the research back up the numerous claims of benefit? This podcast will review the current treatment options available and future potential of regenerative medicine for musculoskeletal problems with Dr. Shane Shapiro, a sports medicine physician in the Department of Orthopedics at the Mayo Clinic. We’ll discuss the current regenerative products and therapies available to optimize patient outcomes, potential adverse effects of the therapies and the numerous claims by many clinicians regarding the benefit potential for regenerative medicine in musculoskeletal disease.</p>
<p> Specific topics discussed:</p>
<ul><li>Challenges of currently available traditional treatment for musculoskeletal conditions</li>
<li>Benefits of stem cell injections for osteoarthritis</li>
<li>Potential adverse effects of stem cell injections</li>
<li>Currently available regenerative medicine therapies that have shown benefit to patients</li>
<li>Validity of the many claims made by clinicians regarding the benefits of stem cell injections</li>
</ul>
<p> Additional educational opportunities from Mayo Clinic: </p>
<ul><li><a href='https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education'>https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education</a></li>
<li><a href='https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/'>https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/eug7ug/VT3985003_-Episode_9_Shapiro7mwdf.mp3" length="20330246" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: www.ce.mayo.edu/regmedonline
Guest: Shane A. Shapiro, M.D. (@ShaneShapiroMD)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Musculoskeletal pain is extremely common and when severe, patients often gain significant benefit from joint replacements. However, until our patients reach the point where surgery is an option, our efforts to help patients with the chronic joint pain often leave much to be desired. A relatively new treatment approach has appeared in the past decade, musculoskeletal regenerative medicine. But does the research back up the numerous claims of benefit? This podcast will review the current treatment options available and future potential of regenerative medicine for musculoskeletal problems with Dr. Shane Shapiro, a sports medicine physician in the Department of Orthopedics at the Mayo Clinic. We’ll discuss the current regenerative products and therapies available to optimize patient outcomes, potential adverse effects of the therapies and the numerous claims by many clinicians regarding the benefit potential for regenerative medicine in musculoskeletal disease.
 Specific topics discussed:
Challenges of currently available traditional treatment for musculoskeletal conditions
Benefits of stem cell injections for osteoarthritis
Potential adverse effects of stem cell injections
Currently available regenerative medicine therapies that have shown benefit to patients
Validity of the many claims made by clinicians regarding the benefits of stem cell injections
 Additional educational opportunities from Mayo Clinic: 
https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education
https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1267</itunes:duration>
                <itunes:episode>246</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Watching Out for Loperamide Abuse</title>
        <itunes:title>Watching Out for Loperamide Abuse</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/watching-out-for-loperamide-abuse/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/watching-out-for-loperamide-abuse/#comments</comments>        <pubDate>Tue, 01 Jun 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/f47a9826-25e2-3e04-87e1-d11974aab891</guid>
                                    <description><![CDATA[<p>Guest: Tyler S. Oesterle, M.D., M.P.H. (<a href='https://twitter.com/OesterleMD'>@OesterleMD</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Opioid abuse remains a significant problem, and as law enforcement and regulatory agencies tighten access to prescription analgesics, individuals are seeking alternatives. It’s been discovered that when taken at very high doses, loperamide can produce similar effects to the opioid analgesics and the drug is inexpensive when compared to the price of both illicit and prescription opioids. As a result, loperamide abuse has become a significant problem. In this episode we discuss loperamide abuse with Tyler Oesterle, M.D., M.P.H., a psychiatrist at Mayo Clinic’s Rochester campus. We’ll review the typical central nervous system effects of high dose loperamide and the associated safety issues.</p>
<p>Specific topics:</p>
<ul><li>Current status of the opioid crisis in the U.S.</li>
<li>Effects of loperamide in both therapeutic and excessive doses</li>
<li>Reasons behind taking high dose loperamide in excessive doses</li>
<li>Safety issues associated with high dose loperamide</li>
<li>Potential of high dose loperamide leading to drug dependence</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Tyler S. Oesterle, M.D., M.P.H. (<a href='https://twitter.com/OesterleMD'>@OesterleMD</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Opioid abuse remains a significant problem, and as law enforcement and regulatory agencies tighten access to prescription analgesics, individuals are seeking alternatives. It’s been discovered that when taken at very high doses, loperamide can produce similar effects to the opioid analgesics and the drug is inexpensive when compared to the price of both illicit and prescription opioids. As a result, loperamide abuse has become a significant problem. In this episode we discuss loperamide abuse with Tyler Oesterle, M.D., M.P.H., a psychiatrist at Mayo Clinic’s Rochester campus. We’ll review the typical central nervous system effects of high dose loperamide and the associated safety issues.</p>
<p>Specific topics:</p>
<ul><li>Current status of the opioid crisis in the U.S.</li>
<li>Effects of loperamide in both therapeutic and excessive doses</li>
<li>Reasons behind taking high dose loperamide in excessive doses</li>
<li>Safety issues associated with high dose loperamide</li>
<li>Potential of high dose loperamide leading to drug dependence</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/anhra5/WF74097_Loperamide_Abuse_V2bnmvs.mp3" length="16939413" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Tyler S. Oesterle, M.D., M.P.H. (@OesterleMD)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Opioid abuse remains a significant problem, and as law enforcement and regulatory agencies tighten access to prescription analgesics, individuals are seeking alternatives. It’s been discovered that when taken at very high doses, loperamide can produce similar effects to the opioid analgesics and the drug is inexpensive when compared to the price of both illicit and prescription opioids. As a result, loperamide abuse has become a significant problem. In this episode we discuss loperamide abuse with Tyler Oesterle, M.D., M.P.H., a psychiatrist at Mayo Clinic’s Rochester campus. We’ll review the typical central nervous system effects of high dose loperamide and the associated safety issues.
Specific topics:
Current status of the opioid crisis in the U.S.
Effects of loperamide in both therapeutic and excessive doses
Reasons behind taking high dose loperamide in excessive doses
Safety issues associated with high dose loperamide
Potential of high dose loperamide leading to drug dependence
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1052</itunes:duration>
                <itunes:episode>245</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>COVID-19 Miniseries Episode 73: Mayo Clinic Q&amp;A - Dissecting COVID-19 Research and Putting Data in Perspective</title>
        <itunes:title>COVID-19 Miniseries Episode 73: Mayo Clinic Q&amp;A - Dissecting COVID-19 Research and Putting Data in Perspective</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-73-mayo-clinic-qa-dissecting-covid-19-research-and-putting-data-in-perspective/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-73-mayo-clinic-qa-dissecting-covid-19-research-and-putting-data-in-perspective/#comments</comments>        <pubDate>Fri, 28 May 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/2b12aff4-685b-300c-97fd-244c2df78365</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded May 24, 2021.</p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)   </p>
<p>The number of <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> cases, hospitalizations and deaths in the U.S. continues to decline. However, cases of COVID-19 are increasing in younger populations. </p>
<p>"It's becoming a childhood disease," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>. "Children have composed over 16,000 hospitalizations for COVID-19 and about 300 have died."</p>
<p>Meanwhile, each day brings fresh research news, including updates on possible side effects of the COVID-19 vaccines. </p>
<p>"We're collecting information as we go and have data on about 4.5 million people now," says Dr. Poland. "That's larger than we would have for any other vaccine." </p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland expands on these latest news items and puts the data in perspective. He also discusses vaccination rates, the possibility of mixing and matching vaccines for COVID-19 boosters, vaccination rates, and much more.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded May 24, 2021.</p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)   </p>
<p>The number of <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> cases, hospitalizations and deaths in the U.S. continues to decline. However, cases of COVID-19 are increasing in younger populations. </p>
<p>"It's becoming a childhood disease," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>. "Children have composed over 16,000 hospitalizations for COVID-19 and about 300 have died."</p>
<p>Meanwhile, each day brings fresh research news, including updates on possible side effects of the COVID-19 vaccines. </p>
<p>"We're collecting information as we go and have data on about 4.5 million people now," says Dr. Poland. "That's larger than we would have for any other vaccine." </p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland expands on these latest news items and puts the data in perspective. He also discusses vaccination rates, the possibility of mixing and matching vaccines for COVID-19 boosters, vaccination rates, and much more.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5f429k/Mayo_Clinic_Q_A_-_Dr_Gregory_Poland_05_26_2173z4w.mp3" length="28850628" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded May 24, 2021.
To claim credit visit: https://ce.mayo.edu/covid19podcast 
Guest:  Gregory A. Poland, M.D. (@drgregpoland) 
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)   
The number of COVID-19 cases, hospitalizations and deaths in the U.S. continues to decline. However, cases of COVID-19 are increasing in younger populations. 
"It's becoming a childhood disease," says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group. "Children have composed over 16,000 hospitalizations for COVID-19 and about 300 have died."
Meanwhile, each day brings fresh research news, including updates on possible side effects of the COVID-19 vaccines. 
"We're collecting information as we go and have data on about 4.5 million people now," says Dr. Poland. "That's larger than we would have for any other vaccine." 
In this Mayo Clinic Q&A podcast, Dr. Poland expands on these latest news items and puts the data in perspective. He also discusses vaccination rates, the possibility of mixing and matching vaccines for COVID-19 boosters, vaccination rates, and much more.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1797</itunes:duration>
                <itunes:episode>244</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>Regenerative Medicine Edition Ep.5: The Mission for Fluency and Safeguarding Patients from Stem Cell Tourism</title>
        <itunes:title>Regenerative Medicine Edition Ep.5: The Mission for Fluency and Safeguarding Patients from Stem Cell Tourism</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/regenerative-medicine-series-ep5-the-mission-for-fluency-and-safeguarding-patients-from-stem-cell-tourism/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/regenerative-medicine-series-ep5-the-mission-for-fluency-and-safeguarding-patients-from-stem-cell-tourism/#comments</comments>        <pubDate>Thu, 27 May 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/f5b009e5-3759-3a49-9574-4c13dcc7bfe1</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='http://www.ce.mayo.edu/regmedonline'>www.ce.mayo.edu/regmedonline</a></p>
<p>Guest: Saranya Wyles, M.D. (<a href='https://twitter.com/SWylesMDPhD'>@SWylesMDPhD</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Much of regenerative medicine is relatively new and some of the future treatment capabilities have the potential to significantly change the way we practice medicine. How do you educate established clinicians as well as clinicians in training regarding this new practice? How do you educate the general public which has been misled by a variety of false claims regarding which medical conditions regenerative medicine can currently effectively treat? This podcast discusses how a relatively new medical field puts together an education program to inform others of its potential. Our guest is Saranya Wyles, M.D., a resident in the Department of Dermatology who has considerable experience in regenerative medicine education.</p>
<p> Specific topics discussed:</p>
<ul><li>Specific groups who need educating regarding the capabilities of regenerative medicine</li>
<li>The importance in training the medical workforce regarding regenerative medicine</li>
<li>What regenerative medicine means for the next generation of healthcare providers</li>
<li>How to incorporate regenerative medicine concepts into an established medical school curriculum</li>
<li>How to educate more advanced learn years such as residents and healthcare providers</li>
<li>Obtaining an advanced degree in the field a regenerative medicine</li>
</ul>
<p>Additional resources:</p>
<ul><li>International Society for Stem Cell Research (ISSCR): <a href='https://www.isscr.org/'>https://www.isscr.org/</a></li>
<li>The ISSCR Patient Handbook on Stem Cell Therapies: <a href='https://www.closerlookatstemcells.org/patient-resources/'>https://www.closerlookatstemcells.org/patient-resources/</a></li>
<li>Regenerative medicine curriculum for next-generation physicians: <a href='https://www.nature.com/articles/s41536-019-0065-8'>https://www.nature.com/articles/s41536-019-0065-8</a></li>
<li>Digital regenerative medicine and surgery pedagogy for virtual learning in the time of COVID-19: <a href='https://www.futuremedicine.com/doi/full/10.2217/rme-2020-0106'>https://www.futuremedicine.com/doi/full/10.2217/rme-2020-0106</a></li>
</ul>
<p>Additional educational opportunities from Mayo Clinic: </p>
<ul><li><a href='https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education'>https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education</a></li>
<li><a href='https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/'>https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='http://www.ce.mayo.edu/regmedonline'>www.ce.mayo.edu/regmedonline</a></p>
<p>Guest: Saranya Wyles, M.D. (<a href='https://twitter.com/SWylesMDPhD'>@SWylesMDPhD</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Much of regenerative medicine is relatively new and some of the future treatment capabilities have the potential to significantly change the way we practice medicine. How do you educate established clinicians as well as clinicians in training regarding this new practice? How do you educate the general public which has been misled by a variety of false claims regarding which medical conditions regenerative medicine can currently effectively treat? This podcast discusses how a relatively new medical field puts together an education program to inform others of its potential. Our guest is Saranya Wyles, M.D., a resident in the Department of Dermatology who has considerable experience in regenerative medicine education.</p>
<p> Specific topics discussed:</p>
<ul><li>Specific groups who need educating regarding the capabilities of regenerative medicine</li>
<li>The importance in training the medical workforce regarding regenerative medicine</li>
<li>What regenerative medicine means for the next generation of healthcare providers</li>
<li>How to incorporate regenerative medicine concepts into an established medical school curriculum</li>
<li>How to educate more advanced learn years such as residents and healthcare providers</li>
<li>Obtaining an advanced degree in the field a regenerative medicine</li>
</ul>
<p>Additional resources:</p>
<ul><li>International Society for Stem Cell Research (ISSCR): <a href='https://www.isscr.org/'>https://www.isscr.org/</a></li>
<li>The ISSCR Patient Handbook on Stem Cell Therapies: <a href='https://www.closerlookatstemcells.org/patient-resources/'>https://www.closerlookatstemcells.org/patient-resources/</a></li>
<li>Regenerative medicine curriculum for next-generation physicians: <a href='https://www.nature.com/articles/s41536-019-0065-8'>https://www.nature.com/articles/s41536-019-0065-8</a></li>
<li>Digital regenerative medicine and surgery pedagogy for virtual learning in the time of COVID-19: <a href='https://www.futuremedicine.com/doi/full/10.2217/rme-2020-0106'>https://www.futuremedicine.com/doi/full/10.2217/rme-2020-0106</a></li>
</ul>
<p>Additional educational opportunities from Mayo Clinic: </p>
<ul><li><a href='https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education'>https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education</a></li>
<li><a href='https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/'>https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nkn7pq/VT3988598_-_Wyles_V2b3z7v.mp3" length="17955295" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: www.ce.mayo.edu/regmedonline
Guest: Saranya Wyles, M.D. (@SWylesMDPhD)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Much of regenerative medicine is relatively new and some of the future treatment capabilities have the potential to significantly change the way we practice medicine. How do you educate established clinicians as well as clinicians in training regarding this new practice? How do you educate the general public which has been misled by a variety of false claims regarding which medical conditions regenerative medicine can currently effectively treat? This podcast discusses how a relatively new medical field puts together an education program to inform others of its potential. Our guest is Saranya Wyles, M.D., a resident in the Department of Dermatology who has considerable experience in regenerative medicine education.
 Specific topics discussed:
Specific groups who need educating regarding the capabilities of regenerative medicine
The importance in training the medical workforce regarding regenerative medicine
What regenerative medicine means for the next generation of healthcare providers
How to incorporate regenerative medicine concepts into an established medical school curriculum
How to educate more advanced learn years such as residents and healthcare providers
Obtaining an advanced degree in the field a regenerative medicine
Additional resources:
International Society for Stem Cell Research (ISSCR): https://www.isscr.org/
The ISSCR Patient Handbook on Stem Cell Therapies: https://www.closerlookatstemcells.org/patient-resources/
Regenerative medicine curriculum for next-generation physicians: https://www.nature.com/articles/s41536-019-0065-8
Digital regenerative medicine and surgery pedagogy for virtual learning in the time of COVID-19: https://www.futuremedicine.com/doi/full/10.2217/rme-2020-0106
Additional educational opportunities from Mayo Clinic: 
https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education
https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1117</itunes:duration>
                <itunes:episode>243</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>COVID-19 Miniseries Episode 72: Mayo Clinic Q&amp;A - Guidelines and Nuances of Wearing a Face Mask</title>
        <itunes:title>COVID-19 Miniseries Episode 72: Mayo Clinic Q&amp;A - Guidelines and Nuances of Wearing a Face Mask</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-72-mayo-clinic-qa-guidelines-and-nuances-of-wearing-a-face-mask/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-72-mayo-clinic-qa-guidelines-and-nuances-of-wearing-a-face-mask/#comments</comments>        <pubDate>Wed, 26 May 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/455d1ccb-c6d6-3def-a146-a00e8c7d72e2</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in May, 2021</p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)   </p>
<p>Recent <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> masking guidelines announced by the Centers for Disease Control and Prevention, continue to generate a public conversation.</p>
<p>"The decision about masking needs to be nuanced," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>. "Wearing a mask should be based on the risk of infection, the percentage of the population vaccinated, a person's own immune system, and then the role of vaccine variants with the durability of our immune response."</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland discusses masking guidelines in further detail. Also, he offers an update on COVID-19 vaccine research for children, and he shares positive news about the decreasing numbers of COVID-19 cases and deaths.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in May, 2021</p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)   </p>
<p>Recent <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> masking guidelines announced by the Centers for Disease Control and Prevention, continue to generate a public conversation.</p>
<p>"The decision about masking needs to be nuanced," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>. "Wearing a mask should be based on the risk of infection, the percentage of the population vaccinated, a person's own immune system, and then the role of vaccine variants with the durability of our immune response."</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland discusses masking guidelines in further detail. Also, he offers an update on COVID-19 vaccine research for children, and he shares positive news about the decreasing numbers of COVID-19 cases and deaths.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/chqvss/Mayo_Clinic_Q_A_-_Dr_Gregory_Poland_-_05_19_217l92v.mp3" length="34388781" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in May, 2021
To claim credit visit: https://ce.mayo.edu/covid19podcast 
Guest:  Gregory A. Poland, M.D. (@drgregpoland) 
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)   
Recent COVID-19 masking guidelines announced by the Centers for Disease Control and Prevention, continue to generate a public conversation.
"The decision about masking needs to be nuanced," says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group. "Wearing a mask should be based on the risk of infection, the percentage of the population vaccinated, a person's own immune system, and then the role of vaccine variants with the durability of our immune response."
In this Mayo Clinic Q&A podcast, Dr. Poland discusses masking guidelines in further detail. Also, he offers an update on COVID-19 vaccine research for children, and he shares positive news about the decreasing numbers of COVID-19 cases and deaths.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2142</itunes:duration>
                <itunes:episode>242</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>The M.I.A.M.I. Approach to Deciphering Lymphadenopathy</title>
        <itunes:title>The M.I.A.M.I. Approach to Deciphering Lymphadenopathy</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/the-miami-approach-to-deciphering-lymphadenopathy/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/the-miami-approach-to-deciphering-lymphadenopathy/#comments</comments>        <pubDate>Tue, 25 May 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/91c5eaec-25f6-3990-b5a3-011d5245f3d8</guid>
                                    <description><![CDATA[<p>Guest: Carrie A. Thompson, M.D. (<a href='https://twitter.com/CaThompsonMD'>@CaThompsonMD</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>It’s common for a patient to see their primary care provider after they’ve discovered an enlarged lymph node and they’re usually concerned that it represents a serious illness. Fortunately, in most cases it’s due to a benign cause and most patients can be reassured once we perform a careful history and physical examination. However, on occasion lymphadenopathy can represent serious disease. Carrie Thompson, M.D. a hematologist, at Mayo Clinic’s Rochester campus joins us to discuss how to tell when lymphadenopathy is due to a benign or serious cause. We’ll review the characteristics of both benign and malignant lymph nodes and the evaluation which should be done both for an enlarged solitary lymph node as well as generalized lymphadenopathy.</p>
<p>Specific topics discussed:</p>
<ul><li>Prevalence of malignancy in patients who seek a medical evaluation for lymphadenopathy</li>
<li>Categories of disease which can have associated lymphadenopathy</li>
<li>Characteristics of benign and malignant lymph nodes</li>
<li>Diagnostic approach for a solitary enlarged lymph node</li>
<li>Diagnostic approach or multiple or generalized lymphadenopathy</li>
<li>Fine needle aspirate vs. excisional biopsy for evaluation of lymphadenopathy</li>
</ul>
<p>Additional resources:</p>
<ul><li>Gaddey, HL. Riegel, AM. Unexplained lymphadenopathy: evaluation and differential diagnosis. Am Fam Physician.2016 December 1; 94(11): 896-903. <a href='https://www.aafp.org/afp/2016/1201/p896.html'>https://www.aafp.org/afp/2016/1201/p896.html</a> </li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Carrie A. Thompson, M.D. (<a href='https://twitter.com/CaThompsonMD'>@CaThompsonMD</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>It’s common for a patient to see their primary care provider after they’ve discovered an enlarged lymph node and they’re usually concerned that it represents a serious illness. Fortunately, in most cases it’s due to a benign cause and most patients can be reassured once we perform a careful history and physical examination. However, on occasion lymphadenopathy can represent serious disease. Carrie Thompson, M.D. a hematologist, at Mayo Clinic’s Rochester campus joins us to discuss how to tell when lymphadenopathy is due to a benign or serious cause. We’ll review the characteristics of both benign and malignant lymph nodes and the evaluation which should be done both for an enlarged solitary lymph node as well as generalized lymphadenopathy.</p>
<p>Specific topics discussed:</p>
<ul><li>Prevalence of malignancy in patients who seek a medical evaluation for lymphadenopathy</li>
<li>Categories of disease which can have associated lymphadenopathy</li>
<li>Characteristics of benign and malignant lymph nodes</li>
<li>Diagnostic approach for a solitary enlarged lymph node</li>
<li>Diagnostic approach or multiple or generalized lymphadenopathy</li>
<li>Fine needle aspirate vs. excisional biopsy for evaluation of lymphadenopathy</li>
</ul>
<p>Additional resources:</p>
<ul><li>Gaddey, HL. Riegel, AM. Unexplained lymphadenopathy: evaluation and differential diagnosis. <em>Am Fam Physician.</em>2016 December 1; 94(11): 896-903. <a href='https://www.aafp.org/afp/2016/1201/p896.html'>https://www.aafp.org/afp/2016/1201/p896.html</a> </li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ckvhar/WF64628_-_Lymphadenopathy9yupb.mp3" length="20803586" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Carrie A. Thompson, M.D. (@CaThompsonMD)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
It’s common for a patient to see their primary care provider after they’ve discovered an enlarged lymph node and they’re usually concerned that it represents a serious illness. Fortunately, in most cases it’s due to a benign cause and most patients can be reassured once we perform a careful history and physical examination. However, on occasion lymphadenopathy can represent serious disease. Carrie Thompson, M.D. a hematologist, at Mayo Clinic’s Rochester campus joins us to discuss how to tell when lymphadenopathy is due to a benign or serious cause. We’ll review the characteristics of both benign and malignant lymph nodes and the evaluation which should be done both for an enlarged solitary lymph node as well as generalized lymphadenopathy.
Specific topics discussed:
Prevalence of malignancy in patients who seek a medical evaluation for lymphadenopathy
Categories of disease which can have associated lymphadenopathy
Characteristics of benign and malignant lymph nodes
Diagnostic approach for a solitary enlarged lymph node
Diagnostic approach or multiple or generalized lymphadenopathy
Fine needle aspirate vs. excisional biopsy for evaluation of lymphadenopathy
Additional resources:
Gaddey, HL. Riegel, AM. Unexplained lymphadenopathy: evaluation and differential diagnosis. Am Fam Physician.2016 December 1; 94(11): 896-903. https://www.aafp.org/afp/2016/1201/p896.html 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1295</itunes:duration>
                <itunes:episode>241</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Regenerative Medicine Edition Ep.4: The Curative Potential of Immunotherapy</title>
        <itunes:title>Regenerative Medicine Edition Ep.4: The Curative Potential of Immunotherapy</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/regenerative-medicine-series-ep4-the-curative-potential-of-immunotherapy/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/regenerative-medicine-series-ep4-the-curative-potential-of-immunotherapy/#comments</comments>        <pubDate>Thu, 20 May 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/69e08716-1319-37de-a90f-990229baaf02</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='http://www.ce.mayo.edu/regmedonline'>www.ce.mayo.edu/regmedonline</a></p>
<p>Guest: Saad J. Kenderian, M.B., Ch.B. (<a href='https://twitter.com/kenderian_ss'>@kenderian_ss</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Regenerative immunotherapy is a treatment that uses the power of our own immune system to fight malignancy. It can include targeted antibodies, cancer vaccines, or tumor infecting viruses to name a few. Some immunotherapy treatments use genetic engineering to enhance our immune cell’s cancer fighting properties and can be used in combination with more traditional treatments including surgery, chemotherapy, or radiation. It’s FDA-approved as a first line treatment of multiple cancers and may also be effective in the management of malignancies that have been resistant to more traditional therapy. This podcast will address regenerative immunotherapy with Dr. Saad Kenderian, a hematologist at the Mayo Clinic. We’ll review the relationship between cancer and our immune system, how we can use our immune system to treat malignancy and which malignancies which have shown the best responses to regenerative immunotherapy.</p>
<p> Specific topics discussed:</p>
<ul><li>Relationship between cancer and our immune system</li>
<li>How we can use our body’s immune system to fight malignancy</li>
<li>Malignancies which can be currently be effectively treated with regenerative immunotherapy</li>
<li>Malignancies which have had the best responses to regenerative immunotherapy</li>
<li>Limitations in regenerative immunotherapy</li>
</ul>
<p> Additional educational opportunities from Mayo Clinic: </p>
<ul><li><a href='https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education'>https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education</a></li>
<li><a href='https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/'>https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='http://www.ce.mayo.edu/regmedonline'>www.ce.mayo.edu/regmedonline</a></p>
<p>Guest: Saad J. Kenderian, M.B., Ch.B. (<a href='https://twitter.com/kenderian_ss'>@kenderian_ss</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Regenerative immunotherapy is a treatment that uses the power of our own immune system to fight malignancy. It can include targeted antibodies, cancer vaccines, or tumor infecting viruses to name a few. Some immunotherapy treatments use genetic engineering to enhance our immune cell’s cancer fighting properties and can be used in combination with more traditional treatments including surgery, chemotherapy, or radiation. It’s FDA-approved as a first line treatment of multiple cancers and may also be effective in the management of malignancies that have been resistant to more traditional therapy. This podcast will address regenerative immunotherapy with Dr. Saad Kenderian, a hematologist at the Mayo Clinic. We’ll review the relationship between cancer and our immune system, how we can use our immune system to treat malignancy and which malignancies which have shown the best responses to regenerative immunotherapy.</p>
<p> Specific topics discussed:</p>
<ul><li>Relationship between cancer and our immune system</li>
<li>How we can use our body’s immune system to fight malignancy</li>
<li>Malignancies which can be currently be effectively treated with regenerative immunotherapy</li>
<li>Malignancies which have had the best responses to regenerative immunotherapy</li>
<li>Limitations in regenerative immunotherapy</li>
</ul>
<p> Additional educational opportunities from Mayo Clinic: </p>
<ul><li><a href='https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education'>https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education</a></li>
<li><a href='https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/'>https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jqjdwb/VT3988592_-_Kenderian8cj7w.mp3" length="21886743" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: www.ce.mayo.edu/regmedonline
Guest: Saad J. Kenderian, M.B., Ch.B. (@kenderian_ss)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Regenerative immunotherapy is a treatment that uses the power of our own immune system to fight malignancy. It can include targeted antibodies, cancer vaccines, or tumor infecting viruses to name a few. Some immunotherapy treatments use genetic engineering to enhance our immune cell’s cancer fighting properties and can be used in combination with more traditional treatments including surgery, chemotherapy, or radiation. It’s FDA-approved as a first line treatment of multiple cancers and may also be effective in the management of malignancies that have been resistant to more traditional therapy. This podcast will address regenerative immunotherapy with Dr. Saad Kenderian, a hematologist at the Mayo Clinic. We’ll review the relationship between cancer and our immune system, how we can use our immune system to treat malignancy and which malignancies which have shown the best responses to regenerative immunotherapy.
 Specific topics discussed:
Relationship between cancer and our immune system
How we can use our body’s immune system to fight malignancy
Malignancies which can be currently be effectively treated with regenerative immunotherapy
Malignancies which have had the best responses to regenerative immunotherapy
Limitations in regenerative immunotherapy
 Additional educational opportunities from Mayo Clinic: 
https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education
https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
 ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1364</itunes:duration>
                <itunes:episode>240</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Identifying Breast Cancer in Men</title>
        <itunes:title>Identifying Breast Cancer in Men</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/identifying-breast-cancer-in-men/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/identifying-breast-cancer-in-men/#comments</comments>        <pubDate>Tue, 18 May 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/887371e3-4b9f-3994-a73e-bcc82d09e068</guid>
                                    <description><![CDATA[<p>Guest: Kathryn J. Ruddy, M.D. (<a href='https://twitter.com/KathrynRuddyMD'>@KathrynRuddyMD</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Breast cancer in men is very uncommon, about 1/100th as common as in women. It’s expected that this year, just under 3000 men are likely to be diagnosed with it, and just over 500 men will die from breast cancer. Because it’s so uncommon, there are very few good studies which have been completed to educate us about this disease. Kathryn Ruddy, M.D., an oncologist at Mayo Clinic’s Rochester campus joins us to discuss breast cancer in men and what we should do as primary care clinicians to care for our male patients who may be at increased risk to develop it. We’ll cover how breast cancer in males differs from that in females, its risk factors, how it’s diagnosed, and the survival rates of men with a diagnosis of breast cancer.</p>
<p>Specific topics:</p>
<ul><li>Prevalence of breast cancer</li>
<li>How most breast cancers in men are found</li>
<li>The recommended evaluation of a male patient with suspected breast cancer</li>
<li>Risk factors for breast cancer in men</li>
<li>Treatment for male breast cancer</li>
<li>Survival rates for breast cancer in men</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Kathryn J. Ruddy, M.D. (<a href='https://twitter.com/KathrynRuddyMD'>@KathrynRuddyMD</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Breast cancer in men is very uncommon, about 1/100th as common as in women. It’s expected that this year, just under 3000 men are likely to be diagnosed with it, and just over 500 men will die from breast cancer. Because it’s so uncommon, there are very few good studies which have been completed to educate us about this disease. Kathryn Ruddy, M.D., an oncologist at Mayo Clinic’s Rochester campus joins us to discuss breast cancer in men and what we should do as primary care clinicians to care for our male patients who may be at increased risk to develop it. We’ll cover how breast cancer in males differs from that in females, its risk factors, how it’s diagnosed, and the survival rates of men with a diagnosis of breast cancer.</p>
<p>Specific topics:</p>
<ul><li>Prevalence of breast cancer</li>
<li>How most breast cancers in men are found</li>
<li>The recommended evaluation of a male patient with suspected breast cancer</li>
<li>Risk factors for breast cancer in men</li>
<li>Treatment for male breast cancer</li>
<li>Survival rates for breast cancer in men</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/68jdpa/WF64627_-_Male_Breast_Cancer6xn1q.mp3" length="15023604" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Kathryn J. Ruddy, M.D. (@KathrynRuddyMD)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Breast cancer in men is very uncommon, about 1/100th as common as in women. It’s expected that this year, just under 3000 men are likely to be diagnosed with it, and just over 500 men will die from breast cancer. Because it’s so uncommon, there are very few good studies which have been completed to educate us about this disease. Kathryn Ruddy, M.D., an oncologist at Mayo Clinic’s Rochester campus joins us to discuss breast cancer in men and what we should do as primary care clinicians to care for our male patients who may be at increased risk to develop it. We’ll cover how breast cancer in males differs from that in females, its risk factors, how it’s diagnosed, and the survival rates of men with a diagnosis of breast cancer.
Specific topics:
Prevalence of breast cancer
How most breast cancers in men are found
The recommended evaluation of a male patient with suspected breast cancer
Risk factors for breast cancer in men
Treatment for male breast cancer
Survival rates for breast cancer in men
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>935</itunes:duration>
                <itunes:episode>239</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Regenerative Medicine Edition Ep.3: Perspectives in Reconstructive Surgery</title>
        <itunes:title>Regenerative Medicine Edition Ep.3: Perspectives in Reconstructive Surgery</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/regenerative-medicine-series-ep3-perspectives-in-reconstructive-surgery/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/regenerative-medicine-series-ep3-perspectives-in-reconstructive-surgery/#comments</comments>        <pubDate>Thu, 13 May 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/1de4be04-b675-3715-9fb3-614ac42311a1</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='http://www.ce.mayo.edu/regmedonline'>www.ce.mayo.edu/regmedonline</a></p>
<p>Guest: Richard E. Hayden, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Currently reconstructive surgery involves taking the patient’s tissue from one area of their body and using it elsewhere to rebuild diseased or damaged tissue. Regenerative reconstructive surgery will allow the patient to grow their own replacement tissue from stem cells. This has incredible potential for allowing significantly better reconstructive surgical results. Currently regenerative reconstructive surgery is in its infancy, however in the next several years this should develop into a new standard of care for patients who need reconstructive surgery. This podcast features Dr. Richard Hayden, a reconstructive surgeon/otolaryngologist. We discuss the future of reconstructive surgery using regenerative medicine techniques, the difficulties in enabling patient access to regenerative therapies, the education that’s needed for not only providers but also for patients, and the future of regenerative reconstructive surgery.</p>
<p>Specific topics discussed:</p>
<ul><li>Role regenerative medicine plays and reconstructive surgery</li>
<li>Importance in adopting and delivering regenerative care</li>
<li>Challenges in current standard of care approaches in reconstructive surgery</li>
<li>Difficulties enabling patient access to regenerative therapies</li>
<li>Educational needs in regenerative reconstructive surgery</li>
<li>The future of regenerative reconstructive surgery</li>
</ul>
<p>Additional educational opportunities from Mayo Clinic: </p>
<ul><li><a href='https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education'>https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education</a></li>
<li><a href='https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/'>https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='http://www.ce.mayo.edu/regmedonline'>www.ce.mayo.edu/regmedonline</a></p>
<p>Guest: Richard E. Hayden, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Currently reconstructive surgery involves taking the patient’s tissue from one area of their body and using it elsewhere to rebuild diseased or damaged tissue. Regenerative reconstructive surgery will allow the patient to grow their own replacement tissue from stem cells. This has incredible potential for allowing significantly better reconstructive surgical results. Currently regenerative reconstructive surgery is in its infancy, however in the next several years this should develop into a new standard of care for patients who need reconstructive surgery. This podcast features Dr. Richard Hayden, a reconstructive surgeon/otolaryngologist. We discuss the future of reconstructive surgery using regenerative medicine techniques, the difficulties in enabling patient access to regenerative therapies, the education that’s needed for not only providers but also for patients, and the future of regenerative reconstructive surgery.</p>
<p>Specific topics discussed:</p>
<ul><li>Role regenerative medicine plays and reconstructive surgery</li>
<li>Importance in adopting and delivering regenerative care</li>
<li>Challenges in current standard of care approaches in reconstructive surgery</li>
<li>Difficulties enabling patient access to regenerative therapies</li>
<li>Educational needs in regenerative reconstructive surgery</li>
<li>The future of regenerative reconstructive surgery</li>
</ul>
<p>Additional educational opportunities from Mayo Clinic: </p>
<ul><li><a href='https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education'>https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education</a></li>
<li><a href='https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/'>https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qrmh6j/VT3988593_-_Haydenbrg5n.mp3" length="23312422" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: www.ce.mayo.edu/regmedonline
Guest: Richard E. Hayden, M.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Currently reconstructive surgery involves taking the patient’s tissue from one area of their body and using it elsewhere to rebuild diseased or damaged tissue. Regenerative reconstructive surgery will allow the patient to grow their own replacement tissue from stem cells. This has incredible potential for allowing significantly better reconstructive surgical results. Currently regenerative reconstructive surgery is in its infancy, however in the next several years this should develop into a new standard of care for patients who need reconstructive surgery. This podcast features Dr. Richard Hayden, a reconstructive surgeon/otolaryngologist. We discuss the future of reconstructive surgery using regenerative medicine techniques, the difficulties in enabling patient access to regenerative therapies, the education that’s needed for not only providers but also for patients, and the future of regenerative reconstructive surgery.
Specific topics discussed:
Role regenerative medicine plays and reconstructive surgery
Importance in adopting and delivering regenerative care
Challenges in current standard of care approaches in reconstructive surgery
Difficulties enabling patient access to regenerative therapies
Educational needs in regenerative reconstructive surgery
The future of regenerative reconstructive surgery
Additional educational opportunities from Mayo Clinic: 
https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education
https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1451</itunes:duration>
                <itunes:episode>238</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>What You Need to Know About Eustachian Tubes and Tonsils</title>
        <itunes:title>What You Need to Know About Eustachian Tubes and Tonsils</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/what-you-need-to-know-about-eustachian-tubes-and-tonsils/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/what-you-need-to-know-about-eustachian-tubes-and-tonsils/#comments</comments>        <pubDate>Tue, 11 May 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/9fc1de0b-2f0f-350c-a3ec-79e39ea3b272</guid>
                                    <description><![CDATA[<p>Guest: Laura J. Orvidas, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Tonsils and eustachian tubes often get taken for granted until they cause problems. Eustachian tube dysfunction is quite common and usually resolves on its own, however some patients will develop recurrent eustachian tube dysfunction and it can result in recurrent episodes of otitis media, especially in children. Although recurrent tonsillitis used to be the most common indication for tonsillectomy, more children are having this procedure for disordered breathing conditions, such as obstructive sleep apnea. In this episode, we’ll discuss disorders of the eustachian tube and tonsils with Laura J. Orvidas, M.D., an otolaryngologist at the Mayo Clinic.</p>
<p>Specific topics discussed:</p>
<ul><li>Purpose of the eustachian tube</li>
<li>Definition of eustachian tube dysfunction</li>
<li>Physical exam findings of eustachian tube dysfunction</li>
<li>Recurrent eustachian tube dysfunction in children and potential for recurrent episodes of otitis media</li>
<li>When pressure equalization tubes are indicated</li>
<li>Relationship between pharyngitis and tonsillitis</li>
<li>Viral versus bacterial causes of tonsillitis</li>
<li>How to suspect a peritonsillar abscess</li>
<li>Indications for tonsillectomy</li>
<li>Management of tonsil stones</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Laura J. Orvidas, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Tonsils and eustachian tubes often get taken for granted until they cause problems. Eustachian tube dysfunction is quite common and usually resolves on its own, however some patients will develop recurrent eustachian tube dysfunction and it can result in recurrent episodes of otitis media, especially in children. Although recurrent tonsillitis used to be the most common indication for tonsillectomy, more children are having this procedure for disordered breathing conditions, such as obstructive sleep apnea. In this episode, we’ll discuss disorders of the eustachian tube and tonsils with Laura J. Orvidas, M.D., an otolaryngologist at the Mayo Clinic.</p>
<p>Specific topics discussed:</p>
<ul><li>Purpose of the eustachian tube</li>
<li>Definition of eustachian tube dysfunction</li>
<li>Physical exam findings of eustachian tube dysfunction</li>
<li>Recurrent eustachian tube dysfunction in children and potential for recurrent episodes of otitis media</li>
<li>When pressure equalization tubes are indicated</li>
<li>Relationship between pharyngitis and tonsillitis</li>
<li>Viral versus bacterial causes of tonsillitis</li>
<li>How to suspect a peritonsillar abscess</li>
<li>Indications for tonsillectomy</li>
<li>Management of tonsil stones</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ubzyyu/WF64626_-_Tosils_and_Ears_-_Orvidas8v1j3.mp3" length="15399040" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Laura J. Orvidas, M.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Tonsils and eustachian tubes often get taken for granted until they cause problems. Eustachian tube dysfunction is quite common and usually resolves on its own, however some patients will develop recurrent eustachian tube dysfunction and it can result in recurrent episodes of otitis media, especially in children. Although recurrent tonsillitis used to be the most common indication for tonsillectomy, more children are having this procedure for disordered breathing conditions, such as obstructive sleep apnea. In this episode, we’ll discuss disorders of the eustachian tube and tonsils with Laura J. Orvidas, M.D., an otolaryngologist at the Mayo Clinic.
Specific topics discussed:
Purpose of the eustachian tube
Definition of eustachian tube dysfunction
Physical exam findings of eustachian tube dysfunction
Recurrent eustachian tube dysfunction in children and potential for recurrent episodes of otitis media
When pressure equalization tubes are indicated
Relationship between pharyngitis and tonsillitis
Viral versus bacterial causes of tonsillitis
How to suspect a peritonsillar abscess
Indications for tonsillectomy
Management of tonsil stones
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>959</itunes:duration>
                <itunes:episode>237</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>COVID-19 Miniseries Episode 71: Mayo Clinic Q&amp;A - Ramping up COVID-19 Vaccination Rate in Race Against Virus</title>
        <itunes:title>COVID-19 Miniseries Episode 71: Mayo Clinic Q&amp;A - Ramping up COVID-19 Vaccination Rate in Race Against Virus</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-71-mayo-clinic-qa-ramping-up-covid-19-vaccination-rate-in-race-against-virus/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-71-mayo-clinic-qa-ramping-up-covid-19-vaccination-rate-in-race-against-virus/#comments</comments>        <pubDate>Fri, 07 May 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/635015b1-0819-30ab-ab29-e4250f471755</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in May 2021.</p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a></p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: DeeDee Stiepan (<a href='https://twitter.com/deedeestiepan?lang=en'>@deedeestiepan</a>)</p>
<p><a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> cases are falling in the U.S. because 245 million doses of one of the available COVID-19 vaccines have been administered, according to <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>. "But at the same time, there are still people who need more information about the safety and the value of getting a COVID-19 vaccine," says Dr. Poland.</p>
<p>While still hopeful, Dr. Poland says he's concerned herd immunity won't be reached in the U.S. through vaccination. And that will mean more tragic deaths due to COVID-19 infection.</p>
<p>"My guess is, because we're such an interconnected global community until everybody's safe, none of us are safe. And we're going to likely see continued circulation of the virus, and that virus will seek out whoever is not immune," says Dr. Poland.</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland also addresses when we will need COVID-19 vaccine boosters will be needed and the latest on masking guidelines from the Center for Disease Control and Prevention. Plus, he will provide an update on COVID-19 treatments and how to handle those who want to visit a newborn baby.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> </a><a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> </a><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> </a><a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in May 2021.</p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a></p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: DeeDee Stiepan (<a href='https://twitter.com/deedeestiepan?lang=en'>@deedeestiepan</a>)</p>
<p><a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> cases are falling in the U.S. because 245 million doses of one of the available COVID-19 vaccines have been administered, according to <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>. "But at the same time, there are still people who need more information about the safety and the value of getting a COVID-19 vaccine," says Dr. Poland.</p>
<p>While still hopeful, Dr. Poland says he's concerned herd immunity won't be reached in the U.S. through vaccination. And that will mean more tragic deaths due to COVID-19 infection.</p>
<p>"My guess is, because we're such an interconnected global community until everybody's safe, none of us are safe. And we're going to likely see continued circulation of the virus, and that virus will seek out whoever is not immune," says Dr. Poland.</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland also addresses when we will need COVID-19 vaccine boosters will be needed and the latest on masking guidelines from the Center for Disease Control and Prevention. Plus, he will provide an update on COVID-19 treatments and how to handle those who want to visit a newborn baby.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> </a><a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> </a><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> </a><a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kcqshv/Mayo_Clinic_Podcast_-_Dr_Gregory_Poland_-_05_05_21bdb0p.mp3" length="18127277" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in May 2021.
To claim credit visit: https://ce.mayo.edu/covid19podcast
Guest:  Gregory A. Poland, M.D. (@drgregpoland)
Host: DeeDee Stiepan (@deedeestiepan)
COVID-19 cases are falling in the U.S. because 245 million doses of one of the available COVID-19 vaccines have been administered, according to Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group. "But at the same time, there are still people who need more information about the safety and the value of getting a COVID-19 vaccine," says Dr. Poland.
While still hopeful, Dr. Poland says he's concerned herd immunity won't be reached in the U.S. through vaccination. And that will mean more tragic deaths due to COVID-19 infection.
"My guess is, because we're such an interconnected global community until everybody's safe, none of us are safe. And we're going to likely see continued circulation of the virus, and that virus will seek out whoever is not immune," says Dr. Poland.
In this Mayo Clinic Q&A podcast, Dr. Poland also addresses when we will need COVID-19 vaccine boosters will be needed and the latest on masking guidelines from the Center for Disease Control and Prevention. Plus, he will provide an update on COVID-19 treatments and how to handle those who want to visit a newborn baby.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1128</itunes:duration>
                <itunes:episode>236</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>Regenerative Medicine Edition Ep.2: Between Hype and Hope – What’s Really Possible?</title>
        <itunes:title>Regenerative Medicine Edition Ep.2: Between Hype and Hope – What’s Really Possible?</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/regenerative-medicine-series-ep2-between-hype-and-hope-%e2%80%93-what-s-really-possible/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/regenerative-medicine-series-ep2-between-hype-and-hope-%e2%80%93-what-s-really-possible/#comments</comments>        <pubDate>Thu, 06 May 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/27e83291-86fb-36c1-be5b-4e3574cd9760</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='http://www.ce.mayo.edu/regmedonline'>www.ce.mayo.edu/regmedonline</a></p>
<p>Guest: Dennis Wigle, M.D., Ph.D. (<a href='https://twitter.com/DrWigle'>@DrWigle</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Regenerative Medicine has some amazing capabilities and in the near future, it’s likely to significantly change how we practice medicine. It faces some challenges in educating both the medical community as well as the general public regarding its current realistic capabilities. There are many unsubstantiated claims made by practitioners to the public regarding the benefits of regenerative medicine therapy. We’ll discuss how the true potential of regenerative medicine is conveyed to both clinicians and the public with Dr. Dennis Wigle, a thoracic surgeon and chair of the Division of General Thoracic Surgery at the Mayo Clinic. We’ll discuss some of the common misperceptions of regenerative medicine and how a consultation service can educate both the public and medical community regarding the benefits of regenerative medicine.</p>
<p>Specific topics discussed:</p>
<ul><li>How to provide education to the public and the medical community</li>
<li>When and why the regenerative consultation service was formed</li>
<li>How the regenerative medicine consultation service works</li>
<li>Common misperceptions community regarding the realistic benefits of regenerative medicine</li>
</ul>
<p> Additional resources:</p>
<ul><li>For more information about Mayo Clinic’s Regenerative Medicine Consult Service, visit: <a href='https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/patient-care/regenerative-medicine-consult-service'>https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/patient-care/regenerative-medicine-consult-service</a></li>
</ul>
<p> Additional educational opportunities from Mayo Clinic: </p>
<ul><li><a href='https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education'>https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education</a></li>
<li><a href='https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/'>https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='http://www.ce.mayo.edu/regmedonline'>www.ce.mayo.edu/regmedonline</a></p>
<p>Guest: Dennis Wigle, M.D., Ph.D. (<a href='https://twitter.com/DrWigle'>@DrWigle</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Regenerative Medicine has some amazing capabilities and in the near future, it’s likely to significantly change how we practice medicine. It faces some challenges in educating both the medical community as well as the general public regarding its current realistic capabilities. There are many unsubstantiated claims made by practitioners to the public regarding the benefits of regenerative medicine therapy. We’ll discuss how the true potential of regenerative medicine is conveyed to both clinicians and the public with Dr. Dennis Wigle, a thoracic surgeon and chair of the Division of General Thoracic Surgery at the Mayo Clinic. We’ll discuss some of the common misperceptions of regenerative medicine and how a consultation service can educate both the public and medical community regarding the benefits of regenerative medicine.</p>
<p>Specific topics discussed:</p>
<ul><li>How to provide education to the public and the medical community</li>
<li>When and why the regenerative consultation service was formed</li>
<li>How the regenerative medicine consultation service works</li>
<li>Common misperceptions community regarding the realistic benefits of regenerative medicine</li>
</ul>
<p> Additional resources:</p>
<ul><li>For more information about Mayo Clinic’s Regenerative Medicine Consult Service, visit: <a href='https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/patient-care/regenerative-medicine-consult-service'>https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/patient-care/regenerative-medicine-consult-service</a></li>
</ul>
<p> Additional educational opportunities from Mayo Clinic: </p>
<ul><li><a href='https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education'>https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education</a></li>
<li><a href='https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/'>https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/iws7hp/VT3988596_Wigle6qzno.mp3" length="19943637" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: www.ce.mayo.edu/regmedonline
Guest: Dennis Wigle, M.D., Ph.D. (@DrWigle)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Regenerative Medicine has some amazing capabilities and in the near future, it’s likely to significantly change how we practice medicine. It faces some challenges in educating both the medical community as well as the general public regarding its current realistic capabilities. There are many unsubstantiated claims made by practitioners to the public regarding the benefits of regenerative medicine therapy. We’ll discuss how the true potential of regenerative medicine is conveyed to both clinicians and the public with Dr. Dennis Wigle, a thoracic surgeon and chair of the Division of General Thoracic Surgery at the Mayo Clinic. We’ll discuss some of the common misperceptions of regenerative medicine and how a consultation service can educate both the public and medical community regarding the benefits of regenerative medicine.
Specific topics discussed:
How to provide education to the public and the medical community
When and why the regenerative consultation service was formed
How the regenerative medicine consultation service works
Common misperceptions community regarding the realistic benefits of regenerative medicine
 Additional resources:
For more information about Mayo Clinic’s Regenerative Medicine Consult Service, visit: https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/patient-care/regenerative-medicine-consult-service
 Additional educational opportunities from Mayo Clinic: 
https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education
https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1240</itunes:duration>
                <itunes:episode>235</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Regenerative Medicine Edition Ep.1: Transforming Care Towards Curative Solutions</title>
        <itunes:title>Regenerative Medicine Edition Ep.1: Transforming Care Towards Curative Solutions</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/regenerative-medicine-series-ep1-transforming-care-towards-curative-solutions/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/regenerative-medicine-series-ep1-transforming-care-towards-curative-solutions/#comments</comments>        <pubDate>Tue, 04 May 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/1e3b28f9-c337-3412-b619-e97886922640</guid>
                                    <description><![CDATA[<p>To claim credit for this episode, visit: <a href='http://www.ce.mayo.edu/regmedonline'>www.ce.mayo.edu/regmedonline</a></p>
<p>Guest: Fredric B. Meyer, M.D.; Andre Terzic, M.D., Ph.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Imagine a patient who has suffered a massive myocardial infarction leaving a significant amount of damaged and non-functioning ventricular myocardium. Treatment for this patient’s subsequent congestive failure does not involve diuretics and beta blockers but rather an injection of the patient’s modified stem cells into surrounding viable ventricular myocardium resulting in the regeneration of new, functioning myocardial cells restoring the cardiac output. This is not science fiction but represents ongoing work by investigators in Regenerative Medicine. This week’s podcast will explore this amazing field of medicine which has the potential to change how medicine is practiced. We’ll discuss the origins of regenerative medicine, what currently be done in regenerative medicine as well as the potential for the future. Our guests today are Andre Terzic, M.D., Ph.D., director of the Mayo Clinic Center for Regenerative Medicine and Fredric B. Meyer, M.D., a neurosurgeon and the Executive Dean for Education at the Mayo Clinic.</p>
<p> Specific topics discussed:</p>
<ul><li>When the field of regenerative medicine began</li>
<li>Which current medical conditions can currently be managed with regenerative medicine</li>
<li>How to determine which patients have potential for regenerative medicine therapies</li>
</ul>
<p>Additional educational opportunities from Mayo Clinic: </p>
<ul><li><a href='https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education'>https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education</a></li>
<li><a href='https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/'>https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To claim credit for this episode, visit: <a href='http://www.ce.mayo.edu/regmedonline'>www.ce.mayo.edu/regmedonline</a></p>
<p>Guest: Fredric B. Meyer, M.D.; Andre Terzic, M.D., Ph.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Imagine a patient who has suffered a massive myocardial infarction leaving a significant amount of damaged and non-functioning ventricular myocardium. Treatment for this patient’s subsequent congestive failure does not involve diuretics and beta blockers but rather an injection of the patient’s modified stem cells into surrounding viable ventricular myocardium resulting in the regeneration of new, functioning myocardial cells restoring the cardiac output. This is not science fiction but represents ongoing work by investigators in Regenerative Medicine. This week’s podcast will explore this amazing field of medicine which has the potential to change how medicine is practiced. We’ll discuss the origins of regenerative medicine, what currently be done in regenerative medicine as well as the potential for the future. Our guests today are Andre Terzic, M.D., Ph.D., director of the Mayo Clinic Center for Regenerative Medicine and Fredric B. Meyer, M.D., a neurosurgeon and the Executive Dean for Education at the Mayo Clinic.</p>
<p> Specific topics discussed:</p>
<ul><li>When the field of regenerative medicine began</li>
<li>Which current medical conditions can currently be managed with regenerative medicine</li>
<li>How to determine which patients have potential for regenerative medicine therapies</li>
</ul>
<p>Additional educational opportunities from Mayo Clinic: </p>
<ul><li><a href='https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education'>https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education</a></li>
<li><a href='https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/'>https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vpiq5b/VT3984339_-_RegenMed_Meyer_Terzicbp6w7.mp3" length="19627406" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To claim credit for this episode, visit: www.ce.mayo.edu/regmedonline
Guest: Fredric B. Meyer, M.D.; Andre Terzic, M.D., Ph.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Imagine a patient who has suffered a massive myocardial infarction leaving a significant amount of damaged and non-functioning ventricular myocardium. Treatment for this patient’s subsequent congestive failure does not involve diuretics and beta blockers but rather an injection of the patient’s modified stem cells into surrounding viable ventricular myocardium resulting in the regeneration of new, functioning myocardial cells restoring the cardiac output. This is not science fiction but represents ongoing work by investigators in Regenerative Medicine. This week’s podcast will explore this amazing field of medicine which has the potential to change how medicine is practiced. We’ll discuss the origins of regenerative medicine, what currently be done in regenerative medicine as well as the potential for the future. Our guests today are Andre Terzic, M.D., Ph.D., director of the Mayo Clinic Center for Regenerative Medicine and Fredric B. Meyer, M.D., a neurosurgeon and the Executive Dean for Education at the Mayo Clinic.
 Specific topics discussed:
When the field of regenerative medicine began
Which current medical conditions can currently be managed with regenerative medicine
How to determine which patients have potential for regenerative medicine therapies
Additional educational opportunities from Mayo Clinic: 
https://www.mayo.edu/research/centers-programs/center-regenerative-medicine/education
https://college.mayo.edu/academics/biomedical-research-training/phd-program/tracks/regenerative-sciences/
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1223</itunes:duration>
                <itunes:episode>234</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: COVID-19 Vaccine Confidence and the Importance of That Second Dose</title>
        <itunes:title>Mayo Clinic Q&amp;A: COVID-19 Vaccine Confidence and the Importance of That Second Dose</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-covid-19-vaccine-confidence-and-the-importance-of-that-second-dose/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-covid-19-vaccine-confidence-and-the-importance-of-that-second-dose/#comments</comments>        <pubDate>Thu, 29 Apr 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/a76c36e9-43cc-3070-b880-b65c1272c7ce</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in April, 2021</p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>) </p>
<p>While the number of people being vaccinated for <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> is dropping, the <a href='https://www.cdc.gov/coronavirus/2019-ncov/vaccines/second-shot.html'>Centers for Disease Control and Prevention</a> and other medical experts continue to strongly encourage people to get vaccinated for COVID-19. And that means that those who are being vaccinated with the Moderna and Pfizer COVID-19 vaccine should get their first and second doses on schedule.</p>
<p>“About 8% of people who got their first dose have not returned for the second dose and this is concerning when you're getting close to 1 in 10," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>. "When you measure in the short term, one dose in a healthy person offers about 80% protection. But that's not 95% protection, like you get after two doses."</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland expands on why people need that second COVID-19 vaccine dose and he talks about whether people should mix and match the different COVID-19 vaccines for their second dose. He also speaks about the status of COVID-19 vaccines for young people, and he addresses listener questions about traveling, being together after vaccination, and the latest rise of additional COVID-19 variants.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in April, 2021</p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>) </p>
<p>While the number of people being vaccinated for <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> is dropping, the <a href='https://www.cdc.gov/coronavirus/2019-ncov/vaccines/second-shot.html'>Centers for Disease Control and Prevention</a> and other medical experts continue to strongly encourage people to get vaccinated for COVID-19. And that means that those who are being vaccinated with the Moderna and Pfizer COVID-19 vaccine should get their first and second doses on schedule.</p>
<p>“About 8% of people who got their first dose have not returned for the second dose and this is concerning when you're getting close to 1 in 10," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>. "When you measure in the short term, one dose in a healthy person offers about 80% protection. But that's not 95% protection, like you get after two doses."</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland expands on why people need that second COVID-19 vaccine dose and he talks about whether people should mix and match the different COVID-19 vaccines for their second dose. He also speaks about the status of COVID-19 vaccines for young people, and he addresses listener questions about traveling, being together after vaccination, and the latest rise of additional COVID-19 variants.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/u75dgm/Mayo_Clinic_Podcast_-_Dr_Gregory_Poland_-_04_28_21btt3c.mp3" length="19468159" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in April, 2021
Guest:  Gregory A. Poland, M.D. (@drgregpoland) 
Host: Halena M. Gazelka, M.D. (@hmgazelkamd) 
While the number of people being vaccinated for COVID-19 is dropping, the Centers for Disease Control and Prevention and other medical experts continue to strongly encourage people to get vaccinated for COVID-19. And that means that those who are being vaccinated with the Moderna and Pfizer COVID-19 vaccine should get their first and second doses on schedule.
“About 8% of people who got their first dose have not returned for the second dose and this is concerning when you're getting close to 1 in 10," says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group. "When you measure in the short term, one dose in a healthy person offers about 80% protection. But that's not 95% protection, like you get after two doses."
In this Mayo Clinic Q&A podcast, Dr. Poland expands on why people need that second COVID-19 vaccine dose and he talks about whether people should mix and match the different COVID-19 vaccines for their second dose. He also speaks about the status of COVID-19 vaccines for young people, and he addresses listener questions about traveling, being together after vaccination, and the latest rise of additional COVID-19 variants.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1212</itunes:duration>
                        <itunes:episodeType>bonus</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>Fact or Fiction: Erectile Dysfunction Treatments</title>
        <itunes:title>Fact or Fiction: Erectile Dysfunction Treatments</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/dasdq/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/dasdq/#comments</comments>        <pubDate>Tue, 27 Apr 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/e0e4ae61-a541-314c-bd27-7de74f481c39</guid>
                                    <description><![CDATA[<p>Guest: Tobias S. Kohler, M.D., M.P.H.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Erectile dysfunction not only causes lifestyle changes, but it may also be the first symptom of peripheral vascular disease. Since many men are reluctant to mention erectile dysfunction to their healthcare provider, it’s important for us to ask our patients whether it is a problem and be knowledgeable in the appropriate evaluation of patients who have it. This reluctance may cause many to seek out readily available but ineffective treatments from questionable sources, even though there are a variety of proven, effective treatments that can be prescribed. Tobias S. Kohler, M.D., M.P.H., a Mayo Clinic Urologist, joins us to discuss the impact of erectile dysfunction, the currently available effective treatments, as well as the unproven, ineffective products currently being used.</p>
<p>Specific topics discussed:</p>
<ul><li>The first historical appearance of treatments for erectile dysfunction</li>
<li>Most common causes of dysfunction</li>
<li>Appropriate evaluation of patients who present with erectile dysfunction</li>
<li>Review of the currently available effective treatment options</li>
<li>Reasons men are reluctant to mention the topic of erectile dysfunction to their provider</li>
<li>Review of some ineffective treatments currently being promoted</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Tobias S. Kohler, M.D., M.P.H.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Erectile dysfunction not only causes lifestyle changes, but it may also be the first symptom of peripheral vascular disease. Since many men are reluctant to mention erectile dysfunction to their healthcare provider, it’s important for us to ask our patients whether it is a problem and be knowledgeable in the appropriate evaluation of patients who have it. This reluctance may cause many to seek out readily available but ineffective treatments from questionable sources, even though there are a variety of proven, effective treatments that can be prescribed. Tobias S. Kohler, M.D., M.P.H., a Mayo Clinic Urologist, joins us to discuss the impact of erectile dysfunction, the currently available effective treatments, as well as the unproven, ineffective products currently being used.</p>
<p>Specific topics discussed:</p>
<ul><li>The first historical appearance of treatments for erectile dysfunction</li>
<li>Most common causes of dysfunction</li>
<li>Appropriate evaluation of patients who present with erectile dysfunction</li>
<li>Review of the currently available effective treatment options</li>
<li>Reasons men are reluctant to mention the topic of erectile dysfunction to their provider</li>
<li>Review of some ineffective treatments currently being promoted</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/28ksi7/WF64620_-_ED_Sham_Treatments_-_Kohler5zf5m.mp3" length="21841291" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Tobias S. Kohler, M.D., M.P.H.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Erectile dysfunction not only causes lifestyle changes, but it may also be the first symptom of peripheral vascular disease. Since many men are reluctant to mention erectile dysfunction to their healthcare provider, it’s important for us to ask our patients whether it is a problem and be knowledgeable in the appropriate evaluation of patients who have it. This reluctance may cause many to seek out readily available but ineffective treatments from questionable sources, even though there are a variety of proven, effective treatments that can be prescribed. Tobias S. Kohler, M.D., M.P.H., a Mayo Clinic Urologist, joins us to discuss the impact of erectile dysfunction, the currently available effective treatments, as well as the unproven, ineffective products currently being used.
Specific topics discussed:
The first historical appearance of treatments for erectile dysfunction
Most common causes of dysfunction
Appropriate evaluation of patients who present with erectile dysfunction
Review of the currently available effective treatment options
Reasons men are reluctant to mention the topic of erectile dysfunction to their provider
Review of some ineffective treatments currently being promoted
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1359</itunes:duration>
                <itunes:episode>233</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>COVID-19 Miniseries Episode 70: Mayo Clinic Q&amp;A - Breakthrough COVID-19 Infections and Booster Vaccines</title>
        <itunes:title>COVID-19 Miniseries Episode 70: Mayo Clinic Q&amp;A - Breakthrough COVID-19 Infections and Booster Vaccines</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-70-mayo-clinic-qa-breakthrough-covid-19-infections-and-booster-vaccines/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-70-mayo-clinic-qa-breakthrough-covid-19-infections-and-booster-vaccines/#comments</comments>        <pubDate>Thu, 22 Apr 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/682d1570-7623-35fd-9829-e9a4554bc211</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded on April 19, 2021.</p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a></p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>) </p>
<p><a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a> says <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a>mutations and the virus spread are happening because of people who don't wear masks, who don't get vaccinated and who don't adhere to safety recommendations.</p>
<p>"I believe that we should be radically transparent and honest," says Dr. Poland. "The more time this virus passes through one person after another, the more likely it continues to mutate. As a result of those mutations, two things are happening. Some of the mutations are making vaccines and plasma monoclonal antibodies less effective. The other thing is that the virus will likely become something that we have to live with for the rest of our lives."</p>
<p>Dr. Poland reminds people that vaccine protection is not 100%. Breakthrough infections can occur.</p>
<p>"Remember that in the clinical trials, 95% means that compared to unvaccinated people, your risk is reduced by 95% — not 100%," he says. "You might have a mild case of COVID-19,but you can still spread it to others, including those who are immune compromised, such as cancer patients. That's why we continue to wear masks until we get very widespread immunization."</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland talks more about breakthrough infections and the Johnson & Johnson COVID-19 vaccine pause, and he answers listeners' questions.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> </a><a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> </a><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> </a><a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded on April 19, 2021.</p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a></p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>) </p>
<p><a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a> says <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a>mutations and the virus spread are happening because of people who don't wear masks, who don't get vaccinated and who don't adhere to safety recommendations.</p>
<p>"I believe that we should be radically transparent and honest," says Dr. Poland. "The more time this virus passes through one person after another, the more likely it continues to mutate. As a result of those mutations, two things are happening. Some of the mutations are making vaccines and plasma monoclonal antibodies less effective. The other thing is that the virus will likely become something that we have to live with for the rest of our lives."</p>
<p>Dr. Poland reminds people that vaccine protection is not 100%. Breakthrough infections can occur.</p>
<p>"Remember that in the clinical trials, 95% means that compared to unvaccinated people, your risk is reduced by 95% — not 100%," he says. "You might have a mild case of COVID-19,but you can still spread it to others, including those who are immune compromised, such as cancer patients. That's why we continue to wear masks until we get very widespread immunization."</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland talks more about breakthrough infections and the Johnson & Johnson COVID-19 vaccine pause, and he answers listeners' questions.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> </a><a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> </a><a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> </a><a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/yjvumd/Mayo_Clinic_Podcast_-_Dr_Gregory_Poland_-_04_21_216eg3c.mp3" length="23754007" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded on April 19, 2021.
To claim credit visit: https://ce.mayo.edu/covid19podcast
Guest:  Gregory A. Poland, M.D. (@drgregpoland)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd) 
Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group says COVID-19mutations and the virus spread are happening because of people who don't wear masks, who don't get vaccinated and who don't adhere to safety recommendations.
"I believe that we should be radically transparent and honest," says Dr. Poland. "The more time this virus passes through one person after another, the more likely it continues to mutate. As a result of those mutations, two things are happening. Some of the mutations are making vaccines and plasma monoclonal antibodies less effective. The other thing is that the virus will likely become something that we have to live with for the rest of our lives."
Dr. Poland reminds people that vaccine protection is not 100%. Breakthrough infections can occur.
"Remember that in the clinical trials, 95% means that compared to unvaccinated people, your risk is reduced by 95% — not 100%," he says. "You might have a mild case of COVID-19,but you can still spread it to others, including those who are immune compromised, such as cancer patients. That's why we continue to wear masks until we get very widespread immunization."
In this Mayo Clinic Q&A podcast, Dr. Poland talks more about breakthrough infections and the Johnson & Johnson COVID-19 vaccine pause, and he answers listeners' questions.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1479</itunes:duration>
                <itunes:episode>232</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>Mayo Clinic Q&amp;A: On the Verge of Another COVID-19 Surge</title>
        <itunes:title>Mayo Clinic Q&amp;A: On the Verge of Another COVID-19 Surge</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-on-the-verge-of-another-covid-19-surge/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-on-the-verge-of-another-covid-19-surge/#comments</comments>        <pubDate>Wed, 21 Apr 2021 07:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/e6d21abf-a85e-3a3a-88f8-58cb6f9e2117</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in April, 2021</p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)   </p>
<p>As spring break travelers return home and the highly transmissible U.K. <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> variant is discovered in all 50 U.S. states, the country is on the verge of a fourth COVID-19 pandemic surge. That's according to a number of health experts, including <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>.  </p>
<p>However, Dr. Poland says there is some good news related to the transmission of COVID-19 on surfaces. </p>
<p>"Wisdom resides in changing your mind and your recommendations as new data and science becomes available," says Dr. Poland. "What the Centers for Disease Control and Prevention is doing is modifying those guidelines, saying that the risk of touching a contaminated surface and then getting infected is very low."</p>
<p>In this Mayo Clinic Q&A podcast Dr. Poland explains more about the CDC guidelines and he addresses other COVID-19 topics in the news, including recent data that says men are more vaccine-hesitant than women.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in April, 2021</p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)   </p>
<p>As spring break travelers return home and the highly transmissible U.K. <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> variant is discovered in all 50 U.S. states, the country is on the verge of a fourth COVID-19 pandemic surge. That's according to a number of health experts, including <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>.  </p>
<p>However, Dr. Poland says there is some good news related to the transmission of COVID-19 on surfaces. </p>
<p>"Wisdom resides in changing your mind and your recommendations as new data and science becomes available," says Dr. Poland. "What the Centers for Disease Control and Prevention is doing is modifying those guidelines, saying that the risk of touching a contaminated surface and then getting infected is very low."</p>
<p>In this Mayo Clinic Q&A podcast Dr. Poland explains more about the CDC guidelines and he addresses other COVID-19 topics in the news, including recent data that says men are more vaccine-hesitant than women.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ghy8kr/Mayo_Clinic_Podcast_-_Dr_Greg_Poland_-_4_14_2197n9u.mp3" length="25709142" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in April, 2021
To claim credit visit: https://ce.mayo.edu/covid19podcast 
Guest:  Gregory A. Poland, M.D. (@drgregpoland) 
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)   
As spring break travelers return home and the highly transmissible U.K. COVID-19 variant is discovered in all 50 U.S. states, the country is on the verge of a fourth COVID-19 pandemic surge. That's according to a number of health experts, including Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group.  
However, Dr. Poland says there is some good news related to the transmission of COVID-19 on surfaces. 
"Wisdom resides in changing your mind and your recommendations as new data and science becomes available," says Dr. Poland. "What the Centers for Disease Control and Prevention is doing is modifying those guidelines, saying that the risk of touching a contaminated surface and then getting infected is very low."
In this Mayo Clinic Q&A podcast Dr. Poland explains more about the CDC guidelines and he addresses other COVID-19 topics in the news, including recent data that says men are more vaccine-hesitant than women.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1601</itunes:duration>
                        <itunes:episodeType>bonus</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>Utilizing Artificial Intelligence to Evaluate Dizziness</title>
        <itunes:title>Utilizing Artificial Intelligence to Evaluate Dizziness</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/utilizing-artificial-intelligence-to-evaluate-dizziness/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/utilizing-artificial-intelligence-to-evaluate-dizziness/#comments</comments>        <pubDate>Tue, 20 Apr 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/ba465290-4fd1-3785-b40e-83303f94a9d6</guid>
                                    <description><![CDATA[<p>Guest: Devin L. McCaslin, Ph.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Being dizzy means different things to different patients and most patients find dizziness difficult to describe. Providers find it difficult to evaluate patients with dizziness and also which specialties can be asked for help in managing the dizzy patient. Dr. Devin McCaslin is the Director of the Vestibular and Balance Laboratory at the Mayo Clinic and an expert in evaluating the dizzy patient. He will discuss such topics as the role of vestibular balance laboratory testing in assessing patients, the most common findings from these evaluations, the multi-disciplinary approach to evaluating patients with dizziness, and how artificial intelligence is being used in the evaluation of a patient complaining of dizziness.</p>
<p>Specific Topics Discussed:</p>
<ul><li>The multi-disciplinary approach to evaluating patients complaining of dizziness.</li>
<li>Most common findings in the evaluation of a patient with dizziness.</li>
<li>The role of vestibular balance laboratory testing in assessing patients who are candidates for these tests.</li>
<li>How artificial intelligence is being used in the evaluation of patients with dizziness.</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Devin L. McCaslin, Ph.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Being dizzy means different things to different patients and most patients find dizziness difficult to describe. Providers find it difficult to evaluate patients with dizziness and also which specialties can be asked for help in managing the dizzy patient. Dr. Devin McCaslin is the Director of the Vestibular and Balance Laboratory at the Mayo Clinic and an expert in evaluating the dizzy patient. He will discuss such topics as the role of vestibular balance laboratory testing in assessing patients, the most common findings from these evaluations, the multi-disciplinary approach to evaluating patients with dizziness, and how artificial intelligence is being used in the evaluation of a patient complaining of dizziness.</p>
<p>Specific Topics Discussed:</p>
<ul><li>The multi-disciplinary approach to evaluating patients complaining of dizziness.</li>
<li>Most common findings in the evaluation of a patient with dizziness.</li>
<li>The role of vestibular balance laboratory testing in assessing patients who are candidates for these tests.</li>
<li>How artificial intelligence is being used in the evaluation of patients with dizziness.</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qbjdss/VT3981657_-_Vertigo8maho.mp3" length="19135600" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Devin L. McCaslin, Ph.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Being dizzy means different things to different patients and most patients find dizziness difficult to describe. Providers find it difficult to evaluate patients with dizziness and also which specialties can be asked for help in managing the dizzy patient. Dr. Devin McCaslin is the Director of the Vestibular and Balance Laboratory at the Mayo Clinic and an expert in evaluating the dizzy patient. He will discuss such topics as the role of vestibular balance laboratory testing in assessing patients, the most common findings from these evaluations, the multi-disciplinary approach to evaluating patients with dizziness, and how artificial intelligence is being used in the evaluation of a patient complaining of dizziness.
Specific Topics Discussed:
The multi-disciplinary approach to evaluating patients complaining of dizziness.
Most common findings in the evaluation of a patient with dizziness.
The role of vestibular balance laboratory testing in assessing patients who are candidates for these tests.
How artificial intelligence is being used in the evaluation of patients with dizziness.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1192</itunes:duration>
                <itunes:episode>231</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: Vacation Travel, Vaccines for Teens and More COVID-19 News</title>
        <itunes:title>Mayo Clinic Q&amp;A: Vacation Travel, Vaccines for Teens and More COVID-19 News</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-vacation-travel-vaccines-for-teens-and-more-covid-19-news/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-vacation-travel-vaccines-for-teens-and-more-covid-19-news/#comments</comments>        <pubDate>Mon, 19 Apr 2021 10:15:59 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/a6e32639-74b6-35ea-86a2-5d9db1cfbd02</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in April, 2021</p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)  </p>
<p> If you're fully vaccinated for <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> you can travel domestically and where travel is allowed internationally, according to new interim <a href='https://www.cdc.gov/media/releases/2021/p0402-travel-guidance-vaccinated-people.html'>travel guidelines</a> from the <a href='https://www.cdc.gov/'>Centers for Disease Control and Prevention (CDC)</a>. Even with those recommendations the CDC continues to recommend not traveling unless it is essential. Regardless, the CDC strongly recommends people continue to wear a face mask, practice social distancing and sanitize their hands.</p>
<p>Meanwhile, COVID-19 vaccine research is continuing in teenagers. "The early data show equal safety in young people aged 12 to 16," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>. "I think this is going to imply that, somewhere between this fall and Christmas, we're going to be able to offer the (COVID-19) vaccine to every age group."</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland answers a number of listener questions, including how long the COVID-19 vaccines are predicted to last and if the current transmission research still supports wiping down household items. Dr. Poland also explains why someone who has had COVID-19 should still get a COVID-19 vaccine.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in April, 2021</p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)  </p>
<p> If you're fully vaccinated for <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>COVID-19</a> you can travel domestically and where travel is allowed internationally, according to new interim <a href='https://www.cdc.gov/media/releases/2021/p0402-travel-guidance-vaccinated-people.html'>travel guidelines</a> from the <a href='https://www.cdc.gov/'>Centers for Disease Control and Prevention (CDC)</a>. Even with those recommendations the CDC continues to recommend not traveling unless it is essential. Regardless, the CDC strongly recommends people continue to wear a face mask, practice social distancing and sanitize their hands.</p>
<p>Meanwhile, COVID-19 vaccine research is continuing in teenagers. "The early data show equal safety in young people aged 12 to 16," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&invsrc=other&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>. "I think this is going to imply that, somewhere between this fall and Christmas, we're going to be able to offer the (COVID-19) vaccine to every age group."</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland answers a number of listener questions, including how long the COVID-19 vaccines are predicted to last and if the current transmission research still supports wiping down household items. Dr. Poland also explains why someone who has had COVID-19 should still get a COVID-19 vaccine.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8xfj8w/Mayo_Clinic_Podcast_-_Dr_Gregory_Poland_4_7_218g17n.mp3" length="20943723" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in April, 2021
To claim credit visit: https://ce.mayo.edu/covid19podcast 
Guest:  Gregory A. Poland, M.D. (@drgregpoland) 
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)  
 If you're fully vaccinated for COVID-19 you can travel domestically and where travel is allowed internationally, according to new interim travel guidelines from the Centers for Disease Control and Prevention (CDC). Even with those recommendations the CDC continues to recommend not traveling unless it is essential. Regardless, the CDC strongly recommends people continue to wear a face mask, practice social distancing and sanitize their hands.
Meanwhile, COVID-19 vaccine research is continuing in teenagers. "The early data show equal safety in young people aged 12 to 16," says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group. "I think this is going to imply that, somewhere between this fall and Christmas, we're going to be able to offer the (COVID-19) vaccine to every age group."
In this Mayo Clinic Q&A podcast, Dr. Poland answers a number of listener questions, including how long the COVID-19 vaccines are predicted to last and if the current transmission research still supports wiping down household items. Dr. Poland also explains why someone who has had COVID-19 should still get a COVID-19 vaccine.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1304</itunes:duration>
                        <itunes:episodeType>bonus</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>This Podcast Will Make Your Head Spin</title>
        <itunes:title>This Podcast Will Make Your Head Spin</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/this-podcast-will-make-your-head-spin/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/this-podcast-will-make-your-head-spin/#comments</comments>        <pubDate>Tue, 13 Apr 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/90e69347-1fe2-33f3-ad64-123d036a1d12</guid>
                                    <description><![CDATA[<p>Guest: Scott D. Eggers, M.D. (<a href='https://twitter.com/sdze'>@sdze</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>) </p>
<p>The complaint of dizziness is a common symptom our patients experience. It has a variety of causes; fortunately, most of them are benign. Despite the fact we frequently see patients with this medical concern, we still struggle evaluating them. Part of the difficulty is that dizziness means different things to different people and the cause of dizziness can be caused by disorders in one of several organ systems. To help us evaluate dizziness, Dr. Scott Eggers, a neurologist at the Mayo Clinic, reviews why dizziness is so difficult to evaluate and how we should evaluate a patient who complains of dizziness. We also explore the most common causes of dizziness including benign positional vertigo and vestibular neuritis. Finally, Dr. Eggers reviews symptoms that are suspicious for an ominous cause of dizziness.</p>
<p>Specific topics discussed:</p>
<ul><li>Why dizziness is difficult to evaluate</li>
<li>How to evaluate the complaint of dizziness</li>
<li>Most common causes of dizziness</li>
<li>Dizziness symptoms which are ominous for serious disease</li>
<li>Description of benign positional vertigo</li>
<li>Description of vestibular neuritis</li>
<li>Description of vestibular migraines</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Scott D. Eggers, M.D. (<a href='https://twitter.com/sdze'>@sdze</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>) </p>
<p>The complaint of dizziness is a common symptom our patients experience. It has a variety of causes; fortunately, most of them are benign. Despite the fact we frequently see patients with this medical concern, we still struggle evaluating them. Part of the difficulty is that dizziness means different things to different people and the cause of dizziness can be caused by disorders in one of several organ systems. To help us evaluate dizziness, Dr. Scott Eggers, a neurologist at the Mayo Clinic, reviews why dizziness is so difficult to evaluate and how we should evaluate a patient who complains of dizziness. We also explore the most common causes of dizziness including benign positional vertigo and vestibular neuritis. Finally, Dr. Eggers reviews symptoms that are suspicious for an ominous cause of dizziness.</p>
<p>Specific topics discussed:</p>
<ul><li>Why dizziness is difficult to evaluate</li>
<li>How to evaluate the complaint of dizziness</li>
<li>Most common causes of dizziness</li>
<li>Dizziness symptoms which are ominous for serious disease</li>
<li>Description of benign positional vertigo</li>
<li>Description of vestibular neuritis</li>
<li>Description of vestibular migraines</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/tjjxjp/VT3982716_-_Eggers7rcv8.mp3" length="25923925" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Scott D. Eggers, M.D. (@sdze)
Host: Darryl S. Chutka, M.D. (@ChutkaMD) 
The complaint of dizziness is a common symptom our patients experience. It has a variety of causes; fortunately, most of them are benign. Despite the fact we frequently see patients with this medical concern, we still struggle evaluating them. Part of the difficulty is that dizziness means different things to different people and the cause of dizziness can be caused by disorders in one of several organ systems. To help us evaluate dizziness, Dr. Scott Eggers, a neurologist at the Mayo Clinic, reviews why dizziness is so difficult to evaluate and how we should evaluate a patient who complains of dizziness. We also explore the most common causes of dizziness including benign positional vertigo and vestibular neuritis. Finally, Dr. Eggers reviews symptoms that are suspicious for an ominous cause of dizziness.
Specific topics discussed:
Why dizziness is difficult to evaluate
How to evaluate the complaint of dizziness
Most common causes of dizziness
Dizziness symptoms which are ominous for serious disease
Description of benign positional vertigo
Description of vestibular neuritis
Description of vestibular migraines
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1613</itunes:duration>
                <itunes:episode>230</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>COVID-19 Miniseries Episode 69: Post-Acute COVID-19 and Central Sensitization</title>
        <itunes:title>COVID-19 Miniseries Episode 69: Post-Acute COVID-19 and Central Sensitization</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-69-post-acute-covid-19-and-central-sensitization/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-69-post-acute-covid-19-and-central-sensitization/#comments</comments>        <pubDate>Tue, 06 Apr 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/6c3b4437-6037-3bdb-94b4-cf6dd46b529d</guid>
                                    <description><![CDATA[<p>Central sensitization (CS) describes pathophysiologic changes in the central nervous system, including alterations in neurochemistry, CNS receptors, endogenous opioid system hyperactivity, cytokine and HPA axis dysregulation, and sympathetic hyperactivity. Collectively, these changes result in amplification of pain and sensory signals, leading to widespread pain, fatigue and other sensory sensitivities. Fibromyalgia and Chronic Fatigue Syndrome are established diagnoses/manifestations of central sensitization. In the era of the COVID-19 pandemic, we continue to learn about Post-Acute COVID-19 Syndrome, a manifestation of central sensitization similar to other post-infectious forms of CS, which underlies the persistent symptoms that many people experience after initial recovery from COVID-19. Elizabeth C. Wight, M.D. joins us to talk about Mayo Clinic’s treatment approach to central sensitization, which is rooted in empowering patients with education and a framework for a self-management program. This includes stress management, moderation, positive thinking, decreasing focus on symptoms, sleep hygiene, and Cognitive Behavioral Therapy among others.</p>
<p>Additional resources:</p>
<ul><li>Post-COVID Recovery on Mayo Clinic Connect: <a href='https://connect.mayoclinic.org/page/post-covid-recovery/'>https://connect.mayoclinic.org/page/post-covid-recovery/</a></li>
</ul>
<ul><li>Mayo Clinic’s “A Systematic Approach to Medically Unexplained Symptoms 2021” course can be found at <a href='https://ce.mayo.edu/internal-medicine/content/systematic-approach-medically-unexplained-symptoms-2021#group-tabs-node-course-default1'>https://ce.mayo.edu/internal-medicine/content/systematic-approach-medically-unexplained-symptoms-2021#group-tabs-node-course-default1</a></li>
<li>Clauw DJ. Fibromyalgia: A clinical review. JAMA. 2014;311(15):1547-1555. doi:<a href='https://jamanetwork.com/journals/jama/article-abstract/1860480'>1001/jama.2014.3266</a></li>
<li>Clauw DJ. Fibromyalgia and related conditions. Mayo Clin Proc. 2015 May;90(5):680-92. <a href='https://doi.org/10.1016/j.mayocp.2015.03.014'>https://doi.org/10.1016/j.mayocp.2015.03.014</a></li>
<li>Harte, SE, Harris, RE, Clauw, DJ. The neurobiology of central sensitization. J Appl Behav Res. 2018; 23(2): e12137. <a href='https://doi.org/10.1111/jabr.12137'>https://doi.org/10.1111/jabr.12137</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Central sensitization (CS) describes pathophysiologic changes in the central nervous system, including alterations in neurochemistry, CNS receptors, endogenous opioid system hyperactivity, cytokine and HPA axis dysregulation, and sympathetic hyperactivity. Collectively, these changes result in amplification of pain and sensory signals, leading to widespread pain, fatigue and other sensory sensitivities. Fibromyalgia and Chronic Fatigue Syndrome are established diagnoses/manifestations of central sensitization. In the era of the COVID-19 pandemic, we continue to learn about Post-Acute COVID-19 Syndrome, a manifestation of central sensitization similar to other post-infectious forms of CS, which underlies the persistent symptoms that many people experience after initial recovery from COVID-19. Elizabeth C. Wight, M.D. joins us to talk about Mayo Clinic’s treatment approach to central sensitization, which is rooted in empowering patients with education and a framework for a self-management program. This includes stress management, moderation, positive thinking, decreasing focus on symptoms, sleep hygiene, and Cognitive Behavioral Therapy among others.</p>
<p>Additional resources:</p>
<ul><li>Post-COVID Recovery on Mayo Clinic Connect: <a href='https://connect.mayoclinic.org/page/post-covid-recovery/'>https://connect.mayoclinic.org/page/post-covid-recovery/</a></li>
</ul>
<ul><li>Mayo Clinic’s “A Systematic Approach to Medically Unexplained Symptoms 2021” course can be found at <a href='https://ce.mayo.edu/internal-medicine/content/systematic-approach-medically-unexplained-symptoms-2021#group-tabs-node-course-default1'>https://ce.mayo.edu/internal-medicine/content/systematic-approach-medically-unexplained-symptoms-2021#group-tabs-node-course-default1</a></li>
<li>Clauw DJ. Fibromyalgia: A clinical review. <em>JAMA</em>. 2014;311(15):1547-1555. doi:<a href='https://jamanetwork.com/journals/jama/article-abstract/1860480'>1001/jama.2014.3266</a></li>
<li>Clauw DJ. Fibromyalgia and related conditions. Mayo Clin Proc. 2015 May;90(5):680-92. <a href='https://doi.org/10.1016/j.mayocp.2015.03.014'>https://doi.org/10.1016/j.mayocp.2015.03.014</a></li>
<li>Harte, SE, Harris, RE, Clauw, DJ. The neurobiology of central sensitization. <em>J Appl Behav Res</em>. 2018; 23(2): e12137. <a href='https://doi.org/10.1111/jabr.12137'>https://doi.org/10.1111/jabr.12137</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mdrdk7/WF130408_Central_Sensitization85mxf.mp3" length="26042023" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Central sensitization (CS) describes pathophysiologic changes in the central nervous system, including alterations in neurochemistry, CNS receptors, endogenous opioid system hyperactivity, cytokine and HPA axis dysregulation, and sympathetic hyperactivity. Collectively, these changes result in amplification of pain and sensory signals, leading to widespread pain, fatigue and other sensory sensitivities. Fibromyalgia and Chronic Fatigue Syndrome are established diagnoses/manifestations of central sensitization. In the era of the COVID-19 pandemic, we continue to learn about Post-Acute COVID-19 Syndrome, a manifestation of central sensitization similar to other post-infectious forms of CS, which underlies the persistent symptoms that many people experience after initial recovery from COVID-19. Elizabeth C. Wight, M.D. joins us to talk about Mayo Clinic’s treatment approach to central sensitization, which is rooted in empowering patients with education and a framework for a self-management program. This includes stress management, moderation, positive thinking, decreasing focus on symptoms, sleep hygiene, and Cognitive Behavioral Therapy among others.
Additional resources:
Post-COVID Recovery on Mayo Clinic Connect: https://connect.mayoclinic.org/page/post-covid-recovery/
Mayo Clinic’s “A Systematic Approach to Medically Unexplained Symptoms 2021” course can be found at https://ce.mayo.edu/internal-medicine/content/systematic-approach-medically-unexplained-symptoms-2021#group-tabs-node-course-default1
Clauw DJ. Fibromyalgia: A clinical review. JAMA. 2014;311(15):1547-1555. doi:1001/jama.2014.3266
Clauw DJ. Fibromyalgia and related conditions. Mayo Clin Proc. 2015 May;90(5):680-92. https://doi.org/10.1016/j.mayocp.2015.03.014
Harte, SE, Harris, RE, Clauw, DJ. The neurobiology of central sensitization. J Appl Behav Res. 2018; 23(2): e12137. https://doi.org/10.1111/jabr.12137
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1623</itunes:duration>
                <itunes:episode>229</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Your Patient Has a Thyroid Nodule – What Now?</title>
        <itunes:title>Your Patient Has a Thyroid Nodule – What Now?</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/your-patient-has-a-thyroid-nodule-%e2%80%93-what-now/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/your-patient-has-a-thyroid-nodule-%e2%80%93-what-now/#comments</comments>        <pubDate>Tue, 30 Mar 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/fc036fd9-1dd3-30dd-aff2-580af4220441</guid>
                                    <description><![CDATA[<p>Guest: Jan L. Kasperbauer, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Thyroid nodules are commonly found in patients by primary care providers, either by physical exam or incidentally by a variety of imaging studies. Fortunately, the vast majority of thyroid nodules are benign, however as primary care providers we need to be comfortable in evaluating them to rule out the possibility that they represent a thyroid cancer. Joining us is Dr. Jan Kasperbauer, an otolaryngologist at the Mayo Clinic. We discuss risk factors for thyroid cancer, how a primary care provider should evaluate and manage patients with thyroid nodules, various types of thyroid cancer, and treatment options as well as the recommended follow-up for patients with thyroid cancer.</p>
<p>Specific topics discussed:</p>
<ul><li>Risk factors for thyroid cancer</li>
<li>Detecting thyroid cancers</li>
<li>How primary care provider should evaluate and manage patients with thyroid nodules</li>
<li>Review of the various types of thyroid cancer</li>
<li>Treatment options for thyroid cancer</li>
<li>Recommendations for primary care providers in following patients with treated thyroid cancer</li>
</ul>
<p>Additional resources:</p>
<ul><li>Classification for risk stratification and follow up recommendations: Grant, EG, et al. Thyroid ultrasound reporting lexicon: white paper of the ACR thyroid imaging, reporting and data system (TIRADS) committee. J Am Coll Radiol. 2015 Dec; 12(12): 1272-1279. doi: <a href='https://doi.org/10.1016/j.jacr.2015.07.011'>https://doi.org/10.1016/j.jacr.2015.07.011</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Jan L. Kasperbauer, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Thyroid nodules are commonly found in patients by primary care providers, either by physical exam or incidentally by a variety of imaging studies. Fortunately, the vast majority of thyroid nodules are benign, however as primary care providers we need to be comfortable in evaluating them to rule out the possibility that they represent a thyroid cancer. Joining us is Dr. Jan Kasperbauer, an otolaryngologist at the Mayo Clinic. We discuss risk factors for thyroid cancer, how a primary care provider should evaluate and manage patients with thyroid nodules, various types of thyroid cancer, and treatment options as well as the recommended follow-up for patients with thyroid cancer.</p>
<p>Specific topics discussed:</p>
<ul><li>Risk factors for thyroid cancer</li>
<li>Detecting thyroid cancers</li>
<li>How primary care provider should evaluate and manage patients with thyroid nodules</li>
<li>Review of the various types of thyroid cancer</li>
<li>Treatment options for thyroid cancer</li>
<li>Recommendations for primary care providers in following patients with treated thyroid cancer</li>
</ul>
<p>Additional resources:</p>
<ul><li>Classification for risk stratification and follow up recommendations: Grant, EG, et al. Thyroid ultrasound reporting lexicon: white paper of the ACR thyroid imaging, reporting and data system (TIRADS) committee. J Am Coll Radiol. 2015 Dec; 12(12): 1272-1279. doi: <a href='https://doi.org/10.1016/j.jacr.2015.07.011'>https://doi.org/10.1016/j.jacr.2015.07.011</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/z5cx8a/WF64622_-_Thyroid_Tumor_for_the_PCP8iy20.mp3" length="29565962" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Jan L. Kasperbauer, M.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Thyroid nodules are commonly found in patients by primary care providers, either by physical exam or incidentally by a variety of imaging studies. Fortunately, the vast majority of thyroid nodules are benign, however as primary care providers we need to be comfortable in evaluating them to rule out the possibility that they represent a thyroid cancer. Joining us is Dr. Jan Kasperbauer, an otolaryngologist at the Mayo Clinic. We discuss risk factors for thyroid cancer, how a primary care provider should evaluate and manage patients with thyroid nodules, various types of thyroid cancer, and treatment options as well as the recommended follow-up for patients with thyroid cancer.
Specific topics discussed:
Risk factors for thyroid cancer
Detecting thyroid cancers
How primary care provider should evaluate and manage patients with thyroid nodules
Review of the various types of thyroid cancer
Treatment options for thyroid cancer
Recommendations for primary care providers in following patients with treated thyroid cancer
Additional resources:
Classification for risk stratification and follow up recommendations: Grant, EG, et al. Thyroid ultrasound reporting lexicon: white paper of the ACR thyroid imaging, reporting and data system (TIRADS) committee. J Am Coll Radiol. 2015 Dec; 12(12): 1272-1279. doi: https://doi.org/10.1016/j.jacr.2015.07.011
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1842</itunes:duration>
                <itunes:episode>228</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: Viruses Cannot Mutate If They Cannot Replicate</title>
        <itunes:title>Mayo Clinic Q&amp;A: Viruses Cannot Mutate If They Cannot Replicate</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-viruses-cannot-mutate-if-they-cannot-replicate/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-viruses-cannot-mutate-if-they-cannot-replicate/#comments</comments>        <pubDate>Fri, 26 Mar 2021 10:46:51 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/6765c9de-3234-34f8-9fbb-96cbb46ec5c0</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in March, 2021</p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>) </p>
<p>The <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a> virus mutates and replicates when people let down their guard and don't follow safety protocols, such as practicing social distancing and wearing a mask. </p>
<p>"I think most of us expect a major surge because of spring break travel and the relaxation of restrictions," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>. "And the sort of COVID fatigue that all of us feel, in one way or another."</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland addresses the potential of a fourth COVID-19 surge, new information regarding the COVID-19 vaccines for pregnant women and he discusses research for next generation vaccines for COVID-19 variants.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in March, 2021</p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>) </p>
<p>The <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a> virus mutates and replicates when people let down their guard and don't follow safety protocols, such as practicing social distancing and wearing a mask. </p>
<p>"I think most of us expect a major surge because of spring break travel and the relaxation of restrictions," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>. "And the sort of COVID fatigue that all of us feel, in one way or another."</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland addresses the potential of a fourth COVID-19 surge, new information regarding the COVID-19 vaccines for pregnant women and he discusses research for next generation vaccines for COVID-19 variants.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gtymfz/Mayo_Clinic_Q_A_Podcast_-_Dr_Gregory_Poland_-_03_24_21aarmb.mp3" length="18371682" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in March, 2021
Guest:  Gregory A. Poland, M.D. (@drgregpoland) 
Host: Halena M. Gazelka, M.D. (@hmgazelkamd) 
The COVID-19 virus mutates and replicates when people let down their guard and don't follow safety protocols, such as practicing social distancing and wearing a mask. 
"I think most of us expect a major surge because of spring break travel and the relaxation of restrictions," says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group. "And the sort of COVID fatigue that all of us feel, in one way or another."
In this Mayo Clinic Q&A podcast, Dr. Poland addresses the potential of a fourth COVID-19 surge, new information regarding the COVID-19 vaccines for pregnant women and he discusses research for next generation vaccines for COVID-19 variants.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1145</itunes:duration>
                        <itunes:episodeType>bonus</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>COVID-19 Miniseries Episode 68: Skin Integrity in Patients with COVID-19</title>
        <itunes:title>COVID-19 Miniseries Episode 68: Skin Integrity in Patients with COVID-19</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-68-skin-integrity-in-patients-with-covid-19/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-68-skin-integrity-in-patients-with-covid-19/#comments</comments>        <pubDate>Tue, 23 Mar 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/e5659254-8aef-3f2d-864d-6fa3666cddd6</guid>
                                    <description><![CDATA[<p>Guest: Jennifer L. Elmer, APRN, CNS, D.N.P.; Brianna M. Skrukrud, APRN, C.N.P.</p>
<p>Host: Amit K. Ghosh, M.D. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>)</p>
<p>Pressure injuries in bedridden patients present significant challenges​, which are compounded in the patient with a COVID-19 diagnosis. In this episode we discuss the problems encountered in preventing, diagnosing, and managing skin alterations in patients with COVID-19. Jennifer L. Elmer, APRN, CNS, D.N.P. and Brianna M. Skrukrud, APRN, C.N.P., two wound care experts at Mayo Clinic, discuss situations ​in which, despite best efforts, pressure injuries are unavoidable and why COVID-19 poses a great risk for skin alterations in hospitalized patients. They also discuss the 2020 position statement of National Pressure Injury Advisory Panel (NPIAP) on the management of skin alterations during the COVID-19 crisis.</p>
<p>Additional resources:</p>
<ul><li>Unavoidable Pressure Injury during COVID-19 Pandemic: A Position Paper from the National Pressure Injury Advisory Panel <a href='https://cdn.ymaws.com/npiap.com/resource/resmgr/white_papers/Unavoidable_in_COVID_Pandemi.pdf'>https://cdn.ymaws.com/npiap.com/resource/resmgr/white_papers/Unavoidable_in_COVID_Pandemi.pdf</a></li>
<li>Skin Manifestations with COVID-19: The Purple Skin and Toes that you are seeing may not be Deep Tissue Pressure Injury <a href='https://cdn.ymaws.com/npiap.com/resource/resmgr/white_papers/COVID_Skin_Manifestations_An.pdf'>https://cdn.ymaws.com/npiap.com/resource/resmgr/white_papers/COVID_Skin_Manifestations_An.pdf</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Jennifer L. Elmer, APRN, CNS, D.N.P.; Brianna M. Skrukrud, APRN, C.N.P.</p>
<p>Host: Amit K. Ghosh, M.D. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>)</p>
<p>Pressure injuries in bedridden patients present significant challenges​, which are compounded in the patient with a COVID-19 diagnosis. In this episode we discuss the problems encountered in preventing, diagnosing, and managing skin alterations in patients with COVID-19. Jennifer L. Elmer, APRN, CNS, D.N.P. and Brianna M. Skrukrud, APRN, C.N.P., two wound care experts at Mayo Clinic, discuss situations ​in which, despite best efforts, pressure injuries are unavoidable and why COVID-19 poses a great risk for skin alterations in hospitalized patients. They also discuss the 2020 position statement of National Pressure Injury Advisory Panel (NPIAP) on the management of skin alterations during the COVID-19 crisis.</p>
<p>Additional resources:</p>
<ul><li>Unavoidable Pressure Injury during COVID-19 Pandemic: A Position Paper from the National Pressure Injury Advisory Panel <a href='https://cdn.ymaws.com/npiap.com/resource/resmgr/white_papers/Unavoidable_in_COVID_Pandemi.pdf'>https://cdn.ymaws.com/npiap.com/resource/resmgr/white_papers/Unavoidable_in_COVID_Pandemi.pdf</a></li>
<li>Skin Manifestations with COVID-19: The Purple Skin and Toes that you are seeing may not be Deep Tissue Pressure Injury <a href='https://cdn.ymaws.com/npiap.com/resource/resmgr/white_papers/COVID_Skin_Manifestations_An.pdf'>https://cdn.ymaws.com/npiap.com/resource/resmgr/white_papers/COVID_Skin_Manifestations_An.pdf</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bf47ia/WF69356_-_Skin_Integrity_in_COVID_Patients63qhs.mp3" length="27951818" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Jennifer L. Elmer, APRN, CNS, D.N.P.; Brianna M. Skrukrud, APRN, C.N.P.
Host: Amit K. Ghosh, M.D. (@AmitGhosh006)
Pressure injuries in bedridden patients present significant challenges​, which are compounded in the patient with a COVID-19 diagnosis. In this episode we discuss the problems encountered in preventing, diagnosing, and managing skin alterations in patients with COVID-19. Jennifer L. Elmer, APRN, CNS, D.N.P. and Brianna M. Skrukrud, APRN, C.N.P., two wound care experts at Mayo Clinic, discuss situations ​in which, despite best efforts, pressure injuries are unavoidable and why COVID-19 poses a great risk for skin alterations in hospitalized patients. They also discuss the 2020 position statement of National Pressure Injury Advisory Panel (NPIAP) on the management of skin alterations during the COVID-19 crisis.
Additional resources:
Unavoidable Pressure Injury during COVID-19 Pandemic: A Position Paper from the National Pressure Injury Advisory Panel https://cdn.ymaws.com/npiap.com/resource/resmgr/white_papers/Unavoidable_in_COVID_Pandemi.pdf
Skin Manifestations with COVID-19: The Purple Skin and Toes that you are seeing may not be Deep Tissue Pressure Injury https://cdn.ymaws.com/npiap.com/resource/resmgr/white_papers/COVID_Skin_Manifestations_An.pdf
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1740</itunes:duration>
                <itunes:episode>227</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: Rapid Pace of COVID-19 Vaccinations</title>
        <itunes:title>Mayo Clinic Q&amp;A: Rapid Pace of COVID-19 Vaccinations</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-rapid-pace-of-covid-19-vaccinations/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-rapid-pace-of-covid-19-vaccinations/#comments</comments>        <pubDate>Fri, 19 Mar 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/920afc8d-d66c-3ab4-bb45-924516652663</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in March 2021. </p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: DeeDee Stiepan (<a href='https://twitter.com/deedeestiepan?lang=en'>@deedeestiepan</a>) </p>
<p>Millions of people in the U.S. are being vaccinated for <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a>. However, discussion is ongoing as to whether people who are immunocompromised, such as patients undergoing cancer treatment, or people who have autoimmune diseases, should be vaccinated for COVID-19. </p>
<p>"Both of those categories (of people) should be vaccinated," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>. "Those are not contraindications. Those are indications to get the vaccine." He adds that research is ongoing, but current information demonstrates the benefits far outweigh the theoretical risks. </p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland talks about vaccine hesitancy, and patients who are immunocompromised or have autoimmune conditions. Also, he discusses next steps in the journey to vaccinate children for COVID-19. And he reviews recent guidance from the Centers for Disease Control and Prevention Control about in-person gatherings. </p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in March 2021. </p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: DeeDee Stiepan (<a href='https://twitter.com/deedeestiepan?lang=en'>@deedeestiepan</a>) </p>
<p>Millions of people in the U.S. are being vaccinated for <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a>. However, discussion is ongoing as to whether people who are immunocompromised, such as patients undergoing cancer treatment, or people who have autoimmune diseases, should be vaccinated for COVID-19. </p>
<p>"Both of those categories (of people) should be vaccinated," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>. "Those are not contraindications. Those are indications to get the vaccine." He adds that research is ongoing, but current information demonstrates the benefits far outweigh the theoretical risks. </p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland talks about vaccine hesitancy, and patients who are immunocompromised or have autoimmune conditions. Also, he discusses next steps in the journey to vaccinate children for COVID-19. And he reviews recent guidance from the Centers for Disease Control and Prevention Control about in-person gatherings. </p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qnx34t/Mayo_Clinic_Podcast_-_Dr_Gregory_Poland_-_03_17_219wzml.mp3" length="13811403" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in March 2021. 
Guest:  Gregory A. Poland, M.D. (@drgregpoland) 
Host: DeeDee Stiepan (@deedeestiepan) 
Millions of people in the U.S. are being vaccinated for COVID-19. However, discussion is ongoing as to whether people who are immunocompromised, such as patients undergoing cancer treatment, or people who have autoimmune diseases, should be vaccinated for COVID-19. 
"Both of those categories (of people) should be vaccinated," says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group. "Those are not contraindications. Those are indications to get the vaccine." He adds that research is ongoing, but current information demonstrates the benefits far outweigh the theoretical risks. 
In this Mayo Clinic Q&A podcast, Dr. Poland talks about vaccine hesitancy, and patients who are immunocompromised or have autoimmune conditions. Also, he discusses next steps in the journey to vaccinate children for COVID-19. And he reviews recent guidance from the Centers for Disease Control and Prevention Control about in-person gatherings. 
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>860</itunes:duration>
                        <itunes:episodeType>bonus</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>Can We Prevent Suicide?</title>
        <itunes:title>Can We Prevent Suicide?</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/can-we-prevent-suicide/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/can-we-prevent-suicide/#comments</comments>        <pubDate>Thu, 18 Mar 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/a1df63fc-b628-328c-8a42-12d6c53c200d</guid>
                                    <description><![CDATA[<p>* WARNING: This episode discusses suicide and suicidal ideation. *</p>
<p>Guest: J. Michael Bostwick, M.D.(<a href='https://twitter.com/DrBostwick'>@DrBostwick</a>)</p>
<p>Host: Amit K. Ghosh, M.D. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>)</p>
<p>In this episode, professor of psychiatry and international authority on suicide risk and challenges in suicide prevention, J. Michael Bostwick, M.D.  from Mayo Clinic in Rochester joins us. He’ll discuss epidemiological-based research looking at the utilization patterns of medical care by individuals who have contemplated or committed suicide. Dr. Bostwick will describe the concept of suicide crisis including risk factors, current events/warning signs, and mental status/agitation. He’ll also explain self-agency, stigma of discussing mental illness, potential value-based societal approach to individuals in distress and despair, and potential solutions to the suicide prevention.</p>
<p>Additional resources:</p>
<ul><li>Suicide Prevention in Primary Care Medicine; Huguet, Nathalie et al.; Mayo Clinic Proceedings, Volume 90, Issue 11, 1459 – 1461; <a href='https://doi.org/10.1016/j.mayocp.2015.09.011'>https://doi.org/10.1016/j.mayocp.2015.09.011</a></li>
<li>Grappling With Suicide Risk; Sublette, M. Elizabeth; Mayo Clinic Proceedings, Volume 93, Issue 6, 682 – 683; <a href='https://doi.org/10.1016/j.mayocp.2018.04.006'>https://doi.org/10.1016/j.mayocp.2018.04.006</a></li>
<li>Suicide Attempt as a Risk Factor for Completed Suicide: Even More Lethal Than We Knew; Bostwick, J. Michael et al.; Amer Journal of Psychiatry; Volume 173, Issue 11, November 01, 2016, 1094-1100; <a href='https://doi.org/10.1176/appi.ajp.2016.15070854'>https://doi.org/10.1176/appi.ajp.2016.15070854</a></li>
</ul>
<p>If you're feeling overwhelmed by thoughts of not wanting to live or you're having urges to attempt suicide, get help now.</p>
<ul><li>Call 911 or your local emergency number immediately.</li>
<li>Call a suicide hotline. In the U.S., call the <a href='https://suicidepreventionlifeline.org/talk-to-someone-now/'>National Suicide Prevention Lifeline</a> at 1-800-273-8255 any time of day — press "1" to reach the <a href='https://www.veteranscrisisline.net/'>Veterans Crisis Line</a> or use <a href='https://suicidepreventionlifeline.org/chat/'>Lifeline Chat</a>.</li>
<li>For a list of suicide hotline numbers outside of the U.S., visit: <a href='https://www.opencounseling.com/suicide-hotlines'>https://www.opencounseling.com/suicide-hotlines</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>* WARNING: This episode discusses suicide and suicidal ideation. *</p>
<p>Guest: J. Michael Bostwick, M.D.(<a href='https://twitter.com/DrBostwick'>@DrBostwick</a>)</p>
<p>Host: Amit K. Ghosh, M.D. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>)</p>
<p>In this episode, professor of psychiatry and international authority on suicide risk and challenges in suicide prevention, J. Michael Bostwick, M.D.  from Mayo Clinic in Rochester joins us. He’ll discuss epidemiological-based research looking at the utilization patterns of medical care by individuals who have contemplated or committed suicide. Dr. Bostwick will describe the concept of suicide crisis including risk factors, current events/warning signs, and mental status/agitation. He’ll also explain self-agency, stigma of discussing mental illness, potential value-based societal approach to individuals in distress and despair, and potential solutions to the suicide prevention.</p>
<p>Additional resources:</p>
<ul><li>Suicide Prevention in Primary Care Medicine; Huguet, Nathalie et al.; Mayo Clinic Proceedings, Volume 90, Issue 11, 1459 – 1461; <a href='https://doi.org/10.1016/j.mayocp.2015.09.011'>https://doi.org/10.1016/j.mayocp.2015.09.011</a></li>
<li>Grappling With Suicide Risk; Sublette, M. Elizabeth; Mayo Clinic Proceedings, Volume 93, Issue 6, 682 – 683; <a href='https://doi.org/10.1016/j.mayocp.2018.04.006'>https://doi.org/10.1016/j.mayocp.2018.04.006</a></li>
<li>Suicide Attempt as a Risk Factor for Completed Suicide: Even More Lethal Than We Knew; Bostwick, J. Michael et al.; Amer Journal of Psychiatry; Volume 173, Issue 11, November 01, 2016, 1094-1100; <a href='https://doi.org/10.1176/appi.ajp.2016.15070854'>https://doi.org/10.1176/appi.ajp.2016.15070854</a></li>
</ul>
<p>If you're feeling overwhelmed by thoughts of not wanting to live or you're having urges to attempt suicide, get help now.</p>
<ul><li>Call 911 or your local emergency number immediately.</li>
<li>Call a suicide hotline. In the U.S., call the <a href='https://suicidepreventionlifeline.org/talk-to-someone-now/'>National Suicide Prevention Lifeline</a> at 1-800-273-8255 any time of day — press "1" to reach the <a href='https://www.veteranscrisisline.net/'>Veterans Crisis Line</a> or use <a href='https://suicidepreventionlifeline.org/chat/'>Lifeline Chat</a>.</li>
<li>For a list of suicide hotline numbers outside of the U.S., visit: <a href='https://www.opencounseling.com/suicide-hotlines'>https://www.opencounseling.com/suicide-hotlines</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pzhwqy/WF91966_-_Suicide_V397jti.mp3" length="25188909" type="audio/mpeg"/>
        <itunes:summary><![CDATA[* WARNING: This episode discusses suicide and suicidal ideation. *
Guest: J. Michael Bostwick, M.D.(@DrBostwick)
Host: Amit K. Ghosh, M.D. (@AmitGhosh006)
In this episode, professor of psychiatry and international authority on suicide risk and challenges in suicide prevention, J. Michael Bostwick, M.D.  from Mayo Clinic in Rochester joins us. He’ll discuss epidemiological-based research looking at the utilization patterns of medical care by individuals who have contemplated or committed suicide. Dr. Bostwick will describe the concept of suicide crisis including risk factors, current events/warning signs, and mental status/agitation. He’ll also explain self-agency, stigma of discussing mental illness, potential value-based societal approach to individuals in distress and despair, and potential solutions to the suicide prevention.
Additional resources:
Suicide Prevention in Primary Care Medicine; Huguet, Nathalie et al.; Mayo Clinic Proceedings, Volume 90, Issue 11, 1459 – 1461; https://doi.org/10.1016/j.mayocp.2015.09.011
Grappling With Suicide Risk; Sublette, M. Elizabeth; Mayo Clinic Proceedings, Volume 93, Issue 6, 682 – 683; https://doi.org/10.1016/j.mayocp.2018.04.006
Suicide Attempt as a Risk Factor for Completed Suicide: Even More Lethal Than We Knew; Bostwick, J. Michael et al.; Amer Journal of Psychiatry; Volume 173, Issue 11, November 01, 2016, 1094-1100; https://doi.org/10.1176/appi.ajp.2016.15070854
If you're feeling overwhelmed by thoughts of not wanting to live or you're having urges to attempt suicide, get help now.
Call 911 or your local emergency number immediately.
Call a suicide hotline. In the U.S., call the National Suicide Prevention Lifeline at 1-800-273-8255 any time of day — press "1" to reach the Veterans Crisis Line or use Lifeline Chat.
For a list of suicide hotline numbers outside of the U.S., visit: https://www.opencounseling.com/suicide-hotlines
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1567</itunes:duration>
                <itunes:episode>226</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: “Brain Fog” is a Lingering Condition for Many COVID-19 Long-Haulers</title>
        <itunes:title>Mayo Clinic Q&amp;A: “Brain Fog” is a Lingering Condition for Many COVID-19 Long-Haulers</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-q-a-brain-fog-is-a-lingering-condition-for-many-covid-19-long-haulers/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-q-a-brain-fog-is-a-lingering-condition-for-many-covid-19-long-haulers/#comments</comments>        <pubDate>Wed, 17 Mar 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/4fee0be9-5e56-3c91-86d2-34b88cb1bed4</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in March, 2021. </p>
<p>Guest:  Billie A. Schultz, M.D. </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>) </p>
<p>Fatigue and what's being called "brain fog" are turning out to be some of the most common issues for long-hauler patients recovering from <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a>. The National Institutes of Health calls these and other symptoms, which can last for several months, <a href='https://directorsblog.nih.gov/tag/post-acute-sequelae-of-covid-19/?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>post-acute sequelae of SARS-CoV-2</a>, or PASC.</p>
<p>Those suffering from brain fog may experience short-term memory loss, confusion, difficulty concentrating, or just feeling different than they did before they had COVID-19, even if it was a mild case of the infection. </p>
<p>And <a href='https://www.mayoclinic.org/biographies/schultz-billie-a-m-d/bio-20055456?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Dr. Billie Schultz</a>, a Mayo Clinic physical medicine and rehabilitation expert, says, though older patients more often to have these symptoms more often, younger people are also showing up with brain fog.</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Schultz says brain fog seems to be more inflammatory than infection, but there are more questions than answers about this neurological concern. Meanwhile, efforts are underway to develop rehabilitation programs to help patients recover.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in March, 2021. </p>
<p>Guest:  Billie A. Schultz, M.D. </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>) </p>
<p>Fatigue and what's being called "brain fog" are turning out to be some of the most common issues for long-hauler patients recovering from <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a>. The National Institutes of Health calls these and other symptoms, which can last for several months, <a href='https://directorsblog.nih.gov/tag/post-acute-sequelae-of-covid-19/?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>post-acute sequelae of SARS-CoV-2</a>, or PASC.</p>
<p>Those suffering from brain fog may experience short-term memory loss, confusion, difficulty concentrating, or just feeling different than they did before they had COVID-19, even if it was a mild case of the infection. </p>
<p>And <a href='https://www.mayoclinic.org/biographies/schultz-billie-a-m-d/bio-20055456?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Dr. Billie Schultz</a>, a Mayo Clinic physical medicine and rehabilitation expert, says, though older patients more often to have these symptoms more often, younger people are also showing up with brain fog.</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Schultz says brain fog seems to be more inflammatory than infection, but there are more questions than answers about this neurological concern. Meanwhile, efforts are underway to develop rehabilitation programs to help patients recover.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wqh2j7/Mayo_Clinic_Podcast_-_Dr_Billie_Schultz_-_03_08_21916w7.mp3" length="15652552" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in March, 2021. 
Guest:  Billie A. Schultz, M.D. 
Host: Halena M. Gazelka, M.D. (@hmgazelkamd) 
Fatigue and what's being called "brain fog" are turning out to be some of the most common issues for long-hauler patients recovering from COVID-19. The National Institutes of Health calls these and other symptoms, which can last for several months, post-acute sequelae of SARS-CoV-2, or PASC.
Those suffering from brain fog may experience short-term memory loss, confusion, difficulty concentrating, or just feeling different than they did before they had COVID-19, even if it was a mild case of the infection. 
And Dr. Billie Schultz, a Mayo Clinic physical medicine and rehabilitation expert, says, though older patients more often to have these symptoms more often, younger people are also showing up with brain fog.
In this Mayo Clinic Q&A podcast, Dr. Schultz says brain fog seems to be more inflammatory than infection, but there are more questions than answers about this neurological concern. Meanwhile, efforts are underway to develop rehabilitation programs to help patients recover.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>975</itunes:duration>
                        <itunes:episodeType>bonus</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>COVID-19 Miniseries Episode 67: Finding a Solution for Every Long-Hauler</title>
        <itunes:title>COVID-19 Miniseries Episode 67: Finding a Solution for Every Long-Hauler</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-67-finding-a-solution-for-every-long-hauler/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-67-finding-a-solution-for-every-long-hauler/#comments</comments>        <pubDate>Tue, 16 Mar 2021 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/a0415db8-3bee-329a-b6c3-537c56447516</guid>
                                    <description><![CDATA[<p>Guest: Ravindra Ganesh, M.B.B.S., M.D.</p>
<p>Host: Amit K. Ghosh, M.D. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>)</p>
<p>It has been estimated that as many as 10-30% of patients who have recovered from COVID-19 have an array of symptoms, ranging from minor to disabling, that persist more than four weeks post-COVID infection. These symptoms have not only been identified in patients who had severe symptoms of COVID-19 requiring intensive care unit treatment, but also those who only experienced mild-to-moderate symptoms.</p>
<p>The exact cause of this state, most popularly called post-COVID long hauler syndrome, is still under investigation. The symptoms range from mild to disabling fatigue, body aches, atypical chest pain, loss of sense of taste and smell, brain fog, among others and many of these patients need additional evaluation and management to deal with their disabling symptoms.</p>
<p>In this podcast Dr. Ravindra Ganesh, the consultant in General Internal Medicine who leads the COVID Frontline Care Team (CFCT) efforts, as well as the Post-COVID Clinic, at Mayo Clinic Rochester, discusses the array of symptoms, management strategies, and research possibilities, as well as opening of an upcoming clinic in Mayo Clinic Rochester that would address the concern of the patient's and deal with the post COVID long hauler symptoms</p>
<p>Additional Resources:</p>
<ul><li>Post-COVID Syndrome on Ask Mayo Expert: <a href='https://askmayoexpert.mayoclinic.org/'>https://askmayoexpert.mayoclinic.org/</a> </li>
<li>To refer a patient to or request an appointment at Mayo Clinic, visit: <a href='https://www.mayoclinic.org/appointments'>https://www.mayoclinic.org/appointments</a> </li>
<li>Post-COVID Recovery on Mayo Clinic Connect: <a href='https://connect.mayoclinic.org/page/post-covid-recovery/'>https://connect.mayoclinic.org/page/post-covid-recovery/</a> </li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Ravindra Ganesh, M.B.B.S., M.D.</p>
<p>Host: Amit K. Ghosh, M.D. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>)</p>
<p>It has been estimated that as many as 10-30% of patients who have recovered from COVID-19 have an array of symptoms, ranging from minor to disabling, that persist more than four weeks post-COVID infection. These symptoms have not only been identified in patients who had severe symptoms of COVID-19 requiring intensive care unit treatment, but also those who only experienced mild-to-moderate symptoms.</p>
<p>The exact cause of this state, most popularly called post-COVID long hauler syndrome, is still under investigation. The symptoms range from mild to disabling fatigue, body aches, atypical chest pain, loss of sense of taste and smell, brain fog, among others and many of these patients need additional evaluation and management to deal with their disabling symptoms.</p>
<p>In this podcast Dr. Ravindra Ganesh, the consultant in General Internal Medicine who leads the COVID Frontline Care Team (CFCT) efforts, as well as the Post-COVID Clinic, at Mayo Clinic Rochester, discusses the array of symptoms, management strategies, and research possibilities, as well as opening of an upcoming clinic in Mayo Clinic Rochester that would address the concern of the patient's and deal with the post COVID long hauler symptoms</p>
<p>Additional Resources:</p>
<ul><li>Post-COVID Syndrome on Ask Mayo Expert: <a href='https://askmayoexpert.mayoclinic.org/'>https://askmayoexpert.mayoclinic.org/</a> </li>
<li>To refer a patient to or request an appointment at Mayo Clinic, visit: <a href='https://www.mayoclinic.org/appointments'>https://www.mayoclinic.org/appointments</a> </li>
<li>Post-COVID Recovery on Mayo Clinic Connect: <a href='https://connect.mayoclinic.org/page/post-covid-recovery/'>https://connect.mayoclinic.org/page/post-covid-recovery/</a> </li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6xfe9p/WF114976_-Post_COVID_Syndrome_-_Ganesh6o1j6.mp3" length="17842190" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Ravindra Ganesh, M.B.B.S., M.D.
Host: Amit K. Ghosh, M.D. (@AmitGhosh006)
It has been estimated that as many as 10-30% of patients who have recovered from COVID-19 have an array of symptoms, ranging from minor to disabling, that persist more than four weeks post-COVID infection. These symptoms have not only been identified in patients who had severe symptoms of COVID-19 requiring intensive care unit treatment, but also those who only experienced mild-to-moderate symptoms.
The exact cause of this state, most popularly called post-COVID long hauler syndrome, is still under investigation. The symptoms range from mild to disabling fatigue, body aches, atypical chest pain, loss of sense of taste and smell, brain fog, among others and many of these patients need additional evaluation and management to deal with their disabling symptoms.
In this podcast Dr. Ravindra Ganesh, the consultant in General Internal Medicine who leads the COVID Frontline Care Team (CFCT) efforts, as well as the Post-COVID Clinic, at Mayo Clinic Rochester, discusses the array of symptoms, management strategies, and research possibilities, as well as opening of an upcoming clinic in Mayo Clinic Rochester that would address the concern of the patient's and deal with the post COVID long hauler symptoms
Additional Resources:
Post-COVID Syndrome on Ask Mayo Expert: https://askmayoexpert.mayoclinic.org/ 
To refer a patient to or request an appointment at Mayo Clinic, visit: https://www.mayoclinic.org/appointments 
Post-COVID Recovery on Mayo Clinic Connect: https://connect.mayoclinic.org/page/post-covid-recovery/ 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1110</itunes:duration>
                <itunes:episode>225</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clostridium Difficile Infection: You Want to Transplant What?!</title>
        <itunes:title>Clostridium Difficile Infection: You Want to Transplant What?!</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/clostridium-difficile-infection-you-want-to-transplant-what/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/clostridium-difficile-infection-you-want-to-transplant-what/#comments</comments>        <pubDate>Tue, 09 Mar 2021 06:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/db547460-29ec-3934-98ba-a7da284ffa03</guid>
                                    <description><![CDATA[<p>Guest: Maria I. Vazquez Roque, M.D. (<a href='https://twitter.com/MVazquezRoqueMD'>@MVazquezRoqueMD</a>) </p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>) </p>
<p>Clostridium difficile is a toxin-producing bacterium that can result in a severe form of antibiotic-associated diarrhea known as clostridium difficile infection or CDI. Cases can vary from mild diarrhea to severe colitis that at times can be fatal. There’s been a dramatic increase in the number as well as severity of CDIs in the U.S. over the past 20 years. Although CDI typically occurs following the use of antibiotics, it can also be spread from one individual to another, especially in hospitals and skilled nursing facilities. Antibiotics have been the traditional treatment for patients with CDI, however recurrent symptoms have been a problem. There’s now a new treatment for CDI, felt to be effective in over 90% of patients with the illness. Our guest to discuss this topic is Dr. Maria Vazquez Roque, a gastroenterologist at the Mayo Clinic. We’ll review the common presenting symptoms, laboratory tests needed to establish a diagnosis, and the current recommendations for treatment including the latest of fecal transplantation. </p>
<p>Additional resources: </p>
<p>Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): <a href='https://doi.org/10.1093/cid/cix1085'>https://doi.org/10.1093/cid/cix1085</a> </p>
<p>Specific topics discussed:</p>
<ul><li>The typical presentation of C. difficile infection</li>
<li>Patients who are at increased risk for a C. difficile infection</li>
<li>Laboratory tests to order to confirm a case of C. difficile infection</li>
<li>Treatment options for C. difficile infection including fecal transplantation</li>
<li>Potential benefit of probiotics for preventing a C. difficile infection</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Maria I. Vazquez Roque, M.D. (<a href='https://twitter.com/MVazquezRoqueMD'>@MVazquezRoqueMD</a>) </p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>) </p>
<p>Clostridium difficile is a toxin-producing bacterium that can result in a severe form of antibiotic-associated diarrhea known as clostridium difficile infection or CDI. Cases can vary from mild diarrhea to severe colitis that at times can be fatal. There’s been a dramatic increase in the number as well as severity of CDIs in the U.S. over the past 20 years. Although CDI typically occurs following the use of antibiotics, it can also be spread from one individual to another, especially in hospitals and skilled nursing facilities. Antibiotics have been the traditional treatment for patients with CDI, however recurrent symptoms have been a problem. There’s now a new treatment for CDI, felt to be effective in over 90% of patients with the illness. Our guest to discuss this topic is Dr. Maria Vazquez Roque, a gastroenterologist at the Mayo Clinic. We’ll review the common presenting symptoms, laboratory tests needed to establish a diagnosis, and the current recommendations for treatment including the latest of fecal transplantation. </p>
<p>Additional resources: </p>
<p>Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): <a href='https://doi.org/10.1093/cid/cix1085'>https://doi.org/10.1093/cid/cix1085</a> </p>
<p>Specific topics discussed:</p>
<ul><li>The typical presentation of C. difficile infection</li>
<li>Patients who are at increased risk for a C. difficile infection</li>
<li>Laboratory tests to order to confirm a case of C. difficile infection</li>
<li>Treatment options for C. difficile infection including fecal transplantation</li>
<li>Potential benefit of probiotics for preventing a C. difficile infection</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rkku9f/VT3986816_-_c-Diffaqgc7.mp3" length="26154942" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Maria I. Vazquez Roque, M.D. (@MVazquezRoqueMD) 
Host: Darryl S. Chutka, M.D. (@ChutkaMD) 
Clostridium difficile is a toxin-producing bacterium that can result in a severe form of antibiotic-associated diarrhea known as clostridium difficile infection or CDI. Cases can vary from mild diarrhea to severe colitis that at times can be fatal. There’s been a dramatic increase in the number as well as severity of CDIs in the U.S. over the past 20 years. Although CDI typically occurs following the use of antibiotics, it can also be spread from one individual to another, especially in hospitals and skilled nursing facilities. Antibiotics have been the traditional treatment for patients with CDI, however recurrent symptoms have been a problem. There’s now a new treatment for CDI, felt to be effective in over 90% of patients with the illness. Our guest to discuss this topic is Dr. Maria Vazquez Roque, a gastroenterologist at the Mayo Clinic. We’ll review the common presenting symptoms, laboratory tests needed to establish a diagnosis, and the current recommendations for treatment including the latest of fecal transplantation. 
Additional resources: 
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): https://doi.org/10.1093/cid/cix1085 
Specific topics discussed:
The typical presentation of C. difficile infection
Patients who are at increased risk for a C. difficile infection
Laboratory tests to order to confirm a case of C. difficile infection
Treatment options for C. difficile infection including fecal transplantation
Potential benefit of probiotics for preventing a C. difficile infection
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1627</itunes:duration>
                <itunes:episode>224</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Q &amp; A: COVID-19 Variants and the Evolving Science</title>
        <itunes:title>Mayo Q &amp; A: COVID-19 Variants and the Evolving Science</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-q-a-covid-19-variants-and-the-evolving-science/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-q-a-covid-19-variants-and-the-evolving-science/#comments</comments>        <pubDate>Wed, 03 Mar 2021 06:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/1ab590ed-fdce-3ad8-a8aa-bf3d6663a4d0</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in February, 2021</p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)   </p>
<p>People may be curious, confused or critical of what seem to be changing messages related to the <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a> pandemic.</p>
<p><a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>, reminds folks that messages change because data changes and the science evolves.</p>
<p>"As we learn new science, we use that science to modify our recommendations," says Dr. Poland. "It's not that scientists are flip-flopping. It is that new data allows us to begin expanding those recommendations."</p>
<p>For instance, COVID-19 cases and deaths in the U.S. are currently declining. But, Dr. Poland says, there are new data predicting the possibility of another surge of COVID-19 infections in March because of U.K. variant transmission.</p>
<p>In this Mayo Clinic Q&A podcast Dr. Poland talks about several issues, including the U.K. variant, vaccine development and the public’s COVID-19 fatigue.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in February, 2021</p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)   </p>
<p>People may be curious, confused or critical of what seem to be changing messages related to the <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a> pandemic.</p>
<p><a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>, reminds folks that messages change because data changes and the science evolves.</p>
<p>"As we learn new science, we use that science to modify our recommendations," says Dr. Poland. "It's not that scientists are flip-flopping. It is that new data allows us to begin expanding those recommendations."</p>
<p>For instance, COVID-19 cases and deaths in the U.S. are currently declining. But, Dr. Poland says, there are new data predicting the possibility of another surge of COVID-19 infections in March because of U.K. variant transmission.</p>
<p>In this Mayo Clinic Q&A podcast Dr. Poland talks about several issues, including the U.K. variant, vaccine development and the public’s COVID-19 fatigue.</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wm9bmy/Mayo_Clinic_Podcast_-_Dr_Gregory_Poland_-_2_24_21btoi0.mp3" length="25250283" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in February, 2021
Guest:  Gregory A. Poland, M.D. (@drgregpoland) 
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)   
People may be curious, confused or critical of what seem to be changing messages related to the COVID-19 pandemic.
Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, reminds folks that messages change because data changes and the science evolves.
"As we learn new science, we use that science to modify our recommendations," says Dr. Poland. "It's not that scientists are flip-flopping. It is that new data allows us to begin expanding those recommendations."
For instance, COVID-19 cases and deaths in the U.S. are currently declining. But, Dr. Poland says, there are new data predicting the possibility of another surge of COVID-19 infections in March because of U.K. variant transmission.
In this Mayo Clinic Q&A podcast Dr. Poland talks about several issues, including the U.K. variant, vaccine development and the public’s COVID-19 fatigue.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1575</itunes:duration>
                        <itunes:episodeType>bonus</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>COVID-19 Miniseries Episode 66: Monoclonal Antibody Treatment for COVID-19</title>
        <itunes:title>COVID-19 Miniseries Episode 66: Monoclonal Antibody Treatment for COVID-19</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-66-monoclonal-antibody-treatment-for-covid-19/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-66-monoclonal-antibody-treatment-for-covid-19/#comments</comments>        <pubDate>Tue, 02 Mar 2021 06:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/603dcfa8-12c9-3fc2-9fab-485c8115393b</guid>
                                    <description><![CDATA[<p>Guest: Ravindra Ganesh, M.B.B.S., M.D. and Raymund R. Razonable, M.D. </p>
<p>Host: Amit K. Ghosh, M.D. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>) </p>
<p>In this episode, Ravindra Ganesh, M.B.B.S., M.D. and Raymund R. Razonable, M.D. join Amit K. Ghosh, M.D. to review the use of monoclonal antibody as a new antiviral agent in the treatment of COVID-19 infection. </p>
<p>Who is most likely to benefit from monoclonal antibody infusions? Drs. Ganesh and Razonable, discuss recent studies on monoclonal antibody infusions in patients with mild to moderate COVID-19 infections. Also discussed are the logistical challenges faced and the innovative solutions that were implemented while administering this therapy, particularly navigating the acceptance of treatment, its real and perceived side effects, and lack of awareness due to inequity and poverty. Research on the development of subcutaneous or intramuscular administration for prophylaxis against COVID-19 in patients at high risk for complications or at high risk for being exposed to SARS-CoV-2 is also discussed in this episode. </p>
<p>Additional resources: </p>
<ul><li>AskMayoExpert COVID-19 Navigator: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </li>
<li>Weinreich DM, Sivapalasingam S, Norton T, et al. REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19. N Engl J Med 2021;384:238-251. </li>
<li>Chen P, Nirula A, Heller B, et al. SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19. N Engl J Med 2021;384:229-237. </li>
<li>Gottlieb RL, Nirula A, Chen P, et al. Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.JAMA. Published online January 21, 2021. doi:10.1001/jama.2021.0202 </li>
<li>An EUA for Bamlanivimab—A Monoclonal Antibody for COVID-19. JAMA. Published online December 11, 2020. doi:10.1001/jama.2020.24415 </li>
<li>Monoclonal Antibodies: Update on this COVID-19 Experimental Therapy  <a href='https://discoverysedge.mayo.edu/2021/02/17/monoclonal-antibodies-update-on-this-covid-19-experimental-therapy/'>https://discoverysedge.mayo.edu/2021/02/17/monoclonal-antibodies-update-on-this-covid-19-experimental-therapy/</a> </li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Ravindra Ganesh, M.B.B.S., M.D. and Raymund R. Razonable, M.D. </p>
<p>Host: Amit K. Ghosh, M.D. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>) </p>
<p>In this episode, Ravindra Ganesh, M.B.B.S., M.D. and Raymund R. Razonable, M.D. join Amit K. Ghosh, M.D. to review the use of monoclonal antibody as a new antiviral agent in the treatment of COVID-19 infection. </p>
<p>Who is most likely to benefit from monoclonal antibody infusions? Drs. Ganesh and Razonable, discuss recent studies on monoclonal antibody infusions in patients with mild to moderate COVID-19 infections. Also discussed are the logistical challenges faced and the innovative solutions that were implemented while administering this therapy, particularly navigating the acceptance of treatment, its real and perceived side effects, and lack of awareness due to inequity and poverty. Research on the development of subcutaneous or intramuscular administration for prophylaxis against COVID-19 in patients at high risk for complications or at high risk for being exposed to SARS-CoV-2 is also discussed in this episode. </p>
<p>Additional resources: </p>
<ul><li>AskMayoExpert COVID-19 Navigator: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </li>
<li>Weinreich DM, Sivapalasingam S, Norton T, et al. REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19. N Engl J Med 2021;384:238-251. </li>
<li>Chen P, Nirula A, Heller B, et al. SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19. N Engl J Med 2021;384:229-237. </li>
<li>Gottlieb RL, Nirula A, Chen P, et al. Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.JAMA. Published online January 21, 2021. doi:10.1001/jama.2021.0202 </li>
<li>An EUA for Bamlanivimab—A Monoclonal Antibody for COVID-19. JAMA. Published online December 11, 2020. doi:10.1001/jama.2020.24415 </li>
<li>Monoclonal Antibodies: Update on this COVID-19 Experimental Therapy  <a href='https://discoverysedge.mayo.edu/2021/02/17/monoclonal-antibodies-update-on-this-covid-19-experimental-therapy/'>https://discoverysedge.mayo.edu/2021/02/17/monoclonal-antibodies-update-on-this-covid-19-experimental-therapy/</a> </li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/b8b8ys/WF76267_Antibody_Treatments6uzzp.mp3" length="25259199" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Ravindra Ganesh, M.B.B.S., M.D. and Raymund R. Razonable, M.D. 
Host: Amit K. Ghosh, M.D. (@AmitGhosh006) 
In this episode, Ravindra Ganesh, M.B.B.S., M.D. and Raymund R. Razonable, M.D. join Amit K. Ghosh, M.D. to review the use of monoclonal antibody as a new antiviral agent in the treatment of COVID-19 infection. 
Who is most likely to benefit from monoclonal antibody infusions? Drs. Ganesh and Razonable, discuss recent studies on monoclonal antibody infusions in patients with mild to moderate COVID-19 infections. Also discussed are the logistical challenges faced and the innovative solutions that were implemented while administering this therapy, particularly navigating the acceptance of treatment, its real and perceived side effects, and lack of awareness due to inequity and poverty. Research on the development of subcutaneous or intramuscular administration for prophylaxis against COVID-19 in patients at high risk for complications or at high risk for being exposed to SARS-CoV-2 is also discussed in this episode. 
Additional resources: 
AskMayoExpert COVID-19 Navigator: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 
Weinreich DM, Sivapalasingam S, Norton T, et al. REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19. N Engl J Med 2021;384:238-251. 
Chen P, Nirula A, Heller B, et al. SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19. N Engl J Med 2021;384:229-237. 
Gottlieb RL, Nirula A, Chen P, et al. Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.JAMA. Published online January 21, 2021. doi:10.1001/jama.2021.0202 
An EUA for Bamlanivimab—A Monoclonal Antibody for COVID-19. JAMA. Published online December 11, 2020. doi:10.1001/jama.2020.24415 
Monoclonal Antibodies: Update on this COVID-19 Experimental Therapy  https://discoverysedge.mayo.edu/2021/02/17/monoclonal-antibodies-update-on-this-covid-19-experimental-therapy/ 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1573</itunes:duration>
                <itunes:episode>223</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>COVID-19 Miniseries Episode 65: Restoring Function for Long-Haulers</title>
        <itunes:title>COVID-19 Miniseries Episode 65: Restoring Function for Long-Haulers</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-66-restoring-function-for-long-haulers/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-66-restoring-function-for-long-haulers/#comments</comments>        <pubDate>Tue, 16 Feb 2021 06:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/207900d5-d159-3bf1-a5a0-1c9b3ad7fcbd</guid>
                                    <description><![CDATA[<p>Guest: Greg Vanichkachorn, M.D., M.P.H.</p>
<p>Host: Amit K. Ghosh, M.D. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>)</p>
<p>For some patients who have had <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a>, symptoms of the disease may last long after the infection is over. Long-haulers syndrome due to COVID-19 could include profound fatigue, shortness of breath, and long-term neurological complaints, including headache, dizziness, or weakness. Mayo Clinic has launched the COVID Activity Rehabilitation Program, or CARP, to help these patients return to daily life and work. CARP is not just for folks who are trying to get back to work, but for anyone trying to get back to their baseline life.</p>
<p>In this episode, <a href='https://www.mayoclinic.org/biographies/vanichkachorn-greg-m-d-m-p-h/bio-20470118?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Dr. Greg Vanichkachorn</a>, a Mayo Clinic preventive, occupational and aerospace medicine specialist who leads the CARP program, gives an overview of COVID long haulers and how post-COVID symptoms affects patients. He also shares the goals and results of Mayo Clinic CARP program.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Greg Vanichkachorn, M.D., M.P.H.</p>
<p>Host: Amit K. Ghosh, M.D. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>)</p>
<p>For some patients who have had <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a>, symptoms of the disease may last long after the infection is over. Long-haulers syndrome due to COVID-19 could include profound fatigue, shortness of breath, and long-term neurological complaints, including headache, dizziness, or weakness. Mayo Clinic has launched the COVID Activity Rehabilitation Program, or CARP, to help these patients return to daily life and work. CARP is not just for folks who are trying to get back to work, but for anyone trying to get back to their baseline life.</p>
<p>In this episode, <a href='https://www.mayoclinic.org/biographies/vanichkachorn-greg-m-d-m-p-h/bio-20470118?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Dr. Greg Vanichkachorn</a>, a Mayo Clinic preventive, occupational and aerospace medicine specialist who leads the CARP program, gives an overview of COVID long haulers and how post-COVID symptoms affects patients. He also shares the goals and results of Mayo Clinic CARP program.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rreawt/WFxxxxx_-_CARP8s8v0.mp3" length="19600445" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Greg Vanichkachorn, M.D., M.P.H.
Host: Amit K. Ghosh, M.D. (@AmitGhosh006)
For some patients who have had COVID-19, symptoms of the disease may last long after the infection is over. Long-haulers syndrome due to COVID-19 could include profound fatigue, shortness of breath, and long-term neurological complaints, including headache, dizziness, or weakness. Mayo Clinic has launched the COVID Activity Rehabilitation Program, or CARP, to help these patients return to daily life and work. CARP is not just for folks who are trying to get back to work, but for anyone trying to get back to their baseline life.
In this episode, Dr. Greg Vanichkachorn, a Mayo Clinic preventive, occupational and aerospace medicine specialist who leads the CARP program, gives an overview of COVID long haulers and how post-COVID symptoms affects patients. He also shares the goals and results of Mayo Clinic CARP program.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1221</itunes:duration>
                <itunes:episode>222</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Answers From the Lab: The Impact of COVID-19 Variants</title>
        <itunes:title>Answers From the Lab: The Impact of COVID-19 Variants</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/answers-from-the-lab-the-impact-of-covid-19-variants/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/answers-from-the-lab-the-impact-of-covid-19-variants/#comments</comments>        <pubDate>Tue, 09 Feb 2021 09:40:55 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/69ed46e7-ac0a-30f9-a167-dda969333895</guid>
                                    <description><![CDATA[<p>This episode is shared from <a href='https://news.mayocliniclabs.com/podcast/answers-from-the-lab/'>Answers from the Lab</a> and was originally published February 2, 2021. </p>
<p>Guest: Matthew J. Binnicker, Ph.D. (<a href='https://twitter.com/DrMattBinnicker'>@DrMattBinnicker</a>)</p>
<p>Host: William G. Morice, II M.D., Ph.D. (<a href='https://twitter.com/moricemdphd'>@moricemdphd</a>)</p>
<p>Matthew Binnicker, Ph.D., vice chair of practice for Mayo Clinic's Department of Laboratory Medicine and Pathology, joins William Morice II, M.D., Ph.D., president of Mayo Clinic Laboratories, for this week's "Answers From the Lab" leadership update. In this episode, Dr. Binnicker and Dr. Morice discuss the impact that emerging COVID-19 variants could have on virus testing, vaccine and spread.</p>
<p>For more, follow the Mayo Clinic Labs on Twitter <a href='https://twitter.com/mayocliniclabs'>@mayocliniclabs</a> or visit <a href='https://news.mayocliniclabs.com/podcast/answers-from-the-lab/'>https://news.mayocliniclabs.com/podcast/answers-from-the-lab/</a> to check out all of their episodes.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from <a href='https://news.mayocliniclabs.com/podcast/answers-from-the-lab/'>Answers from the Lab</a> and was originally published February 2, 2021. </p>
<p>Guest: Matthew J. Binnicker, Ph.D. (<a href='https://twitter.com/DrMattBinnicker'>@DrMattBinnicker</a>)</p>
<p>Host: William G. Morice, II M.D., Ph.D. (<a href='https://twitter.com/moricemdphd'>@moricemdphd</a>)</p>
<p>Matthew Binnicker, Ph.D., vice chair of practice for Mayo Clinic's Department of Laboratory Medicine and Pathology, joins William Morice II, M.D., Ph.D., president of Mayo Clinic Laboratories, for this week's "Answers From the Lab" leadership update. In this episode, Dr. Binnicker and Dr. Morice discuss the impact that emerging COVID-19 variants could have on virus testing, vaccine and spread.</p>
<p>For more, follow the Mayo Clinic Labs on Twitter <a href='https://twitter.com/mayocliniclabs'>@mayocliniclabs</a> or visit <a href='https://news.mayocliniclabs.com/podcast/answers-from-the-lab/'>https://news.mayocliniclabs.com/podcast/answers-from-the-lab/</a> to check out all of their episodes.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/piwqhq/WFxxxxx_-_Morice__2_1ashmz.mp3" length="16084212" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Answers from the Lab and was originally published February 2, 2021. 
Guest: Matthew J. Binnicker, Ph.D. (@DrMattBinnicker)
Host: William G. Morice, II M.D., Ph.D. (@moricemdphd)
Matthew Binnicker, Ph.D., vice chair of practice for Mayo Clinic's Department of Laboratory Medicine and Pathology, joins William Morice II, M.D., Ph.D., president of Mayo Clinic Laboratories, for this week's "Answers From the Lab" leadership update. In this episode, Dr. Binnicker and Dr. Morice discuss the impact that emerging COVID-19 variants could have on virus testing, vaccine and spread.
For more, follow the Mayo Clinic Labs on Twitter @mayocliniclabs or visit https://news.mayocliniclabs.com/podcast/answers-from-the-lab/ to check out all of their episodes.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1001</itunes:duration>
                        <itunes:episodeType>bonus</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/AnswersLabIcon.jpg" />    </item>
    <item>
        <title>COVID-19 Miniseries Episode 64: Leveraging Community Care for Scalable Outpatient Management of COVID-19</title>
        <itunes:title>COVID-19 Miniseries Episode 64: Leveraging Community Care for Scalable Outpatient Management of COVID-19</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-64-leveraging-community-care-for-scalable-outpatient-management-of-covid-19/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-64-leveraging-community-care-for-scalable-outpatient-management-of-covid-19/#comments</comments>        <pubDate>Tue, 09 Feb 2021 06:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/d3ba9205-1058-340c-8c6d-3d9edc135793</guid>
                                    <description><![CDATA[<p>Guest: Ravindra Ganesh, M.B.B.S., M.D.</p>
<p>Host: Amit K. Ghosh, M.D. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>)</p>
<p>The Mayo Clinic COVID Frontline Healthcare Team (CFCT) is an integrated team comprised of doctors and support staff, including nurses, remote monitoring technicians, medical assistants, and desk staff. These teams are responsible for evidence-based management of all newly diagnosed COVID-19 patients. We’re joined by CFCT Codirector Ravindra Ganesh, M.B.B.S., M.D., to discuss the essential roles of CFCT’s during the pandemic.</p>
<p>Topics include how they:</p>
<ol><li>Notify all patients who receive a COVID positive test result in Mayo/Mayo Clinic Health service in the Midwest region through phone call or portal messaging with attached questionnaire</li>
<li>Conduct outpatient monitoring and follow-up as well as identify patient at high risk for decompensation</li>
<li>Prevent COVID positive patients from coming to the Mayo Clinic facilities by remote monitoring and risk assessment</li>
<li>Reinforce social isolation recommendations from public health to all COVID positive patients and assess safety to come off isolation</li>
</ol><p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Ravindra Ganesh, M.B.B.S., M.D.</p>
<p>Host: Amit K. Ghosh, M.D. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>)</p>
<p>The Mayo Clinic COVID Frontline Healthcare Team (CFCT) is an integrated team comprised of doctors and support staff, including nurses, remote monitoring technicians, medical assistants, and desk staff. These teams are responsible for evidence-based management of all newly diagnosed COVID-19 patients. We’re joined by CFCT Codirector Ravindra Ganesh, M.B.B.S., M.D., to discuss the essential roles of CFCT’s during the pandemic.</p>
<p>Topics include how they:</p>
<ol><li>Notify all patients who receive a COVID positive test result in Mayo/Mayo Clinic Health service in the Midwest region through phone call or portal messaging with attached questionnaire</li>
<li>Conduct outpatient monitoring and follow-up as well as identify patient at high risk for decompensation</li>
<li>Prevent COVID positive patients from coming to the Mayo Clinic facilities by remote monitoring and risk assessment</li>
<li>Reinforce social isolation recommendations from public health to all COVID positive patients and assess safety to come off isolation</li>
</ol><p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pp8zdh/WF64621_-_COVID_Frontline_Care_-_Ganesh70o6o.mp3" length="27022086" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Ravindra Ganesh, M.B.B.S., M.D.
Host: Amit K. Ghosh, M.D. (@AmitGhosh006)
The Mayo Clinic COVID Frontline Healthcare Team (CFCT) is an integrated team comprised of doctors and support staff, including nurses, remote monitoring technicians, medical assistants, and desk staff. These teams are responsible for evidence-based management of all newly diagnosed COVID-19 patients. We’re joined by CFCT Codirector Ravindra Ganesh, M.B.B.S., M.D., to discuss the essential roles of CFCT’s during the pandemic.
Topics include how they:
Notify all patients who receive a COVID positive test result in Mayo/Mayo Clinic Health service in the Midwest region through phone call or portal messaging with attached questionnaire
Conduct outpatient monitoring and follow-up as well as identify patient at high risk for decompensation
Prevent COVID positive patients from coming to the Mayo Clinic facilities by remote monitoring and risk assessment
Reinforce social isolation recommendations from public health to all COVID positive patients and assess safety to come off isolation
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1683</itunes:duration>
                <itunes:episode>221</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>COVID-19 Miniseries Episode 63: Mayo Clinic Q&amp;A - #AskTheMayoMom about Sports Participation During COVID-19</title>
        <itunes:title>COVID-19 Miniseries Episode 63: Mayo Clinic Q&amp;A - #AskTheMayoMom about Sports Participation During COVID-19</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-63-mayo-clinic-qa-askthemayomom-about-sports-participation-during-covid-19/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-63-mayo-clinic-qa-askthemayomom-about-sports-participation-during-covid-19/#comments</comments>        <pubDate>Mon, 08 Feb 2021 10:20:43 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/1fa0b0df-eae8-303e-9e24-e59514c0cca9</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in February, 2021</p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  David B. Soma, M.D. (<a href='https://twitter.com/drdavesoma?lang=en'>@DrDaveSoma</a>); Talha Niaz, M.B.B.S.</p>
<p>Host: Angela C. Mattke, M.D. (<a href='https://twitter.com/drangelamattke?lang=en'>@DrAngelaMattke</a>)</p>
<p>There are many benefits to sports participation for children and adolescents. However, during the <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a> pandemic, activities such as youth sports have been put on hold or modified to decrease the spread of COVID-19. Also, the scientific community is learning about when it is safe to return to sports participation following COVID-19 infection.  </p>
<p>On the Mayo Clinic Q&A podcast, "Ask the Mayo Mom" host and Mayo Clinic pediatrician, <a href='https://www.mayoclinic.org/biographies/mattke-angela-c-m-d/bio-20055584?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Dr. Angela Mattke</a> is joined by <a href='https://www.mayo.edu/research/faculty/soma-david-b-m-d/bio-20359298?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.183384481.603635545.1612452633-841877308.1603891377'>Dr. David Soma</a>, a pediatric sports medicine physician at <a href='https://www.mayoclinic.org/departments-centers/childrens-center?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Mayo Clinic Children's Center</a>, to discuss sports participation during the COVID-19 pandemic and what you need to know about return to play after COVID-19 infection. Also joining Drs. Mattke and Soma is Dr. Talha Niaz, a pediatric cardiologist at Mayo Clinic. </p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in February, 2021</p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  David B. Soma, M.D. (<a href='https://twitter.com/drdavesoma?lang=en'>@DrDaveSoma</a>); Talha Niaz, M.B.B.S.</p>
<p>Host: Angela C. Mattke, M.D. (<a href='https://twitter.com/drangelamattke?lang=en'>@DrAngelaMattke</a>)</p>
<p>There are many benefits to sports participation for children and adolescents. However, during the <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a> pandemic, activities such as youth sports have been put on hold or modified to decrease the spread of COVID-19. Also, the scientific community is learning about when it is safe to return to sports participation following COVID-19 infection.  </p>
<p>On the Mayo Clinic Q&A podcast, "Ask the Mayo Mom" host and Mayo Clinic pediatrician, <a href='https://www.mayoclinic.org/biographies/mattke-angela-c-m-d/bio-20055584?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Dr. Angela Mattke</a> is joined by <a href='https://www.mayo.edu/research/faculty/soma-david-b-m-d/bio-20359298?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.183384481.603635545.1612452633-841877308.1603891377'>Dr. David Soma</a>, a pediatric sports medicine physician at <a href='https://www.mayoclinic.org/departments-centers/childrens-center?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Mayo Clinic Children's Center</a>, to discuss sports participation during the COVID-19 pandemic and what you need to know about return to play after COVID-19 infection. Also joining Drs. Mattke and Soma is Dr. Talha Niaz, a pediatric cardiologist at Mayo Clinic. </p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pdj35p/Ask_the_Mayo_Mom_-_02_05_21.mp3" length="32177055" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in February, 2021
To claim credit visit: https://ce.mayo.edu/covid19podcast 
Guest:  David B. Soma, M.D. (@DrDaveSoma); Talha Niaz, M.B.B.S.
Host: Angela C. Mattke, M.D. (@DrAngelaMattke)
There are many benefits to sports participation for children and adolescents. However, during the COVID-19 pandemic, activities such as youth sports have been put on hold or modified to decrease the spread of COVID-19. Also, the scientific community is learning about when it is safe to return to sports participation following COVID-19 infection.  
On the Mayo Clinic Q&A podcast, "Ask the Mayo Mom" host and Mayo Clinic pediatrician, Dr. Angela Mattke is joined by Dr. David Soma, a pediatric sports medicine physician at Mayo Clinic Children's Center, to discuss sports participation during the COVID-19 pandemic and what you need to know about return to play after COVID-19 infection. Also joining Drs. Mattke and Soma is Dr. Talha Niaz, a pediatric cardiologist at Mayo Clinic. 
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2008</itunes:duration>
                <itunes:episode>220</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>COVID-19 Miniseries Episode 62: Mayo Clinic Q&amp;A: COVID-19 Virus, Variants and Vaccines Update</title>
        <itunes:title>COVID-19 Miniseries Episode 62: Mayo Clinic Q&amp;A: COVID-19 Virus, Variants and Vaccines Update</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-62-mayo-clinic-qa-covid-19-virus-variants-and-vaccines-update/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-62-mayo-clinic-qa-covid-19-virus-variants-and-vaccines-update/#comments</comments>        <pubDate>Thu, 04 Feb 2021 06:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/a84437ee-0af1-3bbc-ab37-2e19f428d11d</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in February, 2021</p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@DrGregPoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)   </p>
<p>When it comes to the <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a> pandemic, <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.136537328.1903245515.1583502589-382127956.1576426874?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>, says there's some good news. "Case numbers are falling, masking and distancing do work, and we can control this if we do it right." </p>
<p> </p>
<p>However, the not so good news is that variants are showing up in over 30 countries and are reportedly more transmissible. There also seems to be a reduction in vaccine efficacy against the new variants. </p>
<p>"This is a desperate race between vaccine and virus, between time and opportunity, and we dare not lose that opportunity," emphasizes Dr. Poland. </p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland discusses how COVID-19 viruses mutate into new variants. He also discusses recent COVID-19 research conducted by the NFL, plus he touches on the future of individualized vaccines. "I can see the development of a coronavirus vaccine against multiple types of coronavirus, including the one that causes the common cold, and very likely combine that with the influenza vaccine."</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in February, 2021</p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@DrGregPoland</a>)</p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>)   </p>
<p>When it comes to the <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a> pandemic, <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.136537328.1903245515.1583502589-382127956.1576426874?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Mayo Clinic's Vaccine Research Group</a>, says there's some good news. "Case numbers are falling, masking and distancing do work, and we can control this if we do it right." </p>
<p> </p>
<p>However, the not so good news is that variants are showing up in over 30 countries and are reportedly more transmissible. There also seems to be a reduction in vaccine efficacy against the new variants. </p>
<p>"This is a desperate race between vaccine and virus, between time and opportunity, and we dare not lose that opportunity," emphasizes Dr. Poland. </p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland discusses how COVID-19 viruses mutate into new variants. He also discusses recent COVID-19 research conducted by the NFL, plus he touches on the future of individualized vaccines. "I can see the development of a coronavirus vaccine against multiple types of coronavirus, including the one that causes the common cold, and very likely combine that with the influenza vaccine."</p>
<p>AskMayoExpert COVID-19 Resources:<a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'> https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at<a href='https://ce.mayo.edu/'> https://ce.mayo.edu/</a> or on Twitter<a href='https://twitter.com/MayoMedEd'> @MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/in4qbr/Mayo_Clinic_Podcast_-_Dr_Gregory_Poland_-_02_03_216tlr1.mp3" length="29713072" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in February, 2021
To claim credit visit: https://ce.mayo.edu/covid19podcast 
Guest:  Gregory A. Poland, M.D. (@DrGregPoland)
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)   
When it comes to the COVID-19 pandemic, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, says there's some good news. "Case numbers are falling, masking and distancing do work, and we can control this if we do it right." 
 
However, the not so good news is that variants are showing up in over 30 countries and are reportedly more transmissible. There also seems to be a reduction in vaccine efficacy against the new variants. 
"This is a desperate race between vaccine and virus, between time and opportunity, and we dare not lose that opportunity," emphasizes Dr. Poland. 
In this Mayo Clinic Q&A podcast, Dr. Poland discusses how COVID-19 viruses mutate into new variants. He also discusses recent COVID-19 research conducted by the NFL, plus he touches on the future of individualized vaccines. "I can see the development of a coronavirus vaccine against multiple types of coronavirus, including the one that causes the common cold, and very likely combine that with the influenza vaccine."
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1853</itunes:duration>
                <itunes:episode>219</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>COVID-19 Miniseries Episode 61: Mayo Clinic Q&amp;A: Picking Up the Pace With Rollout of COVID-19 Vaccines</title>
        <itunes:title>COVID-19 Miniseries Episode 61: Mayo Clinic Q&amp;A: Picking Up the Pace With Rollout of COVID-19 Vaccines</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-61-mayo-clinic-qa-picking-up-the-pace-with-rollout-of-covid-19-vaccines/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-61-mayo-clinic-qa-picking-up-the-pace-with-rollout-of-covid-19-vaccines/#comments</comments>        <pubDate>Thu, 04 Feb 2021 05:59:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/c0efaa77-ae75-3f4a-ad20-d45d7621449d</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in January, 2021. </p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Gregory A. Poland, M.D. <a href='https://twitter.com/drgregpoland?lang=en'>(@drgregpoland)</a> </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>) </p>
<p>The distribution kinks for <a href='https://www.mayoclinic.org/coronavirus-covid-19/vaccine?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.35752864.1809251887.1610976384-1506181475.1609349023'>COVID-19 vaccines</a> are getting ironed out, says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.35752864.1809251887.1610976384-1506181475.1609349023'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.35752864.1809251887.1610976384-1506181475.1609349023'>Mayo Clinic's Vaccine Research Group</a>.</p>
<p>"It's a logistics nightmare, but now you're seeing a plan to administer 1 million doses a day and I think that's very achievable," says Dr. Poland<a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.136537328.1903245515.1583502589-382127956.1576426874'>.</a> "And the production of the vaccine is just going to accelerate."</p>
<p>Dr. Poland also repeats the reminders about preventing transmission of <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a>:</p>
<ul><li style="font-weight:400;">Wear a mask.</li>
<li style="font-weight:400;">Wash your hands.</li>
<li style="font-weight:400;">Keep your social distance. </li>
</ul>
<p>"The current estimates are that in the next four weeks, we'll probably have about another 100,000 deaths," adds Dr. Poland. "It's stunning when you think about 1 out of every 860 Americans has now died of this."</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland talks more about the rollout, transmission and <a href='https://www.mayoclinic.org/diseases-conditions/coronavirus/in-depth/herd-immunity-and-coronavirus/art-20486808?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.195750444.1809251887.1610976384-1506181475.1609349023'>herd immunity</a>, as well as fertility issues related to COVID-19, survivor brain fog and more.</p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in January, 2021. </p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Gregory A. Poland, M.D. <a href='https://twitter.com/drgregpoland?lang=en'>(@drgregpoland)</a> </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>) </p>
<p>The distribution kinks for <a href='https://www.mayoclinic.org/coronavirus-covid-19/vaccine?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.35752864.1809251887.1610976384-1506181475.1609349023'>COVID-19 vaccines</a> are getting ironed out, says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.35752864.1809251887.1610976384-1506181475.1609349023'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.35752864.1809251887.1610976384-1506181475.1609349023'>Mayo Clinic's Vaccine Research Group</a>.</p>
<p>"It's a logistics nightmare, but now you're seeing a plan to administer 1 million doses a day and I think that's very achievable," says Dr. Poland<a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.136537328.1903245515.1583502589-382127956.1576426874'>.</a> "And the production of the vaccine is just going to accelerate."</p>
<p>Dr. Poland also repeats the reminders about preventing transmission of <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a>:</p>
<ul><li style="font-weight:400;">Wear a mask.</li>
<li style="font-weight:400;">Wash your hands.</li>
<li style="font-weight:400;">Keep your social distance. </li>
</ul>
<p>"The current estimates are that in the next four weeks, we'll probably have about another 100,000 deaths," adds Dr. Poland. "It's stunning when you think about 1 out of every 860 Americans has now died of this."</p>
<p>In this Mayo Clinic Q&A podcast, Dr. Poland talks more about the rollout, transmission and <a href='https://www.mayoclinic.org/diseases-conditions/coronavirus/in-depth/herd-immunity-and-coronavirus/art-20486808?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.195750444.1809251887.1610976384-1506181475.1609349023'>herd immunity</a>, as well as fertility issues related to COVID-19, survivor brain fog and more.</p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9iubwn/Mayo_Clinic_Podcast_-_Dr_Gregory_Poland_-_01_20_21890r2.mp3" length="31436991" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in January, 2021. 
To claim credit visit: https://ce.mayo.edu/covid19podcast 
Guest:  Gregory A. Poland, M.D. (@drgregpoland) 
Host: Halena M. Gazelka, M.D. (@hmgazelkamd) 
The distribution kinks for COVID-19 vaccines are getting ironed out, says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group.
"It's a logistics nightmare, but now you're seeing a plan to administer 1 million doses a day and I think that's very achievable," says Dr. Poland. "And the production of the vaccine is just going to accelerate."
Dr. Poland also repeats the reminders about preventing transmission of COVID-19:
Wear a mask.
Wash your hands.
Keep your social distance. 
"The current estimates are that in the next four weeks, we'll probably have about another 100,000 deaths," adds Dr. Poland. "It's stunning when you think about 1 out of every 860 Americans has now died of this."
In this Mayo Clinic Q&A podcast, Dr. Poland talks more about the rollout, transmission and herd immunity, as well as fertility issues related to COVID-19, survivor brain fog and more.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1963</itunes:duration>
                <itunes:episode>218</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>Want to Know About Pediatric Enuresis? Well, Urine Luck</title>
        <itunes:title>Want to Know About Pediatric Enuresis? Well, Urine Luck</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/want-to-know-about-pediatric-enuresis-well-urine-luck/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/want-to-know-about-pediatric-enuresis-well-urine-luck/#comments</comments>        <pubDate>Tue, 02 Feb 2021 06:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/6e73c0c3-876c-3c7d-bc41-8b1e7b4690a2</guid>
                                    <description><![CDATA[<p>Guest: Patricio Gargollo, M.D. (<a href='https://twitter.com/pgargollo'>@pgargollo</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Enuresis is relatively common in children, estimated to be present in as many as 5 to 10% of 7-year-olds. This represents up to 7 million children in the United States. As you can imagine, it carries significant social implications for the child. Our guest for this podcast is Dr. Patricio Gargollo, a pediatric urologist at Mayo Clinic in Rochester, Minnesota. Dr. Gargollo will address the natural history of enuresis, how to evaluate the child with enuresis, how often it represents a structural urologic problem and how often a treatable cause is found. Practical advice for parents of children with enuresis is also discussed.</p>
<p>Specific topics:</p>
<ul><li>Potential for children with enuresis to have bladder control problems when they develop into adulthood.</li>
<li>Social impact of enuresis on a child.</li>
<li>Potential risk factors and causes of enuresis.</li>
<li>The role of genetics and enuresis.</li>
<li>The natural history of enuresis.</li>
<li>How often a structural urologic problem is found to explain enuresis.</li>
<li>Pharmacologic treatment options.</li>
<li>The evaluation of a child with enuresis.</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Patricio Gargollo, M.D. (<a href='https://twitter.com/pgargollo'>@pgargollo</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>Enuresis is relatively common in children, estimated to be present in as many as 5 to 10% of 7-year-olds. This represents up to 7 million children in the United States. As you can imagine, it carries significant social implications for the child. Our guest for this podcast is Dr. Patricio Gargollo, a pediatric urologist at Mayo Clinic in Rochester, Minnesota. Dr. Gargollo will address the natural history of enuresis, how to evaluate the child with enuresis, how often it represents a structural urologic problem and how often a treatable cause is found. Practical advice for parents of children with enuresis is also discussed.</p>
<p>Specific topics:</p>
<ul><li>Potential for children with enuresis to have bladder control problems when they develop into adulthood.</li>
<li>Social impact of enuresis on a child.</li>
<li>Potential risk factors and causes of enuresis.</li>
<li>The role of genetics and enuresis.</li>
<li>The natural history of enuresis.</li>
<li>How often a structural urologic problem is found to explain enuresis.</li>
<li>Pharmacologic treatment options.</li>
<li>The evaluation of a child with enuresis.</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8mysrf/VT3984378_-_Pediatric_Enuresis6n37f.mp3" length="20356206" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Patricio Gargollo, M.D. (@pgargollo)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Enuresis is relatively common in children, estimated to be present in as many as 5 to 10% of 7-year-olds. This represents up to 7 million children in the United States. As you can imagine, it carries significant social implications for the child. Our guest for this podcast is Dr. Patricio Gargollo, a pediatric urologist at Mayo Clinic in Rochester, Minnesota. Dr. Gargollo will address the natural history of enuresis, how to evaluate the child with enuresis, how often it represents a structural urologic problem and how often a treatable cause is found. Practical advice for parents of children with enuresis is also discussed.
Specific topics:
Potential for children with enuresis to have bladder control problems when they develop into adulthood.
Social impact of enuresis on a child.
Potential risk factors and causes of enuresis.
The role of genetics and enuresis.
The natural history of enuresis.
How often a structural urologic problem is found to explain enuresis.
Pharmacologic treatment options.
The evaluation of a child with enuresis.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1268</itunes:duration>
                <itunes:episode>217</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Answers From the Lab: National COVID-19 Strategy</title>
        <itunes:title>Answers From the Lab: National COVID-19 Strategy</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/answers-from-the-lab-national-covid-19-strategy/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/answers-from-the-lab-national-covid-19-strategy/#comments</comments>        <pubDate>Thu, 28 Jan 2021 12:19:35 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/46e9489e-2d7c-35aa-8b39-9d6852128876</guid>
                                    <description><![CDATA[<p>This episode is shared from <a href='https://news.mayocliniclabs.com/podcast/answers-from-the-lab/'>Answers from the Lab</a> and was originally published January 28, 2021. </p>
<p>Guest: William G. Morice, II M.D., Ph.D. (<a href='https://twitter.com/moricemdphd'>@moricemdphd</a>) </p>
<p>Host: Bobbi S. Pritt, M.D. (<a href='https://twitter.com/ParasiteGal'>@ParasiteGal</a>) </p>
<p>William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update. In this episode, Dr. Morice and Bobbi Pritt, M.D., discuss the new nationwide strategy that the Biden administration is rolling out to combat COVID-19.
</p>
<p>For more, follow the Mayo Clinic Labs on Twitter <a href='https://twitter.com/mayocliniclabs'>@mayocliniclabs</a> or visit <a href='https://news.mayocliniclabs.com/podcast/answers-from-the-lab/'>https://news.mayocliniclabs.com/podcast/answers-from-the-lab/</a> to check out all of their episodes.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from <a href='https://news.mayocliniclabs.com/podcast/answers-from-the-lab/'>Answers from the Lab</a> and was originally published January 28, 2021. </p>
<p>Guest: William G. Morice, II M.D., Ph.D. (<a href='https://twitter.com/moricemdphd'>@moricemdphd</a>) </p>
<p>Host: Bobbi S. Pritt, M.D. (<a href='https://twitter.com/ParasiteGal'>@ParasiteGal</a>) </p>
<p>William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update. In this episode, Dr. Morice and Bobbi Pritt, M.D., discuss the new nationwide strategy that the Biden administration is rolling out to combat COVID-19.<br>
</p>
<p>For more, follow the Mayo Clinic Labs on Twitter <a href='https://twitter.com/mayocliniclabs'>@mayocliniclabs</a> or visit <a href='https://news.mayocliniclabs.com/podcast/answers-from-the-lab/'>https://news.mayocliniclabs.com/podcast/answers-from-the-lab/</a> to check out all of their episodes.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/svxg2f/WF69816_-_Morice7ypl8.mp3" length="9944012" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Answers from the Lab and was originally published January 28, 2021. 
Guest: William G. Morice, II M.D., Ph.D. (@moricemdphd) 
Host: Bobbi S. Pritt, M.D. (@ParasiteGal) 
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update. In this episode, Dr. Morice and Bobbi Pritt, M.D., discuss the new nationwide strategy that the Biden administration is rolling out to combat COVID-19.
For more, follow the Mayo Clinic Labs on Twitter @mayocliniclabs or visit https://news.mayocliniclabs.com/podcast/answers-from-the-lab/ to check out all of their episodes.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>618</itunes:duration>
                        <itunes:episodeType>bonus</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/AnswersLabIcon.jpg" />    </item>
    <item>
        <title>COVID-19 Miniseries Episode 60: Restoring Joy to Healthcare</title>
        <itunes:title>COVID-19 Miniseries Episode 60: Restoring Joy to Healthcare</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-60-restoring-joy-to-healthcare/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-60-restoring-joy-to-healthcare/#comments</comments>        <pubDate>Tue, 26 Jan 2021 06:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/77f477c3-0423-3440-9111-37926d60bb87</guid>
                                    <description><![CDATA[<p>Guest: Eric J. Cleveland; Danielle M. Teal (<a href='https://twitter.com/dteal'>@dteal</a>)</p>
<p>Host: Amit K. Ghosh, M.D. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>)</p>
<p>Joy has been defined as a human emotion — a state created as we experience positive, poignant, reflective and connective moments. It is transient, never persisting but imparting ripples that impact us long after the moment.</p>
<p>Now more than ever there is a need to develop mindful initiatives that brings joy in our personal lives and in the workplace. In this episode we speak with Eric Cleveland and Danielle Teal, two leaders of the Joy at Mayo Clinic (J@M) initiative. We will discuss the joy equation, the Institute of Health Improvement’s (IHI) <a href='http://www.ihi.org/resources/Pages/IHIWhitePapers/Framework-Improving-Joy-in-Work.aspx'>Framework for Improving Joy in Work</a> and discuss examples of pragmatic initiatives that can bring joy at both the individual and team levels.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Eric J. Cleveland; Danielle M. Teal (<a href='https://twitter.com/dteal'>@dteal</a>)</p>
<p>Host: Amit K. Ghosh, M.D. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>)</p>
<p>Joy has been defined as a human emotion — a state created as we experience positive, poignant, reflective and connective moments. It is transient, never persisting but imparting ripples that impact us long after the moment.</p>
<p>Now more than ever there is a need to develop mindful initiatives that brings joy in our personal lives and in the workplace. In this episode we speak with Eric Cleveland and Danielle Teal, two leaders of the Joy at Mayo Clinic (J@M) initiative. We will discuss the joy equation, the Institute of Health Improvement’s (IHI) <a href='http://www.ihi.org/resources/Pages/IHIWhitePapers/Framework-Improving-Joy-in-Work.aspx'>Framework for Improving Joy in Work</a> and discuss examples of pragmatic initiatives that can bring joy at both the individual and team levels.</p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mvkxy7/VT3984362_-_Joya9w29.mp3" length="42123378" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Eric J. Cleveland; Danielle M. Teal (@dteal)
Host: Amit K. Ghosh, M.D. (@AmitGhosh006)
Joy has been defined as a human emotion — a state created as we experience positive, poignant, reflective and connective moments. It is transient, never persisting but imparting ripples that impact us long after the moment.
Now more than ever there is a need to develop mindful initiatives that brings joy in our personal lives and in the workplace. In this episode we speak with Eric Cleveland and Danielle Teal, two leaders of the Joy at Mayo Clinic (J@M) initiative. We will discuss the joy equation, the Institute of Health Improvement’s (IHI) Framework for Improving Joy in Work and discuss examples of pragmatic initiatives that can bring joy at both the individual and team levels.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2622</itunes:duration>
                <itunes:episode>216</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>COVID-19 Miniseries Episode 59: Mayo Clinic Q&amp;A - Expert Updates on COVID-19 Vaccines</title>
        <itunes:title>COVID-19 Miniseries Episode 59: Mayo Clinic Q&amp;A - Expert Updates on COVID-19 Vaccines</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-59-mayo-clinic-qa-expert-updates-on-covid-19-vaccines/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-59-mayo-clinic-qa-expert-updates-on-covid-19-vaccines/#comments</comments>        <pubDate>Thu, 21 Jan 2021 06:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/ecb2a75a-05aa-3a18-bee8-b068c1d3cb1b</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded on January 11, 2021. </p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Gregory A. Poland, M.D. <a href='https://twitter.com/drgregpoland?lang=en'>(@drgregpoland)</a> </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>) </p>
<p>The U.S. rollout of <a href='https://www.mayoclinic.org/coronavirus-covid-19'>COVID-19</a> vaccines is reportedly ramping up with news that nearly all available doses will soon be released to the American public. </p>
<p>"The new COVID-19 variants are traveling quickly, and this is a warning that we need to take precautions," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.136537328.1903245515.1583502589-382127956.1576426874'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview'>Mayo Clinic's Vaccine Research Group</a>. </p>
<p>Dr. Poland says these new variants are a consequence of an RNA virus being transmitted from human to human. "Even after we get our vaccines, we still need to wear masks out in public. We still need to maintain physical distancing. And we still need to wash our hands until about 80% of people get their COVID-19 vaccines," Dr. Poland emphasizes.In this Mayo Clinic Q&A podcast, Dr. Poland goes into detail about the COVID-19 vaccines, including "sterilizing immunity," testing for antibodies after receiving the vaccine, the possibility of booster doses in the future and much more. </p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded on January 11, 2021. </p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Gregory A. Poland, M.D. <a href='https://twitter.com/drgregpoland?lang=en'>(@drgregpoland)</a> </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>) </p>
<p>The U.S. rollout of <a href='https://www.mayoclinic.org/coronavirus-covid-19'>COVID-19</a> vaccines is reportedly ramping up with news that nearly all available doses will soon be released to the American public. </p>
<p>"The new COVID-19 variants are traveling quickly, and this is a warning that we need to take precautions," says <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.136537328.1903245515.1583502589-382127956.1576426874'>Dr. Gregory Poland</a>, an infectious diseases expert and head of <a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview'>Mayo Clinic's Vaccine Research Group</a>. </p>
<p>Dr. Poland says these new variants are a consequence of an RNA virus being transmitted from human to human. "Even after we get our vaccines, we still need to wear masks out in public. We still need to maintain physical distancing. And we still need to wash our hands until about 80% of people get their COVID-19 vaccines," Dr. Poland emphasizes.In this Mayo Clinic Q&A podcast, Dr. Poland goes into detail about the COVID-19 vaccines, including "sterilizing immunity," testing for antibodies after receiving the vaccine, the possibility of booster doses in the future and much more. </p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/yu59j7/Mayo_Clinic_Podcast_-_Dr_Gregory_Poland_-_01_13_218zff5.mp3" length="29432159" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded on January 11, 2021. 
To claim credit visit: https://ce.mayo.edu/covid19podcast 
Guest:  Gregory A. Poland, M.D. (@drgregpoland) 
Host: Halena M. Gazelka, M.D. (@hmgazelkamd) 
The U.S. rollout of COVID-19 vaccines is reportedly ramping up with news that nearly all available doses will soon be released to the American public. 
"The new COVID-19 variants are traveling quickly, and this is a warning that we need to take precautions," says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group. 
Dr. Poland says these new variants are a consequence of an RNA virus being transmitted from human to human. "Even after we get our vaccines, we still need to wear masks out in public. We still need to maintain physical distancing. And we still need to wash our hands until about 80% of people get their COVID-19 vaccines," Dr. Poland emphasizes.In this Mayo Clinic Q&A podcast, Dr. Poland goes into detail about the COVID-19 vaccines, including "sterilizing immunity," testing for antibodies after receiving the vaccine, the possibility of booster doses in the future and much more. 
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1838</itunes:duration>
                <itunes:episode>215</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>Adult Eating Disorders</title>
        <itunes:title>Adult Eating Disorders</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/adult-eating-disorders/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/adult-eating-disorders/#comments</comments>        <pubDate>Tue, 19 Jan 2021 06:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/0669940e-24e2-378a-a99c-e09f34f799cf</guid>
                                    <description><![CDATA[<p>Guest: Leslie A. Sim, Ph.D., L.P. (<a href='https://twitter.com/DrLeslieSim'>@DrLeslieSim</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>A variety of eating disorders can occur in adults and they are associated with multiple potential health complications, including an increased risk of death. Some studies report that up to 20% of those with Anorexia Nervosa will die as a result of the condition. Would you recognize an eating disorder in the patients you see? What clues should you look for? In this week’s Mayo Clinic Talks, we’ll speak with Dr. Leslie Sim, a psychologist at the Mayo Clinic. We’ll discuss who is most likely to develop an eating disorder, important “red flag” symptoms, questions you should ask patients to help confirm a diagnosis, and how we should approach a patient we suspect has an eating disorder.</p>
<p>Topics discussed:</p>
<ul><li>Definition of an eating disorder</li>
<li>Important “red flag” symptoms that may indicate an eating disorder</li>
<li>Health complications that can occur as a result of an eating disorder</li>
<li>Who is most likely to have an eating disorder</li>
<li>The genetic component to eating disorders</li>
<li>Clues from their childhood that suggest patients may have an eating disorder as an adult</li>
<li>Events which can trigger an eating disorder</li>
<li>When we should suspect an eating disorder</li>
<li>How we should approach a patient we suspect has an eating disorder</li>
<li>Management of eating disorders</li>
<li>Effectiveness of treatment</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Leslie A. Sim, Ph.D., L.P. (<a href='https://twitter.com/DrLeslieSim'>@DrLeslieSim</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>A variety of eating disorders can occur in adults and they are associated with multiple potential health complications, including an increased risk of death. Some studies report that up to 20% of those with Anorexia Nervosa will die as a result of the condition. Would you recognize an eating disorder in the patients you see? What clues should you look for? In this week’s Mayo Clinic Talks, we’ll speak with Dr. Leslie Sim, a psychologist at the Mayo Clinic. We’ll discuss who is most likely to develop an eating disorder, important “red flag” symptoms, questions you should ask patients to help confirm a diagnosis, and how we should approach a patient we suspect has an eating disorder.</p>
<p>Topics discussed:</p>
<ul><li>Definition of an eating disorder</li>
<li>Important “red flag” symptoms that may indicate an eating disorder</li>
<li>Health complications that can occur as a result of an eating disorder</li>
<li>Who is most likely to have an eating disorder</li>
<li>The genetic component to eating disorders</li>
<li>Clues from their childhood that suggest patients may have an eating disorder as an adult</li>
<li>Events which can trigger an eating disorder</li>
<li>When we should suspect an eating disorder</li>
<li>How we should approach a patient we suspect has an eating disorder</li>
<li>Management of eating disorders</li>
<li>Effectiveness of treatment</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/iu2izm/VT3984381_-_Adult_Eating_Disorders_V26nraf.mp3" length="18610259" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Leslie A. Sim, Ph.D., L.P. (@DrLeslieSim)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
A variety of eating disorders can occur in adults and they are associated with multiple potential health complications, including an increased risk of death. Some studies report that up to 20% of those with Anorexia Nervosa will die as a result of the condition. Would you recognize an eating disorder in the patients you see? What clues should you look for? In this week’s Mayo Clinic Talks, we’ll speak with Dr. Leslie Sim, a psychologist at the Mayo Clinic. We’ll discuss who is most likely to develop an eating disorder, important “red flag” symptoms, questions you should ask patients to help confirm a diagnosis, and how we should approach a patient we suspect has an eating disorder.
Topics discussed:
Definition of an eating disorder
Important “red flag” symptoms that may indicate an eating disorder
Health complications that can occur as a result of an eating disorder
Who is most likely to have an eating disorder
The genetic component to eating disorders
Clues from their childhood that suggest patients may have an eating disorder as an adult
Events which can trigger an eating disorder
When we should suspect an eating disorder
How we should approach a patient we suspect has an eating disorder
Management of eating disorders
Effectiveness of treatment
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1157</itunes:duration>
                <itunes:episode>214</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>COVID-19 Miniseries Episode 58: Mayo Clinic Q&amp;A - #AskTheMayoMom about COVID-19 and School Children</title>
        <itunes:title>COVID-19 Miniseries Episode 58: Mayo Clinic Q&amp;A - #AskTheMayoMom about COVID-19 and School Children</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-58-mayo-clinic-qa-askthemayomom-about-covid-19-and-school-children/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-58-mayo-clinic-qa-askthemayomom-about-covid-19-and-school-children/#comments</comments>        <pubDate>Thu, 14 Jan 2021 10:24:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/174d7c3b-813e-3d57-8812-b6f1bfc01c4f</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in January, 2021.</p>
<p>Guests: Emily R. Levy, M.D. (<a href='https://twitter.com/emilylevy797?lang=en'>@EmilyLevy797</a>); Nipunie S. Rajapakse, M.D., M.P.H. (<a href='https://twitter.com/nrajapaksemd?lang=en'>@nrajapakseMD</a>)</p>
<p>Host: Angela C. Mattke, M.D. (<a href='https://twitter.com/drangelamattke?lang=en'>@DrAngelaMattke</a>)</p>
<p>Around the world, <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a> vaccinations are underway, but only in adults. Pfizer's vaccine has been authorized for ages 16 and up, while Moderna's vaccine is currently authorized for ages 18 and up. Vaccines are generally tested in adults first to ensure they are safe for pediatric trials. Both Pfizer and Moderna now have clinical trials underway to study the safety and effectiveness of COVID-19 vaccines in children. </p>
<p>This edition of the Mayo Clinic Q&A podcast features an <a href='https://twitter.com/drangelamattke?lang=en'>#AskMayoMom</a> episode hosted by <a href='https://www.mayoclinic.org/biographies/mattke-angela-c-m-d/bio-20055584?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Dr. Angela Mattke</a>, a pediatrician at <a href='https://www.mayoclinic.org/departments-centers/childrens-center?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Mayo Clinic Children's Center</a>. Joining Dr. Mattke to discuss COVID-19, vaccines and children are <a href='https://www.mayoclinic.org/biographies/rajapakse-nipunie-s-m-d-m-p-h/bio-20308514?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.144383477.1959225198.1609770047-841877308.1603891377'>Dr. Nipunie Rajapakse</a>, a Mayo Clinic pediatric infectious diseases physician, and  <a href='https://www.mayoclinic.org/biographies/levy-emily-r-m-d/bio-20489950?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.144383477.1959225198.1609770047-841877308.1603891377'>Dr. Emily Levy</a>, a Mayo Clinic pediatric critical care and infectious diseases expert. Dr. Levy also discusses <a href='https://www.mayoclinic.org/diseases-conditions/coronavirus/in-depth/mis-c-in-children-covid-19/art-20486809?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>multisystem inflammatory syndrome in children, also known as MIS-C</a>.</p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in January, 2021.</p>
<p>Guests: Emily R. Levy, M.D. (<a href='https://twitter.com/emilylevy797?lang=en'>@EmilyLevy797</a>); Nipunie S. Rajapakse, M.D., M.P.H. (<a href='https://twitter.com/nrajapaksemd?lang=en'>@nrajapakseMD</a>)</p>
<p>Host: Angela C. Mattke, M.D. (<a href='https://twitter.com/drangelamattke?lang=en'>@DrAngelaMattke</a>)</p>
<p>Around the world, <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a> vaccinations are underway, but only in adults. Pfizer's vaccine has been authorized for ages 16 and up, while Moderna's vaccine is currently authorized for ages 18 and up. Vaccines are generally tested in adults first to ensure they are safe for pediatric trials. Both Pfizer and Moderna now have clinical trials underway to study the safety and effectiveness of COVID-19 vaccines in children. </p>
<p>This edition of the Mayo Clinic Q&A podcast features an <a href='https://twitter.com/drangelamattke?lang=en'>#AskMayoMom</a> episode hosted by <a href='https://www.mayoclinic.org/biographies/mattke-angela-c-m-d/bio-20055584?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Dr. Angela Mattke</a>, a pediatrician at <a href='https://www.mayoclinic.org/departments-centers/childrens-center?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Mayo Clinic Children's Center</a>. Joining Dr. Mattke to discuss COVID-19, vaccines and children are <a href='https://www.mayoclinic.org/biographies/rajapakse-nipunie-s-m-d-m-p-h/bio-20308514?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.144383477.1959225198.1609770047-841877308.1603891377'>Dr. Nipunie Rajapakse</a>, a Mayo Clinic pediatric infectious diseases physician, and  <a href='https://www.mayoclinic.org/biographies/levy-emily-r-m-d/bio-20489950?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.144383477.1959225198.1609770047-841877308.1603891377'>Dr. Emily Levy</a>, a Mayo Clinic pediatric critical care and infectious diseases expert. Dr. Levy also discusses <a href='https://www.mayoclinic.org/diseases-conditions/coronavirus/in-depth/mis-c-in-children-covid-19/art-20486809?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>multisystem inflammatory syndrome in children, also known as MIS-C</a>.</p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9arqsa/Ask_the_Mayo_Mom_01_08_21.mp3" length="42857103" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in January, 2021.
Guests: Emily R. Levy, M.D. (@EmilyLevy797); Nipunie S. Rajapakse, M.D., M.P.H. (@nrajapakseMD)
Host: Angela C. Mattke, M.D. (@DrAngelaMattke)
Around the world, COVID-19 vaccinations are underway, but only in adults. Pfizer's vaccine has been authorized for ages 16 and up, while Moderna's vaccine is currently authorized for ages 18 and up. Vaccines are generally tested in adults first to ensure they are safe for pediatric trials. Both Pfizer and Moderna now have clinical trials underway to study the safety and effectiveness of COVID-19 vaccines in children. 
This edition of the Mayo Clinic Q&A podcast features an #AskMayoMom episode hosted by Dr. Angela Mattke, a pediatrician at Mayo Clinic Children's Center. Joining Dr. Mattke to discuss COVID-19, vaccines and children are Dr. Nipunie Rajapakse, a Mayo Clinic pediatric infectious diseases physician, and  Dr. Emily Levy, a Mayo Clinic pediatric critical care and infectious diseases expert. Dr. Levy also discusses multisystem inflammatory syndrome in children, also known as MIS-C.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2677</itunes:duration>
                <itunes:episode>213</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>Motion is Lotion: Staying Healthy While Working Remote</title>
        <itunes:title>Motion is Lotion: Staying Healthy While Working Remote</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/motion-is-lotion-staying-healthy-while-working-remote/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/motion-is-lotion-staying-healthy-while-working-remote/#comments</comments>        <pubDate>Tue, 12 Jan 2021 06:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/bb8fc4bc-f1cf-302d-b3ed-5e213bc5bdd7</guid>
                                    <description><![CDATA[<p>Guest: Corey M. Kunzer, P.T., D.P.T., SCS, (<a href='https://twitter.com/KunzerCorey'>@KunzerCorey</a>) and Edward R. Laskowski, M.D. (<a href='https://twitter.com/DrEdSportsMed'>@DrEdSportsMed</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>) </p>
<p>Over the past decade more individuals have begun working remotely; the numbers have increased dramatically this past year with the COVID-19 pandemic. While there are some advantages to working remotely, there are also some potential problems associated with it. Those working from home often develop a variety of musculoskeletal problems including low back and neck pain, as well as shoulder and extremity discomfort. Drs. Edward Laskowski, a physician and Corey Kunzer, a physical therapist, both in the Department of Physical Medicine and Rehabilitation at the Mayo Clinic will discuss some of the musculoskeletal problems associated with working remotely.</p>
<p>Specific topics discussed:</p>
<ul><li>Frequency of musculoskeletal problems associated with working from home</li>
<li>Differences between working at home vs. the traditional office</li>
<li>Issues to consider when selecting a desk and chair</li>
<li>Recommended positions of the monitor, keyboard and mouse</li>
<li>Benefits of a standing workstation or working while walking on a treadmill</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Corey M. Kunzer, P.T., D.P.T., SCS, (<a href='https://twitter.com/KunzerCorey'>@KunzerCorey</a>) and Edward R. Laskowski, M.D. (<a href='https://twitter.com/DrEdSportsMed'>@DrEdSportsMed</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>) </p>
<p>Over the past decade more individuals have begun working remotely; the numbers have increased dramatically this past year with the COVID-19 pandemic. While there are some advantages to working remotely, there are also some potential problems associated with it. Those working from home often develop a variety of musculoskeletal problems including low back and neck pain, as well as shoulder and extremity discomfort. Drs. Edward Laskowski, a physician and Corey Kunzer, a physical therapist, both in the Department of Physical Medicine and Rehabilitation at the Mayo Clinic will discuss some of the musculoskeletal problems associated with working remotely.</p>
<p>Specific topics discussed:</p>
<ul><li>Frequency of musculoskeletal problems associated with working from home</li>
<li>Differences between working at home vs. the traditional office</li>
<li>Issues to consider when selecting a desk and chair</li>
<li>Recommended positions of the monitor, keyboard and mouse</li>
<li>Benefits of a standing workstation or working while walking on a treadmill</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6m7a7j/VT3984375_Home_Ergonomics8v2qb.mp3" length="24103222" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Corey M. Kunzer, P.T., D.P.T., SCS, (@KunzerCorey) and Edward R. Laskowski, M.D. (@DrEdSportsMed)
Host: Darryl S. Chutka, M.D. (@ChutkaMD) 
Over the past decade more individuals have begun working remotely; the numbers have increased dramatically this past year with the COVID-19 pandemic. While there are some advantages to working remotely, there are also some potential problems associated with it. Those working from home often develop a variety of musculoskeletal problems including low back and neck pain, as well as shoulder and extremity discomfort. Drs. Edward Laskowski, a physician and Corey Kunzer, a physical therapist, both in the Department of Physical Medicine and Rehabilitation at the Mayo Clinic will discuss some of the musculoskeletal problems associated with working remotely.
Specific topics discussed:
Frequency of musculoskeletal problems associated with working from home
Differences between working at home vs. the traditional office
Issues to consider when selecting a desk and chair
Recommended positions of the monitor, keyboard and mouse
Benefits of a standing workstation or working while walking on a treadmill
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1503</itunes:duration>
                <itunes:episode>212</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Can Nutritional Supplements Turn You into an All-Star?</title>
        <itunes:title>Can Nutritional Supplements Turn You into an All-Star?</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/can-nutritional-supplements-turn-you-into-an-all-star/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/can-nutritional-supplements-turn-you-into-an-all-star/#comments</comments>        <pubDate>Tue, 05 Jan 2021 06:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/de070c64-c113-3525-bde2-f201c6e43930</guid>
                                    <description><![CDATA[<p>Guest: Andrew Jagim, Ph.D. (@<a href='https://twitter.com/AJagim'>AJagim</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>) </p>
<p>Billions of dollars per year are spent in the U.S. on nutritional supplements to enhance performance. Multiple nutritional supplements are commercially available and are marketed for enhancing endurance, building muscle strength, improving exercise efficiency, and decreasing the potential for injury. Do these supplements actually deliver the benefits they claim? Are they safe? What age athletes are taking these supplements?  We’ll discuss these topics and more with Dr. Andrew Jagim, the director of sports medicine research at the Mayo Clinic.</p>
<p>Specific topics:</p>
<ul><li>Recommended approach to the athlete who wants to improve their performance</li>
<li>Potential benefits of nutritional supplements for athlete's</li>
<li>Age of athletes taking nutritional supplements</li>
<li>Selecting a high-quality nutritional supplement</li>
<li>Reliable web sites reviewing the available nutritional supplements including potential benefits and safety</li>
<li>Review of commonly taken nutritional supplements</li>
<li>Nutritional supplements which have potential harm</li>
</ul>
<p>Additional Resources:</p>
<ul><li>Mayo Clinic Proceedings Article: <a href='https://www.mayoclinicproceedings.org/article/S0025-6196(20)30363-3/fulltext'>https://www.mayoclinicproceedings.org/article/S0025-6196(20)30363-3/fulltext</a></li>
<li>NIH – Office of Dietary Supplements: <a href='https://ods.od.nih.gov/factsheets/ExerciseAndAthleticPerformance-HealthProfessional/'>https://ods.od.nih.gov/factsheets/ExerciseAndAthleticPerformance-HealthProfessional/</a></li>
<li>International Society of Sports Nutrition (ISSN): <a href='https://www.sportsnutritionsociety.org/'>https://www.sportsnutritionsociety.org/</a></li>
<li>Third-Party Testing Information: <a href='https://examine.com/'>https://examine.com/</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Andrew Jagim, Ph.D. (@<a href='https://twitter.com/AJagim'>AJagim</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>) </p>
<p>Billions of dollars per year are spent in the U.S. on nutritional supplements to enhance performance. Multiple nutritional supplements are commercially available and are marketed for enhancing endurance, building muscle strength, improving exercise efficiency, and decreasing the potential for injury. Do these supplements actually deliver the benefits they claim? Are they safe? What age athletes are taking these supplements?  We’ll discuss these topics and more with Dr. Andrew Jagim, the director of sports medicine research at the Mayo Clinic.</p>
<p>Specific topics:</p>
<ul><li>Recommended approach to the athlete who wants to improve their performance</li>
<li>Potential benefits of nutritional supplements for athlete's</li>
<li>Age of athletes taking nutritional supplements</li>
<li>Selecting a high-quality nutritional supplement</li>
<li>Reliable web sites reviewing the available nutritional supplements including potential benefits and safety</li>
<li>Review of commonly taken nutritional supplements</li>
<li>Nutritional supplements which have potential harm</li>
</ul>
<p>Additional Resources:</p>
<ul><li>Mayo Clinic Proceedings Article: <a href='https://www.mayoclinicproceedings.org/article/S0025-6196(20)30363-3/fulltext'>https://www.mayoclinicproceedings.org/article/S0025-6196(20)30363-3/fulltext</a></li>
<li>NIH – Office of Dietary Supplements: <a href='https://ods.od.nih.gov/factsheets/ExerciseAndAthleticPerformance-HealthProfessional/'>https://ods.od.nih.gov/factsheets/ExerciseAndAthleticPerformance-HealthProfessional/</a></li>
<li>International Society of Sports Nutrition (ISSN): <a href='https://www.sportsnutritionsociety.org/'>https://www.sportsnutritionsociety.org/</a></li>
<li>Third-Party Testing Information: <a href='https://examine.com/'>https://examine.com/</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bvggk6/VT3986817_-_Dietary_Supplements-954md.mp3" length="24946459" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Andrew Jagim, Ph.D. (@AJagim)
Host: Darryl S. Chutka, M.D. (@ChutkaMD) 
Billions of dollars per year are spent in the U.S. on nutritional supplements to enhance performance. Multiple nutritional supplements are commercially available and are marketed for enhancing endurance, building muscle strength, improving exercise efficiency, and decreasing the potential for injury. Do these supplements actually deliver the benefits they claim? Are they safe? What age athletes are taking these supplements?  We’ll discuss these topics and more with Dr. Andrew Jagim, the director of sports medicine research at the Mayo Clinic.
Specific topics:
Recommended approach to the athlete who wants to improve their performance
Potential benefits of nutritional supplements for athlete's
Age of athletes taking nutritional supplements
Selecting a high-quality nutritional supplement
Reliable web sites reviewing the available nutritional supplements including potential benefits and safety
Review of commonly taken nutritional supplements
Nutritional supplements which have potential harm
Additional Resources:
Mayo Clinic Proceedings Article: https://www.mayoclinicproceedings.org/article/S0025-6196(20)30363-3/fulltext
NIH – Office of Dietary Supplements: https://ods.od.nih.gov/factsheets/ExerciseAndAthleticPerformance-HealthProfessional/
International Society of Sports Nutrition (ISSN): https://www.sportsnutritionsociety.org/
Third-Party Testing Information: https://examine.com/
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1555</itunes:duration>
                <itunes:episode>211</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: Opioid Crisis Worsens During COVID-19 Pandemic</title>
        <itunes:title>Mayo Clinic Q&amp;A: Opioid Crisis Worsens During COVID-19 Pandemic</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-opioid-crisis-worsens-during-covid-19-pandemic/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-opioid-crisis-worsens-during-covid-19-pandemic/#comments</comments>        <pubDate>Mon, 04 Jan 2021 11:51:53 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/3f889ed1-d9b2-3f43-af4f-b7b47661008b</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in December, 2020. </p>
<p>Guest: Tyler Oesterle, M.D., M.P.H. (<a href='https://twitter.com/oesterlemd?lang=en'>@OesterleMD</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>) </p>
<p>Stress, isolation and limited access to resources are fueling rising rates of <a href='https://www.mayoclinic.org/diseases-conditions/prescription-drug-abuse/symptoms-causes/syc-20376813?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>substance abuse</a> and overdoses during the <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a> pandemic. While coronavirus has been the focus of so much attention this year, the opioid crisis has continued unabated and has even worsened. More than 40 states have reported increases in opioid related deaths, according to the <a href='https://www.ama-assn.org/system/files/2020-12/issue-brief-increases-in-opioid-related-overdose.pdf'>American Medical Association</a>. </p>
<p>On the Mayo Clinic Q&A podcast, <a href='https://www.mayoclinichealthsystem.org/providers/tyler-oesterle-md'>Dr. Tyler Oesterle</a>, a psychiatrist and addiction expert at Mayo Clinic, discusses opioid use disorders and treatment options, including virtual medicine available during the pandemic. </p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in December, 2020. </p>
<p>Guest: Tyler Oesterle, M.D., M.P.H. (<a href='https://twitter.com/oesterlemd?lang=en'>@OesterleMD</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>) </p>
<p>Stress, isolation and limited access to resources are fueling rising rates of <a href='https://www.mayoclinic.org/diseases-conditions/prescription-drug-abuse/symptoms-causes/syc-20376813?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>substance abuse</a> and overdoses during the <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a> pandemic. While coronavirus has been the focus of so much attention this year, the opioid crisis has continued unabated and has even worsened. More than 40 states have reported increases in opioid related deaths, according to the <a href='https://www.ama-assn.org/system/files/2020-12/issue-brief-increases-in-opioid-related-overdose.pdf'>American Medical Association</a>. </p>
<p>On the Mayo Clinic Q&A podcast, <a href='https://www.mayoclinichealthsystem.org/providers/tyler-oesterle-md'>Dr. Tyler Oesterle</a>, a psychiatrist and addiction expert at Mayo Clinic, discusses opioid use disorders and treatment options, including virtual medicine available during the pandemic. </p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2s7ks6/Mayo_Clinic_Podcast_-_Tyler_Oesterle_-_1_01_21.mp3" length="26135595" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in December, 2020. 
Guest: Tyler Oesterle, M.D., M.P.H. (@OesterleMD) 
Host: Halena M. Gazelka, M.D. (@hmgazelkamd) 
Stress, isolation and limited access to resources are fueling rising rates of substance abuse and overdoses during the COVID-19 pandemic. While coronavirus has been the focus of so much attention this year, the opioid crisis has continued unabated and has even worsened. More than 40 states have reported increases in opioid related deaths, according to the American Medical Association. 
On the Mayo Clinic Q&A podcast, Dr. Tyler Oesterle, a psychiatrist and addiction expert at Mayo Clinic, discusses opioid use disorders and treatment options, including virtual medicine available during the pandemic. 
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1632</itunes:duration>
                        <itunes:episodeType>bonus</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>Mayo Clinic Q&amp;A: COVID-19 Mortality Study Shows Effectiveness of Team-Based Care</title>
        <itunes:title>Mayo Clinic Q&amp;A: COVID-19 Mortality Study Shows Effectiveness of Team-Based Care</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/covid-19-mortality-study-shows-effectiveness-of-team-based-care/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/covid-19-mortality-study-shows-effectiveness-of-team-based-care/#comments</comments>        <pubDate>Fri, 01 Jan 2021 06:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/a2b3aa99-0c17-3408-aea4-e92840611f52</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in December, 2020. </p>
<p>Guest: John (Jack) C. O'Horo, M.D., M.P.H. (<a href='https://twitter.com/jcohoro?lang=en'>@jcohoro</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>) </p>
<p>A recent Mayo Clinic study <a href='https://mayoclinicproceedings.org/pb/assets/raw/Health%20Advance/journals/jmcp/jmcp_ft95_12_2.pdf'>published in Mayo Clinic Proceedings</a>found that patients with <a href='https://www.mayoclinic.org/diseases-conditions/coronavirus/symptoms-causes/syc-20479963?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a> who received care at Mayo Clinic had lower mortality rates than the national average. Mayo Clinic patients were treated using an integrated, team-based approach for patient monitoring and treatment. </p>
<p>On the Mayo Clinic Q&A podcast, <a href='https://www.mayo.edu/research/faculty/o-horo-john-jack-c-m-d-m-p-h/bio-20111628?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Dr. John O'Horo</a>, a Mayo Clinic infectious diseases physician and the study's first author, discusses the study results and explains how the Mayo Clinic Model of Care improves outcomes for patients. </p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in December, 2020. </p>
<p>Guest: John (Jack) C. O'Horo, M.D., M.P.H. (<a href='https://twitter.com/jcohoro?lang=en'>@jcohoro</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>) </p>
<p>A recent Mayo Clinic study <a href='https://mayoclinicproceedings.org/pb/assets/raw/Health%20Advance/journals/jmcp/jmcp_ft95_12_2.pdf'>published in Mayo Clinic Proceedings</a>found that patients with <a href='https://www.mayoclinic.org/diseases-conditions/coronavirus/symptoms-causes/syc-20479963?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a> who received care at Mayo Clinic had lower mortality rates than the national average. Mayo Clinic patients were treated using an integrated, team-based approach for patient monitoring and treatment. </p>
<p>On the Mayo Clinic Q&A podcast, <a href='https://www.mayo.edu/research/faculty/o-horo-john-jack-c-m-d-m-p-h/bio-20111628?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>Dr. John O'Horo</a>, a Mayo Clinic infectious diseases physician and the study's first author, discusses the study results and explains how the Mayo Clinic Model of Care improves outcomes for patients. </p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mp88ab/Mayo_Clinic_Podcast_-_Dr_John_O_Horo_-_12_29_2071w4p.mp3" length="19750781" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in December, 2020. 
Guest: John (Jack) C. O'Horo, M.D., M.P.H. (@jcohoro) 
Host: Halena M. Gazelka, M.D. (@hmgazelkamd) 
A recent Mayo Clinic study published in Mayo Clinic Proceedingsfound that patients with COVID-19 who received care at Mayo Clinic had lower mortality rates than the national average. Mayo Clinic patients were treated using an integrated, team-based approach for patient monitoring and treatment. 
On the Mayo Clinic Q&A podcast, Dr. John O'Horo, a Mayo Clinic infectious diseases physician and the study's first author, discusses the study results and explains how the Mayo Clinic Model of Care improves outcomes for patients. 
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1231</itunes:duration>
                        <itunes:episodeType>bonus</itunes:episodeType>
            </item>
    <item>
        <title>Addressing the Burdens of Family Caregivers</title>
        <itunes:title>Addressing the Burdens of Family Caregivers</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/caring-for-the-caregiver/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/caring-for-the-caregiver/#comments</comments>        <pubDate>Tue, 29 Dec 2020 06:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/05585730-e84b-3b3e-9096-64b1393ed692</guid>
                                    <description><![CDATA[<p>Guest: Alisha Morgan, D.O. (<a href='https://twitter.com/AAMORGAN_DO'>@AAMORGAN_DO</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>It’s estimated that there may be over 30 million individuals in the U.S. who provide ongoing care to older adults, half of these to family members with some form of dementia. The majority of these caregivers are female and a significant percentage of these caregivers have their own major health problems. This has become a major social and economic issue in the care of our geriatric patients. Dr. Alisha Morgan, a family medicine and hospice physician at the Mayo Clinic joins us to address the challenges associated with being a caregiver, how healthcare providers should assess caregiver burden, potential financial resources available to assist caregivers, and interventions to reduce the impact of stress on caregivers.</p>
<p>Specific topics:</p>
<ul><li>Morbidity and mortality of care givers</li>
<li>The amount of time caregivers devote to assisting older adults</li>
<li>Financial burden of providing chronic care to older adults</li>
<li>How primary care providers should acknowledge caregivers</li>
<li>How primary care providers should evaluate</li>
<li>How caregiver stress should be provided</li>
<li>Available financial resources for caregivers</li>
</ul>
<p>Caregiver Resources: <a href='https://www.aarp.org/content/dam/aarp/entertainment/books/2015-04/Caregivers_Excerpt.pdf'>https://www.aarp.org/content/dam/aarp/entertainment/books/2015-04/Caregivers_Excerpt.pdf</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Alisha Morgan, D.O. (<a href='https://twitter.com/AAMORGAN_DO'>@AAMORGAN_DO</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>It’s estimated that there may be over 30 million individuals in the U.S. who provide ongoing care to older adults, half of these to family members with some form of dementia. The majority of these caregivers are female and a significant percentage of these caregivers have their own major health problems. This has become a major social and economic issue in the care of our geriatric patients. Dr. Alisha Morgan, a family medicine and hospice physician at the Mayo Clinic joins us to address the challenges associated with being a caregiver, how healthcare providers should assess caregiver burden, potential financial resources available to assist caregivers, and interventions to reduce the impact of stress on caregivers.</p>
<p>Specific topics:</p>
<ul><li>Morbidity and mortality of care givers</li>
<li>The amount of time caregivers devote to assisting older adults</li>
<li>Financial burden of providing chronic care to older adults</li>
<li>How primary care providers should acknowledge caregivers</li>
<li>How primary care providers should evaluate</li>
<li>How caregiver stress should be provided</li>
<li>Available financial resources for caregivers</li>
</ul>
<p>Caregiver Resources: <a href='https://www.aarp.org/content/dam/aarp/entertainment/books/2015-04/Caregivers_Excerpt.pdf'>https://www.aarp.org/content/dam/aarp/entertainment/books/2015-04/Caregivers_Excerpt.pdf</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/umqpby/VT3981652_-_Caring_for_the_Caregiver-8u1xc.mp3" length="22744590" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Alisha Morgan, D.O. (@AAMORGAN_DO)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
It’s estimated that there may be over 30 million individuals in the U.S. who provide ongoing care to older adults, half of these to family members with some form of dementia. The majority of these caregivers are female and a significant percentage of these caregivers have their own major health problems. This has become a major social and economic issue in the care of our geriatric patients. Dr. Alisha Morgan, a family medicine and hospice physician at the Mayo Clinic joins us to address the challenges associated with being a caregiver, how healthcare providers should assess caregiver burden, potential financial resources available to assist caregivers, and interventions to reduce the impact of stress on caregivers.
Specific topics:
Morbidity and mortality of care givers
The amount of time caregivers devote to assisting older adults
Financial burden of providing chronic care to older adults
How primary care providers should acknowledge caregivers
How primary care providers should evaluate
How caregiver stress should be provided
Available financial resources for caregivers
Caregiver Resources: https://www.aarp.org/content/dam/aarp/entertainment/books/2015-04/Caregivers_Excerpt.pdf
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1415</itunes:duration>
                <itunes:episode>210</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>COVID-19 Miniseries Episode 57: Transcending the Valley of Death - COVID-19 mRNA Vaccine Update</title>
        <itunes:title>COVID-19 Miniseries Episode 57: Transcending the Valley of Death - COVID-19 mRNA Vaccine Update</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-57-transcending-the-valley-of-death-covid-19-mrna-vaccine-update/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-57-transcending-the-valley-of-death-covid-19-mrna-vaccine-update/#comments</comments>        <pubDate>Mon, 21 Dec 2020 06:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/afa5a206-c438-341e-96db-153e28d4121e</guid>
                                    <description><![CDATA[<p>This episode was recorded on December 18, 2020. </p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest: Gregory A. Poland, M.D.<a href='https://twitter.com/drgregpoland?lang=en'> (@drgregpoland</a>) </p>
<p>Host: Amit K. Ghosh, M.D., M.B.A. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>) </p>
<p>It is projected that by March of 2021 1:700 Americans will have died of COVID-19. The historic pace of COVID-19 vaccine development was made possible by the countless sacrifices of many individuals across healthcare, research, health and human services, the Department of Defense, and other key sectors. This interprofessional collaboration required many to set life aside and work tirelessly to bring an effective vaccine to market, quickly. While mRNA vaccines have been in development since the 1990s, the COVID-19 vaccine efficacy rate of 95-100% across studied ages, race and ethnicities, and comorbidities is unprecedented. The questions left to answer are, how long will the efficacy last? In larger population studies, what is the safety/allergy/hypersensitivity profile? What impact does the vaccine have on asymptomatic carrier spread? Who shouldn’t get the vaccine? Dr. Greg Poland breaks down everything you need to know about the mRNA COVID-19 vaccines. </p>
<p>Additional Resources:</p>
<ul><li style="font-weight:400;">Mayo Clinic Vaccine Research Page 
<a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview'>https://www.mayo.edu/research/labs/vaccine-research-group/overview</a> </li>
<li style="font-weight:400;">Vaccine education spectrum disorder: the importance of incorporating psychological and cognitive models into vaccine education </li>
<li style="font-weight:400;"><a href='https://www.sciencedirect.com/science/article/pii/S0264410X11011881'>https://www.sciencedirect.com/science/article/pii/S0264410X11011881</a> </li>
<li style="font-weight:400;">AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode was recorded on December 18, 2020. </p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest: Gregory A. Poland, M.D.<a href='https://twitter.com/drgregpoland?lang=en'> (@drgregpoland</a>) </p>
<p>Host: Amit K. Ghosh, M.D., M.B.A. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>) </p>
<p>It is projected that by March of 2021 1:700 Americans will have died of COVID-19. The historic pace of COVID-19 vaccine development was made possible by the countless sacrifices of many individuals across healthcare, research, health and human services, the Department of Defense, and other key sectors. This interprofessional collaboration required many to set life aside and work tirelessly to bring an effective vaccine to market, quickly. While mRNA vaccines have been in development since the 1990s, the COVID-19 vaccine efficacy rate of 95-100% across studied ages, race and ethnicities, and comorbidities is unprecedented. The questions left to answer are, how long will the efficacy last? In larger population studies, what is the safety/allergy/hypersensitivity profile? What impact does the vaccine have on asymptomatic carrier spread? Who shouldn’t get the vaccine? Dr. Greg Poland breaks down everything you need to know about the mRNA COVID-19 vaccines. </p>
<p>Additional Resources:</p>
<ul><li style="font-weight:400;">Mayo Clinic Vaccine Research Page <br>
<a href='https://www.mayo.edu/research/labs/vaccine-research-group/overview'>https://www.mayo.edu/research/labs/vaccine-research-group/overview</a> </li>
<li style="font-weight:400;">Vaccine education spectrum disorder: the importance of incorporating psychological and cognitive models into vaccine education </li>
<li style="font-weight:400;"><a href='https://www.sciencedirect.com/science/article/pii/S0264410X11011881'>https://www.sciencedirect.com/science/article/pii/S0264410X11011881</a> </li>
<li style="font-weight:400;">AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/u8p4mh/W38530_-_COVID_Vaccine_Rolloutacptx.mp3" length="38010200" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode was recorded on December 18, 2020. 
To claim credit visit: https://ce.mayo.edu/covid19podcast 
Guest: Gregory A. Poland, M.D. (@drgregpoland) 
Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006) 
It is projected that by March of 2021 1:700 Americans will have died of COVID-19. The historic pace of COVID-19 vaccine development was made possible by the countless sacrifices of many individuals across healthcare, research, health and human services, the Department of Defense, and other key sectors. This interprofessional collaboration required many to set life aside and work tirelessly to bring an effective vaccine to market, quickly. While mRNA vaccines have been in development since the 1990s, the COVID-19 vaccine efficacy rate of 95-100% across studied ages, race and ethnicities, and comorbidities is unprecedented. The questions left to answer are, how long will the efficacy last? In larger population studies, what is the safety/allergy/hypersensitivity profile? What impact does the vaccine have on asymptomatic carrier spread? Who shouldn’t get the vaccine? Dr. Greg Poland breaks down everything you need to know about the mRNA COVID-19 vaccines. 
Additional Resources:
Mayo Clinic Vaccine Research Page https://www.mayo.edu/research/labs/vaccine-research-group/overview 
Vaccine education spectrum disorder: the importance of incorporating psychological and cognitive models into vaccine education 
https://www.sciencedirect.com/science/article/pii/S0264410X11011881 
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2371</itunes:duration>
                <itunes:episode>209</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Sensorineural Hearing Loss</title>
        <itunes:title>Sensorineural Hearing Loss</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/sensorineural-hearing-loss/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/sensorineural-hearing-loss/#comments</comments>        <pubDate>Tue, 15 Dec 2020 06:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/d2ae10e6-e64f-3684-8517-56376fb1ce75</guid>
                                    <description><![CDATA[<p>Guest: Matthew L. Carlson, M.D. (<a href='https://twitter.com/MatthewLCarlso1'>@MatthewLCarlso1</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>) </p>
<p>Issues surrounding hearing loss are discussed with Dr. Matthew Carlson, an ENT physician from the Mayo Clinic. Specific topics discussed include the following:</p>
<ul><li>Types of hearing loss (conductive vs. sensorineural)</li>
<li>Social impact of hearing loss</li>
<li>Symptoms patients notice with gradually progressive hearing loss</li>
<li>Tinnitus and it’s management</li>
<li>Causes of sensorineural hearing loss</li>
<li>High frequency tone loss and problems with speech discrimination associated with sensorineural hearing loss</li>
<li>Hearing loss associated with loud noise exposure (acoustic injury and chronic noise exposure)</li>
<li>Hearing loss associated with the use of firearms</li>
<li>Common everyday activities which may result in hearing loss</li>
<li>Management of sensorineural hearing loss (hearing aids, cochlear implants)</li>
<li>Recent advances and improvements in hearing aids</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Matthew L. Carlson, M.D. (<a href='https://twitter.com/MatthewLCarlso1'>@MatthewLCarlso1</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>) </p>
<p>Issues surrounding hearing loss are discussed with Dr. Matthew Carlson, an ENT physician from the Mayo Clinic. Specific topics discussed include the following:</p>
<ul><li>Types of hearing loss (conductive vs. sensorineural)</li>
<li>Social impact of hearing loss</li>
<li>Symptoms patients notice with gradually progressive hearing loss</li>
<li>Tinnitus and it’s management</li>
<li>Causes of sensorineural hearing loss</li>
<li>High frequency tone loss and problems with speech discrimination associated with sensorineural hearing loss</li>
<li>Hearing loss associated with loud noise exposure (acoustic injury and chronic noise exposure)</li>
<li>Hearing loss associated with the use of firearms</li>
<li>Common everyday activities which may result in hearing loss</li>
<li>Management of sensorineural hearing loss (hearing aids, cochlear implants)</li>
<li>Recent advances and improvements in hearing aids</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gge6bq/VT3914354_Hearing_Loss_in_Adults_-_Carlson784pg.mp3" length="23978254" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Matthew L. Carlson, M.D. (@MatthewLCarlso1)
Host: Darryl S. Chutka, M.D. (@ChutkaMD) 
Issues surrounding hearing loss are discussed with Dr. Matthew Carlson, an ENT physician from the Mayo Clinic. Specific topics discussed include the following:
Types of hearing loss (conductive vs. sensorineural)
Social impact of hearing loss
Symptoms patients notice with gradually progressive hearing loss
Tinnitus and it’s management
Causes of sensorineural hearing loss
High frequency tone loss and problems with speech discrimination associated with sensorineural hearing loss
Hearing loss associated with loud noise exposure (acoustic injury and chronic noise exposure)
Hearing loss associated with the use of firearms
Common everyday activities which may result in hearing loss
Management of sensorineural hearing loss (hearing aids, cochlear implants)
Recent advances and improvements in hearing aids
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1493</itunes:duration>
                <itunes:episode>208</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Immunizations: Let’s Get to the Point</title>
        <itunes:title>Immunizations: Let’s Get to the Point</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/immunizations-let-s-get-to-the-point/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/immunizations-let-s-get-to-the-point/#comments</comments>        <pubDate>Tue, 08 Dec 2020 06:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/a6a942ab-738e-33bb-98e0-174adf1b5e1e</guid>
                                    <description><![CDATA[<p>This episode was recorded on October 23, 2020.</p>
<p>Guest: Robert M. Jacobson, M.D. (<a href='https://twitter.com/RobertJMD'>@RobertJMD</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>It’s estimated that immunizations have saved more lives and prevented more disabilities than any other medical intervention. They’re also extremely cost effective and their benefits far outweigh the very small risks they carry. Yet there are individuals who choose to believe that immunizations are potentially harmful. Our guest for this podcast is Dr. Robert Jacobson, a Mayo Clinic pediatrician and expert in the field of immunizations. We cover topics including an update on the COVID-19 vaccine and when it will realistically be available on a large scale for the population. Other important issues discussed include which vaccines are important for children and adults and whether it’s safe to administer multiple vaccines at one time. Finally, many of the concern promoted by the anti-vaccine movement are discussed and dispelled.</p>
<p>Specific topics discussed:</p>
<ul><li>Variety of vaccines in development for COVID-19</li>
<li>Novel techniques being use in the development of the COVID-19 vaccine</li>
<li>Timing on the availability of the COVID-19 vaccine</li>
<li>Important immunizations for children</li>
<li>Important immunizations for adults</li>
<li>Anti-vaccine concerns and myths surrounding vaccines</li>
<li>Updates on the age recommendations for the HPV vaccine</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode was recorded on October 23, 2020.</p>
<p>Guest: Robert M. Jacobson, M.D. (<a href='https://twitter.com/RobertJMD'>@RobertJMD</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>It’s estimated that immunizations have saved more lives and prevented more disabilities than any other medical intervention. They’re also extremely cost effective and their benefits far outweigh the very small risks they carry. Yet there are individuals who choose to believe that immunizations are potentially harmful. Our guest for this podcast is Dr. Robert Jacobson, a Mayo Clinic pediatrician and expert in the field of immunizations. We cover topics including an update on the COVID-19 vaccine and when it will realistically be available on a large scale for the population. Other important issues discussed include which vaccines are important for children and adults and whether it’s safe to administer multiple vaccines at one time. Finally, many of the concern promoted by the anti-vaccine movement are discussed and dispelled.</p>
<p>Specific topics discussed:</p>
<ul><li>Variety of vaccines in development for COVID-19</li>
<li>Novel techniques being use in the development of the COVID-19 vaccine</li>
<li>Timing on the availability of the COVID-19 vaccine</li>
<li>Important immunizations for children</li>
<li>Important immunizations for adults</li>
<li>Anti-vaccine concerns and myths surrounding vaccines</li>
<li>Updates on the age recommendations for the HPV vaccine</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ybtwbf/VT3980152_Vaccines_V3accq7.mp3" length="25812875" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode was recorded on October 23, 2020.
Guest: Robert M. Jacobson, M.D. (@RobertJMD)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
It’s estimated that immunizations have saved more lives and prevented more disabilities than any other medical intervention. They’re also extremely cost effective and their benefits far outweigh the very small risks they carry. Yet there are individuals who choose to believe that immunizations are potentially harmful. Our guest for this podcast is Dr. Robert Jacobson, a Mayo Clinic pediatrician and expert in the field of immunizations. We cover topics including an update on the COVID-19 vaccine and when it will realistically be available on a large scale for the population. Other important issues discussed include which vaccines are important for children and adults and whether it’s safe to administer multiple vaccines at one time. Finally, many of the concern promoted by the anti-vaccine movement are discussed and dispelled.
Specific topics discussed:
Variety of vaccines in development for COVID-19
Novel techniques being use in the development of the COVID-19 vaccine
Timing on the availability of the COVID-19 vaccine
Important immunizations for children
Important immunizations for adults
Anti-vaccine concerns and myths surrounding vaccines
Updates on the age recommendations for the HPV vaccine
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1608</itunes:duration>
                <itunes:episode>207</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>COVID-19 Miniseries Episode 56: Mayo Clinic Q&amp;A - How Messenger RNA Vaccines Work</title>
        <itunes:title>COVID-19 Miniseries Episode 56: Mayo Clinic Q&amp;A - How Messenger RNA Vaccines Work</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-56-mayo-clinic-qa-how-messenger-rna-vaccines-work/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-56-mayo-clinic-qa-how-messenger-rna-vaccines-work/#comments</comments>        <pubDate>Thu, 03 Dec 2020 14:23:15 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/a7ed20a8-c7b6-3c1a-966f-c18ae22cbc7a</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in December, 2020. </p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest: Gregory A. Poland, M.D. <a href='https://twitter.com/drgregpoland?lang=en'>(@drgregpoland)</a> </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>) </p>
<p>The first <a href='https://www.mayoclinic.org/coronavirus-covid-19?_ga=2.65490222.1266057850.1606743266-1478324480.1604952812'>COVID-19</a> vaccines to reach the market are likely to be messenger RNA vaccines, or mRNA. According to the <a href='https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/mrna.html'>Centers for Disease Control and Prevention</a>, mRNA vaccines work by teaching cells in the body how to make a protein that triggers an immune response. Unlike many vaccines that use a weakened or inactivated form of a virus, mRNA vaccines do not use the live virus that causes COVID-19. </p>
<p>On the Mayo Clinic Q&A podcast, <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.136537328.1903245515.1583502589-382127956.1576426874'>Dr. Gregory Poland</a>, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, explains how mRNA vaccines work, gives a status update on the pandemic and answers listener questions.</p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in December, 2020. </p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest: Gregory A. Poland, M.D. <a href='https://twitter.com/drgregpoland?lang=en'>(@drgregpoland)</a> </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>) </p>
<p>The first <a href='https://www.mayoclinic.org/coronavirus-covid-19?_ga=2.65490222.1266057850.1606743266-1478324480.1604952812'>COVID-19</a> vaccines to reach the market are likely to be messenger RNA vaccines, or mRNA. According to the <a href='https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/mrna.html'>Centers for Disease Control and Prevention</a>, mRNA vaccines work by teaching cells in the body how to make a protein that triggers an immune response. Unlike many vaccines that use a weakened or inactivated form of a virus, mRNA vaccines do not use the live virus that causes COVID-19. </p>
<p>On the Mayo Clinic Q&A podcast, <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.136537328.1903245515.1583502589-382127956.1576426874'>Dr. Gregory Poland</a>, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, explains how mRNA vaccines work, gives a status update on the pandemic and answers listener questions.</p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fg43ar/Mayo_Clinic_Podcast_-_Dr_Gregory_Poland_-_12_02_20angug.mp3" length="17202003" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in December, 2020. 
To claim credit visit: https://ce.mayo.edu/covid19podcast 
Guest: Gregory A. Poland, M.D. (@drgregpoland) 
Host: Halena M. Gazelka, M.D. (@hmgazelkamd) 
The first COVID-19 vaccines to reach the market are likely to be messenger RNA vaccines, or mRNA. According to the Centers for Disease Control and Prevention, mRNA vaccines work by teaching cells in the body how to make a protein that triggers an immune response. Unlike many vaccines that use a weakened or inactivated form of a virus, mRNA vaccines do not use the live virus that causes COVID-19. 
On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, explains how mRNA vaccines work, gives a status update on the pandemic and answers listener questions.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1072</itunes:duration>
                <itunes:episode>242</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>COVID-19 Miniseries Episode 55: Mayo Clinic Q&amp;A - Managing the COVID-19 Surge</title>
        <itunes:title>COVID-19 Miniseries Episode 55: Mayo Clinic Q&amp;A - Managing the COVID-19 Surge</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-55-mayo-clinic-qa-managing-the-covid-19-surge/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-55-mayo-clinic-qa-managing-the-covid-19-surge/#comments</comments>        <pubDate>Thu, 03 Dec 2020 14:21:06 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/693a84a3-d1b5-3474-9a0d-7ca987fc9d8b</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in November, 2020. </p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Elie F. Berbari, M.D. </p>
<p>Host: Sanjeev (Sanj) Kakar, M.D. (<a href='https://twitter.com/sanjkakar?lang=en'>@sanjkakar</a>)</p>
<p>The current <a href='https://www.mayoclinic.org/coronavirus-covid-19?_ga=2.56519339.1266057850.1606743266-1478324480.1604952812'>COVID-19</a> surge numbers could worsen in coming days as experts prepare for a post-Thanksgiving holiday increase in cases. Increased positivity rates lead to more people needing hospitalization, straining the health care system and medical staff.</p>
<p>On the Mayo Clinic Q&A podcast, <a href='https://www.mayoclinic.org/biographies/berbari-elie-f-m-d/bio-20053110?_ga=2.83890905.1178857267.1606749775-841877308.1603891377'>Dr. Elie Berbari</a>, chair of the Division of Infectious Diseases at Mayo Clinic, explains how Mayo Clinic is managing staff, supplies and space during the COVID-19 surge.</p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in November, 2020. </p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Elie F. Berbari, M.D. </p>
<p>Host: Sanjeev (Sanj) Kakar, M.D. (<a href='https://twitter.com/sanjkakar?lang=en'>@sanjkakar</a>)</p>
<p>The current <a href='https://www.mayoclinic.org/coronavirus-covid-19?_ga=2.56519339.1266057850.1606743266-1478324480.1604952812'>COVID-19</a> surge numbers could worsen in coming days as experts prepare for a post-Thanksgiving holiday increase in cases. Increased positivity rates lead to more people needing hospitalization, straining the health care system and medical staff.</p>
<p>On the Mayo Clinic Q&A podcast, <a href='https://www.mayoclinic.org/biographies/berbari-elie-f-m-d/bio-20053110?_ga=2.83890905.1178857267.1606749775-841877308.1603891377'>Dr. Elie Berbari</a>, chair of the Division of Infectious Diseases at Mayo Clinic, explains how Mayo Clinic is managing staff, supplies and space during the COVID-19 surge.</p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xkytri/Mayo_Clinic_Podcast_-_Dr_Elli_Berbari_-_12_01_20bqje8.mp3" length="14290816" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in November, 2020. 
To claim credit visit: https://ce.mayo.edu/covid19podcast 
Guest:  Elie F. Berbari, M.D. 
Host: Sanjeev (Sanj) Kakar, M.D. (@sanjkakar)
The current COVID-19 surge numbers could worsen in coming days as experts prepare for a post-Thanksgiving holiday increase in cases. Increased positivity rates lead to more people needing hospitalization, straining the health care system and medical staff.
On the Mayo Clinic Q&A podcast, Dr. Elie Berbari, chair of the Division of Infectious Diseases at Mayo Clinic, explains how Mayo Clinic is managing staff, supplies and space during the COVID-19 surge.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>890</itunes:duration>
                <itunes:episode>205</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>Be Safe Not Sorry: Teaching Patients Proper Handwashing Technique</title>
        <itunes:title>Be Safe Not Sorry: Teaching Patients Proper Handwashing Technique</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/hands/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/hands/#comments</comments>        <pubDate>Tue, 01 Dec 2020 13:55:45 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/23d21e53-fcb7-35ac-b619-7d55c1487a89</guid>
                                    <description><![CDATA[<p>Guest: Gregory A. Poland, M.D. <a href='https://twitter.com/drgregpoland?lang=en'>(@drgregpoland</a>) </p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>) </p>
<p>Many of us learned how to wash our hands at a very early age and have relearned the importance and proper technique periodically along the way. Research suggests that many people may not be doing it correctly. Dr. Greg Poland a Professor of Medicine in Infectious Disease at the Mayo Clinic joins us for National Hand Washing Awareness Week to discuss some tips and tricks to share with your patients to ensure they’re reaching the full potential of this life-saving technique. He’ll also answer questions like does it matter if the water is hot? Is handwashing with soap more effective than anti-bacterial gel or lotions? And, when should we be washing our hands? </p>
<p>Additional resources mentioned (not an endorsement or affiliation): </p>
<p>Glo Germ: Visual Tool for Handwashing </p>
<ul><li><a href='https://www.glogerm.com/'>https://www.glogerm.com/</a>  </li>
</ul>
<p>Jimmy Kimmel and Guillermo Learn How to Wash Their Hands </p>
<ul><li><a href='https://youtu.be/sJfsyhQ0oBs'>https://youtu.be/sJfsyhQ0oBs</a> </li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Gregory A. Poland, M.D. <a href='https://twitter.com/drgregpoland?lang=en'>(@drgregpoland</a>) </p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>) </p>
<p>Many of us learned how to wash our hands at a very early age and have relearned the importance and proper technique periodically along the way. Research suggests that many people may not be doing it correctly. Dr. Greg Poland a Professor of Medicine in Infectious Disease at the Mayo Clinic joins us for National Hand Washing Awareness Week to discuss some tips and tricks to share with your patients to ensure they’re reaching the full potential of this life-saving technique. He’ll also answer questions like does it matter if the water is hot? Is handwashing with soap more effective than anti-bacterial gel or lotions? And, when should we be washing our hands? </p>
<p>Additional resources mentioned (not an endorsement or affiliation): </p>
<p>Glo Germ: Visual Tool for Handwashing </p>
<ul><li><a href='https://www.glogerm.com/'>https://www.glogerm.com/</a>  </li>
</ul>
<p>Jimmy Kimmel and Guillermo Learn How to Wash Their Hands </p>
<ul><li><a href='https://youtu.be/sJfsyhQ0oBs'>https://youtu.be/sJfsyhQ0oBs</a> </li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fxhkm7/VT3981656_-_Handwashing_Awareness_Special7unwy.mp3" length="14463677" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Gregory A. Poland, M.D. (@drgregpoland) 
Host: Darryl S. Chutka, M.D. (@ChutkaMD) 
Many of us learned how to wash our hands at a very early age and have relearned the importance and proper technique periodically along the way. Research suggests that many people may not be doing it correctly. Dr. Greg Poland a Professor of Medicine in Infectious Disease at the Mayo Clinic joins us for National Hand Washing Awareness Week to discuss some tips and tricks to share with your patients to ensure they’re reaching the full potential of this life-saving technique. He’ll also answer questions like does it matter if the water is hot? Is handwashing with soap more effective than anti-bacterial gel or lotions? And, when should we be washing our hands? 
Additional resources mentioned (not an endorsement or affiliation): 
Glo Germ: Visual Tool for Handwashing 
https://www.glogerm.com/  
Jimmy Kimmel and Guillermo Learn How to Wash Their Hands 
https://youtu.be/sJfsyhQ0oBs 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>902</itunes:duration>
                <itunes:episode>204</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>COVID-19 Miniseries Episode 54: The Enigma of COVID-19 Long Haulers</title>
        <itunes:title>COVID-19 Miniseries Episode 54: The Enigma of COVID-19 Long Haulers</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-54-the-enigma-of-covid-19-long-haulers/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-54-the-enigma-of-covid-19-long-haulers/#comments</comments>        <pubDate>Wed, 25 Nov 2020 06:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/7d6eec62-e54a-30e9-a42e-d6624a31b4ec</guid>
                                    <description><![CDATA[<p>This episode was recorded on November 17th, 2020.</p>
<p>Guest: Raymund R. Razonable, M.D. (<a href='https://twitter.com/RazonableMD'>@RazonableMD</a>)</p>
<p>Host: Amit K. Ghosh, M.D., M.B.A. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>)</p>
<p>What causes some patients to develop Long Haul COVID-19? Dr. Raymund Razonable discusses what the current data is showing and what we’re hoping to learn from future research.</p>
<p>Deeper dive:
As Their Numbers Grow, COVID-19 “Long Haulers” Stump Experts
<a href='https://jamanetwork.com/journals/jama/fullarticle/2771111'>https://jamanetwork.com/journals/jama/fullarticle/2771111</a></p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode was recorded on November 17th, 2020.</p>
<p>Guest: Raymund R. Razonable, M.D. (<a href='https://twitter.com/RazonableMD'>@RazonableMD</a>)</p>
<p>Host: Amit K. Ghosh, M.D., M.B.A. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>)</p>
<p>What causes some patients to develop Long Haul COVID-19? Dr. Raymund Razonable discusses what the current data is showing and what we’re hoping to learn from future research.</p>
<p>Deeper dive:<br>
As Their Numbers Grow, COVID-19 “Long Haulers” Stump Experts<br>
<a href='https://jamanetwork.com/journals/jama/fullarticle/2771111'>https://jamanetwork.com/journals/jama/fullarticle/2771111</a></p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/uif5c5/VT3984370_-_COVID-19_Long_Haulers9bfrc.mp3" length="23259114" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode was recorded on November 17th, 2020.
Guest: Raymund R. Razonable, M.D. (@RazonableMD)
Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006)
What causes some patients to develop Long Haul COVID-19? Dr. Raymund Razonable discusses what the current data is showing and what we’re hoping to learn from future research.
Deeper dive:As Their Numbers Grow, COVID-19 “Long Haulers” Stump Expertshttps://jamanetwork.com/journals/jama/fullarticle/2771111
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1446</itunes:duration>
                <itunes:episode>203</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Celiac Disease</title>
        <itunes:title>Celiac Disease</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/celiac-disease-1603902394/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/celiac-disease-1603902394/#comments</comments>        <pubDate>Tue, 24 Nov 2020 06:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/579827af-92b4-3679-9797-f6e931b1679c</guid>
                                    <description><![CDATA[<p>Guest: Joseph A. Murray, M.D. </p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>) </p>
<p>The diagnosis and management of Celiac Disease is discussed with Dr. Joseph Murray, a gastroenterologist from the Mayo Clinic. Specific topics discussed include:</p>
<ul><li>Typical presentations of Celiac Disease in children and adults</li>
<li>Difficulties encountered in establishing a diagnosis</li>
<li>Small bowel pathology seen in Celiac Disease</li>
<li>Mechanism for malabsorption in Celiac Disease</li>
<li>Risk factors for Celiac Disease</li>
<li>Celiac Disease and pregnancy</li>
<li>How to confirm a diagnosis of Celiac Disease<ul><li>Laboratory tests</li>
<li>Necessity of a small bowel biopsy</li>
</ul>
</li>
<li>Management of Celiac Disease</li>
<li>Challenges in maintaining a gluten-free diet</li>
<li>Potential long-term complications of Celiac Disease</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Joseph A. Murray, M.D. </p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>) </p>
<p>The diagnosis and management of Celiac Disease is discussed with Dr. Joseph Murray, a gastroenterologist from the Mayo Clinic. Specific topics discussed include:</p>
<ul><li>Typical presentations of Celiac Disease in children and adults</li>
<li>Difficulties encountered in establishing a diagnosis</li>
<li>Small bowel pathology seen in Celiac Disease</li>
<li>Mechanism for malabsorption in Celiac Disease</li>
<li>Risk factors for Celiac Disease</li>
<li>Celiac Disease and pregnancy</li>
<li>How to confirm a diagnosis of Celiac Disease<ul><li>Laboratory tests</li>
<li>Necessity of a small bowel biopsy</li>
</ul>
</li>
<li>Management of Celiac Disease</li>
<li>Challenges in maintaining a gluten-free diet</li>
<li>Potential long-term complications of Celiac Disease</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/azdjcz/VT3971430_-_Murray_-_Celiac_Diseaseakgbj.mp3" length="22580618" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Joseph A. Murray, M.D. 
Host: Darryl S. Chutka, M.D. (@ChutkaMD) 
The diagnosis and management of Celiac Disease is discussed with Dr. Joseph Murray, a gastroenterologist from the Mayo Clinic. Specific topics discussed include:
Typical presentations of Celiac Disease in children and adults
Difficulties encountered in establishing a diagnosis
Small bowel pathology seen in Celiac Disease
Mechanism for malabsorption in Celiac Disease
Risk factors for Celiac Disease
Celiac Disease and pregnancy
How to confirm a diagnosis of Celiac DiseaseLaboratory tests
Necessity of a small bowel biopsy

Management of Celiac Disease
Challenges in maintaining a gluten-free diet
Potential long-term complications of Celiac Disease
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1408</itunes:duration>
                <itunes:episode>202</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hepatits C</title>
        <itunes:title>Hepatits C</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/hepatits-c/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/hepatits-c/#comments</comments>        <pubDate>Tue, 17 Nov 2020 06:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/67f7cfe7-036b-3874-887f-174b96c7cd19</guid>
                                    <description><![CDATA[<p>Guest: John J. Poterucha, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>) </p>
<p>The topic of Hepatitis C, including risk factors, evaluation and management was discussed with Dr. John Poterucha, a gastroenterologist from the Division of Gastroenterology and Hepatology. Specific topics discussed include:</p>
<ul><li>Serologic testing for hepatitis C</li>
<li>Symptoms of hepatitis C</li>
<li>Risk factors for hepatitis C</li>
<li>Transmission of hepatitis C during pregnancy</li>
<li>Risk of hepatitis C transmission following a needle-stick exposure</li>
<li>Identifying which patients should be tested for hepatitis C</li>
<li>Natural history of hepatitis C</li>
<li>Potential complications of hepatitis C</li>
<li>Available pharmacologic treatment</li>
<li>Potential for reinfection with hepatitis C</li>
<li>Hepatitis C and liver transplantation</li>
<li>Potential for an effective hepatitis C vaccine</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: John J. Poterucha, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>) </p>
<p>The topic of Hepatitis C, including risk factors, evaluation and management was discussed with Dr. John Poterucha, a gastroenterologist from the Division of Gastroenterology and Hepatology. Specific topics discussed include:</p>
<ul><li>Serologic testing for hepatitis C</li>
<li>Symptoms of hepatitis C</li>
<li>Risk factors for hepatitis C</li>
<li>Transmission of hepatitis C during pregnancy</li>
<li>Risk of hepatitis C transmission following a needle-stick exposure</li>
<li>Identifying which patients should be tested for hepatitis C</li>
<li>Natural history of hepatitis C</li>
<li>Potential complications of hepatitis C</li>
<li>Available pharmacologic treatment</li>
<li>Potential for reinfection with hepatitis C</li>
<li>Hepatitis C and liver transplantation</li>
<li>Potential for an effective hepatitis C vaccine</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/biqdf5/VT3865894_-_Hepatitis_C_-_Poteruchaaaefh.mp3" length="19851033" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: John J. Poterucha, M.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD) 
The topic of Hepatitis C, including risk factors, evaluation and management was discussed with Dr. John Poterucha, a gastroenterologist from the Division of Gastroenterology and Hepatology. Specific topics discussed include:
Serologic testing for hepatitis C
Symptoms of hepatitis C
Risk factors for hepatitis C
Transmission of hepatitis C during pregnancy
Risk of hepatitis C transmission following a needle-stick exposure
Identifying which patients should be tested for hepatitis C
Natural history of hepatitis C
Potential complications of hepatitis C
Available pharmacologic treatment
Potential for reinfection with hepatitis C
Hepatitis C and liver transplantation
Potential for an effective hepatitis C vaccine
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1238</itunes:duration>
                <itunes:episode>201</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: Fighting COVID-19 with Mayo Clinic Laboratories</title>
        <itunes:title>Mayo Clinic Q&amp;A: Fighting COVID-19 with Mayo Clinic Laboratories</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-fighting-covid-19-with-mayo-clinic-laboratories/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-fighting-covid-19-with-mayo-clinic-laboratories/#comments</comments>        <pubDate>Thu, 12 Nov 2020 12:55:43 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/9d6563e5-05ee-3867-abec-e9ec5bba2c2f</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in November, 2020. </p>
<p>Guest: William G. Morice, II, M.D., Ph.D. <a href='https://twitter.com/moricemdphd?lang=en'>(@moricemdph)</a>  </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>) </p>
<p>When the <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a> pandemic began, one of the areas of science and research most affected was laboratory medicine. From developing tests that detect the virus, to testing for antibodies in patients who have recovered, <a href='https://www.mayocliniclabs.com/'>Mayo Clinic Laboratories</a> has been at the forefront of COVID-19 testing and research. </p>
<p>On the Mayo Clinic Q&A podcast, <a href='https://www.mayo.edu/research/faculty/morice-william-g-ii-m-d-ph-d/bio-20434957?_ga=2.204257042.329582114.1604934299-841877308.1603891377'>Dr. William Morice II</a>, president of Mayo Clinic Laboratories and chair of the department of Laboratory Medicine and Pathology at Mayo Clinic, explains how a reference lab works and how Mayo Clinic Laboratories quickly ramped up its testing capability to meet pandemic testing needs. </p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in November, 2020. </p>
<p>Guest: William G. Morice, II, M.D., Ph.D. <a href='https://twitter.com/moricemdphd?lang=en'>(@moricemdph)</a>  </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>) </p>
<p>When the <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a> pandemic began, one of the areas of science and research most affected was laboratory medicine. From developing tests that detect the virus, to testing for antibodies in patients who have recovered, <a href='https://www.mayocliniclabs.com/'>Mayo Clinic Laboratories</a> has been at the forefront of COVID-19 testing and research. </p>
<p>On the Mayo Clinic Q&A podcast, <a href='https://www.mayo.edu/research/faculty/morice-william-g-ii-m-d-ph-d/bio-20434957?_ga=2.204257042.329582114.1604934299-841877308.1603891377'>Dr. William Morice II</a>, president of Mayo Clinic Laboratories and chair of the department of Laboratory Medicine and Pathology at Mayo Clinic, explains how a reference lab works and how Mayo Clinic Laboratories quickly ramped up its testing capability to meet pandemic testing needs. </p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2sxs8h/Mayo_Clinic_Podcast_-_Dr_William_Morice_11_12_20b86gz.mp3" length="15656726" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in November, 2020. 
Guest: William G. Morice, II, M.D., Ph.D. (@moricemdph)  
Host: Halena M. Gazelka, M.D. (@hmgazelkamd) 
When the COVID-19 pandemic began, one of the areas of science and research most affected was laboratory medicine. From developing tests that detect the virus, to testing for antibodies in patients who have recovered, Mayo Clinic Laboratories has been at the forefront of COVID-19 testing and research. 
On the Mayo Clinic Q&A podcast, Dr. William Morice II, president of Mayo Clinic Laboratories and chair of the department of Laboratory Medicine and Pathology at Mayo Clinic, explains how a reference lab works and how Mayo Clinic Laboratories quickly ramped up its testing capability to meet pandemic testing needs. 
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>975</itunes:duration>
                        <itunes:episodeType>bonus</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>Influenza Vaccine: Nurses Call the Shots</title>
        <itunes:title>Influenza Vaccine: Nurses Call the Shots</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/influenza-vaccine-nurses-call-the-shots/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/influenza-vaccine-nurses-call-the-shots/#comments</comments>        <pubDate>Tue, 10 Nov 2020 06:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/97b21454-e906-3212-b13e-da641ac31f89</guid>
                                    <description><![CDATA[<p>Guest: Robert M. Jacobson, M.D. (<a href='https://twitter.com/RobertJMD'>@RobertJMD</a>) </p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>) </p>
<p>It is extremely important that our patients receive the influenza vaccine this year. In previous years, less than half of the population has received it. Dr. Robert Jacobson, a pediatrician and vaccine specialist at the Mayo Clinic, joins us to discuss the reasons it’s so important for our patients to receive the influenza vaccine this season.  He’ll share tips for discussing common concerns from vaccine-hesitant patients and how you can increase your patient vaccination rates. </p>
<p>Specific topics discussed: </p>
<ul><li>Importance of the influenza vaccine for our patients in 2020/2021 </li>
<li>How and when the influenza vaccine is developed for the next influenza season </li>
<li>Why we need an influenza vaccine on an annual basis </li>
<li>The best time of the year to receive the influenza vaccine </li>
<li>Whether we lose some immunity to influenza if we receive the vaccine too early in the year </li>
<li>Which vaccine should be given to those 65 years and older </li>
<li>Common myths surrounding the influenza vaccine </li>
<li>Predictions for the severity of influenza for 2020/2021 </li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Robert M. Jacobson, M.D. (<a href='https://twitter.com/RobertJMD'>@RobertJMD</a>) </p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>) </p>
<p>It is extremely important that our patients receive the influenza vaccine this year. In previous years, less than half of the population has received it. Dr. Robert Jacobson, a pediatrician and vaccine specialist at the Mayo Clinic, joins us to discuss the reasons it’s so important for our patients to receive the influenza vaccine this season.  He’ll share tips for discussing common concerns from vaccine-hesitant patients and how you can increase your patient vaccination rates. </p>
<p>Specific topics discussed: </p>
<ul><li>Importance of the influenza vaccine for our patients in 2020/2021 </li>
<li>How and when the influenza vaccine is developed for the next influenza season </li>
<li>Why we need an influenza vaccine on an annual basis </li>
<li>The best time of the year to receive the influenza vaccine </li>
<li>Whether we lose some immunity to influenza if we receive the vaccine too early in the year </li>
<li>Which vaccine should be given to those 65 years and older </li>
<li>Common myths surrounding the influenza vaccine </li>
<li>Predictions for the severity of influenza for 2020/2021 </li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3jgj4e/VT3980152_Flu6qbig.mp3" length="20570716" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Robert M. Jacobson, M.D. (@RobertJMD) 
Host: Darryl S. Chutka, M.D. (@ChutkaMD) 
It is extremely important that our patients receive the influenza vaccine this year. In previous years, less than half of the population has received it. Dr. Robert Jacobson, a pediatrician and vaccine specialist at the Mayo Clinic, joins us to discuss the reasons it’s so important for our patients to receive the influenza vaccine this season.  He’ll share tips for discussing common concerns from vaccine-hesitant patients and how you can increase your patient vaccination rates. 
Specific topics discussed: 
Importance of the influenza vaccine for our patients in 2020/2021 
How and when the influenza vaccine is developed for the next influenza season 
Why we need an influenza vaccine on an annual basis 
The best time of the year to receive the influenza vaccine 
Whether we lose some immunity to influenza if we receive the vaccine too early in the year 
Which vaccine should be given to those 65 years and older 
Common myths surrounding the influenza vaccine 
Predictions for the severity of influenza for 2020/2021 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1282</itunes:duration>
                <itunes:episode>206</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Caring for Patients with Dementia</title>
        <itunes:title>Caring for Patients with Dementia</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/caring-for-patients-with-dementia/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/caring-for-patients-with-dementia/#comments</comments>        <pubDate>Tue, 03 Nov 2020 06:00:00 -0600</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/38ddfa4a-f5b9-3267-b422-01f4b4670ee5</guid>
                                    <description><![CDATA[<p>Guest: Ericka E. Tung, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>) </p>
<p>The topic of Alzheimer’s Disease and other dementias was discussed along with the importance of providing care of the patient’s care-givers by Dr. Ericka Tung, a geriatrician in the Division of Community Internal Medicine at the Mayo Clinic. Specific topics discussed include:</p>
<ul><li>Common symptoms seen in early dementia.</li>
<li>Mild cognitive impairment and its progression to dementia.</li>
<li>Importance of stability of lifestyle in the life of patients with dementia.</li>
<li>Discussing the diagnosis of dementia with the patient and family.</li>
<li>Using a mental status exam in the evaluation of patients with suspected dementia.</li>
<li>Establishing a diagnosis in patients with early dementia.</li>
<li>The role of formal psychological testing in patients with suspected dementia.</li>
<li>The needs of care-givers of dementia patients.</li>
<li>Importance of respite care for the care-givers of dementia patients.</li>
<li>Evaluating driving skills in patients with early dementia.</li>
<li>Advanced care planning for dementia patients.</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Ericka E. Tung, M.D.</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>) </p>
<p>The topic of Alzheimer’s Disease and other dementias was discussed along with the importance of providing care of the patient’s care-givers by Dr. Ericka Tung, a geriatrician in the Division of Community Internal Medicine at the Mayo Clinic. Specific topics discussed include:</p>
<ul><li>Common symptoms seen in early dementia.</li>
<li>Mild cognitive impairment and its progression to dementia.</li>
<li>Importance of stability of lifestyle in the life of patients with dementia.</li>
<li>Discussing the diagnosis of dementia with the patient and family.</li>
<li>Using a mental status exam in the evaluation of patients with suspected dementia.</li>
<li>Establishing a diagnosis in patients with early dementia.</li>
<li>The role of formal psychological testing in patients with suspected dementia.</li>
<li>The needs of care-givers of dementia patients.</li>
<li>Importance of respite care for the care-givers of dementia patients.</li>
<li>Evaluating driving skills in patients with early dementia.</li>
<li>Advanced care planning for dementia patients.</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/g3rfmp/VT3854512_Tungbv0vx.mp3" length="20832270" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Ericka E. Tung, M.D.
Host: Darryl S. Chutka, M.D. (@ChutkaMD) 
The topic of Alzheimer’s Disease and other dementias was discussed along with the importance of providing care of the patient’s care-givers by Dr. Ericka Tung, a geriatrician in the Division of Community Internal Medicine at the Mayo Clinic. Specific topics discussed include:
Common symptoms seen in early dementia.
Mild cognitive impairment and its progression to dementia.
Importance of stability of lifestyle in the life of patients with dementia.
Discussing the diagnosis of dementia with the patient and family.
Using a mental status exam in the evaluation of patients with suspected dementia.
Establishing a diagnosis in patients with early dementia.
The role of formal psychological testing in patients with suspected dementia.
The needs of care-givers of dementia patients.
Importance of respite care for the care-givers of dementia patients.
Evaluating driving skills in patients with early dementia.
Advanced care planning for dementia patients.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1301</itunes:duration>
                <itunes:episode>199</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>COVID-19 Miniseries Episode 53: Mayo Clinic Q&amp;A - CDC Updates Close Contact Guidelines</title>
        <itunes:title>COVID-19 Miniseries Episode 53: Mayo Clinic Q&amp;A - CDC Updates Close Contact Guidelines</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-53-mayo-clinic-qa-cdc-updates-close-contact-guidelines/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-53-mayo-clinic-qa-cdc-updates-close-contact-guidelines/#comments</comments>        <pubDate>Wed, 28 Oct 2020 11:01:58 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/ec3dfb99-3f6b-3d9c-b889-4311eb643f6d</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in October, 2020. </p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Gregory A. Poland, M.D. <a href='https://twitter.com/drgregpoland?lang=en'>(@drgregpoland)</a>  </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>) </p>
<p>The Centers for Disease Control and Prevention (CDC) has <a href='https://www.cdc.gov/coronavirus/2019-ncov/php/contact-tracing/contact-tracing-plan/appendix.html'>updated its guidelines</a> for defining close contact with a person who is positive for <a href='https://www.mayoclinic.org/coronavirus-covid-19?_ga=2.192558114.945607169.1603719114-1498445560.1603141725'>COVID-19</a>. Previously, close contact was defined as occurring when someone was within 6 feet of an infectious person for 15 consecutive minutes. Now close contact includes people who were within 6 feet for a total of 15 minutes over a 24-hour period, as the CDC now advises that repeated, brief encounters also carry a risk of transmission. </p>
<p>On the Mayo Clinic Q&A podcast, <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.136537328.1903245515.1583502589-382127956.1576426874'>Dr. Gregory Poland</a>, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, discusses the updated information from the CDC and the latest information from the Food and Drug Administration on COVID-19 treatments and vaccines. </p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in October, 2020. </p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Gregory A. Poland, M.D. <a href='https://twitter.com/drgregpoland?lang=en'>(@drgregpoland)</a>  </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>) </p>
<p>The Centers for Disease Control and Prevention (CDC) has <a href='https://www.cdc.gov/coronavirus/2019-ncov/php/contact-tracing/contact-tracing-plan/appendix.html'>updated its guidelines</a> for defining close contact with a person who is positive for <a href='https://www.mayoclinic.org/coronavirus-covid-19?_ga=2.192558114.945607169.1603719114-1498445560.1603141725'>COVID-19</a>. Previously, close contact was defined as occurring when someone was within 6 feet of an infectious person for 15 consecutive minutes. Now close contact includes people who were within 6 feet for a total of 15 minutes over a 24-hour period, as the CDC now advises that repeated, brief encounters also carry a risk of transmission. </p>
<p>On the Mayo Clinic Q&A podcast, <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.136537328.1903245515.1583502589-382127956.1576426874'>Dr. Gregory Poland</a>, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, discusses the updated information from the CDC and the latest information from the Food and Drug Administration on COVID-19 treatments and vaccines. </p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kk64v4/Mayo_Clinic_Podcast_-_Dr_Gregory_Poland_-_10_28_20akg17.mp3" length="20793575" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in October, 2020. 
To claim credit visit: https://ce.mayo.edu/covid19podcast 
Guest:  Gregory A. Poland, M.D. (@drgregpoland)  
Host: Halena M. Gazelka, M.D. (@hmgazelkamd) 
The Centers for Disease Control and Prevention (CDC) has updated its guidelines for defining close contact with a person who is positive for COVID-19. Previously, close contact was defined as occurring when someone was within 6 feet of an infectious person for 15 consecutive minutes. Now close contact includes people who were within 6 feet for a total of 15 minutes over a 24-hour period, as the CDC now advises that repeated, brief encounters also carry a risk of transmission. 
On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, discusses the updated information from the CDC and the latest information from the Food and Drug Administration on COVID-19 treatments and vaccines. 
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1296</itunes:duration>
                <itunes:episode>198</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>Chronic Obstructive Pulmonary Disease (COPD)</title>
        <itunes:title>Chronic Obstructive Pulmonary Disease (COPD)</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/chronic-obstructive-pulmonary-disease-copd-1603303029/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/chronic-obstructive-pulmonary-disease-copd-1603303029/#comments</comments>        <pubDate>Tue, 27 Oct 2020 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/0a0d199b-b74f-3a33-bf96-d958948db5f2</guid>
                                    <description><![CDATA[<p>Guest: Lewis J. Wesselius, M.D.</p>
<p> </p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>) </p>
<p> </p>
<p>The topic of COPD including risk factors, evaluation and management is discussed with Dr. Lewis Wesselius, a pulmonologist in the Division of Thoracic Disease at the Mayo Clinic. Specific topics discussed include the following:</p>
<ul><li>Review of the various types of COPD.</li>
<li>Similarities and differences between emphysema and chronic bronchitis.</li>
<li>Financial complications of COPD.</li>
<li>Risk factors for COPD.</li>
<li>Appropriate tests to order when evaluating patients suspected of having COPD.</li>
<li>Determining the severity of COPD.</li>
<li>Management of patients with COPD including the role of bronchodilators, inhaled corticosteroids, antibiotics and oxygen.</li>
<li>COPD and the risk of lung cancer.</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Lewis J. Wesselius, M.D.</p>
<p> </p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>) </p>
<p> </p>
<p>The topic of COPD including risk factors, evaluation and management is discussed with Dr. Lewis Wesselius, a pulmonologist in the Division of Thoracic Disease at the Mayo Clinic. Specific topics discussed include the following:</p>
<ul><li>Review of the various types of COPD.</li>
<li>Similarities and differences between emphysema and chronic bronchitis.</li>
<li>Financial complications of COPD.</li>
<li>Risk factors for COPD.</li>
<li>Appropriate tests to order when evaluating patients suspected of having COPD.</li>
<li>Determining the severity of COPD.</li>
<li>Management of patients with COPD including the role of bronchodilators, inhaled corticosteroids, antibiotics and oxygen.</li>
<li>COPD and the risk of lung cancer.</li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6aahu4/VT3850769_COPD_No_Midroll9v5fe.mp3" length="18439383" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Lewis J. Wesselius, M.D.
 
Host: Darryl S. Chutka, M.D. (@ChutkaMD) 
 
The topic of COPD including risk factors, evaluation and management is discussed with Dr. Lewis Wesselius, a pulmonologist in the Division of Thoracic Disease at the Mayo Clinic. Specific topics discussed include the following:
Review of the various types of COPD.
Similarities and differences between emphysema and chronic bronchitis.
Financial complications of COPD.
Risk factors for COPD.
Appropriate tests to order when evaluating patients suspected of having COPD.
Determining the severity of COPD.
Management of patients with COPD including the role of bronchodilators, inhaled corticosteroids, antibiotics and oxygen.
COPD and the risk of lung cancer.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1149</itunes:duration>
                <itunes:episode>197</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Allergies and Anaphylaxis</title>
        <itunes:title>Allergies and Anaphylaxis</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/allergies-and-anaphylaxis/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/allergies-and-anaphylaxis/#comments</comments>        <pubDate>Tue, 20 Oct 2020 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/66addb3b-7038-3fac-97a3-36f0a24e8997</guid>
                                    <description><![CDATA[<p>Guest: James T C Li, M.D., Ph.D. (<a href='https://twitter.com/jameslimd'>@jameslimd</a>) </p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>) </p>
<p>The topic of anaphylaxis is reviewed including its causes, management and potential complications by James T C Li, M.D., Ph.D., an allergist from the Division of Allergic Disease from the Mayo Clinic. Specific topics discussed include the following:</p>
<ul><li>Truths vs. myths regarding anaphylaxis </li>
<li>Common manifestations and presentations of anaphylaxis </li>
<li>Triggers which more commonly produce an anaphylactic reaction </li>
<li>Anaphylaxis in patients without a history of allergies </li>
<li>When to use antihistamines in treating an allergic reaction </li>
<li>When and how to prescribe epinephrine in treating patients with a history of allergic reactions </li>
<li>Issues related to epinephrine auto-injectors </li>
<li>Natural history of allergies over time </li>
<li>Developments in peanut allergies </li>
<li>Management of an anaphylactic reaction </li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: James T C Li, M.D., Ph.D. (<a href='https://twitter.com/jameslimd'>@jameslimd</a>) </p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>) </p>
<p>The topic of anaphylaxis is reviewed including its causes, management and potential complications by James T C Li, M.D., Ph.D., an allergist from the Division of Allergic Disease from the Mayo Clinic. Specific topics discussed include the following:</p>
<ul><li>Truths vs. myths regarding anaphylaxis </li>
<li>Common manifestations and presentations of anaphylaxis </li>
<li>Triggers which more commonly produce an anaphylactic reaction </li>
<li>Anaphylaxis in patients without a history of allergies </li>
<li>When to use antihistamines in treating an allergic reaction </li>
<li>When and how to prescribe epinephrine in treating patients with a history of allergic reactions </li>
<li>Issues related to epinephrine auto-injectors </li>
<li>Natural history of allergies over time </li>
<li>Developments in peanut allergies </li>
<li>Management of an anaphylactic reaction </li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vzcez4/VT3945694_Anaphylaxis9g42x.mp3" length="20542650" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: James T C Li, M.D., Ph.D. (@jameslimd) 
Host: Darryl S. Chutka, M.D. (@ChutkaMD) 
The topic of anaphylaxis is reviewed including its causes, management and potential complications by James T C Li, M.D., Ph.D., an allergist from the Division of Allergic Disease from the Mayo Clinic. Specific topics discussed include the following:
Truths vs. myths regarding anaphylaxis 
Common manifestations and presentations of anaphylaxis 
Triggers which more commonly produce an anaphylactic reaction 
Anaphylaxis in patients without a history of allergies 
When to use antihistamines in treating an allergic reaction 
When and how to prescribe epinephrine in treating patients with a history of allergic reactions 
Issues related to epinephrine auto-injectors 
Natural history of allergies over time 
Developments in peanut allergies 
Management of an anaphylactic reaction 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1283</itunes:duration>
                <itunes:episode>196</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Differentiating Common Causes of Shoulder Pain</title>
        <itunes:title>Differentiating Common Causes of Shoulder Pain</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/the-easy-and-effective-approach-to-shoulder-pain/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/the-easy-and-effective-approach-to-shoulder-pain/#comments</comments>        <pubDate>Tue, 13 Oct 2020 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/c0b78250-62aa-3302-9680-f60242437718</guid>
                                    <description><![CDATA[<p>Guest: Christopher Camp, M.D. (<a href='https://twitter.com/ChrisCampMD'>@ChrisCampMD</a>) </p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>) </p>
<p>The shoulder is unique in both structure and function. Injuries can occur acutely or overtime from wear and tear. If a patient presents with shoulder pain, when do you order imaging? What is role of steroid injections? When should a patient apply ice or apply heat? Dr. Christopher Camp, an orthopedist from Orthopedics and Sports Medicine at the Mayo Clinic joins us to discuss common injuries broken down by age demographic, treatment options, and when you may need to refer to a surgeon.  </p>
<p> The following topics are discussed: </p>
<ul><li>Anatomy of the shoulder joint and what makes it a unique joint. </li>
<li>Injuries which commonly occur in both younger and older patients. </li>
<li>Review of common pathologic conditions of the shoulder: 
<ul><li>Rotator cuff injuries </li>
<li>Impingement syndrome </li>
<li>Bursitis of the shoulder  </li>
<li>“Frozen shoulder”  </li>
</ul>
</li>
<li>When a steroid injection of the shoulder is of benefit.  </li>
<li>When an X-ray or MRI of the shoulder is of benefit in the evaluation of shoulder pain.  </li>
<li>Benefits of physical therapy in patients with shoulder pain/injuries.  </li>
<li>The use of heat or cold in treating shoulder pain.  </li>
<li>When patients should be referred to an orthopedist for evaluation of shoulder pain.  </li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Christopher Camp, M.D. (<a href='https://twitter.com/ChrisCampMD'>@ChrisCampMD</a>) </p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>) </p>
<p>The shoulder is unique in both structure and function. Injuries can occur acutely or overtime from wear and tear. If a patient presents with shoulder pain, when do you order imaging? What is role of steroid injections? When should a patient apply ice or apply heat? Dr. Christopher Camp, an orthopedist from Orthopedics and Sports Medicine at the Mayo Clinic joins us to discuss common injuries broken down by age demographic, treatment options, and when you may need to refer to a surgeon.  </p>
<p> The following topics are discussed: </p>
<ul><li>Anatomy of the shoulder joint and what makes it a unique joint. </li>
<li>Injuries which commonly occur in both younger and older patients. </li>
<li>Review of common pathologic conditions of the shoulder: 
<ul><li>Rotator cuff injuries </li>
<li>Impingement syndrome </li>
<li>Bursitis of the shoulder  </li>
<li>“Frozen shoulder”  </li>
</ul>
</li>
<li>When a steroid injection of the shoulder is of benefit.  </li>
<li>When an X-ray or MRI of the shoulder is of benefit in the evaluation of shoulder pain.  </li>
<li>Benefits of physical therapy in patients with shoulder pain/injuries.  </li>
<li>The use of heat or cold in treating shoulder pain.  </li>
<li>When patients should be referred to an orthopedist for evaluation of shoulder pain.  </li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gakdxs/VT3833209_Common_Shoulder_Injuries_No_Extras_V29bd5j.mp3" length="22169648" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Christopher Camp, M.D. (@ChrisCampMD) 
Host: Darryl S. Chutka, M.D. (@ChutkaMD) 
The shoulder is unique in both structure and function. Injuries can occur acutely or overtime from wear and tear. If a patient presents with shoulder pain, when do you order imaging? What is role of steroid injections? When should a patient apply ice or apply heat? Dr. Christopher Camp, an orthopedist from Orthopedics and Sports Medicine at the Mayo Clinic joins us to discuss common injuries broken down by age demographic, treatment options, and when you may need to refer to a surgeon.  
 The following topics are discussed: 
Anatomy of the shoulder joint and what makes it a unique joint. 
Injuries which commonly occur in both younger and older patients. 
Review of common pathologic conditions of the shoulder: 
Rotator cuff injuries 
Impingement syndrome 
Bursitis of the shoulder  
“Frozen shoulder”  

When a steroid injection of the shoulder is of benefit.  
When an X-ray or MRI of the shoulder is of benefit in the evaluation of shoulder pain.  
Benefits of physical therapy in patients with shoulder pain/injuries.  
The use of heat or cold in treating shoulder pain.  
When patients should be referred to an orthopedist for evaluation of shoulder pain.  
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1384</itunes:duration>
                <itunes:episode>195</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>COVID-19 Miniseries Episode 52: Mayo Clinic Q&amp;A - How Do Antiviral Drugs Work?</title>
        <itunes:title>COVID-19 Miniseries Episode 52: Mayo Clinic Q&amp;A - How Do Antiviral Drugs Work?</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-52-mayo-clinic-qa-how-do-antiviral-drugs-work/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-52-mayo-clinic-qa-how-do-antiviral-drugs-work/#comments</comments>        <pubDate>Wed, 07 Oct 2020 16:56:41 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/9c3cf367-bca5-3387-9a05-117b707f0830</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in October, 2020. </p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Gregory A. Poland, M.D. <a href='https://twitter.com/drgregpoland?lang=en'>(@drgregpoland)</a> </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>) </p>
<p>Antiviral drugs are medicines that fight against viruses in the human body by impeding the infection process. Antivirals are commonly used to treat HIV/AIDS, influenza, herpes, and hepatitis B and C. The antiviral, <a href='https://www.mayoclinic.org/diseases-conditions/coronavirus/expert-answers/coronavirus-drugs/faq-20485627'>Remdesivir</a>, which was originally developed to fight Ebola, is now being used to treat  <a href='https://newsnetwork.mayoclinic.org/category/covid-19/?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a>. </p>
<p>On the Mayo Clinic Q&A podcast, <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.136537328.1903245515.1583502589-382127956.1576426874'>Dr. Gregory Poland</a>, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, explains how antivirals work to shorten the course of the disease.</p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in October, 2020. </p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Gregory A. Poland, M.D. <a href='https://twitter.com/drgregpoland?lang=en'>(@drgregpoland)</a> </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>) </p>
<p>Antiviral drugs are medicines that fight against viruses in the human body by impeding the infection process. Antivirals are commonly used to treat HIV/AIDS, influenza, herpes, and hepatitis B and C. The antiviral, <a href='https://www.mayoclinic.org/diseases-conditions/coronavirus/expert-answers/coronavirus-drugs/faq-20485627'>Remdesivir</a>, which was originally developed to fight Ebola, is now being used to treat  <a href='https://newsnetwork.mayoclinic.org/category/covid-19/?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a>. </p>
<p>On the Mayo Clinic Q&A podcast, <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.136537328.1903245515.1583502589-382127956.1576426874'>Dr. Gregory Poland</a>, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, explains how antivirals work to shorten the course of the disease.</p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/a8zpdx/Mayo_Clinic_Podcast_-_Dr_Gregory_Poland_-_10_7_20biswb.mp3" length="17991050" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in October, 2020. 
To claim credit visit: https://ce.mayo.edu/covid19podcast 
Guest:  Gregory A. Poland, M.D. (@drgregpoland) 
Host: Halena M. Gazelka, M.D. (@hmgazelkamd) 
Antiviral drugs are medicines that fight against viruses in the human body by impeding the infection process. Antivirals are commonly used to treat HIV/AIDS, influenza, herpes, and hepatitis B and C. The antiviral, Remdesivir, which was originally developed to fight Ebola, is now being used to treat  COVID-19. 
On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, explains how antivirals work to shorten the course of the disease.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1121</itunes:duration>
                <itunes:episode>194</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>The Evolution of Pharmacogenomics</title>
        <itunes:title>The Evolution of Pharmacogenomics</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/the-evolution-of-pharmacogenomics/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/the-evolution-of-pharmacogenomics/#comments</comments>        <pubDate>Tue, 06 Oct 2020 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/fe175d3d-b332-3867-af69-3d8ab46cdf28</guid>
                                    <description><![CDATA[<p>Guest: Richard Weinshilboum, M.D.</p>
<p>Host: Darryl S. Chutka, M.D.</p>
<p>In a similar way to how anesthesia changed the practice of surgery, pharmacogenomics will produce a similar change in how we prescribe medications. Listen in to world-renowned expert Dr. Richard Weinshilboum discuss the evolution of the field and how advances are accelerating its application at the bedside. </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Richard Weinshilboum, M.D.</p>
<p>Host: Darryl S. Chutka, M.D.</p>
<p>In a similar way to how anesthesia changed the practice of surgery, pharmacogenomics will produce a similar change in how we prescribe medications. Listen in to world-renowned expert Dr. Richard Weinshilboum discuss the evolution of the field and how advances are accelerating its application at the bedside. </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gmdrvu/VT_3850769_Weinshilboumbe5o4.mp3" length="20904640" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Richard Weinshilboum, M.D.
Host: Darryl S. Chutka, M.D.
In a similar way to how anesthesia changed the practice of surgery, pharmacogenomics will produce a similar change in how we prescribe medications. Listen in to world-renowned expert Dr. Richard Weinshilboum discuss the evolution of the field and how advances are accelerating its application at the bedside. 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1305</itunes:duration>
                <itunes:episode>193</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: Transplant Surgeries and COVID-19</title>
        <itunes:title>Mayo Clinic Q&amp;A: Transplant Surgeries and COVID-19</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-transplant-surgeries-and-covid-19/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-transplant-surgeries-and-covid-19/#comments</comments>        <pubDate>Wed, 30 Sep 2020 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/c2abd66c-ba85-3f83-b9cd-00000825e7dd</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in September, 2020. </p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Patrick G. Dean, M.D. </p>
<p>Host: Sanjeev (Sanj) Kakar, M.D. (<a href='https://twitter.com/sanjkakar?lang=en'>@sanjkakar</a>) </p>
<p>Transplants are identified as nonelective surgeries, and transplant patients have faced urgent medical needs during the <a href='https://newsnetwork.mayoclinic.org/category/covid-19/?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a> pandemic. </p>
<p>"Our practice, like many others across the country, did slow down in March and April of this year," says <a href='https://www.mayoclinic.org/biographies/dean-patrick-g-m-d/bio-20054709'>Dr. Patrick Dean</a>, a Mayo Clinic transplant surgeon. "Patients and providers were concerned ― appropriately so ― about what would happen with this pandemic and whether it would be safe to have a transplant or for that matter any health care that wasn't absolutely emergent." </p>
<p>In this Mayo Clinic Q&A podcast, Dr. Dean talks about taking care of transplant patients; overcoming surgery challenges during the pandemic; the increased risks transplant patients have of developing SARS-CoV-2, the virus that causes COVID-19, because of compromised immune systems; and the important need for COVID-19 testing. </p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in September, 2020. </p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Patrick G. Dean, M.D. </p>
<p>Host: Sanjeev (Sanj) Kakar, M.D. (<a href='https://twitter.com/sanjkakar?lang=en'>@sanjkakar</a>) </p>
<p>Transplants are identified as nonelective surgeries, and transplant patients have faced urgent medical needs during the <a href='https://newsnetwork.mayoclinic.org/category/covid-19/?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a> pandemic. </p>
<p>"Our practice, like many others across the country, did slow down in March and April of this year," says <a href='https://www.mayoclinic.org/biographies/dean-patrick-g-m-d/bio-20054709'>Dr. Patrick Dean</a>, a Mayo Clinic transplant surgeon. "Patients and providers were concerned ― appropriately so ― about what would happen with this pandemic and whether it would be safe to have a transplant or for that matter any health care that wasn't absolutely emergent." </p>
<p>In this Mayo Clinic Q&A podcast, Dr. Dean talks about taking care of transplant patients; overcoming surgery challenges during the pandemic; the increased risks transplant patients have of developing SARS-CoV-2, the virus that causes COVID-19, because of compromised immune systems; and the important need for COVID-19 testing. </p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/anmx7j/Mayo_Clinic_Podcast_-_Dr_Patrick_Dean_-_9_29_2096q8c.mp3" length="11132517" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in September, 2020. 
To claim credit visit: https://ce.mayo.edu/covid19podcast 
Guest:  Patrick G. Dean, M.D. 
Host: Sanjeev (Sanj) Kakar, M.D. (@sanjkakar) 
Transplants are identified as nonelective surgeries, and transplant patients have faced urgent medical needs during the COVID-19 pandemic. 
"Our practice, like many others across the country, did slow down in March and April of this year," says Dr. Patrick Dean, a Mayo Clinic transplant surgeon. "Patients and providers were concerned ― appropriately so ― about what would happen with this pandemic and whether it would be safe to have a transplant or for that matter any health care that wasn't absolutely emergent." 
In this Mayo Clinic Q&A podcast, Dr. Dean talks about taking care of transplant patients; overcoming surgery challenges during the pandemic; the increased risks transplant patients have of developing SARS-CoV-2, the virus that causes COVID-19, because of compromised immune systems; and the important need for COVID-19 testing. 
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>693</itunes:duration>
                        <itunes:episodeType>bonus</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>Updates in the Evaluation and Treatment of Multiple Sclerosis</title>
        <itunes:title>Updates in the Evaluation and Treatment of Multiple Sclerosis</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/updates-in-the-evaluation-and-treatment-of-multiple-sclerosis/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/updates-in-the-evaluation-and-treatment-of-multiple-sclerosis/#comments</comments>        <pubDate>Tue, 29 Sep 2020 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/b54ac2ca-6be6-3b7d-b14a-573f3cb22129</guid>
                                    <description><![CDATA[<p>Guest: Eoin Flanagan, M.B., B.Ch. (<a href='https://twitter.com/EoinFlanagan14'>@EoinFlanagan14</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>This episode will review the following topics regarding Multiple Sclerosis (MS): </p>
<ul><li>Common presenting symptoms </li>
<li>Risk factors, including the association of MS and vitamin D </li>
<li>Typical pathologic changes found in patients </li>
<li>The difference between the relapsing and progressive forms of MS </li>
<li>Laboratory and imaging studies which are helpful in confirming a diagnosis </li>
<li>Established and new treatment options available </li>
</ul>
Available useful resources for patients with MS:
<ul><li><a href='https://www.mayoclinic.org/diseases-conditions/multiple-sclerosis/symptoms-causes/syc-20350269'>Mayo Clinic website on Multiple Sclerosis</a> </li>
<li><a href='https://www.nationalmssociety.org/coronavirus-covid-19-information?utm_source=covid%20landing%20page&utm_medium=Search&utm_campaign=AlwaysOn_Covid&utm_content=CovidSearch&mrkgadid=1&mrkgcl=1041&mrkgen=gtext&mrkgbflag=1&mrkgcat=awareness&acctid=21700000001680367&dskeywordid=43700053261223080&lid=43700053261223080&ds_s_kwgid=58700005829232446&device=c&network=g&matchtype=e&locationid=9019841&creative=432238535663&targetid=kwd-295947033733&campaignid=9892990464&adgroupid=103997778441&gclid=Cj0KCQjwtsv7BRCmARIsANu-CQeEBtFDM59MoTY3bHCQj44hsj0q6YXgfICyUxsR0QxLWfWvvY19WUkaAshuEALw_wcB&gclsrc=aw.ds'>National MS Society</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Eoin Flanagan, M.B., B.Ch. (<a href='https://twitter.com/EoinFlanagan14'>@EoinFlanagan14</a>)</p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD'>@ChutkaMD</a>)</p>
<p>This episode will review the following topics regarding Multiple Sclerosis (MS): </p>
<ul><li>Common presenting symptoms </li>
<li>Risk factors, including the association of MS and vitamin D </li>
<li>Typical pathologic changes found in patients </li>
<li>The difference between the relapsing and progressive forms of MS </li>
<li>Laboratory and imaging studies which are helpful in confirming a diagnosis </li>
<li>Established and new treatment options available </li>
</ul>
Available useful resources for patients with MS:
<ul><li><a href='https://www.mayoclinic.org/diseases-conditions/multiple-sclerosis/symptoms-causes/syc-20350269'>Mayo Clinic website on Multiple Sclerosis</a> </li>
<li><a href='https://www.nationalmssociety.org/coronavirus-covid-19-information?utm_source=covid%20landing%20page&utm_medium=Search&utm_campaign=AlwaysOn_Covid&utm_content=CovidSearch&mrkgadid=1&mrkgcl=1041&mrkgen=gtext&mrkgbflag=1&mrkgcat=awareness&acctid=21700000001680367&dskeywordid=43700053261223080&lid=43700053261223080&ds_s_kwgid=58700005829232446&device=c&network=g&matchtype=e&locationid=9019841&creative=432238535663&targetid=kwd-295947033733&campaignid=9892990464&adgroupid=103997778441&gclid=Cj0KCQjwtsv7BRCmARIsANu-CQeEBtFDM59MoTY3bHCQj44hsj0q6YXgfICyUxsR0QxLWfWvvY19WUkaAshuEALw_wcB&gclsrc=aw.ds'>National MS Society</a></li>
</ul>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3zrfsj/VT3972207_-_Multiple_Sclerosisb7knk.mp3" length="20646490" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Eoin Flanagan, M.B., B.Ch. (@EoinFlanagan14)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
This episode will review the following topics regarding Multiple Sclerosis (MS): 
Common presenting symptoms 
Risk factors, including the association of MS and vitamin D 
Typical pathologic changes found in patients 
The difference between the relapsing and progressive forms of MS 
Laboratory and imaging studies which are helpful in confirming a diagnosis 
Established and new treatment options available 
Available useful resources for patients with MS:
Mayo Clinic website on Multiple Sclerosis 
National MS Society
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1287</itunes:duration>
                <itunes:episode>192</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Mayo Clinic Q&amp;A: #AskTheMayoMom about COVID-19 and School Children</title>
        <itunes:title>Mayo Clinic Q&amp;A: #AskTheMayoMom about COVID-19 and School Children</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-askthemayomom-about-covid-19-and-school-children/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-askthemayomom-about-covid-19-and-school-children/#comments</comments>        <pubDate>Tue, 22 Sep 2020 12:18:57 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/8e1794c1-2b6a-391d-908a-a8a0f39a9448</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in September, 2020. </p>
<p>Guest:  Angela C. Mattke, M.D. (<a href='https://twitter.com/drangelamattke?lang=en'>@DrAngelaMattke</a>) </p>
<p>Host: Sanjeev (Sanj) Kakar, M.D. (<a href='https://twitter.com/sanjkakar?lang=en'>@sanjkakar</a>) </p>
<p>The <a href='https://newsnetwork.mayoclinic.org/category/covid-19/?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a> pandemic continues to create challenges, including returning to school with hybrid learning modules for children. There are also anxieties and uncertainties to navigate, while trying to follow COVID-19 guidelines. </p>
<p>In this "Mayo Clinic Q&A" podcast<a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.136537328.1903245515.1583502589-382127956.1576426874'>,</a> <a href='https://www.mayoclinic.org/biographies/mattke-angela-c-m-d/bio-20055584?_ga=2.166807678.1765853112.1600439588-906239412.1592407173'>Dr. Angela Mattke</a>, a Mayo Clinic pediatrician and host of <a href='https://newsnetwork.mayoclinic.org/podcast/q-a/#AskTheMayoMom'>#AskTheMayoMom</a>, talks about the concerns her patients have, and what important things parents and caregivers should take into consideration when helping children stay healthy. </p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in September, 2020. </p>
<p>Guest:  Angela C. Mattke, M.D. (<a href='https://twitter.com/drangelamattke?lang=en'>@DrAngelaMattke</a>) </p>
<p>Host: Sanjeev (Sanj) Kakar, M.D. (<a href='https://twitter.com/sanjkakar?lang=en'>@sanjkakar</a>) </p>
<p>The <a href='https://newsnetwork.mayoclinic.org/category/covid-19/?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a> pandemic continues to create challenges, including returning to school with hybrid learning modules for children. There are also anxieties and uncertainties to navigate, while trying to follow COVID-19 guidelines. </p>
<p>In this "Mayo Clinic Q&A" podcast<a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.136537328.1903245515.1583502589-382127956.1576426874'>,</a> <a href='https://www.mayoclinic.org/biographies/mattke-angela-c-m-d/bio-20055584?_ga=2.166807678.1765853112.1600439588-906239412.1592407173'>Dr. Angela Mattke</a>, a Mayo Clinic pediatrician and host of <a href='https://newsnetwork.mayoclinic.org/podcast/q-a/#AskTheMayoMom'>#AskTheMayoMom</a>, talks about the concerns her patients have, and what important things parents and caregivers should take into consideration when helping children stay healthy. </p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xfaagt/Mayo_Clinic_Podcast_-_Dr_Angela_Mattke_-_9_18_20adnge.mp3" length="16657572" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in September, 2020. 
Guest:  Angela C. Mattke, M.D. (@DrAngelaMattke) 
Host: Sanjeev (Sanj) Kakar, M.D. (@sanjkakar) 
The COVID-19 pandemic continues to create challenges, including returning to school with hybrid learning modules for children. There are also anxieties and uncertainties to navigate, while trying to follow COVID-19 guidelines. 
In this "Mayo Clinic Q&A" podcast, Dr. Angela Mattke, a Mayo Clinic pediatrician and host of #AskTheMayoMom, talks about the concerns her patients have, and what important things parents and caregivers should take into consideration when helping children stay healthy. 
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1038</itunes:duration>
                <itunes:episode>191</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>COVID-19 Miniseries Episode 51: Mayo Clinic Q&amp;A - Bringing COVID-19 Vaccines to the Public</title>
        <itunes:title>COVID-19 Miniseries Episode 51: Mayo Clinic Q&amp;A - Bringing COVID-19 Vaccines to the Public</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-51-mayo-clinic-qa-bringing-covid-19-vaccines-to-the-public/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-51-mayo-clinic-qa-bringing-covid-19-vaccines-to-the-public/#comments</comments>        <pubDate>Thu, 17 Sep 2020 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/c971d365-41a5-37c6-850b-77157fe88b52</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded on September 14, 2020. </p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Gregory A. Poland, M.D. <a href='https://twitter.com/drgregpoland?lang=en'>(@drgregpoland)</a> </p>
<p>Host: Danielle Stiepan </p>
<p>Once a vaccine to prevent <a href='https://newsnetwork.mayoclinic.org/category/covid-19/?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a> is approved, there will be logistics to consider. For example, who will receive the vaccine first, and how can the supply chain safely deliver the vaccine to 330 million Americans and potentially more than 7 billion people worldwide? In addition, multiple vaccines may be brought to market within weeks to months of each other, confusing consumers. </p>
<p>On the Mayo Clinic Q&A podcast, <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.136537328.1903245515.1583502589-382127956.1576426874'>Dr. Gregory Poland</a>, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, explains the challenges of rolling out a COVID-19 vaccine. </p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded on September 14, 2020. </p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Gregory A. Poland, M.D. <a href='https://twitter.com/drgregpoland?lang=en'>(@drgregpoland)</a> </p>
<p>Host: Danielle Stiepan </p>
<p>Once a vaccine to prevent <a href='https://newsnetwork.mayoclinic.org/category/covid-19/?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a> is approved, there will be logistics to consider. For example, who will receive the vaccine first, and how can the supply chain safely deliver the vaccine to 330 million Americans and potentially more than 7 billion people worldwide? In addition, multiple vaccines may be brought to market within weeks to months of each other, confusing consumers. </p>
<p>On the Mayo Clinic Q&A podcast, <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.136537328.1903245515.1583502589-382127956.1576426874'>Dr. Gregory Poland</a>, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, explains the challenges of rolling out a COVID-19 vaccine. </p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/izy7py/Mayo_Clinic_Podcast_-_Dr_Gregory_Poland_-_9_16_20b8vsw.mp3" length="15158922" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded on September 14, 2020. 
To claim credit visit: https://ce.mayo.edu/covid19podcast 
Guest:  Gregory A. Poland, M.D. (@drgregpoland) 
Host: Danielle Stiepan 
Once a vaccine to prevent COVID-19 is approved, there will be logistics to consider. For example, who will receive the vaccine first, and how can the supply chain safely deliver the vaccine to 330 million Americans and potentially more than 7 billion people worldwide? In addition, multiple vaccines may be brought to market within weeks to months of each other, confusing consumers. 
On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, explains the challenges of rolling out a COVID-19 vaccine. 
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>945</itunes:duration>
                <itunes:episode>190</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>Updates for Diabetes Treatment and Monitoring</title>
        <itunes:title>Updates for Diabetes Treatment and Monitoring</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/updates-for-diabetes-treatment-and-monitoring/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/updates-for-diabetes-treatment-and-monitoring/#comments</comments>        <pubDate>Tue, 15 Sep 2020 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/6e985909-80c9-3894-aa82-e972786a8713</guid>
                                    <description><![CDATA[<p>Guest:  Bithika M. Thompson, M.D. </p>
<p>Host: Darryl S. Chutka, M.D. </p>
<p>Dr. Bithika Thompson discusses the recognition and treatment of pre-diabetes, individualizing glycemic control goals for patients based on a series of variables, and recent advances in technology for monitoring that help to decrease the burden of care. </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest:  Bithika M. Thompson, M.D. </p>
<p>Host: Darryl S. Chutka, M.D. </p>
<p>Dr. Bithika Thompson discusses the recognition and treatment of pre-diabetes, individualizing glycemic control goals for patients based on a series of variables, and recent advances in technology for monitoring that help to decrease the burden of care. </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/r6edsa/VT3841541_Diabetes_-_Thompson8xyi1.mp3" length="23255255" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest:  Bithika M. Thompson, M.D. 
Host: Darryl S. Chutka, M.D. 
Dr. Bithika Thompson discusses the recognition and treatment of pre-diabetes, individualizing glycemic control goals for patients based on a series of variables, and recent advances in technology for monitoring that help to decrease the burden of care. 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1452</itunes:duration>
                <itunes:episode>189</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>An Essential Update in Preventative Cardiology in the Time of COVID-19</title>
        <itunes:title>An Essential Update in Preventative Cardiology in the Time of COVID-19</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/an-essential-update-in-preventative-cardiology-in-the-time-of-covid-19/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/an-essential-update-in-preventative-cardiology-in-the-time-of-covid-19/#comments</comments>        <pubDate>Tue, 08 Sep 2020 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/37c35c1b-6ed8-39fb-b08c-509a2b4c268b</guid>
                                    <description><![CDATA[<p>To register for notification when the 94th Annual Clinical Reviews Course opens visit: <a href='https://mayocl.in/2GvecAd'>https://mayocl.in/2GvecAd</a> </p>
<p>Guest:  Stephen L. Kopecky, M.D. </p>
<p>With underlying cardiovascular disease as the most lethal comorbidity to have in association with COVID-19, what have we learned about how SARS-CoV-2 affects the heart and what correlation is seen between patients with cardiometabolic disorders and preventative health measures? Dr. Stephen Kopecky shares lessons learned for all cardiologists, all caregivers, and all patients. </p>
<p>“The cardiovascular risk profile that we use from the American College of Cardiology, from the American Heart Association, looks at hypertension, looks at smoking, looks at diabetes, and looks at lipids. That risk profile predicts cardiovascular complications. So it not only predicts disease but it predicts the complications of COVID infection.” </p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>To register for notification when the 94th Annual Clinical Reviews Course opens visit: <a href='https://mayocl.in/2GvecAd'>https://mayocl.in/2GvecAd</a> </p>
<p>Guest:  Stephen L. Kopecky, M.D. </p>
<p>With underlying cardiovascular disease as the most lethal comorbidity to have in association with COVID-19, what have we learned about how SARS-CoV-2 affects the heart and what correlation is seen between patients with cardiometabolic disorders and preventative health measures? Dr. Stephen Kopecky shares lessons learned for all cardiologists, all caregivers, and all patients. </p>
<p>“The cardiovascular risk profile that we use from the American College of Cardiology, from the American Heart Association, looks at hypertension, looks at smoking, looks at diabetes, and looks at lipids. That risk profile predicts cardiovascular complications. So it not only predicts disease but it predicts the complications of COVID infection.” </p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/r9xrey/VT3972183_-_Kopecky6xg5f.mp3" length="27939351" type="audio/mpeg"/>
        <itunes:summary><![CDATA[To register for notification when the 94th Annual Clinical Reviews Course opens visit: https://mayocl.in/2GvecAd 
Guest:  Stephen L. Kopecky, M.D. 
With underlying cardiovascular disease as the most lethal comorbidity to have in association with COVID-19, what have we learned about how SARS-CoV-2 affects the heart and what correlation is seen between patients with cardiometabolic disorders and preventative health measures? Dr. Stephen Kopecky shares lessons learned for all cardiologists, all caregivers, and all patients. 
“The cardiovascular risk profile that we use from the American College of Cardiology, from the American Heart Association, looks at hypertension, looks at smoking, looks at diabetes, and looks at lipids. That risk profile predicts cardiovascular complications. So it not only predicts disease but it predicts the complications of COVID infection.” 
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1741</itunes:duration>
                <itunes:episode>188</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>COVID-19 Miniseries Episode 50: Mayo Clinic Q&amp;A - COVID-19 - Essential Updates with Dr. Poland</title>
        <itunes:title>COVID-19 Miniseries Episode 50: Mayo Clinic Q&amp;A - COVID-19 - Essential Updates with Dr. Poland</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-50-mayo-clinic-qa-covid-19-essential-updates-with-dr-poland/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-50-mayo-clinic-qa-covid-19-essential-updates-with-dr-poland/#comments</comments>        <pubDate>Fri, 04 Sep 2020 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/d6b24099-0d8d-3feb-8754-0a27c46cea3c</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in September, 2020. </p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>) </p>
<p>On the Mayo Clinic Q&A podcast, <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.136537328.1903245515.1583502589-382127956.1576426874'>Dr. Gregory Poland</a>, an infectious diseases expert and head of Mayo Clinic’s Vaccine Research Group, covers the latest news on the <a href='https://newsnetwork.mayoclinic.org/category/covid-19/?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19 pandemic</a>. </p>
<p>Dr. Poland gives an update on progress towards a vaccine for COVID-19, discusses therapies for treating the virus and shares research on how effective face masks and physical distancing are in fighting the spread of the disease. </p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in September, 2020. </p>
<p>Guest:  Gregory A. Poland, M.D. (<a href='https://twitter.com/drgregpoland?lang=en'>@drgregpoland</a>) </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>) </p>
<p>On the Mayo Clinic Q&A podcast, <a href='https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.136537328.1903245515.1583502589-382127956.1576426874'>Dr. Gregory Poland</a>, an infectious diseases expert and head of Mayo Clinic’s Vaccine Research Group, covers the latest news on the <a href='https://newsnetwork.mayoclinic.org/category/covid-19/?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19 pandemic</a>. </p>
<p>Dr. Poland gives an update on progress towards a vaccine for COVID-19, discusses therapies for treating the virus and shares research on how effective face masks and physical distancing are in fighting the spread of the disease. </p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vrt79i/Dr_Poland_7_20_20209dx7h.mp3" length="26818701" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in September, 2020. 
Guest:  Gregory A. Poland, M.D. (@drgregpoland) 
Host: Halena M. Gazelka, M.D. (@hmgazelkamd) 
On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic’s Vaccine Research Group, covers the latest news on the COVID-19 pandemic. 
Dr. Poland gives an update on progress towards a vaccine for COVID-19, discusses therapies for treating the virus and shares research on how effective face masks and physical distancing are in fighting the spread of the disease. 
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1674</itunes:duration>
                <itunes:episode>187</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>Mayo Clinic Q&amp;A - A Healthy Mindset to Start the School Year</title>
        <itunes:title>Mayo Clinic Q&amp;A - A Healthy Mindset to Start the School Year</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-a-healthy-mindset-to-start-the-school-year/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-qa-a-healthy-mindset-to-start-the-school-year/#comments</comments>        <pubDate>Wed, 02 Sep 2020 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/5f2d4cb0-65a5-3cbd-9909-1a5d945acd59</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in August, 2020. </p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Craig N. Sawchuk, Ph.D., L.P. <a href='https://twitter.com/craigsawchukphd?lang=en'>(@CraigSawchukPhD)</a> </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>) </p>
<p>The start of a new school year is always a time that’s filled with excitement and anxiety. This year, <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a> is making back to school even more challenging for kids, teachers and parents. Whether in person, online or a hybrid approach, this school year will be different for students and staff. How can you and your child have a healthy mindset for this school year? </p>
<p>On the Mayo Clinic Q&A podcast, <a href='https://www.mayoclinic.org/biographies/sawchuk-craig-n-ph-d-l-p/bio-20085911?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.79094737.454056417.1597757197-906239412.1592407173'>Dr. Craig Sawchuk</a>, chair of the Division of Integrated Behavioral Health at Mayo Clinic, shares helpful tips and strategies to be resilient and handle the challenges of a school year during the COVID-19 pandemic. </p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in August, 2020. </p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Craig N. Sawchuk, Ph.D., L.P. <a href='https://twitter.com/craigsawchukphd?lang=en'>(@CraigSawchukPhD)</a> </p>
<p>Host: Halena M. Gazelka, M.D. (<a href='https://twitter.com/hmgazelkamd'>@hmgazelkamd</a>) </p>
<p>The start of a new school year is always a time that’s filled with excitement and anxiety. This year, <a href='https://www.mayoclinic.org/coronavirus-covid-19?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721'>COVID-19</a> is making back to school even more challenging for kids, teachers and parents. Whether in person, online or a hybrid approach, this school year will be different for students and staff. How can you and your child have a healthy mindset for this school year? </p>
<p>On the Mayo Clinic Q&A podcast, <a href='https://www.mayoclinic.org/biographies/sawchuk-craig-n-ph-d-l-p/bio-20085911?mc_id=us&utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.79094737.454056417.1597757197-906239412.1592407173'>Dr. Craig Sawchuk</a>, chair of the Division of Integrated Behavioral Health at Mayo Clinic, shares helpful tips and strategies to be resilient and handle the challenges of a school year during the COVID-19 pandemic. </p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/73833s/Mayo_Clinic_Podcast_-_Dr_Craig_Sawchuk_-_8-10-20btc1b.mp3" length="15611864" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in August, 2020. 
To claim credit visit: https://ce.mayo.edu/covid19podcast 
Guest:  Craig N. Sawchuk, Ph.D., L.P. (@CraigSawchukPhD) 
Host: Halena M. Gazelka, M.D. (@hmgazelkamd) 
The start of a new school year is always a time that’s filled with excitement and anxiety. This year, COVID-19 is making back to school even more challenging for kids, teachers and parents. Whether in person, online or a hybrid approach, this school year will be different for students and staff. How can you and your child have a healthy mindset for this school year? 
On the Mayo Clinic Q&A podcast, Dr. Craig Sawchuk, chair of the Division of Integrated Behavioral Health at Mayo Clinic, shares helpful tips and strategies to be resilient and handle the challenges of a school year during the COVID-19 pandemic. 
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>973</itunes:duration>
                        <itunes:episodeType>bonus</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>COVID-19 Miniseries Episode 49: Mayo Clinic Q &amp; A - COVID-19 Back-To-School Recommendations</title>
        <itunes:title>COVID-19 Miniseries Episode 49: Mayo Clinic Q &amp; A - COVID-19 Back-To-School Recommendations</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/mayo-clinic-q-a-covid-19-back-to-school-recommendations/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/mayo-clinic-q-a-covid-19-back-to-school-recommendations/#comments</comments>        <pubDate>Mon, 31 Aug 2020 06:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/824b6678-f863-3648-a792-af7bf81bb069</guid>
                                    <description><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in August, 2020.</p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Nipunie S. Rajapakse, M.D., M.P.H. <a href='https://twitter.com/nrajapaksemd?lang=en'>(@nrajapakseMD)</a> </p>
<p>Host: Sanjeev (Sanj) Kakar, M.D. (<a href='https://twitter.com/sanjkakar?lang=en'>@sanjkakar</a>)</p>
<p>Whether in person, online or a hybrid model of education, families and school districts are planning for how to safely teach students during the <a href='https://www.mayoclinic.org/diseases-conditions/coronavirus/symptoms-causes/syc-20479963'>COVID-19</a> pandemic. No matter which plan is chosen by communities, this school year will be challenging.</p>
<p>On the Mayo Clinic Q&A podcast, <a href='https://www.mayoclinic.org/biographies/rajapakse-nipunie-s-m-d-m-p-h/bio-20308514'>Dr. Nipunie Rajapakse</a>, a pediatric infectious disease specialist at Mayo Clinic, discusses how students, teachers and staff can use public health measures already in place to minimize the risk of exposure to the virus and reduce community spread of COVID-19.</p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from Mayo Clinic Q&A and was recorded in August, 2020.</p>
<p>To claim credit visit: <a href='https://ce.mayo.edu/covid19podcast'>https://ce.mayo.edu/covid19podcast</a> </p>
<p>Guest:  Nipunie S. Rajapakse, M.D., M.P.H. <a href='https://twitter.com/nrajapaksemd?lang=en'>(@nrajapakseMD)</a> </p>
<p>Host: Sanjeev (Sanj) Kakar, M.D. (<a href='https://twitter.com/sanjkakar?lang=en'>@sanjkakar</a>)</p>
<p>Whether in person, online or a hybrid model of education, families and school districts are planning for how to safely teach students during the <a href='https://www.mayoclinic.org/diseases-conditions/coronavirus/symptoms-causes/syc-20479963'>COVID-19</a> pandemic. No matter which plan is chosen by communities, this school year will be challenging.</p>
<p>On the Mayo Clinic Q&A podcast, <a href='https://www.mayoclinic.org/biographies/rajapakse-nipunie-s-m-d-m-p-h/bio-20308514'>Dr. Nipunie Rajapakse</a>, a pediatric infectious disease specialist at Mayo Clinic, discusses how students, teachers and staff can use public health measures already in place to minimize the risk of exposure to the virus and reduce community spread of COVID-19.</p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nyvqkh/Dr_Rajapaske_Podcast_8-3-20207qd0u.mp3" length="18796551" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Mayo Clinic Q&A and was recorded in August, 2020.
To claim credit visit: https://ce.mayo.edu/covid19podcast 
Guest:  Nipunie S. Rajapakse, M.D., M.P.H. (@nrajapakseMD) 
Host: Sanjeev (Sanj) Kakar, M.D. (@sanjkakar)
Whether in person, online or a hybrid model of education, families and school districts are planning for how to safely teach students during the COVID-19 pandemic. No matter which plan is chosen by communities, this school year will be challenging.
On the Mayo Clinic Q&A podcast, Dr. Nipunie Rajapakse, a pediatric infectious disease specialist at Mayo Clinic, discusses how students, teachers and staff can use public health measures already in place to minimize the risk of exposure to the virus and reduce community spread of COVID-19.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1173</itunes:duration>
                <itunes:episode>186</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/Q_A.jpg" />    </item>
    <item>
        <title>Regenerative Medicine Takes on Hair Loss</title>
        <itunes:title>Regenerative Medicine Takes on Hair Loss</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/platelet-rich-plasma-for-hair-loss/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/platelet-rich-plasma-for-hair-loss/#comments</comments>        <pubDate>Tue, 25 Aug 2020 08:26:10 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/a07f44dc-3c18-3fbe-9893-85c1036e15bc</guid>
                                    <description><![CDATA[<p>Guest: Alison J. Bruce, M.B., Ch.B. & Shane A. Shapiro, M.D. </p>
<p>Host: Amit K. Ghosh, M.D., M.B.A. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>) </p>
<p>Androgenic alopecia can have a significant impact on women across a spectrum of age. The psychological and social impact of hair thinning and hair loss can significantly decrease quality of life. Dr. Alison Bruce breaks down different types of hair loss, who’s a candidate, and new therapies on the horizon. Dr. Shane Shapiro will discuss the application of regenerative medicine to this condition and how platelet rich plasma has demonstrated efficacy at regrowing hair. </p>
<p>Deeper Dive: </p>
<ul><li>A Randomized, Controlled Pilot Trial Comparing Platelet-Rich Plasma to Topical Minoxidil Foam for Treatment of Androgenic Alopecia in Women <a href='https://journals.lww.com/dermatologicsurgery/Fulltext/2020/06000/A_Randomized,_Controlled_Pilot_Trial_Comparing.19.aspx'>doi: 10.1097/DSS.0000000000002168</a> </li>
</ul>
<p>Episode transcript: <a href='https://mcdn.podbean.com/mf/web/d545pv/Ep_185-Regenerative_Medicine_Takes_on_Hair_Loss.pdf'>https://mcdn.podbean.com/mf/web/d545pv/Ep_185-Regenerative_Medicine_Takes_on_Hair_Loss.pdf</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Alison J. Bruce, M.B., Ch.B. & Shane A. Shapiro, M.D. </p>
<p>Host: Amit K. Ghosh, M.D., M.B.A. (<a href='https://twitter.com/AmitGhosh006'>@AmitGhosh006</a>) </p>
<p>Androgenic alopecia can have a significant impact on women across a spectrum of age. The psychological and social impact of hair thinning and hair loss can significantly decrease quality of life. Dr. Alison Bruce breaks down different types of hair loss, who’s a candidate, and new therapies on the horizon. Dr. Shane Shapiro will discuss the application of regenerative medicine to this condition and how platelet rich plasma has demonstrated efficacy at regrowing hair. </p>
<p>Deeper Dive: </p>
<ul><li>A Randomized, Controlled Pilot Trial Comparing Platelet-Rich Plasma to Topical Minoxidil Foam for Treatment of Androgenic Alopecia in Women <a href='https://journals.lww.com/dermatologicsurgery/Fulltext/2020/06000/A_Randomized,_Controlled_Pilot_Trial_Comparing.19.aspx'>doi: 10.1097/DSS.0000000000002168</a> </li>
</ul>
<p>Episode transcript: <a href='https://mcdn.podbean.com/mf/web/d545pv/Ep_185-Regenerative_Medicine_Takes_on_Hair_Loss.pdf'>https://mcdn.podbean.com/mf/web/d545pv/Ep_185-Regenerative_Medicine_Takes_on_Hair_Loss.pdf</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zytrcv/Hair_Loss_in_Women_Treatment_with_Plasma79xfr.mp3" length="45142031" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Alison J. Bruce, M.B., Ch.B. & Shane A. Shapiro, M.D. 
Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006) 
Androgenic alopecia can have a significant impact on women across a spectrum of age. The psychological and social impact of hair thinning and hair loss can significantly decrease quality of life. Dr. Alison Bruce breaks down different types of hair loss, who’s a candidate, and new therapies on the horizon. Dr. Shane Shapiro will discuss the application of regenerative medicine to this condition and how platelet rich plasma has demonstrated efficacy at regrowing hair. 
Deeper Dive: 
A Randomized, Controlled Pilot Trial Comparing Platelet-Rich Plasma to Topical Minoxidil Foam for Treatment of Androgenic Alopecia in Women doi: 10.1097/DSS.0000000000002168 
Episode transcript: https://mcdn.podbean.com/mf/web/d545pv/Ep_185-Regenerative_Medicine_Takes_on_Hair_Loss.pdf 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2810</itunes:duration>
                <itunes:episode>185</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>COVID-19 Miniseries Episode 48: Answers from the Lab - Neutralizing Antibody Assay, Explained</title>
        <itunes:title>COVID-19 Miniseries Episode 48: Answers from the Lab - Neutralizing Antibody Assay, Explained</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-48-neutralizing-antibody-assay-explained/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/covid-19-miniseries-episode-48-neutralizing-antibody-assay-explained/#comments</comments>        <pubDate>Fri, 21 Aug 2020 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/f93537d1-291c-3072-b64e-b20f89295bde</guid>
                                    <description><![CDATA[<p>This episode is shared from <a href='https://news.mayocliniclabs.com/podcast/answers-from-the-lab/'>Answers from the Lab</a> and was originally published June 30, 2020. </p>
<p>Guest: John R. Mills, Ph.D. </p>
<p>Host: Bobbi S. Pritt, M.D. (<a href='https://twitter.com/ParasiteGal'>@ParasiteGal</a>) </p>
<p>John Mills, Ph.D., is the co-director of the Neuroimmunology Laboratory at Mayo Clinic and the scientist who oversaw the development and validation of the new neutralizing antibody assay. Today he joins us to explain what the neutralizing antibody assay is, why it is different than other COVID-19 tests, and the science and innovation behind these efforts. </p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from <a href='https://news.mayocliniclabs.com/podcast/answers-from-the-lab/'>Answers from the Lab</a> and was originally published June 30, 2020. </p>
<p>Guest: John R. Mills, Ph.D. </p>
<p>Host: Bobbi S. Pritt, M.D. (<a href='https://twitter.com/ParasiteGal'>@ParasiteGal</a>) </p>
<p>John Mills, Ph.D., is the co-director of the Neuroimmunology Laboratory at Mayo Clinic and the scientist who oversaw the development and validation of the new neutralizing antibody assay. Today he joins us to explain what the neutralizing antibody assay is, why it is different than other COVID-19 tests, and the science and innovation behind these efforts. </p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/49fa77/NeutralizingAntibodyJohnMills.mp3" length="14365147" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Answers from the Lab and was originally published June 30, 2020. 
Guest: John R. Mills, Ph.D. 
Host: Bobbi S. Pritt, M.D. (@ParasiteGal) 
John Mills, Ph.D., is the co-director of the Neuroimmunology Laboratory at Mayo Clinic and the scientist who oversaw the development and validation of the new neutralizing antibody assay. Today he joins us to explain what the neutralizing antibody assay is, why it is different than other COVID-19 tests, and the science and innovation behind these efforts. 
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>897</itunes:duration>
                <itunes:episode>184</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/AnswersLabIcon.jpg" />    </item>
    <item>
        <title>Answers from the Lab: Future of COVID-19 Laboratory Testing</title>
        <itunes:title>Answers from the Lab: Future of COVID-19 Laboratory Testing</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/answers-from-the-lab-future-of-covid-19-laboratory-testing/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/answers-from-the-lab-future-of-covid-19-laboratory-testing/#comments</comments>        <pubDate>Wed, 19 Aug 2020 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/73462375-0fd6-3317-8b76-6a1a2b874c5f</guid>
                                    <description><![CDATA[<p>This episode is shared from <a href='https://news.mayocliniclabs.com/podcast/answers-from-the-lab/'>Answers from the Lab</a> and was originally published June 25, 2020. </p>
<p>Guest: William G. Morice, II M.D., Ph.D. (<a href='https://twitter.com/moricemdphd'>@moricemdphd</a>) </p>
<p>Host: Bobbi S. Pritt, M.D. (<a href='https://twitter.com/ParasiteGal'>@ParasiteGal</a>) </p>
<p>William Morice, II, M.D., Ph.D., Chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and President of Mayo Clinic Laboratories, joins the Answers from the Lab podcast for his weekly leadership update. In this episode, Dr. Morice discusses the future of testing for COVID-19, predicting who would be at the highest risk for severe disease, and challenges with existing diagnostics. </p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This episode is shared from <a href='https://news.mayocliniclabs.com/podcast/answers-from-the-lab/'>Answers from the Lab</a> and was originally published June 25, 2020. </p>
<p>Guest: William G. Morice, II M.D., Ph.D. (<a href='https://twitter.com/moricemdphd'>@moricemdphd</a>) </p>
<p>Host: Bobbi S. Pritt, M.D. (<a href='https://twitter.com/ParasiteGal'>@ParasiteGal</a>) </p>
<p>William Morice, II, M.D., Ph.D., Chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and President of Mayo Clinic Laboratories, joins the Answers from the Lab podcast for his weekly leadership update. In this episode, Dr. Morice discusses the future of testing for COVID-19, predicting who would be at the highest risk for severe disease, and challenges with existing diagnostics. </p>
<p>AskMayoExpert COVID-19 Resources: <a href='https://askmayoexpert.mayoclinic.org/navigator/COVID-19'>https://askmayoexpert.mayoclinic.org/navigator/COVID-19</a> </p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dprq3k/FutureMorice625.mp3" length="12788283" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This episode is shared from Answers from the Lab and was originally published June 25, 2020. 
Guest: William G. Morice, II M.D., Ph.D. (@moricemdphd) 
Host: Bobbi S. Pritt, M.D. (@ParasiteGal) 
William Morice, II, M.D., Ph.D., Chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and President of Mayo Clinic Laboratories, joins the Answers from the Lab podcast for his weekly leadership update. In this episode, Dr. Morice discusses the future of testing for COVID-19, predicting who would be at the highest risk for severe disease, and challenges with existing diagnostics. 
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>797</itunes:duration>
                        <itunes:episodeType>bonus</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog5789954/AnswersLabIcon.jpg" />    </item>
    <item>
        <title>Sorting Out Knee Pain and Treatment Opportunities</title>
        <itunes:title>Sorting Out Knee Pain and Treatment Opportunities</itunes:title>
        <link>https://mayoclinictalks.podbean.com/e/sorting-out-knee-pain-and-treatment-opportunities/</link>
                    <comments>https://mayoclinictalks.podbean.com/e/sorting-out-knee-pain-and-treatment-opportunities/#comments</comments>        <pubDate>Tue, 18 Aug 2020 04:00:00 -0500</pubDate>
        <guid isPermaLink="false">mayoclinictalks.podbean.com/3a45d729-3343-37f3-9491-0973cc5a0670</guid>
                                    <description><![CDATA[<p>Guest: Daniel B. Saris, M.D., Ph.D. (<a href='https://twitter.com/sarisnl?lang=en'>@sarisnl</a>) </p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD?lang=en'>@ChutkaMD</a>) </p>
<p>With over 12 million outpatient visits annually in association with knee pain, it’s a common presentation in primary care. Dr. Daniel Saris discusses what questions we should be asking our patients, when to order imaging studies, and the common causes of pain broken down by age demographic. He’ll also discuss stem cell therapy, who is a good candidate, and who isn’t. </p>
<p>Episode transcript: <a href='https://mcdn.podbean.com/mf/web/cjj292/Ep_183-Sorting_Out_Knee_Pain_and_Treatment_Opportunities.pdf'>https://mcdn.podbean.com/mf/web/cjj292/Ep_183-Sorting_Out_Knee_Pain_and_Treatment_Opportunities.pdf</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Guest: Daniel B. Saris, M.D., Ph.D. (<a href='https://twitter.com/sarisnl?lang=en'>@sarisnl</a>) </p>
<p>Host: Darryl S. Chutka, M.D. (<a href='https://twitter.com/ChutkaMD?lang=en'>@ChutkaMD</a>) </p>
<p>With over 12 million outpatient visits annually in association with knee pain, it’s a common presentation in primary care. Dr. Daniel Saris discusses what questions we should be asking our patients, when to order imaging studies, and the common causes of pain broken down by age demographic. He’ll also discuss stem cell therapy, who is a good candidate, and who isn’t. </p>
<p>Episode transcript: <a href='https://mcdn.podbean.com/mf/web/cjj292/Ep_183-Sorting_Out_Knee_Pain_and_Treatment_Opportunities.pdf'>https://mcdn.podbean.com/mf/web/cjj292/Ep_183-Sorting_Out_Knee_Pain_and_Treatment_Opportunities.pdf</a></p>
<p>Connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/e36sq5/182KneePainSaris.mp3" length="24695669" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Guest: Daniel B. Saris, M.D., Ph.D. (@sarisnl) 
Host: Darryl S. Chutka, M.D. (@ChutkaMD) 
With over 12 million outpatient visits annually in association with knee pain, it’s a common presentation in primary care. Dr. Daniel Saris discusses what questions we should be asking our patients, when to order imaging studies, and the common causes of pain broken down by age demographic. He’ll also discuss stem cell therapy, who is a good candidate, and who isn’t. 
Episode transcript: https://mcdn.podbean.com/mf/web/cjj292/Ep_183-Sorting_Out_Knee_Pain_and_Treatment_Opportunities.pdf
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. ]]></itunes:summary>
        <itunes:author>Mayo Clinic</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1543</itunes:duration>
                <itunes:episode>183</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
</channel>
</rss>
